PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	de Paula, LCM; Soares, AS; de Lima, TW; Delbem, ACB; Coelho, CJ; Filho, ARG				de Paula, Lauro C. M.; Soares, Anderson S.; de Lima, Telma W.; Delbem, Alexandre C. B.; Coelho, Clarimar J.; Filho, Arlindo R. G.			A GPU-Based Implementation of the Firefly Algorithm for Variable Selection in Multivariate Calibration Problems	PLOS ONE			English	Article							REGRESSION; DESIGN	Several variable selection algorithms in multivariate calibration can be accelerated using Graphics Processing Units (GPU). Among these algorithms, the Firefly Algorithm (FA) is a recent proposed metaheuristic that may be used for variable selection. This paper presents a GPU-based FA (FA-MLR) with multiobjective formulation for variable selection in multivariate calibration problems and compares it with some traditional sequential algorithms in the literature. The advantage of the proposed implementation is demonstrated in an example involving a relatively large number of variables. The results showed that the FA-MLR, in comparison with the traditional algorithms is a more suitable choice and a relevant contribution for the variable selection problem. Additionally, the results also demonstrated that the FA-MLR performed in a GPU can be five times faster than its sequential implementation.	[de Paula, Lauro C. M.; Soares, Anderson S.; de Lima, Telma W.] Fed Univ Goias UFG, Inst Informat, Goiania, Go, Brazil; [Delbem, Alexandre C. B.] Univ Sao Paulo, Inst Math Sci & Comp, Sao Carlos, SP, Brazil; [Coelho, Clarimar J.] Pontifical Catholic Univ Goias PUC Goias, Dept Comp Sci, Goiania, Go, Brazil; [Filho, Arlindo R. G.] Technol Inst Aeronaut ITA, Dept Syst & Control, Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Goias; Universidade de Sao Paulo; Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA)	Soares, AS (corresponding author), Fed Univ Goias UFG, Inst Informat, Goiania, Go, Brazil.	engsoares@gmail.com	da Silva Soares, Anderson/AAU-9878-2020; de Paula, Lauro Cássio Martins/F-5359-2014; Filho, Arlindo Rodrigues Galvão/S-8442-2019; Coelho, Clarimar/C-8044-2019; de Lima, Telma W./B-6172-2013; Delbem, Alexandre C B/A-9287-2008	da Silva Soares, Anderson/0000-0002-2967-6077; de Paula, Lauro Cássio Martins/0000-0002-0546-0685; Filho, Arlindo Rodrigues Galvão/0000-0003-2151-8039; Coelho, Clarimar/0000-0002-5163-2986; Delbem, Alexandre C B/0000-0003-1810-1742; Soares, Telma/0000-0002-4927-2221	research agency CAPES; research agency FAPEG; research agency FAPESP; research agency CNPq	research agency CAPES; research agency FAPEG; research agency FAPESP; research agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	The authors thank the research agencies CAPES, FAPEG, FAPESP and CNPq for the support provided to this research. This is also a contribution of the National Institute of Advanced Analytical Science and Technology (INCTAA) (CNPq - proc. no. 573894/2008-6 and FAPESP proc. no. 2008/57808-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054540; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Anderson da Silva Soares AdS, 2013, COMPUTER TECHNOLOGY, V4, P465; Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Banati H, 2011, INT J COMPUT SCI, V8, P473; Bartoli A, 2009, INT J COMPUT VISION, V85, P133, DOI 10.1007/s11263-009-0253-x; Beebe KR, 1998, WILEY INTERSCIENCE S; Box G.E., 2013, TIME SERIES ANAL FOR; Bradstreet RB, 1965, KJELDAHL METHOD ORGA; BROWN SD, 1994, ANAL CHEM, V66, pR315, DOI 10.1021/ac00084a014; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chau FT, 2004, CHEMOMETRICS BASICS, V234; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; CORTINA JM, 1993, J MANAGE, V19, P915, DOI 10.1016/0149-2063(93)90035-L; CUDA N, 2011, NVIDIA CUDA C PROGR; de Lucena Daniel Vitor, 2012, International Journal of Natural Computing Research, V3, P43, DOI 10.4018/jncr.2012100103; de Lucena DV, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1053; Ferreira MMC, 1999, QUIM NOVA, V22, P724, DOI 10.1590/S0100-40421999000500016; Galvao AR, 2011, J BRAZIL CHEM SOC, V22, P2225, DOI 10.1590/S0103-50532011001100029; Galvao RKH, 2008, CHEMOMETR INTELL LAB, V92, P83, DOI 10.1016/j.chemolab.2007.12.004; Gandomi AH, 2011, COMPUT STRUCT, V89, P2325, DOI 10.1016/j.compstruc.2011.08.002; George EI, 2000, J AM STAT ASSOC, V95, P1304, DOI 10.2307/2669776; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hibon M, 1995, EVALUATING ACCURACY; Husselmann A, 2014, STUDIES COMPUTATIONA, V516, P245, DOI [10.1007/978-3-319-02141-6_12, DOI 10.1007/978-3-319-02141-6_12]; Husselmann AV, 2012, P INT C GEN EV METH, P77; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Lawson CL, 1974, SOLVING LEAST SQUARE; Little J, MATLAB GPU COMPUTING; Liu XW, 2013, LECT NOTES ELECTR EN, V255, P251, DOI 10.1007/978-3-642-38460-8_28; Luebke D, 2007, COMPUTER, V40, P96, DOI 10.1109/MC.2007.59; Lukasik S, 2009, LECT NOTES ARTIF INT, V5796, P97; Martens H., 1989, MULTIVARIATE CALIBRA; MathWorks, MATL GPU COMP SUPP N; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Paula LCM, 2013, INT C PAR DISTR PROC, P737; Reese J, GPU PROGRAMMING MATL; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Soares AS, 2014, ELECTRON LETT, V50, P932, DOI 10.1049/el.2013.3284; Soares AD, 2010, J BRAZIL CHEM SOC, V21, P1626, DOI 10.1590/S0103-50532010000900005; Soares AS, 2013, ELECTRON LETT, V49, P80; Tarpey T, 2000, AM STAT, V54, P116, DOI 10.2307/2686028; Tobias RD., 1995, P 20 ANN SAS US GROU, P1250; Tsuchiyama R., 2010, OPENCL PROGRAMMING B; Westad F, 2000, J NEAR INFRARED SPEC, V8, P117, DOI 10.1255/jnirs.271; Yang X.S., 2013, IJSI, V1, P36, DOI [10.1504/IJSI.2013.055801, DOI 10.1504/IJSI.2013.055801]; Yang X.-S., 2008, NATURE INSPIRED META; Yang XS, 2010, INT J BIO-INSPIR COM, V2, P78, DOI 10.1504/IJBIC.2010.032124; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14	55	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114145	10.1371/journal.pone.0114145	http://dx.doi.org/10.1371/journal.pone.0114145			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493625	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400033
J	Miller, TE; Wang, J; Sukhdeo, K; Horbinski, C; Tesar, PJ; Wechsler-Reya, RJ; Rich, JN				Miller, Tyler E.; Wang, Jun; Sukhdeo, Kumar; Horbinski, Craig; Tesar, Paul J.; Wechsler-Reya, Robert J.; Rich, Jeremy N.			Lgr5 Marks Post-Mitotic, Lineage Restricted Cerebellar Granule Neurons during Postnatal Development	PLOS ONE			English	Article							STEM-CELLS; MOUSE; GENE; PROLIFERATION; RECEPTORS; DIFFERENTIATION; IDENTIFICATION; PROGENITORS; PRECURSORS; COCHLEA	Wnt signaling regulates self-renewal and fate commitment of stem and progenitor cells in development and homeostasis. Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) is a co-receptor for Wnt signaling that marks highly proliferative stem and progenitor cells in many epithelial tissue types. Wnt signaling instructs neural developmental and homeostatic processes; however, Lgr5 expression in the developing and adult brain has not been characterized. Here we report that Lgr5 is expressed in the postnatal cerebellum during the maturation and synaptogenesis of cerebellar granule neurons (CGNs), processes controlled by Wnt signaling. Using a transgenic reporter mouse for in vivo Lgr5 expression analysis and lineage tracing, we reveal that Lgr5 specifically identified CGNs and was restricted temporally to the CGN maturation phase within the internal granule layer, but absent in the adult brain. Cells marked by Lgr5 were lineage restricted, post-mitotic and long-lived. The ligand for Lgr5, R-spondin, was secreted in a paracrine fashion that evolved during the maturation of CGNs, which coincided with the Lgr5 expression pattern. Our findings provide potential new insight into the critical regulation of Wnt signaling in the developing cerebellum and support a novel role for Lgr5 in the regulation of post-mitotic cells.	[Miller, Tyler E.; Sukhdeo, Kumar; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Miller, Tyler E.; Sukhdeo, Kumar] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Jun; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Horbinski, Craig] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY USA; [Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Rich, Jeremy N.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; Sanford Burnham Prebys Medical Discovery Institute; University of Kentucky; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Rich, JN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.	richj@ccf.org	Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014; Rich, Jeremy/AAM-1445-2021	Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Sukhdeo, Kumar/0000-0001-8725-6081; Miller, Tyler E/0000-0002-1269-1895	National Institutes of Health (NIH) [CA154130, CA169117, CA171652, NS087913, NS089272, CA122759, CA159859]; James S. McDonnell Foundation; NIH [T32 GM007250]; NCI [F30 CA183510, F30 CA165857]; NATIONAL CANCER INSTITUTE [R01CA169117, R01CA159859, R01CA154130, R01CA122759, R01CA171652, F30CA183510, K08CA155764, P30CA177558, F30CA165857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087913, R01NS089272] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was in part funded by National Institutes of Health (NIH) grants: CA154130, CA169117, CA171652, NS087913, NS089272 (JNR), CA122759, CA159859 (RJWR) and the James S. McDonnell Foundation (JNR). TEM and KS were supported in part by NIH grant T32 GM007250 to the CWRU MSTP. TEM was funded by NCI F30 CA183510. KS was funded by NCI F30 CA165857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Institute for BrainScience, 2012, ALL DEV MOUS BRAIN A; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dickins EM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00162; Ding BJ, 2013, J NEUROSCI, V33, P2860, DOI 10.1523/JNEUROSCI.3533-12.2013; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Kilpatrick DL, 2012, CEREBELLUM, V11, P41, DOI 10.1007/s12311-010-0227-0; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Sukhdeo K, 2014, EXP EYE RES, V119, P106, DOI 10.1016/j.exer.2013.11.003; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	29	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114433	10.1371/journal.pone.0114433	http://dx.doi.org/10.1371/journal.pone.0114433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493560	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400046
J	Bauer, E; Salem, H; Marz, M; Vogel, H; Kaltenpoth, M				Bauer, Eugen; Salem, Hassan; Marz, Manja; Vogel, Heiko; Kaltenpoth, Martin			Transcriptomic Immune Response of the Cotton Stainer Dysdercus fasciatus to Experimental Elimination of Vitamin-Supplementing Intestinal Symbionts	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; MICROBE MUTUALISM; HOST-DEFENSE; WEB SERVER; INSECT; RNA; TRANSMISSION; HEMIPTERA; BACTERIUM; ALIGNMENT	The acquisition and vertical transmission of bacterial symbionts plays an important role in insect evolution and ecology. However, the molecular mechanisms underlying the stable maintenance and control of mutualistic bacteria remain poorly understood. The cotton stainer Dysdercus fasciatus harbours the actinobacterial symbionts Coriobacterium glomerans and Gordonibacter sp. in its midgut. The symbionts supplement limiting B vitamins and thereby significantly contribute to the host's fitness. In this study, we experimentally disrupted the symbionts' vertical transmission route and performed comparative transcriptomic analyses of genes expressed in the gut of aposymbiotic (symbiont-free) and control individuals to study the host immune response in presence and absence of the mutualists. Annotation of assembled cDNA reads identified a considerable number of genes involved in the innate immune system, including different protein isoforms of several immune effector proteins (specifically i-type lysozyme, defensin, hemiptericin, and pyrrhocoricin), suggesting the possibility for a highly differentiated response towards the complex resident microbial community. Gene expression analyses revealed a constitutive expression of transcripts involved in signal transduction of the main insect immune pathways, but differential expression of certain antimicrobial peptide genes. Specifically, qPCRs confirmed the significant down-regulation of c-type lysozyme and up-regulation of hemiptericin in aposymbiotic individuals. The high expression of c-type lysozyme in symbiont-containing bugs may serve to lyse symbiont cells and thereby harvest B-vitamins that are necessary for subsistence on the deficient diet of Malvales seeds. Our findings suggest a sophisticated host response to perturbation of the symbiotic gut microbiota, indicating that the innate immune system not only plays an important role in combating pathogens, but also serves as a communication interface between host and symbionts.	[Bauer, Eugen; Salem, Hassan; Kaltenpoth, Martin] Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, D-07745 Jena, Germany; [Marz, Manja] Univ Jena, Fac Math & Comp Sci, D-07743 Jena, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society; Friedrich Schiller University of Jena; Max Planck Society	Kaltenpoth, M (corresponding author), Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, D-07745 Jena, Germany.	mkaltenpoth@ice.mpg.de	Kaltenpoth, Martin/M-8475-2014; Bauer, Eugen/L-1837-2019	Kaltenpoth, Martin/0000-0001-9450-0345; Marz, Manja/0000-0003-4783-8823; Salem, Hassan/0000-0002-4135-7407	Max Planck Society; German Science Foundation [MA5082-1/1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG))	This study was funded by the Max Planck Society, www.mpg.de (EB, HS, HV, MK) and the German Science Foundation, MA5082-1/1, www. dfg. de (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; COCIANCICH S, 1994, BIOCHEM J, V300, P567, DOI 10.1042/bj3000567; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2009, FEMS MICROBIOL ECOL, V69, P373, DOI 10.1111/j.1574-6941.2009.00722.x; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kim JK, 2013, APPL ENVIRON MICROB, V79, P7229, DOI 10.1128/AEM.02152-13; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Moran NA, 2006, MOL ECOL, V15, P1251, DOI 10.1111/j.1365-294X.2005.02744.x; Muraille E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003203; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Salem H, P ROY SOC B UNPUB; Salem H, 2013, ENVIRON MICROBIOL, V15, P1956, DOI 10.1111/1462-2920.12001; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	40	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114865	10.1371/journal.pone.0114865	http://dx.doi.org/10.1371/journal.pone.0114865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490201	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300087
J	Sugimoto, K; Ohkawara, H; Nakamura, Y; Takuwa, Y; Ishibashi, T; Takeishi, Y				Sugimoto, Koichi; Ohkawara, Hiroshi; Nakamura, Yuichi; Takuwa, Yoh; Ishibashi, Toshiyuki; Takeishi, Yasuchika			Receptor for Advanced Glycation End Products - Membrane Type1 Matrix Metalloproteinase Axis Regulates Tissue Factor Expression via RhoA and Rac1 Activation in High-Mobility Group Box-1 Stimulated Endothelial Cells	PLOS ONE			English	Article							KAPPA-B; PROTEIN; ADHESION; BLOCKADE; MT1-MMP; RELEASE; HMGB1	Background: Atherosclerosis is understood to be a blood vessel inflammation. High-mobility group box-1 (HMGB-1) plays a key role in the systemic inflammation. Tissue factor (TF) is known to lead to inflammation which promotes thrombus formation. Membrane type1 matrix metalloprotease (MT1-MMP) associates with advanced glycation endproducts (AGE) triggered-TF protein expression and phosphorylation of NF-kappa B. However, it is still unclear about the correlation of MT1-MMP and HMBG-1-mediated TF expression. In this study, we investigated the molecular mechanisms of TF expression in response to HMGB-1 stimulation and the involvement of MT1-MMP in endothelial cells. Methods and Results: Pull-down assays and Western blotting revealed that HMGB-1 induced RhoA/Rac1 activation and NF-kappa B phosphorylation in cultured human aortic endothelial cells. HMGB-1 increased the activity of MT1-MMP, and inhibition of RAGE or MT1-MMP by siRNA suppressed HMGB-1-induced TF upregulation as well as HMGB-1-triggered RhoA/Rac1 activation and NF-kappa B phosphorylation. Conclusions: The present study showed that RAGE/MT1-MMP axis modified HMBG-1-mediated TF expression through RhoA and Rac1 activation and NF-kappa B phosphorylation in endothelial cells. These results suggested that MT1-MMP was involved in vascular inflammation and might be a good target for treating atherosclerosis.	[Sugimoto, Koichi; Ohkawara, Hiroshi; Nakamura, Yuichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Takuwa, Yoh] Kanazawa Univ, Grad Sch Med, Dept Physiol, Kanazawa, Ishikawa, Japan; [Ishibashi, Toshiyuki] Ohara Gen Hosp, Fukushima, Japan	Fukushima Medical University; Kanazawa University	Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	ksugi@fmu.ac.jp		Ohkawara, Hiroshi/0000-0002-3129-1977	Japan Society for the Promotion of Science [22790718]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (No. 22790718 to KS) (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2011, J ATHEROSCLER THROMB, V18, P762, DOI 10.5551/jat.6783; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Furlani D, 2012, J CELL MOL MED, V16, P1094, DOI 10.1111/j.1582-4934.2011.01381.x; Gregg D, 2003, AM J PHYSIOL-CELL PH, V285, pC723, DOI 10.1152/ajpcell.00230.2003; Ishibashi T, 2003, ARTERIOSCL THROM VAS, V23, P681, DOI 10.1161/01.ATV.0000065194.00822.C7; Kamioka M, 2011, J CELL PHYSIOL, V226, P1554, DOI 10.1002/jcp.22492; Kamioka M, 2010, J ATHEROSCLER THROMB, V17, P590, DOI 10.5551/jat.3624; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lv B, 2009, THROMB HAEMOSTASIS, V102, P352, DOI 10.1160/TH08-11-0759; Meneghini V, 2013, J NEUROSCI, V33, P6047, DOI 10.1523/JNEUROSCI.2052-12.2013; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; Sakamoto T, 2007, ATHEROSCLEROSIS, V193, P44, DOI 10.1016/j.atherosclerosis.2006.08.036; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Yokoyama K, 2002, CIRCULATION, V105, P962, DOI 10.1161/hc0802.104457	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114429	10.1371/journal.pone.0114429	http://dx.doi.org/10.1371/journal.pone.0114429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490770	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300041
J	Cilli, D; Mirasole, C; Pennisi, R; Pallotta, V; D'Alessandro, A; Antoccia, A; Zolla, L; Ascenzi, P; di Masi, A				Cilli, Domenica; Mirasole, Cristiana; Pennisi, Rosa; Pallotta, Valeria; D'Alessandro, Angelo; Antoccia, Antonio; Zolla, Lello; Ascenzi, Paolo; di Masi, Alessandra			Identification of the Interactors of Human Nibrin (NBN) and of Its 26 kDa and 70 kDa Fragments Arising from the NBN 657del5 Founder Mutation	PLOS ONE			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND-BREAK; DNA-DAMAGE RESPONSE; DISTINCT FUNCTIONAL DOMAINS; DEPENDENT PROTEIN-KINASE; ATAXIA-TELANGIECTASIA; OXIDATIVE STRESS; ATM ACTIVATION; DEFECTIVE RESPONSE; REPAIR PROTEIN	Nibrin (also named NBN or NBS1) is a component of the MRE11/RAD50/NBN complex, which is involved in early steps of DNA double strand breaks sensing and repair. Mutations within the NBN gene are responsible for the Nijmegen breakage syndrome (NBS). The 90% of NBS patients are homozygous for the 657del5 mutation, which determines the synthesis of two truncated proteins of 26 kDa (p26) and 70 kDa (p70). Here, HEK293 cells have been exploited to transiently express either the full-length NBN protein or the p26 or p70 fragments, followed by affinity chromatography enrichment of the eluates. The application of an unsupervised proteomics approach, based upon SDS-PAGE separation and shotgun digestion of protein bands followed by MS/MS protein identification, indicates the occurrence of previously unreported protein interacting partners of the full-length NBN protein and the p26 fragment containing the FHA/BRCT1 domains, especially after cell irradiation. In particular, results obtained shed light on new possible roles of NBN and of the p26 fragment in ROS scavenging, in the DNA damage response, and in protein folding and degradation. In particular, here we show that p26 interacts with PARP1 after irradiation, and this interaction exerts an inhibitory effect on PARP1 activity as measured by NAD+ levels. Furthermore, the p26-PARP1 interaction seems to be responsible for the persistence of ROS, and in turn of DSBs, at 24 h from IR. Since some of the newly identified interactors of the p26 and p70 fragments have not been found to interact with the full-length NBN, these interactions may somehow contribute to the key biological phenomena underpinning NBS.	[Cilli, Domenica; Pennisi, Rosa; Antoccia, Antonio; di Masi, Alessandra] Roma Tre Univ, Dept Sci, Rome, Italy; [Mirasole, Cristiana; Pallotta, Valeria; D'Alessandro, Angelo; Zolla, Lello] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Antoccia, Antonio; Ascenzi, Paolo; di Masi, Alessandra] Consorzio Interuniv, Ist Nazl Biostrut & Biosistemi, Rome, Italy; [Ascenzi, Paolo] Roma Tre Univ, Interdept Lab Electron Microscopy, Rome, Italy	Italfarmaco; Roma Tre University; Tuscia University; Roma Tre University	di Masi, A (corresponding author), Roma Tre Univ, Dept Sci, Rome, Italy.	alessandra.dimasi@uniroma3.it	Pennisi, Rosa/AAQ-7868-2020; di Masi, Alessandra/K-2300-2018; D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Pennisi, Rosa/0000-0001-6542-7898	University Roma Tre (CAL); Italian National Blood Centre (Rome, Italy); Interuniversity Consortium for Biotechnologies (CIB, Italy)	University Roma Tre (CAL); Italian National Blood Centre (Rome, Italy); Interuniversity Consortium for Biotechnologies (CIB, Italy)	Funding: This work was partially supported by grants University Roma Tre (CAL 2012, to AdM). CM, VP, AD and LZ are supported by funds from the Italian National Blood Centre (Rome, Italy). AD acknowledges financial support for a post-doctoral studentship granted by the Interuniversity Consortium for Biotechnologies (CIB, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Antoccia A, 2008, RADIAT RES, V170, P345, DOI 10.1667/RR1357.1; Antoccia A, 2006, GENOME DYN, V1, P191, DOI 10.1159/000092508; Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Bansal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026156; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Becker E, 2006, BIOINFORMATICS, V22, P1289, DOI 10.1093/bioinformatics/btl075; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Brown ML, 2002, P NATL ACAD SCI USA, V99, P4532, DOI 10.1073/pnas.072495299; Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti KM, 2000, MUTAGENESIS, V15, P281, DOI 10.1093/mutage/15.3.281; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen WC, 2002, J NEUROSCI RES, V70, P794, DOI 10.1002/jnr.10435; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; di Masi A, 2013, ADV GENOME SCI PROBI, P101; di Masi A, 2012, CURR TOP BIOCH RES, V14, P73; di Masi A, 2008, CURR GENOMICS, V9, P275, DOI 10.2174/138920208784533610; di Masi A, 2008, BIOCHEM BIOPH RES CO, V369, P835, DOI 10.1016/j.bbrc.2008.02.129; di Masi A, 2011, IUBMB LIFE, V63, P503, DOI 10.1002/iub.472; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Dodson GE, 2010, CELL CYCLE, V9, P1516, DOI 10.4161/cc.9.8.11260; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gatei M, 2000, CANCER RES, V60, P3299; Grobelny JV, 2000, J CELL SCI, V113, P4577; Gullotta F, 2010, CURR MED CHEM, V17, P2017, DOI 10.2174/092986710791233698; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hari FJ, 2010, EMBO REP, V11, P387, DOI 10.1038/embor.2010.30; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Iijima K, 2008, J RADIAT RES, V49, P451, DOI 10.1269/jrr.08065; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Kaplan KB, 2012, TRENDS CELL BIOL, V22, P576, DOI 10.1016/j.tcb.2012.08.006; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krenzlin H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002557; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; LEE CG, 1993, J BIOL CHEM, V268, P16822; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li BJ, 2004, GENE DEV, V18, P1824, DOI 10.1101/gad.1223504; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Maselli J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098616; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Melchers A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005423; Mendez G, 2012, IUBMB LIFE, V64, P853, DOI 10.1002/iub.1077; Naka K, 2002, BIOCHEM BIOPH RES CO, V299, P863, DOI 10.1016/S0006-291X(02)02755-9; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Negorev D, 2013, CANCER RES, V73, P4960, DOI 10.1158/0008-5472.CAN-13-1715; Pesciotta EN, 2012, J PROTEOMICS, V76, P194, DOI 10.1016/j.jprot.2012.08.010; Pluth JM, 2008, DNA REPAIR, V7, P108, DOI 10.1016/j.dnarep.2007.08.004; Porcedda P, 2006, DNA REPAIR, V5, P904, DOI 10.1016/j.dnarep.2006.05.002; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Rolli V., 2000, DNA DAMAGE STRESS SI, P35; Rupnik A, 2010, CHROMOSOMA, V119, P115, DOI 10.1007/s00412-009-0242-4; Sagan D, 2009, CARCINOGENESIS, V30, P408, DOI 10.1093/carcin/bgp004; Salewsky B, 2013, GENE, V519, P217, DOI 10.1016/j.gene.2013.02.033; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Seemanova E, 2006, J MED GENET, V43, P218, DOI 10.1136/jmg.2005.035287; Seidman C E, 2001, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0108s37; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stracker TH, 2007, NATURE, V447, P218, DOI 10.1038/nature05740; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wen J, 2013, ONCOGENE, V32, P4448, DOI 10.1038/onc.2012.443; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Yeager TR, 1999, CANCER RES, V59, P4175; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424; Zhao H, 2008, CELL CYCLE, V7, P1490, DOI 10.4161/cc.7.10.5963; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	128	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114651	10.1371/journal.pone.0114651	http://dx.doi.org/10.1371/journal.pone.0114651			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485873	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600082
J	Ezure, T; Nanatani, K; Sato, Y; Suzuki, S; Aizawa, K; Souma, S; Ito, M; Hohsaka, T; von Heijine, G; Utsumi, T; Abe, K; Ando, E; Uozumi, N				Ezure, Toru; Nanatani, Kei; Sato, Yoko; Suzuki, Satomi; Aizawa, Keishi; Souma, Satoshi; Ito, Masaaki; Hohsaka, Takahiro; von Heijine, Gunnar; Utsumi, Toshihiko; Abe, Keietsu; Ando, Eiji; Uozumi, Nobuyuki			A Cell-Free Translocation System Using Extracts of Cultured Insect Cells to Yield Functional Membrane Proteins	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; ASPARTATE-ALANINE ANTIPORTER; NONNATURAL AMINO-ACIDS; FREE TRANSLATION; TETRAGENOCOCCUS-HALOPHILUS; EFFICIENT INCORPORATION; MICROSOMAL-MEMBRANES; MESSENGER-RNA; TOPOLOGY; ASPT	Cell-free protein synthesis is a powerful method to explore the structure and function of membrane proteins and to analyze the targeting and translocation of proteins across the ER membrane. Developing a cell-free system based on cultured cells for the synthesis of membrane proteins could provide a highly reproducible alternative to the use of tissues from living animals. We isolated Sf21 microsomes from cultured insect cells by a simplified isolation procedure and evaluated the performance of the translocation system in combination with a cell-free translation system originating from the same source. The isolated microsomes contained the basic translocation machinery for polytopic membrane proteins including SRP-dependent targeting components, translocation channel (translocon)-dependent translocation, and the apparatus for signal peptide cleavage and N-linked glycosylation. A transporter protein synthesized with the cell-free system could be functionally reconstituted into a lipid bilayer. In addition, single and double labeling with non-natural amino acids could be achieved at both the lumen side and the cytosolic side in this system. Moreover, tail-anchored proteins, which are post-translationally integrated by the guided entry of tail-anchored proteins (GET) machinery, were inserted correctly into the microsomes. These results showed that the newly developed cell-free translocation system derived from cultured insect cells is a practical tool for the biogenesis of properly folded polytopic membrane proteins as well as tail-anchored proteins.	[Nanatani, Kei; Sato, Yoko; Aizawa, Keishi; Souma, Satoshi; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Mol Engn, Sendai, Miyagi 980, Japan; [Ezure, Toru; Ito, Masaaki; Ando, Eiji] Shimadzu Co Ltd, Clin & Biotechnol BU, Kyoto, Japan; [Suzuki, Satomi; Abe, Keietsu] Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Sendai, Miyagi 980, Japan; [Hohsaka, Takahiro] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa, Japan; [von Heijine, Gunnar] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Utsumi, Toshihiko] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan	Tohoku University; Shimadzu Corporation; Tohoku University; Japan Advanced Institute of Science & Technology (JAIST); Stockholm University; Yamaguchi University	Ezure, T (corresponding author), Shimadzu Co Ltd, Clin & Biotechnol BU, Kyoto, Japan.	ezure@shimadzu.co.jp; uozumi@biophy.che.tohoku.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019	Uozumi, Nobuyuki/0000-0003-4268-1126	Ministry of Education, Culture, Sports, Science, and Technology [24580100, 24246045, 24658090, 25292055]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency [AS2314135E]; Grants-in-Aid for Scientific Research [26450125, 25102006, 13J03082] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (24580100 to KN, 24246045, 24658090 and 25292055 to NU) from the Ministry of Education, Culture, Sports, Science, and Technology, and AS2314135E Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency to TE, KN, YS, EA, and NU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; CHEN HZ, 1983, METHOD ENZYMOL, V101, P674; Denic V, 2013, COLD SPRING HARBOR P, V5; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Ezure T, 2007, PROTEOMICS, V7, P4424, DOI 10.1002/pmic.200700774; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; GASIOR E, 1979, J BIOL CHEM, V254, P3965; Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Kajihara D, 2006, NAT METHODS, V3, P923, DOI 10.1038/NMETH945; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Moriya K, 2013, PLOS ONE, V8; Nanatani K, 2005, BIOCHEM BIOPH RES CO, V328, P20, DOI 10.1016/j.bbrc.2004.12.133; Nanatani K, 2007, J BACTERIOL, V189, P7089, DOI 10.1128/JB.00088-07; Nanatani K, 2009, J BACTERIOL, V191, P2122, DOI 10.1128/JB.00830-08; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ota K, 1998, J BIOL CHEM, V273, P28286, DOI 10.1074/jbc.273.43.28286; Sasahara A, 2011, J BIOL CHEM, V286, P29044, DOI 10.1074/jbc.M111.260224; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Sato Y, 2012, J BIOSCI BIOENG, V114, P677, DOI 10.1016/j.jbiosc.2012.06.015; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; SCHEELE G, 1983, METHOD ENZYMOL, V96, P94; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SWERDEL MR, 1989, COMP BIOCHEM PHYS B, V93, P803, DOI 10.1016/0305-0491(89)90049-7; Taki M, 2006, J BIOSCI BIOENG, V102, P511, DOI 10.1263/jbb.102.511; Utsumi T, 2005, FEBS J, V272, P472, DOI 10.1111/j.1742-4658.2004.04487.x; UTSUMI T, 1995, MOL CELL BIOL, V15, P6398; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028	32	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112874	10.1371/journal.pone.0112874	http://dx.doi.org/10.1371/journal.pone.0112874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486605	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600012
J	Hara, K; Shirasuna, K; Usul, F; Karasawa, T; Mizushina, Y; Kimura, H; Kawashima, A; Ohkuchi, A; Matsuyama, S; Kimura, K; Takahashi, M				Hara, Kyoko; Shirasuna, Koumei; Usul, Fumitake; Karasawa, Tadayoshi; Mizushina, Yoshiko; Kimura, Hiroaki; Kawashima, Akira; Ohkuchi, Akihide; Matsuyama, Shuichi; Kimura, Koji; Takahashi, Masafumi			Interferon-Tau Attenuates Uptake of Nanoparticles and Secretion of Interleukin-1 beta in Macrophages	PLOS ONE			English	Article							IFN-TAU; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; MYOCARDIAL-INFARCTION; MICE; ACTIVATION; CELLS; ENCEPHALOMYELITIS; CASPASE-1; CRYSTALS	Background: Type I interferons (IFNs), including IFN-alpha (IFNA) and IFN-beta (IFNB), have anti-inflammatory properties and are used to treat patients with autoimmune and inflammatory disorders. However, little is known of the role of IFN-tau (IFNT), a type I IFN produced by ruminant animals for inflammation. Because IFNB has recently been shown to inhibit nucleotide-binding oligomerization domain-like receptor, pyrin domain-containing 3 (NLRP3) inflammasome activation and subsequent secretion of the potent inflammatory cytokine interleukin (IL)-1 beta, we examined the effects of ruminant IFNT on NLRP3 inflammasome-mediated IL-1 beta secretion in human THP-1 macrophages. Methods and Results: IFNT dose-dependently inhibited IL-1 beta secretion induced by nano-silica, a well-known activators of NLRP3 inflammasomes, in human macrophages primed with lipopolysaccharide (LPS, TLR4 agonist) and Pam3CSK4 (TLR1/2 agonist). IFNT also suppressed phagocytosis of nano-silica and reactive oxygen species (ROS) generation. Western blot analysis showed that IFNT inhibited both pro-IL-1 beta and mature IL-1 beta. In addition, real-time RT-PCR analysis showed that IFNT suppressed IL-1 beta mRNA expression induced by LPS and Pam3CSK4. Although nano-silica particles did not induce IL-10 secretion, IFNT induced IL-10 secretion in a dose-dependent manner. Furthermore, IFNT-suppressed IL-1 beta secretion was restored by anti-IL-10 neutralizing antibody. Conclusions: Ruminant IFNT inhibits NLRP3 inflammasome-driven IL-1 beta secretion in human macrophages via multiple pathways, including the uptake of nano-silica particles, generation of ROS, and IL-10-mediated inhibition of pro-IL-1 beta induction. It may be a therapeutic alternative to IFNA and IFNB.	[Hara, Kyoko; Shirasuna, Koumei; Usul, Fumitake; Karasawa, Tadayoshi; Mizushina, Yoshiko; Kimura, Hiroaki; Kawashima, Akira; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan; [Shirasuna, Koumei] Tokyo Univ Agr, Dept Agr, Lab Anim Reprod, Atsugi, Kanagawa, Japan; [Ohkuchi, Akihide] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Matsuyama, Shuichi; Kimura, Koji] Natl Inst Livestock & Grassland Sci, Anim Feeding & Management Res Div, Nasushiobara, Tochigi, Japan	Jichi Medical University; Tokyo University of Agriculture; Jichi Medical University; National Agriculture & Food Research Organization - Japan	Shirasuna, K (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan.	masafumi2@jichi.ac.jp	Kimura, Hiroaki/E-3224-2010	Kimura, Hiroaki/0000-0002-7441-0382; Karasawa, Tadayoshi/0000-0002-6738-2360	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)''; Council for Science and Technology Policy (CSTP); MEXT; Grants-in-Aid for Scientific Research [25850222] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)''; Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was performed by the grants from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program),'' initiated by the Council for Science and Technology Policy (CSTP) (MT), MEXT-supported program for the Strategic Foundation at Private Universities (MT), Grant-in-Aid for Young Scientists (B) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexenko AP, 1999, J INTERF CYTOK RES, V19, P1335, DOI 10.1089/107999099312795; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chon TW, 2010, J INTERF CYTOK RES, V30, P477, DOI 10.1089/jir.2009.0089; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Frausto-Del-Rio D, 2012, CYTOKINE, V57, P158, DOI 10.1016/j.cyto.2011.11.008; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Nakajima A, 2002, J INTERF CYTOK RES, V22, P397, DOI 10.1089/107999002753675839; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rauch Isabella, 2013, JAKSTAT, V2, pe23820, DOI 10.4161/jkst.23820; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Rogez-Kreuz C, 2005, INT IMMUNOL, V17, P1047, DOI 10.1093/intimm/dxh285; Shirasuna K, 2015, NANOTOXICOLOGY, V9, P554, DOI 10.3109/17435390.2014.956156; Soos JM, 2002, J IMMUNOL, V169, P2231, DOI 10.4049/jimmunol.169.5.2231; SOOS JM, 1995, J IMMUNOL, V155, P2747; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	34	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113974	10.1371/journal.pone.0113974	http://dx.doi.org/10.1371/journal.pone.0113974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486008	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600031
J	Tang, W; Song, LY; Li, D; Qiao, J; Zhao, TT; Zhao, HP				Tang, Wei; Song, Liyan; Li, Dou; Qiao, Jing; Zhao, Tiantao; Zhao, Heping			Production, Characterization, and Flocculation Mechanism of Cation Independent, pH Tolerant, and Thermally Stable Bioflocculant from Enterobacter sp ETH-2	PLOS ONE			English	Article							BACILLUS-LICHENIFORMIS; KLEBSIELLA-PNEUMONIAE; MICROBIAL FLOCCULANT; WATER TREATMENT; POLYSACCHARIDE; BACTERIA; CULTURE	Synthetic high polymer flocculants, frequently utilized for flocculating efficiency and low cost, recently have been discovered as producing increased risk to human health and the environment. Development of a more efficient and environmentally sound alternative flocculant agent is investigated in this paper. Bioflocculants are produced by microorganisms and may exhibit a high rate of flocculation activity. The bioflocculant ETH-2, with high flocculating activity (2849 mg Kaolin particle/mg ETH-2), produced by strain Enterobacter sp. isolated from activated sludge, was systematically investigated with regard to its production, characterization, and flocculation mechanism. Analyses of microscopic observation, zeta potential and ETH-2 structure demonstrates the bridging mechanism, as opposed to charge neutralization, was responsible for flocculation of the ETH-2. ETH-2 retains high molecular weight (603 to 1820 kDa) and multi-functional groups (hydroxyl, amide and carboxyl) that contributed to flocculation. Polysaccharides mainly composed of mannose, glucose, and galactose, with a molar ratio of 1:2.9:9.8 were identified as the active constituents in bioflocculant. The structure of the long backbone with active sites of polysaccharides was determined as a primary basis for the high flocculation activity. Bioflocculant ETH-2 is cation independent, pH tolerant, and thermally stable, suggesting a potential fit for industrial application.	[Tang, Wei; Song, Liyan; Li, Dou; Qiao, Jing] Chinese Acad Sci, Res Ctr Environm Microbiol & Ecol, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Song, Liyan; Li, Dou] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Key Lab Reservoir Aquat Environm, Chongqing 400714, Peoples R China; [Zhao, Tiantao] Chongqing Univ Technol, Sch Chem & Chem Engn, Chongqing 400054, Peoples R China; [Zhao, Heping] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecosyst Hlth, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Chongqing University of Technology; Zhejiang University	Song, LY (corresponding author), Chinese Acad Sci, Res Ctr Environm Microbiol & Ecol, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.	songliyan@cigit.ac.cn	Song, Liyan/J-6609-2016		Science and technology Cooperation Project (Science and Technology office of Guizhou Province) [2013-3]; Science and technology Cooperation Project (The people's Government of Bijie City) [2013-3]; Science and technology Cooperation Project (Kunming Institute of Chinese Academy of Sciences) [2013-3]; National Natural Science Foundation of China [21107091, 21377109]	Science and technology Cooperation Project (Science and Technology office of Guizhou Province); Science and technology Cooperation Project (The people's Government of Bijie City); Science and technology Cooperation Project (Kunming Institute of Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: We thank the Science and technology Cooperation Project (Science and Technology office of Guizhou Province, The people's Government of Bijie City, and Kunming Institute of Chinese Academy of Sciences) (Grant No. 2013-3) and the National Natural Science Foundation of China (Grant No. 21107091, Grant No. 21377109) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljuboori AHR, 2013, BIORESOURCE TECHNOL, V127, P489, DOI 10.1016/j.biortech.2012.09.016; ASPINALL GO, 1982, POLYSACCHARIDES, V1, P35; BENDER J, 1994, APPL ENVIRON MICROB, V60, P2311, DOI 10.1128/AEM.60.7.2311-2315.1994; Elkady MF, 2011, BIORESOURCE TECHNOL, V102, P8143, DOI 10.1016/j.biortech.2011.05.090; Gong WX, 2008, BIORESOURCE TECHNOL, V99, P4668, DOI 10.1016/j.biortech.2007.09.077; He J, 2010, WORLD J MICROB BIOT, V26, P1135, DOI 10.1007/s11274-009-0281-2; KURANE R, 1994, BIOSCI BIOTECH BIOCH, V58, P1589, DOI 10.1271/bbb.58.1589; KURANE R, 1995, BIOSCI BIOTECH BIOCH, V59, P1652, DOI 10.1271/bbb.59.1652; Kwon GS, 1996, BIOTECHNOL LETT, V18, P1459, DOI 10.1007/BF00129355; Li Z, 2009, BIORESOURCE TECHNOL, V100, P3650, DOI 10.1016/j.biortech.2009.02.029; Li Z, 2009, WORLD J MICROB BIOT, V25, P745, DOI 10.1007/s11274-008-9943-8; Liu CS, 2012, ADV MATER RES-SWITZ, V550-553, P1482, DOI 10.4028/www.scientific.net/AMR.550-553.1482; Liu WJ, 2010, BIORESOURCE TECHNOL, V101, P1044, DOI 10.1016/j.biortech.2009.08.108; Lu WY, 2005, BIOCHEM ENG J, V27, P1, DOI 10.1016/j.bej.2005.04.026; Mabinya LV, 2012, INT J MOL SCI, V13, P1054, DOI 10.3390/ijms13011054; MICHAELS AS, 1955, IND ENG CHEM, V47, P1801, DOI 10.1021/ie50549a029; Nakata K, 1999, BIOSCI BIOTECH BIOCH, V63, P2064, DOI 10.1271/bbb.63.2064; Oh HM, 2001, BIOTECHNOL LETT, V23, P1229, DOI 10.1023/A:1010577319771; Prasertsan P, 2006, CARBOHYD POLYM, V66, P289, DOI 10.1016/j.carbpol.2006.03.011; RIES HE, 1968, SCIENCE, V160, P1449, DOI 10.1126/science.160.3835.1449; Salehizadeh H, 2002, BIOTECHNOL LETT, V24, P35, DOI 10.1023/A:1013853115624; Salehizadeh H, 2001, BIOTECHNOL ADV, V19, P371, DOI 10.1016/S0734-9750(01)00071-4; Salehizadeh H, 2000, BIOCHEM ENG J, V5, P39, DOI 10.1016/S1369-703X(99)00066-2; Song LY, 2015, MICROBIOL RES, V170, P105, DOI 10.1016/j.micres.2014.08.008; Sun M, 2012, APPL MICROBIOL BIOT, V96, P1577, DOI 10.1007/s00253-012-4478-1; Swindell SR, 1997, METHODS MOL BIOL, P70; TAKEDA M, 1992, J FERMENT BIOENG, V74, P408, DOI 10.1016/0922-338X(92)90043-T; TOEDA K, 1991, AGR BIOL CHEM TOKYO, V55, P2793, DOI 10.1080/00021369.1991.10857749; Wang LL, 2011, WORLD J MICROB BIOT, V27, P2559, DOI 10.1007/s11274-011-0726-2; Wu HJ, 2010, J IND MICROBIOL BIOT, V37, P1203, DOI 10.1007/s10295-010-0767-9; Xia SQ, 2008, BIORESOURCE TECHNOL, V99, P6520, DOI 10.1016/j.biortech.2007.11.031; Xiong YY, 2010, APPL ENVIRON MICROB, V76, P2778, DOI 10.1128/AEM.02558-09; Yim JH, 2007, BIORESOURCE TECHNOL, V98, P361, DOI 10.1016/j.biortech.2005.12.021; Yokoi H, 1998, BIOTECHNOL TECH, V12, P511, DOI 10.1023/A:1008843228743; Yokoi H, 1997, BIOTECHNOL LETT, V19, P569, DOI 10.1023/A:1018301807009; Yuan SJ, 2011, ENVIRON SCI TECHNOL, V45, P1152, DOI 10.1021/es1030905; ZAJIC JE, 1973, APPL MICROBIOL, V25, P628, DOI 10.1128/AEM.25.4.628-635.1973; Zhang ZQ, 2010, WATER RES, V44, P3087, DOI 10.1016/j.watres.2010.02.033; Zhao HJ, 2013, BIORESOURCE TECHNOL, V137, P226, DOI 10.1016/j.biortech.2013.03.079; Zheng Y, 2008, BIORESOURCE TECHNOL, V99, P7686, DOI 10.1016/j.biortech.2008.01.068	40	52	52	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114591	10.1371/journal.pone.0114591	http://dx.doi.org/10.1371/journal.pone.0114591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485629	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600079
J	Velayati, AA; Farnia, P; Mozafari, M; Malekshahian, D; Seif, S; Rahideh, S; Mirsaeidi, M				Velayati, Ali Akbar; Farnia, Parissa; Mozafari, Mohadese; Malekshahian, Donya; Seif, Shima; Rahideh, Snaz; Mirsaeidi, Mehdi			Molecular Epidemiology of Nontuberculous Mycobacteria Isolates from Clinical and Environmental Sources of a Metropolitan City	PLOS ONE			English	Article							CYSTIC-FIBROSIS; IDENTIFICATION; SIMIAE; INFECTION; DISEASE; GENE; IRAN	Introduction: While NTM infection is mainly acquired from environmental exposure, monitoring of environmental niches for NTM is not a routine practice. This study aimed to find the prevalence of environmental NTM in soil and water in four highly populated suburbs of Tehran, Iran. Material and Methods: A total of 4014 samples from soil and water resources were collected and studied. Sediments of each treated sample were cultured in Lowenstein-Jensen medium and observed twice per week for growth rate, colony morphology, and pigmentation. Colonies were studied with phenotypic tests. Molecular analysis was performed on single colonies derived from subculture of original isolates. Environmental samples were compared with 34 NTM isolates from patients who were residents of the study locations. Results: Out of 4014 samples, mycobacteria were isolated from 862 (21.4%) specimens; 536 (62.1%) belonged to slow growing mycobacteria (SGM) and 326 (37.8%) were rapid growing mycobacteria (RGM). The five most frequent NTM were M. farcinogens (105/862; 12.1%), M. fortuitum (72/862; 8.3%), M. senegalense (58/862; 6.7%), M. kansasii (54/862; 6.2%), and M. simiae (46/862; 5.3%). In total, 62.5% (539/862) of mycobacterial positive samples were isolated from water and only 37.4% (323/862) of them were isolated from soil samples (P<0.05). Out of 5314 positive clinical samples for mycobacteria, 175 (3.2%) isolates were NTM. The trend of NTM isolates increased from 1.2% (13 out of 1078) in 2004 to 3.8% (39 out of 1005) in 2014 (P<0.0001). The major clinical isolates were M. simiae (51; 29.1%), M. kansasii (26; 14.8%), M. chelonae (28; 16%), and M. fortuitum (13; 7.4%). Conclusions: Comparing the distribution pattern of environmental NTM isolates with clinical isolates suggests a possible transmission link, but this does not apply to all environmental NTM species. Our study confirms an increasing trend of NTM isolation from clinical samples that needs further investigation.	[Velayati, Ali Akbar; Farnia, Parissa; Mozafari, Mohadese; Malekshahian, Donya; Seif, Shima; Rahideh, Snaz] Shahid Beheshti Univ Med Sci, NRITLD, Mycobacteriol Res Ctr, Tehran, Iran; [Mirsaeidi, Mehdi] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA	Shahid Beheshti University Medical Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mirsaeidi, M (corresponding author), Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	mmirsae@uic.edu	Velayati, Ali Akbar/H-1448-2017; farnia, parissa/G-7412-2017	farnia, parissa/0000-0003-3676-2018; Mirsaeidi, Mehdi/0000-0001-5298-8442; Velayati, Ali Akbar/0000-0001-9398-5838; Malekshahian, Donya/0000-0003-2727-5488	NIH [5 T32 HL 82547-7]; National Research Institute of Tuberculosis and Lung Disease of Iran for project costs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL082547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Institute of Tuberculosis and Lung Disease of Iran for project costs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mehdi Mirsaeidi MD is supported by NIH grant 5 T32 HL 82547-7. This study was supported by the National Research Institute of Tuberculosis and Lung Disease of Iran for project costs and in the form of salaries for authors Ali Akbar Velayati, Parissa Farnia, Mohadese Mozafari, Donya Malekshahian, Shima Seif, and Snaz Rahideh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghaei P, 2012, J INFECT DEV COUNTR, V6, P23, DOI 10.3855/jidc.1297; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Hamid Mohamed E, 2014, Vet Med Int, V2014, P247906, DOI 10.1155/2014/247906; Hashemi-Shahraki A, 2013, INFECT GENET EVOL, V20, P312, DOI 10.1016/j.meegid.2013.08.027; Hashemi-Shahraki A, 2013, JPN J INFECT DIS, V66, P475, DOI 10.7883/yoken.66.475; Joao ICP, 2014, NT J MYCOBACTERIOL, V3, P144, DOI DOI 10.1016/J.IJMYC0.2014.04.001.[; Kim H, 2005, J MICROBIOL METH, V62, P199, DOI 10.1016/j.mimet.2005.02.010; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; MASSON A M, 1956, Can Med Assoc J, V75, P798; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirsaeidi M, 2014, EUR J INTERN MED; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Mirsaeidi M, 2013, INT J INFECT DIS, V17, pE1000, DOI 10.1016/j.ijid.2013.03.018; Mirsaeidi S M, 2006, Monaldi Arch Chest Dis, V65, P106; Neumann M, 1997, APPL ENVIRON MICROB, V63, P547, DOI 10.1128/AEM.63.2.547-552.1997; PETERS M, 1995, J INFECTION, V31, P39, DOI 10.1016/S0163-4453(95)91333-5; PORTAELS F, 1988, J GEN MICROBIOL, V134, P849; Rahbar M, 2010, AFR J BIOTECHNOL, V9, P3618; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; Saifi M, 2013, CLIN MICROBIOL INFEC, V19, P723, DOI 10.1111/j.1469-0691.2012.04005.x; Samra Z, 2005, SCAND J INFECT DIS, V37, P838, DOI 10.1080/00365540500264712; Shitrit D, 2008, RESP MED, V102, P1598, DOI 10.1016/j.rmed.2008.05.004; Tabarsi P, 2009, AM J MED SCI, V337, P182, DOI 10.1097/MAJ.0b013e318185d32f; Tadayon K, 2013, IRAN J MICROBIOL, V5, P1; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Velayati AA, 2014, CHEST; Wong TC, 2005, J ARTHROPLASTY, V20, P684, DOI 10.1016/j.arth.2005.03.001	30	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114428	10.1371/journal.pone.0114428	http://dx.doi.org/10.1371/journal.pone.0114428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485795	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600055
J	Witt, S; Leidl, R; Becker, C; Holle, R; Block, M; Brachmann, J; Silber, S; Stollenwerk, B				Witt, Sabine; Leidl, Reiner; Becker, Christian; Holle, Rolf; Block, Michael; Brachmann, Johannes; Silber, Sigmund; Stollenwerk, Bjoern			The Effectiveness of the Cardiovascular Disease Prevention Programme 'KardioPro' Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SECONDARY PREVENTION; RISK; TRIALS; IMPROVEMENT; MANAGEMENT; SCORES	Background: Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world. Methods: The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'. Results: A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrolment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year. Conclusion: The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events.	[Witt, Sabine; Leidl, Reiner; Becker, Christian; Holle, Rolf; Stollenwerk, Bjoern] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Leidl, Reiner] Univ Munich, Munich Ctr Hlth Sci, Munich, Germany; [Block, Michael] Klin Augustinum Munchen, Munich, Germany; [Brachmann, Johannes] Klinikum Coburg, Coburg, Germany; [Silber, Sigmund] Herzzentrum Isar, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Klinikum Coburg	Stollenwerk, B (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.	bjoern.stollenwerk@helmholtz-muenchen.de	Leidl, Reiner/GQY-7389-2022; Leidl, Reiner M/B-7209-2009; Holle, Rolf/D-9333-2013; Brachmann, Johannes/AAD-1499-2021	Leidl, Reiner M/0000-0002-7115-7510; Holle, Rolf/0000-0001-5395-2695; Becker, Christian/0000-0002-8212-1433; Stollenwerk, Bjorn/0000-0002-3189-409X	SBK; Helmholtz Zentrum Munchen, German Research Center for Environmental Health	SBK; Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association)	Funding: Financial support for this study was provided by SBK and by Helmholtz Zentrum Munchen, German Research Center for Environmental Health. The data have been provided by SBK. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. However, SBK had the opportunity to comment upon the paper.	Alexander MT, 2007, BUTTING HEADS MATCHE; Angermayr L, 2010, ANN BEHAV MED, V40, P49, DOI 10.1007/s12160-010-9206-4; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Colkesen EB, 2011, VASC HEALTH RISK MAN, V7, P67, DOI 10.2147/VHRM.S16340; Cummings P, 2003, EPIDEMIOL REV, V25, P43, DOI 10.1093/epirev/mxg002; Danaei G, 2012, AM J EPIDEMIOL, V175, P250, DOI 10.1093/aje/kwr301; Ebrahim S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Eriksson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005195; Falk E, 2011, CURR ATHEROSCLER REP, V13, P345, DOI 10.1007/s11883-011-0195-y; Feng WW, METHOD MACROBASED PR; Fleiss J.L., 2013, STAT METHODS RATES P; Heidrich J, 2005, EUR J CARDIOV PREV R, V12, P521, DOI 10.1097/00149831-200512000-00002; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kirby MG, 2010, CARDIOLOGY, V115, P294, DOI 10.1159/000312008; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Kotseva K, 2010, EUR J CARDIOV PREV R, V17, P530, DOI 10.1097/HJR.0b013e3283383f30; Mack CD, 2013, PHARMACOEPIDEM DR S, V22, P810, DOI 10.1002/pds.3386; Maier LS, 2009, CLIN RES CARDIOL, V98, P413, DOI 10.1007/s00392-009-0027-z; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; McAlister FA, 2009, CAN MED ASSOC J, V181, P897, DOI 10.1503/cmaj.090917; McGrath ER, 2012, AM HEART J, V163, P714, DOI 10.1016/j.ahj.2012.01.027; Nichols M., 2012, EUROPEAN CARDIOVASCU; Parsons LS, 2004, PERFORMING 1 N CASE; Pennant M, 2010, AM J EPIDEMIOL, V172, P501, DOI 10.1093/aje/kwq171; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Schubert I, 2013, DTSCH ARZTEBL INT, V110, P45, DOI 10.3238/arztebl.2013.0045; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Shenoy AU, 2012, EUR J VASC ENDOVASC, V44, P505, DOI 10.1016/j.ejvs.2012.08.010; Sheridan SL, 2010, ARCH INTERN MED, V170, P230, DOI 10.1001/archinternmed.2009.516; Sheridan SL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-60; Snow V, 2010, AM J MED QUAL, V25, P261, DOI 10.1177/1062860610362259; Stock S, 2010, HEALTH POLICY, V96, P51, DOI 10.1016/j.healthpol.2009.12.015; Stollenwerk B, 2009, MED DECIS MAKING, V29, P619, DOI 10.1177/0272989X09331810	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114720	10.1371/journal.pone.0114720	http://dx.doi.org/10.1371/journal.pone.0114720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486421	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600089
J	Ashraf, AP; Alvarez, JA; Dudenbostel, T; Calhoun, D; Griffin, R; Wang, XD; Hanks, LJ; Gower, BA				Ashraf, Ambika P.; Alvarez, Jessica A.; Dudenbostel, Tanja; Calhoun, David; Griffin, Russell; Wang, Xudong; Hanks, Lynae J.; Gower, Barbara A.			Associations between Vascular Health Indices and Serum Total, Free and Bioavailable 25-Hydroxyvitamin D in Adolescents	PLOS ONE			English	Article							VITAMIN-D STATUS; FLOW-MEDIATED VASODILATION; EXPERT CONSENSUS DOCUMENT; PULSE-WAVE VELOCITY; D-BINDING PROTEIN; ARTERIAL STIFFNESS; BLOOD-PRESSURE; INSULIN-RESISTANCE; RACIAL-DIFFERENCES; SUPPLEMENTATION	Objective: The role of vitamin D in cardiovascular health remains debated as results have been inconsistent. Previous studies have not considered the bioavailability of 25-hydroxy vitamin D [25(OH)D]. Objectives of our study were to investigate the association between serum concentrations of total, free and bioavailable 25(OH)D and independent predictors of cardiovascular risk such as flow mediated dilatation (FMD) and augmentation index (AIx). Design: This cross-sectional study included 47 post-menarchal, adolescent females [31 African American (AA) and 16 European American (EA)]. Methods: AIx was standardized to a heart rate of 75 beats/min (AIx75). Free and bioavailable 25(OH)D concentrations were calculated from standard formulas. Results and Conclusions: Mean age of the participants was 15.8 +/- 1.4 years and mean body mass index was 23.1 +/- 4.0 kg/m(2). Serum total 25(OH)D was not associated with FMD, but was positively associated with AIx75 in the adjusted model (rho=0.4, P=0.03). AIx75 was positively associated with bioavailable 25(OH)D (rho=0.4, P=0.004) and free 25(OH) D (rho=0.4, P=0.009) and the associations persisted after adjusting for covariates. In race-specific analyses, total, free and bioavailable 25(OH)D were strongly positively associated with AIx75 in AA (rho=0.5, 0.4, 0.4, respectively), which persisted even after adjusting for covariates. Whereas in EA there was an inverse association between total 25(OH)D and AIx75 in EA (rho=-0.6), which attenuated after adjusting for covariates. Conclusion: Circulating total, free and bioavailable 25(OH)D were associated with arterial stiffness in adolescent girls, and these associations were race dependent. Notwithstanding, the implications of associations between vascular function indices and 25(OH)D remains unclear.	[Ashraf, Ambika P.; Wang, Xudong; Hanks, Lynae J.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Alvarez, Jessica A.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Dudenbostel, Tanja; Calhoun, David] Univ Alabama Birmingham, Birmingham, AL USA; [Griffin, Russell] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Gower, Barbara A.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Emory University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ashraf, AP (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.	AAshraf@peds.uab.edu		Griffin, Russell/0000-0002-5004-7996	Child Health Research Center [K12 HD043397 T0909180013]; National Center for Advancing Translational Research of the National Institutes of Health [UL1TR00165]; NORC core lab [P30DK56336]; DRTC core lab [P60DK079626]; American Heart Association (Greater Southeast Affiliate); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043397] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, P30DK056336] Funding Source: NIH RePORTER	Child Health Research Center; National Center for Advancing Translational Research of the National Institutes of Health; NORC core lab; DRTC core lab; American Heart Association (Greater Southeast Affiliate)(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding to AA through Child Health Research Center Grant K12 HD043397 T0909180013, National Center for Advancing Translational Research of the National Institutes of Health (UL1TR00165), NORC core lab (P30DK56336) and DRTC core lab (P60DK079626). JAA also received funding through the American Heart Association (Greater Southeast Affiliate). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Alvarez Jessica A, 2012, J Clin Med Res, V4, P197, DOI 10.4021/jocmr965w; Ashraf AP, 2013, J CLIN ENDOCRINOL ME; Bhan I, 2012, KIDNEY INT, V82, P84, DOI 10.1038/ki.2012.19; Campia U, 2002, J AM COLL CARDIOL, V40, P754, DOI 10.1016/S0735-1097(02)02015-6; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dahl-Jorgensen K, 2005, DIABETOLOGIA, V48, P1445, DOI 10.1007/s00125-005-1832-1; Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606; Fiscella K, 2010, ANN FAM MED, V8, P11, DOI 10.1370/afm.1035; Forman JP, 2013, HYPERTENSION, V61, P779, DOI 10.1161/HYPERTENSIONAHA.111.00659; Hanks LJ, 2013, J BONE MINER METAB, V31, P695, DOI 10.1007/s00774-013-0454-9; Harris RA, 2011, AM J HYPERTENS, V24, P557, DOI 10.1038/ajh.2011.12; Heffernan KS, 2008, AM J PHYSIOL-HEART C, V295, pH2380, DOI 10.1152/ajpheart.00902.2008; Hollingshead A, 1975, THESIS YALE U NEW HA; Hollis BW, 2014, NEW ENGL J MED, V370, P879, DOI 10.1056/NEJMc1315850; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Morris AA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.002154; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Powe CE, 2014, NEW ENGL J MED, V370, P880, DOI 10.1056/NEJMc1315850; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Reis JP, 2008, AM J CLIN NUTR, V88, P1469, DOI 10.3945/ajcn.2008.26447; Rezai MR, 2011, HYPERTENSION, V58, P247, DOI 10.1161/HYPERTENSIONAHA.111.174425; Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228; Rossi R, 2004, J AM COLL CARDIOL, V44, P1636, DOI 10.1016/j.jacc.2004.07.027; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212; U.S. Department of health and Human Services NIoH National Heart Lung and Blood Institute, 2005, 453 US DEP HHS, P1; Urbina EM, 2010, J PEDIATR-US, V156, P731, DOI 10.1016/j.jpeds.2009.11.011; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Wadwa RP, 2010, DIABETES CARE, V33, P881, DOI 10.2337/dc09-0747; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	40	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114689	10.1371/journal.pone.0114689	http://dx.doi.org/10.1371/journal.pone.0114689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479358	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200112
J	Gonzalez-Rojo, S; Fernandez-Diez, C; Guerra, SM; Robles, V; Herraez, MP				Gonzalez-Rojo, Silvia; Fernandez-Diez, Cristina; Guerra, Susana M.; Robles, Vanesa; Herraez, Maria Paz			Differential Gene Susceptibility to Sperm DNA Damage: Analysis of Developmental Key Genes in Trout	PLOS ONE			English	Article							NUCLEAR BASIC-PROTEINS; ONCORHYNCHUS-MYKISS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; EVOLUTION; CHROMATIN; MODEL; CRYOPRESERVATION; FERTILIZATION; DUPLICATION	Sperm chromatin in mammals is packaged in different blocks associated to protamines (PDNA), histones (HDNA), or nuclear matrix proteins. Differential packaging has been related to early or late transcription and also to differential susceptibility to genotoxic damage. Genes located in the more accessible HDNA could be more susceptible to injuries than those located in PDNA, being potential biomarkers of paternal DNA damage. Fish sperm chromatin organization is much diversified, some species lacking protamines and some others totally depleted of histones. Analyzing genotoxic damage in a species homogeneously compacted with some sperm nuclear basic protein type, could help in deciphering the clues of differential susceptibility to damage. In the present study we analyzed in rainbow trout the differential susceptibility of nine genes to UV irradiation and H2O2 treatment. The absence of histones in the sperm nuclei was confirmed by Western blot. The chromatin fractionation in sensitive and resistant regions to PvuII (presumably HDNA-like and PDNA-like, respectively) revealed that the nine genes locate in the same resistant region. The number of lesions promoted was quantified using a qPCR approach. Location of 8-hydroxyguanosine (8-OHdG) was analyzed by immunocytochemistry and confocal microscopy. UV irradiation promoted similar number of lesions in all the analyzed genes and a homogenous distribution of 8-OHdG within the nuclei. 8-OHdG was located in the peripheral area of the nucleus after H2O2 treatment, which promoted a significantly higher number of lesions in developmental-related genes (8.76-10.95 lesions/10 kb) than in rDNA genes (1.05-1.67 lesions/10 kb). We showed for the first time, that differential susceptibility to damage is dependent on the genotoxic mechanism and relies on positional differences between genes. Sensitive genes were also analyzed in cryopreserved sperm showing a lower number of lesions than the previous treatments and a predominant peripheral distribution of oxidative damage (8-OHdG).	[Gonzalez-Rojo, Silvia; Fernandez-Diez, Cristina; Guerra, Susana M.; Robles, Vanesa; Herraez, Maria Paz] Univ Leon, Dept Mol Biol, E-24071 Leon, Spain	Universidad de Leon	Herraez, MP (corresponding author), Univ Leon, Dept Mol Biol, E-24071 Leon, Spain.	paz.herraez@unileon.es	Susana, Susana/L-9204-2015; rodriguez, vanesa robles/N-7508-2015; FERNÁNDEZ, CRISTINA/C-4929-2016; Herraez, Paz/C-6264-2013; González-Rojo, Silvia/C-4703-2016	Susana, Susana/0000-0003-2243-2376; rodriguez, vanesa robles/0000-0002-7917-7700; Herraez, Paz/0000-0002-0028-3616; González-Rojo, Silvia/0000-0002-9630-4468	Junta de Castilla y Leon (Spain) [LE365A11-2, EDU/828/2014]; Spanish Ministry of Economy and Competitiveness [AGL2011-27787]; Fondo Social Europeo	Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by the Junta de Castilla y Leon (Spain) (project LE365A11-2 and EDU/828/2014), the Spanish Ministry of Economy and Competitiveness (project AGL2011-27787) and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1984, MOL BIOL EVOL, V1, P238; Ausio J, 1997, J MOL EVOL, V45, P91, DOI 10.1007/PL00006207; AVRAMOVA Z, 1983, EUR J CELL BIOL, V31, P137; Benhusein GM, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.4637; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Carton-Garcia F, 2013, AQUACULTURE, V402, P106, DOI 10.1016/j.aquaculture.2013.03.034; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Dietrich GJ, 2005, THERIOGENOLOGY, V64, P1809, DOI 10.1016/j.theriogenology.2005.04.010; Durston AJ, 2012, CURR GENOMICS, V13, P300, DOI 10.2174/138920212800793375; Eirin-Lopez JM, 2006, MOL BIOL EVOL, V23, P1304, DOI 10.1093/molbev/msk021; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Frehlick LJ, 2006, J EXP ZOOL PART A, V305A, P277, DOI 10.1002/jez.a.239; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Han Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/825065; HERRAEZ MP, 2008, METHODS REPROD AQUAC, P385; Hiraku Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P205, DOI 10.1562/2006-03-09-IR-840; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4; Koubek P, 2008, THERIOGENOLOGY, V70, P852, DOI 10.1016/j.theriogenology.2008.05.050; Kurtz K, 2009, J EXP ZOOL PART B, V312B, P149, DOI 10.1002/jez.b.21271; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Moghadam HK, 2005, J MOL EVOL, V61, P804, DOI 10.1007/s00239-004-0230-5; Moussa M, 2002, THERIOGENOLOGY, V57, P1695, DOI 10.1016/S0093-691X(02)00682-9; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Pascual-Anaya J, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-26; Perez-Cerezales S, 2010, THERIOGENOLOGY, V74, P282, DOI 10.1016/j.theriogenology.2010.02.012; Perez-Cerezales S, 2009, THERIOGENOLOGY, V71, P605, DOI 10.1016/j.theriogenology.2008.09.057; Riesco MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067614; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Saperas N, 1997, J MOL EVOL, V44, P422, DOI 10.1007/PL00006162; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Shiao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022266; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Speyer BE, 2010, HUM REPROD, V25, P1609, DOI 10.1093/humrep/deq116; Thummel R, 2004, DEV BIOL, V274, P318, DOI 10.1016/j.ydbio.2004.07.018; Valcarce DG, 2013, ANDROLOGY-US, V1, P723, DOI 10.1111/j.2047-2927.2013.00116.x; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Wondrak GT, 2002, PHOTOCH PHOTOBIO SCI, V1, P355, DOI 10.1039/b202732c; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200	46	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114161	10.1371/journal.pone.0114161	http://dx.doi.org/10.1371/journal.pone.0114161			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479606	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200048
J	Indrelid, S; Mathiesen, G; Jacobsen, M; Lea, T; Kleiveland, CR				Indrelid, Stine; Mathiesen, Geir; Jacobsen, Morten; Lea, Tor; Kleiveland, Charlotte R.			Computational and Experimental Analysis of the Secretome of Methylococcus capsulatus (Bath)	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; SIGNAL PEPTIDES; II SECRETION; LOCALIZATION PREDICTION; GLUTAMINE-SYNTHETASE; SURFACE; SYSTEM; BACTERIA; PATHWAY; IDENTIFICATION	The Gram-negative methanotroph Methylococcus capsulatus (Bath) was recently demonstrated to abrogate inflammation in a murine model of inflammatory bowel disease, suggesting interactions with cells involved in maintaining mucosal homeostasis and emphasizing the importance of understanding the many properties of M. capsulatus. Secreted proteins determine how bacteria may interact with their environment, and a comprehensive knowledge of such proteins is therefore vital to understand bacterial physiology and behavior. The aim of this study was to systematically analyze protein secretion in M. capsulatus (Bath) by identifying the secretion systems present and the respective secreted substrates. Computational analysis revealed that in addition to previously recognized type II secretion systems and a type VII secretion system, a type Vb (two-partner) secretion system and putative type I secretion systems are present in M. capsulatus (Bath). In silico analysis suggests that the diverse secretion systems in M. capsulatus transport proteins likely to be involved in adhesion, colonization, nutrient acquisition and homeostasis maintenance. Results of the computational analysis was verified and extended by an experimental approach showing that in addition an uncharacterized protein and putative moonlighting proteins are released to the medium during exponential growth of M. capsulatus (Bath).	[Indrelid, Stine; Jacobsen, Morten; Kleiveland, Charlotte R.] Ostfold Hosp Trust, Fredrikstad, Norway; [Indrelid, Stine; Mathiesen, Geir; Jacobsen, Morten; Lea, Tor; Kleiveland, Charlotte R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Jacobsen, Morten] Univ Oslo, Inst Clin Med, Dept Gastrointestinal & Children Surg, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Indrelid, S (corresponding author), Ostfold Hosp Trust, Fredrikstad, Norway.	stine.indrelid@nmbu.no		Indrelid, Stine/0000-0002-9628-8066				Alm RA, 1996, MOL MICROBIOL, V22, P161; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berven FD, 2006, ARCH MICROBIOL, V184, P362, DOI 10.1007/s00203-005-0055-7; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Fjellbirkeland A, 1997, ARCH MICROBIOL, V168, P128, DOI 10.1007/s002030050478; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; HARTH G, 1994, P NATL ACAD SCI USA, V91, P9342, DOI 10.1073/pnas.91.20.9342; Henderson B, 2013, BIOL REV, V88, P955, DOI 10.1111/brv.12037; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Karlsen OA, 2008, MOL MICROBIOL, V70, P15, DOI 10.1111/j.1365-2958.2008.06380.x; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kleiveland CR, 2013, APPL ENVIRON MICROB, V79, P48, DOI 10.1128/AEM.02464-12; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; LIDSTROM ME, 1990, ANNU REV MICROBIOL, V44, P27; LOCHT C, 1993, MOL MICROBIOL, V9, P653, DOI 10.1111/j.1365-2958.1993.tb01725.x; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; MUNRO GKL, 1995, MICROBIOL-UK, V141, P1731, DOI 10.1099/13500872-141-7-1731; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rego AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518; Romarheim OH, 2011, J NUTR, V141, P124, DOI 10.3945/jn.110.128900; Romine MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S1; Rondelet A, 2013, RES MICROBIOL, V164, P556, DOI 10.1016/j.resmic.2013.03.005; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Schmid G, 2013, EXTREMOPHILES, V17, P921, DOI 10.1007/s00792-013-0574-0; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	60	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114476	10.1371/journal.pone.0114476	http://dx.doi.org/10.1371/journal.pone.0114476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479164	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000346907200092
J	Maruyama, A; Nakamura, K; Yamanaka, H; Kondoh, M; Minamoto, T				Maruyama, Atsushi; Nakamura, Keisuke; Yamanaka, Hiroki; Kondoh, Michio; Minamoto, Toshifumi			The Release Rate of Environmental DNA from Juvenile and Adult Fish	PLOS ONE			English	Article							WATER SAMPLES; EDNA	The environmental DNA (eDNA) technique is expected to become a powerful, non-invasive tool for estimating the distribution and biomass of organisms. This technique was recently shown to be applicable to aquatic vertebrates by collecting extraorganismal DNA floating in the water or absorbed onto suspended particles. However, basic information on eDNA release rate is lacking, despite it being essential for practical applications. In this series of experiments with bluegill sunfish (Lepomis macrochirus), we examined the effect of fish developmental stage on eDNA release rate. eDNA concentration reached equilibrium 3 days after the individual fish were introduced into the separate containers, enabling calculation of the eDNA release rate (copies h(-1)) from individual fish on the assumption that the number of eDNA released from the fish per unit time equals total degradation in the container (copies h(-1)). The eDNA release rate was 3-4 times higher in the adult (body weight: 30-75 g) than in the juvenile group (0.5-2.0 g). Such positive relationship between fish size and eDNA release rate support the possibility of biomass rather than density estimation using eDNA techniques. However, the eDNA release rate per fish body weight (copies h(-1) g(-1)) was slightly higher in the juvenile than the adult group, which is likely because of the ontogenetic reduction in metabolic activity. Therefore, quantitative eDNA data should be carefully interpreted to avoid overestimating biomass when the population is dominated by juveniles, because the age structure of the focal population is often variable and unseen in the field. eDNA degradation rates (copies l(-1) h(-1)), calculated by curve fitting of time-dependent changes in eDNA concentrations after fish removal, were 5.1-15.9% per hour (half-life: 6.3 h). This suggests that quantitative eDNA data should be corrected using a degradation curve attained in the target field.	[Maruyama, Atsushi; Nakamura, Keisuke; Yamanaka, Hiroki; Kondoh, Michio] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 52021, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 657, Japan; [Minamoto, Toshifumi] Res Inst Humanity & Nat, Kita Ku, Kyoto, Japan	Ryukoku University; Kobe University; Research Institute for Humanity & Nature (RIHN)	Maruyama, A (corresponding author), Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 52021, Japan.	maruyama@rins.ryukoku.ac.jp	Minamoto, Toshifumi/C-6453-2009; Kondoh, Michio/AAE-4332-2019	Minamoto, Toshifumi/0000-0002-5379-1622; 	JSPS KAKENHI [24657020]; CREST from Japan Science Technology Agency	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from Japan Science Technology Agency	The authors were funded by JSPS KAKENHI Grant Number 24657020 (http://www.jsps.go.jp/) and by CREST from the Japan Science Technology Agency (http://www.jst.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; AZUMA M, 1992, HYDROBIOLOGIA, V243, P269, DOI 10.1007/BF00007042; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Horne A.J., 1994, LIMNOLOGY; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Pilliod D.S., 2013, APPL ENV DNA INVENTO; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Renshaw MA, 2014, MOL ECOL RESOUR; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Winberg GG., 1960, RATE METABOLISM FOOD; Yuma M, 1997, B SHIGA U MED SCI GE, V8, P19	26	166	180	9	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114639	10.1371/journal.pone.0114639	http://dx.doi.org/10.1371/journal.pone.0114639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479160	Green Published, gold			2022-12-27	WOS:000346907200109
J	Weller, P; Nel, I; Hassenkamp, P; Gauler, T; Schlueter, A; Lang, S; Dountsop, P; Hoffmann, AC; Lehnerdt, G				Weller, Patrick; Nel, Ivonne; Hassenkamp, Philipp; Gauler, Thomas; Schlueter, Anke; Lang, Stephan; Dountsop, Paulette; Hoffmann, Andreas-Claudius; Lehnerdt, Goetz			Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LOCALLY ADVANCED HEAD; PERIPHERAL-BLOOD; BONE-MARROW; CANCER; METASTASIS; EXPRESSION	Background: Since image based diagnostic tools fail to detect early metastasis in head and neck squamous cell carcinoma (HNSCC) it is crucial to develop minimal invasive diagnostic methods. A promising approach is to identify and characterize circulating tumor cells (CTC) in the peripheral blood of HNSCC patients. In this pilot study, we assessed which non-hematopoietic cell types are identifiable and whether their numbers differ in pre- and postoperative blood samples. Methods: 20 ml citrated peripheral blood was taken from 10 HNSCC patients before and after curative resection. CTC were enriched using density gradient centrifugation. CTC presence was verified by multi-immunofluorescence staining against cytokeratin (CK; epithelial), N-cadherin (mesenchymal); CD133 (stem-cell), CD45 (hematopoietic) and DAPI (nucleus). Individual cell type profiles were analyzed. Results: We were able to detect cells with epithelial properties like CK+/N-cadherin-/CD45- and CK+/CD133-/CD45- as well as cells with mesenchymal features such as N-cadherin+/CK-/CD45- and cells with both characteristics like N-cadherin+/CK+/CD45-. We also observed cells showing stem cell-like features like CD133+/CK-/CD45- and cells with both epithelial and stem cell-like features such as CD133+/CK+/CD45-. The number of CK positive cells (p=0.002), N-cadherin positive cells (p=0.002) and CD133 positive cells (p=0.01) decreased significantly after resection. Kaplan-Meier test showed that the survival was significantly shorter when N-cadherin+ cells were present after resection (p=0.04; 474 vs. 235 days; [HR]=3.1). Conclusions: This is - to the best of our knowledge- the first pilot study identifying different CTC populations in peripheral blood of HNSCC patients and showing that these individual cell type profiles may have distinct clinical implications.	[Weller, Patrick; Hassenkamp, Philipp; Schlueter, Anke; Lang, Stephan; Lehnerdt, Goetz] Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany; [Nel, Ivonne; Hassenkamp, Philipp; Gauler, Thomas; Hoffmann, Andreas-Claudius] Univ Duisburg Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany; [Dountsop, Paulette] Evangel Krankenhaus Duesseldorf, Dept Otorhinolaryngol, Dusseldorf, Germany; [Lehnerdt, Goetz] St Anna Klin, Dept Otorhinolaryngol, Wuppertal, Germany	University of Duisburg Essen; University of Duisburg Essen	Weller, P (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany.	patrick.weller@yahoo.de			Dr. Werner Jackstadt-Stiftung, Wuppertal/Germany	Dr. Werner Jackstadt-Stiftung, Wuppertal/Germany	The work was supported by the Dr. Werner Jackstadt-Stiftung, Laurentiusstrasse 25, 42103 Wuppertal/Germany, www.jackstaedt-stiftung.de (ACH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balasubramanian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042048; Bozec A, 2013, EUR ARCH OTO-RHINO-L, V270, P2745, DOI 10.1007/s00405-013-2399-y; Buglione M, 2012, EUR J CANCER, V48, P3019, DOI 10.1016/j.ejca.2012.05.007; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Gauler TC, 2011, J THORAC ONCOL, V6, pS1114; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Hristozova T, 2011, ANN ONCOL, V22, P1878, DOI 10.1093/annonc/mdr130; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; MOLDENHAUER G, 1987, BRIT J CANCER, V56, P714, DOI 10.1038/bjc.1987.276; Nel I, 2013, BR J CANC; Nel I, 2014, INT J CLIN PHARM TH, V52, P74, DOI 10.5414/CPXCES13EA01; Nel I, 2013, TRANSL ONCOL, V6, P420, DOI 10.1593/tlo.13271; Nguyen PT, 2011, HISTOL HISTOPATHOL, V26, P147, DOI 10.14670/HH-26.147; Nichols AC, 2012, HEAD NECK-J SCI SPEC, V34, P1440, DOI 10.1002/hed.21941; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Winter SC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-424; Yang FC, 1998, BLOOD, V92, P4632, DOI 10.1182/blood.V92.12.4632.424k28_4632_4640; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	31	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113706	10.1371/journal.pone.0113706	http://dx.doi.org/10.1371/journal.pone.0113706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479539	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200029
J	Farke, AA; Maxwell, WD; Cifelli, RL; Wedel, MJ				Farke, Andrew A.; Maxwell, W. Desmond; Cifelli, Richard L.; Wedel, Mathew J.			A Ceratopsian Dinosaur from the Lower Cretaceous of Western North America, and the Biogeography of Neoceratopsia	PLOS ONE			English	Article							2 MEDICINE FORMATION; CLOVERLY FORMATION; EARLY EVOLUTION; GEOGRAPHIC RANGE; CHINA; PROVINCE; EUROPE; AGE; USA; ORNITHISCHIA	The fossil record for neoceratopsian (horned) dinosaurs in the Lower Cretaceous of North America primarily comprises isolated teeth and postcrania of limited taxonomic resolution, hampering previous efforts to reconstruct the early evolution of this group in North America. An associated cranium and lower jaw from the Cloverly Formation (?middle-late Albian, between 104 and 109 million years old) of southern Montana is designated as the holotype for Aquilops americanus gen. et sp. nov. Aquilops americanus is distinguished by several autapomorphies, including a strongly hooked rostral bone with a midline boss and an elongate and sharply pointed antorbital fossa. The skull in the only known specimen is comparatively small, measuring 84 mm between the tips of the rostral and jugal. The taxon is interpreted as a basal neoceratopsian closely related to Early Cretaceous Asian taxa, such as Liaoceratops and Auroraceratops. Biogeographically, A. americanus probably originated via a dispersal from Asia into North America; the exact route of this dispersal is ambiguous, although a Beringian rather than European route seems more likely in light of the absence of ceratopsians in the Early Cretaceous of Europe. Other amniote clades show similar biogeographic patterns, supporting an intercontinental migratory event between Asia and North America during the late Early Cretaceous. The temporal and geographic distribution of Upper Cretaceous neoceratopsians (leptoceratopsids and ceratopsoids) suggests at least intermittent connections between North America and Asia through the early Late Cretaceous, likely followed by an interval of isolation and finally reconnection during the latest Cretaceous.	[Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA; [Maxwell, W. Desmond] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Farke, Andrew A.; Maxwell, W. Desmond; Cifelli, Richard L.; Wedel, Mathew J.] Sam Noble Oklahoma Museum Nat Hist, Norman, OK USA; [Wedel, Mathew J.] Western Univ Hlth Sci, Coll Podiatr Med, Pomona, CA USA	University of the Pacific; Western University of Health Sciences	Farke, AA (corresponding author), Raymond M Alf Museum Paleontol, Claremont, CA 91711 USA.	afarke@webb.org		Farke, Andrew/0000-0002-6930-2002	National Science Foundation [DEB 9401094, 9870173]; National Geographic Society [5918-97]; American Chemical Society (PRF) [38572-AC8]	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); American Chemical Society (PRF)(American Chemical Society)	Funding was received from the National Science Foundation (DEB 9401094, 9870173, http://www.nsf.gov); National Geographic Society (5918-97, http://www.nationalgeographic.com/); and American Chemical Society (PRF #38572-AC8, http://www.acs.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapst DW, 2012, METHODS ECOL EVOL, V3, P803, DOI 10.1111/j.2041-210X.2012.00223.x; Blakey R, 2014, PALEOGEOGRAPHY LIB R; Brown B, 1914, B AM MUS NAT HIST, V33, P567; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Burton D., 2006, GEOLOGICAL SOC AM AB, V38, P52; Campione NE, 2013, PALAEOBIO PALAEOENV, V93, P65, DOI 10.1007/s12549-012-0097-1; Carpenter K., 1998, NEW MEXICO MUSEUM NA, V14, P249; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 1998, IDAHO MUSEUM NATURAL, V14, P297; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; Chinnery-Allgeier Brenda J., 2010, P387; Cifelli RL, 2014, ACTA PALAEONTOL POL, V59, P31, DOI 10.4202/app.2012.0089; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Cifelli RL, J VERTEBRAT IN PRESS; COOMBS WP, 1982, PALAEONTOLOGY, V25, P89; Cragin F. W, 1894, COLORADO COLL STUDIE, V5, P49; Cuenca Bescos G, J VERTEBRAT IN PRESS; Cuenca-Bescos G, 2003, ACTA PALAEONTOL POL, V48, P575; D'emic M, 2008, J VERTEBR PALEONTOL, V28, p68A; D'Emic MD, 2012, J VERTEBR PALEONTOL, V32, P883, DOI 10.1080/02724634.2012.671204; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dong Zhiming, 1997, P68; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Estep J.W., 1998, NEW MEXICO MUSEUM NA, V14, P297; Farke AA, 2010, J VERTEBR PALEONTOL, V30, P1486, DOI 10.1080/02724634.2010.501436; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Gao KQ, 2000, B AM MUS NAT HIST, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Handa N, 2012, PALEONTOL RES, V16, P179, DOI 10.2517/1342-8144-16.3.179; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hay O.P., 1902, USGS BULL, V179, P1, DOI DOI 10.5962/BHL.TITLE.20094; Hay WW, 1999, GEOL S AM S, P1; He HY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025274; Hochuli PA, 2006, J GEOL SOC LONDON, V163, P587, DOI 10.1144/0016-764905-135; Huxley T. H., 1869, GEOLOGICAL SOC LONDO, V204, P3; JACOBS LL, 1991, NEWSL STRATIGR, V24, P35; Jin LY, 2009, ACTA GEOL SIN-ENGL, V83, P200, DOI 10.1111/j.1755-6724.2009.00023.x; KAUFFMAN E. G., 1984, JURASSIC CRETACEOUS, P273; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirkland James I., 2010, P117; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Lambe L. M., 1902, CONTRIBUTIONS CANADI, V3, P23; LAMBE LM, 1904, OTTAWA NATURALIST, V18, P81; Lamsdell JC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-98; Lee YN, 2011, NATURWISSENSCHAFTEN, V98, P39, DOI 10.1007/s00114-010-0739-y; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Ludvigson GA, 2010, J SEDIMENT RES, V80, P955, DOI 10.2110/jsr.2010.086; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Makovicky Peter J., 2001, P243; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; MARSH OC, 1890, AM J SCI, V39, P81; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Meyers J.H., 1992, BASIN RES, V4, P315, DOI [10.1111/j.1365-2117.1992.tb00051.x, DOI 10.1111/J.1365-2117.1992.TB00051.X]; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; NESSOV LA, 1989, THEORETICAL APPL ASP, P144; Nopsca BF, 1923, FORSCHRITTE GEOLOGIE, V2, P1; Nydam RL, 2013, PALAEOBIO PALAEOENV, V93, P535, DOI 10.1007/s12549-013-0129-5; Oreska MPJ, 2013, J VERTEBR PALEONTOL, V33, P264, DOI 10.1080/02724634.2012.717567; Osborn H. F., 1923, American Museum Novitates, V95, P1; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; OSTROM JH, 1970, PEABODY MUSEUM NATUR, V35, P1; Owen R, 1842, 11 M BRIT ASS ADV SC, V1841, P66; Pereda-Suberbiola Javier, 1994, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V232, P133; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Russell Dale E., 1995, Historical Biology, V10, P3; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Sames B, 2011, MICROPALEONTOLOGY, V57, P345; Sames B, 2011, MICROPALEONTOLOGY, V57, P291; Sames B, 2010, EARTH-SCI REV, V101, P207, DOI 10.1016/j.earscirev.2010.05.001; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno Paul C., 2010, P21; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Sues HD, 2009, NATURWISSENSCHAFTEN, V96, P645, DOI 10.1007/s00114-009-0518-9; Sun G, 2011, NATURE, V471, P625, DOI 10.1038/nature09811; Sweetman SC, 2006, PALAEONTOLOGY, V49, P889, DOI 10.1111/j.1475-4983.2006.00564.x; Sweetman SC, 2008, PALAEONTOLOGY, V51, P1367, DOI 10.1111/j.1475-4983.2008.00816.x; Tanoue Kyo, 2010, P234; Tanoue K, 2009, CAN J EARTH SCI, V46, P425, DOI 10.1139/E09-030; Tsubamoto T, 2004, ACTA PALAEONTOL POL, V49, P329; Weishampel D.B., 1989, Journal of Vertebrate Paleontology, V9, P56; Wolfe Douglas G., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P303; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You H, 2010, NEW PERSPECTIVES HOR, P68; You HL, 2007, ACTA GEOL SIN-ENGL, V81, P898; You HL, 2005, ACTA GEOL SIN-ENGL, V79, P593; You HL, 2003, ACTA PALAEONTOL POL, V48, P261; Zaleha MJ, 2006, GEOL SOC AM BULL, V118, P886, DOI 10.1130/B25715.1; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, HIST BIOL, V23, P317, DOI 10.1080/08912963.2010.543952; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681	111	42	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e112055	10.1371/journal.pone.0112055	http://dx.doi.org/10.1371/journal.pone.0112055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494182	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400008
J	Sun, ZL; Wang, HY; Wang, J; Zhou, LM; Yang, PM				Sun, Zhenliang; Wang, Huiyan; Wang, Jing; Zhou, Lianming; Yang, Peiming			Chemical Composition and Anti-Inflammatory, Cytotoxic and Antioxidant Activities of Essential Oil from Leaves of Mentha piperita Grown in China	PLOS ONE			English	Article							DNA-DAMAGE; INFLAMMATION; CONSTITUENTS; SUPPRESSION; APOPTOSIS; OXIDE	The chemical composition, anti- inflammatory, cytotoxic and antioxidant activities of essential oil from leaves of Mentha piperita (MEO) grown in China were investigated. Using GC- MS analysis, the chemical composition of MEO was characterized, showing that it was mainly composed of menthol, menthone and menthy acetate. MEO exhibited potent anti- inflammatory activities in a croton oil-induced mouse ear edema model. It could also effectively inhibit nitric oxide (NO) and prostaglandin E2 (PGE2) production in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. The cytotoxic effect was assessed against four human cancer cells. MEO was found to be significantly active against human lung carcinoma SPC-A1, human leukemia K562 and human gastric cancer SGC-7901 cells, with an IC50 value of 10.89, 16.16 and 38.76 mu g/ml, respectively. In addition, MEO had moderate antioxidant activity. The results of this study may provide an experimental basis for further systematic research, rational development and clinical utilization of peppermint resources.	[Sun, Zhenliang; Yang, Peiming] China State Inst Pharmaceut Ind, Shanghai Inst Pharmaceut Ind, State Key Lab New Drug & Pharmaceut Proc, Shanghai 200040, Peoples R China; [Wang, Huiyan] Ji Lin Med Coll, Changchun 132013, Jilin, Peoples R China; [Wang, Jing; Zhou, Lianming] Southern Med Univ, Fengxian Hosp, Dept Gen Surg, Shanghai 201499, Peoples R China	Southern Medical University - China	Zhou, LM (corresponding author), Southern Med Univ, Fengxian Hosp, Dept Gen Surg, Shanghai 201499, Peoples R China.	lianmingzhou@163.com; qqsohu@163.com						Abbas SR, 2014, FOOD CHEM, V147, P10, DOI 10.1016/j.foodchem.2013.09.113; Chou ST, 2012, FOOD CHEM, V134, P262, DOI 10.1016/j.foodchem.2012.02.131; Duh CY, 1999, J NAT PROD, V62, P1518, DOI 10.1021/np990212d; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; He K, 1997, J NAT PROD, V60, P38, DOI 10.1021/np960513c; Iscan G, 2002, J AGR FOOD CHEM, V50, P3943, DOI 10.1021/jf011476k; Kim JY, 2008, J OLEO SCI, V57, P623, DOI 10.5650/jos.57.623; Lampronti I, 2006, INT J ONCOL, V29, P989; Li LJ, 2011, PHYTOTHER RES, V25, P1095, DOI 10.1002/ptr.3367; Lin CT, 2008, BIORESOURCE TECHNOL, V99, P8783, DOI 10.1016/j.biortech.2008.04.041; Liu J, 2012, J PHARM PHARMACOL, V64, P146, DOI 10.1111/j.2042-7158.2011.01371.x; Liu X, 2012, CARBOHYD POLYM, V90, P1664, DOI 10.1016/j.carbpol.2012.07.047; Lu CG, 2008, J ANHUI AGR SCI, V36, P425; [陆长根 LU Changgen], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P400; Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Menichini F, 2009, FOOD CHEM, V115, P679, DOI 10.1016/j.foodchem.2008.12.067; Mimica-Dukic N, 2003, PLANTA MED, V69, P413, DOI 10.1055/s-2003-39704; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pattrick P, 2008, ESTUAR COAST SHELF S, V79, P251, DOI 10.1016/j.ecss.2008.04.009; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Rashid S, 2013, FOOD CHEM, V138, P693, DOI 10.1016/j.foodchem.2012.10.102; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tung YT, 2008, BIORESOURCE TECHNOL, V99, P3908, DOI 10.1016/j.biortech.2007.07.050; Tyagi AK, 2011, FOOD CONTROL, V22, P1707, DOI 10.1016/j.foodcont.2011.04.002; Xu PengXiang, 2003, Chemistry and Industry of Forest Products, V23, P43; Yadegarinia D, 2006, PHYTOCHEMISTRY, V67, P1249, DOI 10.1016/j.phytochem.2006.04.025; Yu JQ, 2011, FOOD CHEM, V126, P1593, DOI 10.1016/j.foodchem.2010.12.027	28	65	65	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114767	10.1371/journal.pone.0114767	http://dx.doi.org/10.1371/journal.pone.0114767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493616	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400075
J	Tagirov, M; Rutkowska, J				Tagirov, Makhsud; Rutkowska, Joanna			Sexual Dimorphism in the Early Embryogenesis in Zebra Finches	PLOS ONE			English	Article							DOSAGE COMPENSATION; BOVINE EMBRYOS; DEVELOPMENTAL RATES; GROWTH-HORMONE; EXPRESSION; GENES; DIFFERENTIATION; METABOLISM; FEMALE; STAGE	Sex-specific gene expression before the onset of gonadogensis has been documented in embryos of mammals and chickens. In several mammalian species, differences in gene expression are accompanied by faster growth of preimplantation male embryos. Here we asked whether avian embryos before gonadal differentiation are also sex-dimorphic in size and what genes regulate their growth. We used captive zebra finches (Taeniopygia guttata) whose freshly laid eggs were artificially incubated for 36-40 hours. Analyses controlling for the exact time of incubation of 81 embryos revealed that males were larger than females in terms of Hamburger and Hamilton stage and number of somites. Expression of 15 genes involved in cell cycle regulation, growth, metabolic activity, steroidogenic pathway and stress modulation were measured using RT-PCR in 5 male and 5 female embryos incubated for exactly 36 h. We found that in the presence of equal levels of the growth hormone itself, the faster growth of male embryos is most likely achieved by the overexpression of the growth hormone receptor gene and three other genes responsible for cell cycle regulation and metabolism, all of them located on the Z chromosome. Autosomal genes did not show sex-specific expression, except for the steroidogenic factor 1 which was expressed only in female embryos. To our knowledge this is the first report of sexual size dimorphism before gonadogenesis in birds. The finding suggests that faster growth of early male embryos is conserved through the mammalian and bird phyla, irrespective of their differential sex chromosome systems.	[Tagirov, Makhsud] Ukrainian Acad Agrarian Sci, Poultry Res Inst, Borky, Ukraine; [Rutkowska, Joanna] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	National Academy of Agrarian Sciences of Ukraine; State Poultry Research Station of the National Academy of Agrarian Sciences of Ukraine; Jagiellonian University	Rutkowska, J (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	joanna.rutkowska@uj.edu.pl	Rutkowska, Joanna/ABD-6205-2021; Rutkowska, Joanna/A-8309-2008	Rutkowska, Joanna/0000-0003-0396-1790; Rutkowska, Joanna/0000-0003-0396-1790; Tagirov, Makhsud/0000-0001-5720-0802	Polish National Science Center [2012/07/B/NZ8/01293];  [757/K/ZDS/004151]	Polish National Science Center; 	The study was financially supported by the grant from the Polish National Science Center (2012/07/B/NZ8/01293) to J.R. and the 757/K/ZDS/004151, http://www.ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2013, DEV DYNAM, V242, P371, DOI 10.1002/dvdy.23936; AVERY B, 1992, MOL REPROD DEV, V32, P265, DOI 10.1002/mrd.1080320312; Bernardi ML, 1996, HUM REPROD, V11, P621, DOI 10.1093/HUMREP/11.3.621; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Carre GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023959; CASSAR G, 1994, J REPROD FERTIL, V101, P317, DOI 10.1530/jrf.0.1010317; Feng YP, 2009, ACTA BIOCH BIOPH SIN, V41, P285, DOI 10.1093/abbs/gmp012; Ganuza M, 2012, EMBO J, V31, P2498, DOI 10.1038/emboj.2012.94; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Graves JAM, 2014, CHROMOSOME RES, V22, P45, DOI 10.1007/s10577-014-9409-9; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; Gutierrez-Adan A, 2006, REPROD DOMEST ANIM, V41, P54, DOI 10.1111/j.1439-0531.2006.00769.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey S, 2000, J ENDOCRINOL, V166, P489, DOI 10.1677/joe.0.1660489; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jost, 1947, ARCH ANAT MICR MORPH, V36, P271; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; McQueen HA, 2001, CURR BIOL, V11, P253, DOI 10.1016/S0960-9822(01)00070-7; Menezo YJR, 1999, FERTIL STERIL, V72, P221, DOI 10.1016/S0015-0282(99)00256-3; Murray JR, 2013, J MORPHOL, V274, P1090, DOI 10.1002/jmor.20165; PEIPPO J, 1995, MOL REPROD DEV, V40, P56, DOI 10.1002/mrd.1080400108; PERGAMENT E, 1994, HUM REPROD, V9, P1730, DOI 10.1093/oxfordjournals.humrep.a138783; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; RAY PF, 1995, J REPROD FERTIL, V104, P165; RIEGER D, 1992, THERIOGENOLOGY, V37, P75, DOI 10.1016/0093-691X(92)90248-P; Smith CA, 1999, GEN COMP ENDOCR, V113, P187, DOI 10.1006/gcen.1998.7214; Soderstrom K, 2007, J NEUROSCI METH, V164, P116, DOI 10.1016/j.jneumeth.2007.04.007; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125; Tillmann H, 2002, GENE, V291, P57, DOI 10.1016/S0378-1119(02)00627-3; TSUNODA Y, 1985, GAMETE RES, V12, P301, DOI 10.1002/mrd.1120120308; VALDIVIA RPA, 1993, MOL REPROD DEV, V35, P121, DOI 10.1002/mrd.1080350204; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Wallenfang MR, 2002, P NATL ACAD SCI USA, V99, P5527, DOI 10.1073/pnas.082618399; XU KP, 1992, MOL REPROD DEV, V31, P249, DOI 10.1002/mrd.1080310404; YADAV BR, 1993, MOL REPROD DEV, V36, P434, DOI 10.1002/mrd.1080360405; Zhang SBO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-13; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	42	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114625	10.1371/journal.pone.0114625	http://dx.doi.org/10.1371/journal.pone.0114625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493645	gold, Green Submitted, Green Published			2022-12-27	WOS:000346611400061
J	Aper, SJA; van Spreeuwel, ACC; van Turnhout, MC; van der Linden, AJ; Pieters, PA; van der Zon, NLL; de la Rambelje, SL; Bouten, CVC; Merkx, M				Aper, Stijn J. A.; van Spreeuwel, Ariane C. C.; van Turnhout, Mark C.; van der Linden, Ardjan J.; Pieters, Pascal A.; van der Zon, Nick L. L.; de la Rambelje, Sander L.; Bouten, Carlijn V. C.; Merkx, Maarten			Colorful Protein-Based Fluorescent Probes for Collagen Imaging	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; IN-VIVO; EXTRACELLULAR-MATRIX; TISSUE; MICROSCOPY; BINDING; 3D; AUTOFLUORESCENCE; QUANTIFICATION; VISUALIZATION	Real-time visualization of collagen is important in studies on tissue formation and remodeling in the research fields of developmental biology and tissue engineering. Our group has previously reported on a fluorescent probe for the specific imaging of collagen in live tissue in situ, consisting of the native collagen binding protein CNA35 labeled with fluorescent dye Oregon Green 488 (CNA35-OG488). The CNA35-OG488 probe has become widely used for collagen imaging. To allow for the use of CNA35-based probes in a broader range of applications, we here present a toolbox of six genetically-encoded collagen probes which are fusions of CNA35 to fluorescent proteins that span the visible spectrum: mTurquoise2, EGFP, mAmetrine, LSSmOrange, tdTomato and mCherry. While CNA35-OG488 requires a chemical conjugation step for labeling with the fluorescent dye, these protein-based probes can be easily produced in high yields by expression in E. coli and purified in one step using Ni2+-affinity chromatography. The probes all bind specifically to collagen, both in vitro and in porcine pericardial tissue. Some first applications of the probes are shown in multicolor imaging of engineered tissue and two-photon imaging of collagen in human skin. The fully-genetic encoding of the new probes makes them easily accessible to all scientists interested in collagen formation and remodeling.	[Aper, Stijn J. A.; van der Linden, Ardjan J.; Pieters, Pascal A.; van der Zon, Nick L. L.; de la Rambelje, Sander L.; Merkx, Maarten] Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, Eindhoven, Netherlands; [Aper, Stijn J. A.; van der Linden, Ardjan J.; Pieters, Pascal A.; van der Zon, Nick L. L.; de la Rambelje, Sander L.; Merkx, Maarten] Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands; [van Spreeuwel, Ariane C. C.; van Turnhout, Mark C.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	Merkx, M (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, Eindhoven, Netherlands.	m.merkx@tue.nl	Merkx, Maarten/E-7009-2011; Bouten, Carlijn/AAT-5187-2020	Bouten, Carlijn/0000-0003-1035-5094; van der Zon, Nick L L/0000-0003-4198-0634; Pieters, Pascal/0000-0003-2032-0100; van Turnhout, Mark/0000-0002-2465-8427	ERC starting grant [ERC-2011-StG 280255]; Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]	ERC starting grant; Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM)	This work was supported by an ERC starting grant (ERC-2011-StG 280255) and a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant no. FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8; Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Breurken M, 2011, CHEM COMMUN, V47, P7998, DOI 10.1039/c1cc11964h; Breurken M, 2010, CHEMBIOCHEM, V11, P1665, DOI 10.1002/cbic.201000223; Brownfield DG, 2013, CURR BIOL, V23, P703, DOI 10.1016/j.cub.2013.03.032; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chai CK, 2013, J BIOMECH, V46, P1759, DOI 10.1016/j.jbiomech.2013.03.017; Chen JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019097; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; Cox MAJ, 2010, TISSUE ENG PT A, V16, P1527, DOI [10.1089/ten.tea.2009.0263, 10.1089/ten.TEA.2009.0263]; Danila D, 2013, NANOMED-NANOTECHNOL, V9, P1067, DOI 10.1016/j.nano.2013.03.009; de Jonge N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073161; de Jonge N, 2013, ANN BIOMED ENG, V41, P763, DOI 10.1007/s10439-012-0704-3; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Foolen J, 2012, BIOMATERIALS, V33, P7508, DOI 10.1016/j.biomaterials.2012.06.103; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Fritze O, 2010, TISSUE ENG PART C-ME, V16, P705, DOI [10.1089/ten.tec.2009.0309, 10.1089/ten.TEC.2009.0309]; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; GLASSMAN W, 1995, AM J OBSTET GYNECOL, V173, P1550, DOI 10.1016/0002-9378(95)90648-7; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huyghe JM, 2012, BIOMECH MODEL MECHAN, V11, P161, DOI 10.1007/s10237-011-0300-8; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Klink A, 2011, J AM COLL CARDIOL, V58, P2522, DOI 10.1016/j.jacc.2011.09.017; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li Y, 2013, CURR OPIN CHEM BIOL, V17, P968, DOI 10.1016/j.cbpa.2013.10.018; Mees G, 2012, J NUCL MED, V53, P464, DOI 10.2967/jnumed.111.095794; Megens RTA, 2007, MOL IMAGING, V6, P247, DOI 10.2310/7290.2007.00021; Megens RTA, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2965542; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rubbens MP, 2009, ANN BIOMED ENG, V37, P1263, DOI 10.1007/s10439-009-9698-x; Rubbens MP, 2009, TISSUE ENG PT A, V15, P999, DOI 10.1089/ten.tea.2007.0396; Sanders HMHF, 2009, CONTRAST MEDIA MOL I, V4, P81, DOI 10.1002/cmmi.266; Sanders HMHF, 2011, CHEM COMMUN, V47, P1503, DOI 10.1039/c0cc02901g; Schrauwen JTC, 2012, J STRUCT BIOL, V180, P335, DOI 10.1016/j.jsb.2012.06.007; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; van Bochove GS, 2012, EUR J INORG CHEM, P2115, DOI 10.1002/ejic.201200010; van Spreeuwel AC, 2014, INTEGR BIOL CAMB; Vis PWR, 2012, J CELL MOL MED, V16, P730, DOI 10.1111/j.1582-4934.2011.01351.x; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Xia ZY, 2011, ACS CHEM BIOL, V6, P1117, DOI 10.1021/cb200135e; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	52	45	45	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114983	10.1371/journal.pone.0114983	http://dx.doi.org/10.1371/journal.pone.0114983			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490719	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300100
J	Lin, LJ; Liao, MA; Ren, YJ; Luo, L; Zhang, X; Yang, DY; He, J				Lin, Lijin; Liao, Ming'an; Ren, Yajun; Luo, Li; Zhang, Xiao; Yang, Daiyu; He, Jing			Effects of Mulching Tolerant Plant Straw on Soil Surface on Growth and Cadmium Accumulation of Galinsoga parviflora	PLOS ONE			English	Article							HYPERACCUMULATOR; RICE; LEAD; VARIETIES	Pot and field experiments were conducted to study the effects of mulching with straw of cadmium (Cd) tolerant plants (Ranunculus sieboldii, Mazus japonicus, Clinopodium confine and Plantago asiatica) on growth and Cd accumulation of Galinsoga parviflora in Cd-contaminated soil. In the pot experiment, mulching with M. japonicus straw increased the root biomass, stem biomass, leaf biomass, shoot biomass, plant height and activities of antioxidant enzymes (superoxide dismutase, peroxidase and catalase) of G. parviflora compared with the control, whereas mulching with straws of R. sieboldii, C. confine and P. asiatica decreased these parameters. Straws of the four Cd-tolerant plants increased the Cd content in roots of G. parviflora compared with the control. However, only straws of M. japonicus and P. asiatica increased the Cd content in shoots of G. parviflora, reduced the soil pH, and increased the soil exchangeable Cd concentration. Straw of M. japonicus increased the amount of Cd extraction in stems, leaves and shoots of G. parviflora by 21.11%, 29.43% and 24.22%, respectively, compared with the control, whereas straws of the other three Cd-tolerant plants decreased these parameters. In the field experiment, the M. japonicus straw also increased shoot biomass, Cd content in shoots, and amount of Cd extraction in shoots of G. parviflora compared with the control. Therefore, straw of M. japonicus can be used to improve the Cd extraction ability of G. parviflora from Cd-contaminated soil.	[Lin, Lijin; Liao, Ming'an; Ren, Yajun; Luo, Li; Zhang, Xiao; Yang, Daiyu; He, Jing] Sichuan Agr Univ, Coll Hort, Yaan 625014, Sichuan, Peoples R China; [Lin, Lijin] Yaan Soil & Water Conservat Monitoring Substn, Yaan 625000, Sichuan, Peoples R China	Sichuan Agricultural University	Liao, MA (corresponding author), Sichuan Agr Univ, Coll Hort, Yaan 625014, Sichuan, Peoples R China.	lman@sicau.edu.cn						Bao S.D., 2000, AGROCHEMICAL ANAL SO, V3rd ed.; Blanco-Canqui H, 2007, SOIL TILL RES, V95, P240, DOI 10.1016/j.still.2007.01.004; [陈良华 Chen Lianghua], 2012, [四川农业大学学报, Journal of Sichuan Agricultural University], V30, P174; DATTA R, 2004, ENV GEOSCI, V11, P53, DOI DOI 10.1306/eg.08280303014; Du RJ, 2011, INT J PHYTOREMEDIAT, V13, P1024, DOI 10.1080/15226514.2010.549862; Einhellig FA, 1996, AGRON J, V88, P886, DOI 10.2134/agronj1996.00021962003600060007x; Ge Xiao, 2014, Journal of Ecology and Rural Environment, V30, P369; Gong B, 2013, SCI HORTIC-AMSTERDAM, V161, P49, DOI 10.1016/j.scienta.2013.06.027; Hao Z.B., 2004, PLANT PHYSL EXPT; Kulikova ZL, 2010, B ENVIRON CONTAM TOX, V85, P243, DOI 10.1007/s00128-010-0046-5; Li YJ., 2001, ENV PROBLEMS COUNTER; Lin LJ, 2014, ENVIRON TOXICOL CHEM, V33, P2422, DOI 10.1002/etc.2694; Lin LJ, 2014, ENVIRON TOXICOL CHEM, V33, P1950, DOI 10.1002/etc.2626; Liu D, 2007, B ENVIRON CONTAM TOX, V78, P280, DOI 10.1007/s00128-007-9121-y; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042944; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Maestri E, 2010, ENVIRON EXP BOT, V68, P1, DOI 10.1016/j.envexpbot.2009.10.011; Marques APGC, 2009, CRIT REV ENV SCI TEC, V39, P622, DOI 10.1080/10643380701798272; McGrath SP, 2002, ADV AGRON, V75, P1, DOI 10.1016/S0065-2113(02)75002-5; [聂发辉 Nie Fahui], 2005, [生态环境, Ecology and Environment], V14, P136; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Rastmanesh F, 2010, B ENVIRON CONTAM TOX, V85, P515, DOI 10.1007/s00128-010-0149-z; Shan YuHua, 2006, Acta Pedologica Sinica, V43, P941; Tatar E, 1998, MICROCHEM J, V58, P306, DOI 10.1006/mchj.1997.1559; van Asten PJA, 2005, NUTR CYCL AGROECOSYS, V72, P255, DOI 10.1007/s10705-005-3108-z; Wang ME, 2006, ENVIRON POLLUT, V144, P572, DOI 10.1016/j.envpol.2006.01.024; Whitbread A, 2003, AGR ECOSYST ENVIRON, V100, P251, DOI 10.1016/S0167-8809(03)00189-0; Whiting SN, 2001, ENVIRON SCI TECHNOL, V35, P3237, DOI 10.1021/es010644m; Yang YY, 2000, PLANT PHYSIOL, V124, P1019, DOI 10.1104/pp.124.3.1019; Zhang XF, 2011, J HAZARD MATER, V189, P414, DOI 10.1016/j.jhazmat.2011.02.053; Zhao HuaYin, 2011, Journal of Environmental Protection, V2, P932, DOI 10.4236/jep.2011.27106; Zhu HH, 2010, PLANT SOIL, V331, P427, DOI 10.1007/s11104-009-0263-z	32	27	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114957	10.1371/journal.pone.0114957	http://dx.doi.org/10.1371/journal.pone.0114957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490210	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300097
J	Okoli, GN; Otete, HE; Beck, CR; Nguyen-Van-Tam, JS				Okoli, George N.; Otete, Harmony E.; Beck, Charles R.; Nguyen-Van-Tam, Jonathan S.			Use of Neuraminidase Inhibitors for Rapid Containment of Influenza: A Systematic Review and Meta-Analysis of Individual and Household Transmission Studies	PLOS ONE			English	Article							PANDEMIC H1N1 2009; OSELTAMIVIR TREATMENT; HEALTHY-ADULTS; PREVENTION; ZANAMIVIR; INFECTION; PROPHYLAXIS; DURATION; ILLNESS	Objectives: To assess the effectiveness of neuraminidase inhibitors for use in rapid containment of influenza. Method: We conducted a systematic review and meta-analysis in accordance with the PRISMA statement. Healthcare databases and sources of grey literature were searched up to 2012 and records screened against protocol eligibility criteria. Data extraction and risk of bias assessments were performed using a piloted form. Results were synthesised narratively and we undertook meta-analyses to calculate pooled estimates of effect, statistical heterogeneity and assessed publication bias. Findings: Nine randomised controlled trials (RCTs) and eight observational studies met the inclusion criteria. Neuraminidase inhibitors provided 67 to 89% protection for individuals following prophylaxis. Meta-analysis of individual protection showed a significantly lower pooled odds of laboratory confirmed seasonal or influenza A(H1N1) pdm09 infection following oseltamivir usage compared to placebo or no therapy (n=8 studies; odds ratio (OR) 50.11; 95% confidence interval (CI)=50.06 to 0.20; p<0.001; I-2=58.7%). This result was comparable to the pooled odds ratio for individual protection with zanamivir (OR=0.23; 95% CI 0.16 to 0.35). Similar point estimates were obtained with widely overlapping 95% CIs for household protection with oseltamivir or zanamivir. We found no studies of neuraminidase inhibitors to prevent population-wide community transmission of influenza. Conclusion: Oseltamivir and zanamivir are effective for prophylaxis of individuals and households irrespective of treatment of the index case. There are no data which directly support an effect on wider community transmission.	[Okoli, George N.; Otete, Harmony E.; Beck, Charles R.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham	Nguyen-Van-Tam, JS (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	jvt@nottingham.ac.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Otete, Harmony/0000-0003-2467-2605	World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	This study was commissioned and funded by the World Health Organization (WHO) with the purpose of informing the review of its Pandemic Influenza Risk Management Guidance on pandemic influenza preparedness. The University of Nottingham Health Protection and Influenza Research Group is an official WHO Collaborating Centre for pandemic influenza and research. It receives limited funding from the WHO in support of specific activities. The funders contributed towards specifying the research questions but had no role in methodological design, data collection and analysis, or preparation of this manuscript.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2007, WHO GEN TECH REP; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centre for Reviews and Dissemination, 2008, SYSTEMATIC REV; Cooper NJ, 2003, BMJ, V326; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Fallo AA, 2012, PEDIATR INFECT DIS J, V31, P781, DOI 10.1097/INF.0b013e318256c06b; Fry AM, 2014, LANCET INFECT DIS, V14, P109, DOI 10.1016/S1473-3099(13)70267-6; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Higgens J, 2009, COCHRANE HDB SYSTEMA; Jackson RJ, 2011, J INFECTION, V62, P14, DOI 10.1016/j.jinf.2010.10.003; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2014, NEURAMINIDASE INHIBI; Jefferson Tom, 2009, BMJ, V339, pb5106, DOI 10.1136/bmj.b5106; Kaiser L, 2000, CLIN INFECT DIS, V30, P587, DOI 10.1086/313696; LaForce C, 2007, CLIN THER, V29, P1579, DOI 10.1016/j.clinthera.2007.08.023; Langley JM, 2004, CAN MED ASSOC J, V171, P1213, DOI 10.1503/cmaj.1031737; Lee VJ, 2010, NEW ENGL J MED, V362, P2166, DOI 10.1056/NEJMoa0908482; Leung YH, 2011, EPIDEMIOL INFECT, V139, P41, DOI 10.1017/S0950268810001445; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nishiura H, 2011, J INT MED RES, V39, P619, DOI 10.1177/147323001103900231; Odaira F, 2009, EUROSURVEILLANCE, V14, P2; Okoli GN, 2013, PROSPERO; Pebody RG, 2011, EMERG INFECT DIS, V17, P990, DOI [10.3201/eid1706.101161, 10.3201/eid/1706.101161]; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, P449; Wang K, 2012, COCHRANE DATABASE SY; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; World Health Organization, 2011, WHO REG OFF EUR GUID; World Health Organization, 2009, INT WHO GUID SURV HU	41	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113633	10.1371/journal.pone.0113633	http://dx.doi.org/10.1371/journal.pone.0113633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490762	Green Accepted, gold, Green Published			2022-12-27	WOS:000347515300011
J	Badrinarayan, P; Sastry, GN				Badrinarayan, Preethi; Sastry, G. Narahari			Specificity Rendering 'Hot-Spots' for Aurora Kinase Inhibitor Design: The Role of Non-Covalent Interactions and Conformational Transitions	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; P38 MAP KINASE; CRYSTAL-STRUCTURE; INACTIVE CONFORMATIONS; SECONDARY STRUCTURE; PROTEIN-KINASES; A KINASE; BINDING; POTENT; DATABASE	The present study examines the conformational transitions occurring among the major structural motifs of Aurora kinase (AK) concomitant with the DFG-flip and deciphers the role of non-covalent interactions in rendering specificity. Multiple sequence alignment, docking and structural analysis of a repertoire of 56 crystal structures of AK from Protein Data Bank (PDB) has been carried out. The crystal structures were systematically categorized based on the conformational disposition of the DFG-loop [in (D-I) 42, out (D-O) 5 and out-up (D-OU) 9], G-loop [extended (G(E)) 53 and folded (G(F)) 3] and alpha C-helix [in (C-I) 42 and out (C-O) 14]. The overlapping subsets on categorization show the inter-dependency among structural motifs. Therefore, the four distinct possibilities a) 2W1C (D-I, C-I, G(E)) b) 3E5A (D-I, C-I, G(F)) c) 3DJ6 (D-I, C-O, G(F)) d) 3UNZ (D-OU, C-O, G(F)) along with their co-crystals and apo-forms were subjected to molecular dynamics simulations of 40 ns each to evaluate the variations of individual residues and their impact on forming interactions. The non-covalent interactions formed by the 157 AK co-crystals with different regions of the binding site were initially studied with the docked complexes and structure interaction fingerprints. The frequency of the most prominent interactions was gauged in the AK inhibitors from PDB and the four representative conformations during 40 ns. Based on this study, seven major non-covalent interactions and their complementary sites in AK capable of rendering specificity have been prioritized for the design of different classes of inhibitors.	[Badrinarayan, Preethi; Sastry, G. Narahari] Indian Inst Chem Technol, CSIR, Mol Modeling Grp, Hyderabad 500607, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Sastry, GN (corresponding author), Indian Inst Chem Technol, CSIR, Mol Modeling Grp, Hyderabad 500607, Andhra Pradesh, India.	gnsastry@gmail.com	Badrinarayan, Preethi/D-4442-2014	Badrinarayan, Preethi/0000-0001-6167-1754	CSIR 12th Five Year Project GENESIS [BSC 0121]	CSIR 12th Five Year Project GENESIS	Funding for this work came from the CSIR 12th Five Year Project GENESIS (BSC 0121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2012, XLSTAT 2012 DAT AN S; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CB, 2008, ACS CHEM BIOL, V3, P180, DOI 10.1021/cb700200w; Badrinarayan P, 2013, CURR PHARM DESIGN, V19, P4714, DOI 10.2174/1381612811319260005; Badrinarayan P, 2012, J MOL GRAPH MODEL, V34, P89, DOI 10.1016/j.jmgm.2011.12.009; Badrinarayan P, 2011, COMB CHEM HIGH T SCR, V14, P840, DOI 10.2174/138620711797537102; Badrinarayan P, 2011, J CHEM INF MODEL, V51, P115, DOI 10.1021/ci100340w; Bavetsias V, 2013, J MED CHEM, V56, P9122, DOI 10.1021/jm401115g; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Cancilla MT, 2008, BIOORG MED CHEM LETT, V18, P3978, DOI 10.1016/j.bmcl.2008.06.011; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Dietrich J, 2010, BIOORGAN MED CHEM, V18, P5738, DOI 10.1016/j.bmc.2010.05.063; Dixon SL, 2006, CHEM BIOL DRUG DES, V67, P370, DOI 10.1111/j.1747-0285.2006.00384.x; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Eswar M.A., 2006, CURR PROTOC BIOINF, V15, P561; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Ghose AK, 2008, J MED CHEM, V51, P5149, DOI 10.1021/jm800475y; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Guimaraes CRW, 2011, J CHEM INF MODEL, V51, P1199, DOI 10.1021/ci200153c; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Helms V, 1997, PROTEIN SCI, V6, P2336; Heron NM, 2006, BIOORG MED CHEM LETT, V16, P1320, DOI 10.1016/j.bmcl.2005.11.053; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hyeon C, 2009, P NATL ACAD SCI USA, V106, P3023, DOI 10.1073/pnas.0813266106; Hynes J, 2008, J MED CHEM, V51, P4, DOI 10.1021/jm7009414; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kuglstatter A, 2010, BIOORG MED CHEM LETT, V20, P5217, DOI 10.1016/j.bmcl.2010.06.157; Kulkarni RG, 2006, CURR PHARM DESIGN, V12, P2437, DOI 10.2174/138161206777698945; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Libertini S, 2010, RECENT PAT ANTI-CANC, V5, P219, DOI 10.2174/157489210791760517; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin AJM, 2011, BIOINFORMATICS, V27, P2003, DOI 10.1093/bioinformatics/btr191; Martin MP, 2012, ACS CHEM BIOL, V7, P698, DOI 10.1021/cb200508b; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mountzios G, 2008, CANCER TREAT REV, V34, P175, DOI 10.1016/j.ctrv.2007.09.005; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliveira TM, 2011, J PHYS CHEM A, V115, P3895, DOI 10.1021/jp108286r; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Patel RY, 2010, J PROTEOME RES, V9, P4433, DOI 10.1021/pr100662s; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pflug A, 2011, BIOCHEM J, V440, P85, DOI 10.1042/BJ20110592; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Reddy AS, 2008, COMPUT BIOL CHEM, V32, P387, DOI 10.1016/j.compbiolchem.2008.03.017; Reddy AS, 2007, PROTEINS, V67, P1179, DOI 10.1002/prot.21202; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Solanki S, 2011, J MED CHEM, V54, P1626, DOI 10.1021/jm1011726; Telesco SE, 2011, MOL BIOSYST, V7, P2066, DOI 10.1039/c0mb00345j; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Linden OPJ, 2014, J MED CHEM, V57, P249, DOI 10.1021/jm400378w; Vijay D, 2010, CHEM PHYS LETT, V485, P235, DOI 10.1016/j.cplett.2009.12.012; Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016757; Yan AX, 2011, DRUG DISCOV TODAY, V16, P260, DOI 10.1016/j.drudis.2010.12.003; Yang Y, 2012, MOL BIOSYST, V8, P3049, DOI 10.1039/c2mb25217a; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t; Zhou P, 2012, CURR MED CHEM, V19, P226, DOI 10.2174/092986712803414150; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P2108, DOI 10.1021/ct700166f	87	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113773	10.1371/journal.pone.0113773	http://dx.doi.org/10.1371/journal.pone.0113773			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485544	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600026
J	Lee, SJ; Ritchie, CS; Yaffe, K; Cenzer, IS; Barnes, DE				Lee, Sei J.; Ritchie, Christine S.; Yaffe, Kristine; Cenzer, Irena Stijacic; Barnes, Deborah E.			A Clinical Index to Predict Progression from Mild Cognitive Impairment to Dementia Due to Alzheimer's Disease	PLOS ONE			English	Article							OLDER-ADULTS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RISK; RECOMMENDATIONS; CLASSIFICATION; VALIDATION; BIOMARKERS; CONVERSION	Background: Mild cognitive impairment is often a precursor to dementia due to Alzheimer's disease, but many patients with mild cognitive impairment never develop dementia. New diagnostic criteria may lead to more patients receiving a diagnosis of mild cognitive impairment. Objective: To develop a prediction index for the 3-year risk of progression from mild cognitive impairment to dementia relying only on information that can be readily obtained in most clinical settings. Design and Participants: 382 participants diagnosed with amnestic mild cognitive impairment enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI), a multi-site, longitudinal, observational study. Main Predictors Measures: Demographics, comorbid conditions, caregiver report of participant symptoms and function, and participant performance on individual items from basic neuropsychological scales. Main Outcome Measure: Progression to probable Alzheimer's disease. Key Results: Subjects had a mean (SD) age of 75 (7) years and 43% progressed to probable Alzheimer's disease within 3 years. Important independent predictors of progression included being female, resisting help, becoming upset when separated from caregiver, difficulty shopping alone, forgetting appointments, number of words recalled from a 10-word list, orientation and difficulty drawing a clock. The final point score could range from 0 to 16 (mean [SD]: 4.2 [2.9]). The optimism-corrected Harrell's c-statistic was 0.71(95% CI: 0.68-0.75). Fourteen percent of subjects with low risk scores (0-2 points, n=124) converted to probable Alzheimer's disease over 3 years, compared to 51% of those with moderate risk scores (3-8 points, n=223) and 91% of those with high risk scores (9-16 points, n=35). Conclusions: An index using factors that can be obtained in most clinical settings can predict progression from amnestic mild cognitive impairment to probable Alzheimer's disease and may help clinicians differentiate between mild cognitive impairment patients at low vs. high risk of progression.	[Lee, Sei J.; Ritchie, Christine S.; Cenzer, Irena Stijacic] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Lee, Sei J.; Ritchie, Christine S.; Yaffe, Kristine; Cenzer, Irena Stijacic; Barnes, Deborah E.] San Francisco VA Med Ctr, San Francisco, CA USA; [Ritchie, Christine S.] Jewish Home San Francisco, San Francisco, CA USA; [Yaffe, Kristine; Barnes, Deborah E.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine; Barnes, Deborah E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lee, SJ (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.	sei.lee@ucsf.edu			S.D. Bechtel, Jr. Foundation; National Institutes of Health [K24-AG031155, R01-DK69406, R01-AG26720]; Veterans Health Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031155, P30AG044281, R01AG026720] Funding Source: NIH RePORTER	S.D. Bechtel, Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SJL was supported by the S.D. Bechtel, Jr. Foundation (http://sdbjrfoundation.org/). KY was supported for this study by the National Institutes of Health (K24-AG031155, R01-DK69406 and R01-AG26720) and the Veterans Health Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahalt C, 2012, J GEN INTERN MED, V27, P568, DOI 10.1007/s11606-011-1933-0; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Brodaty H, 2013, ALZHEIMERS DEMENT, V9, P310, DOI 10.1016/j.jalz.2011.11.010; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miao Y, 2013, SAS GLOBAL FORUM, P504; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Mohs RC., 1994, ADM SCORING MANUAL A; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Panza F, 2005, AM J GERIAT PSYCHIAT, V13, P633, DOI 10.1176/appi.ajgp.13.8.633; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Robinson L, 2011, INT PSYCHOGERIATR, V23, P1026, DOI 10.1017/S1041610210002437; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Zhou B, 2012, J ALZHEIMERS DIS, V30, P367, DOI 10.3233/JAD-2012-112117	39	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113535	10.1371/journal.pone.0113535	http://dx.doi.org/10.1371/journal.pone.0113535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486250	Green Published, gold			2022-12-27	WOS:000346907600021
J	Walthers, CM; Lee, M; Wu, BM; Dunn, JCY				Walthers, Christopher M.; Lee, Min; Wu, Benjamin M.; Dunn, James C. Y.			Smooth Muscle Strips for Intestinal Tissue Engineering	PLOS ONE			English	Article							COLLAGEN EXPRESSION; INTERSTITIAL-CELLS; SCAFFOLDS; GROWTH; NEUROTRANSMISSION; DIFFERENTIATION; PROLIFERATION; MACROPOROSITY; ARCHITECTURE; TGF-BETA-1	Functionally contracting smooth muscle is an essential part of the engineered intestine that has not been replicated in vitro. The purpose of this study is to produce contracting smooth muscle in culture by maintaining the native smooth muscle organization. We employed intact smooth muscle strips and compared them to dissociated smooth muscle cells in culture for 14 days. Cells isolated by enzymatic digestion quickly lost maturity markers for smooth muscle cells and contained few enteric neural and glial cells. Cultured smooth muscle strips exhibited periodic contraction and maintained neural and glial markers. Smooth muscle strips cultured for 14 days also exhibited regular fluctuation of intracellular calcium, whereas cultured smooth muscle cells did not. After implantation in omentum for 14 days on polycaprolactone scaffolds, smooth muscle strip constructs expressed high levels of smooth muscle maturity markers as well as enteric neural and glial cells. Intact smooth muscle strips may be a useful component for engineered intestinal smooth muscle.	[Walthers, Christopher M.; Wu, Benjamin M.; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Div Adv Prosthodont Biomat, Los Angeles, CA USA; [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Hosp Dent, Los Angeles, CA USA; [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA USA; [Dunn, James C. Y.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dunn, JCY (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	jdunn@mednet.ucla.edu		Wu, Benjamin/0000-0001-5236-8534	National Institutes of Health [R01 DK083119]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an R01 DK083119 from the National Institutes of Health (www.nih.gov) received by JCYD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2001, FASEB J, V15, P1546, DOI 10.1096/fj.00-0756com; Altomare A, 2014, AM J PHYSIOL-GASTR L, V307, pG77, DOI 10.1152/ajpgi.00385.2013; Bines JE, 2009, J GASTROEN HEPATOL, V24, pS86, DOI 10.1111/j.1440-1746.2009.06077.x; Bulick AS, 2009, TISSUE ENG PT A, V15, P815, DOI 10.1089/ten.tea.2008.0179; Cha JM, 2006, ARTIF ORGANS, V30, P704, DOI 10.1111/j.1525-1594.2006.00287.x; de Filippo RE, 2003, TISSUE ENG, V9, P301, DOI 10.1089/107632703764664765; De Philippo RE, 2008, TRANSPLANTATION, V86, P208, DOI 10.1097/TP.0b013e31817f1686; Donohoe CL, 2010, SURG-J R COLL SURG E, V8, P270, DOI 10.1016/j.surge.2010.06.004; GABELLA G, 1981, NEUROSCIENCE, V6, P425, DOI 10.1016/0306-4522(81)90135-4; Gabella Giorgio, 2012, Journal of Smooth Muscle Research, V48, P65; Geisbauer CL, 2012, J SURG RES, V174, P257, DOI 10.1016/j.jss.2010.12.016; Goyal RK, 2010, AM J PHYSIOL-GASTR L, V298, pG10, DOI 10.1152/ajpgi.00426.2009; Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074, DOI 10.1152/ajpgi.1999.277.5.G1074; Guyton AC, 2000, TXB MED PHYSL, P87; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Joshi VS, 2013, J SURG RES, V183, P18, DOI 10.1016/j.jss.2013.01.005; Lee M, 2008, TISSUE ENG PT A, V14, P1395, DOI 10.1089/ten.tea.2007.0232; Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816; Marieb E., 2018, HUMAN ANATOMY PHYSL; Mendoza J, 2006, J SURG RES, V136, P8, DOI 10.1016/j.jss.2006.01.027; Miyasaka EA, 2011, PEDIATR SURG INT, V27, P137, DOI 10.1007/s00383-010-2786-z; Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104; Nair DG, 2011, AM J PHYSIOL-GASTR L, V300, pG903, DOI 10.1152/ajpgi.00528.2010; Nakase Y, 2006, TISSUE ENG, V12, P403, DOI 10.1089/ten.2006.12.403; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ruhl A, 2005, NEUROGASTROENT MOTIL, V17, P777, DOI 10.1111/j.1365-2982.2005.00687.x; Sala FG, 2011, TISSUE ENG PT A, V17, P1841, DOI [10.1089/ten.TEA.2010.0564, 10.1089/ten.tea.2010.0564]; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sarna SK, 2008, AM J PHYSIOL-GASTR L, V294, pG372, DOI 10.1152/ajpgi.00344.2007; Shi XZ, 2013, AM J PHYSIOL-GASTR L, V304, pG337, DOI 10.1152/ajpgi.00369.2012; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Somara S, 2009, GASTROENTEROLOGY, V137, P53, DOI 10.1053/j.gastro.2009.03.036; Stanzel RDP, 2010, AM J PHYSIOL-CELL PH, V299, pC805, DOI 10.1152/ajpcell.00086.2010; TENNYSON VM, 1986, ANAT REC, V215, P267, DOI 10.1002/ar.1092150310; Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7; Tortora GJ, 2008, PRINCIPLES ANATOMY P; Walthers CM, 2014, BIOMATERIALS, V35, P5129, DOI 10.1016/j.biomaterials.2014.03.025; Weih S, 2011, LANGENBECKS ARCH SUR; Yazdani SK, 2009, TISSUE ENG PT A, V15, P827, DOI 10.1089/ten.tea.2008.0092; Zakhem E, 2014, BIOMATERIALS, V35, P1882, DOI 10.1016/j.biomaterials.2013.11.049; Zakhem E, 2012, BIOMATERIALS, V33, P4810, DOI 10.1016/j.biomaterials.2012.03.051	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114850	10.1371/journal.pone.0114850	http://dx.doi.org/10.1371/journal.pone.0114850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486279	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600101
J	Hurlstone, MJ; Lewandowsky, S; Newell, BR; Sewell, B				Hurlstone, Mark J.; Lewandowsky, Stephan; Newell, Ben R.; Sewell, Brittany			The Effect of Framing and Normative Messages in Building Support for Climate Policies	PLOS ONE			English	Article							PLANNED BEHAVIOR; LOSS AVERSION; SOCIAL NORMS; CONSERVATION; ATTITUDES; IDEOLOGY; FAIRNESS; RANK	Deep cuts in greenhouse gas emissions are required to mitigate climate change. However, there is low willingness amongst the public to prioritise climate policies for reducing emissions. Here we show that the extent to which Australians are prepared to reduce their country's CO2 emissions is greater when the costs to future national income are framed as a "foregone-gain''-incomes rise in the future but not by as much as in the absence of emission cuts-rather than as a "loss''-incomes decrease relative to the baseline expected future levels (Studies 1 & 2). The provision of a normative message identifying Australia as one of the world's largest CO2 emitters did not increase the amount by which individuals were prepared to reduce emissions (Study 1), whereas a normative message revealing the emission policy preferences of other Australians did (Study 2). The results suggest that framing the costs of reducing emissions as a smaller increase in future income and communicating normative information about others' emission policy preferences are effective methods for leveraging public support for emission cuts.	[Hurlstone, Mark J.; Lewandowsky, Stephan; Sewell, Brittany] Univ Western Australia, Sch Psychol, Crawley, Australia; [Hurlstone, Mark J.] CSIRO, Ctr Environm & Life Sci, Floreat, Australia; [Lewandowsky, Stephan] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Newell, Ben R.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Bristol; University of New South Wales Sydney	Hurlstone, MJ (corresponding author), Univ Western Australia, Sch Psychol, Crawley, Australia.	mark.hurlstone@uwa.edu.au	Hurlstone, Mark/H-5091-2014; Lewandowsky, Stephan/L-4272-2019	Lewandowsky, Stephan/0000-0003-1655-2013; Newell, Benjamin/0000-0003-1898-205X; Hurlstone, Mark/0000-0001-9920-6284	National Climate Change Adaptation Research Facility (NCCARF) of Australia; Australian Research Council [LP120100224, FT110100151]; Climate Adaptation Flagship of the Commonwealth Scientific and Industrial Research Organisation	National Climate Change Adaptation Research Facility (NCCARF) of Australia; Australian Research Council(Australian Research Council); Climate Adaptation Flagship of the Commonwealth Scientific and Industrial Research Organisation	The research was supported by a grant from the National Climate Change Adaptation Research Facility (NCCARF) of Australia awarded to the second author and grants from the Australian Research Council (LP120100224, FT110100151) to the second and third authors. Preparation of this paper was supported by funding from the Climate Adaptation Flagship of the Commonwealth Scientific and Industrial Research Organisation awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2000, J APPL SOC PSYCHOL, V30, P2439, DOI 10.1111/j.1559-1816.2000.tb02444.x; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Bolsen T, 2014, AM POLIT RES, V42, P65, DOI 10.1177/1532673X13484173; Bord RJ, 1998, CLIMATE RES, V11, P75, DOI 10.3354/cr011075; Boyce CJ, 2010, PSYCHOL SCI, V21, P471, DOI 10.1177/0956797610362671; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown GDA, 2008, IND RELAT, V47, P355, DOI 10.1111/j.1468-232X.2008.00525.x; Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Fox J, 2008, APPL REGRESSION ANAL; Gilovich TD, 2010, HDB SOCIAL PSYCHOL, V2, P15; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Gromet DM, 2013, P NATL ACAD SCI USA, V110, P9314, DOI 10.1073/pnas.1218453110; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hatfield-Dodds S, 2010, 910 CCEP AUSTR NAT U; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; International Energy Agency, 2010, CO2 EM FUEL COMB HIG; IPCC, 2007, CONTRIBUTION WORKING; Johnson D, 2008, AUSTR LOW POLLUTION; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kleiner M, 2007, SPATIAL VISION, V10, P437; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; LEVIN IP, 1988, J CONSUM RES, V15, P374, DOI 10.1086/209174; Levin IP, 1998, ORGAN BEHAV HUM DEC, V76, P149, DOI 10.1006/obhd.1998.2804; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; Manning M, 2009, BRIT J SOC PSYCHOL, V48, P649, DOI 10.1348/014466608X393136; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; Melrose KL, 2013, J BEHAV DECIS MAKING, V26, P174, DOI 10.1002/bdm.1754; MEYEROWITZ BE, 1987, J PERS SOC PSYCHOL, V52, P500, DOI 10.1037/0022-3514.52.3.500; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; Nolan JM, 2008, PERSONALITY SOCIAL P, V34, P84; O'Connor RE, 2002, SOC SCI QUART, V83, P1, DOI 10.1111/1540-6237.00067; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rivis A, 2003, CURR PSYCHOL, V22, P218, DOI 10.1007/s12144-003-1018-2; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Schroder T, 2008, J APPL SOC PSYCHOL, V38, P135; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; Schultz PW, 1999, BASIC APPL SOC PSYCH, V21, P25, DOI 10.1207/s15324834basp2101_3; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Stewart N, 2009, PSYCHOL SCI, V20, P39, DOI 10.1111/j.1467-9280.2008.02255.x; Terry DJ, 1996, PERS SOC PSYCHOL B, V22, P776, DOI 10.1177/0146167296228002; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Thaler R.H., 2021, NUDGE FINAL EDITION; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Tranter B, 2011, ENVIRON POLIT, V20, P78, DOI 10.1080/09644016.2011.538167; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	60	30	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114335	10.1371/journal.pone.0114335	http://dx.doi.org/10.1371/journal.pone.0114335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25501009	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100011
J	Yang, Y; Song, HL; Zhang, W; Wu, BJ; Fu, NN; Zheng, WP; Don, C; Shen, ZY				Yang, Yang; Song, Hong-Li; Zhang, Wen; Wu, Ben-Juan; Fu, Nan-Nan; Zheng, Wei-Ping; Don, Chong; Shen, Zhong-Yang			Reduction of Acute Rejection by Bone Marrow Mesenchymal Stem Cells during Rat Small Bowel Transplantation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALLOGRAFT-REJECTION; STROMAL CELLS; FACTOR-ALPHA; T-CELLS; KIDNEY-TRANSPLANTATION; TIGHT JUNCTION; FAS LIGAND; EXPRESSION; IMMUNOSUPPRESSION	Background: Bone marrow mesenchymal stem cells (BMMSCs) have shown immunosuppressive activity in transplantation. This study was designed to determine whether BMMSCs could improve outcomes of small bowel transplantation in rats. Methods: Heterotopic small bowel transplantation was performed from Brown Norway to Lewis rats, followed by infusion of BMMSCs through the superficial dorsal veins of the penis. Controls included rats infused with normal saline (allogeneic control), isogeneically transplanted rats (BN-BN) and nontransplanted animals. The animals were sacrificed after 1, 5, 7 or 10 days. Small bowel histology and apoptosis, cytokine concentrations in serum and intestinal grafts, and numbers of T regulatory (Treg) cells were assessed at each time point. Results: Acute cellular rejection occurred soon after transplantation and became aggravated over time in the allogeneic control rats, with increase in apoptosis, inflammatory response, and T helper (Th)1/Th2 and Th17/Treg-related cytokines. BMMSCs significantly attenuated acute cellular rejection, reduced apoptosis and suppressed the concentrations of interleukin (IL)-2, IL-6, IL-17, IL-23, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma while upregulating IL-10 and transforming growth factor (TGF)-beta expression and increasing Treg levels. Conclusion: BMMSCs improve the outcomes of allogeneic small bowel transplantation by attenuating the inflammatory response and acute cellular rejection. Treatment with BMMSCs may overcome acute cellular rejection in small bowel transplantation.	[Yang, Yang; Zhang, Wen; Wu, Ben-Juan; Fu, Nan-Nan] Tianjin Med Univ, Tianjin Cent Hosp 1, Tianjin, Peoples R China; [Song, Hong-Li; Zheng, Wei-Ping; Don, Chong; Shen, Zhong-Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Shen, ZY (corresponding author), Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China.	hlsong26@sina.com			Natural Science Foundation of China [81270528, 81170444, 81441022]; Natural Science Foundation of Tianjin, China [08JCYBJC08400, 11JCZDJC27800, 12JCZDJC25200]; Technology Foundation of Health Bureau in Tianjin, China [2011KY11]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin); Technology Foundation of Health Bureau in Tianjin, China	This work was supported by Natural Science Foundation of China (Nos. 81270528, 81170444 and 81441022), Natural Science Foundation of Tianjin, China (grant no. 08JCYBJC08400, grant no. 11JCZDJC27800, grant no. 12JCZDJC25200), and Technology Foundation of Health Bureau in Tianjin, China (grant no. 2011KY11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Abu-Elmagd KM, 2009, ANN SURG, V250, P567, DOI 10.1097/SLA.0b013e3181b67725; Abu-Elmagd KM, 2009, TRANSPL INT, V22, P96, DOI 10.1111/j.1432-2277.2008.00785.x; Adams AB, 2002, AM J TRANSPLANT, V2, P12, DOI 10.1034/j.1600-6143.2002.020104.x; Beinhauer BG, 2004, EUR J IMMUNOL, V34, P74, DOI 10.1002/eji.200324550; Benghiat FS, 2005, TRANSPLANTATION, V79, P648, DOI 10.1097/01.TP.0000155179.61445.78; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; FARMER DG, 1994, J SURG RES, V57, P138, DOI 10.1006/jsre.1994.1121; Fishbein TM, 2009, NEW ENGL J MED, V361, P998, DOI 10.1056/NEJMra0804605; Fishbein TM, 2004, J SURG RES, V119, P51, DOI 10.1016/j.jss.2003.12.028; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Hu AB, 2012, DIGEST LIVER DIS, V44, P988, DOI 10.1016/j.dld.2012.08.002; IMAGAWA DK, 1990, TRANSPLANTATION, V50, P189, DOI 10.1097/00007890-199008000-00003; Josien R, 1998, TRANSPLANTATION, V66, P887, DOI 10.1097/00007890-199810150-00013; Koksoy S, 2005, TRANSPLANTATION, V79, P1492, DOI 10.1097/01.TP.0000159870.01567.02; Kroemer A, 2008, J IMMUNOL, V180, P7818, DOI 10.4049/jimmunol.180.12.7818; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee K, 2004, J IMMUNOL, V172, P6539, DOI 10.4049/jimmunol.172.11.6539; Lee SS, 2007, FASEB J, V21, P3450, DOI 10.1096/fj.07-8472com; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Leung S, 2010, CELL MOL IMMUNOL, V7, P182, DOI 10.1038/cmi.2010.22; Manilay JO, 1998, CURR OPIN IMMUNOL, V10, P532, DOI 10.1016/S0952-7915(98)80219-7; Mazar J, 2009, J BIOL CHEM, V284, P22022, DOI 10.1074/jbc.M109.032235; Perez-Basterrechea M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073526; Perico N, 2013, TRANSPL INT, V26, P867, DOI 10.1111/tri.12132; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Pondrom Sue, 2010, Am J Transplant, V10, P438, DOI 10.1111/j.1600-6143.2009.03057.x; QUAN D, 1994, TRANSPLANTATION, V58, P808, DOI 10.1097/00007890-199410150-00011; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Shen ZY, 2013, WORLD J GASTROENTERO, V19, P3583, DOI 10.3748/wjg.v19.i23.3583; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Sonnino R E, 1988, J Invest Surg, V1, P55, DOI 10.3109/08941938809141076; Sonnino R E, 1988, J Invest Surg, V1, P181, DOI 10.3109/08941938809141104; SONNINO RE, 1986, J PEDIATR SURG, V21, P1073, DOI 10.1016/0022-3468(86)90011-4; Tzvetanov IG, 2010, CURR OPIN ORGAN TRAN, V15, P346, DOI 10.1097/MOT.0b013e3283398fa4; van Emmerik N, 1994, Transpl Int, V7 Suppl 1, pS623; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wang M, 2007, TRANSPL P, V39, P289, DOI 10.1016/j.transproceed.2006.10.200; Wang Y, 2009, TRANSPL P, V41, P4352, DOI 10.1016/j.transproceed.2009.08.072; Webber A, 2011, TRANSPLANTATION, V91, P1057, DOI 10.1097/TP.0b013e3182145306; Wiggins MC, 2000, TRANSPL IMMUNOL, V8, P211, DOI 10.1016/S0966-3274(00)00027-7; Wu H, 2013, MOL THER, V21, P1778, DOI 10.1038/mt.2013.147; Wu T, 2003, TRANSPLANTATION, V75, P1241, DOI 10.1097/01.TP.0000062840.49159.2F; YAMATAKA A, 1993, SURG TODAY, V23, P984, DOI 10.1007/BF00308974	48	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114528	10.1371/journal.pone.0114528	http://dx.doi.org/10.1371/journal.pone.0114528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25500836	Green Submitted, gold, Green Published			2022-12-27	WOS:000346607100015
J	Zhang, JM; Zhou, SY; Zhou, Y; Feng, F; Wang, QM; Zhu, XL; Ai, HS; Huang, XJ; Zhang, XH				Zhang, Jiamin; Zhou, Shiyuan; Zhou, Yi; Feng, Feier; Wang, Qianming; Zhu, Xiaolu; Ai, Huisheng; Huang, Xiaojun; Zhang, Xiaohui			Hepatocyte Growth Factor Gene-Modified Adipose-Derived Mesenchymal Stem Cells Ameliorate Radiation Induced Liver Damage in a Rat Model	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW; IN-VITRO; STROMAL CELLS; INJURY; TISSUE; IRRADIATION; DIFFERENTIATION; TRANSPLANTATION; FIBROSIS	Liver damage caused by radiotherapy is associated with a high mortality rate, but no established treatment exists. Adipose-derived mesenchymal stem cells (ADSCs) are capable of migration to injured tissue sites, where they aid in the repair of the damage. Hepatocyte growth factor (HGF) is critical for damage repair due to its anti-apoptotic, anti-fibrotic and cell regeneration-promoting effects. This study was performed to investigate the therapeutic effects of HGF-overexpressing ADSCs on radiation-induced liver damage (RILD). ADSCs were infected with a lentivirus encoding HGF and HGF-shRNA. Sprague-Dawley (SD) rats received 60Gy of irradiation to induce liver injury and were immediately given either saline, ADSCs, ADSCs + HGF or ADSCs + shHGF. Two days after irradiation, a significant reduction in apoptosis was observed in the HGF-overexpressing ADSC group compared with the RILD group, as assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Scanning electron microscopy showed chromatin condensation after irradiation, which was ameliorated in the group that received ADSCs and was reversed in the group that received HGF-overexpressing ADSCs. HGF-overexpressing ADSCs ameliorated radiation-induced liver fibrosis through down regulation of alpha-SMA and fibronectin. Hepatocyte regeneration was significantly improved in rats treated with ADSCs compared with rats from the RILD group), as assessed by Ki-67 immunohistochemistry. Rats that received HGF-overexpressing ADSCs showed an even greater level of hepatocyte regeneration. HGF-overexpressing ADSCs completely blocked the radiation-induced increase in the enzymes ALT and AST. The effect of mitigating RILD was compromised in the ADSC + shHGF group compared with the ADSC group. Altogether, these results suggest that HGF-overexpressing ADSCs can significantly improve RILD in a rat model, which may serve as a valuable therapeutic alternative.	[Zhang, Jiamin; Zhou, Shiyuan; Zhou, Yi; Feng, Feier; Wang, Qianming; Zhu, Xiaolu; Huang, Xiaojun; Zhang, Xiaohui] Peking Univ, Inst Hematol, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China; [Ai, Huisheng] Acad Mil Med Sci, Affiliated Hosp, Dept Hematol, Beijing, Peoples R China	Peking University; Academy of Military Medical Sciences - China	Huang, XJ (corresponding author), Peking Univ, Inst Hematol, Peking Univ Peoples Hosp, Beijing 100871, Peoples R China.	zhangxh100@sina.com; zhangxhrmyy@126.com	Huang, Xiao-Jun/HIK-3759-2022	Huang, Xiao-Jun/0000-0002-2145-6643	National Key Technology Support Program [2012BAI38B03]; National Natural Science Foundation of China [81270643, 81470343]; Seeding Grant for Medicine and Engineering Sciences of Peking University [2141000008]; Beijing Natural Science Foundation [7132194]; Specialized Research Fund for the Doctoral Program of Higher Education [20120001110026]	National Key Technology Support Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seeding Grant for Medicine and Engineering Sciences of Peking University; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by The National Key Technology Support Program (No. 2012BAI38B03), the National Natural Science Foundation of China (No. 81270643 and No. 81470343), and a Seeding Grant for Medicine and Engineering Sciences of Peking University (No. 2141000008). This work was also supported in part by the Beijing Natural Science Foundation (No. 7132194) and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120001110026). All these funds were received by Xiaohui Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2004, J HEPATOL, V41, P905, DOI 10.1016/j.jhep.2004.08.022; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; Banas A, 2008, STEM CELLS, V26, P2705, DOI 10.1634/stemcells.2008-0034; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Barshishat-Kupper M, 2014, IEEE NETW OP MAN S N, P1; Beitnes JO, 2012, CELL TRANSPLANT, V21, P1697, DOI 10.3727/096368911X627462; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Chi CH, 2005, WORLD J GASTROENTERO, V11, P1496; Christiansen H, 2007, RADIOLOGY, V242, P189, DOI 10.1148/radiol.2421060083; Couto BG, 2011, LIVER INT, V31, P391, DOI 10.1111/j.1478-3231.2010.02424.x; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; DESMET V, 1995, PATHOL RES PRACT, V191, P513, DOI 10.1016/S0344-0338(11)80870-8; FAJARDO LF, 1978, AM J SURG PATHOL, V2, P159, DOI 10.1097/00000478-197806000-00005; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Francois S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/151679; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; Hu SY, 2009, ACTA PHARMACOL SIN, V30, P1415, DOI 10.1038/aps.2009.133; Hu Shun-ying, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P602; Imaeda M, 2014, J RADIAT RES, V55, P665, DOI 10.1093/jrr/rru005; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kubo N, 2012, J GASTROEN HEPATOL, V27, P165, DOI 10.1111/j.1440-1746.2011.06798.x; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Liang L, 2009, HEPATOL RES, V39, P822, DOI 10.1111/j.1872-034X.2009.00506.x; Liu XL, 2014, INT J CLIN EXP PATHO, V7, P174; MICHALOPOULOS G, 1984, CANCER RES, V44, P4414; Motawi TMK, 2014, CELL BIOCHEM BIOPHYS, V68, P111, DOI 10.1007/s12013-013-9698-1; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; OGATA KIKUAKI, 1963, TOKUSHIMA JOUR EXPTL MED, V9, P240; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Pan RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194498; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Ren ML, 2012, CELL TRANSPLANT, V21, P2711, DOI 10.3727/096368912X654966; Saito Y, 2013, J SURG RES, V180, P162, DOI 10.1016/j.jss.2012.10.009; Sato M, 2000, BIOCHEM PHARMACOL, V59, P681, DOI 10.1016/S0006-2952(99)00359-7; Seo KW, 2014, CELL BIOL INT, V38, P106, DOI 10.1002/cbin.10186; Shao CH, 2014, J SURG RES, V186, P408, DOI 10.1016/j.jss.2013.08.016; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Song YS, 2012, CELL TRANSPLANT, V21, P1641, DOI 10.3727/096368912X637488; Spahr L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053719; Tholpady SS, 2003, ANAT REC PART A, V272A, P398, DOI 10.1002/ar.a.10039; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang YL, 2013, TRANSPL P, V45, P3198, DOI 10.1016/j.transproceed.2013.07.061; WHARTON JT, 1973, AM J ROENTGENOL, V117, P73, DOI 10.2214/ajr.117.1.73; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x; Yang JJ, 2012, CELL BIOCHEM FUNCT, V30, P505, DOI 10.1002/cbf.2829; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Zhu XY, 2009, BIOCHEM BIOPH RES CO, V379, P1084, DOI 10.1016/j.bbrc.2009.01.019; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	56	43	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114670	10.1371/journal.pone.0114670	http://dx.doi.org/10.1371/journal.pone.0114670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501583	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400044
J	Cimini, G; Gabrielli, A; Labini, FS				Cimini, Giulio; Gabrielli, Andrea; Labini, Francesco Sylos			The Scientific Competitiveness of Nations	PLOS ONE			English	Article							COMPLEXITY; IMPACT	We use citation data of scientific articles produced by individual nations in different scientific domains to determine the structure and efficiency of national research systems. We characterize the scientific fitness of each nation-that is, the competitiveness of its research system-and the complexity of each scientific domain by means of a non-linear iterative algorithm able to assess quantitatively the advantage of scientific diversification. We find that technological leading nations, beyond having the largest production of scientific papers and the largest number of citations, do not specialize in a few scientific domains. Rather, they diversify as much as possible their research system. On the other side, less developed nations are competitive only in scientific domains where also many other nations are present. Diversification thus represents the key element that correlates with scientific and technological competitiveness. A remarkable implication of this structure of the scientific competition is that the scientific domains playing the role of "markers'' of national scientific competitiveness are those not necessarily of high technological requirements, but rather addressing the most "sophisticated'' needs of the society.	[Cimini, Giulio; Gabrielli, Andrea] UoS Univ Sapienza, CNR, Ist Sistemi Complessi, Rome, Italy; [Gabrielli, Andrea] IMT Inst Adv Studies, Lucca, Italy; [Labini, Francesco Sylos] Ctr Studi & Ric Enrico Fermi, Rome, Italy; [Labini, Francesco Sylos] CNR, Ist Sistemi Complessi, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); IMT School for Advanced Studies Lucca; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Cimini, G (corresponding author), UoS Univ Sapienza, CNR, Ist Sistemi Complessi, Rome, Italy.	giulio.cimini@roma1.infn.it	Cimini, Giulio/I-7413-2019; Labini, Francesco Sylos/AAC-5112-2020; Sylos Labini, Francesco/B-8238-2008; Cimini, Giulio/HGC-2758-2022; Labini, Francesco Sylos/ABC-5418-2020; Gabrielli, Andrea/A-7175-2008	Cimini, Giulio/0000-0001-5698-8597; Sylos Labini, Francesco/0000-0003-2236-4537; Labini, Francesco Sylos/0000-0003-2236-4537; Gabrielli, Andrea/0000-0003-3705-7281	European project FET-Open GROWTHCOM [611272]; Italian PNR project CRISIS-Lab	European project FET-Open GROWTHCOM; Italian PNR project CRISIS-Lab	This work was supported by the European project FET-Open GROWTHCOM (grant num. 611272) and the Italian PNR project CRISIS-Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Baccini A., 2010, VALUTARE RICERCA SCI; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Ioannidis JPA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002778; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; Press WH, 2013, SCIENCE, V342, P817, DOI 10.1126/science.342.6160.817; Ricardo D., 1821, PRINCIPLES POLITICAL; Sivertsen G, 2012, SCIENTOMETRICS, V91, P567, DOI 10.1007/s11192-011-0615-3; Smith Adam, 1976, WEALTH NATIONS; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723	13	57	59	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113470	10.1371/journal.pone.0113470	http://dx.doi.org/10.1371/journal.pone.0113470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493626	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000346611400012
J	Hudjetz, S; Lennartz, G; Kramer, K; Ross-Nickoll, M; Gergs, A; Preuss, TG				Hudjetz, Silvana; Lennartz, Gottfried; Kraemer, Klara; Ross-Nickoll, Martina; Gergs, Andre; Preuss, Thomas G.			Modeling Wood Encroachment in Abandoned Grasslands in the Eifel National Park - Model Description and Testing	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; BROOM CYTISUS-SCOPARIUS; SPATIALLY EXPLICIT; LAND-USE; SPECIES COMPOSITION; TREE REGENERATION; MOUNTAIN FORESTS; LANDSCAPE MODEL; SEED DISPERSAL; DYNAMICS MODEL	The degradation of natural and semi-natural landscapes has become a matter of global concern. In Germany, semi-natural grasslands belong to the most species-rich habitat types but have suffered heavily from changes in land use. After abandonment, the course of succession at a specific site is often difficult to predict because many processes interact. In order to support decision making when managing semi-natural grasslands in the Eifel National Park, we built the WoodS-Model (Woodland Succession Model). A multimodeling approach was used to integrate vegetation dynamics in both the herbaceous and shrub/tree layer. The cover of grasses and herbs was simulated in a compartment model, whereas bushes and trees were modelled in an individual-based manner. Both models worked and interacted in a spatially explicit, raster-based landscape. We present here the model description, parameterization and testing. We show highly detailed projections of the succession of a semi-natural grassland including the influence of initial vegetation composition, neighborhood interactions and ungulate browsing. We carefully weighted the single processes against each other and their relevance for landscape development under different scenarios, while explicitly considering specific site conditions. Model evaluation revealed that the model is able to emulate successional patterns as observed in the field as well as plausible results for different population densities of red deer. Important neighborhood interactions such as seed dispersal, the protection of seedlings from browsing ungulates by thorny bushes, and the inhibition of wood encroachment by the herbaceous layer, have been successfully reproduced. Therefore, not only a detailed model but also detailed initialization turned out to be important for spatially explicit projections of a given site. The advantage of the WoodS-Model is that it integrates these many mutually interacting processes of succession.	[Hudjetz, Silvana; Kraemer, Klara; Ross-Nickoll, Martina; Gergs, Andre; Preuss, Thomas G.] Rhein Westfal TH Aachen, Inst Environm Res Biol 5, D-52074 Aachen, Germany; [Hudjetz, Silvana; Lennartz, Gottfried] Rhein Westfal TH Aachen, Res Inst Ecosyst Anal & Assessment Gaiac, D-52072 Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Hudjetz, S (corresponding author), Rhein Westfal TH Aachen, Inst Environm Res Biol 5, Worringerweg 1, D-52074 Aachen, Germany.	silvana.hudjetz@gaiac.rwth-aachen	RoÃ-NIckoll, Martina/HGE-9656-2022; Preuss, Thomas G./A-7926-2009	Preuss, Thomas G./0000-0001-6249-6003	MUNLV (Ministry of the Environment, Conservation, Agriculture and Consumer Protection of the State of North Rhine-Westphalia); LANUV (North-Rhine-Westphalian Agency for Nature, Environment and Consumer Protection); German National Academic Foundation	MUNLV (Ministry of the Environment, Conservation, Agriculture and Consumer Protection of the State of North Rhine-Westphalia); LANUV (North-Rhine-Westphalian Agency for Nature, Environment and Consumer Protection); German National Academic Foundation	The development of the model was supported by the MUNLV (Ministry of the Environment, Conservation, Agriculture and Consumer Protection of the State of North Rhine-Westphalia) and the LANUV (North-Rhine-Westphalian Agency for Nature, Environment and Consumer Protection) and by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bakker ES, 2004, J APPL ECOL, V41, P571, DOI 10.1111/j.0021-8901.2004.00908.x; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Bergquist J, 2009, SCAND J FOREST RES, V24, P308, DOI 10.1080/02827580903117420; Bithell M, 2007, ECOL MODEL, V200, P59, DOI 10.1016/j.ecolmodel.2006.07.031; BOSSARD CC, 1990, ECOLOGY, V71, P2370, DOI 10.2307/1938647; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Brouwer E, 2005, VLIZ SPECIAL PUBLICA, P229; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Bugmann H., 1994, THESIS SWISS FEDERAL; BUGMANN H, 2005, FORUM WISSEN, P41; Burschel P, 1997, GRUNDRISS WALDBAUS L, V2nd; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; CANHAM CD, 1994, CAN J FOREST RES, V24, P817, DOI 10.1139/x94-107; CBD, 2010, 4 CBD; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; Commission of the European Communities, 2009, COMP REP CONS STAT H; Didion M, 2009, FOREST ECOL MANAG, V258, pS44, DOI 10.1016/j.foreco.2009.06.006; Diemer M, 2001, APPL VEG SCI, V4, P237, DOI 10.1111/j.1654-109X.2001.tb00492.x; Dierschke H., 2002, KULTURGRASLAND; Eiberle K., 1989, Schweizerische Zeitschrift fur Forstwesen, V140, P1031; Ellenberg H, 1996, VEGETATION MITTELEUR; Engler S, 2010, THESIS RWTH AACHEN U; Frost I, 1997, OIKOS, V79, P53, DOI 10.2307/3546089; GBO3, 2010, GLOB BIOD OUTL 3 EX; Gebert C, 2001, MAMMAL REV, V31, P189, DOI 10.1046/j.1365-2907.2001.00090.x; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Gillet F, 2008, ECOL MODEL, V217, P1, DOI 10.1016/j.ecolmodel.2008.05.013; Glavac V, 1996, VEGETATIONSOKOLOGIE; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gross LJ, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P467; Hardtle W, 2008, WALDER TIEFLANDES MI; Harmer R, 2001, J APPL ECOL, V38, P1094, DOI 10.1046/j.1365-2664.2001.00664.x; Harmer R, 2001, BIOL CONSERV, V101, P291, DOI 10.1016/S0006-3207(01)00072-6; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; Heilburg I, 2010, THESIS RWTH AACHEN U; Hejcman M, 2004, GRASSLAND SCI EUROPE, V9, P213; Holst PJ, 2004, AUST J EXP AGR, V44, P553, DOI 10.1071/EA97041; Isselstein J., 2005, Agronomy Research, V3, P139; JARVIS PG, 1964, OIKOS, V15, P56, DOI 10.2307/3564748; Jeltsch F, 2008, PERSPECT PLANT ECOL, V9, P171, DOI 10.1016/j.ppees.2007.11.004; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kalen C, 2004, FOREST ECOL MANAG, V187, P149, DOI 10.1016/S0378-1127(03)00316-5; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kleyer M, 2007, BASIC APPL ECOL, V8, P293, DOI 10.1016/j.baae.2007.04.001; Kochy M, 2000, OIKOS, V91, P385, DOI 10.1034/j.1600-0706.2000.910219.x; Kochy M, 2008, REG ENVIRON CHANGE, V8, P73, DOI 10.1007/s10113-008-0048-6; Kramer K, 2006, FOREST ECOL MANAG, V226, P238, DOI 10.1016/j.foreco.2006.01.037; Kramer K, 2003, FOREST ECOL MANAG, V181, P205, DOI 10.1016/S0378-1127(03)00134-8; Kramer K, 2011, THESIS RWTH AACHEN U; Kramer K, 2009, AUSWIRKUNG VERSCHIED; Kratochwil A, 2001, OKOLOGIE LEBENSGEMEI; Kuiters AT, 2003, FOREST ECOL MANAG, V181, P239, DOI 10.1016/S0378-1127(03)00136-1; Kunstler G, 2007, DIVERS DISTRIB, V13, P799, DOI 10.1111/j.1472-4642.2007.00404.x; Lassig R., 1995, SCHWEIZERISCHE Z FOR, V146, P893; Lennartz G, 2006, ABSCHLUSSBERICHT MOD; Lenth R., 2019, Journal of Statistical Software, V60, P1; LIEFFERS VI, 1993, CAN J FOREST RES, V23, P2070, DOI 10.1139/x93-258; Lischke H, 2006, ECOL MODEL, V199, P409, DOI 10.1016/j.ecolmodel.2005.11.046; LOAGUE K, 1991, Journal of Contaminant Hydrology, V7, P51, DOI 10.1016/0169-7722(91)90038-3; Manzano P, 2005, SEED SCI RES, V15, P21, DOI 10.1079/SSR2004192; Meyer SE, 2008, WOODY PLANT SEED MAN, P466; Miller G. R., 1998, Scottish Forestry, V52, P138; Ministerium fur Ernahrung und landlichen Raum Baden-Wurttemberg, 2001, SCHATZH BEARB DURCH; Moog D, 2002, APPL VEG SCI, V5, P99, DOI 10.1111/j.1654-109X.2002.tb00539.x; Muller J, 1998, BRACHESUKZESSIONEN P, P103; Nationalparkverwaltung Eifel Nationalparkplan Eifel Band, BESTANDSANA IN PRESS, V2; Nothdurft A, 2007, THESIS GEORG AUGUST; Odom DIS, 2003, ECOL ECON, V44, P119, DOI 10.1016/S0921-8009(02)00259-8; Olff H, 1999, PLANT BIOLOGY, V1, P127, DOI 10.1111/j.1438-8677.1999.tb00236.x; Palmer SCF, 2004, FOREST ECOL MANAG, V192, P251, DOI 10.1016/j.foreco.2004.01.038; Pardey A, 2008, NATIONALPARK EIFEL N, V1; Paynter Q, 1998, J APPL ECOL, V35, P582, DOI 10.1046/j.1365-2664.1998.3540582.x; Paynter Q, 2003, J APPL ECOL, V40, P470, DOI 10.1046/j.1365-2664.2003.00817.x; Paynter Quentin, 2000, Plant Protection Quarterly, V15, P149; Peringer A, ECOLOGY SOC IN PRESS; Peringer A, 2011, ECOL MODEL, V222, P3120, DOI 10.1016/j.ecolmodel.2011.05.025; Peters DPC, 2002, ECOL MODEL, V152, P5, DOI 10.1016/S0304-3800(01)00460-4; PETRAK M, 1985, Z JAGDWISS, V31, P73, DOI 10.1007/BF02246115; Petrak M, 2005, HABITAT USE RED DEER, P435; Petrak Michael, 2006, Decheniana, V159, P123; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; POTT R, 1991, HUDELANDSCHAFTEN NOR; Prach K, 2006, PRESLIA, V78, P469; Pretzsch H, 2008, ANN BOT-LONDON, V101, P1065, DOI 10.1093/aob/mcm246; PRETZSCH H., 2001, MODELLIERUNG WALDWAC; Prevosto B, 2004, ACTA OECOL, V25, P73, DOI 10.1016/j.actao.2003.11.005; Rammig A, 2007, EUR J FOREST RES, V126, P49, DOI 10.1007/s10342-005-0088-0; Rammig A, 2006, FOREST ECOL MANAG, V222, P123, DOI 10.1016/j.foreco.2005.10.042; Rammig A, 2005, THESIS SWISS FEDERAL; Rammig A, 2007, FOREST ECOL MANAG, V242, P142, DOI 10.1016/j.foreco.2007.01.036; Reif A., 2007, WALDOEKOLOGIE ONLINE, V5, P79; Renaud PC, 2003, FOREST ECOL MANAG, V181, P31, DOI 10.1016/S0378-1127(03)00126-9; Rickebusch S, 2007, FOREST ECOL MANAG, V246, P251, DOI 10.1016/j.foreco.2007.04.030; Scheller RM, 2007, LANDSCAPE ECOL, V22, P491, DOI 10.1007/s10980-006-9048-4; Schmidt W, 2004, ASUNGSKAPAZITAT WALD, pA; Schreiber K, 2000, METHODEN LANDSCHAFTS; Schreiber KF, 1997, FORSTWISS CENTRALBL, V116, P243, DOI 10.1007/BF02766901; Schulte J, 1998, JAGER LEHRBUCH JAGER; Schumacher S, 2004, ECOL MODEL, V180, P175, DOI 10.1016/j.ecolmodel.2003.12.055; SCHUMACHER S, 2004, THESIS SWISS FEDERAL; Schumacher S, 2006, LANDSCAPE ECOL, V21, P539, DOI 10.1007/s10980-005-2165-7; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Schupp EW, 1998, US FOR SERV RMRS-P, P66; Siehoff S, 2011, THESIS RWTH AACHEN U; Siehoff S, 2011, ECOL MODEL, V222, P3854, DOI 10.1016/j.ecolmodel.2011.10.003; Smit C, 2011, J VEG SCI, V22, P377, DOI 10.1111/j.1654-1103.2011.01264.x; SMITH J M B, 1991, Plant Protection Quarterly, V6, P73; Smith R, 1998, PLANT ECOL, V139, P203, DOI 10.1023/A:1009750216223; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Syphard AD, 2007, ENVIRON MODELL SOFTW, V22, P1641, DOI 10.1016/j.envsoft.2007.01.004; TARREGA R, 1992, VEGETATIO, V102, P139, DOI 10.1007/BF00044730; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tischler B, 2006, THESIS RWTH AACHEN U; Turner JH, 1933, B MISCELLANEOUS INFO, P257; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Wersch C, 2010, THESIS RWTH AACHEN U; Vandenberghe C, 2008, OIKOS, V117, P415, DOI 10.1111/j.2007.0030-1299.16264.x; Vincenot CE, 2011, ECOL MODEL, V222, P210, DOI 10.1016/j.ecolmodel.2010.09.029; Waloff N, 1968, ADV ECOLOGICAL RES; Ward BC, 2004, TECHNICAL REPORT; Watt AS, 1919, J ECOL, V7, P173, DOI 10.2307/2255275; Weber HE, 2008, GEBUSCHE HECKEN KRAU; Weisberg PJ, 2005, ECOL MODEL, V185, P213, DOI 10.1016/j.ecolmodel.2004.12.004; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; [No title captured]	129	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113827	10.1371/journal.pone.0113827	http://dx.doi.org/10.1371/journal.pone.0113827			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494057	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400021
J	Ming, M; Sinnett-Smith, J; Wang, J; Soares, HP; Young, SH; Eibl, G; Rozengurt, E				Ming, Ming; Sinnett-Smith, James; Wang, Jia; Soares, Heloisa P.; Young, Steven H.; Eibl, Guido; Rozengurt, Enrique			Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR SIGNALING SYSTEMS; COUPLED RECEPTOR; INSULIN-RECEPTOR; GROWTH; RISK; NEUROTENSIN; GLUCOSE; PHOSPHORYLATION; APOPTOSIS	Natural products represent a rich reservoir of potential small chemical molecules exhibiting anti-proliferative and chemopreventive properties. Here, we show that treatment of pancreatic ductal adenocarcinoma (PDAC) cells (PANC-1, MiaPaCa-2) with the isoquinoline alkaloid berberine (0.3-6 mu M) inhibited DNA synthesis and proliferation of these cells and delay the progression of their cell cycle in G1. Berberine treatment also reduced (by 70%) the growth of MiaPaCa-2 cell growth when implanted into the flanks of nu/nu mice. Mechanistic studies revealed that berberine decreased mitochondrial membrane potential and intracellular ATP levels and induced potent AMPK activation, as shown by phosphorylation of AMPK alpha subunit at Thr-172 and acetyl-CoA carboxylase (ACC) at Ser(79). Furthermore, berberine dose-dependently inhibited mTORC1 (phosphorylation of S6K at Thr(389) and S6 at Ser(240/244)) and ERK activation in PDAC cells stimulated by insulin and neurotensin or fetal bovine serum. Knockdown of alpha(1) and alpha(2) catalytic subunit expression of AMPK reversed the inhibitory effect produced by treatment with low concentrations of berberine on mTORC1, ERK and DNA synthesis in PDAC cells. However, at higher concentrations, berberine inhibited mitogenic signaling (mTORC1 and ERK) and DNA synthesis through an AMPK-independent mechanism. Similar results were obtained with metformin used at doses that induced either modest or pronounced reductions in intracellular ATP levels, which were virtually identical to the decreases in ATP levels obtained in response to berberine. We propose that berberine and metformin inhibit mitogenic signaling in PDAC cells through dose-dependent AMPK-dependent and independent pathways.	[Ming, Ming; Sinnett-Smith, James; Wang, Jia; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Soares, Heloisa P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Eibl, Guido] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Young, Steven H.; Eibl, Guido; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [P01 CA163200, P30 DK4130, R01 DK100405]; Department of Veterans Affair Grant [1I01BX001473]; Ronald S. Hirschberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100405, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair Grant; Ronald S. Hirschberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants P01 CA163200, P30 DK4130, R01 DK100405, Department of Veterans Affair Grant 1I01BX001473 and funds from the endowed Ronald S. Hirschberg Chair of Pancreatic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat HA, 2007, J AM COLL SURGEONS, V204, P996, DOI 10.1016/j.jamcollsurg.2007.01.067; BANDI HR, 1993, J BIOL CHEM, V268, P4530; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Berker B, 2004, GYNECOL ENDOCRINOL, V19, P125, DOI 10.1080/09513590400007309; Brand Randall E., 1998, Current Opinion in Oncology, V10, P362, DOI 10.1097/00001622-199807000-00014; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ducommun S, 2014, AM J PHYSIOL-ENDOC M, V306, pE688, DOI 10.1152/ajpendo.00672.2013; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Elek J, 2000, ANTICANCER RES, V20, P53; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Goodwin PJ, 2008, CLIN BREAST CANCER, V8, P501, DOI 10.3816/CBC.2008.n.060; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Guha S, 2005, CANCER RES, V65, P2738, DOI 10.1158/0008-5472.CAN-04-3197; Guha S, 2003, CANCER RES, V63, P2379; Guha S, 2002, CANCER RES, V62, P1632; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Heasley LE, 2001, ONCOGENE, V20, P1563, DOI 10.1038/sj.onc.1204183; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kisfalvi K, 2005, J CELL PHYSIOL, V202, P880, DOI 10.1002/jcp.20187; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Larsson SC, 2006, AM J CLIN NUTR, V84, P1171, DOI 10.1093/ajcn/84.5.1171; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Lo T-F, 2013, MICRORNA 21 3P BERBE; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Michaud DS, 2007, CANCER EPIDEM BIOMAR, V16, P2101, DOI 10.1158/1055-9965.EPI-07-0182; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Perrin MC, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-25; Pinto-Garcia L, 2010, PLANTA MED, V76, P1155, DOI 10.1055/s-0030-1249931; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reubi JC, 1998, GUT, V42, P546, DOI 10.1136/gut.42.4.546; Rizvi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018137; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Ryder NM, 2001, J CELL PHYSIOL, V186, P53, DOI 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sinnett-Smith J, 2000, J BIOL CHEM, V275, P30644, DOI 10.1074/jbc.M003702200; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Tsilidis KK, 2014, DIABETES CARE, V37, P2522, DOI 10.2337/dc14-0584; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Wang L, 2000, CLIN CANCER RES, V6, P566; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang Y, 2012, MUTAT RES-FUND MOL M, V734, P20, DOI 10.1016/j.mrfmmm.2012.04.005; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xie WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024520; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Young SH, 2010, BIOCHEM BIOPH RES CO, V401, P154, DOI 10.1016/j.bbrc.2010.09.036; Yue W, 2014, CANCER PREV RES, V7, P388, DOI 10.1158/1940-6207.CAPR-13-0337; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024	88	52	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114573	10.1371/journal.pone.0114573	http://dx.doi.org/10.1371/journal.pone.0114573			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493642	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400054
J	Navara, KJ				Navara, Kristen J.			Low Gestational Weight Gain Skews Human Sex Ratios towards Females	PLOS ONE			English	Article							OFFSPRING SEX; MATERNAL WEIGHT; PREGNANT-WOMEN; ENERGY-INTAKE; BIRTH; MECHANISMS; ADJUSTMENT; SELECTION; DIET	Background: Human males are more vulnerable to adverse conditions than females starting early in gestation and continuing throughout life, and previous studies show that severe food restriction can influence the sex ratios of human births. It remains unclear, however, whether subtle differences in caloric intake during gestation alter survival of fetuses in a sex-specific way. I hypothesized that the ratio of male to female babies born should vary with the amount of weight gained during gestation. I predicted that women who gain low amounts of weight during gestation should produce significantly more females, and that, if gestational weight gain directly influences sex ratios, fetal losses would be more likely to be male when women gain inadequate amounts of weight during pregnancy. Methods: I analyzed data collected from over 68 million births over 23 years to test for a relationship between gestational weight gain and natal sex ratios, as well as between gestational weight gain and sex ratios of fetal deaths at five gestational ages. Results: Gestational weight gain and the proportion of male births were positively correlated; a lower proportion of males was produced by women who gained less weight and this strong pattern was exhibited in four human races. Further, sex ratios of fetal losses at 6 months of gestation were significantly male-biased when mothers had gained low amounts of weight during pregnancy, suggesting that low caloric intake during early fetal development can stimulate the loss of male fetuses. Conclusion: My data indicate that human sex ratios change in response to resource availability via sex-specific fetal loss, and that a pivotal time for influences on male survival is early in fetal development, at 6 months of gestation.	Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Navara, KJ (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	knavara@uga.edu						Bergmann MM, 1997, INT J OBESITY, V21, P1010, DOI 10.1038/sj.ijo.0800509; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Brawarsky P, 2005, INT J GYNECOL OBSTET, V91, P125, DOI 10.1016/j.ijgo.2005.08.008; Bulik CM, 2008, ACTA OBSTET GYN SCAN, V87, P979, DOI 10.1080/00016340802334385; BURGOYNE PS, 1993, DEVELOPMENT, V117, P341; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; Cagnacci A, 2004, HUM REPROD, V19, P442, DOI 10.1093/humrep/deh071; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Caulfield LE, 1996, OBSTET GYNECOL, V87, P760, DOI 10.1016/0029-7844(96)00023-3; Centers for Disease Control and Prevention, 2014, DAT VIT STAT BIRTH D; de Zegher F, 1999, HORM RES, V51, P258, DOI 10.1159/000023382; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Evdokimova V. N., 2000, Ontogenez, V31, P251; Graffelman J, 1999, HUM REPROD, V14, P2917, DOI 10.1093/humrep/14.11.2917; HASSOLD T, 1983, ANN HUM GENET, V47, P39, DOI 10.1111/j.1469-1809.1983.tb00968.x; Hernandez-Julian R, 2013, 7692 IZA; Herring Sharon J, 2008, BMC Pregnancy Childbirth, V8, P54, DOI 10.1186/1471-2393-8-54; Khashan AS, 2010, EPIDEMIOLOGY, V21, P913, DOI 10.1097/EDE.0b013e3181f3327c; KHOURY MJ, 1984, AM J HUM GENET, V36, P1103; Kirchengast S, 2009, J LIFE SCI, V1, P63, DOI DOI 10.1080/09751270.2009.11885136; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Lagiou P, 2004, EUR J CLIN NUTR, V58, P231, DOI 10.1038/sj.ejcn.1601771; Langley-Evans AJ, 2003, J R SOC PROMO HEALTH, V123, P210, DOI 10.1177/146642400312300409; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; Meikle DB, 1998, AM NAT, V124, P173; Navara KJ, 2013, INTEGR COMP BIOL, V53, P877, DOI 10.1093/icb/ict081; Navara KJ, 2010, J COMP PHYSIOL B, V180, P785, DOI 10.1007/s00360-010-0483-9; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; Nonaka K, 1999, HUM BIOL, V71, P875; Olafsdottir AS, 2006, INT J OBESITY, V30, P492, DOI 10.1038/sj.ijo.0803184; Olson CM, 2004, AM J OBSTET GYNECOL, V191, P530, DOI 10.1016/j.ajog.2004.01.027; RAY PF, 1995, J REPROD FERTIL, V104, P165; Rosenfeld CS, 2012, REPROD FERT DEVELOP, V24, P45, DOI 10.1071/RD11906; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SKJERVOLD H, 1979, Z TIERZ ZUCHTUNGSBIO, V95, P293; Song SG, 2012, P ROY SOC B-BIOL SCI, V279, P2883, DOI 10.1098/rspb.2012.0320; Stuebe Am, 2009, AM J OBSTET GYNECOL, V201; Tamimi RM, 2003, BRIT MED J, V326, P1245, DOI 10.1136/bmj.326.7401.1245; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; van Bodegom David, 2013, Evolution Medicine and Public Health, P37, DOI 10.1093/emph/eot002; van Schaik C.P., 1991, American Naturalist, V138, P1555, DOI 10.1086/285300; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Villamor E, 2008, FERTIL STERIL, V89, P1240, DOI 10.1016/j.fertnstert.2007.07.1371; WHO, 2014, GLOB DAT BOD MASS IN; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; Young SS, 2009, P R SOC B, V276, P1211, DOI 10.1098/rspb.2008.1405	48	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114304	10.1371/journal.pone.0114304	http://dx.doi.org/10.1371/journal.pone.0114304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493647	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400040
J	Alford, L; Andrade, TO; Georges, R; Burel, F; van Baaren, J				Alford, Lucy; Andrade, Thiago Oliveira; Georges, Romain; Burel, Francoise; van Baaren, Joan			Could Behaviour and Not Physiological Thermal Tolerance Determine Winter Survival of Aphids in Cereal Fields?	PLOS ONE			English	Article							CHILL COMA RECOVERY; COLD-HARDINESS; ACTIVITY THRESHOLDS; SITOBION-AVENAE; INTERSPECIFIC VARIATION; PEA APHIDS; TEMPERATURE; ACCLIMATION; RESISTANCE; POPULATION	Traits of physiological thermotolerance are commonly measured in the laboratory as predictors of the field success of ectotherms at unfavourable temperatures (e. g. during harsh winters, heatwaves, or under conditions of predicted global warming). Due to being more complicated to measure, behavioural thermoregulation is less commonly studied, although both physiology and behaviour interact to explain the survival of ectotherms. The aphids Metopolophium dirhodum, Rhopalosiphum padi and Sitobion avenae are commercially important pests of temperate cereal crops. Although coexisting, these species markedly differ in winter success, with R. padi being the most abundant species during cold winters, followed by S. avenae and lastly M. dirhodum. To better understand the thermal physiology and behavioural factors contributing to differential winter success, the lethal temperature (physiological thermotolerance) and the behaviour of aphids in a declining temperature regime (behavioural thermotolerance) of these three species were investigated. Physiological thermotolerance significantly differed between the three species, with R. padi consistently the least cold tolerant and S. avenae the most cold tolerant. However, although the least cold tolerant of the study species, significantly more R. padi remained attached to the host plant at extreme sub-zero temperatures than S. avenae and M. dirhodum. Given the success of anholocyclic R. padi in harsh winters compared to its anholocyclic counterparts, this study illustrates that behavioural differences could be more important than physiological thermotolerance in explaining resistance to extreme temperatures. Furthermore it highlights that there is a danger to studying physiological thermotolerance in isolation when ascertaining risks of ectotherm invasions, the establishment potential of exotic species in glasshouses, or predicting species impacts under climate change scenarios.	[Alford, Lucy; Andrade, Thiago Oliveira; Georges, Romain; Burel, Francoise; van Baaren, Joan] Univ Rennes 1, UMR ECOBIO 6553, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Alford, L (corresponding author), Univ Rennes 1, UMR ECOBIO 6553, Rennes, France.	l.alford.02@cantab.net		Alford, Lucy/0000-0002-2967-4274; Georges, Romain/0000-0002-0566-3060; van baaren, joan/0000-0002-8552-9645	Marie Curie Intra-European Fellowship [FP7-PEOPLE-2010-IEF-326943]	Marie Curie Intra-European Fellowship(European Commission)	This work was funded by a Marie Curie Intra-European Fellowship (FP7-PEOPLE-2010-IEF-326943) awarded to L Alford, F Burel and J van Baaren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford L, 2012, J APPL ENTOMOL, V135, P332, DOI 10.1111/j.1439-0418.2011.01658.x; Alford L, 2012, AGR FOREST ENTOMOL, V14, P69, DOI 10.1111/j.1461-9563.2011.00553.x; Andersen JL, 2013, J INSECT PHYSIOL, V59, P1041, DOI 10.1016/j.jinsphys.2013.07.008; Andrade T, 2013, THESIS U RENNES 1; Andrade TO, 2013, ENTOMOL EXP APPL, V147, P167, DOI 10.1111/eea.12055; BALE JS, 1988, ECOL ENTOMOL, V13, P121, DOI 10.1111/j.1365-2311.1988.tb00340.x; BALE JS, 1987, J INSECT PHYSIOL, V33, P899, DOI 10.1016/0022-1910(87)90001-1; Blackman R. L, 1989, APHIDS WORLDS CROPS; Burgi LP, 2012, J INSECT PHYSIOL, V58, P1184, DOI 10.1016/j.jinsphys.2012.05.017; Butts RA, 1997, ECOL ENTOMOL, V22, P26, DOI 10.1046/j.1365-2311.1997.00027.x; CLOUGH MS, 1990, ANN APPL BIOL, V116, P1, DOI 10.1111/j.1744-7348.1990.tb06581.x; Cocu N, 2005, J BIOGEOGR, V32, P615, DOI 10.1111/j.1365-2699.2005.01190.x; Colinet H, 2013, J EXP BIOL, V216, P253, DOI 10.1242/jeb.076216; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Coombs MR, 2013, EXP APPL ACAROL, V59, P435, DOI 10.1007/s10493-012-9619-9; Costanzo JP, 2001, PHYSIOL BIOCHEM ZOOL, V74, P510, DOI 10.1086/322161; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; Everatt MJ, 2013, J INSECT PHYSIOL, V59, P1057, DOI 10.1016/j.jinsphys.2013.08.003; Fabre F, 2006, ECOL MODEL, V193, P457, DOI 10.1016/j.ecolmodel.2005.08.021; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Formby JP, 2013, FLA ENTOMOL, V96, P1530, DOI 10.1653/024.096.0435; HARRINGTON R, 1990, ACTA PHYTOPATHOL HUN, V25, P423; HARRINGTON R, 1990, J ANIM ECOL, V59, P1177, DOI 10.2307/5039; Hart AJ, 2002, PHYSIOL ENTOMOL, V27, P112, DOI 10.1046/j.1365-3032.2002.00276.x; Hazell SP, 2011, J INSECT PHYSIOL, V57, P1085, DOI 10.1016/j.jinsphys.2011.04.004; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Hill MP, 2013, GLOBAL ECOL BIOGEOGR, V22, P942, DOI 10.1111/geb.12059; HONEK A, 1985, Z ANGEW ENTOMOL, V100, P309; Hughes GE, 2011, BIOCONTROL, V56, P19, DOI 10.1007/s10526-010-9314-x; Hughes GE, 2010, PHYSIOL ENTOMOL, V35, P373, DOI 10.1111/j.1365-3032.2010.00754.x; Hughes GE, 2010, BIOCONTROL, V55, P493, DOI 10.1007/s10526-010-9267-0; Hughes GE, 2009, BIOCONTROL, V54, P785, DOI 10.1007/s10526-009-9230-0; HUTCHINSON LA, 1994, J APPL ECOL, V31, P102, DOI 10.2307/2404603; Jarosik Vojtech, 2003, Plant Protection Science, V39, P61; Jones SR, 1997, J MED ENTOMOL, V34, P426, DOI 10.1093/jmedent/34.4.426; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; KNIGHT JD, 1986, ECOL ENTOMOL, V11, P189, DOI 10.1111/j.1365-2311.1986.tb00294.x; Krespi L, 1997, ENVIRON ENTOMOL, V26, P545, DOI 10.1093/ee/26.3.545; Le Lann C, 2011, PHYSIOL ENTOMOL, V36, P21, DOI 10.1111/j.1365-3032.2010.00758.x; Le Ralec A, 2010, CR BIOL, V333, P554, DOI 10.1016/j.crvi.2010.03.010; LEATHER SR, 1989, B ENTOMOL RES, V79, P345, DOI 10.1017/S0007485300018344; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Macdonald SS, 2004, J INSECT PHYSIOL, V50, P695, DOI 10.1016/j.jinsphys.2004.05.004; McConnachie S, 2007, J THERM BIOL, V32, P66, DOI 10.1016/j.jtherbio.2006.10.002; Modlmeier AP, 2012, NATURWISSENSCHAFTEN, V99, P811, DOI 10.1007/s00114-012-0963-8; MONTGOMERY ME, 1977, ENTOMOL EXP APPL, V22, P236, DOI 10.1007/BF00302860; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Navas CA, 1996, J HERPETOL, V30, P478, DOI 10.2307/1565690; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029409; PONS X, 1993, ENVIRON ENTOMOL, V22, P381, DOI 10.1093/ee/22.2.381; Powell SJ, 2008, ECOL ENTOMOL, V33, P95, DOI 10.1111/j.1365-2311.2007.00947.x; Powell SJ, 2006, PHYSIOL ENTOMOL, V31, P348, DOI 10.1111/j.1365-3032.2006.00527.x; Powell SJ, 2005, J EXP BIOL, V208, P2615, DOI 10.1242/jeb.01685; Powell SJ, 2004, J INSECT PHYSIOL, V50, P277, DOI 10.1016/j.jinsphys.2004.01.003; Renault D, 2012, PHYSIOL ENTOMOL, V37, P354, DOI 10.1111/j.1365-3032.2012.00851.x; ROITBERG BD, 1979, CAN ENTOMOL, V111, P515, DOI 10.4039/Ent111515-4; Sinclair BJ, 2006, PHYSIOL ENTOMOL, V31, P98, DOI 10.1111/j.1365-3032.2005.00481.x; STRATHDEE AT, 1995, J INSECT PHYSIOL, V41, P653, DOI 10.1016/0022-1910(95)00029-T; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2005, J INSECT PHYSIOL, V51, P1013, DOI 10.1016/j.jinsphys.2005.04.016; WALTERS KFA, 1986, J APPL ECOL, V23, P905, DOI 10.2307/2403943; Williams C. T., 1980, Bulletin SROP, V3, P63; WINDER L, 1990, ECOL ENTOMOL, V15, P105, DOI 10.1111/j.1365-2311.1990.tb00789.x	69	22	23	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114982	10.1371/journal.pone.0114982	http://dx.doi.org/10.1371/journal.pone.0114982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490555	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000347515300099
J	Gao, FQ; Yang, FY; Zhou, H; Sun, QZ; Zhang, YW; Brown, MA				Gao, Fengqin; Yang, Fuyu; Zhou, He; Sun, Qizhong; Zhang, Yunwei; Brown, Michael A.			Evaluation of Processing Technology for Triarrhena sacchariflora (Maxim.) Nakai for Ethanol Production	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; STEAM EXPLOSION; ENZYMATIC-HYDROLYSIS; OPTIMIZATION; STRAW; FIBER; SIZE	The effects of dilute H2SO4 concentration, forage:sulfuric acid ratio, digestion time, and digestion temperature were evaluated to determine effects on ethanol yield of Triarrhena sacchariflora (Maxim.) Nakai. Twenty single factor experiments were conducted to evaluate H2SO4 concentration (0.5, 1.0, 1.5, 2.0, and 2.5%, w/w), forage: sulfuric acid ratio (1:6, 1:8, 1:10, 1:12, and 1:14, g/ml), digestion time (15, 30, 45, 60, and 90, min), digestion temperature (80, 100, 110, 120, and 125 degrees C) for 3 replicates of the 5 levels of each factor. Based on results of the single factor experiments, an incomplete factorial was designed to evaluate ethanol yield from the best combinations of single factors. Finally, the best combination was tested by enzymatic hydrolysis and fermentation experiment in selected combinations according to pretreatment results. Percentage cellulose, hemicellulose, and lignin contents of forage residue after pretreatment, and glucose and xylose concentrations of the filtrate were analyzed prior to enzymatic hydrolysis, and percentage crystallinity was observed in untreated grass and pretreated residue. In addition, the solid residues were then hydrolysed and fermented by cellulase and yeast, the concentrations of glucose and ethanol being monitored for 96 h. Results showed that the order of the effect of main effect factors was as follows: digestion temperature. dilute H2SO4 concentration. digestion time. forage: sulfuric acid ratio. The best process parameters evaluated were sulfuric acid concentration of 1.5%, forage: sulfuric acid ratio of 1: 6, digestion time of 15 min, and digestion temperature of 120 degrees C. With this combination of factors, 80% of the cellulose was hydrolysed in 96 h, and 78% converted to ethanol. The findings identified that hemicelluloses were the key deconstruction barrier for pretreatment of Triarrhena sacchariflora (Maxim.) Nakai for ethanol production. The results of this research provide evidence of appropriate combinations of processing factors for production of ethanol from Triarrhena sacchariflora (Maxim.) Nakai.	[Gao, Fengqin; Yang, Fuyu; Zhou, He; Zhang, Yunwei] China Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Beijing 100193, Peoples R China; [Gao, Fengqin; Sun, Qizhong] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot 010010, Peoples R China; [Brown, Michael A.] B&B Res & Dev, El Reno, OK 73036 USA	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Zhou, H (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Beijing 100193, Peoples R China.	zhouhe@cau.edu.cn			863 Program [2012AA101802]; Basic Scientific Research Special Fund for the National Public Interest (Grassland Research Institute, Chinese Academy of Agricultural Sciences) [1610332013017]	863 Program(National High Technology Research and Development Program of China); Basic Scientific Research Special Fund for the National Public Interest (Grassland Research Institute, Chinese Academy of Agricultural Sciences)	Study was supported by Grants-in project "863 Program(2012AA101802)'' and "Basic Scientific Research Special Fund for the National Public Interest (Grassland Research Institute, Chinese Academy of Agricultural Sciences) (1610332013017)''. Dr. Brown is currently Managing Partner of B&B Research & Development, LLC. which did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of Dr. Brown is articulated in the 'author contributions' section.	Bjerre AB, 1996, BIOTECHNOL BIOENG, V49, P568, DOI 10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.3.CO;2-4; Bvochora JM, 2000, IND CROP PROD, V11, P11, DOI 10.1016/S0926-6690(99)00029-1; CADOCHE L, 1989, BIOL WASTE, V30, P153, DOI 10.1016/0269-7483(89)90069-4; DeMartini JD, 2013, ENERG ENVIRON SCI, V6, P898, DOI 10.1039/c3ee23801f; Grohmann K., 1986, BIOTECHNOL BIOENG, P59; GROUS WR, 1986, ENZYME MICROB TECH, V8, P274, DOI 10.1016/0141-0229(86)90021-9; HOLTZAPPLE MT, 1991, APPL BIOCHEM BIOTECH, V28-9, P59, DOI 10.1007/BF02922589; Jiang Tao, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P175; Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066; Li XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095455; Liu RH, 2008, PREPARATION PROCESSI; Lu Peng, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P237; MARTINEZ J, 1990, APPL BIOCHEM BIOTECH, V24-5, P127, DOI 10.1007/BF02920239; MORJANOFF PJ, 1987, BIOTECHNOL BIOENG, V29, P733, DOI 10.1002/bit.260290610; Patzek TW, 2004, CRIT REV PLANT SCI, V23, P519, DOI 10.1080/07352680490886905; Pimentel D, 2003, NAT RESOUR RES, V12, P127, DOI DOI 10.1023/A:1024214812527; Schell DJ, 2003, APPL BIOCHEM BIOTECH, V105, P69, DOI 10.1385/ABAB:105:1-3:69; Sun Y, 2005, BIORESOURCE TECHNOL, V96, P1599, DOI 10.1016/j.biortech.2004.12.022; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; TORGET R, 1991, APPL BIOCHEM BIOTECH, V28-9, P75, DOI 10.1007/BF02922590; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010; Xiao B, 2006, BIOENERGY CIRCULAR E; Yu ZD, 2012, BIORESOURCE TECHNOL, V121, P335, DOI 10.1016/j.biortech.2012.06.055; Yuan YF, 2005, J HUBEI AUTO IND, V12, P53; Zhang DS, 2013, BIORESOURCE TECHNOL, V129, P127, DOI 10.1016/j.biortech.2012.11.031; 刘亮, 2001, 自然资源学报, V16, P562	27	5	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114399	10.1371/journal.pone.0114399	http://dx.doi.org/10.1371/journal.pone.0114399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490204	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300037
J	Matsuyama, S; Moriuchi, M; Suico, MA; Yano, S; Morino-Koga, S; Shuto, T; Yamanaka, K; Kondo, T; Araki, E; Kai, H				Matsuyama, Shingo; Moriuchi, Masataka; Suico, Mary Ann; Yano, Shuichiro; Morino-Koga, Saori; Shuto, Tsuyoshi; Yamanaka, Kunitoshi; Kondo, Tatsuya; Araki, Eiichi; Kai, Hirofumi			Mild Electrical Stimulation Increases Stress Resistance and Suppresses Fat Accumulation via Activation of LKB1-AMPK Signaling Pathway in C. elegans	PLOS ONE			English	Article							PROTEIN-KINASE AAK-2; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; DIETARY RESTRICTION; INSULIN-RESISTANCE; ENERGY SENSOR; AMPK; LONGEVITY; CELLS; LKB1	Electrical current at physiological strength has been applied as a therapeutic approach for various diseases. Several of our works showed that mild electrical stimulation (MES) at 0.1-ms pulse width has positive impact on organisms. But despite the growing evidence of the beneficial effects of MES, its effects on individual animals and the molecular underpinnings are poorly understood and rarely studied. Here, we examined the effects of MES on individual animal and its mechanisms by mainly using Caenorhabditis elegans, a powerful genetic model organism. Interestingly, MES increased stress resistance and suppressed excess fat accumulation in wild-type N2 worms but not in AMPK/AAK-2 and LKB1/PAR-4 mutant worms. MES promoted the nuclear localization of transcription factors DAF-16 and SKN-1 and consequently increased the expression of anti-stress genes, whereas MES inhibited the nuclear localization of SBP-1 and suppressed the expression of lipogenic genes. Moreover, we found that MES induced the activation of LKB1/PAR4-AMPK/AAK2 pathway in C. elegans and in several mammalian cell lines. The mitochondrial membrane potential and cellular ATP level were slightly and transiently decreased by MES leading to the activation of LKB1-AMPK signaling pathway. Together, we firstly and genetically demonstrated that MES exerts beneficial effects such as stress resistance and suppression of excess fat accumulation, via activation of LKB1-AMPK signaling pathway.	[Matsuyama, Shingo; Moriuchi, Masataka; Suico, Mary Ann; Yano, Shuichiro; Morino-Koga, Saori; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan; [Yamanaka, Kunitoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto, Japan; [Kondo, Tatsuya] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp		Suico, Mary Ann/0000-0002-6751-8352; Kondo, Tatsuya/0000-0003-4830-8955; Shuto, Tsuyoshi/0000-0003-1275-4988	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19390045]; Japan Society for the Promotion of Science (JSPS) Program of Japan; Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented), MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented), MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to H. Kai (#19390045); Japan Society for the Promotion of Science (JSPS) Program (Research Fellowships for Young Scientists) of Japan; Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented), MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Balakatounis Konstantine C, 2008, Eplasty, V8, pe28; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; BASSETT CAL, 1993, J CELL BIOCHEM, V51, P387, DOI 10.1002/jcb.2400510402; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Fukuda R, 2013, J BIOL CHEM, V288, P16117, DOI 10.1074/jbc.M112.442442; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Kondo T, 2014, DIABETES METAB J, V38, P100, DOI 10.4093/dmj.2014.38.2.100; Kondo T, 2012, DIABETES, V61, P838, DOI 10.2337/db11-1098; Kondo T, 2010, OBES RES CLIN PRACT, V4, pE101, DOI 10.1016/j.orcp.2009.09.007; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Martins I, 2011, AGING-US, V3, P821, DOI 10.18632/aging.100380; Do MT, 2013, FOOD CHEM, V136, P415, DOI 10.1016/j.foodchem.2012.09.012; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Morino-Koga S, 2013, J CELL PHYSIOL, V228, P439, DOI 10.1002/jcp.24149; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Taura M, 2010, CANCER SCI, V101, P1610, DOI 10.1111/j.1349-7006.2010.01567.x; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093	46	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114690	10.1371/journal.pone.0114690	http://dx.doi.org/10.1371/journal.pone.0114690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490091	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300066
J	Stanojevic, B; Saenko, V; Todorovic, L; Petrovic, N; Nikolic, D; Zivaljevic, V; Paunovic, I; Nakashima, M; Yamashita, S; Dzodic, R				Stanojevic, Boban; Saenko, Vladimir; Todorovic, Lidija; Petrovic, Nina; Nikolic, Dragan; Zivaljevic, Vladan; Paunovic, Ivan; Nakashima, Masahiro; Yamashita, Shunichi; Dzodic, Radan			Low VHL mRNA Expression is Associated with More Aggressive Tumor Features of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; RENAL-CELL CARCINOMA; SUPPRESSOR GENE; GERMLINE MUTATIONS; CONSECUTIVE PATIENTS; METHYLATION STATUS; SIGNALING PATHWAY; PROGNOSTIC VALUE; HIGH PREVALENCE; BRAF MUTATIONS	Alterations of the von Hippel-Lindau (VHL) tumor suppressor gene can cause different hereditary tumors associated with VHL syndrome, but the potential role of the VHL gene in papillary thyroid carcinoma (PTC) has not been characterized. This study set out to investigate the relationship of VHL expression level with clinicopathological features of PTC in an ethnically and geographically homogenous group of 264 patients from Serbia, for the first time. Multivariate logistic regression analysis showed a strong correlation between low level of VHL expression and advanced clinical stage (OR=5.78, 95% CI 3.17-10.53, P<0.0001), classical papillary morphology of the tumor (OR=2.92, 95% CI 1.33-6.44, P=0.008) and multifocality (OR=1.96, 95% CI 1.06-3.62, P=0.031). In disease-free survival analysis, low VHL expression had marginal significance (P=0.0502 by the log-rank test) but did not appear to be an independent predictor of the risk for chance of faster recurrence in a proportion hazards model. No somatic mutations or evidence of VHL downregulation via promoter hypermethylation in PTC were found. The results indicate that the decrease of VHL expression associates with tumor progression but the mechanism of downregulation remains to be elucidated.	[Stanojevic, Boban; Saenko, Vladimir; Nakashima, Masahiro; Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Stanojevic, Boban; Todorovic, Lidija; Petrovic, Nina] Univ Belgrade, Vinca Inst Nucl Sci, Lab Radiobiol & Mol Genet, Belgrade, Serbia; [Nikolic, Dragan; Zivaljevic, Vladan; Paunovic, Ivan; Dzodic, Radan] Univ Belgrade, Sch Med, Belgrade, Serbia; [Zivaljevic, Vladan; Paunovic, Ivan] Clin Ctr Serbia, Clin Endocrinol, Ctr Endocrine Surg, Belgrade, Serbia; [Dzodic, Radan] Inst Oncol & Radiol Serbia, Dept Surg Oncol, Belgrade, Serbia	Nagasaki University; University of Belgrade; University of Belgrade; Clinical Centre of Serbia; Institute for Oncology & Radiology of Serbia (IORS)	Stanojevic, B (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki 852, Japan.	boban.stanojevic27@gmail.com	Yamashita, Shunichi/GVS-9508-2022; Todorovic, Lidija/Q-6759-2016; Todorovic, Lidija/CAJ-5290-2022; Nikolic, Dragan/AAC-8023-2021	Todorovic, Lidija/0000-0003-0672-0693; Todorovic, Lidija/0000-0003-0672-0693; Nikolic, Dragan/0000-0001-5919-1575; Dzodic, Radan/0000-0002-3041-7339; Stanojevic, Boban/0000-0002-4674-0384; Yamashita, Shunichi/0000-0001-6399-6261; Petrovic, Nina/0000-0003-2503-1228	Nagasaki University Global COE Program; Ministry of Education, Science and Technological Development of the Republic of Serbia [173049, 145094D]; Grants-in-Aid for Scientific Research [26293222] Funding Source: KAKEN	Nagasaki University Global COE Program; Ministry of Education, Science and Technological Development of the Republic of Serbia; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Nagasaki University Global COE Program; Ministry of Education, Science and Technological Development of the Republic of Serbia, Contracts No. 173049 and 145094D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RE, 2004, TRENDS MOL MED, V10, P466, DOI 10.1016/j.molmed.2004.07.008; Benetatos L, 2008, LEUKEMIA, V22, P1293, DOI 10.1038/sj.leu.2405053; Bindra RS, 2002, CANCER RES, V62, P3014; Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9; Carta C, 2006, CLIN ENDOCRINOL, V64, P105, DOI 10.1111/j.1365-2265.2005.02401.x; Chen CB, 2011, J BONE JOINT SURG AM, V93A, P1833, DOI 10.2106/JBJS.I.01553; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Corless CL, 1997, HUM PATHOL, V28, P459, DOI 10.1016/S0046-8177(97)90035-6; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; De Lellies RA, 2004, PATHOLOGY GENETICS T; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Espinosa AV, 2007, BRIT J CANCER, V96, P16, DOI 10.1038/sj.bjc.6603520; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gallou C, 2004, HUM MUTAT, V24, P215, DOI 10.1002/humu.20082; Grebe SKG, 1997, J CLIN ENDOCR METAB, V82, P3684, DOI 10.1210/jc.82.11.3684; Guo Y, 2009, ONCOGENE, V28, P1864, DOI 10.1038/onc.2009.35; Hatzimichael E, 2009, CLIN LYMPHOMA MYELOM, V9, P239, DOI 10.3816/CLM.2009.n.047; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hes FJ, 2003, J CLIN ENDOCR METAB, V88, P969, DOI 10.1210/jc.2002-021466; Hinze R, 2000, ENDOCR PATHOL, V11, P145, DOI 10.1385/EP:11:2:145; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Hoebeeck J, 2006, INT J CANCER, V119, P624, DOI 10.1002/ijc.21888; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hoque MO, 2005, J CLIN ENDOCR METAB, V90, P4011, DOI 10.1210/jc.2005-0313; Hu SY, 2006, J CLIN ENDOCR METAB, V91, P98, DOI 10.1210/jc.2005-1810; IIDA F, 1969, CANCER, V24, P764, DOI 10.1002/1097-0142(196910)24:4<764::AID-CNCR2820240416>3.0.CO;2-S; KATOH R, 1992, CANCER-AM CANCER SOC, V70, P1585, DOI 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kimura ET, 2003, CANCER RES, V63, P1454; Koch CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-131; Kogan E. A., 2006, Arkhiv Patologii, V68, P8; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Kuzmin I, 1999, ONCOGENE, V18, P5672, DOI 10.1038/sj.onc.1202959; Lazzereschi D, 1997, J EXP CLIN CANC RES, V16, P325; Lida F, 1969, CANCER, V24, P764; Liu T, 2014, INT J MOL MED, V33, P1236, DOI 10.3892/ijmm.2014.1661; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Martinez A, 2001, J CLIN PATHOL-MOL PA, V54, P300, DOI 10.1136/mp.54.5.300; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; McCarthy RP, 2006, CLIN CANCER RES, V12, P2414, DOI 10.1158/1078-0432.CCR-05-2818; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Migdalska-Sek M, 2011, WSPOLCZESNA ONKOL, V15, P191, DOI 10.5114/wo.201124312; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Park SY, 2006, CANCER-AM CANCER SOC, V107, P1831, DOI 10.1002/cncr.22218; Pasquali D, 2011, THYROID, V21, P391, DOI 10.1089/thy.2010.0168; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; Qi H, 2003, CANCER RES, V63, P7076; Ries LAG, 2007, SEER CANC STAT REV 1; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Sakashita N, 1999, HISTOCHEM J, V31, P133, DOI 10.1023/A:1003554712386; SANTORO M, 1994, ONCOGENE, V9, P509; Sgambati MT, 2000, AM J HUM GENET, V66, P84, DOI 10.1086/302726; Shattuck TM, 2005, NEW ENGL J MED, V352, P2406, DOI 10.1056/NEJMoa044190; Siironen P, 2005, TUMOR BIOL, V26, P57, DOI 10.1159/000085586; Stanojevic B, 2011, ENDOCR J, V58, P381, DOI 10.1507/endocrj.K11E-054; Sugg SL, 1998, J CLIN ENDOCR METAB, V83, P4116, DOI 10.1210/jc.83.11.4116; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Xing MZ, 2007, ENDOCRINOLOGY, V148, P948, DOI 10.1210/en.2006-0927; Zatyka M, 2002, CANCER RES, V62, P3803; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3; Zia MK, 2007, INT J MOL MED, V20, P605	71	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114511	10.1371/journal.pone.0114511	http://dx.doi.org/10.1371/journal.pone.0114511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490036	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300045
J	Yi, WB; Qiu, S; Wang, K; Qi, HZ; Zhang, LX; Zhou, P; He, F; Ming, D				Yi, Weibo; Qiu, Shuang; Wang, Kun; Qi, Hongzhi; Zhang, Lixin; Zhou, Peng; He, Feng; Ming, Dong			Evaluation of EEG Oscillatory Patterns and Cognitive Process during Simple and Compound Limb Motor Imagery	PLOS ONE			English	Article							MOVEMENT; BAND; DESYNCHRONIZATION; CONNECTIVITY; PROPAGATION; TOOLBOX; ALPHA	Motor imagery (MI), sharing similar neural representations to motor execution, is regarded as a window to investigate the cognitive motor processes. However, in comparison to simple limb motor imagery, significantly less work has been reported on brain oscillatory patterns induced by compound limb motor imagery which involves several parts of limbs. This study aims to investigate differences of the electroencephalogram (EEG) patterns as well as cognitive process between simple limb motor imagery and compound limb motor imagery. Ten subjects participated in the experiment involving three tasks of simple limbmotor imagery (left hand, right hand, feet) and three tasks of compound limb motor imagery (both hands, left hand combined with right foot, right hand combined with left foot). Simultaneous imagination of different limbs contributes to the activation of larger cortical areas as well as two estimated sources located at corresponding motor areas within beta rhythm. Compared with simple limb motor imagery, compound limb motor imagery presents a network with more effective interactions overlying larger brain regions, additionally shows significantly larger causal flow over sensorimotor areas and larger causal density over both sensorimotor areas and neighboring regions. On the other hand, compound limb motor imagery also shows significantly larger 10-11 Hz alpha desynchronization at occipital areas and central theta synchronization. Furthermore, the phase-locking value (PLV) between central and occipital areas of left/right hand combined with contralateral foot imagery is significantly larger than that of simple limb motor imagery. All these findings imply that there exist apparent intrinsic distinctions of neural mechanism between simple and compound limb motor imagery, which presents a more complex effective connectivity network and may involve a more complex cognitive process during information processing.	[Yi, Weibo; Qiu, Shuang; Wang, Kun; Qi, Hongzhi; Zhang, Lixin; Zhou, Peng; He, Feng; Ming, Dong] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Yi, Weibo; Qiu, Shuang; Wang, Kun; Qi, Hongzhi; Zhang, Lixin; Zhou, Peng; He, Feng; Ming, Dong] Tianjin Key Lab Biomed Detecting Tech & Instrumem, Tianjin, Peoples R China	Tianjin University	Qi, HZ (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China.	qhz@tju.edu.cn; richardming@tju.edu.cn	Qi, Hongzhi/AAY-4423-2020; He, Feng/HHS-6457-2022; Zhang, Li/GWM-7501-2022	He, Feng/0000-0002-1996-0744; Wang, Kun/0000-0002-9365-5107	National Natural Science Foundation of China [81222021, 61172008, 81171423, 51377120, 31271062]; National Key Technology R&D Program of the Ministry of Science and Technology of China [2012BAI34B02]; Program for New Century Excellent Talents in University of the Ministry of Education of China [NCET-10-0618]; Natural Science Foundation of Tianjin [13JCQNJC13900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Program for New Century Excellent Talents in University of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	The research was supported by National Natural Science Foundation of China (No. 81222021, 61172008, 81171423, 51377120, 31271062), National Key Technology R&D Program of the Ministry of Science and Technology of China (No. 2012BAI34B02), Program for New Century Excellent Talents in University of the Ministry of Education of China (No. NCET-10-0618), and Natural Science Foundation of Tianjin (No. 13JCQNJC13900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2012, ADV HUM-COMPUT INTER, V2012, DOI 10.1155/2012/127627; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bedny M, 2008, J NEUROSCI, V28, P11347, DOI 10.1523/JNEUROSCI.3039-08.2008; Blinowska K., 2008, INT J BIOELECTROMAGN, V10, P2; Chen D, 2012, CONTROL SENSOR NETWO, V23, P87; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; FRANASZCZUK PJ, 1985, BIOL CYBERN, V51, P239, DOI 10.1007/BF00337149; Friston K. J., 1993, Human Brain Mapping, V1, P69, DOI 10.1002/hbm.460010108; Ginter J, 2005, METHOD INFORM MED, V44, P106, DOI 10.1055/s-0038-1633932; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, COGNITIVE BRAIN RES, V6, P83, DOI 10.1016/S0926-6410(97)00018-9; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kus R, 2006, ACTA NEUROBIOL EXP, V66, P195; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Stavrinou ML, 2007, BRAIN TOPOGR, V19, P137, DOI 10.1007/s10548-007-0020-7; Tamminga CA, 2004, AM J PSYCHIAT, V161, P2178; Yi WB, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-106; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028; Zhou ZX, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046008	29	30	31	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114853	10.1371/journal.pone.0114853	http://dx.doi.org/10.1371/journal.pone.0114853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489941	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300084
J	Best, NB; Hartwig, T; Budka, JS; Bishop, BJ; Brown, E; Potluri, DPV; Cooper, BR; Premachandra, GS; Johnston, CT; Schulz, B				Best, Norman B.; Hartwig, Thomas; Budka, Joshua S.; Bishop, Brandon J.; Brown, Elliot; Potluri, Devi P. V.; Cooper, Bruce R.; Premachandra, Gnanasiri S.; Johnston, Cliff T.; Schulz, Burkhard			Soilless Plant Growth Media Influence the Efficacy of Phytohormones and Phytohormone Inhibitors	PLOS ONE			English	Article							BRASSINOSTEROID BIOSYNTHESIS; FUNGICIDE PROPICONAZOLE; TRIAZOLE FUNGICIDES; PHYSICAL-PROPERTIES; PACLOBUTRAZOL; UNICONAZOLE; SORPTION; DRENCH; BRASSINOLIDE; DEGRADATION	Plant growth regulators, such as hormones and their respective biosynthesis inhibitors, are effective tools to elucidate the physiological function of phytohormones in plants. A problem of chemical treatments, however, is the potential for interaction of the active compound with the growth media substrate. We studied the interaction and efficacy of propiconazole, a potent and specific inhibitor of brassinosteroid biosynthesis, with common soilless greenhouse growth media for rice, sorghum, and maize. Many of the tested growth media interacted with propiconazole reducing its efficacy up to a hundred fold. To determine the molecular interaction of inhibitors with media substrates, Fourier Transform Infrared Spectroscopy and sorption isotherm analysis was applied. While mica clay substrates absorbed up to 1.3 mg of propiconazole per g substrate, calcined clays bound up to 12 mg of propiconazole per g substrate. The efficacy of the gibberellic acid biosynthesis inhibitor, uniconazole, and the most active brassinosteroid, brassinolide, was impacted similarly by the respective substrates. Conversely, gibberellic acid showed no distinct growth response in different media. Our results suggest that the reduction in efficacy of propiconazole, uniconazole, and brassinolide in bioassays when grown in calcined clay is caused by hydrophobic interactions between the plant growth regulators and the growth media. This was further confirmed by experiments using methanol-water solvent mixes with higher hydrophobicity values, which reduce the interaction of propiconazole and calcined clay.	[Best, Norman B.; Hartwig, Thomas; Budka, Joshua S.; Bishop, Brandon J.; Brown, Elliot; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Hartwig, Thomas] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Budka, Joshua S.] USDA ARS, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Potluri, Devi P. V.] Chicago State Univ, Dept Biol, Chicago, IL USA; [Cooper, Bruce R.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Premachandra, Gnanasiri S.; Johnston, Cliff T.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Institution for Science; United States Department of Agriculture (USDA); Chicago State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Schulz, B (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	bschulz1@umd.edu	Johnston, Cliff T/B-2215-2009; Johnston, Cliff T/A-1331-2015; Best, Norman B/G-1969-2015	Johnston, Cliff T/0000-0002-8462-9724; Johnston, Cliff T/0000-0002-8462-9724; Best, Norman B/0000-0002-6572-5999	National Science Foundation CAREER Integrative Organismal Systems Grant [1054918]	National Science Foundation CAREER Integrative Organismal Systems Grant(National Science Foundation (NSF))	National Science Foundation CAREER Integrative Organismal Systems Grant 1054918 to BS (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen JW, 2006, TOXICOL PATHOL, V34, P853, DOI 10.1080/01926230601047816; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; BANKO T J, 1988, Journal of Environmental Horticulture, V6, P124; Barrett J. E., 1989, Acta Horticulturae, P275; BARRETT JE, 1994, HORTSCIENCE, V29, P893, DOI 10.21273/HORTSCI.29.8.893; Battaglin WA, 2011, WATER AIR SOIL POLL, V218, P307, DOI 10.1007/s11270-010-0643-2; Boyd SA, 2011, WILEY-IUPAC SER BIOP, P51; BRIAN PW, 1955, PHYSIOL PLANTARUM, V8, P669, DOI 10.1111/j.1399-3054.1955.tb07760.x; Bromilow RH, 1999, PESTIC SCI, V55, P1129, DOI 10.1002/(SICI)1096-9063(199912)55:12&lt;1129::AID-; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; Clouse Steven D, 2011, Arabidopsis Book, V9, pe0151, DOI 10.1199/tab.0151; Currey CJ, 2010, HORTTECHNOLOGY, V20, P863, DOI 10.21273/HORTTECH.20.5.863; Evans MR, 2007, HORTTECHNOLOGY, V17, P312, DOI 10.21273/HORTTECH.17.3.312; EVANS MMS, 1995, PLANT PHYSIOL, V108, P475, DOI 10.1104/pp.108.2.475; Faust JE, 2001, HORTTECHNOLOGY, V11, P557, DOI 10.21273/HORTTECH.11.4.557; FELDMANN KA, 1989, SCIENCE, V243, P1351, DOI 10.1126/science.243.4896.1351; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; FLETCHER RA, 1986, PHYSIOL PLANTARUM, V66, P197, DOI 10.1111/j.1399-3054.1986.tb02408.x; FONTENO WC, 1990, J AM SOC HORTIC SCI, V115, P375, DOI 10.21273/JASHS.115.3.375; Garrison AW, 2011, INT J ENV RES PUB HE, V8, P3453, DOI 10.3390/ijerph8083453; Gent MPN, 2000, PLANT GROWTH REGULAT, P89; Ghosh MK, 2012, J PHYS CHEM B, V116, P14254, DOI 10.1021/jp308936g; GROSSMANN K, 1990, PHYSIOL PLANTARUM, V78, P640, DOI 10.1111/j.1399-3054.1990.tb05254.x; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hartwig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036625; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hewitt, 1998, FUNGICIDES CROP PROT; Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; Idowu OS, 2007, J AOAC INT, V90, P291; JIAO J, 1990, HORTSCIENCE, V25, P1244, DOI 10.21273/HORTSCI.25.10.1244; Kim IS, 2003, PEST MANAG SCI, V59, P324, DOI 10.1002/ps.642; Kim IS, 2002, PLANT SOIL, V239, P321, DOI 10.1023/A:1015000328350; Lee JK, 2004, LANGMUIR, V20, P3844, DOI 10.1021/la049748b; Levine SL, 1999, ENVIRON TOXICOL CHEM, V18, P2565, DOI [10.1002/etc.5620181125, 10.1897/1551-5028(1999)018&lt;2565:MOCEIR&gt;2.3.CO;2]; Li H, 2003, SOIL SCI SOC AM J, V67, P122, DOI 10.2136/sssaj2003.0122; Million JB, 1999, HORTSCIENCE, V34, P1099, DOI 10.21273/HORTSCI.34.6.1099; Million JB, 1998, HORTSCIENCE, V33, P852, DOI 10.21273/HORTSCI.33.5.852; Million JB, 1998, HORTSCIENCE, V33, P1030, DOI 10.21273/HORTSCI.33.6.1030; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myers N, 1999, CURR SCI INDIA, V76, P507; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; Ogutu RA, 2009, HORTSCIENCE, V44, P431, DOI 10.21273/HORTSCI.44.2.431; Orozco R., 1995, Acta Horticulturae, P137; Pardos M, 2005, HORTSCIENCE, V40, P1773, DOI 10.21273/HORTSCI.40.6.1773; Pasian CC, 1999, SCI HORTIC-AMSTERDAM, V80, P277, DOI 10.1016/S0304-4238(98)00248-9; PHINNEY BO, 1956, P NATL ACAD SCI USA, V42, P185, DOI 10.1073/pnas.42.4.185; Rademacher W., 2020, PLANT BIOCH REGULATO, P169; Raviv M., 1986, The role of organic matter in modern agriculture, P257; Riise G, 2001, WATER AIR SOIL POLL, V129, P245, DOI 10.1023/A:1010353209449; Roberts T.R., 1999, METABOLIC PATHWAYS 2, P1080; Sannino A, 2004, J AOAC INT, V87, P991; Schoonheydt RA, 2012, HDB CLAY SCI; Schulz B, 1995, PLANT MOL BIOL MAN K, VK3, P1; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Singh N, 2005, PEST MANAG SCI, V61, P191, DOI 10.1002/ps.973; Sopher CR, 1999, CAN J BOT, V77, P279, DOI 10.1139/cjb-77-2-279; STARMAN TW, 1990, HORTSCIENCE, V25, P935, DOI 10.21273/HORTSCI.25.8.935; Sun GB, 2005, TOXICOL LETT, V155, P277, DOI 10.1016/j.toxlet.2004.10.006; Thorstensen CW, 2001, J ENVIRON QUAL, V30, P2046, DOI 10.2134/jeq2001.2046; Vriet C, 2013, MOL PLANT, V6, P1738, DOI 10.1093/mp/sst096; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Wang C, 2011, J AGR FOOD CHEM, V59, P8507, DOI 10.1021/jf200970s; WANG YT, 1991, HORTSCIENCE, V26, P148, DOI 10.21273/HORTSCI.26.2.148; WARREN S L, 1990, Journal of Environmental Horticulture, V8, P151; WARREN S L, 1991, Journal of Environmental Horticulture, V9, P163; Watson Gary W., 2001, Journal of Environmental Horticulture, V19, P119; Watson JT, 2009, PROC FL STATE HORTIC, V122, P370; WEATHERS PJ, 1988, IN VITRO CELL DEV B, V24, P727, DOI 10.1007/BF02623612; Whipker B. E., 1997, HortTechnology, V7, P269; WIGGINS TE, 1984, PESTIC SCI, V15, P206, DOI 10.1002/ps.2780150212; Yabuta T., 1938, J AGR CHEM SOC JAPAN, V14, P1526, DOI DOI 10.1271/NOGEIKAGAKU1924.14.12_1526; Yadav R. K., 2005, Agricultural Reviews, V26, P124; YOSHIDA Y, 1991, BIOCHEM SOC T, V19, P778, DOI 10.1042/bst0190778; Zar JH., 2010, BIOSTAT ANAL, V5th	78	4	4	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e107689	10.1371/journal.pone.0107689	http://dx.doi.org/10.1371/journal.pone.0107689			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485677	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600002
J	Perales, H; Golicher, D				Perales, Hugo; Golicher, Duncan			Mapping the Diversity of Maize Races in Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHIAPAS; LANDRACES; GERMPLASM; BENEFITS	Traditional landraces of maize are cultivated throughout more than one-half of Mexico's cropland. Efforts to organize in situ conservation of this important genetic resource have been limited by the lack of knowledge of regional diversity patterns. We used recent and historic collections of maize classified for race type to determine biogeographic regions and centers of landrace diversity. We also analyzed how diversity has changed over the last sixty years. Based on racial composition of maize we found that Mexico can be divided into 11 biogeographic regions. Six of these biogeographic regions are in the center and west of the country and contain more than 90% of the reported samples for 38 of the 47 races studied; these six regions are also the most diverse. We found no evidence of rapid overall decline in landrace diversity for this period. However, several races are now less frequently reported and two regions seem to support lower diversity than in previous collection periods. Our results are consistent with a previous hypothesis for diversification centers and for migration routes of original maize populations merging in western central Mexico. We provide maps of regional diversity patterns and landrace based biogeographic regions that may guide efforts to conserve maize genetic resources.	[Perales, Hugo] El Colegio Frontera Sur, Grp Agroecol, San Cristobal, Chiapas, Mexico; [Golicher, Duncan] El Colegio Frontera Sur, Grp Conservac & Restaurac Bosques, San Cristobal, Chiapas, Mexico; [Golicher, Duncan] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR); Bournemouth University	Perales, H (corresponding author), El Colegio Frontera Sur, Grp Agroecol, Carretera Panamericana & Periferico S-N, San Cristobal, Chiapas, Mexico.	hperales@ecosur.mx	Perales, Hugo/F-6193-2010; Golicher, Duncan/B-4240-2009	Perales, Hugo/0000-0003-3431-5759; 	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO)	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO)	Funding: Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO) collected the original data and supported the work. CONABIO had no role in the study design, analysis, decision to publish, or preparation of the manuscript.	Almanza H, 2012, RETHINK DEV INEQUALI, V1, P17; Anderson E., 1942, ANN MISSOURI BOT GARD, V29, P69, DOI 10.2307/2394331; Anderson E., 1946, ANN MO BOT GARD, V33, P147, DOI [10.2307/2394428, DOI 10.2307/2394428]; Anderson Edgar, 1947, ANN MISSOURI BOT GARD, V34, P433, DOI 10.2307/2394775; Angeles Arrieta H. H., 2000, Agricultura Tecnica en Mexico, V26, P31; [Anonymous], 1988, ASA MONOGRAPH, DOI DOI 10.2134/AGR0NM0N0GR18.3ED.C2; [Anonymous], 2009, ORIGEN DIVERSIFICACI; Aragon-Cuevas F., 2006, LIBRO TECNICO N 6; Arias LM., 2007, U CIENCIA, V23, P69; Arslan A, 2009, AM J AGR ECON, V91, P956, DOI 10.1111/j.1467-8276.2009.01323.x; Bellon MR, 2006, WORLD DEV, V34, P113, DOI 10.1016/j.worlddev.2005.05.012; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; Benz BF, 1986, THESIS U WISCONSIN M; BIRD RM, 1980, BIOTROPICA, V12, P30, DOI 10.2307/2387771; BRETTING PK, 1990, AM J BOT, V77, P211, DOI 10.2307/2444643; Brickell C.D., 2004, ACTA HORTIC, V647, P1; Brush SB, 2007, AGR ECOSYST ENVIRON, V121, P211, DOI 10.1016/j.agee.2006.12.018; CONABIO, 2014, REC GEN ACT AN INF A; de Candolle A., 1884, ORIGIN CULTIVATED PL; Eakin H, 2014, DEV CHANGE, V45, P133, DOI 10.1111/dech.12074; Espinosa D., 2008, CAPITAL NATURAL MEXI, VI, P33, DOI DOI 10.32800/ABC.2019.42.0187; Golicher D, 2007, METHODOLOGY FLEXIBLE; Guarino L., 2002, P387, DOI 10.1079/9780851995229.0387; Hartkamp A.D., 2000, MAIZE PRODUCTION ENV; Hernandez-Xolocotzi E, 1970, AGROCIENCIA, V5, P3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; INEGI website, 2014, SUBPR FIS; International Maize and Wheat Improvement Center (CIMMYT), 2001, CIMMYT 1999 2000 WOR; KATO TA, 1984, EVOL BIOL, V17, P219; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Leclerc C., 2011, DIVERSITY, V4, P1, DOI [DOI 10.3390/D4010001, 10.3390/d4010001]; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; MANGELSDORF P. C., 1956, Botanical Museum Leaflet, Harvard University, Cambridge, Mass., V17, P151; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mercer K, 2008, EVOL APPL, V1, P489, DOI 10.1111/j.1752-4571.2008.00038.x; Morrone Juan J., 2005, Rev. Mex. Biodiv., V76, P207; Ort DR, 2014, SCIENCE, V344, P483, DOI 10.1126/science.1253884; Ortega PR, 1991, AVANCES ESTUDIO RECU, P161; Parra J. Ron, 2006, SCI CUCBA, V8, P1; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pressoir G, 2004, HEREDITY, V92, P95, DOI 10.1038/sj.hdy.6800388; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reif J, 2006, THEOR APPL GENET, V113, P177, DOI 10.1007/s00122-006-0283-5; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; SANCHEZ GJJ, 1992, ECON BOT, V46, P72, DOI 10.1007/BF02985256; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Sanchez-Gonzalez JJ, 1989, THESIS N CAROLINA ST; Sturtevant E. L, 1894, B TORREY BOT CLUB, V21, P319, DOI DOI 10.2307/2477991; Ureta C, 2012, GLOBAL CHANGE BIOL, V18, P1073, DOI 10.1111/j.1365-2486.2011.02607.x; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; van Heerwaarden J, 2009, THEOR APPL GENET, V119, P875, DOI 10.1007/s00122-009-1096-0; Vavilov NI, 1992, ORIGIN GEOGRAPHY CUL, P207; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Villa Tania Carolina Camacho, 2005, Plant Genetic Resources Characterization and Utilization, V3, P373, DOI 10.1079/PGR200591; Wellhausen EJ., 1952, RACES MAIZE MEXICO; Wellhausen EJ, 1957, PUBLICATION NAS NRC, V511; XOLOCOTZI EH, 1985, ECON BOT, V39, P416, DOI 10.1007/BF02858749; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; Zhao W, 2006, NUCLEIC ACIDS RES, V34, pD752, DOI 10.1093/nar/gkj011	61	58	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114657	10.1371/journal.pone.0114657	http://dx.doi.org/10.1371/journal.pone.0114657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486121	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000346907600085
J	Xie, CP; Chen, YP; Sun, WW; Ding, J; Zhou, LZ; Wang, SH; Wang, SQ; Zhang, YL; Zhu, DS; Wen, XB; Hu, SN; Li, SK				Xie, Chuping; Chen, Yaping; Sun, Wanwei; Ding, Jun; Zhou, Lizhen; Wang, Shasha; Wang, Shuqi; Zhang, Yueling; Zhu, Dashi; Wen, Xiaobo; Hu, Songnian; Li, Shengkang			Transcriptome and Expression Profiling Analysis of the Hemocytes Reveals a Large Number of Immune-Related Genes in Mud Crab Scylla paramamosain during Vibrio parahaemolyticus Infection	PLOS ONE			English	Article							SHRIMP LITOPENAEUS-VANNAMEI; MOLECULAR-CLONING; WHITE SHRIMP; CDNA; IDENTIFICATION; DROSOPHILA; GENERATION; LIVER; HEPATOPANCREAS; ACTIVATION	Background: Mud crab Scylla paramamosain is an economically important marine species in China. However, frequent outbreaks of infectious diseases caused by marine bacteria, such as Vibrio parahaemolyticus, result in great economic losses. Methodology/Principal Findings: Comparative de novo transcriptome analysis of S. paramamosain infected with V. parahaemolyticus was carried out to investigate the molecular mechanisms underlying the immune response to pathogenic bacteria by using the Illumina paired-end sequencing platform. A total of 52,934,042 clean reads from the hemocytes of V. parahaemolyticus-infected mud crabs and controls were obtained and assembled into 186,193 contigs. 59,120 unigenes were identified from 81,709 consensus sequences of mud crabs and 48,934 unigenes were matched proteins in the Nr or Swissprot databases. Among these, 10,566 unigenes belong to 3 categories of Gene Ontology, 25,349 to 30 categories of KEGG, and 15,191 to 25 categories of COG database, covering almost all functional categories. By using the Solexa/Illumina's DGE platform, 1213 differentially expressed genes (P<0.05), including 538 significantly up-regulated and 675 down-regulated, were detected in V. parahaemolyticus-infected crabs as compared to that in the controls. Transcript levels of randomly-chosen genes were further measured by quantitative real-time PCR to confirm the expression profiles. Many differentially expressed genes are involved in various immune processes, including stimulation of the Toll pathway, Immune Deficiency (IMD) pathway, Ras-regulated endocytosis, and proPO-activating system. Conclusions/Significance: Analysis of the expression profile of crabs under infection provides invaluable new data for biological research in S. paramamosain, such as the identification of novel genes in the hemocytes during V. parahaemolyticus infection. These results will facilitate our comprehensive understanding of the mechanisms involved in the immune response to bacterial infection and will be helpful for diseases prevention in crab aquaculture.	[Xie, Chuping; Sun, Wanwei; Ding, Jun; Zhou, Lizhen; Wang, Shasha; Wang, Shuqi; Zhang, Yueling; Zhu, Dashi; Wen, Xiaobo; Li, Shengkang] Shantou Univ, Guangdong Prov Key Lab Marine Biol, Shantou, Peoples R China; [Xie, Chuping; Sun, Wanwei; Ding, Jun; Zhou, Lizhen; Wang, Shasha; Wang, Shuqi; Zhang, Yueling; Zhu, Dashi; Li, Shengkang] Shantou Univ, Inst Marine Biol, Shantou, Peoples R China; [Chen, Yaping; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Shantou University; Shantou University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Li, SK (corresponding author), Shantou Univ, Guangdong Prov Key Lab Marine Biol, Shantou, Peoples R China.	lisk@stu.edu.cn	Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [41376176, 41176103]; Guangdong provincial project of Science and Technology [2012B020308007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong provincial project of Science and Technology	Funding: The work was supported by grants from National Natural Science Foundation of China (41376176, 41176103), Guangdong provincial project of Science and Technology (2012B020308007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; Bayne CJ, 2006, COMP BIOCHEM PHYS D, V1, P396, DOI 10.1016/j.cbd.2006.10.001; Boswell MG, 2009, COMP BIOCHEM PHYS C, V149, P258, DOI 10.1016/j.cbpc.2008.11.005; Cao D, 2001, ANIM GENET, V32, P169, DOI 10.1046/j.1365-2052.2001.00753.x; Cao JS, 2013, FISH SHELLFISH IMMUN, V34, P129, DOI 10.1016/j.fsi.2012.10.018; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Du ZQ, 2013, MOL BIOL REP, V40, P6873, DOI 10.1007/s11033-013-2805-y; Ekert PG, 1997, BRIT MED BULL, V53, P591; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Gao WH, 2012, AQUACULTURE, V364, P186, DOI 10.1016/j.aquaculture.2012.08.024; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He NH, 2004, FISH SHELLFISH IMMUN, V17, P121, DOI 10.1016/j.fsi.2003.11.008; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Li S, 2012, J APPL MICROBIOL, V113, P1341, DOI 10.1111/jam.12008; Li SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073392; Li SK, 2012, FISH SHELLFISH IMMUN, V32, P503, DOI 10.1016/j.fsi.2011.12.002; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Li XC, 2013, DEV COMP IMMUNOL, V39, P313, DOI 10.1016/j.dci.2012.11.011; Liu HP, 2010, FISH SHELLFISH IMMUN, V28, P862, DOI 10.1016/j.fsi.2010.02.008; Liu J, 2009, FISH SHELLFISH IMMUN, V26, P422, DOI 10.1016/j.fsi.2009.01.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102668; Ma THT, 2007, FISH SHELLFISH IMMUN, V23, P430, DOI 10.1016/j.fsi.2006.12.005; Mangkalanan S, 2014, DEV COMP IMMUNOL, V44, P116, DOI 10.1016/j.dci.2013.11.018; Martin SA, 2002, BIOCHEM BIOPH RES CO, V293, P578, DOI 10.1016/S0006-291X(02)00263-2; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mu Y, 2013, BMC GENOMICS, V11, P506; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Schlenke TA, 2005, INSECT MOL BIOL, V14, P175, DOI 10.1111/j.1365-2583.2004.00543.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Taboada X, 2012, GENE, V492, P250, DOI 10.1016/j.gene.2011.10.020; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Vuylsteke M, 2006, PLANT J, V45, P439, DOI 10.1111/j.1365-313X.2005.02630.x; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yan F, 2011, FISH SHELLFISH IMMUN, V30, P354, DOI 10.1016/j.fsi.2010.11.004; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063787; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093452; Zhu L, 2014, FISH SHELLFISH IMMUN, V36, P172, DOI 10.1016/j.fsi.2013.10.023; Zou ZH, 2011, COMP BIOCHEM PHYS D, V6, P150, DOI 10.1016/j.cbd.2010.12.003	58	28	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114500	10.1371/journal.pone.0114500	http://dx.doi.org/10.1371/journal.pone.0114500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486443	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600062
J	Abe, C; Johansson, E; Allzen, E; Savic, I				Abe, Christoph; Johansson, Emilia; Allzen, Elin; Savic, Ivanka			Sexual Orientation Related Differences in Cortical Thickness in Male Individuals	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; SURFACE-BASED ANALYSIS; HUMAN BRAIN; WORKING-MEMORY; PUTATIVE PHEROMONES; GENDER IDENTITY; HOMOSEXUAL-MEN; VISUAL-CORTEX; ADULTS	Previous neuroimaging studies demonstrated sex and also sexual orientation related structural and functional differences in the human brain. Genetic information and effects of sex hormones are assumed to contribute to the male/female differentiation of the brain, and similar effects could play a role in processes influencing human's sexual orientation. However, questions about the origin and development of a person's sexual orientation remain unanswered, and research on sexual orientation related neurobiological characteristics is still very limited. To contribute to a better understanding of the neurobiology of sexual orientation, we used magnetic resonance imaging (MRI) in order to compare regional cortical thickness (Cth) and subcortical volumes of homosexual men (hoM), heterosexual men (heM) and heterosexual women (heW). hoM (and heW) had thinner cortices primarily in visual areas and smaller thalamus volumes than heM, in which hoM and heW did not differ. Our results support previous studies, which suggest cerebral differences between hoM and heM in regions, where sex differences have been reported, which are frequently proposed to underlie biological mechanisms. Thus, our results contribute to a better understanding of the neurobiology of sexual orientation.	[Abe, Christoph; Johansson, Emilia] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Allzen, Elin] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Savic, Ivanka] Karolinska Hosp, Neurol Clin, Div Pediat Neurol, Dept Womens & Childrens Hlth, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Abe, C (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	christoph.abe@ki.se		Abe, Christoph/0000-0002-1680-8480	Swedish Medical Research Council; Stockholm Brain Institutet; KI (Karolisnka Institutet) foundation; AFA insurance fund; FORTE research fund	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Brain Institutet; KI (Karolisnka Institutet) foundation; AFA insurance fund; FORTE research fund	This work was supported by the Swedish Medical Research Council, Stockholm Brain Institutet, KI (Karolisnka Institutet) foundation and by the use of resources and facilities at the Karolinska Institutet, Stockholm. Collection of control data was funded by the AFA insurance fund and the FORTE research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Bluhm RL, 2011, HUM BRAIN MAPP, V32, P1029, DOI 10.1002/hbm.21090; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Dickerson BC, 2012, NEUROLOGY, V78, P84, DOI 10.1212/WNL.0b013e31823efc6c; Durazzo TC, 2013, ADDICT BIOL, V18, P379, DOI 10.1111/j.1369-1600.2011.00407.x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Garcia-Falgueras A, 2010, ENDOCR DEV, V17, P22, DOI 10.1159/000262525; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gooren LJG, 2002, MOL CELL ENDOCRINOL, V198, P31, DOI 10.1016/S0303-7207(02)00366-0; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Hofer P, 2013, EUR NEUROPSYCHOPHARM, V23, P79, DOI 10.1016/j.euroneuro.2012.04.013; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Hu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059426; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Keogh R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029221; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Lentini E, 2013, CEREB CORTEX, V23, P2322, DOI 10.1093/cercor/bhs222; Luders E, 2006, CEREB CORTEX, V16, P1232, DOI 10.1093/cercor/bhj064; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Manning JT, 2003, MED HYPOTHESES, V61, P303, DOI 10.1016/S0306-9877(03)00184-1; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Peper JS, 2011, NEUROSCIENCE, V191, P28, DOI 10.1016/j.neuroscience.2011.02.014; Peper JS, 2011, PSYCHONEUROENDOCRINO, V36, P1101, DOI 10.1016/j.psyneuen.2011.05.004; Ponseti J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000762; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002; Rahman Q, 2003, PERS INDIV DIFFER, V34, P1337, DOI 10.1016/S0191-8869(02)00140-X; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2013, SEX DIFFERENCES CORT; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Savic I, 2010, PROG BRAIN RES, V186, P41, DOI 10.1016/B978-0-444-53630-3.00004-X; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Swaab DF, 2009, FUNCT NEUROL, V24, P17; Tanabe J, 2013, AM J NEURORADIOL, V34, P1150, DOI 10.3174/ajnr.A3347; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Ventre-Dominey J, 2005, COGNITIVE BRAIN RES, V25, P747, DOI 10.1016/j.cogbrainres.2005.09.004; Walhovd KB, 2006, NEUROIMAGE, V31, P1343, DOI 10.1016/j.neuroimage.2006.01.011; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028	57	30	30	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114721	10.1371/journal.pone.0114721	http://dx.doi.org/10.1371/journal.pone.0114721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479554	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200115
J	Ericson, VR; Spilker, KA; Tugizova, MS; Shen, K				Ericson, Vivian R.; Spilker, Kerri A.; Tugizova, Madina S.; Shen, Kang			MTM-6, a Phosphoinositide Phosphatase, is Required to Promote Synapse Formation in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MYOTUBULAR MYOPATHY; NERVOUS-SYSTEM; POSTSYNAPTIC DIFFERENTIATION; ALZHEIMERS-DISEASE; WNT SIGNALS; DROSOPHILA; NEURONS; FAMILY	Forming the proper number of synapses is crucial for normal neuronal development. We found that loss of function of the phosphoinositide phosphatase mtm-6 results in a reduction in the number of synaptic puncta. The reduction in synapses is partially the result of MTM-6 regulation of the secretion of the Wnt ligand EGL-20 from cells in the tail and partially the result of neuronal action. MTM-6 shows relative specificity for EGL-20 over the other Wnt ligands. We suggest that the ability of MTM-6 to regulate EGL-20 secretion is a function of its expression pattern. We conclude that regulation of secretion of different Wnt ligands can use different components. Additionally, we present a novel neuronal function for MTM-6.	[Ericson, Vivian R.; Spilker, Kerri A.; Tugizova, Madina S.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu	Tugizova, Madina/GPC-4412-2022		Howard Hughes Medical Institute; National Science Foundation; Stanford Graduate Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University)	Funding was provided by Investigator Award, Howard Hughes Medical Institute, No Grant Number, http://www.hhmi.org/; National Science Foundation Graduate Fellowship, National Science Foundation, http://www.nsf.gov/; Stanford Graduate Fellowship, http://sgf.stanford.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2012, REV NEUROSCIENCE, V23, P29, DOI [10.1515/RNS.2011.057, 10.1515/rns.2011.057]; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bolis A, 2007, MOL NEUROBIOL, V35, P308, DOI 10.1007/s12035-007-0031-0; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee HW, 2010, J NEUROSCI, V30, P5508, DOI 10.1523/JNEUROSCI.4283-09.2010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Mei J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004979; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Mizumoto K, 2013, CELL REP, V5, P389, DOI 10.1016/j.celrep.2013.09.011; Mizumoto K, 2013, NEURON, V77, P655, DOI 10.1016/j.neuron.2012.12.031; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Neukomm LJ, 2011, DEVELOPMENT, V138, P2003, DOI 10.1242/dev.060012; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Razidlo GL, 2011, J BIOL CHEM, V286, P20005, DOI 10.1074/jbc.M110.197749; Robinson FL, 2008, P NATL ACAD SCI USA, V105, P4916, DOI 10.1073/pnas.0800742105; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sanchez-Juan P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.011; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200; Zou W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000679	67	1	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114501	10.1371/journal.pone.0114501	http://dx.doi.org/10.1371/journal.pone.0114501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479419	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200096
J	Li, CT; Chen, YN; Chang, CH; Tsai, KH				Li, Chun-Ting; Chen, Yen-Nien; Chang, Chih-Han; Tsai, Kuen-Horng			The Effects of Backward Adjustable Thoracic Support in Wheelchair on Spinal Curvature and Back Muscle Activation for Elderly People	PLOS ONE			English	Article							HIP FLEXION; SITTING POSTURES; BODY-COMPOSITION; LUMBAR SUPPORT; CORD-INJURY; RELIABILITY; PRESSURE; POSITION; SYSTEM; HEALTH	Objectives: To investigate the effects of backward adjustable thoracic support on spinal curvature and back muscle activation during wheelchair sitting. Methods: Twenty elderly people were recruited for this study. The backward adjustable thoracic support sitting posture was compared with the slumped, normal, and lumbar support sitting postures. Spinal curvatures (pelvic, lumbar, and thoracic angles) and muscle activations of 4 back muscles on both sides (maximal voluntary isometric contraction of the lumbar multifidus, lumbar erector spinae, iliocostalis lumborum pars thoracis, and thoracic erector spinae at T9) were measured and compared between the different sitting postures using one-way analysis of variance with repeated measures. Results: The backward adjustable thoracic support sitting posture showed a relatively neutral pelvic tilt (-0.32 +/- 4.80 degrees) when compared with the slumped (22.84 +/- 5.27 degrees) and lumbar support (-8.97 +/- 3.31 degrees) sitting postures (P<0.001), and showed relatively higher lumbar lordosis (-23.38 +/- 6.50 degrees) when compared with the slumped (14.77 +/- 7.83 degrees), normal (0.44 +/- 7.47 degrees), and lumbar support (-16.76 +/- 4.77 degrees) sitting postures (P<0.05). It also showed relatively lower back muscle activity when compared with the normal and lumbar support sitting postures (P<0.05). Conclusions: The backward adjustable thoracic support sitting concept was suggested because it maintains a more neutral pelvic tilt, higher lumbar lordosis, and lower back muscle activation, which may help maintain a better sitting posture and reduce the risk of back pain.	[Li, Chun-Ting; Chen, Yen-Nien; Chang, Chih-Han] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Chen, Yen-Nien] Met Ind Res & Dev Ctr, Kaohsiung, Taiwan; [Tsai, Kuen-Horng] Natl Univ Tainan, Grad Inst Mechatron Syst Engn, Tainan, Taiwan	National Cheng Kung University; National University Tainan	Chang, CH (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	cchang@mail.bme.ncku.edu.tw; khnutn@gmail.com		Chen, Yennien/0000-0002-3047-0797; Tsai, Kuen-Horng/0000-0002-4360-3712	National Science Council, Taiwan [NSC 101-2320-B-024-001-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant no. NSC 101-2320-B-024-001-MY2 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSC website: http://web1.nsc.gov.tw/mp.aspx?mp=7.	Adams M, 2002, BIOMECHANICS BACK PA; ANDERSSON BJ, 1974, SCAND J REHABIL MED, V6, P115; ANDERSSON G B J, 1979, Spine, V4, P52, DOI 10.1097/00007632-197901000-00009; Barrett E, 2014, MANUAL THER, V19, P10, DOI 10.1016/j.math.2013.09.003; BENNETT DL, 1989, PHYS THER, V69, P902, DOI 10.1093/ptj/69.11.902; BRIDGER RS, 1989, HUM FACTORS, V31, P679, DOI 10.1177/001872088903100604; Callaghan JP, 2002, CLIN BIOMECH, V17, P353, DOI 10.1016/S0268-0033(02)00023-2; Congdon R, 2005, CLIN BIOMECH, V20, P947, DOI 10.1016/j.clinbiomech.2005.03.011; Cooper R. A., 1998, WHEELCHAIR SELECTION; Dankaerts W, 2004, J ELECTROMYOGR KINES, V14, P333, DOI 10.1016/j.jelekin.2003.07.001; Danneels LA, 2001, MANUAL THER, V6, P145, DOI 10.1054/math.2001.0396; De Carvalho DE, 2012, APPL ERGON, V43, P876, DOI 10.1016/j.apergo.2011.12.007; DEFOA JL, 1989, J ANAT, V163, P243; Dewberry MJ, 2003, CLIN BIOMECH, V18, P494, DOI 10.1016/S0268-0033(03)00096-2; Folsch C, 2012, PM&R, V4, P335, DOI 10.1016/j.pmrj.2012.01.009; Guimond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037450; Hastings JD, 2003, ARCH PHYS MED REHAB, V84, P528, DOI 10.1053/apmr.2003.50036; Huang HC, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-40; Janssen-Potten YJ, 2001, ARCH PHYS MED REHAB, V82, P1393, DOI 10.1053/apmr.2001.25989; Kasahara S, 2008, GAIT POSTURE, V28, P251, DOI 10.1016/j.gaitpost.2007.12.004; Lin F, 2006, ARCH PHYS MED REHAB, V87, P504, DOI 10.1016/j.apmr.2005.11.031; Makhsous M, 2003, SPINE, V28, P1113, DOI 10.1097/00007632-200306010-00006; Makhsous M, 2007, ARCH PHYS MED REHAB, V88, P862, DOI 10.1016/j.apmr.2007.03.017; Makhsous M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-17; May LA, 2004, ARCH PHYS MED REHAB, V85, P1146, DOI 10.1016/j.apmr.2003.08.105; Moutzouri M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-131; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; Nordin M., 2001, BASIC BIOMECHANICS M; O'Sullivan PB, 2006, SPINE, V31, pE707, DOI 10.1097/01.brs.0000234735.98075.50; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Poole DC, 1997, AM J PHYSIOL-HEART C, V272, pH2107, DOI 10.1152/ajpheart.1997.272.5.H2107; Pope MH, 2002, ANNU REV BIOMED ENG, V4, P49, DOI 10.1146/annurev.bioeng.4.092101.122107; Reed MP, 1996, SAE TECHNICAL PAPER, P19; Sabol TP, 2006, CLIN GERIATR MED, V22, P355, DOI 10.1016/j.cger.2005.12.013; Samuelsson K, 2001, DISABIL REHABIL, V23, P677; Solberg G., 2008, POSTURAL DISORDERS M, V2n; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223; Toosizadeh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048625; Uritani D, 2013, J PHYS THER SCI, V25, P1181, DOI 10.1589/jpts.25.1181; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Welsh DG, 1996, CIRC RES, V79, P551, DOI 10.1161/01.RES.79.3.551; Zacharkow D, 1988, POSTURE SITTING STAN	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113644	10.1371/journal.pone.0113644	http://dx.doi.org/10.1371/journal.pone.0113644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25480152	Green Published, gold, Green Submitted			2022-12-27	WOS:000349145400072
J	Palomo, J; Marchiol, T; Piotet, J; Fauconnier, L; Robinet, M; Reverchon, F; Le Bert, M; Togbe, D; Buijs-Offerman, R; Stolarczyk, M; Quesniaux, VFJ; Scholte, BJ; Ryffel, B				Palomo, Jennifer; Marchiol, Tiffany; Piotet, Julie; Fauconnier, Louis; Robinet, Marieke; Reverchon, Flora; Le Bert, Marc; Togbe, Dieudonnee; Buijs-Offerman, Ruvalic; Stolarczyk, Marta; Quesniaux, Valerie F. J.; Scholte, Bob J.; Ryffel, Bernhard			Role of IL-1 beta in Experimental Cystic Fibrosis upon P. aeruginosa Infection	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MUCOID PSEUDOMONAS-AERUGINOSA; ACUTE LUNG INFECTION; MURINE MODEL; MICE; INFLAMMATION; EXPRESSION; DISEASE; CFTR; RECOGNITION	Cystic fibrosis is associated with increased inflammatory responses to pathogen challenge. Here we revisited the role of IL-1 beta in lung pathology using the experimental F508del-CFTR murine model on C57BL/6 genetic background (Cftr(tm1eur) or d/d), on double deficient for d/d and type 1 interleukin-1 receptor (d/d X IL-1R1(-/-)), and antibody neutralization. At steady state, young adult d/d mice did not show any signs of spontaneous lung inflammation. However, IL-1R1 deficiency conferred partial protection to repeated P. aeruginosa endotoxins/LPS lung instillation in d/d mice, as 50% of d/d mice succumbed to inflammation, whereas all d/d x IL-1R1(-/-) double mutants survived with lower initial weight loss and less pulmonary collagen and mucus production, suggesting that the absence of IL-1R1 signaling is protective in d/d mice in LPS-induced lung damage. Using P. aeruginosa acute lung infection we found heightened neutrophil recruitment in d/d mice with higher epithelial damage, increased bacterial load in BALF, and augmented IL-1 beta and TNF-alpha in parenchyma as compared to WT mice. Thus, F508del-CFTR mice show enhanced IL-1 beta signaling in response to P. aeruginosa. IL-1 beta antibody neutralization had no effect on lung homeostasis in either d/d or WT mice, however P. aeruginosa induced lung inflammation and bacterial load were diminished by IL-1 beta antibody neutralization. In conclusion, enhanced susceptibility to P. aeruginosa in d/d mice correlates with an excessive inflammation and with increased IL-1 beta production and reduced bacterial clearance. Further, we show that neutralization of IL-1 beta in d/d mice through the double mutation d/d x IL-1R1(-/-) and in WT via antibody neutralization attenuates inflammation. This supports the notion that intervention in the IL-1R1/IL-1 beta pathway may be detrimental in CF patients.	[Palomo, Jennifer; Piotet, Julie; Reverchon, Flora; Le Bert, Marc; Quesniaux, Valerie F. J.; Ryffel, Bernhard] CNRS, UMR7355, F-45071 Orleans, France; [Palomo, Jennifer; Piotet, Julie; Reverchon, Flora; Quesniaux, Valerie F. J.; Ryffel, Bernhard] Univ Orleans, Orleans, France; [Marchiol, Tiffany; Fauconnier, Louis; Robinet, Marieke; Togbe, Dieudonnee] Artimmune, Orleans, France; [Buijs-Offerman, Ruvalic; Stolarczyk, Marta; Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Ryffel, Bernhard] IDM, Inst Infect Dis & Mol Med, Cape Town, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Erasmus University Rotterdam; Erasmus MC; University of Cape Town	Scholte, BJ (corresponding author), Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.	b.scholte@erasmusmc.nl; bryffel@cnrs-orleans.fr	Le Bert, Marc/AAR-4577-2021; Togbe, Dieudonnee/AAE-1135-2020	Le Bert, Marc/0000-0002-5945-3800; Togbe, Dieudonnee/0000-0001-6658-414X; Marchiol, Tiffany/0000-0003-0714-1191; Reverchon, Flora/0000-0003-1642-4775	French association "Vaincre La Mucoviscidose'' [10IM1016]; ERASMUS Medical Center of Rotterdam (The Netherlands); Region Centre (Respig project); CNRS of Orleans (France); Dutch CF foundation NCFS; Dutch Lung foundation [Longfonds 3.3.10.027]	French association "Vaincre La Mucoviscidose''; ERASMUS Medical Center of Rotterdam (The Netherlands); Region Centre (Respig project)(Region Centre-Val de Loire); CNRS of Orleans (France); Dutch CF foundation NCFS; Dutch Lung foundation	This study was part of the European project no10IM1016 financed by the French association "Vaincre La Mucoviscidose'', supported by the ERASMUS Medical Center of Rotterdam (The Netherlands), and by Region Centre (Respig project) and CNRS of Orleans (France). RBO was supported by the Dutch CF foundation NCFS; MS was supported by the Dutch Lung foundation (Longfonds 3.3.10.027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Mohamed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039888; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; CFF, 2012, PAT REG ANN DAT REP; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; Durie PR, 2004, AM J PATHOL, V164, P1481, DOI 10.1016/S0002-9440(10)63234-8; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Faure E, 2014, AM J RESP CRIT CARE; Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Gaspar MC, 2013, EUR J CLIN MICROBIOL; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Hudock KM, 2012, AM J RESP CELL MOL, V47, P436, DOI 10.1165/rcmb.2012-0104OC; Kanangat S, 1999, INFECT IMMUN, V67, P2834, DOI 10.1128/IAI.67.6.2834-2840.1999; Laval J, 2013, J IMMUNOL, V190, P6043, DOI 10.4049/jimmunol.1201755; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Levy H, 2009, PEDIATR PULM, V44, P580, DOI 10.1002/ppul.21026; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Lubamba B, 2012, J CYST FIBROS, V11, P266, DOI 10.1016/j.jcf.2012.03.003; Meduri GU, 2002, CRIT CARE, V6, P24, DOI 10.1186/cc1450; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Moreno-Vinasco L., 2014, AM J RESP CELL MOL B; Nojiri T., 2014, PULM PHARM THER; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; Saadane A, 2006, J ALLERGY CLIN IMMUN, V117, P1163, DOI 10.1016/j.jaci.2006.01.052; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Secher T, 2011, J ANTIMICROB CHEMOTH, V66, P1100, DOI 10.1093/jac/dkr038; Shikama Y, 2014, J CELL PHYSL; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Stick S, 2013, EUR RESPIR J, V42, P527, DOI 10.1183/09031936.00108212; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tirkos S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-51; Tsay TB, 2013, CYTOKINE, V63, P58, DOI 10.1016/j.cyto.2013.04.002; Turner NA, 2011, INT J BIOCHEM CELL B, V43, P1450, DOI 10.1016/j.biocel.2011.06.008; van Heeckeren AM, 2006, AM J RESP CRIT CARE, V173, P288, DOI 10.1164/rccm.200506-917OC; van Heeckeren AM, 2004, INFECT IMMUN, V72, P1479, DOI 10.1128/IAI.72.3.1479-1486.2004; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Villeret B, 2013, AM J CLIN EXP IMMUNO, V2, P107; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Winfield RD, 2006, SURG CLIN N AM, V86, P317, DOI 10.1016/j.suc.2005.12.007; Zhou Y, 2013, J INNATE IMMUN, V5, P219, DOI 10.1159/000346568	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114884	10.1371/journal.pone.0114884	http://dx.doi.org/10.1371/journal.pone.0114884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500839	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400059
J	van Deurzen, I; van Oorschot, W; van Ingen, E				van Deurzen, Ioana; van Oorschot, Wim; van Ingen, Erik			The Link between Inequality and Population Health in Low and Middle Income Countries: Policy Myth or Social Reality?	PLOS ONE			English	Article							WEALTHIER ALWAYS HEALTHIER; INFANT-MORTALITY; POVERTY; ANEMIA; HOSPITALIZATION; ASSOCIATION	An influential policy idea states that reducing inequality is beneficial for improving health in the low and middle income countries (LMICs). Our study provides an empirical test of this idea: we utilized data collected by the Demographic and Health Surveys between 2000 and 2011 in as much as 52 LMICs, and we examined the relationship between household wealth inequality and two health outcomes: anemia status (of the children and their mothers) and the women' experience of child mortality. Based on multi-level analyses, we found that higher levels of household wealth inequality related to worse health, but this effect was strongly reduced when we took into account the level of individuals' wealth. However, even after accounting for the differences between individuals in terms of household wealth and other characteristics, in those LMICs with higher household wealth inequality more women experienced child mortality and more children were tested with anemia. This effect was partially mediated by the country's level and coverage of the health services and infrastructure. Furthermore, we found higher inequality to be related to a larger health gap between the poor and the rich in only one of the three examined samples. We conclude that an effective way to improve the health in the LMICs is to increase the wealth among the poor, which in turn also would lead to lower overall inequality and potential investments in public health infrastructure and services.	[van Deurzen, Ioana; van Ingen, Erik] Tilburg Univ, Dept Sociol, NL-5000 LE Tilburg, Netherlands; [van Oorschot, Wim] Leuven Univ, Dept Sociol, Leuven, Belgium	Tilburg University; KU Leuven	van Deurzen, I (corresponding author), Tilburg Univ, Dept Sociol, NL-5000 LE Tilburg, Netherlands.	i.a.vandeurzen@uvt.nl		van Ingen, Erik/0000-0003-3896-8079; Pop, Ioana/0000-0003-0747-6581				Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Babones SJ, 2008, SOC SCI MED, V66, P1614, DOI 10.1016/j.socscimed.2007.12.012; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Beckfield J, 2004, J HEALTH SOC BEHAV, V45, P231, DOI 10.1177/002214650404500301; Biggs B, 2010, SOC SCI MED, V71, P266, DOI 10.1016/j.socscimed.2010.04.002; Bourguignon F, 2000, J DEV ECON, V62, P285, DOI 10.1016/S0304-3878(00)00086-9; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; deBenoist B, 2008, WORLDWIDE PREVALENCE; Deininger K., 2000, ASSET DISTRIBUTION I; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Easterly W, 2007, J DEV ECON, V84, P755, DOI 10.1016/j.jdeveco.2006.11.002; Ellison GTH, 2002, SOC SCI MED, V54, P561, DOI 10.1016/S0277-9536(01)00052-1; Fay M, 2005, WORLD DEV, V33, P1267, DOI 10.1016/j.worlddev.2005.03.001; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; GALOR O, 1993, REV ECON STUD, V60, P35, DOI 10.2307/2297811; Grantham-McGregor S, 2001, J NUTR S; Gravelle H, 1998, BMJ-BRIT MED J, V316, P382, DOI 10.1136/bmj.316.7128.382; Huynh M, 2005, INT J EPIDEMIOL, V34, P888, DOI 10.1093/ije/dyi092; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Jylha M, 1998, J GERONTOL B-PSYCHOL, V53, pS144, DOI 10.1093/geronb/53B.3.S144; Kawachi I, 1999, HEALTH SERV RES, V34, P215; Kruk ME, 2008, AM J PUBLIC HEALTH, V98, P142, DOI 10.2105/AJPH.2006.104265; La Ferrara E, 2002, J PUBLIC ECON, V85, P235, DOI 10.1016/S0047-2727(01)00102-5; Larrea C, 2005, SOC SCI MED, V60, P165, DOI 10.1016/j.socscimed.2004.04.024; Li SL, 2004, KIDNEY INT, V65, P1864, DOI 10.1111/j.1523-1755.2004.00584.x; Lynch J, 2000, SOC SCI MED, V51, P1001, DOI 10.1016/S0277-9536(00)00080-0; Macinko JA, 2003, MED CARE RES REV, V60, P407, DOI 10.1177/1077558703257169; Marmot MG, 1998, MILBANK Q, V76, P403, DOI 10.1111/1468-0009.00097; McGuire JW, 2006, WORLD DEV, V34, P405, DOI 10.1016/j.worlddev.2005.08.004; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; OXFAM, 2013, COST IN WEALTH INC E; Perotti Roberto, 1996, J ECON GROWTH, V1, P149, DOI DOI 10.1007/BF00138861; Pickett KE, 2007, BJM; Pop IA, 2013, SOC INDIC RES, V113, P1025, DOI 10.1007/s11205-012-0125-6; Rajan K, 2013, SOC SCI MED, V88, P98, DOI 10.1016/j.socscimed.2013.04.004; Rajan R., 2010, FAULT LINES HIDDEN F; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; Riva E, 2009, HAEMATOL-HEMATOL J, V94, P22, DOI 10.3324/haematol.13449; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rutstein SO, 2006, GUIDE DHS STAT; Save The Children, 2012, BORN EQ RED IN COULD; Simms C, 2007, BITTEREST PILL ALL C; Smits J, 2014, INT WEALTH INDEX IWI; Szwarcwald CL, 2002, SOC SCI MED, V55, P2083, DOI 10.1016/S0277-9536(01)00353-7; The World Health Organization, 2008, CLOS GAP GEN HLTH EQ; UN, 2006, FAST FACTS FAC POV; United Nations, 2012, UN SYST TASK TEAM PO; WDI, 2012, WORLD DEV IND; WENNEMO I, 1993, SOCIOL HEALTH ILL, V15, P429, DOI 10.1111/1467-9566.ep11372773; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 2009, SPIRIT LEVEL MORE EQ	52	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115109	10.1371/journal.pone.0115109	http://dx.doi.org/10.1371/journal.pone.0115109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25501652	Green Published, gold			2022-12-27	WOS:000347146700092
J	Blackard, JT; Ma, G; Welge, JA; King, CC; Taylor, LE; Mayer, KH; Klein, RS; Celentano, DD; Sobel, JD; Jamieson, DJ; Gardner, L				Blackard, Jason T.; Ma, Gang; Welge, Jeffrey A.; King, Caroline C.; Taylor, Lynn E.; Mayer, Kenneth H.; Klein, Robert S.; Celentano, David D.; Sobel, Jack D.; Jamieson, Denise J.; Gardner, Lytt			GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection	PLOS ONE			English	Article							C/HEPATITIS-G VIRUS; MOTHER-TO-INFANT; ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; DISEASE PROGRESSION; SEXUAL TRANSMISSION; LIVER-DISEASE; US WOMEN; COINFECTION; PREVALENCE	Background: GB virus C (GBV-C) may have a beneficial impact on HIV disease progression; however, the epidemiologic characteristics of this virus are not well characterized. Behavioral factors and gender may lead to differential rates of GBV-C infection; yet, studies have rarely addressed GBV-C infections in women or racial/ethnic minorities. Therefore, we evaluated GBV-C RNA prevalence and genotype distribution in a large prospective study of high-risk women in the US. Results: 438 hepatitis C virus (HCV) seropositive women, including 306 HIV-infected and 132 HIV-uninfected women, from the HIV Epidemiologic Research Study were evaluated for GBV-C RNA. 347 (79.2%) women were GBV-C RNA negative, while 91 (20.8%) were GBV-C RNA positive. GBV-C positive women were younger than GBV-C negative women. Among 306 HIV-infected women, 70 (22.9%) women were HIV/GBV-C co-infected. Among HIV-infected women, the only significant difference between GBV-negative and GBV-positive women was age (mean 38.4 vs. 35.1 years; p<0.001). Median baseline CD4 cell counts and plasma HIV RNA levels were similar. The GBV-C genotypes were 1 (n=31; 44.3%), 2 (n=36; 51.4%), and 3 (n=3; 4.3%). The distribution of GBV-C genotypes in co-infected women differed significantly by race/ethnicity. However, median CD4 cell counts and log(10) HIV RNA levels did not differ by GBV-C genotype. GBV-C incidence was 2.7% over a median follow-up of 2.9 (IQR: 1.5, 4.9) years, while GBV-C clearance was 35.7% over a median follow-up of 2.44 (1.4, 3.5) years. 4 women switched genotypes. Conclusions: Age, injection drug use, a history of sex for money or drugs, and number of recent male sex partners were associated with GBV-C infection among all women in this analysis. However, CD4 cell count and HIV viral load of HIV/HCV/GBV-C co-infected women were not different although race was associated with GBV-C genotype.	[Blackard, Jason T.; Ma, Gang] Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45220 USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45221 USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [King, Caroline C.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Taylor, Lynn E.] Brown Univ, Miriam Hosp, Providence, RI USA; [Taylor, Lynn E.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Inst, Boston, MA USA; [Klein, Robert S.] Mt Sinai Sch Med, Mt Sinai St Lukes Hosp, Div Infect Dis, New York, NY USA; [Klein, Robert S.] Mt Sinai Sch Med, Mt Sinai Roosevelt Hosp, New York, NY USA; [Celentano, David D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Sobel, Jack D.] Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA; [Gardner, Lytt] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's; Icahn School of Medicine at Mount Sinai; Mount Sinai West; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University; Centers for Disease Control & Prevention - USA	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH 45220 USA.	jason.blackard@uc.edu		Taylor, Lynn/0000-0002-0472-8125; Jamieson, Denise/0000-0003-2597-1201	National Institute on Allergy and Infectious Diseases [AI081564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institute on Allergy and Infectious Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute on Allergy and Infectious Diseases (award AI081564 to JTB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde R, 2010, VIRUS RES, V151, P148, DOI 10.1016/j.virusres.2010.04.008; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Berzsenyi MD, 2009, J GASTROEN HEPATOL, V24, P1407, DOI 10.1111/j.1440-1746.2009.05920.x; Berzsenyi MD, 2005, J CLIN VIROL, V33, P257, DOI 10.1016/j.jcv.2005.04.002; Berzsenyi MD, 2005, J CLIN VIROL, V33, P243, DOI 10.1016/j.jcv.2005.01.002; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Birk M, 2002, AIDS, V16, P2482, DOI 10.1097/00002030-200212060-00017; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021151; Frey SE, 2002, CLIN INFECT DIS, V34, P1033, DOI 10.1086/339206; Giret MTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018407; Handelsman E, 2007, HIV MED, V8, P561, DOI 10.1111/j.1468-1293.2007.00510.x; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Hino K, 1998, ARCH VIROL, V143, P65, DOI 10.1007/s007050050268; Kao JH, 1997, J MED VIROL, V52, P381, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;381::AID-JMV6&gt;3.0.CO;2-Y; Kaye S, 2005, CLIN INFECT DIS, V40, P876, DOI 10.1086/428123; Larkin MA, 2007, BIOINFORMATICS, V2007, P21, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lefrere JJ, 2000, TRANSFUSION, V40, P602, DOI 10.1046/j.1537-2995.2000.40050602.x; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Mayer KH, 2003, JAIDS-J ACQ IMM DEF, V33, P614, DOI 10.1097/00126334-200308150-00011; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2003, J MED VIROL, V70, P141, DOI 10.1002/jmv.10375; Ohto H, 2000, TRANSFUSION, V40, P725, DOI 10.1046/j.1537-2995.2000.40060725.x; Quiros-Roldan E, 2002, AIDS, V16, P1430, DOI 10.1097/00002030-200207050-00019; Rodriguez B, 2003, J INFECT DIS, V187, P504, DOI 10.1086/368206; Sathar MA, 2004, CLIN INFECT DIS, V38, P405, DOI 10.1086/381092; Sawayama Y, 1999, DIGEST DIS SCI, V44, P1937, DOI 10.1023/A:1026664428194; Schlueter V, 1996, J CLIN MICROBIOL, V34, P2660, DOI 10.1128/JCM.34.11.2660-2664.1996; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; Sheng WH, 2007, CLIN INFECT DIS, V44, P584, DOI 10.1086/511037; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Smith SM, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-38; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Stover CT, 2003, J INFECT DIS, V187, P1388, DOI 10.1086/374649; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Supapol WB, 2011, J MED VIROL, V83, P33, DOI 10.1002/jmv.21946; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Viazov S, 1997, J HEPATOL, V27, P85, DOI 10.1016/S0168-8278(97)80284-X; Weintrob AC, 2004, CLIN INFECT DIS, V38, pE46, DOI 10.1086/382079; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Zanetti AR, 1998, J MED VIROL, V54, P107, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;107::AID-JMV7&gt;3.0.CO;2-A; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114467	10.1371/journal.pone.0114467	http://dx.doi.org/10.1371/journal.pone.0114467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493916	gold, Green Published			2022-12-27	WOS:000346611400047
J	Blasi, MF; Boitani, L				Blasi, Monica F.; Boitani, Luigi			Complex Social Structure of an Endangered Population of Bottlenose Dolphins (Tursiops truncatus) in the Aeolian Archipelago (Italy)	PLOS ONE			English	Article							ASSOCIATION PATTERNS; ALLIANCE FORMATION; PREDATION RISK; SHARK PREDATION; GROUP-SIZE; ADUNCUS; BEHAVIOR; BAY; SARASOTA; ECOLOGY	We investigated social structure and association patterns for a small population of Mediterranean bottlenose dolphins, Tursiops truncatus, inhabiting the Aeolian Archipelago (southern Italy). Specifically we evaluate the role of sex and age composition, residency patterns and interaction with trammel nets on this social organization. Association data for 23 regularly sighted individuals were obtained from summer photoidentification surveys collected from 2005-2012. Using a combined cluster and social network analysis approach, we found associations between dolphins were hierarchically structured, where two mixed-sex social units were subdivided into smaller temporarily dynamic groups. We found non-random and long-term preferred associations in the population; however, the degree of social cohesion, residence pattern and interaction with trammel nets differed considerably between the two social units. Six of eight females occurred in the more resident social unit-1; in addition, social unit-1 individuals had significantly stronger associations, higher preferred associates, lived in larger groups and occurred less frequently with trammel nets. Nine of eleven males were clustered in social unit-2 and five of these males, interacting with trammel nets, formed small groups and preferred associations. We propose that female and male groups associate in the study area during the breeding season and that some males choose to interact with reproductive females forming a distinct but interrelated social unit. Other males may be associating in a larger fission-fusion network, which consists of dolphins that appear to temporarily join the network from the coastal population. We cannot exclude that some males specialized in trammel net foraging, suggesting that this foraging technique may favor a solitary lifestyle. Large group sizes and high degree of social cohesion for females could be an indication of greater protection and more efficiency in detecting, deterring or repelling anthropogenic pressures. Most likely dolphins' social organization depends on a combination of socio-ecological, demographic and anthropogenic factors.	[Blasi, Monica F.] Filicudi WildLife Conservat, I-98055 Lipari, ME, Italy; [Boitani, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol, I-00185 Rome, Italy	Sapienza University Rome	Blasi, MF (corresponding author), Filicudi WildLife Conservat, I-98055 Lipari, ME, Italy.	blasimf@yahoo.com						Allen SJ, 2005, THESIS MACQUARIE U S; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Barros Nelio B., 1995, Bulletin of Marine Science, V57, P278; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 1997, MAR MAMMAL SCI, V13, P650, DOI 10.1111/j.1748-7692.1997.tb00089.x; Bearzi G, 2009, MAMMAL REV, V39, P92, DOI 10.1111/j.1365-2907.2008.00133.x; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Blasi MF, 2013, EUROPEAN RES CETAC E, V06, P255; Blasi Monica F., 2012, Endangered Species Research, V17, P269, DOI 10.3354/esr00422; BRAGER S, 1994, J MAMMAL, V75, P431, DOI 10.2307/1382564; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chilvers BL, 2003, CAN J ZOOL, V81, P1947, DOI 10.1139/Z03-195; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; COCKCROFT VG, 1989, S AFR J ZOOL, V24, P305; Connor RC, 1996, BEHAVIOUR, V133, P37, DOI 10.1163/156853996X00026; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Connor Richard C., 1992, P415; CORKERON P J, 1987, Aquatic Mammals, V13, P109; Corkeron P.J., 1990, P329; Croft DP, 2006, AM NAT, V167, P867, DOI 10.1086/504853; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; De Smgura AG, J MAR BIOL ASS UK, V88, P1185; Duffield DA, 1991, REPORTS INT WHALING, V13, P155; Dunn DG, 2002, J WILDLIFE DIS, V38, P505, DOI 10.7589/0090-3558-38.3.505; Eisfeld SM, 2003, THESIS U WALES BANGO; Fearnbach H, 2012, MAR MAMMAL SCI, V28, P402, DOI 10.1111/j.1748-7692.2011.00481.x; Foley A, 2010, AQUAT MAMM, V36, P372, DOI 10.1578/AM.36.4.2010.372; Forcada J, 2004, MAR ECOL PROG SER, V275, P275, DOI 10.3354/meps275275; Freund RJ, 1986, SAS SYSTEM REGRESSIO; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; Gero S, 2005, CAN J ZOOL, V83, P1566, DOI 10.1139/Z05-155; Gowans S, 2008, ADV MAR BIOL, V53, P195, DOI 10.1016/S0065-2881(07)53003-8; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Holme P, 2007, PHYSICA A, V373, P821, DOI 10.1016/j.physa.2006.04.066; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; JOLLIFFE IT, 1972, J ROY STAT SOC C-APP, V21, P160; Krause J, 2002, LIVING GROUPS; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lauriano G., 2004, Journal of Cetacean Research and Management, V6, P165; Lauriano G, 2009, J MAR BIOL ASSOC UK, V89, P921, DOI 10.1017/S0025315409000393; Lewis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058162; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Lopez BD, 2008, BEHAV ECOL SOCIOBIOL, V62, P887, DOI 10.1007/s00265-007-0512-1; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1998, ANIM BEHAV, V55, P1097, DOI 10.1006/anbe.1997.0637; MANTEL N, 1967, CANCER RES, V27, P209; Miokovik Danijela, 1999, Natura Croatica, V8, P61; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller LM, 2006, BEHAV ECOL SOCIOBIOL, V61, P109, DOI 10.1007/s00265-006-0241-x; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Owen ECG, 2002, CAN J ZOOL, V80, P2072, DOI 10.1139/z02-195; Pace DS, 2012, BEHAV ECOL, V23, P254, DOI 10.1093/beheco/arr180; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Patterson AP, 1998, P ROY SOC LOND B BIO, V265, P167; Rogers CA, 2004, MAR MAMMAL SCI, V20, P688, DOI 10.1111/j.1748-7692.2004.tb01188.x; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; Sall JP, 1981, A102 SAS I INC; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Schroeder J.P., 1990, P435; Scott M.D., 1990, P235; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; TOLLEY KA, 1995, J MAMMAL, V76, P1190, DOI 10.2307/1382611; Wells R.S., 1991, P199; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; WHITE FJ, 1992, AM J PRIMATOL, V26, P203, DOI 10.1002/ajp.1350260306; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H., 2005, ANIM BEHAV, V69, pE1, DOI [10.1016/j.anbehav.2004.11.004, DOI 10.1016/J.ANBEHAV.2004.11.004]; Whitehead H, 2008, COMPILED VERSION SOC, P73; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Wilson Ben, 1993, European Research on Cetaceans, V7, P54; Wiszniewski J, 2012, J MAMMAL, V93, P239, DOI 10.1644/10-MAMM-A-366.1; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; Wiszniewski J, 2009, ANIM BEHAV, V77, P1449, DOI 10.1016/j.anbehav.2009.02.025; Wrangham RW, 1986, ECOLOGICAL ASPECTS S; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	102	22	23	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114849	10.1371/journal.pone.0114849	http://dx.doi.org/10.1371/journal.pone.0114849			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494331	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400079
J	Witkowski, A; Barka, F; Mann, DG; Li, CL; Weisenborn, JLF; Ashworth, MP; Kurzydlowski, KJ; Zglobicka, I; Dobosz, S				Witkowski, Andrzej; Barka, Frederik; Mann, David G.; Li, Chunlian; Weisenborn, Jascha L. F.; Ashworth, Matt P.; Kurzydlowski, Krzysztof J.; Zglobicka, Izabela; Dobosz, Slawomir			A Description of Biremis panamae sp nov., a New Diatom Species from the Marine Littoral, with an Account of the Phylogenetic Position of Biremis DG Mann et EJ Cox (Bacillariophyceae)	PLOS ONE			English	Article							SEXUAL REPRODUCTION; AUXOSPORE FORMATION; LIFE-HISTORY; GENUS; SYSTEMATICS; MORPHOLOGY; INCUNABULA; ISLAND	Here we present a formal description of Biremis panamae Barka, Witkowski et Weisenborn sp. nov., which was isolated from the marine littoral environment of the Pacific Ocean coast of Panama. The description is based on morphology (light and electron microscopy) and the rbcL, psbC and SSU sequences of one clone of this species. The new species is included in Biremis due to its morphological features; i.e. two marginal rows of foramina, chambered striae, and girdle composed of numerous punctate copulae. The new species also possesses a striated valve face which is not seen in most known representatives of marine littoral Biremis species. In this study we also present the relationship of Biremis to other taxa using morphology, DNA sequence data and observations of auxosporulation. Our results based on these three sources point to an evolutionary relationship between Biremis, Neidium and Scoliopleura. The unusual silicified incunabular caps present in them are known otherwise only in Muelleria, which is probably related to the Neidiaceae and Scoliotropidaceae. We also discuss the relationship between Biremis and the recently described Labellicula and Olifantiella.	[Witkowski, Andrzej; Li, Chunlian; Dobosz, Slawomir] Univ Szczecin, Fac Geosci, Palaeoceanol Unit, PL-70383 Szczecin, Poland; [Barka, Frederik] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Mann, David G.] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Mann, David G.] Inst Food & Agr Res & Technol IRTA, E-43540 San Carlos de la Rapita, Catalunya, Spain; [Weisenborn, Jascha L. F.] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60438 Frankfurt, Germany; [Ashworth, Matt P.] Univ Texas Austin, Biol Labs, Sect Integrat Biol, Austin, TX 78712 USA; [Kurzydlowski, Krzysztof J.; Zglobicka, Izabela] Warsaw Univ Technol, Fac Engn & Mat Sci, Warsaw, Poland	University of Szczecin; Goethe University Frankfurt; IRTA; Goethe University Frankfurt; University of Texas System; University of Texas Austin; Warsaw University of Technology	Witkowski, A (corresponding author), Univ Szczecin, Fac Geosci, Palaeoceanol Unit, Mickiewicza 18, PL-70383 Szczecin, Poland.	witkowsk@univ.szczecin.pl	Mann, David G/I-9018-2014	Mann, David G/0000-0003-0522-6802; Zglobicka, Izabela/0000-0002-4432-9196; Kurzydlowski, Krzysztof/0000-0003-3875-4820; Witkowski, Andrzej/0000-0003-1714-218X	National Science Centre in Cracow [2012/04/A/ST10/00544]	National Science Centre in Cracow	AW and CL received support from grant No. 2012/04/A/ST10/00544 from the National Science Centre in Cracow, programme Maestro (http://www.ncn.gov.pl/?language5en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVERSON AJ, 2006, THESIS U TEXAS AUSTI; [Anonymous], 2014, TRACER V1 6; Cleve P.T., 1896, BIHANG KUNGLIGA SVEN, V22, P1; CLEVE PT, 1895, KONGLIGA SVENSKA VET, V27, P1, DOI DOI 10.5962/BHL.TITLE.68663; COX EJ, 1990, OUVRAGE DEDIE MEMOIR, P63; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Edlund M. B., 2006, ADV PHYCOLOGICAL STU, P213; Edlund MB, 2001, DIATOM RES, V16, P295; GEITLER L, 1973, OSTERR BOT Z, V122, P299, DOI 10.1007/BF01376232; GIFFEN M H, 1980, Bacillaria, V3, P129; GIFFEN MH, 1976, BOT MAR, V19, P379, DOI 10.1515/botm.1976.19.6.379; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Herwig W. E., 2011, ADV LIGHT PHOTOMICRO, V185, P12; Hustedt Friedrich, 1942, INTERNAT REV GES HYDROBIOL U HYDROGR, V42, P1, DOI 10.1002/iroh.19420420102; Jones HM, 2005, EUR J PHYCOL, V40, P61, DOI 10.1080/09670260400024675; Kaczmarska I, 2013, DIATOM RES, V28, P263, DOI 10.1080/0269249X.2013.791344; Krammer K., 1986, SUSSWASSERFLORA MITT, V2; Krammer K., 2000, DIATOMS EUROPE DIATO; Mann D.G., 1980, P 6 S REC FOSS DIAT, P279; Mann David G., 1996, P249; Mann DG, 2014, EUR J PHYCOL, V49, P276, DOI 10.1080/09670262.2014.915063; Mann DG, 2013, PHYCOLOGIA, V52, P204, DOI 10.2216/12-077.1; Mann DG, 2011, J PHYCOL, V47, P1368, DOI 10.1111/j.1529-8817.2011.01058.x; Mann DG, 2009, FOTTEA, V9, P211, DOI 10.5507/fot.2009.022; Mann DG, 2005, PHYCOLOGIA, V44, P335, DOI 10.2216/0031-8884(2005)44[335:AMSARI]2.0.CO;2; MANN DG, 1984, BRIT PHYCOL J, V19, P319, DOI 10.1080/00071618400650371; MANN DG, 1993, HYDROBIOLOGIA, V269, P11, DOI 10.1007/BF00027999; MANN DG, 1995, PHYCOLOGIA, V34, P74, DOI 10.2216/i0031-8884-34-1-74.1; Mereschkowsky C., 1902, SCRIPTA BOT HORTI U, V21, P1; Park R.A., 1992, THESIS U EDINBURGH E; Poulickova A, 2006, J PHYCOL, V42, P872, DOI 10.1111/j.1529-8817.2006.00235.x; Riaux-Gobin C, 2012, FOTTEA, V12, P199, DOI 10.5507/fot.2012.015; Riaux-Gobin C, 2009, PHYCOL RES, V57, P178, DOI 10.1111/j.1440-1835.2009.00537.x; Ronquist F., 2012, SYST BIOL; Round F. E., 1990, DIATOMS BIOL MORPHOL; SABBE K, 1995, BOT MAR, V38, P379, DOI 10.1515/botm.1995.38.1-6.379; Sato S, 2013, PHYCOLOGIA, V52, P225, DOI 10.2216/12-072.1; Schrader H.-J., 1971, NOVA HEDWIGIA, V22, P915; Simonsen R., 1992, BIBLIOTHECA DIATOMOL, V24, P1; Spaulding S. A., 1997, Diatom Research, V12, P95; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Van de Vijver B, 2005, CRYPTOGAMIE ALGOL, V26, P125; Van de Vijver B, 2010, PHYCOLOGIA, V49, P22, DOI 10.2216/09-27.1; Vyverman W, 1997, PHYCOLOGIA, V36, P91, DOI 10.2216/i0031-8884-36-2-91.1; Witkowski A., 2000, ICONOGRAPHIA DIATOMO, V7	46	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114508	10.1371/journal.pone.0114508	http://dx.doi.org/10.1371/journal.pone.0114508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494095	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400049
J	Zorn-Kruppa, M; Houdek, P; Wladykowski, E; Engelke, M; Bartok, M; Mewes, KR; Moll, I; Brandner, JM				Zorn-Kruppa, Michaela; Houdek, Pia; Wladykowski, Ewa; Engelke, Maria; Bartok, Melinda; Mewes, Karsten R.; Moll, Ingrid; Brandner, Johanna M.			Determining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories	PLOS ONE			English	Article							EYE IRRITATION TEST; SLUG MUCOSAL IRRITATION; PERMEABILITY TEST; TIERED APPROACH; CELL-CULTURES; VALIDATION; OPACITY; EXTENT; IDENTIFICATION; PREVALIDATION	The depth of injury (DOI) is a mechanistic correlate to the ocular irritation response. Attempts to quantitatively determine the DOI in alternative tests have been limited to ex vivo animal eyes by fluorescent staining for biomarkers of cell death and viability in histological cross sections. It was the purpose of this study to assess whether DOI could also be measured by means of cell viability detected by the MTT assay using 3-dimensional (3D) reconstructed models of cornea and conjunctiva. The formazan-free area of metabolically inactive cells in the tissue after topical substance application is used as the visible correlate of the DOI. Areas of metabolically active or inactive cells are quantitatively analyzed on cryosection images with ImageJ software analysis tools. By incorporating the total tissue thickness, the relative MTT-DOI (rMTT-DOI) was calculated. Using the rMTT-DOI and human reconstructed cornea equivalents, we developed a prediction model based on suitable viability cut-off values. We tested 25 chemicals that cover the whole range of eye irritation potential based on the globally harmonized system of classification and labelling of chemicals (GHS). Principally, the MTT-DOI test method allows distinguishing between the cytotoxic effects of the different chemicals in accordance with all 3 GHS categories for eye irritation. Although the prediction model is slightly over-predictive with respect to non-irritants, it promises to be highly valuable to discriminate between severe irritants (Cat. 1), and mild to moderate irritants (Cat. 2). We also tested 3D conjunctiva models with the aim to specifically address conjunctiva-damaging substances. Using the MTT-DOI method in this model delivers comparable results as the cornea model, but does not add additional information. However, the MTT-DOI method using reconstructed cornea models already provided good predictability that was superior to the already existing established in vitro/ex vivo methods.	[Zorn-Kruppa, Michaela; Houdek, Pia; Wladykowski, Ewa; Moll, Ingrid; Brandner, Johanna M.] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, D-20246 Hamburg, Germany; [Engelke, Maria; Bartok, Melinda] Jacobs Univ Bremen gGmbH, D-28759 Bremen, Germany; [Mewes, Karsten R.] Henkel AG & Co KGaA, D-40589 Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Jacobs University; Henkel	Zorn-Kruppa, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venerol, D-20246 Hamburg, Germany.	m.zorn-kruppa@uke.de			German Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung. BMBF-FKZ [0316010]	German Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung. BMBF-FKZ(Federal Ministry of Education & Research (BMBF))	The study was funded by German Federal Ministry of Education and Research Bundesministerium fur Bildung und Forschung. BMBF-FKZ/grant number: 0316010. URL: http://www.bmbf.de (MZ-K ME MB KM JMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2008, TOXICOL IN VITRO, V22, P1285, DOI 10.1016/j.tiv.2008.02.018; Adriaens E, 2005, TOXICOL IN VITRO, V19, P79, DOI 10.1016/j.tiv.2004.06.004; Adriaens E, 2014, ARCH TOXICOL, V88, P701, DOI 10.1007/s00204-013-1156-8; ANDERSEN I, 1983, SCAND J WORK ENV HEA, V9, P405, DOI 10.5271/sjweh.2393; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Ayaki M, 2008, CLIN EXP OPHTHALMOL, V36, P553, DOI 10.1111/j.1442-9071.2008.01803.x; Barile FA, 2010, J PHARMACOL TOXICOL, V61, P136, DOI 10.1016/j.vascn.2010.01.001; BARROSO J, 2014, AUF SOT M PHOEN 23 2, P23; Barroso J., 2013, IN VITR TEST IND PLA; CHANG RSM, 1954, P SOC EXP BIOL MED, V87, P440; Dohlman CH, 2011, CORNEA, V30, P613, DOI 10.1097/ICO.0b013e3182012a4f; Doucet O, 2006, TOXICOL IN VITRO, V20, P499, DOI 10.1016/j.tiv.2005.09.005; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; ECHEVERRIA D, 1989, BRIT J IND MED, V46, P483; Engelke M, 2013, TOXICOL IN VITRO, V27, P458, DOI 10.1016/j.tiv.2012.07.011; Epstein SP, 2009, J OCUL PHARMACOL TH, V25, P415, DOI 10.1089/jop.2008.0140; Epstein SP, 2009, J OCUL PHARMACOL TH, V25, P113, DOI 10.1089/jop.2008.0098; ESKES C, 2004, REPORT ESTABLISHING; Eskes C, 2014, TOXICOL IN VITRO, V28, P1046, DOI 10.1016/j.tiv.2014.02.009; *EUR UN RISK ASS R, 2003, 108883 CAS, V30; European Center for Ecotoxicology and Toxicology of Chemicals-ECETOC, 1998, 482 ECETOC; GAUTHERON P, 1992, FUND APPL TOXICOL, V18, P442, DOI 10.1016/0272-0590(92)90142-5; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; GUILLOT JP, 1982, FOOD CHEM TOXICOL, V20, P573, DOI 10.1016/S0278-6915(82)80066-5; Hahne M, 2012, J PHARM SCI-US, V101, P2976, DOI 10.1002/jps.23190; Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P43, DOI 10.14573/altex.2010.1.43; Hayashi K, 2012, TOXICOL IN VITRO, V26, P1199, DOI 10.1016/j.tiv.2012.06.008; HOWELL SL, 1974, J CELL SCI, V15, P591; Huhtala A, 2008, TOPICS MULTIFUNCTION, V1, P1; ICCVAM, 2006, NIH PUBLICATION, V07-4519, P1; *ICCVAM, 2007, NIH PUBL; Jeon HS, 2012, CYTOKINE, V59, P280, DOI 10.1016/j.cyto.2012.04.006; Jester JV, 2010, TOXICOL IN VITRO, V24, P597, DOI 10.1016/j.tiv.2009.10.010; Jester JV, 2006, CUTAN OCUL TOXICOL, V25, P41, DOI 10.1080/15569520500536626; Jester JV, 1998, INVEST OPHTH VIS SCI, V39, P922; Jester JV, 1998, INVEST OPHTH VIS SCI, V39, P2610; Jester JV, 2001, TOXICOL IN VITRO, V15, P115, DOI 10.1016/S0887-2333(00)00065-5; Kaluzhny Y, 2011, ATLA-ALTERN LAB ANIM, V39, P339, DOI 10.1177/026119291103900409; Katoh M, 2013, TOXICOL IN VITRO, V27, P2184, DOI 10.1016/j.tiv.2013.08.008; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Kojima H, 2014, J APPL TOXICOL, V34, P766, DOI 10.1002/jat.2937; Kolle SN, 2011, ATLA-ALTERN LAB ANIM, V39, P365, DOI 10.1177/026119291103900410; Manzer AK, 2009, ALTEX-ALTERN TIEREXP, V26, P33; Maurer JK, 2002, REGUL TOXICOL PHARM, V36, P106, DOI 10.1006/rtph.2002.1551; McNamee P, 2009, REGUL TOXICOL PHARM, V54, P197, DOI 10.1016/j.yrtph.2009.04.004; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; *OECD, 2013, OECD GUID TEST CHRM; OECD, 1995, GUID TEST CHEM, DOI [10.1787/9789264069787-en, DOI 10.1787/9789264203709-EN]; OECD, 2012, OECD GUID T IN PRESS; Organization for Economic Cooperation and Development (OECD), 2012, OECD GUID TEST CHEM, DOI DOI 10.1787/9789264076228-EN; Paladino G, 2004, TISSUE CELL, V36, P323, DOI 10.1016/j.tice.2004.05.003; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; PRINSEN MK, 1993, FOOD CHEM TOXICOL, V31, P69, DOI 10.1016/0278-6915(93)90182-X; RAABE HA, 2008, LINZ C 2008 S, V2008; Ramirez-Miranda A, 2011, MOL VIS, V17, P1652; Sakaguchi H, 2011, TOXICOL IN VITRO, V25, P796, DOI 10.1016/j.tiv.2011.01.015; Scheel J, 2011, TOXICOL IN VITRO, V25, P1435, DOI 10.1016/j.tiv.2011.04.017; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scott L, 2010, TOXICOL IN VITRO, V24, P1, DOI 10.1016/j.tiv.2009.05.019; Seaman CW, 2010, TOXICOL IN VITRO, V24, P1862, DOI 10.1016/j.tiv.2010.03.004; Seeber JW, 2008, ATLA-ALTERN LAB ANIM, V36, P569, DOI 10.1177/026119290803600512; Spielmann H, 1996, ATLA-ALTERN LAB ANIM, V24, P741; SUGAI S, 1990, Journal of Toxicological Sciences, V15, P245; Takahashi Y, 2011, TOXICOL IN VITRO, V25, P1425, DOI 10.1016/j.tiv.2011.04.012; Takahashi Y, 2010, CUTAN OCUL TOXICOL, V29, P77, DOI 10.3109/15569521003587327; UN, 2011, GLOB HARM SYST CLASS; Van Goethem F, 2006, TOXICOL IN VITRO, V20, P1, DOI 10.1016/j.tiv.2005.05.002; Van Goethem F, 2010, TOXICOL IN VITRO, V24, P1854, DOI 10.1016/j.tiv.2010.04.012; Verstraelen S, 2013, TOXICOL IN VITRO, V27, P1298, DOI 10.1016/j.tiv.2013.02.018; VONBURG R, 1993, J APPL TOXICOL, V13, P441, DOI 10.1002/jat.2550130612; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Yoshida Y, 2009, INVEST OPHTH VIS SCI, V50, P2103, DOI 10.1167/iovs.08-3046; Zorn-Kruppa M, 2005, ATLA-ALTERN LAB ANIM, V33, P37, DOI 10.1177/026119290503300107; Zorn-Kruppa M, 2004, ALTEX-ALTERN TIEREXP, V21, P129; Zuang V, 2005, ATLA-ALTERN LAB ANIM, V33, P1	75	10	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114181	10.1371/journal.pone.0114181	http://dx.doi.org/10.1371/journal.pone.0114181			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494045	Green Published, gold			2022-12-27	WOS:000346611400035
J	An, HK; Kim, KS; Lee, JW; Park, MH; Moon, HI; Park, SJ; Baik, JS; Kim, CH; Lee, YC				An, Hyun-Kyu; Kim, Kyoung-Sook; Lee, Ji-Won; Park, Mi-Hyun; Moon, Hyung-In; Park, Shin-Ji; Baik, Ji-Sue; Kim, Cheorl-Ho; Lee, Young-Choon			Mimulone-Induced Autophagy through p53-Mediated AMPK/mTOR Pathway Increases Caspase-Mediated Apoptotic Cell Death in A549 Human Lung Cancer Cells	PLOS ONE			English	Article							PAULOWNIA-TOMENTOSA FRUITS; C-GERANYL COMPOUNDS; INHIBITS PROLIFERATION; NCI-H460 CELLS; FLAVANONES; P53; ACTIVATION; GROWTH; MECHANISMS; AGENTS	Anticancer properties and mechanisms of mimulone (MML), C-geranylflavonoid isolated from the Paulownia tomentosa fruits, were firstly elucidated in this study. MML prevented cell proliferation in a dose-and time-dependent way and triggered apoptosis through the extrinsic pathway in A549 human lung adenocarcinoma cells. Furthermore, MML-treated cells displayed autophagic features, such as the formation of autophagic vacuoles, a primary morphological feature of autophagy, and the accumulation of microtubule-associated protein 1 light chain 3 (LC3) puncta, another typical maker of autophagy, as determined by FITC-conjugated immunostaining and monodansylcadaverine (MDC) staining, respectively. The expression levels of LC3-I and LC3-II, specific markers of autophagy, were also augmented by MML treatment. Autophagy inhibition by 3-methyladenine (3-MA), pharmacological autophagy inhibitor, and shRNA knockdown of Beclin-1 reduced apoptotic cell death induced by MML. Autophagic flux was not significantly affected by MML treatment and lysosomal inhibitor, chloroquine (CQ) suppressed MML-induced autophagy and apoptosis. MML-induced autophagy was promoted by decreases in p53 and p-mTOR levels and increase of p-AMPK. Moreover, inhibition of p53 transactivation by pifithrin-alpha (PFT-alpha) and knockdown of p53 enhanced induction of autophagy and finally promoted apoptotic cell death. Overall, the results demonstrate that autophagy contributes to the cytotoxicity of MML in cancer cells harboring wild-type p53. This study strongly suggests that MML is a potential candidate for an anticancer agent targeting both autophagy and apoptotic cell death in human lung cancer. Moreover, co-treatment of MML and p53 inhibitor would be more effective in human lung cancer therapy.	[An, Hyun-Kyu; Kim, Kyoung-Sook; Lee, Ji-Won; Park, Mi-Hyun; Moon, Hyung-In; Park, Shin-Ji; Baik, Ji-Sue; Lee, Young-Choon] Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea; [Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Suwon 440746, South Korea	Dong A University; Sungkyunkwan University (SKKU)	Lee, YC (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea.	yclee@dau.ac.kr	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714	Dong-A University research fund	Dong-A University research fund	This work was supported by the Dong-A University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aredia Francesca, 2012, Cells, V1, P520, DOI 10.3390/cells1030520; Asai T, 2008, PHYTOCHEMISTRY, V69, P1234, DOI 10.1016/j.phytochem.2007.11.011; Avisetti DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087050; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chang WA, 2014, MOL MED REP, V9, P1653, DOI 10.3892/mmr.2014.2015; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hsu HF, 2008, FOOD CHEM TOXICOL, V46, P3785, DOI 10.1016/j.fct.2008.09.068; Huang RY, 2014, CELL PHYSIOL BIOCHEM, V33, P375, DOI 10.1159/000356677; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Kaewpiboon C, 2014, INT J ONCOL, V44, P1233, DOI 10.3892/ijo.2014.2297; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SK, 2010, PHYTOTHER RES, V24, P1898, DOI 10.1002/ptr.3277; Kollar P, 2011, BRIT J PHARMACOL, V162, P1534, DOI 10.1111/j.1476-5381.2010.01171.x; Lee JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083611; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; Navratilova A, 2013, PHYTOCHEMISTRY, V89, P104, DOI 10.1016/j.phytochem.2013.01.002; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Schneiderova K, 2013, NAT PROD RES, V27, P613, DOI 10.1080/14786419.2012.683002; Smejkal K, 2008, PLANTA MED, V74, P1488, DOI 10.1055/s-2008-1081339; Smejkal K, 2007, J NAT PROD, V70, P1244, DOI 10.1021/np070063w; Smejkal K, 2007, MOLECULES, V12, P1210, DOI 10.3390/12061210; Smejkal K, 2010, J NAT PROD, V73, P568, DOI 10.1021/np900681y; Song J, 2014, BIOORG MED CHEM LETT, V24, P1188, DOI 10.1016/j.bmcl.2013.12.111; Tan W, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-27; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Warin RF, 2014, J AGR FOOD CHEM, V62, P1352, DOI 10.1021/jf405573e; Wu SH, 2010, ANTICANCER RES, V30, P2125; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhang YS, 2014, ONCOL LETT, V7, P295, DOI 10.3892/ol.2013.1696	48	33	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114607	10.1371/journal.pone.0114607	http://dx.doi.org/10.1371/journal.pone.0114607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490748	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300060
J	Moens, B; Muller, C; van Noorden, L; Franek, M; Celie, B; Boone, J; Bourgois, J; Leman, M				Moens, Bart; Muller, Chris; van Noorden, Leon; Franek, Marek; Celie, Bert; Boone, Jan; Bourgois, Jan; Leman, Marc			Encouraging Spontaneous Synchronisation with D-Jogger, an Adaptive Music Player That Aligns Movement and Music	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; PHASE-TRANSITIONS; SYNCHRONOUS MUSIC; PHYSICAL-ACTIVITY; EXERCISE DOMAIN; AUDITORY CUES; GAIT; WALKING; BEAT; VARIABILITY	In this study we explore how music can entrain human walkers to synchronise to the musical beat without being instructed to do so. For this, we use an interactive music player, called D-Jogger, that senses the user's walking tempo and phase. D-Jogger aligns the music by manipulating the timing difference between beats and footfalls. Experiments are reported that led to the development and optimisation of four alignment strategies. The first strategy matched the music's tempo continuously to the runner's pace. The second strategy matched the music's tempo at the beginning of a song to the runner's pace, keeping the tempo constant for the remainder of the song. The third alignment starts a song in perfect phase synchrony and continues to adjust the tempo to match the runner's pace. The fourth and last strategy additionally adjusts the phase of the music so each beat matches a footfall. The first two strategies resulted in a minor increase of steps in phase synchrony with the main beat when compared to a random playlist, the last two strategies resulted in a strong increase in synchronised steps. These results may be explained in terms of phase-error correction mechanisms and motor prediction schemes. Finding the phase-lock is difficult due to fluctuations in the interaction, whereas strategies that automatically align the phase between movement and music solve the problem of finding the phase-locking. Moreover, the data show that once the phase-lock is found, alignment can be easily maintained, suggesting that less entrainment effort is needed to keep the phase-lock, than to find the phase-lock. The different alignment strategies of D-Jogger can be applied in different domains such as sports, physical rehabilitation and assistive technologies for movement performance.	[Moens, Bart; Muller, Chris; van Noorden, Leon; Leman, Marc] Univ Ghent, Inst Psychoacoust & Elect Mus, Dept Musicol, B-9000 Ghent, Belgium; [Franek, Marek] Univ Hradec Kralove, Dept Management, Hradec Kralove, Czech Republic; [Celie, Bert; Boone, Jan; Bourgois, Jan] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	Ghent University; University of Hradec Kralove; Ghent University	Leman, M (corresponding author), Univ Ghent, Inst Psychoacoust & Elect Mus, Dept Musicol, B-9000 Ghent, Belgium.	marc.leman@ugent.be	Boone, Jan/AAC-9748-2020; Franěk, Marek/P-7670-2016	Franěk, Marek/0000-0002-9228-5319; Moens, Bart/0000-0002-1281-9406	Flemish Government, Belgium; COST Action on Sonic Interaction Design (SID) by the European Science Foundation [IC 0601]	Flemish Government, Belgium; COST Action on Sonic Interaction Design (SID) by the European Science Foundation	This work was supported by funding by a Methusalem grant from the Flemish Government, Belgium. Several step frequency and gait phase detection methods were developed using funding by the COST IC 0601 Action on Sonic Interaction Design (SID) by the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJNE B, 1968, BIOMETRIKA, V55, P343, DOI 10.1093/biomet/55.2.343; Bacon CJ, 2012, J SPORT MED PHYS FIT, V52, P359; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Chaiwanichsiri D, 2011, ASIAN BIOMED, V5, P649, DOI 10.5372/1905-7415.0505.086; de Bruin N, 2010, PARKINSONS DIS, V2010, P483; Dixon S, 2007, J NEW MUSIC RES, V36, P39, DOI 10.1080/09298210701653310; Fairhurst MT, 2013, CEREB CORTEX, V23, P2592, DOI 10.1093/cercor/bhs243; Fisher N., 1995, STAT ANAL CIRCULAR D; Fritz TH, 2013, P NATL ACAD SCI USA, V110, P17784, DOI 10.1073/pnas.1217252110; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hausdorff J, 2009, CHAOS INTERDISCIPLIN, V19, P026; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hockman J, 2009, P INT C NEW INT MUS, P90; Hoffmann CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045206; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Lane AM, 2011, J SPORT SCI MED, V10, P400; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2014, ACTA PSYCHOL, V147, P10, DOI 10.1016/j.actpsy.2013.10.002; Masahiro N., 2008, P 2008 INT C MUS INF, P193; Mendonca C, 2014, HUM MOVEMENT SCI, V33, P33, DOI 10.1016/j.humov.2013.11.006; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Moens B, 2010, P 7 SOUND MUS COMP C, P451; Moens B, 2010, SENSOR EVALUATION RE; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nowicki L., 2013, PSYCHOMUSICOLOGY, V23, P6, DOI [10.1037/a0032039, DOI 10.1037/A0032039]; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Papetti S, 2011, P INT C NEW INT MUS, P473; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Phillips-Silver J, 2011, NEUROPSYCHOLOGIA, V49, P961, DOI 10.1016/j.neuropsychologia.2011.02.002; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Styns F, 2007, HUM MOVEMENT SCI, V26, P769, DOI 10.1016/j.humov.2007.07.007; Terry PC, 2012, J SCI MED SPORT, V15, P52, DOI 10.1016/j.jsams.2011.06.003; WILKIE D, 1983, J R STAT SOC C-APPL, V32, P311; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Ying H, 2007, IFMBE PROC, V13, P80; Zar JH, 1999, BIOSTATISTICAL ANAL; Zplanede, 2002, EL TIM STRETCH PITCH	55	48	48	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114234	10.1371/journal.pone.0114234	http://dx.doi.org/10.1371/journal.pone.0114234			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AY3YM	25489742	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300022
J	Takahashi, Y; Kondo, K; Miyaji, A; Watanabe, Y; Fan, QH; Honma, T; Tanaka, K				Takahashi, Yoshio; Kondo, Kazuhiro; Miyaji, Asami; Watanabe, Yusuke; Fan, Qiaohui; Honma, Tetsuo; Tanaka, Kazuya			Recovery and Separation of Rare Earth Elements Using Salmon Milt	PLOS ONE			English	Article							HEAVY-METAL IONS; MULTIPLE-SCATTERING; AQUEOUS-SOLUTIONS; DNA; COMPLEXES; EXTRACTION; COLUMNS; REMOVAL; MATRIX	Recycling rare earth elements (REEs) used in advanced materials such as Nd magnets is important for the efficient use of REE resources when the supply of several REEs is limited. In this work, the feasibility of using salmon milt for REE recovery and separation was examined, along with the identification of the binding site of REEs in salmon milt. Results showed that (i) salmon milt has a sufficiently high affinity to adsorb REEs and (ii) the adsorption capacity of the milt is 1.04 mEq/g, which is comparable with that of commercial cation exchange resin. Heavier REEs have higher affinity for milt. A comparison of stability constants and adsorption patterns of REEs discussed in the literature suggests that the phosphate is responsible for the adsorption of REE in milt. The results were supported by dysprosium (Dy) and lutetium (Lu) L-III-edge extended x-ray absorption fine structure (EXAFS) spectroscopy. The REE-P shell was identified for the second neighboring atom, which shows the importance of the phosphate site as REE binding sites. The comparison of REE adsorption pattern and EXAFS results between the milt system and other adsorbent systems (cellulose phosphate, Ln-resin, bacteria, and DNA-filter hybrid) revealed that the coordination number of phosphate is correlated with the slope of the REE pattern. The separation column loaded with milt was tested to separate REE for the practical use of salmon milt for the recovery and separation of REE. However, water did not flow through the column possibly because of the hydrophobicity of the milt. Thus, sequential adsorption-desorption approach using a batch-type method was applied for the separation of REE. As an example of the practical applications of REE separation, Nd and Fe(III) were successfully separated from a synthetic solution of Nd magnet waste by a batch-type method using salmon milt.	[Takahashi, Yoshio; Watanabe, Yusuke; Fan, Qiaohui] Univ Tokyo, Dept Earth & Planetary Sci, Bukyo Ku, Tokyo 1138654, Japan; [Takahashi, Yoshio; Miyaji, Asami] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Kondo, Kazuhiro] Aisin Cosmos R&D Co LTD, Kisarazu, Chiba 2920818, Japan; [Honma, Tetsuo] Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Sayo, Hyogo 6795198, Japan; [Tanaka, Kazuya] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Hiroshima 7398530, Japan	University of Tokyo; Hiroshima University; Aisin Seiki; Japan Synchrotron Radiation Research Institute; Hiroshima University	Takahashi, Y (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bukyo Ku, Hongo 7-3-1, Tokyo 1138654, Japan.	ytakaha@hiroshima-u.ac.jp	Takahashi, Yoshio/F-6733-2011	Takahashi, Yoshio/0000-0001-7860-2341; KONDO, Kazuhiro/0000-0002-3731-6258	Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [22224011] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, CONTINENTAL CRUST; Bunker G., 2010, INTRO XAFS PRACTICAL; BYRNE RH, 1990, GEOCHIM COSMOCHIM AC, V54, P2645, DOI 10.1016/0016-7037(90)90002-3; Du XY, 2011, J IND ECOL, V15, P836, DOI 10.1111/j.1530-9290.2011.00362.x; Eliseeva SV, 2011, NEW J CHEM, V35, P1165, DOI 10.1039/c0nj00969e; Gupta C. K., 2004, EXTRACTIVE METALLURG; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hokkaido Bureau of Economy, TRAD IND; Hopkins BS, 1933, P NATL ACAD SCI USA, V19, P64, DOI 10.1073/pnas.19.1.64; Liao BQ, 2005, SEPAR SCI TECHNOL, V40, P1685, DOI 10.1081/SS-200059604; Matsuura Takanori, 2006, Membrane, V31, P281; Murakami H, 2006, CARBONATITE RELATED, P197; Nebel-Jacobsen Y, 2005, CHEM GEOL, V220, P105, DOI 10.1016/j.chemgeo.2005.03.009; NI YX, 1995, AM MINERAL, V80, P21; ODAY PA, 1994, J AM CHEM SOC, V116, P2938, DOI 10.1021/ja00086a026; Sakai H, 2009, COLLOID SURFACE A, V347, P210, DOI 10.1016/j.colsurfa.2009.04.031; Sigg L., 1992, CHEM SOLID WATER INT, P369; SMITH RM, 1987, SCI TOTAL ENVIRON, V64, P125, DOI 10.1016/0048-9697(87)90127-6; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Takahashi Y, 2004, ANAL SCI, V20, P1301, DOI 10.2116/analsci.20.1301; Takahashi Y, 2007, CHEM GEOL, V244, P569, DOI 10.1016/j.chemgeo.2007.07.005; Takahashi Y, 2012, ANAL SCI, V28, P985, DOI 10.2116/analsci.28.985; Takahashi Y, 2010, GEOCHIM COSMOCHIM AC, V74, P5443, DOI 10.1016/j.gca.2010.07.001; Takeshima T, 2014, POLYM J, V46, P36, DOI 10.1038/pj.2013.58; Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086; Yamada M, 2002, B CHEM SOC JPN, V75, P1627, DOI 10.1246/bcsj.75.1627; Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r; Yamamoto Y, 2010, GEOCHEM J, V44, P39, DOI 10.2343/geochemj.1.0041; Yan CH, 1999, J RARE EARTH, V17, P58; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zinchenko AA, 2009, J HAZARD MATER, V168, P38, DOI 10.1016/j.jhazmat.2009.01.121	31	24	24	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114858	10.1371/journal.pone.0114858	http://dx.doi.org/10.1371/journal.pone.0114858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490035	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300085
J	Gabriel, F; Accoceberry, I; Bessoule, JJ; Salin, B; Lucas-Guerin, M; Manon, S; Dementhon, K; Noel, T				Gabriel, Frederic; Accoceberry, Isabelle; Bessoule, Jean-Jacques; Salin, Benedicte; Lucas-Guerin, Marine; Manon, Stephen; Dementhon, Karine; Noel, Thierry			A Fox2-Dependent Fatty Acid beta-Oxidation Pathway Coexists Both in Peroxisomes and Mitochondria of the Ascomycete Yeast Candida lusitaniae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GLYOXYLATE CYCLE; NEUROSPORA-CRASSA; MOLECULAR-CLONING; PROTEIN; ALBICANS; IDENTIFICATION; DEHYDROGENASE; PURIFICATION; TROPICALIS	It is generally admitted that the ascomycete yeasts of the subphylum Saccharomycotina possess a single fatty acid beta-oxidation pathway located exclusively in peroxisomes, and that they lost mitochondrial beta-oxidation early during evolution. In this work, we showed that mutants of the opportunistic pathogenic yeast Candida lusitaniae which lack the multifunctional enzyme Fox2p, a key enzyme of the beta-oxidation pathway, were still able to grow on fatty acids as the sole carbon source, suggesting that C. lusitaniae harbored an alternative pathway for fatty acid catabolism. By assaying C-14(alpha)-palmitoyl-CoA consumption, we demonstrated that fatty acid catabolism takes place in both peroxisomal and mitochondrial subcellular fractions. We then observed that a fox2 Delta null mutant was unable to catabolize fatty acids in the mitochondrial fraction, thus indicating that the mitochondrial pathway was Fox2p-dependent. This finding was confirmed by the immunodetection of Fox2p in protein extracts obtained from purified peroxisomal and mitochondrial fractions. Finally, immunoelectron microscopy provided evidence that Fox2p was localized in both peroxisomes and mitochondria. This work constitutes the first demonstration of the existence of a Fox2p-dependent mitochondrial beta-oxidation pathway in an ascomycetous yeast, C. lusitaniae. It also points to the existence of an alternative fatty acid catabolism pathway, probably located in peroxisomes, and functioning in a Fox2p-independent manner.	[Gabriel, Frederic; Accoceberry, Isabelle; Lucas-Guerin, Marine; Dementhon, Karine; Noel, Thierry] Univ Bordeaux, UMR 5234, F-33000 Bordeaux, France; [Gabriel, Frederic; Accoceberry, Isabelle; Lucas-Guerin, Marine; Dementhon, Karine; Noel, Thierry] CNRS, UMR 5234, F-33000 Bordeaux, France; [Bessoule, Jean-Jacques] Univ Bordeaux, Lab Biogenese Membranaire, UMR 5200, Bordeaux, France; [Bessoule, Jean-Jacques] CNRS, Lab Biogenese Membranaire, UMR 5200, F-33000 Bordeaux, France; [Salin, Benedicte; Manon, Stephen] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France; [Salin, Benedicte; Manon, Stephen] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Gabriel, F (corresponding author), Univ Bordeaux, UMR 5234, F-33000 Bordeaux, France.	thierry.noel@u-bordeaux2.fr	Manon, Stéphen/C-7088-2017	Noel, Thierry/0000-0003-0320-1126; Manon, Stephen/0000-0002-5792-1084; DEMENTHON, Karine/0000-0003-0974-3663	University of Bordeaux; Centre National de la Recherche Scientifique	University of Bordeaux; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Funding: This work was supported by grants from the University of Bordeaux and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ast J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00297; Baltazar MF, 1999, MICROBIOL-UK, V145, P271, DOI 10.1099/13500872-145-1-271; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Boisnard S, 2009, FUNGAL GENET BIOL, V46, P55, DOI 10.1016/j.fgb.2008.10.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Camougrand N, 2008, METHOD ENZYMOL, V451, P89, DOI 10.1016/S0076-6879(08)03208-4; Cheng Q, 2005, BBA-MOL CELL BIOL L, V1735, P192, DOI 10.1016/j.bbalip.2005.06.006; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; DELAGARZA MM, 1985, EUR J BIOCHEM, V148, P285, DOI 10.1111/j.1432-1033.1985.tb08837.x; Dementhon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032621; Distel Ben, 2006, Methods Mol Biol, V313, P21; DOMMES P, 1983, J BIOL CHEM, V258, P846; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; El-Kirat-Chatel S, 2011, YEAST, V28, P321, DOI 10.1002/yea.1836; Favel A, 2003, DIAGN MICR INFEC DIS, V47, P331, DOI 10.1016/S0732-8893(03)00094-4; Ferdinandusse S, 2004, J LIPID RES, V45, P1104, DOI 10.1194/jlr.M300512-JLR200; Feron G, 2005, FEMS MICROBIOL LETT, V250, P63, DOI 10.1016/j.femsle.2005.06.045; FOSSA A, 1995, MOL GEN GENET, V247, P95, DOI 10.1007/BF00425825; Foulon V, 1999, P NATL ACAD SCI USA, V96, P10039, DOI 10.1073/pnas.96.18.10039; Francois F, 2004, YEAST, V21, P95, DOI 10.1002/yea.1059; Francois F, 2001, J CLIN MICROBIOL, V39, P3906, DOI 10.1128/JCM.39.11.3906-3914.2001; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; HILTUNEN JK, 1992, J BIOL CHEM, V267, P6646; Jansen GA, 2006, BBA-MOL CELL RES, V1763, P1403, DOI 10.1016/j.bbamcr.2006.07.012; KAMIRYO T, 1982, J BACTERIOL, V152, P269; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; KURIHARA T, 1992, J BIOCHEM-TOKYO, V111, P783, DOI 10.1093/oxfordjournals.jbchem.a123836; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Maggio-Hall LA, 2008, FUNGAL GENET BIOL, V45, P180, DOI 10.1016/j.fgb.2007.06.004; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Pauly Diana, 2011, J Vis Exp, DOI 10.3791/3084; Pereira C, 2010, MOL MICROBIOL, V76, P1398, DOI 10.1111/j.1365-2958.2010.07122.x; PICATAGGIO S, 1992, BIO-TECHNOL, V10, P894, DOI 10.1038/nbt0892-894; Piekarska K, 2008, MICROBIOL-SGM, V154, P3061, DOI 10.1099/mic.0.2008/020289-0; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; POLAKIS ES, 1964, BIOCHEM J, V90, P369, DOI 10.1042/bj0900369; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Refsum S, 1947, JAMA-J AM MED ASSOC, V133, P1319, DOI [10.1001/jama.1947.02880170065026, DOI 10.1001/JAMA.1947.02880170065026]; RODRIGUESDEMIRANDA L, 1979, A VAN LEEUW J MICROB, V45, P479, DOI 10.1007/BF00443285; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; SCHERER S, 1987, J CLIN MICROBIOL, V25, P675, DOI 10.1128/JCM.25.4.675-679.1987; Schmidt G, 1996, MICROBIOL-SGM, V142, P419, DOI 10.1099/13500872-142-2-419; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; Shen YQ, 2009, NUCLEIC ACIDS RES, V37, P5619, DOI 10.1093/nar/gkp566; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Smith JJ, 2000, J BIOL CHEM, V275, P20168, DOI 10.1074/jbc.M909285199; Strijbis K, 2010, EUKARYOT CELL, V9, P1809, DOI 10.1128/EC.00172-10; THIERINGER R, 1991, J BIOL CHEM, V266, P13118; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANDERS RJA, 1991, J INHERIT METAB DIS, V14, P349, DOI 10.1007/BF01811700; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004	66	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114531	10.1371/journal.pone.0114531	http://dx.doi.org/10.1371/journal.pone.0114531			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486052	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600071
J	Guan, WH; Li, C				Guan, Weihua; Li, Chun			Design of DNA Pooling to Allow Incorporation of Covariates in Rare Variants Analysis	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; LARGE-SCALE ASSOCIATION; NEXT-GENERATION; POOLED DNA; SAMPLES; TOOL	Background: Rapid advances in next-generation sequencing technologies facilitate genetic association studies of an increasingly wide array of rare variants. To capture the rare or less common variants, a large number of individuals will be needed. However, the cost of a large scale study using whole genome or exome sequencing is still high. DNA pooling can serve as a cost-effective approach, but with a potential limitation that the identity of individual genomes would be lost and therefore individual characteristics and environmental factors could not be adjusted in association analysis, which may result in power loss and a biased estimate of genetic effect. Methods: For case-control studies, we propose a design strategy for pool creation and an analysis strategy that allows covariate adjustment, using multiple imputation technique. Results: Simulations show that our approach can obtain reasonable estimate for genotypic effect with only slight loss of power compared to the much more expensive approach of sequencing individual genomes. Conclusion: Our design and analysis strategies enable more powerful and cost-effective sequencing studies of complex diseases, while allowing incorporation of covariate adjustment.	[Guan, Weihua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Li, Chun] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University	Guan, WH (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA.	wguan@umn.edu; cxl791@case.edu	Li, Chun/R-1095-2019	Li, Chun/0000-0002-8819-2443	National Institutes of Health [R01HG004517]; University of Minnesota; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding: This research was supported by the grant R01HG004517 (CL) from the National Institutes of Health (www.nih.gov) and Grant-in-Aid program (WG) from the University of Minnesota (http://www.research.umn.edu/advance/gia.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Chen XW, 2012, GENET EPIDEMIOL, V36, P549, DOI 10.1002/gepi.21648; Chen Y, 2005, SIZE REGULARIZED CUT, P211; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Day-Williams AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026279; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Lee JS, 2011, GENET EPIDEMIOL, V35, P139, DOI 10.1002/gepi.20561; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Little R.J.A., 2002, STAT ANAL MISSING DA; Mitsui J, 2010, J HUM GENET, V55, P448, DOI 10.1038/jhg.2010.46; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Norton N, 2004, ANN MED, V36, P146, DOI 10.1080/07853890310021724; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Wang T, 2012, J PROBABILITY STAT, V2012, P19; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502; Weinberg CR, 1999, BIOMETRICS, V55, P718, DOI 10.1111/j.0006-341X.1999.00718.x; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	23	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114523	10.1371/journal.pone.0114523	http://dx.doi.org/10.1371/journal.pone.0114523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485788	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600068
J	Ma, LK; Tunney, RJ; Ferguson, E				Ma, Lawrence K.; Tunney, Richard J.; Ferguson, Eamonn			Gratefully Received, Gratefully Repaid: The Role of Perceived Fairness in Cooperative Interactions	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; DIABETIC-RETINOPATHY; INDIRECT RECIPROCITY; PROSOCIAL BEHAVIOR; NORMATIVE CONDUCT; ULTIMATUM GAMES; PROPERTY-RIGHTS; D INSUFFICIENCY; RISK-FACTORS; FOCUS THEORY	It is well documented that people would remunerate fair behaviours and penalize unfair behaviours. It is argued that individuals' reactions following the receipt of a gift depend on the perceived intentions of the donors. Fair intentions should prompt positive affect, like gratitude, triggering cooperative behaviours; while intended unfairness should trigger negative affect, like anger, fostering anti-social actions. It is, however, contended that when people lack information to infer others' intention they may use 'normative' beliefs about fairness - what a typical fair individual 'should' do in these circumstances - to guide their behaviour. In this experiment we examined this assertion. We had 122 participants play a one-shot, double-anonymous game with half playing as potential helpers (P1s) and half as recipients (P2s). Whether a participant was a P1 or P2 was chance-determined and all participants knew this. P1s decided whether to help P2s and whether to make their help unconditional (no repayment needed) or conditional (full or 'taxed' repayment). P2s decided whether to accept the offer and whatever conditions attached but were blind to the list of helping options available to P1s. We anticipated that recipients would refer to the 'injunctive norm' that 'fair people should help "for free" when it is only by chance that they are in a position to help'. Therefore, without knowing P1s' different helping options, unconditional offers should be rated by recipients as fairer than conditional offers, and this should be linked to greater gratitude with greater gratitude linked to greater reciprocation. Path analyses confirmed this serial mediation. The results showed that recipients of unconditional offers, compared to conditional ones, interpreted the helpers' motives as more helpful, experienced greater gratitude and were more eager to reciprocate. The behavioural data further revealed that, when given a latter option to default, 38% of recipients of conditional offers did so.	[Ma, Lawrence K.; Ferguson, Eamonn] Univ Nottingham, Sch Psychol, Personal Social Psychol & Hlth Res Grp, Nottingham NG7 2RD, England; [Tunney, Richard J.] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Ferguson, E (corresponding author), Univ Nottingham, Sch Psychol, Personal Social Psychol & Hlth Res Grp, Nottingham NG7 2RD, England.	eamonn.ferguson@nottingham.ac.uk		Ferguson, Eamonn/0000-0002-7678-1451; Ma, Lawrence K/0000-0003-1234-0195; Tunney, Richard/0000-0003-4673-757X	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors have read the journal's policy and have the following competing interests: 1. The third author - Eamonn Ferguson - holds a joint research grant from The Economic and Social Research Council (ESRC) with one of the suggested reviewers: Alex Wood. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aksoy H, 2000, CLIN BIOCHEM, V33, P47, DOI 10.1016/S0009-9120(99)00085-5; ALBANESE R, 1985, ACAD MANAGE REV, V10, P244, DOI 10.2307/257966; Albert DM, 2007, INVEST OPHTH VIS SCI, V48, P2327, DOI 10.1167/iovs.06-1210; American Diabetes Association, 2002, DIABETES CARE S1, V23, pS4; [Anonymous], 2008, PERSPECTIVES PERSONA; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bahar-Shany K, 2010, J CELL PHYSIOL, V222, P729, DOI 10.1002/jcp.22004; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bicchieri C, 1999, PHILOS PHENOMEN RES, V59, P229, DOI 10.2307/2653473; Bicchieri C, 2006, GRAMMAR SOC NATURE D, P100; Bicchieri C, 2013, ECON PHILOS, V29, P175, DOI 10.1017/S0266267113000187; Bicchieri C, 2010, J BEHAV DECIS MAKING, V23, P161, DOI 10.1002/bdm.648; CASTRO MAC, 1974, J APPL SOC PSYCHOL, V4, P194, DOI 10.1111/j.1559-1816.1974.tb02640.x; Chen J, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-6; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cialdini RB, 2001, INFLUENCE SCI PRACTI, P19; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; CUNNINGHAM MR, 1980, J PERS SOC PSYCHOL, V38, P181, DOI 10.1037/0022-3514.38.2.181; DePaulo BM, 1983, NEW DIRECTIONS HELPI, V1, P223; Emmons R. A., 2008, HDB PERSONALITY THEO, P634; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Fahr R, 2000, ECON LETT, V66, P275, DOI 10.1016/S0165-1765(99)00236-0; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 1999, J POLIT ECON, V107, P106, DOI 10.1086/250052; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 1998, EUR ECON REV, V42, P845, DOI 10.1016/S0014-2921(97)00131-1; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2002, EUR ECON REV, V46, P687, DOI 10.1016/S0014-2921(01)00208-2; Fehr E., 2006, HDB EC GIVING ALTRUI, P615, DOI DOI 10.1016/S1574-0714(06)01008-6; Fehr E, 2004, J EUR ECON ASSOC, V2, DOI 10.1162/1542476042782297; Field A., 2000, DISCOVERING STAT USI; Firrincieli D, 2014, CLIN RES HEPATOL GAS, V38, P5, DOI 10.1016/j.clinre.2013.10.004; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FREY BS, 1995, J INST THEOR ECON, V151, P286; Frijda N. H., 1986, EMOTIONS STUDIES EMO; GERGEN KJ, 1975, J PERS SOC PSYCHOL, V31, P390, DOI 10.1037/h0076482; Greenberg M.S., 1983, NEW DIRECTIONS HELPI, VVol. 1, P85; GREENBERG MS, 1971, SOCIOMETRY, V34, P290, DOI 10.2307/2786418; GROSS AE, 1974, J APPL SOC PSYCHOL, V4, P210, DOI 10.1111/j.1559-1816.1974.tb02641.x; Group DRS, 1981, INVEST OPHTHALMOL, V21, P6; Gyorffy B, 2002, EUR J ENDOCRINOL, V147, P803, DOI 10.1530/eje.0.1470803; Hatfield E., 1983, NEW DIRECTIONS HELPI, Vl, P113; Havakuk O, 2013, ISR MED ASSOC J, V15, P693; Hayes AF, 2013, INTRO MEDIATION MODE, P100; Hayes AF, 2013, INTRO MEDIATION MODE, P143; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; HOFFMAN E, 1985, J LEGAL STUD, V14, P259, DOI 10.1086/467773; Hoffman E, 1996, INT J GAME THEORY, V25, P289, DOI 10.1007/BF02425259; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Irwin K, 2013, SOC FORCES, P1; Jee D, 2013, INVEST OPHTH VIS SCI, V54, P6827, DOI 10.1167/iovs.13-12654; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kallgren CA, 2000, PERS SOC PSYCHOL B, V26, P1002, DOI 10.1177/01461672002610009; Kim K, 2012, ENVIRON RES, V112, P225, DOI 10.1016/j.envres.2011.12.008; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Klein BEK, 2004, ARCH INTERN MED, V164, P1917, DOI 10.1001/archinte.164.17.1917; Komter A., 2004, PSYCHOL GRATITUDE, P195; Lavie CJ, 2013, CIRCULATION, V128, P2404, DOI 10.1161/CIRCULATIONAHA.113.002902; Lazarus R.S., 1996, PASSION REASON MAKIN; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Mangge H, 2013, CURR VASC PHARM; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Miller C, 2009, PHILOS STUD, V142, P247, DOI 10.1007/s11098-007-9185-x; Nadler A., 2012, OXFORD HDB PERSONALI, P394, DOI [10.1093/OXFORDHB/9780195398991.013.0016, DOI 10.1093/OXFORDHB/9780195398991.013.0016]; Nevid JS, 2007, PSYCHOL CHALLENGES L, P20; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Olson DVA, 2005, J SCI STUD RELIG, V44, P123, DOI 10.1111/j.1468-5906.2005.00271.x; Palomer X, 2008, DIABETES OBES METAB, V10, P185, DOI 10.1111/j.1463-1326.2007.00710.x; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Payne JF, 2012, ENDOCR PRACT, V18, P185, DOI 10.4158/EP11147.OR; Personne V, 2013, PRESSE MED, V42, P1334, DOI 10.1016/j.lpm.2013.06.013; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Quraishi M.K., 2013, INT J RHEUM DIS; Ruffle BJ, 1998, GAME ECON BEHAV, V23, P247, DOI 10.1006/game.1997.0630; Schopler J., 1970, ALTRUISM HELP BEHAV, P231; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; SHAVELL S, 1980, BELL J ECON, V11, P466, DOI 10.2307/3003374; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Smith M, 2010, BIOSCI HORIZ, V3, P124; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; STIGLER GJ, 1974, BELL J ECON, V5, P359, DOI 10.2307/3003114; Taverna MJ, 2005, J CLIN ENDOCR METAB, V90, P4803, DOI 10.1210/jc.2004-2407; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; Toriola AT, 2014, CANC EPIDEMIOL BIOMA; Tsang JA, 2006, COGNITION EMOTION, V20, P138, DOI 10.1080/02699930500172341; Tsang JA, 2006, MOTIV EMOTION, V30, P199, DOI 10.1007/s11031-006-9031-z; Tsang Jo-Ann, 2007, J POSITIVE PSYCH, V2, P157, DOI DOI 10.1080/17439760701229019; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Wang Q, 2014, J BIOL CHEM; Watkins PC, 2006, COGNITION EMOTION, V20, P217, DOI 10.1080/02699930500172291; Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431; Weinstein J, 2011, EAST ECON J, V37, P313, DOI 10.1057/eej.2011.6; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yilmaz SS, 2013, J REPROD MED, V58, P511	106	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114976	10.1371/journal.pone.0114976	http://dx.doi.org/10.1371/journal.pone.0114976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25485698	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000346907600106
J	Zagorskaite, E; Sasnauskas, G				Zagorskaite, Evelina; Sasnauskas, Giedrius			Chemical Display of Pyrimidine Bases Flipped Out by Modification-Dependent Restriction Endonucleases of MspJI and PvuRts1I Families	PLOS ONE			English	Article							HEMI-METHYLATED DNA; CPG BINDING DOMAIN; STRUCTURAL BASIS; SRA DOMAIN; RECOGNITION; PROTEIN; RESIDUES; 5-METHYLCYTOSINE; PERMANGANATE; UHRF1	The epigenetic DNA modifications 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) in eukaryotes are recognized either in the context of double-stranded DNA (e.g., by the methyl-CpG binding domain of MeCP2), or in the flipped-out state (e.g., by the SRA domain of UHRF1). The SRA-like domains and the base-flipping mechanism for 5(h)mC recognition are also shared by the recently discovered prokaryotic modification-dependent endonucleases of the MspJI and PvuRts1I families. Since the mechanism of modified cytosine recognition by many potential eukaryotic and prokaryotic 5(h) mC "readers" is still unknown, a fast solution based method for the detection of extrahelical 5(h) mC would be very useful. In the present study we tested base-flipping by MspJI- and PvuRts1I-like restriction enzymes using several solution-based methods, including fluorescence measurements of the cytosine analog pyrrolocytosine and chemical modification of extrahelical pyrimidines with chloroacetaldehyde and KMnO4. We find that only KMnO4 proved an efficient probe for the positive display of flipped out pyrimidines, albeit the method required either non-physiological pH (4.3) or a substitution of the target cytosine with thymine. Our results imply that DNA recognition mechanism of 5(h) mC binding proteins should be tested using a combination of all available methods, as the lack of a positive signal in some assays does not exclude the base flipping mechanism.	[Zagorskaite, Evelina; Sasnauskas, Giedrius] Vilnius State Univ, Inst Biotechnol, Dept Prot DNA Interact, Vilnius, Lithuania	Vilnius University	Sasnauskas, G (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Prot DNA Interact, Vilnius, Lithuania.	gsasnaus@ibt.lt	Sasnauskas, Giedrius/AAE-8191-2019		Research Council of Lithuania [MIP-027/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	Funding: This work was supported by the Research Council of Lithuania (Grant MIP-027/2012 to GS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Berry DA, 2004, TETRAHEDRON LETT, V45, P2457, DOI 10.1016/j.tetlet.2004.01.108; Bischerour J, 2007, NUCLEIC ACIDS RES, V35, P2584, DOI 10.1093/nar/gkm186; Bochtler M, 2006, EMBO J, V25, P2219, DOI 10.1038/sj.emboj.7601096; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Daujotyte D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn200; FRITZSCHE E, 1987, NUCLEIC ACIDS RES, V15, P5517, DOI 10.1093/nar/15.14.5517; GOGOS JA, 1990, NUCLEIC ACIDS RES, V18, P6807, DOI 10.1093/nar/18.23.6807; Hahn MA, 2014, GENOMICS, V104, P314, DOI 10.1016/j.ygeno.2014.08.015; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P12092, DOI 10.1093/nar/gku871; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P7947, DOI 10.1093/nar/gku497; Horton JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep04246; Horton JR, 2012, NUCLEIC ACIDS RES, V40, P9763, DOI 10.1093/nar/gks719; Huang XJ, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-56; Irier HA, 2012, DNA CELL BIOL, V31, pS42, DOI 10.1089/dna.2011.1565; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Kazrani AA, 2014, NUCLEIC ACIDS RES, V42, P5929, DOI 10.1093/nar/gku186; Klimasauskas S, 2009, DNA RNA MODIFICATION, P37; KUSMIEREK JT, 1982, BIOCHEMISTRY-US, V21, P5717, DOI 10.1021/bi00265a050; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Oakeley EJ, 1999, BIOTECHNIQUES, V27, P744, DOI 10.2144/99274st05; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Reddy YVR, 2000, J MOL BIOL, V298, P597, DOI 10.1006/jmbi.2000.3673; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sasnauskas G, 2003, P NATL ACAD SCI USA, V100, P6410, DOI 10.1073/pnas.1131003100; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Serva S, 1998, NUCLEIC ACIDS RES, V26, P3473, DOI 10.1093/nar/26.15.3473; Shao C, 2014, ACTA CRYSTALLOGR D, V70, P2477, DOI 10.1107/S139900471401606X; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Sun ZY, 2013, CELL REP, V3, P567, DOI 10.1016/j.celrep.2013.01.001; Szwagierczak A, 2011, NUCLEIC ACIDS RES, V39, P5149, DOI 10.1093/nar/gkr118; Tamulaitis G, 2002, FEBS LETT, V518, P17, DOI 10.1016/S0014-5793(02)02621-2; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	46	4	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114580	10.1371/journal.pone.0114580	http://dx.doi.org/10.1371/journal.pone.0114580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486533	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600077
J	Zhang, XY; Wang, JX; Zhang, M; Qin, GH; Li, DQ; Zhu, KY; Ma, EB; Zhang, JZ				Zhang, Xueyao; Wang, Jianxin; Zhang, Min; Qin, Guohua; Li, Daqi; Zhu, Kun Yan; Ma, Enbo; Zhang, Jianzhen			Molecular Cloning, Characterization and Positively Selected Sites of the Glutathione S-Transferase Family from Locusta migratoria	PLOS ONE			English	Article							EXPRESSION; EVOLUTION; SYNTHASE; IDENTIFICATION; PROTECTION	Glutathione S-transferases (GSTs) are multifunctional enzymes that are involved in the metabolism of endogenous and exogenous compounds and are related to insecticide resistance. The purpose of this study was to provide new information on the molecular characteristics and the positive selection of locust GSTs. Based on the transcriptome database, we sequenced 28 cytosolic GSTs and 4 microsomal GSTs from the migratory locust (Locusta migratoria). We assigned the 28 cytosolic GSTs into 6 classes-sigma, epsilon, delta, theta, omega and zeta, and the 4 microsomal GSTs into 2 subclasses-insect and MGST3. The tissue-and stage-expression patterns of the GSTs differed at the mRNA level. Further, the substrate specificities and kinetic constants of the cytosolic GSTs differed markedly at the protein level. The results of likelihood ratio tests provided strong evidence for positive selection in the delta class. The result of Bayes Empirical Bayes analysis identified 4 amino acid sites in the delta class as positive selection sites. These sites were located on the protein surface. Our findings will facilitate the elucidation of the molecular characteristics and evolutionary aspects of insect GST-superfamily.	[Zhang, Xueyao; Wang, Jianxin; Zhang, Min; Qin, Guohua; Li, Daqi; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Shanxi University; Kansas State University	Ma, EB (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China.	maenbo2003@sxu.edu.cn; zjz@sxu.edu.cn		Zhu, Kun Yan/0000-0001-9372-8030	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [31320103921]; National Natural Science Foundation of China [31101463, 31201545, 31201548]; Research Fund for the Doctoral Program of Higher Education of China [20111401120009, 20111401110006]; Shanxi Province Science Foundation for Youths [2012021027-1]	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Province Science Foundation for Youths	This research was supported by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (31320103921), the National Natural Science Foundation of China (Grant No. 31101463, 31201545, 31201548), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111401120009, 20111401110006). Shanxi Province Science Foundation for Youths (Grant No. 2012021027-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-13; Board PG, 2011, DRUG METAB REV, V43, P215, DOI 10.3109/03602532.2010.549132; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Espinoza HM, 2013, BIOCHEM PHARMACOL, V85, P839, DOI 10.1016/j.bcp.2012.11.018; Eswar N., 2001, CURRENT PROTOCOLS PR; Flanagan JU, 2011, DRUG METAB REV, V43, P194, DOI 10.3109/03602532.2011.560157; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Johansson K, 2010, FREE RADICAL BIO MED, V49, P1638, DOI 10.1016/j.freeradbiomed.2010.08.013; Kojima F, 2005, FUND CLIN PHARMACOL, V19, P255, DOI 10.1111/j.1472-8206.2005.00316.x; Lan T, 2013, J BIOL CHEM, V288, P24441, DOI 10.1074/jbc.M113.456863; Li XW, 2009, INSECT BIOCHEM MOLEC, V39, P745, DOI 10.1016/j.ibmb.2009.08.010; Mounsey KE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-43; Osorio DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-167; Qin GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058410; Qin GH, 2012, J INSECT PHYSIOL, V58, P220, DOI 10.1016/j.jinsphys.2011.10.011; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ren HL, 2009, DEV COMP IMMUNOL, V33, P980, DOI 10.1016/j.dci.2009.04.003; Schroder O, 2003, BIOCHEM BIOPH RES CO, V312, P271, DOI 10.1016/j.bbrc.2003.10.115; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-39; Shi DS, 2007, PROTEIN SCI, V16, P1689, DOI 10.1110/ps.072919907; Siritantikorn A, 2007, BIOCHEM BIOPH RES CO, V355, P592, DOI 10.1016/j.bbrc.2007.02.018; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Yamada T, 2007, BIOCHEMISTRY-US, V46, P8414, DOI 10.1021/bi700605m; Yang YQ, 2009, HYPERTENSION, V54, P1360, DOI 10.1161/HYPERTENSIONAHA.109.139428; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yong ML, 2009, ARCH INSECT BIOCHEM, V71, P3, DOI 10.1002/arch.20254; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Yu XL, 2012, COMP BIOCHEM PHYS B, V161, P356, DOI 10.1016/j.cbpb.2011.12.009; Zhang XY, 2012, ARCH INSECT BIOCHEM, V80, P77, DOI 10.1002/arch.21025; Zhou HX, 1997, P NATL ACAD SCI USA, V94, P12372, DOI 10.1073/pnas.94.23.12372	36	8	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114776	10.1371/journal.pone.0114776	http://dx.doi.org/10.1371/journal.pone.0114776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486043	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600097
J	Fujie, Y; Fusaki, N; Katayama, T; Hamasaki, M; Soejima, Y; Soga, M; Ban, H; Hasegawa, M; Yamashita, S; Kimura, S; Suzuki, S; Matsuzawa, T; Akari, H; Era, T				Fujie, Yasumitsu; Fusaki, Noemi; Katayama, Tomohiko; Hamasaki, Makoto; Soejima, Yumi; Soga, Minami; Ban, Hiroshi; Hasegawa, Mamoru; Yamashita, Satoshi; Kimura, Shigemi; Suzuki, Saori; Matsuzawa, Tetsuro; Akari, Hirofumi; Era, Takumi			New Type of Sendai Virus Vector Provides Transgene-Free iPS Cells Derived from Chimpanzee Blood	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; EFFICIENT; FIBROBLASTS; MOUSE; DERIVATION; INDUCTION; EVOLUTION; PATTERNS; PRIMATES	Induced pluripotent stem cells (iPSCs) are potentially valuable cell sources for disease models and future therapeutic applications; however, inefficient generation and the presence of integrated transgenes remain as problems limiting their current use. Here, we developed a new Sendai virus vector, TS12KOS, which has improved efficiency, does not integrate into the cellular DNA, and can be easily eliminated. TS12KOS carries KLF4, OCT3/4, and SOX2 in a single vector and can easily generate iPSCs from human blood cells. Using TS12KOS, we established iPSC lines from chimpanzee blood, and used DNA array analysis to show that the global gene-expression pattern of chimpanzee iPSCs is similar to those of human embryonic stem cell and iPSC lines. These results demonstrated that our new vector is useful for generating iPSCs from the blood cells of both human and chimpanzee. In addition, the chimpanzee iPSCs are expected to facilitate unique studies into human physiology and disease.	[Fujie, Yasumitsu; Katayama, Tomohiko; Hamasaki, Makoto; Soejima, Yumi; Soga, Minami; Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, Kumamoto 8600811, Japan; [Fusaki, Noemi; Ban, Hiroshi; Hasegawa, Mamoru] DNAVEC Corp, Tsukuba, Ibaraki 3002611, Japan; [Fusaki, Noemi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Yamashita, Satoshi] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, Kumamoto 8608556, Japan; [Kimura, Shigemi] Kumamoto Univ, Grad Sch Med Sci, Dept Child Dev, Chuo Ku, Kumamoto 8608556, Japan; [Suzuki, Saori; Akari, Hirofumi] Kyoto Univ, Primate Res Inst, Ctr Human Evolut Modeling Res, Sect Comparat Microbiol & Immunol, Inuyama, Aichi 4848506, Japan; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Inuyama, Aichi 4848506, Japan; [Akari, Hirofumi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Lab Evolut Virol, Kyoto 6068507, Japan	Kumamoto University; DNAVEC Corporation; Japan Science & Technology Agency (JST); Kumamoto University; Kumamoto University; Kyoto University; Kyoto University; Kyoto University	Era, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	tera@kumamoto-u.ac.jp	Fusaki, Noemi/U-1628-2019; AKARI, Hirofumi/AGR-4616-2022; Hamasaki, Makoto/AAO-2229-2020; Matsuzawa, Tetsuro/ABE-9654-2021	Matsuzawa, Tetsuro/0000-0002-8147-2725; Akari, Hirofumi/0000-0003-2166-6015; Yamashita, Satoshi/0000-0001-9315-3492	Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST), Japan Science and Project of the Primate Research Institute, Kyoto University; DNAVEC Corporation; JST grant (PRESTO); Grants-in-Aid for Scientific Research [24615005] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST), Japan Science and Project of the Primate Research Institute, Kyoto University; DNAVEC Corporation; JST grant (PRESTO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO), and Core Research for Evolutional Science and Technology (CREST), Japan Science and Project of the Primate Research Institute, Kyoto University. DNAVEC Corporation provided support in the form of salaries for authors MH & HB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NF was provided with salary by JST grant (PRESTO). The specific roles of these authors are articulated in the 'author contributions' section.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Fusaki N BH, 2014, INDUCTION HUMAN PLUR, P171; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzalez JP, 2013, CURR TOP MICROBIOL, V365, P337, DOI 10.1007/82_2012_304; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Hankowski KE, 2011, LAB INVEST, V91, P972, DOI 10.1038/labinvest.2011.85; Kitagawa M, 2012, J BIOL CHEM, V287, P27983, DOI 10.1074/jbc.M112.350074; Langerak AW, 1999, LEUKEMIA, V13, P965, DOI 10.1038/sj.leu.2401427; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mubiru JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094522; Nagai Y, 2011, BIOLOGY OF PARAMYXOVIRUSES, P115; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; REARDEN A, 1986, J IMMUNOL, V136, P2504; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sasaki K, 2005, GENE THER, V12, P203, DOI 10.1038/sj.gt.3302409; Sawatzki HK, 2007, HUM MUTAT, V28, P99, DOI 10.1002/humu.20420; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	40	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113052	10.1371/journal.pone.0113052	http://dx.doi.org/10.1371/journal.pone.0113052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479600	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200014
J	Li, QL; Pratt, CH; Dionne, LA; Fairfield, H; Karst, SY; Sundberg, JP; Uitto, J				Li, Qiaoli; Pratt, C. Herbert; Dionne, Louise A.; Fairfield, Heather; Karst, Son Yong; Sundberg, John P.; Uitto, Jouni			Spontaneous asj-2J Mutant Mouse as a Model for Generalized Arterial Calcification of Infancy: A Large Deletion/Insertion Mutation in the Enpp1 Gene	PLOS ONE			English	Article							CONNECTIVE-TISSUE MINERALIZATION; PSEUDOXANTHOMA ELASTICUM; VASCULAR CALCIFICATION; ECTOPIC MINERALIZATION; MICE; PYROPHOSPHATE; LESSONS; PLASMA	Generalized arterial calcification of infancy (GACI), an autosomal recessive disorder caused by mutations in the ENPP1 gene, manifests with extensive mineralization of the cardiovascular system. The affected individuals in most cases die within the first year of life, and there is currently no effective treatment for this disorder. In this study, we characterized a spontaneous mutant mouse, asj-2J, as a model for GACI. These mice were identified as part of a phenotypic deviant search in a large-scale production colony of BALB/cJ mice at The Jackson Laboratory. They demonstrated a characteristic gait due to stiffening of the joints, with phenotypic similarity to a previously characterized asj ("ages with stiffened joints'') mouse, caused by a missense mutation in the Enpp1 gene. Complementation testing indicated that asj-2J and asj were allelic. PCR-based mutation detection strategy revealed in asj-2J mice a large, 40,035 bp, deletion spanning from intron 1 to the 3 '-untranslated region of the Enpp1 gene, coupled with a 74 bp insertion. This was accompanied with a significant reduction in the plasma PPi concentration and reduced PPi/P-i ratio. As a consequence, extensive aberrant mineralization affecting the arterial vasculature, a number of internal organs, and the dermal sheath of vibrissae, a progressive biomarker of the ectopic mineralization process, was demonstrated by a combination of micro computed tomography, histopathology with calcium-specific stains, and direct chemical assay of calcium. Comparison of the asj and asj-2J mice demonstrated that the latter ones, particularly when placed on an acceleration diet high in phosphate and low in magnesium, had more extensive mineralization. Thus, the asj-2J mouse serves as a novel model for GACI, a currently intractable disorder.	[Li, Qiaoli; Uitto, Jouni] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Pratt, C. Herbert; Dionne, Louise A.; Fairfield, Heather; Karst, Son Yong; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Jefferson University; Jackson Laboratory	Uitto, J (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.	Jouni.Uitto@jefferson.edu		Li, Qiaoli/0000-0002-8495-7103; Pratt, Herb/0000-0002-4964-8292	National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01 AR064766, R21 AR063781, R01 AR28450]; NIH/National Center for Research Resources/Office of Research Infrastructure Programs [OK010972-35, OD011163-02, RR001183, RR032339]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063781, R01AR028450, K01AR064766] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972, R21OD011163] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Center for Research Resources/Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants K01 AR064766 (to QL), R21 AR063781 (to JPS), and R01 AR28450 (to JU). This work was also supported by NIH/National Center for Research Resources/Office of Research Infrastructure Programs grants OK010972-35, OD011163-02, RR001183, and RR032339 (The Jackson Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apschner A, 2014, DIS MODEL MECH, V7, P811, DOI 10.1242/dmm.015693; Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Berndt A, 2013, J INVEST DERMATOL, V133, P833, DOI 10.1038/jid.2012.340; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Edouard T, 2011, EUR J PEDIATR, V170, P1585, DOI 10.1007/s00431-011-1572-9; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jiang QJ, 2012, EXP DERMATOL, V21, P694, DOI 10.1111/j.1600-0625.2012.01553.x; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Le Corre Y, 2012, AM J PATHOL, V180, P2208, DOI 10.1016/j.ajpath.2012.02.007; Li QL, 2008, J INVEST DERMATOL, V128, P1160, DOI 10.1038/sj.jid.5701145; Li QL, 2014, CELL CYCLE, V13, P2609, DOI 10.4161/15384101.2014.943567; Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Li QL, 2013, AM J PATHOL, V183, P10, DOI 10.1016/j.ajpath.2013.03.002; Li QL, 2010, J MOL MED, V88, P173, DOI 10.1007/s00109-009-0522-8; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Mackenzie NCW, 2012, BONE, V51, P961, DOI 10.1016/j.bone.2012.07.014; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Nitschke Yvonne, 2012, Frontiers in Genetics, V3, P302, DOI 10.3389/fgene.2012.00302; Nitschke Y, 2012, TRENDS CARDIOVAS MED, V22, P145, DOI 10.1016/j.tcm.2012.07.011; O'Neill WC, 2010, NEPHROL DIAL TRANSPL, V25, P187, DOI 10.1093/ndt/gfp362; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Otero JE, 2013, J BONE MINER RES, V28, P419, DOI 10.1002/jbmr.1752; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2011, CIRC RES, V109, P578, DOI 10.1161/CIRCRESAHA.111.247965; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Silva K, 2012, LAB MOUSE, P779; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Takabayashi S, 2014, EXP ANIM TOKYO, V63, P193, DOI 10.1538/expanim.63.193; Tolouian R, 2012, CLIN LAB, V58, P1129, DOI 10.7754/Clin.Lab.2012.111101; Zaka R, 2006, CURR OPIN RHEUMATOL, V18, P181, DOI 10.1097/01.bor.0000209432.36355.6e	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113542	10.1371/journal.pone.0113542	http://dx.doi.org/10.1371/journal.pone.0113542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479107	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200023
J	Runge, CE; Waller, M; MacKenzie, A; McGuire, ACL				Runge, Catherine E.; Waller, Michael; MacKenzie, Alison; McGuire, Annabel C. L.			Spouses of Military Members' Experiences and Insights: Qualitative Analysis of Responses to an Open-Ended Question in a Survey of Health and Wellbeing	PLOS ONE			English	Article							DEPLOYMENT; WIVES; FAMILY; IMPACT; SEPARATION; DEMANDS; WARTIME; STRESS; ARMY; US	Introduction: There are few studies on the experiences of spouses of military members, with most focused on adverse impacts of deployment. Responses to an open-ended question in a survey of spouses' health and wellbeing enabled access to perceptions and insights on a broad range of topics. The objective of this investigation was to examine how respondents used the open-ended question and what they discussed, in aim of informing support service agencies and spouses of military members. Methods: Thematic analysis was conducted on responses to the open-ended question. Descriptive analysis was performed on the demographics, military member characteristics and self-reported health of respondents and non-respondents to the open-ended question. Findings: Over a quarter (28.5%) of the 1,332 survey participants answered the open-ended question, with respondents having a significantly higher level of education than non-respondents. Respondents expressed negative and positive experiences and insights on military life, provided personal information, commented on the survey, and qualified their responses to closed-ended questions. Topics included 'inadequate support', 'deployment impacts', 'suggestions for supporting agencies', 'appraisal of experiences' and 'coping strategies'. Conclusions: This investigation uncovered issues of importance to spouses of military members that were not included or identified in a quantitative study. The findings provide a platform from which to explore these issues further, particularly the impact of military life on the non-serving spouse's career. The findings also provide support agencies with evidence to strengthen their services and they give spouses an opportunity to reflect on their own and others' feelings and evaluations of military life.	[Runge, Catherine E.; Waller, Michael; MacKenzie, Alison; McGuire, Annabel C. L.] Univ Queensland, Sch Populat Hlth, Ctr Australian Mil & Vet Hlth, Brisbane, Qld 4072, Australia	University of Queensland	Runge, CE (corresponding author), Univ Queensland, Sch Populat Hlth, Ctr Australian Mil & Vet Hlth, Brisbane, Qld 4072, Australia.	c.runge@uq.edu.au	Waller, Michael/R-6231-2016; Bell, Alison/D-2476-2019	Waller, Michael/0000-0002-1050-4574; Bell, Alison/0000-0002-0624-4685; Runge, Catherine/0000-0002-8888-0449	Australian Government Department of Veterans' Affairs; School of Population Health, The University of Queensland	Australian Government Department of Veterans' Affairs(US Department of Veterans Affairs); School of Population Health, The University of Queensland	The Timor-Leste Family Study was funded by the Australian Government Department of Veterans' Affairs (www.dva.gov.au). Financial support for this particular investigation derived from the Timor-Leste Family Study dataset was provided by the School of Population Health, The University of Queensland. The Australian Government Department of Veterans' Affairs had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript for this particular investigation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aducci CJ, 2011, J FEM FAM THER, V23, P231, DOI 10.1080/08952833.2011.604526; Andres M, 2010, FAMILY LINES LONGITU; Aronson J., 1994, PRAGMATIC VIEW THEMA; Atkins S, 2009, PICTURE AUSTR DEFENC; Bourg C, 1999, ARMED FORCES SOC, V25, P633, DOI 10.1177/0095327X9902500406; Burdett H, 2011, MIL MED, V176, P620, DOI 10.7205/MILMED-D-10-00474; Burrell LM, 2006, ARMED FORCES SOC, V33, P43, DOI 10.1177/0002764206288804; Castaneda LW, 2008, ARMED FORCES SOC, V34, P389, DOI 10.1177/0095327X07307194; Davis J, 2011, J MARITAL FAM THER, V37, P51, DOI 10.1111/j.1752-0606.2009.00154.x; de Burgh HT, 2011, INT REV PSYCHIATR, V23, P192, DOI 10.3109/09540261.2011.560144; Defence Community Organisation, 2014, WHAT WE DO; Entwistle VA, 2011, PATIENT EDUC COUNS, V85, pE291, DOI 10.1016/j.pec.2011.05.014; Faber AJ, 2008, J FAM PSYCHOL, V22, P222, DOI 10.1037/0893-3200.22.2.222; Garcia J, 2004, QUAL QUANT, V38, P113, DOI 10.1023/B:QUQU.0000019394.78970.df; KLEIN HA, 1989, J PSYCHOL, V123, P465, DOI 10.1080/00223980.1989.10543000; Lapp CA, 2010, J FAM NURS, V16, P45, DOI 10.1177/1074840709357347; Leleu TD, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-136; LEWICKA M, 1992, EUR J SOC PSYCHOL, V22, P425, DOI 10.1002/ejsp.2420220502; McGuire A., 2012, TIMOR LESTE FAMILY S; Merolla AJ, 2010, J APPL COMMUN RES, V38, P4, DOI 10.1080/00909880903483557; O'Cathain Alicia, 2004, BMC Med Res Methodol, V4, P25, DOI 10.1186/1471-2288-4-25; Orthner DK, 2009, FAM RELAT, V58, P392, DOI 10.1111/j.1741-3729.2009.00561.x; Padden DL, 2011, WESTERN J NURS RES, V33, P247, DOI 10.1177/0193945910371319; Poncheri RM, 2008, ORGAN RES METHODS, V11, P614, DOI 10.1177/1094428106295504; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rich JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068832; SEGAL MW, 1986, ARMED FORCES SOC, V13, P9, DOI 10.1177/0095327X8601300101; Siebler P, 2003, 1 DSPPR DEP DEF; Wheeler AR, 2009, DISS ABSTR INT A, V70, P2257	29	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114755	10.1371/journal.pone.0114755	http://dx.doi.org/10.1371/journal.pone.0114755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25479135	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200125
J	Wright, FL; Gamboni, F; Moore, EE; Nydam, TL; Mitra, S; Silliman, CC; Banerjee, A				Wright, Franklin L.; Gamboni, Fabia; Moore, Ernest E.; Nydam, Trevor L.; Mitra, Sanchayita; Silliman, Christopher C.; Banerjee, Anirban			Hyperosmolarity Invokes Distinct Anti-Inflammatory Mechanisms in Pulmonary Epithelial Cells: Evidence from Signaling and Transcription Layers	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; HYPERTONIC SALINE RESUSCITATION; ALVEOLAR MACROPHAGE ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; HEMORRHAGIC-SHOCK; ENDOTHELIAL-CELLS; TNF-ALPHA; CYSTIC-FIBROSIS; EXPRESSION	Hypertonic saline (HTS) has been used intravenously to reduce organ dysfunction following injury and as an inhaled therapy for cystic fibrosis lung disease. The role and mechanism of HTS inhibition was explored in the TNF alpha and IL-1 beta stimulation of pulmonary epithelial cells. Hyperosmolar (HOsm) media (400 mOsm) inhibited the production of select cytokines stimulated by TNF alpha and IL-1 beta at the level of mRNA translation, synthesis and release. In TNF alpha stimulated A549 cells, HOsm media inhibited I-kappa B alpha phosphorylation, NF-kappa B translocation into the nucleus and NF-kappa B nuclear binding. In IL-1 beta stimulated cells HOsm inhibited I-kappa B alpha phosphorylation without affecting NF-kappa B translocation or nuclear binding. Incubation in HOsm conditions inhibited both TNF alpha and IL-1 beta stimulated nuclear localization of interferon response factor 1 (IRF-1). Additional transcription factors such as AP-1, Erk-1/2, JNK and STAT-1 were unaffected by HOsm. HTS and sorbitol supplemented media produced comparable outcomes in all experiments, indicating that the effects of HTS were mediated by osmolarity, not by sodium. While not affecting MAPK modules discernibly in A549 cells, both HOsm conditions inhibit IRF-1 against TNF alpha or IL-1 beta, but inhibit p65 NF-kappa B translocation only against TNF alpha but not IL-1 beta. Thus, anti-inflammatory mechanisms of HTS/HOsm appear to disrupt cytokine signals at distinct intracellular steps.	[Wright, Franklin L.; Gamboni, Fabia; Nydam, Trevor L.; Mitra, Sanchayita; Banerjee, Anirban] Univ Colorado Denver, Dept Surg, Trauma Res Ctr, Aurora, CO 80045 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Silliman, Christopher C.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Banerjee, A (corresponding author), Univ Colorado Denver, Dept Surg, Trauma Res Ctr, Aurora, CO 80045 USA.	Anirban.Banerjee@ucdenver.edu		Wright, Franklin/0000-0002-4433-5385	National Institute of General Medical Sciences of the National Institutes of Health [P50 GM049222, T32 GM008315]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM049222, T32GM008315] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by National Institute of General Medical Sciences of the National Institutes of Health under Award Number P50 GM049222 and T32 GM008315. The content is solely the responsibility of the authors and does not necessarily represent the office views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Ananko EA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-56; Banerjee A, 2013, SHOCK, V39, P366, DOI 10.1097/SHK.0b013e3182894016; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Ciesla DJ, 2001, SURGERY, V129, P567, DOI 10.1067/msy.2001.113286; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Cuschieri J, 2002, J IMMUNOL, V168, P1389, DOI 10.4049/jimmunol.168.3.1389; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; Eckels PC, 2009, AM J PHYSL CELL PHYS; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Gundersen Y, 2010, SHOCK, V34, P450, DOI 10.1097/SHK.0b013e3181e68649; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; Henriquet C, 2007, LUNG CANCER, V56, P167, DOI 10.1016/j.lungcan.2006.12.003; Jarrar D, 2002, AM J PHYSIOL-LUNG C, V283, pL799, DOI 10.1152/ajplung.00465.2001; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Levitt JE, 2009, J INTENSIVE CARE MED; Li W, 2007, PEPTIDES, V28, P1252, DOI 10.1016/j.peptides.2007.03.021; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; Matthay Michael A, 2008, Proc Am Thorac Soc, V5, P297, DOI 10.1513/pats.200708-141DR; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Ochi H, 2002, EUR J IMMUNOL, V32, P1821, DOI 10.1002/1521-4141(200207)32:7<1821::AID-IMMU1821>3.0.CO;2-A; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Powers KA, 2005, SURGERY, V137, P66, DOI 10.1016/j.surg.2004.05.051; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Sato H, 2008, MED SCI MONITOR, V14, pBR79; Shapiro L, 1997, EXP CELL RES, V231, P354, DOI 10.1006/excr.1997.3476; Shukla A, 2004, SHOCK, V21, P391, DOI 10.1097/00024382-200405000-00001; Shultz DB, 2009, J INTERF CYTOK RES, V29, P817, DOI 10.1089/jir.2009.0034; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Tarran R, 2007, SEMIN RESP CRIT CARE, V28, P295, DOI 10.1055/s-2007-981650; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Werner T, 2003, FASEB J, V17, P1228, DOI 10.1096/fj.02-0955rev; Wohlauer M, 2012, CRIT CARE MED, V40, P2647, DOI 10.1097/CCM.0b013e3182592006; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Ziegler Elizabeth C, 2005, Sci STKE, V2005, pre6, DOI 10.1126/stke.2842005re6	52	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114129	10.1371/journal.pone.0114129	http://dx.doi.org/10.1371/journal.pone.0114129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479425	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907200045
J	Cao, YB; Xiao, GL; Qiu, XB; Ye, S; Lin, TY				Cao, Yabing; Xiao, Guangli; Qiu, Xibin; Ye, Sheng; Lin, Tongyu			Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; EML4-ALK FUSION GENE; INHIBITOR	Introduction: We report the efficacy and safety of crizotinib treatment among Chinese patients with advanced-stage NSCLC. Methods: We retrospectively analyzed patients with EML4-ALK positive advanced NSCLC who were treated with crizotinib from May 2012 to Aug 2013. Baseline clinical parameters, treatment protocol, response to therapy and survival were noted. The primary goal was to evaluate the efficacy of crizotinib in patients who were previously treated patients or who had poor ECOG performance status (PS). Results: Forty patients were evaluable for safety and efficacy. Median age was 43 years, 100% had adenocarcinoma and stage IV disease, and 42.5% were female. Six patients received frontline treatment with crizotinib, 17 patients had 1 prior treatment, and 17 patients had more than 2 lines of prior treatment. Patients received a median of 5 cycles of treatment (range 1-15 cycles). After the first cycle, 92.5% (37/40) patients archived partial remission (PR). At the end of the follow-up period, the overall PR rate was 70% (28/40), and progression of disease (PD) occurred in 30% of patients (12/40). The median PFS was 28 weeks (95% CI 15.4 to 40.5 weeks), and median OS was 40 weeks (95% CI 38.6 to 49.3 weeks). The most frequent treatment-related AEs were vomiting (47.5%), vision disorder (27.5%) and increased ALT/AST (42%); most toxicities were Grade 1/2. Observed treatment-related Grade 3/4 AEs included increased ALT/AST (10%) and vomiting (5%). The EML4-ALK fusion rate and number of prior chemotherapy cycles did not appear to significantly affect the efficacy of crizotinib. However, PS 0-2 patients had improved PFS (50 weeks vs. 24 weeks, p=0.015). Conclusions: Crizotinib was safe, well-tolerated, and effective in Chinese patients with pre-treated ALK-rearranged NSCLC. QOL was improved and PS appears to have an effect on the efficacy of crizotinib, but prior treatment and ALK fusion rate do not.	[Cao, Yabing; Xiao, Guangli; Qiu, Xibin] Kiang Wu Hosp, Dept Oncol, Macau 999999, Peoples R China; [Ye, Sheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510080, Guangdong, Peoples R China; [Lin, Tongyu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol Southern China, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Cao, YB (corresponding author), Kiang Wu Hosp, Dept Oncol, Estr Repouso, Macau 999999, Peoples R China.	sumscaoyabing@hotmail.com	Cao, Yabing/X-1168-2018					Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Liu Biao, 2012, Chinese Journal of Pathology, V41, P505, DOI 10.3760/cma.j.issn.0529-5807.2012.08.001; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945	10	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114008	10.1371/journal.pone.0114008	http://dx.doi.org/10.1371/journal.pone.0114008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501361	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400021
J	Eipeldauer, S; Thomas, A; Hoechtl-Lee, L; Kecht, M; Binder, H; Koettstorfer, J; Gregori, M; Sarahrudi, K				Eipeldauer, Stefan; Thomas, Anita; Hoechtl-Lee, Leonard; Kecht, Mathias; Binder, Harald; Koettstorfer, Julia; Gregori, Markus; Sarahrudi, Kambiz			Is Sonic Hedgehog Involved in Human Fracture Healing? - A Prospective Study on Local and Systemic Concentrations of SHH	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DIFFERENTIATION; OSTEOGENESIS; TGF-BETA-1; EXPRESSION; GENES; MODEL	Introduction: Sonic Hedgehog (SHH) is a new signalling pathway in bone repair. Evidence exist that SHH pathway plays a significant role in vasculogenesis and limb development during embryogenesis. Some in vitro and animal studies has already proven its potential for bone regeneration. However, no data on the role of SHH in the human fracture healing have been published so far. Methods: Seventy-five patients with long bone fractures were included into the study and divided in 2 groups. First group contained 69 patients with normal fracture healing. Four patients with impaired fracture healing formed the second group. 34 volunteers donated blood samples as control. Serum samples were collected over a period of 1 year following a standardized time schedule. In addition, SHH levels were measured in fracture haematoma and serum of 16 patients with bone fractures. Results: Fracture haematoma and patients serum both contained lower SHH concentrations compared to control serum. The comparison between the patients' serum SHH level and the control serum revealed lower levels for the patients at all measurement time points. Significantly lower concentrations were observed at weeks 1 and 2 after fracture. SHH levels were slightly decreased in patients with impaired fracture healing without statistical significance. Conclusion: This is the first study to report local and systemic concentration of SHH in human fracture healing and SHH serum levels in healthy adults. A significant reduction of the SHH levels during the inflammatory phase of fracture healing was found. SHH concentrations in fracture haematoma and serum were lower than the concentration in control serum for the rest of the healing period. Our findings indicate that there is no relevant involvement of SHH in human fracture healing. Fracture repair process seem to reduce the SHH level in human. Further studies are definitely needed to clarify the underlying mechanisms.	[Eipeldauer, Stefan; Hoechtl-Lee, Leonard; Kecht, Mathias; Binder, Harald; Koettstorfer, Julia; Gregori, Markus; Sarahrudi, Kambiz] Med Univ Vienna, Univ Clin Traumatol, Vienna, Austria; [Thomas, Anita] Med Univ Vienna, Dept Gender Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Sarahrudi, K (corresponding author), Med Univ Vienna, Univ Clin Traumatol, Vienna, Austria.	kambiz.sarahrudi@meduniwien.ac.at		Starlinger, Julia/0000-0001-7462-5730; Binder, Harald/0000-0002-9212-7214; Thomas, Anita/0000-0002-1679-3098				Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; BECK LS, 1993, J BONE MINER RES, V8, P753; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Dohle E, 2010, TISSUE ENG PT A, V16, P1235, DOI [10.1089/ten.tea.2009.0493, 10.1089/ten.TEA.2009.0493]; Dohle E, 2011, EUR CELLS MATER, V21, P144, DOI 10.22203/eCM.v021a12; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; GAZIT D, 1990, ENDOCRINOLOGY, V126, P2607, DOI 10.1210/endo-126-5-2607; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Horikiri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076785; Koyama E, 1996, DEV DYNAM, V207, P344, DOI 10.1002/(SICI)1097-0177(199611)207:3<344::AID-AJA11>3.0.CO;2-4; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691; Miyaji T, 2003, HISTOCHEM CELL BIOL, V119, P233, DOI 10.1007/s00418-003-0501-z; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Park SH, 2003, J ORTHOP TRAUMA, V17, P2, DOI 10.1097/00005131-200301000-00002; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Sarahrudi K, 2011, INJURY, V42, P833, DOI 10.1016/j.injury.2011.03.055; Sarahrudi K, 2010, J ORTHOP RES, V28, P671, DOI 10.1002/jor.21048; Sarahrudi K, 2009, J ORTHOP RES, V27, P1293, DOI 10.1002/jor.20906; Schmidmaier G, 2002, BONE, V31, P165, DOI 10.1016/S8756-3282(02)00798-6; Song K, 2011, INJURY, V42, P796, DOI 10.1016/j.injury.2011.02.003; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Tielinen L, 2002, BIOMATERIALS, V23, P3817, DOI 10.1016/S0142-9612(02)00105-9; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; Warzecha J, 2013, EXP THER MED, V5, P1035, DOI 10.3892/etm.2013.923; Watanabe Y, 1998, DEVELOPMENT, V125, P2631; Weiss S, 2002, J BONE MINER RES, V17, P1280, DOI 10.1359/jbmr.2002.17.7.1280; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114668	10.1371/journal.pone.0114668	http://dx.doi.org/10.1371/journal.pone.0114668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501422	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700042
J	Das, ML; Rowland, M; Austin, JW; De Lazzari, E; Picado, A				Das, Murari Lal; Rowland, Mark; Austin, James W.; De Lazzari, Elisa; Picado, Albert			Do Size and Insecticide Treatment Matter? Evaluation of Different Nets against Phlebotomus argentipes, the Vector of Visceral Leishmaniasis in Nepal	PLOS ONE			English	Article							DELTAMETHRIN-IMPREGNATED BEDNETS; BED-NETS; INDIAN SUBCONTINENT; DIPTERA PSYCHODIDAE; RANDOMIZED-TRIAL; ENDEMIC FOCI; ELIMINATION; SANDFLIES; BIHAR; BANGLADESH	In the Indian subcontinent, Leishmania donovani, the parasite causing visceral leishmaniasis (VL) is transmitted by the sand fly vector Phlebotomus argentipes. Long lasting insecticide treated nets (LN) have been postulated as alternative or complement to Indoor Residual Spraying but there are few field studies evaluating the entomological efficacy of different nets against this vector. We conducted two crossover trials in a VL endemic area in Nepal to compare the barrier effect of (1) LN with different mesh sizes (156 holes/inch(2) vs 625 holes/inch(2)) and (2) alpha-cypermethrin treated LN and untreated nets having the same mesh size (156 holes/inch(2)). Each crossover trial had two arms consisting of a sequence of two different nets for 8 nights. We used 10 cattle sheds per trial. A cow placed under the net was used as bait. CDC light traps placed inside the nets were used to evaluate the number of P. argentipes crossing the net barrier. Negative binomial generalized estimating equation (GEE) population-averaged models adjusted by night and sequence were used to estimate the barrier effect of the different nets. The crossover trials conducted in a rural village in Morang district (South-eastern Nepal) demonstrated that reducing the size of the holes in treated nets (625 holes/inch(2)) increased the barrier effect of LN by 77% (95% confidence interval (CI): 56%-88%) compared with treated nets with larger holes (156 holes/inch(2)). Treating nets with alpha-cypermethrin reduced the number of P. argentipes captured inside the nets by 77% (95% CI: 27%-93%) compared with untreated nets. The effectiveness and acceptability of finer mesh pyrethroid treated LN should be tested for VL prevention in a randomized controlled trial.	[Das, Murari Lal] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Rowland, Mark] London Sch Hyg & Trop Med, London WC1, England; [Austin, James W.] BASF Corp, Res Triangle Pk, NC USA; [De Lazzari, Elisa; Picado, Albert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain	B.P. Koirala Institute of Health Sciences; University of London; London School of Hygiene & Tropical Medicine; BASF; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Picado, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	albert.picado@cresib.cat	Das, Murari/AAK-9157-2021	De Lazzari, Elisa/0000-0003-2614-6545; Das, Murari/0000-0001-6816-2389; Picado, Albert/0000-0001-7344-628X	Royal Society of Tropical Medicine and Hygiene [46]	Royal Society of Tropical Medicine and Hygiene	This work was supported by the Royal Society of Tropical Medicine and Hygiene (Small Grants 2013 - Grant number 46) https://rstmh.org/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER B, 1995, MED VET ENTOMOL, V9, P279, DOI 10.1111/j.1365-2915.1995.tb00134.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Burniston I, 2010, J MED ENTOMOL, V47, P902, DOI 10.1603/ME09184; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; Dinesh DS, 2008, MED VET ENTOMOL, V22, P120, DOI 10.1111/j.1365-2915.2008.00724.x; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Garlapati RB, 2012, J MED ENTOMOL, V49, P515, DOI 10.1603/ME11115; Kasili S, 2010, J VECTOR DIS, V47, P1; LEWIS DJ, 1987, SYST ENTOMOL, V12, P163, DOI 10.1111/j.1365-3113.1987.tb00194.x; MAJORI G, 1989, MED VET ENTOMOL, V3, P441, DOI 10.1111/j.1365-2915.1989.tb00253.x; Maroli M, 1991, Parassitologia, V33 Suppl, P399; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; Mondal D, 2010, TROP MED INT HEALTH, V15, P1382, DOI 10.1111/j.1365-3156.2010.02635.x; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Palit A, 2005, INT J ENVIRON HEAL R, V15, P449, DOI 10.1080/09603120500392525; Picado A, 2012, INDIAN J MED RES, V136, P22; Picado A, 2012, T ROY SOC TROP MED H, V106, P150, DOI 10.1016/j.trstmh.2011.10.014; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2009, MEM I OSWALDO CRUZ, V104, P1183, DOI 10.1590/S0074-02762009000800018; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; Reed JF, 2004, ANN EMERG MED, V43, P54, DOI 10.1016/S0196-0644(03)00661-9; Senn S, 2002, CROSS OVER TRIALS CL; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P60, DOI 10.1111/j.1365-3156.2009.02433.x; WHOPES - WHO Pesticide Evaluation Scheme, 2012, 15 WHOPES WORK GROUP; World Health Organization, 2005, GUID LAB FIELD TEST	27	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114915	10.1371/journal.pone.0114915	http://dx.doi.org/10.1371/journal.pone.0114915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494099	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000346611400084
J	Krishnamoorthi, S; Perotti, LE; Borgstrom, NP; Ajijola, OA; Frid, A; Ponnaluri, AV; Weiss, JN; Qu, ZL; Klug, WS; Ennis, DB; Garfinkel, A				Krishnamoorthi, Shankarjee; Perotti, Luigi E.; Borgstrom, Nils P.; Ajijola, Olujimi A.; Frid, Anna; Ponnaluri, Aditya V.; Weiss, James N.; Qu, Zhilin; Klug, William S.; Ennis, Daniel B.; Garfinkel, Alan			Simulation Methods and Validation Criteria for Modeling Cardiac Ventricular Electrophysiology	PLOS ONE			English	Article							R-WAVE PROGRESSION; HISTOLOGICAL VALIDATION; CONDUCTION SYSTEM; RABBIT; HEART; FIBRILLATION; MECHANISM; MICROSTRUCTURE; HETEROGENEITY; VERIFICATION	We describe a sequence of methods to produce a partial differential equation model of the electrical activation of the ventricles. In our framework, we incorporate the anatomy and cardiac microstructure obtained from magnetic resonance imaging and diffusion tensor imaging of a New Zealand White rabbit, the Purkinje structure and the Purkinje-muscle junctions, and an electrophysiologically accurate model of the ventricular myocytes and tissue, which includes transmural and apex-to-base gradients of action potential characteristics. We solve the electrophysiology governing equations using the finite element method and compute both a 6-lead precordial electrocardiogram (ECG) and the activation wavefronts over time. We are particularly concerned with the validation of the various methods used in our model and, in this regard, propose a series of validation criteria that we consider essential. These include producing a physiologically accurate ECG, a correct ventricular activation sequence, and the inducibility of ventricular fibrillation. Among other components, we conclude that a Purkinje geometry with a high density of Purkinje muscle junctions covering the right and left ventricular endocardial surfaces as well as transmural and apex-to-base gradients in action potential characteristics are necessary to produce ECGs and time activation plots that agree with physiological observations.	[Krishnamoorthi, Shankarjee; Perotti, Luigi E.; Ponnaluri, Aditya V.; Klug, William S.] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA USA; [Borgstrom, Nils P.; Ennis, Daniel B.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Ajijola, Olujimi A.; Weiss, James N.; Qu, Zhilin; Garfinkel, Alan] Univ Calif Los Angeles, Dept Med Cardiol, Los Angeles, CA 90045 USA; [Frid, Anna; Garfinkel, Alan] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Ennis, Daniel B.] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Garfinkel, A (corresponding author), Univ Calif Los Angeles, Dept Med Cardiol, Los Angeles, CA 90045 USA.	AGarfinkel@mednet.ucla.edu		Krishnamoorthi, Shankarjee/0000-0002-7552-9000; Ennis, Daniel/0000-0001-7435-1311; Ajijola, Olujimi/0000-0001-6197-7593; Perotti, Luigi/0000-0002-9010-2144	National Institutes of Health (NIH) [P01 HL78931]; Amadeo Peter Giannini Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078931] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amadeo Peter Giannini Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health (NIH), (grant P01 HL78931; http://grants.nih.gov/grants/funding/funding_program.htm#PSeries) to JW ZQ AG; and the Amadeo Peter Giannini Foundation award (http://apgianninifoundation.org/) to OAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akthar M, 1983, PACING CLIN ELECTROP, V6, P1010; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Atkinson A, 2011, J MOL CELL CARDIOL, V51, P689, DOI 10.1016/j.yjmcc.2011.05.020; Berenfeld O, 1998, CIRC RES, V82, P1063, DOI 10.1161/01.RES.82.10.1063; Bernabeu MO, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P721, DOI 10.1109/CIC.2008.4749143; Bernabeu MO, 2009, PHILOS T R SOC A, V367, P1907, DOI 10.1098/rsta.2008.0309; Bishop MJ, 2013, AM J PHYSIOL-HEART C, V304, pH1240, DOI 10.1152/ajpheart.00894.2012; Bordas R, 2011, PROG BIOPHYS MOL BIO, V107, P90, DOI 10.1016/j.pbiomolbio.2011.05.002; Carusi A, 2012, AM J PHYSIOL-HEART C, V303, pH144, DOI 10.1152/ajpheart.01151.2011; CHEN PS, 1988, CIRC RES, V62, P1191, DOI 10.1161/01.RES.62.6.1191; Committee on Mathematical Foundations of Verification Validation and Uncertainty Quantification Board on Mathematical Sciences and Their Applications Division on Engineering and Physical Sciences National Research Council, 2012, ASS REL COMPL MOD MA; Cooper LL, 2012, AM J PHYSIOL-HEART C, V302, pH1625, DOI 10.1152/ajpheart.00960.2011; Corrias A, 2011, AM J PHYSIOL-HEART C, V300, pH1806, DOI 10.1152/ajpheart.01170.2010; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; FEDIDA D, 1991, J PHYSIOL-LONDON, V442, P191, DOI 10.1113/jphysiol.1991.sp018789; Gahm J, 2011, P INT SOC MAGN RES M, V3894; Gahm JK, 2012, LECT NOTES COMPUT SC, V7511, P494, DOI 10.1007/978-3-642-33418-4_61; Gahm JK, 2013, I S BIOMED IMAGING, P504; Gahm JK, 2014, STAT ATLASES COMPUTA, P135; Goktepe S, 2010, ARCH APPL MECH, V80, P569, DOI 10.1007/s00419-009-0384-0; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Holden A, 1997, COMPUTATIONAL BIOL H; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075; Idriss SF, 2004, J CARDIOVASC ELECTR, V15, P795, DOI 10.1046/j.1540-8167.2004.03622.x; Keener J, 2010, MATH PHYSL 1 CELLULA, V1; Keller DUJ, 2012, IEEE T BIO-MED ENG, V59, P311, DOI 10.1109/TBME.2011.2168397; Kindlmann G, 2007, LECT NOTES COMPUT SC, V4791, P1; Krishnamoorthi S, 2013, THESIS U CALIFORNIA; Krishnamoorthi S, 2013, INT J NUMER METH BIO, V29, P1243, DOI 10.1002/cnm.2573; Kung GL, 2011, J MAGN RESON IMAGING, V34, P1080, DOI 10.1002/jmri.22725; Kwon OI, 2014, PHYS MED BIOL, V59, P2955, DOI 10.1088/0031-9155/59/12/2955; Lines G. T., 2003, Computing and Visualization in Science, V5, P195, DOI 10.1007/s00791-003-0100-5; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Mantravadi R, 2007, CIRC RES, V100, pE72, DOI 10.1161/01.RES.0000264101.06417.33; Niederer SA, 2011, PHILOS T R SOC A, V369, P4331, DOI 10.1098/rsta.2011.0139; Okada J, 2011, AM J PHYSIOL-HEART C, V301, pH200, DOI 10.1152/ajpheart.01241.2010; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Pathmanathan P, 2014, INT J NUMER METH BIO, V30, P525, DOI 10.1002/cnm.2615; Pathmanathan P, 2010, PROG BIOPHYS MOL BIO, V102, P136, DOI 10.1016/j.pbiomolbio.2010.05.006; Rajasekhar S, 1996, P 18 ANN INT C IEEE, V3, P1288; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Squillacote AH, 2007, PARAVIEW GUIDE, V366; Sundnes J, 2007, COMPUTING ELECT ACTI, V1; SURAWICZ B, 1955, CIRCULATION, V12, P391, DOI 10.1161/01.CIR.12.3.391; Taubin G, 1996, COMPUTER VISION ECCV; Ten Tusscher KHWJ, 2008, PROG BIOPHYS MOL BIO, V96, P152, DOI 10.1016/j.pbiomolbio.2007.07.026; Vadakkumpadan F, 2009, J ELECTROCARDIOL, V42; Wiggers CJ, 1940, AM HEART J, V20, P399, DOI 10.1016/S0002-8703(40)90874-2; Xie FG, 2004, J CLIN INVEST, V113, P686, DOI 10.1172/JCI200417341; ZEMA MJ, 1979, J ELECTROCARDIOL, V12, P3, DOI 10.1016/S0022-0736(79)80038-2; ZEMA MJ, 1982, ARCH INTERN MED, V142, P1145, DOI 10.1001/archinte.142.6.1145	53	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114494	10.1371/journal.pone.0114494	http://dx.doi.org/10.1371/journal.pone.0114494			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493967	Green Published, gold			2022-12-27	WOS:000346611400048
J	Kuroda, S; Kubota, T; Aoyama, K; Kikuchi, S; Tazawa, H; Nishizaki, M; Kagawa, S; Fujiwara, T				Kuroda, Shinji; Kubota, Tetsushi; Aoyama, Katsuyuki; Kikuchi, Satoru; Tazawa, Hiroshi; Nishizaki, Masahiko; Kagawa, Shunsuke; Fujiwara, Toshiyoshi			Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model	PLOS ONE			English	Article							EXPRESSION; METASTASES; CARCINOMA; INVASION	Orthotopic models of various types of tumors are widely used in anti-tumor therapeutic experiments in preclinical studies. However, there are few ways to appropriately monitor therapeutic effect in orthotopic tumor models, especially for tumors invisible from the outside. In this study we aimed to establish a non-invasive semi-quantitative bioluminescent imaging method of monitoring an orthotopic esophageal cancer mouse model. We confirmed that the TE8 esophageal cancer cell line implanted orthotopically into the abdominal esophagus of nu/nu mice (n=5) developed not only a main tumor at the implanted site, but also local lymph node metastases and peritoneal disseminations within 6 weeks after inoculation. We established a TE8 cell line that stably expressed the firefly luciferase gene (TE8-Luc). We showed that TE8-Luc cells implanted subcutaneously into nu/nu mice (n=5) grew over time until 5 weeks after inoculation. Tumor volume was strongly correlated with luminescent intensity emitted from the tumor, which was quantified using the IVIS imaging system. We then showed that TE8-Luc cells implanted orthotopically into the mouse abdominal esophagus (n=8) also formed a tumor and that the luminescent intensity of such a tumor, as detected by IVIS, increased over time until 7 weeks after inoculation and was therefore likely to reflect tumor progression. We therefore propose that this orthotopic esophageal cancer model, monitored using the non-invasive semi-quantitative IVIS imaging system, will be useful for in vivo therapeutic experiments against esophageal cancer. This experimental setting is expected to contribute to the development of novel therapeutic technologies for esophageal cancer in preclinical studies.	[Kuroda, Shinji; Kubota, Tetsushi; Aoyama, Katsuyuki; Kikuchi, Satoru; Nishizaki, Masahiko; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan	Okayama University; Okayama University	Kuroda, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan.	shinkuro@okayama-u.ac.jp	Kagawa, Shunsuke/B-2189-2011; TAZAWA, Hiroshi/B-2247-2011	TAZAWA, Hiroshi/0000-0003-4658-1050; Kagawa, Shunsuke/0000-0002-3610-8211; Kikuchi, Satoru/0000-0002-7671-0696	Ministry of Education, Culture, Sports and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports and Technology, Japan (TF) and Grants from the Ministry of Health, Labour and Welfare, Japan (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Chishima T, 1997, CANCER RES, V57, P2042; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Furihata T, 2001, INT J ONCOL, V19, P903; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Gros SJ, 2010, INT J CANCER, V126, P2671, DOI 10.1002/ijc.24980; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kawamata H, 2003, CANCER SCI, V94, P699, DOI 10.1111/j.1349-7006.2003.tb01505.x; Kuroda S, 2010, CANCER RES, V70, P9339, DOI 10.1158/0008-5472.CAN-10-2333; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Ohara T, 2010, CANCER LETT, V293, P207, DOI 10.1016/j.canlet.2010.01.017; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Quatromoni JG, 2014, J IMMUNOTHER, V37, P283, DOI 10.1097/CJI.0000000000000038; Sakaeda T, 2009, ADV DRUG DELIVER REV, V61, P388, DOI 10.1016/j.addr.2008.10.005; Samkoe KS, 2010, INT J RADIAT ONCOL, V76, P251, DOI 10.1016/j.ijrobp.2009.08.041; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Tuli R, 2012, TRANSL ONCOL, V5, P77, DOI 10.1593/tlo.11316; Zhao S, 1999, EUR J NUCL MED, V26, P231, DOI 10.1007/s002590050382	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114562	10.1371/journal.pone.0114562	http://dx.doi.org/10.1371/journal.pone.0114562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493557	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400053
J	Shafique, RH; Klimov, PB; Inam, M; Chaudhary, FR; OConnor, BM				Shafique, Rubaba Hamid; Klimov, Pavel B.; Inam, Muhammad; Chaudhary, Farhana Riaz; OConnor, Barry M.			Group 1 Allergen Genes in Two Species of House Dust Mites, Dermatophagoides farinae and D-pteronyssinus (Acari: Pyroglyphidae): Direct Sequencing, Characterization and Polymorphism	PLOS ONE			English	Article							DER-P-I; MAJOR ALLERGEN; IGE ANTIBODIES; F-I; SPECIFICITY; DER-P-1; BINDING; QUANTIFICATION; EXPRESSION; TASSER	Group 1 allergens of Dermatophagoides farinae (Der f 1) and D. pteronyssinus (Der p 1) dominate overall allergic responses in house dust mite allergy patients. The need for accurate identification and characterization of representative variants of group 1 allergens in any given geographic locality has been emphasized for development of appropriate allergen extracts. Regional amino acid sequence polymorphism has been described but the extent of this polymorphism is not well understood. Such data are completely absent for the USA and many other countries. Most previous studies used cDNA libraries generated by reverse transcriptase (RT-PCR) and/or primers amplifying shorter fragments of this gene. Using novel species-specific primers and direct PCR, we document group 1 allergen gene sequence polymorphism in populations of D. farinae and D. pteronyssinus from the USA and Pakistan. We report two novel introns (nt pos 87 and 291) in both species, and the absence of intron 3 in Der p 1. Thirteen silent and one novel non-synonymous mutation (Tryptophan W-197 to Arginine R-197) were detected in D. farinae. The potential medical significance of the latter mutation is discussed. Two haplotypes of the Der f 1 gene were identified, haplotype 1 (63%) was more frequent than haplotype 2 (18%). Polymorphism in Der f 1 displayed geographical localization, since both haplotypes were present in mite populations from Pakistan whereas haplotype 1 was observed only in the USA. In Der p 1, a silent mutation at nt (aa) position 1011(149) and four non-synonymous mutations at positions 589(50), 935(124), 971(136), 1268(215) were observed. These mutations were reported from many other geographic regions, suggesting that polymorphism in the Der p 1 gene is panmictic. The extent of polymorphism in both genes is substantially lower than that reported previously (0.10-0.16% vs 0.31-0.49%), indicating the need for careful evaluation of potential polymerase errors in studies utilizing RT-PCR.	[Shafique, Rubaba Hamid; Chaudhary, Farhana Riaz] Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Dept Zool, Rawalpindi, Pakistan; [Klimov, Pavel B.; OConnor, Barry M.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Klimov, Pavel B.] Tyumen State Univ, Fac Biol, Tyumen, Russia; [Inam, Muhammad] Univ Punjab, Dept Zool, Physiol Lab, Lahore, Pakistan	Arid Agriculture University; University of Michigan System; University of Michigan; Tyumen State University; University of Punjab	Shafique, RH (corresponding author), Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Dept Zool, Rawalpindi, Pakistan.	rubaba_hamid@hotmail.com	Klimov, Pavel B/E-4017-2010	Shafique, Rubaba Hamid/0000-0001-7380-2141; Inam, Muhammad/0000-0003-3789-5015	Higher Education Commission (HEC), International research support initiative program (IRSIP) in Pakistan; US National Science Foundation grant [DEB-0613769]; cooperative agreement of the Ministry of Education and Science of the Russian Federation [6.1933.2014/K, 1933]; US National Pediculosis Association (NPA) [20142016]; Marty Bloomberg	Higher Education Commission (HEC), International research support initiative program (IRSIP) in Pakistan; US National Science Foundation grant(National Science Foundation (NSF)); cooperative agreement of the Ministry of Education and Science of the Russian Federation; US National Pediculosis Association (NPA); Marty Bloomberg	This work was supported by the Higher Education Commission (HEC), International research support initiative program (IRSIP) in Pakistan to Rubaba Hamid Shafique, a US National Science Foundation grant DEB-0613769 to BMOC, cooperative agreement of the Ministry of Education and Science of the Russian Federation No. 6.1933.2014/K (project code 1933), 20142016, the US National Pediculosis Association (NPA) and Marty Bloomberg to PBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLIAN LG, 1991, EXP APPL ACAROL, V10, P167, DOI 10.1007/BF01198649; ARLIAN LG, 1983, J MED ENTOMOL, V20, P99, DOI 10.1093/jmedent/20.1.99; BEBENEK K, 1993, COLD SPRING HARBOR M, V23, P85; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; CHAPMAN MD, 1987, J IMMUNOL, V139, P1479; CHAPMAN MD, 1978, CLIN EXP IMMUNOL, V34, P126; Chruszcz M, 2012, J BIOL CHEM, V287, P7388, DOI 10.1074/jbc.M111.311159; CHUA KY, 1993, INT ARCH ALLERGY IMM, V101, P364, DOI 10.1159/000236478; Chua KY, 1996, CLIN EXP ALLERGY, V26, P829, DOI 10.1111/j.1365-2222.1996.tb00615.x; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Cui Y, 2008, BRAZ J MED BIOL RES, V41, P380, DOI 10.1590/S0100-879X2008000500006; Cui YB, 2008, INT J ACAROL, V34, P3, DOI 10.1080/01647950808683703; DILWORTH RJ, 1991, CLIN EXP ALLERGY, V21, P25, DOI 10.1111/j.1365-2222.1991.tb00800.x; DREBORG S, 1992, ALLERGY, V47, P418, DOI 10.1111/j.1398-9995.1992.tb02082.x; Hales BJ, 2002, CLIN EXP ALLERGY, V32, P1461, DOI 10.1046/j.1365-2745.2002.01500.x; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; Hewitt CRA, 1997, CLIN EXP ALLERGY, V27, P201, DOI 10.1111/j.1365-2222.1997.tb00694.x; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Hill MR, 1998, ALLERGY, V53, P18, DOI 10.1111/j.1398-9995.1998.tb04991.x; Jeong KY, 2012, EXP APPL ACAROL, V58, P35, DOI 10.1007/s10493-012-9553-x; KENT NA, 1992, INT ARCH ALLERGY IMM, V99, P150, DOI 10.1159/000236349; Klimov PB, 2013, SYST BIOL, V62, P411, DOI 10.1093/sysbio/syt008; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LIND P, 1988, J IMMUNOL, V140, P4256; Milian Evelyn, 2004, P R Health Sci J, V23, P47; NISHIYAMA C, 1993, INT ARCH ALLERGY IMM, V101, P159, DOI 10.1159/000236514; Olsson S, 1998, CLIN EXP ALLERGY, V28, P984, DOI 10.1046/j.1365-2222.1998.00375.x; Park JW, 2002, CLIN EXP ALLERGY, V32, P1042, DOI 10.1046/j.1365-2222.2002.01421.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piboonpocanun S, 2006, CLIN EXP ALLERGY, V36, P510, DOI 10.1111/j.1365-2222.2006.02464.x; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 1998, PRIMER3; Simpson RJ, 1988, PROTEIN SEQ DATA ANA, V2, P17; Smith WA, 2001, J ALLERGY CLIN IMMUN, V107, P985, DOI 10.1067/mai.2001.114652; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Thomas Wayne R, 2004, Chang Gung Med J, V27, P563; Thomas WR, 2010, ASIAN PAC J ALLERGY, V28, P211; Thomas WR, 2007, PROTEIN PEPTIDE LETT, V14, P943, DOI 10.2174/092986607782541169; Thomas WR, 1997, INT ARCH ALLERGY IMM, V113, P96, DOI 10.1159/000237516; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; van Ree R, 2007, J ALLERGY CLIN IMMUN, V119, P270, DOI 10.1016/j.jaci.2006.10.033; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114636	10.1371/journal.pone.0114636	http://dx.doi.org/10.1371/journal.pone.0114636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494056	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400063
J	Wang, XQ; Yang, ZH; Fu, YY; Zhang, GQ; Wang, X; Zhang, YH; Wang, XX				Wang, Xiaoqing; Yang, Zhenhua; Fu, Yanyong; Zhang, Guoqin; Wang, Xu; Zhang, Yuhua; Wang, Xiexiu			Insight to the Epidemiology and Risk Factors of Extrapulmonary Tuberculosis in Tianjin, China during 2006-2011	PLOS ONE			English	Article							INFECTION; HIV	Background: The proportion of extrapulmonary tuberculosis (EPTB) among all the reported tuberculosis (TB) cases has increased in different populations. Despite the large burden of TB in China, the epidemiology of EPTB in China remains largely understudied and the risk factors for having EPTB diagnosis in China have not been identified. Methods: To gain insight to EPTB epidemiology in China, we analyzed TB surveillance data collected in Tianjin, China, during 2006 to 2011. The frequency of EPTB among all TB cases and within different socio-demographic groups of the study patients aged 15 years and older was determined for EPTB in general and by specific types. The distribution of socio-demographic characteristics was compared between pulmonary TB (PTB) group and EPTB group by chi-square test. Crude and multiple logistic regression-derived adjusted odds ratios (aOR) and 95% confidence intervals (CI) were determined to assess the associations between having EPTB diagnosis and each individual explanatory variable in question. Results: About one-tenth (1,512/ 14,561) of the patients investigated in this study had EPTB. Of these 1,512 EPTB cases, about two thirds were pleural TB. Significant difference in age, occupation, and urbanity of residence were found between PTB and EPTB groups (p<0.05). Patients with EPTB diagnosis were more likely to be 65 years or older (aOR=1.22, 95% CI: 1.02, 1.46), to be retired (aOR=1.37, 95% CI: 1.08, 1.75), and to live in urban areas (aOR=1 38, 95% CI: 1.22, 1.55). Conclusions: The findings of this study extends the knowledgebase of EPTB epidemiology in developing countries and highlight the need for improved EPTB detection in China, especially in subpopulations with high risk for EPTB or having limited access to medical facilities with adequate capacity for EPTB diagnosis.	[Wang, Xiaoqing; Yang, Zhenhua] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Fu, Yanyong; Zhang, Guoqin; Wang, Xu; Zhang, Yuhua; Wang, Xiexiu] Tianjin Ctr Dis Control & Prevent, TB Inst, Tianjin, Peoples R China	University of Michigan System; University of Michigan; Tianjin Center for Disease Control & Prevention	Yang, ZH (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	zhenhua@umich.edu; wjsttigo@126.com		Zhang, Guoqin/0000-0001-7229-5248; Wang, Xavier Xu/0000-0001-9506-7934	Global Health Initiative Internship Award of the School of Public Health, University of Michigan; School of Public Health, University of Michigan	Global Health Initiative Internship Award of the School of Public Health, University of Michigan; School of Public Health, University of Michigan	The authors received no specific funding for this work except for the 2012 Global Health Initiative Internship Award of the School of Public Health, University of Michigan to XQW. The internship funder (School of Public Health, University of Michigan) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Cailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023; Centers for Disease Control and Prevention, 2013, CORE CURRICULUM TUBE; Ducomble T, 2013, EURO SURVEILL, V18; Ferrer J, 1997, EUR RESPIR J, V10, P942; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010736; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Jiang XY, 2008, SOUTH MED J, V101, P914, DOI 10.1097/SMJ.0b013e31817c13ab; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Kong Y, 2007, J CLIN MICROBIOL, V45, P409, DOI 10.1128/JCM.01459-06; Leeds IL, 2012, CLIN INFECT DIS, V55, P75, DOI 10.1093/cid/cis303; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Luna JA, 2004, TUBERCULOSIS GUIDE S; Pang PTT, 2010, INT J TUBERC LUNG D, V14, P585; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Sandgren A, 2013, EURO SURVEILL, V18; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; Solovic I, 2013, EUROSURVEILLANCE, V18, P12; Stop TB partnership, 2010, GLOB PLAN STOP TB 20; Tianjin Municipal People's Government, 2013, TIANJ BAS FACTS; Wang Y, 2011, REPORT 5 NATL SAMPLI; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2013, GLOB TUB REP 2013 WH; WHO, 2009, TREATM TUB GUID; World Health Organization, 2005, TB EP SURV WORKSH; Yang ZH, 2005, AM J RESP CRIT CARE, V171, P1436, DOI 10.1164/rccm.200408-1147OC; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Zhang XY, 2011, AM J TROP MED HYG, V85, P285, DOI 10.4269/ajtmh.2011.10-0630	33	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e112213	10.1371/journal.pone.0112213	http://dx.doi.org/10.1371/journal.pone.0112213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494360	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400009
J	LeRiche, K; Eagle, SHC; Crease, TJ				LeRiche, Kaitlynn; Eagle, Shannon H. C.; Crease, Teresa J.			Copy Number of the Transposon, Pokey, in rDNA Is Positively Correlated with rDNA Copy Number in Daphnia obtusa	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; EPIGENETIC REGULATION; DNA; EVOLUTION; ELEMENTS; CRUSTACEA; GENOME; RECOMBINATION; SEQUENCE; PULEX	Pokey is a class II DNA transposon that inserts into 28S ribosomal RNA (rRNA) genes and other genomic regions of species in the subgenus, Daphnia. Two divergent lineages, PokeyA and PokeyB have been identified. Recombination between misaligned rRNA genes changes their number and the number of Pokey elements. We used quantitative PCR (qPCR) to estimate rRNA gene and Pokey number in isolates from natural populations of Daphnia obtusa, and in clonally-propagated mutation accumulation lines (MAL) initiated from a single D. obtusa female. The change in direction and magnitude of Pokey and rRNA gene number did not show a consistent pattern across similar to 87 generations in the MAL; however, Pokey and rRNA gene number changed in concert. PokeyA and 28S gene number were positively correlated in the isolates from both natural populations and the MAL. PokeyB number was much lower than PokeyA in both MAL and natural population isolates, and showed no correlation with 28S gene number. Preliminary analysis did not detect PokeyB outside rDNA in any isolates and detected only 0 to 4 copies of PokeyA outside rDNA indicating that Pokey may be primarily an rDNA element in D. obtusa. The recombination rate in this species is high and the average size of the rDNA locus is about twice as large as that in other Daphnia species such as D. pulicaria and D. pulex, which may have facilitated expansion of PokeyA to much higher numbers in D. obtusa rDNA than these other species.	[LeRiche, Kaitlynn; Eagle, Shannon H. C.; Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Crease, TJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	tcrease@uoguelph.ca	Crease, Teresa/E-2932-2015	Crease, Teresa/0000-0001-8074-8024; Eagle, Shannon/0000-0002-6643-8799	Natural Sciences and Engineering Research Council (NSERC) of Canada; Ontario Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship in Science and Technology	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc.ca) of Canada to TJC, an Ontario Graduate Scholarship in Science and Technology to SHCE (http://osap.gov.on.ca), and a Undergraduate Summer Research Assistantship from NSERC to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-13; Averbeck KT, 2005, GENETICS, V171, P1837, DOI 10.1534/genetics.105.047670; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; CREASE TJ, 1991, MOL BIOL EVOL, V8, P620; Crease TJ, 1998, J MOL EVOL, V46, P307, DOI 10.1007/PL00006307; CREASE TJ, 1995, GENETICS, V141, P1327; Doyle J. J., 1987, PHYTOCHEM B, P11; Eagle SHC, 2012, MOBILE DNA, V3, pe4; Eagle SHC, 2013, THESIS U GUELPH; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Elliott TA, 2011, THESIS U GUELPH; Elliott TA, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-20; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Glass SK, 2008, GENOME, V51, P988, DOI 10.1139/G08-092; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kojima KK, 2003, MOL BIOL EVOL, V20, P351, DOI 10.1093/molbev/msg031; Linquist S, 2013, BIOL REV, V88, P573, DOI 10.1111/brv.12017; Louis EJ, 2002, GENOME BIOL, V3; McTaggart S, 2007, GENETICS, V175, P311, DOI 10.1534/genetics.105.050229; Omilian AR, 2001, MOL BIOL EVOL, V18, P2201, DOI 10.1093/oxfordjournals.molbev.a003767; Penton EH, 2004, MOL BIOL EVOL, V21, P1727, DOI 10.1093/molbev/msh189; Penton EH, 2002, J MOL EVOL, V55, P664, DOI 10.1007/s00239-002-2362-9; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Sullender BW, 2001, J MOL EVOL, V53, P63, DOI 10.1007/s002390010193; Valizadeh P, 2008, J MOL EVOL, V66, P643, DOI 10.1007/s00239-008-9118-0; Xu HF, 2006, MOL GENET GENOMICS, V276, P31, DOI 10.1007/s00438-006-0124-x; Zhang X, 2008, GENETICS, V180, P1617, DOI 10.1534/genetics.108.093716; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179	37	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114773	10.1371/journal.pone.0114773	http://dx.doi.org/10.1371/journal.pone.0114773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490398	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300078
J	Gonzalez-Hunt, CP; Leung, MCK; Bodhicharla, RK; McKeever, MG; Arrant, AE; Margillo, KM; Ryde, IT; Cyr, DD; Kosmaczewski, SG; Hammarlund, M; Meyer, JN				Gonzalez-Hunt, Claudia P.; Leung, Maxwell C. K.; Bodhicharla, Rakesh K.; McKeever, Madeline G.; Arrant, Andrew E.; Margillo, Kathleen M.; Ryde, Ian T.; Cyr, Derek D.; Kosmaczewski, Sara G.; Hammarlund, Marc; Meyer, Joel N.			Exposure to Mitochondrial Genotoxins and Dopaminergic Neurodegeneration in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEAR-DNA DAMAGE; ENVIRONMENTAL RISK-FACTORS; PARKINSONS-DISEASE; CALORIC RESTRICTION; OXIDATIVE DAMAGE; COMPLEX-I; REPAIR; MECHANISMS; BRAIN; NEURONS	Neurodegeneration has been correlated with mitochondrial DNA (mtDNA) damage and exposure to environmental toxins, but causation is unclear. We investigated the ability of several known environmental genotoxins and neurotoxins to cause mtDNA damage, mtDNA depletion, and neurodegeneration in Caenorhabditis elegans. We found that paraquat, cadmium chloride and aflatoxin B-1 caused more mitochondrial than nuclear DNA damage, and paraquat and aflatoxin B-1 also caused dopaminergic neurodegeneration. 6-hydroxydopamine (6-OHDA) caused similar levels of mitochondrial and nuclear DNA damage. To further test whether the neurodegeneration could be attributed to the observed mtDNA damage, C. elegans were exposed to repeated low-dose ultraviolet C radiation (UVC) that resulted in persistent mtDNA damage; this exposure also resulted in dopaminergic neurodegeneration. Damage to GABAergic neurons and pharyngeal muscle cells was not detected. We also found that fasting at the first larval stage was protective in dopaminergic neurons against 6-OHDA-induced neurodegeneration. Finally, we found that dopaminergic neurons in C. elegans are capable of regeneration after laser surgery. Our findings are consistent with a causal role for mitochondrial DNA damage in neurodegeneration, but also support non mtDNA-mediated mechanisms.	[Gonzalez-Hunt, Claudia P.; Leung, Maxwell C. K.; Bodhicharla, Rakesh K.; McKeever, Madeline G.; Margillo, Kathleen M.; Ryde, Ian T.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Arrant, Andrew E.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Cyr, Derek D.] Duke Univ, Ctr Appl Genom & Technol, Durham, NC USA; [Kosmaczewski, Sara G.; Hammarlund, Marc] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Genet, New Haven, CT USA	Duke University; Duke University; Duke University; Yale University	Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	joel.meyer@duke.edu	; Meyer, Joel/G-9836-2017	Arrant, Andrew/0000-0003-4706-9411; Bodhicharla, Rakesh/0000-0002-2344-6318; Gonzalez-Hunt, Claudia/0000-0002-2736-0001; Susco, Sara/0000-0001-9470-0689; Leung, Maxwell/0000-0003-1530-3306; Meyer, Joel/0000-0003-1219-0983	Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods; American Foundation of Aging Research GlaxoSmithKline Foundation Award; RJR-Duke Leon Golberg Toxicology Training Program; National Institute of Neurological Disorders and Stroke [R21 NS065468]; National Institute of Environmental Health Sciences [R01-ES017540-01A2]; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065468] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods; American Foundation of Aging Research GlaxoSmithKline Foundation Award; RJR-Duke Leon Golberg Toxicology Training Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by the Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods (MCKL), American Foundation of Aging Research GlaxoSmithKline Foundation Award (MCKL), RJR-Duke Leon Golberg Toxicology Training Program (JNM and RB), National Institute of Neurological Disorders and Stroke (R21 NS065468 to JNM), and National Institute of Environmental Health Sciences (R01-ES017540-01A2 to JNM). Some strains were provided by the CGC, which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; BACKER JM, 1982, CANCER RES, V42, P2764; Barlow BK, 2007, REPROD TOXICOL, V23, P457, DOI 10.1016/j.reprotox.2007.01.007; Bedard LL, 2006, CANCER LETT, V241, P174, DOI 10.1016/j.canlet.2005.11.018; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Bess A.S, 2012, NUCL ACIDS RES; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boamah EK, 2010, CHEM RES TOXICOL, V23, P1151, DOI 10.1021/tx900420k; Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7; Boyd WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007024; Brar SS, 2012, AM J PHYSL LUNG CELL; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Bronstein J, 2008, ENV HLTH PERSPECT, V117; Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Byrne AB, 2011, IN VIVO LASER AXOTOM, pe2707; Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cline SD, 2010, NUCLEIC ACIDS RES, V38, P7546, DOI 10.1093/nar/gkq656; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cohen BH, 2010, DEV DISABIL RES REV, V16, P189, DOI 10.1002/ddrr.106; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Drechsel DA, 2009, METHOD ENZYMOL, V456, P381, DOI 10.1016/S0076-6879(08)04421-2; Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002; El Bejjani R, 2012, ANNU REV GENET, V46, P499, DOI 10.1146/annurev-genet-110711-155550; Ergun E, 2006, DEUT TIERARZTL WOCH, V113, P363; Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Furda Amy M, 2012, Methods Mol Biol, V920, P111, DOI 10.1007/978-1-61779-998-3_9; GAINES G, 1984, J MOL BIOL, V172, P451, DOI 10.1016/S0022-2836(84)80017-0; Gomez C, 2007, FRONT BIOSCI-LANDMRK, V12, P1079, DOI 10.2741/2128; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; Groopman JD, 2005, TOXICOL APPL PHARM, V206, P131, DOI 10.1016/j.taap.2004.09.020; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hollins DL, 2006, FREE RADICAL BIO MED, V40, P1220, DOI 10.1016/j.freeradbiomed.2005.11.011; Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012; Hunter SE, 2012, DNA REPAIR, V11, P857, DOI 10.1016/j.dnarep.2012.08.002; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Ishiguro H, 2001, IUBMB LIFE, V51, P263, DOI 10.1080/152165401753311816; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Kobayashi H, 2008, FREE RADICAL RES, V42, P651, DOI 10.1080/10715760802270334; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Korr H, 2001, CHEM-BIOL INTERACT, V134, P217, DOI 10.1016/S0009-2797(01)00154-5; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kurochkin IO, 2011, AM J PHYSIOL-REG I, V300, pR21, DOI 10.1152/ajpregu.00279.2010; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9; Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Melrose HL, 2006, EXP BRAIN RES, V173, P196, DOI 10.1007/s00221-006-0461-3; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Miller DB, 2008, METABOLISM, V57, pS44, DOI 10.1016/j.metabol.2008.07.011; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; NASS R, 2007, CURRENT PROTOCOLS TO; Negga R, 2011, NEUROTOXICOLOGY, V32, P331, DOI 10.1016/j.neuro.2011.02.002; NIRANJAN BG, 1986, CANCER RES, V46, P3637; NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067; Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011; Pinto M, 2013, BIOCH BIOPHYSICA ACT; Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Rooney JP, 2014, EXP GERONTOL; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sajan M P, 1996, J Biochem Toxicol, V11, P235; Sajan M. P., 1997, Indian Journal of Experimental Biology, V35, P1187; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Samokhvalov V, 2008, AUTOPHAGY, V4, P1034, DOI 10.4161/auto.6994; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schmidt CW, 2010, ENV HLTH PERSPECT, V118; Shaughnessy DT, 2010, MITOCHONDRION, V10, P579, DOI 10.1016/j.mito.2010.02.001; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; SUZUKI J, 1995, FREE RADICAL BIO MED, V18, P431, DOI 10.1016/0891-5849(94)00152-A; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tokunaga I, 1997, BIOCHEM MOL BIOL INT, V43, P73; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; WUNDERLI.V, 1970, BIOCHEM J, V118, P99, DOI 10.1042/bj1180099; WUNDERLICH V, 1971, CHEM-BIOL INTERACT, V4, P81, DOI 10.1016/0009-2797(72)90001-4; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yu BP, 2001, ANN NY ACAD SCI, V928, P39; Yumino K, 2002, J BIOCHEM, V131, P565, DOI 10.1093/oxfordjournals.jbchem.a003135; Zhou Shaoyu, 2013, Int J Biochem Mol Biol, V4, P191	127	39	40	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114459	10.1371/journal.pone.0114459	http://dx.doi.org/10.1371/journal.pone.0114459			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486066	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600058
J	McDonnell, MD; Yaveroglu, ON; Schmerl, BA; Iannella, N; Ward, LM				McDonnell, Mark D.; Yaveroglu, Omer Nebll; Schmerl, Brett A.; Iannella, Nicolangelo; Ward, Lawrence M.			Motif-Role-Fingerprints: The Building-Blocks of Motifs, Clustering-Coefficients and Transitivities in Directed Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	Complex networks are frequently characterized by metrics for which particular subgraphs are counted. One statistic from this category, which we refer to as motif-role fingerprints, differs from global subgraph counts in that the number of subgraphs in which each node participates is counted. As with global subgraph counts, it can be important to distinguish between motif-role fingerprints that are 'structural' (induced subgraphs) and 'functional' (partial subgraphs). Here we show mathematically that a vector of all functional motif-role fingerprints can readily be obtained from an arbitrary directed adjacency matrix, and then converted to structural motif-role fingerprints by multiplying that vector by a specific invertible conversion matrix. This result demonstrates that a unique structural motif-role fingerprint exists for any given functional motif-role fingerprint. We demonstrate a similar result for the cases of functional and structural motif-fingerprints without node roles, and global subgraph counts that form the basis of standard motif analysis. We also explicitly highlight that motif-role fingerprints are elemental to several popular metrics for quantifying the subgraph structure of directed complex networks, including motif distributions, directed clustering coefficient, and transitivity. The relationships between each of these metrics and motif-role fingerprints also suggest new subtypes of directed clustering coefficients and transitivities. Our results have potential utility in analyzing directed synaptic networks constructed from neuronal connectome data, such as in terms of centrality. Other potential applications include anomaly detection in networks, identification of similar networks and identification of similar nodes within networks. Matlab code for calculating all stated metrics following calculation of functional motif-role fingerprints is provided as S1 Matlab File.	[McDonnell, Mark D.; Schmerl, Brett A.; Iannella, Nicolangelo] Univ S Australia, Inst Telecommun Res, Computat & Theoret Neurosci Lab, Mawson Lakes, SA, Australia; [Yaveroglu, Omer Nebll] Univ Calif Irvine, Calif Inst Telecommun & Informat Technol Calit2, Irvine, CA USA; [McDonnell, Mark D.; Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [McDonnell, Mark D.; Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of South Australia; University of California System; University of California Irvine; University of British Columbia; University of British Columbia	McDonnell, MD (corresponding author), Univ S Australia, Inst Telecommun Res, Computat & Theoret Neurosci Lab, Mawson Lakes, SA, Australia.	mark.mcdonnell@unisa.edu.au	Iannella, Nicolangelo/A-1026-2009; Schmerl, Brett A/O-1054-2018; McDonnell, Mark/A-8374-2008	Iannella, Nicolangelo/0000-0002-1983-9071; Schmerl, Brett A/0000-0003-3611-9065; McDonnell, Mark/0000-0002-7009-3869; Ward, Lawrence/0000-0003-4431-5015	Australian Research Fellowship from Australian Research Council [DP1093425]; Australian Government; National Health and Medical Research Council (NHMRC) of Australia [APP1050832]; Natural Sciences and Engineering Research Council (NSERC) of Canada; United States of America National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) [OIA-1028394]	Australian Research Fellowship from Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States of America National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI)(National Science Foundation (NSF))	Funding: Mark D. McDonnell's contribution was by supported by an Australian Research Fellowship from the Australian Research Council (project number DP1093425) (www.arc.gov.au), an Endeavour Award from the Australian Government (http://www.innovation.gov.au/InternationalEducation/EndeavourAwards/) and the National Health and Medical Research Council (NHMRC) of Australia (project grant, APP1050832) (www.nhrmc.gov.au). Lawrence M. Ward's contribution was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (www.nserc-crsng.gc.ca). Omer Nebil Yaverolu's contribution was supported by the United States of America National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) grant OIA-1028394. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036112; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cook SA, 1971, P 3 ANN ACM S THEOR, P151, DOI DOI 10.1145/800157.805047; Dong CY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-23; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Henderson Keith, 2012, P 18 ACM SIGKDD INT, P1231, DOI DOI 10.1145/2339530.2339723; Itzkovitz S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.058102; Itzkovitz S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026117; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Koschutzki D, 2007, J THEOR BIOL, V248, P471, DOI 10.1016/j.jtbi.2007.05.038; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Marx V, 2012, NATURE, V490, P293, DOI 10.1038/490293a; Mayo M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00357; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088254; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Prettejohn BJ, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00011; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Qian JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017013; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106132; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wong E, 2012, BRIEF BIOINFORM, V13, P202, DOI 10.1093/bib/bbr033; Yaveroglu ON, 2014, SCI REP-UK, V4, DOI 10.1038/srep04547	38	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114503	10.1371/journal.pone.0114503	http://dx.doi.org/10.1371/journal.pone.0114503			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486535	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600063
J	Qiu, Y; Li, WH; Zhang, HQ; Liu, Y; Tian, XX; Fang, WG				Qiu, Ying; Li, Wei-hua; Zhang, Hong-quan; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang			P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells	PLOS ONE			English	Article							P2X(7) RECEPTOR EXPRESSION; EXTRACELLULAR ATP; IN-VITRO; PURINERGIC RECEPTORS; METASTASIS; PROLIFERATION; INTERLEUKIN-8; CALCIUM; GROWTH; VIVO	The ATP-gated P2X7 has been shown to play an important role in invasiveness and metastasis of some tumors. However, the possible links and underlying mechanisms between P2X7 and prostate cancer have not been elucidated. Here, we demonstrated that P2X7 was highly expressed in some prostate cancer cells. Down-regulation of P2X7 by siRNA significantly attenuated ATP- or BzATP-driven migration and invasion of prostate cancer cells in vitro, and inhibited tumor invasiveness and metastases in nude mice. In addition, silencing of P2X7 remarkably attenuated ATP- or BzATP-driven expression changes of EMT/invasion-related genes Snail, E-cadherin, Claudin-1, IL-8 and MMP-3, and weakened the phosphorylation of PI3K/AKT and ERK1/2 in vitro. Similar effects were observed in nude mice. These data indicate that P2X7 stimulates cell invasion and metastasis in prostate cancer cells via some EMT/invasion-related genes, as well as PI3K/AKT and ERK1/2 signaling pathways. P2X7 could be a promising therapeutic target for prostate cancer.	[Qiu, Ying; Li, Wei-hua; Zhang, Hong-quan; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China; [Qiu, Ying; Li, Wei-hua; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100191, Peoples R China; [Zhang, Hong-quan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81321003, 30971152]; Ministry of Science and Technology of China [2010CB529402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants to WGF from National Natural Science Foundation of China (81321003, 30971152), and 973 Program (2010CB529402) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; ALBINI A, 1987, CANCER RES, V47, P3239; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Chen L, 2004, CANCER LETT, V215, P239, DOI 10.1016/j.canlet.2004.05.023; Deli T, 2007, INT J CANCER, V121, P55, DOI 10.1002/ijc.22621; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Ghalali A, 2014, CARCINOGENESIS; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Janssens R, 2001, BRIT J PHARMACOL, V132, P536, DOI 10.1038/sj.bjp.0703833; Jantaratnotai N, 2011, NEUROSCI LETT, V497, P80, DOI 10.1016/j.neulet.2011.04.034; Jelassi B, 2011, P2X 7 RECEPTOR ACTIV; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Liu YX, 2001, CHINESE MED J-PEKING, V114, P35; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Mutini C, 1999, J IMMUNOL, V163, P1958; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Ren SY, 2010, CELL BIOL INT, V34, P1205, DOI 10.1042/CBI20090428; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Stebbing J, 2013, ONCOGENE, V32, P4871, DOI 10.1038/onc.2012.591; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; White N, 2005, CANCER LETT, V224, P81, DOI 10.1016/j.canlet.2004.11.027; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Zhang XJ, 2004, LEUKEMIA RES, V28, P1313, DOI 10.1016/j.leukres.2004.04.001; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	44	83	88	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114371	10.1371/journal.pone.0114371	http://dx.doi.org/10.1371/journal.pone.0114371			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486274	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600048
J	Roquer, J; Rodriguez-Campello, A; Cuadrado-Godia, E; Giralt-Steinhauer, E; Jimenez-Conde, J; Soriano, C; Ois, A				Roquer, Jaume; Rodriguez-Campello, Ana; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Jimenez-Conde, Jordi; Soriano, Carol; Ois, Angel			The Role of HbA1c Determination in Detecting Unknown Glucose Disturbances in Ischemic Stroke	PLOS ONE			English	Article							ADMISSION HYPERGLYCEMIA; BLOOD-GLUCOSE; PREVALENCE; METABOLISM; RISK; ASSOCIATION; POPULATION; HEMOGLOBIN; PROGNOSIS; MORTALITY	Objectives: To evaluate the usefulness of hemoglobin A1c (HbA1c) determinations during the acute ischemic stroke (IS) to identify undiagnosed glucose disturbances in a prospective series of patients with first-ever IS. Methods: Retrospective analysis of a prospective series of first-ever IS patients. Patients with previous diagnosis of diabetes mellitus (DM) were excluded from the study. Patients were classified as non-DM (HbA1c<5.7% and no previous evidence of 2 or more fasting blood glucose>=126 mg/dL), prediabetes (HbA1c from 5.7% to 6.4%), and new suspected DM (HbA1c>=6.5% independently of current blood glucose). Medical charts from hospital discharge to July 2014 of all suspected DM patients were reviewed to confirm the DM diagnosis. Results: The initial cohort included 1283 patients, of which 393 were excluded because of previous DM diagnosis and 136 because HbA1c during acute stroke phase was not available. No demographic differences were observed between patients with and without HbA1c determinations. The final cohort was composed of 754 patients with first-ever IS and unknown DM history. HbA1c determination suggested new DM in 87 cases (11.5%) and detected 273 patients with prediabetes (36.2%). New DM cases were identified in all etiological stroke subtypes. After discharge, DM diagnosis was confirmed in 80.2% of patients with available follow-up. Conclusions: HbA1c determination detected both undiagnosed DM and prediabetes in IS patients without taking into account the blood glucose values during admission, and independently of etiological stroke subtype. HbA1c determination should be included in the systematic screening of all IS patients.	[Roquer, Jaume; Cuadrado-Godia, Elisa] Univ Pompeu Fabra, IMIM Hosp Mar, DCEXS, Serv Neurol, Barcelona, Spain; [Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel] Univ Autonoma Barcelona, IMIM Hosp Mar, Dept Med, Serv Neurol, E-08193 Barcelona, Spain; [Giralt-Steinhauer, Eva; Soriano, Carol] IMIM Hosp Mar, Serv Neurol, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Roquer, J (corresponding author), Univ Pompeu Fabra, IMIM Hosp Mar, DCEXS, Serv Neurol, Barcelona, Spain.	jroquer@hospitaldelmar.cat	JIMENEZ-CONDE, JORDI/C-1941-2012; TARRAGA, CAROLINA SORIANO/AAG-8777-2019; Roquer, Jaume/G-8919-2017; Campello, Ana Rodriguez/AAP-7757-2021; Ois, A/AAE-7583-2022; Ois, A/X-2922-2019	Roquer, Jaume/0000-0001-5992-2606; Campello, Ana Rodriguez/0000-0001-8621-1420; Ois, A/0000-0002-1375-5950; Ois, A/0000-0002-1375-5950; Cuadrado-Godia, Elisa/0000-0002-9147-875X; Giralt Steinhauer, Eva/0000-0002-7463-0983; Soriano Tarraga, Carolina/0000-0002-5635-273X	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III FEDER) [RD12/0042/0020]	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III FEDER)	This work was supported in part by Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III FEDER, RD12/0042/0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2008, GAC SANIT, V22, P565, DOI 10.1016/S0213-9111(08)75355-X; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; CANDELISE L, 1985, ARCH NEUROL-CHICAGO, V42, P661, DOI 10.1001/archneur.1985.04060070051014; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carson AP, 2012, DIABETES CARE, V35, P1845, DOI 10.2337/dc11-2140; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Dave JA, 2010, QJM-INT J MED, V103, P495, DOI 10.1093/qjmed/hcq062; Fonville S, 2013, CEREBROVASC DIS, V36, P283, DOI 10.1159/000353677; Gentile NT, 2006, ACAD EMERG MED, V13, P174, DOI 10.1197/j.aem.2005.08.009; Goldstein LB, 1997, STROKE, V28, P307, DOI 10.1161/01.STR.28.2.307; Huisa BN, 2013, J STROKE CEREBROVASC, V22, pE564, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.023; JAMROZIK K, 1994, STROKE, V25, P51, DOI 10.1161/01.STR.25.1.51; Jia Q, 2012, STROKE, V43, P650, DOI 10.1161/STROKEAHA.111.633784; Picon MJ, 2012, DIABETES CARE, V35, P1648, DOI 10.2337/dc11-2111; Karapanayiotides T, 2004, NEUROLOGY, V62, P1558, DOI 10.1212/01.WNL.0000123252.55688.05; Kernan WN, 2013, CEREBROVASC DIS, V36, P290, DOI 10.1159/000355142; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Khoury JC, 2013, STROKE, V44, P1500, DOI 10.1161/STROKEAHA.113.001318; Li YF, 2013, MMWR-MORBID MORTAL W, V62, P209; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Matz K, 2006, DIABETES CARE, V29, P792, DOI 10.2337/diacare.29.04.06.dc05-1818; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Roquer J, 2008, J NEUROL, V255, P1012, DOI 10.1007/s00415-008-0820-z; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Sung J, 2009, CIRCULATION, V119, P812, DOI 10.1161/CIRCULATIONAHA.108.776989; Urabe T, 2009, STROKE, V40, P1289, DOI 10.1161/STROKEAHA.108.522557; Williams LS, 2002, NEUROLOGY, V59, P67, DOI 10.1212/WNL.59.1.67	30	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e109960	10.1371/journal.pone.0109960	http://dx.doi.org/10.1371/journal.pone.0109960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485761	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600003
J	Hu, YQ; Chan, KH; He, XX; Ho, MKC; Wong, YH				Hu, Yueqing; Chan, King H.; He, Xixin; Ho, Maurice K. C.; Wong, Yung H.			Synthesis and Functional Characterization of Substituted Isoquinolinones as MT2-Selective Melatoninergic Ligands	PLOS ONE			English	Article							RECEPTOR ANTAGONISTS; ACETIC-ACID; IN-VITRO; MT1; AFFINITY; AGONISTS; CELLS; BIOAVAILABILITY; DERIVATIVES; RESPONSES	A series of substituted isoquinolinones were synthesized and their binding affinities and functional activities towards human melatonin MT1 and MT2 receptors were evaluated. Structure-activity relationship analysis revealed that substituted isoquinolinones bearing a 3-methoxybenzyloxyl group at C5, C6 or C7 position respectively (C5 > C6 > C7 in terms of their potency) conferred effective binding and selectivity toward the MT2 receptor, with 15b as the most potent compound. Most of the tested compounds were MT2-selective agonists as revealed in receptormediated cAMP inhibition, intracellular Ca2+ mobilization and phosphorylation of extracellular signal-regulated protein kinases. Intriguingly, compounds 7e and 7f bearing a 4-methoxybenzyloxyl group or 4-methylbenzyloxyl at C6 behaved as weak MT2-selective antagonists. These results suggest that substituted isoquinolinones represent a novel family of MT2-selective melatonin ligands. The position of the substituted benzyloxyl group, and the substituents on the benzyl ring appeared to dictate the functional characteristics of these compounds.	[Hu, Yueqing; Chan, King H.; He, Xixin; Ho, Maurice K. C.; Wong, Yung H.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Hu, Yueqing; Chan, King H.; He, Xixin; Ho, Maurice K. C.; Wong, Yung H.] Hong Kong Univ Sci & Technol, Biotechnol Res Inst, Kowloon, Hong Kong, Peoples R China; [Wong, Yung H.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wong, Yung H.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Wong, YH (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	boyung@hkust.hk	Ho, Maurice K/A-5993-2010	Ho, Maurice K/0000-0002-1211-2347; Wong, Yung Hou/0000-0002-0123-7697	National Key Basic Research Program of China [2013CB530900]; Research Grant Council [HKUST 660108]; University Grant Council of Hong Kong [T13-607/12R]; Hong Kong Jockey Club Charities Trust	National Key Basic Research Program of China(National Basic Research Program of China); Research Grant Council(Hong Kong Research Grants Council); University Grant Council of Hong Kong; Hong Kong Jockey Club Charities Trust	This work was supported in part by the National Key Basic Research Program of China (2013CB530900), Research Grant Council (HKUST 660108), University Grant Council of Hong Kong (T13-607/12R), and the Hong Kong Jockey Club Charities Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the authors confirm that this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Conway S, 2001, BIOCHEM BIOPH RES CO, V282, P1229, DOI 10.1006/bbrc.2001.4722; Doolen S, 1998, EUR J PHARMACOL, V345, P67, DOI 10.1016/S0014-2999(98)00064-8; Drazen DL, 2001, NEUROENDOCRINOLOGY, V74, P178, DOI 10.1159/000054684; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Dubocovich ML, 1997, N-S ARCH PHARMACOL, V355, P365, DOI 10.1007/PL00004956; EBISAWA T, 1994, P NATL ACAD SCI USA, V91, P6133, DOI 10.1073/pnas.91.13.6133; Farce A, 2008, EUR J MED CHEM, V43, P1926, DOI 10.1016/j.ejmech.2007.12.001; Faust R, 2000, J MED CHEM, V43, P1050, DOI 10.1021/jm980684+; Frungieri NB, 2005, ENDOCRINOLOGY, V146, P1541, DOI 10.1210/en.2004-0990; Gerdin MJ, 2003, BIOCHEM PHARMACOL, V66, P315, DOI 10.1016/S0006-2952(03)00239-9; Hogan MV, 2001, J PINEAL RES, V30, P87, DOI 10.1034/j.1600-079X.2001.300204.x; Hu YQ, 2010, BIOORG MED CHEM LETT, V20, P2582, DOI 10.1016/j.bmcl.2010.02.084; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; Karageorge GN, 2004, BIOORG MED CHEM LETT, V14, P5881, DOI 10.1016/j.bmcl.2004.09.024; LEE AWM, 1992, J CHEM SOC PERK T 1, P309, DOI 10.1039/p19920000309; Liu AMF, 2004, J BIOL CHEM, V279, P53196, DOI 10.1074/jbc.M410196200; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Mody SM, 2000, MOL PHARMACOL, V57, P13; Mor M, 2001, BIOORGAN MED CHEM, V9, P1045, DOI 10.1016/S0968-0896(00)00322-9; New DC, 2004, ASSAY DRUG DEV TECHN, V2, P269, DOI 10.1089/1540658041410641; Nonno R, 1999, BRIT J PHARMACOL, V127, P1288, DOI 10.1038/sj.bjp.0702658; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Podda MV, 2003, NEUROSCI LETT, V341, P209, DOI 10.1016/S0304-3940(03)00209-X; Pummerer R, 1910, BER DTSCH CHEM GES, V43, P1401, DOI 10.1002/cber.19100430241; Pummerer R, 1909, BER DTSCH CHEM GES, V42, P2282, DOI 10.1002/cber.190904202126; Ram PT, 2002, CANCER LETT, V179, P141, DOI 10.1016/S0304-3835(01)00873-4; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Rivara S, 2005, J MED CHEM, V48, P4049, DOI 10.1021/jm048956y; Rivara S, 2008, CURR TOP MED CHEM, V8, P954, DOI 10.2174/156802608784936719; Slominski R.M., 2012, MOL CELL ENDOCRINOL; SPADONI G, 1993, J MED CHEM, V36, P4069, DOI 10.1021/jm00077a010; TETSUO M, 1980, LIFE SCI, V27, P105, DOI 10.1016/0024-3205(80)90450-6; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; WALDHAUSER F, 1984, NEUROENDOCRINOLOGY, V39, P307, DOI 10.1159/000123997; Wallez V, 2002, J MED CHEM, V45, P2788, DOI 10.1021/jm0005252; WONG YH, 1994, METHOD ENZYMOL, V238, P81; Zhu J, 2012, XENOBIOTICA, V42, P1138, DOI 10.3109/00498254.2012.691186; Zlotos DP, 2012, CURR MED CHEM, V19, P3532	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113638	10.1371/journal.pone.0113638	http://dx.doi.org/10.1371/journal.pone.0113638			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479338	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200026
J	Gokyu, M; Kobayashi, H; Nanbara, H; Sudo, T; Ikeda, Y; Suda, T; Izumi, Y				Gokyu, Misa; Kobayashi, Hiroaki; Nanbara, Hiromi; Sudo, Takeaki; Ikeda, Yuichi; Suda, Tomonari; Izumi, Yuichi			Thrombospondin-1 Production Is Enhanced by Porphyromonas gingivalis Lipopolysaccharide in THP-1 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INFLAMMATORY T-CELLS; VIRULENCE FACTORS; HUMAN MONOCYTES; GROWTH-FACTOR; IN-VIVO; PERIODONTITIS; DEFICIENCY; ACTIVATION; EXPRESSION	Periodontitis is a chronic inflammatory disease caused by gram-negative anaerobic bacteria. Monocytes and macrophages stimulated by periodontopathic bacteria induce inflammatory mediators that cause tooth-supporting structure destruction and alveolar bone resorption. In this study, using a DNA microarray, we identified the enhanced gene expression of thrombospondin-1 (TSP-1) in human monocytic cells stimulated by Porphyromonas gingivalis lipopolysaccharide (LPS). TSP-1 is a multifunctional extracellular matrix protein that is upregulated during the inflammatory process. Recent studies have suggested that TSP-1 is associated with rheumatoid arthritis, diabetes mellitus, and osteoclastogenesis. TSP-1 is secreted from neutrophils, monocytes, and macrophages, which mediate immune responses at inflammatory regions. However, TSP-1 expression in periodontitis and the mechanisms underlying TSP-1 expression in human monocytic cells remain unknown. Here using real-time RT-PCR, we demonstrated that TSP-1 mRNA expression level was significantly upregulated in inflamed periodontitis gingival tissues and in P. gingivalis LPS-stimulated human monocytic cell line THP-1 cells. TSP-1 was expressed via Toll-like receptor (TLR) 2 and TLR4 pathways. In P. gingivalis LPS stimulation, TSP-1 expression was dependent upon TLR2 through the activation of NF-kappa B signaling. Furthermore, IL-17F synergistically enhanced P. gingivalis LPS-induced TSP-1 production. These results suggest that modulation of TSP-1 expression by P. gingivalis plays an important role in the progression and chronicity of periodontitis. It may also contribute a new target molecule for periodontal therapy.	[Gokyu, Misa; Kobayashi, Hiroaki; Nanbara, Hiromi; Sudo, Takeaki; Ikeda, Yuichi; Suda, Tomonari; Izumi, Yuichi] Tokyo Med & Dent Univ, Biomatrix Dept, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Kobayashi, H (corresponding author), Tokyo Med & Dent Univ, Biomatrix Dept, Grad Sch Med & Dent Sci, Tokyo, Japan.	h-kobayashi.peri@tmd.ac.jp	Sudo, Takeaki/AAH-9035-2019; Ikeda, Yuichi/AAA-3536-2020	Gokyu, Misa/0000-0003-1482-9218; Ikeda, Yuichi/0000-0001-7557-658X	JSPS KAKENHI [25463213, 25293424, 26861805]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25463213, 25293424, 26861805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Costalonga M, 2009, J PERIODONTAL RES, V44, P537, DOI 10.1111/j.1600-0765.2008.01152.x; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dixon DR, 2004, PERIODONTOL 2000, V35, P53, DOI 10.1111/j.0906-6713.2004.003556.x; Fordham JB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00512; Gorska R, 2003, J CLIN PERIODONTOL, V30, P1046, DOI 10.1046/j.0303-6979.2003.00425.x; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P1780, DOI 10.1002/art.1780401009; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; JAFFE EA, 1985, BLOOD, V65, P79; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jandik KA, 2008, J PERIODONTAL RES, V43, P524, DOI 10.1111/j.1600-0765.2007.01064.x; Krishna SM, 2013, INT J CARDIOL, V168, P692, DOI 10.1016/j.ijcard.2013.04.139; Kukreja A, 2009, BLOOD, V114, P3413, DOI 10.1182/blood-2009-03-211920; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026656; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Manns JM, 2006, ARTHRITIS RHEUM, V54, P2415, DOI 10.1002/art.22021; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Mize TW, 2014, J PERIODONT IN PRESS; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rico MC, 2008, TRANSL RES, V152, P95, DOI 10.1016/j.trsl.2008.06.002; Salajegheh M, 2007, J NEUROIMMUNOL, V187, P166, DOI 10.1016/j.jneuroim.2007.04.022; Shaker OG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/174764; SHAPIRA L, 1994, ORAL MICROBIOL IMMUN, V9, P112, DOI 10.1111/j.1399-302X.1994.tb00044.x; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Vallejo AN, 2000, J IMMUNOL, V164, P2947, DOI 10.4049/jimmunol.164.6.2947; Vallejo AN, 2003, J IMMUNOL, V171, P1732, DOI 10.4049/jimmunol.171.4.1732; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Yang KY, 2009, J AUTOIMMUN, V32, P94, DOI 10.1016/j.jaut.2008.12.004; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zhou QD, 2006, INFECT IMMUN, V74, P1204, DOI 10.1128/IAI.74.2.1204-1214.2006	45	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115107	10.1371/journal.pone.0115107	http://dx.doi.org/10.1371/journal.pone.0115107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501558	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400073
J	Huang, YS; Bertrand, V; Bozukova, D; Pagnoulle, C; Labrugere, C; De Pauw, E; De Pauw-Gillet, MC; Durrieu, MC				Huang, Yi-Shiang; Bertrand, Virginie; Bozukova, Dimitriya; Pagnoulle, Christophe; Labrugere, Christine; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire; Durrieu, Marie-Christine			RGD Surface Functionalization of the Hydrophilic Acrylic Intraocular Lens Material to Control Posterior Capsular Opacification	PLOS ONE			English	Article							EPITHELIAL-CELL MIGRATION; POLYETHYLENE TEREPHTHALATE SURFACES; MESENCHYMAL STEM-CELL; INTRA OCULAR LENS; OPTIC EDGE; HYDROPHOBIC RECOVERY; IN-VITRO; ADHESION; TRANSITION; PEPTIDES	Posterior Capsular Opacification (PCO) is the capsule fibrosis developed on implanted IntraOcular Lens (IOL) by the de-differentiation of Lens Epithelial Cells (LECs) undergoing Epithelial Mesenchymal Transition (EMT). Literature has shown that the incidence of PCO is multifactorial including the patient's age or disease, surgical technique, and IOL design and material. Reports comparing hydrophilic and hydrophobic acrylic IOLs have shown that the former has more severe PCO. On the other hand, we have previously demonstrated that the adhesion of LECs is favored on hydrophobic compared to hydrophilic materials. By combining these two facts and contemporary knowledge in PCO development via the EMT pathway, we propose a biomimetically inspired strategy to promote LEC adhesion without dedifferentiation to reduce the risk of PCO development. By surface grafting of a cell adhesion molecule (RGD peptide) onto the conventional hydrophilic acrylic IOL material, the surface-functionalized IOL can be used to reconstitute a capsule-LEC-IOL sandwich structure, which has been considered to prevent PCO formation in literature. Our results show that the innovative biomaterial improves LEC adhesion, while also exhibiting similar optical (light transmittance, optical bench) and mechanical (haptic compression force, IOL injection force) properties compared to the starting material. In addition, compared to the hydrophobic IOL material, our bioactive biomaterial exhibits similar abilities in LEC adhesion, morphology maintenance, and EMT biomarker expression, which is the crucial pathway to induce PCO. The in vitro assays suggest that this biomaterial has the potential to reduce the risk factor of PCO development.	[Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Dept Chem, Liege, Belgium; [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Dept Biomed & Preclin Sci, Mass Spectrometry Lab, Liege, Belgium; [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Mammalian Cell Culture Lab GIGA R, Liege, Belgium; [Huang, Yi-Shiang; Durrieu, Marie-Christine] Univ Bordeaux, Inst Chem & Biol Membranes & Nanoobjects, CBMN UMR5248, Pessac, France; [Bozukova, Dimitriya; Pagnoulle, Christophe] PhysIOL SA, Dept Res & Dev, Liege, Belgium; [Labrugere, Christine] Univ Bordeaux, PLACAMAT, Plateforme Aquitaine Caracterisat Mat, Pessac, France	University of Liege; University of Liege; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	De Pauw-Gillet, MC (corresponding author), Univ Liege, Dept Chem, Liege, Belgium.	marie-claire.depauw@ulg.ac.be; marie-christine.durrieu@inserm.fr	DURRIEU, Marie-Christine/I-4358-2016	DURRIEU, Marie-Christine/0000-0003-0583-9289; De Pauw, Edwin/0000-0003-3475-1315	project LINOLA from Walloon region, Belgium [1117465]; PhysIOL	project LINOLA from Walloon region, Belgium; PhysIOL	This study was financed by project LINOLA (1117465) from Walloon region, Belgium (http://recherchetechnologie.wallonie.be/). YSH and MCG received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DB and CP are employees of PhysIOL. PhysIOL provided support in the form of salaries for authors DB and CP, as well as the materials and installations for performing part of the research activities (i.e. plasma equipment, optical bench, haptic compression force measuring equipment), and had additional role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1; Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6; Agarwal A, 2011, PHACOEMULSIFICATION; Amoozgar B, 2013, J BIOACT COMPAT POL, V28, P637, DOI 10.1177/0883911513504855; Anderson JM, 2001, ANN REV MATER RES, V31, P30; Bartouilh de Taillac L, 2004, COMPOS SCI TECHNOL, V64, P827, DOI 10.1016/j.compscitech.2003.09.011; Behar-Cohen F., 2001, J FR OPHTALMOL, V24, P9; Bertrand V, 2014, J CATARACT REFR SURG, V40, P1536, DOI 10.1016/j.jcrs.2014.01.035; Bhattacharya SD, 2012, SURGERY, V152, P449, DOI 10.1016/j.surg.2012.06.011; Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037; Bozukova D, 2013, J CATARACT REFR SURG, V39, P1404, DOI 10.1016/j.jcrs.2013.01.050; Bozukova D, 2010, MAT SCI ENG R, V69, P63, DOI 10.1016/j.mser.2010.05.002; Briggs D., 1999, SURFACE ANAL POLYM X; Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI 10.1089/ten.TEA.2010.0199; Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30; Celine Chollet SL, 2006, J LASER MICRO NANOEN, V1, P5; Cheng JW, 2007, AM J OPHTHALMOL, V143, P428, DOI 10.1016/j.ajo.2006.11.045; Cheng ZA, 2013, NANO LETT, V13, P3923, DOI 10.1021/nl4020149; Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012; Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024; Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Daniele Tognetto LT, 2002, J CATARACT REFR SURG, V28, P8; Das RK ZO, 2013, ACS NANO, V7, P11; De Giglio E, 2011, J BIOACT COMPAT POL, V26, P420, DOI 10.1177/0883911511410460; Dick HB, 2000, OPHTHALMOLOGY, V107, P241, DOI 10.1016/S0161-6420(99)00082-2; Dimitriya Bozukova CP, 2007, BIOMACROMOLECULES, V8, P9; Eisele G, 2014, J NEURO-ONCOL, V117, P141, DOI 10.1007/s11060-014-1365-x; Fine IH, 2007, J CATARACT REFR SURG, V33, P94, DOI 10.1016/j.jcrs.2006.09.016; Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009; Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002; Gonzalez-Chomon C, 2011, MATERIALS, V4, P1927, DOI 10.3390/ma4111927; Guelcher S. A., 2005, INTRO BIOMATERIALS; Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024; Heatley CJ, 2005, J CATARACT REFR SURG, V31, P718, DOI 10.1016/j.jcrs.2004.08.060; Hongling Liu GF, 2010, IN VITRO STUDY, V16, P8; Huang X, 2013, J OCUL PHARMACOL TH, V29, P208, DOI 10.1089/jop.2012.0184; Hyeon II Lee MKK, 2007, J KOREAN MED SCI, V22, P6; James F., 2002, J CATARACT REFR SURG, V28, P7; Juila M, 1999, EYE, V13, P5; Kanokpanont S, 2013, INT J BIOL MACROMOL, V55, P88, DOI 10.1016/j.ijbiomac.2013.01.003; Katayama Y KS, 2007, OPHTHALMIC RES, P6; Kavoussi SC, 2011, J CATARACT REFR SURG, V37, P2194, DOI 10.1016/j.jcrs.2011.05.049; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817; Kohnen T, 2008, OPHTHALMOLOGY, V115, P1308, DOI 10.1016/j.ophtha.2008.01.002; Latz C, 2000, GRAEF ARCH CLIN EXP, V238, P696, DOI 10.1007/s004170000153; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Legeais JM, 2001, J FR OPHTALMOL, V24, P309; Lei Y ZO, 2013, SMALL, V9, P10; Lei YF, 2012, J MATER SCI-MATER M, V23, P2761, DOI 10.1007/s10856-012-4736-x; Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163; Liliana Werner J-ML, 1999, J BIOMED MATER RES, V46, P8; Lim H, 2001, J VAC SCI TECHNOL A, V19, P1490, DOI 10.1116/1.1382650; Lingli Li LL, 2011, J CONTROL RELEASE, V152, P2; Linnola RJ, 2003, J CATARACT REFR SURG, V29, P146, DOI 10.1016/S0886-3350(02)01422-0; Linnola RJ, 1997, J CATARACT REFR SURG, V23, P4; Linnola RJ WL, 2000, J CATARACT REFR SURG, V26, P12; Linnola RJ WL, 2000, J CATARACT REFR SURG, V26, P15; Liu HL, 2009, GRAEF ARCH CLIN EXP, V247, P801, DOI 10.1007/s00417-008-1007-0; Luensmann D, 2009, J CATARACT REFR SURG, V35, P2000, DOI 10.1016/j.jcrs.2009.05.052; Manju S, 2010, PHARM DEV TECHNOL, V15, P379, DOI 10.3109/10837450903262025; Matsushima H, 2006, J CATARACT REFR SURG, V32, P1035, DOI 10.1016/j.jcrs.2006.02.042; Morarescu D, 2010, BIOMATERIALS, V31, P2399, DOI 10.1016/j.biomaterials.2009.11.108; Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6; Nagamoto T, 2009, ARCH OPHTHALMOL-CHIC, V127, P471, DOI 10.1001/archophthalmol.2009.63; Niranjan Awasthi SG, 2009, ARCH OPHTHALMOL-CHIC, V127, P8; Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0; Nishi O, 2012, J CATARACT REFR SURG, V38, P924, DOI 10.1016/j.jcrs.2012.03.005; Nixon DR, 2006, AM J OPHTHALMOL, V142, P557, DOI 10.1016/j.ajo.2006.05.049; Pagnoulle C, 2012, J CATARACT REFR SURG, V38, P1271, DOI 10.1016/j.jcrs.2012.02.041; Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5; Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037; Porte-Durrieu MC LC, 1999, J BIOMED MATER RES, V46, P8; Poulin S, 2006, APPL SURF SCI, V252, P6738, DOI 10.1016/j.apsusc.2006.02.233; POWER W, 1993, DOC OPHTHALMOL, V84, P351, DOI 10.1007/BF01215449; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Puleo DA, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1; Reardon DA, 2011, FUTURE ONCOL, V7, P339, DOI [10.2217/fon.11.8, 10.2217/FON.11.8]; Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o; Ruoslahti E PM, 1987, SCIENCE, V238, P7; Ryu JJ, 2013, INT J ORAL MAX IMPL, V28, P963, DOI 10.11607/jomi.2421; Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004; Sheardown H, 2003, CELLS PROTEINS MAT F; Spalton D, 2012, BRIT J OPHTHALMOLOGY, V2012; Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261; Sun CB, 2014, COLLOID SURFACE B, V113, P33, DOI 10.1016/j.colsurfb.2013.08.024; Susanne Krag TTA, 2003, INVEST OPHTH VIS SCI, V44, P6; Tatsuo Arita L-RL, 1990, INVESTIGATIVE OPHTHA, V31; Tognetto D, 2003, OPHTHALMOLOGY, V110, P1935, DOI 10.1016/S0161-6420(03)00736-X; Wadajkar AS, 2014, ISRN DENT, V2014, P4; Wang GQ, 2012, INT J OPHTHALMOL-CHI, V5, P84, DOI 10.3980/j.issn.2222-3959.2012.01.17; Wang GQ, 2010, INT J OPHTHALMOL-CHI, V3, P141, DOI 10.3980/j.issn.2222-3959.2010.02.11; Werner JP, 1999, J FR OPHTALMOL, V22, P492; Werner L, 2008, CURR OPIN OPHTHALMOL, V19, P41, DOI 10.1097/ICU.0b013e3282f20132; Werner L, 2010, J CATARACT REFR SURG, V36, P1398, DOI 10.1016/j.jcrs.2010.06.003; Werner LP, 1998, J FR OPHTALMOL, V21, P515; Wright A, 2005, CUTAN OCUL TOXICOL, V24, P53, DOI 10.1081/CUS-200046191; Xu ZX, 2011, BIOPOLYMERS, V95, P682, DOI 10.1002/bip.21635; Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398; Yang CL, 2009, J MATER SCI-MATER M, V20, P2349, DOI 10.1007/s10856-009-3794-1; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zouani OF LY, 2013, SMALL, V9, P6; Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986; Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007; Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042; Zuk A, 1994, DEV DYNAM, V201, P16	108	15	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114973	10.1371/journal.pone.0114973	http://dx.doi.org/10.1371/journal.pone.0114973			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501012	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700079
J	Gehre, F; Ejo, M; Fissette, K; de Rijk, P; Uwizeye, C; Nduwamahoro, E; Goovaerts, O; Affolabi, D; Gninafon, M; Lingoupou, FM; Barry, MD; Sow, O; Merle, C; Olliaro, P; Ba, F; Sarr, M; Piubello, A; Noeske, J; Antonio, M; Rigouts, L; de Jong, BC				Gehre, Florian; Ejo, Mebrat; Fissette, Kristina; de Rijk, Pim; Uwizeye, Cecile; Nduwamahoro, Elie; Goovaerts, Odin; Affolabi, Dissou; Gninafon, Martin; Lingoupou, Fanny M.; Barry, Mamadou Dian; Sow, Oumou; Merle, Corinne; Olliaro, Piero; Ba, Fatoumata; Sarr, Marie; Piubello, Alberto; Noeske, Juergen; Antonio, Martin; Rigouts, Leen; de Jong, Bouke C.			Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; STRAINS; TRANSMISSION; LINEAGE; GAMBIA	In this study, we retrospectively analysed a total of 605 clinical isolates from six West or Central African countries (Benin, Cameroon, Central African Republic, Guinea-Conakry, Niger and Senegal). Besides spoligotyping to assign isolates to ancient and modern mycobacterial lineages, we conducted phenotypic drug-susceptibility-testing for each isolate for the four first-line drugs. We showed that phylogenetically modern Mycobacterium tuberculosis strains are more likely associated with drug resistance than ancient strains and predict that the currently ongoing replacement of the endemic ancient by a modern mycobacterial population in West/Central Africa might result in increased drug resistance in the sub-region.	[Gehre, Florian; Ejo, Mebrat; Fissette, Kristina; de Rijk, Pim; Uwizeye, Cecile; Nduwamahoro, Elie; Goovaerts, Odin; Rigouts, Leen; de Jong, Bouke C.] Inst Trop Med, B-2000 Antwerp, Belgium; [Gehre, Florian; Antonio, Martin] MRC, Gambia Unit, Fajara, Gambia; [Affolabi, Dissou; Gninafon, Martin] Lab Reference Mycobacteries, Cotonou, Benin; [Lingoupou, Fanny M.] Inst Pasteur, Lab Mycobacteries, Bangui, Cent Afr Republ; [Barry, Mamadou Dian; Sow, Oumou] Lab Reference Mycobacteries, Conakry, Guinea; [Merle, Corinne] London Sch Hyg & Trop Med, London WC1, England; [Olliaro, Piero] WHO, Special Programme Res & Training Trop Dis TDR, UNICEF, UNDP,World Bank, CH-1211 Geneva, Switzerland; [Ba, Fatoumata] Lab Reference Mycobacteries, Dakar, Senegal; [Sarr, Marie] Natl TB Programme, Dakar, Senegal; [Piubello, Alberto] Damien Fdn, Niamey, Niger; [de Jong, Bouke C.] NYU, New York, NY USA	Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; The World Bank; World Health Organization; New York University	Gehre, F (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	fgehre@itg.be	Ejo, Mebrat/Q-6071-2019; de Jong, Bouke/A-3636-2013	Ejo, Mebrat/0000-0001-8119-8394; de Jong, Bouke/0000-0002-1017-4675; Piubello, Alberto/0000-0002-6937-3126; Merle, Corinne/0000-0003-4229-365X	European Research Council (ERC) Starting grant "INTERRUPTB'' [311725]; European and Developing Countries Clinical Trial Partnership (EDCTP) grant "Towards strengthening of the West African Node of Excellence for TB, AIDS and malaria: WANETAM plus'' [MSI 2010_10800]; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); MRC [MC_U190081991, MC_U190074190] Funding Source: UKRI; Medical Research Council [MR/K012126/1, MC_U190074190, MC_U190081991] Funding Source: researchfish	European Research Council (ERC) Starting grant "INTERRUPTB''; European and Developing Countries Clinical Trial Partnership (EDCTP) grant "Towards strengthening of the West African Node of Excellence for TB, AIDS and malaria: WANETAM plus''; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)(World Health Organization); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was partially funded by a European Research Council (ERC) Starting grant "INTERRUPTB'', grant agreement no.: 311725, and a European and Developing Countries Clinical Trial Partnership (EDCTP) grant "Towards strengthening of the West African Node of Excellence for TB, AIDS and malaria: WANETAM plus'', project code: MSI 2010_10800. Parts of this study were supported by a grant of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000; Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397; WHO, 2008, STOP TB DEP POL GUID; World Health Organization, 2013, WHO REP GLOB TUB REP; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Yoshiyama T, 2004, INT J TUBERC LUNG D, V8, P31	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e110393	10.1371/journal.pone.0110393	http://dx.doi.org/10.1371/journal.pone.0110393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493429	Green Published, gold, Green Accepted			2022-12-27	WOS:000346611400003
J	Kim, SY; Pramanik, P; Bodelier, PLE; Kim, PJ				Kim, Sang Yoon; Pramanik, Prabhat; Bodelier, Paul L. E.; Kim, Pil Joo			Cattle Manure Enhances Methanogens Diversity and Methane Emissions Compared to Swine Manure under Rice Paddy	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; 16S RIBOSOMAL-RNA; MCRA GENES; PHYLOGENETIC ANALYSIS; SOIL; COMMUNITY; NITROGEN; ARCHAEA; GROWTH; CH4	Livestock manures are broadly used in agriculture to improve soil quality. However, manure application can increase the availability of organic carbon, thereby facilitating methane (CH4) production. Cattle and swine manures are expected to have different CH4 emission characteristics in rice paddy soil due to the inherent differences in composition as a result of contrasting diets and digestive physiology between the two livestock types. To compare the effect of ruminant and non ruminant animal manure applications on CH4 emissions and methanogenic archaeal diversity during rice cultivation (June to September, 2009), fresh cattle and swine manures were applied into experimental pots at 0, 20 and 40 Mg fresh weight (FW) ha(-1) in a greenhouse. Applications of manures significantly enhanced total CH4 emissions as compared to chemical fertilization, with cattle manure leading to higher emissions than swine manure. Total organic C contents in cattle (466 g kg(-1)) and swine (460 g kg(-1)) manures were of comparable results. Soil organic C (SOC) contents were also similar between the two manure treatments, but dissolved organic C (DOC) was significantly higher in cattle than swine manure. The mcrA gene copy numbers were significantly higher in cattle than swine manure. Diverse groups of methanogens which belong to Methanomicrobiaceae were detected only in cattle-manured but not in swine-manured soil. Methanogens were transferred from cattle manure to rice paddy soils through fresh excrement. In conclusion, cattle manure application can significantly increase CH4 emissions in rice paddy soil during cultivation, and its pretreatment to suppress methanogenic activity without decreasing rice productivity should be considered.	[Kim, Sang Yoon; Pramanik, Prabhat; Kim, Pil Joo] Gyeongsang Natl Univ, Div Appl Life Sci, BK Program 21, Jinju, South Korea; [Kim, Pil Joo] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea; [Kim, Sang Yoon; Bodelier, Paul L. E.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Gyeongsang National University; Gyeongsang National University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Kim, PJ (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, BK Program 21, Jinju, South Korea.	pjkim@gnu.ac.kr	Bodelier, Paul L/A-9591-2011; Bodelier, Paul/AAF-8353-2020; KNAW, NIOO-KNAW/A-4320-2012; Kim, Sang Yoon/O-3332-2014	Bodelier, Paul L/0000-0002-5757-5572; Bodelier, Paul/0000-0002-5757-5572; KNAW, NIOO-KNAW/0000-0002-3835-159X; Kim, Sang Yoon/0000-0003-4914-3080; Kim, Pil Joo/0000-0003-1192-4324	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A6A3A03027794]; Ministry of Education and Human Resources Development, South Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Ministry of Education and Human Resources Development, South Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	Sang Yoon Kim was supported by the BK21 fellowship Program of the Ministry of Education and Human Resources Development, South Korea. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A6A3A03027794). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Aulakh MS, 2000, NUTR CYCL AGROECOSYS, V58, P357, DOI 10.1023/A:1009831712602; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Bastida F, 2008, APPL SOIL ECOL, V40, P318, DOI 10.1016/j.apsoil.2008.05.007; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Browne PD, 2013, ARCHAEA, V2013, DOI 10.1155/2013/586369; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Conrad R, 2008, GLOBAL CHANGE BIOL, V14, P657, DOI 10.1111/j.1365-2486.2007.01516.x; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Corton TM, 2000, NUTR CYCL AGROECOSYS, V58, P37, DOI 10.1023/A:1009826131741; Denman K, 2007, CLIMATE CHANGE 2007, P500; Egert M, 2004, FEMS MICROBIOL ECOL, V48, P187, DOI 10.1016/j.femsec.2004.01.007; Flessa H, 2000, J PLANT NUTR SOIL SC, V163, P157, DOI 10.1002/(SICI)1522-2624(200004)163:2<157::AID-JPLN157>3.0.CO;2-9; Gutierrez J, 2013, FIELD CROP RES, V146, P16, DOI 10.1016/j.fcr.2013.03.003; Inubushi K, 2003, GLOBAL CHANGE BIOL, V9, P1458, DOI 10.1046/j.1365-2486.2003.00665.x; IRRI, 2011, INT RIC RES I IRRI W; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; KAMIJI Y, 1993, JPN J CROP SCI, V62, P164, DOI 10.1626/jcs.62.164; Kim SY, 2014, AGR ECOSYST ENVIRON, V197, P60, DOI 10.1016/j.agee.2014.07.013; Kim SY, 2013, PLANT SOIL, V366, P273, DOI 10.1007/s11104-012-1403-4; Kim SY, 2012, AGR ECOSYST ENVIRON, V161, P130, DOI 10.1016/j.agee.2012.07.026; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lu YH, 2000, SOIL SCI SOC AM J, V64, P2011, DOI 10.2136/sssaj2000.6462011x; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Lv MR, 2011, BIOL FERT SOILS, V47, P777, DOI 10.1007/s00374-011-0584-y; Ma K, 2012, APPL ENVIRON MICROB, V78, P445, DOI 10.1128/AEM.06934-11; Ma K, 2010, GLOBAL CHANGE BIOL, V16, P3085, DOI 10.1111/j.1365-2486.2009.02145.x; MARIKO S, 1991, ENVIRON EXP BOT, V31, P343, DOI 10.1016/0098-8472(91)90059-W; McLauchlan KK, 2004, SOIL SCI SOC AM J, V68, P1616, DOI 10.2136/sssaj2004.1616; Moral R, 2005, BIORESOURCE TECHNOL, V96, P153, DOI 10.1016/j.biortech.2004.05.003; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Qin YM, 2010, BIOL FERT SOILS, V46, P825, DOI 10.1007/s00374-010-0493-5; Radl V, 2007, ISME J, V1, P443, DOI 10.1038/ismej.2007.60; RDA (Rural Development Administration), 1999, NAT I AGR SCI TECHN, P148; RDA (Rural Development Administration), 1995, INV METH AGR EXP, V601, P1103; Rolston D.E., 1986, METHODS SOIL ANAL 1, P1103, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C47; Ros M, 2006, SOIL BIOL BIOCHEM, V38, P3443, DOI 10.1016/j.soilbio.2006.05.017; Rural Development Administration Korea (RDA), 1988, METH SOIL CHEM AN, P148; Shin EC, 2004, ANAEROBE, V10, P313, DOI 10.1016/j.anaerobe.2004.08.002; Singh A, 2012, FEMS MICROBIOL ECOL, V82, P118, DOI 10.1111/j.1574-6941.2012.01411.x; Singh S, 1999, SOIL BIOL BIOCHEM, V31, P1219, DOI 10.1016/S0038-0717(99)00027-9; Solomon S., 2007, 4 IPCC; Thangarajan R, 2013, SCI TOTAL ENVIRON, V465, P72, DOI 10.1016/j.scitotenv.2013.01.031; United States Department of Agriculture (USDA), 2010, KEYS SOIL TAX, P1; VANDERGON HACD, 1995, PLANT SOIL, V170, P307, DOI 10.1007/BF00010483; Watanabe T, 2009, SOIL BIOL BIOCHEM, V41, P276, DOI 10.1016/j.soilbio.2008.10.025; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; XU JG, 1993, SOIL BIOL BIOCHEM, V25, P1263, DOI 10.1016/0038-0717(93)90223-X; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517	53	37	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113593	10.1371/journal.pone.0113593	http://dx.doi.org/10.1371/journal.pone.0113593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494364	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400016
J	Labarrere, CA; Woods, JR; Hardin, JW; Jaeger, BR; Zembala, M; Deng, MC; Kassab, GS				Labarrere, Carlos A.; Woods, John R.; Hardin, James W.; Jaeger, Beate R.; Zembala, Marian; Deng, Mario C.; Kassab, Ghassan S.			Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; TISSUE-PLASMINOGEN ACTIVATOR; CARDIOVASCULAR-DISEASE; ENDOTHELIAL ACTIVATION; MYOCARDIAL-INFARCTION; NATURAL ANTIBODIES; PROGNOSTIC VALUE; ELEVATED LEVELS; GRAFT FAILURE	Background: Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and graft failure due to CAV (GFDCAV) in heart transplant patients, which account for 30% of all deaths. Early CAV detection involves invasive, risky, and expensive monitoring approaches. We determined whether prediction of CAV and GFDCAV improves by adding inflammatory markers to a previously validated atherothrombotic (AT) model. Methods and Findings: AT and inflammatory markers interleukin-6 (IL-6) and C-reactive protein (CRP) were measured in heart biopsies and sera of 172 patients followed prospectively for 8.9 +/- 5.0 years. Models were estimated for 5- and 10-year risk using (1) the first post-transplant biopsy only, or (2) all biopsies obtained within 3 months. Multivariate models were adjusted for other covariates and cross-validated by bootstrapping. After adding IL-6 and CRP to the AT models, we evaluated the significance of odds ratios (ORs) associated with the additional inflammatory variables and the degree of improvement in the area under the receiver operating characteristic curve (AUROC). When inflammatory markers were tested alone in prediction models, CRP (not IL-6) was a significant predictor of CAV and GFDCAV at 5 (CAV: p<0.0001; GFDCAV: p=0.005) and 10 years (CAV: p<0.0001; GFDCAV: p=0.003). Adding CRP (not IL-6) to the best AT models improved discriminatory power to identify patients destined to develop CAV (using 1st biopsy: p<0.001 and p=0.001; using all 3-month biopsies: p<0.04 and p=0.008 at 5- and 10-years, respectively) and GFDCAV (using 1st biopsy: 0.92 vs. 0.95 and 0.86 vs. 0.89; using all 3-month biopsies: 0.94 vs. 0.96 and 0.88 vs. 0.89 at 5- and 10-years, respectively), as indicated by an increase in AUROC. Conclusions: Early inflammatory status, measured by a patient's CRP level (a non-invasive, safe and inexpensive test), independently predicts CAV and GFDCAV. Adding CRP to a previously established AT model improves its predictive power.	[Labarrere, Carlos A.] CBL Partners Life, Indianapolis, IN USA; [Labarrere, Carlos A.] Calif Med Innovat Inst, San Diego, CA USA; [Woods, John R.] Indiana Univ Hlth, Methodist Res Inst, Indianapolis, IN USA; [Woods, John R.] Indiana Univ Purdue Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46202 USA; [Hardin, James W.] Univ S Carolina, Columbia, SC 29208 USA; [Jaeger, Beate R.] Dr Stein & Kollegen, Monchengladbach, Germany; [Zembala, Marian] Silesian Ctr Heart Dis, Zabrze, Poland; [Deng, Mario C.] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA; [Kassab, Ghassan S.] Calif Med Innovat Inst, San Diego, CA USA	Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Silesian Center for Heart Diseases; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center	Labarrere, CA (corresponding author), CBL Partners Life, Indianapolis, IN USA.	clabarrere@sbcglobal.net	Hardin, James W/Q-7617-2016; Hardin, James/P-4772-2019	Hardin, James W/0000-0003-0506-5500; Hardin, James/0000-0003-0506-5500	Methodist Research Institute	Methodist Research Institute	Funding for this work was provided by the Methodist Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajeganova S, 2012, J RHEUMATOL, V39, P1146, DOI 10.3899/jrheum.111334; Anania C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3193; Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Caligiuri G, 2007, J AM COLL CARDIOL, V50, P540, DOI 10.1016/j.jacc.2006.11.054; Christenson RH, 2005, CIRCULATION, V112, P3215, DOI 10.1161/CIRCULATIONAHA.105.581918; de Faire U, 2010, J AUTOIMMUN, V34, P73, DOI 10.1016/j.jaut.2009.05.003; de Faire U, 2009, ANN NY ACAD SCI, V1173, P292, DOI 10.1111/j.1749-6632.2009.04748.x; Dhaliwal Amandeep, 2006, Curr Atheroscler Rep, V8, P119, DOI 10.1007/s11883-006-0049-1; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eisenberg MS, 2000, CIRCULATION, V102, P2100, DOI 10.1161/01.CIR.102.17.2100; Faria-Neto JR, 2006, ATHEROSCLEROSIS, V189, P83, DOI 10.1016/j.atherosclerosis.2005.11.033; Gullestad L, 1999, AM J CARDIOL, V84, P999, DOI 10.1016/S0002-9149(99)00487-7; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2001, REGRESSION MODELING; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hognestad A, 2003, J AM COLL CARDIOL, V42, P477, DOI 10.1016/S0735-1097(03)00645-4; Ikonomidis I, 2005, CIRCULATION, V112, P3272, DOI 10.1161/CIRCULATIONAHA.104.532259; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Labarrere CA, 2011, AM J TRANSPLANT, V11, P528, DOI 10.1111/j.1600-6143.2010.03401.x; Labarrere CA, 2000, CIRCULATION, V102, P1549, DOI 10.1161/01.CIR.102.13.1549; Labarrere CA, 1998, AM J MED, V105, P207, DOI 10.1016/S0002-9343(98)00246-0; Labarrere CA, 2000, JAMA-J AM MED ASSOC, V284, P457, DOI 10.1001/jama.284.4.457; LABARRERE CA, 1994, CIRCULATION, V89, P1599, DOI 10.1161/01.CIR.89.4.1599; LABARRERE CA, 1995, NEW ENGL J MED, V333, P1111, DOI 10.1056/NEJM199510263331704; Labarrere CA, 1997, JAMA-J AM MED ASSOC, V278, P1169, DOI 10.1001/jama.278.14.1169; Labarrere CA, 2004, AM J MED, V117, P499, DOI 10.1016/j.amjmed.2004.03.039; Labarrere CA, 2002, LANCET, V360, P1462, DOI 10.1016/S0140-6736(02)11473-5; LABARRERE CA, 1995, TRANSPLANT P, V27, P1939; Labarrere CA, 2001, AM J CARDIOL, V87, P425, DOI 10.1016/S0002-9149(00)01395-3; Labarrere CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036100; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; Mehra MR, 2006, AM J TRANSPLANT, V6, P1248, DOI 10.1111/j.1600-6143.2006.01314.x; Pasceri V, 2000, CIRCULATION, V102, P2165; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Pethig K, 2000, CIRCULATION, V102, P233; Rebuzzi AG, 1998, AM J CARDIOL, V82, P715, DOI 10.1016/S0002-9149(98)00458-5; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1998, CIRCULATION, V97, P425; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Shah PK, 2000, CIRCULATION, V101, P1758, DOI 10.1161/01.CIR.101.15.1758; Singh U, 2005, ARTERIOSCL THROM VAS, V25, P2216, DOI 10.1161/01.ATV.0000183718.62409.ea; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; Ventura HO, 2003, J AM COLL CARDIOL, V42, P483, DOI 10.1016/S0735-1097(03)00646-6; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z	55	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113260	10.1371/journal.pone.0113260	http://dx.doi.org/10.1371/journal.pone.0113260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490200	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300007
J	Pilgrim, T; Rothenbuhler, M; Kalesan, B; Pulver, C; Stefanini, GG; Zanchin, T; Raber, L; Stortecky, S; Jung, S; Mattle, H; Moschovitis, A; Wenaweser, P; Meier, B; Gsponer, T; Windecker, S; Juni, P				Pilgrim, Thomas; Rothenbuehler, Martina; Kalesan, Bindu; Pulver, Cedric; Stefanini, Giulio G.; Zanchin, Thomas; Raeber, Lorenz; Stortecky, Stefan; Jung, Simon; Mattle, Heinrich; Moschovitis, Aris; Wenaweser, Peter; Meier, Bernhard; Gsponer, Thomas; Windecker, Stephan; Jueni, Peter			Additive Effect of Anemia and Renal Impairment on Long-Term Outcome after Percutaneous Coronary Intervention	PLOS ONE			English	Article							IMPACT; HEMOGLOBIN; MORTALITY	Introduction: Anemia and renal impairment are important co-morbidities among patients with coronary artery disease undergoing Percutaneous Coronary Intervention (PCI). Disease progression to eventual death can be understood as the combined effect of baseline characteristics and intermediate outcomes. Methods: Using data from a prospective cohort study, we investigated clinical pathways reflecting the transitions from PCI through intermediate ischemic or hemorrhagic events to all-cause mortality in a multi-state analysis as a function of anemia (hemoglobin concentration <120 g/l and <130 g/l, for women and men, respectively) and renal impairment (creatinine clearance,60 ml/min) at baseline. Results: Among 6029 patients undergoing PCI, anemia and renal impairment were observed isolated or in combination in 990 (16.4%), 384 (6.4%), and 309 (5.1%) patients, respectively. The most frequent transition was from PCI to death (6.7%, 95% CI 6.1-7.3), followed by ischemic events (4.8%, 95 CI 4.3-5.4) and bleeding (3.4%, 95% CI 3.0-3.9). Among patients with both anemia and renal impairment, the risk of death was increased 4-fold as compared to the reference group (HR 3.9, 95% CI 2.9-5.4) and roughly doubled as compared to patients with either anemia (HR 1.7, 95% CI 1.3-2.2) or renal impairment (HR 2.1, 95% CI 1.5-2.9) alone. Hazard ratios indicated an increased risk of bleeding in all three groups compared to patients with neither anemia nor renal impairment. Conclusions: Applying a multi-state model we found evidence for a gradient of risk for the composite of bleeding, ischemic events, or death as a function of hemoglobin value and estimated glomerular filtration rate at baseline.	[Pilgrim, Thomas; Pulver, Cedric; Stefanini, Giulio G.; Zanchin, Thomas; Raeber, Lorenz; Stortecky, Stefan; Moschovitis, Aris; Wenaweser, Peter; Meier, Bernhard; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Rothenbuehler, Martina; Kalesan, Bindu; Gsponer, Thomas; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Rothenbuehler, Martina; Kalesan, Bindu; Gsponer, Thomas; Jueni, Peter] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Jung, Simon; Mattle, Heinrich] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern	Pilgrim, T (corresponding author), Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland.	Thomas.pilgrim@insel.ch	Wenaweser, Peter/AAN-7009-2021; Stortecky, Stefan/AAS-9140-2021; Pilgrim, Thomas/AAS-9120-2021; Stefanini, Giulio G/K-7406-2016; Stefanini, Giulio/GZG-4754-2022; Juni, Peter/Q-8700-2016	Pilgrim, Thomas/0000-0001-8721-4068; Stefanini, Giulio G/0000-0002-3558-6967; Stefanini, Giulio/0000-0002-3558-6967; Juni, Peter/0000-0002-5985-0670; Rothenbuhler, Martina/0000-0001-8009-4104; Stortecky, Stefan/0000-0002-5076-0177				[Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954; Bassand JP, 2010, EUR HEART J, V31, P50, DOI 10.1093/eurheartj/ehp401; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Duncan T, 2004, STAT METHODS GENETIC; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lee PC, 2004, J AM COLL CARDIOL, V44, P541, DOI 10.1016/j.jacc.2004.04.047; McKechnie RS, 2004, CIRCULATION, V110, P271, DOI 10.1161/01.CIR.0000134964.01697.C7; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Moore RA, 2012, EUR J PAIN, V16, P585, DOI 10.1016/j.ejpain.2011.08.009; Nikolsky E, 2004, AM J CARDIOL, V94, P1023, DOI 10.1016/j.amjcard.2004.06.058; Pilgrim T, 2012, CIRC-CARDIOVASC INTE, V5, P202, DOI 10.1161/CIRCINTERVENTIONS.111.965749; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reinecke H, 2003, EUR HEART J, V24, P2142, DOI 10.1016/j.ehj.2003.09.008; Richardson DB, 2009, AM J EPIDEMIOL, V169, P756, DOI 10.1093/aje/kwn411; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Sukhija R, 2010, AM J CARDIOL, V105, P293, DOI 10.1016/j.amjcard.2009.09.031; Zhang RY, 2009, INT J CARDIOL, V136, P72, DOI 10.1016/j.ijcard.2008.04.028	19	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114846	10.1371/journal.pone.0114846	http://dx.doi.org/10.1371/journal.pone.0114846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489846	Green Published, gold			2022-12-27	WOS:000347515300083
J	Steen, GJ; Reijnierse, WG; Burgers, C				Steen, Gerard J.; Reijnierse, W. Gudrun; Burgers, Christian			When Do Natural Language Metaphors Influence Reasoning? A Follow-Up Study to Thibodeau and Boroditsky (2013)	PLOS ONE			English	Article							NEWS; FEAR; TELEVISION; CULTIVATION; MESSAGES; OPINION; BRITISH; POLICY; MODEL	In this article, we offer a critical view of Thibodeau and Boroditsky who report an effect of metaphorical framing on readers' preference for political measures after exposure to a short text on the increase of crime in a fictitious town: when crime was metaphorically presented as a beast, readers became more enforcement-oriented than when crime was metaphorically framed as a virus. We argue that the design of the study has left room for alternative explanations. We report four experiments comprising a follow-up study, remedying several shortcomings in the original design while collecting more encompassing sets of data. Our experiments include three additions to the original studies: (1) a non-metaphorical control condition, which is contrasted to the two metaphorical framing conditions used by Thibodeau and Boroditsky, (2) text versions that do not have the other, potentially supporting metaphors of the original stimulus texts, (3) a pre-exposure measure of political preference (Experiments 1-2). We do not find a metaphorical framing effect but instead show that there is another process at play across the board which presumably has to do with simple exposure to textual information. Reading about crime increases people's preference for enforcement irrespective of metaphorical frame or metaphorical support of the frame. These findings suggest the existence of boundary conditions under which metaphors can have differential effects on reasoning. Thus, our four experiments provide converging evidence raising questions about when metaphors do and do not influence reasoning.	[Steen, Gerard J.; Reijnierse, W. Gudrun] Vrije Univ Amsterdam, Dept Language & Commun, Amsterdam, Netherlands; [Burgers, Christian] Vrije Univ Amsterdam, Dept Commun Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Steen, GJ (corresponding author), Vrije Univ Amsterdam, Dept Language & Commun, Amsterdam, Netherlands.	g.j.steen@vu.nl	Burgers, Christian/C-6093-2011	Burgers, Christian/0000-0002-5652-9021; Reijnierse, W. Gudrun/0000-0003-0147-2643	Netherlands Organization of Scientific Research (NWO) [PGW-11-30]; VENI, Netherlands Organization of Scientific Research (NWO) [275-89-020]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VENI, Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	WGR was supported by grant no. PGW-11-30 awarded by the Netherlands Organization of Scientific Research (NWO), www.nwo.nl. CB was supported by VENI grant no. 275-89-020 awarded by the Netherlands Organization of Scientific Research (NWO), www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowdle BF, 2005, PSYCHOL REV, V112, P193, DOI 10.1037/0033-295X.112.1.193; Charteris-Black J, 2004, LANG COMPUT, P133; Charteris-Black J, 2003, ENGL SPECIF PURP, V22, P153, DOI 10.1016/S0889-4906(02)00012-1; Charteris-Black J, 2001, ENGL SPECIF PURP, V20, P249, DOI 10.1016/S0889-4906(00)00009-0; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Custers K, 2013, COMMUN RES, V40, P96, DOI 10.1177/0093650212440444; Custers K, 2011, POETICS, V39, P107, DOI 10.1016/j.poetic.2011.02.004; Deason G, 2012, BASIC APPL SOC PSYCH, V34, P254, DOI 10.1080/01973533.2012.674450; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gibbs RW, 2011, DISCOURSE PROCESS, V48, P529, DOI 10.1080/0163853X.2011.606103; GIBBS RW, 2008, THE CAMBRIDGE HANDBO; Goodall CE, 2013, J COMMUN, V63, P373, DOI 10.1111/jcom.12020; Gross K, 2003, J COMMUN, V53, P411, DOI 10.1093/joc/53.3.411; Haider-Markel DP, 2001, J POLIT, V63, P520, DOI 10.1111/0022-3816.00077; JACKSON S, 1988, HUM COMMUN RES, V15, P127, DOI 10.1111/j.1468-2958.1988.tb00174.x; JANSEN C, 2009, STUDIES TAALBEHEERSI, V3, P175; Jia LL, 2013, J EXP SOC PSYCHOL, V49, P492, DOI 10.1016/j.jesp.2013.01.009; LAKOFF G, 1996, MORAL POLITICS HOW L; Landau MJ, 2009, PSYCHOL SCI, V20, P1421, DOI 10.1111/j.1467-9280.2009.02462.x; Lecheler S, 2012, J MASS COMMUN Q, V89, P185, DOI 10.1177/1077699011430064; Littlemore J, 2003, METAPHOR SYMBOL, V18, P273, DOI 10.1207/S15327868MS1804_4; Moses JF, 2015, POLIT PSYCHOL, V36, P379, DOI 10.1111/pops.12160; MUSOLFF A, 2004, METAPHOR AND POLITIC; Nelson TE, 1997, POLIT BEHAV, V19, P221, DOI 10.1023/A:1024834831093; Ohl JJ, 2013, COMMUN STUD, V64, P488, DOI 10.1080/10510974.2013.832340; Robins S, 2000, DISCOURSE PROCESS, V30, P57, DOI 10.1207/S15326950dp3001_03; Romer D, 2003, J COMMUN, V53, P88, DOI 10.1111/j.1460-2466.2003.tb03007.x; Smolej M., 2006, J SCANDINAVIAN STUDI, V7, P211, DOI DOI 10.1080/14043850601002429; Steen G, 2008, METAPHOR SYMBOL, V23, P213, DOI 10.1080/10926480802426753; Steen GJ, 2011, REV COGN LINGUIST, V9, P26, DOI 10.1075/rcl.9.1.03ste; Sun Y, 2014, ENGL SPECIF PURP, V33, P4, DOI 10.1016/j.esp.2013.07.005; Thibodeau PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052961; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782	34	49	49	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113536	10.1371/journal.pone.0113536	http://dx.doi.org/10.1371/journal.pone.0113536			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AY3YM	25490704	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300010
J	Cao, HD; Ye, H; Sun, ZP; Shen, X; Song, ZW; Wu, XC; He, WC; Dai, CS; Yang, JW				Cao, Hongdi; Ye, Hong; Sun, Zhiping; Shen, Xia; Song, Zongwei; Wu, Xiaochun; He, Weichun; Dai, Chunsun; Yang, Junwei			Circulatory Mitochondrial DNA Is a Pro-Inflammatory Agent in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CELL-FREE DNA; CARDIOVASCULAR RISK; PLASMA; MORTALITY; SURVIVAL; SEPSIS; INJURY; DYSFUNCTION; FAILURE	Chronic inflammation is highly prevalent in maintenance hemodialysis (MHD) patients, and it has been shown to be a strong predictor of morbidity and mortality. Mitochondrial DNA (mtDNA) released into circulation after cell damage can promote inflammation in patients and animal models. However, the role and mechanisms of circulatory mtDNA in chronic inflammation in MHD patients remain unknown. Sixty MHD patients and 20 health controls were enrolled in this study. The circulatory mtDNA was detected by quantitative real-time PCR assay. Plasma interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) were quantitated by ELISA assay. Dialysis systems in MHD patients and in vitro were used to evaluate the effect of different dialysis patterns on circulatory mtDNA. Circulatory mtDNA was elevated in MHD patients comparing to that of health control. Regression analysis demonstrated that plasma mtDNA was positively associated with TNF-a and the product of serum calcium and phosphorus, while negatively associated with hemoglobin and serum albumin in MHD patients. MtDNA induced the secretion of IL-6 and TNF-alpha in the THP-1 cells. Single high-flux hemodialysis (HF-HD) and on line hemodiafiltration (OL-HDF) but not low-flux hemodialysis (LF-HD) could partially reduce plasma mtDNA in MHD patients. In vitro, both HD and hemofiltration (HF) could fractional remove mtDNA. Collectively, circulatory mtDNA is elevated and its level is closely correlated with chronic inflammation in MHD patients. HF-HD and HDF can partially reduce circulatory mtDNA in MHD patients.	[Cao, Hongdi; Ye, Hong; Sun, Zhiping; Shen, Xia; Song, Zongwei; Wu, Xiaochun; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			Jiangsu Province's Science and Technology Programs of Construction; People's Livelihood [BL2013037]; Nanjing Medical University	Jiangsu Province's Science and Technology Programs of Construction; People's Livelihood; Nanjing Medical University	This work was supported by Jiangsu Province's Science and Technology Programs of Construction and the People's Livelihood (BL2013037) to Junwei Yang. Hongdi Cao was supported by the Yong fellowship from the Nanjing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizono K, 2004, BLOOD PURIFICAT, V22, P26, DOI 10.1159/000081870; Atamaniuk J, 2012, NEPHROL DIAL TRANSPL, V27, P902, DOI 10.1093/ndt/gfr695; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Caglar K, 2002, KIDNEY INT, V62, P1408, DOI 10.1111/j.1523-1755.2002.kid556.x; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Hung A, 2008, HEMODIAL INT, V12, P236, DOI 10.1111/j.1542-4758.2008.00260.x; Hung AM, 2011, J AM SOC NEPHROL, V22, P437, DOI 10.1681/ASN.2010070760; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Korabecna M, 2012, EXPERT OPIN BIOL TH, V12, pS27, DOI 10.1517/14712598.2012.676034; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Malaponte G, 2002, NEPHROL DIAL TRANSPL, V17, P1964, DOI 10.1093/ndt/17.11.1964; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nolan CR, 2005, J AM SOC NEPHROL, V16, pS120, DOI 10.1681/ASN.2005060662; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Puskarich MA, 2012, SHOCK, V38, P337, DOI 10.1097/SHK.0b013e318266a169; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Stenvinkel P, 2002, KIDNEY INT, V62, P1791, DOI 10.1046/j.1523-1755.2002.00637.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; Sursal T, 2013, SHOCK, V39, P55, DOI 10.1097/SHK.0b013e318276f4ca; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	34	41	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113179	10.1371/journal.pone.0113179	http://dx.doi.org/10.1371/journal.pone.0113179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485699	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600015
J	Chen, P; Wang, LX; Wang, Y; Li, SM; Shen, LM; Liu, Q; Ni, JZ				Chen, Ping; Wang, Lixiang; Wang, Yong; Li, Shuiming; Shen, Liming; Liu, Qiong; Ni, Jiazuan			Phosphoproteomic Profiling of Selenate-Treated Alzheimer's Disease Model Cells	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; OXIDATIVE STRESS; MOUSE MODEL; TAU HYPERPHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; PHYSIOLOGICAL LEVELS; AEROBIC GLYCOLYSIS; NEURITE OUTGROWTH; HYDROGEN-PEROXIDE; ENERGY-METABOLISM	The reversible phosphorylation of proteins regulates most biological processes, while abnormal phosphorylation is a cause or consequence of many diseases including Alzheimer's disease (AD). One of the hallmarks of AD is the formation of neurofibrillary tangles (NFTs), which is composed of hyperphosphorylated tau proteins. Sodium selenate has been recently found to reduce tau hyperphosphorylation and NFTs formation, and to improve spatial learning and motor performance in AD mice. In the current study, the phosphoproteomics of N2aSW cells treated with selenate were investigated. To avoid missing low-abundance phosphoproteins, both the total proteins of cells and the phosphor-enriched proteins were extracted and subjected to the two-dimensional gel electrophoresis with Pro-Q diamond staining and then LC-MS/MS analysis. A total of 65 proteins were altered in phosphorylation level, of which 39 were up-regulated and 26 were down-regulated. All identified phosphoproteins were bioinformatically annotated according to their physiochemical features, subcellular location, and biological function. Most of these significantly changed phosphoproteins are involved in crucial neural processes such as protesome activity, oxidative stress, cysteine and methionine metabolism, and energy metabolism. Furthermore, decreases were found in homocysteine, phosphortau and amyloid beta upon selenate treatment. Our results suggest that selenate may intervene in the pathological process of AD by altering the phosphorylation of some key proteins involved in oxidative stress, energy metabolism and protein degradation, thus play important roles in maintaining redox homeostasis, generating ATP, and clearing misfolded proteins and aggregates. The present paper provides some new clues to the mechanism of selenate in AD prevention.	[Chen, Ping; Wang, Yong; Shen, Liming; Ni, Jiazuan] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Peoples R China; [Wang, Lixiang; Li, Shuiming; Liu, Qiong; Ni, Jiazuan] Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Shenzhen 518060, Peoples R China; [Chen, Ping] Shenzhen Univ, Coll Optoelect Engn, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Shenzhen 518060, Peoples R China	Shenzhen University; Shenzhen University; Shenzhen University	Liu, Q (corresponding author), Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Shenzhen 518060, Peoples R China.	liuqiong@szu.edu.cn; jzni@szu.edu.cn	Liu, Qiong/AAK-1556-2021	Shen, Liming/0000-0003-0074-8556	National Natural Science Foundation of China [21271131, 21301120]; Shenzhen Bureau of Science, Technology and Information [JCYJ20120817163755064, JCYJ20130408172946974]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science, Technology and Information	This work was financially supported by the National Natural Science Foundation of China (No. 21271131, 21301120), and the Shenzhen Bureau of Science, Technology and Information (No. JCYJ20120817163755064 & JCYJ20130408172946974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly NT, 2007, EPIDEMIOLOGY, V18, P52, DOI 10.1097/01.ede.0000248202.83695.4e; Arias C, 2002, EXP NEUROL, V176, P163, DOI 10.1006/exnr.2002.7912; Berr C, 2012, BIOFACTORS, V38, P139, DOI 10.1002/biof.1003; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Ceccatelli S, 2007, PHYSIOL BEHAV, V92, P87, DOI 10.1016/j.physbeh.2007.05.048; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066384; Cheng Yibin, 2010, Wei Sheng Yan Jiu, V39, P483; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Di Domenico F, 2011, J PROTEOMICS, V74, P1091, DOI 10.1016/j.jprot.2011.03.033; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Garcia L, 2004, J NEUROSCI RES, V77, P292, DOI 10.1002/jnr.20140; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Golji J, 2012, BIOPHYS J, V102, P2022, DOI 10.1016/j.bpj.2012.01.062; Golji J, 2010, BIOPHYS J, V99, P1073, DOI 10.1016/j.bpj.2010.05.024; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; HALEGOUA S, 1987, DEV BIOL, V121, P97, DOI 10.1016/0012-1606(87)90142-4; Hetz C, 2003, CELL MOL LIFE SCI, V60, P133, DOI 10.1007/s000180300009; Horecker BL, 2002, J BIOL CHEM, V277, P47965, DOI 10.1074/jbc.X200007200; Ishrat T, 2009, BRAIN RES, V1281, P117, DOI 10.1016/j.brainres.2009.04.010; Jin CM, 2013, J CANCER, V4, P662, DOI 10.7150/jca.6641; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Li JG, 2014, ANN NEUROL, V75, P851, DOI 10.1002/ana.24145; Liu GP, 2013, MOL THER, V21, P2247, DOI 10.1038/mt.2013.189; Loef M, 2011, J ALZHEIMERS DIS, V26, P81, DOI 10.3233/JAD-2011-110414; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Morris MS, 2003, LANCET NEUROL, V2, P425, DOI 10.1016/S1474-4422(03)00438-1; Nagamine S, 2010, NEUROCHEM INT, V57, P102, DOI 10.1016/j.neuint.2010.04.015; Nakamura M, 2006, BBA-MOL CELL RES, V1763, P977, DOI 10.1016/j.bbamcr.2006.07.008; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Palmer AM, 1999, J NEURAL TRANSM, V106, P317, DOI 10.1007/s007020050161; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pillai R, 2014, IUBMB LIFE, V66, P229, DOI 10.1002/iub.1262; Rahaman H, 2012, FASEB J, V26; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Song GL, 2014, J ALZHEIMERS DIS, V41, P85, DOI 10.3233/JAD-131805; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Stone JR, 2002, J BIOL CHEM, V277, P15621, DOI 10.1074/jbc.M112153200; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tiwari V, 2014, J ALZHEIMERS DIS, V41, P387, DOI 10.3233/JAD-122449; Tolbert CE, 2013, CELL ADHES MIGR, V7, P219, DOI 10.4161/cam.23184; Tung YT, 2008, NEUROSCI LETT, V440, P38, DOI 10.1016/j.neulet.2008.05.048; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Wang YP, 2006, J NEURAL TRANSM, V113, P1723, DOI 10.1007/s00702-006-0507-5; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Xiong SL, 2007, ANTIOXID REDOX SIGN, V9, P457, DOI 10.1089/ars.2006.1363; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yin YY, 2010, J ALZHEIMERS DIS, V19, P735, DOI 10.3233/JAD-2010-1272; Zetterberg M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-11; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Zhao ZB, 2014, NEUROSCIENCE, V275, P232, DOI 10.1016/j.neuroscience.2014.06.013	75	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113307	10.1371/journal.pone.0113307	http://dx.doi.org/10.1371/journal.pone.0113307			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485856	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600017
J	Rial, D; Castro, AA; Machado, N; Garcao, P; Goncalves, FQ; Silva, HB; Tome, AR; Kofalvi, A; Corti, O; Raisman-Vozari, R; Cunha, RA; Prediger, RD				Rial, Daniel; Castro, Adalberto A.; Machado, Nuno; Garcao, Pedro; Goncalves, Francisco Q.; Silva, Henrique B.; Tome, Angelo R.; Koefalvi, Attila; Corti, Olga; Raisman-Vozari, Rita; Cunha, Rodrigo A.; Prediger, Rui D.			Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; 2-TRIAL MEMORY TASK; DOPAMINERGIC-NEURONS; MOUSE MODELS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; SYNAPTIC PLASTICITY; SPATIAL MEMORY; RAT MODEL; GENE; IMPAIRMENTS	There is considerable evidence showing that the neurodegenerative processes that lead to sporadic Parkinson's disease (PD) begin many years before the appearance of the characteristic motor symptoms. Neuropsychiatric, sensorial and cognitive deficits are recognized as early non-motor manifestations of PD, and are not attenuated by the current anti-parkinsonian therapy. Although loss-of-function mutations in the parkin gene cause early-onset familial PD, Parkin-deficient mice do not display spontaneous degeneration of the nigrostriatal pathway or enhanced vulnerability to dopaminergic neurotoxins such as 6-OHDA and MPTP. Here, we employed adult homozygous C57BL/6 mice with parkin gene deletion on exon 3 (parkin(-/-)) to further investigate the relevance of Parkin in the regulation of non-motor features, namely olfactory, emotional, cognitive and hippocampal synaptic plasticity. Parkin(-/-) mice displayed normal performance on behavioral tests evaluating olfaction (olfactory discrimination), anxiety (elevated plus-maze), depressive-like behavior (forced swimming and tail suspension) and motor function (rotarod, grasping strength and pole). However, parkin(-/-) mice displayed a poor performance in the open field habituation, object location and modified Y-maze tasks suggestive of procedural and short-term spatial memory deficits. These behavioral impairments were accompanied by impaired hippocampal long-term potentiation (LTP). These findings indicate that the genetic deletion of parkin causes deficiencies in hippocampal synaptic plasticity, resulting in memory deficits with no major olfactory, emotional or motor impairments. Therefore, parkin(-/-) mice may represent a promising animal model to study the early stages of PD and for testing new therapeutic strategies to restore learning and memory and synaptic plasticity impairments in PD.	[Rial, Daniel; Castro, Adalberto A.; Prediger, Rui D.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, BR-88049900 Florianopolis, SC, Brazil; [Rial, Daniel; Machado, Nuno; Garcao, Pedro; Goncalves, Francisco Q.; Silva, Henrique B.; Tome, Angelo R.; Koefalvi, Attila; Cunha, Rodrigo A.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Corti, Olga; Raisman-Vozari, Rita] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere, CRICM, Hop Salpetriere Batiment,ICM,CNRS UMR 7225, F-75651 Paris, France; [Tome, Angelo R.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3000456 Coimbra, Portugal; [Cunha, Rodrigo A.] Univ Coimbra, Fac Med, P-3005504 Coimbra, Portugal	Universidade Federal de Santa Catarina (UFSC); Universidade de Coimbra; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universidade de Coimbra; Universidade de Coimbra	Prediger, RD (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, BR-88049900 Florianopolis, SC, Brazil.	ruidsp@hotmail.com	Prediger, Rui D/C-4036-2013; Rial, Daniel/C-3595-2013; Rial, Daniel/D-3219-2009; Corti, Olga/I-4981-2016; Corti, Olga/AAC-3160-2019; Prediger, Rui Daniel/AAV-3419-2020; Prediger, Rui/CAG-4328-2022; Kofalvi, Attila/O-9815-2017; DE CASTRO, ADALBERTO ALVES/F-7387-2012; Cunha, Rodrigo A/E-7475-2015; da silva, Henrique Bernardo/AAY-4358-2020; Tome, Angelo Jose Ribeiro/AAL-1963-2020; de Jesus Machado, Nuno Miguel/C-3771-2013	Prediger, Rui D/0000-0002-7547-6463; Rial, Daniel/0000-0002-2079-7331; Corti, Olga/0000-0003-2093-7389; Prediger, Rui Daniel/0000-0002-7547-6463; Prediger, Rui/0000-0001-5102-0296; Kofalvi, Attila/0000-0001-6910-9707; DE CASTRO, ADALBERTO ALVES/0000-0002-9828-4894; Cunha, Rodrigo A/0000-0003-2550-6422; da silva, Henrique Bernardo/0000-0002-7234-3411; Tome, Angelo Jose Ribeiro/0000-0001-8671-989X; de Jesus Machado, Nuno Miguel/0000-0001-5097-4231; Queiroz Goncalves, Francisco/0000-0001-8042-0221	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES-COFECUB 681-10]; Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC); QREN [CENTRO-07-ST24-FEDER-002006]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); QREN	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-COFECUB 681-10), Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC), Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC), QREN (CENTRO-07-ST24-FEDER-002006). DR and AAC received scholarships from CNPq. RDP is supported by a research fellowship from CNPq. RRV and RAC are supported by Visitant Research fellowships from CNPq (Ciencia sem Fronteiras). The authors have no financial or personal conflicts of interest related to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AS, 2013, NEUROTOX RES, V24, P280, DOI 10.1007/s12640-013-9389-0; Anders S, 2012, BRAIN, V135, P1128, DOI 10.1093/brain/aws040; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Assini FL, 2009, BEHAV BRAIN RES, V204, P206, DOI 10.1016/j.bbr.2009.06.005; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Bjorklund A, 2010, PROG BRAIN RES, V184, P325, DOI 10.1016/S0079-6123(10)84017-8; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Da Cunha C, 2002, CELL MOL NEUROBIOL, V22, P227, DOI 10.1023/A:1020736131907; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Lau LML, 2006, ARCH NEUROL-CHICAGO, V63, P362, DOI 10.1001/archneur.63.3.noc50312; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Ferreira SG, 2012, NEUROCHEM INT, V61, P219, DOI 10.1016/j.neuint.2012.05.009; Ferreira SG, 2009, NEUROPHARMACOLOGY, V56, P676, DOI 10.1016/j.neuropharm.2008.12.001; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Moreira ELG, 2012, J ALZHEIMERS DIS, V32, P495, DOI 10.3233/JAD-2012-120541; Hanson JE, 2010, NEUROMOL MED, V12, P270, DOI 10.1007/s12017-010-8113-y; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koles L, 2013, BRAIN RES BULL, V97, P126, DOI 10.1016/j.brainresbull.2013.06.007; Kurtenbach S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077509; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCLAMB RL, 1988, NEUROSCI LETT, V94, P338, DOI 10.1016/0304-3940(88)90041-9; Moreira ELG, 2010, J NEURAL TRANSM, V117, P1337, DOI 10.1007/s00702-010-0464-x; Muller A, 2002, J CLIN NEUROSCI, V9, P521, DOI 10.1054/jocn.2001.1071; Niu L, 2009, HIPPOCAMPUS, V19, P649, DOI 10.1002/hipo.20540; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Petit GH, 2011, EUR NEUROPSYCHOPHARM, V21, P211, DOI 10.1016/j.euroneuro.2010.09.010; Pinna A, 2014, NEUROTOX RES, V25, P392, DOI 10.1007/s12640-013-9446-8; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Prediger RD, 2009, NEUROTOX RES; Prediger RDS, 2012, NEUROPHARMACOLOGY, V62, P115, DOI 10.1016/j.neuropharm.2011.08.039; Prediger RDS, 2011, J NEURAL TRANSM, V118, P1215, DOI 10.1007/s00702-010-0568-3; Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Saleewong T, 2012, J INTEGR NEUROSCI, V11, P243, DOI 10.1142/S0219635212500173; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; Scullin CS, 2012, BRAIN RES, V1431, P1, DOI 10.1016/j.brainres.2011.10.035; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Soares E, 2013, NEUROSCIENCE, V250, P565, DOI 10.1016/j.neuroscience.2013.07.055; Stebbins GT, 1999, NEUROPSYCHOLOGIA, V37, P503, DOI 10.1016/S0028-3932(98)00068-2; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Vieira C, 2008, NEUROSCI LETT, V445, P170, DOI 10.1016/j.neulet.2008.09.001; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Zhu XR, 2007, EUR J NEUROSCI, V26, P1902, DOI 10.1111/j.1460-9568.2007.05812.x	69	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e0114216	10.1371/journal.pone.0114216	http://dx.doi.org/10.1371/journal.pone.0114216			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486126	Green Published, gold			2022-12-27	WOS:000346907600046
J	Scheibe, A; Gleixner, G				Scheibe, Andrea; Gleixner, Gerd			Influence of Litter Diversity on Dissolved Organic Matter Release and Soil Carbon Formation in a Mixed Beech Forest	PLOS ONE			English	Article							TEMPERATE DECIDUOUS FOREST; RATIO MASS-SPECTROMETRY; STABLE-ISOTOPE ANALYSIS; FAGUS-SYLVATICA L.; LEAF-LITTER; DECOMPOSITION DYNAMICS; NUTRIENT STOCKS; LIGNIN CONTROL; FOLIAR LITTER; NITROGEN	We investigated the effect of leaf litter on below ground carbon export and soil carbon formation in order to understand how litter diversity affects carbon cycling in forest ecosystems. C-13 labeled and unlabeled leaf litter of beech (Fagus sylvatica) and ash (Fraxinus excelsior), characterized by low and high decomposability, were used in a litter exchange experiment in the Hainich National Park (Thuringia, Germany). Litter was added in pure and mixed treatments with either beech or ash labeled with C-13. We collected soil water in 5 cm mineral soil depth below each treatment biweekly and determined dissolved organic carbon (DOC), delta C-13 values and anion contents. In addition, we measured carbon concentrations and delta C-13 values in the organic and mineral soil (collected in 1 cm increments) up to 5 cm soil depth at the end of the experiment. Litter-derived C contributes less than 1% to dissolved organic matter (DOM) collected in 5 cm mineral soil depth. Better decomposable ash litter released significantly more (0.50 +/- 0.17%) litter carbon than beech litter (0.17 +/- 0.07%). All soil layers held in total around 30% of litter-derived carbon, indicating the large retention potential of litter-derived C in the top soil. Interestingly, in mixed (ash and beech litter) treatments we did not find a higher contribution of better decomposable ash-derived carbon in DOM, O horizon or mineral soil. This suggest that the known selective decomposition of better decomposable litter by soil fauna has no or only minor effects on the release and formation of litter-derived DOM and soil organic matter. Overall our experiment showed that 1) litter-derived carbon is of low importance for dissolved organic carbon release and 2) litter of higher decomposability is faster decomposed, but litter diversity does not influence the carbon flow.	[Scheibe, Andrea; Gleixner, Gerd] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Max Planck Society	Gleixner, G (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	gerd.gleixner@bgc-jena.mpg.de	Gleixner, Gerd/O-4215-2019; Gleixner, Gerd/M-8519-2017	Gleixner, Gerd/0000-0002-4616-0953; Gleixner, Gerd/0000-0002-4616-0953	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work within the Graduate School 1086 was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberic P, 2011, RAPID COMMUN MASS SP, V25, P3012, DOI 10.1002/rcm.5212; [Anonymous], 2011, EUROPEAN HUMUS FORMS; Anthoni PM, 2004, AGR FOREST METEOROL, V121, P55, DOI 10.1016/S0168-1923(03)00162-X; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Dittman JA, 2007, ECOLOGY, V88, P1153, DOI 10.1890/06-0834; Don A, 2005, SOIL BIOL BIOCHEM, V37, P2171, DOI 10.1016/j.soilbio.2005.03.019; Eissfeller V, 2013, THESIS GEORG AUGUST; Fahey TJ, 2011, ECOSYSTEMS, V14, P326, DOI 10.1007/s10021-011-9414-1; Feinstein LM, 2013, MOL ECOL, V22, P1171, DOI 10.1111/mec.12160; Feinstein LM, 2012, ENVIRON MICROBIOL, V14, P1488, DOI 10.1111/j.1462-2920.2012.02737.x; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Froberg M, 2007, EUR J SOIL SCI, V58, P108, DOI 10.1111/j.1365-2389.2006.00812.x; Froberg M, 2006, BIOGEOCHEMISTRY, V77, P1, DOI 10.1007/s10533-004-0564-5; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Gleixner G, 2013, ECOL RES, V28, P683, DOI 10.1007/s11284-012-1022-9; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; GUGGENBERGER G, 1994, ORG GEOCHEM, V21, P51, DOI 10.1016/0146-6380(94)90087-6; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hettmann E, 2007, RAPID COMMUN MASS SP, V21, P4135, DOI 10.1002/rcm.3304; Holzwarth FM, 2011, J PLANT NUTR SOIL SC, V174, P799, DOI 10.1002/jpln.201000369; Hongve D, 2000, EUR J SOIL SCI, V51, P667, DOI 10.1046/j.1365-2389.2000.00339.x; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Kaiser K, 2001, BIOGEOCHEMISTRY, V55, P103, DOI 10.1023/A:1010694032121; Kalbitz K, 2006, EUR J SOIL SCI, V57, P504, DOI 10.1111/j.1365-2389.2006.00797.x; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Kammer A, 2011, BIOGEOSCIENCES, V8, P2195, DOI 10.5194/bg-8-2195-2011; Kammer A, 2012, BIOGEOCHEMISTRY, V108, P395, DOI 10.1007/s10533-011-9607-x; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Kramer C, 2010, SOIL BIOL BIOCHEM, V42, P1028, DOI 10.1016/j.soilbio.2010.02.021; Langenbruch C, 2014, J PLANT NUTR SOIL SC, V177, P178, DOI 10.1002/jpln.201200643; LIECHTY HO, 1995, J ENVIRON QUAL, V24, P927, DOI 10.2134/jeq1995.00472425002400050021x; Malik A, 2013, FEMS MICROBIOL ECOL, V86, P139, DOI 10.1111/1574-6941.12182; Malik A, 2012, ENVIRON SCI TECHNOL, V46, P10123, DOI 10.1021/es302467y; McDowell WH, 2003, GEODERMA, V113, P179, DOI 10.1016/S0016-7061(02)00360-9; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Michalzik B, 1999, EUR J SOIL SCI, V50, P579, DOI 10.1046/j.1365-2389.1999.00267.x; Michalzik B, 2001, BIOGEOCHEMISTRY, V52, P173, DOI 10.1023/A:1006441620810; Moller J, 1999, SOIL BIOL BIOCHEM, V31, P367, DOI 10.1016/S0038-0717(98)00138-2; Muller M, 2009, SOIL BIOL BIOCHEM, V41, P1066, DOI 10.1016/j.soilbio.2009.02.007; Ngao J, 2005, GLOBAL CHANGE BIOL, V11, P1768, DOI 10.1111/j.1365-2486.2004.01014.x; Scheibe A, 2012, RAPID COMMUN MASS SP, V26, P173, DOI 10.1002/rcm.5311; Scheu S, 2005, ECOL STUD-ANAL SYNTH, V176, P211; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Steinbeiss S, 2008, SOIL BIOL BIOCHEM, V40, P2634, DOI 10.1016/j.soilbio.2008.07.007; TIETEMA A, 1994, BIOL FERT SOILS, V18, P49, DOI 10.1007/BF00336444; Toosi ER, 2012, SOIL BIOL BIOCHEM, V50, P12, DOI 10.1016/j.soilbio.2012.02.033; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002	56	13	15	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114040	10.1371/journal.pone.0114040	http://dx.doi.org/10.1371/journal.pone.0114040			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486628	Green Published, gold			2022-12-27	WOS:000346907600038
J	Umeh, CC; Peerez, A; Augustine, EF; Dhall, R; Dewey, RB; Mari, Z; Simon, DK; Wills, AMA; Christine, CW; Schneider, JS; Suchowersky, O				Umeh, Chizoba C.; Perez, Adriana; Augustine, Erika F.; Dhall, Rohit; Dewey, Richard B., Jr.; Mari, Zoltan; Simon, David K.; Wills, Anne-Marie A.; Christine, Chadwick W.; Schneider, Jay S.; Suchowersky, Oksana			No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; GENDER-DIFFERENCES; LEVODOPA; DISPARITIES; DYSKINESIA; STROKE	Background: Sex differences in Parkinson disease clinical features have been reported, but few studies have examined sex influences on use of dopaminergic medication in early Parkinson disease. The objective of this study was to test if there are differences in the type of dopaminergic medication used and levodopa equivalent daily dose between men and women with early Parkinson disease enrolled in a large multicenter study of Creatine as a potential disease modifying therapy - the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson Disease Long-Term Study-1. Methods: Baseline data of 1,741 participants from 45 participating sites were analyzed. Participants from the United States and Canada were enrolled within five years of Parkinson Disease diagnosis. Two outcome variables were studied: type of dopaminergic medication used and levodopa equivalent daily dose at baseline in the Long-Term Study-1. Chi-square statistic and linear regression models were used for statistical analysis. Results: There were no statistically significant differences in the frequency of use of different types of dopaminergic medications at baseline between men and women with Parkinson Disease. A small but statistically significant difference was observed in the median unadjusted levodopa equivalent daily dose at baseline between women (300 mg) and men (325 mg), but this was not observed after controlling for disease duration (years since Parkinson disease diagnosis), disease severity (Unified Parkinson's Disease Rating Scale Motor and Activities of Daily Living Scores), and body weight. Conclusions: In this large multicenter study, we did not observe sex differences in the type and dose of dopaminergic medications used in early Parkinson Disease. Further research is needed to evaluate the influence of male or female sex on use of dopaminergic medication in mid-and late-stage Parkinson Disease.	[Umeh, Chizoba C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Perez, Adriana] Univ Texas Austin, Sch Publ Hlth, Dept Biostat, Austin, TX 78712 USA; [Augustine, Erika F.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Dhall, Rohit] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Dewey, Richard B., Jr.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Mari, Zoltan] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Simon, David K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wills, Anne-Marie A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Christine, Chadwick W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Schneider, Jay S.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Suchowersky, Oksana] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Austin; University of Rochester; Barrow Neurological Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Jefferson University; University of Alberta; University of Alberta; University of Alberta	Umeh, CC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA.	cumeh@partners.org	Dewey, Richard B/A-4288-2013; Mari, Zoltan/ABC-4879-2020	Dewey, Richard B/0000-0002-6615-5035; Dhall, Rohit/0000-0001-9436-1920; Perez, Adriana/0000-0002-6859-9916	NIH [U01NS043128]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U10NS044545, K12NS066098, U01NS043128] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD001779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr. Adriana Perez received financial support from NIH grant U01NS043128. NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, Ann Neurol, V39, P37; [Anonymous], 2011, PARKINSONISM RELAT D, V17, P757; Baba Y, 2005, J NEUROL, V252, P1201, DOI 10.1007/s00415-005-0835-7; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Elm JJ, 2012, MOVEMENT DISORD, V27, P1513, DOI 10.1002/mds.25175; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Lyons KE, 1998, CLIN NEUROPHARMACOL, V21, P118; Nyholm D, 2010, EUR J NEUROL, V17, P260, DOI 10.1111/j.1468-1331.2009.02866.x; Olanow CW, 2013, MOVEMENT DISORD, V28, P1064, DOI 10.1002/mds.25364; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Saunders-Pullman R, 1999, NEUROLOGY, V52, P1417, DOI 10.1212/WNL.52.7.1417; SESSION DR, 1994, MED HYPOTHESES, V42, P280, DOI 10.1016/0306-9877(94)90133-3; Shulman Lisa M, 2006, Expert Rev Neurother, V6, P407; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tsang KL, 2000, NEUROLOGY, V54, P2292, DOI 10.1212/WNL.54.12.2292; Willis AW, 2014, NEUROLOGY, V82, P163, DOI 10.1212/WNL.0000000000000017; Zappia M, 2002, CLIN NEUROPHARMACOL, V25, P79, DOI 10.1097/00002826-200203000-00004	21	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112287	10.1371/journal.pone.0112287	http://dx.doi.org/10.1371/journal.pone.0112287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486269	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600009
J	Borruel, S; Molto, JF; Alpanes, M; Fernandez-Duran, E; Alvarez-Blasco, F; Luque-Ramirez, M; Escobar-Morreale, HF				Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.			Surrogate Markers of Visceral Adiposity in Young Adults: Waist Circumference and Body Mass Index Are More Accurate than Waist Hip Ratio, Model of Adipose Distribution and Visceral Adiposity Index	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; FAT THICKNESS; RISK-FACTORS; OBESITY; ULTRASONOGRAPHY; WOMEN; TISSUE	Surrogate indexes of visceral adiposity, a major risk factor for metabolic and cardiovascular disorders, are routinely used in clinical practice because objective measurements of visceral adiposity are expensive, may involve exposure to radiation, and their availability is limited. We compared several surrogate indexes of visceral adiposity with ultrasound assessment of subcutaneous and visceral adipose tissue depots in 99 young Caucasian adults, including 20 women without androgen excess, 53 women with polycystic ovary syndrome, and 26 men. Obesity was present in 7, 21, and 7 subjects, respectively. We obtained body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), model of adipose distribution (MOAD), visceral adiposity index (VAI), and ultrasound measurements of subcutaneous and visceral adipose tissue depots and hepatic steatosis. WC and BMI showed the strongest correlations with ultrasound measurements of visceral adiposity. Only WHR correlated with sex hormones. Linear stepwise regression models including VAI were only slightly stronger than models including BMI or WC in explaining the variability in the insulin sensitivity index (yet BMI and WC had higher individual standardized coefficients of regression), and these models were superior to those including WHR and MOAD. WC showed 0.94 (95% confidence interval 0.88-0.99) and BMI showed 0.91 (0.85-0.98) probability of identifying the presence of hepatic steatosis according to receiver operating characteristic curve analysis. In conclusion, WC and BMI not only the simplest to obtain, but are also the most accurate surrogate markers of visceral adiposity in young adults, and are good indicators of insulin resistance and powerful predictors of the presence of hepatic steatosis.	[Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Univ Alcala, Dept Endocrinol & Nutr, Madrid, Spain; [Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Hosp Univ Ramo & Cajal, Madrid, Spain; [Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Borruel, Susana; Molto, Jose F.] Hosp Univ 12 Octubre, Dept Radiol, Madrid, Spain	Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario 12 de Octubre	Escobar-Morreale, HF (corresponding author), Univ Alcala, Dept Endocrinol & Nutr, Madrid, Spain.	hectorfrancisco.escobar@salud.madrid.org	Ramírez, Manuel Luque/G-5037-2015; Luque-Ramírez, Manuel/AAG-4264-2019; Escobar-Morreale, Héctor F/G-5468-2010; Ramírez, Manuel Luque/AAN-6775-2021	Ramírez, Manuel Luque/0000-0002-6002-4237; Luque-Ramírez, Manuel/0000-0002-6002-4237; Escobar-Morreale, Héctor F/0000-0002-6890-1644; 	Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness [FIS PI080944, PI1100357]; Direccion General de Farmacia, Spanish Ministry of Health, Social Services and Equality, Spain [EC10-096]	Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness(Spanish Government); Direccion General de Farmacia, Spanish Ministry of Health, Social Services and Equality, Spain	This study was supported by grants FIS PI080944 & PI1100357 from Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, and grant EC10-096 from Direccion General de Farmacia, Spanish Ministry of Health, Social Services and Equality, Spain. The sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Ahn SG, 2008, HEART, V94, DOI 10.1136/hrt.2007.118471; Al-Daghri NM, 2013, EUR J CLIN INVEST, V43, P183, DOI 10.1111/eci.12030; Al-Daghri NM, 2013, PEDIAT RES; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Bjorntorp P, 1993, Obes Res, V1, P206; Borruel S, 2013, J CLIN ENDOCR METAB, V98, P1254, DOI 10.1210/jc.2012-3698; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Corona G, 2011, J ENDOCRINOL INVEST, V34, P557, DOI 10.3275/7806; Du T, 2013, INT J OBES; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Escobar-Morreale HF, 2008, J CLIN ENDOCR METAB, V93, P527, DOI 10.1210/jc.2007-2053; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Escobar-Morreale HF, 2000, FERTIL STERIL, V74, P816, DOI 10.1016/S0015-0282(00)00718-4; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Ferrannini E, 2008, EUR HEART J SUPPL, V10, pB4, DOI 10.1093/eurheartj/sum042; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Kim SK, 2004, AM J CLIN NUTR, V79, P593; KISSEBAH AH, 1991, INT J OBESITY, V15, P109; Lee M, 2007, AM J CARDIOL, V99, p68B, DOI 10.1016/j.amjcard.2006.11.007; LEMIEUX S, 1994, DIABETES METAB, V20, P375; Liu KH, 2003, INT J OBESITY, V27, P1267, DOI 10.1038/sj.ijo.0802398; Luyckx FH, 2000, DIABETES METAB, V26, P98; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mazzuca E, 2013, J SLEEP RES; Mohammadreza B, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-20; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Ribeiro FF, 2001, HYPERTENSION, V38, P713, DOI 10.1161/01.HYP.38.3.713; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Vongsuvanh R, 2012, J HEPATOL, V57, P392, DOI 10.1016/j.jhep.2012.03.013; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	37	62	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114112	10.1371/journal.pone.0114112	http://dx.doi.org/10.1371/journal.pone.0114112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479351	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200043
J	Flowers, BM; Rusnak, LE; Wong, KE; Banks, DA; Munyikwa, MR; McFarland, AG; Hinton, SD				Flowers, Brittany M.; Rusnak, Lauren E.; Wong, Kristen E.; Banks, Dallas A.; Munyikwa, Michelle R.; McFarland, Alexander G.; Hinton, Shanta D.			The Pseudophosphatase MK-STYX Induces Neurite-Like Outgrowths in PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; DUAL-SPECIFICITY PHOSPHATASE; SIGNAL-REGULATED KINASE; RNA-BINDING-PROTEIN; MAP KINASE; NEURONAL DIFFERENTIATION; ACTIN DYNAMICS; MESSENGER-RNA; PC-12 CELLS	The rat pheochromocytoma PC12 cell line is a widely used system to study neuronal differentiation for which sustained activation of the extracellular signaling related kinase (ERK) pathway is required. Here, we investigate the function of MK-STYX [MAPK (mitogen-activated protein kinase) phosphoserine/threonine/tyrosine-binding protein] in neuronal differentiation. MK-STYX is a member of the MAPK phosphatase (MKP) family, which is generally responsible for dephosphorylating the ERKs. However, MK-STYX lacks catalytic activity due to the absence of the nucleophilic cysteine in the active site signature motif HC(X-5)R that is essential for phosphatase activity. Despite being catalytically inactive, MK-STYX has been shown to play a role in important cellular pathways, including stress responses. Here we show that PC12 cells endogenously express MK-STYX. In addition, MK-STYX, but not its catalytically active mutant, induced neurite-like outgrowths in PC12 cells. Furthermore, MK-STYX dramatically increased the number of cells with neurite extensions in response to nerve growth factor (NGF), whereas the catalytically active mutant did not. MK-STYX continued to induce neurites in the presence of a MEK (MAP kinase kinase) inhibitor suggesting that MK-STYX does not act through the Ras-ERK/MAPK pathway but is involved in another pathway whose inactivation leads to neuronal differentiation. RhoA activity assays indicated that MK-STYX induced extensions through the Rho signaling pathway. MK-STYX decreased RhoA activation, whereas RhoA activation increased when MK-STYX was down-regulated. Furthermore, MK-STYX affected downstream players of RhoA such as the actin binding protein cofilin. The presence of MK-STYX decreased the phosphorylation of cofilin in non NGF stimulated cells, but increased its phosphorylation in NGF stimulated cells, whereas knocking down MK-STYX caused an opposite effect. Taken together our data suggest that MK-STYX may be a regulator of RhoA signaling, and implicate this pseudophosphatase as a regulator of neuronal differentiation.	[Flowers, Brittany M.; Rusnak, Lauren E.; Wong, Kristen E.; Banks, Dallas A.; Munyikwa, Michelle R.; McFarland, Alexander G.; Hinton, Shanta D.] Coll William & Mary, Dept Biol, Integrated Sci Ctr, Williamsburg, VA 23185 USA	William & Mary	Hinton, SD (corresponding author), Coll William & Mary, Dept Biol, Integrated Sci Ctr, Williamsburg, VA 23185 USA.	sdhinton@wm.edu	Flowers, Brittany/AAK-3757-2021	Wong, Kristen/0000-0002-7497-9835; Banks, Dallas/0000-0002-1873-2387; Munyikwa, Michelle/0000-0003-0794-1754	National Science Foundation Grant (NSF) [MCB1113167]; Women in Scientific Education grant from NSF; James Monroe Scholars Program at the College of William and Mary; Howard Hughes Medical Research Institute grant through the Undergraduate Science Education Program	National Science Foundation Grant (NSF)(National Science Foundation (NSF)); Women in Scientific Education grant from NSF; James Monroe Scholars Program at the College of William and Mary; Howard Hughes Medical Research Institute grant through the Undergraduate Science Education Program	This work was supported by the National Science Foundation Grant (NSF) MCB1113167 to S.D.H., a Women in Scientific Education grant from NSF awarded to the College of William and Mary, Graduate Research Scholarship to L.E.R., James Monroe Scholars Program at the College of William and Mary to K.E.W., and by a Howard Hughes Medical Research Institute grant through the Undergraduate Science Education Program to the College of William and Mary to D.A.B., B.M.F., A.G.M., M.R.M, and K.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barr JE, 2013, FEBS J, V280, P273, DOI 10.1111/febs.12068; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bluthgen N, 2009, FEBS J, V276, P1024, DOI 10.1111/j.1742-4658.2008.06846.x; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hinton SD, 2010, BIOCHEM J, V427, P349, DOI 10.1042/BJ20091383; Ho WC, 2001, EXP CELL RES, V263, P254, DOI 10.1006/excr.2000.5112; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Jeon CY, 2010, EXP MOL MED, V42, P335, DOI 10.3858/emm.2010.42.5.035; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Keegan K, 1993, Curr Opin Neurobiol, V3, P14, DOI 10.1016/0959-4388(93)90029-X; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KONDRATYEV AD, 1990, FEBS LETT, V264, P75, DOI 10.1016/0014-5793(90)80768-E; Liu RY, 2002, MOL CELL NEUROSCI, V20, P2, DOI 10.1006/mcne.2002.1107; Martin S, 2013, J NEUROCHEM; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Niemi NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093896; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pazman C, 2000, DEVELOPMENT, V127, P1715; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; Reiterer V, 2014, TRENDS CELL BIOL; Reiterer V, 2013, P NATL ACAD SCI USA, V110, pE2934, DOI 10.1073/pnas.1301985110; Samstag Y, 2013, IMMUNOL REV, V256, P30, DOI 10.1111/imr.12115; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Talens-Visconti R, 2010, J NEUROCHEM, V112, P1074, DOI 10.1111/j.1471-4159.2009.06526.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tonks NK, 2009, CELL, V139, P464, DOI 10.1016/j.cell.2009.10.008; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; WISHART MJ, 1995, J BIOL CHEM, V270, P26782, DOI 10.1074/jbc.270.45.26782; Wishart MJ, 2002, P NATL ACAD SCI USA, V99, P2112, DOI 10.1073/pnas.251686198; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang H, 2007, AM J PHYSIOL-RENAL, V293, pF148, DOI 10.1152/ajprenal.00294.2006; Zhang Z, 2006, CELL MOL BIOL LETT, V11, P12, DOI 10.2478/s11658-006-0002-x	68	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114535	10.1371/journal.pone.0114535	http://dx.doi.org/10.1371/journal.pone.0114535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479605	gold, Green Published			2022-12-27	WOS:000346907200099
J	Rahmandad, H				Rahmandad, Hazhir			Human Growth and Body Weight Dynamics: An Integrative Systems Model	PLOS ONE			English	Article							RESTING METABOLIC-RATE; PHYSICAL-ACTIVITY LEVEL; CATCH-UP GROWTH; ENERGY-EXPENDITURE; FAT DISTRIBUTION; REFERENCE CHILD; OBESITY; MASS; REQUIREMENTS; OVERWEIGHT	Quantifying human weight and height dynamics due to growth, aging, and energy balance can inform clinical practice and policy analysis. This paper presents the first mechanism-based model spanning full individual life and capturing changes in body weight, composition and height. Integrating previous empirical and modeling findings and validated against several additional empirical studies, the model replicates key trends in human growth including A) Changes in energy requirements from birth to old ages. B) Short and long-term dynamics of body weight and composition. C) Stunted growth with chronic malnutrition and potential for catch up growth. From obesity policy analysis to treating malnutrition and tracking growth trajectories, the model can address diverse policy questions. For example I find that even without further rise in obesity, the gap between healthy and actual Body Mass Indexes (BMIs) has embedded, for different population groups, a surplus of 14%-24% in energy intake which will be a source of significant inertia in obesity trends. In another analysis, energy deficit percentage needed to reduce BMI by one unit is found to be relatively constant across ages. Accompanying documented and freely available simulation model facilitates diverse applications customized to different sub-populations.	[Rahmandad, Hazhir] Virginia Tech, Ind & Syst Engn Dept, Falls Church, VA 22043 USA; [Rahmandad, Hazhir] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Rahmandad, H (corresponding author), Virginia Tech, Ind & Syst Engn Dept, Falls Church, VA 22043 USA.	hazhir@vt.edu	Rahmandad, Hazhir/B-4474-2013	Rahmandad, Hazhir/0000-0002-2784-9042	National Institutes of Health, Office of Behavioral and Social Science Research [HHSN276201000004C, 1R21HL113680-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL113680] Funding Source: NIH RePORTER	National Institutes of Health, Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this project was provided through National Institutes of Health, Office of Behavioral and Social Science Research contract HHSN276201000004C and 1R21HL113680-01. The author received no other funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN PHILIP L., 1962; Boersma B, 1997, ENDOCR REV, V18, P646, DOI 10.1210/er.18.5.646; Brady I, 2014, OBESITY, V22, P1939, DOI 10.1002/oby.20804; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Butte NF, 2000, PEDIATR RES, V47, P578, DOI 10.1203/00006450-200005000-00004; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P953, DOI 10.1079/PHN2005790; Carberry AE, 2010, PEDIATR RES, V68, P84, DOI [10.1203/PDR.0b013e3181df5421, 10.1203/00006450-201011001-00161]; CDC, 2013, NAT HLTH NUTR EX SUR; Christiansen E, 2005, J THEOR BIOL, V234, P99, DOI 10.1016/j.jtbi.2004.11.012; Doucet E, 2001, BRIT J NUTR, V85, P715, DOI 10.1079/BJN2001348; Ellis KJ, 2000, ANN NY ACAD SCI, V904, P374; Fields DA, 2009, GENDER MED, V6, P369, DOI 10.1016/j.genm.2009.07.003; Flatt JP, 2004, OBES RES, V12, P2013, DOI 10.1038/oby.2004.252; FORBES GB, 1987, NUTR REV, V45, P225; Gobel B, 2014, OBESITY, V22, P2105, DOI 10.1002/oby.20813; Gutierrez RG, 2003, STATA J, V3, P412; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2013, LANCET DIABETES ENDO, V1, P97, DOI 10.1016/S2213-8587(13)70051-2; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Kuczmarski R J, 2000, Adv Data, P1; Luhrmann PM, 2001, METABOLISM, V50, P972, DOI 10.1053/meta.2001.24871; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; POEHLMAN ET, 1992, METABOLISM, V41, P915, DOI 10.1016/0026-0495(92)90177-C; POEHLMAN ET, 1993, AM J PHYSIOL, V264, pE450, DOI 10.1152/ajpendo.1993.264.3.E450; Rahmandad H, 2012, RES SOC SCI INT SYST; Salbe AD, 2002, PEDIATRICS, V110, P307, DOI 10.1542/peds.110.2.307; Spadano JL, 2005, AM J CLIN NUTR, V81, P1102; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Talbot FB, 1938, AM J DIS CHILD, V55, P455; Tennefors C, 2003, EUR J CLIN NUTR, V57, P647, DOI 10.1038/sj.ejcn.1601591; Torun B, 2005, PUBLIC HEALTH NUTR, V8, P968, DOI 10.1079/PHN2005791; VISSER M, 1995, AM J CLIN NUTR, V61, P772, DOI 10.1093/ajcn/61.4.772; WADDINGTON C. H., 1957, The strategy of the genes. A discussion of some aspects of theoretical biology. With an appendix by H. Kacser.; WALKER SP, 1988, EUR J CLIN NUTR, V42, P395; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZM, 2012, AM J HUM BIOL, V24, P460, DOI 10.1002/ajhb.22246; Wang ZM, 2005, AM J CLIN NUTR, V81, P799, DOI 10.1093/ajcn/81.4.799; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wells JCK, 2012, AM J CLIN NUTR, V96, P1316, DOI 10.3945/ajcn.112.036970; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229	43	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114609	10.1371/journal.pone.0114609	http://dx.doi.org/10.1371/journal.pone.0114609			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479101	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200108
J	Hoo, R; Lam, JH; Huot, L; Pant, A; Li, R; Hot, D; Alonso, S				Hoo, Regina; Lam, Jian Hang; Huot, Ludovic; Pant, Aakanksha; Li, Rui; Hot, David; Alonso, Sylvie			Evidence for a Role of the Polysaccharide Capsule Transport Proteins in Pertussis Pathogenesis	PLOS ONE			English	Article							ESCHERICHIA-COLI K1; 2-COMPONENT SENSOR PROTEIN; ATP-BINDING COMPONENT; BORDETELLA-PERTUSSIS; BIOFILM FORMATION; BVGAS PHOSPHORELAY; BPS POLYSACCHARIDE; ABC-TRANSPORTER; POLYSIALIC ACID; IN-VIVO	Polysaccharide (PS) capsules are important virulence determinants for many bacterial pathogens. Bordetella pertussis, the agent of whooping cough, produces a surface associated microcapsule but its role in pertussis pathogenesis remained unknown. Here we showed that the B. pertussis capsule locus is expressed in vivo in murine lungs and that absence of the membrane-associated protein KpsT, involved in the transport of the PS polymers across the envelope, but not the surface-exposed PS capsule itself, affects drastically B. pertussis colonization efficacy in mice. Microarray analysis revealed that absence of KpsT in B. pertussis resulted in global down-regulation of gene expression including key virulence genes regulated by BvgA/S, the master two-component system. Using a BvgS phase-locked mutant, we demonstrated a functional link between KpsT and BvgA/S-mediated signal transduction. Whereas pull-down assays do not support physical interaction between BvgS sensor and any of the capsule locus encoded proteins, absence of KpsT impaired BvgS oligomerization, necessary for BvgS function. Furthermore, complementation studies indicated that instead of KpsT alone, the entire PS capsule transport machinery spanning the cell envelope likely plays a role in BvgS-mediated signal transduction. Our work thus provides the first experimental evidence of a role for a virulence-repressed gene in pertussis pathogenesis.	[Hoo, Regina; Lam, Jian Hang; Pant, Aakanksha; Li, Rui; Alonso, Sylvie] Natl Univ Singapore, Dept Microbiol, Immunol Programme, Yong Loo Lin Sch Med,Ctr Life Sci 03 05, 28 Med Dr, Singapore 117597, Singapore; [Huot, Ludovic; Hot, David] Inst Pasteur, CIIL, U1019, UMR8204, F-59019 Lille, France	National University of Singapore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Alonso, S (corresponding author), Natl Univ Singapore, Dept Microbiol, Immunol Programme, Yong Loo Lin Sch Med,Ctr Life Sci 03 05, 28 Med Dr, Singapore 117597, Singapore.	micas@nus.edu.sg	; Hot, David/M-6775-2016	Pant, Aakanksha/0000-0002-1123-2638; Hoo, Regina/0000-0002-0295-9472; Hot, David/0000-0002-2361-0616	Singapore Ministry of Education [MOE2009-T2-2-014]	Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by the Singapore Ministry of Education (MOE2009-T2-2-014 grant allocated to SA.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2001, INFECT IMMUN, V69, P6038, DOI 10.1128/IAI.69.10.6038-6043.2001; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; ANTOINE R, 1990, INFECT IMMUN, V58, P1518, DOI 10.1128/IAI.58.6.1518-1526.1990; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; BEATTIE DT, 1992, INFECT IMMUN, V60, P571, DOI 10.1128/IAI.60.2.571-577.1992; BEIER D, 1995, J MOL BIOL, V248, P596, DOI 10.1006/jmbi.1995.0245; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Bliss JM, 1996, GLYCOBIOLOGY, V6, P445, DOI 10.1093/glycob/6.4.445; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; de Tejada GM, 1998, INFECT IMMUN, V66, P2762, DOI 10.1128/IAI.66.6.2762-2768.1998; DOMENICO P, 1994, INFECT IMMUN, V62, P4495, DOI 10.1128/IAI.62.10.4495-4499.1994; Dupre E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-172; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; Eguchi Y, 2007, P NATL ACAD SCI USA, V104, P18712, DOI 10.1073/pnas.0705768104; ELZER PH, 1995, PLASMID, V33, P51, DOI 10.1006/plas.1995.1006; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Gokhale RS, 1996, BIOCHEMISTRY-US, V35, P7150, DOI 10.1021/bi952890e; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Ho SY, 2008, INFECT IMMUN, V76, P111, DOI 10.1128/IAI.00795-07; Hot D, 2003, MOL GENET GENOMICS, V269, P475, DOI 10.1007/s00438-003-0851-1; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lippa AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000788; Lonnstedt I, 2002, STAT SINICA, V12, P31; Maeda S, 2006, J BIOL CHEM, V281, P37868, DOI 10.1074/jbc.M608680200; MAKINO S, 1981, J BIOCHEM-TOKYO, V89, P651, DOI 10.1093/oxfordjournals.jbchem.a133242; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Merkel TJ, 2003, J BACTERIOL, V185, P6902, DOI 10.1128/JB.185.23.6902-6912.2003; MILLER JF, 1992, J BACTERIOL, V174, P970, DOI 10.1128/jb.174.3.970-979.1992; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; Neo YL, 2010, MICROBES INFECT, V12, P238, DOI 10.1016/j.micinf.2009.12.002; Otto M, 2006, CURR TOP MICROBIOL, V306, P251; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PAVELKA MS, 1994, J BIOL CHEM, V269, P20149; Perraud AL, 2000, BBA-PROTEIN STRUCT M, V1478, P341, DOI 10.1016/S0167-4838(00)00052-2; PIGEON RP, 1994, MOL MICROBIOL, V14, P871, DOI 10.1111/j.1365-2958.1994.tb01323.x; Raffatellu M, 2006, INFECT IMMUN, V74, P19, DOI 10.1128/IAI.74.1.19-27.2006; Reckseidler-Zenteno SL, 2005, INFECT IMMUN, V73, P1106, DOI 10.1128/IAI.73.2.1106-1115.2005; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; ROY CR, 1991, J BACTERIOL, V173, P2385, DOI 10.1128/JB.173.7.2385-2392.1991; Scheu PD, 2010, J BACTERIOL, V192, P3474, DOI 10.1128/JB.00082-10; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Shukla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035984; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Soufi A, 2006, J MOL BIOL, V358, P943, DOI 10.1016/j.jmb.2006.02.020; Steffen P, 1996, EMBO J, V15, P102, DOI 10.1002/j.1460-2075.1996.tb00338.x; Stenson TH, 2005, INFECT IMMUN, V73, P5995, DOI 10.1128/IAI.73.9.5995-6004.2005; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STRAUSS EJ, 1995, CURR BIOL, V5, P706, DOI 10.1016/S0960-9822(95)00139-4; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; Veal-Carr WL, 2005, MOL MICROBIOL, V55, P788, DOI 10.1111/j.1365-2958.2004.04418.x; Williams CL, 2007, J BACTERIOL, V189, P1974, DOI 10.1128/JB.01684-06; Zu T, 1996, MOL MICROBIOL, V21, P557, DOI 10.1111/j.1365-2958.1996.tb02564.x	72	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115243	10.1371/journal.pone.0115243	http://dx.doi.org/10.1371/journal.pone.0115243			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501560	gold, Green Published			2022-12-27	WOS:000346375400087
J	Bordonaro, M; Drago, E; Atamna, W; Lazarova, DL				Bordonaro, Michael; Drago, Eric; Atamna, Wafa; Lazarova, Darina L.			Comprehensive Suppression of All Apoptosis-Induced Proliferation Pathways as a Proposed Approach to Colorectal Cancer Prevention and Therapy	PLOS ONE			English	Article							AZD6244 ARRY-142886; BETA-CATENIN; WNT ACTIVITY; CELL-DEATH; INHIBITOR; COFFEE; RISK; COMBINATION; ANTITUMOR; BUTYRATE	Mutations in the WNT/beta-catenin pathway are present in the majority of all sporadic colorectal cancers (CRCs), and histone deacetylase inhibitors induce apoptosis in CRC cells with such mutations. This apoptosis is counteracted by (1) the signaling heterogeneity of CRC cell populations, and (2) the survival pathways induced by mitogens secreted from apoptotic cells. The phenomena of signaling heterogeneity and apoptosis-induced survival constitute the immediate mechanisms of resistance to histone deacetylase inhibitors, and probably other chemotherapeutic agents. We explored the strategy of augmenting CRC cell death by inhibiting all survival pathways induced by the pro-apoptotic agent LBH589, a histone deacetylase inhibitor: AKT, JAK/STAT, and ERK signaling. The apoptosis-enhancing ability of a cocktail of synthetic inhibitors of proliferation was compared to the effects of the natural product propolis. We utilized colorectal adenoma, drug-sensitive and drug-resistant colorectal carcinoma cells to evaluate the apoptotic potential of the combination treatments. The results suggest that an effective approach to CRC combination therapy is to combine apoptosis-inducing drugs (e.g., histone deacetylase inhibitors, such as LBH589) with agents that suppress all compensatory survival pathways induced during apoptosis (such as the cocktail of inhibitors of apoptosis-associated proliferation). The same paradigm can be applied to a CRC prevention approach, as the apoptotic effect of butyrate, a diet-derived histone deacetylase inhibitor, is augmented by other dietary agents that modulate survival pathways (e.g., propolis and coffee extract). Thus, dietary supplements composed by fermentable fiber, propolis, and coffee extract may effectively counteract neoplastic growth in the colon.	[Bordonaro, Michael; Drago, Eric; Lazarova, Darina L.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Atamna, Wafa] Calif Northstate Univ, Coll Med, Elk Grove, CA 95757 USA	Geisinger Commonwealth School of Medicine	Lazarova, DL (corresponding author), Commonwealth Med Coll, Dept Basic Sci, 525 Pine St, Scranton, PA 18509 USA.	dlazarova@tcmedc.org			National Institutes of Health [1R15CA152852-01]; NATIONAL CANCER INSTITUTE [R15CA152852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (1R15CA152852-01, Lazarova). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Ruiz RB, 2014, MATURITAS, V77, P202, DOI 10.1016/j.maturitas.2013.11.010; Bergmann A, 2010, INT J RADIAT BIOL, V53, P95; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Bordonaro M, 2011, EXP CELL RES, V317, P1368, DOI 10.1016/j.yexcr.2011.03.019; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Dent P, 2009, DRUG RESIST UPDATE, V12, P65, DOI 10.1016/j.drup.2009.03.001; Drago E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073151; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Holt SV, 2012, BRIT J CANCER, V106, P858, DOI 10.1038/bjc.2012.8; Huang D, 2008, WORLD J GASTROENTERO, V14, P1823, DOI 10.3748/wjg.14.1823; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022; Kautenburger T, 2005, J CANCER RES CLIN, V131, P692, DOI 10.1007/s00432-005-0013-4; Lazarova D, 2014, J CANCER, V5, P203, DOI 10.7150/jca.8569; Lazarova DL, 2004, INT J CANCER, V110, P523, DOI 10.1002/ijc.20152; Lazarova DL, 2001, CELL GROWTH DIFFER, V12, P319; Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/c4fo00042k, 10.1039/C4FO00042K]; Murugaesu N, 2013, AM J PATHOL, V182, P1962, DOI 10.1016/j.ajpath.2013.02.026; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Richter M, 2002, EUR J CANCER, V38, P1937, DOI 10.1016/S0959-8049(02)00158-2; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Schiller C, 2005, ALIMENT PHARM THER, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shen T, 2010, BIOL PHARM BULL, V33, P128, DOI 10.1248/bpb.33.128; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328; Sobocanec S, 2011, PHYTOMEDICINE, V18, P852, DOI 10.1016/j.phymed.2011.01.015; Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Suzuki I, 2002, CANCER BIOTHER RADIO, V17, P553, DOI 10.1089/108497802760804781; Valerie K, 2007, MOL CANCER THER, V6, P789, DOI 10.1158/1535-7163.MCT-06-0596; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Wang ZJ, 2013, WORLD J GASTROENTERO, V19, P2683, DOI 10.3748/wjg.v19.i17.2683; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ INT RE; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	45	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115068	10.1371/journal.pone.0115068	http://dx.doi.org/10.1371/journal.pone.0115068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500581	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700091
J	Gabbe, BJ; Simpson, PM; Lyons, RA; Ameratunga, S; Harrison, JE; Derrett, S; Polinder, S; Davie, G; Rivara, FP				Gabbe, Belinda J.; Simpson, Pam M.; Lyons, Ronan A.; Ameratunga, Shanthi; Harrison, James E.; Derrett, Sarah; Polinder, Suzanne; Davie, Gabrielle; Rivara, Frederick P.			Association between the Number of Injuries Sustained and 12-Month Disability Outcomes: Evidence from the Injury-VIBES Study	PLOS ONE			English	Article							SEVERE MULTIPLE INJURIES; QUALITY-OF-LIFE; TRAUMA REGISTRY; MAJOR TRAUMA; FUNCTIONAL CONSEQUENCES; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; HEALTH-STATUS; BRAIN-INJURY; DISEASE	Objective: To determine associations between the number of injuries sustained and three measures of disability 12-months post-injury for hospitalised patients. Methods: Data from 27,840 adult (18+ years) participants, hospitalised for injury, were extracted for analysis from the Validating and Improving injury Burden Estimates (Injury-VIBES) Study. Modified Poisson and linear regression analyses were used to estimate relative risks and mean differences, respectively, for a range of outcomes (Glasgow Outcome Scale-Extended, GOS-E; EQ-5D and 12-item Short Form health survey physical and mental component summary scores, PCS-12 and MCS-12) according to the number of injuries sustained, adjusted for age, sex and contributing study. Findings: More than half (54%) of patients had an injury to more than one ICD-10 body region and 62% had sustained more than one Global Burden of Disease injury type. The adjusted relative risk of a poor functional recovery (GOS-E<7) and of reporting problems on each of the items of the EQ-5D increased by 5-10% for each additional injury type, or body region, injured. Adjusted mean PCS-12 and MCS-12 scores worsened with each additional injury type, or body region, injured by 1.3-1.5 points and 0.5 points, respectively. Conclusions: Consistent and strong relationships exist between the number of injury types and body regions injured and 12-month functional and health status outcomes. Existing composite measures of anatomical injury severity such as the NISS or ISS, which use up to three diagnoses only, may be insufficient for characterising or accounting for multiple injuries in disability studies. Future studies should consider the impact of multiple injuries to avoid under-estimation of injury burden.	[Gabbe, Belinda J.; Simpson, Pam M.; Lyons, Ronan A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Gabbe, Belinda J.; Lyons, Ronan A.] Swansea Univ, Ctr Improvement Populat Hlth E Records Res, Swansea, W Glam, Wales; [Lyons, Ronan A.] Publ Hlth Wales NHS Trust, Cardiff, S Glam, Wales; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand; [Harrison, James E.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA 5001, Australia; [Derrett, Sarah; Davie, Gabrielle] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand; [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Hlth & Social Serv, Palmerston North, New Zealand; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Monash University; Swansea University; University of Auckland; Flinders University South Australia; University of Otago; Massey University; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gabbe, BJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	belinda.gabbe@monash.edu	Harrison, James/B-8958-2009	Harrison, James/0000-0001-9893-8491; Davie, Gabrielle/0000-0001-5466-5364; Lyons, Ronan/0000-0001-5225-000X; Gabbe, Belinda/0000-0001-7096-7688; Derrett, Sarah/0000-0003-2867-0498; Ameratunga, Shanthi/0000-0001-8042-2251	National Health and Medical Research Council (NHMRC) of Australia [GNT1021861]; Health Research Council of New Zealand; Accident Compensation Corporation, New Zealand; Department of Health, State Government of Victoria; TAC through the Institute for Safety, Compensation and Recovery Research; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention [R49/CCR316840]; National Institutes of Health [R01/AG20361]; NHMRC [APP1048731]; Transport Accident Commission (TAC); MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); Accident Compensation Corporation, New Zealand; Department of Health, State Government of Victoria; TAC through the Institute for Safety, Compensation and Recovery Research; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission (TAC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Injury-VIBES project is funded by the National Health and Medical Research Council (NHMRC) of Australia (GNT1021861, www.nhmrc.gov.au). The POIS study is funded by the Health Research Council of New Zealand (2007-2013, www.hrc.govt.nz), and was co-funded by the Accident Compensation Corporation, New Zealand (2007-2010, acc.co.nz). The Victorian State Trauma Registry is a Department of Health, State Government of Victoria and Transport Accident Commission (TAC) funded project (www.tac.vic.gov.au, www.health.vic.gov.au). The Victorian Orthopaedic Trauma Outcomes Registry is funded by the TAC through the Institute for Safety, Compensation and Recovery Research (www.iscrr.com.au). The NSCOT was funded by the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention (Grant R49/CCR316840, www.cdc.gov/Injury) and the National Institutes of Health (Grant #R01/AG20361, www.nih.gov). Belinda Gabbe is supported by a Career Development Fellowship from the NHMRC (APP1048731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson-Daniel L, 2003, INJURY PREV, V9, P156, DOI 10.1136/ip.9.2.156; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558a, 10.1136/ip.2009.022558]; Derrett S, 2009, J TRAUMA, V67, P883, DOI 10.1097/TA.0b013e3181ae6409; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Edwards ER, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2005.02.027; Gabbe BJ, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-040936; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Holtslag HR, 2007, INJURY, V38, P280, DOI 10.1016/j.injury.2006.10.026; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Macpherson AK, 2003, J TRAUMA, V55, P454, DOI 10.1097/01.TA.0000042158.79688.51; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Putz C, 2011, SPINAL CORD, V49, P721, DOI 10.1038/sc.2010.181; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Scivoletto G, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-42; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Soberg HL, 2007, J TRAUMA, V62, P471, DOI 10.1097/TA.0b013e31802e95f4; Van Beeck EF, 2007, J TRAUMA, V62, P534, DOI 10.1097/TA.0b013e31802e70c7; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Ware J., 1998, SF 12 SCORE SF 12 PH; Weninger P, 2008, J TRAUMA, V65, P799, DOI 10.1097/TA.0b013e3181820dae; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113467	10.1371/journal.pone.0113467	http://dx.doi.org/10.1371/journal.pone.0113467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501651	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700008
J	Barene, S; Krustrup, P; Holtermann, A				Barene, Svein; Krustrup, Peter; Holtermann, Andreas			Effects of the Workplace Health Promotion Activities Soccer and Zumba on Muscle Pain, Work Ability and Perceived Physical Exertion among Female Hospital Employees	PLOS ONE			English	Article							CHRONIC NECK PAIN; LOW-BACK-PAIN; AEROBIC CAPACITY; SICK LEAVE; NURSES; EXERCISE; STRENGTH; DETERIORATION; DISORDERS; PROFILE	Objectives: This 40-week workplace physical training RCT investigated the effect of soccer and Zumba, respectively, on muscle pain intensity and duration, work ability, and rating of perceived exertion (RPE) during work among female hospital employees. Methods: 107 hospital employees were cluster-randomized into two training groups, and a control group. The training was conducted outside working hours as two-three 1-h sessions per week for the first 12 weeks, and continued as one-two 1-h sessions per week for the last 28 weeks. Muscle pain intensity and duration, work ability, and RPE during work were measured at baseline and after 12 and 40 weeks. Results: After 12 weeks, both the soccer (-1.9, 95% CI, -3.0, -0.8, P=0.001) and the Zumba group (-1.3, 95% CI, -2.3, -0.3, P=0.01) reduced the pain intensity (on a scale from 0 to 10) in the neck-shoulder region (eta squared=0.109), whereas only the soccer group (-1.9, 95% CI, -3.2, -0.7, P=0.002, eta squared=0.092) showed a reduction after 40 weeks referencing the control group. After 40 weeks, both the soccer (-16.4 days, 95% CI, -29.6, -3.2, P<0.02) and the Zumba group (-16.6 days, 95% CI, -28.9, -4.2, P<0.01) reduced the pain duration during the past 3 months in the neck-shoulder region (eta squared=0.077). No significant effects on intensity or duration of pain in the lower back, RPE during work or work ability were found. Conclusions: The present study indicates that workplace initiated soccer and Zumba training improve neck-shoulder pain intensity as well as duration among female hospital employees.	[Barene, Svein] Hedmark Univ Coll, Fac Publ Hlth, Elverum, Norway; [Barene, Svein] Univ Nordland, Dept Sports, Bodo, Norway; [Barene, Svein; Krustrup, Peter] Univ Copenhagen, Copenhagen Ctr Team Sport & Hlth, Dept Nutr Exercise & Sports, Sect Human Physiol, Copenhagen, Denmark; [Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark	Inland Norway University of Applied Sciences; Nord University; University of Copenhagen; University of Exeter; National Research Centre for the Working Environment	Barene, S (corresponding author), Hedmark Univ Coll, Fac Publ Hlth, Elverum, Norway.	svein.barene@hihm.no	Krustrup, Peter/D-2659-2019	Krustrup, Peter/0000-0002-1461-9838; Barene, Svein/0000-0002-5381-6017	Nordland Hospital (Bodo, Norway); Municipality of Bodo (Norway); Nordea-fonden (Copenhagen, Denmark)	Nordland Hospital (Bodo, Norway); Municipality of Bodo (Norway); Nordea-fonden (Copenhagen, Denmark)	This study was supported by funding from Nordland Hospital (Bodo, Norway) to the Department of Laboratory and the Department of Radiology for conducting the Laboratory analyses and the DXA-scans, and from the Municipality of Bodo (Norway) and Stamina Fitness Centre (Bodo, Norway) for the use of training facilities. The article processing charge was supported by Nordea-fonden (Copenhagen, Denmark). The collection and analysis, decision to publish, funders had no role in study design, data preparation of the manuscript.	Andersen LL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-253; Andersen LL, 2010, MANUAL THER, V15, P100, DOI 10.1016/j.math.2009.08.004; Antes G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1432; Arvidson E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-855; BARENE S, 2013, SCAND J MED SCI SPOR; Barene S, 2014, J SPORT SCI, V32, P1539, DOI 10.1080/02640414.2014.906043; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG G, 1967, ACTA MED SCAND, VS, P194; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Christensen JR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-671; Christensen JR, 2013, J OCCUP ENVIRON MED, V55, P1186, DOI 10.1097/JOM.0b013e31829b2816; Coury HJCG, 2009, BRAZ J PHYS THER, V13, P461, DOI 10.1590/S1413-35552009000600002; Ellingson LD, 2012, MED SCI SPORT EXER, V44, P1401, DOI 10.1249/MSS.0b013e318248f648; Eriksen W, 2003, OCCUP ENVIRON MED, V60, P271, DOI 10.1136/oem.60.4.271; Eriksen W, 2002, J OCCUP ENVIRON MED, V44, P530, DOI 10.1097/00043764-200206000-00014; Fischer FM, 2006, CHRONOBIOL INT, V23, P1165, DOI 10.1080/07420520601065083; Fronteira I, 2011, J CLIN NURS, V20, P2404, DOI 10.1111/j.1365-2702.2011.03721.x; Gram B, 2012, SCAND J WORK ENV HEA, V38, P467, DOI 10.5271/sjweh.3260; Holtermann A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-120; Horneij E, 2002, J REHABIL MED, V34, P176, DOI 10.1080/16501970213235; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P40, DOI 10.1111/j.1600-0838.2010.01110.x; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lee SJ, 2013, INT J NURS STUD, V50, P1648, DOI 10.1016/j.ijnurstu.2013.03.010; Luettgen M, 2012, J SPORT SCI MED, V11, P357; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Ortega E, 2009, EXERC IMMUNOL REV, V15, P42; Pedersen MT, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-287; RONGEN A, 2013, J NURS MANAG; Sherehiy B., 2004, OCCUPATIONAL ERGONOM, V4, P241; Sogaard K, 2012, EUR J APPL PHYSIOL, V112, P173, DOI 10.1007/s00421-011-1964-6; STEEGE LM, 2013, J NURS MANAG; Strijk JE, 2011, OCCUP ENVIRON MED, V68, P753, DOI 10.1136/oem.2010.057646; Strohacker K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002623; Strom V, 2009, EUR J PAIN, V13, P843, DOI 10.1016/j.ejpain.2008.11.003; Sundstrup E, 2014, SCAND J WORK ENV HEA, V40, P244, DOI 10.5271/sjweh.3419; Warming S, 2008, ERGONOMICS, V51, P1530, DOI 10.1080/00140130802238606; Ylinen J, 2003, JAMA-J AM MED ASSOC, V289, P2509, DOI 10.1001/jama.289.19.2509; Ylinen JJ, 2006, J STRENGTH COND RES, V20, P6; Yu WZ, 2013, INT ARCH OCC ENV HEA, V86, P431, DOI 10.1007/s00420-012-0775-3	39	32	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115059	10.1371/journal.pone.0115059	http://dx.doi.org/10.1371/journal.pone.0115059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25494175	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400092
J	Crame, JA; Beu, AG; Ineson, JR; Francis, JE; Whittle, RJ; Bowman, VC				Crame, J. Alistair; Beu, Alan G.; Ineson, Jon R.; Francis, Jane E.; Whittle, Rowan J.; Bowman, Vanessa C.			The Early Origin of the Antarctic Marine Fauna and Its Evolutionary Implications	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; MARAMBIO SEYMOUR ISLAND; LA MESETA FORMATION; NICHE CONSERVATISM; PLANT DIVERSITY; EOCENE CLIMATE; GLOBAL DIVERSITY; TEMPERATURES; EXTINCTION; PALEOGENE	The extensive Late Cretaceous - Early Paleogene sedimentary succession of Seymour Island, N.E. Antarctic Peninsula offers an unparalleled opportunity to examine the evolutionary origins of a modern polar marine fauna. Some 38 modern Southern Ocean molluscan genera (26 gastropods and 12 bivalves), representing approximately 18% of the total modern benthic molluscan fauna, can now be traced back through at least part of this sequence. As noted elsewhere in the world, the balance of the molluscan fauna changes sharply across the Cretaceous Paleogene (K/Pg) boundary, with gastropods subsequently becoming more diverse than bivalves. A major reason for this is a significant radiation of the Neogastropoda, which today forms one of the most diverse clades in the sea. Buccinoidea is the dominant neogastropod superfamily in both the Paleocene Sobral Formation (SF) (56% of neogastropod genera) and Early - Middle Eocene La Meseta Formation (LMF) (47%), with the Conoidea (25%) being prominent for the first time in the latter. This radiation of Neogastropoda is linked to a significant pulse of global warming that reached at least 65 degrees S, and terminates abruptly in the upper LMF in an extinction event that most likely heralds the onset of global cooling. It is also possible that the marked Early Paleogene expansion of neogastropods in Antarctica is in part due to a global increase in rates of origination following the K/ Pg mass extinction event. The radiation of this and other clades at,65 degrees S indicates that Antarctica was not necessarily an evolutionary refugium, or sink, in the Early Middle Eocene. Evolutionary source - sink dynamics may have been significantly different between the Paleogene greenhouse and Neogene icehouse worlds.	[Crame, J. Alistair; Francis, Jane E.; Whittle, Rowan J.; Bowman, Vanessa C.] British Antarctic Survey, NERC, Cambridge, England; [Beu, Alan G.] GNS Sci, Lower Hutt, New Zealand; [Ineson, Jon R.] Geol Survey Denmark & Greenland, Copenhagen, Denmark	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; GNS Science - New Zealand; Geological Survey Of Denmark & Greenland	Crame, JA (corresponding author), British Antarctic Survey, NERC, Cambridge, England.	jacr@bas.ac.uk	Ineson, Jon R/G-9800-2018	Ineson, Jon R/0000-0003-0017-3705; Bowman, Vanessa/0000-0002-4887-3949	Natural Environment Research Council [NE/I005803/1, NE/C506399/1]; NERC [NE/I005803/1, NE/I00582X/2] Funding Source: UKRI; Natural Environment Research Council [NE/I00582X/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was received from the Natural Environment Research Council (http://www. nerc.ac.uk): Research grants NE/I005803/1 and NE/C506399/1, and core funds to the BAS programme 'Environmental Change and Evolution'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERHAN M, 1994, PALAIOS, V9, P516, DOI 10.2307/3515126; ADAMS CG, 1990, PALAEOGEOGR PALAEOCL, V77, P289; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; [Anonymous], MONOGRAPHIE COMPLETE; Archibald SB, 2010, PALEOBIOLOGY, V36, P374, DOI 10.1666/09021.1; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Berggren WA, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P1; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bona P, 2010, ANTARCT SCI, V22, P531, DOI 10.1017/S0954102010000362; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bouchet P, 2010, MALACOLOGIA, V52, P4; Bowman VC, 2013, GEOLOGY, V41, P1227, DOI 10.1130/G34891.1; Bowman VC, 2012, REV PALAEOBOT PALYNO, V171, P40, DOI 10.1016/j.revpalbo.2011.11.004; Casadio S, 2001, AMEGHINIANA, V38, P321; Case JA, 2007, 20071047 USGS; Case Judd A., 1992, Antarctic Research Series, V56, P119; Collinson ME, 2001, PALAEOBIOLOGY, VII, P112; Crame JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054139; Crame JA, 2004, CRETACEOUS RES, V25, P411, DOI 10.1016/j.cretres.2004.02.002; Dingle RV, 1998, PALAEOGEOGR PALAEOCL, V141, P215, DOI 10.1016/S0031-0182(98)00056-X; Dingle RV, 1998, J S AM EARTH SCI, V11, P571, DOI 10.1016/S0895-9811(98)00035-2; Douglas PMJ, 2014, P NATL ACAD SCI USA, V111, P6582, DOI 10.1073/pnas.1321441111; Dutton AL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000593; Dzik J, 2001, PALAEOGEOGR PALAEOCL, V172, P297, DOI 10.1016/S0031-0182(01)00304-2; Eberle JJ, 2012, GEOL SOC AM BULL, V124, P3, DOI 10.1130/B30571.1; Elliot D.H., 1982, ANTARCT GEOSCI, P287; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; Erwin DH, 2009, CURR BIOL, V19, pR575, DOI 10.1016/j.cub.2009.05.047; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Feldmann RM, 1988, GEOL SOC AM MEM, V169; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Francis J. E., 2008, ANTARCTICA KEYSTONE, P19, DOI [10.3133/of2007-1047, DOI 10.3133/OF2007-1047]; Francis JE, 2002, PALAEOGEOGR PALAEOCL, V182, P47, DOI 10.1016/S0031-0182(01)00452-7; Francis JE, 2006, GEOL SOC LOND SPEC P, V258; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; HANSEN TA, 1988, PALEOBIOLOGY, V14, P37, DOI 10.1017/S0094837300011787; Harasewych MG, 2009, J PALEONTOL, V83, P750, DOI 10.1666/09-004.1; Hathway B, 2000, J GEOL SOC LONDON, V157, P417, DOI 10.1144/jgs.157.2.417; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hayami I, 1975, B U MUS U TOKYO, V10; Heinberg C, 1999, PALAEOGEOGR PALAEOCL, V154, P87, DOI 10.1016/S0031-0182(99)00088-7; Hollis CJ, 2009, GEOLOGY, V37, P99, DOI 10.1130/G25200A.1; Huber B.T., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V119, P427, DOI 10.2973/odp.proc.sr.119.142.1991; Ivany LC, 2007, 20071047 USGS; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2008, P NATL ACAD SCI USA, V105, P11528, DOI 10.1073/pnas.0801919105; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Jansson R, 2013, EVOLUTION, V67, P1741, DOI 10.1111/evo.12089; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Keating-Bitonti CR, 2011, GEOLOGY, V39, P771, DOI 10.1130/G32054.1; Kemp DB, 2014, GEOLOGY, V42, P583, DOI 10.1130/G35512.1; Koch CF, 1998, ADEQUACY OF THE FOSSIL RECORD, P189; Kosnik MA, 2005, PALEOBIOLOGY, V31, P459, DOI 10.1666/0094-8373(2005)031[0459:CILCTB]2.0.CO;2; Lockwood R, 2003, P NATL ACAD SCI USA, V100, P2478, DOI 10.1073/pnas.0535132100; Mannion PD, 2014, TRENDS ECOL EVOL, V29, P42; Marenssi SA, 1998, ASOC PAL ARGENT PUBL, P137; Marenssi S, 2012, ANDEAN GEOL, V39, P67, DOI 10.5027/andgeoV39N1-a04; Marenssi SA, 2006, GEOL SOC SPEC PUBL, V258, P125, DOI 10.1144/GSL.SP.2006.258.01.09; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Oleinik AE, 1996, J PALEONTOL, V70, P923, DOI 10.1017/S0022336000038610; OLIVER PG, 1981, MALACOLOGIA, V21, P61; Patzkowsky ME, 2012, STRATIGRAPHIC PALEOB; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pirrie D, 1991, INT ASS SEDIMENTOLOG, V12, P293; Pross J, 2012, NATURE, V488, P73, DOI 10.1038/nature11300; Reguero Marcelo A, 2012, Rev. peru biol., V19, P275; Ricklefs Robert E., 1993, P350; Rinaldi C. A., 1978, CONTRIBUCION I ANTAR, V217, P1; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Sadler P. M, 1988, GEOLOGY PALEONTOLOGY, V169, P303, DOI DOI 10.1130/MEM169-P303; Schweitzer C.E., 2009, Scripta Geologica (Leiden), V138, P1; Sepkoski Jr JJ, 2002, B AM PALEONT, V363; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Sohl N.F., 1983, US GEOLOGICAL SURVEY, V83-451, P1, DOI [10.3133/ofr83451, DOI 10.3133/OFR83451]; Sohl N.F., 1984, US GEOL SURV OPEN FI, V83, P1; SOHL NF, 1992, J PALEONTOL, V66, P414, DOI 10.1017/S0022336000033977; SOHL NF, 1987, US GEOL SURV OPEN FI, V87, P1; STEHLI FG, 1969, SCIENCE, V164, P947, DOI 10.1126/science.164.3882.947; Stilwell JD, 2003, CRETACEOUS RES, V24, P111, DOI 10.1016/S0195-6671(03)00035-1; Stilwell JD, 2002, J PALEONTOL, V76, P1102, DOI 10.1666/0022-3360(2002)076<1102:ANLAGM>2.0.CO;2; Stilwell JD, 1992, ANT RES SER, V55; Stilwell Jeffrey D., 2004, Bulletins of American Paleontology, V367, P1; Stott L.D., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P849, DOI 10.2973/odp.proc.sr.113.187.1990; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tobin TS, 2012, PALAEOGEOGR PALAEOCL, V350, P180, DOI 10.1016/j.palaeo.2012.06.029; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Valentine J. W., 1969, Palaeontology, V12, P684; Valentine JW, 2013, PALEOBIOLOGY, V39, P1, DOI 10.1666/0094-8373-39.1.1; VERMEIJ G J, 1977, Paleobiology, V3, P245; Wallace CC, 2008, J PALEONTOL, V82, P313, DOI 10.1666/06-091.1; Weijers JWH, 2007, EARTH PLANET SC LETT, V261, P230, DOI 10.1016/j.epsl.2007.06.033; Whittle RJ, 2011, PALAEONTOLOGY, V54, P935, DOI 10.1111/j.1475-4983.2011.01061.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wolfe JA, 1985, AGU GEOPHYS MONOGR S, V32; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; Zelaya DG, 2009, MALACOLOGIA, V51, P271, DOI 10.4002/040.051.0204; Zinsmeister W.J., 1988, Geological Society of America Memoir, V169, P253; ZINSMEISTER WJ, 1989, J PALEONTOL, V63, P731, DOI 10.1017/S0022336000036453; Zinsmeister WJ, 2001, J GEOL, V109, P213, DOI 10.1086/319239; ZINSMEISTER WJ, 1980, J PALEONTOL, V54, P1; ZINSMEISTER WJ, 1982, J GEOL SOC LONDON, V139, P779, DOI 10.1144/gsjgs.139.6.0779	118	25	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114743	10.1371/journal.pone.0114743	http://dx.doi.org/10.1371/journal.pone.0114743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493546	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000346611400074
J	Katz, L; Fink, RV; Bozeman, SR; McNeil, BJ				Katz, Luba; Fink, Rebecca V.; Bozeman, Samuel R.; McNeil, Barbara J.			Using Health Care Utilization and Publication Patterns to Characterize the Research Portfolio and to Plan Future Research Investments	PLOS ONE			English	Article							CANCER; DISEASE; BURDEN; ALLOCATION; PRIORITIES	Objective: Government funders of biomedical research are under increasing pressure to demonstrate societal benefits of their investments. A number of published studies attempted to correlate research funding levels with the societal burden for various diseases, with mixed results. We examined whether research funded by the Department of Veterans Affairs (VA) is well aligned with current and projected veterans' health needs. The organizational structure of the VA makes it a particularly suitable setting for examining these questions. Methods: We used the publication patterns and dollar expenditures of VA-funded researchers to characterize the VA research portfolio by disease. We used health care utilization data from the VA for the same diseases to define veterans' health needs. We then measured the level of correlation between the two and identified disease groups that were under-or over-represented in the research portfolio relative to disease expenditures. Finally, we used historic health care utilization trends combined with demographic projections to identify diseases and conditions that are increasing in costs and/or patient volume and consequently represent potential targets for future research investments. Results: We found a significant correlation between research volume/expenditures and health utilization. Some disease groups were slightly under- or over-represented, but these deviations were relatively small. Diseases and conditions with the increasing utilization trend at the VA included hypertension, hypercholesterolemia, diabetes, hearing loss, sleeping disorders, complications of pregnancy, and several mental disorders. Conclusions: Research investments at the VA are well aligned with veteran health needs. The VA can continue to meet these needs by supporting research on the diseases and conditions with a growing number of patients, costs of care, or both. Our approach can be used by other funders of disease research to characterize their portfolios and to plan research investments.	[Katz, Luba; Fink, Rebecca V.; Bozeman, Samuel R.] ABT Associates Inc, US Hlth Div, Cambridge, MA 02138 USA; [McNeil, Barbara J.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	ABT Associates; Harvard University; Harvard Medical School	Katz, L (corresponding author), ABT Associates Inc, US Hlth Div, Cambridge, MA 02138 USA.	luba_katz@abtassoc.com			Department of Veterans Affairs [GS-10F-0086K/V101-G-17108]; Abt Associates Inc.	Department of Veterans Affairs(US Department of Veterans Affairs); Abt Associates Inc.	The study was supported by contract #GS-10F-0086K/V101-G-17108 with the Department of Veterans Affairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Luba Katz, Rebecca V. Fink and Samuel R. Bozeman are employed by Abt Associates Inc. Abt Associates Inc. provided support in the form of salaries for authors Luba Katz, Rebecca V. Fink and Samuel R. Bozeman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, EV MED RES PROGR DEP; Aoun S, 2004, AUST NZ J PUBL HEAL, V28, P80, DOI 10.1111/j.1467-842X.2004.tb00637.x; Bisias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034569; Branton PE, 2008, LANCET ONCOL, V9, P82, DOI 10.1016/S1470-2045(08)70007-X; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526; Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI [10.1590/S1135-57272009000100011, 10.1590/s1135-57272009000100011]; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Epstein JA, 2011, J CLIN INVEST, V121, P3362, DOI 10.1172/JCI60182; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Kupersmith J, 2010, AM J MED, V123, pE3, DOI 10.1016/j.amjmed.2010.10.002; Leydesdorff L, 2013, SCIENTOMETRICS, V94, P589, DOI 10.1007/s11192-012-0784-8; Longo WE, 2005, AM J SURG, V190, P662, DOI 10.1016/j.amjsurg.2005.07.001; Luengo-Fernandez R, 2012, EUR J NEUROL, V19, P149, DOI 10.1111/j.1468-1331.2011.03500.x; Mitchell RJ, 2009, MED J AUSTRALIA, V191, P648, DOI 10.5694/j.1326-5377.2009.tb03365.x; Mohr DC, 2011, ACAD MED, V86, P938, DOI 10.1097/ACM.0b013e3182223b76; Nahin RL, 2005, FASEB J, V19, P1209, DOI 10.1096/fj.05-3727LFE; Rubin JB, 2010, ANN BIOMED ENG, V38, P2237, DOI 10.1007/s10439-010-9982-9; Sampat BN, 2013, MILBANK Q, V91, P163, DOI 10.1111/milq.12005	19	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114873	10.1371/journal.pone.0114873	http://dx.doi.org/10.1371/journal.pone.0114873			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493576	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400081
J	Miller, KD; Roque, R; Clegg, CH				Miller, Keith D.; Roque, Richard; Clegg, Christopher H.			Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier	PLOS ONE			English	Article							T-CELL RESPONSES; EPITOPE DENSITY; SWISS-MODEL; IMMUNOGENICITY; PEPTIDE; AFFINITY; SUPPRESSION; STRATEGIES; ADJUVANTS; EFFICACY	Tobacco addiction represents one of the largest public health problems in the world and is the leading cause of cancer and heart disease, resulting in millions of deaths a year. Vaccines for smoking cessation have shown considerable promise in preclinical models, although functional antibody responses induced in humans are only modestly effective in preventing nicotine entry into the brain. The challenge in generating serum antibodies with a large nicotine binding capacity is made difficult by the fact that this drug is non-immunogenic and must be conjugated as a hapten to a protein carrier. To circumvent the limitations of traditional carriers like keyhole limpet hemocyanin (KLH), we have synthesized a short trimeric coiled-coil peptide (TCC) that creates a series of B and T cell epitopes with uniform stoichiometry and high density. Here we compared the relative activities of a TCC-nic vaccine and two control KLH-nic vaccines using Alum as an adjuvant or GLA-SE, which contains a synthetic TLR4 agonist formulated in a stable oil-in-water emulsion. The results showed that the TCC's high hapten density correlated with a better immune response in mice as measured by anti-nicotine Ab titer, affinity, and specificity, and was responsible for a reduction in anti-carrier immunogenicity. The Ab responses achieved with this synthetic vaccine resulted in a nicotine binding capacity in serum that could prevent >90% of a nicotine dose equivalent to three smoked cigarettes (0.05 mg/kg) from reaching the brain.	[Miller, Keith D.; Roque, Richard; Clegg, Christopher H.] TRIA Biosci Corp, Seattle, WA 98102 USA		Clegg, CH (corresponding author), TRIA Biosci Corp, Seattle, WA 98102 USA.	cclegg@triabio.com			National Institute on Drug Abuse, National Institutes of Health [R43DA033845]; NATIONAL INSTITUTE ON DRUG ABUSE [R43DA033845] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institute on Drug Abuse, National Institutes of Health Grant R43DA033845. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boylan NJ, 2013, BIOCONJUGATE CHEM, V24, P1008, DOI 10.1021/bc4000564; Brimijoin S, 2013, EXPERT REV VACCINES, V12, P323, DOI [10.1586/erv.13.1, 10.1586/ERV.13.1]; Carpenter MJ, 2013, DRUGS, V73, P407, DOI 10.1007/s40265-013-0038-y; Chandrudu S, 2013, MOLECULES, V18, P4373, DOI 10.3390/molecules18044373; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Clegg CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088979; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; de Villiers SHL, 2013, VACCINE, V31, P6185, DOI 10.1016/j.vaccine.2013.10.051; DeFranco AL, 2012, IMMUNOL REV, V247, P64, DOI 10.1111/j.1600-065X.2012.01115.x; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hartmann-Boyce J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007072.pub2; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hu K, 2012, BIOSCI TRENDS, V6, P52, DOI 10.5582/bst.2012.v6.2.52; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; Kim MT, 2014, BIOCONJUGATE CHEM, V25, P1223, DOI 10.1021/bc5000109; KLAUS GGB, 1974, CELL IMMUNOL, V14, P226, DOI 10.1016/0008-8749(74)90208-1; Komegae EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071185; La Rosa C, 2012, J INFECT DIS, V205, P1294, DOI 10.1093/infdis/jis107; Li QA, 2010, CHEMBIOCHEM, V11, P1686, DOI 10.1002/cbic.201000235; Liu WL, 2005, EUR J IMMUNOL, V35, P505, DOI 10.1002/eji.200425749; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; McCluskie MJ, 2013, 19 ANN M SOC RES NIC; Micklatcher C, 1999, CURR OPIN CHEM BIOL, V3, P724, DOI 10.1016/S1367-5931(99)00031-9; Moreno AY, 2009, PHARMACOL BIOCHEM BE, V92, P199, DOI 10.1016/j.pbb.2009.01.015; Pedersen MK, 2006, J IMMUNOL METHODS, V311, P198, DOI 10.1016/j.jim.2006.02.008; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Pobre K, 2014, VACCINE, V32, P1423, DOI 10.1016/j.vaccine.2014.01.047; Polosa R, 2011, TRENDS PHARMACOL SCI, V32, P281, DOI 10.1016/j.tips.2010.12.008; Pryde DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076557; Raupach T, 2012, DRUGS, V72, P1; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Sant AJ, 2007, EXPERT REV VACCINES, V6, P357, DOI 10.1586/14760584.6.3.357; Sant AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00340; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; STEVENS FJ, 1987, MOL IMMUNOL, V24, P1055, DOI 10.1016/0161-5890(87)90073-3; Suzuki K, 1998, PROTEIN ENG, V11, P1051, DOI 10.1093/protein/11.11.1051; Tonstad S, 2013, NICOTINE TOB RES, V15, P1492, DOI 10.1093/ntr/ntt003; U. S. Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP	53	23	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114366	10.1371/journal.pone.0114366	http://dx.doi.org/10.1371/journal.pone.0114366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494044	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400042
J	Raihani, NJ; McAuliffe, K				Raihani, Nichola J.; McAuliffe, Katherine			Dictator Game Giving: The Importance of Descriptive versus Injunctive Norms	PLOS ONE			English	Article							NORMATIVE CONDUCT; MODEL SELECTION; SOCIAL NORMS; FOCUS THEORY; CONSERVATION; REGRESSION	Human behaviour is influenced by social norms but norms can entail two types of information. Descriptive norms refer to what others do in this context, while injunctive norms refer to what ought to be done to ensure social approval. In many real-world situations these norms are often presented concurrently meaning that their independent effects on behaviour are difficult to establish. Here we used an online Dictator Game to test how descriptive and injunctive norms would influence dictator donations when presented independently of one another. In addition, we varied the cost of complying with the norm: By stating that $0.20 or $0.50 cent donations from a $1 stake were normal or suggested, respectively. Specifying a higher target amount was associated with increased mean donation size. In contrast to previous studies, descriptive norms did not seem to influence giving behaviour in this context, whereas injunctive norms were associated with increased likelihood to give at least the target amount to the partner. This raises the question of whether injunctive norms might be more effective than descriptive norms at promoting prosocial behaviour in other settings.	[Raihani, Nichola J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [McAuliffe, Katherine] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of London; University College London; Yale University	Raihani, NJ (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	nicholaraihani@gmail.com	Raihani, Nichola J/C-2083-2015	Raihani, Nichola J/0000-0003-2339-9889	Royal Society fellowship	Royal Society fellowship(Royal Society of London)	This study was funded by a Royal Society fellowship to NR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Ariely D., 2012, HONEST TRUTH DISHONE; Bailey J., 2004, J BUSINESS MANAGEMEN, V9, P327; Barton K, 2009, MUMLN MULTIMODEL INT; Bicchieri C, 2009, J BEHAV DECIS MAKING, V22, P191, DOI 10.1002/bdm.621; Bryan CJ, 2011, P NATL ACAD SCI USA, V108, P12653, DOI 10.1073/pnas.1103343108; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cialdini R.B., 2006, SOC INFLUENCE, V1, p3, DOI [10.1080/15534510500181459, DOI 10.1080/15534510500181459]; Cialdini R.B, 2001, INFLUENCE SCI PRACTI; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cialdini RB, 1988, HDB SOCIAL PSYCHOL, V2, P151; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; Cladiere N, 2012, PSYCHOL BULL, V138, P126, DOI DOI 10.1037/A0025868; Costa DL, 2013, J EUR ECON ASSOC, V11, P680, DOI 10.1111/jeea.12011; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Irwin K, 2013, SOC SCI RES, V42, P562, DOI 10.1016/j.ssresearch.2012.10.004; Jacobson RP, 2011, J PERS SOC PSYCHOL, V100, P433, DOI 10.1037/a0021470; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Kallgren CA, 2000, PERS SOC PSYCHOL B, V26, P1002, DOI 10.1177/01461672002610009; Kredentser MS, 2012, SOC PSYCHOL PERS SCI, V3, P341, DOI 10.1177/1948550611420481; Krupka E, 2009, J ECON PSYCHOL, V30, P307, DOI 10.1016/j.joep.2008.11.005; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Parks CD, 2010, J PERS SOC PSYCHOL, V99, P303, DOI 10.1037/a0018403; R Core Team, 2016, R FDN STAT COMP; Raihani NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0884; Raihani NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073131; Raihani NJ, 2012, P ROY SOC B-BIOL SCI, V279, P3556, DOI 10.1098/rspb.2012.0758; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; Rivis A, 2003, CURR PSYCHOL, V22, P218, DOI 10.1007/s12144-003-1018-2; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Smith S, EC J; Stok FM, 2014, BRIT J HEALTH PSYCH, V19, P52, DOI 10.1111/bjhp.12030; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wilson TD, 1996, J EXP PSYCHOL GEN, V125, P387, DOI 10.1037/0096-3445.125.4.387	46	26	26	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113826	10.1371/journal.pone.0113826	http://dx.doi.org/10.1371/journal.pone.0113826			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493945	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400020
J	Torma, F; Koltai, E; Nagy, E; Ziaaldini, MM; Posa, A; Koch, LG; Britton, SL; Boldogh, I; Radak, Z				Torma, Ferenc; Koltai, Erika; Nagy, Eniko; Ziaaldini, Mohammad Mosaferi; Posa, Aniko; Koch, Lauren G.; Britton, Steven L.; Boldogh, Istvan; Radak, Zsolt			Exercise Increases Markers of Spermatogenesis in Rats Selectively Bred for Low Running Capacity	PLOS ONE			English	Article							TESTIS-SPECIFIC GENE; OUTER DENSE FIBERS; OXIDATIVE STRESS; SEMEN QUALITY; SIRT1; P53; ACTIVATION; PROTEIN; PGC-1-ALPHA; DISORDERS	The oxidative stress effect of exercise training on testis function is under debate. In the present study we used a unique rat model system developed by artificial selection for low and high intrinsic running capacity (LCR and HCR, respectively) to evaluate the effects of exercise training on apoptosis and spermatogenesis in testis. Twentyfour 13-month-old male rats were assigned to four groups: control LCR (LCR-C), trained LCR (LCR-T), control HCR (HCR-C), and trained HCR (HCR-T). Ten key proteins connecting aerobic exercise capacity and general testes function were assessed, including those that are vital for mitochondrial biogenesis. The VO2 max of LCR-C group was about 30% lower than that of HCR-C rats, and the SIRT1 levels were also significantly lower than HCR-C. Twelve weeks of training significantly increased maximal oxygen consumption in LCR by nearly 40% whereas HCR remained unchanged. LCR-T had significantly higher levels of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1 alpha), decreased levels of reactive oxygen species and increased acetylated p53 compared to LCR-C, while training produced no significant changes for these measures in HCR rats. BAX and Blc-2 were not different among all four groups. The levels of outer dense fibers -1 (Odf-1), a marker of spermatogenesis, increased in LCR-T rats, but decreased in HCR-TR rats. Moreover, exercise training increased the levels of lactate dehydrogenase C (LDHC) only in LCR rats. These data suggest that rats with low inborn exercise capacity can increase whole body oxygen consumption and running exercise capacity with endurance training and, in turn, increase spermatogenesis function via reduction in ROS and heightened activity of p53 in testes.	[Torma, Ferenc; Koltai, Erika; Nagy, Eniko; Ziaaldini, Mohammad Mosaferi; Radak, Zsolt] Semmelweis Univ, Res Inst Sport Sci, H-1085 Budapest, Hungary; [Posa, Aniko] Univ Szeged, Fac Sci & Informat, Dept Physiol Anat & Neurosci, Szeged, Hungary; [Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Sealy Ctr Mol Med, Galveston, TX 77555 USA	Semmelweis University; Szeged University; University of Michigan System; University of Michigan; University of Texas System; University of Texas Medical Branch Galveston	Radak, Z (corresponding author), Semmelweis Univ, Res Inst Sport Sci, H-1085 Budapest, Hungary.	radak@tf.hu	Ziaaldini, Mohammad Mosaferi/AAE-4262-2019	Ziaaldini, Mohammad Mosaferi/0000-0001-7193-663X; Posa, Aniko/0000-0003-2167-2888; Radak, Zsolt/0000-0003-1297-6804	National Center for Research Resources [R24RR017718]; Office of Research Infrastructure Programs/OD grant from the National Institutes of Health [R24OD010950]; National Institutes of Health [R01 DK077200, R01GM104194]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104194] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010950] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The LCR-HCR rat model system was funded by the National Center for Research Resources grant R24RR017718 and is currently supported by the Office of Research Infrastructure Programs/OD grant R24OD010950 (to LGK and SLB) from the National Institutes of Health. SLB was also supported by National Institutes of Health grants R01 DK077200 and R01GM104194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYERS JWT, 1985, FERTIL STERIL, V43, P917; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chigurupati S, 2008, J ENDOCRINOL, V199, P333, DOI 10.1677/JOE-08-0306; Coussens M, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0001571, 10.1371/journal.pone.0002640]; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; HACKNEY AC, 1988, MED SCI SPORT EXER, V20, P60, DOI 10.1249/00005768-198802000-00009; Hart N, 2014, DOSE-RESPONSE, V12, P57, DOI 10.2203/dose-response.13-010.Radak; Hart N, 2013, FOOD CHEM TOXICOL, V61, P53, DOI 10.1016/j.fct.2013.01.051; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lindemann CB, 1996, CELL MOTIL CYTOSKEL, V34, P258, DOI 10.1002/(SICI)1097-0169(1996)34:4<258::AID-CM1>3.0.CO;2-4; Manna I, 2003, ACTA PHYSIOL SCAND, V178, P33, DOI 10.1046/j.1365-201X.2003.01095.x; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; O'Bryan MK, 1998, MOL REPROD DEV, V50, P313, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;313::AID-MRD7&gt;3.0.CO;2-M; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Radak Z, 2013, FREE RADICAL BIO MED, V58, P87, DOI 10.1016/j.freeradbiomed.2013.01.004; Safarinejad MR, 2009, J ENDOCRINOL, V200, P259, DOI 10.1677/JOE-08-0477; Schalles U, 1998, DEV BIOL, V199, P250, DOI 10.1006/dbio.1998.8931; Sharpe RM, 2000, BRIT MED BULL, V56, P630, DOI 10.1258/0007142001903436; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P245, DOI 10.1016/j.bbrc.2012.06.084; Vaamonde D, 2009, FERTIL STERIL, V92, P1941, DOI 10.1016/j.fertnstert.2008.09.010; van Leeuwen I, 2009, ADV CANCER RES, V102, P171, DOI 10.1016/S0065-230X(09)02005-3; WHEELER GD, 1984, JAMA-J AM MED ASSOC, V252, P514, DOI 10.1001/jama.252.4.514; Wu L, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.008	38	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114075	10.1371/journal.pone.0114075	http://dx.doi.org/10.1371/journal.pone.0114075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493948	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400028
J	Kuan, CS; Yee, YH; Too, WCS; Few, LL				Kuan, Chee Sian; Yee, Yoke Hiang; Too, Wei Cun See; Few, Ling Ling			Ets and GATA Transcription Factors Play a Critical Role in PMA-Mediated Repression of the ck beta Promoter via the Protein Kinase C Signaling Pathway	PLOS ONE			English	Article							GH3 PITUITARY-CELLS; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; PHOSPHATIDYLCHOLINE SYNTHESIS; DOWN-REGULATION; CPG ISLANDS; CHOLINE; DIFFERENTIATION; 13-ACETATE; SEQUENCE	Background: Choline kinase is the most upstream enzyme in the CDP-choline pathway. It catalyzes the phosphorylation of choline to phosphorylcholine in the presence of ATP and Mg2+ during the biosynthesis of phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. In humans, choline kinase (CK) is encoded by two separate genes, ck alpha and ck beta, which produce three isoforms, CK alpha 1, CK alpha 2, and CK beta. Previous studies have associated ck beta with muscle development; however, the molecular mechanism underlying the transcriptional regulation of ck beta has never been elucidated. Methodology/Principal Findings: In this report, the distal promoter region of the ck beta gene was characterized. Mutational analysis of the promoter sequence and electrophoretic mobility shift assays (EMSA) showed that Ets and GATA transcription factors were essential for the repression of ck beta promoter activity. Supershift and chromatin immunoprecipitation (ChIP) assays further identified that GATA3 but not GATA2 was bound to the GATA site of ck beta promoter. In addition, phorbol-12-myristate-13-acetate (PMA) decreased ck beta promoter activity through Ets and GATA elements. PMA also decreased the ck beta mRNA and protein levels about 12 hours after the promoter activity was down-regulated. EMSA further revealed that PMA treatment increased the binding of both Ets and GATA transcription factors to their respective DNA elements. The PMA-mediated repressive effect was abolished by chronic PMA treatment and by treatment with the PKC inhibitor PKC412, but not the PKC inhibitor Go 6983, suggesting PKC epsilon or PKC eta as the PKC isozyme involved in the PMA-mediated repression of ck beta promoter. Further confirmation by using PKC isozyme specific inhibitors identified PKC epsilon as the isozyme that mediated the PMA repression of ck beta promoter. Conclusion/Significance: These results demonstrate the participation of the PKC signaling pathway in the regulation of ck beta gene transcription by Ets and GATA transcription factors.	[Kuan, Chee Sian; Yee, Yoke Hiang; Too, Wei Cun See; Few, Ling Ling] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian 16150, Kelantan, Malaysia	Universiti Sains Malaysia	Few, LL (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	fewling@usm.my	Few, Ling Ling/E-1964-2012; See Too, Wei Cun/C-9382-2016	Few, Ling Ling/0000-0001-8296-8135; See Too, Wei Cun/0000-0003-1933-3107	Universiti Sains Malaysia Research University [1001/PPSK/813034, 1001/PPSK/815101]	Universiti Sains Malaysia Research University(Universiti Sains Malaysia)	This work was supported by Universiti Sains Malaysia Research University Grants 1001/PPSK/813034 and 1001/PPSK/815101. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1390, P1, DOI 10.1016/S0005-2760(97)00177-X; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Batarseh A, 2008, BIOCHEMISTRY-US, V47, P12886, DOI 10.1021/bi8012643; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chua SL, 2011, CYTOTECHNOLOGY, V63, P645, DOI 10.1007/s10616-011-9383-4; Clement SA, 2002, FREE RADICAL BIO MED, V32, P341, DOI 10.1016/S0891-5849(01)00802-4; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gilles C, 1997, CLIN EXP METASTAS, V15, P519, DOI 10.1023/A:1018427027270; Gruber J, 2012, FEBS J, V279, P1915, DOI 10.1111/j.1742-4658.2012.08573.x; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kim Taehyun, 2011, Int J Alzheimers Dis, V2011, P857368, DOI 10.4061/2011/857368; Kiss Z, 1996, ARCH BIOCHEM BIOPHYS, V335, P191, DOI 10.1006/abbi.1996.0497; Kobayashi M, 2001, J NEUROCHEM, V76, P361, DOI 10.1046/j.1471-4159.2001.00007.x; KOLESNICK RN, 1987, J BIOL CHEM, V262, P14525; KOLESNICK RN, 1987, J BIOL CHEM, V262, P9204; Li CY, 2008, BBA-GENE REGUL MECH, V1779, P606, DOI 10.1016/j.bbagrm.2008.06.004; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Monks DE, 1996, PLANT PHYSIOL, V110, P1197, DOI 10.1104/pp.110.4.1197; Naito S, 1998, AM J PHYSIOL-CELL PH, V274, pC472, DOI 10.1152/ajpcell.1998.274.2.C472; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ORKIN SH, 1992, BLOOD, V80, P575; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; SLACK BE, 1995, BIOCHEM J, V305, P621, DOI 10.1042/bj3050621; Takai Daiya, 2003, In Silico Biology, V3, P235; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; WITTENBERG J, 1953, J BIOL CHEM, V202, P431; WOOTEN MW, 1994, CELL GROWTH DIFFER, V5, P395; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Yee Y H., 2011, HLTH ENV J, V1, P12; Zheng WH, 2000, J BIOL CHEM, V275, P13377, DOI 10.1074/jbc.275.18.13377	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113485	10.1371/journal.pone.0113485	http://dx.doi.org/10.1371/journal.pone.0113485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490397	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300008
J	Sato, K; Ishiai, M; Takata, M; Kurumizaka, H				Sato, Koichi; Ishiai, Masamichi; Takata, Minoru; Kurumizaka, Hitoshi			Defective FANCI Binding by a Fanconi Anemia-Related FANCD2 Mutant	PLOS ONE			English	Article							CROSS-LINK REPAIR; CORE-COMPLEX PROTEIN; DNA-REPAIR; GENE; IDENTIFICATION; INTERACTS; NUCLEASE; PATHWAY; FAAP20; MONOUBIQUITINATION	FANCD2 is a product of one of the genes associated with Fanconi anemia (FA), a rare recessive disease characterized by bone marrow failure, skeletal malformations, developmental defects, and cancer predisposition. FANCD2 forms a complex with FANCI (ID complex) and is monoubiquitinated, which facilitates the downstream interstrand crosslink (ICL) repair steps, such as ICL unhooking and nucleolytic end resection. In the present study, we focused on the chicken FANCD2 (cFANCD2) mutant harboring the Leu234 to Arg (L234R) substitution. cFANCD2 L234R corresponds to the human FANCD2 L231R mutation identified in an FA patient. We found that cFANCD2 L234R did not complement the defective ICL repair in FANCD2(-/-) DT40 cells. Purified cFANCD2 L234R did not bind to chicken FANCI, and its monoubiquitination was significantly deficient, probably due to the abnormal ID complex formation. In addition, the histone chaperone activity of cFANCD2 L234R was also defective. These findings may explain some aspects of Fanconi anemia pathogenesis by a FANCD2 missense mutation.	[Sato, Koichi; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan; [Ishiai, Masamichi; Takata, Minoru] Kyoto Univ, Ctr Radiat Biol, Lab DNA Damage Signaling, Dept Late Effects Studies, Kyoto 606, Japan	Waseda University; Kyoto University	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan.	kurumizaka@waseda.jp		Takata, Minoru/0000-0002-4926-3675; Sato, Koichi/0000-0002-0574-774X; Kurumizaka, Hitoshi/0000-0001-7412-3722	JSPS KAKENHI [25250023, 24310042, 26281021, 26830128]; MEXT KAKENHI [25116002, 23114010, 25131706]; Waseda Research Institute for Science and Engineering; Waseda University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Waseda Research Institute for Science and Engineering; Waseda University	This work was supported in part by JSPS KAKENHI Grant Numbers 25250023 [to H. K.], 24310042 [to M. T.], 26281021 [to M. I.], and 26830128 [to K. S.], and by MEXT KAKENHI Grant Numbers 25116002 [to H. K.], 23114010 [to M. T.], and 25131706 [to M. I]. H. K. was also supported by the Waseda Research Institute for Science and Engineering and Waseda University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Blom E, 2004, DNA REPAIR, V3, P77, DOI 10.1016/j.dnarep.2003.09.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandrasekharappa SC, 2013, BLOOD, V121, pE138, DOI 10.1182/blood-2012-12-474585; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Hemphill AW, 2009, CYTOGENET GENOME RES, V125, P165, DOI 10.1159/000230001; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Kook H, 2005, HEMATOLOGY, V10, P108, DOI 10.1080/10245330512331390096; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kruyt FAE, 1999, J BIOL CHEM, V274, P34212, DOI 10.1074/jbc.274.48.34212; Lachaud C, 2014, J CELL SCI, V127, P2811, DOI 10.1242/jcs.146167; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Leveille F, 2004, J BIOL CHEM, V279, P39421, DOI 10.1074/jbc.M407034200; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Mouw KW, 2014, DNA REPAIR, V19, P130, DOI 10.1016/j.dnarep.2014.03.019; Murina O, 2014, CELL REP, V7, P1030, DOI 10.1016/j.celrep.2014.03.069; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Reuter T, 2000, BLOOD, V95, P719, DOI 10.1182/blood.V95.2.719; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2011, ACTA CRYSTALLOGR D, V67, P578, DOI 10.1107/S0907444911014818; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018	63	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114752	10.1371/journal.pone.0114752	http://dx.doi.org/10.1371/journal.pone.0114752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489943	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300074
J	Vargas, L; Brigida, ABS; Mota, JP; de Carvalho, TG; Rojas, CA; Vaneechoutte, D; Van Bel, M; Farrinelli, L; Ferreira, PCG; Vandepoele, K; Hemerly, AS				Vargas, Livia; Santa Brigida, Ailton B.; Mota Filho, Jose P.; de Carvalho, Thais G.; Rojas, Cristian A.; Vaneechoutte, Dries; Van Bel, Michiel; Farrinelli, Laurent; Ferreira, Paulo C. G.; Vandepoele, Klaas; Hemerly, Adriana S.			Drought Tolerance Conferred to Sugarcane by Association with Gluconacetobacter diazotrophicus: A Transcriptomic View of Hormone Pathways	PLOS ONE			English	Article							ABSCISIC-ACID; ABIOTIC STRESS; NITROGEN-FIXATION; SIGNALING PATHWAYS; PLANT-RESPONSES; GENE FAMILY; ARABIDOPSIS; EXPRESSION; ETHYLENE; GROWTH	Sugarcane interacts with particular types of beneficial nitrogen-fixing bacteria that provide fixed-nitrogen and plant growth hormones to host plants, promoting an increase in plant biomass. Other benefits, as enhanced tolerance to abiotic stresses have been reported to some diazotrophs. Here we aim to study the effects of the association between the diazotroph Gluconacetobacter diazotrophicus PAL5 and sugarcane cv. SP70-1143 during water depletion by characterizing differential transcriptome profiles of sugarcane. RNA-seq libraries were generated from roots and shoots of sugarcane plants free of endophytes that were inoculated with G. diazotrophicus and subjected to water depletion for 3 days. A sugarcane reference transcriptome was constructed and used for the identification of differentially expressed transcripts. The differential profile of non-inoculated SP70-1143 suggests that it responds to water deficit stress by the activation of drought-responsive markers and hormone pathways, as ABA and Ethylene. qRT-PCR revealed that root samples had higher levels of G. diazotrophicus 3 days after water deficit, compared to roots of inoculated plants watered normally. With prolonged drought only inoculated plants survived, indicating that SP70-1143 plants colonized with G. diazotrophicus become more tolerant to drought stress than non-inoculated plants. Strengthening this hypothesis, several gene expression responses to drought were inactivated or regulated in an opposite manner, especially in roots, when plants were colonized by the bacteria. The data suggests that colonized roots would not be suffering from stress in the same way as non-inoculated plants. On the other hand, shoots specifically activate ABA-dependent signaling genes, which could act as key elements in the drought resistance conferred by G. diazotrophicus to SP70-1143. This work reports for the first time the involvement of G. diazotrophicus in the promotion of drought-tolerance to sugarcane cv. SP70-1143, and it describes the initial molecular events that may trigger the increased drought tolerance in the host plant.	[Vargas, Livia; Santa Brigida, Ailton B.; Mota Filho, Jose P.; de Carvalho, Thais G.; Rojas, Cristian A.; Ferreira, Paulo C. G.; Hemerly, Adriana S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Biol Mol Plantas, Rio De Janeiro, RJ, Brazil; [Rojas, Cristian A.] Univ Fed Integracao Latino Americana, Foz Do Iguacu, PR, Brazil; [Vaneechoutte, Dries; Van Bel, Michiel; Vandepoele, Klaas] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Vaneechoutte, Dries; Van Bel, Michiel; Vandepoele, Klaas] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Farrinelli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland	Universidade Federal do Rio de Janeiro; Universidade Federal da Integracao Latino-Americana; Flanders Institute for Biotechnology (VIB); Ghent University	Hemerly, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Biol Mol Plantas, Cidade Univ, Rio De Janeiro, RJ, Brazil.	hemerly@bioqmed.ufrj.br	Ferreira, Paulo C G/I-2836-2015; Vandepoele, Klaas/E-7514-2010; Rojas, Cristian/X-1027-2018	Ferreira, Paulo C G/0000-0002-5510-999X; Vandepoele, Klaas/0000-0003-4790-2725; Rojas, Cristian/0000-0002-9085-6261; Van Bel, Michiel/0000-0002-1873-2563	Instituto Nacional de Ciencia de Tecnologia (INCT) in Biological Nitrogen Fixation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; Ghent University [01MR0310W]; CNPq	Instituto Nacional de Ciencia de Tecnologia (INCT) in Biological Nitrogen Fixation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ghent University(Ghent University); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was supported by Instituto Nacional de Ciencia de Tecnologia (INCT) in Biological Nitrogen Fixation, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). LV is indebted to CAPES for graduate fellowships. KV acknowledges the Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks" Project (no 01MR0310W) of Ghent University. ASH and PCGF receive support from CNPq research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto MK, 2012, PLANT SCI, V182, P19, DOI 10.1016/j.plantsci.2011.08.009; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Arencibia AD, 2006, PLANT SIGNAL BEHAV, V1, P265, DOI 10.4161/psb.1.5.3390; Arzanesh M. H., 2009, International Journal of Botany, V5, P244; Babak B, 2013, DNA RES, V20, P315, DOI 10.1093/dnares/dst012; Baldani JI, 1997, SOIL BIOL BIOCHEM, V29, P911, DOI 10.1016/S0038-0717(96)00218-0; Bertalan M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-450; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Bhattacharjee RB, 2008, APPL MICROBIOL BIOT, V80, P199, DOI 10.1007/s00253-008-1567-2; Blanco Y, 2005, J BIOSCI BIOENG, V99, P366, DOI 10.1263/jbb.99.366; BODDEY RM, 1995, PLANT SOIL, V174, P195, DOI 10.1007/BF00032247; Brechenmacher L, 2010, PLANT PHYSIOL, V153, P1808, DOI 10.1104/pp.110.157800; Chandna R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P181, DOI 10.1007/978-1-4614-0634-1_10; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen CN, 2002, PLANT MOL BIOL, V49, P633, DOI 10.1023/A:1015593715144; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Creus CM, 2004, CAN J BOT, V82, P273, DOI [10.1139/b03-119, 10.1139/B03-119]; Davies WJ, 2005, J PLANT GROWTH REGUL, V24, P285, DOI 10.1007/s00344-005-0103-1; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Dominguez-Nunez JA, 2012, FOREST SYST, V21, P364, DOI 10.5424/fs/2012213-02135; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hsiao TC, 2000, J EXP BOT, V51, P1595, DOI 10.1093/jexbot/51.350.1595; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; James EK, 1998, CRIT REV PLANT SCI, V17, P77, DOI 10.1016/S0735-2689(98)00357-8; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Ma N, 2006, J EXP BOT, V57, P2763, DOI 10.1093/jxb/erl033; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Matsuoka S, 2009, IN VITRO CELL DEV-PL, V45, P372, DOI 10.1007/s11627-009-9220-z; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Muthukumarasamy R, 2000, CURR SCI INDIA, V78, P1063; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Oliveira ALM, 2002, PLANT SOIL, V242, P205, DOI 10.1023/A:1016249704336; OLIVEIRA ALM, 2003, BRAZ J MICROBIOL, V34, P59; Pedraza RO, 2008, INT J FOOD MICROBIOL, V125, P25, DOI 10.1016/j.ijfoodmicro.2007.11.079; Polizel AM, 2011, GENET MOL RES, V10, P3641, DOI 10.4238/2011.October.21.4; Ravikumar G, 2014, TRANSGENIC RES, V23, P421, DOI 10.1007/s11248-013-9776-6; Reis RR, 2014, PLANT SCI, V221, P59, DOI 10.1016/j.plantsci.2014.02.003; Rodriguez-Salazar J, 2009, FEMS MICROBIOL LETT, V296, P52, DOI 10.1111/j.1574-6968.2009.01614.x; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Ruiz-Sanchez M, 2011, J PLANT PHYSIOL, V168, P1031, DOI 10.1016/j.jplph.2010.12.019; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Taji T, 1999, PLANT CELL PHYSIOL, V40, P119, DOI 10.1093/oxfordjournals.pcp.a029469; Tammisola Jussi, 2010, GM Crops, V1, P181, DOI 10.4161/gmcr.1.4.13173; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; URQUIAGA S, 1992, SOIL SCI SOC AM J, V56, P105, DOI 10.2136/sssaj1992.03615995005600010017x; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Vargas L, 2012, PLANT SOIL, V356, P127, DOI 10.1007/s11104-012-1274-8; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xie ZJ, 2003, PLANT GROWTH REGUL, V41, P117, DOI 10.1023/A:1027371906349; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yang W, 2011, PLANTA, V233, P219, DOI 10.1007/s00425-010-1279-6; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803	102	60	60	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114744	10.1371/journal.pone.0114744	http://dx.doi.org/10.1371/journal.pone.0114744			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489849	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300073
J	Li, CL; Yang, JG; Lin, D; Zhao, YS; Liu, S; Xing, SN; Zhao, S; Chen, CQ; Jiang, ZM; Pu, FF; Cao, JP; Ma, DC				Li, Chang-Ling; Yang, Jin-Gang; Lin, Di; Zhao, Yong-Shan; Liu, Shuo; Xing, Si-Ning; Zhao, Song; Chen, Cong-Qin; Jiang, Zhi-Ming; Pu, Fei-Fei; Cao, Jian-Ping; Ma, Dong-Chu			Phosphorylation of Ribosomal Protein S6 Kinase 1 at Thr421/Ser424 and Dephosphorylation at Thr389 Regulates SP600125-Induced Polyploidization of Megakaryocytic Cell Lines	PLOS ONE			English	Article							JNK INHIBITOR SP600125; MEGAKARYOBLASTIC LEUKEMIA; MUSCLE-CELLS; DAMI CELL; MTOR; ACTIVATION; ENDOMITOSIS; PLOIDY; ESTABLISHMENT; LOCALIZATION	Megakaryocytes (MKs) are one of the few cell types that become polyploid; however, the mechanisms by which these cells are designated to become polyploid are not fully understood. In this investigation, we successfully established two relatively synchronous polyploid cell models by inducing Dami and CMK cells with SP600125. We found that SP600125 induced the polyploidization of Dami and CMK cells, concomitant with the phosphorylation of ribosomal protein S6 kinase 1 (S6K1) at Thr421/Ser424 and dephosphorylation at Thr389. The polyploidization was partially blocked by H-89, a cAMP-dependent protein kinase (PKA) inhibitor, through direct binding to S6K1, leading to dephosphorylation at Thr421/Ser424 and phosphorylation at Thr389, independent of PKA. Overexpression of a rapamycinresistant mutant of S6K1 further enhanced the inhibitory effect of LY294002 on the SP600125-induced polyploidization of Dami and CMK cells. SP600125 also induced the polyploidization of Meg-01 cells, which are derived from a patient with chronic myelogenous leukemia, without causing a significant change in S6K1 phosphorylation. Additionally, SP600125 induced the polyploidization of HEL cells, which are derived from a patient with erythroleukemia, and phosphorylation at Thr389 of S6K1 was detected. However, the polyploidization of both Meg-01 cells and HEL cells as a result of SP600125 treatment was lower than that of SP600125-induced Dami and CMK cells, and it was not blocked by H-89 despite the increased phosphorylation of S6K1 at Thr389 in both cell lines in response to H-89. Given that the Dami and CMK cell lines were derived from patients with acute megakaryocytic leukemia (AMKL) and expressed high levels of platelet-specific antigens, our data suggested that SP600125-induced polyploidization is cell-type specific, that these cell lines were more differentiated, and that phosphorylation at Thr421/Ser424 and dephosphorylation at Thr389 of S6K1 may play an important role in the SP600125-induced polyploidization of these cell lines synergistically with other signaling pathways.	[Li, Chang-Ling; Yang, Jin-Gang; Lin, Di; Liu, Shuo; Xing, Si-Ning; Zhao, Song; Jiang, Zhi-Ming; Pu, Fei-Fei; Cao, Jian-Ping; Ma, Dong-Chu] Shenyang Mil Area Command, Gen Hosp, Dept Expt Med, Shenyang, Liaoning, Peoples R China; [Zhao, Yong-Shan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Liaoning, Peoples R China; [Chen, Cong-Qin] Shenyang Pharmaceut Univ, Shenyang, Liaoning, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Ma, DC (corresponding author), Shenyang Mil Area Command, Gen Hosp, Dept Expt Med, Shenyang, Liaoning, Peoples R China.	mdc580819@sina.com		Ma, Dongchu/0000-0002-3229-9719; Yang, Jingang/0000-0003-3719-9853	Fundation of the State Key Lab of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences [2013-001]; National natural science foundation of China [61302003]; Natural Science Foundation of Liaoning Province [20062079]	Fundation of the State Key Lab of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences; National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was funded by the Fundation of the State Key Lab of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences (2013-001), National natural science foundation of China (61302003) and Natural Science Foundation of Liaoning Province (20062079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Bluteau D, 2009, J THROMB HAEMOST, V7, P227, DOI 10.1111/j.1538-7836.2009.03398.x; Carow CE, 2001, J CELL PHYSIOL, V188, P291, DOI 10.1002/jcp.1120; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; GREENBERG SM, 1988, BLOOD, V72, P1968; Guerriero R, 2006, J CELL SCI, V119, P744, DOI 10.1242/jcs.02784; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Kim JA, 2010, ONCOGENE, V29, P1702, DOI 10.1038/onc.2009.464; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; Ma DC, 1996, EUR J HAEMATOL, V57, P121; Ma Dong-Chu, 2001, Shengli Xuebao, V53, P296; Ma DC, 2009, J CELL PHYSIOL, V219, P31, DOI 10.1002/jcp.21647; MacLeod RAF, 1997, BLOOD, V90, P2850, DOI 10.1182/blood.V90.7.2850.2850_2850_2850; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; McCrann DJ, 2010, BLOOD, V116, P2192, DOI 10.1182/blood-2010-04-280420; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Miyamoto-Yamasaki Y, 2007, CELL BIOL INT, V31, P1501, DOI 10.1016/j.cellbi.2007.07.002; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; OGURA M, 1985, BLOOD, V66, P1384; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raslova H, 2006, BLOOD, V107, P2303, DOI 10.1182/blood-2005-07-3005; Rosner M, 2012, AMINO ACIDS, V42; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Vitrat N, 1998, BLOOD, V91, P3711; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; WANG ZY, 1995, BLOOD, V86, P3783, DOI 10.1182/blood.V86.10.3783.bloodjournal86103783; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Wen Q, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002043; Zhang Y, 2004, BLOOD, V103, P3717, DOI 10.1182/blood-2003-09-3365	42	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114389	10.1371/journal.pone.0114389	http://dx.doi.org/10.1371/journal.pone.0114389			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486532	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600051
J	Pauksch, L; Hartmann, S; Szalay, G; Alt, V; Lips, KS				Pauksch, Linda; Hartmann, Sonja; Szalay, Gabor; Alt, Volker; Lips, Katrin S.			In Vitro Assessment of Nanosilver-Functionalized PMMA Bone Cement on Primary Human Mesenchymal Stem Cells and Osteoblasts	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTIONS; SILVER NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL; DIFFERENTIATION; GENTAMICIN; IONS; BIOCOMPATIBILITY; CYTOTOXICITY; EFFICACY	Peri-prosthetic infections caused by multidrug resistant bacteria have become a serious problem in surgery and orthopedics. The aim is to introduce biomaterials that avoid implant-related infections caused by multiresistant bacteria. The efficacy of silver nanoparticles (AgNP) against a broad spectrum of bacteria and against multiresistant pathogens has been repeatedly described. In the present study polymethylmethacrylate (PMMA) bone cement functionalized with AgNP and/or gentamicin were tested regarding their biocompatibility with bone forming cells. Therefore, influences on viability, cell number and differentiation of primary human mesenchymal stem cells (MSCs) and MSCs cultured in osteogenic differentiation media (MSC-OM) caused by the implant materials were studied. Furthermore, the growth behavior and the morphology of the cells on the testing material were observed. Finally, we examined the induction of cell stress, regarding antioxidative defense and endoplasmatic reticulum stress. We demonstrated similar cytocompatibility of PMMA loaded with AgNP compared to plain PMMA or PMMA loaded with gentamicin. There was no decrease in cell number, viability and osteogenic differentiation and no induction of cell stress for all three PMMA variants after 21 days. Addition of gentamicin to AgNP-loaded PMMA led to a slight decrease in osteogenic differentiation. Also an increase in cell stress was detectable for PMMA loaded with gentamicin and AgNP. In conclusion, supplementation of PMMA bone cement with gentamicin, AgNP, and both results in bone implants with an antibacterial potency and suitable cytocompatibility in MSCs and MSC-OM.	[Pauksch, Linda; Hartmann, Sonja; Lips, Katrin S.] Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany; [Szalay, Gabor; Alt, Volker] Univ Hosp Giessen & Marburg, Dept Trauma Surg, Giessen, Germany	Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Lips, KS (corresponding author), Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany.	Katrin.S.Lips@chiru.med.uni-giessen.de			Federal Ministry of Education and Research [03X0103D]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding: This work was financially supported by the Federal Ministry of Education and Research [03X0103D]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; Ahamed MIN, 2015, INT J BIOL MACROMOL, V72, P680, DOI 10.1016/j.ijbiomac.2014.08.055; Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538; Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078; [Anonymous], 2011, JRC SCI TECHNICAL RE; Arora M, 2013, WORLD J ORTHOP, V4, P67, DOI 10.5312/wjo.v4.i2.67; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Chang Y, 2013, BONE JOINT RES, V2, P220, DOI 10.1302/2046-3758.210.2000188; Chang YH, 2006, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000229324.75911.c7; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Darwiche H, 2010, CLIN ORTHOP RELAT R, V468, P2392, DOI 10.1007/s11999-010-1325-5; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Galvez-Lopez R, 2014, DIAGN MICR INFEC DIS, V78, P70, DOI 10.1016/j.diagmicrobio.2013.09.014; GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576, DOI 10.2106/00004623-199510000-00015; Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1; GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; Hanssen A D, 1999, Instr Course Lect, V48, P111; Ince A, 2007, INT ORTHOP, V31, P223, DOI 10.1007/s00264-006-0144-5; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; Lentino Joseph R, 2004, Curr Infect Dis Rep, V6, P388, DOI 10.1007/s11908-004-0038-x; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Liu XJ, 2014, J BIOMED NANOTECHNOL, V10, P1277, DOI 10.1166/jbn.2014.1824; Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001; Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046; Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Okafor F, 2013, INT J ENV RES PUB HE, V10, P5221, DOI 10.3390/ijerph10105221; Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037; Qin H, 2014, INT J NANOMED, V9, P2469, DOI 10.2147/IJN.S59753; Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343; Renaud A, 2012, CAN J SURG, V55, P394, DOI 10.1503/cjs.033610; Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/nnm.12.18, 10.2217/NNM.12.18]; Samberg ME, 2011, NANOTOXICOLOGY, V5, P244, DOI 10.3109/17435390.2010.525669; Singh RP, 2012, TOXICOL LETT, V213, P249, DOI 10.1016/j.toxlet.2012.07.009; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Teodoro JS, 2011, TOXICOL IN VITRO, V25, P664, DOI 10.1016/j.tiv.2011.01.004; Trampuz A, 2005, SWISS MED WKLY, V135, P243; van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557; Wright JB, 1998, AM J INFECT CONTROL, V26, P572, DOI 10.1053/ic.1998.v26.a93527; Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	53	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114740	10.1371/journal.pone.0114740	http://dx.doi.org/10.1371/journal.pone.0114740			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485700	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600093
J	Xu, Y; Luo, Q; Lin, T; Zeng, ZP; Wang, GH; Zeng, DQ; Ding, R; Sun, CL; Zhang, XK; Chen, HF				Xu, Yang; Luo, Qiang; Lin, Ting; Zeng, Zhiping; Wang, Guanghui; Zeng, Dequan; Ding, Rong; Sun, Cuiling; Zhang, Xiao-kun; Chen, Haifeng			U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID UDCA; COLON-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; MTOR INHIBITOR; MITOCHONDRIAL DYSFUNCTION; INDUCE APOPTOSIS; BINDING-PROTEIN; LIVER; GROWTH; EXPRESSION	U12, one of 20 derivatives synthesized from ursodeoxycholic acid (UDCA), has been found to have anticancer effects in liver cancer cell lines (SMMC-7721 and HepG2) and to protect normal liver cells from deoxycholic acid (DCA) damage (QSG-7701). Its anticancer mechanism was investigated using computer-aided network pharmacology and comparative proteomics. Results showed that its anti-malignancy activities were activated by mTOR/S6K1, cyclinD1/CDK2/4 and caspase-dependent apoptotic signaling pathways in hepatocellular carcinoma cells (HCC). The action of U12 may be similar to that of rapamycin. Animal testing confirmed that U12 exerted better anti-tumor activity than UDCA and had less severe side effects than fluorouracil (5-Fu). These observations indicate that U12 differs from UDCA and other derivatives and may be a suitable lead for the development of compounds useful in the treatment of HCC.	[Xu, Yang; Luo, Qiang; Lin, Ting; Zeng, Zhiping; Wang, Guanghui; Zeng, Dequan; Ding, Rong; Sun, Cuiling; Zhang, Xiao-kun; Chen, Haifeng] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China; [Zhang, Xiao-kun] Sanford Burnham Med Res Inst, La Jolla, CA USA	Xiamen University; Sanford Burnham Prebys Medical Discovery Institute	Zhang, XK (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China.	xzhang@burnham.org; haifeng@xmu.edu.cn			Fundamental Research Funds for the Central Universities [2010121100, 2011121055]; National Natural Science Foundation of China [81202419, 81202956]; Xiamen Science and Technology Key program grant [3502Z20100006]; Natural Science Foundation of Fujian Province of China [2011 J05098]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology Key program grant; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	Funding was provided by Fundamental Research Funds for the Central Universities (No. 2010121100, 2011121055), the Grants from the National Natural Science Foundation of China (No. 81202419, 81202956), Xiamen Science and Technology Key program grant (No. 3502Z20100006) and the Natural Science Foundation of Fujian Province of China (No. 2011 J05098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2005, J NATL CANCER I, V97, P846, DOI 10.1093/jnci/dji144; Amadori S, 2012, BRIT J HAEMATOL, V156, P205, DOI 10.1111/j.1365-2141.2011.08940.x; Amaral JD, 2007, J BIOL CHEM, V282, P34250, DOI 10.1074/jbc.M704075200; Amaral JD, 2009, TRENDS MOL MED, V15, P531, DOI 10.1016/j.molmed.2009.09.005; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Aravalli RN, 2012, ARCH TOXICOL; Asciutti S, 2009, ANTICANCER RES, V29, P4971; Barilli A, 2008, CARDIOVASC RES, V78, P563, DOI 10.1093/cvr/cvn024; Chen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020729; Choi YH, 2003, CANCER LETT, V199, P157, DOI 10.1016/S0304-3835(03)00351-3; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Endo M, 2012, CLIN CANC RES; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fiorucci S, 2004, BRIT J PHARMACOL, V143, P33, DOI 10.1038/sj.bjp.0705780; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P8897, DOI 10.1073/pnas.151136298; Grewe M, 1999, CANCER RES, V59, P3581; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Im E, 2005, CANCER LETT, V229, P49, DOI 10.1016/j.canlet.2004.11.055; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Im EO, 2001, CANCER LETT, V163, P83, DOI 10.1016/S0304-3835(00)00671-6; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Kappler M, 2012, ALIMENT PHARM THER; Khare S, 2008, NUTR CANCER, V60, P389, DOI 10.1080/01635580701883003; Kudo M, 2011, DIGEST DIS, V29, P310, DOI 10.1159/000327565; Li YF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-329; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Nojiri S, 2009, HEPATOL RES, V39, P21, DOI 10.1111/j.1872-034X.2008.00406.x; Paolini M, 2002, HEPATOLOGY, V36, P305, DOI 10.1053/jhep.2002.34939; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Rabenhorst U, 2009, HEPATOLOGY, V50, P1121, DOI 10.1002/hep.23098; Saito K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049456; Sola S, 2003, J BIOL CHEM, V278, P48831, DOI 10.1074/jbc.M300468200; Xu Y, 2009, J PROTEOME RES, V8, P1585, DOI 10.1021/pr801001j; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X	39	8	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113479	10.1371/journal.pone.0113479	http://dx.doi.org/10.1371/journal.pone.0113479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486097	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600020
J	Zutkis, AA; Anbalagan, S; Chaussee, MS; Dmitriev, AV				Zutkis, Anastasia A.; Anbalagan, Srivishnupriya; Chaussee, Michael S.; Dmitriev, Alexander V.			Inactivation of the Rgg2 Transcriptional Regulator Ablates the Virulence of Streptococcus pyogenes	PLOS ONE			English	Article							BIOFILM FORMATION; EXPRESSION; COMPETENCE; METABOLISM; STRAIN; GENE	Streptococcus pyogenes adapts to different niches encountered in the human host via the activity of numerous regulatory proteins including the Rgg family of transcriptional regulators. The S. pyogenes chromosome encodes four Rgg paralogues designated Rgg1 (RopB), Rgg2 (MutR), Rgg3, and Rgg4 (ComR). In order to understand the role of the Rgg2 protein in the regulation of metabolic and virulence-associated properties of S. pyogenes, the rgg2 gene was inactivated in the M1 serotype strain SF370. Inactivation of rgg2 increased the growth yield of S. pyogenes in THY broth, increased biofilm formation, and increased production of SIC, which is an important virulence factor that inhibits complement mediated lysis. To identify Rgg2-regulated genes, the transcriptomes of SF370 and the rgg2 mutant strains were compared in the middle-exponential and post-exponential phases of growth. Rgg2 was found to control the expression of dozens of genes primarily in the exponential phase of growth, including genes associated with virulence (sse, scpA, slo, nga, mf-3), DNA transformation, and nucleotide metabolism. Inactivation of rgg2 decreased the ability of S. pyogenes to adhere to epithelial cells. In addition, the mutant strain was more sensitive to killing when incubated with human blood and avirulent in a murine bacteremia model. Finally, inoculation of mice with the avirulent rgg2 mutant of S. pyogenes SF370 conferred complete protection to mice subsequently challenged with the wild-type strain. Restoration of an intact rgg2 gene in mutant strain restored the wild-type phenotypes. Overall, the results demonstrate that Rgg2 is an important regulatory protein in S. pyogenes involved in controlling genes associated with both metabolism and virulence.	[Zutkis, Anastasia A.; Dmitriev, Alexander V.] Russian Acad Med Sci, Dept Mol Microbiol, Inst Expt Med, St Petersburg, Russia; [Anbalagan, Srivishnupriya; Chaussee, Michael S.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Dmitriev, Alexander V.] St Petersburg State Univ, St Petersburg 199034, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; University of South Dakota; Saint Petersburg State University	Dmitriev, AV (corresponding author), Russian Acad Med Sci, Dept Mol Microbiol, Inst Expt Med, St Petersburg, Russia.	admitriev10@yandex.ru						Anbalagan S, 2011, J BACTERIOL, V193, P4933, DOI 10.1128/JB.00429-11; Bortoni ME, 2009, MICROBIOL-SGM, V155, P4123, DOI 10.1099/mic.0.028282-0; BRIKO NI, 2014, ZH MIKROBIO IN PRESS; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Dmitriev AV, 2008, FEMS MICROBIOL LETT, V284, P43, DOI 10.1111/j.1574-6968.2008.01171.x; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; MALKE H, 1994, FEMS MICROBIOL LETT, V116, P107; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Morrison DA, 2013, J BACTERIOL, V195, P2612, DOI 10.1128/JB.00230-13; [Полякова Екатерина Михайловна Polyakova E.M.], 2010, [Медицинский академический журнал, Medical Academic Journal, Meditsinskii akademicheskii zhurnal], V10, P39; Ricker A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23419; Santiago AE, 2009, VACCINE, V27, P2426, DOI 10.1016/j.vaccine.2009.02.073; Wang JY, 2001, INFECT IMMUN, V69, P4734, DOI 10.1128/IAI.69.8.4734-4741.2001; Watson ME, 2013, INFECT IMMUN, V81, P1606, DOI 10.1128/IAI.00021-13	28	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114784	10.1371/journal.pone.0114784	http://dx.doi.org/10.1371/journal.pone.0114784			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486272	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600100
J	Wang, WJ; Du, ZY; Yan, JQ; Ma, D; Shi, MM; Zhang, MJ; Peng, CH; Li, HW				Wang, Weijie; Du, Zhiyong; Yan, Jiqi; Ma, Di; Shi, Minmin; Zhang, Mingjun; Peng, Chenghong; Li, Hongwei			Mesenchymal Stem Cells Promote Liver Regeneration and Prolong Survival in Small-For-Size Liver Grafts: Involvement of C-Jun N-Terminal Kinase, Cyclin D1, and NF-kappa B	PLOS ONE			English	Article							IN-VITRO; HEPATOCYTE PROLIFERATION; ISCHEMIA-REPERFUSION; TRANSPLANTATION; INJURY; HEPATECTOMY; MECHANISMS; FIBROSIS; THERAPY	Background: The therapeutic potential of mesenchymal stem cells (MSCs) has been highlighted recently for treatment of acute or chronic liver injury, by possibly differentiating into hepatocyte-like cells, reducing inflammation, and enhancing tissue repair. Despite recent progress, exact mechanisms of action are not clearly elucidated. In this study, we attempted to explore whether and how MSCs protected hepatocytes and stimulated allograft regeneration in small-for-size liver transplantation (SFSLT). Methods: SFSLT model was established with a 30% partial liver transplantation (30PLT) in rats. The differentiation potential and characteristics of bone marrow derived MSCs were explored in vitro. MSCs were infused transvenously immediately after graft implantation in therapy group. Expressions of apoptosis-, inflammatory-, anti-inflammatory-, and growth factor-related genes were measured by RT-PCR, activities of transcription factors AP-1 and NF-kappa B were analyzed by EMSA, and proliferative responses of the hepatic graft were evaluated by immunohistochemistry and western blot. Results: MSCs were successfully induced into hepatocyte-like cells, osteoblasts and adipocytes in vitro. MSCs therapy could not only alleviate ischemia reperfusion injury and acute inflammation to promote liver regeneration, but also profoundly improve one week survival rate. It markedly up-regulated the mRNA expressions of HGF, Bcl-2, Bcl-XL, IL-6, IL-10, IP-10, and CXCR2, however, down-regulated TNF-alpha. Increased activities of AP-1 and NF-kappa B, as well as elevated expressions of p-c-Jun, cyclin D1, and proliferating cell nuclear antigen (PCNA), were also found in MSCs therapy group. Conclusion: These data suggest that MSCs therapy promotes hepatocyte proliferation and prolongs survival in SFSLT by reducing ischemia reperfusion injury and acute inflammation, and sustaining early increased expressions of c-Jun N-terminal Kinase, Cyclin D1, and NF-kappa B.	[Wang, Weijie; Yan, Jiqi; Ma, Di; Shi, Minmin; Zhang, Mingjun; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Wang, Weijie] Zhengzhou Univ, Sch Med, Affiliated Hosp 1, Dept Surg, Zhengzhou 450052, Henan Province, Peoples R China; [Du, Zhiyong] Cent Hosp Wuhan, Dept Hepatobiliary Surg, Wuhan, Hubei Province, Peoples R China	Shanghai Jiao Tong University; Zhengzhou University	Yan, JQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	jiqiyan@yahoo.com		Peng, Chenghong/0000-0002-5573-7873	National Natural Science Foundation of China [81070358]; Municipal Natural Science Foundation of Shanghai Municipality [09ZR1418600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Natural Science Foundation of Shanghai Municipality	This study was supported by grants from The National Natural Science Foundation of China (81070358) and Municipal Natural Science Foundation of Shanghai Municipality (09ZR1418600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bishi DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092397; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Du ZY, 2013, J SURG RES, V183, P907, DOI 10.1016/j.jss.2013.02.009; Fouraschen SMG, 2012, STEM CELLS DEV, V21, P2410, DOI 10.1089/scd.2011.0560; Fu WY, 2013, HEPATOL RES, V43, P300, DOI 10.1111/j.1872-034X.2012.01071.x; Holden NS, 2011, J PHARMACOL TOX MET, V63, P7, DOI 10.1016/j.vascn.2010.03.002; Jeon H, 2010, CURR OPIN ORGAN TRAN, V15, P283, DOI 10.1097/MOT.0b013e32833983ee; Jiang SM, 2009, LIVER TRANSPLANT, V15, P1043, DOI 10.1002/lt.21797; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; KAMADA N, 1983, SURGERY, V93, P64; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Kubo N, 2012, J GASTROEN HEPATOL, V27, P165, DOI 10.1111/j.1440-1746.2011.06798.x; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Ma T, 2012, AM J TRANSPLANT, V12, P620, DOI 10.1111/j.1600-6143.2011.03870.x; Malato Y, 2012, GASTROENTEROLOGY, V143, P1597, DOI 10.1053/j.gastro.2012.08.030; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011; Nesher E, 2011, TRANSPL P, V43, P1736, DOI 10.1016/j.transproceed.2010.11.031; Niu J, 2014, CLIN EXP IMMUNOL, V176, P473, DOI 10.1111/cei.12283; Njoku DB, 2009, J AUTOIMMUN, V32, P52, DOI 10.1016/j.jaut.2008.11.003; Pan GZ, 2012, J SURG RES, V178, P935, DOI 10.1016/j.jss.2012.04.070; Pan QW, 2011, LIVER TRANSPLANT, V17, P596, DOI 10.1002/lt.22260; Puglisi MA, 2011, J BIOMED BIOTECHNOL, V2011, P1; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Salomone F, 2013, STEM CELL RES, V11, P1037, DOI 10.1016/j.scr.2013.07.003; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Seki T, 2012, J SURG RES, V178, P63, DOI 10.1016/j.jss.2012.02.014; Shao CH, 2014, J SURG RES, V186, P408, DOI 10.1016/j.jss.2013.08.016; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Tiberio L, 2006, CYTOKINE, V34, P131, DOI 10.1016/j.cyto.2006.04.009; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang WJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083908, 10.1371/journal.pone.0084654]; Xia XF, 2012, LIVER TRANSPLANT, V18, P696, DOI 10.1002/lt.23414; Yang ZF, 2007, LIVER TRANSPLANT, V13, P558, DOI 10.1002/lt.21094; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Yu Y, 2010, STEM CELLS DEV, V19, P903, DOI 10.1089/scd.2009.0254; Zhang HY, 2012, TRANSFUS MED REV, V26, P129, DOI 10.1016/j.tmrv.2011.09.002; Zhao W, 2012, WORLD J GASTROENTERO, V18, P1048, DOI 10.3748/wjg.v18.i10.1048; Zhong Z, 2006, TRANSPLANTATION, V82, P241, DOI 10.1097/01.tp.0000228867.98158.d2	44	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112532	10.1371/journal.pone.0112532	http://dx.doi.org/10.1371/journal.pone.0112532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479410	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200011
J	Degerman, S; Domellof, M; Landfors, M; Linder, J; Lundin, M; Haraldsson, S; Elgh, E; Roos, G; Forsgren, L				Degerman, Sofie; Domellof, Magdalena; Landfors, Mattias; Linder, Jan; Lundin, Mathias; Haraldsson, Susann; Elgh, Eva; Roos, Goran; Forsgren, Lars			Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism	PLOS ONE			English	Article							AGING-ASSOCIATED ALTERATION; LEWY BODY; DISEASE; PATHOGENESIS; CRITERIA; CELLS	Telomere length (TL) is regarded as a marker of cellular aging due to the gradual shortening by each cell division, but is influenced by a number of factors including oxidative stress and inflammation. Parkinson's disease and atypical forms of parkinsonism occur mainly in the elderly, with oxidative stress and inflammation in afflicted cells. In this study the relationship between blood TL and prognosis of 168 patients with idiopathic parkinsonism (136 Parkinson's disease [PD], 17 Progressive Supranuclear Palsy [PSP], and 15 Multiple System Atrophy [MSA]) and 30 controls was investigated. TL and motor and cognitive performance were assessed at baseline (diagnosis) and repeatedly up to three to five years follow up. No difference in TL between controls and patients was shown at baseline, nor any significant difference in TL stability or attrition during follow up. Interestingly, a significant relationship between TL at diagnosis and cognitive phenotype at follow up in PD and PSP patients was found, with longer mean TL at diagnosis in patients that developed dementia within three years.	[Degerman, Sofie; Landfors, Mattias; Haraldsson, Susann; Roos, Goran] Umea Univ, Dept Med Biosci, Umea, Sweden; [Domellof, Magdalena; Linder, Jan; Forsgren, Lars] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Lundin, Mathias] Umea Univ, Dept Stat, S-90187 Umea, Sweden; [Elgh, Eva] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Degerman, S (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	sofie.degerman@umu.se		Degerman, Sofie/0000-0002-2783-0712	Swedish Research Council; Swedish Parkinson Foundation; Swedish Parkinson's Disease Association; Swedish Cancer Society; Umea University; Foundation for Clinical Neuroscience at Umea University Hospital; Vasterbotten County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; Swedish Parkinson's Disease Association; Swedish Cancer Society(Swedish Cancer Society); Umea University; Foundation for Clinical Neuroscience at Umea University Hospital; Vasterbotten County Council	This work was supported by grants from the Swedish Research Council (LF, GR), the Swedish Parkinson Foundation (LF), the Swedish Parkinson's Disease Association (LF), the Swedish Cancer Society (GR), Umea University (LF, GR), the Foundation for Clinical Neuroscience at Umea University Hospital (LF), and Vasterbotten County Council (ALF) (LF, GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZY, 2013, NEUROMOL MED, V15, P25, DOI 10.1007/s12017-012-8207-9; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Domellof ME, 2013, THESIS UMEA U MED; Eerola J, 2010, J GERONTOL A-BIOL, V65, P1181, DOI 10.1093/gerona/glq125; Emre Murat, 2007, Handb Clin Neurol, V83, P401, DOI 10.1016/S0072-9752(07)83018-1; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Guan JZ, 2008, J GERONTOL A-BIOL, V63, P467, DOI 10.1093/gerona/63.5.467; Hudson G, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.022; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Maeda T, 2012, J NEUROGENET, V26, P245, DOI 10.3109/01677063.2011.651665; Maeda T, 2009, J GERONTOL A-BIOL, V64, P949, DOI 10.1093/gerona/glp070; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Saunders JAH, 2012, J NEUROIMMUNE PHARM, V7, P927, DOI 10.1007/s11481-012-9402-z; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Schurks M, 2014, EUR J NEUROL, V21, P93, DOI 10.1111/ene.12252; Svenson U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055543; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; Watfa G, 2011, J NUTR HEALTH AGING, V15, P277, DOI 10.1007/s12603-010-0275-7	27	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113387	10.1371/journal.pone.0113387	http://dx.doi.org/10.1371/journal.pone.0113387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501556	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400009
J	Mayer, C; Metscher, BD; Muller, GB; Mitteroecker, P				Mayer, Christine; Metscher, Brian D.; Mueller, Gerd B.; Mitteroecker, Philipp			Studying Developmental Variation with Geometric Morphometric Image Analysis (GMIA)	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; EVOLUTION; VISUALIZATION; EPIGENETICS; CONSTRAINTS; PLASTICITY; SHAPE	The ways in which embryo development can vary across individuals of a population determine how genetic variation translates into adult phenotypic variation. The study of developmental variation has been hampered by the lack of quantitative methods for the joint analysis of embryo shape and the spatial distribution of cellular activity within the developing embryo geometry. By drawing from the strength of geometric morphometrics and pixel/voxel-based image analysis, we present a new approach for the biometric analysis of two-dimensional and three-dimensional embryonic images. Well-differentiated structures are described in terms of their shape, whereas structures with diffuse boundaries, such as emerging cell condensations or molecular gradients, are described as spatial patterns of intensities. We applied this approach to microscopic images of the tail fins of larval and juvenile rainbow trout. Inter-individual variation of shape and cell density was found highly spatially structured across the tail fin and temporally dynamic throughout the investigated period.	[Mayer, Christine; Metscher, Brian D.; Mueller, Gerd B.; Mitteroecker, Philipp] Univ Vienna, Fac Life Sci, Dept Theoret Biol, A-1090 Vienna, Austria	University of Vienna	Mitteroecker, P (corresponding author), Univ Vienna, Fac Life Sci, Dept Theoret Biol, Althanstr 14, A-1090 Vienna, Austria.	philipp.mitteroecker@univie.ac.at	Metscher, Brian/I-1238-2019; Mitteroecker, Philipp/A-1591-2012	Metscher, Brian/0000-0002-6514-4406; Mitteroecker, Philipp/0000-0002-5308-3837; Syrowatka, Christine/0000-0002-0315-5142	Focus of Excellence Grant "Biometrics of EvoDevo'' of the Faculty of Life Sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	Focus of Excellence Grant "Biometrics of EvoDevo'' of the Faculty of Life Sciences, University of Vienna; Open Access Publishing Fund of the University of Vienna	This study was supported by the Focus of Excellence Grant "Biometrics of EvoDevo'' of the Faculty of Life Sciences, University of Vienna, to PM (http://lifesciences.univie.ac.at/). This article was supported by the Open Access Publishing Fund of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bookstein F., 1994, PSYCOLOQUY, V5; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Bookstein FL, 2014, EVOL BIOL; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hallgrimsson B, 2011, EPIGENETICS: LINKING GENOTYPE AND PHENOTYPE IN DEVELOPMENT AND EVOLUTION, P1; Hallgrimsson B, 2008, INTEGR COMP BIOL, V48, P373, DOI 10.1093/icb/icn076; Huttegger SM, 2011, EVOL BIOL, V38, P335, DOI 10.1007/s11692-011-9123-x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; LANITIS A, 1995, IMAGE VISION COMPUT, V13, P393, DOI 10.1016/0262-8856(95)99726-H; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Low FM, 2012, EVOL BIOL, V39, P650, DOI 10.1007/s11692-011-9157-0; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Martinez-Abadias N, 2012, EVOL BIOL, V39, P554, DOI 10.1007/s11692-012-9210-7; Metscher BD, 2011, DEV DYNAM, V240, P2301, DOI 10.1002/dvdy.22733; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2012, EVOL BIOL, V39, P536, DOI 10.1007/s11692-012-9178-3; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Mitteroecker P, 2009, EVOL BIOL, V36, P377, DOI 10.1007/s11692-009-9075-6; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mitteroecker P, 2009, EVOLUTION, V63, P727, DOI 10.1111/j.1558-5646.2008.00587.x; Muller GB, 2007, NAT REV GENET, V8, P943, DOI 10.1038/nrg2219; Muller GB, 2003, VIENNA SEE THEOR BIO; Newman SA, 2000, J EXP ZOOL, V288, P304, DOI 10.1002/1097-010X(20001215)288:4&lt;304::AID-JEZ3&gt;3.0.CO;2-G; O'Higgins P, 2012, EVOL BIOL, V39, P521, DOI 10.1007/s11692-012-9173-8; Pigliucci Massimo, 2010, EVOLUTION EXTENDED S, DOI DOI 10.1016/j.tree.2008.04.005; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Salazar-Ciudad I, 2006, J EXP ZOOL PART B, V306B, P107, DOI 10.1002/jez.b.21078; SENSEN CW, 2009, ADV IMAGING BIOL MED; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; West-Eberhard Mary Jane, 2003, pi; Zhang D, 2005, LECT NOTES COMPUT SC, V3497; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	46	13	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115076	10.1371/journal.pone.0115076	http://dx.doi.org/10.1371/journal.pone.0115076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500820	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400070
J	Byrnes, JEK; Ranganathan, J; Walker, BLE; Faulkes, Z				Byrnes, Jarrett E. K.; Ranganathan, Jai; Walker, Barbara L. E.; Faulkes, Zen			To Crowdfund Research, Scientists Must Build an Audience for Their Work	PLOS ONE			English	Article							PUBLIC ENGAGEMENT; SCIENCE COMMUNICATION; PERSPECTIVES; INCENTIVES; CONTEXTS; TIME	As rates of traditional sources of scientific funding decline, scientists have become increasingly interested in crowdfunding as a means of bringing in new money for research. In fields where crowdfunding has become a major venue for fundraising such as the arts and technology, building an audience for one's work is key for successful crowdfunding. For science, to what extent does audience building, via engagement and outreach, increase a scientist's abilities to bring in money via crowdfunding? Here we report on an analysis of the #SciFund Challenge, a crowdfunding experiment in which 159 scientists attempted to crowdfund their research. Using data gathered from a survey of participants, internet metrics, and logs of project donations, we find that public engagement is the key to crowdfunding success. Building an audience or "fanbase'' and actively engaging with that audience as well as seeking to broaden the reach of one's audience indirectly increases levels of funding. Audience size and effort interact to bring in more people to view a scientist's project proposal, leading to funding. We discuss how projects capable of raising levels of funds commensurate with traditional funding agencies will need to incorporate direct involvement of the public with science. We suggest that if scientists and research institutions wish to tap this new source of funds, they will need to encourage and reward activities that allow scientists to engage with the public.	[Byrnes, Jarrett E. K.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Byrnes, Jarrett E. K.; Ranganathan, Jai] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Walker, Barbara L. E.] Univ Calif Santa Barbara, Inst Social Behav & Econ Res, Santa Barbara, CA 93106 USA; [Faulkes, Zen] Univ Texas Pan Amer, Dept Biol, Edinburg, TX 78539 USA	University of Massachusetts System; University of Massachusetts Boston; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Texas System; University of Texas Rio Grande Valley	Byrnes, JEK (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	jarrett.byrnes@umb.edu	Faulkes, Zen/A-5777-2009	Faulkes, Zen/0000-0003-4049-7034; Byrnes, Jarrett/0000-0002-9791-9472; Endemano Walker, Barbara/0000-0002-1977-0596				Ahmed SM, 2010, AM J PUBLIC HEALTH, V100, P1380, DOI 10.2105/AJPH.2009.178137; [Anonymous], 2007, RISING GATHERING STO; [Anonymous], RES TECHNOL MANAGE; Barry D, 1996, CONSERV BIOL, V10, P905, DOI 10.1046/j.1523-1739.1996.10030904-2.x; Burns TW, 2003, PUBLIC UNDERST SCI, V12, P183, DOI 10.1177/09636625030122004; Byrnes J, 2012, SCIFUND SUCCESS SOCI; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Committee on Research Universities, 2012, RES U FUT AM 10 BREA; Delgado A, 2011, PUBLIC UNDERST SCI, V20, P826, DOI 10.1177/0963662510363054; Ecklund EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036240; Ellison J., 2008, SCHOLARSHIP PUBLIC K; Faulkes Z, 2012, SCIFUND ROUND 2 SUCC; Faulkes Z, 2012, SCIFUND ROUND 3 SUCC; Gaggioli A, 2008, SCIENCE, V321, P1443, DOI 10.1126/science.321.5895.1443a; Gamerman Ellen, 2013, WALL STREET J, pD1; Gascoigne T, 1997, SCI COMMUN, V18, P265, DOI 10.1177/1075547097018003005; Goldberg-Freeman C, 2010, J EMPIR RES HUM RES, V5, P65, DOI 10.1525/jer.2010.5.4.65; Green RG, 2008, J SOC WORK EDUC, V44, P117, DOI 10.5175/JSWE.2008.200700003; Greenwald T, 2012, TECHNOL REV, V116, P117; Hackett EJ, 2011, SCI ENG ETHICS, V17, P823, DOI 10.1007/s11948-011-9307-x; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Holbrook J. B., 2009, SOC EPISTEMOL, V23, P177, DOI [DOI 10.1080/02691720903438169, 10.1080/02691720903438169]; Holbrook JB, 2005, TECHNOL SOC, V27, P437, DOI 10.1016/j.techsoc.2005.08.001; Hughes V, 2012, NAT MED, V18, P1307, DOI 10.1038/nm0912-1307; Human Food Project, 2013, AM GUT WHATS YOUR GU; Intersociety Working Group, 2012, RES DEV FY 2013; Johnson DR, 2014, SCI COMMUN, V36, P81, DOI 10.1177/1075547013499142; Kennedy C, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.2.3; Kouper I, 2010, JCOM-J SCI COMMUN, V9; Laursen Sandra, 2007, CBE Life Sci Educ, V6, P49, DOI 10.1187/cbe.06-05-0165; McCullagh P., 1989, GEN LINEAR MODELS 2; Meyer JL, 2010, FRONT ECOL ENVIRON, V8, P299, DOI 10.1890/090143; Mitchell K, 2008, PRACTISING PUBLIC SC; National Science Board, 2012, DIM FUND RIS EXP TRE; Nyden P, 2003, J GEN INTERN MED, V18, P576, DOI 10.1046/j.1525-1497.2003.20350.x; Ordanini A, 2011, J SERV MANAGE, V22, P443, DOI 10.1108/09564231111155079; Palmer A, 2012, AMANDA PALMER BUILT; Pebble Technology, 2012, PEBBL E PAP WATCH IP; Perlstein E, 2013, MICRORYZA CAMPAIGN T; Pinholster G, 2013, SCIENCE, V342, P1464; Planetary Resources, 2013, ARK SPAC TEL EV; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; Portalarium Inc, 2013, SHROUD AV FORS VIRT; Priem J, 2012, ARXIV12034745CSDL; Procter R, 2010, PHILOS T R SOC A, V368, P4039, DOI 10.1098/rsta.2010.0155; R Development Core Team, 2012, R LANG ENV STAT COMP; Resnik DB, 2010, ACCOUNT RES, V17, P198, DOI 10.1080/08989621.2010.493095; Richman J, 2013, UBIOME SEQUENCING YO; Rockey S, 2012, COMMUNICATION; Royal Society, 2006, SCI COMM EXC SCI SUR; Rubin S, 2012, FORBES, V190, P62; Russo G., 2010, NATURE, V468, P465, DOI [DOI 10.1038/NJ7322-465A, 10.1038/nj7322- 465a]; Scott JM, 2007, CONSERV BIOL, V21, P29, DOI 10.1111/j.1523-1739.2006.00641.x; Shema H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035869, 10.4161/psb.19467]; Silka L, 2010, J EMPIR RES HUM RES, V5, P3, DOI 10.1525/jer.2010.5.4.3; Sismondo S, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, P13; Stilgoe J, 2014, PUBLIC UNDERST SCI, V23, P4, DOI 10.1177/0963662513518154; Valanciene L., 2013, EC MANAGEMENT, V18, P39, DOI DOI 10.5755/J01.EM.18.1.3713; Waananen L, 2012, 3 YEARS KICKSTARTER; Wasik J, 2012, FORBES, V189, P144; Weigold MF, 2001, SCI COMMUN, V23, P164, DOI 10.1177/1075547001023002005; Wheat RE, 2013, TRENDS ECOL EVOL, V28, P71, DOI 10.1016/j.tree.2012.11.001; Wilcox C, 2012, BIOL BULL-US, V222, P85, DOI 10.1086/BBLv222n2p85; Williams KP, 2012, J CANCER EDUC, V27, P3, DOI 10.1007/s13187-012-0332-5	64	42	42	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e110329	10.1371/journal.pone.0110329	http://dx.doi.org/10.1371/journal.pone.0110329			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25494306	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400002
J	Zhu, X; Ma, Z; Wang, JJ; Chou, SL; Shan, AS				Zhu, Xin; Ma, Zhi; Wang, Jiajun; Chou, Shuli; Shan, Anshan			Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide	PLOS ONE			English	Article							BACTERIAL BIOFILM FORMATION; CATION-PI INTERACTIONS; ANTIBACTERIAL AGENTS; CELL SELECTIVITY; ANTIBIOTICS; DEFENSE; DESIGN; LL-37; RECOGNITION; INHIBITION	Here, we found that simple substitution of amino acids in the middle position of the hydrophobic face of an amphipathic peptide RI16 with tryptophan (T9W) considerably transformed into an antimicrobial peptide specifically targeting Pseudomonas aeruginosa. Minimal inhibitory concentration (MIC) results demonstrated that T9W had a strong and specifically antimicrobial activity against P. aeruginosa, including antibiotic-resistant strains, but was not active against Escherichia coli, Salmonella typhimurium, Staphylococcus aureus and Staphyfococcus epidermidis. Fluorescent spectroscopic assays indicated that T9W interacted with the membrane of P. aeruginosa, depolarizing the outer and the inner membrane of bacterial cells. Salt susceptibility assay showed that T9W still maintained its strong anti-pseudomonas activity in the presence of salts at physiological concentrations, and in hemolytic and MTT assays T9W also showed no toxicity against human blood cells and macrophages. In vivo assay demonstrated that T9W also displayed no toxicity to Chinese Kun Ming (KM) mice. Furthermore, the strong antibiofilm activity was also observed with the peptide T9W, which decreased the percentage of biomass formation in a dose-dependent manner. Overall, these findings indicated that design of single-pathogen antimicrobial agents can be achieved by simple amino acid mutation in naturally occurring peptide sequences and this study suggested a model of optimization/design of anti-pseudomonas drugs in which the tryptophan residue was a conserved element.	[Zhu, Xin; Ma, Zhi; Wang, Jiajun; Chou, Shuli; Shan, Anshan] Northeast Agr Univ, Inst Anim Nutr, Harbin, Peoples R China	Northeast Agricultural University - China	Shan, AS (corresponding author), Northeast Agr Univ, Inst Anim Nutr, Harbin, Peoples R China.	asshan@neau.edu.cn	Shan, Anshan/U-9119-2019	Wang, Jiajun/0000-0002-2086-2105; Zhu, Xin/0000-0001-6556-4147	National Basic Research Program [2012CB124703]; National Key Research Program [2013BAD10B03]; National Natural Science Foundation of China [31072046, 31272453]	National Basic Research Program(National Basic Research Program of China); National Key Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Basic Research Program (Grant No. 2012CB124703), the National Key Research Program (2013BAD10B03) and the National Natural Science Foundation of China (Grant No. 31072046 and No. 31272453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengoechea JA, 1996, INFECT IMMUN, V64, P4891, DOI 10.1128/IAI.64.12.4891-4899.1996; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Dong N, 2012, ANTIMICROB AGENTS CH, V56, P2994, DOI 10.1128/AAC.06327-11; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gopal R, 2013, AMINO ACIDS, V44, P645, DOI 10.1007/s00726-012-1388-6; Hilpert K, 2006, CHEM BIOL, V13, P1101, DOI 10.1016/j.chembiol.2006.08.014; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Lee JK, 2013, BBA-BIOMEMBRANES, V1828, P443, DOI 10.1016/j.bbamem.2012.09.005; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Oradd G, 2011, BBA-BIOMEMBRANES, V1808, P244, DOI 10.1016/j.bbamem.2010.08.015; Ouberai M, 2011, BBA-BIOMEMBRANES, V1808, P1716, DOI 10.1016/j.bbamem.2011.01.014; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pasupuleti M, 2009, BBA-GEN SUBJECTS, V1790, P800, DOI 10.1016/j.bbagen.2009.03.029; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Ravi HK, 2013, CHEM COMMUN, V49, P8821, DOI 10.1039/c3cc44912b; Rydberg HA, 2012, BIOCHEM BIOPH RES CO, V427, P261, DOI 10.1016/j.bbrc.2012.09.030; Schmidtchen A, 2011, BBA-BIOMEMBRANES, V1808, P1081, DOI 10.1016/j.bbamem.2010.12.020; Scocchi M, 2005, FEBS J, V272, P4398, DOI 10.1111/j.1742-4658.2005.04852.x; Singh V, 2012, ANTIMICROB AGENTS CH, V56, P4360, DOI 10.1128/AAC.00544-12; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Spellberg B, 2013, NAT REV DRUG DISCOV, V12, P963, DOI 10.1038/nrd3957-c1; STORICI P, 1994, FEBS LETT, V337, P303, DOI 10.1016/0014-5793(94)80214-9; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Wiradharma N, 2013, MACROMOL RAPID COMM, V34, P74, DOI 10.1002/marc.201200534; Wiradharma N, 2011, BIOMATERIALS, V32, P2204, DOI 10.1016/j.biomaterials.2010.11.054; Wu GQ, 2008, CURR MICROBIOL, V57, P552, DOI 10.1007/s00284-008-9241-6; Xu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098935; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2000, ANTIMICROB AGENTS CH, V44, P3317, DOI 10.1128/AAC.44.12.3317-3321.2000; Zhu X, 2014, ACTA BIOMATER, V10, P244, DOI 10.1016/j.actbio.2013.08.043	48	26	29	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114605	10.1371/journal.pone.0114605	http://dx.doi.org/10.1371/journal.pone.0114605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494332	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400058
J	Espinosa, S; Branch, LC; Cueva, R				Espinosa, Santiago; Branch, Lyn C.; Cueva, Ruben			Road Development and the Geography of Hunting by an Amazonian Indigenous Group: Consequences for Wildlife Conservation	PLOS ONE			English	Article							SOURCE-SINK SYSTEMS; PROTECTED AREAS; RESOURCE USE; FOREST; MODEL; SUSTAINABILITY; EXTRACTION; IMPACTS; GAME; DEFORESTATION	Protected areas are essential for conservation of wildlife populations. However, in the tropics there are two important factors that may interact to threaten this objective: 1) road development associated with large-scale resource extraction near or within protected areas; and 2) historical occupancy by traditional or indigenous groups that depend on wildlife for their survival. To manage wildlife populations in the tropics, it is critical to understand the effects of roads on the spatial extent of hunting and how wildlife is used. A geographical analysis can help us answer questions such as: How do roads affect spatial extent of hunting? How does market vicinity relate to local consumption and trade of bushmeat? How does vicinity to markets influence choice of game? A geographical analysis also can help evaluate the consequences of increased accessibility in landscapes that function as source-sink systems. We applied spatial analyses to evaluate the effects of increased landscape and market accessibility by road development on spatial extent of harvested areas and wildlife use by indigenous hunters. Our study was conducted in Yasuni Biosphere Reserve, Ecuador, which is impacted by road development for oil extraction, and inhabited by the Waorani indigenous group. Hunting activities were self-reported for 12-14 months and each kill was georeferenced. Presence of roads was associated with a two-fold increase of the extraction area. Rates of bushmeat extraction and trade were higher closer to markets than further away. Hunters located closer to markets concentrated their effort on large-bodied species. Our results clearly demonstrate that placing roads within protected areas can seriously reduce their capacity to sustain wildlife populations and potentially threaten livelihoods of indigenous groups who depend on these resources for their survival. Our results critically inform current policy debates regarding resource extraction and road building near or within protected areas.	[Espinosa, Santiago; Branch, Lyn C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Espinosa, Santiago] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Quito, Ecuador; [Cueva, Ruben] Wildlife Conservat Soc, Ecuador Program, Quito, Ecuador	State University System of Florida; University of Florida; Pontificia Universidad Catolica del Ecuador	Espinosa, S (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	srespinosa@puce.edu.ec	Espinosa, Santiago/M-4751-2019	Espinosa, Santiago/0000-0002-7416-7167	University of Florida; World Wildlife Fund; Wildlife Conservation Society	University of Florida(University of Florida); World Wildlife Fund; Wildlife Conservation Society	This work was supported by the University of Florida (Department of Wildlife Ecology and Conservation, Tropical Conservation and Development Program, and Amazon Leadership Conservation initiative), the World Wildlife Fund (Russel E. Train Education for Nature Program) and the Wildlife Conservation Society (Research Fellowship Program and WCS-Ecuador Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert B, 2007, CURR ANTHROPOL, V48, P584, DOI 10.1086/519914; Alers M, 2007, REDUCING THREATS PRO; Asquith NM, 1997, ECOLOGY, V78, P941, DOI 10.1890/0012-9658(1997)078[0941:DMCCCR]2.0.CO;2; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Beck H, 2010, J TROP ECOL, V26, P407, DOI 10.1017/S0266467410000106; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett EL, 2000, BIOL RESOURCE MANAGE, P1; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Brandon K., 1998, PARKS PERIL PEOPLE P; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brugiere D, 2009, AFR J ECOL, V47, P630, DOI 10.1111/j.1365-2028.2008.01013.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Damania R, 2005, P ROY SOC B-BIOL SCI, V272, P259, DOI 10.1098/rspb.2004.2945; De Souza-Mazurek RR, 2000, BIODIVERS CONSERV, V9, P579, DOI 10.1023/A:1008999201747; Espinosa S, 2012, THESIS U FLORIDA GAI; Fahrig L, 2009, ECOL SOC, V14; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finer M., 2014, HIGH RESOLUTION SATE; Finer M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014012; Finer M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034005; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; FRANZEN M, 2005, THESIS U CALIFORNIA; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; GODOY R, 1995, HUM ECOL, V23, P29, DOI 10.1007/BF01190097; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HAMES RB, 1979, HUM ECOL, V7, P219, DOI 10.1007/BF00889493; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Hill, ADAPTIVE RESPONSES N, P139; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; JOSHI NV, 1991, THEOR POPUL BIOL, V40, P211, DOI 10.1016/0040-5809(91)90053-I; Kauffman R. G., 2001, MEAT SCI APPL, V1, P1; Laurance WF, 2005, TRENDS ECOL EVOL, V20, P645, DOI 10.1016/j.tree.2005.10.009; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2008, CONSERV BIOL, V22, P721, DOI 10.1111/j.1523-1739.2008.00917.x; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Levi T, 2011, EVOL ECOL RES, V13, P171; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; McCullough DR, 1996, J WILDLIFE MANAGE, V60, P1, DOI 10.2307/3802033; Mena P, 2000, BIOL RESOURCE MANAGE, P57; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Naranjo EJ, 2007, BIOL CONSERV, V138, P412, DOI 10.1016/j.biocon.2007.05.010; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Novaro AJ, 2005, J APPL ECOL, V42, P910, DOI 10.1111/j.1365-2664.2005.01067.x; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 1996, BIOL CONSERV, V77, P115, DOI 10.1016/0006-3207(96)00010-9; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; RAISG, 2012, AM 2012 PROT AR IND; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; Rival Laura, 1996, HIJOS SOL PADRES JAG; Robinson J.G., 1991, P415; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; ROSS EB, 1978, CURR ANTHROPOL, V19, P1, DOI 10.1086/201999; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; Sierra R, 1999, ECOL ECON, V30, P107, DOI 10.1016/S0921-8009(98)00101-3; Silverman B.W., 1986, DENSITY ESTIMATION S; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Smith DA, 2008, BIOL CONSERV, V141, P925, DOI 10.1016/j.biocon.2007.12.021; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Sunquist M., 2002, WILDCATS WORLD; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; USHER MB, 1988, BIOL CONSERV, V44, P119, DOI 10.1016/0006-3207(88)90007-9; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warriss P.D, 2000, MEAT SCI INTRO TEXT; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; WILKIE DS, 1992, CONSERV BIOL, V6, P570, DOI 10.1046/j.1523-1739.1992.06040570.x; Wilkie DS, 2000, SCIENCE, V287, P975; Yost JA, 1983, ADAPTIVE RESPONSES N, P198	87	54	58	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114916	10.1371/journal.pone.0114916	http://dx.doi.org/10.1371/journal.pone.0114916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489954	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300094
J	Fiory, F; Parrillo, L; Raciti, GA; Zatterale, F; Nigro, C; Mirra, P; Falco, R; Ulianich, L; Di Jeso, B; Formisano, P; Miele, C; Beguinot, F				Fiory, Francesca; Parrillo, Luca; Raciti, Gregory Alexander; Zatterale, Federica; Nigro, Cecilia; Mirra, Paola; Falco, Roberta; Ulianich, Luca; Di Jeso, Bruno; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco			PED/PEA-15 Inhibits Hydrogen Peroxide-Induced Apoptosis in Ins-1E Pancreatic Beta-Cells via PLD-1	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; PHOSPHOLIPASE-D ISOZYMES; SKELETAL-MUSCLE CELLS; PHOSPHATIDIC-ACID; GLUCOSE-TRANSPORT; GLIOMA-CELLS; PKC-ZETA; DEATH; KINASE; ACTIVATION	The small scaffold protein PED/PEA-15 is involved in several different physiologic and pathologic processes, such as cell proliferation and survival, diabetes and cancer. PED/PEA-15 exerts an anti-apoptotic function due to its ability to interfere with both extrinsic and intrinsic apoptotic pathways in different cell types. Recent evidence shows that mice overexpressing PED/PEA-15 present larger pancreatic islets and increased beta-cells mass. In the present work we investigated PED/PEA-15 role in hydrogen peroxide-induced apoptosis in Ins-1E beta-cells. In pancreatic islets isolated from TgPED/PEA-15 mice hydrogen peroxide-induced DNA fragmentation was lower compared to WT islets. TUNEL analysis showed that PED/PEA-15 overexpression increases the viability of Ins-1E beta-cells and enhances their resistance to apoptosis induced by hydrogen peroxide exposure. The activity of caspase-3 and the cleavage of PARP-1 were markedly reduced in Ins-1E cells overexpressing PED/PEA-15 (Ins-1EPED/PEA-15). In parallel, we observed a decrease of the mRNA levels of pro-apoptotic genes Bcl-xS and Bad. In contrast, the expression of the anti-apoptotic gene Bcl-xL was enhanced. Accordingly, DNA fragmentation was higher in control cells compared to Ins-1EPED/PEA-15 cells. Interestingly, the preincubation with propranolol, an inhibitor of the pathway of PLD-1, a known interactor of PED/PEA-15, responsible for its deleterious effects on glucose tolerance, abolishes the antiapoptotic effects of PED/PEA-15 overexpression in Ins-1E beta-cells. The same results have been obtained by inhibiting PED/PEA-15 interaction with PLD-1 in Ins-1EPED/PEA-15. These results show that PED/PEA-15 overexpression is sufficient to block hydrogen peroxide-induced apoptosis in Ins-1E cells through a PLD-1 mediated mechanism.	[Fiory, Francesca; Parrillo, Luca; Raciti, Gregory Alexander; Zatterale, Federica; Nigro, Cecilia; Mirra, Paola; Falco, Roberta; Ulianich, Luca; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco] Univ Naples Federico II, Dipartimento Sci Med & Traslaz, Naples, Italy; [Fiory, Francesca; Parrillo, Luca; Zatterale, Federica; Nigro, Cecilia; Mirra, Paola; Falco, Roberta; Ulianich, Luca; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, URT, I-80125 Naples, Italy; [Di Jeso, Bruno] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Salento	Miele, C (corresponding author), Univ Naples Federico II, Dipartimento Sci Med & Traslaz, Naples, Italy.	c.miele@ieos.cnr.it; beguino@unina.it	Nigro, Cecilia/K-7338-2016; Formisano, Pietro/J-4237-2018; Parrillo, Luca/AIA-1186-2022; Ulianich, Luca/ABD-2530-2020; Luca, Parrillo/Q-3874-2018; NIGRO, Cecilia/AAB-9189-2019; Zatterale, Federica/AAU-5898-2020	NIGRO, Cecilia/0000-0001-8924-9731; Zatterale, Federica/0000-0002-1653-8652; RACITI, GREGORYALEXANDER/0000-0003-2742-5634; Parrillo, Luca/0000-0001-9801-9778; di jeso, bruno/0000-0001-8713-5984; Formisano, Pietro/0000-0001-7020-6870	European Foundation; Associazione Italiana per la Ricerca sul cancro (AIRC); Ministero dell'Universita e della Ricerca Scientifica [PON 01_02460, FIRB-MERIT]; Societa Italiana di Diabetologia (SID-FO.DI.RI); P.O.R. Campania FSE , Project CREMe	European Foundation(European Science Foundation (ESF)); Associazione Italiana per la Ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Societa Italiana di Diabetologia (SID-FO.DI.RI); P.O.R. Campania FSE , Project CREMe(Regione Campania)	This work has been supported by: the European Foundation for the Study of Diabetes (EFSD), the Associazione Italiana per la Ricerca sul cancro (AIRC), the Ministero dell'Universita e della Ricerca Scientifica (grants PRIN and FIRB-MERIT, and PON 01_02460) and the Societa Italiana di Diabetologia (SID-FO.DI.RI). This work was also supported by the P.O.R. Campania FSE 2007-2013, Project CREMe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2008, J LEUKOCYTE BIOL, V83, P1019, DOI 10.1189/jlb.0807531; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DANZIGER N, 1995, J NEUROCHEM, V64, P1016; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fagman H, 2011, DEV BIOL, V359, P163, DOI 10.1016/j.ydbio.2011.08.015; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Hao CH, 2001, CANCER RES, V61, P1162; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Jang JH, 2004, REDOX REP, V9, P343, DOI 10.1179/135100004225006858; Jang YH, 2008, CELL SIGNAL, V20, P2198, DOI 10.1016/j.cellsig.2008.07.010; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim KO, 2003, EXP MOL MED, V35, P38, DOI 10.1038/emm.2003.6; Kim R, 2005, ONCOL REP, V14, P595; Lombardi A, 2012, DIABETOLOGIA, V55, P141, DOI 10.1007/s00125-011-2315-1; Ma WN, 2010, EXP MOL MED, V42, P456, DOI 10.3858/emm.2010.42.6.047; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Mohanty S, 2005, CLIN CANCER RES, V11, P6730, DOI 10.1158/1078-0432.CCR-05-0450; Peng YH, 2007, J GASTROINTEST SURG, V11, P1712, DOI 10.1007/s11605-007-0314-9; Renault F, 2003, BIOCHEM PHARMACOL, V66, P1581, DOI 10.1016/S0006-2952(03)00514-8; Sampson SR, 2010, APOPTOSIS, V15, P1165, DOI 10.1007/s10495-010-0517-5; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Singh M, 2007, MITOCHONDRION, V7, P367, DOI 10.1016/j.mito.2007.07.003; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Stassi G, 2005, CANCER RES, V65, P6668, DOI 10.1158/0008-5472.CAN-04-4009; Sulzmaier Florian, 2012, Small GTPases, V3, P173, DOI 10.4161/sgtp.20021; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Tsukamoto T, 2000, CANCER LETT, V149, P105, DOI 10.1016/S0304-3835(99)00350-X; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; Valks DM, 2003, J BIOL CHEM, V278, P25542, DOI 10.1074/jbc.M303760200; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Yamada M, 2004, BIOCHEM J, V378, P649, DOI 10.1042/BJ20031398	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113655	10.1371/journal.pone.0113655	http://dx.doi.org/10.1371/journal.pone.0113655			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489735	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300012
J	Ho, TW; Tsai, YJ; Ruan, SY; Huang, CT; Lai, FP; Yu, CJ				Ho, Te-Wei; Tsai, Yi-Ju; Ruan, Sheng-Yuan; Huang, Chun-Ta; Lai, Feipei; Yu, Chong-Jen		HINT Study Grp	In-Hospital and One-Year Mortality and Their Predictors in Patients Hospitalized for First-Ever Chronic Obstructive Pulmonary Disease Exacerbations: A Nationwide Population-Based Study	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; QUALITY-OF-LIFE; BETA-BLOCKERS; STATIN USE; COPD; MORBIDITY; RISK; OUTCOMES; SYSTEM; ASTHMA	Introduction: Natural history of chronic obstructive pulmonary disease (COPD) is punctuated by exacerbations; however, little is known about prognosis of the first-ever COPD exacerbation and variables predicting its outcomes. Materials and Methods: A population-based cohort study among COPD patients with their first-ever exacerbations requiring hospitalizations was conducted. Main outcomes were in-hospital mortality and one-year mortality after discharge. Demographics, comorbidities, medications and in-hospital events were obtained to explore outcome predictors. Results: The cohort comprised 4204 hospitalized COPD patients, of whom 175 (4%) died during the hospitalization. In-hospital mortality was related to higher age (odds ratio [OR]: 1.05 per year; 95% confidence interval [CI]: 1.03-1.06) and Charlson comorbidity index score (OR: 1.08 per point; 95% CI: 1.01-1.15); angiotensin II receptor blockers (OR: 0.61; 95% CI: 0.38-0.98) and beta blockers (OR: 0.63; 95% CI: 0.41-0.95) conferred a survival benefit. At one year after discharge, 22% (871/4029) of hospital survivors were dead. On multivariate Cox regression analysis, age and Charlson comorbidity index remained independent predictors of one-year mortality. Longer hospital stay (hazard ratio [HR] 1.01 per day; 95% CI:1.01-1.01) and ICU admission (HR: 1.33; 95% CI: 1.03-1.73) during the hospitalization were associated with higher mortality risks. Prescription of beta blockers (HR: 0.79; 95% CI: 0.67-0.93) and statins (HR: 0.66; 95% CI: 0.47-0.91) on hospital discharge were protective against one-year mortality. Conclusions: Even the first-ever severe COPD exacerbation signifies poor prognosis in COPD patients. Comorbidities play a crucial role in determining outcomes and should be carefully assessed. Angiotensin II receptor blockers, b blockers and statins may, in theory, have dual cardiopulmonary protective properties and probably alter prognosis of COPD patients. Nevertheless, the limitations inherent to a claims database study, such as the diagnostic accuracy of COPD and its exacerbation, should be born in mind.	[Ho, Te-Wei; Lai, Feipei] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Ruan, Sheng-Yuan; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lai, Feipei] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Lai, Feipei] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan; [HINT Study Grp] Hospitalist Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	huangct@ntu.edu.twv	Ho, Te-Wei/F-1309-2015	Ho, Te-Wei/0000-0002-4371-6936; RUAN, SHENG-YUAN/0000-0002-7949-7253; HUANG, CHUN-TA/0000-0002-5234-4986; Yu, Chong-Jen/0000-0001-5664-9392	National Science Council [NSC101c7905-2]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, grant number: NSC101c7905-2 (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Andreas S, 2006, EUR RESPIR J, V27, P972, DOI 10.1183/09031936.06.00098105; Andreas S, 2005, CHEST, V128, P3618, DOI 10.1378/chest.128.5.3618; [Anonymous], TAIW 2012 PUBL HLTH; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Chandra Divay, 2007, Indian J Chest Dis Allied Sci, V49, P13; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-359; Chua AP, 2005, CHEST, V128, P518, DOI 10.1378/chest.128.2.518; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; Donaldson GC, 2005, AM J RESP CRIT CARE, V171, P446, DOI 10.1164/rccm.200408-1054OC; Dransfield MT, 2008, THORAX, V63, P301, DOI 10.1136/thx.2007.081893; Egred M, 2005, QJM-INT J MED, V98, P493, DOI 10.1093/qjmed/hci080; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fairman K., 2000, J MANAGE CARE PHARM, V6, P499, DOI [10.18553/jmcp.2000.6.6.499, DOI 10.18553/JMCP.2000.6.6.499]; Fragoso CAV, 2012, EUR RESPIR J, V40, P37, DOI 10.1183/09031936.00128711; Gil A, 2006, HUM VACCINES, V2, P181, DOI 10.4161/hv.2.4.3104; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kaparianos A, 2011, CURR MED CHEM, V18, P3506, DOI 10.2174/092986711796642562; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lieberman D, 2002, CHEST, V122, P1264, DOI 10.1378/chest.122.4.1264; Lipworth BJ, 2009, LANCET, V373, P104, DOI 10.1016/S0140-6736(09)60018-0; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; Mohan Alladi, 2006, BMC Pulm Med, V6, P27, DOI 10.1186/1471-2466-6-27; National Health Institutes, TAIW INTR NAT HLTH I; Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180; Ranieri P, 2008, J AM GERIATR SOC, V56, P909, DOI 10.1111/j.1532-5415.2008.01683.x; Rivera-Fernandez R, 2006, CRIT CARE MED, V34, P2317, DOI 10.1097/01.CCM.0000233859.01815.38; Roche N, 2008, EUR RESPIR J, V32, P953, DOI 10.1183/09031936.00129507; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Shrikrishna D, 2012, CLIN SCI, V123, P487, DOI 10.1042/CS20120081; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Steer J, 2010, QJM-INT J MED, V103, P817, DOI 10.1093/qjmed/hcq126; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang MT, 2013, AM J MED, V126, P598, DOI 10.1016/j.amjmed.2013.01.036; Ward A, 2006, CLIN THER, V28, P1912, DOI 10.1016/j.clinthera.2006.11.002; Wildman MJ, 2009, QJM-INT J MED, V102, P389, DOI 10.1093/qjmed/hcp036; Wong MH, 2012, AM J RESP CELL MOL, V46, P641, DOI 10.1165/rcmb.2011-0289OC; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Young RP, 2009, POSTGRAD MED J, V85, P414, DOI 10.1136/pgmj.2008.078477	48	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114866	10.1371/journal.pone.0114866	http://dx.doi.org/10.1371/journal.pone.0114866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490399	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300088
J	Idelevich, EA; Grunewald, CM; Wullenweber, J; Becker, K				Idelevich, Evgeny A.; Grunewald, Camilla M.; Wuellenweber, Joerg; Becker, Karsten			Rapid Identification and Susceptibility Testing of Candida spp. from Positive Blood Cultures by Combination of Direct MALDI-TOF Mass Spectrometry and Direct Inoculation of Vitek 2	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MICRODILUTION REFERENCE METHOD; STREAM INFECTIONS; ANTIFUNGAL SUSCEPTIBILITY; INVASIVE CANDIDIASIS; BIOTYPER SYSTEM; AMPHOTERICIN-B; SEPTIC SHOCK; YEAST; MS	Fungaemia is associated with high mortality rates and early appropriate antifungal therapy is essential for patient management. However, classical diagnostic workflow takes up to several days due to the slow growth of yeasts. Therefore, an approach for direct species identification and direct antifungal susceptibility testing (AFST) without prior time-consuming sub-culturing of yeasts from positive blood cultures (BCs) is urgently needed. Yeast cell pellets prepared using Sepsityper kit were used for direct identification by MALDI-TOF mass spectrometry (MS) and for direct inoculation of Vitek 2 AST-YS07 card for AFST. For comparison, MALDI-TOF MS and Vitek 2 testing were performed from yeast subculture. A total of twenty four positive BCs including twelve C. glabrata, nine C. albicans, two C. dubliniensis and one C. krusei isolate were processed. Applying modified thresholds for species identification (score >= 1.5 with two identical consecutive propositions), 62.5% of BCs were identified by direct MALDI-TOF MS. AFST results were generated for 72.7% of BCs directly tested by Vitek 2 and for 100% of standardized suspensions from 24 h cultures. Thus, AFST comparison was possible for 70 isolate-antifungal combinations. Essential agreement (minimum inhibitory concentration difference <= 1 double dilution step) was 88.6%. Very major errors (VMEs) (false-susceptibility), major errors (false-resistance) and minor errors (false categorization involving intermediate result) amounted to 33.3% (of resistant isolates), 1.9% (of susceptible isolates) and 1.4% providing 90.0% categorical agreement. All VMEs were due to fluconazole or voriconazole. This direct method saved on average 23.5 h for identification and 15.1 h for AFST, compared to routine procedures. However, performance for azole susceptibility testing was suboptimal and testing from subculture remains indispensable to validate the direct finding.	[Idelevich, Evgeny A.; Grunewald, Camilla M.; Wuellenweber, Joerg; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	University of Munster	Idelevich, EA (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	evgeny.idelevich@ukmuenster.de	Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341				[Anonymous], 2007, ISOFDIS 20776 22007; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; bioMerieux SA, 2010, VITEK 2 SYSTEMS PROD, V410791; Buchan BW, 2013, J CLIN MICROBIOL, V51, P1359, DOI 10.1128/JCM.03105-12; Buchan BW, 2012, J CLIN MICROBIOL, V50, P346, DOI 10.1128/JCM.05021-11; Cassagne C, 2013, MED MYCOL, V51, P371, DOI 10.3109/13693786.2012.720720; Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gorton RL, 2014, MYCOSES, V57, P592, DOI 10.1111/myc.12205; Hamprecht A, 2014, MED MICROBIOL IMMUN, V203, P93, DOI 10.1007/s00430-013-0319-9; Idelevich EA, 2014, CLIN MICROBIOL INFEC, V20, P1001, DOI 10.1111/1469-0691.12640; Idelevich EA, 2014, J CLIN MICROBIOL, V52, P4058, DOI 10.1128/JCM.02400-14; Iriart X, 2012, J CLIN MICROBIOL, V50, P2107, DOI 10.1128/JCM.06713-11; Jamal W, 2013, DIAGN MICR INFEC DIS, V76, P404, DOI 10.1016/j.diagmicrobio.2013.04.013; Kerremans JJ, 2004, EUR J CLIN MICROBIOL, V23, P892, DOI 10.1007/s10096-004-1247-9; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Lavergne RA, 2013, MED MYCOL, V51, P652, DOI 10.3109/13693786.2012.762607; Ling TKW, 2003, J CLIN MICROBIOL, V41, P4705, DOI 10.1128/JCM.41.10.4705-4707.2003; Machen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087870; Marinach-Patrice C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008862; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Nonnemann B, 2013, APMIS, V121, P871, DOI 10.1111/apm.12050; Peterson JF, 2011, J CLIN MICROBIOL, V49, P1765, DOI 10.1128/JCM.02517-10; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P3522, DOI 10.1128/JCM.00403-07; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P796, DOI 10.1128/JCM.01986-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Pinto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025712; Schmalreck AF, 2014, ANTIMICROB AGENTS CH, V58, P1575, DOI 10.1128/AAC.01799-13; Schmalreck AF, 2012, MYCOSES, V55, pe124, DOI 10.1111/j.1439-0507.2011.02165.x; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Theel ES, 2012, J CLIN MICROBIOL, V50, P3093, DOI 10.1128/JCM.01045-12; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, 2009, GUID IND FDA CLASS 2; Van Herendael BH, 2012, EUR J CLIN MICROBIOL, V31, P841, DOI 10.1007/s10096-011-1383-y; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yan YJ, 2011, J CLIN MICROBIOL, V49, P2528, DOI 10.1128/JCM.00339-11	43	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114834	10.1371/journal.pone.0114834	http://dx.doi.org/10.1371/journal.pone.0114834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489741	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300082
J	Li, ZP; Zhang, ZG; Xu, C; Zhao, JB; Liu, HL; Fan, ZY; Yang, FH; Wright, ADG; Li, GY				Li, Zhipeng; Zhang, Zhigang; Xu, Chao; Zhao, Jingbo; Liu, Hanlu; Fan, Zhongyuan; Yang, Fuhe; Wright, Andre-Denis G.; Li, Guangyu			Bacteria and Methanogens Differ along the Gastrointestinal Tract of Chinese Roe Deer (Capreolus pygargus)	PLOS ONE			English	Article							DAIRY-COWS; PREVOTELLA-RUMINICOLA; MICROBIAL-POPULATIONS; DIFFERENT DIETARY; RUMINAL BACTERIA; CERVUS-NIPPON; 7TH ORDER; RUMEN; DIVERSITY; COMMUNITY	The current study provides the insight into the bacteria in the gastrointestinal tract (GIT) and methanogens presented in the rumen and cecum of the Chinese roe deer (Capreolus pygargus). The ruminal, ileal, cecal, and colonic contents, as well as feces, were obtained from each of the three, free-range, roe deer ingesting natural pasture after euthanasia. For the bacterial community, a total of 697,031 high-quality 16S rRNA gene sequences were generated using high-throughput sequencing, and assigned to 2,223 core operational taxonomic units (OTUs) (12 bacterial phyla and 87 genera). The phyla Firmicutes (51.2%) and Bacteroidetes (39.4%) were the dominant bacteria in the GIT of roe deer. However, the bacterial community in the rumen was significantly (P<0.01) different from the other sampled regions along the GIT. Secondly, Prevotella spp., Anaerovibrio spp., and unidentified bacteria within the families Veillonellaceae and Paraprevotellaceae were more abundant in the rumen than in the other regions. Unidentified bacteria within the family Enterobacteriaceae, Succinivibrio spp., and Desulfovibrio spp. were more predominant in the colon than in other regions. Unidentified bacteria within the family Ruminococcaceae, and Bacteroides spp. were more prevalent in the ileum, cecum and fecal pellets. For methanogens in the rumen and cecum, a total of 375,647 high quality 16S rRNA gene sequences were obtained and assigned to 113 core OTUs. Methanobrevibacter millerae was the dominant species accounting for 77.3 +/- 7.4 (S. E) % and 68.9 +/- 4.4 (S. E) % of total sequences in the rumen and cecum of roe deer, respectively. However, the abundance of Methanobrevibacter smithii was higher in the rumen than in the cecum (P=0.004). These results revealed that there was intra variation in the bacterial community composition across the GIT of roe deer, and also showed that the methanogen community in the rumen differed from that in the cecum.	[Li, Zhipeng; Xu, Chao; Zhao, Jingbo; Liu, Hanlu; Fan, Zhongyuan; Yang, Fuhe; Li, Guangyu] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Jilin Prov Key Lab Mol Biol Special Econ Anim, Changchun, Peoples R China; [Zhang, Zhigang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wright, Andre-Denis G.] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Arizona	Zhang, ZG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangzhigang@mail.kiz.ac.cn; tcslgy@126.com	xu, chao/GWR-1175-2022; WRIGHT, ANDRE-DENIS/ABI-2584-2020		leading talent and creative team project [20121810]; natural science foundation from Jilin province [20130101104JC]; key projects in the national science & technology pillar program [2011BAI03B02]; Foundation of State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences [GREKF14-14]	leading talent and creative team project; natural science foundation from Jilin province; key projects in the national science & technology pillar program; Foundation of State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences	This work is supported by a leading talent and creative team project (20121810), natural science foundation (20130101104JC) from Jilin province, key projects in the national science & technology pillar program (2011BAI03B02), and Foundation of State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences (GREKF14-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An DD, 2005, ANAEROBE, V11, P207, DOI 10.1016/j.anaerobe.2005.02.001; ARMSTRONG DG, 1979, P NUTR SOC, V38, P283, DOI 10.1079/PNS19790050; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Barker CJ, 2013, VET MICROBIOL, V167, P554, DOI 10.1016/j.vetmic.2013.08.025; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; BIAVATI B, 1988, APPL ENVIRON MICROB, V54, P768, DOI 10.1128/AEM.54.3.768-771.1988; Borrel G, 2013, GENOME BIOL EVOL, V5, P1769, DOI 10.1093/gbe/evt128; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2014, APPL ENVIRON MICROB, V80, P586, DOI 10.1128/AEM.03131-13; Carloline Chae-Hyun K, 2012, THESIS MASSEY U; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; COTTA MA, 1992, APPL ENVIRON MICROB, V58, P48, DOI 10.1128/AEM.58.1.48-54.1992; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans PN, 2009, APPL ENVIRON MICROB, V75, P2598, DOI 10.1128/AEM.02436-08; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; GARDNER RG, 1995, APPL ENVIRON MICROB, V61, P3288, DOI 10.1128/AEM.61.9.3288-3292.1995; Gill M, 2010, ANIMAL, V4, P323, DOI 10.1017/S1751731109004662; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089682; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; HOWARD BH, 1976, APPL ENVIRON MICROB, V32, P598, DOI 10.1128/AEM.32.4.598-602.1976; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ishaq SL, 2014, MICROB ECOL, V68, P185, DOI 10.1007/s00248-014-0399-0; Ishaq SL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-212; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kong YH, 2013, FEMS MICROBIOL ECOL, V84, P302, DOI 10.1111/1574-6941.12062; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Li ZP, 2013, MICROB ECOL, V66, P879, DOI 10.1007/s00248-013-0282-4; Li ZP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-151; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Malmuthuge N, 2012, FEMS MICROBIOL ECOL, V79, P337, DOI 10.1111/j.1574-6941.2011.01220.x; Matsui H, 2000, CURR MICROBIOL, V41, P45, DOI 10.1007/s002840010089; MURRAY RM, 1976, BRIT J NUTR, V36, P1, DOI 10.1079/BJN19760053; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; OHERRIN SM, 1993, APPL ENVIRON MICROB, V59, P748, DOI 10.1128/AEM.59.3.748-755.1993; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P215, DOI 10.1017/S002185960300306X; Pitta DW, 2014, ANAEROBE, V25, P31, DOI 10.1016/j.anaerobe.2013.11.008; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Rea S, 2007, INT J SYST EVOL MICR, V57, P450, DOI 10.1099/ijs.0.63984-0; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; St-Pierre B, 2013, ANIMAL, V7, P49, DOI 10.1017/S1751731112000912; St-Pierre B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-1; Stackebrandt E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P419, DOI 10.1007/0-387-30743-5_20; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Sundset MA, 2009, FEMS MICROBIOL ECOL, V70, P553, DOI 10.1111/j.1574-6941.2009.00750.x; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Wright AJ, 2007, LIBR J, V132, P73; Wright ADG, 2008, MICROB ECOL, V56, P390, DOI 10.1007/s00248-007-9351-x; Wu S., 2012, METAGENOMICS, V1, P1; Zhou M, 2011, J APPL MICROBIOL, V111, P1148, DOI 10.1111/j.1365-2672.2011.05126.x; Zhou M, 2010, APPL ENVIRON MICROB, V76, P3776, DOI 10.1128/AEM.00010-10	74	42	45	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114513	10.1371/journal.pone.0114513	http://dx.doi.org/10.1371/journal.pone.0114513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490208	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300047
J	Macher, HC; Suarez-Artacho, G; Guerrero, JM; Gomez-Bravo, MA; Alvarez-Gomez, S; Bernal-Bellido, C; Dominguez-Pascual, I; Rubio, A				Macher, Hada C.; Suarez-Artacho, Gonzalo; Guerrero, Juan M.; Gomez-Bravo, Miguel A.; Alvarez-Gomez, Sara; Bernal-Bellido, Carmen; Dominguez-Pascual, Inmaculada; Rubio, Amalia			Monitoring of Transplanted Liver Health by Quantification of Organ-Specific Genomic Marker in Circulating DNA from Receptor	PLOS ONE			English	Article							CELL-FREE DNA; ACUTE REJECTION; RENAL-TRANSPLANTATION; GRAFT-REJECTION; DONOR DNA; RECIPIENTS; PLASMA; KIDNEY; PCR; ORIGIN	Background: Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ maintenance. Nowadays, the measurement of cell-free DNA from grafts in the circulation of transplant recipients has been considered a potential biomarker of organ rejection or transplant associated complications in an attempt to replace or reduce liver biopsy. However, methods developed to date are expensive and extremely time-consuming. Our approach was to measure the SRY gene, as a male organ biomarker, in a setting of sex-mismatched female recipients of male donor organs. Methods: Cell-free DNA quantization of the SRY gene was performed by real-time quantitative PCR beforehand, at the moment of transplantation during reperfusion (day 0) and during the stay at the intensive care unit. Beta-globin cell-free DNA levels, a general cellular damage marker, were also quantified. Results: Beta-globin mean values of patients, who accepted the graft without any complications during the first week after surgery, diminished from day 0 until patient stabilization. This decrease was not so evident in patients who suffered some kind of post-transplantation complications. All patients showed an increase in SRY levels at day 0, which decreased during hospitalization. Different complications that did not compromise donated organs showed increased beta-globin levels but no SRY gene levels. However, when a donated organ was damaged the patients exhibited high levels of both genes. Conclusion: Determination of a SRY gene in a female recipient's serum is a clear and specific biomarker of donated organs and may give us important information about graft health in a short period of time by a non-expensive technique. This approach may permit clinicians to maintain a close follow up of the transplanted patient.	[Macher, Hada C.; Guerrero, Juan M.; Alvarez-Gomez, Sara; Dominguez-Pascual, Inmaculada; Rubio, Amalia] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS,Dept Clin Biochem, Seville, Spain; [Suarez-Artacho, Gonzalo; Gomez-Bravo, Miguel A.; Bernal-Bellido, Carmen] Virgen Rocio Univ Hosp, Hepatobiliary & Liver Transplantat Unit, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Rubio, A (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS,Dept Clin Biochem, Seville, Spain.	amaliarubio@us.es	Guerrero, Josep M./D-5519-2014; IBIS, NEUROINMUNO/O-9306-2015; Bernal-Bellido, Carmen/F-5802-2016; Rubio, Amalia/L-1992-2017; Guerrero, Josep M./Y-2929-2019	Guerrero, Josep M./0000-0001-5236-4592; Rubio, Amalia/0000-0002-5905-0534; Guerrero, Juan Miguel/0000-0001-7553-0119; Suarez Artacho, Gonzalo/0000-0003-4710-2488; Macher, Hada/0000-0002-8622-1175; Bernal-Bellido, Carmen/0000-0001-8940-3452; GOMEZ BRAVO, MIGUEL ANGEL/0000-0002-5155-3508	Red tematica de investigacion cooperativa en envejecimiento y fragilidad [RETICEF RD06/00130001]; Ayuda para la Consolidacion de Grupos de Investigacion y Desarrollo Tecnologico de la Comunidad Autonoma Andaluza [P06-CTS-0160]	Red tematica de investigacion cooperativa en envejecimiento y fragilidad; Ayuda para la Consolidacion de Grupos de Investigacion y Desarrollo Tecnologico de la Comunidad Autonoma Andaluza	The work was supported by "Red tematica de investigacion cooperativa en envejecimiento y fragilidad'' (RETICEF RD06/00130001), and by "Ayuda para la Consolidacion de Grupos de Investigacion y Desarrollo Tecnologico de la Comunidad Autonoma Andaluza'' (P06-CTS-0160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2013, ANN SURG, V258, P409, DOI 10.1097/SLA.0b013e3182a15db4; Beck J, 2013, CLIN CHEM, V59, P1732, DOI 10.1373/clinchem.2013.210328; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gadi VK, 2006, CLIN CHEM, V52, P379, DOI 10.1373/clinchem.2005.058974; Moreira VG, 2009, CLIN CHEM, V55, P1958, DOI 10.1373/clinchem.2009.129072; Grant A., 1999, Gut, V45, pIV1; Lo YMD, 2011, CLIN CHEM, V57, P941, DOI 10.1373/clinchem.2011.166686; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Lui YYN, 2003, CLIN CHEM, V49, P495, DOI 10.1373/49.3.495; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Macher HC, 2012, CLIN CHIM ACTA, V413, P490, DOI 10.1016/j.cca.2011.11.004; Millan O, 2013, CYTOKINE, V61, P556, DOI 10.1016/j.cyto.2012.10.026; Mortarino M, 2011, HAEMOPHILIA, V17, P952, DOI 10.1111/j.1365-2516.2011.02537.x; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Vivarelli M, 1995, EUR J GASTROEN HEPAT, V7, P1215; Yu SC, 2014, P NATL ACAD SCI US; Yu SCY, 2013, CLIN CHEM, V59, P1228, DOI 10.1373/clinchem.2013.203679; Zhang J, 1999, CLIN CHEM, V45, P1741; Zhang ZH, 2003, CHINESE MED J-PEKING, V116, P191; Zhong XY, 2001, ANN NY ACAD SCI, V945, P250	22	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113987	10.1371/journal.pone.0113987	http://dx.doi.org/10.1371/journal.pone.0113987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489845	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300013
J	Gao, H; Li, L; Rao, SQ; Shen, GQ; Xi, QS; Chen, SH; Zhang, Z; Wang, K; Ellis, SG; Chen, QY; Topol, EJ; Wang, QK				Gao, Hanxiang; Li, Lin; Rao, Shaoqi; Shen, Gongqing; Xi, Quansheng; Chen, Shenghan; Zhang, Zheng; Wang, Kai; Ellis, Stephen G.; Chen, Qiuyun; Topol, Eric J.; Wang, Qing K.			Genome-Wide Linkage Scan Identifies Two Novel Genetic Loci for Coronary Artery Disease: In GeneQuest Families	PLOS ONE			English	Article							HEART-DISEASE; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; HAPLOTYPE ASSOCIATION; PARENTAL HISTORY; RISK; METAANALYSIS; POLYMORPHISM; DEATH; CAD	Coronary artery disease (CAD) is the leading cause of death worldwide. Recent genome-wide association studies (GWAS) identified >50 common variants associated with CAD or its complication myocardial infarction (MI), but collectively they account for <20% of heritability, generating a phenomena of "missing heritability''. Rare variants with large effects may account for a large portion of missing heritability. Genome-wide linkage studies of large families and follow-up fine mapping and deep sequencing are particularly effective in identifying rare variants with large effects. Here we show results from a genome-wide linkage scan for CAD in multiplex GeneQuest families with early onset CAD and MI. Whole genome genotyping was carried out with 408 markers that span the human genome by every 10 cM and linkage analyses were performed using the affected relative pair analysis implemented in GENEHUNTER. Affected only nonparametric linkage (NPL) analysis identified two novel CAD loci with highly significant evidence of linkage on chromosome 3p25.1 (peak NPL =5.49) and 3q29 (NPL =6.84). We also identified four loci with suggestive linkage on 9q22.33, 9q34.11, 17p12, and 21q22.3 (NPL = 3.18-4.07). These results identify novel loci for CAD and provide a framework for fine mapping and deep sequencing to identify new susceptibility genes and novel variants associated with risk of CAD.	[Gao, Hanxiang; Zhang, Zheng] Lanzhou Univ, Affiliated Hosp 1, Ctr Heart, Lanzhou 730000, Gansu, Peoples R China; [Gao, Hanxiang; Li, Lin; Rao, Shaoqi; Shen, Gongqing; Xi, Quansheng; Chen, Shenghan; Chen, Qiuyun; Wang, Qing K.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med,Dept Mol Med, Ctr Cardiovasc Genet,Lerner Res Inst,Dept Mol Car, Cleveland, OH 44106 USA; [Rao, Shaoqi] Guangdong Med Coll, Inst Med Syst Biol, Dongguan 523808, Guangdong, Peoples R China; [Rao, Shaoqi] Guangdong Med Coll, Inst Sch Publ Hlth, Dongguan 523808, Guangdong, Peoples R China; [Wang, Kai; Ellis, Stephen G.; Wang, Qing K.] Cleveland Clin, Sydell & Arnold Miller Family Heart & Vasc Inst, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH USA; [Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, Scripps Clin, La Jolla, CA 92037 USA; [Wang, Qing K.] Cleveland Clin, Ctr Sleep Med, Neurol Inst, Cleveland, OH 44106 USA; [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44195 USA; [Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China; [Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Lanzhou University; Case Western Reserve University; Cleveland Clinic Foundation; Guangdong Medical University; Guangdong Medical University; Cleveland Clinic Foundation; Scripps Research Institute; Cleveland Clinic Foundation; Case Western Reserve University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Topol, EJ (corresponding author), Scripps Res Inst, Scripps Translat Sci Inst, Scripps Clin, La Jolla, CA 92037 USA.	etopol@scripps.edu; wangq2@ccf.org		Zhang, Zheng/0000-0002-7917-7057; Rao, Shaoqi/0000-0001-7809-3700	National Institute of Health grants [R01 HL121358, R01 HL094498, P50 HL77107]; American Heart Association grants [0630193N, 11SDG5510001, 11IRG5570046]; National Natural Science Foundation of China [31071166, 81373085]; Science and Technology Planning Project of Guangdong Province [2009A030301004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107, R01HL121358, R01HL094498] Funding Source: NIH RePORTER	National Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grants(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health grants (R01 HL121358, R01 HL094498 and P50 HL77107), the American Heart Association grants (0630193N, 11SDG5510001 and 11IRG5570046), the National Natural Science Foundation of China (grant nos. 31071166, 81373085 to SR) and Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004 to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Banerjee A, 2012, INT J CLIN PRACT, V66, P536, DOI 10.1111/j.1742-1241.2012.02908.x; Chiodini BD, 2003, ARTERIOSCL THROM VAS, V23, P1863, DOI 10.1161/01.ATV.0000093281.10213.DB; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COLDITZ GA, 1991, AM J CARDIOL, V67, P933, DOI 10.1016/0002-9149(91)90163-F; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Di Cara F, 2013, J CELL SCI, V126, P4769, DOI 10.1242/jcs.133306; Ding SD, 2012, WIEN KLIN WOCHENSCHR, V124, P671, DOI 10.1007/s00508-012-0223-0; Engert JC, 2008, EUR J HUM GENET, V16, P105, DOI 10.1038/sj.ejhg.5201920; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Girelli D, 2009, SEMIN THROMB HEMOST, V35, P671, DOI 10.1055/s-0029-1242721; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1996, NAT GENET, V14, P132, DOI 10.1038/ng1096-132; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Ouwehand WH, 2009, J THROMB HAEMOST, V7, P305, DOI 10.1111/j.1538-7836.2009.03441.x; Pandey AK, 2014, ATHEROSCLEROSIS, V232, P369, DOI 10.1016/j.atherosclerosis.2013.11.042; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; S.A.G.E, 2006, STAT AN GEN EP 5 3 C; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samani NJ, 2005, AM J HUM GENET, V77, P1011; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seidelmann SB, 2008, J LIPID RES, V49, P1034, DOI 10.1194/jlr.M700576-JLR200; Shalata A, 2013, AM J HUM GENET, V93, P1061, DOI 10.1016/j.ajhg.2013.10.025; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Shen GQ, 2013, GENE, V521, P78, DOI 10.1016/j.gene.2013.03.022; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Wienke A, 2001, Twin Res, V4, P266, DOI 10.1375/twin.4.4.266; Yang R, 2010, J LIPID RES, V51, P1442, DOI 10.1194/jlr.M004325; Yip AG, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S100; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113935	10.1371/journal.pone.0113935	http://dx.doi.org/10.1371/journal.pone.0113935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485937	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600030
J	Nosek, BA; Bar-Anan, Y; Sriram, N; Axt, J; Greenwald, AG				Nosek, Brian A.; Bar-Anan, Yoav; Sriram, N.; Axt, Jordan; Greenwald, Anthony G.			Understanding and Using the Brief Implicit Association Test: Recommended Scoring Procedures	PLOS ONE			English	Article							SELF-ESTEEM; ATTITUDES; INFORMATION; COGNITION; SALIENCE; VALIDITY; BELIEFS; TASK	A brief version of the Implicit Association Test (BIAT) has been introduced. The present research identified analytical best practices for overall psychometric performance of the BIAT. In 7 studies and multiple replications, we investigated analytic practices with several evaluation criteria: sensitivity to detecting known effects and group differences, internal consistency, relations with implicit measures of the same topic, relations with explicit measures of the same topic and other criterion variables, and resistance to an extraneous influence of average response time. The data transformation algorithms D outperformed other approaches. This replicates and extends the strong prior performance of D compared to conventional analytic techniques. We conclude with recommended analytic practices for standard use of the BIAT.	[Nosek, Brian A.; Axt, Jordan] Univ Virginia, Charlottesville, VA 22908 USA; [Nosek, Brian A.] Ctr Open Sci, Charlottesville, VA USA; [Bar-Anan, Yoav] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Sriram, N.] Implisci, Charlottesville, VA USA; [Greenwald, Anthony G.] Univ Washington, Seattle, WA 98195 USA	University of Virginia; Ben Gurion University; University of Washington; University of Washington Seattle	Nosek, BA (corresponding author), Univ Virginia, Charlottesville, VA 22908 USA.	nosek@virginia.edu	Greenwald, Anthony G./AAB-2397-2020; Bar-Anan, Yoav/AAM-7229-2021	Greenwald, Anthony G./0000-0001-6865-8552; Nosek, Brian/0000-0001-6797-5476	Project Implicit	Project Implicit	This project was supported by a gift from Project Implicit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemeyer, 1996, AUTHORITARIAN SPECTE; Bar-Anan Y, 2014, BEHAV RES METHODS, V46, P668, DOI 10.3758/s13428-013-0410-6; Bar-Anan Y, 2009, EXP PSYCHOL, V56, P329, DOI 10.1027/1618-3169.56.5.329; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Cai HJ, 2004, SOC COGNITION, V22, P673, DOI 10.1521/soco.22.6.673.54821; Chang BPI, 2009, Q J EXP PSYCHOL, V62, P2030, DOI 10.1080/17470210802651737; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; Gawronski B., 2010, HDB IMPLICIT SOCIAL; Greenwald A.G., 2008, ATTITUDES INSIGHTS N, P65; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kinoshita S, 2005, PSYCHON B REV, V12, P442, DOI 10.3758/BF03193786; Lindner NM, 2009, POLIT PSYCHOL, V30, P67, DOI 10.1111/j.1467-9221.2008.00681.x; McConahay JB., 1986, PREJUDICE DISCRIMINA, P91; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; Mierke J, 2003, J PERS SOC PSYCHOL, V85, P1180, DOI 10.1037/0022-3514.85.6.1180; Nosek B.A., 2012, HDB SOCIAL COGNITION, P31, DOI DOI 10.4135/9781446247631.N3; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Nosek BA., 2007, SOCIAL PSYCHOL UNCON, P265; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Nosek BA, 2007, J EXP SOC PSYCHOL, V43, P393, DOI 10.1016/j.jesp.2006.10.018; Nosek BA, 2007, EXP PSYCHOL, V54, P14, DOI 10.1027/1618-3169.54.1.14; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; PELHAM BW, 1989, J PERS SOC PSYCHOL, V57, P672, DOI 10.1037/0022-3514.57.4.672; Petroczi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010457; Ranganath KA, 2008, J EXP SOC PSYCHOL, V44, P386, DOI 10.1016/j.jesp.2006.12.008; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Rothermund K, 2010, EXP PSYCHOL, V57, P233, DOI 10.1027/1618-3169/a000060; Rusch N, 2010, J BEHAV THER EXP PSY, V41, P60, DOI 10.1016/j.jbtep.2009.10.002; Sheets P, 2011, POLIT PSYCHOL, V32, P459, DOI 10.1111/j.1467-9221.2010.00820.x; Smith CT, 2012, SOC COGNITION, V30, P199, DOI 10.1521/soco.2012.30.2.199; Sriram N, 2010, Stat Methodol, V7, P277; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Sriram N, 2013, SCALE INVARIAN UNPUB; Unkelbach C, 2008, J PERS SOC PSYCHOL, V95, P36, DOI 10.1037/0022-3514.95.1.36; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x	43	84	85	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e110938	10.1371/journal.pone.0110938	http://dx.doi.org/10.1371/journal.pone.0110938			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25485938	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600005
J	So, KS; Kim, CH; Rho, JK; Kim, SY; Choi, YJ; Song, JS; Kim, WS; Choi, CM; Chun, YJ; Lee, JC				So, Kwang Sup; Kim, Cheol Hyeon; Rho, Jin Kyung; Kim, Sun Ye; Choi, Yun Jung; Song, Joon Seon; Kim, Woo Sung; Choi, Chang Min; Chun, Young Jin; Lee, Jae Cheol			Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							PROTEIN-KINASE CK2; GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; MUTATION; GEFITINIB; ERLOTINIB; APOPTOSIS; SURVIVAL; CHEMOTHERAPY; CHAPERONE	Protein kinase CK2 has diverse functions promoting and maintaining cancer phenotypes. We investigated the effect of CK2 inhibition in lung cancer cells with T790M-mediated resistance to the EGFR-TK inhibitor. Resistant sublines of PC-9 to gefitinib (PC-9/GR) and erlotinib (PC-9/ER) were established by previous study, and T790M secondary mutation was found in both resistant sublines. A decrease of EGFR by siRNA treatment effectively controlled the growth of resistant cells, thus suggesting that they still have EGFR-dependency. CX-4945, a potent and selective CK2 inhibitor, induced autophagy in PC-9/GR and PC-9/ER, and which was supported by the induction of autophagic vacuoles and microtubule-associated protein 1 light chain 3 (LC3) expression, and the increase of punctate fluorescent signals in resistant cells pre-transfected with green fluorescent protein (GFP)tagged LC3. However, the withdrawal of CX-4945 led to the recovery of cancer cells with autophagy. We found that the induction of autophagy by CX-4945 in both resistant cells was CK2 dependent by using small interfering RNA against CK2. The treatment with CX-4945 alone induced a minimal growth inhibition in resistant cells. However, combined treatment of CX-4945 and EGFR-TKI effectively inhibited cancer-cell proliferation and induced apoptosis. CX-4945 increased the translocation of EGFR from the cell surface into the autophagosome, subsequently leading to the decrease of EGFR while inhibition of autophagy by 3MA or Atg7-targeted siRNA pretreatment reduced the decrease of EGFR by CX-4945. Accordingly, apoptosis by a combination of CX-4945 and EGFR-TKI was suppressed by 3MA or Atg7-targeted siRNA pretreatment, thus suggesting that autophagosome-mediated EGFR down-regulation would have an important role regarding apoptotic cell death by EGFR-TKI. Combined treatment of the CK2 inhibitor and EGFR-TKI may be a promising strategy for overcoming T790M-mediated resistance.	[So, Kwang Sup; Rho, Jin Kyung; Kim, Sun Ye; Choi, Yun Jung; Kim, Woo Sung; Choi, Chang Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Song, Joon Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Choi, Chang Min; Lee, Jae Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Rho, Jin Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [So, Kwang Sup; Chun, Young Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Kim, Cheol Hyeon] Korea Canc Ctr Hosptial, Dept Internal Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Chung Ang University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	yjchun@cau.ac.kr; jclee@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021		Korean Health Technology R&D Project, Ministry of Health Welfare [HI12C1146000013]; Asan Institute for Life Science, Seoul, Republic of Korea [2011-0529]	Korean Health Technology R&D Project, Ministry of Health Welfare; Asan Institute for Life Science, Seoul, Republic of Korea	This work was funded by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI12C1146000013) and a grant (2011-0529) from Asan Institute for Life Science, Seoul, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2007, MOL CANCER THER, V6, P1006, DOI 10.1158/1535-7163.MCT-06-0491; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Berardi R, 2013, ONCOTARGETS THER, V6, P563, DOI 10.2147/OTT.S28155; Chen G, 2013, BIOCHEM BIOPH RES CO, V431, P623, DOI 10.1016/j.bbrc.2012.12.070; Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Hessenauer A, 2011, CELL SIGNAL, V23, P145, DOI 10.1016/j.cellsig.2010.08.014; Homma MK, 2008, MOL CELL BIOCHEM, V316, P49, DOI 10.1007/s11010-008-9823-4; Ihle NT, 2005, MOL CANCER THER, V4, P1349, DOI 10.1158/1535-7163.MCT-05-0149; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Kwak E, 2011, ONCOLOGIST, V16, P1498, DOI 10.1634/theoncologist.2011-0087; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Miyata Y, 2004, ANN NY ACAD SCI, V1030, P150, DOI 10.1196/annals.1329.019; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moreira-Leite FF, 2010, J THORAC ONCOL, V5, P765, DOI 10.1097/JTO.0b013e3181d95d93; Olsen BB, 2012, INT J ONCOL, V41, P1967, DOI 10.3892/ijo.2012.1635; Ou SHI, 2012, CRIT REV ONCOL HEMAT, V83, P407, DOI 10.1016/j.critrevonc.2011.11.010; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sakuma Y, 2013, LAB INVEST, V93, P1137, DOI 10.1038/labinvest.2013.102; Sequist LV, 2013, J CLIN ONCOL, V31; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Unger GM, 2004, CURR CANCER DRUG TAR, V4, P77, DOI 10.2174/1568009043481687; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	45	26	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114000	10.1371/journal.pone.0114000	http://dx.doi.org/10.1371/journal.pone.0114000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486409	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600035
J	Wahl, M; Al Sofyani, A; Saha, M; Kruse, I; Lenz, M; Sawall, Y				Wahl, Martin; Al Sofyani, Abdulmohsin; Saha, Mahasweta; Kruse, Inken; Lenz, Mark; Sawall, Yvonne			Large Scale Patterns of Antimicrofouling Defenses in the Hard Coral Pocillopora verrucosa in an Environmental Gradient along the Saudi Arabian Coast of the Red Sea	PLOS ONE			English	Article							SEASONAL-VARIATION; ANTIMICROBIAL ACTIVITY; ANTIFOULING ACTIVITY; GEOGRAPHIC-VARIATION; TEMPORAL DYNAMICS; RESISTANCE; MUCUS; BACTERIA; VARIABILITY; POPULATIONS	Large scale patterns of ecologically relevant traits may help identify drivers of their variability and conditions beneficial or adverse to the expression of these traits. Antimicrofouling defenses in scleractinian corals regulate the establishment of the associated biofilm as well as the risks of infection. The Saudi Arabian Red Sea coast features a pronounced thermal and nutritional gradient including regions and seasons with potentially stressful conditions to corals. Assessing the patterns of antimicrofouling defenses across the Red Sea may hint at the susceptibility of corals to global change. We investigated microfouling pressure as well as the relative strength of 2 alternative antimicrofouling defenses (chemical antisettlement activity, mucus release) along the pronounced environmental gradient along the Saudi Arabian Red Sea coast in 2 successive years. Microfouling pressure was exceptionally low along most of the coast but sharply increased at the southernmost sites. Mucus release correlated with temperature. Chemical defense tended to anti-correlate with mucus release. As a result, the combined action of mucus release and chemical antimicrofouling defense seemed to warrant sufficient defense against microbes along the entire coast. In the future, however, we expect enhanced energetic strain on corals when warming and/or eutrophication lead to higher bacterial fouling pressure and a shift towards putatively more costly defense by mucus release.	[Wahl, Martin; Saha, Mahasweta; Kruse, Inken; Lenz, Mark; Sawall, Yvonne] GEOMAR Helmholtz Ctr Ocean Res, Dept Benth Ecol, Kiel, Germany; [Al Sofyani, Abdulmohsin] King Abdulaziz Univ, Dept Marine Biol, Jeddah 21413, Saudi Arabia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; King Abdulaziz University	Wahl, M (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Dept Benth Ecol, Kiel, Germany.	mwahl@geomar.de	Kruse, Inken/E-4207-2014; Kruse, Inken/B-5949-2016; Lenz, Mark/AAG-1734-2021; Wahl, Martin/D-2038-2016; Saha, Mahasweta/K-4867-2014	Wahl, Martin/0000-0001-8703-3857; Kruse, Inken/0000-0001-7176-6300; Saha, Mahasweta/0000-0001-9308-1054	KAU, Jeddah, Saudi Arabia [T-065/430-DSR]	KAU, Jeddah, Saudi Arabia	This collaboration of the Jeddah Transect Project between King Abdulaziz University (KAU) and Helmholtz-Center for Ocean Research GEOMAR was funded by KAU, Jeddah, Saudi Arabia, under grant no. T-065/430-DSR. Further support was given by GEOMAR and King Abdullah University for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Dube D, 2002, MAR ECOL PROG SER, V231, P139, DOI 10.3354/meps231139; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Fischer M, 2013, SEA TECHNOL, V54, P49; Flothe CR, 2013, J PHYCOL, V49, P468, DOI 10.1111/jpy.12059; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Harder T., 2008, MARINE IND BIOFOULIN; Heindl H, 2010, SYST APPL MICROBIOL, V33, P94, DOI 10.1016/j.syapm.2009.12.002; Hellio C, 2004, MAR BIOTECHNOL, V6, P67, DOI 10.1007/s10126-003-0020-x; Henrikson AA, 1998, BIOFOULING, V12, P245, DOI 10.1080/08927019809378357; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Kuerten B, 2014, J SEA RES, V85, P379, DOI 10.1016/j.seares.2013.07.008; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Lenihan HS, 2010, MAR ECOL PROG SER, V409, P51, DOI 10.3354/meps08595; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Long JD, 2007, MAR ECOL PROG SER, V333, P75, DOI 10.3354/meps333075; Lyons DA, 2007, MAR BIOL, V153, P179, DOI 10.1007/s00227-007-0795-9; MAIDA M, 1993, J CHEM ECOL, V19, P2285, DOI 10.1007/BF00979664; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Marechal JP, 2004, J EXP MAR BIOL ECOL, V313, P47, DOI 10.1016/j.jembe.2004.07.016; Marti R, 2005, SCI MAR, V69, P485; McConnell O., 1989, BIOORG MAR CHEM, V3, P86; Muscatine L, 1973, NUTR CORALS; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Page M, 2005, J CHEM ECOL, V31, P1161, DOI 10.1007/s10886-005-4254-0; Plouguerne E, 2010, J APPL PHYCOL, V22, P717, DOI 10.1007/s10811-010-9511-0; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ridgway T, 2001, MAR BIOL, V139, P175; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez-Troncoso AP, 2010, CIENC MAR, V36, P91, DOI 10.7773/cm.v36i1.1701; Rohde S, 2008, J EXP MAR BIOL ECOL, V367, P227, DOI 10.1016/j.jembe.2008.10.003; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Saha M, 2013, BIOFOULING, V29, P661, DOI 10.1080/08927014.2013.795953; Sawall Y., 2014, J ECOL ECOGR, VS4, P003, DOI DOI 10.4172/2157-7625.S4-003; Sawall Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103179; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Slattery M, 2001, MAR BIOL, V138, P1183; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; STEINBERG PD, 1995, OECOLOGIA, V102, P169, DOI 10.1007/BF00333248; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; Veron J.E.N., 2000, CORALS WORLD, V1-3; WAHL M, 1994, MAR ECOL PROG SER, V110, P45, DOI 10.3354/meps110045; Wahl M, 1998, BIOFOULING, V12, P205, DOI 10.1080/08927019809378355; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310	60	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e106573	10.1371/journal.pone.0106573	http://dx.doi.org/10.1371/journal.pone.0106573			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485603	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600001
J	Wang, YF; Ma, SR; Wang, WM; Huang, CF; Zhao, ZL; Liu, B; Zhang, WF; Zhao, YF; Zhang, L; Sun, ZJ				Wang, Yu-Fan; Ma, Si-Rui; Wang, Wei-Ming; Huang, Cong-Fa; Zhao, Zhi-Li; Liu, Bing; Zhang, Wen-Feng; Zhao, Yi-Fang; Zhang, Lu; Sun, Zhi-Jun			Inhibition of Survivin Reduces HIF-1 alpha, TGF-beta 1 and TFE3 in Salivary Adenoid Cystic Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; TARGETING SURVIVIN; LACRIMAL GLAND; FACTOR PATHWAY	In the present study, we explored the expression and correlation of survivin with HIF-1 alpha, TGF-beta 1 and TFE3 in adenoid cystic carcinoma (AdCC). The expression of survivin, HIF-1 alpha, TGF-beta 1 and TFE3 was assessed by immunohistochemical staining of a tissue microarray containing tissue samples of normal salivary gland (NSG), pleomorphic adenoma (PA) and AdCC. Correlation analysis of these proteins revealed that increased survivin expression was associated with the overexpression of HIF-1 alpha (P<0.001, r=0.5599), TGF-beta 1 (P<0.001, r=0.6616) and TFE3 (P<0.001, r=0.7747). The expression of survivin, HIF-1 alpha, TGF-beta 1 and TFE3 was not correlated with the pathological type of human AdCC (P>0.05). Selective inhibition of survivin by YM155 and siRNA significantly reduced human SACC-83 cell proliferation, with the corresponding decrease in expression of HIF-1 alpha, TGF-beta 1 and TFE3. The data indicate that the overexpression of survivin in AdCC is related to HIF-1 alpha, TGF-beta 1 and TFE3. We hypothesize from these findings that the inhibition of survivin may be a novel strategy for neoadjuvant chemotherapeutic and radiosensitive treatment of AdCC.	[Wang, Yu-Fan; Ma, Si-Rui; Wang, Wei-Ming; Huang, Cong-Fa; Zhao, Zhi-Li; Zhang, Lu; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Wang, Yu-Fan; Ma, Si-Rui; Wang, Wei-Ming; Huang, Cong-Fa; Zhao, Zhi-Li; Zhang, Lu; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Liu, Bing; Zhang, Wen-Feng; Zhao, Yi-Fang; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhang, L (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China.	luzhang2012@whu.edu.cn; zhijundejia@163.com	Sun, Zhi-Jun/AAD-8791-2022; zhao, zhili/F-4137-2016	Sun, Zhi-Jun/0000-0003-0932-8013; zhao, zhili/0000-0002-9030-1979	National Natural Science Foundation of China [81072203, 81272963, 81371106, 81272946, 81170977]; program for new century excellent talents in university, ministry of education of China [NCET-13-0439]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for new century excellent talents in university, ministry of education of China(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China)	This work was funded by National Natural Science Foundation of China (81072203, 81272963) to Z.-J. Sun, (81371106) to L. Zhang, (81272946) to W.-F. Zhang, and (81170977) to Y.-F. Zhao. Z.-J. Sun supported by program for new century excellent talents in university (NCET-13-0439), ministry of education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Arlt A, 2013, CANCER LETT, V332, P346, DOI 10.1016/j.canlet.2010.10.015; BARNES L, 2005, WHO CLASSIFICATION T, P221; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Chen YQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-29; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Costa AF, 2012, HISTOPATHOLOGY, V60, P816, DOI 10.1111/j.1365-2559.2011.04128.x; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Dong L, 2013, ORAL ONCOL, V49, P1051, DOI 10.1016/j.oraloncology.2013.07.012; Dresang LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080543; Ellington CL, 2012, CANCER-AM CANCER SOC, V118, P4444, DOI 10.1002/cncr.27408; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; Ge XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101207; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hanna C, 2013, AM J PHYSIOL-RENAL, V305, pF1323, DOI 10.1152/ajprenal.00155.2013; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Helbig L, 2014, INT J RADIAT ONCOL, V88, P159, DOI 10.1016/j.ijrobp.2013.09.047; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083479; Hung SP, 2013, CELL TRANSPLANT, V22, P1869, DOI 10.3727/096368912X657954; Ikeguchi M, 2005, J EXP CLIN CANC RES, V24, P415; Jia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051549; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Ko YH, 2007, JPN J CLIN ONCOL, V37, P805, DOI 10.1093/jjco/hym119; Ko YH, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-30; Lamers F, 2012, EUR J CANCER, V48, P763, DOI 10.1016/j.ejca.2011.10.012; Laurie SA, 2011, LANCET ONCOL, V12, P815, DOI 10.1016/S1470-2045(10)70245-X; Liao YC, 2009, EXP EYE RES, V88, P4, DOI 10.1016/j.exer.2008.09.015; Mulay K, 2013, HISTOPATHOLOGY, V62, P840, DOI 10.1111/his.12073; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Poh Y. W., 2012, Experimental Oncology, V34, P85; Pollard P, 2005, J PATHOL, V205, P41, DOI 10.1002/path.1686; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schlette EJ, 2004, J CLIN ONCOL, V22, P1682, DOI 10.1200/JCO.2004.10.172; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Sun ZJ, 2010, J PHARMACOL EXP THER, V334, P500, DOI 10.1124/jpet.110.167692; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Tang YL, 2014, ONCOTARGET, V5, P1491, DOI 10.18632/oncotarget.1606; Thavaraj S, 2005, J PATHOL, V205, P14, DOI 10.1002/path.1683; Veekony H, 2007, CLIN CANCER RES, V13, P3133, DOI 10.1158/1078-0432.CCR-06-2555; Wang L, 2013, ONCOL REP, V30, P207, DOI 10.3892/or.2013.2460; Wang YF, 2014, APOPTOSIS, V19, P748, DOI 10.1007/s10495-013-0960-1; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	51	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114051	10.1371/journal.pone.0114051	http://dx.doi.org/10.1371/journal.pone.0114051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485635	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600040
J	Drexler, N; Miller, M; Gerding, J; Todd, S; Adams, L; Dahlgren, FS; Bryant, N; Weis, E; Herrick, K; Francies, J; Komatsu, K; Piontkowski, S; Velascosoltero, J; Shelhamer, T; Hamilton, B; Eribes, C; Brock, A; Sneezy, P; Goseyun, C; Bendle, H; Hovet, R; Williams, V; Massung, R; McQuiston, JH				Drexler, Naomi; Miller, Mark; Gerding, Justin; Todd, Suzanne; Adams, Laura; Dahlgren, F. Scott; Bryant, Nelva; Weis, Erica; Herrick, Kristen; Francies, Jessica; Komatsu, Kenneth; Piontkowski, Stephen; Velascosoltero, Jose; Shelhamer, Timothy; Hamilton, Brian; Eribes, Carmen; Brock, Anita; Sneezy, Patsy; Goseyun, Cye; Bendle, Harty; Hovet, Regina; Williams, Velda; Massung, Robert; McQuiston, Jennifer H.			Community-Based Control of the Brown Dog Tick in a Region with High Rates of Rocky Mountain Spotted Fever, 2012-2013	PLOS ONE			English	Article							RHIPICEPHALUS-SANGUINEUS TICKS; RICKETTSIA-RICKETTSII; EASTERN ARIZONA; LYME-DISEASE; PREVENTION; IXODIDAE; ACARI; PREVALENCE; EXPOSURE	Rocky Mountain spotted fever (RMSF) transmitted by the brown dog tick (Rhipicephalus sanguineus sensu lato) has emerged as a significant public health risk on American Indian reservations in eastern Arizona. During 2003-2012, more than 250 RMSF cases and 19 deaths were documented among Arizona's American Indian population. The high case fatality rate makes community-level interventions aimed at rapid and sustained reduction of ticks urgent. Beginning in 2012, a two year pilot integrated tick prevention campaign called the RMSF Rodeo was launched in a, similar to 600-home tribal community with high rates of RMSF. During year one, long-acting tick collars were placed on all dogs in the community, environmental acaricides were applied to yards monthly, and animal care practices such as spay and neuter and proper tethering procedures were encouraged. Tick levels, indicated by visible inspection of dogs, tick traps and homeowner reports were used to monitor tick presence and evaluate the efficacy of interventions throughout the project. By the end of year one, <1% of dogs in the RMSF Rodeo community had visible tick infestations five months after the project was started, compared to 64% of dogs in Non-Rodeo communities, and environmental tick levels were reduced below detectable levels. The second year of the project focused on use of the long-acting collar alone and achieved sustained tick control with fewer than 3% of dogs in the RMSF Rodeo community with visible tick infestations by the end of the second year. Homeowner reports of tick activity in the domestic and peridomestic setting showed similar decreases in tick activity compared to the non-project communities. Expansion of this successful project to other areas with Rhipicephalus-transmitted RMSF has the potential to reduce brown dog tick infestations and save human lives.	[Drexler, Naomi; Todd, Suzanne; Dahlgren, F. Scott; Bryant, Nelva; Massung, Robert; McQuiston, Jennifer H.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Miller, Mark; Gerding, Justin] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Todd, Suzanne; Adams, Laura] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Adams, Laura; Weis, Erica; Herrick, Kristen; Francies, Jessica; Komatsu, Kenneth] Arizona Dept Hlth Serv, Dept Publ Hlth Serv, Phoenix, AZ 85007 USA; [Weis, Erica] Intertribal Council Arizona Inc, Tribal Epidemiol Ctr, Phoenix, AZ USA; [Piontkowski, Stephen; Velascosoltero, Jose; Shelhamer, Timothy] Indian Hlth Serv, Off Environm Hlth & Engn, Phoenix Area Unit, Phoenix, AZ USA; [Hamilton, Brian] Indian Hlth Serv, Phoenix Area Unit, Phoenix, AZ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Arizona Department of Health Services	Drexler, N (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	isj3@cdc.gov	Dahlgren, Fredrick Scott/AAW-4396-2021	Dahlgren, Fredrick Scott/0000-0003-1790-2804; Drexler, Naomi/0000-0001-6998-5520	CDC Emerging Infections funds; PetSmart Charities; Indian Health Service and Housing and Urban Development; Centers for Disease Control and Prevention; Arizona Department of Health Services; Intertribal Council of Arizona Inc.; U.S. Department of Agriculture; Indian Health Service; Tribe B. Students and staff at North Carolina State University; Virginia-Maryland Regional College of Veterinary Medicine	CDC Emerging Infections funds; PetSmart Charities; Indian Health Service and Housing and Urban Development; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Arizona Department of Health Services; Intertribal Council of Arizona Inc.; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Indian Health Service(United States Department of Health & Human Services); Tribe B. Students and staff at North Carolina State University; Virginia-Maryland Regional College of Veterinary Medicine	Parts of this project were funded with CDC Emerging Infections funds. Spay and neuter services were partially provided through a grant from PetSmart Charities (http://www.petsmartcharities.org/pro/grants/spay-neuter) managed by the CDC Foundation. Bayer Healthcare donated Seresto collars and Bayer Advanced acaricidal spray that were used during the project. Funding provided by Indian Health Service and Housing and Urban Development permitted purchase of collars and product and spay-neuter services in 2013. Additionally, financial and personnel contributions have been provided by the Centers for Disease Control and Prevention, the Arizona Department of Health Services, Intertribal Council of Arizona Inc., U.S. Department of Agriculture, Indian Health Service, and Tribe B. Students and staff at North Carolina State University and the Virginia-Maryland Regional College of Veterinary Medicine donated their time in 2012 to help provide free spay and neuter capabilities to the tribe. Grantors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizona Department of Health Services, 2012, ROCK MOUNT SPOTT FEV; BURGDORFER W, 1975, J MED ENTOMOL, V12, P269, DOI 10.1093/jmedent/12.3.269; Centers for Disease Control and Prevention, 2014, MMWR SURVEILL SUMM, V61, P102; Chapman AS, 2006, MMWR RECOMM REP, V55, P19; Clark RP, 2008, INFECT DIS CLIN N AM, V22, P381, DOI 10.1016/j.idc.2008.03.007; Council of State and Territorial Epidemiologists, 2009, PUBL HLTH REP NAT NO; Cruz-Vazquez C, 1999, EXP APPL ACAROL, V23, P277, DOI 10.1023/A:1006075232455; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Dantas-Torres F, 2011, PARASITOLOGY, V138, P527, DOI 10.1017/S0031182010001502; Demma LJ, 2006, VECTOR-BORNE ZOONOT, V6, P423, DOI 10.1089/vbz.2006.6.423; Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043; Diniz PPVP, 2010, VECTOR-BORNE ZOONOT, V10, P117, DOI 10.1089/vbz.2008.0184; Fritz CL, 2012, ZOONOSES PUBLIC HLTH, V59, P4, DOI 10.1111/j.1863-2378.2011.01414.x; HATTWICK MAW, 1978, JAMA-J AM MED ASSOC, V240, P1499; IBM SPSS Data Collection Remote Interviewing Software, 2008, MRINTERVIEW 5 6; KOCH HG, 1986, ANN ENTOMOL SOC AM, V79, P11, DOI 10.1093/aesa/79.1.11; KOCH HG, 1982, J MED ENTOMOL, V19, P293, DOI 10.1093/jmedent/19.3.293; Marshall GS, 2003, ARCH PEDIAT ADOL MED, V157, P443, DOI 10.1001/archpedi.157.5.443; McQuiston JH, 2011, ZOONOSES PUBLIC HLTH, V58, P85, DOI 10.1111/j.1863-2378.2009.01300.x; Nicholson WL, 2006, ANN NY ACAD SCI, V1078, P338, DOI 10.1196/annals.1374.065; Nicholson WL, 2006, ANN NY ACAD SCI, V1078, P519, DOI 10.1196/annals.1374.102; NORMENT BR, 1984, AM J VET RES, V45, P1706; Openshaw JJ, 2010, AM J TROP MED HYG, V83, P174, DOI 10.4269/ajtmh.2010.09-0752; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Range B., 2001, LEVEL 3 ECOREGIONS A, P175; SAS Institute Inc, 2011, SAS STAT STAT SOFTW; SPACH DH, 1993, NEW ENGL J MED, V329, P936, DOI 10.1056/NEJM199309233291308; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-102; Tinoco-Gracia L, 2009, VET REC, V164, P59, DOI 10.1136/vr.164.2.59; U.S. Census Bureau, 2010, PROF GEN POP HOUS CH; U.S. Department of Commerce, 2014, 1981 2010 STAT NORM; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wilson ME, 2002, MED CLIN N AM, V86, P219, DOI 10.1016/S0025-7125(03)00084-1; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	35	43	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112368	10.1371/journal.pone.0112368	http://dx.doi.org/10.1371/journal.pone.0112368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479289	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200009
J	Kolb, D; Pritz, E; Steinecker-Frohnwieser, B; Lohberger, B; Deutsch, A; Kroneis, T; El-Heliebi, A; Dohr, G; Meditz, K; Wagner, K; Koefeler, H; Leitinger, G; Leithner, A; Liegl-Atzwanger, B; Zweytick, D; Rinner, B				Kolb, Dagmar; Pritz, Elisabeth; Steinecker-Frohnwieser, Bibiane; Lohberger, Birgit; Deutsch, Alexander; Kroneis, Thomas; El-Heliebi, Amin; Dohr, Gottfried; Meditz, Katharina; Wagner, Karin; Koefeler, Harald; Leitinger, Gerd; Leithner, Andreas; Liegl-Atzwanger, Bernadette; Zweytick, Dagmar; Rinner, Beate			Extended Ultrastructural Characterization of Chordoma Cells: The Link to New Therapeutic Options	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; GLUCOSYLCERAMIDE SYNTHASE; ION CHANNELS; CANCER; CA2+; MITOCHONDRIA; SPHINGOLIPIDS; APOPTOSIS; SURVIVAL; TUMOR	Chordomas are rare bone tumors, developed from the notochord and largely resistant to chemotherapy. A special feature of this tumor is the heterogeneity of its cells. By combining high pressure freezing (HPF) with electron tomography we were able to illustrate the connections within the cells, the cell-cell interface, and the mitochondria-associated endoplasmic reticulum membrane complex that appears to play a special role among the characteristics of chordoma. These lipid raft-like regions are responsible for lipid syntheses and for calcium signaling. Compared to other tumor cells, chordoma cells show a close connection of rough endoplasmic reticulum and mitochondria, which may influence the sphingolipid metabolism and calcium release. We quantified levels of ceramide and glycosylceramide species by the methyl tert-butyl ether extraction method and we assessed the intracellular calcium concentration with the ratiometric fluorescent dye Fura-2(AM). Measurements of the changes in the intracellular calcium concentration revealed an increase in calcium due to the application of acetylcholine. With regard to lipid synthesis, glucosylceramide levels in the chordoma cell line were significantly higher than those in normal healthy cells. The accumulation of glycosylceramide in drug resistant cancer cells has been confirmed in many types of cancer and may also account for drug resistance in chordoma. This study aimed to provide a deep morphological description of chordoma cells, it demonstrated that HPF analysis is useful in elucidating detailed structural information. Furthermore we demonstrate how an accumulation of glycosylceramide in chordoma provides links to drug resistance and opens up the field for new research options.	[Kolb, Dagmar; Meditz, Katharina; Wagner, Karin; Koefeler, Harald; Rinner, Beate] Med Univ Graz, Med Res Ctr, Graz, Austria; [Kolb, Dagmar; Pritz, Elisabeth; Kroneis, Thomas; El-Heliebi, Amin; Dohr, Gottfried; Leitinger, Gerd] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Steinecker-Frohnwieser, Bibiane] Ludwig Boltzmann Cluster Rheumatol Balneol & Reha, Ludwig Boltzmann Inst Rehabil Internal Dis, Saalfelden, Austria; [Lohberger, Birgit; Leithner, Andreas] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Deutsch, Alexander] Med Univ Graz, Div Hematol, Dept Internal Med, Graz, Austria; [Liegl-Atzwanger, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria; [Zweytick, Dagmar] Graz Univ, Div Biophys, Inst Mol Biosci, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Rinner, B (corresponding author), Med Univ Graz, Med Res Ctr, Graz, Austria.	beate.rinner@medunigraz.at	Kroneis, Thomas/D-1373-2011; Dohr, Gottfried/E-8070-2010; Deutsch, Alexander AJ/F-2168-2010	Kroneis, Thomas/0000-0002-4761-9340; Deutsch, Alexander AJ/0000-0003-0914-2809; Rinner, Beate/0000-0002-6340-4905; Zweytick, Dagmar/0000-0002-4766-7713; Steinecker-Frohnwieser, Bibiane/0000-0001-6852-4466; Leitinger, Gerd/0000-0002-5281-9830; Kofeler, Harald/0000-0002-2725-9616	Medical University of Graz	Medical University of Graz	Financial support from the Medical University of Graz is gratefully acknowledged. No commercial benefits of any kind have been or will be received from institutions related directly or indirectly to the subject of the manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Casali PG, 2007, CURR OPIN ONCOL, V19, P367, DOI 10.1097/CCO.0b013e3281214448; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Don AS, 2014, BIOMOLECULES, V4, P315, DOI 10.3390/biom4010315; El-Heliebi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087663; ERLANDSON RA, 1968, CANCER RES, V28, P2115; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Kok JW, 2000, INT J CANCER, V87, P172, DOI 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Liu Ying, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1727; Lucci A, 1998, ANTICANCER RES, V18, P475; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; MORTON DL, 1994, PROG BRAIN RES, V101, P251; Muro Kenji, 2007, Expert Rev Neurother, V7, P1295, DOI 10.1586/14737175.7.10.1295; Nibu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826435; Nicholson KM, 1999, BRIT J CANCER, V81, P423, DOI 10.1038/sj.bjc.6690711; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Rinner B, 2012, INT J ONCOL, V40, P443, DOI 10.3892/ijo.2011.1235; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Sciubba DM, 2008, NEUROSURG CLIN N AM, V19, P5, DOI 10.1016/j.nec.2007.09.006; Sietsma H, 2001, J MEMBRANE BIOL, V181, P153, DOI 10.1007/s00232-001-0033-1; Smoll NR, 2013, CANCER-AM CANCER SOC, V119, P2029, DOI 10.1002/cncr.28032; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; THURIN J, 1986, FEBS LETT, V208, P17, DOI 10.1016/0014-5793(86)81522-8; Vance JE, 2013, BIOCHIM BIOPHYS ACTA, V1841, P595; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; Williams BJ, 2013, J NATL COMPR CANC NE, V11, P726, DOI 10.6004/jnccn.2013.0089; Yamaguchi T, 2005, MODERN PATHOL, V18, P1005, DOI 10.1038/modpathol.3800378	45	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114251	10.1371/journal.pone.0114251	http://dx.doi.org/10.1371/journal.pone.0114251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479055	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200056
J	Petryk, N; Zhou, YF; Sybirna, K; Mucchielli, MH; Guiard, B; Bao, WG; Stasyk, OV; Stasyk, OG; Krasovska, OS; Budin, K; Reymond, N; Imbeaud, S; Coudouel, S; Delacroix, H; Sibirny, A; Bolotin-Fukuhara, M				Petryk, Nataliya; Zhou, You-Fang; Sybirna, Kateryna; Mucchielli, Marie-Helene; Guiard, Bernard; Bao, Wei-Guo; Stasyk, Oleh V.; Stasyk, Olena G.; Krasovska, Olena S.; Budin, Karine; Reymond, Nancie; Imbeaud, Sandrine; Coudouel, Sophie; Delacroix, Herve; Sibirny, Andriy; Bolotin-Fukuhara, Monique			Functional Study of the Hap4-Like Genes Suggests That the Key Regulators of Carbon Metabolism HAP4 and Oxidative Stress Response YAP1 in Yeast Diverged from a Common Ancestor	PLOS ONE			English	Article							CCAAT-BINDING COMPLEX; SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; IRON-DEFICIENCY; FACTOR PHP4; EXPRESSION; PROTEIN; OVEREXPRESSION; EVOLUTION; CONTAINS	The transcriptional regulator HAP4, induced by respiratory substrates, is involved in the balance between fermentation and respiration in S. cerevisiae. We identified putative orthologues of the Hap4 protein in all ascomycetes, based only on a conserved sixteen amino acid-long motif. In addition to this motif, some of these proteins contain a DNA-binding motif of the bZIP type, while being nonetheless globally highly divergent. The genome of the yeast Hansenula polymorpha contains two HAP4-like genes encoding the protein HpHap4-A which, like ScHap4, is devoid of a bZIP motif, and HpHap4-B which contains it. This species has been chosen for a detailed examination of their respective properties. Based mostly on global gene expression studies performed in the S. cerevisiae HAP4 disruption mutant (Sc Delta hap4), we show here that HpHap4-A is functionally equivalent to ScHap4, whereas HpHap4-B is not. Moreover HpHAP4-B is able to complement the H2O2 hypersensitivity of the ScYap1 deletant, YAP1 being, in S. cerevisiae, the main regulator of oxidative stress. Finally, a transcriptomic analysis performed in theSc Delta yap1 strain overexpressing HpHAP4-B shows that HpHap4-B acts both on oxidative stress response and carbohydrate metabolism in a manner different from both ScYap1 and ScHap4. Deletion of these two genes in their natural host, H. polymorpha, confirms that HpHAP4-A participates in the control of the fermentation/respiration balance, while HpHAP4-B is involved in oxidative stress since its deletion leads to hypersensitivity to H2O2. These data, placed in an evolutionary context, raise new questions concerning the evolution of the HAP4 transcriptional regulation function and suggest that Yap1 and Hap4 have diverged from a unique regulatory protein in the fungal ancestor.	[Petryk, Nataliya; Zhou, You-Fang; Sybirna, Kateryna; Bao, Wei-Guo; Budin, Karine; Bolotin-Fukuhara, Monique] Univ Paris 11, Inst Genet & Microbiol, IFR Genome 115, F-91405 Orsay, France; [Petryk, Nataliya; Zhou, You-Fang; Sybirna, Kateryna; Bao, Wei-Guo; Budin, Karine; Bolotin-Fukuhara, Monique] CNRS, F-91405 Orsay, France; [Petryk, Nataliya; Stasyk, Oleh V.; Stasyk, Olena G.; Krasovska, Olena S.; Sibirny, Andriy] Natl Acad Sci, Inst Cell Biol, Lvov, Ukraine; [Mucchielli, Marie-Helene; Budin, Karine; Reymond, Nancie; Imbeaud, Sandrine; Coudouel, Sophie; Delacroix, Herve] Gif Orsay DNA MicroArray Platform, Gif Sur Yvette, France; [Petryk, Nataliya; Mucchielli, Marie-Helene; Guiard, Bernard; Reymond, Nancie; Delacroix, Herve] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Stasyk, Olena G.] Ivan Franko Lviv Natl Univ, Dept Biochem, Lvov, Ukraine; [Sibirny, Andriy] Univ Rzeszow, Rzeszow, Poland	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); National Academy of Sciences Ukraine; Institute of Cell Biology of NASU; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv; University of Rzeszow	Bolotin-Fukuhara, M (corresponding author), Univ Paris 11, Inst Genet & Microbiol, IFR Genome 115, F-91405 Orsay, France.	monique.bolotin@u-psud.fr	Stasyk, Oleh/E-9496-2019; Stasyk, Olena/K-9254-2017; Imbeaud, Sandrine/P-8780-2017	Stasyk, Oleh/0000-0001-8135-6102; Stasyk, Olena/0000-0002-0253-2372; Imbeaud, Sandrine/0000-0001-8439-6732; Sibirny, Andriy/0000-0001-8579-1566; Bolotin-Fukuhara, Monique/0000-0002-5285-5006; Petryk, Nataliya/0000-0001-8629-1475	CNRS [UMR8621]; EC [GARNISH QLK3-2000-174]; French government; bilateral CNRS-Ukrainian NAS program; Ile de France; FEBS collaborative experimental Scholarship for Central and Eastern Europe; INTAS [05-109-4177]	CNRS(Centre National de la Recherche Scientifique (CNRS)); EC(European CommissionEuropean Commission Joint Research Centre); French government; bilateral CNRS-Ukrainian NAS program; Ile de France; FEBS collaborative experimental Scholarship for Central and Eastern Europe; INTAS(INTASEuropean Commission)	Experiments were funded by recurrent national fundings (CNRS and University) to the IGM (UMR8621). The EC contract GARNISH QLK3-2000-174 to MBF contributed to the start of this work. NP was supported by a French government fellowship for joint PhD, a bilateral CNRS-Ukrainian NAS program and a regional support from Ile de France grant for joint PhD. KS was supported by a FEBS collaborative experimental Scholarship for Central and Eastern Europe and an INTAS fellowship grant for young Scientist (05-109-4177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoutzias GD, 2004, COMP FUNCT GENOM, V5, P79, DOI 10.1002/cfg.365; Bao WG, 2008, EUKARYOT CELL, V7, P1895, DOI 10.1128/EC.00018-08; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; BOSSIER P, 1993, J BIOL CHEM, V268, P23640; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Delahodde A, 2001, MOL MICROBIOL, V39, P304, DOI 10.1046/j.1365-2958.2001.02182.x; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dumond H, 2000, MOL MICROBIOL, V36, P830, DOI 10.1046/j.1365-2958.2000.01845.x; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; Goffeau A, 2000, FEBS LETT, V480, P37, DOI 10.1016/S0014-5793(00)01775-0; HOEFNAGEL MHN, 1995, EUR J BIOCHEM, V233, P531, DOI 10.1111/j.1432-1033.1995.531_2.x; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Kaniuga Z, 1969, INHIBITORS TOOLS CEL, P282; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lascaris R, 2004, MICROBIOL-SGM, V150, P929, DOI 10.1099/mic.0.26742-0; Lascaris R, 2003, GENOME BIOL, V4; Lelandais G, 2011, CR BIOL, V334, P655, DOI 10.1016/j.crvi.2011.05.014; LEVINE DW, 1973, APPL MICROBIOL, V26, P982, DOI 10.1128/AEM.26.6.982-990.1973; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marisa L, 2007, BIOINFORMATICS, V23, P2339, DOI 10.1093/bioinformatics/btm321; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; OLESEN JT, 1991, MOL CELL BIOL, V11, P611, DOI 10.1128/MCB.11.2.611; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; SUDBERY PE, 1988, BIOCHEM SOC T, V16, P1081; Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Sybirna K, 2010, YEAST, V27, P941, DOI 10.1002/yea.1802; TAN XQ, 1995, J CELL BIOL, V128, P307, DOI 10.1083/jcb.128.3.307; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Veiga A, 2003, FEMS YEAST RES, V3, P141, DOI 10.1016/S1567-1356(02)00189-7; Voronovsky AY, 2005, FEMS YEAST RES, V5, P1055, DOI 10.1016/j.femsyr.2005.09.001	54	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112263	10.1371/journal.pone.0112263	http://dx.doi.org/10.1371/journal.pone.0112263			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479159	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200007
J	Prahm, KP; Witting, N; Vissing, J				Prahm, Kira P.; Witting, Nanna; Vissing, John			Decreased Variability of the 6-Minute Walk Test by Heart Rate Correction in Patients with Neuromuscular Disease	PLOS ONE			English	Article							RELIABILITY	Objective: The 6-minute walk test is widely used to assess functional status in neurological disorders. However, the test is subject to great inter-test variability due to fluctuating motivation, fatigue and learning effects. We investigated whether inter-test variability of the 6MWT can be reduced by heart rate correction. Methods: Sixteen patients with neuromuscular diseases, including Facioscapulohumeral muscular dystrophy, Limb-girdle muscular dystrophy, Charcot-Marie-Tooths, Dystrophia Myotonica and Congenital Myopathy and 12 healthy subjects were studied. Patients were excluded if they had cardiac arrhythmias, if they received drug treatment for hypertension or any other medical conditions that could interfere with the interpretation of the heart rate and walking capability. All completed three 6-minute walk tests on three different test-days. Heart rate was measured continuously. Results: Successive standard 6-minute walk tests showed considerable learning effects between Tests 1 and 2 (4.9%; P=0.026), and Tests 2 and 3 (4.5%; P=0.020) in patients. The same was seen in controls between Tests 1 and 2 (8.1%; P=0.039)). Heart rate correction abolished this learning effect. Conclusion: A modified 6-minute walk test, by correcting walking distance with average heart rate during walking, decreases the variability among repeated 6-minute walk tests, and should be considered as an alternative outcome measure to the standard 6-minute walk test in future clinical follow-up and treatment trials.	[Prahm, Kira P.; Witting, Nanna; Vissing, John] Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Dept Neurol, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Vissing, J (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Dept Neurol, DK-1168 Copenhagen, Denmark.	john.vissing@regionh.dk		Witting, Nanna/0000-0002-0664-0709				[Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; ASTRAND PO, 1986, TXB WORK PHYSL PHYSL, P354; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Guyton A.C., 2006, TXB MED PHYSL, P1062; Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003; Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; Kierkegaard M, 2007, NEUROMUSCULAR DISORD, V17, P943, DOI 10.1016/j.nmd.2007.08.003; KNOX AJ, 1988, THORAX, V43, P388, DOI 10.1136/thx.43.5.388; Wu G, 2003, AM HEART J, V146, P129, DOI 10.1016/S0002-8703(03)00119-4	11	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114273	10.1371/journal.pone.0114273	http://dx.doi.org/10.1371/journal.pone.0114273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479403	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200062
J	Geuss, LR; Wu, DC; Ramamoorthy, D; Alford, CD; Suggs, LJ				Geuss, Laura R.; Wu, Douglas C.; Ramamoorthy, Divya; Alford, Corinne D.; Suggs, Laura J.			Paramagnetic Beads and Magnetically Mediated Strain Enhance Cardiomyogenesis in Mouse Embryoid Bodies	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; CYCLIC STRAIN; CARDIAC DIFFERENTIATION; MECHANICAL CONTROL; INTEGRINS; INHIBITION; EXPRESSION; ADHESION; DELIVERY; STRESS	Mechanical forces play an important role in proper embryologic development, and similarly such forces can directly impact pluripotency and differentiation of mouse embryonic stem cells (mESC) in vitro. In addition, manipulation of the embryoid body (EB) microenvironment, such as by incorporation of microspheres or microparticles, can similarly influence fate determination. In this study, we developed a mechanical stimulation regimen using permanent neodymium magnets to magnetically attract cells within an EB. Arginine-Glycine-Aspartic Acid (RGD)-conjugated paramagnetic beads were incorporated into the interior of the EBs during aggregation, allowing us to exert force on individual cells using short-term magnetization. EBs were stimulated for one hour at different magnetic field strengths, subsequently exerting a range of force intensity on the cells at different stages of early EB development. Our results demonstrated that following exposure to a 0.2 Tesla magnetic field, ESCs respond to magnetically mediated strain by activating Protein Kinase A (PKA) and increasing phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2) expression. The timing of stimulation can also be tailored to guide ESC differentiation: the combination of bone morphogenetic protein 4 (BMP4) supplementation with one hour of magnetic attraction on Day 3 enhances cardiomyogenesis by increasing contractile activity and the percentage of sarcomeric a-actin-expressing cells compared to control samples with BMP4 alone. Interestingly, we also observed that the beads alone had some impact on differentiation by increasingly slightly, albeit not significantly, the percentage of cardiomyocytes. Together these results suggest that magnetically mediated strain can be used to enhance the percentage of mouse ESC-derived cardiomyocytes over current differentiation protocols.	[Geuss, Laura R.; Wu, Douglas C.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Ramamoorthy, Divya; Alford, Corinne D.; Suggs, Laura J.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Suggs, LJ (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	suggs@utexas.edu	Wu, Douglas/ABF-2497-2020	Wu, Douglas/0000-0001-6179-3110; /0000-0002-1419-8017; Ramamoorthy, Divya/0000-0001-9438-0419	National Science Foundation Career Award grant [CBET-0845239]	National Science Foundation Career Award grant(National Science Foundation (NSF))	The National Science Foundation Career Award grant awarded to LS (grant no. CBET-0845239) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat FJ, 2009, J CELL BIOCHEM, V106, P529, DOI 10.1002/jcb.22001; Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Bratt-Leal AM, 2013, BIOMATERIALS, V34, P7227, DOI 10.1016/j.biomaterials.2013.05.079; Bukoreshtliev NV, 2013, CELL TISSUE RES, V352, P77, DOI 10.1007/s00441-012-1531-4; Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Dawson J, 2011, IN VITRO CELL DEV-AN, V47, P653, DOI 10.1007/s11626-011-9453-0; Geuss LR, 2013, BIOTECHNOL PROGR, V29, P1089, DOI 10.1002/btpr.1794; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050; Heo JS, 2011, J CELL BIOCHEM, V112, P1880, DOI 10.1002/jcb.23108; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Laboureau J, 2004, EXP DERMATOL, V13, P70, DOI 10.1111/j.0906-6705.2004.00117.x; Lee MY, 2011, BIOCHEM BIOPH RES CO, V416, P51, DOI 10.1016/j.bbrc.2011.10.140; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Pimton P, 2011, CELL ADHES MIGR, V5, P73, DOI 10.4161/cam.5.1.13704; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Sargent CY, 2009, TISSUE ENG PT A, V15, P331, DOI 10.1089/ten.tea.2008.0145; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007; Tahaa MF, 2008, INT J CARDIOL, V127, P78, DOI 10.1016/j.ijcard.2007.04.173; Toh YC, 2011, FASEB J, V25, P1208, DOI 10.1096/fj.10-168971; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Uda Y, 2011, BIOCHEM BIOPH RES CO, V415, P396, DOI 10.1016/j.bbrc.2011.10.080; VONSWEENEY NO, 2004, CARDIOVASC RES, V63, P625, DOI DOI 10.1016/J.CARDIORES.2004.05.008; Wan CR, 2011, ANN BIOMED ENG, V39, P1840, DOI 10.1007/s10439-011-0275-8; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wolfe RP, 2012, INTEGR BIOL-UK, V4, P1263, DOI 10.1039/c2ib20040f; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yanada S, 2006, J BIOMED MATER RES A, V77A, P773, DOI 10.1002/jbm.a.30635; Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113982	10.1371/journal.pone.0113982	http://dx.doi.org/10.1371/journal.pone.0113982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501004	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400020
J	Lederer, H; Muggli, B; Speich, R; Treder, U; Stricker, H; Goede, J; Ulrich, S; Stampfli, SF; Breitenstein, A				Lederer, Heidi; Muggli, Bettina; Speich, Rudolf; Treder, Ula; Stricker, Hans; Goede, Jeroen; Ulrich, Silvia; Stampfli, Simon F.; Breitenstein, Alexander			Haemosiderin-Laden Sputum Macrophages for Diagnosis in Pulmonary Veno-Occlusive Disease	PLOS ONE			English	Article							CLINICAL MANAGEMENT; HYPERTENSION; HEMORRHAGE; EDEMA	Aims: Pulmonary veno-occlusive disease (PVOD) is a rare condition of pulmonary arterial hypertension (PAH), in which post-capillary veins are affected. Since the therapeutic approach in PVOD differs from other forms of PAH, it is crucial to establish the diagnosis. Due to the fact that affected patients are often hemodynamically unstable, minimal invasive procedures are necessary for the diagnostic work-up. Chronic alveolar haemorrhage has been observed during bronchoalveolar lavage in PVOD cases. This study therefore investigates whether signs of alveolar haemorrhage can also be found in the sputum of these patients. Methods and Results: Six patients suffering from PVOD were included in this analysis. As controls, patients with idiopathic PAH (n=11), chronic thromboembolic PH (n=9) and with sclerodermia-associated PH (n=10) were assessed. Sputum from every patient was obtained by a non-invasive manner. The amount of haemosiderin-laden macrophages was determined using the Golde score. There were statistically significant more haemosiderin-laden macrophages in the sputum of patients suffering from PVOD as compared to the other groups (P<0.05). Assuming a cut-off of 200 on the Golde score, all of the 6 PVOD patients surpassed this value compared with only 1 out of the 30 cases with precapillary PH. Thus, sensitivity and specificity with respect to the diagnosis of PVOD was 100% and 97%, respectively. Conclusion: The content of haemosiderin-laden macrophages in the sputum of patients suffering from PVOD is significantly higher as compared to other forms of PH and may be useful in the non-invasive diagnostic work-up of these patients.	[Lederer, Heidi; Speich, Rudolf; Treder, Ula; Ulrich, Silvia; Breitenstein, Alexander] Univ Zurich Hosp, Clin Internal Med, Zurich Pulm Hypertens Program, CH-8091 Zurich, Switzerland; [Muggli, Bettina; Stampfli, Simon F.; Breitenstein, Alexander] Univ Zurich Hosp, Univ Heart Ctr, CH-8091 Zurich, Switzerland; [Stricker, Hans] Osped La Carita, Locarno, Switzerland; [Goede, Jeroen] Univ Zurich Hosp, Dept Hematol, CH-8091 Zurich, Switzerland; [Breitenstein, Alexander] St Bartholomews Hosp, Barts Hlth NHS Trust, Dept Cardiol, London, England	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Barts Health NHS Trust; University of London; Queen Mary University London	Breitenstein, A (corresponding author), Univ Zurich Hosp, Clin Internal Med, Zurich Pulm Hypertens Program, CH-8091 Zurich, Switzerland.	alexander.breitenstein@usz.ch		Stampfli, Simon F./0000-0003-3690-8216; Ulrich, Silvia/0000-0002-5250-5022	Actelion Switzerland	Actelion Switzerland	Dr. Breitenstein received educational funding from Actelion Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P749, DOI 10.1590/S1806-37132008000900015; Chaisson NF, 2013, CHEST, V144, P1346, DOI 10.1378/chest.12-2396; Creagh-Brown BC, 2008, THORAX, V63, P933, DOI 10.1136/thx.2007.088831; ELLIOTT CG, 1988, RESPIRATION, V53, P262; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GOLDE DW, 1975, BMJ-BRIT MED J, V2, P166, DOI 10.1136/bmj.2.5964.166; Holcomb BW, 2000, CHEST, V118, P1671, DOI 10.1378/chest.118.6.1671; Huertas A, 2011, EXPERT REV RESP MED, V5, P217, DOI [10.1586/ers.11.15, 10.1586/ERS.11.15]; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Lang IM, 2014, CIRCULATION, V130, P508, DOI 10.1161/CIRCULATIONAHA.114.009309; Lantuejoul S, 2006, AM J SURG PATHOL, V30, P850, DOI 10.1097/01.pas.0000209834.69972.e5; Mandel J, 2000, AM J RESP CRIT CARE, V162, P1964, DOI 10.1164/ajrccm.162.5.9912045; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Montani D, 2008, MEDICINE, V87, P220, DOI 10.1097/MD.0b013e31818193bb; Palmer SM, 1998, CHEST, V113, P237, DOI 10.1378/chest.113.1.237; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Rabillier A, 2006, EUR RESPIR J, V27, P108, DOI 10.1183/09031936.06.00054105; Resten A, 2004, AM J ROENTGENOL, V183, P65, DOI 10.2214/ajr.183.1.1830065; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SHACKELFORD GD, 1977, AM J ROENTGENOL, V128, P643, DOI 10.2214/ajr.128.4.643; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Zamanian RT, 2014, CIRC RES, V115, P131, DOI 10.1161/CIRCRESAHA.115.303827	22	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115219	10.1371/journal.pone.0115219	http://dx.doi.org/10.1371/journal.pone.0115219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501010	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000346375400085
J	Yilmazer, A; Tian, B; Kostarelos, K				Yilmazer, Acelya; Tian, Bowen; Kostarelos, Kostas			Development of Dual-Activity Vectors by Co-Envelopment of Adenovirus and SiRNA in Artificial Lipid Bilayers	PLOS ONE			English	Article							GENE DELIVERY; ANTITUMOR-ACTIVITY; IN-VITRO; RNA; LIPOPLEXES; LIPOSOMES; THERAPY; VIRUSES; GROWTH; PDNA	Gene therapy with human adenovirus type 5 (Ad5) has been extensively explored for the treatment of diseases resistant to traditional therapies. Intravenous administration leads to rapid clearance from blood circulation and high liver accumulation, which restrict the use of Ad-based vectors in clinical gene therapy protocols that involve systemic administration. We have previously proposed that such limitations can be improved by engineering artificial lipid envelopes around Ad and designed a variety of artificial lipid bilayer envelopes around the viral capsid. In this study, we sought to explore further opportunities that the artificially enveloped virus constructs could offer, by designing a previously unreported gene therapy vector by simultaneous envelopment of Ad and siRNA within the same lipid bilayer. Such a dual-activity vector can offer efficacious therapy for different genetic disorders where both turning on and switching off genes would be needed. Dynamic light scattering, transmission electron microscopy and atomic force microscopy were used to characterize these vectors. Agarose gel electrophoresis, Ribo green and dot blot assays showed that siRNA and Ad virions can be enveloped together within lipid bilayers at high envelopment efficiency. Cellular uptake and in vitro transfection experiments were carried out to show the feasibility of combining siRNA-mediated gene silencing with viral gene transfer using these newly designed dual-activity vectors.	[Yilmazer, Acelya; Kostarelos, Kostas] UCL, Fac Life Sci, Nanomed Lab, London, England; [Tian, Bowen] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; [Kostarelos, Kostas] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Kostarelos, Kostas] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Yilmazer, Acelya] Ankara Univ, Fac Sci, Dept Biol, TR-06100 Ankara, Turkey	University of London; University College London; University of Nottingham; University of Manchester; University of Manchester; Ankara University	Kostarelos, K (corresponding author), UCL, Fac Life Sci, Nanomed Lab, London, England.	kostas.kostarelos@manchester.ac.uk	Yilmazer, Acelya/L-4562-2013; Kostarelos, Kostas/AAP-6879-2021	Yilmazer, Acelya/0000-0003-2712-7450; Kostarelos, Kostas/0000-0002-2224-6672	Turkish Ministry of Education; Engineering and Physical Sciences Research Council [EP/K005014/1] Funding Source: researchfish; EPSRC [EP/K005014/1] Funding Source: UKRI	Turkish Ministry of Education(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a full-time PhD studentship by the Turkish Ministry of Education to AY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MT, 2010, MOL THER, V18, P171, DOI 10.1038/mt.2009.208; Bates K, 2013, ADV DRUG DELIVER REV, V65, P2023, DOI 10.1016/j.addr.2013.10.003; Bauzon M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00074; Cho SK, 2012, BIOMATERIALS, V33, P3316, DOI 10.1016/j.biomaterials.2012.01.027; Ciani L, 2004, BBA-BIOMEMBRANES, V1664, P70, DOI 10.1016/j.bbamem.2004.04.003; Eltoukhy AA, 2013, ADV MATER, V25, P1487, DOI 10.1002/adma.201204346; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kang HC, 2011, BIOMATERIALS, V32, P4914, DOI 10.1016/j.biomaterials.2011.03.042; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Ozpolat B, 2010, J INTERN MED, V267, P44, DOI 10.1111/j.1365-2796.2009.02191.x; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Pan QW, 2008, ACTA ONCOL, V47, P135, DOI 10.1080/02841860701403053; Rhinn H, 2009, BBA-GEN SUBJECTS, V1790, P219, DOI 10.1016/j.bbagen.2009.01.005; Shen W, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-81; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Singh R, 2008, FASEB J, V22, P3389, DOI 10.1096/fj.08-103275; Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565; Tada Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/572609; Tagami T, 2007, INT J PHARM, V333, P62, DOI 10.1016/j.ijpharm.2006.09.057; Tran MA, 2009, PIGM CELL MELANOMA R, V22, P388, DOI 10.1111/j.1755-148X.2009.00581.x; Van den Bossche J, 2011, BIOMATERIALS, V32, P3085, DOI 10.1016/j.biomaterials.2010.12.043; Wiseman JW, 2003, GENE THER, V10, P1654, DOI 10.1038/sj.gt.3302050; Wong HH, 2010, VIRUSES-BASEL, V2, P78, DOI 10.3390/v2010078; Yilmazer A, 2013, BIOMATERIALS, V34, P1354, DOI 10.1016/j.biomaterials.2012.10.053; Zhang H, 2009, MOL THER, V17, P57, DOI 10.1038/mt.2008.236; Zhang Y, 2010, INT J PHARMACEUT, V390, P198, DOI 10.1016/j.ijpharm.2010.01.035; Zhang YA, 2006, CANCER RES, V66, P9736, DOI 10.1158/0008-5472.CAN-06-1617; Zheng JN, 2009, CANCER GENE THER, V16, P20, DOI 10.1038/cgt.2008.61; Zheng JN, 2009, CANCER BIOL THER, V8, P84, DOI 10.4161/cbt.8.1.7204	30	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114985	10.1371/journal.pone.0114985	http://dx.doi.org/10.1371/journal.pone.0114985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501573	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400065
J	Masters, SH; Burstein, R; DeCenso, B; Moore, K; Haakenstad, A; Ikilezi, G; Achan, J; Osei, I; Garshong, B; Kisia, C; Njuguna, P; Babigumira, J; Kumar, S; Hanlon, M; Gakidou, E				Masters, Samuel H.; Burstein, Roy; DeCenso, Brendan; Moore, Kelsey; Haakenstad, Annie; Ikilezi, Gloria; Achan, Jane; Osei, Ivy; Garshong, Bertha; Kisia, Caroline; Njuguna, Pamela; Babigumira, Joseph; Kumar, Santosh; Hanlon, Michael; Gakidou, Emmanuela			Pharmaceutical Availability across Levels of Care: Evidence from Facility Surveys in Ghana, Kenya, and Uganda	PLOS ONE			English	Article							ESSENTIAL MEDICINES; AFFORDABILITY; ANTIMALARIALS; SERVICES; DISEASES; QUALITY; OUTLETS; CHOICE; ACCESS	Objective: In this study we use facility-level data from nationally representative surveys conducted in Ghana, Kenya, and Uganda to understand pharmaceutical availability within the three countries. Methods: In 2012, we conducted a survey to capture information on pharmaceuticals and other facility indicators from over 200 facilities in each country. We analyze data on the availability of pharmaceuticals and quantify its association with various facility-level indicators. We analyze both availability of essential medicines, as defined by the various essential medicine lists (EMLs) of each respective country, and availability of all surveyed pharmaceuticals deemed important for treatment of various high-burden diseases, including those on the EMLs. Results: We find that there is heterogeneity with respect to availability across the three countries with Ghana generally having better availability than Uganda and Kenya. To analyze the relationship between facility-level factors and pharmaceutical stock-out we use a binomial regression model. We find that the factors associated with stock-out vary by country, but across all countries both presence of a laboratory at the facility and presence of a vehicle at the facility are significantly associated with reduced stock-out. Conclusion: The results of this study highlight the poor availability of essential medicines across these three countries and suggest more needs to be done to strengthen the supply system so that stock remains uninterrupted.	[Masters, Samuel H.] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA; [Burstein, Roy; Haakenstad, Annie; Hanlon, Michael] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [DeCenso, Brendan] RTI Int, Durham, NC USA; [Ikilezi, Gloria; Achan, Jane] Infect Dis Res Collaborat, Kampala, Uganda; [Osei, Ivy; Garshong, Bertha] Ghana Hlth Serv, Accra, Ghana; [Kisia, Caroline; Njuguna, Pamela] Act Africa Help Int, Nairobi, Kenya; [Babigumira, Joseph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Kumar, Santosh] Sam Houston State Univ, Dept Econ & Int Business, Huntsville, TX 77340 USA	University of North Carolina; University of North Carolina Chapel Hill; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Research Triangle Institute; Ghana Health Service; University of Washington; University of Washington Seattle; Texas State University System; Sam Houston State University	Masters, SH (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC 27599 USA.	masters@unc.edu	Babigumira, Joseph/T-4208-2019	Masters, Samuel/0000-0001-7581-8219				Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Buabeng KO, 2008, CLIN PHARMACOL THER, V84, P613, DOI 10.1038/clpt.2008.130; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cheraghali AM, 2009, PHARM WORLD SCI, V31, P209, DOI 10.1007/s11096-009-9282-3; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; DAVIS BL, 2013, EM APPR SPEECH ACQ, P1, DOI DOI 10.1186/1475-2875-12-135; Ghana National Drugs Program Ministry of Health, 2010, GHAN ESS MED LIST; Hanson K, 2005, HEALTH ECON, V14, P687, DOI 10.1002/hec.959; IHME, 2014, HLTH SERV PROV KEN A; Institute for Health Metrics and Evaluation (IHME), 2013, ACC BOTTL COSTS EQ A; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; Kenya Ministry of Medical Services Kenya Ministry of Public Health & Sanitation, 2010, KEN ESS MED LIST; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Mugisha F, 2004, B WORLD HEALTH ORGAN, V82, P572; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nabbuye-Sekandi J, 2011, INT J QUAL HEALTH C, V23, P516, DOI 10.1093/intqhc/mzr040; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tumwine Y, 2010, TROPICAL J PHARM RES, V9; Uganda Ministry of Health, 2011, UG ESS MED LIST; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; WHO, 2013, WHO MOD LISTS ESS ME; World Health Organization and Health Action International, 2003, MED PRIC NEW APPR ME; Yang H, 2010, HEALTH POLICY PLANN, V25, P219, DOI 10.1093/heapol/czp056	29	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114762	10.1371/journal.pone.0114762	http://dx.doi.org/10.1371/journal.pone.0114762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25500832	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700051
J	Badiola, KA; Quan, DH; Triccas, JA; Todd, MH				Badiola, Katrina A.; Quan, Diana H.; Triccas, James A.; Todd, Matthew H.			Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science	PLOS ONE			English	Article							SOURCE DRUG DISCOVERY; MYCOBACTERIUM-TUBERCULOSIS; MEMBRANE; MMPL3; LEADS	Tuberculosis afflicts an estimated 2 billion people worldwide and causes 1.3 million deaths annually. Chemotherapeutic solutions rely on drugs developed many years ago, with only one new therapeutic having been approved in the last 40 years. Given the rise of drug-resistant strains, there is an urgent need for the development of a more robust drug development pipeline. GlaxoSmithKline recently placed the structures and activities of 177 novel anti-tubercular leads in the public domain, as well as the results of ongoing optimisation of some of the series. Since many of the compounds arose from screening campaigns, their provenance was unclear and synthetic routes were in many cases not reported. Here we present the efficient synthesis of several novel analogues of one family of the GSK compounds-termed "Spiros''-using an oxa-Pictet-Spengler reaction. The new compounds are attractive from a medicinal chemistry standpoint and some were potent against the virulent strain, suggesting this class is worthy of further study. The research was carried out using open source methodology, providing the community with full access to all raw experimental data in real time.	[Badiola, Katrina A.; Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Quan, Diana H.; Triccas, James A.] Univ Sydney, Dept Infect Dis & Immunol, Microbial Pathogenesis & Immun Grp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Todd, MH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au	Triccas, Jamie/AAD-7629-2020; Todd, Matthew/S-2678-2018	Todd, Matthew/0000-0001-7096-4751; Quan, Diana/0000-0002-7341-8921; Triccas, James/0000-0003-3730-2339	University of Sydney; National Health and Medical Research Council Centre of Research Excellence on Tuberculosis Control [APP1043225]	University of Sydney(University of Sydney); National Health and Medical Research Council Centre of Research Excellence on Tuberculosis Control	This work was supported by the University of Sydney (KAB, MHT) and the National Health and Medical Research Council Centre of Research Excellence on Tuberculosis Control (APP1043225)(JAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; [Anonymous], 2012, INT GUID US BED TREA; [Anonymous], 2008, Clinical Trial, Patent No. [WO 2008155132 A1, 2008155132, NCT01218217]; Badiola K, 2013, ELECT LAB NOTEBOOK S; Badiola K, 2013, NMR DATA SYNTHESIS S; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Bouguerne B, 2010, SYNTHETIC COMMUN, V40, P915, DOI 10.1080/00397910903026715; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lun SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3907; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; MCCALLUM C, 1975, ELECTROCHIM ACTA, V20, P815, DOI 10.1016/0013-4686(75)87002-2; OLOFSON RA, 1984, J ORG CHEM, V49, P2081, DOI 10.1021/jo00185a072; OLOFSON RA, 1988, PURE APPL CHEM, V60, P1715, DOI 10.1351/pac198860111715; RAM S, 1987, SYNTHETIC COMMUN, V17, P415, DOI 10.1080/00397918708063919; Remuinan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060933; Robertson MN, 2014, PARASITOLOGY, V141, P148, DOI 10.1017/S0031182013001121; Shao L., 2011, Preparation of Thienopyranylmethanamine Derivatives and Analogs for Use as Nervous System Agents, Patent No. [WO2011069063A2, 2011069063]; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; WHO, 2013, WORLD HLTH ORG GLOB; Woelfle M, 2011, NAT CHEM, V3, P745, DOI 10.1038/nchem.1149; Zumia A, 2013, NAT REV DRUG DISCOV, V12, P388	24	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111782	10.1371/journal.pone.0111782	http://dx.doi.org/10.1371/journal.pone.0111782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493550	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400004
J	Ewers, H; Tada, T; Petersen, JD; Racz, B; Sheng, M; Choquet, D				Ewers, Helge; Tada, Tomoko; Petersen, Jennifer D.; Racz, Bence; Sheng, Morgan; Choquet, Daniel			A Septin-Dependent Diffusion Barrier at Dendritic Spine Necks	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR DYNAMICS; SYNAPTIC-TRANSMISSION; MAMMALIAN SEPTINS; AMPA RECEPTORS; MEMBRANE; COMPARTMENTALIZATION; PROTEINS; NEURONS; PHOSPHORYLATION; MORPHOLOGY	Excitatory glutamatergic synapses at dendritic spines exchange and modulate their receptor content via lateral membrane diffusion. Several studies have shown that the thin spine neck impedes the access of membrane and solute molecules to the spine head. However, it is unclear whether the spine neck geometry alone restricts access to dendritic spines or if a physical barrier to the diffusion of molecules exists. Here, we investigated whether a complex of septin cytoskeletal GTPases localized at the base of the spine neck regulates diffusion across the spine neck. We found that, during development, a marker of the septin complex, Septin7 (Sept7), becomes localized to the spine neck where it forms a stable structure underneath the plasma membrane. We show that diffusion of receptors and bulk membrane, but not cytoplasmic proteins, is slower in spines bearing Sept7 at their neck. Finally, when Sept7 expression was suppressed by RNA interference, membrane molecules explored larger membrane areas. Our findings indicate that Sept7 regulates membrane protein access to spines.	[Ewers, Helge; Petersen, Jennifer D.; Choquet, Daniel] Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Ewers, Helge; Petersen, Jennifer D.; Choquet, Daniel] CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Tada, Tomoko; Sheng, Morgan] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02446 USA; [Tada, Tomoko; Sheng, Morgan] MIT, Dept Biol, Cambridge, MA 02446 USA; [Racz, Bence] Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, H-1078 Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Hungarian University of Agriculture & Life Sciences	Choquet, D (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France.	daniel.choquet@u-bordeaux2.fr	Ewers, Helge/ABF-3629-2021; Rácz, Bence/J-4220-2019; Petersen, Jennifer/GLU-9899-2022; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018	Ewers, Helge/0000-0003-3948-4332; Rácz, Bence/0000-0002-1933-5332; Petersen, Jennifer/0000-0003-1107-8535; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Sheng, Morgan/0000-0002-8703-5366	FEBS Long-Term Fellowship; Human Frontiers Short-Term Fellowship; Hungarian Scientific Research Fund Grant [OTKA K83830]; Hungarian Academy of Sciences; CNRS; ERC Advanced Grant	FEBS Long-Term Fellowship; Human Frontiers Short-Term Fellowship; Hungarian Scientific Research Fund Grant; Hungarian Academy of Sciences(Hungarian Academy of Sciences); CNRS(Centre National de la Recherche Scientifique (CNRS)); ERC Advanced Grant(European Research Council (ERC))	H.E. was supported by a FEBS Long-Term Fellowship, T.T. by a Human Frontiers Short-Term Fellowship, and M.S. was an Investigator of the Howard Hughes Medical Institute. B.R. is supported by the Hungarian Scientific Research Fund Grant (OTKA K83830) and by the Janos Bolyai research fellowship by the Hungarian Academy of Sciences. D.C was supported by the CNRS and an ERC Advanced Grant. Morgan Sheng is an employee of Genentech, and Tomoko Tada is an employee of Otsuka Pharmaceutical, and both received funding in the form of salary from these companies. The electron microscopy of cultured neurons and confocal microscopy were done in the Bordeaux Imaging Center of the University of Bordeaux Segalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Barral Y, 2007, CURR BIOL, V17, pR961, DOI 10.1016/j.cub.2007.10.001; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	35	62	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113916	10.1371/journal.pone.0113916	http://dx.doi.org/10.1371/journal.pone.0113916			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494357	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000346611400023
J	Miccoli, L; Delgado, R; Rodriguez-Ruiz, S; Guerra, P; Garcia-Marmol, E; Fernandez-Santaella, MC				Miccoli, Laura; Delgado, Rafael; Rodriguez-Ruiz, Sonia; Guerra, Pedro; Garcia-Marmol, Eduardo; Carmen Fernandez-Santaella, M.			Meet OLAF, a Good Friend of the IAPS! The Open Library of Affective Foods: A Tool to Investigate the Emotional Impact of Food in Adolescents	PLOS ONE			English	Article							AFFECTIVE PICTURE SYSTEM; EATING-DISORDERS; BRAIN RESPONSES; IMAGE DATABASE; HIGH-CALORIE; STIMULI; PREFERENCES; VALIDATION; ACTIVATION; PSYCHOLOGY	In the last decades, food pictures have been repeatedly employed to investigate the emotional impact of food on healthy participants as well as individuals who suffer from eating disorders and obesity. However, despite their widespread use, food pictures are typically selected according to each researcher's personal criteria, which make it difficult to reliably select food images and to compare results across different studies and laboratories. Therefore, to study affective reactions to food, it becomes pivotal to identify the emotional impact of specific food images based on wider samples of individuals. In the present paper we introduce the Open Library of Affective Foods (OLAF), which is a set of original food pictures created to reliably select food pictures based on the emotions they prompt, as indicated by affective ratings of valence, arousal, and dominance and by an additional food craving scale. OLAF images were designed to allow simultaneous use with affective images from the International Affective Picture System (IAPS), which is a well-known instrument to investigate emotional reactions in the laboratory. The ultimate goal of the OLAF is to contribute to understanding how food is emotionally processed in healthy individuals and in patients who suffer from eating and weight-related disorders. The present normative data, which was based on a large sample of an adolescent population, indicate that when viewing affective non-food IAPS images, valence, arousal, and dominance ratings were in line with expected patterns based on previous emotion research. Moreover, when viewing food pictures, affective and food craving ratings were consistent with research on food cue processing. As a whole, the data supported the methodological and theoretical reliability of the OLAF ratings, therefore providing researchers with a standardized tool to reliably investigate the emotional and motivational significance of food. The OLAF database is publicly available at zenodo.org.	[Miccoli, Laura; Delgado, Rafael; Rodriguez-Ruiz, Sonia; Guerra, Pedro; Carmen Fernandez-Santaella, M.] Univ Granada, Dept Personal, Granada, Spain; [Garcia-Marmol, Eduardo] Univ Granada, Dept Phys Educ & Sports, Granada, Spain	University of Granada; University of Granada	Miccoli, L (corresponding author), Univ Granada, Dept Personal, Granada, Spain.	lauramiccoli@ugr.es	Delgado Rodríguez, Rafael F./L-5176-2018; Guerra, Pedro/ABH-1639-2020; Guerra, Pedro/ABF-1291-2020; Fernández, María Carmen/H-5469-2011; Garcia-Marmol, Eduardo/AAS-7475-2021	Delgado Rodríguez, Rafael F./0000-0003-4971-6643; Guerra, Pedro/0000-0003-0614-629X; Fernández, María Carmen/0000-0001-7094-1138; Garcia-Marmol, Eduardo/0000-0001-9746-6859; Miccoli, Laura/0000-0002-2523-3746	Junta de Andalucia (Spain) [P12.SEJ.391]	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission)	This research was funded by a grant from Junta de Andalucia (Spain) to MCFS (grant code P12.SEJ.391). (http://www.juntadeandalucia.es/servicios/ayudas/detalle/69962.html; Convocatoria 2012. Resolucion de concesion de incentivos para proyectos de investigacion de excelencia (Resoluciones y anexos, zip); ANEXO III DE RESOLUCION PERSONAL-firmada.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Munoz MA, 2010, MOTIV EMOTION, V34, P93, DOI 10.1007/s11031-009-9145-1; [Anonymous], 2004, SOCIAL THEORY HLTH, DOI DOI 10.1057/PALGRAVE.STH.8700030; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Berridge KC, 2009, INQUIRY, V52, P378, DOI 10.1080/00201740903087359; BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Blechert J, 2011, PSYCHOSOM MED, V73, P415, DOI 10.1097/PSY.0b013e318211b871; Blechert J, 2010, APPETITE, V54, P262, DOI 10.1016/j.appet.2009.11.007; Bradley M.M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00493; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cepeda-Benito A, 2000, BEHAV THER, V31, P151, DOI 10.1016/S0005-7894(00)80009-X; Datta R, 2006, LECT NOTES COMPUT SC, V3953, P288, DOI 10.1007/11744078_23; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Echeburua E., 1995, EVALUACION TRATAMIEN; Foroni F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00051; Giel KE, 2011, INT J EAT DISORDER, V44, P105, DOI 10.1002/eat.20785; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Hill AJ, 2007, P NUTR SOC, V66, P277, DOI 10.1017/S0029665107005502; HOLM S, 1979, SCAND J STAT, V6, P65; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Lang P.J., 2008, A8 U FLOR; Mauler BI, 2006, J ABNORM PSYCHOL, V115, P567, DOI 10.1037/0021-843X.115.3.567; McCaffery JM, 2009, AM J CLIN NUTR, V90, P928, DOI 10.3945/ajcn.2009.27924; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; Molto J, 2013, AN PSICOL-SPAIN, V29, P965, DOI 10.6018/analesps.29.3.153591; Munoz MA, 2013, TOB CONTROL, V22, P123, DOI 10.1136/tobaccocontrol-2011-050070; Neumark-Sztainer D, 2009, J ADOLESCENT HEALTH, V44, P206, DOI 10.1016/j.jadohealth.2008.11.005; Nijs IMT, 2012, CURR OBES REP, V1, P106, DOI 10.1007/s13679-012-0011-1; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nijs Ilse M T, 2008, Eat Behav, V9, P462, DOI 10.1016/j.eatbeh.2008.07.009; Ortega-Roldan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102595; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Rodriguez S, 2007, EUR EAT DISORD REV, V15, P231, DOI 10.1002/erv.724; Rodriguez-Ruiz S, 2012, J PSYCHOPHYSIOL, V26, P10, DOI 10.1027/0269-8803/a000064; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Smeets PAM, 2012, P NUTR SOC, V71, P511, DOI 10.1017/S0029665112000808; StaSoft Inc, 2008, STAT DATA ANAL SOFTW; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Stockburger J, 2009, NEUROIMAGE, V47, P1819, DOI 10.1016/j.neuroimage.2009.04.071; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Versace F, 2012, ADDICT BIOL, V17, P991, DOI 10.1111/j.1369-1600.2011.00372.x; Verschuere B, 2001, PSYCHOL BELG, V41, P205; Vila J., 2001, REV PSICOLOG A GEN A, V54, P635, DOI DOI 10.6018/analesps.29.3.153591; World Health Organization, 1986, YOUNG PEOPL HTH CHAL	56	39	39	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114515	10.1371/journal.pone.0114515	http://dx.doi.org/10.1371/journal.pone.0114515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490404	Green Published, gold			2022-12-27	WOS:000347515300048
J	Levin, A; Neufeldt, CJ; Pang, D; Wilson, K; Loewen-Dobler, D; Joyce, MA; Wozniak, RW; Tyrrell, DLJ				Levin, Aviad; Neufeldt, Christopher J.; Pang, Daniel; Wilson, Kristen; Loewen-Dobler, Darci; Joyce, Michael A.; Wozniak, Richard W.; Tyrrell, D. Lorne J.			Functional Characterization of Nuclear Localization and Export Signals in Hepatitis C Virus Proteins and Their Role in the Membranous Web	PLOS ONE			English	Article							RNA REPLICATION; CORE PROTEIN; HIV-1 INTEGRASE; ENTRY; INFECTION; CELLS; DETERMINANTS; RECEPTOR; BIOLOGY; REV	The hepatitis C virus (HCV) is a positive strand RNA virus of the Flavivirus family that replicates in the cytoplasm of infected hepatocytes. Previously, several nuclear localization signals (NLS) and nuclear export signals (NES) have been identified in HCV proteins, however, there is little evidence that these proteins travel into the nucleus during infection. We have recently shown that nuclear pore complex (NPC) proteins (termed nucleoporins or Nups) are present in the membranous web and are required during HCV infection. In this study, we identify a total of 11 NLS and NES sequences in various HCV proteins. We show direct interactions between HCV proteins and importin alpha 5 (IPOA5/kap alpha 1), importin beta 3 (IPO5/kap beta 3), and exportin 1 (XPO1/CRM1) both in-vitro and in cell culture. These interactions can be disrupted using peptides containing the specific NLS or NES sequences of HCV proteins. Moreover, using a synchronized infection system, we show that these peptides inhibit HCV infection during distinct phases of the HCV life cycle. The inhibitory effects of these peptides place them in two groups. The first group binds IPOA5 and inhibits infection during the replication stage of HCV life cycle. The second group binds IPO5 and is active during both early replication and early assembly. This work delineates the entire life cycle of HCV and the active involvement of NLS sequences during HCV replication and assembly. Given the abundance of NLS sequences within HCV proteins, our previous finding that Nups play a role in HCV infection, and the relocation of the NLS double-GFP reporter in HCV infected cells, this work supports our previous hypothesis that NPC-like structures and nuclear transport factors function in the membranous web to create an environment conducive to viral replication.	[Levin, Aviad; Pang, Daniel; Wilson, Kristen; Joyce, Michael A.; Tyrrell, D. Lorne J.] Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Levin, Aviad; Neufeldt, Christopher J.; Wozniak, Richard W.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Levin, A (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	aviad@ualberta.ca; rwozniak@ualberta.ca; lorne.tyrrell@ualberta.ca	Neufeldt, Christopher/AAD-1702-2019	Neufeldt, Christopher/0000-0002-4551-1811	Canadian institute of Health Research [MOP 130404, MOP 106502, MOP 97566]; Alberta Innovates Health Solutions [SIF 200900863]; Li Ka Shing Institute of Virology; Banting Postdoctoral Fellowship Program; AIHS Postdoctoral Fellowship; Alberta Innovates [201201140] Funding Source: researchfish	Canadian institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Li Ka Shing Institute of Virology; Banting Postdoctoral Fellowship Program; AIHS Postdoctoral Fellowship; Alberta Innovates	Funding: Funds for this work were provided by the Canadian institute of Health Research to RWW (MOP 130404 and MOP 106502) and DLJT (MOP 97566) (http://www.cihr-irsc.gc.ca/e/193.html), Alberta Innovates Health Solutions (SIF 200900863) (http://www.aihealthsolutions.ca/), and the Li Ka Shing Institute of Virology (http://likashingvirology.med.ualberta.ca/). AL is supported by the Banting Postdoctoral Fellowship Program, administered by the Government of Canada and by AIHS Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Bird G, 2008, J VIROL, V82, P9848, DOI 10.1128/JVI.01221-08; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cerutti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025854; CHANG SC, 1994, BIOCHEM BIOPH RES CO, V205, P1284, DOI 10.1006/bbrc.1994.2804; Chang SJ, 2007, CLIN CHEM LAB MED, V45, P1219, DOI 10.1515/CCLM.2007.263; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chung KM, 2000, J VIROL, V74, P5233, DOI 10.1128/JVI.74.11.5233-5241.2000; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Germain MA, 2014, MOL CELL PROTEOMICS, V13, P184, DOI 10.1074/mcp.M113.030155; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Huang YP, 2005, WORLD J GASTROENTERO, V11, P4709, DOI 10.3748/wjg.v11.i30.4709; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Joyce MA, 2010, MICROBES INFECT, V12, P263, DOI 10.1016/j.micinf.2009.12.012; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Katta SS, 2014, TRENDS CELL BIOL, V24, P221, DOI 10.1016/j.tcb.2013.10.006; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Levin A, 2010, VIRUS GENES, V40, P341, DOI 10.1007/s11262-010-0458-7; Levin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004155; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Miller DJ, 2003, J VIROL, V77, P12193, DOI 10.1128/JVI.77.22.12193-12202.2003; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Muramatsu S, 1997, J VIROL, V71, P4954, DOI 10.1128/JVI.71.7.4954-4961.1997; Neufeldt CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003744; Overby AK, 2011, VIRULENCE, V2, P238, DOI 10.4161/viru.2.3.16162; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosenbluh J, 2007, J BIOL CHEM, V282, P15743, DOI 10.1074/jbc.M609864200; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Song J, 2000, VIRUS RES, V69, P109, DOI 10.1016/S0168-1702(00)00206-9; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898	81	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114629	10.1371/journal.pone.0114629	http://dx.doi.org/10.1371/journal.pone.0114629			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485706	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600080
J	Liu, J; Fordham, DA; Cooke, BD; Cox, T; Mutze, G; Strive, T				Liu, June; Fordham, Damien A.; Cooke, Brian D.; Cox, Tarnya; Mutze, Greg; Strive, Tanja			Distribution and Prevalence of the Australian Non-Pathogenic Rabbit Calicivirus Is Correlated with Rainfall and Temperature	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; PARTIAL CROSS-PROTECTION; SOUTH-WESTERN AUSTRALIA; RHDV-LIKE VIRUS; WILD RABBITS; ORYCTOLAGUS-CUNICULUS; SEROLOGICAL EVIDENCE; BIOLOGICAL-CONTROL; POPULATIONS; IMPACT	Background: Australia relies heavily on rabbit haemorrhagic disease virus (RHDV) for the biological control of introduced European wild rabbits Oryctolagus cuniculus, which are significant economic and environmental pests. An endemic nonpathogenic rabbit calicivirus termed RCV-A1 also occurs in wild rabbits in Australian and provides partial protection against lethal RHDV infection, thus interfering with effective rabbit control. Despite its obvious importance for rabbit population management, little is known about the epidemiology of this benign rabbit calicivirus. Methods: We determined the continent-wide distribution and prevalence of RCV-A1 by analysing 1,805 serum samples from wild rabbit populations at 78 sites across Australia for the presence of antibodies to RCV-A1 using a serological test that specifically detects RCV-A1 antibodies and does not cross-react with co-occurring RHDV antibodies. We also investigated possible correlation between climate variables and prevalence of RCV-A1 by using generalised linear mixed effect models. Results: Antibodies to RCV-A1 were predominantly detected in rabbit populations in cool, high rainfall areas of the south-east and south-west of the continent. There was strong support for modelling RCV-A1 prevalence as a function of average annual rainfall and minimum temperature. The best ranked model explained 26% of the model structural deviance. According to this model, distribution and prevalence of RCV-A1 is positively correlated with periods of above average rainfall and negatively correlated with periods of drought. Implications: Our statistical model of RCV-A1 prevalence will greatly increase our understanding of RCV-A1 epidemiology and its interaction with RHDV in Australia. By defining the environmental conditions associated with the prevalence of RCV-A1, it also contributes towards understanding the distribution of similar viruses in New Zealand and Europe.	[Liu, June; Strive, Tanja] Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Canberra, ACT 2601, Australia; [Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Fordham, Damien A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Cooke, Brian D.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Liu, June; Cooke, Brian D.; Cox, Tarnya; Strive, Tanja] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia; [Cox, Tarnya] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Orange, NSW 2800, Australia; [Mutze, Greg] Dept Water Land & Biodivers Conservat, Nat Resources Management Biosecur Unit, Adelaide, SA 5001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; University of Adelaide; University of Canberra; University of Canberra; NSW Department of Primary Industries	Strive, T (corresponding author), Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Canberra, ACT 2601, Australia.	tanja.strive@csiro.au	Strive, Tanja/C-1486-2008; Fordham, Damien A/E-9255-2013; Cox, Tarnya/L-8213-2019; Liu, June/C-7871-2009	Fordham, Damien A/0000-0003-2137-5592; Cox, Tarnya/0000-0001-9581-9227; 	Wildlife Pests and Diseases Preparedness Program (WEDPP), Australian Bureau of Agriculture and Resource Economics and Sciences (ABARES) of the Australian Department of Agriculture, Fisheries and Forestry; ARC Linkage Grant [LP12020024]; Super Science Fellowship [FS110200051]	Wildlife Pests and Diseases Preparedness Program (WEDPP), Australian Bureau of Agriculture and Resource Economics and Sciences (ABARES) of the Australian Department of Agriculture, Fisheries and Forestry; ARC Linkage Grant(Australian Research Council); Super Science Fellowship	This project was partially funded by grants from the Wildlife Pests and Diseases Preparedness Program (WEDPP), Australian Bureau of Agriculture and Resource Economics and Sciences (ABARES) of the Australian Department of Agriculture, Fisheries and Forestry. D.A.F. was supported by an ARC Linkage Grant (LP12020024) and Super Science Fellowship (FS110200051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 1998, VIRUS RES, V54, P123, DOI 10.1016/S0168-1702(98)00017-3; Barnes S. L., 1964, J APPL METEOROLOGY, V3, P395; Bates BC, 2008, CLIMATIC CHANGE, V89, P339, DOI 10.1007/s10584-007-9390-9; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowen Z, 1998, WILDLIFE RES, V25, P655, DOI 10.1071/WR98004; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Bruce JS, 2004, WILDLIFE RES, V31, P605, DOI 10.1071/WR04009; Bruce JS, 2004, WILDLIFE RES, V31, P31, DOI 10.1071/WR02069; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Capucci L, 1996, J VIROL, V70, P8614, DOI 10.1128/JVI.70.12.8614-8623.1996; Cooke BD, 2002, WILDLIFE RES, V29, P673, DOI 10.1071/WR00092; Cooke B, 2013, AUST ECON HIST REV, V53, P91, DOI 10.1111/aehr.12000; Cooke BD, 2012, WILDLIFE RES, V39, P279, DOI 10.1071/WR11166; Davison AC, 1997, BOOTSTRAP METHODS TH; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elsworth P, 2014, VIROLOGY, V464, P415, DOI 10.1016/j.virol.2014.06.037; FENNER F, 1953, J HYG-CAMBRIDGE, V51, P225, DOI 10.1017/S0022172400015655; Forrester NL, 2009, VIROLOGY, V393, P42, DOI 10.1016/j.virol.2009.07.008; Fouchet D, 2008, J THEOR BIOL, V250, P593, DOI 10.1016/j.jtbi.2007.10.037; Gall A, 2007, VET MICROBIOL, V120, P17, DOI 10.1016/j.vetmic.2006.10.006; GILBERT N, 1987, AUST WILDLIFE RES, V14, P491; Henzell RP, 2002, WILDLIFE RES, V29, P523, DOI 10.1071/WR00083; Jahnke M, 2010, J VIROL, V84, P12397, DOI 10.1128/JVI.00777-10; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Kovaliski J, 1998, J WILDLIFE DIS, V34, P421, DOI 10.7589/0090-3558-34.3.421; Kovaliski J, 2014, MOL ECOL, V23, P408, DOI 10.1111/mec.12596; Le Gall-Recule G, 2011, VIROLOGY, V410, P395, DOI 10.1016/j.virol.2010.12.001; Lees AC, 2008, MAMMAL REV, V38, P304, DOI 10.1111/j.1365-2907.2008.00116.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lenghaus C, 1994, RABBIT HAEMORRHAGIC, P104; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Liu JE, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-182; Liu JN, 2012, VET MICROBIOL, V157, P345, DOI 10.1016/j.vetmic.2012.01.018; McColl KA, 2002, EPIDEMIOL INFECT, V129, P655, DOI 10.1017/S0950268802007756; McPhee SR, 2010, WILDLIFE RES, V37, P68, DOI 10.1071/WR09103; McPhee SR, 2009, WILDLIFE RES, V36, P447, DOI 10.1071/WR08137; Mutze G, 1998, J WILDLIFE DIS, V34, P221, DOI 10.7589/0090-3558-34.2.221; Mutze G, 2008, LAGOMORPH BIOL EVOLU, P179; Mutze G, 2010, WILDLIFE RES, V37, P311, DOI 10.1071/WR09162; Nagesha HS, 2000, ARCH VIROL, V145, P749, DOI 10.1007/s007050050668; O'Keefe JS, 1999, VET MICROBIOL, V66, P29, DOI 10.1016/S0378-1135(98)00307-1; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson BJ, 2007, WILDLIFE RES, V34, P398, DOI 10.1071/WR06117; Robinson AJ, 2002, WILDLIFE RES, V29, P663, DOI 10.1071/WR00119; Robinson AJ, 2002, WILDLIFE RES, V29, P655, DOI 10.1071/WR00096; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Strive T, 2009, VIROLOGY, V384, P97, DOI 10.1016/j.virol.2008.11.004; Strive T, 2010, VIROLOGY, V398, P125, DOI 10.1016/j.virol.2009.11.045; Strive T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-51	52	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113976	10.1371/journal.pone.0113976	http://dx.doi.org/10.1371/journal.pone.0113976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486092	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600032
J	Shahrin, L; Leung, DT; Matin, N; Pervez, MM; Azim, T; Bardhan, PK; Heffelfinger, JD; Chisti, MJ				Shahrin, Lubaba; Leung, Daniel T.; Matin, Nashaba; Pervez, Mohammed Moshtaq; Azim, Tasnim; Bardhan, Pradip Kumar; Heffelfinger, James D.; Chisti, Mohammod Jobayer			Characteristics and Predictors of Death among Hospitalized HIV-Infected Patients in a Low HIV Prevalence Country: Bangladesh	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; MORTALITY; AIDS; MIGRATION; ADULTS; HEALTH; HAART; MEN	Background: Predictors of death in hospitalized HIV-infected patients have not been previously reported in Bangladesh. Objective: The primary aim of this study was to determine predictors of death among hospitalized HIV-infected patients at a large urban hospital in Bangladesh. Methods: A study was conducted in the HIV in-patient unit (Jagori Ward) of icddr,b's Dhaka Hospital. Characteristics of patients who died during hospitalization were compared to those of patients discharged from the ward. Bivariate analysis was performed to determine associations between potential risk factors and death. Multivariable logistic regression was used to identify factors independently associated with death. Results: Of 293 patients admitted to the Jagori Ward, 57 died during hospitalization. Most hospitalized patients (67%) were male and the median age was 35 (interquartile range: 2-65) years. Overall, 153 (52%) patients were diagnosed with HIV within 6 months of hospitalization. The most common presumptive opportunistic infections (OIs) identified were tuberculosis (32%), oesophageal candidiasis (9%), Pneumocystis jirovecii pneumonia (PJP) (8%), and histoplasmosis (7%). On multivariable analysis, independent predictors of mortality were CD4 count <= 200 cells/mm(3) (adjusted odds ratio [aOR]: 16.6, 95% confidence interval [CI]: 3.7-74.4), PJP (aOR: 18.5, 95% CI: 4.68-73.3), oesophageal candidiasis (aOR: 27.5, 95% CI: 5.5-136.9), malignancy (aOR: 15.2, 95% CI: 2.3-99.4), and bacteriuria (aOR: 7.9, 95% CI: 1.2-50.5). Being on antiretroviral therapy prior to hospitalization (aOR: 0.2, 95% CI: 0.06-0.5) was associated with decreased mortality. Conclusion: This study showed that most patients who died during hospitalization on the Jagori Ward had HIV-related illnesses which could have been averted with earlier diagnosis of HIV and proper management of OIs. It is prudent to develop a national HIV screening programme to facilitate early identification of HIV.	[Shahrin, Lubaba; Pervez, Mohammed Moshtaq; Bardhan, Pradip Kumar; Chisti, Mohammod Jobayer] Dhaka Hosp, Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Shahrin, Lubaba; Pervez, Mohammed Moshtaq; Chisti, Mohammod Jobayer] Int Ctr Diarrheal Dis Res, CNFS, Dhaka, Bangladesh; [Shahrin, Lubaba; Leung, Daniel T.; Pervez, Mohammed Moshtaq; Azim, Tasnim] Int Ctr Diarrheal Dis Res, Ctr HIV AIDS CHIV, Dhaka, Bangladesh; [Leung, Daniel T.] Int Ctr Diarrheal Dis Res, CVS, Dhaka, Bangladesh; [Matin, Nashaba] Royal London Hosp, Barts Hlth NHS Trust, London E1 1BB, England; [Heffelfinger, James D.] Ctr Dis Control & Prevent CDC, Global Dis Detect Branch, Div Global Hlth Promot, Ctr Global Hlth, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); Barts Health NHS Trust; Royal London Hospital; Centers for Disease Control & Prevention - USA	Shahrin, L (corresponding author), Dhaka Hosp, Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.	lubabashahrin@icddrb.org	Chisti, Mohammod J/A-7216-2018; Shahrin, Lubaba/AAF-1019-2020	Shahrin, Lubaba/0000-0002-5676-3280; Leung, Daniel/0000-0001-8401-0801	icddr,b; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI100923] Funding Source: NIH RePORTER	icddr,b; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research protocol was funded by the icddr,b and its donors who provide unrestricted support to this organization for its infrastructure (such as Dhaka Hospital) and research. Current donors providing unrestricted support include the following: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency, Embassy of the Kingdom of Netherlands, Swedish International Development Cooperation Agency, Swiss Agency for Development and Cooperation and Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaba PA, 2011, J INFECT DEV COUNTR, V5, P377, DOI 10.3855/jidc.1096; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Azim T, 2008, INT J STD AIDS, V19, P327, DOI 10.1258/ijsa.2007.007269; Azim T, 2009, 20 YEARS HIV BANGLAD, V2009, P1; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Charles BHEL, 2003, REV HUMAN IMMUNODEFI, P652; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Dhaka Tribune, 2013, WORLD AIDS DAY OBS 3; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; HOEPELMAN AIM, 1992, AIDS, V6, P179, DOI 10.1097/00002030-199202000-00006; International Organization for Migration (IOM), 2013, SIT AN MIGR HIV BANG, P1; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV AS PAC UNAIDS RE; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Mamtaz A, 1999, J Prev Soc Med, V18, P74; Matin N, 2011, J HEALTH POPUL NUTR, V29, P14; Mercer A, 2007, SEX TRANSM DIS, V34, P265, DOI 10.1097/01.olq.0000240384.61924.65; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Pervez MM, 2013, HLTH SCI B, V11, P15; Pinho Ana Maria Felix De, 1994, Genitourinary Medicine, V70, P30; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Sani MU, 2006, J NATL MED ASSOC, V98, P862; Schneider M, 2005, NATURAL HIST MORTALI; UNAIDS, 2021, PREV HIV INF TIM NEW; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; World Bank, 2016, HLTH RISKS PART MATT, P1; World Health Organization, 2013, POCK BOOK HOSP CAR C	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113095	10.1371/journal.pone.0113095	http://dx.doi.org/10.1371/journal.pone.0113095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485634	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600014
J	Ziakas, PD; Zervou, FN; Zacharioudakis, IM; Mylonakis, E				Ziakas, Panayiotis D.; Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios			Graft-Versus-Host Disease Prophylaxis after Transplantation: A Network Meta-Analysis	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC-CELL TRANSPLANTATION; SEVERE APLASTIC-ANEMIA; TRIAL COMPARING CYCLOSPORINE; PROSPECTIVE RANDOMIZED-TRIAL; MYCOPHENOLATE-MOFETIL; GVHD PROPHYLAXIS; UNRELATED DONORS; ANTITHYMOCYTE GLOBULIN; THYMOCYTE GLOBULIN	Background: Graft-versus-host Disease (GvHD) prophylaxis after allogeneic hematopoietic stem-cell transplantation (HSCT) is an ongoing effort but relative effects of different policies are not systematically explored. Methods: We systematically reviewed 30-year evidence on GvHD prophylaxis and quantified the relative effect of different policies using a network meta-analysis. We searched PubMed and the Cochrane Library for randomized studies on the topic. The primary outcome of interest was grade II-IV acute GvHD over 0 or I (with odds ratio OR <1 denoting benefit). Findings: Thirty-three eligible studies that enrolled 3,440 patients (published up to June 2014), provided data on seven immunosuppressive drugs namely cyclosporin A (CsA), methotrexate (MTX), anti-thymocyte globulin (ATG), mycophenolate mofetil (MMF), tacrolimus, sirolimus or corticosteroids and their combinations to calculate 14 direct and 21 indirect effects. The majority of trials (32/33) referred to myeloablative conditioning and sibling transplants (25/33). Tacrolimus/MTX (OR 0.44; 95% 0.27-0.70, number needed to treat to benefit, i.e. to avert a case of II-IV GvHD, NNTB=5) and ATG/CsA/MTX (OR 0.45; 95% CI 0.26-0.78; NNTB=5) were superior over CsA/MTX. ATG/CsA/MTX did not differ from tacrolimus/MTX (indirect evidence). Sirolimus-based prophylaxis outperformed CsA/MTX (OR 0.10; 95% CI 0.02-0.49, NNTB=4) and marginally outperformed tacrolimus/MTX (OR 0.22; 95% CI 0.05-1.11). Add-on corticosteroids had no benefit over CsA/MTX. Conclusions: Tacrolimus/MTX and ATG/CsA/MTX were the outperformers over CsA/MTX, but sirolimus-based regimens showed also potential. More randomized data are needed for reduced-intensity conditioning, as well as for MMF and sirolimus-containing regimens.	[Ziakas, Panayiotis D.; Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	Brown University	Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA.	emylonakis@lifespan.org		Ziakas, Panayiotis/0000-0002-5943-8635	Astellas Pharma	Astellas Pharma(Astellas Pharmaceuticals)	Eleftherios Mylonakis reports grant support by Astellas Pharma for studies unrelated to this report and a previous advisory board participation with the same company. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Eleftherios Mylonakis is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.	ATKINSON K, 1991, AUST NZ J MED, V21, P850, DOI 10.1111/j.1445-5994.1991.tb01406.x; Bacigalupo A, 2005, CURR OPIN HEMATOL, V12, P457, DOI 10.1097/01.moh.0000183726.42063.ec; Bacigalupo A, 2010, BONE MARROW TRANSPL, V45, P385, DOI 10.1038/bmt.2009.151; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; BIGGS JC, 1986, TRANSPLANT P, V18, P253; Bolwell B, 2004, BONE MARROW TRANSPL, V34, P621, DOI 10.1038/sj.bmt.1704647; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Champlin RE, 2007, BLOOD, V109, P4582, DOI 10.1182/blood-2006-10-052308; Chao NJ, 2000, BIOL BLOOD MARROW TR, V6, P254, DOI 10.1016/S1083-8791(00)70007-3; CHAO NJ, 1993, NEW ENGL J MED, V329, P1225, DOI 10.1056/NEJM199310213291703; Chatellier G, 1996, BRIT MED J, V312, P426; Cutler C, 2008, BLOOD, V112, P4425, DOI 10.1182/blood-2008-07-169342; DEEG HJ, 1985, BLOOD, V65, P1325, DOI 10.1182/blood.V65.6.1325.bloodjournal6561325; Deeg HJ, 1997, BLOOD, V89, P3880, DOI 10.1182/blood.V89.10.3880.3880_3880_3887; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dignan FL, 2012, BRIT J HAEMATOL, V158, P30, DOI 10.1111/j.1365-2141.2012.09129.x; DONEY KC, 1981, TRANSPLANTATION, V31, P141, DOI 10.1097/00007890-198102000-00015; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Frassoni F, 1991, Bone Marrow Transplant, V7 Suppl 2, P130; George B, 2012, TRANSPL INFECT DIS, V14, P141, DOI 10.1111/j.1399-3062.2011.00706.x; GRATWOHL A, 1995, BLOOD, V86, P813, DOI 10.1182/blood.V86.2.813.bloodjournal862813; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hadjigeorgiou GM, 2013, J CLIN PHARM THER, V38, P433, DOI 10.1111/jcpt.12090; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hiraoka A, 2001, BONE MARROW TRANSPL, V28, P181, DOI 10.1038/sj.bmt.1703097; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lee KH, 2004, BONE MARROW TRANSPL, V34, P627, DOI 10.1038/sj.bmt.1704624; Locatelli F, 2000, BLOOD, V96, P1690; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P922, DOI 10.1016/j.bbmt.2011.11.010; MRSIC M, 1990, BONE MARROW TRANSPL, V6, P137; Nash RA, 2000, BLOOD, V96, P2062; Niederwieser D, 2003, BLOOD, V101, P1620, DOI 10.1182/blood-2002-05-1340; Omer AK, 2013, BIOL BLOOD MARROW TR, V19, P1190, DOI 10.1016/j.bbmt.2013.05.018; Pasquini Marcelo C, 2010, Clin Transpl, P87; Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Perkins J, 2010, BIOL BLOOD MARROW TR, V16, P937, DOI 10.1016/j.bbmt.2010.01.010; Pidala J, 2012, HAEMATOL-HEMATOL J, V97, P1882, DOI 10.3324/haematol.2012.067140; Pinana JL, 2010, BONE MARROW TRANSPL, V45, P1449, DOI 10.1038/bmt.2009.362; Pulsipher MA, 2014, BLOOD, V123, P2017, DOI 10.1182/blood-2013-10-534297; Ram R, 2009, BONE MARROW TRANSPL, V43, P643, DOI 10.1038/bmt.2008.373; RAMSAY NKC, 1982, NEW ENGL J MED, V306, P392, DOI 10.1056/NEJM198202183060703; Ratanatharathorn V, 1998, BLOOD, V92, P2303; RINGDEN O, 1986, BONE MARROW TRANSPL, V1, P41; Ruutu T, 1998, BONE MARROW TRANSPL, V22, P614, DOI 10.1038/sj.bmt.1701377; Ruutu T, 2000, BLOOD, V96, P2391; Ruutu T, 2014, BONE MARROW TRANSPL, V49, P168, DOI 10.1038/bmt.2013.107; Ruutu T, 2012, BONE MARROW TRANSPL, V47, P1459, DOI 10.1038/bmt.2012.45; Shayani S, 2013, BIOL BLOOD MARROW TR, V19, P298, DOI 10.1016/j.bbmt.2012.10.006; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; STORB R, 1985, BLOOD, V66, P698; STORB R, 1990, BLOOD, V76, P1037; STORB R, 1986, BLOOD, V68, P119; STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; Theurich S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009159.pub2; TORRES A, 1989, BLUT, V58, P63, DOI 10.1007/BF00320650; Van Lint MT, 1998, BLOOD, V92, P2288; Versluis J, 2014, LEUKEMIA; WEAVER CH, 1994, BONE MARROW TRANSPL, V14, P885; WEIDEN PL, 1979, TRANSPLANTATION, V27, P227, DOI 10.1097/00007890-197904000-00003; Ziakas PD, 2014, CLIN THER, V36, P292, DOI 10.1016/j.clinthera.2013.11.010; Zikos P, 1998, BLOOD, V91, P3503, DOI 10.1182/blood.V91.9.3503.3503_3503_3508	69	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114735	10.1371/journal.pone.0114735	http://dx.doi.org/10.1371/journal.pone.0114735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485632	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600092
J	Baig, MH; Sudhakar, DR; Kalaiarasan, P; Subbarao, N; Wadhawa, G; Lohani, M; Khan, MKA; Khan, AU				Baig, Mohd Hassan; Sudhakar, D. Raja; Kalaiarasan, Ponnusamy; Subbarao, Naidu; Wadhawa, Gulshan; Lohani, Mohtashim; Khan, M. Kalim A.; Khan, Asad U.			Insight into the Effect of Inhibitor Resistant S130G Mutant on Physico-Chemical Properties of SHV Type Beta-Lactamase: A Molecular Dynamics Study	PLOS ONE			English	Article							PROTEIN STABILITY; ESCHERICHIA-COLI; CLAVULANIC ACID; TEM-1; CONSEQUENCES; INACTIVATION; COMBINATIONS; PERTURBATION; MUTAGENESIS; TAZOBACTAM	Bacterial resistance is a serious threat to human health. The production of beta-lactamase, which inactivates beta-lactams is most common cause of resistance to the beta-lactam antibiotics. The Class A enzymes are most frequently encountered among the four beta-lactamases in the clinic isolates. Mutations in class A beta-lactamases play a crucial role in substrate and inhibitor specificity. SHV and TEM type are known to be most common class A beta-lactamases. In the present study, we have analyzed the effect of inhibitor resistant S130G point mutation of SHV type Class-A beta-lactamase using molecular dynamics and other in silico approaches. Our study involved the use of different in silico methods to investigate the affect of S130G point mutation on the major physico-chemical properties of SHV type class A beta-lactamase. We have used molecular dynamics approach to compare the dynamic behaviour of native and S130G mutant form of SHV beta-lactamase by analyzing different properties like root mean square deviation (RMSD), H-bond, Radius of gyration (Rg) and RMS fluctuation of mutation. The results clearly suggest notable loss in the stability of S130G mutant that may further lead to decrease in substrate specificity of SHV. Molecular docking further indicates that S130G mutation decreases the binding affinity of all the three inhibitors in clinical practice.	[Baig, Mohd Hassan; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Baig, Mohd Hassan; Lohani, Mohtashim; Khan, M. Kalim A.] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India; [Sudhakar, D. Raja; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Kalaiarasan, Ponnusamy] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Wadhawa, Gulshan] Govt India, Dept Biotechnol, New Delhi, India	Aligarh Muslim University; Integral University; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Subbarao, Prof Naidu/AAZ-1832-2020; Khan, Asad U/K-8157-2013; Lohani, Mohtashim/AAR-3394-2021; Ahmad Khan, Mohammad Kalim/AAA-2751-2022	Subbarao, Prof Naidu/0000-0002-1720-2165; Khan, Asad U/0000-0001-9191-9423; Ahmad Khan, Mohammad Kalim/0000-0002-8004-1448; Lohani, Mohtashim/0000-0001-9414-4539; Baig, Mohd Hassan/0000-0001-8227-4838	Department of Biotechnology [BT/PR11610/BRB/10/669/2008, BT/PR11453/BID/07/296/2009]; Indian Council of Medical Research, New Delhi, India [BIC/11(06)/2013]	Department of Biotechnology; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by Department of Biotechnology, grants no. BT/PR11610/BRB/10/669/2008 and BT/PR11453/BID/07/296/2009 to AUK. Indian Council of Medical Research, New Delhi, India provided a Senior Research Fellowship to Mohd Hassan Baig (BIC/11(06)/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasov BP, 2000, P NATL ACAD SCI USA, V97, P3160, DOI 10.1073/pnas.060027897; Aumeran C, 2003, ANTIMICROB AGENTS CH, V47, P2958, DOI 10.1128/AAC.47.9.2958-2961.2003; Baig MH, 2012, BIOINFORMATION, V8, P1225, DOI 10.6026/97320630081225; Barry GH, 2005, J ANTIMICROB CHEMOTH, V55, P1050; BUSH K, 1988, Clinical Microbiology Reviews, V1, P109; Buynak JD, 2006, BIOCHEM PHARMACOL, V71, P930, DOI 10.1016/j.bcp.2005.11.012; Danishuddin Mohd, 2011, In Silico Biology, V11, P273, DOI 10.3233/ISB-2012-0443; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Gong SS, 2009, BIOCHEM SOC T, V37, P727, DOI 10.1042/BST0370727; Helfand MS, 2005, CURR OPIN PHARMACOL, V5, P452, DOI 10.1016/j.coph.2005.04.013; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; IMTIAZ U, 1994, BIOCHEMISTRY-US, V33, P5728, DOI 10.1021/bi00185a009; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kumar KR, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/151273; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; Lee N, 2003, DRUGS, V63, P1511, DOI 10.2165/00003495-200363140-00006; Leflon-Guibout W, 2002, J ANTIMICROB CHEMOTH, V49, P367, DOI 10.1093/jac/49.2.367; Meroueh SO, 2002, J AM CHEM SOC, V124, P9422, DOI 10.1021/ja026547q; Nisius L, 2012, NAT CHEM, V4, P711, DOI [10.1038/NCHEM.1396, 10.1038/nchem.1396]; Page MGF, 2000, DRUG RESIST UPDATE, V3, P109, DOI 10.1054/drup.2000.0137; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Ripoll A, 2011, ANTIMICROB AGENTS CH, V55, P4530, DOI 10.1128/AAC.00178-11; SANDERS CC, 1988, ANTIMICROB AGENTS CH, V32, P1365, DOI 10.1128/AAC.32.9.1365; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Thomas VL, 2005, BIOCHEMISTRY-US, V44, P9330, DOI 10.1021/bi0502700; Vakulenko SB, 1998, ANTIMICROB AGENTS CH, V42, P1542, DOI 10.1128/AAC.42.7.1542; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang L, 1998, PROTEINS, V32, P438, DOI 10.1002/(SICI)1097-0134(19980901)32:4<438::AID-PROT4>3.0.CO;2-C; Wang XJ, 2002, J BIOL CHEM, V277, P32149, DOI 10.1074/jbc.M204212200; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Williams JD, 1999, INT J ANTIMICROB AG, V12, pS3, DOI 10.1016/S0924-8579(99)00085-0	37	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112456	10.1371/journal.pone.0112456	http://dx.doi.org/10.1371/journal.pone.0112456			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479359	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200010
J	McKinney, GJ; Varian, A; Scardina, J; Nichols, KM				McKinney, Garrett J.; Varian, Anna; Scardina, Julie; Nichols, Krista M.			Genetic and Morphological Divergence in Three Strains of Brook Trout Salvelinus fontinalis Commonly Stocked in Lake Superior	PLOS ONE			English	Article							NATURAL-SELECTION; LOCAL ADAPTATION; LIFE-HISTORY; NIPIGON BAY; HABITAT USE; CHARR; POPULATIONS; EVOLUTION; TRAITS; WILD	Fitness related traits often show spatial variation across populations of widely distributed species. Comparisons of genetic variation among populations in putatively neutral DNA markers and in phenotypic traits susceptible to selection (Q(ST) F-ST analysis) can be used to determine to what degree differentiation among populations can be attributed to selection or genetic drift. Traditionally, Q(ST) F-ST analyses require a large number of populations to achieve sufficient statistical power; however, new methods have been developed that allow Q(ST) F-ST comparisons to be conducted on as few as two populations if their pedigrees are informative. This study compared genetic and morphological divergence in three strains of brook trout Salvelinus fontinalis that were historically or currently used for stocking in the Lake Superior Basin. Herein we examined if morphological divergence among populations showed temporal variation, and if divergence could be attributed to selection or was indistinguishable from genetic drift. Multivariate Q(ST) F-ST analysis showed evidence for divergent selection between populations. Univariate analyses suggests that the pattern observed in the multivariate analyses was largely driven by divergent selection for length and weight, and moreover by divergence between the Assinica strain and each of the Iron River and Siskiwit strains rather than divergent selection between each population pair. While it could not be determined if divergence was due to natural selection or inadvertent artificial selection in hatcheries, selected differences were consistent with patterns of domestication commonly found in salmonids.	[McKinney, Garrett J.; Scardina, Julie; Nichols, Krista M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Varian, Anna] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nichols, KM (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.	krista.nichols@noaa.gov			Purdue University	Purdue University	Funding was provided by Purdue University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 1995, J FISH BIOL, V47, P177, DOI 10.1111/j.1095-8649.1995.tb06054.x; Boula D, 2002, ENVIRON BIOL FISH, V64, P229, DOI 10.1023/A:1016054119783; Bourke P, 1997, J FISH BIOL, V51, P783, DOI 10.1111/j.1095-8649.1997.tb01999.x; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; COCKERHAM CC, 1973, GENETICS, V74, P679; Cooper AM, 2010, CONSERV GENET, V11, P1087, DOI 10.1007/s10592-009-9841-0; D'Amelio S, 2008, N AM J FISH MANAGE, V28, P1343, DOI 10.1577/M05-193.1; D'Amelio S, 2008, T AM FISH SOC, V137, P1213, DOI 10.1577/T05-275.1; FLICK WA, 1977, NAT CAN, V104, P353; Fraser DJ, 2005, EVOLUTION, V59, P611; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HOAR WS, 1976, J FISH RES BOARD CAN, V33, P1233, DOI 10.1139/f76-158; Huckins CJ, 2008, N AM J FISH MANAGE, V28, P1321, DOI 10.1577/M05-191.1; Huckins CJ, 2008, T AM FISH SOC, V137, P1229, DOI 10.1577/T05-274.1; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Karhunen M, 2013, MOL ECOL RESOUR, V13, P746, DOI 10.1111/1755-0998.12111; KARHUNEN M, 2013, RAFM REFERENCE MANUA; Kostow KE, 2003, T AM FISH SOC, V132, P780, DOI 10.1577/T02-051; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LEIDER SA, 1990, AQUACULTURE, V88, P239, DOI 10.1016/0044-8486(90)90151-C; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leonard JBK, 2013, N AM J FISH MANAGE, V33, P359, DOI 10.1080/02755947.2012.754801; Mavarez J, 2009, J EVOLUTION BIOL, V22, P1708, DOI 10.1111/j.1420-9101.2009.01785.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Mucha JM, 2008, T AM FISH SOC, V137, P1203, DOI 10.1577/T05-273.1; MUCHA JM, 2003, THESIS; Newman L.E., 2003, GREAT LAKES FISHERY; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Ovaskainen O, 2011, GENETICS, V189, P621, DOI 10.1534/genetics.111.129387; PLUMMER M, 2012, CODA REFERENCE MANUA; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; Rohlf FJ, 2007, TPSRELW RELATIVE WAR; Seamons TR, 2012, EVOL APPL, V5, P705, DOI 10.1111/j.1752-4571.2012.00247.x; Sutton TM, 2002, N AM J AQUACULT, V64, P188, DOI 10.1577/1548-8454(2002)064&lt;0188:HPAONA&gt;2.0.CO;2; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Theriault V, 2003, J FISH BIOL, V63, P1144, DOI 10.1046/j.1095-8649.2003.00233.x; Van Offelen Henry K., 1993, North American Journal of Fisheries Management, V13, P86, DOI 10.1577/1548-8675(1993)013<0086:SGMADO>2.3.CO;2; Varian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012950; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Wilson CC, 2008, N AM J FISH MANAGE, V28, P1307, DOI 10.1577/M05-190.1; Wright S, 1931, GENETICS, V16, P0097	45	9	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113809	10.1371/journal.pone.0113809	http://dx.doi.org/10.1371/journal.pone.0113809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479612	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200031
J	Pandith, AH; Islam, N				Pandith, Altaf Hussain; Islam, Nasarul			Electron Transport and Nonlinear Optical Properties of Substituted Aryldimesityl Boranes: A DFT Study	PLOS ONE			English	Article							AMORPHOUS MOLECULAR MATERIALS; OXIDATION-REDUCTION REACTIONS; BAND-STRUCTURE; HYPERPOLARIZABILITIES; STATE; POLYMERIZATION; APPROXIMATION; CHEMOSENSOR; COPOLYMERS; OLIGOMERS	A comprehensive theoretical study was carried out on a series of aryldimesityl borane (DMB) derivatives using Density Functional theory. Optimized geometries and electronic parameters like electron affinity, reorganization energy, frontiers molecular contours, polarizability and hyperpolarizability have been calculated by employing B3PW91/6-311++G (d, p) level of theory. Our results show that the Hammett function and geometrical parameters correlates well with the reorganization energies and hyperpolarizability for the series of DMB derivatives studied in this work. The orbital energy study reveals that the electron releasing substituents increase the LUMO energies and electron withdrawing substituents decrease the LUMO energies, reflecting the electron transport character of aryldimesityl borane derivatives. From frontier molecular orbitals diagram it is evident that mesityl rings act as the donor, while the phenylene and Boron atom appear as acceptors in these systems. The calculated hyperpolarizability of secondary amine derivative of DMB is 40 times higher than DMB (1). The electronic excitation contributions to the hyperpolarizability studied by using TDDFT calculation shows that hyperpolarizability correlates well with dipole moment in ground and excited state and excitation energy in terms of the two-level model. Thus the results of these calculations can be helpful in designing the DMB derivatives for efficient electron transport and nonlinear optical material by appropriate substitution with electron releasing or withdrawing substituents on phenyl ring of DMB system.	[Pandith, Altaf Hussain; Islam, Nasarul] Univ Kashmir, Dept Chem, Srinagar 190006, Kashmir, India	University of Kashmir	Pandith, AH (corresponding author), Univ Kashmir, Dept Chem, Srinagar 190006, Kashmir, India.	altafpandit23@gmail.com	Islam, Nasarul/I-3442-2012	Islam, Nasarul/0000-0002-5719-0795; Pandith, Altaf/0000-0002-2601-5580				Bauernschmitt R, 1996, CHEM PHYS LETT, V256, P454, DOI 10.1016/0009-2614(96)00440-X; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Chen EYX, 2000, CHEM REV, V100, P1391, DOI 10.1021/cr980462j; Cheng YC, 2003, J CHEM PHYS, V118, P3764, DOI 10.1063/1.1539090; Dagani R, 1996, CHEM ENG NEWS, V74, P22, DOI 10.1021/cen-v074n004.p022; Datta A, 2006, CHEM SOC REV, V35, P1305, DOI 10.1039/b605478a; Doi H, 2003, CHEM MATER, V15, P1080, DOI 10.1021/cm020948n; Entwistle CD, 2004, CHEM MATER, V16, P4574, DOI 10.1021/cm0495717; Entwistle CD, 2002, ANGEW CHEM INT EDIT, V41, P2927, DOI 10.1002/1521-3773(20020816)41:16<2927::AID-ANIE2927>3.0.CO;2-L; Erker G, 2005, DALTON T, P1883, DOI 10.1039/b503688g; Ervin KM, 2003, J PHYS CHEM A, V107, P8521, DOI 10.1021/jp0357323; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fu YW, 2008, MACROMOL THEOR SIMUL, V17, P385, DOI 10.1002/mats.200800041; Gao HZ, 2011, J PHYS CHEM A, V115, P9259, DOI 10.1021/jp202976m; Garcia G, 2011, J PHYS CHEM C, V115, P6922, DOI 10.1021/jp112165r; GLOGOWSKI ME, 1981, J ORGANOMET CHEM, V218, P137, DOI 10.1016/S0022-328X(00)86094-5; Huh JO, 2010, CHEM COMMUN, V46, P1138, DOI 10.1039/b918263b; Islam N, 2014, SPECTROCHIM ACTA A, V131, P461, DOI 10.1016/j.saa.2014.04.089; Jakle F, 2006, COORDIN CHEM REV, V250, P1107, DOI 10.1016/j.ccr.2006.01.007; Jia WL, 2004, CHEM-EUR J, V10, P994, DOI 10.1002/chem.200305579; KANIS DR, 1992, J AM CHEM SOC, V114, P10338, DOI 10.1021/ja00052a035; Kinoshita M, 2002, ADV FUNCT MATER, V12, P780, DOI 10.1002/adfm.200290007; Kubo Y, 2003, ANGEW CHEM INT EDIT, V42, P2036, DOI 10.1002/anie.200250788; Lam ST, 2009, INORG CHEM, V48, P9664, DOI 10.1021/ic900803a; Leffler JE., 1989, RATES EQUILIBRIA ORG; Lewis G. N., 1923, VALENCE STRUCTURE AT; Li X, 2012, CHINESE SCI BULL, V57, P1772, DOI 10.1007/s11434-012-5059-5; Lin BC, 2005, J AM CHEM SOC, V127, P66, DOI 10.1021/ja045087t; Lin BC, 2003, J PHYS CHEM A, V107, P5241, DOI 10.1021/jp0304529; Lindsay GA, 1995, POLYM 2 ORDER NONLIN; Liu CG, 2009, INORG CHEM, V48, P6548, DOI 10.1021/ic9004906; Liu Y, 2009, INORG CHEM, V48, P10018, DOI 10.1021/ic9002675; MARCUS RA, 1957, J CHEM PHYS, V26, P872, DOI 10.1063/1.1743424; MARCUS RA, 1957, J CHEM PHYS, V26, P867, DOI 10.1063/1.1743423; Matsumi N, 1999, MACROMOLECULES, V32, P4467, DOI 10.1021/ma980785h; Naka S, 2000, SYNTHETIC MET, V111, P331, DOI 10.1016/S0379-6779(99)00358-6; Noda T, 2000, J LUMIN, V87-9, P1168, DOI 10.1016/S0022-2313(99)00583-9; OUDAR JL, 1977, J CHEM PHYS, V66, P2664, DOI 10.1063/1.434213; Parab K, 2006, J AM CHEM SOC, V128, P12879, DOI 10.1021/ja063302v; Parisel O, 1996, CHEM PHYS LETT, V250, P178, DOI 10.1016/0009-2614(96)00016-4; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Persoons A, 2011, OPT MATER EXPRESS, V1, P5, DOI 10.1364/OME.1.000005; Piers WE, 2005, ADV ORGANOMET CHEM, V52, P1, DOI 10.1016/S0065-3055(04)52001-4; Qin Y, 2005, MACROMOLECULES, V38, P8987, DOI 10.1021/ma051615p; Qin Y, 2002, J AM CHEM SOC, V124, P12672, DOI 10.1021/ja020773i; Sakuda E, 2005, J PHYS CHEM B, V109, P22326, DOI 10.1021/jp054601u; Sakuda E, 2010, J PHYS CHEM A, V114, P9144, DOI 10.1021/jp1057463; Shirota Y, 2000, J AM CHEM SOC, V122, P11021, DOI 10.1021/ja0023332; Spassova M, 2007, CHEM PHYS LETT, V439, P213, DOI 10.1016/j.cplett.2007.03.055; Sun Y, 2010, INORG CHEM, V49, P4394, DOI 10.1021/ic1004159; Sundaraganesan N, 2009, SPECTROCHIM ACTA A, V73, P11, DOI 10.1016/j.saa.2009.01.007; Uchida M, 2001, J PHOTOPOLYM SCI TEC, V4, P301; ULMAN A, 1988, J PHYS CHEM-US, V92, P2385, DOI 10.1021/j100319a056; Yamada T, 2011, ORG ELECTRON, V12, P169, DOI 10.1016/j.orgel.2010.10.022; Yamada T, 2010, ORG ELECTRON, V11, P255, DOI 10.1016/j.orgel.2009.11.003; Yamaguchi S, 2001, J AM CHEM SOC, V123, P11372, DOI 10.1021/ja015957w; Yang YT, 2006, J PHYS CHEM B, V110, P3180, DOI 10.1021/jp0540252; Zhang R, 2010, SPECTROCHIM ACTA A, V75, P1115, DOI 10.1016/j.saa.2009.12.067; Zhao Q, 2008, INORG CHEM, V47, P9256, DOI 10.1021/ic800500c	59	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114125	10.1371/journal.pone.0114125	http://dx.doi.org/10.1371/journal.pone.0114125			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479382	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200044
J	Gan, M; Jiang, PZ; McLean, P; Kanekiyo, T; Bu, GJ				Gan, Ming; Jiang, Peizhou; McLean, Pamela; Kanekiyo, Takahisa; Bu, Guojun			Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Regulates the Stability and Function of GluA1 alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor in Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; AMYLOID-BETA; GLUTAMATE RECEPTORS; PLASMINOGEN-ACTIVATOR; PHOSPHORYLATION SITES; MEDIATED ENDOCYTOSIS; PKA PHOSPHORYLATION; HIPPOCAMPAL-NEURONS	The low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor abundantly expressed in neurons. Increasing evidence demonstrates that LRP1 regulates synaptic integrity and function at the post synapses, at least partially by regulating glutamate receptors. The alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) are critical ionotropic glutamate receptors consisting of homotetramer or heterotetramer of GluA1-4 subunits and play an essential role in synaptic transmission and synaptic plasticity. Our previous work has shown that neuronal deletion of the Lrp1 gene in mice leads to decreased level of GluA1 and reduced long-term potentiation. To understand the underlying mechanism, we investigated the cellular and functional consequences of LRP1 deletion in primary neurons. Here, we show that LRP1 interacts with and regulates the cellular distribution and turnover of GluA1. LRP1 knockdown in mouse primary neurons led to accelerated turnover and decreased cell surface distribution of GluA1, which correspond to decreased phosphorylation of GluA1 at S845 and S831 sites. Decreased LRP1 expression also attenuated AMPA-evoked calcium influx and reduced GluA1-regulated neurite outgrowth and filopodia density. Our results reveal a novel mechanism by which LRP1 controls synaptic integrity and function, specifically by regulating GluA1 trafficking, phosphorylation and turnover. They further demonstrate that LRP1-GluA1 pathway may hold promises as a therapeutic target for restoring synaptic functions in neurodegenerative diseases.	[Gan, Ming; Jiang, Peizhou; McLean, Pamela; Kanekiyo, Takahisa; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Mayo Clinic; Xiamen University	Kanekiyo, T (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	kanekiyo.takahisa@mayo.edu; bu.guojun@mayo.edu		McLean, Pamela/0000-0003-4870-5715	NIH [R01AG035355, R01AG027924, R01AG046205, P01AG030128, P01NS074969]; Cure Alzheimer's Fund; Alzheimer's Association NIRG; Mayo Clinic CRM Career Developmental Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046205, P01AG030128, RF1AG046205, R01AG027924, R01AG035355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Alzheimer's Association NIRG; Mayo Clinic CRM Career Developmental Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH (http://grants.nih.gov/grants/oer.htm) grants R01AG035355 (GB), R01AG027924 (GB), R01AG046205(GB), P01AG030128 (GB), P01NS074969 (GB), a grant from the Cure Alzheimer's Fund (http://www.curealzfund.org/) (GB), and Alzheimer's Association NIRG and Mayo Clinic CRM Career Developmental Award (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; BU GJ, 1994, J BIOL CHEM, V269, P18521; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chen W, 2009, NEUROSCIENCE, V159, P172, DOI 10.1016/j.neuroscience.2008.11.038; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coutinho-Budd J, 2012, J CELL SCI, V125, P3390, DOI 10.1242/jcs.098962; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gendron TF, 2004, EUR J PHARMACOL, V493, P45, DOI 10.1016/j.ejphar.2004.04.026; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kawata K, 2012, J CELL SCI, V125, P2965, DOI 10.1242/jcs.101956; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001; Lin CH, 2012, J NEUROSCI, V32, P1826, DOI 10.1523/JNEUROSCI.3380-11.2012; Liu QA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000575; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Maier W, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-25; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Metzger F, 1998, J NEUROSCI, V18, P1735; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364; Prithviraj R, 2008, DEV NEUROBIOL, V68, P247, DOI 10.1002/dneu.20590; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sans N, 2003, J NEUROSCI, V23, P9367; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Stein V, 2003, J NEUROSCI, V23, P5503; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valastro B, 2001, NEUROBIOL AGING, V22, P9, DOI 10.1016/S0197-4580(00)00177-9; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhang C, 2008, PROG NEURO-PSYCHOPH, V32, P62, DOI 10.1016/j.pnpbp.2007.07.009; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	68	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113237	10.1371/journal.pone.0113237	http://dx.doi.org/10.1371/journal.pone.0113237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500815	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400007
J	Wang, Y; Nelissen, N; Adamczuk, K; De Weer, AS; Vandenbulcke, M; Sunaert, S; Vandenberghe, R; Dupont, P				Wang, Yu; Nelissen, Natalie; Adamczuk, Katarzyna; De Weer, An-Sofie; Vandenbulcke, Mathieu; Sunaert, Stefan; Vandenberghe, Rik; Dupont, Patrick			Reproducibility and Robustness of Graph Measures of the Associative-Semantic Network	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL BRAIN NETWORKS; SMALL-WORLD; TOPOLOGICAL PATTERNS; THEORETICAL ANALYSIS; CORTICAL THICKNESS; ORGANIZATION; SYSTEM; WORDS	Graph analysis is a promising tool to quantify brain connectivity. However, an essential requirement is that the graph measures are reproducible and robust. We have studied the reproducibility and robustness of various graph measures in group based and in individual binary and weighted networks derived from a task fMRI experiment during explicit associative-semantic processing of words and pictures. The nodes of the network were defined using an independent study and the connectivity was based on the partial correlation of the time series between any pair of nodes. The results showed that in case of binary networks, global graph measures exhibit a good reproducibility and robustness for networks which are not too sparse and these figures of merit depend on the graph measure and on the density of the network. Furthermore, group based binary networks should be derived from groups of sufficient size and the lower the density the more subjects are required to obtain robust values. Local graph measures are very variable in terms of reproducibility and should be interpreted with care. For weighted networks, we found good reproducibility (average test-retest variability <5% and ICC values >0.4) when using subject specific networks and this will allow us to relate network properties to individual subject information.	[Wang, Yu; Nelissen, Natalie; Adamczuk, Katarzyna; De Weer, An-Sofie; Vandenberghe, Rik; Dupont, Patrick] Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium; [Vandenberghe, Rik] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Vandenbulcke, Mathieu] Univ Hosp Leuven, Dept Psychiat, Leuven, Belgium; [Sunaert, Stefan; Dupont, Patrick] Univ Leuven, MIRC, Leuven, Belgium; [Sunaert, Stefan; Dupont, Patrick] Univ Hosp Leuven, Leuven, Belgium; [Sunaert, Stefan] Univ Hosp Leuven, Dept Radiol, Leuven, Belgium; [Vandenbulcke, Mathieu; Sunaert, Stefan; Vandenberghe, Rik; Dupont, Patrick] Alzheimer Res Ctr KU Leuven, Leuven Inst Neurosci & Dis, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Dupont, P (corresponding author), Katholieke Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium.	patrick.dupont@med.kuleuven.be	Vandenberghe, Rik/K-2145-2014; Dupont, Patrick/B-8044-2009; Vandenberghe, Rik/AAR-7485-2020; Sunaert, Stefan/E-8031-2011	Vandenberghe, Rik/0000-0001-6237-2502; Dupont, Patrick/0000-0003-1980-2540; Vandenberghe, Rik/0000-0001-6237-2502; Sunaert, Stefan/0000-0002-1177-4680	Research Foundation Flanders (FWO) [G0660.09, G0A0913N]; KU Leuven [OT/12/097]; Federaal Wetenschapsbeleid belspo [IAP-VII P7/11]; Stichting voor Alzheimer Onderzoek [SAO11020, 13007]; Chinese Scholarship Council	Research Foundation Flanders (FWO)(FWO); KU Leuven(KU Leuven); Federaal Wetenschapsbeleid belspo; Stichting voor Alzheimer Onderzoek; Chinese Scholarship Council(China Scholarship Council)	This work was supported by Research Foundation Flanders (FWO) [G0660.09 & G0A0913N to RV and PD], KU Leuven [OT/12/097 to RV and PD], Federaal Wetenschapsbeleid belspo [IAP-VII P7/11] and Stichting voor Alzheimer Onderzoek (SAO11020 & 13007). YW has a grant from the Chinese Scholarship Council, KA is a doctoral fellow of the FWO and RV is a senior clinical investigator of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adamczuk K, 2013, NEUROIMAGE-CLIN, V2, P512, DOI 10.1016/j.nicl.2013.04.001; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barnes Kelly Anne, 2012, Cereb Cortex, V22, P1148, DOI 10.1093/cercor/bhr189; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Dupont P., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Faria AV, 2012, NEUROIMAGE, V61, P613, DOI 10.1016/j.neuroimage.2012.03.078; Finn J. D., 1974, GEN MODEL MULTIVARIA, P182; Fornito A, 2015, CURRENT OPINION NEUR, V30, P44; Goldberg RF, 2007, J NEUROSCI, V27, P3790, DOI 10.1523/JNEUROSCI.2381-06.2007; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hosseini SMH, 2013, NEUROIMAGE, V71, P260, DOI 10.1016/j.neuroimage.2013.01.013; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Li H, 2014, HUM BRAIN MAPP, V35, P396, DOI 10.1002/hbm.22185; Li LC, 2012, NEUROIMAGE, V61, P1017, DOI 10.1016/j.neuroimage.2012.03.071; Liu JX, 2013, EXP NEUROL, V248, P196, DOI 10.1016/j.expneurol.2013.04.012; Ma S, 2012, NEUROIMAGE, V62, P1694, DOI 10.1016/j.neuroimage.2012.05.048; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Moussa MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044428; Nelissen N, 2007, BRAIN, V130, P2055, DOI 10.1093/brain/awm133; Nelissen N, 2011, J MOL NEUROSCI, V45, P637, DOI 10.1007/s12031-011-9603-6; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Niu HJ, 2014, NEUROSCIENTIST, V20, P173, DOI 10.1177/1073858413502707; Niu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072425; Owen JP, 2013, BRAIN CONNECT, V3, P160, DOI 10.1089/brain.2012.0121; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Seghier ML, 2011, J NEUROSCI, V31, P14745, DOI 10.1523/JNEUROSCI.2238-11.2011; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081388; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Steen M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016111; Stifanelli PF, 2013, J BIOMED INFORM, V46, P894, DOI 10.1016/j.jbi.2013.07.002; Telesford QK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00067; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Van Doren L, 2010, NEUROIMAGE, V49, P3295, DOI 10.1016/j.neuroimage.2009.12.005; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Vandenberghe R, 2013, BRAIN LANG, V127, P264, DOI 10.1016/j.bandl.2012.09.005; Vandenbulcke M, 2007, CEREB CORTEX, V17, P542, DOI 10.1093/cercor/bhj179; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Weber MJ, 2013, COGN AFFECT BEHAV NE, V13, P627, DOI 10.3758/s13415-013-0181-7; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Wu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073670; Wylie KP, 2012, NEUROIMAGE, V63, P73, DOI 10.1016/j.neuroimage.2012.06.079; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001	72	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115215	10.1371/journal.pone.0115215	http://dx.doi.org/10.1371/journal.pone.0115215			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500823	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400084
J	Kasper, E; Schuster, C; Machts, J; Kaufmann, J; Bittner, D; Vielhaber, S; Benecke, R; Teipel, S; Prudlo, J				Kasper, Elisabeth; Schuster, Christina; Machts, Judith; Kaufmann, Joern; Bittner, Daniel; Vielhaber, Stefan; Benecke, Reiner; Teipel, Stefan; Prudlo, Johannes			Microstructural White Matter Changes Underlying Cognitive and Behavioural Impairment in ALS - An In Vivo Study Using DTI	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DIFFUSION-TENSOR MRI; VERBAL FLUENCY; TRACT DAMAGE; RETRIEVAL; CRITERIA; MEMORY; NEURODEGENERATION; TRACTOGRAPHY; DYSFUNCTION	Background: A relevant fraction of patients with amyotrophic lateral sclerosis (ALS) exhibit a fronto-temporal pattern of cognitive and behavioural disturbances with pronounced deficits in executive functioning and cognitive control of behaviour. Structural imaging shows a decline in fronto-temporal brain areas, but most brain imaging studies did not evaluate cognitive status. We investigated microstructural white matter changes underlying cognitive impairment using diffusion tensor imaging (DTI) in a large cohort of ALS patients. Methods: We assessed 72 non-demented ALS patients and 65 matched healthy control subjects using a comprehensive neuropsychological test battery and DTI. We compared DTI measures of fiber tract integrity using tract-based spatial statistics among ALS patients with and without cognitive impairment and healthy controls. Neuropsychological performance and behavioural measures were correlated with DTI measures. Results: Patients without cognitive impairment demonstrated white matter changes predominantly in motor tracts, including the corticospinal tract and the body of corpus callosum. Those with impairments (ca. 30%) additionally presented significant white matter alterations in extra-motor regions, particularly the frontal lobe. Executive and memory performance and behavioural measures were correlated with fiber tract integrity in large association tracts. Conclusion: In non-demented cognitively impaired ALS patients, white matter changes measured by DTI are related to disturbances of executive and memory functions, including prefrontal and temporal regions. In a group comparison, DTI is able to observe differences between cognitively unimpaired and impaired ALS patients.	[Kasper, Elisabeth; Teipel, Stefan] Univ Rostock, Dept Psychosomat Med, D-18055 Rostock, Germany; [Schuster, Christina; Teipel, Stefan; Prudlo, Johannes] DZNE German Ctr Neurodegenerat Dis, Rostock, Germany; [Machts, Judith; Vielhaber, Stefan] DZNE German Ctr Neurodegenerat Dis, Magdeburg, Germany; [Kaufmann, Joern; Bittner, Daniel; Vielhaber, Stefan] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Benecke, Reiner; Prudlo, Johannes] Univ Rostock, Dept Neurol, D-18055 Rostock, Germany	University of Rostock; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University; University of Rostock	Kasper, E (corresponding author), Univ Rostock, Dept Psychosomat Med, D-18055 Rostock, Germany.	elisabeth.kasper@med.uni-rostock.de	Machts, Judith/J-2508-2019	Machts, Judith/0000-0002-8660-095X				Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; [Anonymous], 1992, WST WORTSCHATZTEST; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Barbagallo G, 2014, NEUROL SCI, V35, P911, DOI 10.1007/s10072-013-1626-z; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Baumler G., 1985, FARB WORT INTERFEREN; Bede P, 2012, J NEUROLOGY NEUROSUR; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Christidi F, 2013, BRAIN IMAGING BEHAV, P1; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Foerster BR, 2013, 25 YEARS NEUROIMAGIN; Glindmann R, 2002, BOGENHAUSENER SEMANT; Goldstein LH, 2011, J NEUROL, V258, P2186, DOI 10.1007/s00415-011-6088-8; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grace J, 2002, FRONTAL SYSTEMS BEHA; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Helmstaedter C, 2001, VERBALER VEM MERKFAH; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kohler J, 2003, PLANUNGSTEST PT; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Lange K.W., 2000, RWT REGENSBURGER WOR; Laun FB, 2009, MAGN RESON IMAGING, V27, P541, DOI 10.1016/j.mri.2008.08.011; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Mantovan MC, 2003, EUR J NEUROL, V10, P221, DOI 10.1046/j.1468-1331.2003.00607.x; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mioshi E, 2013, NEUROLOGY; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niemann H., 2008, CVLT CALIFORNIA VERB; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pettit L, 2013, J NEUROL NEUROSUR PS, V84, pe1; Pettit LD, 2013, BRAIN; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Radiology ACo, 2005, PHANT TEST GUID ACR; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Schuster C, NEUROBIOLOGY AGING; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Taylor LJ, J NEUROL NEUROSURG P; Trojsi F, 2013, AMYOTROPH LAT SCL FR, V14, P553, DOI 10.3109/21678421.2013.785569; Tsujimoto M, 2011, J NEUROL SCI, V307, P34, DOI 10.1016/j.jns.2011.05.025; Wechsler D, 1987, WMS R WECHSLER MEMOR; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Woolley SC, 2011, AMYOTROPH LATERAL SC, V12, P52, DOI 10.3109/17482968.2010.521842	57	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114543	10.1371/journal.pone.0114543	http://dx.doi.org/10.1371/journal.pone.0114543			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501028	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700030
J	Chen, H; Wu, B; Nelson, DR; Wu, K; Liu, C				Chen, Haimei; Wu, Bin; Nelson, David R.; Wu, Kai; Liu, Chang			Computational Identification and Systematic Classification of Novel Cytochrome P450 Genes in Salvia miltiorrhiza	PLOS ONE			English	Article							TANSHINONE BIOSYNTHESIS; P450; ORGANIZATION; SUPERFAMILY; METABOLISM; PROTEINS; REVEALS; FAMILY	Salvia miltiorrhiza is one of the most economically important medicinal plants. Cytochrome P450 (CYP450) genes have been implicated in the biosynthesis of its active components. However, only a dozen full-length CYP450 genes have been described, and there is no systematic classification of CYP450 genes in S. miltiorrhiza. We obtained 77,549 unigenes from three tissue types of S. miltiorrhiza using RNA-Seq technology. Combining our data with previously identified CYP450 sequences and scanning with the CYP450 model from Pfam resulted in the identification of 116 full-length and 135 partial-length CYP450 genes. The 116 genes were classified into 9 clans and 38 families using standard criteria. The RNA-Seq results showed that 35 CYP450 genes were co-expressed with CYP76AH1, a marker gene for tanshinone biosynthesis, using r >= 0.9 as a cutoff. The expression profiles for 16 of 19 randomly selected CYP450 obtained from RNA-Seq were validated by qRT-PCR. Comparing against the KEGG database, 10 CYP450 genes were found to be associated with diterpenoid biosynthesis. Considering all the evidence, 3 CYP450 genes were identified to be potentially involved in terpenoid biosynthesis. Moreover, we found that 15 CYP450 genes were possibly regulated by antisense transcripts (r >= 0.9 or r <=-0.9). Lastly, a web resource (SMCYP450, http://www.herbalgenomics.org/samicyp450) was set up, which allows users to browse, search, retrieve and compare CYP450 genes and can serve as a centralized resource.	[Chen, Haimei; Wu, Bin; Wu, Kai; Liu, Chang] Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Chen, Haimei; Wu, Bin; Wu, Kai; Liu, Chang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Nelson, David R.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Tennessee System; University of Tennessee Health Science Center	Liu, C (corresponding author), Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu@implad.ac.cn	Liu, Chang/A-1148-2014	Nelson, David/0000-0003-0583-5421	National Science Foundation [81373912, 81202859, 81274015]; Program for Changjiang Scholars and Innovative Research Teams in the Universities from Ministry of Education of China [IRT1150]	National Science Foundation(National Science Foundation (NSF)); Program for Changjiang Scholars and Innovative Research Teams in the Universities from Ministry of Education of China	This work was supported by grants from the National Science Foundation to CLIU (No. 81373912), HMC (No. 81202859) and BW (No. 81274015); the Program for Changjiang Scholars and Innovative Research Teams in the Universities from Ministry of Education of China (IRT1150). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Babu PR, 2013, GENE, V513, P156, DOI 10.1016/j.gene.2012.10.040; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cheng TO, 2006, J AM COLL CARDIOL, V47, P1498, DOI 10.1016/j.jacc.2006.01.001; Di P, 2013, ACS CHEM BIOL, V8, P1537, DOI 10.1021/cb3006962; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-73; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Guttikonda SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-243; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hefner J, 1996, CHEM BIOL, V3, P479, DOI 10.1016/S1074-5521(96)90096-4; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kumar MS, 2014, PLANT SYST EVOL, DOI [10.1007/s00606-00014-01066-00600, DOI 10.1007/S00606-00014-01066-00600]; Leister D, 2005, PLANT FUNCTIONAL GEN, P595; Li Ying, 2010, Yaoxue Xuebao, V45, P524; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2014, PHYSL PLANT; Ma LJ, 2007, J CHROMATOGR B, V846, P139, DOI 10.1016/j.jchromb.2006.08.048; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Paquette SM, 2009, PHYTOCHEMISTRY, V70, P1940, DOI 10.1016/j.phytochem.2009.08.024; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Reddy SM, 2014, TREE GENET GENOMES, V10, P399; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Song J, 2012, ACTA PHYSIOL PLANT, V34, P1501, DOI 10.1007/s11738-012-0948-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JW, 2010, APPL MICROBIOL BIOT, V88, P437, DOI 10.1007/s00253-010-2797-7; Wang Q, 2012, PLANT PHYSIOL, V158, P1418, DOI 10.1104/pp.111.187518; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Zerbe P, 2013, PLANT PHYSIOL, V162, P1073, DOI 10.1104/pp.113.218347; Zhao YJ, 2014, APPL MICROBIOL BIOT, V98, P2371, DOI 10.1007/s00253-013-5496-3; Zi JC, 2013, ORG BIOMOL CHEM, V11, P7650, DOI 10.1039/c3ob41885e	42	39	46	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115149	10.1371/journal.pone.0115149	http://dx.doi.org/10.1371/journal.pone.0115149			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493946	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400097
J	Donohue, E; Balgi, AD; Komatsu, M; Roberge, M				Donohue, Elizabeth; Balgi, Aruna D.; Komatsu, Masaaki; Roberge, Michel			Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; SINGLET OXYGEN; CIGARETTE-SMOKE; NITRIC-OXIDE; CHEMICAL MODULATORS; STRUCTURAL BASIS; FORMATION SITE; CELLS; INACTIVATION; ACTIVATION	Autophagy is a cellular catabolic process responsible for the degradation of cytoplasmic constituents, including organelles and long-lived proteins, that helps maintain cellular homeostasis and protect against various cellular stresses. Verteporfin is a benzoporphyrin derivative used clinically in photodynamic therapy to treat macular degeneration. Verteporfin was recently found to inhibit autophagosome formation by an unknown mechanism that does not require exposure to light. We report that verteporfin directly targets and modifies p62, a scaffold and adaptor protein that binds both polyubiquitinated proteins destined for degradation and LC3 on autophagosomal membranes. Western blotting experiments revealed that exposure of cells or purified p62 to verteporfin causes the formation of covalently crosslinked p62 oligomers by a mechanism involving low-level singlet oxygen production. Rose bengal, a singlet oxygen producer structurally unrelated to verteporfin, also produced crosslinked p62 oligomers and inhibited autophagosome formation. Co-immunoprecipitation experiments demonstrated that crosslinked p62 oligomers retain their ability to bind to LC3 but show defective binding to polyubiquitinated proteins. Mutations in the p62 PB1 domain that abolish self-oligomerization also abolished crosslinked oligomer formation. Interestingly, small amounts of crosslinked p62 oligomers were detected in untreated cells, and other groups noted the accumulation of p62 forms with reduced SDS-PAGE mobility in cellular and animal models of oxidative stress and aging. These data indicate that p62 is particularly susceptible to oxidative crosslinking and lead us to propose a model whereby oxidized crosslinked p62 oligomers generated rapidly by drugs like verteporfin or over time during the aging process interfere with autophagy.	[Donohue, Elizabeth; Balgi, Aruna D.; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	University of British Columbia; Tokyo Metropolitan Institute of Medical Science	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@mail.ubc.ca	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722	Canadian Cancer Society Research Institute; University of British Columbia	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); University of British Columbia	This work was supported by a Canadian Cancer Society Research Institute Innovation Grant. ED was funded by a graduate fellowship from the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Alarcon E, 2009, PHOTOCH PHOTOBIO SCI, V8, P933, DOI 10.1039/b901056d; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; Bae SI, 2008, BIOCHEM PHARMACOL, V76, P1653, DOI 10.1016/j.bcp.2008.09.003; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brodowska K, 2014, EXP EYE RES, V124, P67, DOI 10.1016/j.exer.2014.04.011; Chen B, 2005, INT J RADIAT ONCOL, V61, P1216, DOI 10.1016/j.ijrobp.2004.08.006; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalsgaard TK, 2007, J AGR FOOD CHEM, V55, P10968, DOI 10.1021/jf071948g; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375; Donohue E, 2013, J CANCER, V4, P585, DOI 10.7150/jca.7030; Donohue E, 2011, J BIOL CHEM, V286, P7290, DOI 10.1074/jbc.M110.139915; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Epperlein MM, 1996, INT J EXP PATHOL, V77, P197, DOI 10.1046/j.1365-2613.1996.9930331.x; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fateye B, 2012, PHOTOCHEM PHOTOBIOL, V88, P1265, DOI 10.1111/j.1751-1097.2012.01160.x; Ferrario A, 2007, CANCER RES, V67, P4989, DOI 10.1158/0008-5472.CAN-06-4785; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; FOOTE CS, 1984, METHOD ENZYMOL, V105, P36; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; GOOSEY JD, 1980, SCIENCE, V208, P1278, DOI 10.1126/science.7375939; Gornati R, 2013, TOXICOL LETT, V218, P118, DOI 10.1016/j.toxlet.2013.01.023; Granville D J, 2000, Curr Opin Drug Discov Devel, V3, P232; Granville DJ, 1999, AM J PATHOL, V155, P1021, DOI 10.1016/S0002-9440(10)65202-9; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He YY, 2008, PHOTOCHEM PHOTOBIOL, V84, P69, DOI 10.1111/j.1751-1097.2007.00199.x; Henderson BW, 2007, CLIN CANCER RES, V13, P3156, DOI 10.1158/1078-0432.CCR-06-2950; HUNT DWC, 1995, PHOTOCHEM PHOTOBIOL, V61, P417, DOI 10.1111/j.1751-1097.1995.tb08633.x; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Isogai S, 2011, J BIOL CHEM, V286, P31864, DOI 10.1074/jbc.M111.259630; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kessel D, 2006, AUTOPHAGY, V2, P289, DOI 10.4161/auto.2792; Kim SY, 2001, BIOCHIMIE, V83, P437, DOI 10.1016/S0300-9084(01)01258-5; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; LEVY JG, 1995, TRENDS BIOTECHNOL, V13, P14, DOI 10.1016/S0167-7799(00)88895-2; Lin HL, 2012, CHEM RES TOXICOL, V25, P2642, DOI 10.1021/tx3002753; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Luo J, 2006, ANTIOXID REDOX SIGN, V8, P1307, DOI 10.1089/ars.2006.8.1307; LYONS MJ, 1958, NATURE, V181, P1003, DOI 10.1038/1811003a0; Men L, 2007, J PROTEOME RES, V6, P216, DOI 10.1021/pr0603809; Min D B, 2002, Compr Rev Food Sci Food Saf, V1, P58, DOI 10.1111/j.1541-4337.2002.tb00007.x; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PACZKOWSKI J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P341, DOI 10.1016/0748-5514(85)90146-1; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Pittilo RM, 2000, INT J EXP PATHOL, V81, P219; Pogue BW, 2003, CANCER RES, V63, P1025; Pyo JO, 2013, DIABETES METAB J, V37, P333, DOI 10.4093/dmj.2013.37.5.333; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ren J, 2014, SCI CHINA LIFE SCI, V57, P69, DOI 10.1007/s11427-013-4592-z; Renno RZ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1002, DOI 10.1001/archopht.122.7.1002; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salem AF, 2013, CELL CYCLE, V12, P818, DOI 10.4161/cc.23722; Schmidt-Erfurth U, 2000, SURV OPHTHALMOL, V45, P195, DOI 10.1016/S0039-6257(00)00158-2; Shen HR, 1996, J PHOTOCH PHOTOBIO B, V35, P213, DOI 10.1016/S1011-1344(96)07300-9; Shen HR, 1996, J PHOTOCH PHOTOBIO B, V34, P203, DOI 10.1016/1011-1344(96)07286-7; Sumimoto Hideki, 2007, Sci STKE, V2007, pre6, DOI 10.1126/stke.4012007re6; Suto D, 2007, ARCH BIOCHEM BIOPHYS, V461, P151, DOI 10.1016/j.abb.2007.03.020; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; TOMITA M, 1969, BIOCHEMISTRY-US, V8, P5149, DOI 10.1021/bi00840a069; VERWEIJ H, 1982, PHOTOCHEM PHOTOBIOL, V35, P265, DOI 10.1111/j.1751-1097.1982.tb03845.x; Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao Y, 2013, J INVEST DERMATOL, V133, P1629, DOI 10.1038/jid.2013.26	105	49	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114964	10.1371/journal.pone.0114964	http://dx.doi.org/10.1371/journal.pone.0114964			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494214	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400085
J	Tagawa, M; Hamano, T; Nishi, H; Tsuchida, K; Hanafusa, N; Fukatsu, A; Iseki, K; Tsubakihara, Y				Tagawa, Miho; Hamano, Takayuki; Nishi, Hiroshi; Tsuchida, Kenji; Hanafusa, Norio; Fukatsu, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study	PLOS ONE			English	Article							REGULAR DIALYSIS TREATMENT; MAINTENANCE HEMODIALYSIS; PARATHYROID-HORMONE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; PRACTICE PATTERNS; SERUM-CALCIUM; RISK-FACTORS; DISEASE; MORTALITY	Background/Aims: The associations between phosphate, calcium, and intact parathyroid hormone (PTH) levels and composite cardiovascular end points have been studied. This study examined the associations of these markers with myocardial infarction (MI) and stroke separately. Methods: This is a longitudinal study on 65,849 hemodialysis patients from the Japan Renal Data Registry. Patients with prior events at baseline were excluded. Predictors were phosphate, albumin-corrected calcium, intact PTH, and calcium times phosphate product levels. Outcome was the first episode of MI or stroke during a 1-year observation period. Data were analyzed using multiple logistic regression analyses, adjusted for potential confounders. Results: There were 1,048, 651, and 2,089 events of incident MI, hemorrhagic, and ischemic stroke, respectively. Incident MI was associated with phosphate levels >= 6.5 mg/dL (odds ratio 1.49; confidence interval 1.23-1.80) compared with phosphate levels of 4.7-5.4 mg/dL and intact PTH levels>500 pg/mL (1.35; 1.03-1.79) compared with intact PTH levels of 151-300 pg/mL. Higher albumin-corrected calcium level was positively associated with MI (p=0.04 by trend analysis). Hemorrhagic stroke was associated only with intact PTH levels>500 pg/mL (1.54; 1.10-2.17). Incident ischemic stroke had no association with phosphate, calcium, or intact PTH levels. The association of calcium times phosphate product with outcomes was essentially the same pattern as that of phosphate and outcomes. Conclusions: MI was associated with phosphate, calcium, and intact PTH levels, whereas hemorrhagic stroke was associated only with intact PTH. Ischemic stroke was not associated with any of them. The potential distinct beneficial effect on MI and stroke by managing bone and mineral disease should be investigated in future studies.	[Tagawa, Miho] Kyoto Katsura Hosp, Dept Nephrol, Kyoto, Japan; [Hamano, Takayuki; Nishi, Hiroshi; Tsuchida, Kenji; Hanafusa, Norio; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Fukatsu, Atsushi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Kyoto University	Tagawa, M (corresponding author), Kyoto Katsura Hosp, Dept Nephrol, Kyoto, Japan.	tagawa_miho@yahoo.co.jp	Hamano, TAKAYUKI/AAZ-4837-2021; FUKATSU, ATSUSHI/R-7941-2019	Hamano, TAKAYUKI/0000-0002-2100-9106; 				[Anonymous], 2003, AM J KIDNEY DIS S13, V42, pS1; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Floege J, 2011, NEPHROL DIAL TRANSPL, V26, P1948, DOI 10.1093/ndt/gfq219; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Kimata Naoki, 2007, Hemodial Int, V11, P340, DOI 10.1111/j.1542-4758.2007.00190.x; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0; Nakai S, 2008, THER APHER DIAL, V12, P49, DOI 10.1111/j.1744-9987.2007.00540.x; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Navarro-Gonzalez JF, 2009, CLIN J AM SOC NEPHRO, V4, P1646, DOI 10.2215/CJN.02420409; ONOYAMA K, 1986, JPN HEART J, V27, P685; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rashid G, 2007, AM J PHYSIOL-RENAL, V292, pF1215, DOI 10.1152/ajprenal.00406.2006; Seliger SL, 2003, J AM SOC NEPHROL, V14, P2623, DOI 10.1097/01.ASN.0000088722.56342.A8; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Takase B, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-61; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	29	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114678	10.1371/journal.pone.0114678	http://dx.doi.org/10.1371/journal.pone.0114678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494334	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400065
J	Wang, RL; Bencic, DC; Garcia-Reyero, N; Perkins, EJ; Villeneuve, DL; Ankley, GT; Biales, AD				Wang, Rong-Lin; Bencic, David C.; Garcia-Reyero, Natalia; Perkins, Edward J.; Villeneuve, Daniel L.; Ankley, Gerald T.; Biales, Adam D.			Natural Variation in Fish Transcriptomes: Comparative Analysis of the Fathead Minnow (Pimephales promelas) and Zebrafish (Danio rerio)	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; NOISE; CONSEQUENCES; MECHANISMS; MOLECULES; EVOLUTION; VARIANCE; PATTERNS; BRAIN; MOUSE	Fathead minnow and zebrafish are among the most intensively studied fish species in environmental toxicogenomics. To aid the assessment and interpretation of subtle transcriptomic effects from treatment conditions of interest, better characterization and understanding are needed for natural variation in gene expression among fish individuals from lab cultures. Leveraging the transcriptomics data from a number of our toxicogenomics studies conducted over the years, we conducted a meta-analysis of nearly 600 microarrays generated from the ovary tissue of untreated, reproductively mature fathead minnow and zebrafish samples. As expected, there was considerable batch-to-batch transcriptomic variation; this "batch-effect'' appeared to differentially impact subsets of fish transcriptomes in a nonsystematic way. Temporally more closely spaced batches tended to share a greater transcriptomic similarity among one another. The overall level of within-batch variation was quite low in fish ovary tissue, making it a suitable system for studying chemical stressors with subtle biological effects. The observed differences in the within-batch variability of gene expression, at the levels of both individual genes and pathways, were probably both technical and biological. This suggests that biological interpretation and prioritization of genes and pathways targeted by experimental conditions should take into account both their intrinsic variability and the size of induced transcriptional changes. There was significant conservation of both the genomes and transcriptomes between fathead minnow and zebrafish. The high degree of conservation offers promising opportunities in not only studying fish molecular responses to environmental stressors by a comparative biology approach, but also effective sharing of a large amount of existing public transcriptomics data for developing toxicogenomics applications.	[Wang, Rong-Lin; Bencic, David C.; Biales, Adam D.] US EPA, Ecol Exposure Res Div, Natl Exposure Res Lab, Cincinnati, OH 45268 USA; [Garcia-Reyero, Natalia] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Starkville, MS USA; [Perkins, Edward J.] US Army Corps Engn, US Army Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS USA; [Wang, Rong-Lin; Villeneuve, Daniel L.; Ankley, Gerald T.] US EPA, Midcontinent Ecol Div, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA	United States Environmental Protection Agency; Mississippi State University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); United States Environmental Protection Agency	Wang, RL (corresponding author), US EPA, Ecol Exposure Res Div, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	wang.rong-lin@epa.gov		Biales, Adam/0000-0003-2323-6721	U.S. EPA; U.S. Army [BAA 11-4838]	U.S. EPA(United States Environmental Protection Agency); U.S. Army(United States Department of DefenseUnited States Army)	Funding was provided by U.S. EPA and U.S. Army (grant BAA 11-4838). The manuscript has been approved for publication by U.S. EPA and U.S. Army Corps Chief of Engineers. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Ankley GT, 2006, AQUAT TOXICOL, V78, P91, DOI 10.1016/j.aquatox.2006.01.018; Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chibon F, 2013, EUR J CANCER, V49, P2000, DOI 10.1016/j.ejca.2013.02.021; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cui XQ, 2006, GENETICS, V174, P627, DOI 10.1534/genetics.106.060251; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Drew RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-323; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher MA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-108; Flick RW, 2014, AQUAT TOXICOL, V152, P353, DOI 10.1016/j.aquatox.2014.04.026; Garcia-Reyero N, 2014, GEN COMP ENDOCR, V203, P193, DOI 10.1016/j.ygcen.2014.03.022; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hodgins-Davis A, 2009, TRENDS ECOL EVOL, V24, P649, DOI 10.1016/j.tree.2009.06.011; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Komurov K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-154; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Martyniuk CJ, 2013, COMP BIOCHEM PHYS D, V8, P283, DOI 10.1016/j.cbd.2013.08.002; Martyniuk CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059093; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pilpel Y, 2011, METHODS MOL BIOL, V759, P407, DOI 10.1007/978-1-61779-173-4_23; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sanz-Pamplona R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048877; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scherer A., 2009, BATCH EFFECT EXPT NO; Schirmer K, 2010, ANAL BIOANAL CHEM, V397, P917, DOI 10.1007/s00216-010-3662-3; Scott CP, 2009, MOL ECOL, V18, P2832, DOI 10.1111/j.1365-294X.2009.04235.x; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Skolness SY, 2011, AQUAT TOXICOL, V103, P170, DOI 10.1016/j.aquatox.2011.02.016; Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Villeneuve DL, 2012, ENVIRON SCI TECHNOL, V46, P51, DOI 10.1021/es201150a; Villeneuve DL, 2010, AQUAT TOXICOL, V98, P354, DOI 10.1016/j.aquatox.2010.03.006; Villeneuve DL, 2009, ENVIRON TOXICOL CHEM, V28, P1767, DOI 10.1897/08-653.1; Wang RL, 2008, ENVIRON TOXICOL CHEM, V27, P652, DOI 10.1897/07-191.1; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014	56	13	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114178	10.1371/journal.pone.0114178	http://dx.doi.org/10.1371/journal.pone.0114178			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493933	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400034
J	Caceres, O; Rastogi, N; Bartra, C; Couvin, D; Galarza, M; Asencios, L; Mendoza-Ticona, A				Caceres, Omar; Rastogi, Nalin; Bartra, Carlos; Couvin, David; Galarza, Marco; Asencios, Luis; Mendoza-Ticona, Alberto			Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SOUTH-AMERICA; COMPLEX; SPOLIGOTYPES; STRAINS; MUTATIONS; SEQUENCES; DATABASE; TOOL; TB	Background: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosis (XDR-TB) have been detected. Little information exists about the genetic diversity of drug-susceptible vs. MDR-TB and XDR-TB. Methods: Cryopreserved samples of XDR strains from 2007 to 2009 (second semester), were identified and collected. Starting from 227 frozen samples, a total of 142 XDR-TB strains of Mycobacterium tuberculosis complex (MTBC; 1 isolate per patient) were retained for this study. Each strain DNA was analyzed by spoligotyping and the 15-loci Mycobacterial Interspersed Repetitive Unit (MIRU-15). Results: Among the 142 isolates analyzed, only 2 samples (1.41%) could not be matched to any lineage. The most prevalent sublineage was Haarlem (43.66%), followed by T (27.46%), LAM (16.2%), Beijing (9.15%), and X clade (1.41%). Spoligotype analysis identified clustering for 128/142 (90.1%) isolates vs. 49/142 (34.5%) with MIRUs. Of the samples, 90.85% belonged to retreated patients. The drug resistant profile demonstrated that 62.67% showed resistance to injectable drugs capreomycin (CAP) and kanamycin (KAN) vs. 15.5% to CAP alone and 21.8% to KAN alone. The SIT219/T1 and SIT50/H3 were the most prevalent patterns in our study. The spoligoforest analysis showed that SIT53/T1 was at the origin of many of the T lineage strains as well as a big proportion of Haarlem lineage strains (SIT50/H3, followed by SIT47/H1, SIT49/H3, and SIT2375/H1), as opposed to the SIT1/Beijing strains that did not appear to evolve into minor Beijing sublineages among the XDR-TB strains. Conclusion: In contrast with other Latin-American countries where LAM sublineage is the most predominant, we found the Haarlem to be the most common followed by T sublineage among the XDR-TB strains.	[Caceres, Omar; Galarza, Marco] Inst Nacl Salud, Biotechnol & Mol Biol Lab, Lima, Peru; [Rastogi, Nalin; Couvin, David] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Les Abymes, Guadeloupe, France; [Bartra, Carlos; Asencios, Luis] Inst Nacl Salud, Mycobacterias Natl Reference Lab, Lima, Peru; [Mendoza-Ticona, Alberto] Minist Salud MINSA, Lima, Peru	Instituto Nacional de Salud - Peru; Instituto Nacional de Salud - Peru	Caceres, O (corresponding author), Inst Nacl Salud, Biotechnol & Mol Biol Lab, Lima, Peru.	caceresreyomar@gmail.com	RASTOGI, NALIN/AAP-1958-2020; Galarza, Marco/L-3632-2017	RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023; Caceres, Omar/0000-0003-1529-2475; Galarza, Marco/0000-0002-6547-2354; Bartra More, Carlos Arturo/0000-0003-4760-8972	International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru; International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru	International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru; International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru	AM and OC were supported by International Association of National Public Health Institutes (IANPHI) Research Seed Grant (www.ianphi.org) and Instituto Nacional de Salud, Peru (www.ins.gob.pe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Alonso-Rodriguez N, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-34; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Barletta F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-397; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; Del Castillo Hernán, 2009, Rev. perú. med. exp. salud publica, V26, P380; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Driscoll JR, 2002, EMERG INFECT DIS, V8, P1306, DOI 10.3201/eid0811.020174; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent P. T, 1995, PUBLIC HLTH MYCOBACT; Nieto LM, 2012, J CLIN MICROBIOL, V50, P4185, DOI 10.1128/JCM.01946-12; Mendoza-Ticona Alberto, 2007, Rev. perú. med. exp. salud publica, V24, P313; Ministerio de Salud, DIR SAL LIM CIUD AN; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Olano J, 2007, TUBERCULOSIS, V87, P502, DOI 10.1016/j.tube.2007.05.011; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rosales S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-208; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	33	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e112789	10.1371/journal.pone.0112789	http://dx.doi.org/10.1371/journal.pone.0112789			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489950	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300004
J	Da Silva, S; Moreira, B; Da Costa, N				Da Silva, Sergio; Moreira, Bruno; Da Costa, Newton, Jr.			2D:4D Digit Ratio Predicts Delay of Gratification in Preschoolers	PLOS ONE			English	Article							TESTOSTERONE; CHILDREN; 2ND	We replicate the Stanford marshmallow experiment with a sample of 141 preschoolers and find a correlation between lack of self-control and 2D:4D digit ratio. Children with low 2D:4D digit ratio are less likely to delay gratification. Low 2D:4D digit ratio may indicate high fetal testosterone. If this hypothesis is true, our finding means high fetal testosterone children are less likely to delay gratification.	[Da Silva, Sergio; Da Costa, Newton, Jr.] Univ Fed Santa Catarina, Grad Program Econ, BR-88049970 Florianopolis, SC, Brazil; [Moreira, Bruno] Fed Inst Minas Gerais, BR-35570000 Formiga, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG)	Da Silva, S (corresponding author), Univ Fed Santa Catarina, Grad Program Econ, BR-88049970 Florianopolis, SC, Brazil.	professorsergiodasilva@gmail.com	da Costa Jr., Newton C. A./AAZ-4155-2020; Da Silva, Sergio/A-2477-2008	da Costa Jr., Newton C. A./0000-0001-7723-2676; Da Silva, Sergio/0000-0002-7987-4098	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [304342/2009-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by: BM: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) PhD scholarship, www.capes.gov.br. NDC.J: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), www.cnpq.br. Grant Number: 304342/2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1532; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Da Silva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109520; Hampson E, 2012, EVOL HUM BEHAV, V33, P557, DOI 10.1016/j.evolhumbehav.2012.02.003; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Honekopp Johannes, 2013, Front Endocrinol (Lausanne), V4, P185, DOI 10.3389/fendo.2013.00185; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Johnston DW, 2009, DEMOGRAPHY, V46, P281, DOI 10.1353/dem.0.0053; Llaurens V, 2009, PHILOS T R SOC B, V364, P881, DOI 10.1098/rstb.2008.0235; Manning J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00009; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; McCabe LA, 2007, INFANT MENT HEALTH J, V28, P584, DOI 10.1002/imhj.20155; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; Moreira B, 2010, J ECON PSYCHOL, V31, P794, DOI 10.1016/j.joep.2010.03.005; NISAN M, 1976, CHILD DEV, V47, P195; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Voracek M, 2009, PSYCHOL REP, V104, P922, DOI 10.2466/PR0.104.3.922-956; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	22	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114394	10.1371/journal.pone.0114394	http://dx.doi.org/10.1371/journal.pone.0114394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490040	gold, Green Published			2022-12-27	WOS:000347515300035
J	Lobo, MR; Wang, XY; Gillespie, GY; Woltjer, RL; Pike, MM				Lobo, Merryl R.; Wang, Xiaoyan; Gillespie, G. Yancey; Woltjer, Randall L.; Pike, Martin M.			Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TYROSINE KINASE INHIBITOR; CELL-DEATH; TARGETED THERAPIES; INDUCED APOPTOSIS; TUMOR HYPOXIA; GROWTH; GLIOBLASTOMA; VASCULATURE; RESISTANCE	We have previously reported that the in vivo anti-glioma efficacy of the anti-angiogenic receptor tyrosine kinase inhibitor cediranib is substantially enhanced via combination with the late-stage autophagy inhibitor quinacrine. The current study investigates the role of hypoxia and autophagy in combined cediranib/quinacrine efficacy. EF5 immunostaining revealed a prevalence of hypoxia in mouse intracranial 4C8 glioma, consistent with high-grade glioma. MTS cell viability assays using 4C8 glioma cells revealed that hypoxia potentiated the efficacy of combined cediranib/quinacrine: cell viability reductions induced by 1 mu M cediranib +2.5 mu M quinacrine were 78 +/- 7% (hypoxia) vs. 31 +/- 3% (normoxia), p<0.05. Apoptosis was markedly increased for cediranib/quinacrine/hypoxia versus all other groups. Autophagic vacuole biomarker LC3-II increased robustly in response to cediranib, quinacrine, or hypoxia. Combined cediranib/quinacrine increased LC3-II further, with the largest increases occurring with combined cediranib/quinacrine/ hypoxia. Early stage autophagy inhibitor 3-MA prevented LC3-II accumulation with combined cediranib/quinacrine/hypoxia and substantially attenuated the associated reduction in cell viability. Combined efficacy of cediranib with bafilomycin A1, another late-stage autophagy inhibitor, was additive but lacked substantial potentiation by hypoxia. Substantially lower LC3-II accumulation was observed with bafilomycin A1 in comparison to quinacrine. Cediranib and quinacrine each strongly inhibited Akt phosphoryation, while bafilomycin A1 had no effect. Our results provide compelling evidence that autophagic vacuole accumulation plays a causal role in the anti-glioma cytotoxic efficacy of combined cediranib/quinacrine. Such accumulation is likely related to stimulation of autophagosome induction by hypoxia, which is prevalent in the glioma tumor microenvironment, as well as Akt signaling inhibition from both cediranib and quinacrine. Quinacrine's unique ability to inhibit both Akt and autophagic vacuole degradation may enhance its ability to drive cytotoxic autophagic vacuole accumulation. These findings provide a rationale for a clinical evaluation of combined cediranib/quinacrine therapy for malignant glioma.	[Lobo, Merryl R.; Pike, Martin M.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Lobo, Merryl R.; Pike, Martin M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Wang, Xiaoyan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham	Pike, MM (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA.	pikema@ohsu.edu		Gillespie, George/0000-0001-6436-9542	National Institutes of Health, National Cancer Institute [1R21 CA167302-01]; NATIONAL CANCER INSTITUTE [R21CA167302] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the National Institutes of Health, National Cancer Institute (#1R21 CA167302-01, MMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi R, 2009, CANCER BIOL THER, V8, P130, DOI DOI 10.4161/CBT.8.21.10416; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Calvo E, 2009, ONCOTARGETS THER, V2, P135; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DYER CA, 1995, J NEUROPATH EXP NEUR, V54, P852, DOI 10.1097/00005072-199511000-00012; Ehsanian R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-13; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Guo C, 2009, ONCOGENE, V28, P1151, DOI 10.1038/onc.2008.460; Guo CH, 2011, P NATL ACAD SCI USA, V108, P7968, DOI 10.1073/pnas.1105369108; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jordan BF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00094; Joshi AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044372; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kaza N, 2012, BRAIN PATHOL, V22, P89, DOI 10.1111/j.1750-3639.2011.00544.x; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lindberg N, 2012, UPSALA J MED SCI, V117, P92, DOI 10.3109/03009734.2012.654860; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Marceau F, 2009, DRUG METAB DISPOS, V37, P2271, DOI 10.1124/dmd.109.028480; Martinho O, 2013, TRANSL ONCOL, V6, P187, DOI 10.1593/tlo.12400; Mercer RW, 2009, BIODRUGS, V23, P25, DOI 10.2165/00063030-200923010-00003; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Nazarenko I, 2012, UPSALA J MED SCI, V117, P99, DOI 10.3109/03009734.2012.665097; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rouschop KMA, 2009, CURR MOL MED, V9, P417, DOI 10.2174/156652409788167131; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Thaker NG, 2009, EXPERT REV NEUROTHER, V9, P1815, DOI 10.1586/ERN.09.116; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Weinmann M, 2004, ONCOGENE, V23, P3757, DOI 10.1038/sj.onc.1207481; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yung L, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-53; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang RG, 2011, CANCER BIOTHER RADIO, V26, P335, DOI 10.1089/cbr.2010.0814	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114110	10.1371/journal.pone.0114110	http://dx.doi.org/10.1371/journal.pone.0114110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490024	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300015
J	Merz, WM; Leufgen, C; Fimmers, R; Stoffel-Wagner, B; Gembruch, U				Merz, Waltraut M.; Leufgen, Christina; Fimmers, Rolf; Stoffel-Wagner, Birgit; Gembruch, Ulrich			Reference Intervals for N-Terminal Pro-B-Type Natriuretic Peptide in Amniotic Fluid between 10 and 34 Weeks of Gestation	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; BNP MEASUREMENTS USEFUL; CORD BLOOD; UMBILICAL ARTERY; FETAL ANEMIA; DIAGNOSIS; VOLUME; MANAGEMENT; FETUSES; CIRCULATION	Background: In adult and pediatric cardiology, n-terminal pro-B-type natriuretic peptide (nt-proBNP) serves as biomarker in the diagnosis and management of cardiovascular dysfunction. Elevated levels of circulating nt-proBNP are present in fetal conditions associated with myocardial pressure or volume load. Compared to fetal blood sampling, amniocentesis is technically easier and can be performed from early pregnancy onwards. We aimed to investigate amniotic fluid (AF) nt-proBNP concentrations in normal pregnancies between 10 and 34 weeks of gestation. Methods: Nt-proBNP and total protein (TP) was measured in AF by chemiluminescence assay (photometry, respectively). To adjust for a potential dilutional effect, the AF-nt-proBNP/AF-TP ratio was analyzed. Reference intervals were constructed by regression modeling across gestational age. Results: 132 samples were analyzed. A negative correlation between AF-nt-proBNP/AF-TP ratio and gestational age was observed. Curves for the mean and the 5% and 95% reference interval between 10 and 34 weeks of gestation were established. Conclusion: In normal pregnancy, nt-proBNP is present in AF and decreases during gestation. Our data provide the basis for research on AF-nt-proBNP as biomarker in fetal medicine.	[Merz, Waltraut M.; Leufgen, Christina; Gembruch, Ulrich] Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Sch Med, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Sch Med, Inst Clin Chem & Pharmacol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Merz, WM (corresponding author), Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany.	waltraut.merz@ukb.uni-bonn.de	Sánchez-Margalet, Victor/AAB-9986-2021; Gembruch, Ulrich/Q-8228-2017	Sánchez-Margalet, Victor/0000-0001-8638-8680; Gembruch, Ulrich/0000-0001-8284-4669				Anderson DF, 2013, AM J PHYSIOL-REG I, V305, pR506, DOI 10.1152/ajpregu.00175.2013; Bahlmann F, 2011, J PERINAT MED, V39, P529, DOI [10.1515/JPM.2011.065, 10.1515/jpm.2011.065]; Bar-Oz B, 2005, CLIN CHEM, V51, P926, DOI 10.1373/clinchem.2005.048892; Brace RA, 2004, AM J OBSTET GYNECOL, V191, P837, DOI 10.1016/j.ajog.2004.01.048; BRACE RA, 1995, PLACENTA, V16, P1, DOI 10.1016/0143-4004(95)90077-2; Carvajal JA, 2009, REPROD SCI, V16, P32, DOI 10.1177/1933719108324137; Clerico A, 2004, CLIN CHEM, V50, P33, DOI 10.1373/clinchem.2003.024760; Delabaere A, 2010, ULTRASOUND OBST GYN, V35, P620, DOI 10.1002/uog.7579; Deprest JA, 2010, PRENATAL DIAG, V30, P653, DOI 10.1002/pd.2571; Desai AS, 2013, CIRCULATION, V127, P509, DOI 10.1161/CIRCULATIONAHA.112.120493; Girsen A, 2007, ULTRASOUND OBST GYN, V29, P296, DOI 10.1002/uog.3934; Godfrey ME, 2012, ULTRASOUND OBST GYN, V39, P131, DOI 10.1002/uog.9064; Habli M, 2010, AM J OBSTET GYNECOL, V203; Hammerer-Lercher A, 2005, CLIN CHEM, V51, P913, DOI 10.1373/clinchem.2004.046557; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; ITOH H, 1993, J CLIN ENDOCR METAB, V76, P907, DOI 10.1210/jc.76.4.907; Januzzi JL, 2013, CIRCULATION, V127, P500, DOI 10.1161/CIRCULATIONAHA.112.120485; Kocylowski RD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.009; Lechner E, 2009, PEDIATR RES, V66, P466, DOI 10.1203/PDR.0b013e3181b3aee4; Luterek K, 2011, NEUROENDOCRINOL LETT, V32, P657; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Matsumoto LC, 2000, AM J OBSTET GYNECOL, V182, P699, DOI 10.1067/mob.2000.104226; McElhinney DB, 2010, CIRCULATION, V121, P1256, DOI 10.1161/CIRCULATIONAHA.109.870246; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Merz WM, 2014, ULTRASOUND OBST GYN, V44, P377, DOI 10.1002/uog.13443; Merz WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063664; Merz WM, 2012, PEDIATR RES, V72, P174, DOI 10.1038/pr.2012.53; Merz WM, 2012, CLIN RES CARDIOL, V101, P73, DOI 10.1007/s00392-011-0366-4; Merz WM, 2010, CLIN BIOCHEM, V43, P519, DOI 10.1016/j.clinbiochem.2009.11.012; Michielsen ECHJ, 2008, ANN CLIN BIOCHEM, V45, P389, DOI 10.1258/acb.2007.007069; Moriichi A, 2013, J PERINATOL, V33, P182, DOI 10.1038/jp.2012.94; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Ng LL, 2004, CLIN SCI, V106, P129, DOI 10.1042/CS20030234; Ogawa T, 2014, NATRIURETIC PEPTIDES, P1; Ross M G, 2001, J Matern Fetal Med, V10, P2, DOI 10.1080/714904292; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Tosse V, 2012, NEONATOLOGY, V101, P260, DOI 10.1159/000334826; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090; Tutschek B, 2011, SEMIN FETAL NEONAT M, V16, P13, DOI 10.1016/j.siny.2010.09.005; van Mieghem T, 2012, BEST PRACT RES CL OB, V26, P711, DOI 10.1016/j.bpobgyn.2012.03.005; Van Mieghem T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.013	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114416	10.1371/journal.pone.0114416	http://dx.doi.org/10.1371/journal.pone.0114416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490554	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300039
J	You, YA; Park, YJ; Kwon, WS; Yoon, SJ; Ryu, BY; Kim, YJ; Pang, MG				You, Young-Ah; Park, Yoo-Jin; Kwon, Woo-Sung; Yoon, Sung-Jae; Ryu, Buom-Yong; Kim, Young Ju; Pang, Myung-Geol			Increased Frequency of Aneuploidy in Long-Lived Spermatozoa	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; INTRACYTOPLASMIC SPERM INJECTION; NUMERICAL CHROMOSOME-ABNORMALITIES; MULTICOLOR FISH; HEALTHY-MEN; HUMANS; AGE; ETIOLOGY; ORIGIN	Aneuploidy commonly causes spontaneous abortions, stillbirths, and aneuploid births in humans. Notably, the majority of sex chromosome aneuploidies in live births have a paternal origin. An increased frequency of aneuploidy is also associated with male infertility. However, the dynamics and behavior of aneuploid spermatozoa during fertilization in humans have not been studied in detail. Therefore, we compared the frequency of aneuploidy and euploidy in live spermatozoa from normozoospermic men over a 3-day period. To assess the dynamics and behavior of aneuploid spermatozoa, we simultaneously evaluated sperm viability using the hypo-osmotic swelling test and sperm aneuploidy using fluorescence in situ hybridization. Whereas the frequency of viable euploid spermatozoa significantly decreased over 3 days, the frequency of viable spermatozoa with aneuploidy interestingly showed a time-dependent increase. In addition, spermatozoa with abnormal sex chromosomes survived longer. To compared with spermatozoa with other swelling patterns, those with tail-tip swelling patterns had a lower frequency of aneuploidy at all time points. This study revealed the novel finding that the frequency of aneuploid spermatozoa with fertilization capability significantly increased compared to that of euploid spermatozoa over 3 days, suggesting that aneuploid spermatozoa can survive longer than euploid spermatozoa and have a greater chance of fertilizing oocytes.	[You, Young-Ah; Park, Yoo-Jin; Kwon, Woo-Sung; Yoon, Sung-Jae; Ryu, Buom-Yong; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea; [Kim, Young Ju] Ewha Womans Univ, Dept Obstet & Gynecol, Seoul 158710, South Korea	Chung Ang University; Ewha Womans University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Kwon, Woo-Sung/J-6731-2019; Pang, Myung-Geol/AAV-2014-2021	Kwon, Woo-Sung/0000-0002-0848-7189; Pang, Myung-Geol/0000-0003-2019-3789; You, Younag-Ah/0000-0001-6714-7144	Ministry of Food and Drug Safety, Republic of Korea [14162MFDS661]	Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a 2014 grant (14162MFDS661) from the Ministry of Food and Drug Safety, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRUZZO MA, 1995, ENVIRON MOL MUTAGEN, V25, P38, DOI 10.1002/em.2850250608; Bernardini L, 1997, MOL HUM REPROD, V3, P431, DOI 10.1093/molehr/3.5.431; Collodel G, 2007, ARCH ANDROLOGY, V53, P229, DOI 10.1080/01485010701426471; Demaliaj E, 2012, ANEUPLOIDY HLTH DIS, P121; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; HOEGERMAN SF, 1995, LANCET, V346, P1095; Hook E B, 1985, Basic Life Sci, V36, P7; Hossain AM, 1998, HUM REPROD, V13, P1578, DOI 10.1093/humrep/13.6.1578; Hossain AM, 2008, FERTIL STERIL, V89, P237, DOI 10.1016/j.fertnstert.2007.01.170; Jacobs PA, 1995, ADV GENET, V33, P101, DOI 10.1016/S0065-2660(08)60332-6; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Johnson MD, 1998, FERTIL STERIL, V70, P397, DOI 10.1016/S0015-0282(98)00209-X; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; Martin RH, 1987, AM J HUM GENET, V84, P179; Martini AC, 2006, FERTIL STERIL, V85, P1840, DOI 10.1016/j.fertnstert.2005.11.048; McAuliffe ME, 2012, ENVIRON HEALTH PERSP, V120, P535, DOI 10.1289/ehp.1104017; Meschede D, 1997, HUM REPROD, V12, P1913, DOI 10.1093/humrep/12.9.1913; 유영아, 2009, Clinical and Experimental Reproductive Medicine, V36, P45; Mohamed EA, 2012, ANEUPLOIDY ETIOLOGY, P123; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Olson SB, 1988, PREFERENTIAL PATERNA, P583; Pang MG, 1999, HUM REPROD, V14, P1266, DOI 10.1093/humrep/14.5.1266; Pang MG, 2010, FERTIL STERIL, V94, P1012, DOI 10.1016/j.fertnstert.2009.04.043; Pehlivan T, 2003, Reprod Biomed Online, V6, P232; Pfeffer J, 1999, FERTIL STERIL, V72, P472, DOI 10.1016/S0015-0282(99)00279-4; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Robbins WA, 1997, ENVIRON MOL MUTAGEN, V30, P175, DOI 10.1002/(SICI)1098-2280(1997)30:2<175::AID-EM10>3.0.CO;2-A; Rodrigo L, 2004, HUM REPROD, V19, P118, DOI 10.1093/humrep/deh012; Shi Q, 2000, CYTOGENET CELL GENET, V90, P79, DOI 10.1159/000015668; Silber S, 2003, FERTIL STERIL, V79, P30, DOI 10.1016/S0015-0282(02)04407-2; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Sloter ED, 2000, AM J HUM GENET, V67, P862, DOI 10.1086/303088; Templado C, 2005, CYTOGENET GENOME RES, V111, P199, DOI 10.1159/000086890; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Vegetti W, 2000, HUM REPROD, V15, P351, DOI 10.1093/humrep/15.2.351; Vera M, 2012, ANEUPLOIDY HLTH DIS, P141; Verheyen G, 1997, HUM REPROD UPDATE, V3, P195, DOI 10.1093/humupd/3.3.195; WRAMSBY H, 1987, NEW ENGL J MED, V316, P121, DOI 10.1056/NEJM198701153160301; Wyrobek AJ, 2000, NATO SCI SERIES, V313, P134	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114600	10.1371/journal.pone.0114600	http://dx.doi.org/10.1371/journal.pone.0114600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490252	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300057
J	Ozdemir, BC; Hensel, J; Secondini, C; Wetterwald, A; Schwaninger, R; Fleischmann, A; Raffelsberger, W; Poch, O; Delorenzi, M; Temanni, R; Mills, IG; van der Pluijm, G; Thalmann, GN; Cecchini, MG				Oezdemir, Berna C.; Hensel, Janine; Secondini, Chiara; Wetterwald, Antoinette; Schwaninger, Ruth; Fleischmann, Achim; Raffelsberger, Wolfgang; Poch, Olivier; Delorenzi, Mauro; Temanni, Ramzi; Mills, Ian G.; van der Pluijm, Gabri; Thalmann, George N.; Cecchini, Marco G.			The Molecular Signature of the Stroma Response in Prostate Cancer-Induced Osteoblastic Bone Metastasis Highlights Expansion of Hematopoietic and Prostate Epithelial Stem Cell Niches	PLOS ONE			English	Article							VEGF-INDUCED ANGIOGENESIS; GENE-EXPRESSION; TUMOR MICROENVIRONMENT; STIMULATING FACTOR-1; N-CADHERIN; MARROW; ADHESION; GROWTH; PROGRESSION; ACTIVATION	The reciprocal interaction between cancer cells and the tissue-specific stroma is critical for primary and metastatic tumor growth progression. Prostate cancer cells colonize preferentially bone (osteotropism), where they alter the physiological balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption, and elicit prevalently an osteoblastic response (osteoinduction). The molecular cues provided by osteoblasts for the survival and growth of bone metastatic prostate cancer cells are largely unknown. We exploited the sufficient divergence between human and mouse RNA sequences together with redefinition of highly species-specific gene arrays by computer-aided and experimental exclusion of cross-hybridizing oligonucleotide probes. This strategy allowed the dissection of the stroma (mouse) from the cancer cell (human) transcriptome in bone metastasis xenograft models of human osteoinductive prostate cancer cells (VCaP and C4-2B). As a result, we generated the osteoblastic bone metastasis-associated stroma transcriptome (OB-BMST). Subtraction of genes shared by inflammation, wound healing and desmoplastic responses, and by the tissue type-independent stroma responses to a variety of non-osteotropic and osteotropic primary cancers generated a curated gene signature ("Core" OB-BMST) putatively representing the bone marrow/bone-specific stroma response to prostate cancer-induced, osteoblastic bone metastasis. The expression pattern of three representative Core OB-BMST genes (PTN, EPHA3 and FSCN1) seems to confirm the bone specificity of this response. A robust induction of genes involved in osteogenesis and angiogenesis dominates both the OB-BMST and Core OB-BMST. This translates in an amplification of hematopoietic and, remarkably, prostate epithelial stem cell niche components that may function as a self-reinforcing bone metastatic niche providing a growth support specific for osteoinductive prostate cancer cells. The induction of this combinatorial stem cell niche is a novel mechanism that may also explain cancer cell osteotropism and local interference with hematopoiesis (myelophthisis). Accordingly, these stem cell niche components may represent innovative therapeutic targets and/or serum biomarkers in osteoblastic bone metastasis.	[Oezdemir, Berna C.; Hensel, Janine; Secondini, Chiara; Wetterwald, Antoinette; Schwaninger, Ruth; Thalmann, George N.; Cecchini, Marco G.] Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland; [Fleischmann, Achim] Univ Bern, Dept Clin Res, Bern, Switzerland; [Raffelsberger, Wolfgang] Univ Bern, Inst Pathol, Bern, Switzerland; [Poch, Olivier] IGBMC, Strasbourg, France; [Delorenzi, Mauro] Univ Strasbourg, ICube, UMR7357, Strasbourg, France; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Dept Oncol, Lausanne, Switzerland; [Temanni, Ramzi] SIB, Lausanne, Switzerland; [Mills, Ian G.] Sidra Med & Res Ctr, Biomed Informat Div, Doha, Qatar; [van der Pluijm, Gabri] Univ Oslo, NCMM, Prostate Canc Res Grp, Oslo, Norway; [Temanni, Ramzi] LUMC, Dept Urol, Leiden, Netherlands	University of Bern; University of Bern; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne; Swiss Institute of Bioinformatics; Sidra Medical & Research Center; University of Oslo; Leiden University; Leiden University Medical Center (LUMC)	Cecchini, MG (corresponding author), Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland.	marco.cecchini@dkf.unibe.ch	Özdemir, Berna C./ABY-1073-2022; Mills, Ian/AAK-9292-2020	Özdemir, Berna C./0000-0002-7380-0055; Mills, Ian/0000-0001-5347-5083; TEMANNI, Mohamed Ramzi/0000-0001-9125-1136; van der Pluijm, Gabri/0000-0002-1351-1884	European Commission [CANCURE-2006-020970, ITN PRO-NEST-238278]; Swiss National Foundation [3100A0-116237]; OncoSuisse MD/PhD Scholarship [323630-128865/1]; Department of Clinical Research, University of Bern, Switzerland	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Foundation(Swiss National Science Foundation (SNSF)); OncoSuisse MD/PhD Scholarship; Department of Clinical Research, University of Bern, Switzerland	Funding: This work was supported by grants from the European Commission (CANCURE-2006-020970 and FP7 Marie Curie ITN PRO-NEST-238278) and from the Swiss National Foundation (3100A0-116237). B.C.O. received funding from the OncoSuisse MD/PhD Scholarship (323630-128865/1). Part of the costs for the microarray hybridization was supported by the Department of Clinical Research, University of Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Amali AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058857; Arai F, 2012, ANN NY ACAD SCI, V1266, P72, DOI 10.1111/j.1749-6632.2012.06576.x; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Blum R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013024; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charbord P, 2005, ANN NY ACAD SCI, V1044, P159, DOI 10.1196/annals.1349.020; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Contie S, 2011, INT J CANCER, V128, P352, DOI 10.1002/ijc.25591; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Genander M, 2012, CELL ADHES MIGR, V6, P126, DOI 10.4161/cam.18932; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kitagawa Y, 2005, CANCER RES, V65, P10921, DOI 10.1158/0008-5472.CAN-05-1809; Koeneman KS, 1999, PROSTATE, V39, P246; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Korenchuk S, 2001, IN VIVO, V15, P163; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Makoni SN, 2004, AM J HEMATOL, V76, P92, DOI 10.1002/ajh.20046; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martin TJ, 2010, ADV EXP MED BIOL, V658, P51, DOI 10.1007/978-1-4419-1050-9_6; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miles FL, 2014, MOL CANCER RES, V12, P297, DOI 10.1158/1541-7786.MCR-13-0535; Mohamedali KA, 2011, CLIN CANCER RES, V17, P2328, DOI 10.1158/1078-0432.CCR-10-2943; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104; Nakayoshi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092626; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; ORR B, 2010, PROSTATE, V71, P305, DOI DOI 10.1002/PR0S.21244; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pennisi A, 2009, BLOOD, V114, P1803, DOI 10.1182/blood-2009-01-201954; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Planche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018640; Raffelsberger W, 2008, BIOINFORMATICS, V24, P276, DOI 10.1093/bioinformatics/btm556; Richardson AM, 2007, DIAGN MOL PATHOL, V16, P189, DOI 10.1097/PDM.0b013e3180de20ac; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sadler NM, 2013, AM J BLOOD RES, V3, P271; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Shiozawa Y, 2011, CLIN CANCER RES, V17, P5553, DOI 10.1158/1078-0432.CCR-10-2505; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sleeman JP, 2012, CANCER METAST REV, V31, P429, DOI 10.1007/s10555-012-9373-9; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tan VY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-52; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; THALMANN GN, 1994, CANCER RES, V54, P2577; Ting MJ, 2010, EXP HEMATOL, V38, P1087, DOI 10.1016/j.exphem.2010.07.007; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiesner C, 2008, NEOPLASIA, V10, P996, DOI 10.1593/neo.08618; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	95	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114530	10.1371/journal.pone.0114530	http://dx.doi.org/10.1371/journal.pone.0114530			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485970	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600070
J	Parameswaran, S; Sharma, RK				Parameswaran, Sreejit; Sharma, Rajendra K.			Ischemia and Reperfusion Induce Differential Expression of Calpastatin and Its Homologue High Molecular Weight Calmodulin-Binding Protein in Murine Cardiomyocytes	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; ALTERED EXPRESSION; CARDIAC-MUSCLE; RAT-HEART; CALPAIN; CALCIUM; INJURY; APOPTOSIS; CALCINEURIN; CULTURE	In the heart, calpastatin (Calp) and its homologue high molecular weight calmodulin-binding protein (HMWCaMBP) regulate calpains (Calpn) by inhibition. A rise in intracellular myocardial Ca2+ during cardiac ischemia activates Calpn thereby causing damage to myocardial proteins, which leads to myocyte death and consequently to loss of myocardial structure and function. The present study aims to elucidate expression of Calp and HMWCaMBP with respect to Calpn during induced ischemia and reperfusion in primary murine cardiomyocyte cultures. Ischemia and subsequently reperfusion was induced in similar to 80% confluent cultures of neonatal murine cardiomyocytes (NMCC). Flow cytometric analysis (FACS) has been used for analyzing protein expression concurrently with viability. Confocal fluorescent microscopy was used to observe protein localization. We observed that ischemia induces increased expression of Calp, HMWCaMBP and Calpn. Calpn expressing NMCC on co-expressing Calp survived ischemic induction compared to NMCC co-expressing HMWCaMBP. Similarly, living cells expressed Calp in contrast to dead cells which expressed HMWCaMBP following reperfusion. A significant difference in the expression of Calp and its homologue HMWCaMBP was observed in localization studies during ischemia. The current study adds to the existing knowledge that HMWCaMBP could be a putative isoform of Calp. NMCC on co-expressing Calp and Calpn-1 survived ischemic and reperfusion inductions compared to NMCC co-expressing HMWCaMBP and Calpn-1. A significant difference in expression of Calp and HMWCaMBP was observed in localization studies during ischemia.	[Parameswaran, Sreejit; Sharma, Rajendra K.] Univ Saskatchewan, Coll Med, Dept Pathol & Lab Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Sharma, RK (corresponding author), Univ Saskatchewan, Coll Med, Dept Pathol & Lab Med, Saskatoon, SK S7N 0W0, Canada.	rajendra.sharma@usask.ca			Heart and Stroke Foundation of Saskatchewan, Canada [411894]	Heart and Stroke Foundation of Saskatchewan, Canada	Funding: This work was supported by the Heart and Stroke Foundation of Saskatchewan, Canada (Grant number - 411894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Gedik N, 2013, ARCH MED SCI, V9, P968, DOI 10.5114/aoms.2013.38175; Haas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031669; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heidrich FM, 2009, CIRC RES, V104, pE19, DOI 10.1161/CIRCRESAHA.108.191072; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Kakkar R, 2001, CELL CALCIUM, V29, P59, DOI 10.1054/ceca.2000.0157; Kakkar R, 1997, MOL CELL BIOCHEM, V177, P215, DOI 10.1023/A:1006886111569; Kakkar R, 2000, J PATHOL, V191, P208, DOI 10.1002/(SICI)1096-9896(200006)191:2<208::AID-PATH618>3.0.CO;2-6; Kakkar R, 1997, BIOCHEMISTRY-US, V36, P11550, DOI 10.1021/bi9711083; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kleinbongard P, 2014, BR J PHARM; Li HZ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-18; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parameswaran S, 2014, BIOCHEM BIOPH RES CO, V443, P604, DOI 10.1016/j.bbrc.2013.12.019; Parameswaran S, 2013, CAN J PHYSIOL PHARM, V91, P985, DOI 10.1139/cjpp-2013-0161; Parameswaran S, 2012, CARDIOVASC DRUG THER, V26, P321, DOI 10.1007/s10557-012-6399-8; Pikkarainen S, 2009, J BIOL CHEM, V284, P27195, DOI 10.1074/jbc.M109.037887; Saucerman JJ, 2012, J MOL CELL CARDIOL, V52, P312, DOI 10.1016/j.yjmcc.2011.06.005; SHARMA RK, 1990, J BIOL CHEM, V265, P1152; Singh N, 2008, BIOCHEM BIOPH RES CO, V373, P387, DOI 10.1016/j.bbrc.2008.06.040; Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; YOSHIDA K, 1995, JPN CIRC J, V59, P40	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114653	10.1371/journal.pone.0114653	http://dx.doi.org/10.1371/journal.pone.0114653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486053	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600084
J	Zaccaria, A; Cristelli, M; Tacchella, A; Pietronero, L				Zaccaria, Andrea; Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano			How the Taxonomy of Products Drives the Economic Development of Countries	PLOS ONE			English	Article								We introduce an algorithm able to reconstruct the relevant network structure on which the time evolution of country-product bipartite networks takes place. The significant links are obtained by selecting the largest values of the projected matrix. We first perform a number of tests of this filtering procedure on synthetic cases and a toy model. Then we analyze the bipartite network constituted by countries and exported products, using two databases for a total of almost 50 years. It is then possible to build a hierarchically directed network, in which the taxonomy of products emerges in a natural way. We study the influence of the structure of this taxonomy network on countries' development; in particular, guided by an example taken from the industrialization of South Korea, we link the structure of the taxonomy network to the empirical temporal connections between product activations, finding that the most relevant edges for countries' development are the ones suggested by our network. These results suggest paths in the product space which are easier to achieve, and so can drive countries' policies in the industrialization process.	[Zaccaria, Andrea; Cristelli, Matthieu; Tacchella, Andrea; Pietronero, Luciano] CNR, ISC, I-00185 Rome, Italy; [Tacchella, Andrea; Pietronero, Luciano] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Pietronero, Luciano] LIMS, London, England	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Zaccaria, A (corresponding author), CNR, ISC, Via Taurini 19, I-00185 Rome, Italy.	andrea.zaccaria@roma1.infn.it	Zaccaria, Andrea/F-8476-2018; Pietronero, Luciano/O-4473-2018	Zaccaria, Andrea/0000-0002-4478-3292; Pietronero, Luciano/0000-0001-6424-8863; Tacchella, Andrea/0000-0003-3940-9404	European project FET-Open GROWTHCOM [611272]; Italian PNR project CRISIS-Lab	European project FET-Open GROWTHCOM; Italian PNR project CRISIS-Lab	This work was supported by the European project FET-Open GROWTHCOM (grant num. 611272) and the Italian PNR project CRISIS-Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHION P, 1992, ECONOMETRICA, V60, P323, DOI 10.2307/2951599; [Anonymous], 1934, THEORY EC DEV INQUIR; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Battiston F, 2014, METRICS COUNTR UNPUB; BOWEN HP, 1987, AM ECON REV, V77, P791; Cadot O, 2011, REV ECON STAT, V93, P590, DOI 10.1162/REST_a_00078; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Fagerberg J, 2009, RES POLICY, V38, P218, DOI 10.1016/j.respol.2008.12.006; FEENSTRA R. C, 2005, TECHNICAL REPORT; Flanders, 1991, HECKSCHER OHLIN TRAD; Hausmann R, 2003, J DEV ECON, V72, P603, DOI 10.1016/S0304-3878(03)00124-X; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo C.A., 2009, DYNAMICS EC COMPLEXI; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kauffman S.A., 2002, INVESTIGATIONS; Kauffman S.A., 1993, ORIGINS ORDER; Lall Sanjaya, 2000, OXFORD DEV STUDIES, V28, P337, DOI [10.1080/713688318, DOI 10.1080/713688318]; LEAMER EE, 1980, J POLIT ECON, V88, P495, DOI 10.1086/260882; LEONTIEF W, 1956, REV ECON STAT, V38, P386, DOI 10.2307/1926500; Leontief W, 1954, DOMESTIC PRODUCTION, P2; Nelson R.R., 2009, EVOLUTIONARY THEORY; Page Lawrence, 1999, 199966 STANF INFOLAB; Ricardo D., 1891, PRINCIPLES POLITICAL; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Zhou T, 2007, PHYS REV E, V76	27	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113770	10.1371/journal.pone.0113770	http://dx.doi.org/10.1371/journal.pone.0113770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25486526	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600025
J	Chen, TJ; Sun, LP; He, CY; Gong, YH; Xu, Q; Yuan, Y				Chen, Tiejun; Sun, Liping; He, Caiyun; Gong, Yuehua; Xu, Qian; Yuan, Yuan			Serum OPN Expression for Identification of Gastric Cancer and Atrophic Gastritis and Its Influencing Factors	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PLASMA OSTEOPONTIN LEVELS; BONE-MINERAL DENSITY; INTESTINAL METAPLASIA; POSTMENOPAUSAL WOMEN; PROGRESSION; INVASION; RECEPTOR; METASTASIS; CARCINOMA	Background: Most studies have found that osteopontin (OPN) expression level is related to the poor prognosis of gastric cancer. However, few studies have examined the relationship between OPN expression and gastric precancerous diseases, and the potential role of OPN in the formation and development of GC. We investigated the relationships between serum OPN levels and the risks of gastric cancer (GC) and its precancerous disease, to explore the diagnostic efficacy of serum OPN level for GC and atrophic gastritis and its influencing factors. Methods: A total of 1,452 patients were enrolled, including 609 with mild superficial gastritis (SG), 594 with atrophic gastritis (AG) and 249 with GC. The levels of serum OPN and serum Helicobacter pylori IgG antibody were detected by enzyme-linked immunosorbent assay. Results: Serum OPN levels increased from mild SG (1.99 +/- 1.91 ng/ml) to AG (2.37 +/- 2.27 ng/ml) to GC (5.94 +/- 4.52 ng/ml) (P <= 0.002), along with increasing severity of gastric disease. OPN levels were significantly higher in patients with GC compared with the non-cancer population (2.17 +/- 2.10, P < 0.0001). Serum OPN level was positively correlated with age and was higher in men than women, but was not correlated with H. pylori infection status. The area under the receiver operating characteristic curve was 0.805, the optimal cutoff was 2.56 ng/ml and the sensitivity and specificity were 74.3% and 71.8%, respectively, for the ability of serum OPN to discriminate GC. Conclusions: Serum OPN expression was closely related to the risks of GC and AG, and it might be a useful marker for the discrimination of GC. OPN level was positively correlated with age and male sex, but was not affected by H. pylori infection, and it was promoted by smoking and drinking, in patients with mild SG.	[Chen, Tiejun; Sun, Liping; He, Caiyun; Gong, Yuehua; Xu, Qian; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang 110001, Peoples R China; [Chen, Tiejun; Sun, Liping; He, Caiyun; Gong, Yuehua; Xu, Qian; Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang 110001, Peoples R China; [Chen, Tiejun] Benxi Cent Hosp, Dept Med Oncol, Benxi, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang 110001, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; Science Technology Project in Liaoning Province [2011225002]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Science Technology Project in Liaoning Province	This work is supported by grants from the National Key Basic Research Program of China (973 Program Ref No. 2010CB529304), and the Science Technology Project in Liaoning Province (Ref No. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; [Anonymous], GENES CHROMOSOMES CA, V49, P28; Banerjee A, 2009, TOXICOL PATHOL, V37, P492, DOI 10.1177/0192623309335633; Blasberg JD, 2010, J CLIN ONCOL, V28, P936, DOI 10.1200/JCO.2009.25.5711; Cao ZM, 2002, EXP NEPHROL, V10, P19; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7; Chang WL, 2011, HELICOBACTER, V16, P217, DOI 10.1111/j.1523-5378.2011.00832.x; Chen YJ, 2009, J AM ACAD DERMATOL, V60, P225, DOI 10.1016/j.jaad.2008.09.046; Cho EH, 2013, J KOREAN MED SCI, V28, P1496, DOI 10.3346/jkms.2013.28.10.1496; Cristaudo A, 2010, INT J BIOL MARKER, V25, P164, DOI 10.1177/172460081002500307; Dai N, 2007, ONCOLOGY-BASEL, V72, P89, DOI 10.1159/000111108; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Dirnu R, 2012, ROM J MORPHOL EMBRYO, V53, P293; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Farr JN, 2012, J CLIN ENDOCR METAB, V97, P4219, DOI 10.1210/jc.2012-2381; Fodor D, 2013, J INVEST MED, V61, P15, DOI 10.2310/JIM.0b013e3182761264; Gong Yue-hua, 2006, Zhonghua Zhongliu Zazhi, V28, P691; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Higashiyama M, 2007, ANN SURG ONCOL, V14, P3419, DOI 10.1245/s10434-007-9564-8; Hillas G, 2013, CYTOKINE, V61, P251, DOI 10.1016/j.cyto.2012.10.002; Imano M, 2010, AM SURGEON, V76, P91; Imano M, 2009, J GASTROINTEST SURG, V13, P1577, DOI 10.1007/s11605-009-0955-y; Kong Ling-bo, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P207; Miyajima Jiro, 2010, Kurume Medical Journal, V57, P73, DOI 10.2739/kurumemedj.57.73; Negrini R, 1996, GASTROENTEROLOGY, V111, P655, DOI 10.1053/gast.1996.v111.pm8780570; Paliwal P, 2012, AGING-US, V4, P553, DOI 10.18632/aging.100477; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Ribeiro-Silva A, 2008, INT J BIOL MARKER, V23, P154, DOI 10.1177/172460080802300304; Sakaki N, 2002, ALIMENT PHARM THERAP, V16, P198, DOI 10.1046/j.1365-2036.16.s2.13.x; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Shimoyama T, 2001, J CLIN PATHOL, V54, P332, DOI 10.1136/jcp.54.4.332; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Sullivan J, 2011, HISTOL HISTOPATHOL, V26, P893, DOI 10.14670/HH-26.893; Sun Xian-jun, 2005, Zhonghua Zhongliu Zazhi, V27, P292; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Tang HW, 2008, CANCER INVEST, V26, P60, DOI 10.1080/07357900701519279; Wasilewska A, 2011, ADV MED SCI-POLAND, V56, P193, DOI 10.2478/v10039-011-0034-y; Wijkstrom H, 2000, SCAND J UROL NEPHROL, V34, P116, DOI 10.1080/00365590050509878; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Yuan Yuan, 2013, Cancer Biology Medicine, V10, P72, DOI 10.7497/j.issn.2095-3941.2013.02.002; Zhang X, 2009, ONCOL REP, V21, P609, DOI 10.3892/or_00000263; Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114005	10.1371/journal.pone.0114005	http://dx.doi.org/10.1371/journal.pone.0114005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479069	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200039
J	Khanna, A; Pascual-Leone, A; Farzan, F				Khanna, Arjun; Pascual-Leone, Alvaro; Farzan, Faranak			Reliability of Resting-State Microstate Features in Electroencephalography	PLOS ONE			English	Article							NEUROPHYSIOLOGICAL MARKERS; BRAIN STATE; FIELD MAPS; EEG; DURATION; SCHIZOPHRENIA; DYNAMICS; MILD; SEGMENTATION; WAKEFULNESS	Background: Electroencephalographic (EEG) microstate analysis is a method of identifying quasi-stable functional brain states ("microstates") that are altered in a number of neuropsychiatric disorders, suggesting their potential use as biomarkers of neurophysiological health and disease. However, use of EEG microstates as neurophysiological biomarkers requires assessment of the test-retest reliability of microstate analysis. Methods: We analyzed resting-state, eyes-closed, 30-channel EEG from 10 healthy subjects over 3 sessions spaced approximately 48 hours apart. We identified four microstate classes and calculated the average duration, frequency, and coverage fraction of these microstates. Using Cronbach's alpha and the standard error of measurement (SEM) as indicators of reliability, we examined: (1) the test-retest reliability of microstate features using a variety of different approaches; (2) the consistency between TAAHC and k-means clustering algorithms; and (3) whether microstate analysis can be reliably conducted with 19 and 8 electrodes. Results: The approach of identifying a single set of "global" microstate maps showed the highest reliability (mean Cronbach's alpha>0.8, SEM approximate to 10% of mean values) compared to microstates derived by each session or each recording. There was notably low reliability in features calculated from maps extracted individually for each recording, suggesting that the analysis is most reliable when maps are held constant. Features were highly consistent across clustering methods (Cronbach's alpha>0.9). All features had high test-retest reliability with 19 and 8 electrodes. Conclusions: High test-retest reliability and cross-method consistency of microstate features suggests their potential as biomarkers for assessment of the brain's neurophysiological health.	[Khanna, Arjun; Pascual-Leone, Alvaro; Farzan, Faranak] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Farzan, Faranak] Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Farzan, F (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA.	faranak.farzan@camh.ca	Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Farzan, Faranak/0000-0001-9249-2994	Canadian Institute of Health Research [CIHR - 201102MFE-246635-181538]; Sidney R. Baer Jr. Foundation; National Institutes of Health [R01HD069776, R01NS073601, R21 MH099196, R21 NS082870, R21 NS085491, R21 HD07616]; Harvard Catalyst - The Harvard Clinical and Translational Science Center (NCRR); Harvard Catalyst - The Harvard Clinical and Translational Science Center (NCATS NIH) [M01-RR-01066, UL1 RR025758]; Temerty Family through the Centre for Addiction and Mental Health (CAMH) Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069776] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD007616] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085491, R21NS082870, R01NS073601] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Sidney R. Baer Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst - The Harvard Clinical and Translational Science Center (NCRR); Harvard Catalyst - The Harvard Clinical and Translational Science Center (NCATS NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Temerty Family through the Centre for Addiction and Mental Health (CAMH) Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in by the Canadian Institute of Health Research (CIHR - 201102MFE-246635-181538), the Sidney R. Baer Jr. Foundation, the National Institutes of Health (R01HD069776, R01NS073601, R21 MH099196, R21 NS082870, R21 NS085491, R21 HD07616), Harvard Catalyst - The Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, M01-RR-01066, UL1 RR025758), and the Temerty Family through the Centre for Addiction and Mental Health (CAMH) Foundation. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila MT, 2002, J ABNORM PSYCHOL, V111, P259, DOI 10.1037//0021-843X.111.2.259; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Britz J, 2009, CEREB CORTEX, V19, P55, DOI 10.1093/cercor/bhn056; Brodbeck V, 2012, NEUROIMAGE, V62, P2129, DOI 10.1016/j.neuroimage.2012.05.060; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Cantero JL, 1999, BRAIN TOPOGR, V11, P257, DOI 10.1023/A:1022213302688; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; Charter RA, 2001, J CLIN EXP NEUROPSYC, V23, P530, DOI 10.1076/jcen.23.4.530.1227; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dierks T, 1997, J NEURAL TRANSM, V104, P483, DOI 10.1007/BF01277666; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Ingber L, 2011, MATH BIOSCI, V229, P160, DOI 10.1016/j.mbs.2010.12.003; Irisawa S, 2006, NEUROPSYCHOBIOLOGY, V54, P134, DOI 10.1159/000098264; Jelic V, 2000, NEUROBIOL AGING, V21, P533, DOI 10.1016/S0197-4580(00)00153-6; Kikuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022912; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Koenig T., 2009, ELECT NEUROIMAGING, P169, DOI DOI 10.1017/CBO9780511596889; Kondakor I, 1997, J NEURAL TRANSM, V104, P161, DOI 10.1007/BF01273178; KONDAKOR I, 1995, J MED ENG TECHNOL, V19, P66, DOI 10.3109/03091909509030277; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D, 2005, PSYCHIAT RES-NEUROIM, V138, P141, DOI 10.1016/j.pscychresns.2004.05.007; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lehmann D, 1998, INT J PSYCHOPHYSIOL, V29, P1, DOI 10.1016/S0167-8760(97)00098-6; LEHMANN D, 1993, PSYCHIAT RES-NEUROIM, V50, P275, DOI 10.1016/0925-4927(93)90005-3; Lehmann D, 1994, Int J Neurosci, V74, P239; Mohr C, 2005, CEREB CORTEX, V15, P1451, DOI 10.1093/cercor/bhi025; Muller TJ, 2005, J NEURAL TRANSM, V112, P565, DOI 10.1007/s00702-004-0194-z; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nishida K, 2013, CLIN NEUROPHYSIOL, V124, P1106, DOI 10.1016/j.clinph.2013.01.005; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Perkins DO, 2000, BIOL PSYCHIAT, V47, P762, DOI 10.1016/S0006-3223(00)00837-4; Ponomareva NV, 1998, DEMENT GERIATR COGN, V9, P267, DOI 10.1159/000017071; ROEBROECK ME, 1993, PHYS THER, V73, P386, DOI 10.1093/ptj/73.6.386; Schlegel F, 2012, BRAIN TOPOGR, V25, P20, DOI 10.1007/s10548-011-0189-7; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Stevens A, 1996, EUR ARCH PSY CLIN N, V246, P310, DOI 10.1007/BF02189024; STRIK WK, 1995, J NEURAL TRANSM-GEN, V99, P213, DOI 10.1007/BF01271480; Strik WK, 1997, PSYCHIAT RES-NEUROIM, V75, P183, DOI 10.1016/S0925-4927(97)00054-1; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; WACKERMANN J, 1993, ELECTROEN CLIN NEURO, V86, P193, DOI 10.1016/0013-4694(93)90007-I; Yoshimura M, 2007, PSYCHOPHARMACOLOGY, V191, P995, DOI 10.1007/s00213-007-0737-8; Yuan H, 2012, NEUROIMAGE, V60, P2062, DOI 10.1016/j.neuroimage.2012.02.031	46	85	86	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114163	10.1371/journal.pone.0114163	http://dx.doi.org/10.1371/journal.pone.0114163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479614	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200049
J	Lei, XT; Xiao, Y; Xia, W; Mason, AS; Yang, YD; Ma, ZL; Peng, M				Lei, Xintao; Xiao, Yong; Xia, Wei; Mason, Annaliese S.; Yang, Yaodong; Ma, Zilong; Peng, Ming			RNA-Seq Analysis of Oil Palm under Cold Stress Reveals a Different C-Repeat Binding Factor (CBF) Mediated Gene Expression Pattern in Elaeis guineensis Compared to Other Species	PLOS ONE			English	Article							COMPARATIVE TRANSCRIPTOME ANALYSIS; ARABIDOPSIS-THALIANA; FREEZING TOLERANCE; LOW-TEMPERATURE; SIGNAL-TRANSDUCTION; ACCLIMATION; RESPONSES; DROUGHT; ACCUMULATION; ACTIVATORS	Elaeis guineensis as a tropical oil-crop is particularly sensitive to low temperature. Improvement of cold-tolerance may significantly increase the total cultivation area of this tropical oil-crop worldwide. We sequenced cold-treated and control (untreated) samples of Elaeis guineensis. De novo assembly generated 51,452 unigenes with an average length of 703 bp. Subsequently, these expressed sequences were functionally annotated. In the K category (transcription factors) of COG (Cluster of Orthologous Group) annotation, the largest proportion of genes induced and repressed at least two-fold under cold stress were from the AP2/ERE family, indicating that C-repeat binding factor, (CBFs, members of the AP2/ERE family) may play a central role in cold tolerance in Elaeis guineensis. Subsequently, the CBF-mediated signal transduction pathway was reconstructed based on transcriptome data and the gene expression profile involving the pathway was examined using real-time quantitative RT-PCR (qRT-PCR). CBFs reached maximum transcript level both at medium (4 h) and long period time points (7 days), contrary to the expression pattern of CBFs in Arabidopsis and rice. Moreover, the promoters of downstream Cold Responsive gene (CORs) regulated by CBFs were analyzed. Conservation, mutation and absence of the DRE core motif were detected in the promoters of six CORs. These mutations in DRE motifs suggest that CORs may not be induced via cold stress in Elaeis guineensis.	[Lei, Xintao; Xiao, Yong; Xia, Wei; Yang, Yaodong] Chinese Acad Trop Agr Sci, Coconut Res Inst, Hainan Key Lab Trop Oil Crops Biol, Wenchang, Hainan, Peoples R China; [Ma, Zilong; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China; [Mason, Annaliese S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Mason, Annaliese S.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences; University of Queensland; University of Queensland	Xiao, Y (corresponding author), Chinese Acad Trop Agr Sci, Coconut Res Inst, Hainan Key Lab Trop Oil Crops Biol, Wenchang, Hainan, Peoples R China.	xiaoyong1980@webmail.hzau.edu.cn	Mason, Annaliese S/B-8809-2011; Yang, Yaodong/L-8445-2019	Mason, Annaliese S/0000-0003-2701-7964; Yang, Yaodong/0000-0002-6599-5665	Natural Science Foundation of China [31101179]; Major Technology Project of Hainan [ZDZX2013023-1]; Australia Research Council Discovery Early Career Researcher Award [DE120100668]; Natural Science Foundation of Hainan Province [314145]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Technology Project of Hainan; Australia Research Council Discovery Early Career Researcher Award(Australian Research Council); Natural Science Foundation of Hainan Province	This work was supported by the Natural Science Foundation of China (No. 31101179), The Major Technology Project of Hainan (ZDZX2013023-1), an Australia Research Council Discovery Early Career Researcher Award (DE120100668), and Natural Science Foundation of Hainan Province (314145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Aprile A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-279; Atici O, 2003, PHYTOCHEMISTRY, V64, P1187, DOI 10.1016/S0031-9422(03)00420-5; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Browse J, 2001, CURR OPIN PLANT BIOL, V4, P241, DOI 10.1016/S1369-5266(00)00167-9; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chutipaijit S, 2009, PAK J BOT, V41, P2497; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; Fabienne B, 2011, P NATL SCI US, V108, P12527; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Ferwerda JD, 1997, ECOPHYSIOLOGY TROPIC, P351; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Li R, 2000, PLANT GROWTH REGUL, V32, P295, DOI 10.1023/A:1010755901072; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sun CX, 2011, AFR J BIOTECHNOL, V10, P10465; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xia W, 2014, J BIOTECHNOL, V184, P63, DOI 10.1016/j.jbiotec.2014.05.008; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Xiao Y, 2012, PLANT OMICS, V5, P584; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020092; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	52	25	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114482	10.1371/journal.pone.0114482	http://dx.doi.org/10.1371/journal.pone.0114482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479236	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200093
J	Moriuchi, T; Iso, N; Sagari, A; Ogahara, K; Kitajima, E; Tanaka, K; Tabira, T; Higashi, T				Moriuchi, Takefumi; Iso, Naoki; Sagari, Akira; Ogahara, Kakuya; Kitajima, Eiji; Tanaka, Koji; Tabira, Takayuki; Higashi, Toshio			Excitability of the Primary Motor Cortex Increases More Strongly with Slow- than with Normal-Speed Presentation of Actions	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; VENTRAL PREMOTOR CORTEX; CORTICOSPINAL EXCITABILITY; CORTICAL INTERACTIONS; GRASPING MOVEMENTS; CLINICAL-RELEVANCE; ACTION RECOGNITION; HAND MOVEMENTS; MODULATION	Introduction: The aim of the present study was to investigate how the speed of observed action affects the excitability of the primary motor cortex (M1), as assessed by the size of motor evoked potentials (MEPs) induced by transcranial magnetic stimulation (TMS). Methods: Eighteen healthy subjects watched a video clip of a person catching a ball, played at three different speeds (normal-, half-, and quarter-speed). MEPs were induced by TMS when the model's hand had opened to the widest extent just before catching the ball ("open") and when the model had just caught the ball ("catch"). These two events were locked to specific frames of the video clip ("phases"), rather than occurring at specific absolute times, so that they could easily be compared across different speeds. MEPs were recorded from the thenar (TH) and abductor digiti minimi (ADM) muscles of the right hand. Results: The MEP amplitudes were higher when the subjects watched the video clip at low speed than when they watched the clip at normal speed. A repeated-measures ANOVA, with the factor VIDEO-SPEED, showed significant main effects. Bonferroni's post hoc test showed that the following MEP amplitude differences were significant: TH, normal vs. quarter; ADM, normal vs. half; and ADM, normal vs. quarter. Paired t-tests showed that the significant MEP amplitude differences between TMS phases under each speed condition were TH, "catch" higher than "open" at quarter speed; ADM, "catch" higher than "open" at half speed. Conclusions: These results indicate that the excitability of M1 was higher when the observed action was played at low speed. Our findings suggest that the action observation system became more active when the subjects observed the video clip at low speed, because the subjects could then recognize the elements of action and intention in others.	[Moriuchi, Takefumi; Iso, Naoki; Sagari, Akira; Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Nagasaki 852, Japan; [Moriuchi, Takefumi; Iso, Naoki] Tojinkai Miharadai Hosp, Med Corp, Nagasaki, Japan; [Sagari, Akira] Nagasaki Genbaku Hosp, Japanese Red Cross Soc, Nagasaki, Japan; [Ogahara, Kakuya] Kanagawa Univ Human Serv, Fac Hlth & Social Work, Sch Rehabil, Kanagawa, Japan; [Kitajima, Eiji] Nagasaki Univ, Ctr Ind, Univ & Govt Cooperat, Nagasaki 852, Japan; [Tanaka, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Unit Phys & Occupat Therapy, Nagasaki 852, Japan; [Tabira, Takayuki] Nishikyushu Univ, Fac Rehabil Sci, Saga, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Higashi, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Nagasaki 852, Japan.	higashi-t@nagasaki-u.ac.jp	Tabira, takayuki/AAS-4222-2021; TANAKA, KOJI/ABC-4601-2021	TANAKA, KOJI/0000-0002-7932-8601				Abdollahi RO, 2013, CEREB CORTEX, V23, P2734, DOI 10.1093/cercor/bhs264; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Bang DH, 2013, CLIN REHABIL, V27, P1118, DOI 10.1177/0269215513501528; BARKER AT, 1985, LANCET, V1, P1106; Biagi L, 2010, BRAIN RES BULL, V81, P434, DOI 10.1016/j.brainresbull.2009.12.002; Borroni P, 2008, SOC NEUROSCI-UK, V3, P276, DOI 10.1080/17470910701515269; Bucchioni G, 2013, BRAIN COGNITION, V81, P176, DOI 10.1016/j.bandc.2012.11.001; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Candidi M, 2010, CEREB CORTEX, V20, P2832, DOI 10.1093/cercor/bhq033; Castiello U, 2009, NEUROPSYCHOLOGIA, V47, P835, DOI 10.1016/j.neuropsychologia.2008.12.016; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; Davare M, 2009, CORTEX, V45, P1050, DOI 10.1016/j.cortex.2009.02.011; Enticott PG, 2011, BRAIN RES BULL, V85, P89, DOI 10.1016/j.brainresbull.2011.03.018; Enticott PG, 2010, NEUROPSYCHOLOGIA, V48, P2675, DOI 10.1016/j.neuropsychologia.2010.05.014; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Ertelt D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-42; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franceschini M, 2012, NEUROREHAB NEURAL RE, V26, P456, DOI 10.1177/1545968311427406; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Lago A, 2010, NEUROPSYCHOLOGIA, V48, P1802, DOI 10.1016/j.neuropsychologia.2010.02.030; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Maeda F., 2002, INT C SERIES, V1232, P889, DOI [10.1016/S0531-5131(01)00729-4, DOI 10.1016/S0531-5131(01)00729-4]; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Ogawa K, 2012, EXP BRAIN RES, V216, P61, DOI 10.1007/s00221-011-2908-4; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sartori L, 2013, SOC COGN AFFECT NEUR, V8, P662, DOI 10.1093/scan/nss044; Sartori L, 2013, NEUROREPORT, V24, P63, DOI 10.1097/WNR.0b013e32835c6e6a; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; Senot P, 2011, EXP BRAIN RES, V211, P161, DOI 10.1007/s00221-011-2635-x; Small SL, 2012, DEV PSYCHOBIOL, V54, P293, DOI 10.1002/dev.20504; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Turella L, 2009, NEUROIMAGE, V46, P844, DOI 10.1016/j.neuroimage.2009.03.002; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Winter D. A., 2005, BIOMECHANICS MOTOR C, P36	65	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114355	10.1371/journal.pone.0114355	http://dx.doi.org/10.1371/journal.pone.0114355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479161	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200075
J	Le, QV; Isbell, LA; Matsumoto, J; Le, VQ; Hori, E; Tran, AH; Maior, RS; Tomaz, C; Ono, T; Nishijo, H				Quan Van Le; Isbell, Lynne A.; Matsumoto, Jumpei; Van Quang Le; Hori, Etsuro; Anh Hai Tran; Maior, Rafael S.; Tomaz, Carlos; Ono, Taketoshi; Nishijo, Hisao			Monkey Pulvinar Neurons Fire Differentially to Snake Postures	PLOS ONE			English	Article							RAPID DETECTION; RESPONSES; AMYGDALA; STIMULI; THREAT; ATTENTION; DISTANCE; BEHAVIOR; GRASS; FEAR	There is growing evidence from both behavioral and neurophysiological approaches that primates are able to rapidly discriminate visually between snakes and innocuous stimuli. Recent behavioral evidence suggests that primates are also able to discriminate the level of threat posed by snakes, by responding more intensely to a snake model poised to strike than to snake models in coiled or sinusoidal postures (Etting and Isbell 2014). In the present study, we examine the potential for an underlying neurological basis for this ability. Previous research indicated that the pulvinar is highly sensitive to snake images. We thus recorded pulvinar neurons in Japanese macaques (Macaca fuscata) while they viewed photos of snakes in striking and non-striking postures in a delayed non-matching to sample (DNMS) task. Of 821 neurons recorded, 78 visually responsive neurons were tested with the all snake images. We found that pulvinar neurons in the medial and dorsolateral pulvinar responded more strongly to snakes in threat displays poised to strike than snakes in non-threat-displaying postures with no significant difference in response latencies. A multidimensional scaling analysis of the 78 visually responsive neurons indicated that threat-displaying and non-threat-displaying snakes were separated into two different clusters in the first epoch of 50 ms after stimulus onset, suggesting bottom-up visual information processing. These results indicate that pulvinar neurons in primates discriminate between poised to strike from those in non-threat-displaying postures. This neuronal ability likely facilitates behavioral discrimination and has clear adaptive value. Our results are thus consistent with the Snake Detection Theory, which posits that snakes were instrumental in the evolution of primate visual systems.	[Quan Van Le; Matsumoto, Jumpei; Van Quang Le; Hori, Etsuro; Anh Hai Tran; Ono, Taketoshi; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Isbell, Lynne A.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil; [Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Inst Biol, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil	University of Toyama; University of California System; University of California Davis; Universidade de Brasilia; Universidade de Brasilia	Nishijo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	nishijo@med.u-toyama.ac.jp	Maior, Rafael S./F-3994-2012; Tomaz, Carlos A B/F-8626-2012	Maior, Rafael S./0000-0001-7219-8675; Matsumoto, Jumpei/0000-0003-4729-2816	Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [25290005]; National Bio-Resource Project "Japanese Monkeys" of the MEXT, Japan	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Bio-Resource Project "Japanese Monkeys" of the MEXT, Japan	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program; the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25290005); National Bio-Resource Project "Japanese Monkeys" of the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1984, ANIM BEHAV, V32, P1108, DOI 10.1016/S0003-3472(84)80227-4; Asahi T, 2003, NEUROSCI RES, V47, P255, DOI 10.1016/S0168-0102(03)00202-5; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; DELLOMO G, 1994, PHYSIOL BEHAV, V55, P125, DOI 10.1016/0031-9384(94)90019-1; Etting SF, 2014, ETHOLOGY IN PRESS; Etting SF, 2014, AM J PRIMATOL, V76, P135, DOI 10.1002/ajp.22216; Greene H.W., 1988, Biology of Reptilia, V16, P1; Greene H. W., 1997, SNAKES EVOLUTION MYS; Hayakawa S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00080; Isbell L. A., 2009, FRUIT TREE SERPENT W; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kusama T., 1970, STEREOTAXIC ATLAS BR; LEVINE S, 1993, BEHAV NEURAL BIOL, V60, P225, DOI 10.1016/0163-1047(93)90428-K; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; LoBue V, 2011, VIS COGN, V19, P129, DOI 10.1080/13506285.2010.522216; LoBue V, 2010, DEVELOPMENTAL SCI, V13, P221, DOI 10.1111/j.1467-7687.2009.00872.x; Maior RS, 2011, NEUROSCI LETT, V504, P257, DOI 10.1016/j.neulet.2011.09.042; Maior RS, 2010, BEHAV BRAIN RES, V215, P129, DOI 10.1016/j.bbr.2010.07.009; Masataka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015122; Matsuda K., 1996, NEUROSCI RES, V25, pS270, DOI [10.1016/0168-0102(96)89315-1, DOI 10.1016/0168-0102(96)89315-1]; Nguyen MN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00085; Nguyen MN, 2013, EUR J NEUROSCI, V37, P35, DOI 10.1111/ejn.12020; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Nelson EE, 2003, EMOTION, V3, P3, DOI 10.1037/1528-3542.3.1.3; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; Penkunas MJ, 2013, DEVELOPMENTAL SCI, V16, P1; RANDALL JA, 1995, BEHAV ECOL SOCIOBIOL, V36, P243, DOI 10.1007/s002650050146; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Shibasaki M, 2009, J COMP PSYCHOL, V123, P131, DOI 10.1037/a0015095; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Tazumi T, 2010, NEUROSCIENCE, V169, P287, DOI 10.1016/j.neuroscience.2010.04.028; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; Ward R, 2005, CURR BIOL, V15, P571, DOI 10.1016/j.cub.2005.01.056; WIENER SG, 1992, DEV PSYCHOBIOL, V25, P127, DOI 10.1002/dev.420250205; Young F.W., 1987, MULTIDIMENSIONAL SCA	44	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114258	10.1371/journal.pone.0114258	http://dx.doi.org/10.1371/journal.pone.0114258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479158	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200058
J	Wald, DS; Bestwick, JP; Reiman, L; Brendell, R; Wald, NJ				Wald, David S.; Bestwick, Jonathan P.; Reiman, Lewis; Brendell, Rebecca; Wald, Nicholas J.			Randomised Trial of Text Messaging on Adherence to Cardiovascular Preventive Treatment (INTERACT Trial)	PLOS ONE			English	Article							DISEASE	Background: About one third of patients prescribed blood pressure or lipid-lowering drugs for the prevention of coronary heart disease and stroke do not take their medication as prescribed. We conducted a randomized trial to evaluate text messaging as a means of improving adherence to cardiovascular disease preventive treatment. Methods: 303 patients taking blood pressure and/or lipid-lowering medications were randomly assigned to being sent text messages (Text group, 151) or not being sent them (No text group, 152). Texts were sent daily for 2 weeks, alternate days for 2 weeks and weekly thereafter for 22 weeks (6 months overall), using an automated computer programme. Patients were asked to respond on whether they had taken their medication, whether the text reminded them to do so if they had forgotten, and if they had not taken their medication to determine if there was a reason for not doing so. At 6 months, use of medication was assessed. Results: Two patients were lost to follow-up, providing data on 301 for analysis. In the No text group 38/151 (25%) took less than 80% of the prescribed regimen (ie. stopped medication completely or took it on fewer than 22 of the last 28 days of follow-up) compared to 14/150 patients (9%) in the Text group - an improvement in adherence affecting 16 per 100 patients (95% CI 7 to 24), p<0.001. The texts reminded 98/151 patients (65%) to take medication on at least one occasion and lead to 20/151 (13%) who stopped taking medication because of concern over efficacy or side-effects, resuming treatment. Conclusions: In patients taking blood pressure or lipid-lowering treatment for the prevention of cardiovascular disease, text messaging improved medication adherence compared with no text messaging.	[Wald, David S.; Bestwick, Jonathan P.; Reiman, Lewis; Brendell, Rebecca; Wald, Nicholas J.] Queen Mary Univ London, Wolfson Inst Prevent Med, London EC1M 6BQ, England	University of London; Queen Mary University London	Wald, DS (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Charterhouse Sq, London EC1M 6BQ, England.	d.s.wald@qmul.ac.uk	Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021		Astra Zeneca; Queen Mary Innovation	Astra Zeneca(AstraZeneca); Queen Mary Innovation	This work was supported by Astra Zeneca, Barts Hospital Special Trustees and Queen Mary Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AW, 2009, ARCH DERMATOL, V145, P1230, DOI 10.1001/archdermatol.2009.269; Cocosila M, 2009, INT J MED INFORM, V78, P230, DOI 10.1016/j.ijmedinf.2008.07.011; Karve S, 2009, CURR MED RES OPIN, V25, P2303, DOI 10.1185/03007990903126833; Leong KC, 2006, FAM PRACT, V23, P699, DOI 10.1093/fampra/cml044; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Marquez Contreras E, 2004, ATEN PRIM, V34, P399; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; National Hospital for Neurology and Neurosurgery, NAT HOSP IPLATE LAUN; OK Communications, 2014 FACTS FIG; Ollivier L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-236; Pew Research Center's Internet & American Life Project, 2013, TRACK SURV; Suffoletto B, 2012, ACAD EMERG MED, V19, P949, DOI 10.1111/j.1553-2712.2012.01411.x; Vilella A, 2004, PREV MED, V38, P503, DOI 10.1016/j.ypmed.2003.12.005; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WHO, ADHERENCE LONG TERM; World Health Organization, TOP 10 CAUS DEATH	17	63	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114268	10.1371/journal.pone.0114268	http://dx.doi.org/10.1371/journal.pone.0114268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479285	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200060
J	Wooliver, R; Senior, JK; Schweitzer, JA; O'Reilly-Wapstra, JM; Langley, JA; Chapman, SK; Bailey, JK				Wooliver, Rachel; Senior, John K.; Schweitzer, Jennifer A.; O'Reilly-Wapstra, Julianne M.; Langley, J. Adam; Chapman, Samantha K.; Bailey, Joseph K.			Evolutionary History and Novel Biotic Interactions Determine Plant Responses to Elevated CO2 and Nitrogen Fertilization	PLOS ONE			English	Article							PHYLOGENETIC NICHE CONSERVATISM; ECOSYSTEM RESPONSE; DIVERSITY; GROWTH; DEPOSITION; TRAITS; BIODIVERSITY; PLANTATIONS; ADAPTATION; LIMITATION	A major frontier in global change research is predicting how multiple agents of global change will alter plant productivity, a critical component of the carbon cycle. Recent research has shown that plant responses to climate change are phylogenetically conserved such that species within some lineages are more productive than those within other lineages in changing environments. However, it remains unclear how phylogenetic patterns in plant responses to changing abiotic conditions may be altered by another agent of global change, the introduction of non-native species. Using a system of 28 native Tasmanian Eucalyptus species belonging to two subgenera, Symphyomyrtus and Eucalyptus, we hypothesized that productivity responses to abiotic agents of global change (elevated CO2 and increased soil N) are unique to lineages, but that novel interactions with a non-native species mediate these responses. We tested this hypothesis by examining productivity of 1) native species monocultures and 2) mixtures of native species with an introduced hardwood plantation species, Eucalyptus nitens, to experimentally manipulated soil N and atmospheric CO2. Consistent with past research, we found that N limits productivity overall, especially in elevated CO2 conditions. However, monocultures of species within the Symphyomyrtus subgenus showed the strongest response to N (gained 127% more total biomass) in elevated CO2 conditions, whereas those within the Eucalyptus subgenus did not respond to N. Root: shoot ratio (an indicator of resource use) was on average greater in species pairs containing Symphyomyrtus species, suggesting that functional traits important for resource uptake are phylogenetically conserved and explaining the phylogenetic pattern in plant response to changing environmental conditions. Yet, native species mixtures with E. nitens exhibited responses to CO2 and N that differed from those of monocultures, supporting our hypothesis and highlighting that both plant evolutionary history and introduced species will shape community productivity in a changing world.	[Wooliver, Rachel; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Senior, John K.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [O'Reilly-Wapstra, Julianne M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia; [Langley, J. Adam; Chapman, Samantha K.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tasmania; University of Tasmania; Villanova University	Wooliver, R (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	rwoolive@utk.edu	O'Reilly-Wapstra, Julianne M/J-7275-2014	O'Reilly-Wapstra, Julianne M/0000-0003-4801-4412; Wooliver, Rachel/0000-0002-7723-437X				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Aiken L. S., 1991, MULTIPLE REGRESSION; Amr A, 2001, J FOOD COMPOS ANAL, V14, P59, DOI 10.1006/jfca.2000.0950; Anekonda TS, 1999, FUNCT ECOL, V13, P675, DOI 10.1046/j.1365-2435.1999.00367.x; Barbour RC, 2010, FOREST ECOL MANAG, V260, P2079, DOI 10.1016/j.foreco.2010.08.049; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Churkina G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003291; Cleland EE, 2010, ANN NY ACAD SCI, V1195, P46, DOI 10.1111/j.1749-6632.2010.05458.x; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; Davis CC, 2010, PHILOS T R SOC B, V365, P3201, DOI 10.1098/rstb.2010.0130; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dimarco RD, 2013, ECOL ENTOMOL, V38, P535, DOI 10.1111/een.12046; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Felker-Quinn E, 2011, ECOLOGY, V92, P1208, DOI 10.1890/10-1370.1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Genung MA, 2014, PEERJ, V2, DOI 10.7717/peerj.288; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2011, OECOLOGIA, V166, P197, DOI 10.1007/s00442-010-1808-9; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Judd TS, 1996, FOREST ECOL MANAG, V82, P87, DOI 10.1016/0378-1127(95)03693-8; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019992; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kulmatiski A, 2007, CAN J FOREST RES, V37, P1574, DOI 10.1139/X07-040; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lankau RA, 2013, ECOLOGY, V94, P32, DOI 10.1890/12-0675.1; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; May B, 2009, REV FERTILISER USE A; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; NOBLE IR, 1989, AUST J BOT, V37, P207, DOI 10.1071/BT9890207; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schweitzer JA, 1999, J TORREY BOT SOC, V126, P15, DOI 10.2307/2997251; Senior JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060088; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Strauss Sharon Y, 2006, Ecol Lett, V9, P357, DOI 10.1111/j.1461-0248.2005.00874.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallis IR, 2010, FOREST ECOL MANAG, V260, P814, DOI 10.1016/j.foreco.2010.05.040; Warren CR, 2002, TREE PHYSIOL, V22, P11, DOI 10.1093/treephys/22.1.11; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams K. J., 1996, Tasforests, V8, P39; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100	64	3	3	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114596	10.1371/journal.pone.0114596	http://dx.doi.org/10.1371/journal.pone.0114596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479056	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200107
J	Isomura, T; Kono, T; Hindmarch, I; Kikuchi, N; Murakami, A; Inuzuka, K; Kawana, S				Isomura, Tatsuya; Kono, Takeshi; Hindmarch, Ian; Kikuchi, Norimasa; Murakami, Aya; Inuzuka, Kyoko; Kawana, Seiji			Central Nervous System Effects of the Second-Generation Antihistamines Marketed in Japan -Review of Inter-Drug Differences Using the Proportional Impairment Ratio (PIR)-	PLOS ONE			English	Review							POSITRON-EMISSION-TOMOGRAPHY; PSYCHOMOTOR PERFORMANCE; HEALTHY-VOLUNTEERS; DOUBLE-BLIND; H-1-RECEPTOR ANTAGONISTS; COGNITIVE PERFORMANCE; DRIVING PERFORMANCE; DOSE FEXOFENADINE; CETIRIZINE; PLACEBO	Background: Second-generation antihistamines (AHs) have, in general, fewer sedative effects than the first-generation. However, important inter-drug differences remain in the degree of cognitive and/or psychomotor impairment. The extent to which a particular compound causes disruption can be conveniently compared, to all other AHs, using the Proportional Impairment Ratio (PIR). Although the PIR can differentiate the relative impairment caused by individual drugs, there is no indication of the reliability of the ratios obtained. Objective: To calculate the PIRs -together with 95% confidence intervals (CIs), as an index of reliability- and compare AHs currently, or soon to be, available in Japan, with respect to their intrinsic capacity to cause impairment. Methods: Results from studies of cetirizine, desloratadine, ebastine, fexofenadine, levocetirizine, loratadine, mequitazine, and olopatadine were included in the PIR calculations. All data utilised came from crossover studies in healthy volunteers which were randomised and placebo and positive-internal controlled. Existing databases from studies reporting the sedative effects of AHs on objective (speed, accuracy, memory) and subjective (feeling) psychometrics were augmented, via results from suitable studies published after the previous reviews. The null value for a PIR was one. Results: A total of 45 studies were finally included for this review. Of the AHs assessed, fexofenadine, ebastine, and levocetirizine showed a PIR for objective tests of 0. However, only fexofenadine (PIR=0.49) had an upper limit of the 95% CI of less than 1. Fexofenadine, levocetirizine, desloratadine, olopatadine, loratadine, and mequitazine all had a PIR for subjective ratings of 0, but the upper limits of the 95% CIs were all in excess of 1, although fexofenadine (PIR=2.57) was the lowest. Conclusions: The results show that there are differences between second-generation AHs in the extent of sedation produced. However, subjective ratings indicate that patients may not necessarily be aware of this.	[Isomura, Tatsuya; Kikuchi, Norimasa; Murakami, Aya; Inuzuka, Kyoko] CLINICAL STUDY SUPPORT Inc, Nagoya, Aichi, Japan; [Isomura, Tatsuya] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan; [Kono, Takeshi] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Dermatol, Chiba, Japan; [Hindmarch, Ian] Univ Surrey, Guildford GU2 5XH, Surrey, England; [Kawana, Seiji] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan	Tokyo Medical University; Nippon Medical School; University of Surrey; Nippon Medical School	Isomura, T (corresponding author), CLINICAL STUDY SUPPORT Inc, Nagoya, Aichi, Japan.	tatsuya_isomura@jp-css.com			Sanofi.K.K.	Sanofi.K.K.	CLINICAL STUDY SUPPORT, Inc., which some authors belong to, was funded by Sanofi.K.K. for data collection and analysis as well as reporting. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annpey P., 1997, DRUG INF J, V31, P1167; Barbier A. J., 2007, CNS & Neurological Disorders-Drug Targets, V6, P31, DOI 10.2174/187152707779940790; Bower EA, 2003, AVIAT SPACE ENVIR MD, V74, P145; Boyle J, 2006, CURR MED RES OPIN, V22, P1343, DOI 10.1185/030079906X112660; BRADLEY CM, 1987, EUR J CLIN PHARMACOL, V32, P419, DOI 10.1007/BF00543979; BROOKHUIS KA, 1993, BRIT J CLIN PHARMACO, V36, P67, DOI 10.1111/j.1365-2125.1993.tb05894.x; Cockburn IM, 1999, J OCCUP ENVIRON MED, V41, P948, DOI 10.1097/00043764-199911000-00005; Cookson J, 2002, USE DRUGS PSYCHIAT E; Cornfield J, 1956, STAT PROBLEM ARISING, P135; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; GAILLARD AWK, 1988, EUR J CLIN PHARMACOL, V35, P249, DOI 10.1007/BF00558261; Gandon JM, 2002, BRIT J CLIN PHARMACO, V54, P51, DOI 10.1046/j.1365-2125.2002.01611.x; GENGO FM, 1987, CLIN PHARMACOL THER, V42, P265, DOI 10.1038/clpt.1987.145; GENGO FM, 1990, ANN ALLERGY, V64, P520; GENGO FM, 1987, ANN ALLERGY, V59, P53; Hindmarch I, 1999, BRIT J CLIN PHARMACO, V48, P200, DOI 10.1046/j.1365-2125.1999.00993.x; Hindmarch I, 2002, CLIN EXP ALLERGY, V32, P133, DOI 10.1046/j.0022-0477.2001.01245.x; Hindmarch I, 2001, CURR MED RES OPIN, V17, P273; Hindmarch I, 2001, CURR MED RES OPIN, V17, P241, DOI 10.1185/0300799019117011; Hindmarch I, 2009, HUM PSYCHOPHARMACOL, V24; Hindmarch I, 2004, ADV STUDIES MED, V4, pS501; Hindmarch I, 2002, ADV STUD MED, V2, P867; Holgate ST, 2003, CLIN EXP ALLERGY, V33, P1305, DOI 10.1046/j.1365-2222.2003.01769.x; HOPES H, 1992, EUR J CLIN PHARMACOL, V42, P55, DOI 10.1007/BF00314920; Huitfeldt B, 2001, DRUG INF J, V35, P1147, DOI 10.1177/009286150103500411; Kamei H, 2003, HUM PSYCHOPHARM CLIN, V18, P611, DOI 10.1002/hup.538; Kamei H, 2012, ARCH DERMATOL RES, V304, P263, DOI 10.1007/s00403-011-1192-2; Kavanagh JJ, 2012, CLIN NEUROPHYSIOL, V123, P780, DOI 10.1016/j.clinph.2011.07.046; LEVANDER S, 1991, EUR J CLIN PHARMACOL, V41, P435, DOI 10.1007/BF00626365; Mansfield L, 2003, ANN ALLERG ASTHMA IM, V90, P554, DOI 10.1016/S1081-1206(10)61850-9; McDonald K, 2008, HUM PSYCHOPHARM CLIN, V23, P555, DOI 10.1002/hup.962; NICHOLSON AN, 1983, EUR J CLIN PHARMACOL, V25, P563, DOI 10.1007/BF00542129; Nicholson AN, 2000, AVIAT SPACE ENVIR MD, V71, P2; Nicholson AN, 1998, AVIAT SPACE ENVIR MD, V69, P166; Nicholson AN, 2003, AVIAT SPACE ENVIR MD, V74, P809; Nolen TM, 1997, CLIN THER, V19, P39, DOI 10.1016/S0149-2918(97)80071-9; OHANLON JF, 1988, CUTIS, V42, P10; Passalacqua G, 1993, Allergol Immunopathol (Madr), V21, P79; Poza J, 2007, P ANN INT IEEE EMBS, P23, DOI 10.1109/IEMBS.2007.4352213; Ridout F, 2003, CLIN THER, V25, P1518, DOI 10.1016/S0149-2918(03)80137-6; Ridout F, 2003, ANN ALLERG ASTHMA IM, V90, P404, DOI 10.1016/S1081-1206(10)61824-8; ROTH T, 1987, J ALLERGY CLIN IMMUN, V80, P94, DOI 10.1016/S0091-6749(87)80197-5; SCHWEITZER PK, 1994, J ALLERGY CLIN IMMUN, V94, P716, DOI 10.1016/0091-6749(94)90179-1; Senn S, 2002, CROSS OVER TRIALS CL; Shamsi Z, 2000, HUM PSYCHOPHARM CLIN, V15, pS3, DOI 10.1002/1099-1077(200010)15:1+<::AID-HUP247>3.0.CO;2-S; Shamsi Z, 2001, EUR J CLIN PHARMACOL, V56, P865, DOI 10.1007/s002280000257; Shamsi Z, 2000, INT J NEUROPSYCHOPH, V3, pS174; Simons FER, 1995, ANN ALLERG ASTHMA IM, V75, P507; Simons FER, 1996, CLIN EXP ALLERGY, V26, P1092; STARMER G, 1985, ACCIDENT ANAL PREV, V17, P311, DOI 10.1016/0001-4575(85)90032-6; Tagawa M, 2002, BRIT J CLIN PHARMACO, V53, P296, DOI 10.1046/j.0306-5251.2001.01183.x; Tashiro M, 2005, HUM PSYCHOPHARM CLIN, V20, P501, DOI 10.1002/hup.713; Tashiro M, 2004, J CLIN PHARMACOL, V44, P890, DOI 10.1177/0091270004267590; Tashiro M, 2009, HUM PSYCHOPHARM CLIN, V24, P540, DOI 10.1002/hup.1051; Theunissen EL, 2006, BRIT J CLIN PHARMACO, V61, P79, DOI 10.1111/j.1365-2125.2005.02524.x; Theunissen EL, 2004, CLIN EXP ALLERGY, V34, P250, DOI 10.1111/j.1365-2222.2004.01874.x; Vacchiano C, 2008, AVIAT SPACE ENVIR MD, V79, P754, DOI 10.3357/ASEM.2212.2008; Valk PJL, 2004, AVIAT SPACE ENVIR MD, V75, P433; Vermeeren A, 1998, J ALLERGY CLIN IMMUN, V101, P306, DOI 10.1016/S0091-6749(98)70240-4; Verster JC, 2003, PSYCHOPHARMACOLOGY, V169, P84, DOI 10.1007/s00213-003-1462-6; Verster JC, 2003, J ALLERGY CLIN IMMUN, V111, P623, DOI 10.1067/mai.2003.63; VOLKERTS ER, 1992, HUM PSYCHOPHARM CLIN, V7, P227, DOI 10.1002/hup.470070402; Vuurman EFPM, 2004, EUR J CLIN PHARMACOL, V60, P307, DOI 10.1007/s00228-004-0757-9; Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034; WALSH JK, 1992, ANN ALLERGY, V69, P195; Yanai K, 2011, EXPERT OPIN DRUG SAF, V10, P613, DOI 10.1517/14740338.2011.562889	66	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114336	10.1371/journal.pone.0114336	http://dx.doi.org/10.1371/journal.pone.0114336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501360	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400029
J	Abbott, CJ; Choe, TE; Burgoyne, CF; Cull, G; Wang, L; Fortune, B				Abbott, Carla J.; Choe, Tiffany E.; Burgoyne, Claude F.; Cull, Grant; Wang, Lin; Fortune, Brad			Comparison of Retinal Nerve Fiber Layer Thickness In Vivo and Axonal Transport after Chronic Intraocular Pressure Elevation in Young versus Older Rats	PLOS ONE			English	Article							RETROGRADE AXOPLASMIC-TRANSPORT; GANGLION-CELL LOSS; INDUCED OCULAR HYPERTENSION; OPEN-ANGLE GLAUCOMA; ACUTE IOP ELEVATION; OPTIC-NERVE; PREDICTIVE FACTORS; BLOOD-PRESSURE; RISK-FACTORS; HEAD	Purpose: To compare in young and old rats longitudinal measurements of retinal nerve fiber layer thickness (RNFLT) and axonal transport 3-weeks after chronic IOP elevation. Method: IOP was elevated unilaterally in 2- and 9.5-month-old Brown-Norway rats by intracameral injections of magnetic microbeads. RNFLT was measured by spectral domain optical coherence tomography. Anterograde axonal transport was assessed from confocal scanning laser ophthalmolscopy of superior colliculi (SC) after bilateral intravitreal injections of cholera toxin-B-488. Optic nerve sections were graded for damage. Results: Mean IOP was elevated in both groups (young 37, old 38 mmHg, p=0.95). RNFL in young rats exhibited 10% thickening at 1-week (50.9 +/- 8.1 mm, p<0.05) vs. baseline (46.4 +/- 2.4 mu m), then 7% thinning at 2-weeks (43.0 +/- 7.2 mu m, p>0.05) and 3-weeks (43.5 +/- 4.4 mu m, p>0.05), representing 20% loss of dynamic range. RNFLT in old rats showed no significant change at 1-week (44.9 +/- 4.1 mu m) vs. baseline (49.2 +/- 5.3 mm), but progression to 22% thinning at 2-weeks (38.0 +/- 3.7 mu m, p<0.01) and 3-weeks (40.0 +/- 6.6 mu m, p<0.05), representing 59% loss of dynamic range. Relative SC fluorescence intensity was reduced in both groups (p<0.001), representing 77-80% loss of dynamic range and a severe transport deficit. Optic nerves showed 75-95% damage (p<0.001). There was greater RNFL thinning in old rats (p<0.05), despite equivalent IOP insult, transport deficit and nerve damage between age groups (all p>0.05). Conclusion: Chronic IOP elevation resulted in severely disrupted axonal transport and optic nerve axon damage in all rats, associated with mild RNFL loss in young rats but a moderate RNFL loss in old rats despite the similar IOP insult. Hence, the glaucomatous injury response within the RNFL depends on age.	[Abbott, Carla J.; Choe, Tiffany E.; Burgoyne, Claude F.; Cull, Grant; Wang, Lin; Fortune, Brad] Devers Eye Inst & Legacy Res Inst, Discoveries Sight Res Labs, Portland, OR 97232 USA	Devers Eye Institute	Fortune, B (corresponding author), Devers Eye Inst & Legacy Res Inst, Discoveries Sight Res Labs, Portland, OR 97232 USA.	bfortune@deverseye.org	Abbott, Carla J/H-9510-2019	Abbott, Carla J/0000-0002-1432-8977; Burgoyne, Claude/0000-0002-2765-4739; Wang, Lin/0000-0003-0385-8478; Fortune, Brad/0000-0003-0284-5173	National Institutes of Health, National Eye Institute [R21-EY021311]; Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH; NATIONAL EYE INSTITUTE [R21EY021311] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Legacy Good Samaritan Foundation; Heidelberg Engineering, GmbH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by National Institutes of Health, National Eye Institute Grant: R21-EY021311 (BF), Legacy Good Samaritan Foundation (BF) and Heidelberg Engineering, GmbH (equipment support, CFB, BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; Abbott CJ, 2013, BIOMED OPT EXPRESS, V4, P364, DOI 10.1364/BOE.4.000364; Agudo-Barriuso M, 2013, CURR OPIN PHARMACOL, V13, P5, DOI 10.1016/j.coph.2012.09.006; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Araie M, 2013, JPN J OPHTHALMOL, V57, P1, DOI 10.1007/s10384-012-0181-0; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Belforte N, 2010, INVEST OPHTH VIS SCI, V51, P5768, DOI 10.1167/iovs.10-5660; Ben Simon GJ, 2006, AM J OPHTHALMOL, V141, P1105, DOI 10.1016/j.ajo.2006.01.073; Benozzi J, 2002, INVEST OPHTH VIS SCI, V43, P2196; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Bui BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070513; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Bui BV, 2013, J OPHTHALMOL, V2013, P1; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Calkins DJ, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12784; Cepurna WO, 2005, EXP EYE RES, V80, P877, DOI 10.1016/j.exer.2004.12.021; Charng J, 2013, OPTOMETRY VISION SCI, V90, P275, DOI 10.1097/OPX.0b013e3182826025; Chauhan BC, 2006, INVEST OPHTH VIS SCI, V47, P634, DOI 10.1167/iovs.05-1206; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Choe TE, 2014, PLOS ONE IN PRESS; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Chrysostomou V, 2010, OPHTHALMIC RES, V44, P173, DOI 10.1159/000316478; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Cull GA, 2012, INVEST OPHTH VIS SCI, V53, P7766, DOI 10.1167/iovs.12-10752; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; Fortune B, 2013, INVEST OPHTH VIS SCI, V54, P5653, DOI 10.1167/iovs.13-12219; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; Fortune B, 2009, INVEST OPHTH VIS SCI, V50, P4719, DOI 10.1167/iovs.08-3289; Gramlich OW, 2014, INVEST OPHTH VIS SCI, V55, P600, DOI 10.1167/iovs.13-12714; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; Holcombe DJ, 2008, ACTA OPHTHALMOL, V86, P408, DOI 10.1111/j.1600-0420.2007.01052.x; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2013, EXP NEUROL, V246, P54, DOI 10.1016/j.expneurol.2012.01.014; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; JOHANSSON JO, 1986, EXP EYE RES, V43, P653, DOI 10.1016/S0014-4835(86)80031-8; JOHANSSON JO, 1988, EXP EYE RES, V46, P223, DOI 10.1016/S0014-4835(88)80079-4; Joos KM, 2010, INVEST OPHTH VIS SCI, V51, P6431, DOI 10.1167/iovs.10-5212; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P3028, DOI 10.1167/iovs.13-11865; KITAZAWA Y, 1975, AM J OPHTHALMOL, V79, P557, DOI 10.1016/0002-9394(75)90792-8; Kong YXG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.026; LAND PW, 1979, SCIENCE, V205, P698, DOI 10.1126/science.462177; Lee SH, 2010, J GLAUCOMA, V19, P637, DOI 10.1097/IJG.0b013e3181ca7cbe; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liang Y, 2009, INVEST OPHTH VIS SCI, V50, P2154, DOI 10.1167/iovs.08-2882; Liu X, 2010, INT J OPHTHALMOL-CHI, V3, P152, DOI 10.3980/j.issn.2222-3959.2010.02.14; Lozano DC, 2013, INVEST OPHTH VIS SCI, V54, P6446, DOI 10.1167/iovs.13-12575; Manni G, 1996, GRAEF ARCH CLIN EXP, V234, pS209, DOI 10.1007/BF02343074; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; MINCKLER DS, 1977, INVEST OPHTH VIS SCI, V16, P426; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Mwanza JC, 2010, INVEST OPHTH VIS SCI, V51, P5724, DOI 10.1167/iovs.10-5222; Nagata A, 2009, INVEST OPHTH VIS SCI, V50, P2809, DOI 10.1167/iovs.08-2764; Ngumah QC, 2006, EXP EYE RES, V83, P390, DOI 10.1016/j.exer.2006.01.015; Nguyen C, 2013, INVEST OPHTH VIS SCI, V54, P1767, DOI 10.1167/iovs.12-10952; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Patel NB, 2011, INVEST OPHTH VIS SCI, V52, P2477, DOI 10.1167/iovs.10-6105; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P640; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; Reynaud J, 2012, INVEST OPHTH VIS SCI, V53, P2951, DOI 10.1167/iovs.11-9274; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Samsel PA, 2011, INVEST OPHTH VIS SCI, V52, P1671, DOI 10.1167/iovs.09-3921; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Sung Velota C T, 2004, Curr Opin Ophthalmol, V15, P136, DOI 10.1097/00055735-200404000-00014; Thuen M, 2008, J MAGN RESON IMAGING, V28, P855, DOI 10.1002/jmri.21504; Torngren L, 2000, J CATARACT REFR SURG, V26, P1247, DOI 10.1016/S0886-3350(00)00407-7; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Weber AJ, 2001, J NEUROSCI METH, V111, P39, DOI 10.1016/S0165-0270(01)00443-5	87	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114546	10.1371/journal.pone.0114546	http://dx.doi.org/10.1371/journal.pone.0114546			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501362	Green Published, gold			2022-12-27	WOS:000347146700031
J	Kim, J; Noh, JW; Park, J; Kwon, YD				Kim, Jinseok; Noh, Jin-Won; Park, Jumin; Kwon, Young Dae			Body Mass Index and Depressive Symptoms in Older Adults: A Cross-Lagged Panel Analysis	PLOS ONE			English	Article							GENERAL-POPULATION; JOLLY FAT; OBESITY; ASSOCIATION; PREVALENCE; OVERWEIGHT; DISORDER; WEIGHT; KOREA	Background: There are conflicting results about the association between body mass index (BMI) and depressive symptoms in older adults. The present study examined the relationship between weight and depressive symptoms over time in older adults in South Korea. Methods: We used data from three waves of the Korean Longitudinal Study of Aging and ran a series of cross-lagged panel models to test the reciprocal relationship between depressive symptoms and obesity in older Korean adults. We assumed a temporally stable relationship between depressive symptoms and obesity and, thus imposed equality constraints over time. Results: After controlling for the effect of depressive symptoms two years prior, underweight older adults had a higher depressive symptom score than those of normal weight. When controlling for obesity status from two years prior, older adults with higher levels of depressive symptoms were more likely to be underweight and less likely to be overweight than normal weight. The same patterns were observed in data from 2006 to 2008 and from 2008 to 2010. Conclusions: These results show that there is a correlation between depressive symptoms and weight status. In middle-aged and elderly Asian populations, depression can lead to weight loss rather than obesity, and underweight may develop depressive symptoms.	[Kim, Jinseok] Seoul Womens Univ, Dept Social Welf, Seoul, South Korea; [Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Songnam, South Korea; [Park, Jumin] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Kwon, Young Dae] Catholica Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholica Univ Korea, Catholica Inst Healthcare Management, Seoul, South Korea	Seoul Women's University; Eulji University; University System of Maryland; University of Maryland Baltimore; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholica Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.	snukydl@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832				Andersen I, 2011, SCAND J PUBLIC HEALT, V39, P857, DOI 10.1177/1403494811424611; [Anonymous], 2013, OB OV; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251; Chang HH, 2012, AGING MENT HEALTH, V16, P173, DOI 10.1080/13607863.2011.605053; Cho MJ, 1998, J NERV MENT DIS, V186, P304, DOI 10.1097/00005053-199805000-00007; CRISP AH, 1980, J PSYCHOSOM RES, V24, P233, DOI 10.1016/0022-3999(80)90013-6; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Dong C, 2004, INT J OBESITY, V28, P790, DOI 10.1038/sj.ijo.0802626; Forman-Hoffman VL, 2007, J GERONTOL B-PSYCHOL, V62, pS43, DOI 10.1093/geronb/62.1.S43; Konttinen H, 2014, INT J OBESITY, V38, P668, DOI 10.1038/ijo.2013.151; Kuo SY, 2011, PSYCHOL MED, V41, P1665, DOI 10.1017/S0033291710002473; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; McCrea R, 2011, INT J OBES LOND, V36, P414, DOI DOI 10.1038/IJ0.2011.65; Ohayon MM, 2007, J PSYCHIAT RES, V41, P207, DOI 10.1016/j.jpsychires.2006.10.006; Ohayon MM, 2006, J PSYCHIATR RES, V40, P30, DOI 10.1016/j.jpsychires.2005.02.003; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Puhl Rebecca, 2003, Eat Behav, V4, P53, DOI 10.1016/S1471-0153(02)00096-X; Sachs-Ericsson N, 2007, AM J GERIAT PSYCHIAT, V15, P815, DOI 10.1097/JGP.0b013e3180a725d6; Seidell Jacob C, 2005, Semin Vasc Med, V5, P3, DOI 10.1055/s-2005-871737; Shadish WR, 2002, EXPT QUASIEXPERIMENT, P506; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Yasamy M.T., 2012, DEPRESSION GLOBAL PU; Yu Nan-Wen, 2011, Chang Gung Med J, V34, P620; Zhong WJ, 2010, DEPRESS ANXIETY, V27, P846, DOI 10.1002/da.20666	30	27	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114891	10.1371/journal.pone.0114891	http://dx.doi.org/10.1371/journal.pone.0114891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25501372	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700063
J	Ding, BQ; Daugherty, DW; Husemann, M; Chen, M; Howe, AE; Danley, PD				Ding, Baoqing; Daugherty, Daniel W.; Husemann, Martin; Chen, Ming; Howe, Aimee E.; Danley, Patrick D.			Quantitative Genetic Analyses of Male Color Pattern and Female Mate Choice in a Pair of Cichlid Fishes of Lake Malawi, East Africa	PLOS ONE			English	Article							SEXUAL SELECTION; REPRODUCTIVE ISOLATION; SYMPATRIC SPECIATION; VICTORIA CICHLIDS; MATING PREFERENCE; PARENTAL CARE; EVOLUTION; ARCHITECTURE; TANGANYIKA; RECOGNITION	The traits involved in sexual selection, such as male secondary sexual characteristics and female mate choice, often co-evolve which can promote population differentiation. However, the genetic architecture of these phenotypes can influence their evolvability and thereby affect the divergence of species. The extraordinary diversity of East African cichlid fishes is often attributed to strong sexual selection and thus this system provides an excellent model to test predictions regarding the genetic architecture of sexually selected traits that contribute to reproductive isolation. In particular, theory predicts that rapid speciation is facilitated when male sexual traits and female mating preferences are controlled by a limited number of linked genes. However, few studies have examined the genetic basis of male secondary sexual traits and female mating preferences in cichlids and none have investigated the genetic architecture of both jointly. In this study, we artificially hybridized a pair of behaviorally isolated cichlid fishes from Lake Malawi and quantified both melanistic color pattern and female mate choice. We investigated the genetic architecture of both phenotypes using quantitative genetic analyses. Our results suggest that 1) many non-additively acting genetic factors influence melanistic color patterns, 2) female mate choice may be controlled by a minimum of 1-2 non-additive genetic factors, and 3) F-2 female mate choice is not influenced by male courting effort. Furthermore, a joint analysis of color pattern and female mate choice indicates that the genes underlying these two traits are unlikely to be physically linked. These results suggest that reproductive isolation may evolve rapidly owing to the few genetic factors underlying female mate choice. Hence, female mate choice likely played an important role in the unparalleled speciation of East African cichlid fish.	[Ding, Baoqing; Daugherty, Daniel W.; Husemann, Martin; Chen, Ming; Howe, Aimee E.; Danley, Patrick D.] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Ding, BQ (corresponding author), Baylor Univ, Dept Biol, 1 Bear Pl 97388, Waco, TX 76798 USA.	Baoqing_Ding@Baylor.edu	Husemann, Martin/C-4414-2015	Husemann, Martin/0000-0001-5536-6681; Ding, Baoqing/0000-0001-7183-9653; Danley, Patrick/0000-0001-8782-5045	Folmar Grants; American Cichlid Association; C. Gus Glasscock, Jr. Endowed Fund for Excellence in Environmental Sciences; Faculty Research Investment Program; Vice Provost for Research at Baylor University	Folmar Grants; American Cichlid Association; C. Gus Glasscock, Jr. Endowed Fund for Excellence in Environmental Sciences; Faculty Research Investment Program; Vice Provost for Research at Baylor University	The study was funded by Folmar Grants to BD & MH, a Jordan Grant from the American Cichlid Association to MH, the C. Gus Glasscock, Jr. Endowed Fund for Excellence in Environmental Sciences to MH and funds to PDD from the Faculty Research Investment Program and the Vice Provost for Research at Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerends GP., 1950, BEHAVIOUR S2, VI, P243; Barson NJ, 2007, J EVOLUTION BIOL, V20, P45, DOI 10.1111/j.1420-9101.2006.01228.x; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bonduriansky R, 2013, J EVOLUTION BIOL, V26, P76, DOI 10.1111/jeb.12028; Broadhurst PL, 1979, THEORETICAL ADV BEHA, P43; BUTLIN RK, 1989, BIOL J LINN SOC, V37, P237, DOI 10.1111/j.1095-8312.1989.tb01902.x; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Chenoweth SF, 2006, NAT REV GENET, V7, P681, DOI 10.1038/nrg1924; Chenoweth SF, 2010, ANNU REV ECOL EVOL S, V41, P81, DOI 10.1146/annurev-ecolsys-102209-144657; Couldridge VCK, 2002, BEHAV ECOL, V13, P59, DOI 10.1093/beheco/13.1.59; Craig Albertson R, 2014, MOL ECOLOGY; Danley PD, 2011, ENVIRON BIOL FISH, V92, P275, DOI 10.1007/s10641-011-9838-7; Danley PD, 2012, INT J EVOLUTIONARY B, V2012, P20, DOI DOI 10.1155/2012/; Dijkstra PD, 2007, J EVOLUTION BIOL, V20, P496, DOI 10.1111/j.1420-9101.2006.01266.x; Dijkstra PD, 2009, BEHAV ECOL, V20, P138, DOI 10.1093/beheco/arn125; Ding B, 2014, HYDROBIOLOGIA; DOMINEY WJ, 1984, EVOLUTION FISH SPECI; Falconer D. S., 1996, INTRO QUANTITATIVE G; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Genner MJ, 2012, MOL BIOL EVOL, V29, P195, DOI 10.1093/molbev/msr183; GOLDSCHMIDT T, 1990, OIKOS, V58, P356, DOI 10.2307/3545227; Gonzalez-Voyer A, 2008, EVOLUTION, V62, P2015, DOI 10.1111/j.1558-5646.2008.00426.x; Haesler MP, 2005, P ROY SOC B-BIOL SCI, V272, P237, DOI 10.1098/rspb.2004.2946; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; HAYMAN BI, 1960, BIOMETRICS, V16, P369, DOI 10.2307/2527688; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; Husemann M, 2014, J EVOLUTION BIOL, V27, P826, DOI 10.1111/jeb.12353; Kelley JL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2730; Kidd MR, 2013, BEHAV ECOL SOCIOBIOL, V67, P1307, DOI 10.1007/s00265-013-1559-9; Kidd MR, 2006, J FISH BIOL, V68, P373, DOI 10.1111/j.0022-1112.2006.00896.x; Knight ME, 1998, MOL ECOL, V7, P1605, DOI 10.1046/j.1365-294x.1998.00478.x; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A., 2016, MALAWI CICHLIDS THEI; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; KUWAMURA T, 1986, J ETHOL, V4, P129, DOI 10.1007/BF02348115; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Laturney M, 2012, INT J EVOLUTIONARY B, V2012, P13; Lynch M., 1998, GENETICS ANAL QUANTI; Magalhaes IS, 2010, J EVOLUTION BIOL, V23, P914, DOI 10.1111/j.1420-9101.2010.01960.x; MCELROY DM, 1990, ENVIRON BIOL FISH, V28, P273, DOI 10.1007/BF00751041; Merrill RM, 2011, P ROY SOC B-BIOL SCI, V278, P511, DOI 10.1098/rspb.2010.1493; Moehring AJ, 2006, GENETICS, V173, P215, DOI 10.1534/genetics.105.052993; Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; O'Quin CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-287; O'Quin CT, 2012, J EXP ZOOL PART B, V318B, P199, DOI 10.1002/jez.b.22006; OHTA T, 1974, BIOL BULL, V146, P258, DOI 10.2307/1540622; Orr HA, 2001, GENETICS, V157, P875; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Parker A, 1996, ENVIRON BIOL FISH, V47, P345, DOI 10.1007/BF00005049; Pfennig D.W., 2013, NON GENET INHERIT, V1, P17, DOI DOI 10.2478/NGI-2013-0002; Plenderleith M, 2005, BIOL LETT-UK, V1, P411, DOI 10.1098/rsbl.2005.0355; R Development Core Team, 2012, R LANG ENV STAT COMP; Rettelbach A, 2011, THEOR POPUL BIOL, V79, P82, DOI 10.1016/j.tpb.2010.12.001; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Safran RJ, 2013, TRENDS ECOL EVOL, V28, P643, DOI 10.1016/j.tree.2013.08.004; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Sefc KM, 2011, INT J EVOLUTIONARY B, V2011; Shaw KL, 2009, P NATL ACAD SCI USA, V106, P9737, DOI 10.1073/pnas.0900229106; Steinwender B, 2012, HYDROBIOLOGIA, V682, P121, DOI 10.1007/s10750-011-0766-5; Stelkens RB, 2010, EVOLUTION, V64, P617, DOI 10.1111/j.1558-5646.2009.00849.x; Streelman JT, 2003, MOL ECOL, V12, P2465, DOI 10.1046/j.1365-294X.2003.01920.x; Svensson O, 2011, INT J EVOLUTIONARY B, DOI 10.4061/2011/426179; Takahashi T, 2013, MOL ECOL, V22, P3049, DOI 10.1111/mec.12120; TREXLER JC, 1990, ANN ZOOL FENN, V27, P149; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; van der Sluijs I, 2010, CURR ZOOL, V56, P57, DOI 10.1093/czoolo/56.1.57; van Doorn GS, 1998, P ROY SOC B-BIOL SCI, V265, P1915, DOI 10.1098/rspb.1998.0520; Van Staaden MJ, 2011, CURR ZOOL, V57, P237, DOI 10.1093/czoolo/57.2.237; Velthuis BJ, 2005, ANIM BEHAV, V69, P1107, DOI 10.1016/j.anbehav.2004.06.032; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; ZENG ZB, 1992, GENETICS, V131, P987	82	15	15	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114798	10.1371/journal.pone.0114798	http://dx.doi.org/10.1371/journal.pone.0114798			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494046	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400077
J	Kuwabara, H; Heishman, SJ; Brasic, JR; Contoreggi, C; Cascella, N; Mackowick, KM; Taylor, R; Rousset, O; Willis, W; Huestis, MA; Concheiro, M; Wand, G; Wong, DF; Volkow, ND				Kuwabara, Hiroto; Heishman, Stephen J.; Brasic, James R.; Contoreggi, Carlo; Cascella, Nicola; Mackowick, Kristen M.; Taylor, Richard; Rousset, Olivier; Willis, William; Huestis, Marilyn A.; Concheiro, Marta; Wand, Gary; Wong, Dean F.; Volkow, Nora D.			Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STRIATAL DOPAMINE RELEASE; WITHDRAWAL SYMPTOMS; SMOKING; FMRI; QUANTIFICATION; REPLACEMENT; MODULATION; OCCUPANCY; RESPONSES	The rewarding effects of nicotine are associated with activation of nicotine receptors. However, there is increasing evidence that the endogenous opioid system is involved in nicotine's rewarding effects. We employed PET imaging with [C-11] carfentanil to test the hypotheses that acute cigarette smoking increases release of endogenous opioids in the human brain and that smokers have an upregulation of mu opioid receptors (MORs) when compared to nonsmokers. We found no significant changes in binding potential (BPND) of [C-11] carfentanil between the placebo and the active cigarette sessions, nor did we observe differences in MOR binding between smokers and nonsmokers. Interestingly, we showed that in smokers MOR availability in bilateral superior temporal cortices during the placebo condition was negatively correlated with scores on the Fagerstrom Test for Nicotine Dependence (FTND). Also in smokers, smoking-induced decreases in [C-11] carfentanil binding in frontal cortical regions were associated with self-reports of cigarette liking and wanting. Although we did not show differences between smokers and nonsmokers, the negative correlation with FTND corroborates the role of MORs in superior temporal cortices in nicotine addiction and provides preliminary evidence of a role of endogenous opioid signaling in frontal cortex in nicotine reward.	[Kuwabara, Hiroto; Brasic, James R.; Rousset, Olivier; Willis, William; Wong, Dean F.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Heishman, Stephen J.; Cascella, Nicola; Wong, Dean F.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA; [Wand, Gary] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Wong, Dean F.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Heishman, Stephen J.; Contoreggi, Carlo; Mackowick, Kristen M.; Taylor, Richard; Huestis, Marilyn A.; Concheiro, Marta] NIDA, Intramural Res Program, Baltimore, MD USA; [Volkow, Nora D.] NIDA, Rockville, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Kuwabara, H (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	hkuwaba1@jhmi.edu	Concheiro, Marta/A-6360-2011; Rousset, Olivier G/J-6053-2012	Concheiro, Marta/0000-0002-3858-1280; Rousset, Olivier G/0000-0003-4414-149X	NIH, National Institute on Drug Abuse; NIDA [K24 DA000412]; Radiology Internal Funds; National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH) [UL1 TR 001079]; NIH Roadmap for Medical Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000413, K24DA000412] Funding Source: NIH RePORTER	NIH, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Radiology Internal Funds; National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was provided by the Intramural Research Program of NIH, National Institute on Drug Abuse (SH, CC, KM, RT), and an award from NIDA, K24 DA000412 (DFW), as well as Radiology Internal Funds (DFW). All authors declare no conflicts of interest. Additionally, resources were provided by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by grant number UL1 TR 001079 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 2003, HUMAN BRAIN FUNCTION, V2nd, P635, DOI DOI 10.1016/B978-012264841-0/50034-2; Balfour DJK, 1996, PHARMACOL THERAPEUT, V72, P51, DOI 10.1016/S0163-7258(96)00099-X; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Baumann B, 1999, J NEUROPSYCH CLIN N, V11, P71, DOI 10.1176/jnp.11.1.71; Berrendero F, 2002, J NEUROSCI, V22, P10935; Brody AL, 2009, INT J NEUROPSYCHOPH, V12, P305, DOI 10.1017/S146114570800922X; Brody AL, 2009, NEUROPSYCHOPHARMACOL, V34, P282, DOI 10.1038/npp.2008.87; Buchhalter AR, 2005, ADDICTION, V100, P550, DOI 10.1111/j.1360-0443.2005.01030.x; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1124; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Colasanti A, 2012, BIOL PSYCHIAT, V72, P371, DOI 10.1016/j.biopsych.2012.01.027; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; DANNALS RF, 1985, INT J APPL RADIAT IS, V36, P303, DOI 10.1016/0020-708X(85)90089-4; DHATT RK, 1995, J NEUROCHEM, V64, P1878; Donny EC, 2007, ADDICTION, V102, P324, DOI 10.1111/j.1360-0443.2006.01670.x; Endres CJ, 2003, NUCL MED BIOL, V30, P177, DOI 10.1016/S0969-8051(02)00411-0; Esterlis I, 2010, J NUCL MED, V51, P1226, DOI 10.2967/jnumed.109.072447; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Hadjiconstantinou M, 2011, NEUROPHARMACOLOGY, V60, P1209, DOI 10.1016/j.neuropharm.2010.11.010; Hahn B, 2013, BIOL PSYCHIAT, V74, P436, DOI 10.1016/j.biopsych.2013.03.017; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heishman SJ, 2008, NICOTINE TOB RES, V10, P643, DOI 10.1080/14622200801908174; Hughes J, 1998, TOB CONTROL, V7, P92, DOI 10.1136/tc.7.1.92a; Hughes JR, 2006, NICOTINE TOB RES, V8, P153, DOI 10.1080/14622200500494856; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Krishnan-Sarin S, 1999, ARCH GEN PSYCHIAT, V56, P663, DOI 10.1001/archpsyc.56.7.663; Kuwabara H, 2012, J NUCL MED, V53, P805, DOI 10.2967/jnumed.111.098186; Lee JH, 2005, APPL PSYCHOPHYS BIOF, V30, P195, DOI 10.1007/s10484-005-6377-z; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MALIN DH, 1993, PSYCHOPHARMACOLOGY, V112, P339, DOI 10.1007/BF02244930; Martin-Soelch C, 2003, EUR J NEUROSCI, V18, P680, DOI 10.1046/j.1460-9568.2003.02791.x; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Rahmim A, 2005, PHYS MED BIOL, V50, P4887, DOI 10.1088/0031-9155/50/20/010; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Scott DJ, 2007, NEUROPSYCHOPHARMACOL, V32, P450, DOI 10.1038/sj.npp.1301238; Sossi V, 2005, IEEE NUCL SCI CONF R, P2195; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Weerts EM, 2013, INT J NEUROPSYCHOPH, V16, P47, DOI 10.1017/S146114571200017X; Weerts EM, 2011, ALCOHOL CLIN EXP RES, V35, P2162, DOI 10.1111/j.1530-0277.2011.01565.x; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	49	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113694	10.1371/journal.pone.0113694	http://dx.doi.org/10.1371/journal.pone.0113694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493427	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400017
J	Mueller, K; Horstman, A; Moller, HE; Anwander, A; Lepsien, J; Schroeter, ML; Villringer, A; Pleger, B				Mueller, Karsten; Horstman, Annette; Moeller, Harald E.; Anwander, Alfred; Lepsien, Joeran; Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard			Obesity Associated Cerebral Gray and White Matter Alterations Are Interrelated in the Female Brain	PLOS ONE			English	Article							BODY-MASS INDEX; LEPTIN CONCENTRATIONS; DIFFUSION; CONNECTIVITY; REGISTRATION; PARCELLATION; TRACTOGRAPHY; ENHANCEMENT; SYSTEM; CORTEX	Obesity is known to affect the brain's gray matter (GM) and white matter (WM) structure but the interrelationship of such changes remains unclear. Here we used T1-weighted magnetic resonance imaging (MRI) in combination with voxel-based morphometry (VBM) and diffusion-tensor imaging (DTI) with tract-based spatial statistics (TBSS) to assess the relationship between obesity-associated alterations of gray matter density (GMD) and anisotropic water diffusion in WM, respectively. In a small cohort of lean to obese women, we confirmed previous reports of obesity-associated alterations of GMD in brain regions involved in executive control (i.e., dorsolateral prefrontal cortex, DLPFC) and habit learning (i.e., dorsal striatum). Gray matter density alterations of the DLPFC were negatively correlated with radial diffusivity in the entire corpus callosum. Within the genu of the corpus callosum we found a positive correlation with axial diffusivity. In posterior region and inferior areas of the body of the corpus callosum, axial diffusivity correlated negatively with altered GMD in the dorsal striatum. These findings suggest that, in women, obesity-related alterations of GMD in brain regions involved in executive control and habit learning might relate to alterations of associated WM fiber bundles within the corpus callosum.	[Mueller, Karsten; Horstman, Annette; Moeller, Harald E.; Anwander, Alfred; Lepsien, Joeran; Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Horstman, Annette; Villringer, Arno] Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Schroeter, Matthias L.; Villringer, Arno; Pleger, Burkhard] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany	Max Planck Society; Leipzig University	Mueller, K (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	karstenm@cbs.mpg.de	Möller, Harald/AAB-4679-2019; Anwander, Alfred/B-5874-2011; Horstmann, Annette/C-9083-2011; Moller, Harald E/A-1565-2008	Möller, Harald/0000-0002-5659-1925; Anwander, Alfred/0000-0002-4861-4808; Horstmann, Annette/0000-0001-6184-8484; Moller, Harald E/0000-0002-5659-1925; Villringer, Arno/0000-0003-2604-2404	BMBF(IFB Adiposity Diseases, Federal Ministry of Education and Research, Germany) [FKZ 01E01001]; BMBF (Bernstein Focus, State Dependencies of Learning) [01GQ0975, 18GL4DW4]; BMBF (German FTLD Consortium) [FKZ 01GI1007A]; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases; Parkinson's Disease Foundation [PDF-IRG-1307]; German Research Foundation (DFG) [1052A1, 1052A5, 1052A6]; LIFE-Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union; European Regional Development Fund (ERFD); Free State of Saxony	BMBF(IFB Adiposity Diseases, Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); BMBF (Bernstein Focus, State Dependencies of Learning)(Federal Ministry of Education & Research (BMBF)); BMBF (German FTLD Consortium)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases; Parkinson's Disease Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); LIFE-Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union(European Commission); European Regional Development Fund (ERFD)(European Commission); Free State of Saxony	This work was supported by the BMBF (IFB Adiposity Diseases, Federal Ministry of Education and Research, Germany, FKZ 01E01001to AH and AV; Bernstein Focus, State Dependencies of Learning 01GQ0975, Project 18GL4DW4 to BP; German FTLD Consortium, Grant No. FKZ 01GI1007A to MLS) and in part funded by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases. Furthermore, KM and MLS are supported by the Parkinson's Disease Foundation (Grant No. PDF-IRG-1307). The work of AH, BP, and AV is supported by the German Research Foundation (DFG) within the framework of the CRC 1052 'Obesity Mechanisms', Projects 1052A1, 1052A5 and 1052A6. AV and MLS are supported by LIFE-Leipzig Research Center for Civilization Diseases at the University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERFD) and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Cazettes F, 2011, BRAIN RES, V1373, P101, DOI 10.1016/j.brainres.2010.12.008; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; deWeijer B., 2011, EJNMMI RES, V37, P1, DOI DOI 10.1186/2191-219X-1-37; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Eisenstein SA, 2013, SYNAPSE, V67, P748, DOI 10.1002/syn.21680; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Labadie C, 2014, MAGN RESON MED, V71, P375, DOI 10.1002/mrm.24670; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Marshall JA, 2000, OBES RES, V8, P543, DOI 10.1038/oby.2000.70; Metzler-Baddeley C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059849; Muller DK, 2013, J MAGN RESON, V230, P88, DOI 10.1016/j.jmr.2013.01.013; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Pannacciulli N, 2007, NEUROSCI LETT, V412, P248, DOI 10.1016/j.neulet.2006.11.019; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Park KG, 2004, DIABETES RES CLIN PR, V63, P135, DOI 10.1016/j.diabres.2003.09.010; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Small DM, 2007, ANN NY ACAD SCI, V1121, P136, DOI 10.1196/annals.1401.002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Streitburger DP, 2014, NEUROIMAGE, V87, P170, DOI 10.1016/j.neuroimage.2013.10.051; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6	48	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114206	10.1371/journal.pone.0114206	http://dx.doi.org/10.1371/journal.pone.0114206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494174	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400036
J	Oliver, PM; Couper, PJ; Pepper, M				Oliver, Paul M.; Couper, Patrick J.; Pepper, Mitzy			Independent Transitions between Monsoonal and Arid Biomes Revealed by Systematic Revison of a Complex of Australian Geckos (Diplodactylus; Diplodactylidae)	PLOS ONE			English	Article							SPECIES-GROUP; PHYLOGENETIC ANALYSES; MOLECULAR PHYLOGENY; POPULATION-GROWTH; WESTERN-AUSTRALIA; DNA POLYMORPHISM; ZONE BIOTA; EVOLUTION; RADIATION; DIVERSIFICATION	How the widespread expansion and intensification of aridity through the Neogene has shaped the Austral biota is a major question in Antipodean biogeography. Lineages distributed across wide aridity gradients provide opportunities to examine the timing, frequency, and direction of transitions between arid and mesic regions. Here, we use molecular genetics and morphological data to investigate the systematics and biogeography of a nominal Australian gecko species (Diplodactylus conspicillatus sensu lato) with a wide distribution spanning most of the Australian Arid Zone (AAZ) and Monsoonal Tropics (AMT). Our data support a minimum of seven genetically distinct and morphologically diagnosable taxa; we thus redefine the type species, ressurrect three names from synonymy, and describe three new species. Our inferred phylogeny suggests the history and diversification of lineages in the AAZ and AMT are intimately linked, with evidence of multiple independent interchanges since the late Miocene. However, despite this shared history, related lineages in these two regions also show evidence of broadly contrasting intra-regional responses to aridification; vicarance and speciation in older and increasingly attenuated mesic regions, versus a more dynamic history including independent colonisations and recent range expansions in the younger AAZ.	[Oliver, Paul M.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Oliver, Paul M.] Museum Victoria, Dept Sci, Melbourne, Vic, Australia; [Oliver, Paul M.; Pepper, Mitzy] Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia; [Couper, Patrick J.] Queensland Museum, Brisbane, Qld 4101, Australia	University of Melbourne; Museum Victoria; Australian National University; Queensland Museum	Oliver, PM (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	Paul.oliver@anu.edu.au		Pepper, Mitzy/0000-0003-4828-9977; Oliver, Paul/0000-0003-4291-257X	Mckenzie Postdoctoral Fellowship at the University of Melbourne; Australian Research Council linage Grant; Australian Biological Resources Survey Grant; Queensland Museum; Australian Research Council grant	Mckenzie Postdoctoral Fellowship at the University of Melbourne; Australian Research Council linage Grant(Australian Research Council); Australian Biological Resources Survey Grant; Queensland Museum; Australian Research Council grant(Australian Research Council)	This work was supported by Mckenzie Postdoctoral Fellowship at the University of Melbourne to Paul Oliver, an Australian Research Council linage Grant to Paul Oliver, Mike Lee and Paul Doughty, an Australian Biological Resources Survey Grant to Mark Hutchinson, Mark Adams, Paul Oliver and Paul Doughty, and the Queensland Museum. MP's contributions were supported by an Australian Research Council grant to J. Scott Keogh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, EVOLUTION, V57, P2619; Allen Gerald R., 1998, Aqua (Graffignana), V3, P9; Alley NF, 1998, PALAEOGEOGR PALAEOCL, V144, P239, DOI 10.1016/S0031-0182(98)00120-5; [Anonymous], 2014, TRACER V1 6; Archer M., 1991, AUSTR LOST WORLD PRE; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Catullo RA, 2014, J BIOGEOGR, V41, P659, DOI 10.1111/jbi.12230; Chapple DG, 2004, BIOL J LINN SOC, V83, P157, DOI 10.1111/j.1095-8312.2004.00378.x; Cogger H. G., 1983, ZOOLOGICAL CATALOGUE; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dolman G, 2008, MOL PHYLOGENET EVOL, V49, P782, DOI 10.1016/j.ympev.2008.09.021; Donnellan S., 1993, P121; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eldridge MDB, 2011, AUST J ZOOL, V59, P270, DOI 10.1071/ZO12012; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Fujioka T, 2009, GEOLOGY, V37, P51, DOI 10.1130/G25042A.1; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Fujita MK, 2010, EVOLUTION, V64, P2293, DOI 10.1111/j.1558-5646.2010.00993.x; Horner Paul, 2007, Beagle, P1; Jaensch R., 2009, FLOODPLAIN WETLANDS; Jennings WB, 2003, SYST BIOL, V52, P757, DOI 10.1080/10635150390250974; Kluge A. G., 1963, Memoirs of the Queensland Museum, V14, P77; KLUGE A. G., 1967, AUST J ZOOL, V15, P1007, DOI 10.1071/ZO9671007; Kuch U, 2005, NATURWISSENSCHAFTEN, V92, P121, DOI 10.1007/s00114-004-0602-0; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longman H. A., 1915, Memoirs of the Queensland Museum, V3; Lucas AHS, 1897, P ROYAL SOC VICTORIA, P54; MACDONALD J D, 1969, Emu, V69, P169; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Marin J, 2013, BIOL J LINN SOC, V110, P427, DOI 10.1111/bij.12132; Marin J, 2013, J BIOGEOGR, V40, P928, DOI 10.1111/jbi.12045; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Melville J, 2011, MOL PHYLOGENET EVOL, V58, P257, DOI 10.1016/j.ympev.2010.11.025; MERTENS ROBERT, 1967, SENCKENBERG BIOL, V48, P1; Oliver PM, 2007, AUST J ZOOL, V55, P197, DOI 10.1071/ZO07008; Oliver PM, 2014, J BIOGEOGR, V41, P2068, DOI 10.1111/jbi.12364; Oliver PM, 2012, WILDLIFE RES, V39, P429, DOI 10.1071/WR12024; Oliver PM, 2011, MOL PHYLOGENET EVOL, V59, P664, DOI 10.1016/j.ympev.2011.03.018; Oliver PM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-386; Oliver PM, 2009, P ROY SOC B-BIOL SCI, V276, P2001, DOI 10.1098/rspb.2008.1881; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; PARKER H. W., 1926, ANN & MAG NAT HIST, V17, P665; Pepper M, 2006, MOL PHYLOGENET EVOL, V41, P539, DOI 10.1016/j.ympev.2006.05.028; Pepper M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078110; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P810, DOI 10.1016/j.ympev.2011.08.012; Pepper M, 2011, MOL ECOL, V20, P1529, DOI 10.1111/j.1365-294X.2011.05036.x; Pianka E., 1986, ECOLOGY NATURAL HIST; Powney GD, 2010, GLOBAL ECOL BIOGEOGR, V19, P386, DOI 10.1111/j.1466-8238.2009.00521.x; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Read K, 2001, MOL PHYLOGENET EVOL, V21, P294, DOI 10.1006/mpev.2001.1014; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Rollins LA, 2012, ECOL EVOL, V2, P1208, DOI 10.1002/ece3.259; Shea G, 2011, ZOOTAXA, P1; Sistrom M, 2013, MOL PHYLOGENET EVOL, V68, P135, DOI 10.1016/j.ympev.2013.03.007; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Smith L. A., 2007, Records of the Western Australian Museum, V23, P309; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sternfield R, 1924, ABHANDLUNGEN SENCKEN, V38, P221; Storr GM, 1990, LIZARDS W AUSTR 3 GE; TAJIMA F, 1989, GENETICS, V123, P585; Toon A, 2007, MOL ECOL, V16, P2525, DOI 10.1111/j.1365-294X.2007.03289.x; Uetz P, 2013, REPTILE DATABASE; Wells R.W., 1983, Australian Journal of Herpetology, V1, P73; Williams K.J., 2010, HARNESSING CONTINENT	79	30	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111895	10.1371/journal.pone.0111895	http://dx.doi.org/10.1371/journal.pone.0111895			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493936	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400006
J	Gastardelo, TS; Cunha, BR; Raposo, LS; Maniglia, JV; Cury, PM; Lisoni, FCR; Tajara, EH; Oliani, SM				Gastardelo, Thais Santana; Cunha, Bianca Rodrigues; Raposo, Luis Sergio; Maniglia, Jose Victor; Cury, Patricia Maluf; Rodrigues Lisoni, Flavia Cristina; Tajara, Eloiza Helena; Oliani, Sonia Maria			Inflammation and Cancer: Role of Annexin A1 and FPR2/ALX in Proliferation and Metastasis in Human Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTORS; MAST-CELLS; DIFFERENTIAL EXPRESSION; PANCREATIC-CANCER; TUMOR; NEUTROPHILS; MECHANISMS; ANGIOGENESIS; POLARIZATION; GALECTIN-1	The anti-inflammatory protein annexin A1 (ANXA1) has been associated with cancer progression and metastasis, suggesting its role in regulating tumor cell proliferation. We investigated the mechanism of ANXA1 interaction with formylated peptide receptor 2 (FPR2/ALX) in control, peritumoral and tumor larynx tissue samples from 20 patients, to quantitate the neutrophils and mast cells, and to evaluate the protein expression and co-localization of ANXA1/FPR2 in these inflammatory cells and laryngeal squamous cells by immunocytochemistry. In addition, we performed in vitro experiments to further investigate the functional role of ANXA1/FPR2 in the proliferation and metastasis of Hep-2 cells, a cell line from larynx epidermoid carcinoma, after treatment with ANXA1(2-26) (annexin A1 N-terminal-derived peptide), Boc2 (antagonist of FPR) and/or dexamethasone. Under these treatments, the level of Hep-2 cell proliferation, pro-inflammatory cytokines, ANXA1/FPR2 co-localization, and the prostaglandin signalling were analyzed using ELISA, immunocytochemistry and real-time PCR. An influx of neutrophils and degranulated mast cells was detected in tumor samples. In these inflammatory cells of peritumoral and tumor samples, ANXA1/FPR2 expression was markedly exacerbated, however, in laryngeal carcinoma cells, this expression was downregulated. ANXA1(2-26) treatment reduced the proliferation of the Hep-2 cells, an effect that was blocked by Boc2, and up-regulated ANXA1/FPR2 expression. ANXA1(2-26) treatment also reduced the levels of pro-inflammatory cytokines and affected the expression of metalloproteinases and EP receptors, which are involved in the prostaglandin signalling. Overall, this study identified potential roles for the molecular mechanism of the ANXA1/FPR2 interaction in laryngeal cancer, including its relationship with the prostaglandin pathway, providing promising starting points for future research. ANXA1 may contribute to the regulation of tumor growth and metastasis through paracrine mechanisms that are mediated by FPR2/ALX. These data may lead to new biological targets for therapeutic intervention in human laryngeal cancer.	[Gastardelo, Thais Santana; Oliani, Sonia Maria] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Sao Paulo, Brazil; [Cunha, Bianca Rodrigues; Tajara, Eloiza Helena] Fac Med FAMERP, Dept Mol Biol, Sao Jose Do Rio Preto, SP, Brazil; [Raposo, Luis Sergio; Maniglia, Jose Victor] Fac Med FAMERP, Dept Otorhinolaringol, Sao Jose Do Rio Preto, SP, Brazil; [Cury, Patricia Maluf] Fac Med FAMERP, Dept Pathol, Sao Jose Do Rio Preto, SP, Brazil; [Rodrigues Lisoni, Flavia Cristina] Sao Paulo State Univ UNESP, Dept Biol & Zoot, Ilha Solteira, SP, Brazil; [Tajara, Eloiza Helena] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil; [Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Dept Biol, Inst Biociencias Letras & Ciencias Exatas IBILCE, Saa Jose Do Rio Preto, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Oliani, SM (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Sao Paulo, Brazil.	smoliani@ibilce.unesp.br	Maniglia, José V/K-3129-2016; Oliani, Sonia Maria/E-3476-2012; Tajara, Eloiza H/G-7586-2012; Rodrigues-Lisoni, Flavia Cristina/P-2447-2015; Cury, Patricia/GRX-5489-2022; Bizotto, Thaís Santana Gastardelo/I-9056-2012	Maniglia, José V/0000-0002-9765-2659; Oliani, Sonia Maria/0000-0003-0918-2130; Tajara, Eloiza H/0000-0002-2603-2057; Rodrigues-Lisoni, Flavia Cristina/0000-0002-8855-9049; Bizotto, Thaís Santana Gastardelo/0000-0002-0627-8631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/08187-4, 2008/01655-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [302768/2010-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (grants 2008/08187-4 to SMO and 2008/01655-2 to TSG) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (grant 302768/2010-6 to SMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao AC, 2010, ORAL ONCOL, V46, P880, DOI 10.1016/j.oraloncology.2010.09.005; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045639; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Conti P, 2007, ANN CLIN LAB SCI, V37, P315; Cooray SN, 2013, P NATL ACAD SCI US; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dansky Ullmann C, 2012, CANCER; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Esteban F, 2009, HISTOPATHOLOGY, V54, P258, DOI 10.1111/j.1365-2559.2008.03193.x; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Galli J, 2006, Acta Otorhinolaryngol Ital, V26, P260; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatae N, 2002, J BIOCHEM, V131, P781, DOI 10.1093/oxfordjournals.jbchem.a003165; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; John CD, 2007, FASEB J, V21, P1037, DOI 10.1096/fj.06-7299com; Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860; Kankkunen JP, 1997, INT J CANCER, V72, P385, DOI 10.1002/(SICI)1097-0215(19970729)72:3<385::AID-IJC1>3.0.CO;2-L; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lin CY, 2008, J SURG ONCOL, V97, P544, DOI 10.1002/jso.20992; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marusawa H, 2013, CANC LETT; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; Mendes RA, 2009, ORAL ONCOL, V45, pE124, DOI 10.1016/j.oraloncology.2009.03.016; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Paweletz CP, 2000, CANCER RES, V60, P6293; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pimentel TA, 2011, LAB INVEST, V91, P33, DOI 10.1038/labinvest.2010.140; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Remedi MM, 2009, INT J EXP PATHOL, V90, P44, DOI 10.1111/j.1365-2613.2008.00628.x; Ribatti D, 2009, INT REV CEL MOL BIO, V275, P89, DOI 10.1016/S1937-6448(09)75004-X; Rodrigues-Lisoni FC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-14; Sansone P, 2011, CURR OPIN GENET DEV, V21, P80, DOI 10.1016/j.gde.2010.11.001; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Sawatsubashi M, 2000, VIRCHOWS ARCH, V436, P243, DOI 10.1007/s004280050037; Sena AAS, 2006, CLIN EXP ALLERGY, V36, P1260, DOI 10.1111/j.1365-2222.2006.02570.x; Sena A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076969; Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Vokes EE, 2003, NEW ENGL J MED, V349, P2087, DOI 10.1056/NEJMp038171; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	69	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e111317	10.1371/journal.pone.0111317	http://dx.doi.org/10.1371/journal.pone.0111317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490767	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300001
J	Robertson, JA; Thomas, AW; Prato, FS; Johansson, M; Nittby, H				Robertson, John A.; Thomas, Alex W.; Prato, Frank S.; Johansson, Mikael; Nittby, Henrietta			Simultaneous fMRI and EEG during the Multi-Source Interference Task	PLOS ONE			English	Article							SINGLE-SUBJECT; SCHIZOPHRENIA; NETWORK; NEGATIVITY; ACTIVATION; ERRORS	Background: fMRI and EEG are two non-invasive functional imaging techniques within cognitive neuroscience that have complementary advantages to obtain both temporal and spatial information. The multi-source interference task (MSIT) has been shown to generate robust activations of the dorsal anterior cingulate cortex (dACC) on both a single-subject level and in group averages, in fMRI studies. We have now simultaneously acquired fMRI and EEG during a cognitive interference task. Materials and Methods: Healthy volunteers were tested in an MRI scanner with simultaneous EEG and fMRI recordings during the MSIT. Results: The interference condition significantly increased the reaction time in the task. The fMRI analyses revealed activation of dACC as expected, in all subjects at the individual level and in group analyses. The posterior cingulate cortex was deactivated. Simultaneous EEG showed the expected anterior distribution of the interference effect, as it was restricted to frontal sites within a time frame of 80-120 ms post response. Conclusion: The MSIT task is a reliable task for interference evaluation. fMRI shows robust activation of dACC and by adding EEG, an interference effect can be noticed within a temporal interval of 80-120 ms after the response, as a CRN (correct response negativity). This means that EEG could add a more detailed temporal aspect to the fMRI data from an interference task, and that despite the hostile environment within an MRI scanner, EEG data could be used.	[Robertson, John A.; Thomas, Alex W.; Prato, Frank S.] St Josephs Hlth Care, Lawson Hlth Res Inst, London, ON, Canada; [Robertson, John A.] Univ Hlth Network, Techna Inst, Toronto, ON, Canada; [Johansson, Mikael] Lund Univ, Dept Psychol, SE-22185 Lund, Sweden; [Nittby, Henrietta] Lund Univ, Dept Neurosurg, SE-22185 Lund, Sweden	Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Lund University; Lund University	Nittby, H (corresponding author), Lund Univ, Dept Neurosurg, BMC D10, SE-22185 Lund, Sweden.	Henrietta.Nittby@med.lu.se	Prato, Frank S/C-9117-2014; Johansson, Mikael/A-5338-2008	Johansson, Mikael/0000-0002-2903-6301; Nittby Redebrandt, Henrietta/0000-0003-0140-8107; Prato, Frank/0000-0002-4592-2522	Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF)	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF)	This study was supported by and depended on infrastructure funded by the Canadian Foundation for Innovation (CFI) and Ontario Research Fund (ORF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates AT, 2002, CLIN NEUROPHYSIOL, V113, P1454, DOI 10.1016/S1388-2457(02)00154-2; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 2009, NEUROPSYCHOPHARMACOL, P1; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Formaggio E, 2008, BRAIN TOPOGR, V21, P100, DOI 10.1007/s10548-008-0058-1; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Harrison BJ, 2007, ACTA PSYCHIAT SCAND, V116, P271, DOI 10.1111/j.1600-0447.2007.01002.x; Heckers S, 2004, AM J PSYCHIAT, V161, P707, DOI 10.1176/appi.ajp.161.4.707; Hesselmann G, 2011, NEUROIMAGE, V56, P1608, DOI 10.1016/j.neuroimage.2011.03.017; Hoffmann S, 2012, INT J PSYCHOPHYSIOL, V83, P208, DOI 10.1016/j.ijpsycho.2011.11.015; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0	14	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114599	10.1371/journal.pone.0114599	http://dx.doi.org/10.1371/journal.pone.0114599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490131	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300056
J	Sos-Hegedus, A; Juhasz, Z; Poor, P; Kondrak, M; Antal, F; Tari, I; Mauch-Mani, B; Banfalvi, Z				Sos-Hegedus, Anita; Juhasz, Zsofia; Poor, Peter; Kondrak, Mihaly; Antal, Ferenc; Tari, Irma; Mauch-Mani, Brigitte; Banfalvi, Zsofia			Soil Drench Treatment with beta-Aminobutyric Acid Increases Drought Tolerance of Potato	PLOS ONE			English	Article							INDUCED RESISTANCE; NITRIC-OXIDE; ARABIDOPSIS; GENE; GROWTH; LEAVES; PLANTS	The non-protein amino acid beta-aminobutyric acid (BABA) is known to be a priming agent for a more efficient activation of cellular defence responses and a potent inducer of resistance against biotic and abiotic stresses in plants. Nevertheless, most of the studies on priming have been carried out in Arabidopsis. In potato, the effect of BABA was demonstrated only on biotic stress tolerance. We investigated the effect of BABA on the drought tolerance of potato and found that soil drenched with BABA at a final concentration of 0.3 mM improves the drought tolerance of potato. Water loss from the leaves of the primed plants is attenuated and the yield is increased compared to the unprimed drought-stressed plants. The metabolite composition of the tubers of the BABA-treated plants is less affected by drought than the tuber composition of the non-treated plants. Nitric oxide and ROS (reactive oxygen species) production is increased in the BABA-treated roots but not in the leaves. In the leaves of the BABA-treated plants, the expression of the drought-inducible gene StDS2 is delayed, but the expression of ETR1, encoding an ethylene receptor, is maintained for a longer period under the drought conditions than in the leaves of the non-treated, drought-stressed control plants. This result suggests that the ethylene-inducible gene expression remains suppressed in primed plants leading to a longer leaf life and increased tuber yield compared to the non-treated, drought-stressed plants. The priming effect of BABA in potato, however, is transient and reverts to an unprimed state within a few weeks.	[Sos-Hegedus, Anita; Juhasz, Zsofia; Kondrak, Mihaly; Antal, Ferenc; Banfalvi, Zsofia] NARIC, Agr Biotechnol Inst, H-2101 Godollo, Hungary; [Poor, Peter; Tari, Irma] Univ Szeged, Dept Plant Biol, H-6701 Szeged, Hungary; [Mauch-Mani, Brigitte] Univ Neuchatel, Fac Sci, CH-2000 Neuchatel, Switzerland	Szeged University; University of Neuchatel	Sos-Hegedus, A (corresponding author), NARIC, Agr Biotechnol Inst, POB 411, H-2101 Godollo, Hungary.	banfalvi@abc.hu	Mauch-Mani, Brigitte/O-2387-2014; Poór, Péter/C-9466-2012; Bánfalvi, Zsófia/D-3494-2012	Poór, Péter/0000-0002-4539-6358; Mauch-Mani, Brigitte/0000-0002-6743-8520	Swiss National Science Foundation; Nemzeti Innovacios Hivatal	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nemzeti Innovacios Hivatal	This work was supported by the Swiss National Science Foundation (nfp.snf.ch/E/international/europe/scopes to ASH, ZJ, MK, FA, BMM, ZB), and Nemzeti Innovacios Hivatal (http://www.nih.gov.hu to ASH, ZJ, MK, FA, ZB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Arasimowicz-Jelonek M, 2013, PLANT SCI, V198, P83, DOI 10.1016/j.plantsci.2012.10.004; Baudouin E, 2011, PLANT BIOLOGY, V13, P233, DOI 10.1111/j.1438-8677.2010.00403.x; Capone R, 2004, PLANT PHYSIOL BIOCH, V42, P425, DOI 10.1016/j.plaphy.2004.03.005; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Doczi R, 2002, PLANT CELL ENVIRON, V25, P1197, DOI 10.1046/j.1365-3040.2002.00904.x; Fernie AR, 2011, PLANT CELL, V23, P2477, DOI 10.1105/tpc.111.086272; Floryszak-Wieczorek J, 2012, MOL PLANT MICROBE IN, V25, P1469, DOI 10.1094/MPMI-02-12-0044-R; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Kolbert Zsuzsanna, 2012, Acta Biologica Szegediensis, V56, P37; Maggio A, 2008, EUR J AGRON, V28, P343, DOI 10.1016/j.eja.2007.10.003; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Sani E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r59; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; STIEKEMA WJ, 1988, PLANT MOL BIOL, V11, P255, DOI 10.1007/BF00027383; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; VANLOON CD, 1981, AM POTATO J, V58, P51, DOI 10.1007/BF02855380; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zimmerli L, 2008, PLANT J, V53, P144, DOI 10.1111/j.1365-313X.2007.03343.x	33	22	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114297	10.1371/journal.pone.0114297	http://dx.doi.org/10.1371/journal.pone.0114297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489951	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000347515300024
J	Davis, JS; He, V; Anstey, NM; Condon, JR				Davis, Joshua S.; He, Vincent; Anstey, Nicholas M.; Condon, John R.			Long Term Outcomes Following Hospital Admission for Sepsis Using Relative Survival Analysis: A Prospective Cohort Study of 1,092 Patients with 5 Year Follow Up	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ENDOTHELIAL DYSFUNCTION; ORGAN DYSFUNCTION; IMMUNOSUPPRESSION; RESUSCITATION; EPIDEMIOLOGY; INFLAMMATION; MULTICENTER; PNEUMONIA; EFFICACY	Background: Sepsis is a leading cause of death in intensive care units and is increasing in incidence. Current trials of novel therapeutic approaches for sepsis focus on 28-day mortality as the primary outcome measure, but excess mortality may extend well beyond this time period. Methods: We used relative survival analysis to examine excess mortality in a cohort of 1,028 patients admitted to a tertiary referral hospital with sepsis during 2007-2008, over the first 5 years of follow up. Expected survival was estimated using the Ederer II method, using Australian life tables as the reference population. Cumulative and interval specific relative survival were estimated by age group, sex, sepsis severity and Indigenous status. Results: Patients were followed for a median of 4.5 years (range 0-5.2). Of the 1028 patients, the mean age was 46.9 years, 52% were male, 228 (22.2%) had severe sepsis and 218 (21%) died during the follow up period. Mortality based on cumulative relative survival exceeded that of the reference population for the first 2 years post admission in the whole cohort and for the first 3 years in the subgroup with severe sepsis. Independent predictors of mortality over the whole follow up period were male sex, Indigenous Australian ethnicity, older age, higher Charlson Comorbidity Index, and sepsis-related organ dysfunction at presentation. Conclusions: The mortality rate of patients hospitalised with sepsis exceeds that of the general population until 2 years post admission. Efforts to improve outcomes from sepsis should examine longer term outcomes than the traditional primary endpoints of 28-day and 90-day mortality.	[Davis, Joshua S.; He, Vincent; Anstey, Nicholas M.; Condon, John R.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Davis, Joshua S.; Anstey, Nicholas M.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research	Davis, JS (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Joshua.Davis@menzies.edu.au	Condon, John R/N-2281-2013; Davis, Joshua/N-2288-2013	Condon, John R/0000-0003-4952-0990; Davis, Joshua/0000-0001-9864-5699	National Health and Medical Research Council [1013411, 1042072, 496600]; University Postgraduate Research Scholarship from Charles Darwin University	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University Postgraduate Research Scholarship from Charles Darwin University	The study was supported by the National Health and Medical Research Council: Early Career Fellowship # 1013411 to JSD and Practitioner Fellowship(1042072) and Program Grant (496600) to NMA. VH was supported by University Postgraduate Research Scholarship from Charles Darwin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alberti C, 2003, AM J RESP CRIT CARE, V168, P77, DOI 10.1164/rccm.200208-785OC; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Baker C H, 1994, J Fla Med Assoc, V81, P119; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Davis JS, 2011, MED J AUSTRALIA, V194, P519, DOI 10.5694/j.1326-5377.2011.tb03088.x; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; Dent OF, 2009, ANN SURG, V249, P402, DOI 10.1097/SLA.0b013e31819a0469; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Dickman PW, 2009, STATA J; Eerola H, 2001, INT J CANCER, V93, P368, DOI 10.1002/ijc.1341; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Feigin VL, 2002, CEREBROVASC DIS, V13, P219, DOI 10.1159/000057846; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Ghelani D, 2009, J EVAL CLIN PRACT, V15, P425, DOI 10.1111/j.1365-2753.2008.01030.x; Hack CE, 2001, CRIT CARE MED, V29, pS21, DOI 10.1097/00003246-200107001-00011; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HOLLENBERG SM, 1994, J CRIT CARE, V9, P262, DOI 10.1016/0883-9441(94)90006-X; Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Lemay AC, 2013, AM J MED SCI; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Scoll BJ, 2009, J UROLOGY, V181, P506, DOI 10.1016/j.juro.2008.10.026; Storgaard M, 2013, SCAND J INFECT DIS; Vincent JL, 2004, CRIT CARE MED, V32, pS209, DOI 10.1097/01.CCM.0000126124.41743.86; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	39	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112224	10.1371/journal.pone.0112224	http://dx.doi.org/10.1371/journal.pone.0112224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486241	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600008
J	Garcia-Quintanilla, M; Pulido, MR; Pachon, J; McConnell, MJ				Garcia-Quintanilla, Meritxell; Pulido, Marina R.; Pachon, Jeronimo; McConnell, Michael J.			Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection	PLOS ONE			English	Article							MULTIDRUG-RESISTANT ACINETOBACTER; NEISSERIA-MENINGITIDIS; VACCINE CANDIDATE; PNEUMONIA; MUTANT; MICE	The increasing clinical importance of infections caused by multidrug resistant Acinetobacter baumannii warrants the development of novel approaches for prevention and treatment. In this context, vaccination of certain patient populations may contribute to reducing the morbidity and mortality caused by this pathogen. Vaccines against Gram-negative bacteria based on inactivated bacterial cells are highly immunogenic and have been shown to produce protective immunity against a number of bacterial species. However, the high endotoxin levels present in these vaccines due to the presence of lipopolysaccharide complicates their use in human vaccination. In the present study, we used a laboratory-derived strain of A. baumannii that completely lacks lipopolysaccharide due to a mutation in the lpxD gene (IB010), one of the genes involved in the first steps of lipopolysaccharide biosynthesis, for vaccination. We demonstrate that IB010 has greatly reduced endotoxin content (<1.0 endotoxin unit/10(6) cells) compared to wild type cells. Immunization with formalin inactivated IB010 produced a robust antibody response consisting of both IgG1 and IgG2c subtypes. Mice immunized with IB010 had significantly lower post-infection tissue bacterial loads and significantly lower serum levels of the pro-inflammatory cytokines IL-1 beta, TNF-alpha and IL-6 compared to control mice in a mouse model of disseminated A. baumannii infection. Importantly, immunized mice were protected from infection with the ATCC 19606 strain and an A. baumannii clinical isolate. These data suggest that immunization with inactivated A. baumannii whole cells deficient in lipopolysaccharide could serve as the basis for a vaccine for the prevention of infection caused by A. baumannii.	[Garcia-Quintanilla, Meritxell; Pulido, Marina R.; Pachon, Jeronimo; McConnell, Michael J.] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	McConnell, MJ (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	mcconnell.mike75@gmail.com	Pulido, Marina/J-3176-2018; Quintanilla, Meritxell/AAB-4069-2019; Pachon, Jeronimo/M-4337-2014	Garcia-Quintanilla, Meritxell/0000-0003-1889-1377; McConnell, Michael/0000-0003-1028-381X; Pulido, Marina Rosa/0000-0003-1633-4294; Pachon, Jeronimo/0000-0002-8166-5308	Ministerio de Economia y Competitividad of Spain [RD06/0008/0000, PI-0046-2011, CP11/00314]	Ministerio de Economia y Competitividad of Spain(Spanish Government)	Support was provided by REIPI REIPI RD06/0008/0000 Consejeria de Salud de la Junta de Andalucia (PI-0046-2011) Subprograma Miguel Servet from the Ministerio de Economia y Competitividad of Spain (CP11/00314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATSON HC, 1950, J EXP MED, V91, P219, DOI 10.1084/jem.91.2.219; BAUMANN P, 1968, J BACTERIOL, V96, P39, DOI 10.1002/path.1700960105; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004; Fernandez-Cuenca F, 2004, ENFERM INFEC MICR CL, V22, P267, DOI 10.1016/S0213-005X(04)73085-2; Garcia-Quintanilla M, 2013, CURR PHARM IN PRESS; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Ho PL, 2009, CHEST, V136, P1119, DOI 10.1378/chest.09-0285; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; McConnell MJ, 2006, INFECT IMMUN, V74, P1009, DOI 10.1128/IAI.74.2.1009-1015.2006; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Ong CWM, 2009, RESPIROLOGY, V14, P1200, DOI 10.1111/j.1440-1843.2009.01630.x; Pachon J, 2014, VACCINE IN PRESS; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Rodriguez-Hernandez MJ, 2000, J ANTIMICROB CHEMOTH, V45, P493, DOI 10.1093/jac/45.4.493; Steeghs L, 1999, INFECT IMMUN, V67, P4988, DOI 10.1128/IAI.67.10.4988-4993.1999; Tasbakan MS, 2009, MIKROBIYOL BUL, V43, P61; TONG MJ, 1972, J AMER MED ASSOC, V219, P1044, DOI 10.1001/jama.219.8.1044; Valencia R, 2009, INFECT CONT HOSP EP, V30, P257, DOI 10.1086/595977; van der Ley P, 2003, J ENDOTOXIN RES, V9, P124, DOI 10.1179/096805103125001522; Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509	33	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114410	10.1371/journal.pone.0114410	http://dx.doi.org/10.1371/journal.pone.0114410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485716	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600054
J	Silverstein, SM; Keane, BP; Papathomas, TV; Lathrop, KL; Kourtev, H; Feigenson, K; Roche, MW; Wang, YS; Mikkilineni, D; Paterno, D				Silverstein, Steven M.; Keane, Brian P.; Papathomas, Thomas V.; Lathrop, Kira L.; Kourtev, Hristian; Feigenson, Keith; Roche, Matthew W.; Wang, Yushi; Mikkilineni, Deepthi; Paterno, Danielle			Processing of Spatial-Frequency Altered Faces in Schizophrenia: Effects of Illness Phase and Duration	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; MAGNOCELLULAR PATHWAY; CONTRAST SENSITIVITY; PSYCHOTIC DISORDER; DEPTH INVERSION; DYSFUNCTION; IMPAIRMENT; ABNORMALITIES; INFORMATION; INTEGRATION	Low spatial frequency (SF) processing has been shown to be impaired in people with schizophrenia, but it is not clear how this varies with clinical state or illness chronicity. We compared schizophrenia patients (SCZ, n=34), first episode psychosis patients (FEP, n=22), and healthy controls (CON, n=35) on a gender/facial discrimination task. Images were either unaltered (broadband spatial frequency, BSF), or had high or low SF information removed (LSF and HSF conditions, respectively). The task was performed at hospital admission and discharge for patients, and at corresponding time points for controls. Groups were matched on visual acuity. At admission, compared to their BSF performance, each group was significantly worse with low SF stimuli, and most impaired with high SF stimuli. The level of impairment at each SF did not depend on group. At discharge, the SCZ group performed more poorly in the LSF condition than the other groups, and showed the greatest degree of performance decline collapsed over HSF and LSF conditions, although the latter finding was not significant when controlling for visual acuity. Performance did not change significantly over time for any group. HSF processing was strongly related to visual acuity at both time points for all groups. We conclude the following: 1) SF processing abilities in schizophrenia are relatively stable across clinical state; 2) face processing abnormalities in SCZ are not secondary to problems processing specific SFs, but are due to other known difficulties constructing visual representations from degraded information; and 3) the relationship between HSF processing and visual acuity, along with known SCZ- and medication-related acuity reductions, and the elimination of a SCZ-related impairment after controlling for visual acuity in this study, all raise the possibility that some prior findings of impaired perception in SCZ may be secondary to acuity reductions.	[Silverstein, Steven M.; Keane, Brian P.; Feigenson, Keith; Roche, Matthew W.; Wang, Yushi; Mikkilineni, Deepthi; Paterno, Danielle] Rutgers Univ Behav Hlth Care, Piscataway, NJ 08854 USA; [Silverstein, Steven M.] Rutgers Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ USA; [Keane, Brian P.; Papathomas, Thomas V.; Kourtev, Hristian] Rutgers State Univ, Ctr Cognit Sci, New Brunswick, NJ 08903 USA; [Lathrop, Kira L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Lathrop, Kira L.] Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA; [Feigenson, Keith] Albright Coll, Dept Psychol, Reading, PA 19612 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Silverstein, SM (corresponding author), Rutgers Univ Behav Hlth Care, Piscataway, NJ 08854 USA.	steven.silverstein@rutgers.edu		Keane, Brian/0000-0002-7011-3380	National Institute of Metal Health [R01MH093439]; National Institutes of Health, NIH IRACDA [1K12GM093854-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093439] Funding Source: NIH RePORTER	National Institute of Metal Health; National Institutes of Health, NIH IRACDA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: The work was supported by the following: National Institute of Metal Health grant R01MH093439, SS, http://www.nimh.nih.gov/index.shtml; and National Institutes of Health, NIH IRACDA Postdoctoral Training Grant 1K12GM093854-05, KF, MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bauser DS, 2012, PSYCHIAT RES, V195, P9, DOI 10.1016/j.psychres.2011.07.017; Brandies R, 2008, NEUROSCI BIOBEHAV R, V32, P611, DOI 10.1016/j.neubiorev.2007.09.004; BRUCE V, 1987, CAN J PSYCHOL, V41, P510, DOI 10.1037/h0084165; Calderone DJ, 2013, CEREB CORTEX, V23, P1849, DOI 10.1093/cercor/bhs169; Chen Y, 2003, AM J PSYCHIAT, V160, P1795, DOI 10.1176/appi.ajp.160.10.1795; Chen Y, 2011, SCHIZOPHRENIA BULL, V37, P709, DOI 10.1093/schbul/sbr020; CORBE C, 1992, J NEUROL, V239, pS22; CUESTA MJ, 1995, SCHIZOPHRENIA BULL, V21, P473, DOI 10.1093/schbul/21.3.473; Delord S, 2006, VISUAL NEUROSCI, V23, P645, DOI 10.1017/S0952523806233017; Deruelle C, 2005, J EXP CHILD PSYCHOL, V90, P172, DOI 10.1016/j.jecp.2004.09.001; First MB, 2002, STRUCTURED CLIN INTE; Flevaris AV, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00277; Green MF, 2012, ARCH GEN PSYCHIAT, V69, P1216, DOI 10.1001/archgenpsychiatry.2012.652; Green MF, 2011, SCHIZOPHRENIA BULL, V37, P700, DOI 10.1093/schbul/sbr051; HARRIS J P, 1990, Eye (London), V4, P806; Hauser R. M., 1996, SOCIOECONOMIC INDEXE; Holladay JT, 1997, J REFRACT SURG, V13, P388; Javitt DC, 2009, SCHIZOPHRENIA BULL, V35, P1059, DOI 10.1093/schbul/sbp110; Joseph J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00547; Joshua N, 2009, SCHIZOPHR RES, V112, P99, DOI 10.1016/j.schres.2009.03.033; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keane BP, 2014, PSYCHON B REV; Keane BP, 2013, J ABNORM PSYCHOL, V122, P506, DOI 10.1037/a0032110; Kelemen O, 2013, PROG NEURO-PSYCHOPH, V47, P13, DOI 10.1016/j.pnpbp.2013.07.024; Keri S, 2005, PSYCHOL MED, V35, P1445, DOI 10.1017/S0033291705005398; Keri S, 2002, J NEUROPSYCH CLIN N, V14, P190, DOI 10.1176/appi.neuropsych.14.2.190; Keri Szabolcs, 1998, Orvosi Hetilap, V139, P235; Kiss I, 2006, J ABNORM PSYCHOL, V115, P636, DOI 10.1037/0021-843X.115.3.636; Kiss I, 2010, J ABNORM PSYCHOL, V119, P586, DOI 10.1037/a0019610; KNIGHT RA, 1985, J ABNORM PSYCHOL, V94, P427, DOI 10.1037/0021-843X.94.4.427; Knight RA, 1998, ORIGINS AND DEVELOPMENT OF SCHIZOPHRENIA, P247, DOI 10.1037/10305-010; KNIGHT RA, 1984, NEBR S MOT 1983 THEO, P93; Koethe D, 2009, EUR ARCH PSY CLIN N, V259, P195, DOI 10.1007/s00406-008-0851-6; Labbate LFM, 2009, HDB PSYCHIAT DRUG TH; Laprevote V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00248; Laprevote V, 2010, NEUROPSYCHOLOGIA, V48, P4164, DOI 10.1016/j.neuropsychologia.2010.10.017; Lee WW, 2013, INVEST OPHTH VIS SCI, V54, P7785, DOI 10.1167/iovs.13-12534; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Lieberman Joseph A 3rd, 2004, Prim Care Companion J Clin Psychiatry, V6, P20; Lindenmayer Jean-Pierre, 1994, Psychiatric Quarterly (New York), V65, P299, DOI 10.1007/BF02354306; LINDENMAYER JP, 1995, PSYCHOPATHOLOGY, V28, P22, DOI 10.1159/000284896; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; McBain R, 2010, SCHIZOPHR RES, V122, P151, DOI 10.1016/j.schres.2010.03.034; McClure RK, 2001, PROG NEURO-PSYCHOPH, V25, P301, DOI 10.1016/S0278-5846(00)00166-4; Meier MH, 2013, AM J PSYCHIAT, V170, P1451, DOI 10.1176/appi.ajp.2013.13020234; MERIGAN WH, 1990, VISUAL NEUROSCI, V5, P347, DOI 10.1017/S0952523800000432; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mitelman SA, 2007, INT REV PSYCHIATR, V19, P347, DOI 10.1080/09540260701486563; Mouchetant-Rostaing Y, 2003, J COGNITIVE NEUROSCI, V15, P900, DOI 10.1162/089892903322370816; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; NUECHTERLEIN KH, 1986, SCHIZOPHRENIA BULL, V12, P408, DOI 10.1093/schbul/12.3.408; NUECHTERLEIN KH, 1983, SCIENCE, V220, P327, DOI 10.1126/science.6836276; O'Donnell BF, 2002, J ABNORM PSYCHOL, V111, P620, DOI 10.1037//0021-843X.111.4.620; Perez VB, 2012, PSYCHOL MED, V42, P2167, DOI 10.1017/S0033291712000426; Rassovsky Y, 2011, PSYCHOL MED, V41, P487, DOI 10.1017/S0033291710001054; Richa S, 2010, CNS DRUGS, V24, P501, DOI 10.2165/11533180-000000000-00000; Rusaka M, 2014, ANN GEN PSYCHIATR, V13, DOI 10.1186/1744-859X-13-4; Salvatore P, 2011, J CLIN PSYCHIAT, V72, P183, DOI 10.4088/JCP.09m05311yel; Schiffman J, 2006, SCHIZOPHR RES, V81, P253, DOI 10.1016/j.schres.2005.08.008; Schneider U, 2002, SCHIZOPHR RES, V53, P101, DOI 10.1016/S0920-9964(00)00172-9; Schubert EW, 2005, ACTA PSYCHIAT SCAND, V112, P385, DOI 10.1111/j.1600-0447.2005.00584.x; Schwarzer G, 2003, VISION RES, V43, P2783, DOI 10.1016/S0042-6989(03)00478-4; Shipley W.C., 2009, SHIPLEY 2 MANUAL; Silverstein S, 2006, SCHIZOPHR RES, V83, P41, DOI 10.1016/j.schres.2006.01.003; Silverstein S., 2009, LEARN PERCEPT, V1, P229, DOI [10.1556/LP.1.2009.2.111, DOI 10.1556/LP.1.2009.2.111]; Silverstein SM, 2010, PSYCHOL MED, V40, P1159, DOI 10.1017/S0033291709991735; Silverstein SM, 1996, J ABNORM PSYCHOL, V105, P410, DOI 10.1037/0021-843X.105.3.410; Silverstein SM, 2012, J EXP PSYCHOPATHOL, V3, P702, DOI 10.5127/jep.023311; Silverstein SM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00466; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P681, DOI 10.1093/schbul/sbr053; Skottun BC, 2007, VISION RES, V47, P2923, DOI 10.1016/j.visres.2007.07.016; Skottun BC, 2008, NEURO-OPHTHALMOLOGY, V32, P179, DOI 10.1080/01658100802274952; Smith D, 1997, AUST NZ J PSYCHIAT, V31, P252, DOI 10.3109/00048679709073828; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Turetsky BI, 2007, SCHIZOPHR RES, V94, P253, DOI 10.1016/j.schres.2007.05.001; Viertio S, 2007, SOC PSYCH PSYCH EPID, V42, P902, DOI 10.1007/s00127-007-0252-6; Vinckier F, 2014, NEUROPSYCHOLOGIA, V53, P187, DOI 10.1016/j.neuropsychologia.2013.10.004	83	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114642	10.1371/journal.pone.0114642	http://dx.doi.org/10.1371/journal.pone.0114642			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485784	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000346907600081
J	Wang, ZG; Jin, X; Bao, XG; Li, XF; Zhao, JH; Sun, JH; Christie, P; Li, L				Wang, Zhi-Gang; Jin, Xin; Bao, Xing-Guo; Li, Xiao-Fei; Zhao, Jian-Hua; Sun, Jian-Hao; Christie, Peter; Li, Long			Intercropping Enhances Productivity and Maintains the Most Soil Fertility Properties Relative to Sole Cropping	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; WHEAT TRITICUM-AESTIVUM; INTERSPECIFIC INTERACTIONS; NITROGEN-FIXATION; RESOURCE CAPTURE; N-2 FIXATION; WHITE LUPIN; PHOSPHORUS; SYSTEMS; MAIZE	Yield and nutrient acquisition advantages are frequently found in intercropping systems. However, there are few published reports on soil fertility in intercropping relative to monocultures. A field experiment was therefore established in 2009 in Gansu province, northwest China. The treatments comprised maize/faba bean, maize/soybean, maize/chickpea and maize/turnip intercropping, and their correspoding monocropping. In 2011 (the 3rd year) and 2012 (the 4th year) the yields and some soil chemical properties and enzyme activities were examined after all crop species were harvested or at later growth stages. Both grain yields and nutrient acquisition were significantly greater in all four intercropping systems than corresponding monocropping over two years. Generally, soil organic matter (OM) did not differ significantly from monocropping but did increase in maize/chickpea in 2012 and maize/turnip in both years. Soil total N (TN) did not differ between intercropping and monocropping in either year with the sole exception of maize/faba bean intercropping receiving 80 kg P ha(-1) in 2011. Intercropping significantly reduced soil Olsen-P only in 2012, soil exchangeable K in both years, soil cation exchangeable capacity (CEC) in 2012, and soil pH in 2012. In the majority of cases soil enzyme activities did not differ across all the cropping systems at different P application rates compared to monocrops, with the exception of soil acid phosphatase activity which was higher in maize/legume intercropping than in the corresponding monocrops at 40 kg ha(-1) P in 2011. P fertilization can alleviate the decline in soil Olsen-P and in soil CEC to some extent. In summary, intercropping enhanced productivity and maintained the majority of soil fertility properties for at least three to four years, especially at suitable P application rates.The results indicate that maize-based intercropping may be an efficient cropping system for sustainable agriculture with carefully managed fertilizer inputs.	[Wang, Zhi-Gang; Jin, Xin; Li, Xiao-Fei; Christie, Peter; Li, Long] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Minist Educ, Beijing 100193, Peoples R China; [Bao, Xing-Guo; Zhao, Jian-Hua; Sun, Jian-Hao] Gansu Acad Agr Sci, Inst Soils Fertilizers & Water Saving Agr, Lanzhou 730070, Peoples R China	China Agricultural University	Li, L (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Minist Educ, Beijing 100193, Peoples R China.	lilong@cau.edu.cn	Li, xiaofei/GXF-7187-2022; Christie, Peter/B-7919-2008; Li, Long/A-4998-2013; Li, Xiaofei/ABB-4458-2022	Christie, Peter/0000-0002-1939-7277; Li, Long/0000-0003-0523-3308; 	National Basic Research Program of China [2011CB100405]; Chinese Ministry of Science and Technology [2012BAD14B04, 2012BAD14B10]	National Basic Research Program of China(National Basic Research Program of China); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	The study was supported financially by the National Basic Research Program of China (Project No. 2011CB100405) and Chinese Ministry of Science and Technology (Project Nos. 2012BAD14B04 and 2012BAD14B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Andrade JF, 2012, AGRON J, V104, P1049, DOI 10.2134/agronj2012.0051; Antonious GF, 2003, J ENVIRON SCI HEAL B, V38, P479, DOI 10.1081/PFC-120021667; Batjes NH, 1997, SOIL USE MANAGE, V13, P9, DOI 10.1111/j.1475-2743.1997.tb00550.x; Beedy TL, 2010, AGR ECOSYST ENVIRON, V138, P139, DOI 10.1016/j.agee.2010.04.008; Conn C, 2000, SOIL BIOL BIOCHEM, V32, P489, DOI 10.1016/S0038-0717(99)00178-9; Dalal R. C., 1977, Advances in Agronomy, V29, P83; de Carvalho LM, 2009, HORTIC BRAS, V27, P458, DOI 10.1590/S0102-05362009000400010; Dick WA, 2000, SOIL BIOL BIOCHEM, V32, P1915, DOI 10.1016/S0038-0717(00)00166-8; Doran JW, 2002, AGR ECOSYST ENVIRON, V88, P119, DOI 10.1016/S0167-8809(01)00246-8; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Eskandari H, 2011, AFR J BIOTECHNOL, V10, P17755, DOI 10.5897/AJB11.2250; FAO, 1988, SOILS MAP WORLD REV; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; GARDNER WK, 1983, PLANT SOIL, V70, P391, DOI 10.1007/BF02374894; GILLER KE, 1994, SOIL SCIENCE AND SUSTAINABLE LAND MANAGEMENT IN THE TROPICS, P173; GILLER KE, 1995, PLANT SOIL, V174, P255, DOI 10.1007/BF00032251; Gu Y, 2009, EUR J SOIL BIOL, V45, P436, DOI 10.1016/j.ejsobi.2009.06.003; Guan S.Y, 1986, SOIL ENZYME RES METH; Gunes A, 2007, J PLANT NUTR, V30, P1555, DOI 10.1080/01904160701615467; Hauggaard-Nielsen H, 2001, FIELD CROP RES, V72, P185, DOI 10.1016/S0378-4290(01)00176-9; Haynes RJ, 1999, BIOL FERT SOILS, V28, P253, DOI 10.1007/s003740050490; He ZQ, 2010, J FOOD AGRIC ENVIRON, V8, P1112; HOGBERG P, 1986, CAN J FOREST RES, V16, P1165, DOI 10.1139/x86-207; HORST WJ, 1987, Z PFLANZ BODENKUNDE, V150, P1, DOI 10.1002/jpln.19871500102; Ilany T, 2010, AGROFOREST SYST, V80, P399, DOI 10.1007/s10457-010-9317-8; Inal A, 2007, PLANT PHYSIOL BIOCH, V45, P350, DOI 10.1016/j.plaphy.2007.03.016; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Jensen ES, 1996, PLANT SOIL, V182, P25, DOI 10.1007/BF00010992; Jensen ES, 2003, PLANT SOIL, V252, P177, DOI 10.1023/A:1024189029226; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Klose S, 2000, BIOL FERT SOILS, V31, P191, DOI 10.1007/s003740050645; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Kumar BM, 1998, AGROFOREST SYST, V42, P81, DOI 10.1023/A:1006199910985; Li L, 2001, FIELD CROP RES, V71, P173, DOI 10.1016/S0378-4290(01)00157-5; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2013, ENCY BIODIVERSITY, P382, DOI [10.1016/B978-0-12-384719-5.00363-4, DOI 10.1016/B978-0-12-384719-5.00363-4]; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Li SM, 2004, ANN BOT-LONDON, V94, P297, DOI 10.1093/aob/mch140; Li WX, 2003, J PLANT NUTR, V26, P629, DOI 10.1081/PLN-120017670; Li YY, 2009, PLANT SOIL, V323, P295, DOI 10.1007/s11104-009-9938-8; Lopez-Bellido L, 2006, FIELD CROP RES, V98, P253, DOI 10.1016/j.fcr.2006.03.001; Lyman JK, 1986, MULTIPLE CROPPING SY; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mei PP, 2012, FIELD CROP RES, V130, P19, DOI 10.1016/j.fcr.2012.02.007; MORRIS RA, 1993, FIELD CROP RES, V34, P303, DOI 10.1016/0378-4290(93)90119-8; MORRIS RA, 1993, FIELD CROP RES, V34, P319, DOI 10.1016/0378-4290(93)90120-C; Mucheru-Muna M, 2010, FIELD CROP RES, V115, P132, DOI 10.1016/j.fcr.2009.10.013; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Ouma G., 2009, THE J, V1, P13; Pellegrino E, 2011, AGR ECOSYST ENVIRON, V140, P245, DOI 10.1016/j.agee.2010.12.011; Radulov I., 2011, Research Journal of Agricultural Science, V43, P160; Raghothama KG, 2005, PLANT SOIL, V274, P37, DOI 10.1007/s11104-004-2005-6; ROSS DJ, 1983, SOIL BIOL BIOCHEM, V15, P287, DOI 10.1016/0038-0717(83)90073-1; Rusinamhodzi L, 2012, FIELD CROP RES, V136, P12, DOI 10.1016/j.fcr.2012.07.014; Saikh H, 1998, PLANT SOIL, V204, P175, DOI 10.1023/A:1004323426199; Sardans J, 2008, EUR J SOIL BIOL, V44, P509, DOI 10.1016/j.ejsobi.2008.09.011; SEARLE PGE, 1981, FIELD CROP RES, V4, P133, DOI 10.1016/0378-4290(81)90063-0; Singh DK, 2008, CHEMOSPHERE, V71, P412, DOI 10.1016/j.chemosphere.2007.11.005; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; STEPHENS BD, 1983, PLANT PHYSIOL, V71, P731, DOI 10.1104/pp.71.4.731; Sultani MI, 2007, INT J ENVIRON SCI TE, V4, P109, DOI 10.1007/BF03325968; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tang C, 1997, AUST J EXP AGR, V37, P563, DOI 10.1071/EA96151; Thevathasan NV, 2004, AGROFOREST SYST, V61-2, P257, DOI 10.1023/B:AGFO.0000029003.00933.6d; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Vandermeer J.H., 1992, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Vanlauwe B, 1998, EUR J SOIL SCI, V49, P417, DOI 10.1046/j.1365-2389.1998.4930417.x; Velmourougane K, 2013, GEODERMA, V197, P186, DOI 10.1016/j.geoderma.2013.01.011; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Willey R. W., 1979, Field Crop Abstracts, V32, P1; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Yang WT, 2013, FIELD CROP RES, V146, P44, DOI 10.1016/j.fcr.2013.03.008; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhiping Q, 2004, J SUSTAIN AGR, V23, P39, DOI 10.1300/J064v23n04_05; Zhou XG, 2011, EUR J SOIL BIOL, V47, P279, DOI 10.1016/j.ejsobi.2011.07.001; Zomer RJ, 2009, 89 ICRAF WORLD AGR C	80	34	39	7	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113984	10.1371/journal.pone.0113984	http://dx.doi.org/10.1371/journal.pone.0113984			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486249	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600033
J	Grell, AS; Thigarajah, R; Edvinsson, L; Samraj, AK				Grell, Anne-Sofie; Thigarajah, Rushani; Edvinsson, Lars; Samraj, Ajoy Kumar			Regulatory Mechanism of Endothelin Receptor B in the Cerebral Arteries after Focal Cerebral Ischemia	PLOS ONE			English	Article							SP1 PHOSPHORYLATION; UP-REGULATION; IN-VITRO; MITHRAMYCIN; BINDING; CHROMOMYCIN; ANTAGONIST; EXPRESSION; INHIBITOR; OCCLUSION	Background and Purpose: Increased expression of endothelin receptor type B (ETBR), a vasoactive receptor, has recently been implied in the reduced cerebral blood flow and exacerbated neuronal damage after ischemia-reperfusion (I/R). The study explores the regulatory mechanisms of ETBR to identify drug targets to restore normal cerebral artery contractile function as part of successful neuroprotective therapy. Methods: We have employed in vitro methods on human and rat cerebral arteries to study the regulatory mechanisms and the efficacy of target selective inhibitor, Mithramycin A (MitA), to block the ETBR mediated contractile properties. Later, middle cerebral artery occluded (MCAO) rats were used to substantiate the observations. Quantative PCR, immunohistochemistry, western blot and wire myograph methods were employed to study the expression and contractile properties of cerebral arteries. Results: Increased expression of specificity protein (Sp1) was observed in human and rat cerebral arteries after organ culture, strongly correlating with the ETBR upregulation. Similar observations were made in MCAO rats. Treatment with MitA, a Sp1 specific inhibitor, significantly downregulated the ETBR mRNA and protein levels. It also significantly reduced the ETBR mediated cerebrovascular contractility. Detailed analysis indicated that ERK1/2 mediated phosphorylation of Sp1 might be essential for ETBR transcription. Conclusion: Transcription factor Sp1 regulates the ETBR mediated vasoconstriction in focal cerebral ischemia via MEK-ERK signaling, which is also conserved in humans. The results show that MitA can effectively be used to block ETBR mediated vasoconstriction as a supplement to an existing ischemic stroke therapy.	[Grell, Anne-Sofie; Edvinsson, Lars; Samraj, Ajoy Kumar] Univ Copenhagen, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Thigarajah, Rushani; Edvinsson, Lars] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden	University of Copenhagen; Lund University	Samraj, AK (corresponding author), Univ Copenhagen, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	aksamraj@gmail.com		Edvinsson, Lars/0000-0002-1805-1346	Lundbeck foundation for Centre of Excellence grant, Denmark; Swedish Heart and Lung foundation; Swedish Research council [5958]	Lundbeck foundation for Centre of Excellence grant, Denmark; Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Swedish Research council(Swedish Research CouncilEuropean Commission)	Lundbeck foundation for Centre of Excellence grant, Denmark, and the Swedish Heart and Lung foundation, and the Swedish Research council (grant no. 5958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnstedt H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-5; Ansar S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-12; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71.abs; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DORLEANSJUSTE P, 1993, BRIT J PHARMACOL, V110, P687, DOI 10.1111/j.1476-5381.1993.tb13866.x; Dutcher JP, 1997, LEUKEMIA RES, V21, P375, DOI 10.1016/S0145-2126(96)00108-7; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; EHRENREICH H, 1995, CLEV CLIN J MED, V62, P105, DOI 10.3949/ccjm.62.2.105; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Henriksson M, 2004, BRIT J PHARMACOL, V142, P1155, DOI 10.1038/sj.bjp.0705803; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041852; KENNEDY BJ, 1995, MED PEDIATR ONCOL, V24, P327, DOI 10.1002/mpo.2950240511; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Maddahi A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-56; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; MEMEZAWA H, 1992, EXP BRAIN RES, V89, P67; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; NISHIGAYA K, 1991, STROKE, V22, P635, DOI 10.1161/01.STR.22.5.635; Povlsen GK, 2012, EXP BRAIN RES, V219, P507, DOI 10.1007/s00221-012-3108-6; ROUBERT P, 1991, J CARDIOVASC PHARM, V17, pS104, DOI 10.1097/00005344-199100177-00027; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Zhang RL, 2008, STROKE, V39, P2830, DOI 10.1161/STROKEAHA.108.515684	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113624	10.1371/journal.pone.0113624	http://dx.doi.org/10.1371/journal.pone.0113624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479176	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200024
J	Lerma, LL; Benomar, N; Knapp, CW; Galeote, DC; Galvez, A; Abriouel, H				Lerma, Leyre Lavilla; Benomar, Nabil; Knapp, Charles W.; Galeote, David Correa; Galvez, Antonio; Abriouel, Hikmate			Diversity, Distribution and Quantification of Antibiotic Resistance Genes in Goat and Lamb Slaughterhouse Surfaces and Meat Products	PLOS ONE			English	Article							ESCHERICHIA-COLI; TETRACYCLINE RESISTANCE; SULFONAMIDE RESISTANCE; ANTIMICROBIAL RESISTANCE; HEALTHY HUMANS; SALMONELLA; PREVALENCE; BACTERIA; POULTRY; STRAINS	The distribution and quantification of tetracycline, sulfonamide and beta-lactam resistance genes were assessed in slaughterhouse zones throughout meat chain production and the meat products; this study represents the first to report quantitatively monitor antibiotic resistance genes (ARG) in goat and lamb slaughterhouse using a culture independent approach, since most studies focused on individual bacterial species and their specific resistance types. Quantitative PCR (qPCR) revealed a high prevalence of tetracycline resistance genes tetA and tetB in almost all slaughterhouse zones. Sulfonamide resistance genes were largely distributed, while beta-lactam resistance genes were less predominant. Statistical analysis revealed that resistant bacteria, in most cases, were spread by the same route in almost all slaughterhouse zones, except for tetB, bla(CTX) and bla(TEM) genes, which occurred in few zones as isolated 'hot spots.' The sum of all analyzed ARG indicated that slaughterhouse surfaces and end products act as reservoirs of ARG, mainly tet genes, which were more prevalent in slaughtering room (SR), cutting room (CR) and commercial meat products (MP). Resistance gene patterns suggest they were disseminated throughout slaughterhouse zones being also detected in commercial meat products, with significant correlations between different sampling zones/end products and total resistance in SR, CR and white room (WR) zones, and also refrigerator 4 (F4) and MP were observed. Strategically controlling key zones in slaughterhouse (SR, CR and WR) by adequate disinfection methods could strategically reduce the risks of ARG transmission and minimize the issues of food safety and environment contamination.	[Lerma, Leyre Lavilla; Benomar, Nabil; Galvez, Antonio; Abriouel, Hikmate] Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen 23071, Spain; [Knapp, Charles W.] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland; [Galeote, David Correa] Agencia CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain	Universidad de Jaen; University of Strathclyde; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Abriouel, H (corresponding author), Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen 23071, Spain.	hikmate@ujaen.es	Correa-Galeote, David/I-8336-2017; Correa-Galeote, David/A-9780-2019; Abriouel, Hikmate/K-9769-2017; Knapp, Charles W/D-3373-2009; Galvez, Antonio/M-2359-2014	Correa-Galeote, David/0000-0002-9776-8424; Correa-Galeote, David/0000-0002-9776-8424; Knapp, Charles W/0000-0001-7997-8543; Galvez, Antonio/0000-0002-5894-5029; Lavilla- Lerma, Maria Leyre/0000-0002-1295-1968; Abriouel, Hikmate/0000-0002-0666-3978; Benomar El Bakali, Nabil/0000-0002-7297-6171	Ministerio de Innovacion y Ciencia [AGL2009-08921]; Junta de Andalucia [P08-AGR-4295]; Plan propio de la Universidad de Jaen; Campus de Excelencia Internacional Agroalimentario CeiA3; Spanish Ministry of Education and Science	Ministerio de Innovacion y Ciencia(Spanish Government); Junta de Andalucia(Junta de Andalucia); Plan propio de la Universidad de Jaen; Campus de Excelencia Internacional Agroalimentario CeiA3; Spanish Ministry of Education and Science(Spanish Government)	This work was supported by grants AGL2009-08921 (Ministerio de Innovacion y Ciencia), P08-AGR-4295 (Junta de Andalucia), Plan propio de la Universidad de Jaen, and Campus de Excelencia Internacional Agroalimentario CeiA3. Leyre Lavilla Lerma was beneficiary of a fellowship from Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Aradhye A. A., 2014, African Journal of Microbiology Research, V8, P277; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Barza M, 2002, CLIN INFECT DIS, V34, pS71, DOI 10.1086/340241; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; Brtkova A, 2009, J FOOD NUTR RES-SLOV, V48, P121; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dancey C., 2004, STAT MATHS PSYCHOL U; DELOSREYESGAVILAN CG, 1992, APPL ENVIRON MICROB, V58, P3429; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Florez AB, 2008, INT J FOOD MICROBIOL, V121, P189, DOI 10.1016/j.ijfoodmicro.2007.11.029; Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07; Gregova G, 2012, ANN AGR ENV MED, V19, P75; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Hammerum AM, 2006, INT J FOOD MICROBIOL, V106, P235, DOI 10.1016/j.ijfoodmicro.2005.06.023; HOLMBERG SD, 1984, NEW ENGL J MED, V311, P617, DOI 10.1056/NEJM198409063111001; HUMMEL R, 1986, J BASIC MICROB, V26, P461, DOI 10.1002/jobm.3620260806; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Lerma LL, 2013, INT J FOOD MICROBIOL, V161, P97, DOI 10.1016/j.ijfoodmicro.2012.11.028; LEVY SB, 1976, NEW ENGL J MED, V295, P583, DOI 10.1056/NEJM197609092951103; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Sambrook J., 2002, MOL CLONING LAB MANU; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; Skockova A, 2012, J MICROB BIOTEC FOOD, V1, P777; Smith DeWaal C, 2013, ANTIBIOTIC RESISTANC, P1; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Sunde M, 2006, J ANTIMICROB CHEMOTH, V58, P741, DOI 10.1093/jac/dkl294; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Trobos M, 2008, INT J ANTIMICROB AG, V32, P367, DOI 10.1016/j.ijantimicag.2008.04.021; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	44	15	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114252	10.1371/journal.pone.0114252	http://dx.doi.org/10.1371/journal.pone.0114252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479100	Green Published, Green Accepted, gold			2022-12-27	WOS:000346907200057
J	Rhiel, L; Krah, S; Gunther, R; Becker, S; Kolmar, H; Hock, B				Rhiel, Laura; Krah, Simon; Guenther, Ralf; Becker, Stefan; Kolmar, Harald; Hock, Bjoern			REAL-Select: Full-Length Antibody Display and Library Screening by Surface Capture on Yeast Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DIRECTED EVOLUTION; PROTEIN-A; HETEROLOGOUS PROTEINS; AFFINITY MATURATION; ESCHERICHIA-COLI; BINDING; FRAGMENTS; EXPRESSION; PHAGE	We describe a novel approach named REAL-Select for the non-covalent display of IgG-molecules on the surface of yeast cells for the purpose of antibody engineering and selection. It relies on the capture of secreted native full-length antibodies on the cell surface via binding to an externally immobilized ZZ domain, which tightly binds antibody Fc. It is beneficial for high-throughput screening of yeast-displayed IgG-libraries during antibody discovery and development. In a model experiment, antibody-displaying yeast cells were isolated from a 1: 1,000,000 mixture with control cells confirming the maintenance of genotype-phenotype linkage. Antibodies with improved binding characteristics were obtained by affinity maturation using REAL-Select, demonstrating the ability of this system to display antibodies in their native form and to detect subtle changes in affinity by flow cytometry. The biotinylation of the cell surface followed by functionalization with a streptavidin-ZZ fusion protein is an approach that is independent of the genetic background of the antibody-producing host and therefore can be expected to be compatible with other eukaryotic expression hosts such as P. pastoris or mammalian cells.	[Rhiel, Laura; Guenther, Ralf; Becker, Stefan; Hock, Bjoern] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol, Darmstadt, Germany; [Krah, Simon; Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany	Merck KGaA; EMD Serono Inc.; Technical University of Darmstadt	Kolmar, H (corresponding author), Tech Univ Darmstadt, Inst Organ Chem & Biochem, Darmstadt, Germany.	Kolmar@Biochemie-TUD.de; Bjoern.Hock@merckgroup.com	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993				Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Blaise L, 2004, GENE, V342, P211, DOI 10.1016/j.gene.2004.08.014; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Doerner A, 2014, FEBS LETT, V588, P278, DOI 10.1016/j.febslet.2013.11.025; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; HORWITZ AH, 1988, P NATL ACAD SCI USA, V85, P8678, DOI 10.1073/pnas.85.22.8678; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Mazor Y, 2010, FEBS J, V277, P2291, DOI 10.1111/j.1742-4658.2010.07645.x; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; NILSSON J, 1994, EUR J BIOCHEM, V224, P103, DOI 10.1111/j.1432-1033.1994.tb20000.x; OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Rakestraw JA, 2011, PROTEIN ENG DES SEL, V24, P525, DOI 10.1093/protein/gzr008; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Sato N, 2002, APPL MICROBIOL BIOT, V60, P469, DOI 10.1007/s00253-002-1121-6; Schreuder MP, 1996, TRENDS BIOTECHNOL, V14, P115, DOI 10.1016/0167-7799(96)10017-2; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Traxlmayr MW, 2013, PROTEIN ENG DES SEL, V26, P255, DOI 10.1093/protein/gzs102; Ueda M, 2000, BIOTECHNOL ADV, V18, P121, DOI 10.1016/S0734-9750(00)00031-8; van den Beucken T, 2003, FEBS LETT, V546, P288, DOI 10.1016/S0014-5793(03)00602-1; VanderVaart JM, 1997, APPL ENVIRON MICROB, V63, P615, DOI 10.1128/AEM.63.2.615-620.1997; Vanhoefer U, 2004, J CLIN ONCOL, V22, P175, DOI 10.1200/JCO.2004.05.114; Wang Z, 2005, PROTEIN ENG DES SEL, V18, P337, DOI 10.1093/protein/gzi036; Weaver-Feldhaus JM, 2004, FEBS LETT, V564, P24, DOI 10.1016/S0014-5793(04)00309-6; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005	35	16	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114887	10.1371/journal.pone.0114887	http://dx.doi.org/10.1371/journal.pone.0114887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501029	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400060
J	Domingues, CSB; Waldman, EA				Bruniera Domingues, Carmen-Silvia; Waldman, Eliseu Alves			Causes of Death among People Living with AIDS in the Pre- and Post-HAART Eras in the City of S(a)over-tildeo Paulo, Brazil	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; ACTIVE ANTIRETROVIRAL THERAPY; SURVEYS ANRS EN19; RIO-DE-JANEIRO; INTERNATIONAL CLASSIFICATION; MORTALITY-RATES; PERSISTENT ROLE; UNITED-STATES; DISEASES; CANCERS	Objective: We examine the trend in causes of death among people living with AIDS in the city of S (a) over tildeo Paulo, Brazil, in the periods before and after the introduction of highly active antiretroviral therapy (HAART), and we investigate potential disparities across districts of residence. Methods: Descriptive study of three periods: pre-HAART (1991-1996); early post-HAART (1997-1999); and late post-HAART (2000-2006). The data source was the S (a) over tildeo Paulo State STD/AIDS Program and S (a) over tildeo Paulo State Data Analysis Foundation. Causes of death were classified by the ICD-9 (1991-1995) and ICD-10 (1996-2006). We estimated age-adjusted mortality rates for leading underlying causes of death and described underlying and associated causes of death according to sociodemographic characteristics and area of residence. We used Pearson's chi-square test or Fisher's exact test to compare categorical variables. Areas of residence were categorized using a socioeconomic index. To analyze trends we apply generalized linear model with Poisson regression. Results: We evaluated 32,808 AIDS-related deaths. Between the pre- and late post-HAART periods, the proportion of deaths whose underlying causes were non-AIDS-related diseases increased from 0.2% to 9.6% (p < 0.001): from 0.01% to 1.67% (p < 0.001) for cardiovascular diseases; 0.01% to 1.62% (p < 0.001) for bacterial/unspecified pneumonia; and 0.03% to 1.46% (p < 0.001) for non-AIDS-defining cancers. In the late post-HAART period, the most common associated causes of death were bacterial/unspecified pneumonia (35.94%), septicemia (33.46%), cardiovascular diseases (10.11%) and liver diseases (8.0%); and common underlying causes, besides AIDS disease, included non-AIDS-defining cancers in high-income areas, cardiovascular diseases in middle-income areas and assault in low-income areas. Conclusions: The introduction of HAART has shifted the mortality profile away from AIDS-related conditions, suggesting changes in the pattern of morbidity, but heterogeneously according to area of residence. There is a need for public policies aimed at adapting health care services to address the new scenario.	[Bruniera Domingues, Carmen-Silvia] Referral & Training Ctr, Sao Paulo State Dept Hlth STD & AIDS, Sao Paulo State Program STDs & AIDS, Sao Paulo, Brazil; [Bruniera Domingues, Carmen-Silvia; Waldman, Eliseu Alves] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Waldman, EA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.	eawaldma@usp.br	Waldman, Eliseu A/I-9401-2012	Waldman, Eliseu A/0000-0001-7807-6898	Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnolo3gico (CNPq, National Council for Scientific and Technological Development) [309502/2003-9]	Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnolo3gico (CNPq, National Council for Scientific and Technological Development)	Financial support for this research was provided by a grant from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnolo3gico (CNPq, National Council for Scientific and Technological Development; Grant no. 309502/2003-9 to EAW). The funder had no role in the data collection, data analysis, preparation of the manuscript or decision to publish. No additional external funding was received for this study.	Adih William K, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P5, DOI 10.1177/1545109710384505; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Bonnet F, 2009, CLIN INFECT DIS, V48, P633, DOI 10.1086/596766; Crabtree-Ramirez B, 2014, JAIDS-J ACQ IMM DEF, V67, pS96, DOI 10.1097/QAI.0000000000000261; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Fazito E, 2012, SEX TRANSM INFECT, V88, pI86, DOI 10.1136/sextrans-2012-050632; Ferreira MP, 2006, SAO PAULO PERSPECT, V20, P5; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Gopal M, 2009, CURR CARDIOL REV, V5, P149, DOI 10.2174/157340309788166705; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Grinsztejn B, 2009, AIDS, V23, P2107, DOI 10.1097/QAD.0b013e32832ec494; Hacker MA, 2007, CAD SAUDE PUBLICA, V23, pS345, DOI 10.1590/S0102-311X2007001500003; Hessamfar-Bonarek M, 2010, INT J EPIDEMIOL, V39, P135, DOI 10.1093/ije/dyp300; Khunnawat C, 2008, AM J CARDIOL, V102, P635, DOI 10.1016/j.amjcard.2008.04.035; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Rezende ELLF, 2010, BRAZ J INFECT DIS, V14, P558, DOI [10.1016/S1413-8670(10)70112-4, 10.1590/S1413-86702010000600003]; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Martinez E, 2009, CURR OPIN INFECT DIS, V22, P28, DOI 10.1097/QCO.0b013e328320a849; Melo VH, 2014, J LOW GENIT TRACT DI, V18, P128, DOI 10.1097/LGT.0b013e31829ee855; Ministerio da Saude do Brasil Secretaria de Politicas de Saude Coordenacao Nacional de DST e Aids, 2002, VIG HIV BRAS NOV DIR; Ministerio da Saude do Brasil Secretaria de Vigilancia em Saude Departamento de DST Aids e Hepatites Virais, 2010, B EPIDEMIOLOGICO AID, VVI, P8; Ministerio da Saude do Brasil Secretaria de Vigilancia em Saude Programa Nacional de DST e Aids, 2004, CRIT DEF CAS AIDS AD; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Pacheco AG, 2011, AIDS RES HUM RETROV, V27, P25, DOI 10.1089/aid.2010.0089; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Prefeitura da Cidade de Sao Paulo, 2002, SECR MUN DES TRAB SO; Prefeitura da Cidade de Sao Paulo. Secretaria Municipal de Saude, 2010, B EPIDEMIOLOGICO AID, VXIV, P17; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Santo AH, 2000, REV SAUDE PUBL, V34, P21, DOI 10.1590/S0034-89102000000100005; Santo AH, 1999, REV BRASIL EPIDEMIOL, P90; Santos SS, 2013, J INT AIDS SOC, V16, P17344; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Simard EP, 2010, CLIN INFECT DIS, V51, P957, DOI 10.1086/656416; Suarez LC, 2006, REV ESP SALUD PUBLIC, V80, P157, DOI [10.1590/s1135-57272006000200005, 10.1590/S1135-57272006000200005]; Peres MFT, 2011, REV PANAM SALUD PUBL, V29, P17, DOI 10.1590/S1020-49892011000100003; Waldvogel BC, 2010, DADOS REPENSAR AIDS, P9; Waldvogel Bernadette Cunha, 2006, Rev. bras. estud. popul., V23, P187, DOI 10.1590/S0102-30982006000100011	42	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114661	10.1371/journal.pone.0114661	http://dx.doi.org/10.1371/journal.pone.0114661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500837	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700041
J	Yu, SH; Huang, CY; Lee, SD; Hsu, MF; Wang, RY; Kao, CL; Kuo, CH				Yu, Szu-Hsien; Huang, Chih-Yang; Lee, Shin-Da; Hsu, Ming-Fen; Wang, Ray-Yau; Kao, Chung-Lan; Kuo, Chia-Hua			Decreased Eccentric Exercise-Induced Macrophage Infiltration in Skeletal Muscle after Supplementation with a Class of Ginseng-Derived Steroids	PLOS ONE			English	Article							FACTOR-KAPPA-B; PANAX-GINSENG; REGENERATION; HYPERTROPHY; IMPROVEMENT; MODULATION; GROWTH; CELLS	Dammarane steroids (DS) are a class of chemical compounds present in Panax ginseng. Here, we evaluated the effect of 10 weeks of DS supplementation on inflammatory modulation in the soleus muscle following eccentric exercise (EE)induced muscle damage (downhill running). Eighty rats were randomized into 4 groups of DS supplementation (saline, 20, 60, 120 mg/kg body weight). Inflammatory markers were measured at rest and again 1 h after EE. At rest, NFkB signaling, TNF-alpha and IL-6 mRNAs, 3-nitrotyrosine, glutathione peroxidase, and GCS (glutamylcysteine synthetase) levels were significantly elevated in the skeletal muscle of DS-treated rats in a dose-dependent manner. Additionally, there were no detectable increases in the number of necrotic muscle fibers or CD68(+) M1 macrophages. However, muscle strength, centronucleation, IL-10 mRNA expression, and the number of CD163(+) M2 macrophages increased significantly over controls with DS treatment in rat soleus muscle. Under EE-challenged conditions, significant increases in muscle fiber necrosis, CD68(+) M1 macrophage distribution, and 3-nitrotyrosine were absent in rats that received low and medium doses (20 and 60 mg/kg) of DS treatment, suggesting that DS possess anti-inflammatory action protecting against a muscle-damaging challenge. However, this protective activity was diminished when a high dose of DS (120 mg/kg) was administered, suggesting that DS possess hormetic properties. In conclusion, our study provides new evidence suggesting that DS is an ergogenic component of ginseng that potentiate inflammation at baseline but that produce anti-inflammatory effects on skeletal muscle following muscle-damaging exercise. Furthermore, high doses should be avoided in formulating ginseng-based products.	[Yu, Szu-Hsien; Hsu, Ming-Fen; Kuo, Chia-Hua] Univ Taipei, Lab Exercise Biochem, Taipei, Taiwan; [Yu, Szu-Hsien] Natl Ilan Univ, Dept Leisure Ind & Hlth Promot, Taipei, Yilan Cty, Taiwan; [Huang, Chih-Yang; Lee, Shin-Da; Kao, Chung-Lan] China Med Univ, Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang; Lee, Shin-Da] Asia Univ, Dept Hlth & Biotechnol, Taichung, Taiwan; [Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan	University of Taipei; National Ilan University; China Medical University Taiwan; Asia University Taiwan; National Yang Ming Chiao Tung University	Kuo, CH (corresponding author), Univ Taipei, Lab Exercise Biochem, Taipei, Taiwan.	kch@utaipei.edu.tw	Yuang, Chih-Yang/O-5111-2015; Lee, Shin-Da/Q-2798-2015	Lee, Shin-Da/0000-0002-8393-8349; Kuo, Chia-Hua/0000-0002-1731-4984	National Science Council of Taiwan; Pegasus Pharmaceuticals [101-2622-H-154-001-CC2]; University of Taipei, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Pegasus Pharmaceuticals; University of Taipei, Taiwan	This study was supported in part by National Science Council of Taiwan, Pegasus Pharmaceuticals (101-2622-H-154-001-CC2), http://www.ppginco.com/eng/aboutus/index.html, and the University of Taipei, Taiwan, www.utaipei.edu.tw. The funders had no role in study design, data collection and analysis, manuscript preparation, or decision to publish.	Adori C, 2010, BEHAV BRAIN RES, V206, P299, DOI 10.1016/j.bbr.2009.09.031; Bahrke MS, 2000, SPORTS MED, V29, P113, DOI 10.2165/00007256-200029020-00004; Bucci LR, 2000, AM J CLIN NUTR, V72, p624S, DOI 10.1093/ajcn/72.2.624S; Chen CY, 2010, CHINESE J PHYSIOL, V53, P62, DOI 10.4077/CJP.2010.AMK078; de Oliveira ACC, 2001, COMP BIOCHEM PHYS C, V130, P369, DOI 10.1016/S1532-0456(01)00262-9; de Oliveira ACC, 2005, J ETHNOPHARMACOL, V97, P211, DOI 10.1016/j.jep.2004.10.029; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Gumieniczek A, 2001, CLIN CHIM ACTA, V314, P39, DOI 10.1016/S0009-8981(01)00680-5; Howell JM, 2014, NEUROMUSCULAR DISORD, V24, P167, DOI 10.1016/j.nmd.2013.10.003; Jensen KT, 2008, J ORTHOP RES, V26, P816, DOI 10.1002/jor.20600; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Ji LL, 2007, APPL PHYSIOL NUTR ME, V32, P930, DOI 10.1139/H07-098; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; Kim WK, 2013, EUR J PHARMACOL, V702, P285, DOI 10.1016/j.ejphar.2013.01.048; Lima-Cabello E, 2010, J APPL PHYSIOL, V108, P575, DOI 10.1152/japplphysiol.00816.2009; MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; Monda M, 2009, J MUSCLE RES CELL M, V30, P139, DOI 10.1007/s10974-009-9182-0; Novak ML, 2009, AM J PHYSIOL-REG I, V296, pR1132, DOI 10.1152/ajpregu.90874.2008; Park IH, 2002, CHEM PHARM BULL, V50, P538, DOI 10.1248/cpb.50.538; Park SH, 2010, TOXICOLOGY, V278, P131, DOI 10.1016/j.tox.2010.04.003; Przybyla B, 2006, EXP GERONTOL, V41, P320, DOI 10.1016/j.exger.2005.12.007; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Scholz D, 2004, BIOORG MED CHEM LETT, V14, P2983, DOI 10.1016/j.bmcl.2004.02.104; Sievenpiper JL, 2004, J AM COLL NUTR, V23, P248, DOI 10.1080/07315724.2004.10719368; Sievenpiper JL, 2003, EUR J CLIN NUTR, V57, P243, DOI 10.1038/sj.ejcn.1601550; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; Song SB, 2012, J GINSENG RES, V36, P146, DOI 10.5142/jgr.2012.36.2.146; STPIERRE BA, 1994, J APPL PHYSIOL, V77, P290, DOI 10.1152/jappl.1994.77.1.290; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Ungaro R, 2009, AM J PHYSIOL-GASTR L, V296, pG1167, DOI 10.1152/ajpgi.90496.2008; Vezzoli M, 2011, ANTIOXID REDOX SIGN, V15, P2161, DOI 10.1089/ars.2010.3341; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang Y, 2012, HORM METAB RES, V44, P33, DOI 10.1055/s-0031-1295416; Zhao JM, 2011, BIOORG MED CHEM LETT, V21, P1027, DOI 10.1016/j.bmcl.2010.12.035; Zheng GQ, 2011, J ETHNOPHARMACOL, V133, P724, DOI 10.1016/j.jep.2010.01.064	38	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114649	10.1371/journal.pone.0114649	http://dx.doi.org/10.1371/journal.pone.0114649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500579	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700040
J	Brandl, HB; van Dongen, WFD; Darolova, A; Kristofik, J; Majtan, J; Hoi, H				Brandl, Hanja B.; van Dongen, Wouter F. D.; Darolova, Alzbeta; Kristofik, Jan; Majtan, Juraj; Hoi, Herbert			Composition of Bacterial Assemblages in Different Components of Reed Warbler Nests and a Possible Role of Egg Incubation in Pathogen Regulation	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; ANTIMICROBIAL PROPERTIES; CLOACAL BACTERIA; GUT MICROBIOTA; EGGSHELL; WILD; TRANSMISSION; COMMUNITIES; INFECTION; GROWTH	Bacteria play a central role in animal health. Yet, little is known about the acquisition of bacteria and the extent to which bacteria are acquired from different environmental sources. For example, bird nests host diverse bacteria associated with the eggs, nestlings and nesting material, but previous research has typically focussed on only a limited number of nest components at a time. It therefore remains unknown to what extent bacteria are transmitted between these components. Using both molecular and culture techniques, we characterised nest-associated bacterial assemblages throughout the entire nesting cycle of reed warblers by sampling bacteria on eggs before and during incubation, within nestling faeces, and on the nesting material of post-breeding nests. We found that bacterial assemblages clustered by nest component. Yet some overlap existed between nest components, suggesting that bacterial transmission across components is likely to occur. Eggs and nestlings from the same nest harboured more similar bacteria than expected by chance, suggesting an influence of environment or genetics on bacterial assemblages. Bacterial loads were not lower on incubated eggs. Instead, incubation was associated with a change in the structure of assemblages, including a decrease in potentially-harmful Gram-negative bacteria. In addition we show for the first time, that incubation is associated with the complete extinction of harmful haemolytic bacteria. Overall, our study appears to be the first to demonstrate differences in bacterial assemblages between bird nest components. In addition, we highlight the complexity of nest bacterial assemblages and provide new insights into the benefits of incubation.	[Brandl, Hanja B.; van Dongen, Wouter F. D.; Hoi, Herbert] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, A-1160 Vienna, Austria; [Darolova, Alzbeta; Kristofik, Jan; Majtan, Juraj] Slovak Acad Sci, Inst Zool, Bratislava 84506, Slovakia	University of Veterinary Medicine Vienna; Slovak Academy of Sciences	Brandl, HB (corresponding author), Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Savoyenstr 1a, A-1160 Vienna, Austria.	hanja.b@gmx.net	Majtan, Juraj/N-5841-2018; Brandl, Hanja/M-9233-2019	Majtan, Juraj/0000-0002-7268-1584; Brandl, Hanja/0000-0001-6972-5403; Darolova, Alzbeta/0000-0002-3269-2895	VEGA - Scientific grant agency of the Ministry of Education of the Slovak Republic; Slovak Academy of Sciences [VEGA 2/0034/15]	VEGA - Scientific grant agency of the Ministry of Education of the Slovak Republic(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Slovak Academy of Sciences(Slovak Academy of Sciences)	This study was financially supported by VEGA - Scientific grant agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences (VEGA 2/0034/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WILDLIFE REHAB; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Baltag E, 2011, NORTH-WEST J ZOOL, V7, P176; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bojesen AM, 2003, AVIAN PATHOL, V32, P503, DOI 10.1080/0307945031000154107; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; CARLSON HC, 1968, AVIAN DIS, V12, P297, DOI 10.2307/1588229; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Christensen H, 2003, INT J SYST EVOL MICR, V53, P275, DOI 10.1099/ijs.0.02330-0; CLARK L, 1990, PARASITOL TODAY, V6, P358, DOI 10.1016/0169-4758(90)90415-Z; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Corrigan A, 2011, APPL ENVIRON MICROB, V77, P6653, DOI 10.1128/AEM.05028-11; D'Alba L, 2014, J EXP BIOL, V217, P1116, DOI 10.1242/jeb.098343; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; De Reu K, 2008, WORLD POULTRY SCI J, V64, P5, DOI 10.1017/S0043933907001687; De Reu K, 2005, BRIT POULTRY SCI, V46, P149, DOI 10.1080/00071660500065359; De Vylder J, 2009, POULTRY SCI, V88, P2491, DOI 10.3382/ps.2009-00203; Ibanez-Alamo JD, 2014, J AVIAN BIOL, V45, P354, DOI 10.1111/jav.00353; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Duchesne P, 2006, MOL ECOL NOTES, V6, P965, DOI 10.1111/j.1471-8286.2006.01414.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flint JF, 2009, J APPL POULTRY RES, V18, P367, DOI 10.3382/japr.2008-00133; Glunder G, 2002, DEUT TIERARZTL WOCH, V109, P266; Glutz von Blotzheim U., 1991, HDB VOGEL MITTELEURO; Gomis SM, 1997, AVIAN DIS, V41, P234, DOI 10.2307/1592464; Gonzalez-Braojos S, 2012, ACTA ORNITHOL, V47, P119, DOI 10.3161/000164512X662223; Gonzalez-Braojos S, 2012, J ORNITHOL, V153, P181, DOI 10.1007/s10336-011-0725-y; Goodenough AE, 2012, MICROB ECOL, V63, P986, DOI 10.1007/s00248-011-9992-7; Gorley C.K., 2006, GETTING STARTED PRIM; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; Gross W. B., 1959, Avian Diseases, V3, P370, DOI 10.2307/1587575; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gunderson AR, 2009, J AVIAN BIOL, V40, P440, DOI 10.1111/j.1600-048X.2008.04650.x; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Kilgas P, 2012, J ORNITHOL, V153, P833, DOI 10.1007/s10336-011-0801-3; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Koller H, 2006, J MAR BIOL ASSOC UK, V86, P1113, DOI 10.1017/S0025315406014093; Kovacs A, 2010, RES MICROBIOL, V161, P192, DOI 10.1016/j.resmic.2010.01.006; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; LIN MY, 1993, AVIAN DIS, V37, P6, DOI 10.2307/1591450; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Lopes M, 2013, POULTRY SCI, V92, P638, DOI 10.3382/ps.2012-02700; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Mills TK, 1999, AUK, V116, P947; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; Morishita TY, 1997, J AVIAN MED SURG, V11, P77; Or A, 2013, RES MICROBIOL, V164, P262, DOI 10.1016/j.resmic.2012.12.004; PECKHAM MC, 1966, AVIAN DIS, V10, P413, DOI 10.2307/1588248; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Ruiz-de-Castaneda R, 2012, CONDOR, V114, P203, DOI 10.1525/cond.2011.100230; Ruiz-Rodriguez M, 2009, BIOL J LINN SOC, V96, P406, DOI 10.1111/j.1095-8312.2008.01127.x; Saag P, 2011, MICROB ECOL, V61, P740, DOI 10.1007/s00248-010-9789-0; SATO GIHEI., 1960, JAPANESE JOUR VET RES, V8, P285; Schottner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055505; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Slovak Hydrometeorological Institute, 2012, ANN BOOK CLIM OBS 20; Soler JJ, 2012, J EVOLUTION BIOL, V25, P1779, DOI 10.1111/j.1420-9101.2012.02561.x; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Wang JM, 2011, ECOLOGY, V92, P1137, DOI 10.1890/i0012-9658-92-5-1137; Wellman-Labadie O, 2010, J AGR FOOD CHEM, V58, P10156, DOI 10.1021/jf101954g; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; White J, 2010, ECOL LETT, V13, P1515, DOI 10.1111/j.1461-0248.2010.01542.x; Wienemann T, 2011, SYST APPL MICROBIOL, V34, P542, DOI 10.1016/j.syapm.2011.06.003; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	82	38	39	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114861	10.1371/journal.pone.0114861	http://dx.doi.org/10.1371/journal.pone.0114861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493434	gold, Green Published			2022-12-27	WOS:000346611400080
J	Klein, C; Betz, J; Hirschbuehl, M; Fuchs, C; Schmiedtova, B; Engelbrecht, M; Mueller-Paul, J; Rosenberg, R				Klein, Christoph; Betz, Juliane; Hirschbuehl, Martin; Fuchs, Caroline; Schmiedtova, Barbara; Engelbrecht, Martina; Mueller-Paul, Julia; Rosenberg, Raphael			Describing Art - An Interdisciplinary Approach to the Effects of Speaking on Gaze Movements during the Beholding of Paintings	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL-ATTENTION; LANGUAGE; PERCEPTION; MEDIATION; OBJECTS	Ever since the Renaissance speaking about paintings has been a fundamental approach for beholders, especially experts. However, it is unclear whether and how speaking about art modifies the way we look at it and this was not yet empirically tested. The present study investigated to the best of our knowledge for the first time in what way speaking modifies the patterns of fixations and gaze movements while looking at paintings. Ninety nine university students looked at four paintings selected to cover different art historical typologies for periods of 15 minutes each while gaze movement data were recorded. After 10 minutes, the participants of the experimental group were asked open questions about the painting. Speaking dramatically reduced the duration of fixations and painting area covered by fixations while at the same time increasing the frequencies of fixations, gaze length and the amount of repeated transitions between fixation clusters. These results suggest that the production of texts as well-organised sequences of information, structures the gazes of art beholders by making them quicker, more focused and better connected.	[Klein, Christoph; Mueller-Paul, Julia] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Klein, Christoph] Univ Freiburg, Dept Child & Adolescent Psychiat Psychotherapy &, D-79106 Freiburg, Germany; [Betz, Juliane; Hirschbuehl, Martin; Engelbrecht, Martina] Heidelberg Univ, Inst European Art Hist, Heidelberg, Germany; [Hirschbuehl, Martin; Fuchs, Caroline; Rosenberg, Raphael] Univ Vienna, Dept Art Hist, Vienna, Austria; [Hirschbuehl, Martin; Fuchs, Caroline; Rosenberg, Raphael] Univ Vienna, Cognit Res Platform, Vienna, Austria; [Schmiedtova, Barbara] Heidelberg Univ, Inst German Foreign Language Philol, Heidelberg, Germany	Bangor University; University of Freiburg; Ruprecht Karls University Heidelberg; University of Vienna; University of Vienna; Ruprecht Karls University Heidelberg	Klein, C (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	c.klein@bangor.ac.uk	Kabongo, Jean Claude/ABC-5756-2021	Mertins, Barbara/0000-0002-0271-0431	Deutsche Forschungsgemeinschaft (DFG) [RO 2281/3-1]; Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	Research was supported by the Deutsche Forschungsgemeinschaft (DFG, RO 2281/3-1). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 2007, J MEM LANG, V57, P502, DOI 10.1016/j.jml.2006.12.004; Altmann GTM, 2009, COGNITION, V111, P55, DOI 10.1016/j.cognition.2008.12.005; Athanasopoulos P, 2008, APPL PSYCHOLINGUIST, V29, P105, DOI 10.1017/S0142716408080053; Billman D, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P615; Billman D, 1998, PROCEEDINGS OF THE TWENTIETH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P156; Boehm G., 1995, BESCHREIBUNGSKUNST K; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; de Piles R., 1677, CONVERSATIONS CONNAI; Doni AF, 1552, MARMI; Engelbrecht M, 2010, IMAGE, P11; Felibien A, 1666, ENTRETIENS VIE OUVRA; FISK AD, 1987, CURR PSYCHOL RES REV, V5, P315; Gauvin HS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00818; Gennari SP, 2002, COGNITION, V83, P49, DOI 10.1016/S0010-0277(01)00166-4; Griffin ZM, 2006, BRAIN LANG, V99, P272, DOI 10.1016/j.bandl.2005.08.003; Griffin ZM, 2011, MENT LEX, V6, P53, DOI 10.1075/ml.6.1.03gri; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Ho C, 2005, NEUROSCI LETT, V389, P35, DOI 10.1016/j.neulet.2005.07.003; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Holsanova J., 2008, DISCOURSE VISION COG; Kase O, 2010, WORTEN SEHEN LERNEN; Kathmann N, 1999, PSYCHOPHYSIOLOGY, V36, P158, DOI 10.1017/S0048577299981167; Klein C, 2008, BRAIN COGNITION, V68, P215, DOI 10.1016/j.bandc.2008.08.012; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Levinson SC, 2002, COGNITION, V84, P155, DOI 10.1016/S0010-0277(02)00045-8; Meyer AS, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P253, DOI 10.1016/B978-044451020-4/50015-3; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Molnar F., 1981, ADV INTRINSIC MOTIVA, P385, DOI 10.1007/978-1-4613-3195-7_16; MOLNAR F, 1987, EYE MOVEMENTS PHYSL, P363; Naigles LR, 1998, PSYCHOL SCI, V9, P363, DOI 10.1111/1467-9280.00069; NODINE CF, 1993, LEONARDO, V26, P219, DOI 10.2307/1575815; Papafragou A, 2008, COGNITION, V108, P155, DOI 10.1016/j.cognition.2008.02.007; Piai V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00832; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; ROSENBERG R, 1995, Z KUNSTGESCHICHTE, V58, P297, DOI 10.2307/1482816; Rosenberg R, 2008, KUNSTHISTORISCHES JB, V6, P127; Rosenberg R, 2014, JB BAYERISCHEN AKAD, V27, P78; Salverda AP, 2011, J EXP PSYCHOL HUMAN, V37, P1122, DOI 10.1037/a0023101; SIGMAN M, 1991, COGNITIVE DEV, V6, P47, DOI 10.1016/0885-2014(91)90005-X; Slobin D., 1996, RETHINKING LINGUISTI, P70, DOI DOI 10.1016/S0378-2166(97)83851-9; Smith J., 2001, EMPIRICAL STUDIES AR, V19, P229, DOI [10.2190/5MQM-59JH-X21R-JN5J, DOI 10.2190/5MQM-59JH-X21R-JN5J]; Vogt S, 2007, PERCEPTION, V36, P91, DOI 10.1068/p5262; Wade NJ, 2005, MOVING TABLET EYE OR; Welzel Barbara, 1997, GESELLIGKEIT GESELLS, P495; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e102439	10.1371/journal.pone.0102439	http://dx.doi.org/10.1371/journal.pone.0102439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AW9YP	25494170	Green Published, gold			2022-12-27	WOS:000346611400001
J	Zhang, XS; Pebody, R; De Angelis, D; White, PJ; Charlett, A; McCauley, JW				Zhang, Xu-Sheng; Pebody, Richard; De Angelis, Daniela; White, Peter J.; Charlett, Andre; McCauley, John W.			The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment	PLOS ONE			English	Article							A H1N1 VIRUS; CROSS-PROTECTION; INFECTION; IMMUNITY; DYNAMICS; VACCINES; LIVE; TRANSMISSION; A(H1N1)PDM09; PATTERNS	Background: One pathway through which pandemic influenza strains might emerge is reassortment from coinfection of different influenza A viruses. Seasonal influenza vaccines are designed to target the circulating strains, which intuitively decreases the prevalence of coinfection and the chance of pandemic emergence due to reassortment. However, individual-based analyses on 2009 pandemic influenza show that the previous seasonal vaccination may increase the risk of pandemic A(H1N1) pdm09 infection. In view of pandemic influenza preparedness, it is essential to understand the overall effect of seasonal vaccination on pandemic emergence via reassortment. Methods and Findings: In a previous study we applied a population dynamics approach to investigate the effect of infection-induced cross-immunity on reducing such a pandemic risk. Here the model was extended by incorporating vaccination for seasonal influenza to assess its potential role on the pandemic emergence via reassortment and its effect in protecting humans if a pandemic does emerge. The vaccination is assumed to protect against the target strains but only partially against other strains. We find that a universal seasonal vaccine that provides full-spectrum cross-immunity substantially reduces the opportunity of pandemic emergence. However, our results show that such effectiveness depends on the strength of infection-induced cross-immunity against any novel reassortant strain. If it is weak, the vaccine that induces cross-immunity strongly against non-target resident strains but weakly against novel reassortant strains, can further depress the pandemic emergence; if it is very strong, the same kind of vaccine increases the probability of pandemic emergence. Conclusions: Two types of vaccines are available: inactivated and live attenuated, only live attenuated vaccines can induce heterosubtypic immunity. Current vaccines are effective in controlling circulating strains; they cannot always help restrain pandemic emergence because of the uncertainty of the oncoming reassortant strains, however. This urges the development of universal vaccines for prevention of pandemic influenza.	[Zhang, Xu-Sheng; White, Peter J.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London, England; [Zhang, Xu-Sheng; White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC,Ctr Outbreak Anal & Modelling, London, England; [Pebody, Richard] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Resp Dis, London, England; [De Angelis, Daniela; Charlett, Andre] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Stat Unit, London, England; [De Angelis, Daniela] Univ Forvie Site, MRC, Biostat Unit, Cambridge, England; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, NIHR Hlth Protect Res Unit Modelling Methodol, London, England; [McCauley, John W.] Natl Inst Med Res, MRC, London NW7 1AA, England	Public Health England; Imperial College London; Public Health England; Public Health England; MRC Biostatistics Unit; University of Cambridge; Imperial College London; MRC National Institute for Medical Research	Zhang, XS (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London, England.	xu-sheng.zhang@phe.gov.uk		De Angelis, Daniela/0000-0001-6619-6112; Pebody, Richard/0000-0002-9069-2885; Zhang, Xu-Sheng/0000-0002-6596-4500	Public Health England; MRC [MR/K010174/1]; UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London; Public Health England (PHE) [HPRU-2012-10080]; MRC NIMR programme [u117512723]; Medical Research Council [MC_U105260556, MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; MRC [MC_U105260556] Funding Source: UKRI	Public Health England; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London; Public Health England (PHE); MRC NIMR programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Public Health England. PJW thanks the MRC for Centre funding [grant number MR/K010174/1], and also thanks the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) for funding [grant number HPRU-2012-10080]. JWM was supported by MRC NIMR programme No. u117512723. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Cassetti Maria Cristina, 2005, Vaccine, V23, P1529, DOI 10.1016/j.vaccine.2004.09.004; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen JR, 2014, P NATL ACAD SCI USA, V111, P2476, DOI 10.1073/pnas.1323954111; Coburn BJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S6; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; DAVIES JR, 1986, J HYG-CAMBRIDGE, V96, P345, DOI 10.1017/S0022172400066092; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI 10.1586/ERV.10.123; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, GLOBAL PATTERNS SEAS; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gilbert SC, 2013, INFLUENZA OTHER RESP, V7, P750, DOI 10.1111/irv.12013; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Girard MP, 2008, VACCINE, V26, P3969, DOI [10.1016/j.vaccine.2008.04.051, 10.1016/j.vaccine.2008.03.006]; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Gregory V, 2002, VIROLOGY, V300, P1, DOI 10.1006/viro.2002.1513; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; HOSKINS TW, 1976, LANCET, V1, P105; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kafatos G, 2013, INFLUENZA OTHER RESP, V7, P1175, DOI 10.1111/irv.12163; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Keeling MJ, 2011, J R SOC INTERFACE, V8, P661, DOI 10.1098/rsif.2010.0474; Kelly H, 2009, Euro Surveill, V14; Kelly H, 2012, VACCINE, V30, P2037, DOI 10.1016/j.vaccine.2011.11.060; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007366; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Liu W, 2010, CLIN INFECT DIS, V50, P1359, DOI 10.1086/652143; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; MASUREL N, 1969, B WORLD HEALTH ORGAN, V41, P461; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Mercer GN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S11; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Pebody R, 2011, EUROSURVEILLANCE, V16, P8; Perera RAPM, 2011, EMERG INFECT DIS, V17, P1897, DOI 10.3201/eid1710.110629; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pitzer VE, 2011, P NATL ACAD SCI USA, V108, P19353, DOI 10.1073/pnas.1110507108; Plosker GL, 2012, DRUGS, V72, P1543, DOI 10.2165/11209650-000000000-00000; Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rabadan R, 2008, INFLUENZA OTHER RESP, V2, P9, DOI 10.1111/j.1750-2659.2007.00030.x; Restif O, 2007, J R SOC INTERFACE, V4, P143, DOI 10.1098/rsif.2006.0167; Rios-Doria D, 2009, J THEOR BIOL, V261, P584, DOI 10.1016/j.jtbi.2009.08.020; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Worobey M, 2014, P NATL ACAD SCI USA, V111, P8107, DOI 10.1073/pnas.1324197111; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x; Xiao YY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-589; Xie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016650; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Yin JK, 2012, VACCINE, V30, P3209, DOI 10.1016/j.vaccine.2012.02.048; Zhang XS, 2013, EPIDEMICS-NETH, V5, P20, DOI 10.1016/j.epidem.2012.10.003	77	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114637	10.1371/journal.pone.0114637	http://dx.doi.org/10.1371/journal.pone.0114637			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494180	gold, Green Submitted, Green Published			2022-12-27	WOS:000346611400064
J	Iguchi, Y; Kosugi, S; Nishikawa, H; Lin, ZQ; Minabe, Y; Toda, S				Iguchi, Yoshio; Kosugi, Sakurako; Nishikawa, Hiromi; Lin, Ziqiao; Minabe, Yoshio; Toda, Shigenobu			Repeated Exposure of Adult Rats to Transient Oxidative Stress Induces Various Long-Lasting Alterations in Cognitive and Behavioral Functions	PLOS ONE			English	Article							TRANSPORTER KNOCKOUT MICE; INDUCED LOCOMOTOR-ACTIVITY; TERM SPATIAL MEMORY; CHRONIC MILD STRESS; GLUTATHIONE DEPLETION; DOPAMINE-TRANSPORTER; ANIMAL-MODEL; HYPERDOPAMINERGIC MICE; NUCLEUS ACCUMBENS; HABIT FORMATION	Exposure of neonates to oxidative stress may increase the risk of psychiatric disorders such as schizophrenia in adulthood. However, the effects of moderate oxidative stress on the adult brain are not completely understood. To address this issue, we systemically administrated 2-cyclohexen-1-one (CHX) to adult rats to transiently reduce glutathione levels. Repeated administration of CHX did not affect the acquisition or motivation of an appetitive instrumental behavior (lever pressing) rewarded by a food outcome under a progressive ratio schedule. In addition, response discrimination and reversal learning were not affected. However, acute CHX administration blunted the sensitivity of the instrumental performance to outcome devaluation, and this effect was prolonged in rats with a history of repeated CHX exposure, representing pro-depression-like phenotypes. On the other hand, repeated CHX administration reduced immobility in forced swimming tests and blunted acute cocaine-induced behaviors, implicating antidepressant-like effects. Multivariate analyses segregated a characteristic group of behavioral variables influenced by repeated CHX administration. Taken together, these findings suggest that repeated administration of CHX to adult rats did not cause a specific mental disorder, but it induced long-term alterations in behavioral and cognitive functions, possibly related to specific neural correlates.	[Iguchi, Yoshio; Kosugi, Sakurako; Nishikawa, Hiromi; Lin, Ziqiao; Minabe, Yoshio; Toda, Shigenobu] Kanazawa Univ, Sch Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9808641, Japan	Kanazawa University	Toda, S (corresponding author), Kanazawa Univ, Sch Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9808641, Japan.	yiguchi@med.kanazawa-u.ac.jp	Iguchi, Yoshio/R-3318-2019	Iguchi, Yoshio/0000-0001-8240-3345	Ministry of Education, Culture, Sports and Technology, Japan [20452097, 25860994, 24791208, 26860920, 25461727, 25116510, 26120712]; Eli Lilly; Japan Foundation for Neuroscience and Mental Health; Takeda Research Foundation; Matsubara Saburoh Memorial Research Foundation for Psychiatry	Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eli Lilly(Eli Lilly); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Takeda Research Foundation(Takeda Science Foundation (TSF)); Matsubara Saburoh Memorial Research Foundation for Psychiatry	This study was supported by Grants-in-Aids from the Ministry of Education, Culture, Sports and Technology, Japan (20452097 and 25860994 to YI; 24791208 to SK; 26860920 to HN; 25461727, 25116510, and 26120712 to ST), Eli Lilly (to YI), Japan Foundation for Neuroscience and Mental Health (to YI), Takeda Research Foundation (to ST) and Matsubara Saburoh Memorial Research Foundation for Psychiatry (to SK, ZL and YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; ASHER IM, 1974, BRAIN RES, V82, P1, DOI 10.1016/0006-8993(74)90888-9; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Castagne V, 2004, NEUROSCIENCE, V123, P821, DOI 10.1016/j.neuroscience.2003.11.012; Choy KHC, 2010, EUR J PHARMACOL, V649, P224, DOI 10.1016/j.ejphar.2010.09.035; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; CREESE I, 1975, BRAIN RES, V83, P419, DOI 10.1016/0006-8993(75)90834-3; Cruz-Aguado R, 2001, BRAIN RES BULL, V55, P327, DOI 10.1016/S0361-9230(01)00484-1; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Dean O, 2009, BEHAV BRAIN RES, V198, P258, DOI 10.1016/j.bbr.2008.11.017; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Garcia-Fuster MJ, 2010, EUR J NEUROSCI, V31, P79, DOI 10.1111/j.1460-9568.2009.07045.x; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groppetti A, 1974, BIOCH PHARM S1, V23, P756; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; Hilario MRF, 2008, FRONT NEUROSCI-SWITZ, V2, P208, DOI 10.3389/neuro.01.030.2008; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Johnson AW, 2013, P NATL ACAD SCI USA, V110, P12462, DOI 10.1073/pnas.1307925110; Kalivas PW, 2003, METH MOLEC MED, V79, P3; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kulak A, 2012, BEHAV BRAIN RES, V226, P563, DOI 10.1016/j.bbr.2011.10.020; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lu RZ, 2009, NEUROCHEM INT, V55, P552, DOI 10.1016/j.neuint.2009.05.009; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; MASUKAWA T, 1989, LIFE SCI, V44, P417, DOI 10.1016/0024-3205(89)90266-X; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Perona MTG, 2008, BEHAV PHARMACOL, V19, P566, DOI 10.1097/FBP.0b013e32830cd80f; PIJNENBURG AJJ, 1975, PSYCHOPHARMACOLOGIA, V41, P87, DOI 10.1007/BF00421062; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prasad BM, 1995, ANN NY ACAD SCI, V771, P617, DOI 10.1111/j.1749-6632.1995.tb44714.x; R Core Team, 2012, R LANG ENV STAT COMP; Ramadan E, 2012, INT J NEUROSCI, V122, P373, DOI 10.3109/00207454.2012.665972; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Roberts D.C.S., 1992, ANIMAL MODELS DRUG A, P233, DOI [10.1385/0-89603-217-5:233, DOI 10.1385/0-89603-217-5:233]; Sasaoka T, 2012, CLIN EXP PHARMACOL P, V39, P597, DOI 10.1111/j.1440-1681.2012.05723.x; Schiavone S, 2013, ANTIOXID REDOX SIGN, V18, P1475, DOI 10.1089/ars.2012.4720; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2010, PSYCHONEUROENDOCRINO, V35, P977, DOI 10.1016/j.psyneuen.2009.12.010; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Shukitt-Hale B, 1998, FREE RADICAL BIO MED, V24, P1149, DOI 10.1016/S0891-5849(97)00399-7; Simeone A, 2011, MOL NEUROBIOL, V43, P107, DOI 10.1007/s12035-010-8148-y; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Suo L, 2013, NEUROPSYCHOPHARMACOL, V38, P1387, DOI 10.1038/npp.2013.67; Szumlinski KK, 2003, PSYCHOPHARMACOLOGY, V165, P329, DOI 10.1007/s00213-002-1274-0; Tagliari B, 2010, J NEURAL TRANSM, V117, P1067, DOI 10.1007/s00702-010-0445-0; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; WEST AP, 1990, PROG NEURO-PSYCHOPH, V14, P863, DOI 10.1016/0278-5846(90)90073-P; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	68	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114024	10.1371/journal.pone.0114024	http://dx.doi.org/10.1371/journal.pone.0114024			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489939	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300014
J	Liu, HL; Huang, CY; Chen, JY; Wang, HYJ; Chen, PY; Wei, KC				Liu, Hao-Li; Huang, Chiung-Yin; Chen, Ju-Yu; Wang, Hay-Yan Jack; Chen, Pin-Yuan; Wei, Kuo-Chen			Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma Treatment	PLOS ONE			English	Article							ANTITUMOR AGENT TEMOZOLOMIDE; GLIOBLASTOMA-MULTIFORME; HUMAN PLASMA; ADJUVANT TEMOZOLOMIDE; PHASE-III; RAT; DISRUPTION; RADIATION; TUMOR; DRUG	Focused ultrasound (FUS) exposure with the presence of microbubbles has been shown to transiently open the blood-brain barrier (BBB), and thus has potential to enhance the delivery of various kinds of therapeutic agents into brain tumors. The purpose of this study was to assess the preclinical therapeutic efficacy of FUS-BBB opening for enhanced temozolomide (TMZ) delivery in glioma treatment. FUS exposure with microbubbles was delivered to open the BBB of nude mice that were either normal or implanted with U87 human glioma cells. Different TMZ dose regimens were tested, ranging from 2.5 to 25 mg/kg. Plasma and brain samples were obtained at different time-points ranging from 0.5 to 4 hours, and the TMZ concentration within samples was quantitated via a developed LC-MS/MS procedure. Tumor progression was followed with T2-MRI, and animal survival and brain tissue histology were conducted. Results demonstrated that FUS-BBB opening caused the local TMZ accumulation in the brain to increase from 6.98 to 19 ng/mg. TMZ degradation time in the tumor core was found to increase from 1.02 to 1.56 hours. Improved tumor progression and animal survival were found at different TMZ doses (up to 15% and 30%, respectively). In conclusion, this study provides preclinical evidence that FUS-BBB opening increases the local concentration of TMZ to improve the control of tumor progression and animal survival, suggesting the potential for clinical application to improve current brain tumor treatment.	[Liu, Hao-Li; Chen, Ju-Yu] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Huang, Chiung-Yin; Chen, Pin-Yuan; Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Wang, Hay-Yan Jack] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Liu, Hao-Li] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; National Sun Yat Sen University; Chang Gung University	Liu, HL (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.	haoliliu@mail.cgu.edu.tw; kuochenwei@adm.cgmh.org.tw		Chen, Ju-Yu/0000-0001-8064-9392; Wei, Kuochen/0000-0003-3505-2196	Ministry of Science and Technology, Taiwan [101-2221-E-182-002-MY3, 102-2221-E-182-020-MY3, 103-2622-B-182A-001, 103-2325-B-182A-007]; Chang-Gung Memorial Hospital, Taiwan [CMRPD2A0031-33, CMRPG380041]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang-Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This research was supported by the Ministry of Science and Technology, Taiwan, grant nos. 101-2221-E-182-002-MY3, 102-2221-E-182-020-MY3, 103-2622-B-182A-001, 103-2325-B-182A-007, and Chang-Gung Memorial Hospital, Taiwan, grant nos. CMRPD2A0031-33 and CMRPG380041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SD, 1999, CLIN CANCER RES, V5, P309; BURGER PC, 1987, MAYO CLIN PROC, V62, P527, DOI 10.1016/S0025-6196(12)65479-2; Chowdhury SK, 1999, J PHARMACEUT BIOMED, V19, P659, DOI 10.1016/S0731-7085(98)00198-8; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Galanis E, 2000, BRIT J CANCER, V82, P1371, DOI 10.1054/bjoc.1999.1075; GROOTHUIS DR, 1982, J NEUROPATH EXP NEUR, V41, P164, DOI 10.1097/00005072-198203000-00006; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Grossman SA, 2003, J CLIN ONCOL, V21, P1485, DOI 10.1200/JCO.2003.10.035; Gupta Vinay, 2006, Neurosurg Focus, V20, pE20, DOI 10.3171/foc.2006.20.4.13; HALPERIN EC, 1988, INT J RADIAT ONCOL, V15, P505, DOI 10.1016/S0360-3016(98)90036-0; Hammond LA, 1999, J CLIN ONCOL, V17, P2604, DOI 10.1200/JCO.1999.17.8.2604; Hassouna I, 2008, INT J RADIAT ONCOL, V72, P927, DOI 10.1016/j.ijrobp.2008.06.1923; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2003, ACT NEUR S, V86, P555; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Kim H, 2001, J PHARMACEUT BIOMED, V24, P461, DOI 10.1016/S0731-7085(00)00466-0; Kim HK, 1997, J CHROMATOGR B, V703, P225, DOI 10.1016/S0378-4347(97)00431-3; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; NEUWELT EA, 1982, P NATL ACAD SCI-BIOL, V79, P4420, DOI 10.1073/pnas.79.14.4420; NEUWELT EA, 1986, NEUROSURGERY, V19, P573, DOI 10.1227/00006123-198610000-00011; NEUWELT EA, 1985, CANCER RES, V45, P2827; NEUWELT EA, 1986, CANCER, V58, P1609, DOI 10.1002/1097-0142(19861015)58:8<1609::AID-CNCR2820580805>3.0.CO;2-7; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Reyderman L, 2004, XENOBIOTICA, V34, P487, DOI 10.1080/00498250410001685737; SHEN F, 1995, J CHROMATOGR B, V667, P291, DOI 10.1016/0378-4347(95)00040-P; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; STEVENS MFG, 1987, CANCER RES, V47, P5846; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tralins KS, 2002, J NUCL MED, V43, P1667; Von Hoff DD, 2004, HDB ANTICANCER PHARM, P57992; Wei KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058995	35	63	65	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114311	10.1371/journal.pone.0114311	http://dx.doi.org/10.1371/journal.pone.0114311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490097	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300026
J	Qin, M; Liu, XY; Tang, XM; Suo, JX; Tao, GR; Suo, X				Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun			Transfection of Eimeria mitis with Yellow Fluorescent Protein as Reporter and the Endogenous Development of the Transgenic Parasite	PLOS ONE			English	Article							TOXOPLASMA-GONDII; TRANSIENT TRANSFECTION; STABLE TRANSFECTION; VACCINE DEVELOPMENT; FINE-STRUCTURE; TENELLA; EXPRESSION; COCCIDIOSIS; CHICKENS; MICROGAMETOGENESIS	Background: Advancements have been made in the genetic manipulation of apicomplexan parasites. Both the in vitro transient and in vivo stable transfection of Eimeria tenella have been developed successfully. Herein, we report the transient and stable transfection of Eimeria mitis. Methods and Findings: Sporozoites of E. mitis transfected with enhanced yellow fluorescent protein (EYFP) expression plasmid were inoculated into chickens via the cloacal route. The recovered fluorescent oocysts were sorted by fluorescence activated cell sorting (FACS) and then passaged 6 generations successively in chickens. The resulting population was analyzed by genome walking and Western blot. The endogenous development of the transgenic E. mitis was observed and its reproduction potential was tested. The stable transfection of E. mitis was developed. Genome walking confirmed the random integration of plasmid DNA into the genome; while Western blot analysis demonstrated the expression of foreign proteins. Constitutive expression of EYFP was observed in all stages of merogony, gametogony and sporogony. The peak of the transgenic oocyst output was delayed by 24 h and the total oocyst reproduction was reduced by 7-fold when compared to the parental strain. Conclusion: Stable transfection of E. mitis was successfully developed. The expression of foreign antigens in the transgenic parasites will facilitate the development of transgenic E. mitis as a vaccine vector.	[Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China; [Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Liu, Xian Yong; Suo, Xun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Suo, X (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn		Tang, Xinming/0000-0003-0127-1235; LIU, XIANYONG/0000-0001-9425-6784	National Natural Science Foundation of China [31330076, 31001060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Key project, 31330076; 31001060).	Blake DP, 2014, TRENDS PARASITOL, V30, P12, DOI 10.1016/j.pt.2013.10.003; CHEN H, 2013, J PARASITOL RES, V2013, DOI DOI 10.1155/2013/591520; Clark JD, 2008, MOL BIOCHEM PARASIT, V162, P77, DOI 10.1016/j.molbiopara.2008.07.006; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; COLLEY FC, 1967, J PROTOZOOL, V14, P663, DOI 10.1111/j.1550-7408.1967.tb02059.x; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; FERGUSON DJP, 1977, ACTA PATH MICRO IM B, V85, P67; FERNANDO MA, 1973, Z PARASITENKD, V43, P33, DOI 10.1007/BF00329535; Fitz-Coy S, 1991, AVIAN DIS, V36, P44; FITZCOY SH, 1992, AVIAN DIS, V36, P718, DOI 10.2307/1591771; GOONEWARDENE R, 1993, P NATL ACAD SCI USA, V90, P5234, DOI 10.1073/pnas.90.11.5234; Hao LL, 2007, MOL BIOCHEM PARASIT, V153, P213, DOI 10.1016/j.molbiopara.2007.02.005; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Huang XX, 2011, J IMMUNOL, V187, P3595, DOI 10.4049/jimmunol.1100043; Jenkins M, 2010, AVIAN DIS, V54, P1002, DOI 10.1637/9137-111109-Reg.1; JOYNER LP, 1958, PARASITOLOGY, V48, P101, DOI 10.1017/S0031182000021090; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kelleher M, 1998, MOL BIOCHEM PARASIT, V97, P21, DOI 10.1016/S0166-6851(98)00128-5; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Lee SH, 2007, POULTRY SCI, V86, P63, DOI 10.1093/ps/86.1.63; Liu XY, 2008, MOL BIOCHEM PARASIT, V161, P72, DOI 10.1016/j.molbiopara.2008.06.006; Liu XY, 2013, VET PARASITOL, V193, P1, DOI 10.1016/j.vetpar.2012.12.019; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; MEHLHORN H, 1972, Z PARASITENK, V40, P151, DOI 10.1007/BF00329150; Michels MG, 2011, VET PARASITOL, V177, P55, DOI 10.1016/j.vetpar.2010.11.022; RUFF MD, 1982, AM J VET RES, V43, P507; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; SCHOLTYSECK E, 1972, Z PARASITENK, V38, P95, DOI 10.1007/BF00329023; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; SPEER CA, 1972, SCIENCE, V178, P763, DOI 10.1126/science.178.4062.763; Tyzzer EE, 1929, AM J HYG, V10, P0269, DOI 10.1093/oxfordjournals.aje.a112759; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013; Yin GW, 2013, PARASITOL RES, V112, P2105, DOI 10.1007/s00436-013-3307-5; Yin GW, 2011, INT J PARASITOL, V41, P813, DOI 10.1016/j.ijpara.2011.04.001; Zou J, 2009, INT J PARASITOL, V39, P1189, DOI 10.1016/j.ijpara.2009.03.006	39	17	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114188	10.1371/journal.pone.0114188	http://dx.doi.org/10.1371/journal.pone.0114188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490541	gold, Green Submitted, Green Published			2022-12-27	WOS:000347515300019
J	Tran, CH; Sugimoto, JD; Pulliam, JRC; Ryan, KA; Myers, PD; Castleman, JB; Doty, R; Johnson, J; Stringfellow, J; Kovacevich, N; Brew, J; Cheung, LL; Caron, B; Lipori, G; Harle, CA; Alexander, C; Yang, Y; Longini, IM; Halloran, ME; Morris, JG; Small, PA				Tran, Cuc H.; Sugimoto, Jonathan D.; Pulliam, Juliet R. C.; Ryan, Kathleen A.; Myers, Paul D.; Castleman, Joan B.; Doty, Randell; Johnson, Jackie; Stringfellow, Jim; Kovacevich, Nadia; Brew, Joe; Cheung, Lai Ling; Caron, Brad; Lipori, Gloria; Harle, Christopher A.; Alexander, Charles; Yang, Yang; Longini, Ira M., Jr.; Halloran, M. Elizabeth; Morris, J. Glenn, Jr.; Small, Parker A., Jr.			School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SCHOOLCHILDREN; CHILDREN; TECUMSEH; OUTBREAK	Background: School-located influenza vaccination (SLIV) programs can substantially enhance the sub-optimal coverage achieved under existing delivery strategies. Randomized SLIV trials have shown these programs reduce laboratory-confirmed influenza among both vaccinated and unvaccinated children. This work explores the effectiveness of a SLIV program in reducing the community risk of influenza and influenza-like illness (ILI) associated emergency care visits. Methods: For the 2011/12 and 2012/13 influenza seasons, we estimated age-group specific attack rates (AR) for ILI from routine surveillance and census data. Age-group specific SLIV program effectiveness was estimated as one minus the AR ratio for Alachua County versus two comparison regions: the 12 county region surrounding Alachua County, and all non-Alachua counties in Florida. Results: Vaccination of,50% of 5-17 year-olds in Alachua reduced their risk of ILI-associated visits, compared to the rest of Florida, by 79% (95% confidence interval: 70, 85) in 2011/12 and 71% (63, 77) in 2012/13. The greatest indirect effectiveness was observed among 0-4 year-olds, reducing AR by 89% (84, 93) in 2011/12 and 84% (79, 88) in 2012/13. Among all non-school age residents, the estimated indirect effectiveness was 60% (54, 65) and 36% (31, 41) for 2011/12 and 2012/13. The overall effectiveness among all age-groups was 65% (61, 70) and 46% (42, 50) for 2011/12 and 2012/13. Conclusion: Wider implementation of SLIV programs can significantly reduce the influenza-associated public health burden in communities.	[Tran, Cuc H.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Tran, Cuc H.; Sugimoto, Jonathan D.; Pulliam, Juliet R. C.; Ryan, Kathleen A.; Cheung, Lai Ling; Yang, Yang; Longini, Ira M., Jr.; Morris, J. Glenn, Jr.; Small, Parker A., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Tran, Cuc H.; Harle, Christopher A.] Univ Florida, Clin Translat Sci Inst, Gainesville, FL USA; [Sugimoto, Jonathan D.; Brew, Joe] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Sugimoto, Jonathan D.; Brew, Joe] Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL USA; [Sugimoto, Jonathan D.; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Pulliam, Juliet R. C.; Harle, Christopher A.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA; [Pulliam, Juliet R. C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Ryan, Kathleen A.; Small, Parker A., Jr.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Myers, Paul D.; Kovacevich, Nadia; Brew, Joe; Caron, Brad] Florida Dept Hlth Alachua Cty, Gainesville, FL USA; [Castleman, Joan B.] Univ Florida, Coll Nursing, Gainesville, FL 32611 USA; [Doty, Randell] Univ Florida, Coll Pharm, Gainesville, FL USA; [Johnson, Jackie] Alachua Cty Publ Sch, Gainesville, FL USA; [Stringfellow, Jim] Partnership Strong Families, Gainesville, FL USA; [Lipori, Gloria] Univ Florida Hlth Integrated Data Repository, UF Hlth, Gainesville, FL USA; [Harle, Christopher A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Alexander, Charles] Florida Dept Hlth, Tallahassee, FL USA; [Yang, Yang; Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Yang, Yang; Longini, Ira M., Jr.] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Small, Parker A., Jr.] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); State University System of Florida; University of Florida; Florida Department of Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Florida Department of Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	JGMorris@epi.ufl.edu	Brew, Joe R/K-6654-2017; Pulliam, Juliet RC/A-6516-2008	Brew, Joe R/0000-0002-4119-0117; Pulliam, Juliet RC/0000-0003-3314-8223; Sugimoto, Jonathan/0000-0002-1761-328X; Tran, Cuc/0000-0003-4798-8039	University of Florida Emerging Pathogens Institute; National Institutes of Health [NIH R37 AI032042, NIH U01 GM070749, NIH U54 GM111274, UL1 TR000064, TL1TR000066, KL2TR000065]; Alachua County Board of Commissioners Community Health Offering Innovative Care & Educational Services (CHOICES); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000065, TL1TR000066, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749, U54GM111274] Funding Source: NIH RePORTER	University of Florida Emerging Pathogens Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alachua County Board of Commissioners Community Health Offering Innovative Care & Educational Services (CHOICES); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by internal funding from the University of Florida Emerging Pathogens Institute and funding from the National Institutes of Health (NIH R37 AI032042, NIH U01 GM070749, NIH U54 GM111274 to J.D.S., Y.Y, I.M.L., M.E.H), (UL1 TR000064 & TL1TR000066 to C.H.T), (UL1 TR000064 & KL2TR000065 to C.A.H). The Alachua County School-located Influenza Vaccination program (Florida Department of Health in Alachua County) is supported by the Alachua County Board of Commissioners Community Health Offering Innovative Care & Educational Services (CHOICES), and vaccine reimbursement from private health insurance and Medicaid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVA E, 2014, VACCINE; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; *BUR EP FL DEP HLT, 2013, FLOR FLU REV 2012 20; *CDCP, 2013, MMWR RECOMM REP, V2013, P1; *CDCP, 2013, FLUVIEW WEB PORT NAT; Ding H., 2010, Morbidity and Mortality Weekly Report, V59, P477; Furlow Carolyn, 2011, Morbidity and Mortality Weekly Report, V60, P737; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Glezen WP, 2010, J INFECT DIS, V202, P1626, DOI 10.1086/657089; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grijalva Carlos G, 2010, PLoS One, V5, pe15097, DOI 10.1371/journal.pone.0015097; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Halloran ME., 2010, DESIGN ANAL VACCINE; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2010, VACCINE, V28, P7737, DOI 10.1016/j.vaccine.2010.09.064; Kjos SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072243; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lu PJ, 2013, MMWR SURVEILL SUMM, V62, P1; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Pannaraj PS, 2014, CLIN INFECT DIS, V59, P325, DOI 10.1093/cid/ciu340; PEBODY R, 2014, EURO SURVEILL, V19; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; R Core Team, 2021, R LANGUAGE ENV STAT; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Stevenson M., 2014, EPIR R PACKAGE ANAL; Tran CH, 2010, BIOSECUR BIOTERROR, V8, P331, DOI 10.1089/bsp.2010.0029; *UK DEP HLTH JOINT, 2012, JVCI STAT ROUT ANN I; *US CENS BUR, 2010, CENS POP HOUS DEM PR, V1; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	33	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114479	10.1371/journal.pone.0114479	http://dx.doi.org/10.1371/journal.pone.0114479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489850	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300043
J	Cazamea-Catalan, D; Besseau, L; Falcon, J; Magnanou, E				Cazamea-Catalan, Damien; Besseau, Laurence; Falcon, Jack; Magnanou, Elodie			The Timing of Timezyme Diversification in Vertebrates	PLOS ONE			English	Article							ARYLALKYLAMINE N-ACETYLTRANSFERASE; WHOLE-GENOME DUPLICATION; MELATONIN SYNTHESIS; PINEAL ORGAN; PROVIDES EVIDENCE; CIRCADIAN CLOCKS; EC 2.3.1.87; EVOLUTION; AANAT; EXPRESSION	All biological functions in vertebrates are synchronized with daily and seasonal changes in the environment by the time keeping hormone melatonin. Its nocturnal surge is primarily due to the rhythmic activity of the arylalkylamine N-acetyl transferase AANAT, which thus became the focus of many investigations regarding its evolution and function. Various vertebrate isoforms have been reported from cartilaginous fish to mammals but their origin has not been clearly established. Using phylogeny and synteny, we took advantage of the increasing number of available genomes in order to test whether the various rounds of vertebrate whole genome duplications were responsible for the diversification of AANAT. We highlight a gene secondary loss of the AANAT2 in the Sarcopterygii, revealing for the first time that the AAANAT1/2 duplication occurred before the divergence between Actinopterygii (bony fish) and Sarcopterygii (tetrapods, lobe-finned fish, and lungfish). We hypothesize the teleost-specific whole genome duplication (WDG) generated the appearance of the AANAT1a/1b and the AANAT2/2'paralogs, the 2' isoform being rapidly lost in the teleost common ancestor (ray-finned fish). We also demonstrate the secondary loss of the AANAT1a in a Paracantopterygii (Atlantic cod) and of the 1b in some Ostariophysi (zebrafish and cave fish). Salmonids present an even more diverse set of AANATs that may be due to their specific WGD followed by secondary losses. We propose that vertebrate AANAT diversity resulted from 3 rounds of WGD followed by previously uncharacterized secondary losses. Extant isoforms show subfunctionalized localizations, enzyme activities and affinities that have increased with time since their emergence.	[Cazamea-Catalan, Damien; Besseau, Laurence; Falcon, Jack; Magnanou, Elodie] Univ Paris 06, Sorbonne Univ, Observ Oceanol, BIOM,UMR 7232, Banyuls Sur Mer, France; [Cazamea-Catalan, Damien; Besseau, Laurence; Falcon, Jack; Magnanou, Elodie] CNRS, BIOM, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Magnanou, E (corresponding author), Univ Paris 06, Sorbonne Univ, Observ Oceanol, BIOM,UMR 7232, Banyuls Sur Mer, France.	elodie.magnanou@obs-banyuls.fr	Besseau, Laurence/O-9942-2015	Besseau, Laurence/0000-0002-9617-8190; Magnanou, Elodie/0000-0002-8375-9682	Agence Nationale de la Recherche [ANR 07-BLAN-0097-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Agence Nationale de la Recherche (grant number: ANR 07-BLAN-0097-01), JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allendorf F.W., 1984, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartell PA, 2007, J BIOL RHYTHM, V22, P515, DOI 10.1177/0748730407308167; Begay V, 1998, ENDOCRINOLOGY, V139, P905, DOI 10.1210/en.139.3.905; Benyassi A, 2000, NEUROREPORT, V11, P255, DOI 10.1097/00001756-200002070-00006; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Canestro C, 2013, SEMIN CELL DEV BIOL, V24, P83, DOI 10.1016/j.semcdb.2012.12.008; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cazamea-Catalan D, 2013, J EXP BIOL, V216, P1938, DOI 10.1242/jeb.080960; Cazamea-Catalan D, 2012, MOL ECOL, V21, P5027, DOI 10.1111/j.1365-294X.2012.05725.x; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; COLLIN JP, 1988, RECHERCHE, V19, P1154; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 1999, J BIOL CHEM, V274, P9076, DOI 10.1074/jbc.274.13.9076; Coon SL, 2001, J BIOL CHEM, V276, P24097, DOI 10.1074/jbc.M011298200; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Davies WL, 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a9780470022890, DOI 10.1002/9780470015902.A9780470022890]; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Drummond AJ, 2010, GENEIOUS V5 3; Ekstrom P, 2003, PHILOS T R SOC B, V358, P1679, DOI 10.1098/rstb.2003.1303; Falcon J, 1996, PFLUG ARCH EUR J PHY, V432, P386, DOI 10.1007/s004240050149; Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Falcon Jack, 2007, Journal de la Societe de Biologie, V201, P21, DOI 10.1051/jbio:2007003; Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002; Falcon J, 2014, P NATL ACAD SCI USA, V111, P314, DOI 10.1073/pnas.1312634110; Falcon J, 2009, ANN NY ACAD SCI, V1163, P101, DOI 10.1111/j.1749-6632.2009.04435.x; Ferry G, 2004, PROTEIN EXPRES PURIF, V38, P84, DOI 10.1016/j.pep.2004.07.004; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Froschauer A, 2006, CURR GENOMICS, V7, P43, DOI 10.2174/138920206776389766; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Isorna E, 2006, MOL CELL ENDOCRINOL, V252, P11, DOI 10.1016/j.mce.2006.03.032; Isorna E, 2011, J PINEAL RES, V51, P434, DOI 10.1111/j.1600-079X.2011.00907.x; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Iuvone PM, 2002, INVEST OPHTH VIS SCI, V43, P564; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Koop BF, 2008, GENOMICS GENOME DUPL, P77; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Opazo JC, 2013, MOL BIOL EVOL, V30, P140, DOI 10.1093/molbev/mss212; REITER RJ, 1991, ADV EXP MED BIOL, V294, P149; Ribelayga C, 2004, J PHYSIOL-LONDON, V554, P467, DOI 10.1113/jphysiol.2003.053710; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Shi Q, 2004, GEN COMP ENDOCR, V136, P311, DOI 10.1016/j.ygcen.2004.01.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosini G, 2012, EXP EYE RES, V103, P82, DOI 10.1016/j.exer.2012.08.009; VOISIN P, 1984, J BIOL CHEM, V259, P913; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Zilberman-Peled B, 2006, BRAIN RES, V1073, P220, DOI 10.1016/j.brainres.2005.12.028; Zilberman-Peled B, 2004, GEN COMP ENDOCR, V138, P139, DOI 10.1016/j.ygcen.2004.05.007; Zilberman-Peled B, 2011, MAR DRUGS, V9, P906, DOI 10.3390/md9050906	66	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112380	10.1371/journal.pone.0112380	http://dx.doi.org/10.1371/journal.pone.0112380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486407	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600010
J	De Vos, L; Steenkamp, ET; Martin, SH; Santana, QC; Fourie, G; van der Merwe, NA; Wingfield, MJ; Wingfield, BD				De Vos, Lieschen; Steenkamp, Emma T.; Martin, Simon H.; Santana, Quentin C.; Fourie, Gerda; van der Merwe, Nicolaas A.; Wingfield, Michael J.; Wingfield, Brenda D.			Genome-Wide Macrosynteny among Fusarium Species in the Gibberella fujikuroi Complex Revealed by Amplified Fragment Length Polymorphisms	PLOS ONE			English	Article							SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; MATING POPULATION; GENETIC-MAP; GRAMINEARUM; MAIZE; EVOLUTION; AFLP	The Gibberella fujikuroi complex includes many Fusarium species that cause significant losses in yield and quality of agricultural and forestry crops. Due to their economic importance, whole-genome sequence information has rapidly become available for species including Fusarium circinatum, Fusarium fujikuroi and Fusarium verticillioides, each of which represent one of the three main clades known in this complex. However, no previous studies have explored the genomic commonalities and differences among these fungi. In this study, a previously completed genetic linkage map for an interspecific cross between Fusarium temperatum and F. circinatum, together with genomic sequence data, was utilized to consider the level of synteny between the three Fusarium genomes. Regions that are homologous amongst the Fusarium genomes examined were identified using in silico and pyrosequenced amplified fragment length polymorphism (AFLP) fragment analyses. Homology was determined using BLAST analysis of the sequences, with 777 homologous regions aligned to F. fujikuroi and F. verticillioides. This also made it possible to assign the linkage groups from the interspecific cross to their corresponding chromosomes in F. verticillioides and F. fujikuroi, as well as to assign two previously unmapped supercontigs of F. verticillioides to probable chromosomal locations. We further found evidence of a reciprocal translocation between the distal ends of chromosome 8 and 11, which apparently originated before the divergence of F. circinatum and F. temperatum. Overall, a remarkable level of macrosynteny was observed among the three Fusarium genomes, when comparing AFLP fragments. This study not only demonstrates how in silico AFLPs can aid in the integration of a genetic linkage map to the physical genome, but it also highlights the benefits of using this tool to study genomic synteny and architecture.	[De Vos, Lieschen; Martin, Simon H.; Santana, Quentin C.; van der Merwe, Nicolaas A.; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, FABI, Dept Genet, ZA-0002 Pretoria, South Africa; [Steenkamp, Emma T.; Fourie, Gerda] Univ Pretoria, FABI, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	De Vos, L (corresponding author), Univ Pretoria, FABI, Dept Genet, Private Bag X20, ZA-0002 Pretoria, South Africa.	lieschen.bahlmann@up.ac.za	Steenkamp, Emma T/B-7958-2009; Wingfield, Michael J/A-9473-2008; Wingfield, Brenda D./B-1376-2008; Santana, Quentin C/D-4969-2009; De Vos, Lieschen/G-2328-2016; Martin, Simon H/H-4400-2019; Van der Merwe, Nicolaas A/A-9096-2008; Martin, Simon Henry/D-1410-2011	Steenkamp, Emma T/0000-0003-0217-8219; Wingfield, Brenda D./0000-0002-6189-1519; Santana, Quentin C/0000-0002-1178-2533; De Vos, Lieschen/0000-0001-9824-9768; van der Merwe, Albe/0000-0003-3185-348X; Fourie, Gerda/0000-0003-2650-5448; Martin, Simon Henry/0000-0002-0747-7456	University of Pretoria; Tree Protection Cooperative Program (TPCP); Mellon Foundation; National Research Foundation (NRF)/Department of Science and Technology (DST); Centre of Excellence in Tree Health Biotechnology (CTHB); THRIP initiative of the Department of Trade and Industry (DTI) in South Africa; National Research Foundation of South Africa [(UID) 83924]; NRF	University of Pretoria; Tree Protection Cooperative Program (TPCP); Mellon Foundation; National Research Foundation (NRF)/Department of Science and Technology (DST)(Department of Science & Technology (India)); Centre of Excellence in Tree Health Biotechnology (CTHB); THRIP initiative of the Department of Trade and Industry (DTI) in South Africa; National Research Foundation of South Africa(National Research Foundation - South Africa); NRF	Funding: The authors thank the University of Pretoria, members of the Tree Protection Cooperative Program (TPCP), the Mellon Foundation, the National Research Foundation (NRF)/Department of Science and Technology (DST), Centre of Excellence in Tree Health Biotechnology (CTHB) and the THRIP initiative of the Department of Trade and Industry (DTI) in South Africa for financial assistance. This work was based on the research supported in part by a number of grants from the National Research Foundation of South Africa (includes Grant specific unique reference number (UID) 83924). The Grant holders acknowledge that opinions, findings and conclusions or recommendations expressed in any publication generated by the NRF supported research are that of the author(s), and that the NRF accepts no liability whatsoever in this regard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BLACKWELL PUB PROF; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; De Vos L, 2007, FUNGAL GENET BIOL, V44, P701, DOI 10.1016/j.fgb.2007.02.007; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Desjardins AE, 2000, MYCOL RES, V104, P865, DOI 10.1017/S0953756299002002; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; Jurgenson JE, 2002, APPL ENVIRON MICROB, V68, P1972, DOI 10.1128/AEM.68.4.1972-1979.2002; Kvas M, 2009, FUNGAL DIVERS, V34, P1; Lee J, 2008, APPL ENVIRON MICROB, V74, P2349, DOI 10.1128/AEM.01866-07; Lind M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048347; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morrow CA, 2012, MBIO, V3, DOI 10.1128/mBio.00310-11; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Parkin IAP, 2002, GENOME, V45, P356, DOI 10.1139/G01-160; Peters JL, 2001, PLANT PHYSIOL, V127, P1579, DOI 10.1104/pp.010504; Revanna KV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-316; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rombauts S, 2003, BIOINFORMATICS, V19, P776, DOI 10.1093/bioinformatics/btg090; Scauflaire J, 2011, MYCOLOGIA, V103, P586, DOI 10.3852/10-135; Singh PK, 2010, J BIOSCIENCES, V35, P539, DOI 10.1007/s12038-010-0062-y; Steenkamp ET, 2001, MOL PLANT PATHOL, V2, P215, DOI 10.1046/j.1464-6722.2001.00072.x; Steenkamp ET, 2002, MYCOLOGIA, V94, P1032, DOI 10.2307/3761868; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wingfield BD, 2012, S AFR J SCI, V108, P104, DOI 10.4102/sajs.v108i1/2.537; Xu JR, 1996, GENETICS, V143, P175; XU JR, 1995, MOL PLANT MICROBE IN, V8, P74, DOI 10.1094/MPMI-8-0074	37	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114682	10.1371/journal.pone.0114682	http://dx.doi.org/10.1371/journal.pone.0114682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486277	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600087
J	Li, Y; Rivera, CM; Ishll, H; Jin, FL; Selvaraj, S; Lee, AY; Dixon, JR; Ren, B				Li, Yan; Rivera, Chloe M.; Ishll, Haruhiko; Jin, Fulai; Selvaraj, Siddarth; Lee, Ah Young; Dixon, Jesse R.; Ren, Bing			CRISPR Reveals a Distal Super-Enhancer Required for Sox2 Expression in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							MASTER TRANSCRIPTION FACTORS; DEVELOPMENTAL REGULATORS; POLYCOMB; INTERACTOME; SEQUENCES; IDENTITY; DOMAINS; GENOMES; MAP	The pluripotency of embryonic stem cells (ESCs) is maintained by a small group of master transcription factors including Oct4, Sox2 and Nanog. These core factors form a regulatory circuit controlling the transcription of a number of pluripotency factors including themselves. Although previous studies have identified transcriptional regulators of this core network, the cis-regulatory DNA sequences required for the transcription of these key pluripotency factors remain to be defined. We analyzed epigenomic data within the 1.5 Mb gene-desert regions around the Sox2 gene and identified a 13kb-long super-enhancer (SE) located 100kb downstream of Sox2 in mouse ESCs. This SE is occupied by Oct4, Sox2, Nanog, and the mediator complex, and physically interacts with the Sox2 locus via DNA looping. Using a simple and highly efficient double-CRISPR genome editing strategy we deleted the entire 13-kb SE and characterized transcriptional defects in the resulting monoallelic and biallelic deletion clones with RNA-seq. We showed that the SE is responsible for over 90% of Sox2 expression, and Sox2 is the only target gene along the chromosome. Our results support the functional significance of a SE in maintaining the pluripotency transcription program in mouse ESCs.	[Li, Yan; Rivera, Chloe M.; Ishll, Haruhiko; Jin, Fulai; Selvaraj, Siddarth; Lee, Ah Young; Dixon, Jesse R.; Ren, Bing] Ludwig Inst Canc Res, San Diego, CA USA; [Rivera, Chloe M.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, San Diego, CA 92103 USA; [Dixon, Jesse R.] Univ Calif San Diego, Sch Med, Med Scientist Training Program, San Diego, CA 92103 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Cellular & Mol Med,Inst Genome Med, San Diego, CA 92103 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, San Diego, CA USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Jin, Fulai/0000-0003-0025-4337; Ishii, Haruhiko/0000-0002-1593-096X	Ludwig Institute for Cancer Research; US National Institutes of Health [U54 HG006997]; UCSD Genetics Training Program through National Institute of General Medical Sciences [T32 GM008666]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, T32GM007198] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Genetics Training Program through National Institute of General Medical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work is supported by funds from the Ludwig Institute for Cancer Research, and US National Institutes of Health (U54 HG006997) to BR. CMR was supported in part by the UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences, T32 GM008666. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jin FL, 2011, TRANSCR-AUSTIN, V2, P226, DOI 10.4161/trns.2.5.17712; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zappone MV, 2000, DEVELOPMENT, V127, P2367	40	71	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114485	10.1371/journal.pone.0114485	http://dx.doi.org/10.1371/journal.pone.0114485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486255	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600060
J	Liu, XJ; Wang, BW; Zhao, M; Zhang, C; Chen, YH; Hu, CQ; Zhao, H; Wang, H; Chen, X; Tao, FB; Xu, DX				Liu, Xiao-Jing; Wang, Bi-Wei; Zhao, Mei; Zhang, Cheng; Chen, Yuan-Hua; Hu, Chun-Qiu; Zhao, Hui; Wang, Hua; Chen, Xi; Tao, Fang-Biao; Xu, De-Xiang			Effects of Maternal LPS Exposure during Pregnancy on Metabolic Phenotypes in Female Offspring	PLOS ONE			English	Article							CATCH-UP GROWTH; INTRAUTERINE FETAL-DEATH; FATTY LIVER-DISEASE; FOR-GESTATIONAL-AGE; INCREASED SUSCEPTIBILITY; INSULIN SENSITIVITY; PRETERM DELIVERY; BIRTH-WEIGHT; GLUCOSE-TOLERANCE; N-ACETYLCYSTEINE	It is increasingly recognized that intra-uterine growth restriction (IUGR) is associated with an increased risk of metabolic disorders in late life. Previous studies showed that mice exposed to LPS in late gestation induced fetal IUGR. The present study investigated the effects of maternal LPS exposure during pregnancy on metabolic phenotypes in female adult offspring. Pregnant mice were intraperitoneally injected with LPS (50 mg/kg) daily from gestational day (GD) 15 to GD17. After lactation, female pups were fed with standard-chow diets (SD) or high-fat diets (HFD). Glucose tolerance test (GTT) and insulin tolerance test (ITT) were assessed 8 and 12 weeks after diet intervention. Hepatic triglyceride content was examined 12 weeks after diet intervention. As expected, maternal LPS exposure during pregnancy resulted in fetal IUGR. Although there was an increasing trend on fat mass in female offspring whose dams were exposed to LPS during pregnancy, maternal LPS exposure during pregnancy did not elevate the levels of fasting blood glucose and serum insulin and hepatic triglyceride content in female adult offspring. Moreover, maternal LPS exposure during pregnancy did not alter insulin sensitivity in adipose tissue and liver in female adult offspring. Further analysis showed that maternal LPS exposure during pregnancy did not exacerbate HFD-induced glucose tolerance and insulin resistance in female adult offspring. In addition, maternal LPS exposure during pregnancy did not aggravate HFD-induced elevation of hepatic triglyceride content in female adult offspring. In conclusion, LPS-induced IUGR does not alter metabolic phenotypes in adulthood.	[Liu, Xiao-Jing; Wang, Bi-Wei; Zhang, Cheng; Chen, Yuan-Hua; Hu, Chun-Qiu; Wang, Hua; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China; [Liu, Xiao-Jing; Zhao, Mei; Chen, Yuan-Hua; Wang, Hua; Tao, Fang-Biao; Xu, De-Xiang] Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China; [Liu, Xiao-Jing; Chen, Xi] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Zhao, Hui] Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China.	fbtao@126.com; xudex@126.com			National Natural Science Foundation of China [81172711, 81100449]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Natural Science Foundation of China (81172711, 81100449). The funders contributed to study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Cao L, 2012, ENDOCRINOLOGY, V153, P4955, DOI 10.1210/en.2012-1349; Chen YH, 2012, J IMMUNOL, V189, P454, DOI 10.4049/jimmunol.1103579; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Crume TL, 2014, OBESITY, V22, P608, DOI 10.1002/oby.20565; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Rubio APD, 2014, J PINEAL RES, V56, P154, DOI 10.1111/jpi.12108; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Guo Y, 2013, TOXICOL LETT, V221, P212, DOI 10.1016/j.toxlet.2013.06.238; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Park SY, 2012, INT J OBESITY, V36, P273, DOI 10.1038/ijo.2011.83; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Rivera DL, 1998, FASEB J, V12, P189, DOI 10.1096/fasebj.12.2.189; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Schmitz T, 2007, J IMMUNOL, V178, P1115, DOI 10.4049/jimmunol.178.2.1115; Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Shen L, 2014, TOXICOL APPL PHARM, V274, P263, DOI 10.1016/j.taap.2013.11.009; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006; Wolf G, 2003, NUTR REV, V61, P176, DOI 10.1301/nr.2003.may.176-179; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Xu DX, 2006, AM J OBSTET GYNECOL, V195, P1707, DOI 10.1016/j.ajog.2006.03.047; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027; Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082713; Zhao M, 2014, TOXICOL LETT, V224, P201, DOI 10.1016/j.toxlet.2013.10.021; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	50	15	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114780	10.1371/journal.pone.0114780	http://dx.doi.org/10.1371/journal.pone.0114780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479255	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200127
J	Tamosiunas, A; Luksiene, D; Baceviciene, M; Bernotiene, G; Radisauskas, R; Malinauskiene, V; Kranciukaite-Butylkiniene, D; Virviciute, D; Peasey, A; Bobak, M				Tamosiunas, Abdonas; Luksiene, Delia; Baceviciene, Migle; Bernotiene, Gailute; Radisauskas, Ricardas; Malinauskiene, Vilija; Kranciukaite-Butylkiniene, Daina; Virviciute, Delia; Peasey, Anne; Bobak, Martin			Health Factors and Risk of All-Cause, Cardiovascular, and Coronary Heart Disease Mortality: Findings from the MONICA and HAPIEE Studies in Lithuania	PLOS ONE			English	Article							LIFE EXPECTANCY; MEN; WOMEN; PROFILE; ASSOCIATION; POPULATION; STROKE; SMOKING; TRENDS; IMPACT	Aims: This study investigated the trends and levels of the prevalence of health factors, and the association of all-cause and cardiovascular (CVD) mortality with healthy levels of combined risk factors among Lithuanian urban population. Methods: Data from five general population surveys in Kaunas, Lithuania, conducted between 1983 and 2008 were used. Healthy factors measured at baseline include non-smoking, normal weight, normal arterial blood pressure, normal level of total serum cholesterol, normal physical activity and normal level of fasting glucose. Among 9,209 men and women aged 45-64 (7,648 were free from coronary heart disease (CHD) and stroke at baseline), 1,219 death cases from any cause, 589 deaths from CVD, and 342 deaths from CHD occurred during follow up. Cox proportional hazards regression was used to estimate the association between health factors and mortality from all causes, CVD and CHD. Results: Between 1983 and 2008, the proportion of subjects with 6 healthy levels of risk factors was higher in 2006-2008 than in 1983-1984 (0.6% vs. 0.2%; p=0.09), although there was a significant increase in fasting glucose and a decline in intermediate physical activity. Men and women with normal or intermediate levels of risk factors had significantly lower all-cause, CVD and CHD mortality risk than persons with high levels of risk factors. Subjects with 5-6 healthy factors had hazard ratio (HR) of CVD mortality 0.35 (95% confidence interval (CI) 0.15-0.83) compared to average risk in the whole population. The hazard ratio for CVD mortality risk was significant in men (HR 0.34, 95% CI 0.12-0.97) but not in women (HR 0.38, 95% CI 0.09-1.67). Conclusions: An inverse association of most healthy levels of cardiovascular risk factors with risk of all-cause and CVD mortality was observed in this urban population-based cohort. A greater number of cardiovascular health factors were related with significantly lower risk of CVD mortality, particularly among men.	[Tamosiunas, Abdonas; Luksiene, Delia; Baceviciene, Migle; Bernotiene, Gailute; Radisauskas, Ricardas; Malinauskiene, Vilija; Kranciukaite-Butylkiniene, Daina; Virviciute, Delia] Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania; [Peasey, Anne; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England	Lithuanian University of Health Sciences; University of London; University College London	Tamosiunas, A (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania.	abdonas.tamosiunas@lsmuni.lt	Tamosiunas, Abdonas/AAD-4274-2021; Baceviciene, Migle/AAG-1246-2020; Radišauskas, Ričardas/AAT-8920-2021	Baceviciene, Migle/0000-0002-9819-2316; Radišauskas, Ričardas/0000-0002-1227-2674; Bobak, Martin/0000-0002-2633-6851; Peasey, Anne/0000-0001-7434-2079	Wellcome Trust [081081/Z/06/Z]; US National Institute on Aging [1R0I AG23522]; MacArthur Foundation (Health and Social Upheaval network); NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation (Health and Social Upheaval network); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HAPIEE study was funded by grants from the Wellcome Trust (grant no. 081081/Z/06/Z), the US National Institute on Aging (grant no. 1R0I AG23522), and by the MacArthur Foundation (Health and Social Upheaval network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, J HLTH WELFARE STAT; [Anonymous], 2013, HLTH BALT COUNTR 201; Artero EG, 2012, MAYO CLIN PROC, V87, P944, DOI 10.1016/j.mayocp.2012.07.015; Baceviciene M, 2012, MEDICINA-LITHUANIA, V48, P632, DOI 10.3390/medicina48120093; Byun W, 2010, MED SCI SPORT EXER, V42, P1632, DOI 10.1249/MSS.0b013e3181d43f29; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Carlsson AC, 2013, INT J CARDIOL, V168, P946, DOI 10.1016/j.ijcard.2012.10.045; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; Clarke R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3513; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Giampaoli S, 2006, AM J EPIDEMIOL, V163, P893, DOI 10.1093/aje/kwj110; Grabauskas V, 2008, MEDICINA-LITHUANIA, V44, P633, DOI 10.3390/medicina44080082; Kurth T, 2006, ARCH INTERN MED, V166, P1403, DOI 10.1001/archinte.166.13.1403; Kuzmickiene I, 2013, CANCER EPIDEMIOL, V37, P133, DOI 10.1016/j.canep.2012.10.001; Lee CD, 2009, ARCH INTERN MED, V169, P2096, DOI 10.1001/archinternmed.2009.414; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Luksiene D, 2012, PREV MED, V55, P299, DOI 10.1016/j.ypmed.2012.08.002; Mendis S, 2011, WHO GLOBAL ATLAS CAR; Mitchell JA, 2010, AM HEART J, V160, P102, DOI 10.1016/j.ahj.2010.05.001; Norkus A., 2000, LITH ENDOCRINOL, V3, P234; Organization WH, 2009, GLOB HLTH RISKS MORT; Palmieri L, 2006, EUR J CARDIOV PREV R, V13, P562, DOI 10.1097/01.hjr.0000221866.27039.4b; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; Yamamoto T, 2008, CIRC J, V72, P545; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zeng Q, 2013, INT J CARDIOL, V167, P2311, DOI 10.1016/j.ijcard.2012.06.022	32	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114283	10.1371/journal.pone.0114283	http://dx.doi.org/10.1371/journal.pone.0114283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479610	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200066
J	Xu, XB; Bai, HQ; Liu, CP; Chen, EY; Chen, QG; Zhuang, JY; Shen, B				Xu, Xiangbin; Bai, Haiqi; Liu, Chaoping; Chen, Eryong; Chen, Qifeng; Zhuang, Jieyun; Shen, Bo			Genome-Wide Analysis of MicroRNAs and Their Target Genes Related to Leaf Senescence of Rice	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; INDUCED CELL-DEATH; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; STRESS RESPONSES; SMALL RNAS; SIGNAL-TRANSDUCTION; REGULATORY NETWORK; SALICYLIC-ACID	Grain production of rice (Oryza sativa L.) is a top priority in ensuring food security for human beings. One of the approaches to increase yield is to delay leaf senescence and to extend the available time for photosynthesis. MicroRNAs (miRNAs) are key regulators of aging and cellular senescence in eukaryotes. Here, to help understand their biological role in rice leaf senescence, we report identification of miRNAs and their putative target genes by deep sequencing of six small RNA libraries, six RNA-seq libraries and two degradome libraries from the leaves of two super hybrid rice, Nei-2-You 6 (N2Y6, age-resistant rice) and Liang-You-Pei 9 (LYP9, age-sensitive rice). In total 372 known miRNAs, 162 miRNA candidates and 1145 targets were identified. Compared with the expression of miRNAs in the leaves of LYP9, the numbers of miRNAs up-regulated and down-regulated in the leaves of N2Y6 were 47 and 30 at early stage of grain-filling, 21 and 17 at the middle stage, and 11 and 37 at the late stage, respectively. Six miRNA families, osa-miR159, osa-miR160 osa-miR164, osa-miR167, osa-miR172 and osa-miR1848, targeting the genes encoding APETALA2 (AP2), zinc finger proteins, salicylic acid-induced protein 19 (SIP19), auxin response factors (ARF) and NAC transcription factors, respectively, were found to be involved in leaf senescence through phytohormone signaling pathways. These results provided valuable information for understanding the miRNA-mediated leaf senescence of rice, and offered an important foundation for rice breeding.	[Xu, Xiangbin; Bai, Haiqi; Liu, Chaoping; Chen, Eryong; Chen, Qifeng; Shen, Bo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhuang, Jieyun] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Zhuang, JY (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	jz1803@hzcnc.com; bshen65@163.com	Zhuang, Jie-Yun/B-4131-2012; SHEN, BO/GOK-2179-2022	Zhuang, Jie-Yun/0000-0002-1439-5061; SHEN, BO/0000-0003-0490-2071	Natural Science Foundation of Zhejiang Province [LY12C06004]; National Key Technology RD Program [2011BAD35B02-03]; Program of Key Technology and Innovation Group of Zhejiang Province [2010R50024-6]; State Key Laboratory of Rice Biology [120124]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key Technology RD Program(National Key Technology R&D Program); Program of Key Technology and Innovation Group of Zhejiang Province; State Key Laboratory of Rice Biology	This work was supported by the Natural Science Foundation of Zhejiang Province (LY12C06004), the National Key Technology R&D Program (2011BAD35B02-03), the Program of Key Technology and Innovation Group of Zhejiang Province (2010R50024-6) and the State Key Laboratory of Rice Biology (120124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Choi DS, 2011, PLANT CELL, V23, P823, DOI 10.1105/tpc.110.082081; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076029; Guilfoyle TJ, 2010, J PLANT GROWTH REGUL, V10, P281; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones B, 2010, PLANT CELL, V22, P2956, DOI 10.1105/tpc.110.074856; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Lim PO, 2003, TRENDS PLANT SCI, V8, P272, DOI 10.1016/S1360-1385(03)00103-1; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C., 2000, HYBRID RICE, V15, P4; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Masselink H, 2001, CANCER LETT, V171, P87, DOI 10.1016/S0304-3835(01)00631-0; Matsumura K, 2009, SUSTAIN SCI, V4, P301, DOI 10.1007/s11625-009-0077-1; Morcillo F, 2007, PLANTA, V226, P1353, DOI 10.1007/s00425-007-0574-3; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Rao MV, 2002, PLANT J, V32, P447, DOI 10.1046/j.1365-313X.2002.01434.x; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Roberts IN, 2006, PLANTA, V224, P1437, DOI 10.1007/s00425-006-0312-2; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shen Bo, 2007, Agricultural Sciences in China, V6, P17, DOI 10.1016/S1671-2927(07)60012-1; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song JB, 2012, PLANT CELL PHYSIOL, V53, P1283, DOI 10.1093/pcp/pcs080; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Wang RongFu, 2004, Acta Agronomica Sinica, V30, P393; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Xu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070959; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhou ZC, 2005, CHINESE AGR SCI B, V21, P184; Zou YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064770	64	24	32	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114313	10.1371/journal.pone.0114313	http://dx.doi.org/10.1371/journal.pone.0114313			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479006	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200072
J	Baldeon, RL; Weigelt, K; de Wit, H; Ozcan, B; van Oudenaren, A; Sempertegui, F; Sijbrands, E; Grosse, L; Freire, W; Drexhage, HA; Leenen, PJM				Baldeon, Lucy R.; Weigelt, Karin; de Wit, Harm; Ozcan, Behiye; van Oudenaren, Adri; Sempertegui, Fernando; Sijbrands, Eric; Grosse, Laura; Freire, Wilma; Drexhage, Hemmo A.; Leenen, Pieter J. M.			Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; BLOOD MONONUCLEAR-CELLS; NF-KAPPA-B; HUMAN RESISTIN; MICRORNAS; RECEPTOR; OBESITY; CANCER; EXPRESSION; ALPHA	Background: There is increasing evidence that chronic inflammation is an important determinant in insulin resistance and in the pathogenesis of type 2 diabetes (T2D). MicroRNAs constitute a newly discovered system of cell regulation and in particular two microRNAs (miR-146a and miR-155) have been described as regulators and biomarkers of inflammation. Aim: To determine a putative association between the levels of miR-146a and miR-155 in serum of T2D patients, clinical parameters and serological indicators of inflammation. Methods: We performed quantitative Real Time PCR (qPCR) of microRNAs from serum (56 Ecuadorian T2D ambulatory patients and 40 non-diabetic controls). In addition, we evaluated T2D-related serum cytokines. chemokines and growth factors using a commercially available multi-analyte cytometric bead array system. We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state. Results: The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients. The serum levels of miR-146a were significantly reduced in T2D patients as compared to these non-diabetic, but obese/dyslipidemic control group (mean patients 0.61, mean controls set at 1; p=0.042), those of miR-155 were normal. The serum levels of both microRNAs correlated to each other (r=0.478; p<0.001) and to leptin levels. The microRNAs did not correlate to BMI, glycemia and dyslipidemia. From the tested cytokines, chemokines and growth factors, we found IL-8 and HGF significantly raised in T2D patients versus non-diabetic controls (p=0.011 and 0.023 respectively). Conclusions: This study shows decreased serum anti-inflammatory miR-146a, increased pro-inflammatory IL- 8 and increased HGF (a vascular/insular repair factor) as discriminating markers of failure of glucose control occurring on the background of obesity and dyslipidemia.	[Baldeon, Lucy R.; Weigelt, Karin; de Wit, Harm; van Oudenaren, Adri; Drexhage, Hemmo A.; Leenen, Pieter J. M.] Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Ozcan, Behiye; Sijbrands, Eric] Univ Med Ctr, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Baldeon, Lucy R.; Sempertegui, Fernando] Cent Univ Ecuador, Dept Immunol, Quito, Ecuador; [Freire, Wilma] Univ San Francisco Quito, Inst Res Hlth & Nutr, Quito, Ecuador; [Grosse, Laura] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Drexhage, Hemmo A.] Cent Univ Ecuador, Prometeo Program SENESCYT, Quito, Ecuador; Univ Fuerzas Armadas, Quito, Ecuador	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universidad Central del Ecuador; University of Munster; Universidad Central del Ecuador	Baldeon, RL (corresponding author), Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands.	l.baldeonrojas@erasmusmc.nl	Sijbrands, Eric/A-1065-2009; Baldeon, Lucy/AAE-6323-2022; Leenen, Pieter JM/I-5839-2013	Sijbrands, Eric/0000-0001-8857-7389; Baldeon, Lucy/0000-0002-0447-0136; Leenen, Pieter JM/0000-0001-9860-2920; Grosse, Laura/0000-0001-6273-5035	Dutch Diabetes Research Foundation (Diabetes Fonds), The Netherlands	Dutch Diabetes Research Foundation (Diabetes Fonds), The Netherlands	This study was supported by grants from The Dutch Diabetes Research Foundation (Diabetes Fonds), The Netherlands (www.diabetesfonds.nl; to PL and LB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Belmont P., 2013, ENSANUT ECU 2011 201, VI; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Corral-Fernandez NE, 2013, EXP CLIN ENDOCR DIAB, V121, P347, DOI 10.1055/s-0033-1341516; Costantini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039486; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; El-Ekiaby N, 2012, FEBS OPEN BIO, V2, P179, DOI 10.1016/j.fob.2012.07.005; Febbraio MA, 2014, TRENDS ENDOCRINOLOGY; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Hooper PL, 2009, CELL STRESS CHAPERON, V14, P113, DOI 10.1007/s12192-008-0073-x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028146; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; Liu Fen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P540; McClelland AD, 2014, CLIN SCI, V126, P95, DOI 10.1042/CS20130079; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Qu D, 2014, BRIT J PHARM; Rashid S, 2013, RHEUMATOL CURR RES, V3; Saiki A, 2006, INT J OBESITY, V30, P1676, DOI 10.1038/sj.ijo.0803316; Satani K, 2006, DIABETIC MED, V23, P617, DOI 10.1111/j.1464-5491.2006.01849.x; Scazzocchio B, 2009, J LIPID RES, V50, P832, DOI 10.1194/jlr.M800402-JLR200; Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833	53	81	86	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115209	10.1371/journal.pone.0115209	http://dx.doi.org/10.1371/journal.pone.0115209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500583	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400083
J	Betekhtin, A; Jenkins, G; Hasterok, R				Betekhtin, Alexander; Jenkins, Glyn; Hasterok, Robert			Reconstructing the Evolution of Brachypodium Genomes Using Comparative Chromosome Painting	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CHLOROPLAST NDHF GENE; MODEL GRASS; ARABIDOPSIS-THALIANA; KARYOTYPE EVOLUTION; DISTACHYON; REARRANGEMENTS; BRASSICACEAE; PHYLOGENY; POACEAE	Brachypodium distachyon is a model for the temperate cereals and grasses and has a biology, genomics infrastructure and cytogenetic platform fit for purpose. It is a member of a genus with fewer than 20 species, which have different genome sizes, basic chromosome numbers and ploidy levels. The phylogeny and interspecific relationships of this group have not to date been resolved by sequence comparisons and karyotypical studies. The aims of this study are not only to reconstruct the evolution of Brachypodium karyotypes to resolve the phylogeny, but also to highlight the mechanisms that shape the evolution of grass genomes. This was achieved through the use of comparative chromosome painting (CCP) which hybridises fluorescent, chromosome-specific probes derived from B. distachyon to homoeologous meiotic chromosomes of its close relatives. The study included five diploids (B. distachyon 2n=10, B. sylvaticum 2n=18, B. pinnatum 2n=16; 2n=18, B. arbuscula 2n=18 and B. stacei 2n=20) three allotetraploids (B. pinnatum 2n=28, B. phoenicoides 2n=28 and B. hybridum 2n=30), and two species of unknown ploidy (B. retusum 2n=38 and B. mexicanum 2n=40). On the basis of the patterns of hybridisation and incorporating published data, we propose two alternative, but similar, models of karyotype evolution in the genus Brachypodium. According to the first model, the extant genome of B. distachyon derives from B. mexicanum or B. stacei by several rounds of descending dysploidy, and the other diploids evolve from B. distachyon via ascending dysploidy. The allotetraploids arise by interspecific hybridisation and chromosome doubling between B. distachyon and other diploids. The second model differs from the first insofar as it incorporates an intermediate 2n=18 species between the B. mexicanum or B. stacei progenitors and the dysploidic B. distachyon.	[Betekhtin, Alexander; Hasterok, Robert] Silesian Univ, Dept Plant Anat & Cytol, Fac Biol & Environm Protect, Katowice, Poland; [Jenkins, Glyn] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	University of Silesia in Katowice; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Hasterok, R (corresponding author), Silesian Univ, Dept Plant Anat & Cytol, Fac Biol & Environm Protect, Katowice, Poland.	robert.hasterok@us.edu.pl	Hasterok, Robert/A-1629-2008; Betekhtin, Alexander/O-4619-2018	Betekhtin, Alexander/0000-0001-6146-1669; Hasterok, Robert/0000-0001-6667-2721	Polish National Science Centre [DEC-2012/04/A/NZ3/00572]; UPGOW project - European Social Fund	Polish National Science Centre; UPGOW project - European Social Fund	RH and AB acknowledge financial support from the Polish National Science Centre (grant no. DEC-2012/04/A/NZ3/00572). AB acknowledges scholarships from the UPGOW project financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Almeida C, 2013, THEOR APPL GENET, V126, P1909, DOI 10.1007/s00122-013-2106-9; Bishop R, 2010, BIOSCI HORIZONS, V3, P85, DOI DOI 10.1093/BIOHORIZONS/HZQ009; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Catalan P, 2000, PLANT SYST EVOL, V220, P1, DOI 10.1007/BF00985367; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; CATALAN P, 1995, BOT J LINN SOC, V117, P263, DOI 10.1006/bojl.1995.0018; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Fonseca A, 2013, GENOME, V56, P335, DOI 10.1139/gen-2013-0025; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hasterok R, 2002, FOLIA HISTOCHEM CYTO, V40, P319; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-20; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Henegariu O, 2000, NAT BIOTECHNOL, V18, P345, DOI 10.1038/73815; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jones N, 2005, NEW PHYTOL, V165, P391, DOI 10.1111/j.1469-8137.2004.01225.x; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; Lou QF, 2014, PLANT J, V78, P169, DOI 10.1111/tpj.12453; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2010, CYTOGENET GENOME RES, V129, P184, DOI 10.1159/000312951; Lysak MA, 2001, PLANT J, V28, P689, DOI 10.1046/j.1365-313x.2001.01194.x; Ma L, 2010, CHROMOSOME RES, V18, P841, DOI 10.1007/s10577-010-9166-3; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Mandakova T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-367; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; MOORE G, 1995, CURR OPIN GENET DEV, V5, P717, DOI 10.1016/0959-437X(95)80003-N; Muller S, 1999, CHROMOSOMA, V108, P393, DOI 10.1007/s004120050391; Peters SA, 2012, PLANT J, V71, P602, DOI 10.1111/j.1365-313X.2012.05012.x; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Qi LL, 2010, FUNCT INTEGR GENOMIC, V10, P477, DOI 10.1007/s10142-010-0190-3; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2011, CR BIOL, V334, P205, DOI 10.1016/j.crvi.2010.12.014; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Schubert Ingo, 2001, Methods in Cell Science, V23, P57, DOI 10.1023/A:1013137415093; SHI Y, 1993, PLANT SYST EVOL, V188, P125; Szinay D, 2010, CYTOGENET GENOME RES, V129, P199, DOI 10.1159/000313502; Szinay D, 2012, NEW PHYTOL, V195, P688, DOI 10.1111/j.1469-8137.2012.04195.x; Tayale A, 2013, CYTOGENET GENOME RES, V140, P79, DOI 10.1159/000351318; TKACHUK DC, 1991, GENET ANAL-BIOMOL E, V8, P67, DOI 10.1016/1050-3862(91)90051-R; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Verlaan MG, 2011, PLANT J, V68, P1093, DOI 10.1111/j.1365-313X.2011.04762.x; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wolny E, 2011, CHROMOSOMA, V120, P199, DOI 10.1007/s00412-010-0303-8; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Xie SL, 2010, GENOME, V53, P439, DOI [10.1139/g10-018, 10.1139/G10-018]	57	43	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115108	10.1371/journal.pone.0115108	http://dx.doi.org/10.1371/journal.pone.0115108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493646	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400096
J	Campuzano, O; Sarquella-Brugada, G; Mademont-Soler, I; Allegue, C; Cesar, S; Ferrer-Costa, C; Coll, M; Mates, J; Iglesias, A; Brugada, J; Brugada, R				Campuzano, Oscar; Sarquella-Brugada, Georgia; Mademont-Soler, Irene; Allegue, Catarina; Cesar, Sergi; Ferrer-Costa, Carles; Coll, Monica; Mates, Jesus; Iglesias, Anna; Brugada, Josep; Brugada, Ramon			Identification of Genetic Alterations, as Causative Genetic Defects in Long QT Syndrome, Using Next Generation Sequencing Technology	PLOS ONE			English	Article							DELETION; DUPLICATIONS; PREVALENCE; DIAGNOSIS; VARIANTS; KCNH2	Background: Long QT Syndrome is an inherited channelopathy leading to sudden cardiac death due to ventricular arrhythmias. Despite that several genes have been associated with the disease, nearly 20% of cases remain without an identified genetic cause. Other genetic alterations such as copy number variations have been recently related to Long QT Syndrome. Our aim was to take advantage of current genetic technologies in a family affected by Long QT Syndrome in order to identify the cause of the disease. Methods: Complete clinical evaluation was performed in all family members. In the index case, a Next Generation Sequencing custom-built panel, including 55 sudden cardiac death-related genes, was used both for detection of sequence and copy number variants. Next Generation Sequencing variants were confirmed by Sanger method. Copy number variations variants were confirmed by Multiplex Ligation dependent Probe Amplification method and at the mRNA level. Confirmed variants and copy number variations identified in the index case were also analyzed in relatives. Results: In the index case, Next Generation Sequencing revealed a novel variant in TTN and a large deletion in KCNQ1, involving exons 7 and 8. Both variants were confirmed by alternative techniques. The mother and the brother of the index case were also affected by Long QT Syndrome, and family cosegregation was observed for the KCNQ1 deletion, but not for the TTN variant. Conclusions: Next Generation Sequencing technology allows a comprehensive genetic analysis of arrhythmogenic diseases. We report a copy number variation identified using Next Generation Sequencing analysis in Long QT Syndrome. Clinical and familiar correlation is crucial to elucidate the role of genetic variants identified to distinguish the pathogenic ones from genetic noise.	[Campuzano, Oscar; Mademont-Soler, Irene; Allegue, Catarina; Coll, Monica; Mates, Jesus; Iglesias, Anna; Brugada, Ramon] Univ Girona IdIBGi, Cardiovasc Genet Ctr, Girona, Spain; [Sarquella-Brugada, Georgia; Cesar, Sergi; Brugada, Josep] Univ Barcelona, Hosp St Joan Deu, Arrhythmia Unit, Barcelona, Spain; [Ferrer-Costa, Carles] Gendiag SL, Barcelona, Spain; [Brugada, Ramon] Hosp Josep Trueta, Serv Cardiol, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Brugada, R (corresponding author), Univ Girona IdIBGi, Cardiovasc Genet Ctr, Girona, Spain.	ramon@brugada.org	campuzano, oscar/J-1968-2014; Cesar, Sergi/ABH-4429-2020; Sarquella-Brugada, Georgia/W-9278-2018	campuzano, oscar/0000-0001-5298-5276; Sarquella-Brugada, Georgia/0000-0002-6857-8904; BRUGADA, JOSEP/0000-0002-5662-8302; CESAR, SERGI/0000-0002-2798-1756; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159; Mademont-Soler, Irene/0000-0002-6501-9250	"La Caixa'' Foundation; Fundacio Privada Daniel Bravo Andreu	"La Caixa'' Foundation(La Caixa Foundation); Fundacio Privada Daniel Bravo Andreu	This study has been funding by "La Caixa'' Foundation and Fundacio Privada Daniel Bravo Andreu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barc Julien, 2011, J Am Coll Cardiol, V57, P40, DOI 10.1016/j.jacc.2010.08.621; Bisgaard AM, 2006, AM J MED GENET A, V140A, P644, DOI 10.1002/ajmg.a.31130; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Caselli R, 2008, AM J MED GENET A, V146A, P1195, DOI 10.1002/ajmg.a.32197; Darbar D, 2006, HEART RHYTHM, V3, P56, DOI 10.1016/j.hrthm.2005.10.029; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Eddy CA, 2008, HEART RHYTHM, V5, P1275, DOI 10.1016/j.hrthm.2008.05.033; Gurrieri F, 2013, EUR J HUM GENET, V21, P965, DOI 10.1038/ejhg.2012.280; Kirkpatrick B, 2013, J GENET COUNS, V22, P407, DOI 10.1007/s10897-013-9572-8; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Koopmann TT, 2006, HEART RHYTHM, V3, P52, DOI 10.1016/j.hrthm.2005.10.014; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Refsgaard L, 2012, EUR J HUM GENET, V20, P905, DOI 10.1038/ejhg.2012.23; Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Stattin EL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-95; Tester DJ, 2010, AM J CARDIOL, V106, P1124, DOI 10.1016/j.amjcard.2010.06.022; Xu HY, 2011, HUM MUTAT, V32, P1341, DOI 10.1002/humu.21601	18	24	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114894	10.1371/journal.pone.0114894	http://dx.doi.org/10.1371/journal.pone.0114894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494010	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400083
J	Asano, E; Ebara, T; Yamada-Namikawa, C; Kitaori, T; Suzumori, N; Katano, K; Ozaki, Y; Nakanishi, M; Sugiura-Ogasawara, M				Asano, Eriko; Ebara, Takeshi; Yamada-Namikawa, Chisato; Kitaori, Tamao; Suzumori, Nobuhiro; Katano, Kinue; Ozaki, Yasuhiko; Nakanishi, Makoto; Sugiura-Ogasawara, Mayumi			Genotyping Analysis for the 46 C/T Polymorphism of Coagulation Factor XII and the Involvement of Factor XII Activity in Patients with Recurrent Pregnancy Loss	PLOS ONE			English	Article							ASPIRIN PLUS HEPARIN; LUPUS ANTICOAGULANT; ANTIBODIES; GENE; MISCARRIAGE; WOMEN; DEFICIENCY; TRIAL	Background: Established causes of recurrent pregnancy loss (RPL) include antiphospholipid syndrome, uterine anomalies, parental chromosomal abnormalities, particularly translocations and abnormal embryonic karyotype. A systematic review concluded that coagulation factor XII (FXII) deficiency was associated with RPL. However, it could not be established whether the 46 C/T SNP of FXII or low activity of FXII was a risk factor for RPL, because of the small sample size. Methods and Findings: We conducted a cross-sectional and cohort study in 279 patients with two or more unexplained consecutive pregnancy losses and 100 fertile women. The association between the lupus anticoagulant (LA) activity and FXII activity was examined. The frequency of the CC, CT and TT genotypes and the FXII activity were also compared between the patients and controls. Subsequent miscarriage rates among the CC, CT, TT genotypes and according to the FXII activity was examined. LA was associated with reduced FXII activity. The CT, but not the TT, genotype was confirmed to be a risk factor for RPL in the cross-sectional study using multivariate logistic regression analysis (OR, 2.8; 95% CI, 1.37-5.85). The plasma FXII activity in the patients was similar to that in the controls. Neither low FXII activity nor the CT genotype predicted the subsequent pregnancy outcome in the cohort study. On the other hand, and intermediate FXII activity level of 85-101% was predictive of subsequent miscarriage. Conclusions: Low FXII activity was not associated with RPL. The FXII gene was found to be one of the significant susceptibility genes for RPL, similar to the FV Leiden mutation. However, the clinical influence of the CT genotype might be relatively small, because the presence/absence of this genotype did not have any predictive value for the subsequent pregnancy outcome. This was the first study indicating the influence of FXII 46C/T on further pregnancy outcomes.	[Asano, Eriko; Kitaori, Tamao; Suzumori, Nobuhiro; Katano, Kinue; Ozaki, Yasuhiko; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi, Japan; [Ebara, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Yamada-Namikawa, Chisato; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem 2, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University	Sugiura-Ogasawara, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi, Japan.	og.mym@med.nagoya-cu.ac.jp	Ebara, Takeshi/W-6525-2018	Ebara, Takeshi/0000-0003-3342-1058; Suzumori, Nobuhiro/0000-0001-9003-1289	Ministry of Education, Culture, Sports, Science and Technology of Japan [ID 24592472]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, ID 24592472, (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi M, 2011, J MATERN-FETAL NEO M, V24, P545, DOI 10.3109/14767058.2010.511331; Braat EAM, 1999, EUR J BIOCHEM, V263, P904, DOI 10.1046/j.1432-1327.1999.00593.x; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; COWCHOCK FS, 1992, AM J OBSTET GYNECOL, V166, P1318, DOI 10.1016/0002-9378(92)91596-3; de Laat B, 2006, ANN RHEUM DIS, V65, P1468, DOI 10.1136/ard.2005.045237; Dossenbach-Glaninger A, 2008, FERTIL STERIL, V90, P1155, DOI 10.1016/j.fertnstert.2007.07.1376; FARQUHARSON RG, 1984, LANCET, V2, P228; Gallimore MJ, 1998, THROMB HAEMOSTASIS, V79, P87; Hayashi Y, 2013, FERTIL STERIL, V100, P1018, DOI 10.1016/j.fertnstert.2013.06.020; Iinuma Y, 2002, FERTIL STERIL, V77, P353, DOI 10.1016/S0015-0282(01)02989-2; Johnson CY, 2011, AM J EPIDEMIOL, V173, P136, DOI 10.1093/aje/kwq349; Jones DW, 2000, BRIT J HAEMATOL, V110, P721, DOI 10.1046/j.1365-2141.2000.02251.x; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kanaji T, 1998, BLOOD, V91, P2010, DOI 10.1182/blood.V91.6.2010.2010_2010_2014; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; LAMMLE B, 1991, THROMB HAEMOSTASIS, V65, P117; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Ogasawara M, 1996, LUPUS, V5, P587, DOI 10.1177/096120339600500605; Ogasawara MS, 2001, FERTIL STERIL, V75, P916, DOI 10.1016/S0015-0282(01)01688-0; Pauer HU, 2003, FERTIL STERIL, V80, P590, DOI 10.1016/S0015-0282(03)00788-X; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; SAMUEL M, 1992, J BIOL CHEM, V267, P19691; Sotiriadis A, 2007, OBSTET GYNECOL, V109, P1146, DOI 10.1097/01.AOG.0000260873.94196.d6; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Sugiura-Ogasawara M, 2004, FERTIL STERIL, V81, P367, DOI 10.1016/j.fertnstert.2003.07.014; Sugiura-Ogasawara M, 2012, HUM REPROD, V27, P2297, DOI 10.1093/humrep/des179; Sugiura-Ogasawara M, 2010, FERTIL STERIL, V93, P1983, DOI 10.1016/j.fertnstert.2008.12.097; Walch K, 2005, BJOG-INT J OBSTET GY, V112, P1434, DOI 10.1111/j.1471-0528.2005.00686.x	30	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114452	10.1371/journal.pone.0114452	http://dx.doi.org/10.1371/journal.pone.0114452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489738	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300042
J	Franke, M; Kramarczyk, A; Taylan, C; Maintz, D; Hoppe, B; Koerber, F				Franke, Mareike; Kramarczyk, Annette; Taylan, Christina; Maintz, David; Hoppe, Bernd; Koerber, Friederike			Ultrasound-Guided Percutaneous Renal Biopsy in 295 Children and Adolescents: Role of Ultrasound and Analysis of Complications	PLOS ONE			English	Article							ARTERIOVENOUS-FISTULA; NATIVE KIDNEYS; SINGLE-CENTER; SAFETY; EXPERIENCE; DIAGNOSIS	Introduction: Percutaneous renal biopsy (PRB) is a decisive diagnostic procedure for children and adolescents with renal diseases. Aim of this study was to evaluate retrospectively the complication rates of percutaneous kidney biopsies and their therapeutic consequences to assess the role of ultrasound-guidance including Doppler ultrasound examinations in preparation, execution and follow-up care and to present a recommended protocol. Patients and Methods: Institutional review board approved this retrospective study; informed consent was waived. Between 1997 and 2011 a total of 438 ultrasound-guided biopsies were performed in 295 patients, 169 of the biopsies were performed on kidney transplants. Average age of patients was 10.2+/-5.2 years (range of 15 days until age of 23). Before and post biopsy ultrasound examination including Doppler examination was carried out. Biopsy itself was ultrasound monitored. Complications were analysed with regard to age of patient, kidney transplants, year of occurrence, number of punctures, performing physician and time interval of occurrence to develop an optimized protocol for ultrasound-guidance. Results: In 99% of cases successful PRB were performed, i.e. enough kidney parenchyma for histological analysis was obtained. No lethal or major complication that required surgical intervention occurred. Eighteen relevant complications were observed (complication rate: 4.1%). Except in one case in which additional MRI diagnostic was necessary, ultrasound examination after 4 hours post biopsy or even earlier when symptoms occurred, was able to detect complications and determine indications for intervention. Conclusion: Ultrasound-guided PRB is an established and effective method in children and adolescents, but shows a certain rate of complications and therefore should not be indicated without diligence. Ultrasound including Doppler ultrasound is a valuable tool in preparation, guidance of biopsy, detection of complications and in follow-up care. Ultrasound examinations (including Doppler) pre-, during and 4 hours post kidney biopsy and, depending from case, a few days until weeks after biopsy is recommended.	[Franke, Mareike; Maintz, David; Koerber, Friederike] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Kramarczyk, Annette; Taylan, Christina] Univ Hosp Cologne, Dept Pediat, Cologne, Germany; [Hoppe, Bernd] Univ Hosp Bonn, Dept Pediat, Bonn, Germany	University of Cologne; University of Cologne; University of Bonn	Koerber, F (corresponding author), Univ Hosp Cologne, Dept Radiol, Cologne, Germany.	friederike.koerber@uk-koeln.de	Maintz, David/ABG-3220-2020					ALRASHEED SA, 1990, PEDIATR NEPHROL, V4, P600, DOI 10.1007/BF00858632; Bilge I, 1999, NEPHROL DIAL TRANSPL, V14, P2726, DOI 10.1093/ndt/14.11.2726; Cameron JS, 1997, AM J NEPHROL, V17, P347; DAVIS CL, 1995, J AM SOC NEPHROL, V6, P1250; Feneberg R, 1998, NEPHRON, V79, P438, DOI 10.1159/000045090; GAINZA FJ, 1995, CLIN NEPHROL, V43, P303; Heffernan E, 2009, J CLIN ULTRASOUND, V37, P226, DOI 10.1002/jcu.20465; HUBSCH P, 1991, NEPHRON, V59, P482, DOI 10.1159/000186613; Hussain F, 2003, PEDIATR NEPHROL, V18, P53, DOI 10.1007/s00467-002-1003-2; Hussain F, 2010, NEPHROL DIAL TRANSPL, V25, P485, DOI 10.1093/ndt/gfp434; Ishikawa E, 2009, CLIN EXP NEPHROL, V13, P325, DOI 10.1007/s10157-009-0165-7; KARAFIN L, 1970, J UROLOGY, V103, P332, DOI 10.1016/S0022-5347(17)61954-2; MATSELL DG, 1992, PEDIATR NEPHROL, V6, P562, DOI 10.1007/BF00866508; Maya ID, 2009, SEMIN DIALYSIS, V22, P458, DOI 10.1111/j.1525-139X.2009.00609.x; Nammalwar BR, 2006, PEDIATR NEPHROL, V21, P286, DOI 10.1007/s00467-005-2084-5; Okamura T, 1998, UROL INT, V61, P261, DOI 10.1159/000030325; Ozdemir S., 1998, International Urology and Nephrology, V30, P689, DOI 10.1007/BF02564854; Printza N, 2011, HIPPOKRATIA, V15, P258; Riccabona M, 1998, J ULTRAS MED, V17, P505; Schwarz A, 2005, AM J TRANSPLANT, V5, P1992, DOI 10.1111/j.1600-6143.2005.00988.x; Simckes AM, 2000, PEDIATR NEPHROL, V14, P946, DOI 10.1007/s004670000316; Sinha MD, 2006, J NEPHROL, V19, P41; Skalova S, 2010, SINGAP MED J, V51, P481; Stratta P, 2007, EUR J CLIN INVEST, V37, P954, DOI 10.1111/j.1365-2362.2007.01885.x; Sweeney C, 2006, PEDIATR TRANSPLANT, V10, P159, DOI 10.1111/j.1399-3046.2005.00433.x; Tondel C, 2012, CLIN J AM SOC NEPHRO, V7, P1591, DOI 10.2215/CJN.02150212; Munoz AT, 2011, ARCH MED SCI, V7, P823, DOI 10.5114/aoms.2011.25557; Waldo B, 2009, NEPHROL DIAL TRANSPL, V24, P2433, DOI 10.1093/ndt/gfp073; Whittier WL, 2004, CURR OPIN NEPHROL HY, V13, P661, DOI 10.1097/00041552-200411000-00013; ZEIS PM, 1976, J PEDIATR-US, V89, P263, DOI 10.1016/S0022-3476(76)80463-5	30	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114737	10.1371/journal.pone.0114737	http://dx.doi.org/10.1371/journal.pone.0114737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489731	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300072
J	Novello, C; Pazzaglia, L; Conti, A; Quattrini, I; Pollino, S; Perego, P; Picci, P; Benassi, MS				Novello, Chiara; Pazzaglia, Laura; Conti, Amalia; Quattrini, Irene; Pollino, Serena; Perego, Paola; Picci, Piero; Benassi, Maria Serena			p53-Dependent Activation of microRNA-34a in Response to Etoposide-Induced DNA Damage in Osteosarcoma Cell Lines Not Impaired by Dominant Negative p53 Expression	PLOS ONE			English	Article							GROWTH ARREST; METHYLATION; MIR-34A; APOPTOSIS; MUTATION	Osteosarcoma (OS) is the most common primary malignant bone tumor and prevalently occurs in the second decade of life. Etoposide, a chemotherapeutic agent used in combined treatments of recurrent human OS, belongs to the topoisomerase inhibitor family and causes DNA breakage. In this study we evaluated the cascade of events determined by etoposide-induced DNA damage in OS cell lines with different p53 status focusing on methylation status and expression of miR-34a that modulate tumor cell growth and cell cycle progression. Wild-type p53 U2-OS cells and U2-OS cells expressing dominant-negative form of p53 (U2-OS175) were more sensitive to etoposide than p53-deficient MG63 and Saos-2 cells, showing increased levels of unmethylated miR-34a, reduced expression of CDK4 and cell cycle arrest in G1 phase. In contrast, MG63 and Saos-2 cell lines presented aberrant methylation of miR-34a promoter gene with no miR-34a induction after etoposide treatment, underlining the close connection between p53 expression and miR-34a methylation status. Consistently, in p53siRNA transfected U2-OS cells we observed loss of miR-34a induction after etoposide exposure associated with a partial gain of gene methylation and cell cycle progress towards G2/M phase. Our results suggest that the open and unmethylated conformation of the miR-34a gene may be regulated by p53 able to bind the gene promoter. In conclusion, cell response to etoposide-induced DNA damage was not compromised in cells with dominant-negative p53 expression.	[Novello, Chiara; Pazzaglia, Laura; Conti, Amalia; Quattrini, Irene; Pollino, Serena; Picci, Piero; Benassi, Maria Serena] Rizzoli Orthopaed Inst, Expt Oncol Lab, Bologna, Italy; [Pollino, Serena] Univ Parma, Ctr Mol & Translat Oncol, I-43100 Parma, Italy; [Pollino, Serena] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Perego, Paola] IRCCS, Ist Nazl Tumori, Mol Pharmacol Unit, Milan, Italy	IRCCS Istituto Ortopedico Rizzoli; University of Parma; University of Parma; Fondazione IRCCS Istituto Nazionale Tumori Milan	Benassi, MS (corresponding author), Rizzoli Orthopaed Inst, Expt Oncol Lab, Bologna, Italy.	mariaserena.benassi@ior.it	Quattrini, Irene/C-6672-2019; Perego, Paola/J-7647-2016; Pazzaglia, Laura/C-7918-2019; Conti, Amalia/AAC-5159-2022; Novello, Chiara/K-2569-2016; Picci, Piero/J-5979-2016; Quattrini, Irene/C-6672-2019	Quattrini, Irene/0000-0002-4482-0612; Perego, Paola/0000-0003-2806-7269; Pazzaglia, Laura/0000-0001-5937-4953; Novello, Chiara/0000-0001-5405-0300; Picci, Piero/0000-0002-8519-4101; Quattrini, Irene/0000-0003-2221-3376; Pollino, Serena/0000-0001-6426-5372	Fondazione Umberto Veronesi; FIRC Triennial fellowship "Mario e Valeria Rindi" [13748]; EU Project "Eurosarc"; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); FIRC Triennial fellowship "Mario e Valeria Rindi"(Fondazione AIRC per la ricerca sul cancro); EU Project "Eurosarc"; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from: 5% donation (Italy). Amalia Conti was supported by post-doctoral fellowship "Fondazione Umberto Veronesi", Chiara Novello was supported by FIRC Triennial fellowship "Mario e Valeria Rindi" (Research project n<SUP>o</SUP>13748). The work was supported also by EU Project "Eurosarc". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Bai L, 2006, J CANC MOL, V2, P141; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Chim CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-197; D'Adamo DR, 2011, SEMIN ONCOL, V38, pS19, DOI 10.1053/j.seminoncol.2011.09.004; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; ESMO European Sarcoma Network Work, 2012, ANN ONCOL, V23, P100, DOI 10.1093/annonc/mds254; Ezoe S, 2012, INT J ENV RES PUB HE, V9, P2444, DOI 10.3390/ijerph9072444; Fitzgibbon C, 2013, INVEST NEW DRUG, V31, P1466, DOI 10.1007/s10637-013-0031-z; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gatti L, 2002, CELL DEATH DIFFER, V9, P1352, DOI 10.1038/sj.cdd.4401109; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; He CL, 2009, BIOCHEM BIOPH RES CO, V388, P35, DOI 10.1016/j.bbrc.2009.07.101; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kawabe T, 2004, MOL CANCER THER, V3, P513; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Mikeska T, 2012, EXPERT REV MOL DIAGN, V12, P473, DOI [10.1586/ERM.12.45, 10.1586/erm.12.45]; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsang WP, 2005, INT J CANCER, V114, P331, DOI 10.1002/ijc.20818; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Zhu JJ, 2006, LIFE SCI, V78, P1469, DOI 10.1016/j.lfs.2005.07.044	33	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114757	10.1371/journal.pone.0114757	http://dx.doi.org/10.1371/journal.pone.0114757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490093	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300076
J	Aguila, S; Martinez-Martinez, I; Dichiara, G; Gutierrez-Gallego, R; Navarro-Fernandez, J; Vicente, V; Corral, J				Aguila, Sonia; Martinez-Martinez, Irene; Dichiara, Gilda; Gutierrez-Gallego, Ricardo; Navarro-Fernandez, Jose; Vicente, Vicente; Corral, Javier			Increased N-Glycosylation Efficiency by Generation of an Aromatic Sequon on N135 of Antithrombin	PLOS ONE			English	Article							HIGH-AFFINITY HEPARIN; ENDOPLASMIC-RETICULUM; BETA-ANTITHROMBIN; ALLOSTERIC ACTIVATION; BINDING; MECHANISM; SERPINS; THROMBOSIS; STABILITY; PROTEINS	The inefficient glycosylation of consensus sequence on N135 in antithrombin explains the two glycoforms of this key anticoagulant serpin found in plasma: alpha and beta, with four and three N-glycans, respectively. The lack of this N-glycan increases the heparin affinity of the beta-glycoform. Recent studies have demonstrated that an aromatic sequon (Phe-Y-Asn-X-Thr) in reverse beta-turns enhances N-glycosylation efficiency and stability of different proteins. We evaluated the effect of the aromatic sequon in this defective glycosylation site of antithrombin, despite of being located in a loop between the helix D and the strand 2A. We analyzed the biochemical and functional features of variants generated in a recombinant cell system (HEK-EBNA). Cells transfected with wild-type plasmid (K133-Y-N135-X-S137) generated 50% of alpha and beta-antithrombin. The S137T, as previously reported, K133F, and the double mutant (K133F/S137T) had improved glycosylation efficiency, leading to the secretion of alpha-antithrombin, as shown by electrophoretic and mass analysis. The presence of the aromatic sequon did not significantly affect the stability of this conformationally sensitive serpin, as revealed by thermal denaturation assay. Moreover, the aromatic sequon hindered the activation induced by heparin, in which is involved the helix D. Accordingly, K133F and particularly K133F/S137T mutants had a reduced anticoagulant activity. Our data support that aromatic sequons in a different structural context from reverse turns might also improve the efficiency of N-glycosylation.	[Aguila, Sonia; Martinez-Martinez, Irene; Navarro-Fernandez, Jose; Vicente, Vicente; Corral, Javier] Univ Murcia, Hosp Morales Meseguer, Ctr Reg Hemodonac, IMIB, Murcia, Spain; [Dichiara, Gilda] Univ Navarra, Ctr Appl Med Res, Lab Thrombosis & Haemostasis, Div Cardiovasc Sci, E-31080 Pamplona, Spain; [Gutierrez-Gallego, Ricardo] UPF, Dept Expt & Hlth Sci, IMIM Hosp Mar, Bioanal Grp, Barcelona, Spain; [Gutierrez-Gallego, Ricardo] Anapharm Biotech, Barcelona, Spain	University of Murcia; University of Navarra; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Corral, J (corresponding author), Univ Murcia, Hosp Morales Meseguer, Ctr Reg Hemodonac, IMIB, Murcia, Spain.	javier.corral@carm.es	Vicente, Vicente/L-6185-2019; Martínez-Martínez, Irene/AAM-8862-2020; Aguila, Sonia/Q-2822-2019	Vicente, Vicente/0000-0002-4278-3264; Martínez-Martínez, Irene/0000-0002-1067-6464; Aguila, Sonia/0000-0001-5794-5177; Gutierrez Gallego, Ricardo/0000-0001-9639-2181; Dichiara Rodriguez, Gilda/0000-0003-2374-1787; Corral, Javier/0000-0003-0288-1107	ISCIII [PI12/00657]; FEDER [PI12/00657]; Redes RIC (ISCIII) [RD12/0042/0050, RD12/0042/0009]; Redes RIC (FEDER) [RD12/0042/0050, RD12/0042/0009]; Ministerio de Ciencia e Innovacion	ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); Redes RIC (ISCIII); Redes RIC (FEDER); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding: This work has been supported by PI12/00657 (ISCIII, (www.isciii.es) & FEDER), and Redes RIC (RD12/0042/0050 & RD12/0042/0009) (ISCIII & FEDER), S.A is holder of a FPI grant from Ministerio de Ciencia e Innovacion (www.idi.mineco.gob.es), I.M.M. is a Miguel Servet researcher from ISCIII and J.N.F. holders a post-doctoral contract Sara Borrell from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainle FN, 2011, J BIOL CHEM, V286, P1323, DOI 10.1074/jbc.M110.159475; Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200; Brooks AR, 2013, J THROMB HAEMOST, V11, P1699, DOI 10.1111/jth.12300; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Carrell RW, 2003, BIOCHEM SOC SYMP, V70, P163, DOI 10.1042/bss0700163; CHOAY J, 1989, ANN NY ACAD SCI, V556, P61; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hernandez-Espinosa D, 2007, THROMB HAEMOSTASIS, V98, P557, DOI 10.1160/TH07-02-0152; Huntington JA, 2003, J THROMB HAEMOST, V1, P1535, DOI 10.1046/j.1538-7836.2003.00305.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; Liu Y, 2009, BIOTECHNOL PROGR, V25, P1468, DOI 10.1002/btpr.241; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Mushunje A, 2004, J THROMB HAEMOST, V2, P2170, DOI 10.1111/j.1538-7836.2004.01047.x; Ni HY, 2000, THROMB RES, V99, P407, DOI 10.1016/S0049-3848(00)00263-2; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Olson ST, 1997, ARCH BIOCHEM BIOPHYS, V341, P212, DOI 10.1006/abbi.1997.9973; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; PETERSON CB, 1985, J BIOL CHEM, V260, P610; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Preston RJS, 2013, BLOOD, V121, P3801, DOI 10.1182/blood-2012-10-415000; Price JL, 2012, BIOPOLYMERS, V98, P195, DOI 10.1002/bip.22030; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1	42	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114454	10.1371/journal.pone.0114454	http://dx.doi.org/10.1371/journal.pone.0114454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485983	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600057
J	Berdel, HO; Yin, H; Liu, JY; Grochowska, K; Middleton, C; Yanasak, N; Abdelsayed, R; Berdel, WE; Mozaffari, M; Yu, JC; Baban, B				Berdel, Henrik O.; Yin, Hongyu; Liu, Jun Yao; Grochowska, Karolina; Middleton, Christopher; Yanasak, Nathan; Abdelsayed, Rafik; Berdel, Wolfgang E.; Mozaffari, Mahmood; Yu, Jack C.; Baban, Babak			Targeting Serum Glucocorticoid-Regulated Kinase-1 in Squamous Cell Carcinoma of the Head and Neck: A Novel Modality of Local Control	PLOS ONE			English	Article							STEM-LIKE CELLS; ANDROGEN RECEPTOR; PLUS CETUXIMAB; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; PROSTATE-CANCER; UP-REGULATION; CHEMOTHERAPY; EXPRESSION; SGK1	Purpose: The inhibition of serum glucocorticoid-regulated kinase-1 (SGK-1) has been found to decrease growth of colon and prostate cancer cells. The purpose of this study is to evaluate the therapeutic effect of SGK-1 inhibition in head and neck squamous cell carcinoma (SCC). Experimental Design: Human head and neck tumors (HTB41/43) were established in athymic mice. Growth rates between mice treated with vehicle (PBS) injection (group 1, n=5), SGK-1 Inhibitor GSK 650394 (group 2, n=6), systemic cisplatin (group 3, n=6), and a combination of SGK-1 Inhibitor and cisplatin (group 4, n=6) were compared using repeated measures one-way ANOVA with Newman-Keuls Multiple Comparison Test. Tumor cells were subsequently submitted to further analyses. Results: At the end of the experiment mean tumor sizes were 122.33+/-105.86, 76.73+/-36.09, 94.52+/-75.92, and 25.76+/-14.89 mm(2) (mean +/- SD) for groups 1 to 4. Groups 2 and 3 showed decreased tumor growth compared to controls (p<0.001). Group 4 displayed even greater growth suppression (p<0.0001). Importantly, group 4 fared better than group 3 (p<0.001). CD44 expression was reduced in group 2 (p<0.05), and to an even greater extent in groups 3 and 4 (p<0.0025). A trend towards reduction of HER 2 expression was noted in group 4. Conclusions: SGK-1 inhibition suppresses tumor growth, and in combination with systemic cisplatin exceeds the effect of cisplatin alone. Decreased expression of CD44 and HER 2 implies depletion of tumor stem cells, and less tumorigenicity. SGK-1 inhibition represents a potential modality of local control for palliation in advanced cases.	[Berdel, Henrik O.; Yin, Hongyu; Liu, Jun Yao; Grochowska, Karolina; Middleton, Christopher; Yanasak, Nathan; Abdelsayed, Rafik; Mozaffari, Mahmood; Yu, Jack C.; Baban, Babak] Georgia Regents Univ, Augusta, GA 30901 USA; [Berdel, Henrik O.] Univ S Carolina, Sch Med, Palmetto Health, Columbia, SC USA; [Yin, Hongyu] Chinese Acad Med Sci, Plast Surg Hosp, Beijing, Peoples R China; [Yin, Hongyu] Peking Union Med Coll, Beijing, Peoples R China; [Berdel, Wolfgang E.] Univ Hosp Muenster, Dept Med A, Munster, Germany	University System of Georgia; Augusta University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Munster	Baban, B (corresponding author), Georgia Regents Univ, Augusta, GA 30901 USA.	bbaban@gru.edu	Yanasak, Nathan/CAG-5116-2022		Milford B. Hatcher Endowment	Milford B. Hatcher Endowment	This study was supported by institutional funds (provided to BB) and the Milford B. Hatcher Endowment (provided to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-4; ALSARRAF M, 1988, SEMIN ONCOL, V15, P70; Amato R, 2013, ONCOGENE, V32, P4572, DOI 10.1038/onc.2012.470; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Baban B, 2014, AM J HYPERTENS, V27, P846, DOI 10.1093/ajh/hpt269; Baban B, 2013, EXP MOL PATHOL, V95, P288, DOI 10.1016/j.yexmp.2013.09.002; Baban B, 2013, EXP MOL PATHOL, V94, P343, DOI 10.1016/j.yexmp.2012.11.004; Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Bachaud JM, 1996, INT J RADIAT ONCOL, V36, P999, DOI 10.1016/S0360-3016(96)00430-0; Baskin R, 2012, CELL SIGNAL, V24, P435, DOI 10.1016/j.cellsig.2011.09.016; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bloom C, 1998, CAN ASSOC RADIOL J, V49, P370; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Facompre N, 2012, ADV PHARMACOL, V65, P235, DOI 10.1016/B978-0-12-397927-8.00008-7; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Guardiola E, 2004, CANCER, V101, P2028, DOI 10.1002/cncr.20623; Hanna E, 2004, ARCH OTOLARYNGOL, V130, P861, DOI 10.1001/archotol.130.7.861; HAUGHEY BH, 1992, ANN OTO RHINOL LARYN, V101, P105, DOI 10.1177/000348949210100201; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705, DOI 10.1016/0360-3016(92)90642-U; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Masoumy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095720; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Moniz Larissa S, 2013, Biochem J, V452, pe11, DOI 10.1042/BJ20130617; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Polakis P, 2000, GENE DEV, V14, P1837; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schmidt EM, 2012, FEBS J, V279, P1231, DOI 10.1111/j.1742-4658.2012.08515.x; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P156, DOI 10.1038/ncponc0750; Shanmugam I, 2007, CELL DEATH DIFFER, V14, P2085, DOI 10.1038/sj.cdd.4402227; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; Szmulewitz RZ, 2012, PROSTATE, V72, P157, DOI 10.1002/pros.21416; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; Trog D, 2006, PROTEOMICS, V6, P2924, DOI 10.1002/pmic.200500587; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; VOKES EE, 1993, INT J RADIAT ONCOL, V27, P481, DOI 10.1016/0360-3016(93)90263-U; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113795	10.1371/journal.pone.0113795	http://dx.doi.org/10.1371/journal.pone.0113795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485633	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600027
J	Chen, MF; Song, PF; Zou, D; Hu, XS; Zhao, SC; Gao, SJ; Ling, F				Chen, Minfeng; Song, Pengfei; Zou, Dan; Hu, Xuesong; Zhao, Shancen; Gao, Shengjie; Ling, Fei			Comparison of Multiple Displacement Amplification (MDA) and Multiple Annealing and Looping-Based Amplification Cycles (MALBAC) in Single-Cell Sequencing	PLOS ONE			English	Article							WHOLE GENOME AMPLIFICATION; DNA; MUTATION; RECOMBINATION; POLYMERASE	Single-cell sequencing promotes our understanding of the heterogeneity of cellular populations, including the haplotypes and genomic variability among different generation of cells. Whole-genome amplification is crucial to generate sufficient DNA fragments for single-cell sequencing projects. Using sequencing data from single sperms, we quantitatively compare two prevailing amplification methods that extensively applied in single-cell sequencing, multiple displacement amplification (MDA) and multiple annealing and looping-based amplification cycles (MALBAC). Our results show that MALBAC, as a combination of modified MDA and tweaked PCR, has a higher level of uniformity, specificity and reproducibility.	[Chen, Minfeng; Ling, Fei] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Chen, Minfeng; Hu, Xuesong; Zhao, Shancen; Gao, Shengjie] BGI Shenzhen, Shenzhen 518033, Peoples R China; [Song, Pengfei] Fourth Peoples Hosp Shenzhen, Futian Hosp, Shenzhen 518033, Peoples R China; [Zou, Dan] Natl Univ Def Technol, Sch Comp, Changsha 410073, Hunan, Peoples R China; [Gao, Shengjie] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Gao, Shengjie] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Zhao, Shancen] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark	South China University of Technology; Beijing Genomics Institute (BGI); National University of Defense Technology - China; Chinese University of Hong Kong; Chinese University of Hong Kong; Aarhus University	Zhao, SC (corresponding author), BGI Shenzhen, Shenzhen 518033, Peoples R China.	zhaoshancen@genomics.cn; gaoshengjie@genomics.cn; lingfeiscut@gmail.com	Galaxy, Yuuki/S-4013-2017; Gao, Shengjie/S-4016-2017	Galaxy, Yuuki/0000-0002-7135-520X; Gao, Shengjie/0000-0002-5221-8381	School of Bioscience and Bioengineering, South China University of Technology; BGI-ShenZhen; National Natural Science Foundation of China [31271322]; Fundamental Research Funds for the Central Universities of South China University of Technology [2014ZG0017]	School of Bioscience and Bioengineering, South China University of Technology; BGI-ShenZhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of South China University of Technology	Funding: This work was supported by School of Bioscience and Bioengineering, South China University of Technology and BGI-ShenZhen. This project was granted by the National Natural Science Foundation of China (31271322) and the Fundamental Research Funds for the Central Universities of South China University of Technology (2014ZG0017). BGI-ShenZhen provided support in the form of salaries for authors MC, XH, SZ & SG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Deorowicz S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-160; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Lao Kaiqin, 2008, Biotechnol J, V3, P378, DOI 10.1002/biot.200700253; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lasken RS, 2013, NAT BIOTECHNOL, V31, P211, DOI 10.1038/nbt.2523; Lasken RS, 2009, BIOCHEM SOC T, V37, P450, DOI 10.1042/BST0370450; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XM, 2003, GENOME RES, V13, P1916, DOI 10.1101/gr.1251803; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Voet T, 2013, NUCLEIC ACIDS RES, V41, P6119, DOI 10.1093/nar/gkt345; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	25	35	40	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114520	10.1371/journal.pone.0114520	http://dx.doi.org/10.1371/journal.pone.0114520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485707	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600067
J	See, LC; Kuo, CF; Yu, KH; Luo, SF; Chou, IJ; Ko, YS; Chiou, MJ; Liu, JR				See, Lai-Chu; Kuo, Chang-Fu; Yu, Kuang-Hui; Luo, Shue-Fen; Chou, I-Jun; Ko, Yu-Shien; Chiou, Meng-Jiun; Liu, Jia-Rou			Hyperthyroid and Hypothyroid Status Was Strongly Associated with Gout and Weakly Associated with Hyperuricaemia	PLOS ONE			English	Article							METABOLIC SYNDROME; KIDNEY-FUNCTION; RENAL-FUNCTION; RISK; EPIDEMIOLOGY; HYPERTENSION; POPULATION; PREVALENCE; CREATININE; ARTHRITIS	Objectives: The aim of this study was to estimate the risk of hyperuricaemia and gout in people with hypothyroid or hyperthyroid status. Methods: This study analyzed data from individuals who participated in health screening programs at Chang Gung Memorial Hospital in northern Taiwan (2000-2010). Participants were categorized as having euthyroid, hypothyroid, or hyperthyroid status according to their thyroid-stimulating hormone (TSH) levels. Multinomial logistic regression models were used to calculate the odds ratios (95% CI) for hyperuricaemia and gout in participants with thyroid dysfunction compared to euthyroid participants. Results: A total of 87,813 (euthyroid, 83,502; hypothyroid, 1,460; hyperthyroid, 2,851) participants were included. The prevalence of hyperuricaemia was higher in hyperthyroid subjects (19.4%) than in euthyroid subjects (17.8%) but not in hypothyroid subjects (19.3%). The prevalence of gout was significantly higher in both hypothyroid (6.0%) and hyperthyroid (5.3%) subjects than in euthyroid subjects (4.3%). In men, hypothyroid or hyperthyroid status was not associated with hyperuricaemia. However, hypothyroid or hyperthyroid status was associated with ORs (95% CI) of 1.47 (1.10-1.97) and 1.37 (1.10-1.69), respectively, for gout. In women, hypothyroid status was not associated with hyperuricaemia or gout. However, hyperthyroid status was associated with ORs (95% CI) of 1.42 (1.24-1.62) for hyperuricaemia and 2.13 (1.58-2.87) for gout. Conclusions: Both hyperthyroid and hypothyroid status were significantly associated with gout and weakly associated with hyperuricaemia. A thyroid function test for gout patients may by warranted.	[See, Lai-Chu; Chiou, Meng-Jiun; Liu, Jia-Rou] Chang Gung Univ, Mol Med Res Ctr, Dept Publ Hlth, Taoyuan, Taiwan; [See, Lai-Chu; Chiou, Meng-Jiun; Liu, Jia-Rou] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan; [Kuo, Chang-Fu; Yu, Kuang-Hui; Luo, Shue-Fen] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Kuo, Chang-Fu] Univ Nottingham, Sch Clin Sci, Div Acad Rheumatol, Nottingham NG7 2RD, England; [Chou, I-Jun] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Ko, Yu-Shien] Chang Gung Mem Hosp, Hlth Evaluat Ctr, Taoyuan, Taiwan; [Ko, Yu-Shien] Chang Gung Mem Hosp, Div Cardiol 1, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; University of Nottingham; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yu, KH (corresponding author), Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan.	gout@cgmh.org.tw	Kuo, Chang-Fu/Q-1714-2016	Kuo, Chang-Fu/0000-0002-9770-5730; See, Lai-Chu/0000-0002-1379-8969	Ministry of Education, Taiwan [EMRPD1D0101]; Chang Gung Memorial Hospital [CMRPG390211]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Funding: The authors would like to thank the Ministry of Education, Taiwan (EMRPD1D0101) and Chang Gung Memorial Hospital (CMRPG390211) for financially supporting this research in data collection and analysis, and preparation of the manuscript.	ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Arromdee E, 2002, J RHEUMATOL, V29, P2403; Chang HY, 2001, J RHEUMATOL, V28, P1640; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Choi HK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8190; Domrongkitchaiporn S, 2005, J AM SOC NEPHROL, V16, P791, DOI 10.1681/ASN.2004030208; DURWARD WF, 1976, ARTHRITIS RHEUM, V19, P123, DOI 10.1002/art.1780190125; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; ERICKSON AR, 1994, AM J MED, V97, P231, DOI 10.1016/0002-9343(94)90005-1; Giordano N, 2001, CLIN EXP RHEUMATOL, V19, P661; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Kellgren JH, 1963, EPIDEMIOL CHRON, P327; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Kuo CF, 2014, ANN RHEUM DIS; Kuo CF, 2010, RHEUMATOLOGY, V49, P141, DOI 10.1093/rheumatology/kep364; KUZELL W C, 1955, J Chronic Dis, V2, P645, DOI 10.1016/0021-9681(55)90193-4; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LIN HY, 1989, NEW ENGL J MED, V321, P287, DOI 10.1056/NEJM198908033210504; Mariani LH, 2012, J AM SOC NEPHROL, V23, P22, DOI 10.1681/ASN.2010070766; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; MCLAUGHLIN KJ, 1994, NEPHROL DIAL TRANSPL, V9, P1521; Mooraki A, 1998, CLIN NEPHROL, V49, P59; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Raber W, 1999, WIEN KLIN WOCHENSCHR, V111, P326; Saini V, 2012, CLIN BIOCHEM, V45, P212, DOI 10.1016/j.clinbiochem.2011.10.012; SATO A, 1995, METABOLISM, V44, P207, DOI 10.1016/0026-0495(95)90266-X; See LC, 2011, CLIN RHEUMATOL, V30, P323, DOI 10.1007/s10067-010-1461-z; Sheane BJ, 2007, JCR-J CLIN RHEUMATOL, V13, P293, DOI 10.1097/RHU.0b013e3181571119; STEIGER MJ, 1991, J ROY SOC MED, V84, P688; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; YU TF, 1982, AM J MED, V72, P95, DOI 10.1016/0002-9343(82)90593-9; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114579	10.1371/journal.pone.0114579	http://dx.doi.org/10.1371/journal.pone.0114579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486420	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600076
J	Sonderman, JS; Munro, HM; Blot, WJ; Tarone, RE; McLaughlin, JK				Sonderman, Jennifer S.; Munro, Heather M.; Blot, William J.; Tarone, Robert E.; McLaughlin, Joseph K.			Suicides, Homicides, Accidents, and Other External Causes of Death among Blacks and Whites in the Southern Community Cohort Study	PLOS ONE			English	Article							MORTALITY FOLLOWBACK SURVEY; CIGARETTE-SMOKING; SOCIOECONOMIC-STATUS; HEALTH DISPARITIES; COMPLETED SUICIDE; INJURY DEATH; RISK; METAANALYSIS; MEN; ADULTHOOD	Prior studies of risk factors associated with external causes of death have been limited in the number of covariates investigated and external causes examined. Herein, associations between numerous demographic, lifestyle, and health-related factors and the major causes of external mortality, such as suicide, homicide, and accident, were assessed prospectively among 73,422 black and white participants in the Southern Community Cohort Study (SCCS). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated in multivariate regression analyses using the Cox proportional hazards model. Men compared with women (HR=2.32; 95% CI: 1.87-2.89), current smokers (HR=1.74; 95% CI: 1.40-2.17), and unemployed/never employed participants at the time of enrollment (HR=1.67; 95% CI 1.38-2.02) had increased risk of dying from all external causes, with similarly elevated HRs for suicide, homicide, and accidental death among both blacks and whites. Blacks compared with whites had lower risk of accidental death (HR=0.46; 95% CI: 0.38-0.57) and suicide (HR=0.55; 95% CI: 0.31-0.99). Blacks and whites in the SCCS had comparable risks of homicide death (HR=1.05; 95% CI: 0.63-1.76); however, whites in the SCCS had unusually high homicide rates compared with all whites who were resident in the 12 SCCS states, while black SCCS participants had homicide rates similar to those of all blacks residing in the SCCS states. Depression was the strongest risk factor for suicide, while being married was protective against death from homicide in both races. Being overweight/obese at enrollment was associated with reduced risks in all external causes of death, and the number of comorbid conditions was a risk factor for iatrogenic deaths. Most risk factors identified in earlier studies of external causes of death were confirmed in the SCCS cohort, in spite of the low SES of SCCS participants. Results from other epidemiologic cohorts are needed to confirm the novel findings identified in this study.	[Sonderman, Jennifer S.; Munro, Heather M.; Blot, William J.; McLaughlin, Joseph K.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Blot, William J.; Tarone, Robert E.; McLaughlin, Joseph K.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University	McLaughlin, JK (corresponding author), Int Epidemiol Inst, Rockville, MD 20850 USA.	jkm@iei.us			National Cancer Institute at the National Institutes of Health [R01 CA092447]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Southern Community Cohort Study is supported by a grant from the National Cancer Institute at the National Institutes of Health (R01 CA092447). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Angst J, 1998, J AFFECT DISORDERS, V51, P55, DOI 10.1016/S0165-0327(98)00156-6; Batty GD, 2008, BRIT J PSYCHIAT, V193, P461, DOI 10.1192/bjp.bp.107.037424; Batty GD, 2008, PSYCHIAT RES, V161, P112, DOI 10.1016/j.psychres.2008.01.006; Campbell A, 2007, OXFORD HDB EVOLUTION; Castle K, 2004, AM J PSYCHIAT, V161, P452, DOI 10.1176/appi.ajp.161.3.452; Centers for Disease Control and Prevention, 2013, MMWR MORB MORTAL WKL, V62, P321; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatters LM, 2011, ARCH SUICIDE RES, V15, P337, DOI 10.1080/13811118.2011.615703; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Cuijpers Pim, 2004, Curr Psychiatry Rep, V6, P430, DOI 10.1007/s11920-004-0007-y; Fassberg MM, 2012, INT J ENV RES PUB HE, V9, P722, DOI 10.3390/ijerph9030722; Gibbs JT, 1997, SUICIDE LIFE-THREAT, V27, P68; GLUCKSMAN E, 1994, BRIT MED BULL, V50, P76, DOI 10.1093/oxfordjournals.bmb.a072886; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Iwasaki M, 2005, ANN EPIDEMIOL, V15, P286, DOI 10.1016/j.annepidem.2004.08.011; Kung HC, 1998, SOC PSYCH PSYCH EPID, V33, P155, DOI 10.1007/s001270050038; Leistikow B N, 2000, Inj Prev, V6, P277, DOI 10.1136/ip.6.4.277; Leistikow BN, 1998, PREV MED, V27, P871, DOI 10.1006/pmed.1998.0374; Leistikow BN, 1999, PREV MED, V28, P255, DOI 10.1006/pmed.1998.0412; Li DJ, 2012, J PSYCHIATR RES, V46, P1257, DOI 10.1016/j.jpsychires.2012.03.013; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Murphy SL, 2013, NATL VITAL STAT REPO; National Cancer Institute, 2013, MORT ALL COD AGGR ST; Pokorski R J, 1994, J Insur Med, V26, P46; Rebholz CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-56; SEEMAN I, 1989, PUBLIC HEALTH REP, V104, P183; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P163; Wray M, 2011, ANNU REV SOCIOL, V37, P505, DOI 10.1146/annurev-soc-081309-150058	35	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114852	10.1371/journal.pone.0114852	http://dx.doi.org/10.1371/journal.pone.0114852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25486418	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600102
J	Almelli, T; Nuel, G; Bischoff, E; Aubouy, A; Elati, M; Wang, CW; Dillies, MA; Coppee, JY; Ayissi, GN; Basco, LK; Rogier, C; Ndam, NT; Deloron, P; Tahar, R				Almelli, Talleh; Nuel, Gregory; Bischoff, Emmanuel; Aubouy, Agnes; Elati, Mohamed; Wang, Christian William; Dillies, Marie-Agnes; Coppee, Jean-Yves; Ayissi, Georges Nko; Basco, Leonardo Kishi; Rogier, Christophe; Ndam, Nicaise Tuikue; Deloron, Philippe; Tahar, Rachida			Differences in Gene Transcriptomic Pattern of Plasmodium falciparum in Children with Cerebral Malaria and Asymptomatic Carriers	PLOS ONE			English	Article							MAURERS CLEFTS; INFECTED ERYTHROCYTES; EXPRESSION; ANTIGENS; SURFACE; SELECTION; MEMBRANE; BINDING; PFEMP1; TRAFFICKING	The mechanisms underlying the heterogeneity of clinical malaria remain largely unknown. We hypothesized that differential gene expression contributes to phenotypic variation of parasites which results in a specific interaction with the host, leading to different clinical features of malaria. In this study, we analyzed the transcriptomes of isolates obtained from asymptomatic carriers and patients with uncomplicated or cerebral malaria. We also investigated the transcriptomes of 3D7 clone and 3D7-Lib that expresses severe malaria associated-variant surface antigen. Our findings revealed a specific up-regulation of genes involved in pathogenesis, adhesion to host cell, and erythrocyte aggregation in parasites from patients with cerebral malaria and 3D7-Lib, compared to parasites from asymptomatic carriers and 3D7, respectively. However, we did not find any significant difference between the transcriptomes of parasites from cerebral malaria and uncomplicated malaria, suggesting similar transcriptomic pattern in these two parasite populations. The difference between isolates from asymptomatic children and cerebral malaria concerned genes coding for exported proteins, Maurer's cleft proteins, transcriptional factor proteins, proteins implicated in protein transport, as well as Plasmodium conserved and hypothetical proteins. Interestingly, UPs A1, A2, A3 and UPs B1 of var genes were predominantly found in cerebral malaria-associated isolates and those containing architectural domains of DC4, DC5, DC13 and their neighboring rif genes in 3D7-lib. Therefore, more investigations are needed to analyze the effective role of these genes during malaria infection to provide with new knowledge on malaria pathology. In addition, concomitant regulation of genes within the chromosomal neighborhood suggests a common mechanism of gene regulation in P. falciparum.	[Almelli, Talleh; Ndam, Nicaise Tuikue; Deloron, Philippe; Tahar, Rachida] Univ Paris 05, Pres Sorbonne Paris Cite, UMR Mere & Enfant Face Infect Trop 216, IRD, Paris, France; [Almelli, Talleh; Nuel, Gregory; Ndam, Nicaise Tuikue; Deloron, Philippe; Tahar, Rachida] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Pharm, Paris, France; [Bischoff, Emmanuel] Inst Pasteur, Unit Mol Immunol Parasites, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol, Paris, France; [Bischoff, Emmanuel] CNRS, URA 3012, Paris, France; [Aubouy, Agnes] Univ Toulouse 3, UMR Pharmacochim & Pharmacol Dev PHARMA DEV 152, IRD, F-31062 Toulouse, France; [Elati, Mohamed] Univ Evry, CNRS, Inst Syst & Synthet Biol, Evry, France; [Wang, Christian William] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Wang, Christian William] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Dillies, Marie-Agnes; Coppee, Jean-Yves] Inst Pasteur, Dept Genomes & Genet, Paris, France; [Ayissi, Georges Nko] Hop Olembe, Yaounde, Cameroon; [Basco, Leonardo Kishi; Tahar, Rachida] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Basco, Leonardo Kishi] Aix Marseille Univ, Fac Med La Timone, UMR Unite Rech Malad Infect & Trop Emergentes 198, IRD, Marseille, France; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Rigshospitalet; University of Copenhagen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Tahar, R (corresponding author), Univ Paris 05, Pres Sorbonne Paris Cite, UMR Mere & Enfant Face Infect Trop 216, IRD, Paris, France.	Rachida.Tahar@ird.fr	Deloron, Philippe/G-6305-2010; Bischoff, Emmanuel/F-1197-2011; Aubouy, Agnes/J-7792-2015; Rachida, Tahar/ABF-1506-2021	Deloron, Philippe/0000-0003-4705-2484; Bischoff, Emmanuel/0000-0003-4655-4247; Aubouy, Agnes/0000-0003-2265-4972; TAHAR, Rachida/0000-0003-1799-231X; Wang, Christian/0000-0003-3140-6989; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Elati, Mohamed/0000-0002-4440-2904	French Direction Generale des Armees (DGA), Paris, France	French Direction Generale des Armees (DGA), Paris, France	This study was funded by the French Direction Generale des Armees (DGA), Paris, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bertin GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068368; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Daily JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-30; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez I, 2008, J STAT SOFTW, V23, P1; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; JENSEN JB, 1978, AM J TROP MED HYG, V27, P1274, DOI 10.4269/ajtmh.1978.27.1274; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999; Kuss C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010645; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; LAMBERT ZV, 1975, J MARKETING RES, V12, P468, DOI 10.2307/3151100; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; Oberli A, 2014, 10 ANN BIOMALPAR; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Ranjit MR, 2005, T ROY SOC TROP MED H, V99, P389, DOI 10.1016/j.trstmh.2004.09.010; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tuikue Ndam N, 2008, PLOS ONE, V3, pe1855; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Wang CW, 2009, INT J PARASITOL, V39, P655, DOI 10.1016/j.ijpara.2008.11.014; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; World Health Organization, 2012, SUMM KEY POINTS	62	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114401	10.1371/journal.pone.0114401	http://dx.doi.org/10.1371/journal.pone.0114401			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479608	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907200083
J	Hinrichs, JB; Renne, J; Schoenfeld, C; Gutberlet, M; Haverich, A; Warnecke, G; Welte, T; Wacker, F; Gottlieb, J; Vogel-Claussen, J				Hinrichs, Jan B.; Renne, Julius; Schoenfeld, Christian; Gutberlet, Marcel; Haverich, Axel; Warnecke, Gregor; Welte, Tobias; Wacker, Frank; Gottlieb, Jens; Vogel-Claussen, Jens			Cardiac Mass and Function Decrease in Bronchiolitis Obliterans Syndrome after Lung Transplantation: Relationship to Physical Activity?	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; PULMONARY-HYPERTENSION; PERCENT EMPHYSEMA; HYPERTROPHY; HEART; METAANALYSIS; RECIPIENTS; UPDATE	Rationale: There is a need to expand knowledge on cardio-pulmonary pathophysiology of bronchiolitis obliterans syndrome (BOS) following lung transplantation (LTx). Objectives: The purpose of this study was to assess MRI-derived biventricular cardiac mass and function parameters as well as flow hemodynamics in patients with and without BOS after LTx. Methods: Using 1.5T cardiac MRI, measurements of myocardial structure and function as well as measurements of flow in the main pulmonary artery and ascending aorta were performed in 56 lung transplant patients. The patients were dichotomized into two gender matched groups of comparable age range: one with BOS (BOS stages 1-3) and one without BOS (BOS 0/0p). Measurements and Main Results: Significantly lower biventricular cardiac mass, right and left ventricular end-diastolic volume, biventricular stroke volume, flow hemodynamics and significant higher heart rate but preserved cardiac output were observed in patients with BOS 1-3 compared to the BOS 0/0p group (p<0.05). In a stepwise logistic regression analysis global cardiac mass (p=0.046) and days after LTx (p=0.0001) remained independent parameters to predict BOS. In a second model an indicator for the physical fitness level - walking number of stairs - was added to the logistic regression model. In this second model, time after LTx (p=0.005) and physical fitness (p=0.01) remained independent predictors for BOS. Conclusion: The observed changes in biventricular cardiac mass and function as well as changes in hemodynamic flow parameters in the pulmonary trunk and ascending aorta are likely attributed to the physical fitness level of patients after lung transplantation, which in turn is strongly related to lung function.	[Hinrichs, Jan B.; Renne, Julius; Schoenfeld, Christian; Gutberlet, Marcel; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany; [Welte, Tobias; Gottlieb, Jens] Hannover Med Sch, Clin Pneumol, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany; [Haverich, Axel; Warnecke, Gregor] Hannover Med Sch, Clin Cardiothorac Transplant & Vasc Surg, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de	Vogel-Claussen, Jens/Q-3374-2019; Haverich, Axel/AAC-7552-2022; Renne, Julius/A-8060-2016	Renne, Julius/0000-0003-3727-8180; Vogel-Claussen, Jens/0000-0001-5595-6948; Gottlieb, Prof. Jens/0000-0002-9540-9022	German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302). Funding had no influence on study design, data collection, analysis, decision to publish or preparation of the manuscript.	Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P940, DOI 10.1002/art.27349; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Gottlieb Jens, 2008, Ther Adv Respir Dis, V2, P237, DOI 10.1177/1753465808093514; Grau M, 2013, CHEST, V144, P136, DOI 10.1378/chest.12-1779; HACHEM RR, 2005, SEMINARS IN THORACIC, V16, P350, DOI DOI 10.1053/J.SEMTCVS.2004.09.011; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Henk CB, 1998, CHEST, V114, P771, DOI 10.1378/chest.114.3.771; Kasimir MT, 2004, EUR J CARDIO-THORAC, V26, P776, DOI 10.1016/j.ejcts.2004.05.057; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Kotsimbos T, 2012, EUR RESPIR REV, V21, P271, DOI 10.1183/09059180.00006312; Kreitner KF, 2013, CIRC-CARDIOVASC IMAG, V6, P722, DOI 10.1161/CIRCIMAGING.112.000276; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; Meyer KC, 2012, CURR PULMONOL REP, V1, P147, DOI 10.1007/s13665-012-0020-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nathan SD, 2009, RESP MED, V103, P1816, DOI 10.1016/j.rmed.2009.07.011; Paoletti E, 2010, TRANSPL P, V42, pS41, DOI 10.1016/j.transproceed.2010.07.007; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Sandstede J, 2000, EUR RADIOL, V10, P438, DOI 10.1007/s003300050072; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Srichai MB, 2009, AM J ROENTGENOL, V192, P662, DOI 10.2214/AJR.07.3744; Suhling H, 2013, TRANSPLANTATION, V95, P1045, DOI 10.1097/TP.0b013e31828555d0; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Turkbey EB, 2010, HEART, V96, P42, DOI 10.1136/hrt.2009.178426; Vogel-Claussen J, 2011, INVEST RADIOL, V46, P567, DOI 10.1097/RLI.0b013e31821b7041; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Yamamoto H, 1998, SURG TODAY, V28, P900, DOI 10.1007/s005950050250; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114001	10.1371/journal.pone.0114001	http://dx.doi.org/10.1371/journal.pone.0114001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479016	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200038
J	Mao, Y; Qu, Q; Zhang, YZ; Liu, JJ; Chen, XS; Shen, KW				Mao, Yan; Qu, Qing; Zhang, Yuzi; Liu, Junjun; Chen, Xiaosong; Shen, Kunwei			The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PATHOLOGICAL COMPLETE RESPONSE; SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; T-CELLS; SURVIVAL; PROGNOSIS; THERAPY; TRASTUZUMAB; DOXORUBICIN; DOCETAXEL	Background: We carried out a systematic review and meta-analysis to evaluate the predictive roles of tumor infiltrating lymphocytes (TILs) in response to neoadjuvant chemotherapy (NAC) in breast cancer. Method: A PubMed and Web of Science literature search was designed. Random or fixed effect models were adopted to estimate the summary odds ratio (OR). Heterogeneity and sensitivity analyses were performed to explore heterogeneity among studies and to assess the effects of study quality. Publication bias was evaluated using a funnel plot, Egger's test and Begg's test. We included studies where the predictive significance of TILs, and/or TILs subset on the pathologic complete response (pCR) were determined in NAC of breast cancer. Results: A total of 13 published studies (including 3251 patients) were eligible. In pooled analysis, the detection of higher TILs numbers in pre-treatment biopsy was correlated with better pCR to NAC (OR=3.93, 95% CI, 3.26-4.73). Moreover, TILs predicted higher pCR rates in triple negative (OR=2.49, 95% CI: 1.61-3.83), HER2 positive (OR=5.05, 95% CI: 2.86-8.92) breast cancer, but not in estrogen receptor (ER) positive (OR=6.21, 95% CI: 0.86-45.15) patients. In multivariate analysis, TILs were still an independent marker for high pCR rate (OR=1.41, 95% CI: 1.19-1.66). For TILs subset, higher levels of CD8+ and FOXP3+ T-lymphocytes in pretreatment biopsy respectively predicted better pathological response to NAC (OR=6.44, 95% CI: 2.52-16.46; OR=2.94, 95% CI: 1.05-8.26). Only FOXP3+ lymphocytes in post-NAC breast tissue were a predictive marker for low pCR rate in univariate (OR=0.41, 95% CI: 0.21-0.80) and multivariate (OR=0.36, 95% CI: 0.13-0.95) analysis. Conclusion: Higher TILs levels in pre-treatment biopsy indicated higher pCR rates for NAC. TILs subset played different roles in predicting response to NAC.	[Mao, Yan; Zhang, Yuzi; Liu, Junjun; Chen, Xiaosong; Shen, Kunwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China; [Qu, Qing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, KW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Comprehens Breast Hlth Ctr, Shanghai 200030, Peoples R China.	kunwshenrj@163.com			National Natural funding of China [81202087, 81202088, 81172520]; Shanghai Municipal Science and Technology Commission funding [12ZR1446400, 12140901503]; Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine [BXJ201213]	National Natural funding of China; Shanghai Municipal Science and Technology Commission funding; Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine	This study was supported by the National Natural funding of China (81202087,81202088, 81172520), Shanghai Municipal Science and Technology Commission funding (12ZR1446400, 12140901503); Doctor Innovation funding of Shanghai Jiao Tong University School of Medicine (BXJ201213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; Aruga T, 2009, ONCOL REP, V22, P273, DOI 10.3892/or_00000434; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhargava R, 2010, CANCER-AM CANCER SOC, V116, P1431, DOI 10.1002/cncr.24876; Caras I, 2004, CANCER IMMUNOL IMMUN, V53, P1146, DOI 10.1007/s00262-004-0556-2; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; de Jong RA, 2009, GYNECOL ONCOL, V114, P105, DOI 10.1016/j.ygyno.2009.03.022; Denkert C, 2013, ANN ONCOL, V24, P2786, DOI 10.1093/annonc/mdt350; Denkert C, 2013, CANC RES S, V73; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Di Cosimo S, 2013, CANC RES S, V73; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Fisher CS, 2012, ANN SURG ONCOL, V19, P253, DOI 10.1245/s10434-011-1877-y; Garcia-Martinez E, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-P5-01-08; Giatromanolaki A, 2008, GYNECOL ONCOL, V110, P216, DOI 10.1016/j.ygyno.2008.04.021; Hayes DF, 2006, BREAST CANCER RES TR, V100, P237, DOI 10.1007/s10549-006-9253-5; Hornychova H, 2008, CANCER INVEST, V26, P1024, DOI 10.1080/07357900802098165; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Ismael G, 2012, LANCET ONCOL, V13, P869, DOI 10.1016/S1470-2045(12)70329-7; Issa-Nummer Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079775; Kondratiev S, 2004, CLIN CANCER RES, V10, P4450, DOI 10.1158/1078-0432.CCR-0732-3; Kong XN, 2011, EUR J CANCER, V47, P2084, DOI 10.1016/j.ejca.2011.06.014; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Lee HJ, 2013, J BREAST CANCER, V16, P32, DOI 10.4048/jbc.2013.16.1.32; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liu FF, 2012, BREAST CANCER RES TR, V135, P459, DOI 10.1007/s10549-012-2132-3; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Melichar B, 2012, MED ONCOL, V29, P2577, DOI 10.1007/s12032-012-0195-y; Menard S, 1997, CLIN CANCER RES, V3, P817; Mohammed ZMA, 2012, BRIT J CANCER, V107, P864, DOI 10.1038/bjc.2012.347; Montagna E, 2010, BREAST CANCER RES TR, V124, P689, DOI 10.1007/s10549-010-1027-4; Oda N, 2012, BREAST CANCER RES TR, V136, P107, DOI 10.1007/s10549-012-2245-8; Ohno S, 2013, BREAST CANCER RES TR, V142, P69, DOI 10.1007/s10549-013-2691-y; Ono M, 2012, BREAST CANCER RES TR, V132, P793, DOI 10.1007/s10549-011-1554-7; Seo AN, 2013, BRIT J CANCER, V109, P2705, DOI 10.1038/bjc.2013.634; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Straver ME, 2010, ANN SURG ONCOL, V17, P2411, DOI 10.1245/s10434-010-1008-1; Tan MC, 2009, AM J SURG, V198, P520, DOI 10.1016/j.amjsurg.2009.06.004; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072; Yamagami W, 2011, INT J GYNECOL CANCER, V21, P1628, DOI 10.1097/IGC.0b013e31822c271f; Yamaguchi R, 2012, HUM PATHOL, V43, P1688, DOI 10.1016/j.humpath.2011.12.013; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	53	129	132	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115103	10.1371/journal.pone.0115103	http://dx.doi.org/10.1371/journal.pone.0115103			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501357	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400072
J	Hu, HF; Gao, ZY; Liu, LM; Liu, HH; Gao, JF; Xu, SZ; Li, W; Huang, L				Hu, Huaifei; Gao, Zhiyong; Liu, Liman; Liu, Haihua; Gao, Junfeng; Xu, Shengzhou; Li, Wei; Huang, Lu			Automatic Segmentation of the Left Ventricle in Cardiac MRI Using Local Binary Fitting Model and Dynamic Programming Techniques	PLOS ONE			English	Article							BORDER DETECTION; DISEASE	Segmentation of the left ventricle is very important to quantitatively analyze global and regional cardiac function from magnetic resonance. The aim of this study is to develop a novel algorithm for segmenting left ventricle on short-axis cardiac magnetic resonance images (MRI) to improve the performance of computer-aided diagnosis (CAD) systems. In this research, an automatic segmentation method for left ventricle is proposed on the basis of local binary fitting (LBF) model and dynamic programming techniques. The validation experiments are performed on a pool of data sets of 45 cases. For both endo- and epi-cardial contours of our results, percentage of good contours is about 93.5%, the average perpendicular distance are about 2 mm. The overlapping dice metric is about 0.91. The regression and determination coefficient between the experts and our proposed method on the LV mass is 1.038 and 0.9033, respectively; they are 1.076 and 0.9386 for ejection fraction (EF). The proposed segmentation method shows the better performance and has great potential in improving the accuracy of computer-aided diagnosis systems in cardiovascular diseases.	[Hu, Huaifei; Gao, Zhiyong; Liu, Liman; Liu, Haihua; Gao, Junfeng; Li, Wei] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Xu, Shengzhou] South Cent Univ Nationalities, Coll Comp Sci, Wuhan, Peoples R China; [Huang, Lu] Huazhong Univ Sci & Technol, Dept Radiol, Tongji Hosp, Wuhan 430074, Peoples R China	South Central Minzu University; South Central Minzu University; Huazhong University of Science & Technology	Liu, HH (corresponding author), South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China.	liuhh@mail.scuec.edu.cn			National Natural Science Foundation of China [91320102, 61305044, 61302192, 81271659]; Natural Science Foundation of Hubei Province of China [2014CFB922]; State Ethnic Affairs Commission Foundation of China [CZQ13010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); State Ethnic Affairs Commission Foundation of China	The work is supported by National Natural Science Foundation of China (No. 91320102, 61305044, 61302192 and 81271659), Natural Science Foundation of Hubei Province of China (No. 2014CFB922), and State Ethnic Affairs Commission Foundation of China (No. CZQ13010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bayati M., 2013, ADV BREAST CANC RES, V02, P72, DOI [10.4236/ABCR.2013.23013, DOI 10.4236/ABCR.2013.23013, 10.4236/abcr.2013.23013]; Ammar M, 2012, J DIGIT IMAGING, V25, P294, DOI 10.1007/s10278-011-9404-z; Chen T, 2008, IEEE T MED IMAGING, V27, P1084, DOI 10.1109/TMI.2008.918327; Eslami A, 2012, MED IMAGE ANAL; Grosgeorge D, 2011, INT J COMPUT ASS RAD, V6, P573, DOI 10.1007/s11548-010-0532-6; Hadhoud MM, 2012, AM J BIOMEDICAL ENG, V2, P131, DOI DOI 10.5923/j.ajbe.20120203.07; Haggerty CM, 2013, J MAGNETIC RESONANCE; Hu HF, 2013, MAGN RESON IMAGING, V31, P575, DOI 10.1016/j.mri.2012.10.004; Huang S. Y., 2010, J STRENGTH COND RES, P1, DOI DOI 10.1007/S10278-010-9315-4; Kaus MR, 2004, MED IMAGE ANAL, V8, P245, DOI 10.1016/j.media.2004.06.015; Lee HY, 2010, IEEE T BIO-MED ENG, V57, P905, DOI 10.1109/TBME.2009.2014545; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Liu H, 2012, ACAD RADIOL, V19, P723, DOI 10.1016/j.acra.2012.02.011; Lu Y, 2011, J CARDIOVASC MAGN R, V13, P4; [路远景 LU Yuan-jing], 2009, [现代制造工程, Modern Manufacturing Engineering], P49; Nambakhsh C, 2013, MED IMAGE ANAL; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; O'Brien SP, 2011, IEEE T MED IMAGING, V30, P461, DOI 10.1109/TMI.2010.2086465; Otsu N, 1975, AUTOMATICA, V11, P285; Pednekar A, 2006, IEEE T BIO-MED ENG, V53, P1425, DOI 10.1109/TBME.2006.873684; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Plueimpitiwiriyawej C, 2005, IEEE T MED IMAGING, V24, P593, DOI 10.1109/TMI.2005.843740; Radau P, MIDAS J CARDIAC MR L; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Souto M, 2013, DIAGNOSTICS, V3, P271, DOI 10.3390/diagnostics3020271; Uzumcu M, 2006, INVEST RADIOL, V41, P52, DOI 10.1097/01.rli.0000194070.88432.24; Wijnhout J, 2009, MIDAS J, P43; Xu XY, 2011, PATTERN RECOGN LETT, V32, P956, DOI 10.1016/j.patrec.2011.01.021; Yeh JY, 2005, COMPUT METH PROG BIO, V79, P19, DOI 10.1016/j.cmpb.2004.10.010; Zhang HH, 2010, IEEE T MED IMAGING, V29, P350, DOI 10.1109/TMI.2009.2030799	30	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114760	10.1371/journal.pone.0114760	http://dx.doi.org/10.1371/journal.pone.0114760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500580	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700050
J	Factor-Litvak, P; Insel, B; Calafat, AM; Liu, XH; Perera, F; Rauh, VA; Whyatt, RM				Factor-Litvak, Pam; Insel, Beverly; Calafat, Antonia M.; Liu, Xinhua; Perera, Frederica; Rauh, Virginia A.; Whyatt, Robin M.			Persistent Associations between Maternal Prenatal Exposure to Phthalates on Child IQ at Age 7 Years	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BISPHENOL-A; ENVIRONMENTAL CHEMICALS; TEMPORAL VARIABILITY; NATIONAL-HEALTH; MALE RATS; IN-VITRO; METABOLITES; NEURODEVELOPMENT; INTELLIGENCE	Background: Prior research reports inverse associations between maternal prenatal urinary phthalate metabolite concentrations and mental and motor development in preschoolers. No study evaluated whether these associations persist into school age. Methods: In a follow up of 328 inner-city mothers and their children, we measured prenatal urinary metabolites of di-n-butyl phthalate (DnBP), butylbenzyl phthalate (BBzP), di-isobutyl phthalate (DiBP), di-2-ethylhexyl phthalate and diethyl phthalate in late pregnancy. The Wechsler Intelligence Scale for Children, 4th edition was administered at child age 7 years and evaluates four areas of cognitive function associated with overall intelligence quotient (IQ). Results: Child full-scale IQ was inversely associated with prenatal urinary metabolite concentrations of DnBP and DiBP: b=-22.69 (95% confidence interval [CI] = -4.33, -1.05) and b= -2.69 (95% CI= -4.22, -1.16) per log unit increase. Among children of mothers with the highest versus lowest quartile DnBP and DiBP metabolite concentrations, IQ was 6.7 (95% CI= 1.9, 11.4) and 7.6 (95% CI= 3.2, 12.1) points lower, respectively. Associations were unchanged after control for cognition at age 3 years. Significant inverse associations were also seen between maternal prenatal metabolite concentrations of DnBP and DiBP and child processing speed, perceptual reasoning and working memory; DiBP and child verbal comprehension; and BBzP and child perceptual reasoning. Conclusion: Maternal prenatal urinary metabolite concentrations measured in late pregnancy of DnBP and DiBP are associated with deficits in children's intellectual development at age 7 years. Because phthalate exposures are ubiquitous and concentrations seen here within the range previously observed among general populations, results are of public health significance.	[Factor-Litvak, Pam; Insel, Beverly] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Calafat, Antonia M.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Liu, Xinhua] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Perera, Frederica; Whyatt, Robin M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, Columbia Ctr Childrens Environm Hlth, New York, NY USA; [Rauh, Virginia A.] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA	Columbia University; Centers for Disease Control & Prevention - USA; Columbia University; Columbia University; Columbia University	Factor-Litvak, P (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	prf1@columbia.edu	Calafat, Antonia/GOP-1115-2022; Calafat, Antonia/N-1183-2019	Calafat, Antonia/0000-0002-9796-7482; Perera, Frederica/0000-0002-1364-9250	National Institute of Environmental Health Sciences (NIEHS) [R01ES013543, R01ES014393, R01ES08977]; NIEHS/United States Environmental Protection Agency [P50 ES09600/RD 83214101]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008977, R01ES013543, R01ES014393, P30ES009089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS/United States Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences (NIEHS) grants R01ES013543, R01ES014393, and R01ES08977 and by NIEHS/United States Environmental Protection Agency grant P50 ES09600/RD 83214101. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Bellinger DC, 2013, SAF HEALTH WORK-KR, V4, P1, DOI 10.5491/SHAW.2013.4.1.1; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185; Braun JM, 2013, CURR OPIN PEDIATR, V25, P247, DOI 10.1097/MOP.0b013e32835e1eb6; Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009; Brown L., 1990, TEST NONVERBAL INTEL; Caldwell B.M., 1979, HOME OBSERVATION MEA; CDC, 4 CDCP; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Li YF, 2009, J APPL TOXICOL, V29, P603, DOI 10.1002/jat.1447; Matsuda S, 2012, PROG NEURO-PSYCHOPH, V39, P273, DOI 10.1016/j.pnpbp.2012.06.016; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; O'Connor JC, 2002, TOXICOL SCI, V69, P79, DOI 10.1093/toxsci/69.1.79; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330; Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Wechsler D, 1974, WECHSLER INTELLIGENC; Weiss B, 2012, NEUROTOXICOLOGY, V33, P1410, DOI 10.1016/j.neuro.2012.05.014; Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	44	103	104	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114003	10.1371/journal.pone.0114003	http://dx.doi.org/10.1371/journal.pone.0114003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493564	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400026
J	Henaut, Y; Corbara, B; Pelozuelo, L; Azemar, F; Cereghino, R; Herault, B; Dejean, A				Henaut, Yann; Corbara, Bruno; Pelozuelo, Laurent; Azemar, Frederic; Cereghino, Regis; Herault, Bruno; Dejean, Alain			A Tank Bromeliad Favors Spider Presence in a Neotropical Inundated Forest	PLOS ONE			English	Article							JUMPING SPIDERS; ANT MIMICRY; VISUAL CUES; CUPIENNIUS; PREDATION; ARANEAE; PREY; STRATEGIES; CAPTURE; VISION	Tank bromeliads are good models for understanding how climate change may affect biotic associations. We studied the relationships between spiders, the epiphytic tank bromeliad, Aechmea bracteata, and its associated ants in an inundated forest in Quintana Roo, Mexico, during a drought period while, exceptionally, this forest was dry and then during the flooding that followed. We compared spider abundance and diversity between 'Aechmea-areas' and 'control-areas' of the same surface area. We recorded six spider families: the Dipluridae, Ctenidae, Salticidae, Araneidae, Tetragnathidae and Linyphiidae among which the funnel-web tarantula, Ischnothele caudata, the only Dipluridae noted, was the most abundant. During the drought period, the spiders were more numerous in the Aechmea-areas than in the control-areas, but they were not obligatorily associated with the Aechmea. During the subsequent flooding, the spiders were concentrated in the A. bracteata patches, particularly those sheltering an ant colony. Also, a kind of specificity existed between certain spider taxa and ant species, but varied between the drought period and subsequent flooding. We conclude that climatic events modulate the relationship between A. bracteata patches and their associated fauna. Tank bromeliads, previously considered only for their ecological importance in supplying food and water during drought, may also be considered refuges for spiders during flooding. More generally, tank bromeliads have an important role in preserving non-specialized fauna in inundated forests.	[Henaut, Yann] Colegio Frontera Sur, Dept Conservac Biodiversidad, Quintana Roo, Chetumal, Mexico; [Corbara, Bruno] Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Corbara, Bruno] Univ Blaise Pascal, CNRS, Unite Mixte Rech 6023, Aubiere, France; [Pelozuelo, Laurent; Azemar, Frederic; Cereghino, Regis; Dejean, Alain] Univ Toulouse 3, Lab Ecol Fonct & Environm, F-31062 Toulouse, France; [Pelozuelo, Laurent; Azemar, Frederic; Cereghino, Regis; Dejean, Alain] CNRS, Unite Mixte Rech 5245, Lab Ecol Fonct & Environm, Toulouse, France; [Herault, Bruno] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech 93, Kourou, France; [Dejean, Alain] Ecol Forets Guyane, Kourou, France	El Colegio de la Frontera Sur (ECOSUR); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CIRAD; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles	Henaut, Y (corresponding author), Colegio Frontera Sur, Dept Conservac Biodiversidad, Quintana Roo, Chetumal, Mexico.	yhenaut@ecosur.mx	Hérault, Bruno/B-2765-2011; Azémar, Frédéric/A-9041-2010	Hérault, Bruno/0000-0002-6950-7286; Azémar, Frédéric/0000-0002-3098-8676; Dejean, Alain/0000-0002-3561-2248; CORBARA, Bruno/0000-0003-4232-8234	French Agence Nationale pour la Recherche (RAINWEBS) [ANR-12-BSV7-0022-01]; internal fund of El Colegio de la Frontera Sur (ECOSUR)	French Agence Nationale pour la Recherche (RAINWEBS)(French National Research Agency (ANR)); internal fund of El Colegio de la Frontera Sur (ECOSUR)	All the financial support for this study was provided by the French Agence Nationale pour la Recherche (RAINWEBS ANR-12-BSV7-0022-01) and internal fund of El Colegio de la Frontera Sur (ECOSUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adis J, 1997, CENTRAL AMAZON FLOOD, P299, DOI 10.1007/978-3-662-03416-3_14; Allan RA, 1996, P ROY SOC B-BIOL SCI, V263, P69, DOI 10.1098/rspb.1996.0012; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; BARTH FG, 1988, OECOLOGIA, V77, P187, DOI 10.1007/BF00379185; Benzing D. H., 2008, VASCULAR EPIPHYTES G; Beutelspacher BCR, 1999, BROMELIACEAS COMO EC; Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129; COYLE FA, 1995, B AM MUS NAT HIST, P3; De Omena PM, 2008, BIOL J LINN SOC, V94, P653, DOI 10.1111/j.1095-8312.2008.01039.x; de Omena PM, 2010, BEHAV ECOL, V21, P690, DOI 10.1093/beheco/arq040; DEJEAN A, 1995, BIOTROPICA, V27, P57, DOI 10.2307/2388903; Dejean A, 1997, J NAT HIST, V31, P1313, DOI 10.1080/00222939700770741; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027004; Dias Sidclay Calaça, 2004, Rev. Bras. Zool., V21, P789, DOI 10.1590/S0101-81752004000400011; Durkee CA, 2011, ENVIRON ENTOMOL, V40, P1223, DOI 10.1603/EN11057; Frank J.H., 2009, Terrestrial Arthropod Reviews, V1, P125; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Gillespie Rosemary G., 1993, Pacific Science, V47, P21; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Halaj J, 1997, OECOLOGIA, V109, P313, DOI 10.1007/s004420050089; Harwood JD, 2001, J APPL ECOL, V38, P88, DOI 10.1046/j.1365-2664.2001.00572.x; Henaut Y, 2001, ENTOMOL EXP APPL, V98, P1, DOI 10.1023/A:1018731906296; Henaut Y, 2014, ANIM COGN, V17, P185, DOI 10.1007/s10071-013-0651-x; Huang JN, 2011, P ROY SOC B-BIOL SCI, V278, P1356, DOI 10.1098/rspb.2010.1896; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Jackson RR, 1996, ANNU REV ENTOMOL, V41, P287, DOI 10.1146/annurev.en.41.010196.001443; Kohonen T., 2001, SELF ORG MAPS; LAND MF, 1992, J EXP BIOL, V164, P227; McCracken SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085470; Nakaegawa T, 2014, THEOR APPL CLIMATOL, V116, P155, DOI 10.1007/s00704-013-0934-9; Nelson XJ, 2006, BEHAV ECOL, V17, P676, DOI 10.1093/beheco/ark017; Nelson XJ, 2014, BEHAV ECOL SOCIOBIOL, V68, P773, DOI 10.1007/s00265-014-1690-2; Nelson XJ, 2005, J ARACHNOL, V33, P813, DOI 10.1636/S04-12.1; Nelson XJ, 2004, NEW ZEAL J ZOOL, V31, P45, DOI 10.1080/03014223.2004.9518358; NENTWIG W, 1986, OECOLOGIA, V69, P571, DOI 10.1007/BF00410365; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Philander S.G., 1990, NINO NINA SO OSCILLA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raizer J, 2001, J ARACHNOL, V29, P227, DOI 10.1636/0161-8202(2001)029[0227:DTSCOA]2.0.CO;2; Romero GQ, 2004, BIOTROPICA, V36, P596, DOI 10.1111/j.1744-7429.2004.tb00353.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanders D, 2007, OECOLOGIA, V150, P611, DOI 10.1007/s00442-006-0538-5; Santos AJ, 2004, J ARACHNOL, V32, P188, DOI 10.1636/H03-01; Schmidt CA, 2014, ZOOTAXA, V3817, P1, DOI 10.11646/zootaxa.3817.1.1; SCHUSTER M, 1994, J ARACHNOL, V22, P32; Styrsky JD, 2014, ECOL EVOL, V4, P276, DOI 10.1002/ece3.930; Weihmann T, 2010, J COMP PHYSIOL A, V196, P421, DOI 10.1007/s00359-010-0527-3; Zhang SC, 2012, P ROY SOC B-BIOL SCI, V279, P1824, DOI 10.1098/rspb.2011.2193; Zschokke S, 2006, CAN J ZOOL, V84, P964, DOI 10.1139/Z06-074	50	15	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114592	10.1371/journal.pone.0114592	http://dx.doi.org/10.1371/journal.pone.0114592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494055	Green Published, gold			2022-12-27	WOS:000346611400056
J	Horton, TW; Bierregaard, RO; Zawar-Reza, P; Holdaway, RN; Sagar, P				Horton, Travis W.; Bierregaard, Richard O.; Zawar-Reza, Peyman; Holdaway, Richard N.; Sagar, Paul			Juvenile Osprey Navigation during Trans-Oceanic Migration	PLOS ONE			English	Article							MAGNETIC COMPASS ORIENTATION; WIND DRIFT; GECARCOIDEA-NATALIS; PANDION-HALIAETUS; AVIAN ORIENTATION; COMPENSATION; BEHAVIOR; FIELD; SEA; MAP	To compensate for drift, an animal migrating through air or sea must be able to navigate. Although some species of bird, fish, insect, mammal, and reptile are capable of drift compensation, our understanding of the spatial reference frame, and associated coordinate space, in which these navigational behaviors occur remains limited. Using high resolution satellite-monitored GPS track data, we show that juvenile ospreys (Pandion haliaetus) are capable of non-stop constant course movements over open ocean spanning distances in excess of 1500 km despite the perturbing effects of winds and the lack of obvious landmarks. These results are best explained by extreme navigational precision in an exogenous spatio-temporal reference frame, such as positional orientation relative to Earth's magnetic field and pacing relative to an exogenous mechanism of keeping time. Given the age (< 1 year-old) of these birds and knowledge of their hatching site locations, we were able to transform Enhanced Magnetic Model coordinate locations such that the origin of the magnetic coordinate space corresponded with each bird's nest. Our analyses show that trans-oceanic juvenile osprey movements are consistent with bicoordinate positional orientation in transformed magnetic coordinate or geographic space. Through integration of movement and meteorological data, we propose a new theoretical framework, chord and clock navigation, capable of explaining the precise spatial orientation and temporal pacing performed by juvenile ospreys during their long-distance migrations over open ocean.	[Horton, Travis W.] Univ Canterbury, Dept Geol Sci, Christchurch 1, New Zealand; [Bierregaard, Richard O.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Zawar-Reza, Peyman] Univ Canterbury, Dept Geog, Christchurch 1, New Zealand; [Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Sagar, Paul] Natl Inst Water & Atmospher Res, Christchurch, New Zealand	University of Canterbury; University of North Carolina; University of North Carolina Charlotte; University of Canterbury; University of Canterbury; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Horton, TW (corresponding author), Univ Canterbury, Dept Geol Sci, Christchurch 1, New Zealand.	travis.horton@canterbury.ac.nz		Horton, Travis/0000-0003-0558-2970	tobacco company	tobacco company	The authors thank Public Service of New Hampshire and anonymous donors who funded the transmitters and Massachusetts Audubon who administered the funds for the Massachusetts birds. The anonymous donors do not have any competing interests in relation to this work, nor were their identities relevant to the assessment of the validity of this work. None of the research costs or authors' salaries were funded by a tobacco company. The authors are not aware of any competing interests.	ABLE KP, 1995, CONDOR, V97, P592, DOI 10.2307/1369049; Adamczewska AM, 2001, BIOL BULL, V200, P305, DOI 10.2307/1543512; Akesson S, 1998, J AVIAN BIOL, V29, P618, DOI 10.2307/3677182; Alerstam T., 1990, P331; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; BARLOW JS, 1964, J THEOR BIOL, V6, P76; Batschelet E, 1981, CIRCULAR STAT BIOL; Bierregaard RO, 2014, J RAPTOR RES, V48, P86, DOI 10.3356/JRR-13-00016.1; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; BINGMAN VP, 1982, ANIM BEHAV, V30, P49, DOI 10.1016/S0003-3472(82)80236-4; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bloom Peter H., 2007, P193; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Bostrom JE, 2012, ECOGRAPHY, V35, P1039, DOI 10.1111/j.1600-0587.2012.07507.x; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; DeVries P, 2004, T AM FISH SOC, V133, P1379, DOI 10.1577/T03-173.1; EMLEN ST, 1969, SCIENCE, V165, P716, DOI 10.1126/science.165.3894.716; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Gronroos J, 2013, J ORNITHOL, V154, P385, DOI 10.1007/s10336-012-0902-7; GWINNER E, 1967, NATURWISSENSCHAFTEN, V54, P447, DOI 10.1007/BF00603157; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Hake M, 2001, J AVIAN BIOL, V32, P47, DOI 10.1034/j.1600-048X.2001.320107.x; HICKS JW, 1985, AUST J ZOOL, V33, P127, DOI 10.1071/ZO9850127; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KEETON WT, 1979, ANNU REV PHYSIOL, V41, P353, DOI 10.1146/annurev.ph.41.030179.002033; Kjellen N, 2001, J AVIAN BIOL, V32, P57, DOI 10.1034/j.1600-048X.2001.320108.x; KRAMER G, 1950, NATURWISSENSCHAFTEN, V37, P377, DOI 10.1007/BF00626007; Krupczynski P, 2008, CURR BIOL, V18, P1961, DOI 10.1016/j.cub.2008.10.066; Larkin T., 1978, ANIMAL MIGRATION NAV, DOI [10.1007/978-3-662-11147-5_8, DOI 10.1007/978-3-662-11147-5_8]; Lea MA, 2010, MAR ECOL PROG SER, V419, P233, DOI 10.3354/meps08758; LEDNOR AJ, 1984, J EXP BIOL, V111, P259; LINDAUER M, 1968, Z VERGL PHYSIOL, V60, P219, DOI 10.1007/BF00298600; Liu Xiaofeng, 2012, Chinese Birds, V3, P1; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lohmann KJ, 2012, CURR OPIN NEUROBIOL, V22, P336, DOI 10.1016/j.conb.2011.11.005; Maus S, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003026; McLaren JD, 2012, BEHAV ECOL, V23, P1089, DOI 10.1093/beheco/ars078; MERRIAM JB, 1992, GEOPHYS J INT, V108, P415, DOI 10.1111/j.1365-246X.1992.tb04624.x; Meyer SK, 2000, BEHAVIOUR, V137, P379, DOI 10.1163/156853900502132; Muggeo V.M., 2008, R NEWS, V8, P20; Narazaki T, 2009, J EXP BIOL, V212, P4019, DOI 10.1242/jeb.034637; PAPI F, 1989, ETHOL ECOL EVOL, V1, P219, DOI 10.1080/08927014.1989.9525511; PHILLIPS JB, 1986, J COMP PHYSIOL A, V158, P103, DOI 10.1007/BF00614524; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; PIPER JDA, 1989, PHYS EARTH PLANET IN, V55, P37, DOI 10.1016/0031-9201(89)90232-X; Putman NF, 2013, CURR BIOL, V23, P312, DOI 10.1016/j.cub.2012.12.041; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Rao JS., 2001, TOPICS CIRCULAR STAT; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Safi K, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-4; Sapir N, 2014, J ORNITHOL, V155, P745, DOI 10.1007/s10336-014-1060-x; Schmidt AJ, 2012, ANIM BEHAV, V84, P333, DOI 10.1016/j.anbehav.2012.04.023; SHAMAROCK WC, 2005, NCARTN468STR; Shamoun-Baranes J, 2010, INTEGR COMP BIOL, V50, P280, DOI 10.1093/icb/icq011; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Viguier C., 1882, REV PHILOSOPHIQUE FR, V14, P1; WEHNER R, 1970, EXPERIENTIA, V26, P967, DOI 10.1007/BF02114135; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054; Wiltschko R, 2010, CURR ZOOL, V56, P265, DOI 10.1093/czoolo/56.3.265; Wiltschko W., 1972, ANIMAL ORIENTATION N, P569	71	17	17	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114557	10.1371/journal.pone.0114557	http://dx.doi.org/10.1371/journal.pone.0114557			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493430	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400052
J	Chen, Y; Huang, WN; Peng, B				Chen, Yi; Huang, Weina; Peng, Bei			Determination of Optimal Parameters for Dual-Layer Cathode of Polymer Electrolyte Fuel Cell Using Computational Intelligence-Aided Design	PLOS ONE			English	Article							SERPENTINE FLOW-FIELD; SENSITIVITY EXAMINATION; MODEL; OPTIMIZATION; SIMULATION; PERFORMANCE; VALIDATION; TRANSPORT	Because of the demands for sustainable and renewable energy, fuel cells have become increasingly popular, particularly the polymer electrolyte fuel cell (PEFC). Among the various components, the cathode plays a key role in the operation of a PEFC. In this study, a quantitative dual-layer cathode model was proposed for determining the optimal parameters that minimize the over-potential difference g and improve the efficiency using a newly developed bat swarm algorithm with a variable population embedded in the computational intelligence-aided design. The simulation results were in agreement with previously reported results, suggesting that the proposed technique has potential applications for automating and optimizing the design of PEFCs.	[Chen, Yi; Huang, Weina; Peng, Bei] Univ Elect Sci & Technol China, Sch Mech Engn, Chengdu 611731, Peoples R China; [Chen, Yi; Huang, Weina; Peng, Bei] Univ Elect Sci & Technol China, Robot Res Ctr, Chengdu 611731, Peoples R China; [Chen, Yi] Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Glasgow Caledonian University	Peng, B (corresponding author), Univ Elect Sci & Technol China, Sch Mech Engn, Chengdu 611731, Peoples R China.	beipeng@uestc.edu.cn	Chen, Yi/P-8641-2017	Chen, Yi/0000-0001-7960-8374	National Natural Science Foundation of China [91123023, 51105061]; National Program for Support of Top-Notch Young Professionals	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-Notch Young Professionals	This work was supported by the National Natural Science Foundation of China (No. 91123023 and 51105061) and the National Program for Support of Top-Notch Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMPHLETT JC, 1995, J ELECTROCHEM SOC, V142, P1, DOI 10.1149/1.2043866; Askarzadeh A, 2012, IEEE T IND ELECTRON, V59, P3473, DOI 10.1109/TIE.2011.2172173; Baschuk JJ, 2000, J POWER SOURCES, V86, P181, DOI 10.1016/S0378-7753(99)00426-7; BERNARDI DM, 1992, J ELECTROCHEM SOC, V139, P2477, DOI 10.1149/1.2221251; Bevers D, 1997, J APPL ELECTROCHEM, V27, P1254, DOI 10.1023/A:1018488021355; Chen Y, 2014, SWARMDOLPHIN SWARM D; Chen Y, 2013, SWARMBAT ARTIFICIAL; Chen Y, 2011, J APPL PHYS, V110; Chen Y, 2013, SECFLAB SIMPLE ECONO; Chen Y, 2012, 2012 P 58 ANN REL MA; Chen Y, 2014, APPL THERM ENG, V70, P263, DOI 10.1016/j.applthermaleng.2014.05.004; Chen Y, 2014, J CLEAN PROD, V69, P143, DOI 10.1016/j.jclepro.2014.01.058; Chen Y, 2013, ENERGIES, V6, P3082, DOI 10.3390/en6063082; Chen Y, 2013, INFORM FUSION, V14, P327, DOI 10.1016/j.inffus.2011.12.003; Chen Y, 2013, ENTROPY-SWITZ, V15, P10, DOI 10.3390/e15010010; Chen Y, 2012, J DYN SYST-T ASME, V134, DOI 10.1115/1.4006220; Chen Y, 2012, APPL SOFT COMPUT, V12, P2631, DOI 10.1016/j.asoc.2012.04.014; Chen Y, 2012, EXPERT SYST APPL, V39, P6469, DOI 10.1016/j.eswa.2011.12.060; Chen Y, 2007, IEEE C EVOL COMPUTAT, P987; Feng XH, 2010, ELECTROCHIM ACTA, V55, P4579, DOI 10.1016/j.electacta.2010.03.013; Gao F, 2010, J POWER SOURCES, V195, P7609, DOI 10.1016/j.jpowsour.2010.06.006; Grujicic M, 2004, APPL SURF SCI, V227, P56, DOI 10.1016/j.apsusc.2003.10.035; Jung JH, 2011, IEEE T IND ELECTRON, V58, P4217, DOI 10.1109/TIE.2010.2098365; Khajeh-Hosseini-Dalasm N, 2010, INT J HYDROGEN ENERG, V35, P2417, DOI 10.1016/j.ijhydene.2009.12.111; Kulikovsky AA, 1999, J ELECTROCHEM SOC, V146, P3981, DOI 10.1149/1.1392580; Min CH, 2006, J POWER SOURCES, V160, P374, DOI 10.1016/j.jpowsour.2006.01.080; Molaeimanesh GR, 2014, J POWER SOURCES, V258, P89, DOI 10.1016/j.jpowsour.2014.02.027; Noorkami M, 2014, INT J HYDROGEN ENERG, V39, P1439, DOI 10.1016/j.ijhydene.2013.10.156; Pathak R, 2013, ELECTROCHIM ACTA, V113, P42, DOI 10.1016/j.electacta.2013.08.033; Pathapati PR, 2005, RENEW ENERG, V30, P1, DOI 10.1016/j.renene.2004.05.001; Ramadass P, 2003, J POWER SOURCES, V123, P230, DOI 10.1016/S0378-7753(03)00531-7; Rowe A, 2001, J POWER SOURCES, V102, P82, DOI 10.1016/S0378-7753(01)00798-4; Sayyaadi H, 2013, INT J ENERG RES, V37, P1872, DOI 10.1002/er.3004; Song DT, 2004, J POWER SOURCES, V126, P104, DOI 10.1016/j.jpowsour.2003.08.043; Song JM, 2001, J POWER SOURCES, V94, P78, DOI 10.1016/S0378-7753(00)00629-7; SPRINGER TE, 1991, J ELECTROCHEM SOC, V138, P2334, DOI 10.1149/1.2085971; Tao WQ, 2006, J POWER SOURCES, V160, P359, DOI 10.1016/j.jpowsour.2006.01.078; Wang L, 2003, INT J HYDROGEN ENERG, V28, P1263, DOI 10.1016/S0360-3199(02)00284-7; Wang XD, 2008, J POWER SOURCES, V175, P397, DOI 10.1016/j.jpowsour.2007.09.009; Wang XD, 2014, J TAIWAN INST CHEM E, V45, P1532, DOI 10.1016/j.jtice.2014.03.011; Wang XD, 2012, INT J HYDROGEN ENERG, V37, P15766, DOI 10.1016/j.ijhydene.2012.04.029; Wang XD, 2011, INT J HEAT MASS TRAN, V54, P2375, DOI 10.1016/j.ijheatmasstransfer.2011.02.024; Wang XD, 2010, INT J HYDROGEN ENERG, V35, P4247, DOI 10.1016/j.ijhydene.2010.02.059; Wang Y, 2008, J ELECTROCHEM SOC, V155, pA8; Wang Y, 2011, APPL ENERG, V88, P981, DOI 10.1016/j.apenergy.2010.09.030; Wang Y, 2009, J ELECTROCHEM SOC, V156, pB403, DOI 10.1149/1.3056057; Weber AZ, 2004, CHEM REV, V104, P4679, DOI 10.1021/cr020729l; [徐彦杰 Xu Yanjie], 2012, [中国药学杂志, Chinese Pharmaceutical Journal], V47, P669; Yang XS, 2010, STUD COMPUT INTELL, V284, P65, DOI 10.1007/978-3-642-12538-6_6; Yerramalla S, 2003, J POWER SOURCES, V124, P104, DOI 10.1016/S0378-7753(03)00733-X; 刘晓红, 2012, [中国卫生统计, Chinese Journal of Health Statistics], V29, P846	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114223	10.1371/journal.pone.0114223	http://dx.doi.org/10.1371/journal.pone.0114223			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490761	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300021
J	Duan-Porter, WD; Woods, VL; Maurer, KD; Li, S; Rosen, A				Duan-Porter, Wei D.; Woods, Virgil L., Jr.; Maurer, Kimberly D.; Li, Sheng; Rosen, Antony			Dynamic Conformations of Nucleophosmin (NPM1) at a Key Monomer-Monomer Interface Affect Oligomer Stability and Interactions with Granzyme B	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; NUCLEOLAR PROTEIN; HYDROGEN-EXCHANGE; CRYSTAL-STRUCTURE; HYDROGEN/DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; AUTOANTIGEN B23; AUTOANTIBODIES; DOMAINS; CORE	Nucleophosmin (NPM1) is an abundant, nucleolar tumor antigen with important roles in cell proliferation and putative contributions to oncogenesis. Wild-type NPM1 forms pentameric oligomers through interactions at the amino-terminal core domain. A truncated form of NPM1 found in some hepatocellular carcinoma tissue formed an unusually stable oligomer and showed increased susceptibility to cleavage by granzyme B. Initiation of translation at the seventh methionine generated a protein (M7-NPM) that shared all these properties. We used deuterium exchange mass spectrometry (DXMS) to perform a detailed structural analysis of wild-type NPM1 and M7-NPM, and found dynamic conformational shifts or local "unfolding" at a specific monomer-monomer interface which included the beta-hairpin "latch." We tested the importance of interactions at the beta-hairpin "latch" by replacing a conserved tyrosine in the middle of the beta-hairpin loop with glutamic acid, generating Y67E-NPM. Y67E-NPM did not form stable oligomers and further, prevented wild-type NPM1 oligomerization in a dominant-negative fashion, supporting the critical role of the b beta-hairpin "latch" in monomer-monomer interactions. Also, we show preferential cleavage by granzyme B at one of two available aspartates (either D161 or D122) in M7-NPM and Y67E-NPM, whereas wild-type NPM1 was cleaved at both sites. Thus, we observed a correlation between the propensity to form oligomers and granzyme B cleavage site selection nucleophosmin proteins, suggesting that a small change at an important monomer-monomer interface can affect conformational shifts and impact protein-protein interactions.	[Duan-Porter, Wei D.] Durham VA Med Ctr, Durham, NC 27705 USA; [Duan-Porter, Wei D.] Duke Univ, Med Ctr, Durham, NC 27705 USA; [Woods, Virgil L., Jr.; Li, Sheng] Univ Calif San Diego, La Jolla, CA 92093 USA; [Maurer, Kimberly D.; Rosen, Antony] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of California System; University of California San Diego; Johns Hopkins University	Rosen, A (corresponding author), Johns Hopkins Univ, Sch Med, 5200 Eastern Ave,Mason F Lord Bldg,Ctr Tower, Baltimore, MD 21224 USA.	arosen@jhmi.edu			Dana Foundation; National Institutes of Health [R37-DE12354, R01AI081982, R01GM020501, 27220090004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501] Funding Source: NIH RePORTER	Dana Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the the Dana Foundation (www.dana.org) and the National Institutes of Health: R37-DE12354, R01AI081982, R01GM020501, and 27220090004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balafanova Z, 2002, J BIOL CHEM, V277, P15021, DOI 10.1074/jbc.M112451200; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Brankin B, 1998, CANCER EPIDEM BIOMAR, V7, P1109; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; Chung EW, 1997, PROTEIN SCI, V6, P1316, DOI 10.1002/pro.5560060620; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; Cravello L, 2003, RAPID COMMUN MASS SP, V17, P2387, DOI 10.1002/rcm.1207; Darrah E, 2010, CELL DEATH DIFFER, V17, P624, DOI 10.1038/cdd.2009.197; Deng YH, 1998, BIOCHEMISTRY-US, V37, P6256, DOI 10.1021/bi972711o; Deng YZ, 1999, J MOL BIOL, V294, P247, DOI 10.1006/jmbi.1999.3251; Deng YZ, 1999, ANAL BIOCHEM, V276, P150, DOI 10.1006/abio.1999.4347; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dingwall C, 1990, Semin Cell Biol, V1, P11; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; ENGLANDER SW, 1994, METHOD ENZYMOL, V232, P26; Ferraro DM, 2004, BIOCHEMISTRY-US, V43, P587, DOI 10.1021/bi035943y; Gallo A, 2012, J BIOL CHEM, V287, P26539, DOI 10.1074/jbc.M112.371013; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hellberg CB, 1998, BIOCHEM BIOPH RES CO, V252, P313, DOI 10.1006/bbrc.1998.9581; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; IMAI H, 1992, AM J PATHOL, V140, P859; IMAI H, 1993, INTERVIROLOGY, V35, P73, DOI 10.1159/000150297; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lambert B, 2006, FEBS LETT, V580, P345, DOI 10.1016/j.febslet.2005.12.025; Lartigue A, 2005, ARTHRITIS RES THER, V7, pR1394, DOI 10.1186/ar1838; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Marasco D, 2013, BIOCHEM BIOPH RES CO, V430, P523, DOI 10.1016/j.bbrc.2012.12.002; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Miranker A, 1996, FASEB J, V10, P93, DOI 10.1096/fasebj.10.1.8566553; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Ramos-Echazabal G, 2012, J CELL BIOCHEM, V113, P2364, DOI 10.1002/jcb.24108; Seeley KW, 2012, J PROTEOMICS, V75, P1691, DOI 10.1016/j.jprot.2011.11.025; So CH, 2012, J BIOL CHEM, V287, P17088, DOI 10.1074/jbc.M112.353854; Szebeni A, 1999, PROTEIN SCI, V8, P905; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; Ulanet DB, 2004, ARTHRITIS RHEUM, V50, P233, DOI 10.1002/art.11485; Ulanet DB, 2003, P NATL ACAD SCI USA, V100, P12361, DOI 10.1073/pnas.2035245100; Ulanet DB, 2003, ARTHRIT RHEUM-ARTHR, V49, P85, DOI 10.1002/art.10914; Umekawa H, 2001, J BIOCHEM-TOKYO, V130, P199, DOI 10.1093/oxfordjournals.jbchem.a002973; Van Damme P, 2014, MOL CELL PROTEOMICS, V13, P1245, DOI 10.1074/mcp.M113.036442; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; YUNG BYM, 1987, BIOCHIM BIOPHYS ACTA, V925, P74, DOI 10.1016/0304-4165(87)90149-8; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	66	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e115062	10.1371/journal.pone.0115062	http://dx.doi.org/10.1371/journal.pone.0115062			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490769	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300101
J	Fabregat, G; Garcia-de-la-Asuncion, J; Sarria, B; Cortijo, J; De Andres, J; Mata, M; Pastor, E; Belda, FJ				Fabregat, Gustavo; Garcia-de-la-Asuncion, Jose; Sarria, Benjamin; Cortijo, Julio; De Andres, Jose; Mata, Manuel; Pastor, Ernesto; Javier Belda, Francisco			Increased Expression of AQP 1 and AQP 5 in Rat Lungs Ventilated with Low Tidal Volume is Time Dependent	PLOS ONE			English	Article							MECHANICAL VENTILATION; FLUID TRANSPORT; PULMONARY-EDEMA; INJURY; MICE; AQUAPORIN-1; PRESSURE; INFLATION; CYTOKINES; STRATEGY	Background and Goals: Mechanical ventilation (MV) can induce or worsen pulmonary oedema. Aquaporins (AQPs) facilitate the selective and rapid bidirectional movement of water. Their role in the development and resolution of pulmonary oedema is controversial. Our objectives are to determine if prolonged MV causes lung oedema and changes in the expression of AQP 1 and AQP 5 in rats. Methods: 25 male Wistar rats were subjected to MV with a tidal volume of 10 ml/kg, during 2 hours (n=12) and 4 hours (n=13). Degree of oedema was compared with a group of non-ventilated rats (n=5). The expression of AQP 1 and AQP 5 were determined by western immunoblotting, measuring the amount of mRNA (previously amplified by RT-PCR) and immunohistochemical staining of AQPs 1 and 5 in lung samples from all groups. Results: Lung oedema and alveolar-capillary membrane permeability did not change during MV. AQP-5 steady state levels in the western blot were increased (p<0.01) at 2 h and 4 h of MV. But in AQP-1 expression these differences were not found. However, the amount of mRNA for AQP-1 was increased at 2 h and 4 h of MV; and for AQP 5 at 4 h of MV. These findings were corroborated by representative immunohistochemical lung samples. Conclusion: In lungs from rats ventilated with a low tidal volume the expression of AQP 5 increases gradually with MV duration, but does not cause pulmonary oedema or changes in lung permeability. AQPs may have a protective effect against the oedema induced by MV.	[Fabregat, Gustavo] Hosp Gen Univ, Valencia, Spain; [Garcia-de-la-Asuncion, Jose; Pastor, Ernesto] Hosp Clin Univ, Valencia, Spain; [Sarria, Benjamin; Cortijo, Julio] Univ Valencia, Sch Med, Dept Pharmacol, Valencia, Spain; [Cortijo, Julio] Hosp Gen Univ, Res Fdn, Valencia, Spain; [De Andres, Jose; Javier Belda, Francisco] Univ Valencia, Sch Med, Valencia, Spain; [Mata, Manuel] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain; [Javier Belda, Francisco] Hosp Clin Univ, Anaesthesia & Crit Care Dept, Valencia, Spain; [Javier Belda, Francisco] Hosp Clin Univ, Fdn Invest, Inst Invest Clin INCLIVA, Valencia, Spain	Hospital Clinic Universitari de Valencia; Hospital Clinic Universitari de Valencia; University of Valencia; University of Valencia; University of Valencia	Fabregat, G (corresponding author), Hosp Gen Univ, Valencia, Spain.		Morcillo, Esteban/I-1552-2015; De Andres, Jose/AAG-3413-2019; Roig, Manuel Mata/G-4338-2015; Fabregat, Gustavo/AAF-8107-2021; Sarria Chust, Benjamin/D-5900-2016	Morcillo, Esteban/0000-0003-4373-9457; Roig, Manuel Mata/0000-0002-1506-7983; Fabregat, Gustavo/0000-0002-1658-1466; Sarria Chust, Benjamin/0000-0002-8570-7827				Allen GB, 2006, AM J PHYSIOL-LUNG C, V291, pL710, DOI 10.1152/ajplung.00532.2005; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bai CX, 1999, J CLIN INVEST, V103, P555, DOI 10.1172/JCI4138; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bueno PCS, 2002, BRAZ J MED BIOL RES, V35, P191, DOI 10.1590/S0100-879X2002000200007; Cao Chun-shui, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P426; Caruso P, 2003, INTENS CARE MED, V29, P1808, DOI 10.1007/s00134-003-1908-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Dong CL, 2012, RESP PHYSIOL NEUROBI, V181, P21, DOI 10.1016/j.resp.2011.12.008; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Hales CA, 2001, RESP PHYSIOL, V124, P159, DOI 10.1016/S0034-5687(00)00193-6; HEDENSTIERNA G, 1989, EUR RESPIR J, V2, P528; Hegeman MA, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/435236; Jiao GY, 2002, CHINESE MED J-PEKING, V115, P963; Jin LD, 2013, INT IMMUNOPHARMACOL, V16, P288, DOI 10.1016/j.intimp.2013.03.031; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; King LS, 1996, J CLIN INVEST, V97, P2183, DOI 10.1172/JCI118659; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Ma TH, 2000, J CLIN INVEST, V105, P93, DOI 10.1172/JCI8258; Papadimitriou D, 2008, LAB ANIM-UK, V42, P265, DOI 10.1258/la.2007.006035; Plotz FB, 2002, INTENS CARE MED, V28, P486, DOI 10.1007/s00134-002-1216-7; Schmalstieg FC, 2001, ASAIO J, V47, P365, DOI 10.1097/00002480-200107000-00014; Schwarte LA, 2000, BASIC RES CARDIOL, V95, P510, DOI 10.1007/s003950070029; Song YL, 2000, J PHYSIOL-LONDON, V525, P771, DOI 10.1111/j.1469-7793.2000.00771.x; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wang F, 2010, HEPATO-GASTROENTEROL, V57, P1553; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wrigge H, 2000, ANESTHESIOLOGY, V93, P1413, DOI 10.1097/00000542-200012000-00012; Wu XM, 2009, LUNG, V187, P225, DOI 10.1007/s00408-009-9155-5; Yue Dong-Mei, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P147; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	40	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114247	10.1371/journal.pone.0114247	http://dx.doi.org/10.1371/journal.pone.0114247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489856	gold, Green Submitted, Green Published			2022-12-27	WOS:000347515300023
J	Ugarte, JP; Orozco-Duque, A; Tobon, C; Kremen, V; Novak, D; Saiz, J; Oesterlein, T; Schmitt, C; Luik, A; Bustamante, J				Ugarte, Juan P.; Orozco-Duque, Andres; Tobon, Catalina; Kremen, Vaclav; Novak, Daniel; Saiz, Javier; Oesterlein, Tobias; Schmitt, Clauss; Luik, Armin; Bustamante, John			Dynamic Approximate Entropy Electroanatomic Maps Detect Rotors in a Simulated Atrial Fibrillation Model	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; ELECTROGRAM FRACTIONATION; IONIC MECHANISMS; SAMPLE ENTROPY; COMPUTER-MODEL; FOCAL IMPULSE; ABLATION; IRREGULARITY; MORPHOLOGY; HUMANS	There is evidence that rotors could be drivers that maintain atrial fibrillation. Complex fractionated atrial electrograms have been located in rotor tip areas. However, the concept of electrogram fractionation, defined using time intervals, is still controversial as a tool for locating target sites for ablation. We hypothesize that the fractionation phenomenon is better described using non-linear dynamic measures, such as approximate entropy, and that this tool could be used for locating the rotor tip. The aim of this work has been to determine the relationship between approximate entropy and fractionated electrograms, and to develop a new tool for rotor mapping based on fractionation levels. Two episodes of chronic atrial fibrillation were simulated in a 3D human atrial model, in which rotors were observed. Dynamic approximate entropy maps were calculated using unipolar electrogram signals generated over the whole surface of the 3D atrial model. In addition, we optimized the approximate entropy calculation using two real multicenter databases of fractionated electrogram signals, labeled in 4 levels of fractionation. We found that the values of approximate entropy and the levels of fractionation are positively correlated. This allows the dynamic approximate entropy maps to localize the tips from stable and meandering rotors. Furthermore, we assessed the optimized approximate entropy using bipolar electrograms generated over a vicinity enclosing a rotor, achieving rotor detection. Our results suggest that high approximate entropy values are able to detect a high level of fractionation and to locate rotor tips in simulated atrial fibrillation episodes. We suggest that dynamic approximate entropy maps could become a tool for atrial fibrillation rotor mapping.	[Ugarte, Juan P.; Orozco-Duque, Andres; Bustamante, John] Univ Pontificia Bolivariana, Ctr Bioingn, Medellin, Colombia; [Tobon, Catalina] Inst Tecnol Metropolitano, GI2B, Medellin, Colombia; [Kremen, Vaclav; Novak, Daniel] Czech Tech Univ, Czech Inst Informat Robot & Cybernet, CR-16635 Prague, Czech Republic; [Kremen, Vaclav] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Saiz, Javier] Univ Politecn Valencia, I3BH, E-46071 Valencia, Spain; [Oesterlein, Tobias] Karlsruhe Inst Technol, Inst Biomed Engn, D-76021 Karlsruhe, Germany; [Schmitt, Clauss; Luik, Armin] Staedt Klinikum Karlsruhe, Med Klin 4, Karlsruhe, Germany	Universidad Pontificia Bolivariana; Czech Technical University Prague; Czech Technical University Prague; Universitat Politecnica de Valencia; Helmholtz Association; Karlsruhe Institute of Technology; Municipal Hospital Karlsruhe	Ugarte, JP (corresponding author), Univ Pontificia Bolivariana, Ctr Bioingn, Medellin, Colombia.	juan.ugartem@alfa.upb.edu.co	Ugarte, Juan Pablo/R-2624-2019; Saiz, Javier/I-1295-2015; Novak, Daniel/G-9231-2014; Bustamante, John/D-1372-2012; Orozco-Duque, Andres/M-8332-2014; Luik, Armin/ABE-0996-2022; Kremen, Vaclav/G-7612-2017; Ugarte, Juan Pablo/HCI-9870-2022	Ugarte, Juan Pablo/0000-0001-8008-3528; Saiz, Javier/0000-0002-9850-0825; Novak, Daniel/0000-0001-6996-9344; Bustamante, John/0000-0002-4855-9896; Orozco-Duque, Andres/0000-0001-8582-8015; Kremen, Vaclav/0000-0001-9844-7617; Ugarte, Juan Pablo/0000-0001-8008-3528	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia [121056933647]; Programa de Formacion de Investigadores Francisco Jose de Caldas; Ministry of Education, Youth and Sports of the Czech Republic [MSM6840770012]; Czech Science Foundation [P103/11/P106]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia; Programa de Formacion de Investigadores Francisco Jose de Caldas; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	JPU, CT, and JB were partially supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia (www.colciencias.gov.co), project # 121056933647; AO was supported by the Programa de Formacion de Investigadores Francisco Jose de Caldas (www.colciencias.gov.co); VK and DN were partially supported by research project # MSM6840770012 Interdisciplinary Biomedical Engineering Research II from the Ministry of Education (www.msmt.cz), Youth and Sports of the Czech Republic, and VK was partially supported by post-doctoral research project GACR # P103/11/P106 of the Czech Science Foundation (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz R, 2010, BIOMED SIGNAL PROCES, V5, P1, DOI 10.1016/j.bspc.2009.11.001; Anier A, 2012, BRIT J ANAESTH, V109, P928, DOI 10.1093/bja/aes312; Berenfeld O, 2011, CIRC-ARRHYTHMIA ELEC, V4, P426, DOI 10.1161/CIRCEP.111.964841; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Ciaccio EJ, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-4; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; Grzeda R, 2009, NIH PUBLIC ACCESS, V6, P1475; Gupta Anoop Kumar, 2002, Indian Pacing Electrophysiol J, V2, P20; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; HOEKSTRA BPT, 1995, J CARDIOVASC ELECTR, V6, P419, DOI 10.1111/j.1540-8167.1995.tb00416.x; Hunter RJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P622, DOI 10.1161/CIRCEP.111.962928; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jadidi AS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P32, DOI 10.1161/CIRCEP.111.964197; Jalife J, 1998, J CARDIOVASC ELECTR, V9, pS2; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Konings KTS, 1997, CIRCULATION, V95, P1231; Kremen V, 2009, IEEE ENG MED BIO, P2502, DOI 10.1109/IEMBS.2009.5335161; Kremen V, 2008, PHYSIOL MEAS, V29, P1371, DOI 10.1088/0967-3334/29/12/002; Kremen V, 2008, THESIS CZECH TU PRAG; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Nademanee K, 2010, J CARDIOL, V55, P1, DOI 10.1016/j.jjcc.2009.11.002; Narayan SM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P58, DOI 10.1161/CIRCEP.111.977264; Narayan SM, 2012, HEART RHYTHM, V9, P1436, DOI 10.1016/j.hrthm.2012.03.055; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Navoret N, 2013, IEEE T BIO-MED ENG, V60, P1975, DOI 10.1109/TBME.2013.2247402; Navoret N, 2012, COMPUT CARDIOL CONF, V39, P893; Navoret N, 2010, IEEE ENG MED BIO, P3249, DOI 10.1109/IEMBS.2010.5627235; NOVAK D, 2009, C P ANN INT C IEEE E, P1812; Orozco-Duque A, 2013, COMPUT CARDIOL CONF, V40, P903; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1992, P NATL ACAD SCI USA, V89, P4432, DOI 10.1073/pnas.89.10.4432; Reddy V, 2009, CARDIOL CLIN, V27, P201, DOI 10.1016/j.ccl.2008.10.002; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROBERGE FA, 1986, CIRC RES, V58, P461, DOI 10.1161/01.RES.58.4.461; Scherr D, 2007, HEART RHYTHM, V4, P1013, DOI 10.1016/j.hrthm.2007.04.021; Schilling C., 2012, ANAL ATRIAL ELECTROG, V17; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; Umapathy K, 2008, HEART RHYTHM, V5, P1029, DOI 10.1016/j.hrthm.2008.03.022; Van Wagoner DR, 2003, PACE, V26, P1572; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	48	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e0114577	10.1371/journal.pone.0114577	http://dx.doi.org/10.1371/journal.pone.0114577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489858	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300053
J	Uscher-Pines, L; Mulcahy, A; Maurer, J; Harris, K				Uscher-Pines, Lori; Mulcahy, Andrew; Maurer, Jurgen; Harris, Katherine			The Relationship between Influenza Vaccination Habits and Location of Vaccination	PLOS ONE			English	Article							SEASONAL INFLUENZA	Objectives: Although use of non-medical settings for vaccination such as retail pharmacies has grown in recent years, little is known about how various settings are used by individuals with different vaccination habits. We aimed to assess the relationship between repeated, annual influenza vaccination and location of vaccination. Study Design: We conducted a cross-sectional survey of 4,040 adults in 2010. Methods: We fielded a nationally representative survey using an online research panel operated by Knowledge Networks. The completion rate among sampled panelists was 73%. Results: 39% of adults reported that they have never received a seasonal influenza vaccination. Compared to those who were usually or always vaccinated from year to year, those who sometimes or rarely received influenza vaccinations were significantly more likely to be vaccinated in a medical setting in 2009-2010. Conclusions: Results indicate that while medical settings are the dominant location for vaccination overall, they play an especially critical role in serving adults who do not regularly receive vaccinations. By exploring vaccination habits, we can more appropriately choose among interventions designed to encourage the initiation vs. maintenance of desired behaviors.	[Uscher-Pines, Lori; Mulcahy, Andrew] RAND Corp, Arlington, VA 22202 USA; [Maurer, Jurgen] Univ Lausanne, Lausanne, Switzerland; [Harris, Katherine] IMPAQ Int, Washington, DC USA	RAND Corporation; University of Lausanne; American Institutes for Research	Uscher-Pines, L (corresponding author), RAND Corp, Arlington, VA 22202 USA.	luscherp@rand.org		/0000-0002-3923-677X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was supported by GlaxoSmithKline. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed here are solely those of the authors and do not represent those of RAND or	Accessed 2011 Jun 17, 2013, INCR AD VACC STRAT L; [Anonymous], 2009, KNOWLEDGEPANEL FACT; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P781; Centers for Disease Control and Prevention, 2012, FIN STAT LEV INFL VA; Centers for Disease Control and Prevention, 2012, REC INFL VACC TRENDS; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Dennis M, 2010, KNOWLEDGEPANEL DESIG; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris KM, 2012, BLUEPRINT IMPROVING; Knowledge Networks, 2009, OV KNOWLEDGEPANEL ST; Lin CJ, 2010, VACCINE, V28, P7706, DOI 10.1016/j.vaccine.2010.07.009; Lu PJ, 2013, AM J EPIDEMIOL, V178, P1478, DOI 10.1093/aje/kwt158; Mamelund SE, 2011, VACCINE, V29, P9441, DOI 10.1016/j.vaccine.2011.10.035; Maurer J, 2011, PREV MED, V52, P459, DOI 10.1016/j.ypmed.2011.03.016; National Vaccine Advisory Committee, 2011, AD IMM COMPL CHALL R; Nichol KL, 1997, INFECT CONT HOSP EP, V18, P189; Nowalk Mary Patricia, 2010, J Healthc Qual, V32, P35; Postema A S, 2000, MMWR Recomm Rep, V49, P1; Uscher-Pines L, 2011, AM J PUBLIC HEALTH, V101, P1252, DOI 10.2105/AJPH.2011.300133; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114863	10.1371/journal.pone.0114863	http://dx.doi.org/10.1371/journal.pone.0114863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490092	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300086
J	Evrard, S; Poston, G; Kissmeyer-Nielsen, P; Diallo, A; Desolneux, G; Brouste, V; Lalet, C; Mortensen, F; Stattner, S; Fenwick, S; Malik, H; Konstantinidis, I; DeMatteo, R; D'Angelica, M; Allen, P; Jarnagin, W; Mathoulin-Pelissier, S; Fong, YM				Evrard, Serge; Poston, Graeme; Kissmeyer-Nielsen, Peter; Diallo, Abou; Desolneux, Gregoire; Brouste, Veronique; Lalet, Caroline; Mortensen, Frank; Staettner, Stefan; Fenwick, Stephen; Malik, Hassan; Konstantinidis, Ioannis; DeMatteo, Ronald; D'Angelica, Michael; Allen, Peter; Jarnagin, William; Mathoulin-Pelissier, Simone; Fong, Yuman			Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases	PLOS ONE			English	Article							INTRAOPERATIVE RADIOFREQUENCY ABLATION; HEPATIC RESECTION; WEDGE RESECTION; HEPATECTOMY; OUTCOMES; CANCER; COMPLICATIONS; CHEMOTHERAPY; MORTALITY; SURGERY	Background: Combined intra-operative ablation and resection (CARe) is proposed to treat extensive colorectal liver metastases (CLM). This multicenter study was conducted to evaluate overall survival (OS), local recurrence-free survival (LRFS), hepatic recurrence-free survival (HRFS) and progression-free survival (PFS), to identify factors associated with survival, and to report complications. Materials and Methods: Four centers combined retropectively their clinical experiences regarding CLM treated by CARe. CLM characteristics, pre- and postoperative chemotherapy regimens, surgical procedures, complications and survivals were analyzed. Results: Of the 288 patients who received CARe, 210 (73%) had synchronous and 255 (88%) had bilateral CLM. Twenty-two patients (8%) had extrahepatic disease. Median follow-up was 3.17 years (95% CI 2.83-4.08). Median OS was 3.33 years (95% CI 3.08-4.17) and 5-year OS was 37% (95% CI 29-45). One-and 5-year LRFS from ablated lesions were 87.9% (95% CI 83.3-91.2) and 78.0% (95% CI 71-83), respectively. Median HRFS and PFS were 14 months (95% CI 11-18) and 9 months (95% CI 8-11), respectively. One hundred patients experienced complications: 29 grade I, 68 grade II-III-IV, and three deaths. In the multivariate models adjusted for center, the occurrence of complications was confirmed as a major independent factor associated with 3-year OS (HR 1.80; P=0.008). Five-year OS was 25.6% (95% CI 14.9-37.6) for patients with complications and 45% (95% CI 33.3-53.4) for patients without. Conclusions: Recent strategies facing advanced CLM include non-anatomic resections, portal-induced hypertrophy of the future remnant liver and aggressive medical preoperative treatments. CARe has the qualities of an approach that allows effective tumor clearance while maintaining good tolerance for the patient.	[Evrard, Serge; Desolneux, Gregoire] Inst Bergonie, Digest Tumours Unit, Bordeaux, France; [Evrard, Serge; Mathoulin-Pelissier, Simone] Univ Bordeaux Segalen, Bordeaux, France; [Poston, Graeme; Staettner, Stefan; Fenwick, Stephen; Malik, Hassan] Aintree Univ Hosp NHS Fdn Trust, Fdn Trust, North Western Hepatobiliary Ctr, Dept Hepatobiliary Surg, Liverpool L9 7AL, Merseyside, England; [Kissmeyer-Nielsen, Peter; Mortensen, Frank] Aarhus Univ Hosp, Dept Surg, Aarhus C, Denmark; [Diallo, Abou; Brouste, Veronique; Lalet, Caroline; Mathoulin-Pelissier, Simone] Inst Bergonie, Clin & Epidemiol Res Unit, Bordeaux, France; [Staettner, Stefan] Paracelsus Private Med Univ, Dept Gen Surg, HPB Unit, Salzburg, Austria; [Konstantinidis, Ioannis; DeMatteo, Ronald; D'Angelica, Michael; Allen, Peter; Jarnagin, William; Fong, Yuman] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Mathoulin-Pelissier, Simone] ISPED, Ctr INSERM, Clin Epidemiol & Clin Invest Ctr CIC1401, Epidemiol Biostat U897, Bordeaux, France	UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; Aintree University Hospitals NHS Foundation Trust; Aarhus University; UNICANCER; Institut Bergonie; Paracelsus Private Medical University; Memorial Sloan Kettering Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Evrard, S (corresponding author), Inst Bergonie, Digest Tumours Unit, Bordeaux, France.	s.evrard@bordeaux.unicancer.fr		Mortensen, Frank Viborg/0000-0001-7580-8037; Stattner, Stefan/0000-0002-5226-7597; EVRARD, Serge/0000-0003-1063-6822	La Ligue Nationale contre le Cancer; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by La Ligue Nationale contre le Cancer : http://www.liguecancer.net/. The funders supported data collection and analysis.	Abbott DE, 2014, J SURG ONCOL, V109, P516, DOI 10.1002/jso.23539; Adam R, 2009, J CLIN ONCOL, V27, P1829, DOI 10.1200/JCO.2008.19.9273; Brouquet A, 2011, J CLIN ONCOL, V29, P1083, DOI 10.1200/JCO.2010.32.6132; Cardona K, 2014, ANN SURG ONCOL, V21, P815, DOI 10.1245/s10434-013-3351-5; Cauchy F, 2012, ANN SURG, V256, P746, DOI 10.1097/SLA.0b013e3182738204; DeMatteo RP, 2000, J GASTROINTEST SURG, V4, P178, DOI 10.1016/S1091-255X(00)80054-2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dupuy D.E., 2013, IMAGE GUIDED CANC TH; Eltawil KM, 2014, J SURG ONCOL, V110, P734, DOI 10.1002/jso.23689; Evrard S, 2013, EJSO-EUR J SURG ONC, V39, P1400, DOI 10.1016/j.ejso.2013.08.028; Evrard S, 2012, BRIT J SURG, V99, P558, DOI [10.1002/bjs.8665, 10.1002/bjs.8724]; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; Gold JS, 2008, ANN SURG, V247, P109, DOI 10.1097/SLA.0b013e3181557e47; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karanicolas PJ, 2013, JAMA SURG, V148, P597, DOI 10.1001/jamasurg.2013.1431; Karoui M, 2006, ANN SURG, V243, P1, DOI 10.1097/01.sla.0000193603.26265.c3; Leblanc F, 2008, EJSO-EUR J SURG ONC, V34, P185, DOI 10.1016/j.ejso.2007.09.028; Matsuda A, 2013, ANN SURG ONCOL, V20, P2485, DOI 10.1245/s10434-013-2972-z; Pugalenthi A, 2014, ADV SURG, V48, P259; Ruers T, 2012, ANN ONCOL, V23, P2619, DOI 10.1093/annonc/mds053; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; SHUSTER JJ, 1991, J CLIN ONCOL, V9, P191, DOI 10.1200/JCO.1991.9.1.191; Torzilli G, 2009, SURGERY, V146, P60, DOI 10.1016/j.surg.2009.02.017; Tzeng CWD, 2013, ANN SURG ONCOL, V20, P2457, DOI 10.1245/s10434-013-2974-x; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44; Zorzi D, 2006, J GASTROINTEST SURG, V10, P86, DOI 10.1016/j.gassur.2005.07.022	28	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114404	10.1371/journal.pone.0114404	http://dx.doi.org/10.1371/journal.pone.0114404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485541	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600052
J	Guzman, JM; Luckenbach, JA; Yamamoto, Y; Swanson, P				Guzman, Jose M.; Luckenbach, J. Adam; Yamamoto, Yoji; Swanson, Penny			Expression Profiles of Fsh-Regulated Ovarian Genes during Oogenesis in Coho Salmon	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MESSENGER-RNA EXPRESSION; TISSUE GROWTH-FACTOR; TROUT ONCORHYNCHUS-MYKISS; SECONDARY OOCYTE GROWTH; GRANULOSA-CELLS; RAINBOW-TROUT; STEROIDOGENIC ENZYMES; IN-VITRO; GONADOTROPIN RECEPTORS	The function of follicle-stimulating hormone (Fsh) during oogenesis in fishes is poorly understood. Using coho salmon as a fish model, we recently identified a suite of genes regulated by Fsh in vitro and involved in ovarian processes mostly unexplored in fishes, like cell proliferation, differentiation, survival or extracellular matrix (ECM) remodeling. To better understand the role of these Fsh-regulated genes during oocyte growth in fishes, we characterized their mRNA levels at discrete stages of the ovarian development in coho salmon. While most of the transcripts were expressed at low levels during primary growth (perinucleolus stage), high expression of genes associated with cell proliferation (pim1, pcna, and mcm4) and survival (ddit4l) was found in follicles at this stage. The transition to secondary oocyte growth (cortical alveolus and lipid droplet stage ovarian follicles) was characterized by a marked increase in the expression of genes related to cell survival (clu1, clu2 and ivns1abpa). Expression of genes associated with cell differentiation and growth (wt2l and adh8l), growth factor signaling (inha), steroidogenesis (cyp19a1a) and the ECM (col1a1, col1a2 and dcn) peaked in vitellogenic follicles, showing a strong and positive correlation with transcripts for fshr. Other genes regulated by Fsh and associated with ECM function (ctgf, wapl and fn1) and growth factor signaling (bmp16 and smad5l) peaked in maturing follicles, along with increases in steroidogenesis-related gene transcripts. In conclusion, ovarian genes regulated by Fsh showed marked differences in their expression patterns during oogenesis in coho salmon. Our results suggest that Fsh regulates different ovarian processes at specific stages of development, likely through interaction with other intra- or extra-ovarian factors.	[Guzman, Jose M.; Luckenbach, J. Adam; Yamamoto, Yoji; Swanson, Penny] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA; [Luckenbach, J. Adam; Swanson, Penny] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Yamamoto, Yoji] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Yamamoto, Yoji] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan	National Oceanic Atmospheric Admin (NOAA) - USA; Washington State University; University of Washington; University of Washington Seattle; Tokyo University of Marine Science & Technology	Guzman, JM (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA.	jose.guzman-jimenez@noaa.gov	Yamamoto, Yoji/O-1958-2014	Yamamoto, Yoji/0000-0002-9628-6706	NOAA Fisheries; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2007-35203-18088]; Fundacion Alfonso Martin Escudero (Spain); National Academy of Sciences (US)	NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Fundacion Alfonso Martin Escudero (Spain); National Academy of Sciences (US)	This research was partially funded by NOAA Fisheries and by National Research Initiative Competitive Grant no. 2007-35203-18088 from the USDA National Institute of Food and Agriculture to PS, and postdoctoral fellowships from the Fundacion Alfonso Martin Escudero (Spain) and The National Academy of Sciences (US) to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASEM EK, 1992, ACTA ENDOCRINOL-COP, V127, P466, DOI 10.1530/acta.0.1270466; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Campbell B, 2006, BIOL REPROD, V75, P34, DOI 10.1095/biolreprod.105.049494; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chang B, 2009, CELL CYCLE, V8, P780, DOI 10.4161/cc.8.5.7887; Chun SY, 1999, BIOL REPROD, V60, P365, DOI 10.1095/biolreprod60.2.365; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Coffman MA, 2000, BIOL REPROD, V62, P928, DOI 10.1095/biolreprod62.4.928; Dasmahapatra AK, 2005, COMP BIOCHEM PHYS B, V140, P657, DOI 10.1016/j.cbpc.2005.01.007; Davies B, 1999, GEN COMP ENDOCR, V115, P155, DOI 10.1006/gcen.1999.7301; Deloffre LAM, 2012, GENE, V506, P69, DOI 10.1016/j.gene.2012.06.047; Garcia-Lopez A, 2011, COMP BIOCHEM PHYS A, V160, P374, DOI 10.1016/j.cbpa.2011.07.006; Garczynski MA, 1997, BIOL REPROD, V57, P856, DOI 10.1095/biolreprod57.4.856; Ge W, 2005, MOL CELL ENDOCRINOL, V237, P1, DOI 10.1016/j.mce.2005.03.012; Gen K, 2001, BIOL REPROD, V65, P1186, DOI 10.1095/biolreprod65.4.1186; Gomez JM, 1999, GEN COMP ENDOCR, V113, P413, DOI 10.1006/gcen.1998.7222; Grieshaber NA, 2003, ENDOCRINOLOGY, V144, P29, DOI 10.1210/en.2002-220477; Harlow CR, 2007, J ENDOCRINOL, V192, P41, DOI 10.1677/joe.1.06689; Horiguchi M, 2008, ZOOL SCI, V25, P937, DOI 10.2108/zsj.25.937; HSU SY, 1995, MOL ENDOCRINOL, V9, P1356, DOI 10.1210/me.9.10.1356; Huet C, 1997, BIOL REPROD, V56, P1025, DOI 10.1095/biolreprod56.4.1025; Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; KAMADA S, 1992, HORM RES, V37, P141, DOI 10.1159/000182299; Kim DJ, 2005, GEN COMP ENDOCR, V141, P282, DOI 10.1016/j.ygcen.2005.01.001; Kitano H, 2011, GEN COMP ENDOCR, V172, P268, DOI 10.1016/j.ygcen.2011.03.012; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Korfsmeier KH, 2002, ACTA HISTOCHEM, V104, P73, DOI 10.1078/0065-1281-00632; Kumar RS, 2000, BIOL REPROD, V63, P1676, DOI 10.1095/biolreprod63.6.1676; Kusakabe M, 2002, ENDOCRINOLOGY, V143, P2062, DOI 10.1210/en.143.6.2062; Lankford SE, 2010, GEN COMP ENDOCR, V166, P250, DOI 10.1016/j.ygcen.2009.09.007; Layman LC, 2000, MOL CELL ENDOCRINOL, V161, P9, DOI 10.1016/S0303-7207(99)00217-8; Layman LC, 2000, SEMIN REPROD MED, V18, P5, DOI 10.1055/s-2000-13470; Le Menn Francoise, 2007, P1; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Levi L, 2008, BIOL REPROD, V79, P570, DOI 10.1095/biolreprod.107.066548; Li CW, 2011, BIOL REPROD, V85, P977, DOI 10.1095/biolreprod.111.092239; Logan KA, 2003, BIOL REPROD, V68, P635, DOI 10.1095/biolreprod.102.008946; Lubzens E, 2003, MOL ASPECTS MED, V24, P441, DOI 10.1016/S0098-2997(03)00040-2; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Luckenbach JA, 2013, MOL CELL ENDOCRINOL, V366, P38, DOI 10.1016/j.mce.2012.11.015; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Luckenbach JA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-2; Lyman-Gingerich Jamie, 2007, P141, DOI 10.1007/978-1-4020-6235-3_6; Mahon MG, 1999, J BIOL CHEM, V274, P4036, DOI 10.1074/jbc.274.7.4036; Makanji Y, 2011, VITAM HORM, V85, P299, DOI 10.1016/B978-0-12-385961-7.00014-7; Matsubara H, 2003, FISHERIES SCI, V69, P979, DOI 10.1046/j.1444-2906.2003.00716.x; Moles G, 2012, GEN COMP ENDOCR, V176, P70, DOI 10.1016/j.ygcen.2011.12.029; Montserrat N, 2004, GEN COMP ENDOCR, V137, P123, DOI 10.1016/j.ygcen.2004.02.011; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Nakamura I, 2005, GEN COMP ENDOCR, V144, P224, DOI 10.1016/j.ygcen.2005.06.004; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Picha ME, 2012, GEN COMP ENDOCR, V177, P220, DOI 10.1016/j.ygcen.2012.04.017; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Polzonetti-Magni AM, 2004, INT REV CYTOL, V239, P1, DOI 10.1016/S0074-7696(04)39001-7; Poon SK, 2009, REPRODUCTION, V138, P709, DOI 10.1530/REP-09-0198; Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Rimon E, 2004, INT J ONCOL, V24, P1325; Rocha A, 2009, GEN COMP ENDOCR, V162, P265, DOI 10.1016/j.ygcen.2009.03.023; SAKAI N, 1994, FEBS LETT, V350, P309, DOI 10.1016/0014-5793(94)00795-0; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Spicer LJ, 2007, BIOL REPROD, V77, P18, DOI 10.1095/biolreprod.106.058230; SRIVASTAVA RK, 1994, J EXP ZOOL, V270, P263, DOI 10.1002/jez.1402700305; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; SWANSON P, 1991, BIOL REPROD, V44, P29, DOI 10.1095/biolreprod44.1.29; Thomas FH, 2005, ENDOCRINOLOGY, V146, P941, DOI 10.1210/en.2004-0826; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; TYLER CR, 1991, GEN COMP ENDOCR, V84, P291, DOI 10.1016/0016-6480(91)90052-8; Wandji SA, 2000, ENDOCRINOLOGY, V141, P2648, DOI 10.1210/en.141.7.2648; Wang YJ, 2003, BIOL REPROD, V69, P1998, DOI 10.1095/biolreprod.103.020826; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wu HJ, 2008, NEPHROLOGY, V13, P607, DOI 10.1111/j.1440-1797.2008.00961.x; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yamamoto Y, 2011, GEN COMP ENDOCR, V172, P331, DOI 10.1016/j.ygcen.2011.03.017; Yamamoto Y, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-52; Zhu GY, 2012, GEN COMP ENDOCR, V178, P314, DOI 10.1016/j.ygcen.2012.06.018; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1; Zwain I, 2000, EXP CELL RES, V257, P101, DOI 10.1006/excr.2000.4885	86	24	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114176	10.1371/journal.pone.0114176	http://dx.doi.org/10.1371/journal.pone.0114176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485989	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600044
J	Huntsman, MAH; Olivares, FJ; Tran, CP; Billimek, J; Hui, EE				Huntsman, Mary Ann H.; Olivares, Faith J.; Tran, Christina P.; Billimek, John; Hui, Elliot E.			Pain Reduction and Financial Incentives to Improve Glucose Monitoring Adherence in a Community Health Center	PLOS ONE			English	Article							BLOOD-GLUCOSE; CARE	Self-monitoring of blood glucose is a critical component of diabetes management. However, patients often do not maintain the testing schedule recommended by their healthcare provider. Many barriers to testing have been cited, including cost and pain. We present a small pilot study to explore whether the use of financial incentives and pain-free lancets could improve adherence to glucose testing in a community health center patient population consisting largely of non-English speaking ethnic minorities with low health literacy. The proportion of patients lost to follow-up was 17%, suggesting that a larger scale study is feasible in this type of setting, but we found no preliminary evidence suggesting a positive effect on adherence by either financial incentives or pain-free lancets. Results from this pilot study will guide the design of larger-scale studies to evaluate approaches to overcome the variety of barriers to glucose testing that are present in disadvantaged patient populations.	[Huntsman, Mary Ann H.; Olivares, Faith J.; Tran, Christina P.] Share Our Selves Community Hlth Ctr, Costa Mesa, CA USA; [Billimek, John] Univ Calif Irvine, Hlth Policy Res Inst, Irvine, CA USA; [Billimek, John] Univ Calif Irvine, Div Gen Internal Med, Irvine, CA USA; [Hui, Elliot E.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Hui, EE (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	eehui@uci.edu	Hui, Elliot/E-2169-2011	Hui, Elliot/0000-0001-8286-9815	Campus Community Research Incubator grant through the Institute for Clinical and Translational Science (ICTS) at UC Irvine; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000153]; ACON Laboratories; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000153] Funding Source: NIH RePORTER	Campus Community Research Incubator grant through the Institute for Clinical and Translational Science (ICTS) at UC Irvine; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ACON Laboratories; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a Campus Community Research Incubator grant through the Institute for Clinical and Translational Science (ICTS) at UC Irvine. The ICTS is supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported by a gift from ACON Laboratories (www.aconlabs.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2001, MISSING DATA; Barner JC, 2004, DIABETES EDUCATOR, V30, P112, DOI 10.1177/014572170403000119; Billimek J, 2013, HLTH PSYCHOL; Fisher WA, 2011, DIABETES EDUCATOR, V37, P85, DOI 10.1177/0145721710391479; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; GOLDSTEIN DE, 1995, DIABETES CARE, V18, P896, DOI 10.2337/diacare.18.6.896; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Klein E, 2010, J AM GERIATR SOC, V58, P1758, DOI 10.1111/j.1532-5415.2010.03030.x; Kocher Serge, 2009, J Diabetes Sci Technol, V3, P1136; Lekarcyk Joyce, 2009, J Diabetes Sci Technol, V3, P1144; Levine DA, 2009, ETHNIC DIS, V19, P97; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; Meredith SE, 2014, PSYCHOL RES BEHAV MA, V7, P103, DOI 10.2147/PRBM.S59792; Wagner Julie, 2005, Diabetes Technol Ther, V7, P612, DOI 10.1089/dia.2005.7.612	16	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114875	10.1371/journal.pone.0114875	http://dx.doi.org/10.1371/journal.pone.0114875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486531	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600103
J	Jung, ME; Bourne, JE; Little, JP				Jung, Mary E.; Bourne, Jessica E.; Little, Jonathan P.			Where Does HIT Fit? An Examination of the Affective Response to High-Intensity Intervals in Comparison to Continuous Moderate- and Continuous Vigorous-Intensity Exercise in the Exercise Intensity-Affect Continuum	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INTERMITTENT EXERCISE; HYPERGLYCEMIA; BODY	Affect experienced during an exercise session is purported to predict future exercise behaviour. Compared to continuous moderate-intensity exercise (CMI), the affective response to continuous vigorous-intensity exercise (CVI) has consistently been shown to be more aversive. The affective response, and overall tolerability to high-intensity interval training (HIT), is less studied. To date, there has yet to be a comparison between HIT, CVI, and CMI. The purpose of this study was to compare the tolerability and affective responses during HIT to CVI and CMI. This study utilized a repeated measures, randomized, counter-balanced design. Forty-four participants visited the laboratory on four occasions. Baseline fitness testing was conducted to establish peak power output in Watts (Wpeak). Three subsequent visits involved a single bout of a) HIT, corresponding to 1-minute at similar to 100% Wpeak and 1-minute at similar to 20% Wpeak for 20 minutes, b) CMI, corresponding to similar to 40% Wpeak for 40 minutes, and c) CVI, corresponding to similar to 80% Wpeak for 20 minutes. The order of the sessions was randomized. Affective responses were measured before, during and after each session. Task self-efficacy, intentions, enjoyment and preference were measured after sessions. Participants reported greater enjoyment of HIT as compared to CMI and CVI, with over 50% of participants reporting a preference to engage in HIT as opposed to either CMI or CVI. HIT was considered more pleasurable than CVI after exercise, but less pleasurable than CMI at these times. Despite this participants reported being just as confident to engage in HIT as they were CMI, but less confident to engage in CVI. This study highlights the utility of HIT in inactive individuals, and suggests that it may be a viable alternative to traditionally prescribed continuous modalities of exercise for promoting self-efficacy and enjoyment of exercise.	[Jung, Mary E.; Bourne, Jessica E.; Little, Jonathan P.] Univ British Columbia, Sch Hlth & Exercise Sci, Okanagan, BC, Canada	University of British Columbia; University of British Columbia Okanagan	Jung, ME (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Okanagan, BC, Canada.	mary.jung@ubc.ca	Little, Jonathan P./T-4076-2019	Little, Jonathan P./0000-0002-9796-2008	UBC (Hampton Research Fund)	UBC (Hampton Research Fund)	Funding: This research was funded by an internal UBC grant (Hampton Research Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Blanchard CM, 2001, J SCI MED SPORT, V4, P30, DOI 10.1016/S1440-2440(01)80005-0; Borg G., 1998, BORGS PERCEIVED EXER; Brewer BW, 2000, J SPORT EXERCISE PSY, V22, P119, DOI 10.1123/jsep.22.2.119; Canadian Society for Exercise Physiology (CSEP), 2002, PHYS ACT READ QUEST; Colley R. C., 2011, HLTH REPORTS, V22, P15; Ekkekakis P, 2005, PSYCHOL SPORT EXERC, V6, P83, DOI 10.1016/j.psychsport.2003.10.005; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2002, PSYCHOL SPORT EXERC, V3, P35, DOI 10.1016/S1469-0292(01)00028-0; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; EMMONS RA, 1986, J RES PERS, V20, P309, DOI 10.1016/0092-6566(86)90137-6; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gillen JB, 2012, DIABETES OBES METAB, V14, P575, DOI 10.1111/j.1463-1326.2012.01564.x; Godin G, 1997, MED SCI SPORTS EXERC, V29, P36, DOI DOI 10.1097/00005768-199706001-00009; Hall EE, 2002, BRIT J HEALTH PSYCH, V7, P47, DOI 10.1348/135910702169358; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Heydari M, 2012, J OBES, V2012, DOI 10.1155/2012/480467; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kilpatrick M, 2003, RES Q EXERCISE SPORT, V74, P353, DOI 10.1080/02701367.2003.10609103; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Little JP, APPL PHYSL IN PRESS; MCAULEY E, 1998, ADV SPORT EXERCISE P, P371; MORGAN WP, 1994, MED SCI SPORT EXER, V26, P1071, DOI 10.1249/00005768-199409000-00001; O'Connor PJ, 2005, MED SCI SPORT EXER, V37, P299, DOI 10.1249/01.MSS.0000152802.89770.CF; Oliveira BRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079965; Parfitt G, 2009, J EXERC SCI FIT, V7, pS34, DOI 10.1016/S1728-869X(09)60021-6; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; Tate AK, 1995, J SPORT MED PHYS FIT, V35, P295; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Tritter A, 2013, PSYCHOL SPORT EXERC, V14, P886, DOI 10.1016/j.psychsport.2013.08.002; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Williams DM, 2012, ANN BEHAV MED, V44, P43, DOI 10.1007/s12160-012-9362-9	41	190	193	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114541	10.1371/journal.pone.0114541	http://dx.doi.org/10.1371/journal.pone.0114541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25486273	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600074
J	Pedas, P; Stokholm, MS; Hegelund, JN; Ladegard, AH; Schjoerring, JK; Husted, S				Pedas, Pai; Stokholm, Michaela Schiller; Hegelund, Josefine Nymark; Ladegard, Anne Hald; Schjoerring, Jan Kofod; Husted, Soren			Golgi Localized Barley MTP8 Proteins Facilitate Mn Transport	PLOS ONE			English	Article							METAL-NICOTIANAMINE TRANSPORTER; AFFINITY MANGANESE UPTAKE; ARABINOSYLTRANSFERASE ACTIVITY; GENOTYPIC DIFFERENCES; ARABIDOPSIS-THALIANA; SECRETORY PATHWAY; CA2+/MN2+ PUMP; IRON; GROWTH; IDENTIFICATION	Many metabolic processes in plants are regulated by manganese (Mn) but limited information is available on the molecular mechanisms controlling cellular Mn homeostasis. In this study, a yeast assay was used to isolate and characterize two genes, MTP8.1 and MTP8.2, which encode membrane-bound proteins belonging to the cation diffusion facilitator (CDF) family in the cereal species barley (Hordeum vulgare). Transient expression in onion epidermal cells showed that MTP8.1 and MTP8.2 proteins fused to the green fluorescent protein (GFP) are localized to Golgi. When heterologously expressed in yeast, MTP8.1 and MTP8.2 were found to be Mn transporters catalysing Mn efflux in a similar manner as the Golgi localized endogenous yeast protein Pmr1p. The level of MTP8.1 transcripts in barley roots increased with external Mn supply ranging from deficiency to toxicity, while MTP8.2 transcripts decreased under the same conditions, indicating non-overlapping functions for the two genes. In barley leaves, the expression of both MTP8 genes declined in response to toxic Mn additions to the roots suggesting a role in ensuring proper delivery of Mn to Golgi. Based on the above we suggest that barley MTP8 proteins are involved in Mn loading to the Golgi apparatus and play a role in Mn homeostasis by delivering Mn to Mn-dependent enzymes and/or by facilitating Mn efflux via secretory vesicles. This study highlights the importance of MTP transporters in Mn homeostasis and is the first report of Golgi localized Mn2+ transport proteins in a monocot plant species.	[Pedas, Pai; Stokholm, Michaela Schiller; Hegelund, Josefine Nymark; Ladegard, Anne Hald; Schjoerring, Jan Kofod; Husted, Soren] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Plant & Soil Sci Lab, Copenhagen, Denmark	University of Copenhagen	Pedas, P (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Plant & Soil Sci Lab, Copenhagen, Denmark.	pp@plen.ku.dk	Pedas, Pai/G-3494-2014; Schjoerring, Jan K./A-5387-2009; Hegelund, Josefine Nymark/N-4732-2014; Schjoerring, Jan K./M-4044-2019; Stokholm, Michaela S/B-4593-2017; Husted, Søren/H-4649-2014	Pedas, Pai/0000-0001-6733-7300; Schjoerring, Jan K./0000-0002-2852-3298; Hegelund, Josefine Nymark/0000-0002-5663-9503; Schjoerring, Jan K./0000-0002-2852-3298; Stokholm, Michaela S/0000-0003-3092-0281; Husted, Søren/0000-0003-2020-1902	Ministry of Science, Technology and Innovation [274-06-0325]; Danish Ministry of Science, Innovation and Higher Education (Research Council grant) [DSF-10-093498-NUTRIEFFICIENT]	Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Danish Ministry of Science, Innovation and Higher Education (Research Council grant)	This work was supported financially by grants from The Ministry of Science, Technology and Innovation (contract 274-06-0325) and the Danish Ministry of Science, Innovation and Higher Education (Research Council grant DSF-10-093498-NUTRIEFFICIENT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Baldwin TC, 2001, PLANT CELL, V13, P2283, DOI 10.1105/tpc.13.10.2283; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; Burnell J.N., 1988, MANGANESE SOILS PLAN, P125, DOI DOI 10.1007/978-94-009-2817-6_10; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hebbern CA, 2005, PLANT SOIL, V272, P233, DOI 10.1007/s11104-004-5048-9; Hebbern CA, 2009, PHYSIOL PLANTARUM, V135, P307, DOI 10.1111/j.1399-3054.2008.01188.x; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Marschner H, 1995, MINERAL NUTR HIGHER, P325; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nunan KJ, 2003, PLANT PHYSIOL, V132, P331, DOI 10.1104/pp.102.019406; ONO T, 1992, SCIENCE, V258, P1335, DOI 10.1126/science.258.5086.1335; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Pearson JN, 1997, ANN BOT-LONDON, V80, P803, DOI 10.1006/anbo.1997.0523; Pedas P, 2005, PLANT PHYSIOL, V139, P1411, DOI 10.1104/pp.105.067561; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittman JK, 2004, PLANT MOL BIOL, V56, P959, DOI 10.1007/s11103-004-6446-3; Pittman JK, 2005, NEW PHYTOL, V167, P733, DOI 10.1111/j.1469-8137.2005.01453.x; Porchia AC, 2002, PLANT PHYSIOL, V130, P432, DOI 10.1104/pp.003400; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Rengel Z, 2000, MET IONS BIOL SYST, V37, P57; Reuter D.J., 1997, PLANT ANAL INTERPRET, P83; Reyes F, 2008, CURR OPIN PLANT BIOL, V11, P244, DOI 10.1016/j.pbi.2008.03.008; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Sasaki A, 2011, PLANT PHYSIOL, V157, P1832, DOI 10.1104/pp.111.186031; Schaaf G, 2002, PLANT BIOLOGY, V4, P612, DOI 10.1055/s-2002-35432; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WHITE AR, 1993, BIOCHEM J, V294, P231, DOI 10.1042/bj2940231; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Yang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083990; Zeng W, 2008, PLANT PHYSIOL, V147, P78, DOI 10.1104/pp.107.115576	60	44	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113759	10.1371/journal.pone.0113759	http://dx.doi.org/10.1371/journal.pone.0113759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486417	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600024
J	Singh, AK; Menendez-Conejero, R; Martin, CS; van Raaij, MJ				Singh, Abhimanyu K.; Menendez-Conejero, Rosa; Martin, Carmen San; van Raaij, Mark J.			Crystal Structure of the Fibre Head Domain of the Atadenovirus Snake Adenovirus 1	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; C-TERMINAL DOMAIN; CRYSTALLOGRAPHIC STRUCTURE; BACTERIOPHAGE-T4 FIBRITIN; 1.7-ANGSTROM RESOLUTION; CELLULAR RECEPTOR; GENE-THERAPY; DESMOGLEIN 2; COILED-COIL; SIALIC-ACID	Adenoviruses are non-enveloped icosahedral viruses with trimeric fibre proteins protruding from their vertices. There are five known genera, from which only Mastadenoviruses have been widely studied. Apart from studying adenovirus as a biological model system and with a view to prevent or combat viral infection, there is a major interest in using adenovirus for vaccination, cancer therapy and gene therapy purposes. Adenoviruses from the Atadenovirus genus have been isolated from squamate reptile hosts, ruminants and birds and have a characteristic gene organization and capsid morphology. The carboxy-terminal virus-distal fibre head domains are likely responsible for primary receptor recognition. We determined the high-resolution crystal structure of the Snake Adenovirus 1 (SnAdV-1) fibre head using the multi-wavelength anomalous dispersion (MAD) method. Despite the absence of significant sequence homology, this Atadenovirus fibre head has the same beta-sandwich propeller topology as other adenovirus fibre heads. However, it is about half the size, mainly due to much shorter loops connecting the betastrands. The detailed structure of the SnAdV-1 fibre head and other animal adenovirus fibre heads, together with the future identification of their natural receptors, may lead to the development of new strategies to target adenovirus vectors to cells of interest.	[Singh, Abhimanyu K.; Menendez-Conejero, Rosa; Martin, Carmen San; van Raaij, Mark J.] CSIC, CNB, Dept Estruct Macromol, Madrid, Spain; [Singh, Abhimanyu K.; Menendez-Conejero, Rosa; Martin, Carmen San; van Raaij, Mark J.] CSIC, CNB, NanoBiomed Initiat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	van Raaij, MJ (corresponding author), CSIC, CNB, Dept Estruct Macromol, Madrid, Spain.	mjvanraaij@cnb.csic.es	Singh, Abhimanyu K./C-2243-2019; van Raaij, Mark J/B-3678-2009; San Martín, Carmen/A-4074-2010; Singh, Abhimanyu K./U-5881-2019	Singh, Abhimanyu K./0000-0002-9998-020X; van Raaij, Mark J/0000-0002-4781-1375; San Martín, Carmen/0000-0001-9799-175X; Singh, Abhimanyu K./0000-0002-9998-020X	Spanish Ministry of Economy and Competitiveness [BFU2011-24843, BFU2010-16382, BFU2013-41249-P]; Spanish Ministry of Health and Social Protection [FIS2011-16090-E]; La Caixa; Instituto de Salud Carlos III of Spain	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Health and Social Protection; La Caixa(La Caixa Foundation); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III)	This research was sponsored by grants BFU2011-24843 (Mark J. van Raaij), BFU2010-16382 (Carmen San Martin) and BFU2013-41249-P (Carmen San Martin) from the Spanish Ministry of Economy and Competitiveness and the BioFiViNet network, grant number FIS2011-16090-E from the Spanish Ministry of Health and Social Protection (Carmen San Martin and Mark J. van Raaij). Abhimanyu K. Singh is a recipient of a predoctoral fellowship from La Caixa. Rosa Menendez-Conejero held a predoctoral fellowship from the Instituto de Salud Carlos III of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; El Bakkouri M, 2008, VIROLOGY, V378, P169, DOI 10.1016/j.virol.2008.05.011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Guardado-Calvo P, 2009, J GEN VIROL, V90, P672, DOI 10.1099/vir.0.008276-0; Guardado-Calvo P, 2007, J GEN VIROL, V88, P2407, DOI 10.1099/vir.0.82845-0; Guardado-Calvo P, 2010, J VIROL, V84, P10558, DOI 10.1128/JVI.00997-10; Harrach B., 2011, VIRUS TAXONOMY CLASS, P95; HESS M, 1995, J MOL BIOL, V252, P379, DOI 10.1006/jmbi.1995.0504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JUHASZ A, 1993, ARCH VIROL, V130, P429, DOI 10.1007/BF01309671; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Loser P, 1999, GENE THER MOL BIOL, V4, P33; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mitraki A, 2006, ADV PROTEIN CHEM, V73, P97, DOI 10.1016/S0065-3233(06)73004-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Pantelic RS, 2008, J VIROL, V82, P7346, DOI 10.1128/JVI.00764-08; Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008; Penzes JJ, 2014, J VIROL, V88, P11304, DOI 10.1128/JVI.00306-14; Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190; Philipson L, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P1; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Martin CS, 2012, VIRUSES-BASEL, V4, P847, DOI 10.3390/v4050847; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Singh AK, 2013, ACTA CRYSTALLOGR F, V69, P1374, DOI 10.1107/S1744309113029308; Singh AK, 2013, ACTA CRYSTALLOGR F, V69, P1135, DOI 10.1107/S174430911302397X; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HJ, 2013, J VIROL, V87, P11346, DOI 10.1128/JVI.01825-13; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	59	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114373	10.1371/journal.pone.0114373	http://dx.doi.org/10.1371/journal.pone.0114373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486282	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600049
J	Jia, TQ; Wei, DF; Meng, S; Allan, AC; Zeng, LH				Jia, Tianqi; Wei, Danfeng; Meng, Shan; Allan, Andrew C.; Zeng, Lihui			Identification of Regulatory Genes Implicated in Continuous Flowering of Longan (Dimocarpus longan L.)	PLOS ONE			English	Article							LOCUS-T; POTASSIUM CHLORATE; CIRCADIAN CLOCK; AMBIENT-TEMPERATURE; FLORAL INITIATION; ARABIDOPSIS; TIME; TRANSCRIPTION; GIBBERELLIN; PROTEIN	Longan (Dimocarpus longan L.) is a tropical/subtropical fruit tree of significant economic importance in Southeast Asia. However, a lack of transcriptomic and genomic information hinders research on longan traits, such as the control of flowering. In this study, high-throughput RNA sequencing (RNA-Seq) was used to investigate differentially expressed genes between a unique longan cultivar 'Sijimi'(S) which flowers throughout the year and a more typical cultivar 'Lidongben'(L) which flowers only once in the season, with the aim of identifying candidate genes associated with continuous flowering. 36,527 and 40,982 unigenes were obtained by de novo assembly of the clean reads from cDNA libraries of L and S cultivars. Additionally 40,513 unigenes were assembled from combined reads of these libraries. A total of 32,475 unigenes were annotated by BLAST search to NCBI non-redundant protein (NR), Swiss-Prot, Clusters of Orthologous Groups (COGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Of these, almost fifteen thousand unigenes were identified as significantly differentially expressed genes (DEGs) by using Reads Per kb per Million reads (RPKM) method. A total of 6,415 DEGs were mapped to 128 KEGG pathways, and 8,743 DEGs were assigned to 54 Gene Ontology categories. After blasting the DEGs to public sequence databases, 539 potential flowering-related DEGs were identified. In addition, 107 flowering-time genes were identified in longan, their expression levels between two longan samples were compared by RPKM method, of which the expression levels of 15 were confirmed by real-time quantitative PCR. Our results suggest longan homologues of SHORT VEGETATIVE PHASE (SVP), GIGANTEA (GI), F-BOX 1 (FKF1) and EARLY FLOWERING 4 (ELF4) may be involved this flowering trait and ELF4 may be a key gene. The identification of candidate genes related to continuous flowering will provide new insight into the molecular process of regulating flowering time in woody plants.	[Jia, Tianqi; Wei, Danfeng; Meng, Shan; Zeng, Lihui] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China; [Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Auckland, New Zealand	Fujian Agriculture & Forestry University; New Zealand Institute for Plant & Food Research Ltd	Zeng, LH (corresponding author), Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China.	lhzeng@hotmail.com	Allan, Andrew C/L-3253-2016	Allan, Andrew C/0000-0003-1944-7067	National Natural Science Foundation of P. R. China [30971989]; Plant & Food Research Limited	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Plant & Food Research Limited	This work was supported by the National Natural Science Foundation of P. R. China (No. 30971989). Andrew C. Allan is an employee of The New Zealand Institute for Plant & Food Research Limited. He received support in the form of salary from Plant & Food Research Limited, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Elwafa SF, 2011, J EXP BOT, V62, P3359, DOI 10.1093/jxb/erq321; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Brunner AM, 2004, NEW PHYTOL, V164, P43, DOI 10.1111/j.1469-8137.2004.01165.x; Chen Hu, 2010, Genomics and Applied Biology, V29, P288; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Ding L, 2013, ARABIDOPSIS PLANT PH, V163, P1243; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Goldberg-Moeller R, 2013, PLANT SCI, V198, P46, DOI 10.1016/j.plantsci.2012.09.012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hegele M, 2008, EUR J HORTIC SCI, V73, P49; Heller WP, 2014, TROP PLANT BIOL, V7, P19, DOI 10.1007/s12042-013-9134-0; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim Y, 2012, MOL PLANT, V5, P678, DOI 10.1093/mp/sss005; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; Marquardt S, 2006, J EXP BOT, V57, P3379, DOI 10.1093/jxb/erl073; Matsumoto TK, 2006, PLANT SCI, V170, P500, DOI 10.1016/j.plantsci.2005.09.016; Matsumoto TK, 2007, HORTTECHNOLOGY, V17, P296, DOI 10.21273/HORTTECH.17.3.296; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mizuno T, 2014, PLANT CELL PHYSIOL, V55, P958, DOI 10.1093/pcp/pcu030; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nakagawa M, 2012, SCI HORTIC-AMSTERDAM, V139, P108, DOI 10.1016/j.scienta.2012.03.005; Peng J, 2010, ACTA HORTIC, V863, P249, DOI 10.17660/ActaHortic.2010.863.32; Pillitteri LJ, 2004, PLANT PHYSIOL, V135, P1540, DOI 10.1104/pp.103.036178; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Potchanasin P, 2009, SCI HORTIC-AMSTERDAM, V122, P312, DOI 10.1016/j.scienta.2009.06.007; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Sringarm K, 2009, SCI HORTIC-AMSTERDAM, V122, P295, DOI 10.1016/j.scienta.2008.11.031; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Susawaengsup C, 2011, TALANTA, V85, P897, DOI 10.1016/j.talanta.2011.04.073; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Winterhagen P, 2013, PLANT PHYSIOL BIOCH, V71, P184, DOI 10.1016/j.plaphy.2013.07.013; Wu SH, 2010, ACTA HORTIC, V863, P37; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshida R, 2009, NEW PHYTOL, V182, P838, DOI 10.1111/j.1469-8137.2009.02809.x; Zawaski C, 2011, PLANTA, V234, P1285, DOI 10.1007/s00425-011-1485-x; Zhang JZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-63; Zhou CM, 2013, SCIENCE, V340, P1097, DOI 10.1126/science.1234340; Zhu J, 2013, J PLANT GENET RESOUR, V14, P61	69	20	27	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114568	10.1371/journal.pone.0114568	http://dx.doi.org/10.1371/journal.pone.0114568			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479005	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200106
J	Kawamoto, R; Ninomiya, D; Hasegawa, Y; Kasai, Y; Kusunoki, T; Ohtsuka, N; Kumagi, T; Abe, M				Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Kumagi, Teru; Abe, Masanori			Mildly Elevated Serum Bilirubin Levels Are Negatively Associated with Carotid Atherosclerosis among Elderly Persons	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; GILBERTS-SYNDROME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEART-DISEASE; RENAL-DISEASE; RISK-FACTOR; URIC-ACID	Serum bilirubin may have a beneficial role in preventing oxidative changes in atherosclerosis. Limited information is available on whether serum total bilirubin is an independent confounding factor for carotid atherosclerosis {for example, intima-media thickness (IMT), plaque} measured noninvasively by B-mode ultrasonography only among elderly persons. The study subjects were 325 men aged 79 +/- 8 (mean +/- standard deviation) years and 509 women aged 81 +/- 8 years that were enrolled consecutively from patients aged >= 60 years in the medical department. Carotid IMT and plaque were derived via B-mode ultrasonography. Multiple linear regression analysis showed that in men age (beta=0.199, p=0.002), smoking status (beta=0.154, p=0.006), GGT (beta=-0.139, p=0.039), and GGT (beta=-0.133, p=0.022) were significantly and independently associated with carotid IMT, and in women age (beta=0.186, p<0.001), systolic blood pressure (beta=0.104, p=0.046), diastolic blood pressure (beta=-0.148, p=0.004), prevalence of antihypertensive medication (beta=0.126, p=0.004), fasting plasma glucose (beta=0.135, p=0.003), GGT (beta=-0.104, p=0.032), estimated glomerular filtration rate, serum bilirubin (beta=-0.119, p=0.006), and prevalence of cardiovascular disease (CVD) (beta=0.103, p=0.017) were also independently associated with carotid IMT. The odds ratios (ORs) {95% confidence interval (CI)} of increasing serum bilirubin category were negatively associated with carotid IMT >= 1.0 mm and plaque in both genders. Compared to subjects with a serum bilirubin of Quartile-1, the multivariate-OR (95% CI) of carotid plaque was 0.25 (0.11-0.57) in the Quartile-4 male group, and 0.41 (0.21-0.78) in the Quartile-2 female group, 0.51 (0.26-0.98) in the Quartile-3 female group, and 0.46 (0.24-0.89) in the Quartile-4 female group. Our data demonstrated an independently negative association between serum bilirubin and carotid atherosclerosis in both genders.	[Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kumagi, Teru; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime, Japan; [Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Seiyo City, Ehime, Japan	Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime, Japan.	rykawamo@m.ehime.ca.jp	Kumagi, Teru/AAS-7427-2021	Kumagi, Teru/0000-0002-2292-7750	Foundation for Development of Community	Foundation for Development of Community	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2012). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Bulmer AC, 2013, PROG LIPID RES, V52, P193, DOI 10.1016/j.plipres.2012.11.001; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Dekker D, 2011, ARTERIOSCL THROM VAS, V31, P458, DOI 10.1161/ATVBAHA.110.211789; Demirkol S, 2013, ANGIOLOGY       0127; Djousse L, 2003, AM J CARDIOL, V91, P485, DOI 10.1016/S0002-9149(02)03256-3; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; FELSHER BF, 1975, GASTROENTEROLOGY, V69, P42; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Huang SS, 2010, HEART, V96, P1227, DOI 10.1136/hrt.2009.192393; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Ishizaka N, 2001, STROKE, V32, P581, DOI 10.1161/01.STR.32.2.580-b; Jiang SM, 2012, CHINESE MED J-PEKING, V125, P2649, DOI 10.3760/cma.j.issn.0366-6999.2012.15.002; Kalkan GY, 2014, ANGIOLOGY, V65, P308, DOI 10.1177/0003319713507627; Kang SJ, 2014, ANN MED, V46, P138, DOI 10.3109/07853890.2014.895588; Kao TW, 2012, INTERN MED J, V42, P1199, DOI 10.1111/j.1445-5994.2011.02620.x; Kawamoto R, 2005, J ATHEROSCLER THROMB, V12, P143, DOI 10.5551/jat.12.143; Kawamoto R, 2005, INTERNAL MED, V44, P787, DOI 10.2169/internalmedicine.44.787; Kawamoto R, 2007, J ATHEROSCLER THROMB, V14, P78, DOI 10.5551/jat.14.78; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Madhavan M, 1997, ATHEROSCLEROSIS, V131, P107, DOI 10.1016/S0021-9150(97)06088-7; Mayer M, 2000, CLIN CHEM, V46, P1723; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pae HO, 2006, ATHEROSCLEROSIS, V187, P274, DOI 10.1016/j.atherosclerosis.2005.09.010; Park BH, 2012, ENDOCRINOL METAB, V27, P126, DOI 10.3803/EnM.2012.27.2.126; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; Sidhu PS, 1997, BRIT J RADIOL, V70, P85, DOI 10.1259/bjr.70.829.9059301; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Takayama S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-2; Tanaka M, 2009, ATHEROSCLEROSIS, V206, P287, DOI 10.1016/j.atherosclerosis.2009.02.010; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Vitek L, 2006, CEREBROVASC DIS, V21, P408, DOI 10.1159/000091966; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x	42	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114281	10.1371/journal.pone.0114281	http://dx.doi.org/10.1371/journal.pone.0114281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479598	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200065
J	Norback, D; Lampa, E; Engvall, K				Norback, Dan; Lampa, Erik; Engvall, Karin			Asthma, Allergy and Eczema among Adults in Multifamily Houses in Stockholm (3-HE Study) - Associations with Building Characteristics, Home Environment and Energy Use for Heating	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; RESPIRATORY SYMPTOMS; MITE ALLERGEN; HEALTH-RISKS; F 1; INDOOR; PREVALENCE; FORMALDEHYDE; ENDOTOXIN; EXPOSURE	Risk factors for asthma, allergy and eczema were studied in a stratified random sample of adults in Stockholm. In 2005, 472 multifamily buildings (10,506 dwellings) were invited (one subject/dwelling) and 7,554 participated (73%). Associations were analyzed by multiple logistic regression, adjusting for gender, age, smoking, country of birth, income and years in the dwelling. In total, 11% had doctor's diagnosed asthma, 22% doctor's diagnosed allergy, 23% pollen allergy and 23% eczema. Doctor's diagnosed asthma was more common in dwellings with humid air (OR=1.74) and mould odour (OR=1.79). Doctor's diagnosed allergy was more common in buildings with supply exhaust air ventilation as compared to exhaust air only (OR=1.45) and was associated with redecoration (OR=1.48) and mould odour (OR=2.35). Pollen allergy was less common in buildings using more energy for heating (OR=0.75) and was associated with humid air (OR=1.76) and mould odour (OR=2.36). Eczema was more common in larger buildings (OR 1.07) and less common in buildings using more energy for heating (OR=0.85) and was associated with water damage (OR=1.47), humid air (OR=1.73) and mould odour (OR=2.01). Doctor's diagnosed allergy was less common in buildings with management accessibility both in the neighbourhood and in larger administrative divisions, as compared to management in the neighbourhood only (OR=0.49; 95% CI 0.29-0.82). Pollen allergy was less common if the building maintenance was outsourced (OR=0.67; 95% CI 0.51-0.88). Eczema was more common when management accessibility was only at the division level (OR=1.49; 95% CI 1.06-2.11). In conclusions, asthma, allergy or eczema were more common in buildings using less energy for heating, in larger buildings and in dwellings with redecorations, mould odour, dampness and humid air. There is a need to reduce indoor chemical emissions and to control dampness. Energy saving may have consequences for allergy and eczema. More epidemiological studies are needed on building management organization.	[Norback, Dan; Lampa, Erik; Engvall, Karin] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden	Uppsala University	Norback, D (corresponding author), Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden.	dan.norback@medsci.uu.se		Norback, Dan/0000-0002-5174-6668	Swedish Asthma and Allergy Association's Research Foundation [22012041-K]; Swedish Research Council FORMAS [294-2008-80, 244-2010-277]; Swedish Property Foundation (FORMAS) [244-2008-80]; Property Federation in Stockholm (FORMAS) [244-2008-80]; City of Stockholm (FORMAS) [244-2008-80]; Fortum corporation (FORMAS) [244-2008-80]; FORMAS [294-2008-80]	Swedish Asthma and Allergy Association's Research Foundation; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Property Foundation (FORMAS)(Swedish Research Council Formas); Property Federation in Stockholm (FORMAS); City of Stockholm (FORMAS); Fortum corporation (FORMAS); FORMAS(Swedish Research Council Formas)	The study was supported by grants from The Swedish Asthma and Allergy Association's Research Foundation (contract 22012041-K), The Swedish Research Council FORMAS (contracts 294-2008-80 and 244-2010-277), The Swedish Property Foundation (FORMAS contract 244-2008-80), The Property Federation in Stockholm (FORMAS contract 244-2008-80), The City of Stockholm (FORMAS contract 244-2008-80) and the Fortum corporation (FORMAS contract 244-2008-80). The contract 294-2008-80 with FORMAS included requested co-sponsorship by the organizations or companies mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breysse J, 2011, PUBLIC HEALTH REP, V126, P64, DOI 10.1177/00333549111260S110; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, P573, DOI 10.1289/ehp.02110s4573; Ekerljung L, 2010, INT J TUBERC LUNG D, V14, P764; Engvall K, 2001, INT J TUBERC LUNG D, V5, P468; Engvall K, 2010, METHODS QUALITY ASSU; Engvall K, 2014, INDOOR AIR, V14, P23; Eriksson J, 2012, CLIN RESPIR J, V6, P159, DOI 10.1111/j.1752-699X.2011.00269.x; Fabian MP, 2014, J ALLERGY CLIN IMMUN, V133, P77, DOI 10.1016/j.jaci.2013.06.003; Gordian ME, 2010, INT J ENV RES PUB HE, V7, P3051, DOI 10.3390/ijerph7083051; Harrell FE, 2001, REGRESSION MODELING; Harrop J, 2007, CLIN EXP ALLERGY, V37, P526, DOI 10.1111/j.1365-2222.2007.02679.x; Herr CEW, 2004, INT ARCH OCC ENV HEA, V77, P90, DOI 10.1007/s00420-003-0489-7; Hirsch T, 2000, ALLERGY, V55, P79, DOI 10.1034/j.1398-9995.2000.00250.x; Howden-Chapman P, 2011, INT J PUBLIC HEALTH, V56, P583, DOI 10.1007/s00038-011-0287-z; Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249; Jie Y, 2011, J FORMOS MED ASSOC, V110, P555, DOI 10.1016/j.jfma.2011.07.003; Liu LQ, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-34; Moniruzzaman S, 2012, INT J ENVIRON HEAL R, V22, P22, DOI 10.1080/09603123.2011.588322; Nguyen T, 2010, PUBLIC HEALTH REP, V125, P877, DOI 10.1177/003335491012500615; NORBACK D, 1995, OCCUP ENVIRON MED, V52, P388, DOI 10.1136/oem.52.6.388; Peden D, 2010, J ALLERGY CLIN IMMUN, V125, pS150, DOI 10.1016/j.jaci.2009.10.073; Quansah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047526; Radon K, 2006, OCCUP ENVIRON MED, V63, P73, DOI 10.1136/oem.2004.017616; Ronmark EP, 2012, BRIT J DERMATOL, V166, P1301, DOI 10.1111/j.1365-2133.2012.10904.x; Sahlberg B, 2012, INDOOR AIR, V22, P331, DOI 10.1111/j.1600-0668.2012.00766.x; Sahlberg B, 2010, SCAND J PUBLIC HEALT, V38, P232, DOI 10.1177/1403494809350517; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Sobottka A, 1996, TOXICOL LETT, V88, P365, DOI 10.1016/0378-4274(96)03763-0; Spertini F, 2010, ALLERGY, V65, P623, DOI 10.1111/j.1398-9995.2009.02230.x; Sun Y, 2009, INDOOR AIR, V19, P174, DOI 10.1111/j.1600-0668.2008.00577.x; Takaoka M, 2011, INDOOR BUILT ENVIRON, V20, P369, DOI 10.1177/1420326X11403194; The National Board of Housing Building and Planning (Boverket), 2009, REG DAT EN DECL FORM; The Swedish Council for Building Research, 1996, EN BOOK A RES PRES K; Thomson H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008657.pub2; Thomson NC, 2007, CURR ALLERGY ASTHM R, V7, P303, DOI 10.1007/s11882-007-0045-8; THORNTON EW, 1994, NATURE, V372, P327, DOI 10.1038/372327a0; WHO, WHO GUID IND AIR QUA; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Wilson Jonathan, 2014, Energy Efficiency, V7, P151, DOI 10.1007/s12053-013-9216-8; Zock JP, 2007, AM J RESP CRIT CARE, V176, P735, DOI 10.1164/rccm.200612-1793OC	41	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112960	10.1371/journal.pone.0112960	http://dx.doi.org/10.1371/journal.pone.0112960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479551	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200013
J	Collins, JJ; Bender, TJ; Bonner, EM; Bodner, KM; Kreft, AM				Collins, James J.; Bender, Thomas John; Bonner, Eileen M.; Bodner, Kenneth M.; Kreft, Alisa M.			Brain Cancer in Workers Employed at a Laboratory Research Facility	PLOS ONE			English	Article							PETROCHEMICAL RESEARCH FACILITY; HISTORICAL COHORT; CHEMICAL-RESEARCH; SWEDISH CHEMISTS; MORTALITY; OCCUPATION; ENVIRONMENT; POPULATION; ARCHITECTS; PATTERNS	Background: An earlier study of research facility workers found more brain cancer deaths than expected, but no workplace exposures were implicated. Methods: Adding four additional years of vital-status follow-up, we reassessed the risk of death from brain cancer in the same workforce, including 5,284 workers employed between 1963, when the facility opened, and 2007. We compared the work histories of the brain cancer decedents in relationship to when they died and their ages at death. Results: As in most other studies of laboratory and research workers, we found low rates of total mortality, total cancers, accidents, suicides, and chronic conditions such as heart disease and diabetes. We found no new brain cancer deaths in the four years of additional follow-up. Our best estimate of the brain cancer standardized mortality ratio (SMR) was 1.32 (95% confidence interval [95% CI] 0.66-2.37), but the SMR might have been as high as 1.69. Deaths from benign brain tumors and other non-malignant diseases of the nervous system were at or below expected levels. Conclusion: With the addition of four more years of follow-up and in the absence of any new brain cancers, the updated estimate of the risk of brain cancer death is smaller than in the original study. There was no consistent pattern among the work histories of decedents that indicated a common causative exposure.	[Collins, James J.] Saginaw Valley State Univ, Univ Ctr, University Ctr, MI 48710 USA; [Bender, Thomas John] Dow Chem Co USA, Hlth Serv Epidemiol, Midland, MI 48674 USA; [Bonner, Eileen M.] Dow Chem Co USA, Hlth Serv, Collegeville, PA USA; [Bodner, Kenneth M.] Kelly Serv, Epidemiology, South Lake Tahoe, CA USA; [Kreft, Alisa M.] Dow Chem Co USA, EH&S Delivery Expertise, Bristol, PA USA	Dow Chemical Company; Dow Chemical Company; Dow Chemical Company	Collins, JJ (corresponding author), Saginaw Valley State Univ, Univ Ctr, University Ctr, MI 48710 USA.	jjcollin@svsu.edu			Dow Chemical Company	Dow Chemical Company	This study was funded by The Dow Chemical Company. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexander BH, 2013, ARCH ENVIRON OCCUP H, V68, P218, DOI 10.1080/19338244.2012.701248; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Beall C, 2001, J OCCUP ENVIRON MED, V43, P914, DOI 10.1097/00043764-200110000-00011; BELLI S, 1990, LANCET, V335, P1597, DOI 10.1016/0140-6736(90)91432-A; Carozza SE, 2000, AM J EPIDEMIOL, V152, P838, DOI 10.1093/aje/152.9.838; CARPENTER L, 1991, LANCET, V338, P1080, DOI 10.1016/0140-6736(91)91938-Q; CARSTENSEN JM, 1990, AM J IND MED, V18, P535, DOI 10.1002/ajim.4700180503; CHECKOWAY H, 1985, BRIT J IND MED, V42, P525; Chen YC, 2012, ENVIRON INT, V39, P111, DOI 10.1016/j.envint.2011.10.008; CHIAZZE L, 1986, J OCCUP ENVIRON MED, V28, P1185; CLAUDE JC, 1988, INT J CANCER, V41, P371, DOI 10.1002/ijc.2910410309; Cordier S, 1995, SCAND J WORK ENV HEA, V21, P450, DOI 10.5271/sjweh.61; DALY L, 1994, OCCUP ENVIRON MED, V51, P295, DOI 10.1136/oem.51.5.295; DELL L, 1995, AM J IND MED, V28, P373, DOI 10.1002/ajim.4700280307; DIVINE BJ, 1986, AM J IND MED, V10, P371, DOI 10.1002/ajim.4700100405; DOSEMECI M, 1992, EPIDEMIOLOGY, V3, P258, DOI 10.1097/00001648-199205000-00012; Goodman M, 2012, CRIT REV TOXICOL, V42, P474, DOI 10.3109/10408444.2012.675315; GREENWALD P, 1981, J OCCUP ENVIRON MED, V23, P690, DOI 10.1097/00043764-198110000-00012; Gustavsson P, 1999, CANCER CAUSE CONTROL, V10, P59, DOI 10.1023/A:1008892830922; HOAR SK, 1981, J OCCUP ENVIRON MED, V23, P485, DOI 10.1097/00043764-198107000-00016; HUNTER WJ, 1993, AM J IND MED, V23, P615, DOI 10.1002/ajim.4700230409; KOEPSELL TD, 2003, COHORT STUDIES EPIDE, P354; LI FP, 1969, J NATL CANCER I, V43, P1159; MAHER KV, 1986, ARCH ENVIRON HEALTH, V41, P109, DOI 10.1080/00039896.1986.9937419; Marsh GM, 1998, J OCCUP ENVIRON MED, V40, P351, DOI 10.1097/00043764-199804000-00010; National Institute for Occupational Safety and Health, LIF TABL AN SYST LTA; OLIN GR, 1982, ANN NY ACAD SCI, V381, P197, DOI 10.1111/j.1749-6632.1982.tb50385.x; OLIN GR, 1978, AM IND HYG ASSOC J, V39, P557, DOI 10.1080/0002889778507808; OLIN GR, 1980, ENVIRON RES, V22, P154, DOI 10.1016/0013-9351(80)90127-9; OTT MG, 1985, AM J EPIDEMIOL, V122, P311, DOI 10.1093/oxfordjournals.aje.a114103; OTT MG, 1976, J OCCUP ENVIRON MED, V18, P171, DOI 10.1097/00043764-197603000-00011; Rodu B, 2001, AM J IND MED, V39, P29; Sathiakumar N, 2001, J OCCUP ENVIRON MED, V43, P166, DOI 10.1097/00043764-200102000-00017; Takada S, 2008, IND HEALTH, V46, P166, DOI 10.2486/indhealth.46.166; VAGERO D, 1990, BRIT J IND MED, V47, P317; WALRATH J, 1985, AM J PUBLIC HEALTH, V75, P883, DOI 10.2105/AJPH.75.8.883	36	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113997	10.1371/journal.pone.0113997	http://dx.doi.org/10.1371/journal.pone.0113997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493437	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400025
J	Hughes, S; Wilkinson, H; Gilbert, SPR; Kishida, M; Ding, SS; Woollard, A				Hughes, Samantha; Wilkinson, Henry; Gilbert, Sophie P. R.; Kishida, Marcia; Ding, Siyu Serena; Woollard, Alison			The C. elegans TPR Containing Protein, TRD-1, Regulates Cell Fate Choice in the Developing Germ Line and Epidermis	PLOS ONE			English	Article							SEX-DETERMINATION GENE; RNA-BINDING PROTEIN; CAENORHABDITIS-ELEGANS; TETRATRICOPEPTIDE REPEAT; ASYMMETRIC DIVISION; DEPENDENT CONTROL; MITOTIC REGION; STEM-CELLS; SPERMATOGENESIS; HERMAPHRODITE	Correct cell fate choice is crucial in development. In post-embryonic development of the hermaphroditic Caenorhabitis elegans, distinct cell fates must be adopted in two diverse tissues. In the germline, stem cells adopt one of three possible fates: mitotic cell cycle, or gamete formation via meiosis, producing either sperm or oocytes. In the epidermis, the stem cell-like seam cells divide asymmetrically, with the daughters taking on either a proliferative (seam) or differentiated (hypodermal or neuronal) fate. We have isolated a novel conserved C. elegans tetratricopeptide repeat containing protein, TRD-1, which is essential for cell fate determination in both the germline and the developing epidermis and has homologs in other species, including humans (TTC27). We show that trd-1(RNAi) and mutant animals have fewer seam cells as a result of inappropriate differentiation towards the hypodermal fate. In the germline, trd-1 RNAi results in a strong masculinization phenotype, as well as defects in the mitosis to meiosis switch. Our data suggests that trd-1 acts downstream of tra-2 but upstream of fem-3 in the germline sex determination pathway, and exhibits a constellation of phenotypes in common with other Mog (masculinization of germline) mutants. Thus, trd-1 is a new player in both the somatic and germline cell fate determination machinery, suggestive of a novel molecular connection between the development of these two diverse tissues.	[Hughes, Samantha; Wilkinson, Henry; Gilbert, Sophie P. R.; Kishida, Marcia; Ding, Siyu Serena; Woollard, Alison] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Woollard, A (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	alison.woollard@bioch.ox.ac.uk	Ding, Serena/AAM-2834-2020	Ding, Serena/0000-0002-8590-3908; Hughes, Samantha/0000-0001-8447-2563; Wilkinson, Henry Charles/0000-0001-7810-8300	Association for International Cancer Research Grants [08-0458, 12-0028]; Wellcome Trust; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1106660] Funding Source: researchfish; Worldwide Cancer Research [12-0028] Funding Source: researchfish	Association for International Cancer Research Grants; Wellcome Trust(Wellcome TrustEuropean Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Worldwide Cancer Research	This work was funded by the Association for International Cancer Research Grants 08-0458 and 12-0028 to AW and SH (http://www.aicr.org.uk) and a Wellcome Trust Studentship to SSD (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachorik JL, 2005, P NATL ACAD SCI USA, V102, P10893, DOI 10.1073/pnas.0504593102; BARTON MK, 1987, GENETICS, V115, P107; Belfiore M, 2004, DEVELOPMENT, V131, P2935, DOI 10.1242/dev.01154; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BRENNER S, 1974, GENETICS, V77, P71; Byrd DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088372; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DONIACH T, 1986, GENETICS, V114, P53; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Ellis R, 2007, SEX DETERMINATION GE; ELLIS RE, 1995, GENETICS, V139, P561; Ellis RE, 2014, SEMIN CELL DEV BIOL, V29, P17, DOI 10.1016/j.semcdb.2014.04.005; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Gallegos M, 1998, EMBO J, V17, P6337, DOI 10.1093/emboj/17.21.6337; GRAHAM PL, 1993, DEV GENET, V14, P471, DOI 10.1002/dvg.1020140608; GRAHAM PL, 1993, GENETICS, V133, P919; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; Hughes S, 2013, BIOL OPEN, V2, P718, DOI 10.1242/bio.20134549; Kagoshima H, 2007, DEVELOPMENT, V134, P3905, DOI 10.1242/dev.008276; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kasturi P, 2010, DEV BIOL, V344, P593, DOI 10.1016/j.ydbio.2010.05.009; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Koh K, 2001, DEVELOPMENT, V128, P2867; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Matus DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000654; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Nimmo R, 2008, DEV BIOL, V313, P492, DOI 10.1016/j.ydbio.2007.11.002; Puoti A, 1999, MOL CELL BIOL, V19, P2189; Puoti A, 2001, EMBO REP, V2, P899, DOI 10.1093/embo-reports/kve209; Rybarska A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000494; Sawa H, 2012, CURR TOP DEV BIOL, V101, P55, DOI 10.1016/B978-0-12-394592-1.00003-X; SCHEDL T, 1988, GENETICS, V119, P43; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Thompson BE, 2005, DEVELOPMENT, V132, P3471, DOI 10.1242/dev.01921; Worrall LJ, 2008, BBA-PROTEINS PROTEOM, V1784, P496, DOI 10.1016/j.bbapap.2007.12.003; Zanetti S, 2011, DEV BIOL, V354, P232, DOI 10.1016/j.ydbio.2011.04.001; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	41	6	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114998	10.1371/journal.pone.0114998	http://dx.doi.org/10.1371/journal.pone.0114998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493563	Green Published, gold			2022-12-27	WOS:000346611400088
J	Knutson, SK; Warholic, NM; Johnston, LD; Klaus, CR; Wigle, TJ; Iwanowicz, D; Littlefield, BA; Porter-Scott, M; Smith, JJ; Moyer, MP; Copeland, RA; Pollock, RM; Kuntz, KW; Raimondi, A; Keilhack, H				Knutson, Sarah K.; Warholic, Natalie M.; Johnston, L. Danielle; Klaus, Christine R.; Wigle, Tim J.; Iwanowicz, Dorothy; Littlefield, Bruce A.; Porter-Scott, Margaret; Smith, Jesse J.; Moyer, Mikel P.; Copeland, Robert A.; Pollock, Roy M.; Kuntz, Kevin W.; Raimondi, Alejandra; Keilhack, Heike			Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; PROTEIN METHYLTRANSFERASES; SELECTIVE-INHIBITION; MOLECULAR SUBTYPES; SOMATIC MUTATIONS; DRUG DISCOVERY; MECHANISMS; CANCER; RESISTANCE; APOPTOSIS	Patients with non-Hodgkin lymphoma (NHL) are treated today with a cocktail of drugs referred to as CHOP (Cyclophosphamide, Hydroxyldaunorubicin, Oncovin, and Prednisone). Subsets of patients with NHL of germinal center origin bear oncogenic mutations in the EZH2 histone methyltransferase. Clinical testing of the EZH2 inhibitor EPZ-6438 has recently begun in patients. We report here that combining EPZ-6438 with CHOP in preclinical cell culture and mouse models results in dramatic synergy for cell killing in EZH2 mutant germinal center NHL cells. Surprisingly, we observe that much of this synergy is due to Prednisolone - a glucocorticoid receptor agonist (GRag) component of CHOP. Dramatic synergy was observed when EPZ-6438 is combined with Prednisolone alone, and a similar effect was observed with Dexamethasone, another GRag. Remarkably, the anti-proliferative effect of the EPZ-6438+GRag combination extends beyond EZH2 mutant-bearing cells to more generally impact germinal center NHL. These preclinical data reveal an unanticipated biological intersection between GR-mediated gene regulation and EZH2-mediated chromatin remodeling. The data also suggest the possibility of a significant and practical benefit of combining EZH2 inhibitors and GRag that warrants further investigation in a clinical setting.	[Knutson, Sarah K.; Warholic, Natalie M.; Johnston, L. Danielle; Klaus, Christine R.; Wigle, Tim J.; Iwanowicz, Dorothy; Porter-Scott, Margaret; Smith, Jesse J.; Moyer, Mikel P.; Copeland, Robert A.; Pollock, Roy M.; Kuntz, Kevin W.; Raimondi, Alejandra; Keilhack, Heike] Epizyme Inc, Res & Dev, Cambridge, MA 02139 USA; [Littlefield, Bruce A.] Eisai Inc, Oncol, Andover, MA USA	Eisai Co Ltd	Keilhack, H (corresponding author), Epizyme Inc, Res & Dev, Cambridge, MA 02139 USA.	hkeilhack@epizyme.com			Eisai Inc.	Eisai Inc.(Eisai Co Ltd)	This work was funded by Eisai Inc. through collaboration between Epizyme and Eisai. The funding entity had no input in study design, data collection and analysis and decision to publish. The funders were not involved in the preparation of the manuscript, but did review and approve it.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Barrett-Lee PJ, 2009, ANN ONCOL, V20, P816, DOI 10.1093/annonc/mdn728; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Copeland RA, 2013, ONCOGENE, V32, P939, DOI 10.1038/onc.2012.552; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Furusawa C, 2012, SCIENCE, V338, P215, DOI 10.1126/science.1224311; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; George AA, 2009, INT J BIOCHEM CELL B, V41, P214, DOI 10.1016/j.biocel.2008.09.019; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Maxwell SA, 2013, EXP BIOL MED, V238, P971, DOI 10.1177/1535370213498985; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nastoupil LJ, 2012, ONCOLOGY-NY, V26, P488; Niitsu N, 2010, INT J HEMATOL, V92, P231, DOI 10.1007/s12185-010-0666-x; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Rutz HP, 2004, CANCER BIOL THER, V3, P715, DOI 10.4161/cbt.3.8.966; Rutz HP, 2002, LANCET, V360, P1969, DOI 10.1016/S0140-6736(02)11922-2; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Van Bogaert T, 2010, CYTOKINE GROWTH F R, V21, P275, DOI 10.1016/j.cytogfr.2010.04.003; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wigle TJ, 2013, CURR OPIN CHEM BIOL, V17, P369, DOI 10.1016/j.cbpa.2013.03.035	42	52	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111840	10.1371/journal.pone.0111840	http://dx.doi.org/10.1371/journal.pone.0111840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493630	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400005
J	Lansade, L; Valenchon, M; Foury, A; Neveux, C; Cole, SW; Laye, S; Cardinaud, B; Levy, F; Moisan, MP				Lansade, Lea; Valenchon, Mathilde; Foury, Aline; Neveux, Claire; Cole, Steve W.; Laye, Sophie; Cardinaud, Bruno; Levy, Frederic; Moisan, Marie-Pierre			Behavioral and Transcriptomic Fingerprints of an Enriched Environment in Horses (Equus caballus)	PLOS ONE			English	Article							TEMPERAMENT TRAIT; YOUNG HORSES; COGNITIVE BIAS; TIME; EXPRESSION; INFLAMMATION; INHIBITION; REACTIVITY; RESPONSES; WELFARE	The use of environmental enrichment (EE) has grown in popularity over decades, particularly because EE is known to promote cognitive functions and well-being. Nonetheless, little is known about how EE may affect personality and gene expression. To address this question in a domestic animal, 10-month-old horses were maintained in a controlled environment or EE for 12 weeks. The control horses (n=9) lived in individual stalls on wood shaving bedding. They were turned out to individual paddocks three times a week and were fed three times a day with pellets or hay. EE-treated horses (n=10) were housed in large individual stalls on straw bedding 7 hours per day and spent the remainder of the time together at pasture. They were fed three times a day with flavored pellets, hay, or fruits and were exposed daily to various objects, odors, and music. The EE modified three dimensions of personality: fearfulness, reactivity to humans, and sensory sensitivity. Some of these changes persisted >3 months after treatment. These changes are suggestive of a more positive perception of the environment and a higher level of curiosity in EE-treated horses, explaining partly why these horses showed better learning performance in a Go/No-Go task. Reduced expression of stress indicators indicated that the EE also improved well-being. Finally, whole-blood transcriptomic analysis showed that in addition to an effect on the cortisol level, the EE induced the expression of genes involved in cell growth and proliferation, while the control treatment activated genes related to apoptosis. Changes in both behavior and gene expression may constitute a psychobiological signature of the effects of enrichment and result in improved well-being. This study illustrates how the environment interacts with genetic information in shaping the individual at both the behavioral and molecular levels.	[Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] CNRS, Physiol Reprod & Comportements UMR7247, Nouzilly, France; [Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] Univ Tours, Tours, France; [Lansade, Lea; Valenchon, Mathilde; Neveux, Claire; Levy, Frederic] IFCE, Nouzilly, France; [Foury, Aline; Laye, Sophie] INRA, UMR 1286, Bordeaux, France; [Foury, Aline; Laye, Sophie] Univ Bordeaux, UMR 1286, Bordeaux, France; [Cole, Steve W.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Cardinaud, Bruno] INSERM, U1035, Bordeaux, France; [Cardinaud, Bruno] Inst Polytech Bordeaux, Talence, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Los Angeles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Lansade, L (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	lansade@tours.inra.fr	Moisan, Marie-Pierre/AAO-9971-2021; Laye, Sophie/AAX-2501-2020	Moisan, Marie-Pierre/0000-0001-7315-5319; Laye, Sophie/0000-0002-3843-1012; Valenchon, Mathilde/0000-0003-0226-8433; Foury, Aline/0000-0002-4552-3222	French Institute of horse and Riding (IFCE); department of animal genetics of the French National Institute for Agricultural Research (INRA)	French Institute of horse and Riding (IFCE); department of animal genetics of the French National Institute for Agricultural Research (INRA)	This study was supported by the French Institute of horse and Riding (IFCE) and by the department of animal genetics of the French National Institute for Agricultural Research (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrey E, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-29; Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Cole SW, 2013, AM J PUBLIC HEALTH, V103, P84, DOI 10.2105/AJPH.2012.301183; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Cole SW, 2005, BIOINFORMATICS, V21, P803, DOI 10.1093/bioinformatics/bti038; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Criaud M, 2013, NEUROSCI BIOBEHAV R, V37, P11, DOI 10.1016/j.neubiorev.2012.11.003; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Fureix C, 2012, PLOS ONE, V7; Goodwin D, 2007, VET REC, V160, P548, DOI 10.1136/vr.160.16.548; Goodwin D, 2005, APPL ANIM BEHAV SCI, V90, P337, DOI 10.1016/j.applanim.2004.08.013; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; Houpt K, 2000, J EQUINE VET SCI, V20, P691, DOI 10.1016/S0737-0806(00)80155-0; Jorgensen GHM, 2011, APPL ANIM BEHAV SCI, V129, P100, DOI 10.1016/j.applanim.2010.11.004; Konig v. Borstel U., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138006; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064853; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pedersen GR, 2004, J EQUINE VET SCI, V24, P153, DOI 10.1016/j.jevs.2004.03.013; Petrosini L, 2009, BRAIN RES REV, V61, P221, DOI 10.1016/j.brainresrev.2009.07.002; Raabymagle P, 2006, J EQUINE VET SCI, V26, P11, DOI 10.1016/j.jevs.2005.11.015; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; Rivera E, 2002, APPL ANIM BEHAV SCI, V78, P235, DOI 10.1016/S0168-1591(02)00091-6; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Slavich GM, 2013, CLIN PSYCHOL SCI, V1, P331, DOI 10.1177/2167702613478594; Sondergaard E, 2004, APPL ANIM BEHAV SCI, V87, P105, DOI 10.1016/j.applanim.2003.12.010; Valenchon M, 2013, ANIM BEHAV, V86, P1233, DOI 10.1016/j.anbehav.2013.09.026; Valenchon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062324; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; Waters AJ, 2002, EQUINE VET J, V34, P572, DOI 10.2746/042516402776180241; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002; Young T, 2012, APPL ANIM BEHAV SCI, V140, P33, DOI 10.1016/j.applanim.2012.05.008	51	24	24	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114384	10.1371/journal.pone.0114384	http://dx.doi.org/10.1371/journal.pone.0114384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494179	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400043
J	Thiers, L; Louzao, M; Ridoux, V; Le Corre, M; Jaquemet, S; Weimerskirch, H				Thiers, Laurie; Louzao, Maite; Ridoux, Vincent; Le Corre, Matthieu; Jaquemet, Sebastien; Weimerskirch, Henri			Combining Methods to Describe Important Marine Habitats for Top Predators: Application to Identify Biological Hotspots in Tropical Waters	PLOS ONE			English	Article							SEABIRD COMMUNITY STRUCTURE; PRODUCTIVITY GRADIENT; MOZAMBIQUE CHANNEL; ISLAND; OCEAN; CONSERVATION; BIRD; PATTERNS; BEHAVIOR; EDDIES	In tropical waters resources are usually scarce and patchy, and predatory species generally show specific adaptations for foraging. Tropical seabirds often forage in association with sub-surface predators that create feeding opportunities by bringing prey close to the surface, and the birds often aggregate in large multispecific flocks. Here we hypothesize that frigatebirds, a tropical seabird adapted to foraging with low energetic costs, could be a good predictor of the distribution of their associated predatory species, including other seabirds (e.g. boobies, terns) and subsurface predators (e.g., dolphins, tunas). To test this hypothesis, we compared distribution patterns of marine predators in the Mozambique Channel based on a long-term dataset of both vessel- and aerial surveys, as well as tracking data of frigatebirds. By developing species distribution models (SDMs), we identified key marine areas for tropical predators in relation to contemporaneous oceanographic features to investigate multi-species spatial overlap areas and identify predator hotspots in the Mozambique Channel. SDMs reasonably matched observed patterns and both static (e.g. bathymetry) and dynamic (e.g. Chlorophyll a concentration and sea surface temperature) factors were important explaining predator distribution patterns. We found that the distribution of frigatebirds included the distributions of the associated species. The central part of the channel appeared to be the best habitat for the four groups of species considered in this study (frigatebirds, brown terns, boobies and sub-surface predators).	[Thiers, Laurie; Ridoux, Vincent; Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Stn Ecol Chize La Rochelle, UMR 7372, F-79360 Villiers En Bois, France; [Louzao, Maite] CO Xixon, Inst Espanol Oceanog, Xixon 33212, Spain; [Ridoux, Vincent] Univ La Rochelle, UMS 3462, CNRS, Observ PELAGIS, F-17000 La Rochelle, France; [Le Corre, Matthieu; Jaquemet, Sebastien] Univ Reunion, Lab ECOMAR, FRE 3560, CNRS, F-97744 St Denis 9, Reunion, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Spanish Institute of Oceanography; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); University of La Reunion	Thiers, L (corresponding author), CNRS, Ctr Etud Biol Chize, Stn Ecol Chize La Rochelle, UMR 7372, F-79360 Villiers En Bois, France.	thiers@cebc.cnrs.fr	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Louzao, Maite/N-5379-2014	Weimerskirch, Henri/0000-0002-0457-586X; Louzao, Maite/0000-0002-9997-5144; Ridoux, Vincent/0000-0002-9779-9319	Programme FREGATES (Appel d'Offre Eparses CNRS-INEE, TAAF); Conseil Regional Poitou Charentes; Fondation prince Albert 2 de Monaco; Juan de la Cierva (Ministerio de Cienciae Innovacion) [JCI-2010-07639]; Marie Curie Career Integration Grant [PCIG09-GA-2011-293774]	Programme FREGATES (Appel d'Offre Eparses CNRS-INEE, TAAF); Conseil Regional Poitou Charentes(Region Nouvelle-Aquitaine); Fondation prince Albert 2 de Monaco; Juan de la Cierva (Ministerio de Cienciae Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie Career Integration Grant	This study was funded partly by Programme FREGATES (Appel d'Offre Eparses CNRS-INEE, TAAF). Laurie Thiers was funded by Conseil Regional Poitou Charentes and Fondation prince Albert 2 de Monaco. Maite Louzao was funded by a Juan de la Cierva post-doctoral contract (JCI-2010-07639, Ministerio de Cienciae Innovacion) and a Marie Curie Career Integration Grant (PCIG09-GA-2011-293774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Ashmole N.P., 1971, P223; Asseid BS, 2006, AFR J MAR SCI, V28, P109, DOI 10.2989/18142320609504138; AU DWK, 1986, CONDOR, V88, P304, DOI 10.2307/1368877; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Ballance Lisa T., 2007, Marine Ornithology, V35, P127; Ballance LT, 1997, ECOLOGY, V78, P1502, DOI 10.1890/0012-9658(1997)078[1502:SCSAAP]2.0.CO;2; Ballard G, 2012, BIOL CONSERV, V156, P72, DOI 10.1016/j.biocon.2011.11.017; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Davoren GK, 2003, MAR ECOL PROG SER, V256, P229, DOI 10.3354/meps256229; De Monte S, 2012, J R SOC INTERFACE, V9, P3351, DOI 10.1098/rsif.2012.0509; Ford R. Glenn, 2004, Marine Ornithology, V32, P77; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hammond PS, 1995, LIFE, V92; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hyrenbach KD, 2007, DEEP-SEA RES PT I, V54, P1129, DOI 10.1016/j.dsr.2007.05.002; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jaquemet S, 2007, DEEP-SEA RES PT I, V54, P130, DOI 10.1016/j.dsr.2006.10.003; Jaquemet S, 2005, MAR BIOL, V147, P573, DOI 10.1007/s00227-005-1610-0; Jaquemet S, 2014, DEEP-SEA RES PT II, V100, P200, DOI 10.1016/j.dsr2.2013.10.027; Jaquemet S, 2004, MAR ECOL PROG SER, V268, P281, DOI 10.3354/meps268281; Kai ET, 2010, PROG OCEANOGR, V86, P214, DOI 10.1016/j.pocean.2010.04.010; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; Le Corre M, 2005, ESTUAR COAST SHELF S, V63, P421, DOI 10.1016/j.ecss.2004.11.013; Le Corre M, 2001, J ZOOL, V254, P239, DOI 10.1017/S0952836901000759; LeCorre M, 1997, REV ECOL-TERRE VIE, V52, P205; LOUGHLIN TR, 1984, J WILDLIFE MANAGE, V48, P729, DOI 10.2307/3801420; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Mannocci L, 2014, ECOGRAPHY, V37, P261, DOI 10.1111/j.1600-0587.2013.00317.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; Peron C, 2010, MAR ECOL PROG SER, V416, P267, DOI 10.3354/meps08785; Rodhouse PG, 1996, MAR ECOL PROG SER, V136, P37, DOI 10.3354/meps136037; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Sabarros PS, 2009, MAR ECOL PROG SER, V395, P101, DOI 10.3354/meps08087; Schneider D.C., 1990, Polar Research, V8, P17, DOI 10.1111/j.1751-8369.1990.tb00370.x; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Spear LB, 2001, MAR ECOL PROG SER, V219, P275, DOI 10.3354/meps219275; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Ternon JF, 2014, DEEP-SEA RES PT II, V100, P10, DOI 10.1016/j.dsr2.2013.10.013; van Erkel AR, 1998, EUR J RADIOL, V27, P88, DOI 10.1016/S0720-048X(97)00157-5; Weimerskirch H, 2006, CONDOR, V108, P220, DOI 10.1650/0010-5422(2006)108[0220:PMOFTW]2.0.CO;2; Weimerskirch H, 2005, MAR ECOL PROG SER, V288, P251, DOI 10.3354/meps288251; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wong SNP, 2014, J GEOPHYS RES-OCEANS, V119, P1691, DOI 10.1002/2013JC009198; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	62	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115057	10.1371/journal.pone.0115057	http://dx.doi.org/10.1371/journal.pone.0115057			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494047	Green Published, gold			2022-12-27	WOS:000346611400091
J	Heckt, T; Bickert, T; Jeschke, A; Seitz, S; Schulze, J; Ito, WD; Zimmermann, W; Amling, M; Schinke, T; Horst, AK; Keller, J				Heckt, Timo; Bickert, Thomas; Jeschke, Anke; Seitz, Sebastian; Schulze, Jochen; Ito, Wulf D.; Zimmermann, Wolfgang; Amling, Michael; Schinke, Thorsten; Horst, Andrea Kristina; Keller, Johannes			Increased Osteoclastogenesis in Mice Lacking the Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1	PLOS ONE			English	Article							DIFFERENTIATION; DEFICIENCY; RECEPTOR; PHYSIOLOGY; CYTOKINE; LIGAND	Alterations in bone remodeling are a major public health issue, as therapeutic options for widespread bone disorders such as osteoporosis and tumor-induced osteolysis are still limited. Therefore, a detailed understanding of the regulatory mechanism governing bone cell differentiation in health and disease are of utmost clinical importance. Here we report a novel function of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a member of the immunoglobulin superfamily involved in inflammation and tumorigenesis, in the physiologic regulation of bone remodeling. Assessing the expression of all members of the murine Ceacam family in bone tissue and marrow, we found CEACAM1 and CEACAM10 to be differentially expressed in both bone-forming osteoblasts and bone-resorbing osteoclasts. While Ceacam10-deficient mice displayed no alteration in structural bone parameters, static histomorphometry demonstrated a reduced trabecular bone mass in mice lacking CEACAM1. Furthermore, cellular and dynamic histomorphometry revealed an increased osteoclast formation in Ceacam1-deficient mice, while osteoblast parameters and the bone formation rate remained unchanged. In line with these findings, we detected accelerated osteoclastogenesis in Ceacam1-deficient bone marrow cells, while osteoblast differentiation, as determined by mineralization and alkaline phosphatase assays, was not affected. Therefore, our results provide in vivo and in vitro evidence for a physiologic role of CEACAM1 in the regulation of osteoclastogenesis.	[Heckt, Timo; Jeschke, Anke; Seitz, Sebastian; Schulze, Jochen; Amling, Michael; Schinke, Thorsten; Keller, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany; [Bickert, Thomas; Horst, Andrea Kristina] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, D-20246 Hamburg, Germany; [Ito, Wulf D.] Cardiovasc Ctr Oberallgau Kempten, D-87509 Immenstadt, Germany; [Zimmermann, Wolfgang] Univ Munich, Klinikum Grosshadern, LIFE Ctr, Tumor Immunol Lab, D-81377 Munich, Germany; [Horst, Andrea Kristina] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Keller, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany.	j.keller@uke.de		Keller, Johannes/0000-0002-8925-7288	Deutsche Forschungsgemeinschaft [SPP1468]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SPP1468 IMMUNOBONE - Project SCHI 504/7-2 and IT13-3 - http://www.immunobone.de/ - TS WDI AKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Bickert T, 2012, ARTERIOSCL THROM VAS, V32, P2566, DOI 10.1161/ATVBAHA.112.300015; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chen LF, 2012, IMMUNITY, V37, P930, DOI 10.1016/j.immuni.2012.07.016; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Finkenzeller D, 2003, MOL CELL BIOL, V23, P272, DOI 10.1128/MCB.23.1.272-279.2003; Goltzman D, 2001, J CLIN INVEST, V107, P1219, DOI 10.1172/JCI13073; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Horst AK, 2009, BLOOD, V113, P6726, DOI 10.1182/blood-2008-10-184556; Huang S, 2010, BONE, V46, P1138, DOI 10.1016/j.bone.2009.12.020; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Ludewig P, 2013, CIRC RES, V113, P1013, DOI 10.1161/CIRCRESAHA.113.301207; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Michigami T, 2000, BLOOD, V96, P1953, DOI 10.1182/blood.V96.5.1953.h8001953_1953_1960; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; ROODMAN GD, 1995, BONE, V17, pS57, DOI 10.1016/8756-3282(95)00179-H; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	33	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114360	10.1371/journal.pone.0114360	http://dx.doi.org/10.1371/journal.pone.0114360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490771	gold, Green Submitted, Green Published			2022-12-27	WOS:000347515300031
J	Lin, J; Reilly, MP; Terembula, K; Wilson, FP				Lin, Jennie; Reilly, Muredach P.; Terembula, Karen; Wilson, F. Perry			Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; RISK-FACTOR; PREDICTIVE-VALUE; CALCIFICATION; ABNORMALITIES; MORTALITY; PATHOPHYSIOLOGY	Background: CKD, an independent risk factor for CV disease, increases mortality in T2DM. Treating modifiable CV risk factors decreases mortality in diabetics with microalbuminuria, but the role of early CV prevention in diabetics with mild CKD by GFR criteria alone remains unclear. The purpose of this study was to probe whether T2DM patients with mild GFR impairment have atherogenic lipid profiles compared to diabetic counterparts with normal renal function. Methods: In the Penn Diabetes Heart Study (PDHS), a single-center observational cohort of T2DM patients without clinical CVD, cross-sectional analyses were performed for directly measured lipid fractions in 1852 subjects with eGFR. 60 mL/min/1.73 m(2) determined by the CKD-EPI equation (n=1852). Unadjusted and multivariable analyses of eGFR association with log-transformed lipid parameters in incremental linear and logistic regression models (with eGFR 90 mL/min/1.73 m(2) as a cut-point) were performed. Results: Mild GFR impairment (eGFR 60-90 mL/min/1.73 m(2), median urinary ACR 5.25 mg/g) was associated with higher log-transformed Lp(a) values (OR 1.17, p=0.005) and with clinically atherogenic Lp(a) levels above 30 mg/dL (OR 1.35, p=0.013) even after full adjustment for demographics, medications, metabolic parameters, and albuminuria. Logistic regression demonstrated a trend towards significance between worse kidney function and apoB (p=0.17) as well as apoC-III (p=0.067) in the fully adjusted model. Conclusions: Elevated Lp(a) levels have a robust association with mild GFR impairment in type 2 diabetics independent of race, insulin resistance, and albuminuria.	[Lin, Jennie] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Reilly, Muredach P.; Terembula, Karen] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Wilson, F. Perry] Yale Univ, Sch Med, Dept Med, Sect Nephrol,Program Appl Translat Res, New Haven, CT 06510 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Yale University	Lin, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	linjenn@mail.med.upenn.edu		Reilly, Muredach/0000-0002-3035-9386; Lin, Jennie/0000-0002-9328-6700; Wilson, Francis Perry/0000-0002-2633-2412	National Institute of Diabetes and Digestive and Kidney Diseases [T32-DK00700640, K23-DK097201]; National Heart, Lung and Blood Institute [K24-HL107643]; Clinical and Translational Science Award from the National Center for Research Resources [UL1RR024134]; Diabetes and Endocrine Research Center award [P20-DK 019525]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL107643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097201, T32DK007006, P30DK019525] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Clinical and Translational Science Award from the National Center for Research Resources; Diabetes and Endocrine Research Center award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases: T32-DK00700640, JL. K23-DK097201, FPW; National Heart, Lung and Blood Institute: K24-HL107643, MPR; Clinical and Translational Science Award (UL1RR024134) from the National Center for Research Resources and a Diabetes and Endocrine Research Center award (P20-DK 019525) awarded to the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Anderson JL, 2013, AM J CARDIOL, V112, P799, DOI 10.1016/j.amjcard.2013.05.009; [Anonymous], 2014, KIDNEY INT, V85, P1303, DOI DOI 10.1038/KI.2014.31; Attman PO, 2011, NEPHROL DIAL TRANSPL, V26, P2572, DOI 10.1093/ndt/gfq762; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; Attman PO, 1998, NEPHROL DIAL TRANSPL, V13, P2833, DOI 10.1093/ndt/13.11.2833; ATTMAN PO, 1993, AM J KIDNEY DIS, V21, P573, DOI 10.1016/S0272-6386(12)80030-8; Chan DC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0309-9; Chan DT, 2009, J LIPID RES, V50, P2524, DOI 10.1194/jlr.P900003-JLR200; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Boer IH, 2008, ATHEROSCLEROSIS, V197, P407, DOI 10.1016/j.atherosclerosis.2007.06.018; Dohi T, 2011, NEPHROL DIAL TRANSPL, V26, P2906, DOI 10.1093/ndt/gfq820; ELOSUA R, 2014, TACG, P15, DOI DOI 10.2147/TACG.S35301; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Holzmann MJ, 2012, ANN MED, V44, P262, DOI 10.3109/07853890.2010.532153; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Jacobson TA, 2013, MAYO CLIN PROC, V88, P1294, DOI 10.1016/j.mayocp.2013.09.003; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; Keane WF, 2013, J ATHEROSCLER THROMB, V20, P123, DOI 10.5551/jat.12849; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Kronenberg F, 1997, J LIPID RES, V38, P1755; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Lamprea-Montealegre JA, 2013, ARTERIOSCL THROM VAS, V33, P652, DOI 10.1161/ATVBAHA.112.300624; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lilly SM, 2013, ATHEROSCLEROSIS, V230, P17, DOI 10.1016/j.atherosclerosis.2013.06.004; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Martin SS, 2011, AM J CARDIOL, V107, P393, DOI 10.1016/j.amjcard.2010.09.033; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mulvey CK, 2014, DIABETES CARE, V37, P124, DOI 10.2337/dc12-1880; Nakamura T, 2011, ATHEROSCLEROSIS, V218, P163, DOI 10.1016/j.atherosclerosis.2011.04.040; *NAT KIDN FDN, 2012, YAJKD, V60, P850, DOI DOI 10.1053/J.AJKD.2012.07.005; O'Donoghue ML, 2014, J AM COLL CARDIOL, V63, P520, DOI 10.1016/j.jacc.2013.09.042; Ooi EMM, 2011, J LIPID RES, V52, P794, DOI 10.1194/jlr.M011163; Pennell P, 2006, CLIN NEPHROL, V66, P336; Qasim AN, 2013, ATHEROSCLEROSIS, V226, P419, DOI 10.1016/j.atherosclerosis.2012.11.011; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Reilly MP, 2004, J CLIN ENDOCR METAB, V89, P3872, DOI 10.1210/jc.2003-031676; Rosas S, 2008, AM J NEPHROL, V28, P361, DOI 10.1159/000112225; Samuelsson O, 1996, NEPHROL DIAL TRANSPL, V11, P2237, DOI 10.1093/oxfordjournals.ndt.a027142; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sechi LA, 1999, KIDNEY INT, V56, P1049, DOI 10.1046/j.1523-1755.1999.00621.x; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Uhlig K, 2005, AM J KIDNEY DIS, V45, P28, DOI 10.1053/j.ajkd.2004.08.043; Virani SS, 2012, CIRCULATION, V125, P241, DOI 10.1161/CIRCULATIONAHA.111.045120; Wang XW, 2012, CARDIORENAL MED, V2, P57, DOI 10.1159/000335509; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willey JZ, 2011, AM HEART J, V161, P886, DOI 10.1016/j.ahj.2011.01.018	54	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114397	10.1371/journal.pone.0114397	http://dx.doi.org/10.1371/journal.pone.0114397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490096	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300036
J	Ericsson, A; Turner, N; Hansson, GI; Wallenius, K; Oakes, ND				Ericsson, Anette; Turner, Nigel; Hansson, Goran I.; Wallenius, Kristina; Oakes, Nicholas D.			Pharmacological PPAR alpha Activation Markedly Alters Plasma Turnover of the Amino Acids Glycine, Serine and Arginine in the Rat	PLOS ONE			English	Article							INDIRECT CALORIMETRY; LIVER-REGENERATION; METABOLISM; AGONIST; MICE; INCREASES; REVERSES; EXCHANGE; MUSCLE; MODEL	The current study extends previously reported PPAR alpha agonist WY 14,643 (30 mmol/kg/day for 4 weeks) effects on circulating amino acid concentrations in rats fed a 48% saturated fat diet. Steady-state tracer experiments were used to examine in vivo kinetic mechanisms underlying altered plasma serine, glycine and arginine levels. Urinary urea and creatinine excretion were measured to assess whole-body amino acid catabolism. WY 14,643 treated animals demonstrated reduced efficiency to convert food consumed to body weight gain while liver weight was increased compared to controls. WY 14,643 raised total amino acid concentration (38%), largely explained by glycine, serine and threonine increases. H-3-glycine, C-14-serine and C-14-arginine tracer studies revealed elevated rates of appearance (R-a) for glycine (45.5 +/- 5.8 versus 17.4 +/- 2.7 mu mol/kg/min) and serine (21.0 +/- 1.4 versus 12.0 +/- 1.0) in WY 14,643 versus control. Arginine was substantially decreased (-62%) in plasma with estimated R-a reduced from 3.1 +/- 0.3 to 1.2 +/- 0.2 mu mol/kg/min in control versus WY 14,643. Nitrogen excretion over 24 hours was unaltered. Hepatic arginase activity was substantially decreased by WY 14,643 treatment. In conclusion, PPAR alpha agonism potently alters metabolism of several specific amino acids in the rat. The changes in circulating levels of serine, glycine and arginine reflected altered fluxes into the plasma rather than changes in clearance or catabolism. This suggests that PPAR alpha has an important role in modulating serine, glycine and arginine de novo synthesis.	[Ericsson, Anette; Hansson, Goran I.; Wallenius, Kristina; Oakes, Nicholas D.] AstraZeneca R&D, Dept Biosci, Molndal, Sweden; [Turner, Nigel] Garvan Inst Med Res, Sydney, NSW, Australia; [Turner, Nigel] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia	AstraZeneca; Garvan Institute of Medical Research; University of New South Wales Sydney	Ericsson, A (corresponding author), AstraZeneca R&D, Dept Biosci, Molndal, Sweden.	Anette.E.Ericsson@astrazeneca.com	Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328; Wallenius, Kristina/0000-0002-3231-2733	AstraZeneca; Australian Research Council Future Fellowship	AstraZeneca(AstraZeneca); Australian Research Council Future Fellowship(Australian Research Council)	AstraZeneca is the funder of all work. Co-authors Anette Ericsson, Goran I. Hansson, Kristina Wallenius and Nicholas D. Oakes are employed by AstraZeneca R&D Molndal. Nigel Turner is supported by an Australian Research Council Future Fellowship. The funder, AstraZeneca, provided support in the form of salaries for authors AE, GIH, KW and NDO, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The decision to publish was made by an internal AstraZeneca review of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alhonen L, 2002, BIOCHEM J, V362, P149, DOI 10.1042/0264-6021:3620149; Bjorndal B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066926; Carrillo MC, 1996, MECH AGEING DEV, V91, P55, DOI 10.1016/0047-6374(96)01779-4; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Cunningham Michael L, 2007, Toxic Rep Ser, P1; De Souza AT, 2006, TOXICOL SCI, V92, P578, DOI 10.1093/toxsci/kfl019; Dejong CHC, 1998, CLIN SCI, V95, P409, DOI 10.1042/CS19980002; DISTEFANO JJ, 1982, AM J PHYSIOL, V243, pR1, DOI 10.1152/ajpregu.1982.243.1.R1; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Evoy D, 1998, NUTRITION, V14, P611, DOI 10.1016/S0899-9007(98)00005-7; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; GEYER JW, 1971, ANAL BIOCHEM, V39, P412, DOI 10.1016/0003-2697(71)90431-3; Guelzim N, 2011, AMINO ACIDS, V41, P969, DOI 10.1007/s00726-010-0797-7; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kim H, 2003, DIABETES, V52, P1770, DOI 10.2337/diabetes.52.7.1770; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Linz W, 2009, ACTA PHARMACOL SIN, V30, P935, DOI 10.1038/aps.2009.58; Luiking YC, 2004, CRIT CARE MED, V32, P2135, DOI 10.1097/01.CCM.0000142939.81045.A0; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Rose ML, 1997, CHEM RES TOXICOL, V10, P1198, DOI 10.1021/tx970079u; Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Wallenius K, 2013, PPAR RES, V2013, DOI 10.1155/2013/305347; WATERLOW JC, 1981, BRIT MED BULL, V37, P5, DOI 10.1093/oxfordjournals.bmb.a071676; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113328	10.1371/journal.pone.0113328	http://dx.doi.org/10.1371/journal.pone.0113328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486018	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600019
J	Fronkova, E; Klocperk, A; Svaton, M; Novakova, M; Kotrova, M; Kayserova, J; Kallna, T; Keslova, P; Votava, F; Vinohradska, H; Freiberger, T; Mejstrikova, E; Trka, J; Sediva, A				Fronkova, Eva; Klocperk, Adam; Svaton, Mlchael; Novakova, Michaela; Kotrova, Mlchaela; Kayserova, Jana; Kallna, Tomas; Keslova, Petra; Votava, Felix; Vinohradska, Hana; Freiberger, Tomas; Mejstrikova, Ester; Trka, Jan; Sediva, Anna			The TREC/KREC Assay for the Diagnosis and Monitoring of Patients with DiGeorge Syndrome	PLOS ONE			English	Article							T-CELL-RECEPTOR; MINIMAL RESIDUAL DISEASE; DELETION SYNDROME; THYMIC OUTPUT; IMMUNODEFICIENCY; PROLIFERATION; REPERTOIRES	DiGeorge syndrome (DGS) presents with a wide spectrum of thymic pathologies. Nationwide neonatal screening programs of lymphocyte production using T-cell recombination excision circles (TREC) have repeatedly identified patients with DGS. We tested what proportion of DGS patients could be identified at birth by combined TREC and kappa-deleting element recombination circle (KREC) screening. Furthermore, we followed TREC/KREC levels in peripheral blood (PB) to monitor postnatal changes in lymphocyte production. Methods: TREC/KREC copies were assessed by quantitative PCR (qPCR) and were related to the albumin control gene in dry blood spots (DBSs) from control (n=56), severe immunodeficiency syndrome (SCID, n=10) and DGS (n=13) newborns. PB was evaluated in DGS children (n=32), in diagnostic samples from SCID babies (n=5) and in 91 controls. Results: All but one DGS patient had TREC levels in the normal range at birth, albeit quantitative TREC values were significantly lower in the DGS cohort. One patient had slightly reduced KREC at birth. Postnatal DGS samples revealed reduced TREC numbers in 5 of 32 (16%) patients, whereas KREC copy numbers were similar to controls. Both TREC and KREC levels showed a more pronounced decrease with age in DGS patients than in controls (p<0.0001 for both in a linear model). DGS patients had higher percentages of NK cells at the expense of T cells (p<0.0001). The patients with reduced TREC levels had repeated infections in infancy and developed allergy and/or autoimmunity, but they were not strikingly different from other patients. In 12 DGS patients with paired DBS and blood samples, the TREC/KREC levels were mostly stable or increased and showed similar kinetics in respective patients. Conclusions: The combined TREC/KREC approach with correction via control gene identified 1 of 13 (8%) of DiGeorge syndrome patients at birth in our cohort. The majority of patients had TREC/KREC levels in the normal range.	[Fronkova, Eva; Svaton, Mlchael; Novakova, Michaela; Kotrova, Mlchaela; Kallna, Tomas; Keslova, Petra; Mejstrikova, Ester; Trka, Jan] Charles Univ Prague, Sch Med 2, Dept Paediat Haematol Oncol, CLIP, Prague, Czech Republic; [Fronkova, Eva; Klocperk, Adam; Svaton, Mlchael; Novakova, Michaela; Kotrova, Mlchaela; Kayserova, Jana; Kallna, Tomas; Keslova, Petra; Mejstrikova, Ester; Trka, Jan; Sediva, Anna] Charles Univ Prague, Sch Med 2, Dept Immunol, Prague, Czech Republic; [Klocperk, Adam; Kayserova, Jana; Sediva, Anna] Univ Hosp Motol, Prague, Czech Republic; [Votava, Felix] Charles Univ Prague, Sch Med 3, Dept Pediat, Prague, Czech Republic; [Votava, Felix] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic; [Vinohradska, Hana] Masaryk Univ, Fac Med, Children Hosp, Dept Clin Biochem, Brno, Czech Republic; [Freiberger, Tomas] Masaryk Univ, Dept Clin Immunol & Allergol, Fac Med, Brno, Czech Republic; [Freiberger, Tomas] Cent European Inst Technol, Brno, Czech Republic; [Freiberger, Tomas] Ctr Cardiovasc Surg & Transplantat, Mol Genet Lab, Brno, Czech Republic	Charles University Prague; Charles University Prague; Motol University Hospital; Charles University Prague; University Hospital Vinohrady; Masaryk University Brno; Masaryk University Brno	Sediva, A (corresponding author), Charles Univ Prague, Sch Med 2, Dept Immunol, Prague, Czech Republic.	anna.sediva@fnmotol.cz	Freiberger, Tomas/D-8421-2011; Sediva, Anna/AAE-2774-2019; Kalina, Tomas/AAC-6655-2019; Kalina, Tomas/C-1078-2009; Svaton, Michael/AAB-3869-2019; Trka, Jan/Y-4820-2019; Klocperk, Adam/L-6185-2017; Kalina, Tomas/AAE-5036-2019; Sediva, Anna/J-5904-2017	Freiberger, Tomas/0000-0001-6532-7053; Sediva, Anna/0000-0001-7730-2304; Kalina, Tomas/0000-0003-4475-2872; Klocperk, Adam/0000-0002-1526-4557; Kalina, Tomas/0000-0003-4475-2872; Novakova, Michaela/0000-0003-2964-5956; Kotrova, Michaela/0000-0001-5394-1072	Czech Science Foundation (GACR) Centre of Excellence [P302/12/G101]; Internal Grant Agency of the Ministry of Health of the Czech Republic [IGA MZCR NT/13287-4/2012]; Ministry of Health of the Czech Republic (MH CZ-DRO), University Hospital Motol, Prague, Czech Republic [00064203]; L'Oreal for Women in Science Fellowship; Science Development Program at Charles University in Prague, PRVOUK [P31]	Czech Science Foundation (GACR) Centre of Excellence; Internal Grant Agency of the Ministry of Health of the Czech Republic; Ministry of Health of the Czech Republic (MH CZ-DRO), University Hospital Motol, Prague, Czech Republic; L'Oreal for Women in Science Fellowship; Science Development Program at Charles University in Prague, PRVOUK	Funding: Support was provided by the Czech Science Foundation (GACR) Centre of Excellence, P302/12/G101, http://www.gacr.cz/en/, (EF, JT); Internal Grant Agency of the Ministry of Health of the Czech Republic, IGA MZCR NT/13287-4/2012, http://iga.mzcr.cz/publicWeb/ (AS); Ministry of Health of the Czech Republic (MH CZ-DRO), University Hospital Motol, Prague, Czech Republic, 00064203, http://www.mzcr.cz/ (AS); L'Oreal for Women in Science Fellowship in 2013, http://www.prozenyvevede.cz (EF); Science Development Program at Charles University in Prague, PRVOUK P31. http://ips.fsv.cuni.cz/IPSENG-53.html (FV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SP, 2014, J CLIN IMMUNOL, V34, P323, DOI 10.1007/s10875-014-0007-6; Borte S, 2011, ANN NY ACAD SCI, V1246, P118, DOI 10.1111/j.1749-6632.2011.06350.x; Cancrini C, 2005, J CLIN IMMUNOL, V25, P265, DOI 10.1007/s10875-005-4085-3; Chinn IK, 2013, CLIN EXP IMMUNOL, V173, P140, DOI 10.1111/cei.12088; Davies EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00322; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Framme JL, 2014, J CLIN IMMUNOL, V34, P514, DOI 10.1007/s10875-014-0002-y; Fronkova E, 2008, BONE MARROW TRANSPL, V42, P187, DOI 10.1038/bmt.2008.122; Gennery AR, 2012, CELL MOL LIFE SCI, V69, P17, DOI 10.1007/s00018-011-0842-z; Janda A, 2007, PEDIATR TRANSPLANT, V11, P441, DOI 10.1111/j.1399-3046.2007.00702.x; JUNKER AK, 1995, J PEDIATR-US, V127, P231, DOI 10.1016/S0022-3476(95)70300-4; Kamae C, 2013, J ALLERGY CLIN IMMUN, V131, P1437, DOI 10.1016/j.jaci.2012.10.059; Kelly Brian T, 2013, Clin Epidemiol, V5, P363, DOI 10.2147/CLEP.S48890; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; Lima K, 2010, CLIN EXP IMMUNOL, V161, P98, DOI 10.1111/j.1365-2249.2010.04152.x; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Patel K, 2012, J PEDIATR-US, V161, P950, DOI 10.1016/j.jpeds.2012.06.018; Pierdominici M, 2003, CLIN EXP IMMUNOL, V132, P323, DOI 10.1046/j.1365-2249.2003.02134.x; Pongers-Willemse MJ, 1998, LEUKEMIA, V12, P2006, DOI 10.1038/sj.leu.2401246; Sediva A, 2005, MED SCI MONITOR, V11; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; van Zelm MC, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00012; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458	25	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114514	10.1371/journal.pone.0114514	http://dx.doi.org/10.1371/journal.pone.0114514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485546	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600065
J	Wu, CT; Lai, JN; Tsai, YT				Wu, Chien-Tung; Lai, Jung-Nien; Tsai, Yueh-Ting			The Prescription Pattern of Chinese Herbal Products That Contain Dang-Qui and Risk of Endometrial Cancer among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; SURGICAL ADJUVANT BREAST; PROJECT NSABP B-14; ALTERNATIVE MEDICINE; THERAPY; PREVENTION; CARCINOMA; METHYLTRANSFERASE; COMPLEMENTARY; TRIALS	Purpose: The increased practice of traditional Chinese medicine worldwide has raised concerns regarding herb-drug interactions. We analyzed the usage of Chinese herbal products containing dang-qui and investigated whether dang-qui therapy increases endometrial cancer risk among tamoxifen-treated breast cancer survivors in Taiwan. Methods: All patients newly diagnosed with invasive breast cancer who received tamoxifen treatment from January 1, 1998, to December 31, 2008 were selected from the National Health Insurance Research Database. The usage, frequency of service and type of Chinese herbal products containing dang-qui prescribed across the 31,970 survivors were evaluated. Logistic regression method was employed to estimate the odds ratios for utilization of Chinese herbal products containing dang-qui. Cox proportional hazard regression was performed to calculate the hazard ratio of endometrial cancer associated with dang-qui use within the cohort. Results: Almost one in two study subjects had used dang-qui. Among 31,938 tamoxifen-treated breast cancer survivors, 157 cases of subsequent endometrial cancer were identified. The hazard ratio for development of endometrial cancer among breast cancer survivors aged 20-79 years who had taken dang-qui after tamoxifen treatment was decreased compared to survivors who had never used dang-qui (HR: 0.61, 95% CI: 0.44-0.84). To minimise potential confounding factors, women with breast cancer in the reproductive age were excluded from further analysis, and the negative relationship between dang-qui consumption and subsequent endometrial cancer among breast cancer survivors aged 55-79 years was still observed, although not significantly (HR: 0.74, 95% CI: 0.46-1.17). Conclusions: Dang-qui consumption is common among breast cancer survivors aged 20-79 years and seems decrease the risk of subsequent endometrial cancer after less than a cumulative dose of 7,500 mg of tamoxifen treatment.	[Wu, Chien-Tung; Lai, Jung-Nien; Tsai, Yueh-Ting] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Lai, Jung-Nien] Taipei City Hosp, Dept Chinese Med, Yangming Branch, Taipei, Taiwan; [Wu, Chien-Tung; Lai, Jung-Nien; Tsai, Yueh-Ting] Taiwan Assoc Tradit Chinese Med Family, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital	Tsai, YT (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	kareny@ms10.hinet.net			National Science Council [NSC-102WFA2200187]; National Research Institutes of Chinese Medicine [NRICM-10002]; Ministry of Health and Welfare	National Science Council(Ministry of Science and Technology, Taiwan); National Research Institutes of Chinese Medicine; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	The study was partially supported by the National Science Council (NSC-102WFA2200187), the National Research Institutes of Chinese Medicine (NRICM-10002), and the Ministry of Health and Welfare (http://www.mohw.gov.tw/EN/Ministry/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1991, J NATL CANCER I, V83, P1013, DOI 10.1093/jnci/83.14.1013; [Anonymous], 2013, LIST 100 UN FORM; Bergman L, 2000, LANCET, V356, P881, DOI 10.1016/S0140-6736(00)02677-5; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; BUSH TL, 1993, EPIDEMIOL REV, V15, P233, DOI 10.1093/oxfordjournals.epirev.a036110; Centers for Disease Control and Prevention, 2013, INT CLASS DIS; Chen Ming-Chen, 2013, J Tradit Complement Med, V3, P256, DOI 10.4103/2225-4110.119734; Clarke M, 1998, LANCET, V351, P1451; COOK LS, 1995, J NATL CANCER I, V87, P1359, DOI 10.1093/jnci/87.18.1359; Curtis RE, 2004, JNCI-J NATL CANCER I, V96, P70, DOI 10.1093/jnci/djh007; Curtis RE, 1996, J NATL CANCER I, V88, P832, DOI 10.1093/jnci/88.12.832; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Department of Chinese Medicine and Pharmacy Ministry of Health and Welfare, 2014, LIST 21 MOST IMP ANC; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; FORNANDER T, 1989, LANCET, V1, P117; Gelmon K, 2000, LANCET, V356, P868, DOI 10.1016/S0140-6736(00)02670-2; HARDELL L, 1988, LANCET, V2, P1432; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Kuo CC, 2007, INT J CANCER, V121, P2293, DOI 10.1002/ijc.22927; Lai JN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697893; Lai JN, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/891893; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; LOVE RR, 1994, J NATL CANCER I, V86, P1025, DOI 10.1093/jnci/86.13.1025; Mignotte H, 1998, INT J CANCER, V76, P325, DOI 10.1002/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X; NAYFIELD SG, 1991, J NATL CANCER I, V83, P1450, DOI 10.1093/jnci/83.20.1450; Rakovitch E, 2005, BREAST CANCER RES TR, V90, P139, DOI 10.1007/s10549-004-3779-1; Reyes-Gibby CC, 2008, LANCET ONCOL, V9, P777, DOI 10.1016/S1470-2045(08)70197-9; Rubino C, 2003, BRIT J CANCER, V89, P840, DOI 10.1038/sj.bjc.6601138; RUTQVIST LE, 1995, J NATL CANCER I, V87, P645, DOI 10.1093/jnci/87.9.645; Sasco AJ, 1996, LANCET, V347, P761, DOI 10.1016/S0140-6736(96)90111-7; SUNDERLAND MC, 1991, J CLIN ONCOL, V9, P1283, DOI 10.1200/JCO.1991.9.7.1283; Swerdlow AJ, 2005, JNCI-J NATL CANCER I, V97, P375, DOI 10.1093/jnci/dji057; Tagliaferri M, 2001, SEMIN ONCOL, V28, P121, DOI 10.1053/sonc.2001.20749; VANLEEUWEN FE, 1994, LANCET, V343, P448, DOI 10.1016/S0140-6736(94)92692-1; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r	36	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113887	10.1371/journal.pone.0113887	http://dx.doi.org/10.1371/journal.pone.0113887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485843	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600029
J	Shen, JY; Zhou, CL; Zhu, S; Shi, WQ; Hu, MS; Fu, XW; Wang, CD; Wang, YC; Zhang, Q; Yu, Y				Shen, Junye; Zhou, Chuanli; Zhu, Shien; Shi, Wenqing; Hu, Maishun; Fu, Xiangwei; Wang, Chuduan; Wang, Yachun; Zhang, Qin; Yu, Ying			Comparative Transcriptome Analysis Reveals Early Pregnancy-Specific Genes Expressed in Peripheral Blood of Pregnant Sows	PLOS ONE			English	Article							PROSTAGLANDIN SYNTHESIS; MATERNAL RECOGNITION; EMBRYO IMPLANTATION; MESSENGER-RNA; ENDOMETRIUM; DIAGNOSIS; TIME; SWINE; LEUKOCYTES	Early and accurate diagnosis of pregnancy is important for effective management of an economical pig farm. Besides the currently available methods used in early diagnosis of sows, circulating nucleic acids in peripheral blood may contain some early pregnancy-specific molecular markers. For the first time, microarray analysis of peripheral blood from pregnant sows versus non-pregnant sows identified 127 up-regulated and 56 down-regulated genes at day 14 post-insemination. Gene Ontology annotation grouped the total differently expressed genes into 3 significantly enriched terms, cell surface receptor linked signal transduction, G-protein coupled receptor protein signaling pathway and regulation of vesicle-mediated transport. Signaling pathway analysis revealed the only one significantly changed pathway was arachidonic acid metabolism. Of the differently expressed genes, nine (including LPAR3, RXFP4, GALP, CBR1, CBR2, GPX6, USP18, LHB and NR5A1) were found to exert function related to early pregnancy processes. This study provides a clue that differentially abundant RNAs in maternal peripheral blood can help to identify the molecular markers of early pregnancy in pigs.	[Shen, Junye; Zhou, Chuanli; Wang, Chuduan; Wang, Yachun; Zhang, Qin; Yu, Ying] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China; [Shen, Junye; Zhou, Chuanli; Zhu, Shien; Hu, Maishun; Fu, Xiangwei; Wang, Chuduan; Wang, Yachun; Zhang, Qin; Yu, Ying] China Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Shi, Wenqing] Anim Husb & Vet Stn Beijing, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Yu, Y (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China.	yuying@cau.edu.cn	Deng, Shou-Long/GWV-0452-2022		Beijing Municipal Bureau of Agriculture R D Program [20100222]; Kunming Bureau of science and technology Key Program [09H130302]; Key Development of New Transgenic Breeds Programs [2009ZX08009-146B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]	Beijing Municipal Bureau of Agriculture R D Program; Kunming Bureau of science and technology Key Program; Key Development of New Transgenic Breeds Programs; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Beijing Municipal Bureau of Agriculture R & D Program (grant number 20100222, 2010), Kunming Bureau of science and technology Key Program (grant number 09H130302, 2011), Key Development of New Transgenic Breeds Programs (grant number 2009ZX08009-146B, 2009) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1191). The funders had no role in study design and data analysis, decision to publish, or preparation of the manuscript.	Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Chen Y, 2000, BRIT J CANCER, V82, P2000; Chiu RWK, 2006, CLIN CHEM, V52, P313, DOI 10.1373/clinchem.2005.059691; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Gifford CA, 2008, BIOL REPROD, V79, P518, DOI 10.1095/biolreprod.108.069468; Gifford CA, 2007, J DAIRY SCI, V90, P274, DOI 10.3168/jds.S0022-0302(07)72628-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung ECW, 2009, J CLIN PATHOL, V62, P308, DOI 10.1136/jcp.2007.048470; Kaczmarek MM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103564; Kauffman AS, 2005, HORM BEHAV, V48, P141, DOI 10.1016/j.yhbeh.2005.01.010; Klein C, 2010, BIOL REPROD, V83, P102, DOI 10.1095/biolreprod.109.081612; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee FY, 2011, DEV CELL, V21, P315, DOI 10.1016/j.devcel.2011.06.028; Markowska-Daniel I., 2009, Zycie Weterynaryjne, V84, P794; Mayer J, 2013, THERIOGENOLOGY, V79, P173, DOI 10.1016/j.theriogenology.2012.09.024; Miller GM, 2003, J SWINE HEALTH PROD, V11, P233; Mistry HD, 2012, AM J OBSTET GYNECOL, V206, P21, DOI 10.1016/j.ajog.2011.07.034; Mlynarczuk J, 2013, ANIM REPROD SCI; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Nitta A, 2011, REPRODUCTION, V142, P879, DOI 10.1530/REP-11-0157; Ostrup E, 2011, REPROD FERT DEVELOP, V23, P964, DOI 10.1071/RD11140; Ostrup E, 2010, BIOL REPROD, V83, P277, DOI 10.1095/biolreprod.109.082321; Poon LLM, 2000, CLIN CHEM, V46, P1832; Port JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-503; Purohit G., 2010, WEBMEDCENTRAL REPROD, V1, DOI 10.9754/journal.wmc.2010.001305; Quan K, 2011, AFR J BIOTECHNOL, V10, P9710; Raymond F, 2009, J CLIN MICROBIOL, V47, P743, DOI 10.1128/JCM.01297-08; Ren QA, 2010, INT J MOL SCI, V11, P2322, DOI 10.3390/ijms11062322; Sedrak M, 2011, GENET TEST MOL BIOMA, V15, P627, DOI 10.1089/gtmb.2010.0263; Silvertown JD, 2010, REGUL PEPTIDES, V159, P44, DOI 10.1016/j.regpep.2009.09.007; Vigano P, 2003, PLACENTA, V24, pS56, DOI 10.1016/S0143-4004(03)00137-1; Waclawik A, 2011, REPRODUCTION, V142, P389, DOI 10.1530/REP-11-0033; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Williams SI, 2008, CAN VET J, V49, P269; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zhang H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-45; Ziecik AJ, 2002, DOMEST ANIM ENDOCRIN, V23, P265, DOI 10.1016/S0739-7240(02)00162-5	38	8	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114036	10.1371/journal.pone.0114036	http://dx.doi.org/10.1371/journal.pone.0114036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479131	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200040
J	Okata, T; Toyoda, K; Okamoto, A; Miyata, T; Nagatsuka, K; Minematsu, K				Okata, Takuya; Toyoda, Kazunori; Okamoto, Akira; Miyata, Toshiyuki; Nagatsuka, Kazuyuki; Minematsu, Kazuo			Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; WARFARIN	Objectives: In Japan, low-dose rivaroxaban [15 mg QD/10 mg QD for creatinine clearance of 30-49 mL/min] was approved for clinical use in NVAF patients partly because of its unique pharmacokinetics in Japanese subjects. The aim of the study was to determine the anticoagulation intensity of rivaroxaban and its determinant factors in Japanese stroke patients. Methods: Consecutive stroke patients with NVAF admitted between July 2012 and December 2013 were studied. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and estimated plasma concentration of rivaroxaban (C-riv) based on an anti-factor Xa chromogenic assay were measured just before and 4 and 9 h after administration at the steady state level of rivaroxaban. Determinant factors for C-riv were explored using a linear mixed-model approach. Results: Of 110 patients (37 women, 75+/-9 years old), 59 took 15 mg QD of rivaroxaban and 51 took 10 mg QD. C-riv at 4 h was 186 ng/mL for patients taking 15 mg QD and 147 ng/mL for those taking 10 mg QD. Both PT and aPTT were positively correlated with C-riv. C-riv was 72% lower at 4 h in 15 patients receiving crushed tablets than in the other patients, and tablet crushing was significantly associated with lower C-riv (adjusted estimate -0.43, 95% CI -0.60 to -0.26) after multivariate-adjustment. Conclusion: The anticoagulation effects of rivaroxaban in the acute stroke setting for Japanese NVAF patients were relatively low as compared with those in the ROCKET-AF and J-ROCKET AF trials. Tablet crushing, common in dysphagic patients, decreased C-riv.	[Okata, Takuya; Toyoda, Kazunori; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Osaka, Japan; [Okamoto, Akira] Natl Cerebral & Cardiovasc Ctr, Dept Clin Chem, Osaka, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka, Japan; [Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Toyoda, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Osaka, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	National Cerebral and Cardiovascular Center [23-4-3, 25-6-4]	National Cerebral and Cardiovascular Center(National Cerebral & Cardiovascular Center - Japan)	The present study was supported by Intramural Research Funds (23-4-3, 25-6-4) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, XAR PACK INS; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dyke CK, 2002, CIRCULATION, V105, P2385, DOI 10.1161/01.CIR.0000016351.12759.52; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Kaneko M, 2013, DRUG METAB PHARMACOK, V28, P321, DOI 10.2133/dmpk.DMPK-12-RG-109; LANGE N, 1989, J AM STAT ASSOC, V84, P241, DOI 10.2307/2289869; Moore KT, 2012, ACCP ANN M; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Samama MM, 2012, THROMB HAEMOSTASIS, V107, P379, DOI 10.1160/TH11-06-0391; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Samama MM, 2002, PATHOPHYSIOL HAEMO T, V32, P218, DOI 10.1159/000073570; Tanigawa T, 2013, DRUG METAB PHARMACOK, V28, P59, DOI 10.2133/dmpk.DMPK-12-RG-034; Toyoda K, 2013, CONTRIB NEPHROL, V179, P1, DOI 10.1159/000346944; Toyoda K, 2012, NEUROLOGY, V78, P1898, DOI 10.1212/WNL.0b013e318259e29f	19	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113641	10.1371/journal.pone.0113641	http://dx.doi.org/10.1371/journal.pone.0113641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25479967	Green Submitted, gold, Green Published			2022-12-27	WOS:000349145400071
J	Carrasco, A; Brown, TA; Lomber, SG				Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.			Spectral and Temporal Acoustic Features Modulate Response Irregularities within Primary Auditory Cortex Columns	PLOS ONE			English	Article							CAT PRIMARY; CEREBRAL-CORTEX; LAYER-III; FUNCTIONAL-ORGANIZATION; SOMATOSENSORY CORTICES; PROJECTION NEURONS; MACAQUE MONKEY; VISUAL-CORTEX; IN-VITRO; LAMINAR	Assemblies of vertically connected neurons in the cerebral cortex form information processing units (columns) that participate in the distribution and segregation of sensory signals. Despite well-accepted models of columnar architecture, functional mechanisms of inter-laminar communication remain poorly understood. Hence, the purpose of the present investigation was to examine the effects of sensory information features on columnar response properties. Using acute recording techniques, extracellular response activity was collected from the right hemisphere of eight mature cats (felis catus). Recordings were conducted with multichannel electrodes that permitted the simultaneous acquisition of neuronal activity within primary auditory cortex columns. Neuronal responses to simple (pure tones), complex (noise burst and frequency modulated sweeps), and ecologically relevant (con-specific vocalizations) acoustic signals were measured. Collectively, the present investigation demonstrates that despite consistencies in neuronal tuning (characteristic frequency), irregularities in discharge activity between neurons of individual A1 columns increase as a function of spectral (signal complexity) and temporal (duration) acoustic variations.	[Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.] Univ Western Ontario, Cerebral Syst Lab, London, ON, Canada; [Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Carrasco, Andres; Brown, Trecia A.; Lomber, Stephen G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Lomber, SG (corresponding author), Univ Western Ontario, Cerebral Syst Lab, London, ON, Canada.	steve.lomber@uwo.ca	Carrasco, Andres/GVU-9039-2022; Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909; Carrasco, Andres/0000-0002-7217-8567	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	Funding provided by the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Anderson LA, 2009, BRAIN RES, V1252, P130, DOI 10.1016/j.brainres.2008.11.037; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Atencio CA, 2010, J NEUROPHYSIOL, V103, P192, DOI 10.1152/jn.00624.2009; Atencio CA, 2009, P NATL ACAD SCI USA, V106, P21894, DOI 10.1073/pnas.0908383106; Brodmann K, 1909, IHREN PRINZIPIEN DAR; BROWN KA, 1978, DEV PSYCHOBIOL, V11, P559, DOI 10.1002/dev.420110605; Carrasco A, 2011, J NEUROPHYSIOL, V106, P1166, DOI 10.1152/jn.00940.2010; Carrasco A, 2010, J NEUROSCI, V30, P1476, DOI 10.1523/JNEUROSCI.5708-09.2009; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Carrasco A, 2009, J NEUROSCI, V29, P8350, DOI 10.1523/JNEUROSCI.6001-08.2009; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; Christianson GB, 2011, J NEUROSCI, V31, P12837, DOI 10.1523/JNEUROSCI.2863-11.2011; CODE RA, 1985, J COMP NEUROL, V242, P485, DOI 10.1002/cne.902420404; DIAMOND IT, 1979, PROGR PSYCHOBIOLOGY, V8, P1; FAVOROV O, 1988, BRAIN RES REV, V13, P25, DOI 10.1016/0165-0173(88)90003-3; FAVOROV O, 1988, BRAIN RES REV, V13, P43, DOI 10.1016/0165-0173(88)90004-5; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P144, DOI 10.1152/jn.00807.2006; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Huetz C, 2011, HEARING RES, V271, P147, DOI 10.1016/j.heares.2010.01.010; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; Jones EG, 2000, P NATL ACAD SCI USA, V97, P5019, DOI 10.1073/pnas.97.10.5019; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2008, J COMP NEUROL, V507, P1901, DOI 10.1002/cne.21614; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; Mathers DA, 2007, NEUROPHARMACOLOGY, V52, P1160, DOI 10.1016/j.neuropharm.2006.12.004; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; MITANI A, 1985, J COMP NEUROL, V235, P430, DOI 10.1002/cne.902350403; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Mountcastle VB, 2003, CEREB CORTEX, V13, P2, DOI 10.1093/cercor/13.1.2; OONISHI S, 1965, JPN J PHYSIOL, V15, P342; PHILLIPS DP, 1981, J NEUROPHYSIOL, V45, P48, DOI 10.1152/jn.1981.45.1.48; Prieto JJ, 1999, J COMP NEUROL, V404, P332, DOI 10.1002/(SICI)1096-9861(19990215)404:3<332::AID-CNE5>3.0.CO;2-R; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Reser DH, 2000, CEREB CORTEX, V10, P574, DOI 10.1093/cercor/10.6.574; ROMAND R, 1984, DEV PSYCHOBIOL, V17, P629, DOI 10.1002/dev.420170606; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; SCHWARK HD, 1992, EXP BRAIN RES, V91, P425; Shen JX, 1999, HEARING RES, V137, P174, DOI 10.1016/S0378-5955(99)00149-5; Sugimoto S, 1997, HEARING RES, V112, P175, DOI 10.1016/S0378-5955(97)00119-6; SZENTAGOTHAI J, 1975, BRAIN RES, V95, P475, DOI 10.1016/0006-8993(75)90122-5; Szymanski FD, 2011, J NEUROSCI, V31, P15787, DOI 10.1523/JNEUROSCI.1416-11.2011; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Essen D.C., 1985, P259; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00072; WALLACE MN, 1991, EXP BRAIN RES, V86, P527; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Winer J.A., 1992, Springer Handbook of Auditory Research, V1, P222; WINER JA, 1984, J COMP NEUROL, V229, P476, DOI 10.1002/cne.902290404; WINER JA, 1984, J COMP NEUROL, V224, P535, DOI 10.1002/cne.902240405; WINER JA, 1984, J COMP NEUROL, V229, P512, DOI 10.1002/cne.902290406; WINER JA, 1985, J COMP NEUROL, V238, P10, DOI 10.1002/cne.902380103; Winer JA, 2001, J COMP NEUROL, V434, P379, DOI 10.1002/cne.1183; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	73	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114550	10.1371/journal.pone.0114550	http://dx.doi.org/10.1371/journal.pone.0114550			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494365	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400051
J	Gao, RW; Uchida, S; Shahab, A; Shafait, F; Frinken, V				Gao, Renwu; Uchida, Seiichi; Shahab, Asif; Shafait, Faisal; Frinken, Volkmar			Visual Saliency Models for Text Detection in Real World	PLOS ONE			English	Article							ATTENTION; TASK	This paper evaluates the degree of saliency of texts in natural scenes using visual saliency models. A large scale scene image database with pixel level ground truth is created for this purpose. Using this scene image database and five state-of-the-art models, visual saliency maps that represent the degree of saliency of the objects are calculated. The receiver operating characteristic curve is employed in order to evaluate the saliency of scene texts, which is calculated by visual saliency models. A visualization of the distribution of scene texts and non-texts in the space constructed by three kinds of saliency maps, which are calculated using Itti's visual saliency model with intensity, color and orientation features, is given. This visualization of distribution indicates that text characters are more salient than their non-text neighbors, and can be captured from the background. Therefore, scene texts can be extracted from the scene images. With this in mind, a new visual saliency architecture, named hierarchical visual saliency model, is proposed. Hierarchical visual saliency model is based on Itti's model and consists of two stages. In the first stage, Itti's model is used to calculate the saliency map, and Otsu's global thresholding algorithm is applied to extract the salient region that we are interested in. In the second stage, Itti's model is applied to the salient region to calculate the final saliency map. An experimental evaluation demonstrates that the proposed model outperforms Itti's model in terms of captured scene texts.	[Gao, Renwu; Uchida, Seiichi; Frinken, Volkmar] Kyushu Univ, Dept Adv Informat Technol, Fukuoka 812, Japan; [Shahab, Asif] German Res Ctr Artificial Intelligence, Kaiserslautern, Rhineland Palat, Germany; [Shafait, Faisal] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia	Kyushu University; University of Western Australia	Gao, RW (corresponding author), Kyushu Univ, Dept Adv Informat Technol, Fukuoka 812, Japan.	kou@human.ait.kyushu-u.ac.jp		Uchida, Seiichi/0000-0001-8592-7566	Creation of Human-Harmonized Information Technology for Convivial Society (CREST); Grants-in-Aid for Scientific Research [26240024] Funding Source: KAKEN	Creation of Human-Harmonized Information Technology for Convivial Society (CREST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the support of Creation of Human-Harmonized Information Technology for Convivial Society (CREST), which is a project organized by Japan Science and Technology Agency (JST), http://www.jst.go.jp/kisoken/crest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Butko NJ, 2008, IEEE INT CONF ROBOT, P2398, DOI 10.1109/ROBOT.2008.4543572; Cerf M, 2009, J VISION, V9, DOI 10.1167/9.12.10; Coates A, 2011, PROC INT CONF DOC, P440, DOI 10.1109/ICDAR.2011.95; Crandall D., 2003, International Journal on Document Analysis and Recognition, V5, P138, DOI 10.1007/s10032-002-0091-7; Epshtein B, 2010, PROC CVPR IEEE, P2963, DOI 10.1109/CVPR.2010.5540041; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Frintrop S, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658355; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Koch C., 1987, MATTERINTELLIGENCE, P115, DOI [10.1007/978-94-009-3833-5, DOI 10.1007/978-94-009-3833-5, DOI 10.1007/978-94-009-3833-5_5]; Lee JJ, 2011, PROC INT CONF DOC, P429, DOI 10.1109/ICDAR.2011.93; Levin DT, 1997, PSYCHON B REV, V4, P501, DOI 10.3758/BF03214339; Mishra A, 2012, PROC CVPR IEEE, P2687, DOI 10.1109/CVPR.2012.6247990; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Qiaoyu Sun, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3991, DOI 10.1109/ICPR.2010.971; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rensink R, 1997, INVEST OPHTHALMOL, V38, P3273; Shahab A., 2012, Proceedings of the 10th IAPR International Workshop on Document Analysis Systems (DAS 2012), P317, DOI 10.1109/DAS.2012.42; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Uchida S., 2014, HDB DOCUMENT IMAGE P, P843, DOI DOI 10.1007/978-0-85729-859-1_28; Uchida S, 2011, PROC INT CONF DOC, P819, DOI 10.1109/ICDAR.2011.168; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	26	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114539	10.1371/journal.pone.0114539	http://dx.doi.org/10.1371/journal.pone.0114539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494196	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400050
J	Liu, YJ; Zhang, WT; Yao, YZ; Ren, D				Liu, Yujia; Zhang, Weiting; Yao, Yunzhi; Ren, Dong			A New Fossil of Necrotauliidae (Insecta: Trichoptera) from the Jiulongshan Formation of China and Its Taxonomic Significance	PLOS ONE			English	Article							CADDISFLIES INSECTA; SOUTHERN ENGLAND; INNER-MONGOLIA; PHYLOGENY; EVOLUTION; LEPIDOPTERA; ORDER; AGE	Background: Acisarcuatus variradius gen. et sp. nov., an extinct new species representing a new genus, is described from the Middle Jurassic Jiulongshan Formation in Daohugou Village, Inner Mongolia, China. Methodology/Principal Findings: In this paper, we revised the diagnosis of Necrotauliidae Handlirsch, 1906. One new genus and species of Necrotauliidae is described. An analysis based on the fossil morphological characters clarified the taxonomic status of the new taxa. Conclusions/Significance: New fossil evidence supports the viewpoint that the family Necrotauliidae belongs to the Integripalpia.	[Liu, Yujia; Yao, Yunzhi; Ren, Dong] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing 100048, Peoples R China; [Zhang, Weiting] Shijiazhuang Univ Econ, Geosci Museum, Shijiazhuang 050031, Peoples R China	Capital Normal University; Hebei GEO University	Yao, YZ (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing 100048, Peoples R China.	yaoyz100@gmail.com			National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [31372242, 41272006, 31230065, 41402009]; Project of Outstanding Young Talents of Beijing Municipal Commission of Education [CITTCD201304163]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [131021]; General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China [KM201210028016]; Project of Great Wall Scholars and KEY Project of Beijing Municipal Commission of Education Project [KZ201310028033]; PhD Research Startup Foundation of Shijiazhuang University of Economics [BQ201319]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Outstanding Young Talents of Beijing Municipal Commission of Education; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China; Project of Great Wall Scholars and KEY Project of Beijing Municipal Commission of Education Project; PhD Research Startup Foundation of Shijiazhuang University of Economics	This research was funded by grants from the National Basic Research Program of China (973 Program) (No. 2012CB821900), The National Natural Science Foundation of China (Nos. 31372242, 41272006, 31230065, 41402009), the Project of Outstanding Young Talents of Beijing Municipal Commission of Education (No. CIT&TCD201304163), the Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (No. 131021), the General Program of Science and Technology Development Project of Beijing Municipal Education Commission of China (No. KM201210028016), the Project of Great Wall Scholars and KEY Project of Beijing Municipal Commission of Education Project (grant KZ201310028033), and the PhD Research Startup Foundation of Shijiazhuang University of Economics (No. BQ201319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge Joerg, 2002, Nova Supplementa Entomologica, V15, P55; Ansorge Joerg, 2003, Acta Zoologica Cracoviensia, V46, P285; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gao Yan, 2012, Chinese Journal of Applied Entomology, V49, P543; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Grimaldi David, 2005, pi; Handlirsch A., 1906, HDB PALAONTOLOGEN ZO; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Hennig W., 1981, INSECT PHYLOGENY; Holzenthal RW, 2007, ZOOTAXA, P639; Hong Y. C., 1983, MIDDLE JURASSIC FOSS; Ivanov V.D., 2002, HIST INSECTS, P194; JARZEMBOWSKI E A, 1991, Proceedings of the Geologists' Association, V102, P93; Jarzembowski EA, 1995, CRETACEOUS RES, V16, P695, DOI 10.1006/cres.1995.1043; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; KUKALOVAPECK J, 1990, CAN J EARTH SCI, V27, P459, DOI 10.1139/e90-041; Lin Q.B., 1986, EARLY MESOZOIC FOSSI; Lin QB, 2006, PROG NAT SCI-MATER, V16, P309; Martynova OM, 1958, MAT K OSNOVAM PALEON, P69; Martynova OM, 1962, OSNOVY PALEONTOLOGII, V9, P294; Morse J.C., TRICHOPTERA WORLD CH; Morse JC, 1997, ANNU REV ENTOMOL, V42, P427, DOI 10.1146/annurev.ento.42.1.427; NOVOKSHONOV VG, 1992, ZOOL ZH, V71, P58; RIEK E. F., 1955, AUSTRALIAN JOUR ZOOL, V3, P654, DOI 10.1071/ZO9550654; ROSS HH, 1967, ANNU REV ENTOMOL, V12, P169, DOI 10.1146/annurev.en.12.010167.001125; SHIELDS O, 1988, J PALEONTOL, V62, P251, DOI 10.1017/S0022336000029899; SOHN JC, 2012, ZOOTAXA 0430, P1; Sukacheva I.D., 1982, Trudy Paleontologicheskogo Instituta, V197, P1; Sukacheva ID, 1985, T PALEONTOLOGICHESKO, P96; Sukatscheva I.D., 1976, Paleontological J, V10, P198; Sukatsheva I.D., 1968, YURSKIE NASEKOMYE KA, P175; SUKATSHEVA ID, 1980, ZH OBSHCH BIOL, V41, P457; Sukatsheva ID, 2001, CRETACEOUS RES, V22, P685, DOI 10.1006/cres.2001.0292; Tillyard RJ, 1926, P LINN SOC N S W, P265; Tillyard RJ., 1933, FOSSIL INSECTS, V3, P15; Wang XL, 2005, CHINESE SCI BULL, V50, P2369, DOI 10.1360/982005-581; Weaver III J.S., 1984, P 4 INT S TRICH, P413; Wiggins G. B., 1994, AQUATIC INSECTS CHIN, P260; WIGGINS GB, 1989, J N AM BENTHOL SOC, V8, P260, DOI 10.2307/1467330; WILLIAMS NE, 1988, PALAEOGEOGR PALAEOCL, V62, P493, DOI 10.1016/0031-0182(88)90069-7; Willmann R, 1989, ABH SENCKENB NAT, V544, P1; WOOTTON RJ, 1988, PALAEOGEOGR PALAEOCL, V62, P477, DOI 10.1016/0031-0182(88)90068-5	43	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114968	10.1371/journal.pone.0114968	http://dx.doi.org/10.1371/journal.pone.0114968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494387	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400086
J	Soares, SC; Lindstrom, B; Esteves, F; Ohman, A				Soares, Sandra C.; Lindstrom, Bjorn; Esteves, Francisco; Ohman, Arne			The Hidden Snake in the Grass: Superior Detection of Snakes in Challenging Attentional Conditions	PLOS ONE			English	Article							VISUAL-SEARCH; RAPID DETECTION; EVOLVED MODULE; HUMAN PULVINAR; FEAR; STIMULUS; EMOTION; LOAD; RECOGNITION; COMPETITION	Snakes have provided a serious threat to primates throughout evolution. Furthermore, bites by venomous snakes still cause significant morbidity and mortality in tropical regions of the world. According to the Snake Detection Theory (SDT Isbell, 2006; 2009), the vital need to detect camouflaged snakes provided strong evolutionary pressure to develop astute perceptual capacity in animals that were potential targets for snake attacks. We performed a series of behavioral tests that assessed snake detection under conditions that may have been critical for survival. We used spiders as the control stimulus because they are also a common object of phobias and rated negatively by the general population, thus commonly lumped together with snakes as "evolutionary fear-relevant''. Across four experiments (N=205) we demonstrate an advantage in snake detection, which was particularly obvious under visual conditions known to impede detection of a wide array of common stimuli, for example brief stimulus exposures, stimuli presentation in the visual periphery, and stimuli camouflaged in a cluttered environment. Our results demonstrate a striking independence of snake detection from ecological factors that impede the detection of other stimuli, which suggests that, consistent with the SDT, they reflect a specific biological adaptation. Nonetheless, the empirical tests we report are limited to only one aspect of this rich theory, which integrates findings across a wide array of scientific disciplines.	[Soares, Sandra C.] Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal; [Soares, Sandra C.] Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging & Life Sci, Coimbra, Portugal; [Soares, Sandra C.] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, P-4100 Oporto, Portugal; [Lindstrom, Bjorn; Ohman, Arne] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Esteves, Francisco] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Universidade de Aveiro; Universidade de Coimbra; Universidade do Porto; Karolinska Institutet; Mid-Sweden University	Soares, SC (corresponding author), Univ Aveiro, Dept Educ, P-3800 Aveiro, Portugal.	sandra.soares@ua.pt	Esteves, Francisco/I-1206-2012; Soares, Sandra C./K-5576-2013	Esteves, Francisco/0000-0002-5403-0091; Soares, Sandra C./0000-0002-0346-7840	Foundation of Science and Technology of the Portuguese Ministry of Science, Technology and Higher Education [SFRH/19513/2004, PTDC/PSI/73429/2006]; Operational Program of Science and Innovation; European Social Funding; Swedish Research Council; NOS-S Excellence Center for Cognitive Control in Memory, Attention, Language and Emotion; U.S. National Institute of Mental [P50MH72850];  [421-2010-2117]	Foundation of Science and Technology of the Portuguese Ministry of Science, Technology and Higher Education; Operational Program of Science and Innovation; European Social Funding; Swedish Research Council(Swedish Research CouncilEuropean Commission); NOS-S Excellence Center for Cognitive Control in Memory, Attention, Language and Emotion; U.S. National Institute of Mental; 	This study was supported by grants SFRH/19513/2004 (to SCS) and PTDC/PSI/73429/2006 (to SCS and FE), from the Foundation of Science and Technology of the Portuguese Ministry of Science, Technology and Higher Education (www.fct.pt), and co-financed by The Operational Program of Science and Innovation 2010 and the European Social Funding. The study also received financial support of AO from the Swedish Research Council; (Grant 421-2010-2117); The NOS-S Excellence Center for Cognitive Control in Memory, Attention, Language and Emotion; and the U.S. National Institute of Mental (P50MH72850) to the Center for the Study of Emotion Attention at the University of Florida, Gainesville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAS S, 1969, COMPR PSYCHIAT, V10, P151, DOI 10.1016/0010-440X(69)90022-4; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Arend I, 2008, PROG BRAIN RES, V171, P475, DOI 10.1016/S0079-6123(08)00669-9; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Coss RG, 2000, BEHAVIOUR, V137, P315, DOI 10.1163/156853900502105; Cuthbert B. N, 2005, A6 U FLOR; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Fabre-Thorpe M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00243; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Forster S, 2008, VIS COGN, V16, P200, DOI 10.1080/13506280701465049; Fredrikson M, 1996, BEHAV RES THER, V34, P33, DOI 10.1016/0005-7967(95)00048-3; FRISEN L, 1975, INVEST OPHTH VISUAL, V14, P528; Greene H. W., 1997, SNAKES EVOLUTION MYS; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Headland TN, 2011, P NATL ACAD SCI USA, V108, pE1470, DOI 10.1073/pnas.1115116108; Isbell L.A., 2009, FRUIT TREE SERPENT; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Isbister GK, 2004, TOXICON, V43, P477, DOI 10.1016/j.toxicon.2004.02.002; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Leonard CJ, 2011, J VISION, V11, DOI 10.1167/11.13.11; Lim SL, 2008, NEUROPSYCHOLOGIA, V46, P1267, DOI 10.1016/j.neuropsychologia.2007.12.003; LoBue V, EMOTION; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; LoBue V, 2010, CURR DIR PSYCHOL SCI, V19, P375, DOI 10.1177/0963721410388801; LoBue V, 2011, VIS COGN, V19, P129, DOI 10.1080/13506285.2010.522216; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Nyffeler M, 1999, J ARACHNOL, V27, P317; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 2008, HDB EMOTIONS, P709; Ohman A., 1985, THEORETICAL ISSUES B, V1, P123; Ohman A, 2007, PHYSIOL BEHAV, V92, P180, DOI 10.1016/j.physbeh.2007.05.057; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Ohman A, 2010, COGNITION EMOTION, V24, P1216, DOI 10.1080/02699930903166882; Ohman A, 2009, SCAND J PSYCHOL, V50, P543, DOI 10.1111/j.1467-9450.2009.00784.x; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rauschenberger R, 2006, J EXP PSYCHOL GEN, V135, P116, DOI 10.1037/0096-3445.135.1.116; Scharf I, 2006, AM NAT, V168, P350, DOI 10.1086/506921; Shibasaki M, 2009, J COMP PSYCHOL, V123, P131, DOI 10.1037/a0015095; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Soares SC, 2013, PSYCH J, V2, P11, DOI 10.1002/pchj.18; Soares SC, 2009, BEHAV RES THER, V47, P1032, DOI 10.1016/j.brat.2009.07.022; Soares SC, 2009, J ANXIETY DISORD, V23, P136, DOI 10.1016/j.janxdis.2008.05.002; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; Van Strien JW, 2009, NEUROREPORT, V20, P445, DOI 10.1097/WNR.0b013e3283262e26; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016	65	54	55	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114724	10.1371/journal.pone.0114724	http://dx.doi.org/10.1371/journal.pone.0114724			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493937	gold, Green Published			2022-12-27	WOS:000346611400069
J	Deng, XD; Yang, JH; Wu, XX; Li, YJ; Fei, XW				Deng, Xiaodong; Yang, Jinghao; Wu, Xiaoxia; Li, YaJun; Fei, Xiaowen			A C2H2 Zinc Finger Protein FEMU2 Is Required for fox1 Expression in Chlamydomonas reinhardtii	PLOS ONE			English	Article							ALGA CHLAMYDOMONAS-REINHARDTII; DEFICIENCY-RESPONSIVE ELEMENT; DNA-BINDING SPECIFICITY; IRON-UPTAKE; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; MULTICOPPER OXIDASE; METAL TRANSPORTER	Chlamydomonas reinhardtii fox1 gene encodes a ferroxidase that is involved in cellular Fe uptake and highly induced during Fe deficient conditions. In an effort to identify fox1 promoter regulatory elements, an insertional library was generated in a transgenic Chlamydomonas strain (2A38) harboring an arylsulfatase (ARS) reporter gene driven by the fox1 promoter. Mutants with a defective response to low iron conditions were selected for further study. Among these, a strain containing a disrupted femu2 gene was identified. Activation of the fox1 promoter by the femu2 gene product was confirmed by silencing the femu2 gene using RNA interference. In three femu2 RNAi transgenic lines (IR3, IR6, and IR7), ARS reporter gene activities declined by 84.3%, 86.4%, and 88.8%, respectively under Fe deficient conditions. Furthermore, RT-PCR analysis of both the femu2 mutant and the RNAi transgenic lines showed significantly decreased transcript abundance of the endogenous fox1 gene under Fe deficient conditions. Amino acid sequence analysis of the femu2 gene product identified three potential C2H2 zinc finger (ZF) motifs and a nuclear localization study suggests that FEMU2 is localized to the nucleus. In addition, a potential FEMU2 binding site ((G/T) TTGG(G/T)(G/T)T) was identified using PCR-mediated random binding site selection. Taken together, this evidence suggests that FEMU2 is involved in up-regulation of the fox1 gene in Fe deficient cells.	[Deng, Xiaodong; Yang, Jinghao; Wu, Xiaoxia; Li, YaJun] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Peoples R China; [Fei, Xiaowen] Hainan Med Coll, Sch Sci, Haikou 571101, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan Medical University	Fei, XW (corresponding author), Hainan Med Coll, Sch Sci, Haikou 571101, Peoples R China.	feixw2000@hotmail.com	fei, xiaowen/GRJ-8141-2022; Deng, Xiaodong/AAF-3261-2019	Deng, Xiaodong/0000-0002-6938-1214	National Natural Science Foundation of China [31160050, 31360051]; Major Technology Project of Hainan [ZDZX2013023-1]; National Nonprofit Institute Research Grants [CATAS-ITBB110507, 130305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Technology Project of Hainan; National Nonprofit Institute Research Grants	This work was supported by the National Natural Science Foundation of China (31160050, 31360051), the Major Technology Project of Hainan (ZDZX2013023-1), and the National Nonprofit Institute Research Grants (CATAS-ITBB110507, 130305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; DAVIES JP, 1994, MOL CELL BIOL, V14, P5165, DOI 10.1128/MCB.14.8.5165; DEHOSTOS EL, 1988, J CELL BIOL, V106, P29, DOI 10.1083/jcb.106.1.29; Deng X, 2007, EUKARYOT CELL, V6, P2163, DOI 10.1128/EC.00324-07; Deng XD, 2011, BIOMASS BIOENERG, V35, P1811, DOI 10.1016/j.biombioe.2011.01.005; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Ellis PD, 2002, BIOCHEM J, V364, P547, DOI 10.1042/BJ20020269; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Fei XW, 2007, PLANT CELL PHYSIOL, V48, P1496, DOI 10.1093/pcp/pcm110; Fei XW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/790247; Fei XW, 2009, J BIOCHEM, V146, P157, DOI 10.1093/jb/mvp056; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Herbik A, 2002, PLANT PHYSIOL, V130, P2039, DOI 10.1104/pp.013060; Hutners H, 1946, J BACTERIOL, V52, P213; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Ling HQ, 2002, P NATL ACAD SCI USA, V99, P13938, DOI 10.1073/pnas.212448699; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Martin KM, 2000, BIOCHEM J, V345, P529, DOI 10.1042/0264-6021:3450529; Martin KM, 2003, BIOCHEM J, V375, P457, DOI 10.1042/BJ20030870; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; OKUMURA N, 1994, PLANT MOL BIOL, V25, P705, DOI 10.1007/BF00029608; Osada S, 1996, J BIOL CHEM, V271, P3891; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rubinelli P, 2002, PLANTA, V215, P1, DOI 10.1007/s00425-001-0711-3; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Song A, 2002, J BIOL CHEM, V277, P30055, DOI 10.1074/jbc.M204278200; Stacey MG, 1999, PLANT CELL, V11, P349, DOI 10.1105/tpc.11.3.349; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26	66	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112977	10.1371/journal.pone.0112977	http://dx.doi.org/10.1371/journal.pone.0112977			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485540	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600013
J	Gui, SP; Ni, SS; Jia, J; Gong, YH; Gao, LB; Zhang, L; Zhou, R				Gui, Shunping; Ni, Shanshan; Jia, Jin; Gong, Yunhui; Gao, Linbo; Zhang, Lin; Zhou, Rong			Inconformity of CXCL3 Plasma Level and Placenta Expression in Preeclampsia and Its Effect on Trophoblast Viability and Invasion	PLOS ONE			English	Article							INTERLEUKIN-8 CXCL8; CHEMOKINE RECEPTOR; ANGIOGENIC FACTORS; CELL-MIGRATION; PREGNANCY; IMMUNE	As a member of the chemokine family, CXCL3 was previously known to participate in many pathophysiological events. However, whether CXCL3 stimulates trophoblast invasion as a key process of preeclampsia pathogenesis remains largely unknown. Therefore, the aim of this study was to investigate this hypothesis and determine the effect of CXCL3 on the first trimester trophoblast. Seventy gravidas were included in this study. ELISA was used to detect CXCL3 plasma levels on preeclampsia and normal pregnant groups. CXCL3 protein and mRNA levels were detected via Western blot and real-time quantitative PCR analysis after immunolocalized in human placenta. Moreover, the CXCL3 function in HTR-8/Svneo was analyzed via WST-1 assay, flow cytometry and invasion test. The plasma CXCL3 level in preeclampsia was significantly higher than that in normal pregnancy. CXCL3 expression was observed in the cytoplasm of placental trophoblasts and vascular endothelium in all groups without significant difference between maternal and fetal sides. In addition, placenta CXCL3 expression in severe preeclampsia was significantly lower than those in normal and mild PE groups. Moreover, exogenous CXCL3 can promote the proliferation and invasion of HTR-8/Svneo; however, its effect on apoptosis remains unclear. In summary, a significant abnormality of plasma CXCL3 level and placental CXCL3 expression was discovered in severe preeclampsia; CXCL3 had a function in trophoblast invasion, which indicated its participation in shallow implantation. Therefore CXCL3 might be involved in severe preeclampsia pathogenesis.	[Gui, Shunping; Ni, Shanshan; Jia, Jin; Gong, Yunhui; Zhou, Rong] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynaecol, Chengdu 610064, Peoples R China; [Gao, Linbo; Zhang, Lin] Minist Educ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu, Peoples R China; [Gao, Linbo; Zhang, Lin] Sichuan Univ, West China Univ Hosp 2, West China Inst Women & Childrens Hlth, Lab Mol & Translat Med, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Zhou, R (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynaecol, Chengdu 610064, Peoples R China.	zhourong_hx@scu.edu.cn	ZHANG, LIN/GYD-9123-2022		National Science Foundation of China [81300512]; Doctoral Fund of Ministry of Education of China [20110181110010]; Sichuan Provincial Science and technology [2013SZ0074]; Office of Science & Technology of Chengdu [12PPYB097SF-002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Sichuan Provincial Science and technology; Office of Science & Technology of Chengdu	Grants were received from the National Science Foundation of China (Grant No. 81300512), Doctoral Fund of Ministry of Education of China (Grant NO. 20110181110010), Sichuan Provincial Science and technology support project (Grant NO. 2013SZ0074) and the Office of Science & Technology of Chengdu (Grant NO. 12PPYB097SF-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Boulanger H, 2007, NEPHROL THER, V3, P437, DOI 10.1016/j.nephro.2007.07.001; Cavanagh PC, 2009, AM J PHYSIOL-CELL PH, V297, pC17, DOI 10.1152/ajpcell.00013.2009; Chau SE, 2013, HUM REPROD, V28, P1497, DOI 10.1093/humrep/det060; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Drake PM, 2004, DEV DYNAM, V229, P877, DOI 10.1002/dvdy.10477; Farioli-Vecchioli S, 2012, J NEUROSCI, V32, P15547, DOI 10.1523/JNEUROSCI.0412-12.2012; Hannan NJ, 2006, BIOL REPROD, V74, P896, DOI 10.1095/biolreprod.105.045518; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Huang Y, 2006, HUM REPROD, V21, P1083, DOI 10.1093/humrep/dei436; Hwang HS, 2012, EUR J OBSTET GYN R B, V160, P137, DOI 10.1016/j.ejogrb.2011.10.007; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kauma S, 2002, OBSTET GYNECOL, V100, P706, DOI 10.1016/S0029-7844(02)02169-5; Kocher AA, 2006, J MOL CELL CARDIOL, V40, P455, DOI 10.1016/j.yjmcc.2005.11.013; Li MQ, 2011, INT J CLIN EXP PATHO, V4, P276; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2013, AM J PATHOL, V183, P841, DOI 10.1016/j.ajpath.2013.05.029; Makikallio K, 2012, CYTOKINE, V60, P377, DOI 10.1016/j.cyto.2012.07.008; Molvarec A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-124; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Schanz A, 2011, EUR J OBSTET GYN R B, V157, P32, DOI 10.1016/j.ejogrb.2011.02.023; See ALP, 2014, CURR CANCER DRUG TAR, V14, P294, DOI 10.2174/1568009614666140305222328; Shen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044340; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Toulza F, 2005, INT J CANCER, V115, P429, DOI 10.1002/ijc.20705; Wallace AE, 2013, ARTERIOSCL THROM VAS, V33, pE93, DOI 10.1161/ATVBAHA.112.300354; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Zhang H, 2013, HUM REPROD	38	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114408	10.1371/journal.pone.0114408	http://dx.doi.org/10.1371/journal.pone.0114408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485631	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600053
J	Jiang, W; Zhang, LM; Lang, R; Li, ZH; Gilkeson, G				Jiang, Wei; Zhang, Lumin; Lang, Ren; Li, Zihai; Gilkeson, Gary			Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PLASMACYTOID DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; BLOOD MONOCYTES; RHEUMATOID-ARTHRITIS; TNF-ALPHA; FRACTALKINE EXPRESSION; MONOCLONAL-ANTIBODY; CYTOKINE PRODUCTION	Introduction: TLR7/8 and TLR9 signaling pathways have been extensively studied in systemic lupus erythematosus (SLE) as possible mediators of disease. Monocytes are a major source of pro-inflammatory cytokines and are understudied in SLE. In the current project, we investigated sex differences in monocyte activation and its implications in SLE disease pathogenesis. Methods: Human blood samples from 27 healthy male controls, 32 healthy female controls, and 25 female patients with SLE matched for age and race were studied. Monocyte activation was tested by flow cytometry and ELISA, including subset proportions, CD14, CD80 and CD86 expression, the percentage of IL-6-producing monocytes, plasma levels of sCD14 and IL-6, and urine levels of creatinine. Results: Monocytes were significantly more activated in women compared to men and in patients with SLE compared to controls in vivo. We observed increased proportions of non-classic monocytes, decreased proportions of classic monocytes, elevated levels of plasma sCD14 as well as reduced surface expression of CD14 on monocytes comparing women to men and lupus patients to controls. Plasma levels of IL-6 were positively related to sCD14 and serum creatinine. Conclusion: Monocyte activation and TLR4 responsiveness are altered in women compared to men and in patients with SLE compared to controls. These sex differences may allow persistent systemic inflammation and resultant enhanced SLE susceptibility.	[Jiang, Wei; Zhang, Lumin; Li, Zihai] Med Univ S Carolina, Dept Med, Dept Microbiol & Immunol, Div Infect Dis, Charleston, SC 29425 USA; [Lang, Ren] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Beijing 100020, Peoples R China; [Gilkeson, Gary] Med Univ S Carolina, Dept Med, Div Rheumatol, Charleston, SC 29425 USA	Medical University of South Carolina; Capital Medical University; Medical University of South Carolina	Jiang, W (corresponding author), Med Univ S Carolina, Dept Med, Dept Microbiol & Immunol, Div Infect Dis, Charleston, SC 29425 USA.	jianw@musc.edu	zhang, lumin/R-3456-2016		National Institute of Allergy and Infectious Diseases [AI91526, AI077283]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [P60 AR062755]; Medical Research Service at the Ralph H. Johnson VA Medical Center Merit grant VA CSRD MERIT [CX001211]; BLRD MERIT [BX000470]; Medical University of South Carolina of the Multidisciplinary Clinical Research Center; South Carolina Clinical and Translational Institute at the Medical University of South Carolina; Oral Health Research (COHR) Cores at the Medical University of South Carolina by National Institute of General Medical Sciences [P30GM103331];  [UL1 RR029882]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077283, R01AI091526, R01AI070603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR062755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001211] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Service at the Ralph H. Johnson VA Medical Center Merit grant VA CSRD MERIT; BLRD MERIT; Medical University of South Carolina of the Multidisciplinary Clinical Research Center; South Carolina Clinical and Translational Institute at the Medical University of South Carolina; Oral Health Research (COHR) Cores at the Medical University of South Carolina by National Institute of General Medical Sciences; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Funding: The external funding from the National Institute of Allergy and Infectious Diseases grant AI91526 and AI077283 and National Institute of Arthritis and Musculoskeletal and Skin Diseases grant P60 AR062755 had a role in research data collection, reagent purchase, study design, and manuscript preparation. The external funding from UL1 RR029882, the Medical Research Service at the Ralph H. Johnson VA Medical Center Merit grant VA CSRD MERIT (CX001211), BLRD MERIT (BX000470), and the Medical University of South Carolina internal funding of the Multidisciplinary Clinical Research Center and South Carolina Clinical and Translational Institute at the Medical University of South Carolina had a role in participant recruitment, consent, and clinical data collection and analysis. The external funding from the Oral Health Research (COHR) Cores at the Medical University of South Carolina was funded by National Institute of General Medical Sciences grant P30GM103331 and had a role in providing some instruments to conduct this project.	Afshan G, 2012, CLIN LAB, V58, P567; Aguilar-Ruiz SR, 2011, J LEUKOCYTE BIOL, V90, P1119, DOI 10.1189/jlb.0111022; Amir O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/616384; Aringer M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2341; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Ball EMA, 2014, LUPUS, V23, P46, DOI 10.1177/0961203313512882; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bouman A, 2001, FERTIL STERIL, V76, P555, DOI 10.1016/S0015-0282(01)01971-9; Cairns AP, 2002, RHEUMATOL INT, V21, P189, DOI 10.1007/s00296-001-0165-8; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cunningham MA, 2012, CLIN IMMUNOL, V144, P1, DOI 10.1016/j.clim.2012.04.001; FINGERLE G, 1993, BLOOD, V82, P3170; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Heine GH, 2012, NAT REV NEPHROL, V8, P362, DOI 10.1038/nrneph.2012.41; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Kramer PR, 2007, MOL CELL ENDOCRINOL, V279, P16, DOI 10.1016/j.mce.2007.08.014; Kramer PR, 2004, ARTHRITIS RHEUM, V50, P1967, DOI 10.1002/art.20309; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Lartigue A, 2009, J IMMUNOL, V183, P6207, DOI 10.4049/jimmunol.0803219; Lee TP, 2010, J AUTOIMMUN, V35, P358, DOI 10.1016/j.jaut.2010.07.007; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Liang BL, 2006, IMMUNOLOGY, V119, P296, DOI 10.1111/j.1365-2567.2006.02433.x; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu MF, 1999, SCAND J IMMUNOL, V49, P82, DOI 10.1046/j.1365-3083.1999.00452.x; Liu XH, 2010, J CLIN INVEST, V120, P2497, DOI 10.1172/JCI42382; Liu YY, 2012, J IMMUNOL, V188, P2070, DOI 10.4049/jimmunol.1102835; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lorenzo N, 2012, AUTOIMMUNITY, V45, P449, DOI 10.3109/08916934.2012.697592; McCrohon JA, 1999, CIRCULATION, V100, P2319, DOI 10.1161/01.CIR.100.23.2319; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mellor-Pita S, 2009, CYTOM PART B-CLIN CY, V76B, P261, DOI 10.1002/cyto.b.20468; Merrill JT, 2011, ANN RHEUM DIS, V70, P1905, DOI 10.1136/ard.2010.144485; Mihara M, 1998, CLIN EXP IMMUNOL, V112, P397; Nakatani K, 2010, AM J PHYSIOL-RENAL, V299, pF207, DOI 10.1152/ajprenal.00482.2009; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V96, P15; Petri M, 1997, ARTHRITIS RHEUM, V40, P797, DOI 10.1002/art.1780400504; Phiel KL, 2005, IMMUNOL LETT, V97, P107, DOI 10.1016/j.imlet.2004.10.007; Pisetsky DS, 2011, CLIN VACCINE IMMUNOL, V18, P1420, DOI 10.1128/CVI.05110-11; Polancec DS, 2012, J LEUKOCYTE BIOL, V91, P229, DOI 10.1189/jlb.1210655; Robak E, 2009, CURR DRUG TARGETS, V10, P26, DOI 10.2174/138945009787122833; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; SALEH MN, 1995, BLOOD, V85, P2910, DOI 10.1182/blood.V85.10.2910.bloodjournal85102910; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Seillet C, 2013, J IMMUNOL, V190, P5459, DOI 10.4049/jimmunol.1203312; Seillet C, 2012, BLOOD, V119, P454, DOI 10.1182/blood-2011-08-371831; Shirota Y, 2013, ANN RHEUM DIS, V72, P118, DOI 10.1136/annrheumdis-2012-201310; Suenaga R, 1998, J RHEUMATOL, V25, P1305; Summers SA, 2010, J AUTOIMMUN, V35, P291, DOI 10.1016/j.jaut.2010.05.004; Swaak AJG, 1996, SCAND J RHEUMATOL, V25, P233, DOI 10.3109/03009749609069992; Voskuhl Rhonda, 2011, Biol Sex Differ, V2, P1, DOI 10.1186/2042-6410-2-1; WADA K, 1992, GEN PHARMACOL, V23, P693, DOI 10.1016/0306-3623(92)90150-I; Weckerle CE, 2011, CLIN REV ALLERG IMMU, V40, P42, DOI 10.1007/s12016-009-8192-4; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Zhai JX, 2012, MOL BIOL REP, V39, P6763, DOI 10.1007/s11033-012-1501-7; Zhang Y, 2011, EUR J IMMUNOL, V41, P1154, DOI 10.1002/eji.201040767	67	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114589	10.1371/journal.pone.0114589	http://dx.doi.org/10.1371/journal.pone.0114589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485543	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600078
J	Ozcakir, A; Dogan, FO; Cakir, YT; Bayram, N; Bilgel, N				Ozcakir, Alis; Dogan, Fatma Oflu; Cakir, Yakup Tolga; Bayram, Nuran; Bilgel, Nazan			Subjective Well-Being among Primary Health Care Patients	PLOS ONE			English	Article							OXFORD HAPPINESS QUESTIONNAIRE; CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; POSITIVE PSYCHOLOGY; DISPOSITIONAL OPTIMISM; TURKISH VERSION; SATISFACTION; ANXIETY; PEOPLE; INTERVENTIONS	Background: The psychological importance of subjective well-being for a healthy life has been well recognized. It is also well known that depressive and anxiety disorders have a negative effect on subjective well-being. The aim of this cross-sectional, descriptive study was to assess the subjective well-being status of a group of primary healthcare patients in relation to socio-demographic characteristics, personal health and mood-status. Methods: A total of 284 patients participated in the study. The Oxford Happiness Scale, Life Satisfaction Scale, DASS-42 (Depression, Anxiety and Stress Scales-42) and a questionnaire about socio-demographic characteristics were completed by the participants. Results: In general, the participants were found to be moderately happy and satisfied with their lives. They had mild levels of depression, anxiety and stress. In terms of happiness, an older age (>= 40 years), educated to secondary level or higher and not having depression or anxiety were found to be factors increasing happiness. In terms of life satisfaction, female gender, an older age (>= 40 years), educated to secondary level or higher, being single and not having depression were found to increase life satisfaction. Conclusion: Primary healthcare providers should give more importance to the mood status of their patients. Screening for depression and anxiety should be applied at the primary healthcare level because negative mood status is more important than some socio-demographic characteristics in respect of unhappiness and dissatisfaction.	[Ozcakir, Alis; Dogan, Fatma Oflu; Cakir, Yakup Tolga; Bilgel, Nazan] Uludag Univ, Fac Med, Dept Family Med, Bursa, Turkey; [Bayram, Nuran] Uludag Univ, Fac Econ & Adm Sci, Dept Econometr, Bursa, Turkey	Uludag University; Uludag University	Ozcakir, A (corresponding author), Uludag Univ, Fac Med, Dept Family Med, Bursa, Turkey.	alis_o@yahoo.com	Bayram, Nuran/AAG-9068-2021; OZCAKIR, Alis/AAG-8209-2021	Bayram, Nuran/0000-0001-5492-184X; OZCAKIR, Alis/0000-0001-5588-2037; Bilgel, Nazan/0000-0002-4539-5849				Abbott P., 2006, J HAPPINESS STUD, V7, P251, DOI [DOI 10.1007/S10902-005-5563-2, 10.1007/s10902-005-5563-2]; [Anonymous], DEPR; Argyle M., 2001, THE PSYCHOLOGY OF HA; Bergsma A, 2011, J POSIT PSYCHOL, V6, P253, DOI 10.1080/17439760.2011.577086; Beyaztas FY, 2012, J PAK MED ASSOC, V62, P221; Bilgel N, 2010, NOROPSIKIYATRI ARS, V47, P118, DOI 10.4274/npa.5344; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Christoph Bernhard., 2003, SOCIAL INDICATORS RE, V64, P521, DOI [10.1023/A:1025983431755, DOI 10.1023/A:1025983431755]; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; Cohen S, 2006, PSYCHOSOM MED, V68, P809, DOI 10.1097/01.psy.0000245867.92364.3c; Daig I, 2009, QUAL LIFE RES, V18, P669, DOI 10.1007/s11136-009-9481-3; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, DEV PSYCHOL, V21, P542, DOI 10.1037/0012-1649.21.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Dogan T, 2012, DUNSEN ADAM, V25, P297, DOI 10.5350/DAJPN2012250401; Dogan T, 2012, PROCD SOC BEHV, V55, P612, DOI 10.1016/j.sbspro.2012.09.543; Dumludag D, 2013, SOC INDIC RES, V114, P1199, DOI 10.1007/s11205-012-0197-3; *EUR VAL STUD GROU, 2006, EUROPEAN AND WORLD V; Fuentes N, 2001, SOC INDIC RES, V53, P289, DOI 10.1023/A:1007189429153; Giltay EJ, 2004, ARCH GEN PSYCHIAT, V61, P1126, DOI 10.1001/archpsyc.61.11.1126; Haller M, 2006, SOC INDIC RES, V75, P169, DOI 10.1007/s11205-004-6297-y; Hayo B, 2003, J ECON PSYCHOL, V24, P329, DOI 10.1016/S0167-4870(02)00173-3; Hills P, 2002, PERS INDIV DIFFER, V33, P1073, DOI 10.1016/S0191-8869(01)00213-6; Kobau Rosemarie, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2010.300083; Koker S., 1991, UNPUBLISHED MASTER T; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P1393, DOI 10.1001/archpsyc.64.12.1393; Kubzansky LD, 2001, PSYCHOSOM MED, V63, P910, DOI 10.1097/00006842-200111000-00009; Lambert D., 2014, P 2014 IEEE RAD EFF, P1, DOI DOI 10.1017/S146342361300056X; LEEDHAM B, 1995, HEALTH PSYCHOL, V14, P74, DOI 10.1037/0278-6133.14.1.74; Lovibond SH, 1995, MANUAL DEPRESSION AN; Maruta T, 2000, MAYO CLIN PROC, V75, P140; Norberg MM, 2008, J ANXIETY DISORD, V22, P1516, DOI 10.1016/j.janxdis.2008.03.005; Ostir GV, 2001, PSYCHOSOM MED, V63, P210, DOI 10.1097/00006842-200103000-00003; Revicki DA, 2008, QUAL LIFE RES, V17, P1285, DOI 10.1007/s11136-008-9406-6; SCHEIER MF, 1989, J PERS SOC PSYCHOL, V57, P1024, DOI 10.1037/0022-3514.57.6.1024; Seker, 2006, PSIKOLOJIDE VE EGITI; Seligman MEP, 2008, APPL PSYCHOL-INT REV, V57, P3, DOI 10.1111/j.1464-0597.2008.00351.x; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Selim S, 2008, SOC INDIC RES, V88, P531, DOI 10.1007/s11205-007-9218-z; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Tsou M.-W., 2001, J HAPPINESS STUD, V2, P269, DOI [10.1023/A:1011816429264, DOI 10.1023/A:1011816429264]; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1; VEENHOVEN R, 2012, WORLD DATABASE OF HA; WHO, 2013, MENTAL HEALTH ACTION; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Williams RB, 2002, PSYCHOSOM MED, V64, P552, DOI 10.1097/01.PSY.0000023410.02546.5D; Xu JP, 2010, HEALTH PSYCHOL, V29, P9, DOI 10.1037/a0016767; YETIM U, 1993, THESIS	51	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114496	10.1371/journal.pone.0114496	http://dx.doi.org/10.1371/journal.pone.0114496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25486293	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600061
J	Hill, CG; Jabbari, N; Matyunina, LV; McDonald, JF				Hill, Christopher G.; Jabbari, Neda; Matyunina, Lilya V.; McDonald, John F.			Functional and Evolutionary Significance of Human MicroRNA Seed Region Mutations	PLOS ONE			English	Article							EXPRESSION; SEQUENCE; TARGETS	MicroRNAs have emerged in recent years as important regulators of cell function in both normal and diseased cells. MiRNAs coordinately regulate large suites of target genes by mRNA degradation and/or translational inhibition. The mRNA target specificities of miRNAs in animals are primarily encoded within a 7 nt "seed region" mapping to positions 2-8 at the molecule's 5' end. We here combine computational analyses with experimental studies to explore the functional significance of sequence variation within the seed region of human miRNAs. The results indicate that a substitution of even a single nucleotide within the seed region changes the spectrum of mRNA targets by >50%. The high functional cost of even single nucleotide changes within seed regions is consistent with their high sequence conservation among miRNA families both within and between species and suggests processes that may underlie the evolution of miRNA regulatory control.	[McDonald, John F.] Georgia Inst Technol, Integrated Canc Res Ctr, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McDonald, JF (corresponding author), Georgia Inst Technol, Integrated Canc Res Ctr, Sch Biol, 315 Ferst Dr, Atlanta, GA 30332 USA.	john.mcdonald@biology.gatech.edu		McDonald, John F/0000-0002-4263-8155; Jabbari, Neda/0000-0002-3252-0655	Ovarian Cancer Institute; Northside Hospital (Atlanta); Deborah Nash Endowment Fund; Josephine Robinson Family; J.D. Rhodes Trust	Ovarian Cancer Institute; Northside Hospital (Atlanta); Deborah Nash Endowment Fund; Josephine Robinson Family; J.D. Rhodes Trust	Funding for this project was provided by the Ovarian Cancer Institute, Northside Hospital (Atlanta), The Deborah Nash Endowment Fund, The Josephine Robinson Family, and The J.D. Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BUICK RN, 1985, CANCER RES, V45, P3668; Eijssen LMT, 2013, NUCLEIC ACIDS RES, V41, pW71, DOI 10.1093/nar/gkt293; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hill CG, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-36; Jabbari N, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-12; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Nana-Sinkam SP, 2010, IDRUGS, V13, P843; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Shahab SW, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-33; Shahab SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022508; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	24	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115241	10.1371/journal.pone.0115241	http://dx.doi.org/10.1371/journal.pone.0115241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501359	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400086
J	Martinez, KG; Franco-Chaves, JA; Milad, MR; Quirk, GJ				Martinez, Karen G.; Franco-Chaves, Jose A.; Milad, Mohammed R.; Quirk, Gregory J.			Ethnic Differences in Physiological Responses to Fear Conditioned Stimuli	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANXIETY DISORDERS; EXTINCTION; CONTEXT; RECOMMENDATIONS; METAANALYSIS; MECHANISMS; CULTURE; HUMANS; SEX	The idea that emotional expression varies with ethnicity is based largely on questionnaires and behavioral observations rather than physiological measures. We therefore compared the skin conductance responses (SCR) of Hispanic (Puerto Rican) and White non-Hispanic subjects in a fear conditioning and fear extinction task. Subjects were recruited from two sites: San Juan, Puerto Rico (PR), and Boston, Massachusetts (MA), using identical methods. A total of 78 healthy subjects (39 from PR, 39 from MA) were divided by sex and matched for age and educational level. Females from the two sites did not differ in their SCRs during any experimental phase of fear conditioning (habituation, conditioning, or extinction). In contrast, PR males responded significantly to the conditioned stimulus than MA males or PR females. Subtracting ethnic differences observed during the habituation phase (prior to conditioning) eliminated differences from subsequent phases, suggesting that PR males are elevated in their response to novelty rather than fear learning. Our findings suggest that, in addition to sex differences, there are ethnic differences in physiological responses to novel stimuli at least in males, which could be relevant for the assessment and treatment of anxiety disorders.	[Martinez, Karen G.; Franco-Chaves, Jose A.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA; [Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Milad, Mohammed R.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Milad, Mohammed R.] Harvard Univ, Sch Med, Charlestown, MA USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Harvard University; Massachusetts General Hospital; Harvard University	Martinez, KG (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA.	Karen.martinez4@upr.edu	Martinez, Karen G./AAS-1944-2021; Milad, Mohammed R/O-4553-2018	Martinez, Karen G./0000-0001-7011-2751	National Center for Research Resources [U54 RR026139]; National Institute on Minority Health and Health Disparities [8U54MD 007587-03]; HISPANICS-IN-RESEARCH CAPABILITY: SoHP & SoM PARTNERSHIP (HiREC) [S21MD001830]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); HISPANICS-IN-RESEARCH CAPABILITY: SoHP & SoM PARTNERSHIP (HiREC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project described was supported by award number U54 RR026139 from the National Center for Research Resources, award number 8U54MD 007587-03 from the National Institute on Minority Health and Health Disparities and the HISPANICS-IN-RESEARCH CAPABILITY: SoHP & SoM PARTNERSHIP (HiREC) Endowment Program award number: S21MD001830 (kgm). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara C, 2013, CLIN PSYCHOL REV, V33, P107, DOI 10.1016/j.cpr.2012.10.005; Asnaani A, 2010, J NERV MENT DIS, V198, P551, DOI 10.1097/NMD.0b013e3181ea169f; Blackford JU, 2013, SOC COGN AFFECT NEUR, V8, P143, DOI 10.1093/scan/nsr078; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Carter MM, 2012, J ANXIETY DISORD, V26, P488, DOI 10.1016/j.janxdis.2012.02.002; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cover KK, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.67; Falicov CJ, 2010, FAM PROCESS, V49, P309, DOI 10.1111/j.1545-5300.2010.01325.x; Hirai M, 2006, J PSYCHOPATHOL BEHAV, V28, P49, DOI 10.1007/s10862-006-4541-2; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Lewis-Fernandez R, 2010, DEPRESS ANXIETY, V27, P212, DOI 10.1002/da.20647; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2012, DEPRESS ANXIETY, V29, P257, DOI 10.1002/da.21922; Matsumoto D, 2008, J PERS SOC PSYCHOL, V94, P925, DOI 10.1037/0022-3514.94.6.925; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; Milad MR, 2010, NEUROSCIENCE, V168, P652, DOI 10.1016/j.neuroscience.2010.04.030; Milad MR, 2006, BEHAV NEUROSCI, V120, P1196, DOI 10.1037/0735-7044.120.5.1196; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Ortega AN, 2000, AM J PSYCHIAT, V157, P615, DOI 10.1176/appi.ajp.157.4.615; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Pole N, 2007, J ABNORM PSYCHOL, V116, P352, DOI 10.1037/0021-843X.116.2.352; Spielberger C., 1975, IDARE INVENTARIO ANS; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tsai JL, 2006, EMOTION, V6, P484, DOI 10.1037/1528-3542.6.3.484	27	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114977	10.1371/journal.pone.0114977	http://dx.doi.org/10.1371/journal.pone.0114977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25501365	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400064
J	Eriksen, M; Lebreton, LCM; Carson, HS; Thiel, M; Moore, CJ; Borerro, JC; Galgani, F; Ryan, PG; Reisser, J				Eriksen, Marcus; Lebreton, Laurent C. M.; Carson, Henry S.; Thiel, Martin; Moore, Charles J.; Borerro, Jose C.; Galgani, Francois; Ryan, Peter G.; Reisser, Julia			Plastic Pollution in the World's Oceans: More than 5 Trillion Plastic Pieces Weighing over 250,000 Tons Afloat at Sea	PLOS ONE			English	Article							DENSITY POLYETHYLENE; MARINE DEBRIS; MICROPLASTICS; INGESTION; ACCUMULATION; TRANSPORT; CHEMICALS; ENVIRONMENT; BACTERIA; LIFE	Plastic pollution is ubiquitous throughout the marine environment, yet estimates of the global abundance and weight of floating plastics have lacked data, particularly from the Southern Hemisphere and remote regions. Here we report an estimate of the total number of plastic particles and their weight floating in the world's oceans from 24 expeditions (2007-2013) across all five sub-tropical gyres, costal Australia, Bay of Bengal and the Mediterranean Sea conducting surface net tows (N=680) and visual survey transects of large plastic debris (N=891). Using an oceanographic model of floating debris dispersal calibrated by our data, and correcting for wind-driven vertical mixing, we estimate a minimum of 5.25 trillion particles weighing 268,940 tons. When comparing between four size classes, two microplastic <4.75 mm and meso- and macroplastic >4.75 mm, a tremendous loss of microplastics is observed from the sea surface compared to expected rates of fragmentation, suggesting there are mechanisms at play that remove <4.75 mm plastic particles from the ocean surface.	[Eriksen, Marcus] Five Gyres Inst, Los Angeles, CA 90016 USA; [Lebreton, Laurent C. M.] Dumpk Data Sci, Wellington, New Zealand; [Carson, Henry S.] Univ Hawaii, Dept Marine Sci, Hilo, HI 96720 USA; [Carson, Henry S.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Thiel, Martin] Univ Catolica Norte, Fac Ciencias Mar, Coquimbo, Chile; [Thiel, Martin] Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Thiel, Martin] Ctr Estudios Avanzados & Zonas Aridas, Coquimbo, Chile; [Moore, Charles J.] Algalita Marine Res & Educ, Long Beach, CA USA; [Borerro, Jose C.] eCoast Ltd, Raglan, New Zealand; [Galgani, Francois] IFREMER, Inst Francais Rech Exploitat Mer, Dept Oceanog & Dynam Ecosyst, Bastia, Corsica, France; [Ryan, Peter G.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, ZA-7700 Rondebosch, South Africa; [Reisser, Julia] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; [Reisser, Julia] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia	University of Hawaii System; University Hawaii Hilo; Washington Department of Fish & Wildlife (WDFW); Universidad Catolica del Norte; Ifremer; University of Cape Town; University of Western Australia; University of Western Australia	Eriksen, M (corresponding author), Five Gyres Inst, Los Angeles, CA 90016 USA.	marcus@5gyres.org	galgani, francois/A-1973-2011; Reisser, Julia/K-2065-2013	galgani, francois/0000-0001-8770-6054; Reisser, Julia/0000-0002-1785-1042	Will J. Reid Foundation; Seaver Institute; IPRS; CSIRO's Flagship Postgraduate scholarship; Chilean Millennium Initiative [NC120030]	Will J. Reid Foundation; Seaver Institute; IPRS; CSIRO's Flagship Postgraduate scholarship; Chilean Millennium Initiative	Financial support from the Will J. Reid Foundation (HSC) and Seaver Institute (ME) made much of this work possible. J. Reisser is sponsored by an IPRS and a CSIRO's Flagship Postgraduate scholarship and M. Thiel was supported by the Chilean Millennium Initiative (grant NC120030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir A, 2014, ENVIRON POLLUT, V185, P16, DOI 10.1016/j.envpol.2013.10.007; Balasubramanian V, 2010, LETT APPL MICROBIOL, V51, P205, DOI 10.1111/j.1472-765X.2010.02883.x; Barnes DKA, 2010, MAR ENVIRON RES, V70, P250, DOI 10.1016/j.marenvres.2010.05.006; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Black K.P., 1990, ACANTHASTER CORAL RE, P151, DOI [10.1007/978-3-642-46726-4_9, DOI 10.1007/978-3-642-46726-4_9]; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Cummings JA, 2005, Q J ROY METEOR SOC, V131, P3583, DOI 10.1256/qj.05.105; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Goldstein M, 2013, PEERJ, V184, P2; Goldstein MC, 2014, MAR BIOL, V161, P1441, DOI 10.1007/s00227-014-2432-8; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Hinojosa IA, 2009, MAR POLLUT BULL, V58, P341, DOI 10.1016/j.marpolbul.2008.10.020; Jantz LA, 2013, MAR POLLUT BULL, V69, P97, DOI 10.1016/j.marpolbul.2013.01.019; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lumpkin R, 2012, J ATMOS OCEAN TECH, V29, P300, DOI 10.1175/JTECH-D-11-00100.1; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Plastics Europe, 2013, PLAST FACTS 2013 AN; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Ryan PG, 2014, MAR POLLUT BULL, V79, P220, DOI 10.1016/j.marpolbul.2013.12.010; Ryan PG, 2013, MAR POLLUT BULL, V69, P128, DOI 10.1016/j.marpolbul.2013.01.016; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; SMITH SD, 1988, J GEOPHYS RES-OCEANS, V93, P15467, DOI 10.1029/JC093iC12p15467; Tanaka K, 2013, MAR POLLUT BULL, V69, P219, DOI 10.1016/j.marpolbul.2012.12.010; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	42	2156	2252	122	2024	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111913	10.1371/journal.pone.0111913	http://dx.doi.org/10.1371/journal.pone.0111913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494041	Green Published, gold			2022-12-27	WOS:000346611400007
J	Lahti, M; Eriksson, JG; Heinonen, K; Kajantie, E; Lahti, J; Wahlbeck, K; Tuovinen, S; Pesonen, AK; Mikkonen, M; Osmond, C; Raikkonen, K				Lahti, Marius; Eriksson, Johan G.; Heinonen, Kati; Kajantie, Eero; Lahti, Jari; Wahlbeck, Kristian; Tuovinen, Soile; Pesonen, Anu-Katriina; Mikkonen, Maiju; Osmond, Clive; Raikkonen, Katri			Maternal Grand Multiparity and the Risk of Severe Mental Disorders in Adult Offspring	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; BIRTH COHORT; OBSTETRIC COMPLICATIONS; PERINATAL CIRCUMSTANCES; NEONATAL OUTCOMES; PRETERM INFANTS; FOLLOW-UP; SCHIZOPHRENIA; VALIDITY; FINLAND	Background: Previous studies have shown that maternal grand multiparity may predict an increased risk of mental disorders in young adult offspring, but whether such effects persist throughout adulthood remains unknown. The current study examined if maternal grand multiparity predicts the risks of severe mental disorders, suicides, suicide attempts and dementias throughout adult life. Methods: Our study sample comprised 13243 Helsinki Birth Cohort Study 1934-1944 participants (6905 men and 6338 women). According to hospital birth records, 341 offspring were born to grand multiparous mothers. From Finnish national hospital discharge and causes of death registers, we identified 1682 participants diagnosed with mental disorders during 1969-2010. Results: Maternal grand multiparity predicted significantly increased risks of mood disorders (Hazard Ratio=1.64, p=0.03), non-psychotic mood disorders (Hazard Ratio=2.02, p=0.002), and suicide attempts (Hazard Ratio=3.94, p=0.01) in adult offspring. Furthermore, women born to grand multiparous mothers had significantly increased risks of any severe mental disorder (Hazard Ratio=1.79, p=0.01), non-psychotic substance use disorders (Hazard Ratio=2.77, p=0.02) schizophrenia, schizotypal and delusional disorders (Hazard Ratio=2.40, p=0.02), mood disorders (Hazard Ratio=2.40, p=0.002), non-psychotic mood disorders (Hazard Ratio=2.91, p<0.001), and suicide attempts (Hazard Ratio=5.05, p=0.01) in adulthood. The effects of maternal grand multiparity on offspring psychopathology risk were independent of maternal age and body mass index at childbirth, and of year of birth, sex, childhood socioeconomic position, and birth weight of the offspring. In contrast, no significant effects were found among men. Conclusions: Women born to grand multiparous mothers are at an increased risk of severe mental disorders and suicide attempts across adulthood. Our findings may inform the development of preventive interventions for mental disorders.	[Lahti, Marius; Heinonen, Kati; Lahti, Jari; Tuovinen, Soile; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Eriksson, Johan G.; Kajantie, Eero; Wahlbeck, Kristian; Mikkonen, Maiju] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Wahlbeck, Kristian] Finnish Assoc Mental Hlth, Helsinki, Finland; [Osmond, Clive] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Vaasa Central Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Southampton	Lahti, M (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	marius.lahti@helsinki.fi	Lahti, Jari/P-7987-2018; Lahti, Jari/P-2283-2019; Wahlbeck, Kristian/F-8394-2011; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Pesonen, Anu-Katriina/0000-0002-0662-6261; Wahlbeck, Kristian/0000-0003-3754-3933; Raikkonen, Katri/0000-0003-3124-3470; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Tuovinen, Soile/0000-0001-5410-0611; Eriksson, Johan/0000-0002-2516-2060; Heinonen, Kati/0000-0002-1262-5599; Osmond, Clive/0000-0002-9054-4655	Academy of Finland [261661, 140278, 135132, 132614, 129911, 129457]; University of Helsinki; Finnish Foundation of Cardiovascular Research; Finnish Diabetes Research Foundation; Finnish Medical Society; Finska Lakaresallskapet; National Doctoral Programme of Psychology; Paivikki and Sakari Sohlberg Foundation; Juho Vainio Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Signe and Ane Gyllenberg Foundation; Jalmari and Rauha Ahokas Foundation; Emil Aaltonen Foundation; Finnish Ministry of Education; Finnish Foundation for Paediatric Research	Academy of Finland(Academy of Finland); University of Helsinki; Finnish Foundation of Cardiovascular Research; Finnish Diabetes Research Foundation; Finnish Medical Society; Finska Lakaresallskapet; National Doctoral Programme of Psychology; Paivikki and Sakari Sohlberg Foundation; Juho Vainio Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Signe and Ane Gyllenberg Foundation; Jalmari and Rauha Ahokas Foundation; Emil Aaltonen Foundation; Finnish Ministry of Education; Finnish Foundation for Paediatric Research	This study was supported by grants from the Academy of Finland (grant numbers 261661, 140278, 135132, 132614, 129911, and 129457), University of Helsinki, the Finnish Foundation of Cardiovascular Research, the Finnish Diabetes Research Foundation, the Finnish Medical Society, Finska Lakaresallskapet, the National Doctoral Programme of Psychology, the Paivikki and Sakari Sohlberg Foundation, the Juho Vainio Foundation, the Yrjo Jahnsson Foundation, Samfundet Folkhalsan, the Signe and Ane Gyllenberg Foundation, the Jalmari and Rauha Ahokas Foundation, the Emil Aaltonen Foundation, the Finnish Ministry of Education and the Finnish Foundation for Paediatric Research. The funders were not involved in the conduct of the study or in the collection, management, analysis or interpretation of the data.	Alaraisanen A, 2012, SOC PSYCH PSYCH EPID, V47, P1783, DOI 10.1007/s00127-012-0479-8; Aliyu MH, 2005, OBSTET GYNECOL, V105, P1045, DOI 10.1097/01.AOG.0000157444.74674.75; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Bjorngaard JH, 2013, AM J EPIDEMIOL, V177, P638, DOI 10.1093/aje/kwt014; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Ekeus C, 2006, PSYCHOL MED, V36, P269, DOI 10.1017/S0033291705006549; Fazel S, 2012, J PERS DISORD, V26, P737, DOI 10.1521/pedi.2012.26.5.737; Johnson JG, 2001, ARCH GEN PSYCHIAT, V58, P453, DOI 10.1001/archpsyc.58.5.453; Kapusta ND, 2011, ARCH GEN PSYCHIAT, V68, P1050, DOI 10.1001/archgenpsychiatry.2011.66; Kemppainen L, 2000, SOC PSYCH PSYCH EPID, V35, P104, DOI 10.1007/s001270050191; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Keskinen E, 1966, SCHIZOPHR RES, V145, P56; Kieseppa T, 2000, ACTA NEUROPSYCHIATR, V12, P106, DOI 10.1017/S0924270800035535; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Lawson DW, 2009, EVOL HUM BEHAV, V30, P170, DOI 10.1016/j.evolhumbehav.2008.12.001; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Morgan Z, 2012, SOC PSYCH PSYCH EPID, V47, P1707, DOI 10.1007/s00127-012-0481-1; Niederkrotenthaler T, 2012, EUR J EPIDEMIOL, V27, P729, DOI 10.1007/s10654-012-9724-4; Nordhov SM, 2012, PEDIATRICS, V129, pE9, DOI 10.1542/peds.2011-0248; Paananen R, 2013, J EPIDEMIOL COMMUN H, V67, P1025, DOI 10.1136/jech-2013-202768; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pihlajamaa J, 2008, NORD J PSYCHIAT, V62, P198, DOI 10.1080/08039480801983596; POIKOLAINEN K, 1983, DRUG ALCOHOL DEPEN, V12, P315, DOI 10.1016/0376-8716(83)90002-9; Raikkonen K, 2011, J PSYCHIATR RES, V45, P332, DOI 10.1016/j.jpsychires.2010.07.003; Riordan DV, 2012, SOC PSYCH PSYCH EPID, V47, P975, DOI 10.1007/s00127-011-0405-5; Roman H, 2004, OBSTET GYNECOL, V103, P1294, DOI 10.1097/01.AOG.0000127426.95464.85; Ruusunen A, 2014, J AFFECT DISORDERS, V159, P1, DOI 10.1016/j.jad.2014.01.020; Solomon A, 2014, ALZHEIMERS DEMENT, V10, P303, DOI 10.1016/j.jalz.2013.03.004; Spencer-Smith MM, 2012, PEDIATRICS, V130, P1094, DOI 10.1542/peds.2012-0426; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Suvisaari JM, 2013, SCHIZOPHRENIA BULL, V39, P1056, DOI 10.1093/schbul/sbs109; Teguete I, 2012, ACTA OBSTET GYN SCAN, V91, P580, DOI 10.1111/j.1600-0412.2012.01372.x; Yasmeen S, 2005, J MATERN-FETAL NEO M, V17, P277, DOI 10.1080/14767050500123798	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114679	10.1371/journal.pone.0114679	http://dx.doi.org/10.1371/journal.pone.0114679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493431	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000346611400066
J	van Diessen, E; Zweiphenning, WJEM; Jansen, FE; Stam, CJ; Braun, KPJ; Otte, WM				van Diessen, Eric; Zweiphenning, Willemiek J. E. M.; Jansen, Floor E.; Stam, Cornelis J.; Braun, Kees P. J.; Otte, Willem M.			Brain Network Organization in Focal Epilepsy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRAPH-THEORETICAL ANALYSIS; FUNCTIONAL CONNECTIVITY; SMALL-WORLD; CORTICAL THICKNESS; COGNITIVE DECLINE; SCALE; CONNECTOME; EFFICIENCY; DISORDERS	Normal brain functioning is presumed to depend upon interacting regions within large-scale neuronal networks. Increasing evidence exists that interictal network alterations in focal epilepsy are associated with cognitive and behavioral deficits. Nevertheless, the reported network alterations are inconclusive and prone to low statistical power due to small sample sizes as well as modest effect sizes. We therefore systematically reviewed the existing literature and conducted a meta-analysis to characterize the changes in whole-brain interictal focal epilepsy networks at sufficient power levels. We focused on the two most commonly used metrics in whole-brain networks: average path length and average clustering coefficient. Twelve studies were included that reported whole-brain network average path length and average clustering coefficient characteristics in patients and controls. The overall group difference, quantified as the standardized mean average path length difference between epilepsy and control groups, corresponded to a significantly increased average path length of 0.29 (95% confidence interval (CI): 0.12 to 0.45, p=0.0007) in the epilepsy group. This suggests a less integrated interictal whole-brain network. Similarly, a significantly increased standardized mean average clustering coefficient of 0.35 (CI: 0.05 to 0.65, p=0.02) was found in the epilepsy group in comparison with controls, pointing towards a more segregated interictal network. Sub-analyses revealed similar results for functional and structural networks in terms of effect size and directionality for both metrics. In addition, we found individual network studies to be prone to low power due to the relatively small group differences in average path length and average clustering coefficient in combination with small sample sizes. The pooled network characteristics support the hypothesis that focal epilepsy has widespread detrimental effects, that is, reduced integration and increased segregation, on whole brain interictal network organization, which may relate to the co-morbid cognitive and behavioral impairments often reported in patients with focal epilepsy.	[van Diessen, Eric; Zweiphenning, Willemiek J. E. M.; Jansen, Floor E.; Braun, Kees P. J.; Otte, Willem M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Pediat Neurol, Utrecht, Netherlands; [Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Otte, Willem M.] Univ Med Ctr Utrecht, Image Sci Inst, Biomed MR Imaging & Spect Grp, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	van Diessen, E (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Pediat Neurol, Utrecht, Netherlands.	e.vandiessen-3@umcutrecht.nl	Otte, Wim/I-1228-2013	Otte, Wim/0000-0003-1511-6834; Stam, Cornelis/0000-0001-9163-7274	National Epilepsy Fund, The Netherlands [NEF 09-93, NEF 12-05, NEF 08-10]	National Epilepsy Fund, The Netherlands	Eric van Diessen, Willem M. Otte and Kees P.J. Braun are supported by the National Epilepsy Fund, The Netherlands (NEF 09-93, NEF 12-05 and NEF 08-10, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036104; Asano E, 2013, BRAIN DEV-JPN, V35, P706, DOI 10.1016/j.braindev.2013.04.004; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Bernhardt BC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00624; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Bosma Ingeborg, 2009, Nonlinear Biomed Phys, V3, P9, DOI 10.1186/1753-4631-3-9; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; Constable RT, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00039; Cummings P, 2011, ARCH PEDIAT ADOL MED, V165, P592, DOI 10.1001/archpediatrics.2011.97; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Douw L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010839; Engel J, 2013, CURR OPIN NEUROL, V26, P186, DOI 10.1097/WCO.0b013e32835ee5b8; Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kim H, 2008, EPILEPSY RES, V81, P136, DOI 10.1016/j.eplepsyres.2008.05.005; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; Kramer MA, 2010, J NEUROSCI, V30, P10076, DOI 10.1523/JNEUROSCI.6309-09.2010; Lemieux L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00012; Li C, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/11/P11018; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Ortega GJ, 2008, NEUROSCI LETT, V447, P129, DOI 10.1016/j.neulet.2008.09.080; Otte WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039078; Otte WM, 2012, EPILEPSIA, V53, P659, DOI 10.1111/j.1528-1167.2012.03426.x; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Quraan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068609; Raj A, 2010, NEUROIMAGE, V52, P1302, DOI 10.1016/j.neuroimage.2010.05.045; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Riley JD, 2010, EPILEPSIA, V51, P536, DOI 10.1111/j.1528-1167.2009.02508.x; Risse GL, 2006, EPILEPSIA, V47, P87, DOI 10.1111/j.1528-1167.2006.00699.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Stam C, 2014, INT J PSYCHOPHYSIOL, V24, P2; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Vaessen MJ, 2013, CEREB CORTEX, V23, P1997, DOI 10.1093/cercor/bhs186; Vaessen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090068; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; van Dellen E, 2014, NEUROIMAGE, V86, P354, DOI 10.1016/j.neuroimage.2013.10.010; van Dellen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050122; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; van Diessen E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00067; van Diessen E, 2013, EPILEPSIA, V54, P1855, DOI 10.1111/epi.12350; van Diessen E, 2013, NEUROIMAGE, V82, P564, DOI 10.1016/j.neuroimage.2013.06.031; Van Diessen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059764; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	71	82	82	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114606	10.1371/journal.pone.0114606	http://dx.doi.org/10.1371/journal.pone.0114606			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493432	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400059
J	Ali, TY; Pipkin, FB; Khan, RN				Ali, Tayyba Y.; Pipkin, Fiona Broughton; Khan, Raheela N.			The Effect of pH and Ion Channel Modulators on Human Placental Arteries	PLOS ONE			English	Article							DOMAIN K+ CHANNELS; POTASSIUM CHANNELS; FETOPLACENTAL VASOCONSTRICTION; VASCULAR-RESISTANCE; INTRACELLULAR PH; BLOOD-FLOW; TREK-1; LOCALIZATION; STIMULATION; EXPRESSION	Chorionic plate arteries (CPA) are located at the maternofetal interface where they are able to respond to local metabolic changes. Unlike many other types of vasculature, the placenta lacks nervous control and requires autoregulation for controlling blood flow. The placental circulation, which is of low-resistance, may become hypoxic easily leading to fetal acidosis and fetal distress however the role of the ion channels in these circumstances is not well-understood. Active potassium channel conductances that are subject to local physicochemical modulation may serve as pathways through which such signals are transduced. The aim of this study was to investigate the modulation of CPA by pH and the channels implicated in these responses using wire myography. CPA were isolated from healthy placentae and pre-contracted with U46619 before testing the effects of extracellular pH using 1 M lactic acid over the pH range 7.4 - 6.4 in the presence of a variety of ion channel modulators. A change from pH 7.4 to 7.2 produced a 29 +/- 3% (n=9) relaxation of CPA which increased to 61 +/- 4% at the lowest pH of 6.4. In vessels isolated from placentae of women with pre-eclampsia (n=6), pH responses were attenuated. L-methionine increased the relaxation to 67 +/- 7% (n=6; p<0.001) at pH 6.4. Similarly the TASK 1/3 blocker zinc chloride (1 mM) gave a maximum relaxation of 72 +/- 5% (n=8; p<0.01) which compared with the relaxation produced by the TREK-1 opener riluzole (75 +/- 5%; n=6). Several other modulators induced no significant changes in vascular responses. Our study confirmed expression of several ion channel subtypes in CPA with our results indicating that extracellular pH within the physiological range has an important role in controlling vasodilatation in the human term placenta.	[Ali, Tayyba Y.; Pipkin, Fiona Broughton; Khan, Raheela N.] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England	University of Nottingham	Khan, RN (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Div Med Sci & Grad Entry Med, Uttoxeter Rd, Derby DE22 3DT, England.	raheela.khan@nottingham.ac.uk		Khan, Raheela N/0000-0002-6034-269X	British Heart Foundation [FS/05/049]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation; FS/05/049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 1990, J HYPERTENS, V8, P197, DOI 10.1097/00004872-199003000-00001; Aalkjaer C, 1997, ACTA PHYSIOL SCAND, V161, P557, DOI 10.1046/j.1365-201X.1997.00263.x; ALLEN J, 1987, BRIT J ANAESTH, V59, P1273, DOI 10.1093/bja/59.10.1273; Ashworth JR, 1999, HYPERTENS PREGNANCY, V18, P57, DOI 10.3109/10641959909009611; Bai XL, 2005, J SOC GYNECOL INVEST, V12, P77, DOI 10.1016/j.jsgi.2004.08.004; Baker SA, 2008, BRIT J PHARMACOL, V153, P1259, DOI 10.1038/sj.bjp.0707690; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Bobrow CS, 1999, ARCH DIS CHILD-FETAL, V80, pF246, DOI 10.1136/fn.80.3.F246; Brereton MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057451; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chanrachakul B, 2004, AM J PHYSIOL-CELL PH, V287, pC1747, DOI 10.1152/ajpcell.00236.2004; Chavez RA, 1999, J BIOL CHEM, V274, P7887, DOI 10.1074/jbc.274.12.7887; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; Dabertrand F, 2012, CIRC RES, V110, P285, DOI 10.1161/CIRCRESAHA.111.258145; Divya CS, 2006, MOL CARCINOGEN, V45, P320, DOI 10.1002/mc.20170; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Duprat F, 2000, MOL PHARMACOL, V57, P906; Enyeart JA, 2008, BIOCHEM BIOPH RES CO, V370, P623, DOI 10.1016/j.bbrc.2008.04.001; Gruss M, 2004, MOL PHARMACOL, V66, P530; Hampl V, 2002, AM J PHYSIOL-HEART C, V283, pH2440, DOI 10.1152/ajpheart.01033.2001; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hoeldtke NJ, 1997, AM J OBSTET GYNECOL, V177, P1088, DOI 10.1016/S0002-9378(97)70020-6; Horiuchi T, 2002, STROKE, V33, P844, DOI 10.1161/hs0302.104112; HOWARD RB, 1987, AM J OBSTET GYNECOL, V157, P1261, DOI 10.1016/S0002-9378(87)80307-1; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Hussain AS, 1997, CAN J PHYSIOL PHARM, V75, P807, DOI 10.1139/cjpp-75-7-807; Ishizaka H, 1996, CIRC RES, V78, P50, DOI 10.1161/01.RES.78.1.50; Jakoubek V, 2006, PLACENTA, V27, P1030, DOI 10.1016/j.placenta.2005.10.006; Jakoubek V, 2008, AM J PHYSIOL-HEART C, V294, pH1638, DOI 10.1152/ajpheart.01120.2007; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kleiner-Assaf A, 1999, AM J PHYSIOL-HEART C, V276, pH2204, DOI 10.1152/ajpheart.1999.276.6.H2204; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Larcombe-McDouall JB, 1998, PFLUG ARCH EUR J PHY, V435, P810, DOI 10.1007/s004240050588; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Magloire H, 2003, J DENT RES, V82, P542, DOI 10.1177/154405910308200711; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Malin GL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1471; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Mills TA, 2009, FREE RADICAL BIO MED, V47, P159, DOI 10.1016/j.freeradbiomed.2009.04.019; MYATT L, 1992, PLACENTA, V13, P329, DOI 10.1016/0143-4004(92)90057-Z; Omo-Aghoja L, 2014, ANN MED HEALTH SCI R, V4, P8, DOI 10.4103/2141-9248.126602; PARRATT J, 1994, LANCET, V344, P717, DOI 10.1016/S0140-6736(94)92209-8; Poston L, 1997, EXP PHYSIOL, V82, P377, DOI 10.1113/expphysiol.1997.sp004033; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Terrenoire C, 2001, CIRC RES, V89, P336, DOI 10.1161/hh1601.094979; Wareing M, 2002, PLACENTA, V23, P400, DOI 10.1053/plac.2002.0825; Wareing M, 2006, AM J PHYSIOL-REG I, V291, pR437, DOI 10.1152/ajpregu.00040.2006; WRAY S, 1990, J PHYSIOL-LONDON, V423, P411, DOI 10.1113/jphysiol.1990.sp018030; YANG JM, 1995, ACTA OBSTET GYN SCAN, V74, P419, DOI 10.3109/00016349509024402	63	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114405	10.1371/journal.pone.0114405	http://dx.doi.org/10.1371/journal.pone.0114405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490401	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300038
J	Gan, MX				Gan, Mingxin			Walking on a User Similarity Network towards Personalized Recommendations	PLOS ONE			English	Article							DIVERSITY; ACCURACY; SYSTEMS; SEARCH	Personalized recommender systems have been receiving more and more attention in addressing the serious problem of information overload accompanying the rapid evolution of the world-wide-web. Although traditional collaborative filtering approaches based on similarities between users have achieved remarkable success, it has been shown that the existence of popular objects may adversely influence the correct scoring of candidate objects, which lead to unreasonable recommendation results. Meanwhile, recent advances have demonstrated that approaches based on diffusion and random walk processes exhibit superior performance over collaborative filtering methods in both the recommendation accuracy and diversity. Building on these results, we adopt three strategies (power-law adjustment, nearest neighbor, and threshold filtration) to adjust a user similarity network from user similarity scores calculated on historical data, and then propose a random walk with restart model on the constructed network to achieve personalized recommendations. We perform cross-validation experiments on two real data sets (MovieLens and Netflix) and compare the performance of our method against the existing state-of-the-art methods. Results show that our method outperforms existing methods in not only recommendation accuracy and diversity, but also retrieval performance.	Univ Sci & Technol, Dongling Sch Econ & Management, Dept Management Sci & Engn, Beijing, Peoples R China	University of Science & Technology Beijing	Gan, MX (corresponding author), Univ Sci & Technol, Dongling Sch Econ & Management, Dept Management Sci & Engn, Beijing, Peoples R China.	ganmx@ustb.edu.cn			National Natural Science Foundation of China [71101010, 71471016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (71101010 and 71471016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Aggarwal C.C., 1999, P 5 ACM SIGKDD INT C, P201, DOI DOI 10.1145/312129.312230; Al-Masri E., 2008, P 17 INT C WORLD WID, P795, DOI DOI 10.1145/1367497.1367605; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Baluja S., 2008, P 17 INT C WORLD WID, P895; Barragans-Martinez AB, 2010, INFORM SCIENCES, V180, P4290, DOI 10.1016/j.ins.2010.07.024; Biau G, 2010, ANN STAT, V38, P1568, DOI 10.1214/09-AOS759; Bogers T, 2011, INT J ELECTRON COMM, V15, P31, DOI 10.2753/JEC1086-4415150303; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Burke R, 2002, USER MODEL USER-ADAP, V12, P331, DOI 10.1023/A:1021240730564; Chen Y, 2011, BIOINFORMATICS, V27, pI167, DOI 10.1093/bioinformatics/btr213; Cheng JS, 2011, J ASSOC INF SYST, V12, P463; Chiang MF, 2013, KNOWL INF SYST, V36, P59, DOI 10.1007/s10115-012-0523-8; Deshpande M, 2004, ACM T INFORM SYST, V22, P143, DOI 10.1145/963770.963776; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Fouss F, 2012, NEURAL NETWORKS, V31, P53, DOI 10.1016/j.neunet.2012.03.001; Gan MX, 2013, DECIS SUPPORT SYST, V55, P811, DOI 10.1016/j.dss.2013.03.006; Gan MX, 2013, EXPERT SYST APPL, V40, P4044, DOI 10.1016/j.eswa.2013.01.004; Georgiou O, 2010, IFIP ADV INF COMM TE, V339, P12; Gori M., 2006, P 12 ACM SIGKDD INT, P127; Hotho A, 2006, LECT NOTES COMPUT SC, V4011, P411; Jamali M, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P397; Jeong B, 2010, INFORM SCIENCES, V180, P602, DOI 10.1016/j.ins.2009.10.016; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Medo Matus, 2013, DYNAMICS COMPLEX NET, P315, DOI 10.1007/978-1-4614-6729-8_16; Nie GH, 2009, PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON INNOVATION AND MANAGEMENT, VOLS I AND II, P1489; Padmanabhan B, 2012, P 6 ACM C REC SYST, P257; Paterek A., 2007, P KDD CUP WORKSH 200, P5; Perez IJ, 2011, EXPERT SYST APPL, V38, P1675, DOI 10.1016/j.eswa.2010.07.092; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Wijaya D. T., 2008, P 17 ACM C INFORM KN, P951; Wu M, 2007, P KDD CUP WORKSH; Yildirim H, 2008, RECSYS'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P131; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062624; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	37	18	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114662	10.1371/journal.pone.0114662	http://dx.doi.org/10.1371/journal.pone.0114662			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489942	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300064
J	Hammerl, JA; Jackel, C; Alter, T; Janzcyk, P; Stingl, K; Knuver, MT; Hertwig, S				Hammerl, Jens A.; Jaeckel, Claudia; Alter, Thomas; Janzcyk, Pawel; Stingl, Kerstin; Knuever, Marie Theres; Hertwig, Stefan			Reduction of Campylobacter jejuni in Broiler Chicken by Successive Application of Group II and Group III Phages	PLOS ONE			English	Article							BACTERIOPHAGE; COLI; COLONIZATION; INFECTION; PATHOGENS; EFFICACY; SURFACE; SKIN	Background: Bacteriophage treatment is a promising tool to reduce Campylobacter in chickens. Several studies have been published where group II or group III phages were successfully applied. However, these two groups of phages are different regarding their host ranges and host cell receptors. Therefore, a concerted activity of group II and group III phages might enhance the efficacy of a treatment and decrease the number of resistant bacteria. Results: In this study we have compared the lytic properties of some group II and group III phages and analysed the suitability of various phages for a reduction of C. jejuni in broiler chickens. We show that group II and group III phages exhibit different kinetics of infection. Two group III and one group II phage were selected for animal experiments and administered in different combinations to three groups of chickens, each containing ten birds. While group III phage CP14 alone reduced Campylobacter counts by more than 1 log(10) unit, the concomitant administration of a second group III phage (CP81) did not yield any reduction, probably due to the development of resistance induced by this phage. One group of chickens received phage CP14 and, 24 hours later, group II phage CP68. In this group of animals, Campylobacter counts were reduced by more than 3 log10 units. Conclusion: The experiments illustrated that Campylobacter phage cocktails have to be carefully composed to achieve the best results.	[Hammerl, Jens A.; Jaeckel, Claudia; Janzcyk, Pawel; Stingl, Kerstin; Knuever, Marie Theres; Hertwig, Stefan] Bundesinst Risikobewertung, Berlin, Germany; [Alter, Thomas] Free Univ Berlin, Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin	Hertwig, S (corresponding author), Bundesinst Risikobewertung, Berlin, Germany.	stefan.hertwig@bfr.bund.de	Alter, Thomas/J-4810-2014; Hammerl, Jens Andre/Y-6406-2018	Hammerl, Jens Andre/0000-0002-6930-4358; Stingl, Kerstin/0000-0002-8338-717X; Alter, Thomas/0000-0002-6048-5666	Federal Office for Agriculture and Food ("Bundesanstalt fur Landwirtschaft und Ernahrung" project: CAMPYQUANT) [2816100107]	Federal Office for Agriculture and Food ("Bundesanstalt fur Landwirtschaft und Ernahrung" project: CAMPYQUANT)	The work of JAH was supported by a grant of the German Federal Office for Agriculture and Food ("Bundesanstalt fur Landwirtschaft und Ernahrung" project: CAMPYQUANT, No. 2816100107); http://www.ble.de/EN/00_Home/homepage_node.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Conlan AJK, 2011, J R SOC INTERFACE, V8, P1720, DOI 10.1098/rsif.2011.0125; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Coward C, 2006, APPL ENVIRON MICROB, V72, P4638, DOI 10.1128/AEM.00184-06; Eberle KN, 2012, POULTRY SCI, V91, P255, DOI 10.3382/ps.2011-01414; ECDC, 2013, ANN EP REP 2012 ANN; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053899; Ghareeb K, 2012, POULTRY SCI, V91, P1825, DOI 10.3382/ps.2012-02168; Gibbens JC, 2001, PREV VET MED, V48, P85, DOI 10.1016/S0167-5877(00)00189-6; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; Hammerl JA, 2012, J VIROL, V86, P8896, DOI 10.1128/JVI.01252-12; Hammerl JA, 2011, J VIROL, V85, P8597, DOI 10.1128/JVI.00395-11; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hertwig S, 2013, BERL MUNCH TIERARZTL, V126, P357, DOI 10.2376/0005-9366-126-357; Humphrey T. J., 2000, Microbiology Today, V27, P10; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Javed MA, 2014, ARCH VIROL, V159, P181, DOI 10.1007/s00705-013-1788-2; Kittler S, 2013, APPL ENVIRON MICROB, V79, P7525, DOI 10.1128/AEM.02703-13; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Loc-Carrillo CM, 2004, THESIS U NOTTINGHAM; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Orquera Stefanie, 2012, J Mol Genet Med, V6, P273; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Sails AD, 1998, J MED MICROBIOL, V47, P123, DOI 10.1099/00222615-47-2-123; Sambrook J., 2001, MOL CLONING LAB MANU; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Shane SM, 2000, REV SCI TECH OIE, V19, P376, DOI 10.20506/rst.19.2.1224; Siringan P, 2011, APPL ENVIRON MICROB, V77, P3320, DOI 10.1128/AEM.02704-10; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002	34	46	49	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114785	10.1371/journal.pone.0114785	http://dx.doi.org/10.1371/journal.pone.0114785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490713	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300080
J	Jones, CN; Moore, M; Dimisko, L; Alexander, A; Ibrahim, A; Hassell, BA; Warren, HS; Tompkins, RG; Fagan, SP; Irimia, D				Jones, Caroline N.; Moore, Molly; Dimisko, Laurie; Alexander, Andrew; Ibrahim, Amir; Hassell, Bryan A.; Warren, H. Shaw; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel			Spontaneous Neutrophil Migration Patterns during Sepsis after Major Burns	PLOS ONE			English	Article							CHEMOTAXIS; GRADIENTS; INJURY; INTERLEUKIN-6; PROCALCITONIN; EXPRESSION; INFECTION; RESPONSES; KINETICS; SURVIVAL	Finely tuned to respond quickly to infections, neutrophils have amazing abilities to migrate fast and efficiently towards sites of infection and inflammation. Although neutrophils ability to migrate is perturbed in patients after major burns, no correlations have yet been demonstrated between altered migration and higher rate of infections and sepsis in these patients when compared to healthy individuals. To probe if such correlations exist, we designed microfluidic devices to quantify the neutrophil migration phenotype with high precision. Inside these devices, moving neutrophils are confined in channels smaller than the neutrophils and forced to make directional decisions at bifurcations and around posts. We employed these devices to quantify neutrophil migration across 18 independent parameters in 74 blood samples from 13 patients with major burns and 3 healthy subjects. Blinded, retrospective analysis of clinical data and neutrophil migration parameters revealed that neutrophils isolated from blood samples collected during sepsis migrate spontaneously inside the microfluidic channels. The spontaneous neutrophil migration is a unique phenotype, typical for patients with major burns during sepsis and often observed one or two days before the diagnosis of sepsis is confirmed. The spontaneous neutrophil migration phenotype is rare in patients with major burns in the absence of sepsis, and is not encountered in healthy individuals. Our findings warrant further studies of neutrophils and their utility for early diagnosing and monitoring sepsis in patients after major burns.	[Jones, Caroline N.; Moore, Molly; Dimisko, Laurie; Alexander, Andrew; Ibrahim, Amir; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Jones, Caroline N.; Moore, Molly; Dimisko, Laurie; Alexander, Andrew; Ibrahim, Amir; Warren, H. Shaw; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Jones, Caroline N.; Dimisko, Laurie; Hassell, Bryan A.; Irimia, Daniel] BioMEMS Resource Ctr, Ctr Engn Med & Surg Serv, Boston, MA USA; [Jones, Caroline N.; Ibrahim, Amir; Warren, H. Shaw; Irimia, Daniel] Shriners Hosp Children, Boston, MA USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Dept Med, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Irimia, D (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	dirimia@mgh.harvard.edu	Irimia, Daniel/A-4095-2008; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Hassell, Bryan/0000-0002-2946-439X; xiao, wenzhong/0000-0003-4944-6380; Dimisko, Laurie/0000-0002-4974-8250	Kidder Burn Critical Care Fellowship; National Institutes of Health [GM007035, GM092804, EB002503]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007035, R24GM102656, R01GM092804, U54GM062119] Funding Source: NIH RePORTER	Kidder Burn Critical Care Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MM was the recipient of the Kidder Burn Critical Care Fellowship. CNJ has been supported by an institutional training grant from the National Institutes of Health: GM007035. This research has been supported through research grants from the National Institutes of Health GM092804 and EB002503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f; Anand D, 2014, J CRIT CARE; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BJERKNES R, 1990, BLOOD CELLS, V16, P127; BJERKNES R, 1989, BURNS, V15, P77, DOI 10.1016/0305-4179(89)90133-2; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; D'Avignon LC, 2010, BURNS, V36, P773, DOI 10.1016/j.burns.2009.11.007; Danikas DD, 2008, CLIN EXP IMMUNOL, V154, P87, DOI 10.1111/j.1365-2249.2008.03737.x; DECHALAIN TMB, 1994, BURNS, V20, P416, DOI 10.1016/0305-4179(94)90033-7; Fan H, 2014, RENAL FAILURE, V36, P1399, DOI 10.3109/0886022X.2014.945184; Fitrolaki DM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-31; Fjaertoft G, 2007, SCAND J INFECT DIS, V39, P525, DOI 10.1080/00365540601113693; Fournier PE, 2013, NAT REV MICROBIOL, V11, P574, DOI 10.1038/nrmicro3068; Gong YL, 2014, BURNS, V40, P402, DOI 10.1016/j.burns.2013.07.010; Hamza B, 2014, INTEGR BIOL-UK, V6, P175, DOI 10.1039/c3ib40175h; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hietbrink F, 2013, SHOCK, V40, P21, DOI 10.1097/SHK.0b013e318295a40a; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Irimia D, 2009, BIOPHYS J, V96, P3897, DOI 10.1016/j.bpj.2008.12.3967; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jeschke MG, 2013, INT J BURNS TRAUMA, V3, P137; Karzai W, 1997, INFECTION, V25, P329, DOI 10.1007/BF01740811; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; KIM Y, 1989, BURNS, V15, P93, DOI 10.1016/0305-4179(89)90137-X; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Kuster H, 1998, LANCET, V352, P1271, DOI 10.1016/S0140-6736(98)08148-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Martensson J, 2010, INTENS CARE MED, V36, P1333, DOI 10.1007/s00134-010-1887-4; Oberhoffer M, 1999, CRIT CARE MED, V27, P1814, DOI 10.1097/00003246-199909000-00018; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Pascual C, 1998, CRIT CARE MED, V26, P705, DOI 10.1097/00003246-199804000-00019; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Sackmann EK, 2012, BLOOD, V120, pE45, DOI 10.1182/blood-2012-03-416453; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]; SOLOMKIN JS, 1984, ANN SURG, V200, P742, DOI 10.1097/00000658-198412000-00012; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; WARDEN GD, 1975, ANN SURG, V181, P363, DOI 10.1097/00000658-197503000-00019; WARDEN GD, 1974, J CLIN INVEST, V54, P1001, DOI 10.1172/JCI107815; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	52	50	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114509	10.1371/journal.pone.0114509	http://dx.doi.org/10.1371/journal.pone.0114509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489947	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300044
J	Grande, V; Manassero, G; Vercelli, A				Grande, Valentina; Manassero, Giusi; Vercelli, Alessandro			Neuroprotective and Anti-Inflammatory Roles of the Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy	PLOS ONE			English	Article							KAINIC ACID; TUMOR-SUPPRESSOR; STATUS EPILEPTICUS; SYNAPTIC PLASTICITY; REACTIVE ASTROCYTES; NEURONAL APOPTOSIS; KAINATE RECEPTORS; CELLS; BRAIN; DEATH	Excitotoxic damage represents the major mechanism leading to cell death in many human neurodegenerative diseases such as ischemia, trauma and epilepsy. Caused by an excess of glutamate that acts on metabotropic and ionotropic excitatory receptors, excitotoxicity activates several death signaling pathways leading to an extensive neuronal loss and a consequent strong activation of astrogliosis. Currently, the search for a neuroprotective strategy is aimed to identify the level in the signaling pathways to block excitotoxicity avoiding the loss of important physiological functions and side effects. To this aim, PTEN can be considered an ideal candidate: downstream the excitatory receptors activated in excitotoxicity (whose inhibition was shown to be not clinically viable), it is involved in neuronal damage and in the first stage of the reactive astrogliosis in vivo. In this study, we demonstrated the involvement of PTEN in excitotoxicity through its pharmacological inhibition by dipotassium bisperoxo (picolinato) oxovanadate [bpv(pic)] in a model of temporal lobe epilepsy, obtained by intraperitoneal injection of kainate in 2-month-old C57BL/6J male mice. We have demonstrated that inhibition of PTEN by bpv(pic) rescues neuronal death and decreases the reactive astrogliosis in the CA3 area of the hippocampus caused by systemic administration of kainate. Moreover, the neurotoxin administration increases significantly the scanty presence of mitochondrial PTEN that is significantly decreased by the administration of the inhibitor 6 hr after the injection of kainate, suggesting a role of PTEN in mitochondrial apoptosis. Taken together, our results confirm the key role played by PTEN in the excitotoxic damage and the strong anti-inflammatory and neuroprotective potential of its inhibition.	[Grande, Valentina; Manassero, Giusi; Vercelli, Alessandro] Univ Turin, Dept Neurosci, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [Manassero, Giusi] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy	University of Turin; University of Genoa	Grande, V (corresponding author), Univ Turin, Dept Neurosci, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy.	valentina.grande@unito.it	Vercelli, Alessandro/A-1926-2012	Vercelli, Alessandro/0000-0002-5909-2128	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) PRIN grant, to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Blair PJ, 2012, J PHYSIOL-LONDON, V590, P1017, DOI 10.1113/jphysiol.2012.227868; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Bononi A, 2013, CELL DEATH DIFFER, V20, P1631, DOI 10.1038/cdd.2013.77; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen ZG, 2005, J NEUROBIOL, V62, P207, DOI 10.1002/neu.20099; Cho JY, 2002, NEUROSCI LETT, V334, P131, DOI 10.1016/S0304-3940(02)01122-9; Choy MS, 2006, NEUROSCI LETT, V405, P120, DOI 10.1016/j.neulet.2006.06.037; Crossman AR, 2000, J ANAT, V196, P519, DOI 10.1046/j.1469-7580.2000.19640519.x; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Haberny KA, 2002, TOXICOL SCI, V68, P9, DOI 10.1093/toxsci/68.1.9; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jarrett SG, 2008, NEUROBIOL DIS, V30, P130, DOI 10.1016/j.nbd.2007.12.009; Lee HN, 2010, NEUROCHEM RES, V35, P114, DOI 10.1007/s11064-009-0036-3; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Lipton SA, 2008, NAT NEUROSCI, V11, P381, DOI 10.1038/nn0408-381; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marino S, 2002, DEVELOPMENT, V129, P3513; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sperow M, 2012, J PHYSIOL-LONDON, V590, P777, DOI 10.1113/jphysiol.2011.220236; Spigolon G, 2010, EUR J NEUROSCI, V31, P1261, DOI 10.1111/j.1460-9568.2010.07158.x; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sury MD, 2011, NEUROBIOL DIS, V41, P201, DOI 10.1016/j.nbd.2010.09.007; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010; Zu LY, 2011, AM J PHYSIOL-HEART C, V300, pH2177, DOI 10.1152/ajpheart.01138.2010	46	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114554	10.1371/journal.pone.0114554	http://dx.doi.org/10.1371/journal.pone.0114554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501575	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400035
J	Mykkanen, OT; Huotari, A; Herzig, KH; Dunlop, TW; Mykkanen, H; Kirjavainen, PV				Mykkanen, Otto T.; Huotari, Anne; Herzig, Karl-Heinz; Dunlop, Thomas W.; Mykkanen, Hannu; Kirjavainen, Pirkka V.			Wild Blueberries (Vaccinium myrtillus) Alleviate Inflammation and Hypertension Associated with Developing Obesity in Mice Fed with a High-Fat Diet	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; BLOOD-PRESSURE; AMELIORATES HYPERGLYCEMIA; GLUCOSE-INTOLERANCE; BERRY ANTHOCYANINS; INTERFERON-GAMMA; C57BL/6J MOUSE; WHOLE BERRIES; T-CELLS	Background: Low-grade metabolic inflammation and hypertension are primary mechanisms involved in obesity-associated adverse health effects. Berries, especially Nordic wild blueberries (hereafter referred to as bilberries), represent an important source of dietary anthocyanins, a group of polyphenols with potential beneficial effects to combat obesity-associated metabolic disturbances. Methods: The effects of 5% or 10% (w/w) of whole bilberries (BB) were studied on the development of obesity and its metabolic disturbances in C57BL mice fed with a high-fat diet (HFD) for three months. Cytokines, inflammatory cells, systolic blood pressure, glucose tolerance, insulin sensitivity, weight gain, body fat, food consumption and energy metabolism were assessed. Results: Bilberries ameliorated type 1 pro-inflammatory responsiveness induced by HFD. This was indicated by the altered cytokine profile and the reduced prevalence of interferon gamma - producing T-cells, in particular T helper type 1 cells. Bilberries also prevented the progression of obesity associated long term increase in systolic blood pressure in mice. Conclusions: Bilberries reduce the development of systemic inflammation and prevent the progression of chronic hypertension, thus supporting their potential role in alleviating the adverse health effects associated with developing obesity.	[Mykkanen, Otto T.; Mykkanen, Hannu; Kirjavainen, Pirkka V.] Univ Eastern Finland, Food & Hlth Res Ctr, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Huotari, Anne; Dunlop, Thomas W.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Herzig, Karl-Heinz] Univ Oulu, Med Ctr, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Univ Oulu, Med Ctr, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu, Finland; [Kirjavainen, Pirkka V.] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare	Mykkanen, OT (corresponding author), Univ Eastern Finland, Food & Hlth Res Ctr, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland.	otto.mykkanen@uef.fi	Kirjavainen, Pirkka/AAW-6833-2021; Kirjavainen, Pirkka/AAX-8069-2020	Kirjavainen, Pirkka/0000-0001-6119-8768; 	Academy of Finland [133431, 108478, 129568]; Graduate School of Applied Biosciences; Yrjo Jahnsson Foundation; Northern Savo Fund of Finnish Cultural Foundation; Olvi Foundation; University of Eastern Finland	Academy of Finland(Academy of Finland); Graduate School of Applied Biosciences; Yrjo Jahnsson Foundation; Northern Savo Fund of Finnish Cultural Foundation; Olvi Foundation; University of Eastern Finland	The work was supported by the Academy of Finland project #133431 (Effects of berry consumption on obesity-associated metabolic disorders) (http://www.aka.fi/), the Graduate School of Applied Biosciences (http://www.vetmed.helsinki.fi/abs/), Yrjo Jahnsson Foundation (http://www.yjs.fi/), The Northern Savo Fund of Finnish Cultural Foundation (https://www.skr.fi/), Olvi Foundation (http://www.olvisaatio.fi/), the University of Eastern Finland (http://www.uef.fi/) and in part by grants from the Academy of Finland (#108478 and #129568). Bilberries were kindly provided as gift from a local company, Joswola, Iisalmi, Finland and freeze dried within European networks project collaboration (ELLU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Aoqui C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-31; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Baumann M, 2009, J CLIN HYPERTENS, V11, P11, DOI 10.1111/j.1751-7176.2008.00057.x; Bell DR, 2006, J APPL PHYSIOL, V100, P1164, DOI 10.1152/japplphysiol.00626.2005; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; De Ciuceis C, 2014, IMMUNE MECH HYPERTEN; DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200; Graf D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066690; H Xu, 2013, DRUG DISCOV TODAY DI, V10, P21, DOI DOI 10.1016/J.DDMEC.2013.03.006; Harrison David G, 2008, Curr Cardiol Rep, V10, P464; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Helmstadter A, 2010, PHARMAZIE, V65, P315, DOI 10.1691/ph.2010.9402; Heyman L, 2014, J NUTR METAB, V2014, DOI 10.1155/2014/403041; Houston M, 2013, J CLIN HYPERTENS, V15, P752, DOI 10.1111/jch.12188; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Johns C, 1996, HYPERTENSION, V28, P1064, DOI 10.1161/01.HYP.28.6.1064; Joseph SV, 2014, J AGR FOOD CHEM; Kalea AZ, 2010, J NUTR BIOCHEM, V21, P14, DOI 10.1016/j.jnutbio.2008.09.005; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karlsen A, 2010, EUR J NUTR, V49, P345, DOI 10.1007/s00394-010-0092-0; Kirjavainen PV, 2009, CLIN VACCINE IMMUNOL, V16, P29, DOI 10.1128/CVI.00323-08; Kirjavainen PV, 1999, CLIN DIAGN LAB IMMUN, V6, P799, DOI 10.1128/CDLI.6.6.799-802.1999; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Kolehmainen M, 2012, MOL NUTR FOOD RES, V56, P1501, DOI 10.1002/mnfr.201200195; Koponen JM, 2007, J AGR FOOD CHEM, V55, P1612, DOI 10.1021/jf062897a; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mendes A, 2003, FUND CLIN PHARMACOL, V17, P673, DOI 10.1046/j.1472-8206.2003.00198.x; MILLS E, 1993, AM J PHYSIOL, V264, pR73, DOI 10.1152/ajpregu.1993.264.1.R73; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Mykkanen OT, 2012, MOL VIS, V18, P2338; Nile SH, 2014, NUTRITION, V30, P134, DOI 10.1016/j.nut.2013.04.007; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ovaskainen ML, 2008, J NUTR, V138, P562; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Papadopoulos Dimitrios P, 2005, J Clin Hypertens (Greenwich), V7, P729, DOI 10.1111/j.1524-6175.2005.04888.x; Park HK, 2013, DIABETES METAB J, V37, P404, DOI [10.4093/dmj.2013.37.6.404, 10.4093/dmj.2013.37.2.113]; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Prior RL, 2008, J AGR FOOD CHEM, V56, P647, DOI 10.1021/jf071993o; Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d; Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026; Riihinen K, 2008, FOOD CHEM, V110, P156, DOI 10.1016/j.foodchem.2008.01.057; Riso P, 2013, EUR J NUTR, V52, P949, DOI 10.1007/s00394-012-0402-9; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rodriguez-Mateos A, 2013, BRIT J NUTR, V109, P1746, DOI 10.1017/S0007114512003911; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Sautebin L, 2004, PLANTA MED, V70, P745, DOI 10.1055/s-2004-827206; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Shaughnessy KS, 2009, NUTR RES, V29, P130, DOI 10.1016/j.nutres.2009.01.001; Shindo M, 2007, J NUTR SCI VITAMINOL, V53, P90, DOI 10.3177/jnsv.53.90; Stas SN, 2004, REV ENDOCR METAB DIS, V5, P221, DOI 10.1023/B:REMD.0000032410.75638.da; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Takano H, 2007, TRENDS PHARMACOL SCI, V28, P512, DOI 10.1016/j.tips.2007.09.002; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Tauriainen E, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/525094; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010; Vlasova M, 2010, ACTA PHYSIOL, V200, P107, DOI 10.1111/j.1748-1716.2010.02171.x; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Winer S, 2012, IMMUNOL CELL BIOL, V90, P755, DOI 10.1038/icb.2011.110; Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang M, 2011, CURR MED CHEM, V18, P291, DOI 10.2174/092986711794088380	82	57	59	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114790	10.1371/journal.pone.0114790	http://dx.doi.org/10.1371/journal.pone.0114790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501421	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400051
J	Kwak, W; Song, KD; Oh, JD; Heo, KN; Lee, JH; Lee, WK; Yoon, SH; Kim, H; Cho, S; Lee, HK				Kwak, Woori; Song, Ki-Duk; Oh, Jae-Don; Heo, Kang-Nyeong; Lee, Jun-Heon; Lee, Woon Kyu; Yoon, Sook Hee; Kim, Heebal; Cho, Seoae; Lee, Hak-Kyo			Uncovering Genomic Features and Maternal Origin of Korean Native Chicken by Whole Genome Sequencing	PLOS ONE			English	Article							PROTEIN; GENE; EXPRESSION; GENERATION; ALIGNMENT; FORMAT; MODEL; SNPS; CELL	The Korean Native Chicken (KNC) is an important endemic biological resource in Korea. While numerous studies have been conducted exploring this breed, none have used next-generation sequencing to identify its specific genomic features. We sequenced five strains of KNC and identified 10.9 million SNVs and 1.3 million InDels. Through the analysis, we found that the highly variable region common to all 5 strains had genes like PCHD15, CISD1, PIK3C2A, and NUCB2 that might be related to the phenotypic traits of the chicken such as auditory sense, growth rate and egg traits. In addition, we assembled unaligned reads that could not be mapped to the reference genome. By assembling the unaligned reads, we were able to present genomic sequences characteristic to the KNC. Based on this, we also identified genes related to the olfactory receptors and antigen that are common to all 5 strains. Finally, through the reconstructed mitochondrial genome sequences, we performed phylogenomic analysis and elucidated the maternal origin of the artificially restored KNC. Our results revealed that the KNC has multiple maternal origins which are in agreement with Korea's history of chicken breed imports. The results presented here provide a valuable basis for future research on genomic features of KNC and further understanding of KNC's origin.	[Kwak, Woori; Cho, Seoae] C&K Genom, Seoul, South Korea; [Kwak, Woori] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Song, Ki-Duk; Oh, Jae-Don; Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Ansong, South Korea; [Heo, Kang-Nyeong] Natl Inst Anim Sci, Poultry Sci Div, Cheonan, South Korea; [Lee, Woon Kyu] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Taejon, South Korea; [Lee, Woon Kyu] Inha Univ, Sch Med, Inha Res Inst Med Sci, Inchon, South Korea; [Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Hankyong National University; National Institute of Animal Science, Republic of Korea; Chungnam National University; Inha University; Seoul National University (SNU); Seoul National University (SNU)	Lee, HK (corresponding author), Hankyong Natl Univ, Genom Informat Ctr, Ansong, South Korea.	breedlee@empas.com	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Lee, Jun Heon/0000-0003-3996-9209	next generation BioGreen 21 Project of Rural Development Administration, Republic of Korea [PJ008196]	next generation BioGreen 21 Project of Rural Development Administration, Republic of Korea	This study was supported by next generation BioGreen 21 Project (PJ008196) of Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2010, FASTQC QUALITY CONTR; Bolger AM, 2014, BIOINFORMATICS; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hall T., 2004, BIOEDIT VERSION 7 0; Hoque MR, 2011, ASIAN AUSTRAL J ANIM, V24, P1637, DOI 10.5713/ajas.2011.11144; Hoque MR, 2013, RECONSTRUCTION PHYLO; Horwitz GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008627; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Kong HS, 2006, ASIAN AUSTRAL J ANIM, V19, P1546, DOI 10.5713/ajas.2006.1546; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XD, 2012, ASIAN AUSTRAL J ANIM, V25, P895, DOI 10.5713/ajas.2011.11374; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Luo J, 2007, DEV DYNAM, V236, P2331, DOI 10.1002/dvdy.21248; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mann K, 2007, PROTEOMICS, V7, P106, DOI 10.1002/pmic.200600635; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miao Y, 2012, HEREDITY; Oh JD, 2006, ASIAN AUSTRAL J ANIM, V19, P1065; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; PLOTREE D, 1989, PHYLIP PHYLOGENY INF; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tarailo-Graovac M., 2009, CURRENT PROTOCOLS BI; Wang XF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-351; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Yoon S, 2014, MOL CELLS, V37, P314, DOI 10.14348/molcells.2014.2360	34	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114763	10.1371/journal.pone.0114763	http://dx.doi.org/10.1371/journal.pone.0114763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501044	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700052
J	Fujise, L; Yamashita, H; Suzuki, G; Sasaki, K; Liao, LM; Koike, K				Fujise, Lisa; Yamashita, Hiroshi; Suzuki, Go; Sasaki, Kengo; Liao, Lawrence M.; Koike, Kazuhiko			Moderate Thermal Stress Causes Active and Immediate Expulsion of Photosynthetically Damaged Zooxanthellae (Symbiodinium) from Corals	PLOS ONE			English	Article							REEF CORALS; STYLOPHORA-PISTILLATA; OXIDATIVE STRESS; SURFACE-AREA; NITRIC-OXIDE; MASS EXPULSION; CELL-DEATH; TEMPERATURE; MECHANISMS; PATTERNS	The foundation of coral reef biology is the symbiosis between corals and zooxanthellae (dinoflagellate genus Symbiodinium). Recently, coral bleaching, which often results in mass mortality of corals and the collapse of coral reef ecosystems, has become an important issue around the world as coral reefs decrease in number year after year. To understand the mechanisms underlying coral bleaching, we maintained two species of scleractinian corals (Acroporidae) in aquaria under non-thermal stress (27 degrees C) and moderate thermal stress conditions (30 degrees C), and we compared the numbers and conditions of the expelled Symbiodinium from these corals. Under non-thermal stress conditions corals actively expel a degraded form of Symbiodinium, which are thought to be digested by their host coral. This response was also observed at 30 degrees C. However, while the expulsion rates of Symbiodinium cells remained constant, the proportion of degraded cells significantly increased at 30 degrees C. This result indicates that corals more actively digest and expel damaged Symbiodinium under thermal stress conditions, likely as a mechanism for coping with environmental change. However, the increase in digested Symbiodinium expulsion under thermal stress may not fully keep up with accumulation of the damaged cells. There are more photosynthetically damaged Symbiodinium upon prolonged exposure to thermal stress, and corals release them without digestion to prevent their accumulation. This response may be an adaptive strategy to moderate stress to ensure survival, but the accumulation of damaged Symbiodinium, which causes subsequent coral deterioration, may occur when the response cannot cope with the magnitude or duration of environmental stress, and this might be a possible mechanism underlying coral bleaching during prolonged moderate thermal stress.	[Fujise, Lisa; Liao, Lawrence M.; Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan; [Yamashita, Hiroshi; Suzuki, Go] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Sasaki, Kengo] Western Reg Ind Res Ctr, Higashihiroshima, Hiroshima, Japan	Hiroshima University; Japan Fisheries Research & Education Agency (FRA)	Koike, K (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan.	kazkoike@hiroshima-u.ac.jp	Koike, Kazuhiko/A-3392-2019; Liao, Lawrence Manzano/Y-9944-2018	Liao, Lawrence Manzano/0000-0001-5484-6560; Kazuhiko, Koike/0000-0001-5380-5839; Yamashita, Hiroshi/0000-0002-3909-5073	Ministry of Education, Culture, Sports, Science and Technology of Japan [24570028]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid (No. 24570028) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WALL STREET J; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Baghdasarian G, 2000, BIOL BULL-US, V199, P278, DOI 10.2307/1543184; Baird AH, 1998, CORAL REEFS, V17, P376, DOI 10.1007/s003380050142; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bhagooli R, 2004, MAR BIOL, V145, P329, DOI 10.1007/s00227-004-1309-7; BROWN BE, 1995, MAR BIOL, V122, P655, DOI 10.1007/BF00350687; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2000, MAR ECOL PROG SER, V195, P117, DOI 10.3354/meps195117; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Bythell JC, 2001, CORAL REEFS, V20, P193; Courtney LA, 2007, J EXP MAR BIOL ECOL, V351, P234, DOI 10.1016/j.jembe.2007.06.021; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; EGANA AC, 1982, PAC SCI, V36, P61; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Fujise Lisa, 2013, Galaxea - Tokyo, V15, P29; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Glynn PW, 2001, B MAR SCI, V69, P79; GOREAU TF, 1964, SCIENCE, V145, P383, DOI 10.1126/science.145.3630.383; GOREAU TJ, 1994, AMBIO, V23, P176; Hawkins TD, 2014, CORAL REEFS, V33, P141, DOI 10.1007/s00338-013-1103-4; Hawkins TD, 2013, FASEB J, V27, P4790, DOI 10.1096/fj.13-235051; Hikosaka-Katayama T, 2012, ZOOL SCI, V29, P559, DOI 10.2108/zsj.29.559; Hill R, 2007, MAR ECOL PROG SER, V352, P137, DOI 10.3354/meps07159; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; HOEGHGULDBERG O, 1988, CORAL REEFS, V7, P113, DOI 10.1007/BF00300970; Holmes G, 2008, J EXP MAR BIOL ECOL, V365, P67, DOI 10.1016/j.jembe.2008.07.045; JAAP WC, 1979, B MAR SCI, V29, P414; Jones AM, 2008, CORAL REEFS, V27, P521, DOI 10.1007/s00338-008-0354-y; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; KOBLUK DR, 1994, B MAR SCI, V54, P142; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Ladriere O, 2008, CAH BIOL MAR, V49, P215; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH JA, 1970, ECOLOGY, V51, P254; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P157, DOI 10.4319/lo.1985.30.1.0157; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; NHK Online, 2013, NHK ONLINE      0830; Oh-Uchi, 2007, GALAXEA, V9, P1, DOI DOI 10.3755/JCRS.9.1; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Podesta GP, 2001, B MAR SCI, V69, P43; Podesta GP, 1997, J GEOPHYS RES-OCEANS, V102, P15749, DOI 10.1029/96JC03557; Ralph PJ, 2005, J EXP MAR BIOL ECOL, V316, P17, DOI 10.1016/j.jembe.2004.10.003; Ralph PJ, 2001, MAR ECOL PROG SER, V220, P163, DOI 10.3354/meps220163; Reaka-Kudla Marjorie L., 1997, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; Rosenberg E, 1999, REEF ENCOUNTER, V25, P8; Shimpo Ryukyu, 2013, RYUKYU SHIMPO   0818; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilkinson C, 2008, STATUS CORAL REEFS W; Winter A, 1998, CORAL REEFS, V17, P377, DOI 10.1007/s003380050143; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z	70	46	49	4	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114321	10.1371/journal.pone.0114321	http://dx.doi.org/10.1371/journal.pone.0114321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493938	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400041
J	Hong, KW; Jeong, SW; Chung, M; Cho, SB				Hong, Kyung-Won; Jeong, Seok Won; Chung, Myungguen; Cho, Seong Beom			Association between Expression Quantitative Trait Loci and Metabolic Traits in Two Korean Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIPOPROTEIN-LIPASE GENE; BLOOD-PRESSURE; HERITABILITY; DISEASE; RISK; SNPS	Most genome-wide association studies consider genes that are located closest to single nucleotide polymorphisms (SNPs) that are highly significant for those studies. However, the significance of the associations between SNPs and candidate genes has not been fully determined. An alternative approach that used SNPs in expression quantitative trait loci (eQTL) was reported previously for Crohn's disease; it was shown that eQTL-based preselection for follow-up studies was a useful approach for identifying risk loci from the results of moderately sized GWAS. In this study, we propose an approach that uses eQTL SNPs to support the functional relationships between an SNP and a candidate gene in a genome-wide association study. The genome-wide SNP genotypes and 10 biochemical measures (fasting glucose levels, BUN, serum albumin levels, AST, ALT, gamma GTP, total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol) were obtained from the Korean Association Resource (KARE) consortium. The eQTL SNPs were isolated from the SNP dataset based on the RegulomeDB eQTL-SNP data from the ENCODE projects and two recent eQTL reports. A total of 25,658 eQTL SNPs were tested for their association with the 10 metabolic traits in 2 Korean populations (Ansung and Ansan). The proportion of phenotypic variance explained by eQTL and non-eQTL SNPs showed that eQTL SNPs were more likely to be associated with the metabolic traits genetically compared with non-eQTL SNPs. Finally, via a meta-analysis of the two Korean populations, we identified 14 eQTL SNPs that were significantly associated with metabolic traits. These results suggest that our approach can be expanded to other genome-wide association studies.	[Hong, Kyung-Won; Jeong, Seok Won; Chung, Myungguen; Cho, Seong Beom] KCDC, Natl Inst Hlth, Ctr Genome Sci, Div Biomed Informat, Cheongwon Gun, South Korea; [Chung, Myungguen] Hanyang Univ, Div Mol & Life Sci, Seoul 133791, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Hanyang University	Cho, SB (corresponding author), KCDC, Natl Inst Hlth, Ctr Genome Sci, Div Biomed Informat, Cheongwon Gun, South Korea.	sbcho@korea.kr			Korean Genome Analysis Project [4845-301, 2013-NG72001-00]; Korean Biobank Project [4851-307, KBP-2013-000]; Center for Disease Control and Prevention, Republic of Korea	Korean Genome Analysis Project; Korean Biobank Project; Center for Disease Control and Prevention, Republic of Korea	The genotypes and epidemiological traits were provided with biospecimens and data from Korean Genome Analysis Project (4845-301, 2013-NG72001-00), the Korean Genome and Epidemiology Study (4851-302), and the Korean Biobank Project (4851-307, KBP-2013-000). These were supported by the Center for Disease Control and Prevention, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cheng Hsing-Hsien, 1999, Acta Paediatrica Sinica, V40, P225; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; GILLARD BK, 1989, J IMMUNOL, V142, P3826; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Hong KW, 2011, J HUM GENET, V56, P205, DOI 10.1038/jhg.2010.167; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Jee SH, 2002, YONSEI MED J, V43, P160, DOI 10.3349/ymj.2002.43.2.160; Jee Sun Ha, 2005, Korean Circulation Journal, V35, P233; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Ko KP, 2011, ANN EPIDEMIOL, V21, P42, DOI 10.1016/j.annepidem.2010.10.006; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Lippi G, 2008, INTERNAL MED, V47, P705, DOI 10.2169/internalmedicine.47.0810; Maglione V, 2010, J NEUROSCI, V30, P4072, DOI 10.1523/JNEUROSCI.6348-09.2010; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rueedi R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004132; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schrimpe-Rutledge AC, 2012, J PROTEOME RES, V11, P3520, DOI 10.1021/pr3002996; Sung J, 2009, J CLIN ENDOCR METAB, V94, P4946, DOI 10.1210/jc.2009-1268; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang XL, 2014, J MED GENET, V51, P319, DOI 10.1136/jmedgenet-2013-102045; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Williams SM, 2011, ANN HUM GENET, V75, P348, DOI 10.1111/j.1469-1809.2011.00640.x; Wung SF, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-19; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114128	10.1371/journal.pone.0114128	http://dx.doi.org/10.1371/journal.pone.0114128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493549	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400032
J	Kostermans, E; Stoolmiller, M; de Leeuw, RNH; Engels, RCME; Sargent, JD				Kostermans, Evelien; Stoolmiller, Mike; de Leeuw, Rebecca N. H.; Engels, Rutger C. M. E.; Sargent, James D.			Exposure to Movie Reckless Driving in Early Adolescence Predicts Reckless, but Not Inattentive Driving	PLOS ONE			English	Article							SENSATION SEEKING; SMOKING INITIATION; TEENAGE DRIVERS; NOVICE DRIVERS; BEHAVIOR; DISTRACTION; PERSONALITY; PASSENGERS; CHILDREN; INCREASE	Objective: We examine the association between exposure to depictions of reckless driving in movies and unsafe driving, modeling inattentive and reckless driving as separate outcomes. Methods: Data were obtained by telephone from 1,630 US adolescents aged 10 to 14 years at baseline who were drivers at a survey 6 years later. Exposure to movie reckless driving was measured based on movies seen from a randomly selected list of 50 movie titles that had been content coded for reckless driving among characters. Associations were tested with inattentive and reckless driving behaviors in the subsequent survey-controlling for baseline age, sex, socioeconomic status, parental education, school performance, extracurricular activities, daily television and video/computer game exposure, number of movies watched per week, self-regulation and sensation seeking. Results: Exposure to movie reckless driving was common, with approximately 10% of movie characters having driven recklessly. Confirmatory factor analysis revealed a significant distinction between items tapping reckless and inattentive driving at the 6th wave. Age and exposure to movie reckless driving at baseline were directly associated with wave-6 reckless (but not inattentive) driving. Additionally, growth in sensation seeking mediated a prospective relation between the total number of movies watched per week at baseline and reckless driving, independent of exposure to movie reckless driving. Males and high sensation seekers reported lower seatbelt usage and more reckless driving, whereas lower self-regulation predicted inattentive driving. Discussion: In this study, exposure to movie reckless driving during early adolescence predicted adolescents' reckless driving, suggesting a direct modeling effect. Other aspects of movies were also associated with reckless driving, with that association mediated through growth in sensation seeking. Predictors of reckless driving were different from predictors of inattentive driving, with lower self-regulation associated with the latter outcome. Making a clear distinction between interventions for reckless or inattentive driving seems crucial for accident prevention.	[Kostermans, Evelien; de Leeuw, Rebecca N. H.; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Kostermans, Evelien] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stoolmiller, Mike] Univ Oregon, Coll Educ, Eugene, OR 97403 USA; [Sargent, James D.] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA	Radboud University Nijmegen; Radboud University Nijmegen; University of Oregon; Dartmouth College	Kostermans, E (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	e.kostermans@donders.ru.nl	Sargent, James D/I-2773-2013	Engels, Rutger/0000-0003-1944-9126	NIH [CA 077023]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The collection of the data and the effort of Drs Stoolmiller and Sargent was supported by NIH grant CA 077023, Sargent PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT J, 1994, PERS INDIV DIFFER, V16, P289, DOI 10.1016/0191-8869(94)90165-1; Bandura A., 1986, SOCIAL FDN THOUGHT A; Beullens K, 2011, HUM COMMUN RES, V37, P488, DOI 10.1111/j.1468-2958.2011.01412.x; Beullens K, 2011, ACCIDENT ANAL PREV, V43, P58, DOI 10.1016/j.aap.2010.07.011; Blincoe LJ., 2002, EC IMPACT MOTOR VEHI; Blows S, 2005, ACCIDENT ANAL PREV, V37, P619, DOI 10.1016/j.aap.2005.03.003; Bonneson J, 2001, REV EVALUATION FACTO; Buckley KE, 2006, LEA COMMUN SER, P363; Burkey LM, 2004, DETAILED INVESTIGATI; Carson V, 2011, PREV MED, V52, P99, DOI 10.1016/j.ypmed.2010.07.005; Chen LH, 2000, JAMA-J AM MED ASSOC, V283, P1578, DOI 10.1001/jama.283.12.1578; Cin Dal, 2011, J HEALTH COMMUN, P1; Dahlen ER, 2005, ACCIDENT ANAL PREV, V37, P341, DOI 10.1016/j.aap.2004.10.006; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Ehsani JP, 2011, J SAFETY RES, V42, P193, DOI 10.1016/j.jsr.2011.04.002; Elmitiny N, 2010, ACCIDENT ANAL PREV, V42, P101, DOI 10.1016/j.aap.2009.07.007; Ferguson SA, 2003, ACCIDENT ANAL PREV, V35, P825, DOI 10.1016/S0001-4575(02)00087-8; Fischer P, 2012, EUR REV SOC PSYCHOL, V30, P230; Fischer P, 2008, BASIC APPL SOC PSYCH, V30, P230, DOI 10.1080/01973530802375029; Fischer P, 2007, J EXP PSYCHOL-APPL, V13, P22, DOI 10.1037/1076-898X.13.1.22; Fonagy P, 2002, PSYCHOANAL INQ, V22, P307, DOI 10.1080/07351692209348990; Green F. K., 2003, RED LIGHT RUNNING; Hanewinkel R, 2008, ADDICTION, V103, P1722, DOI 10.1111/j.1360-0443.2008.02308.x; Hanewinkel R, 2008, PEDIATRICS, V121, pE108, DOI 10.1542/peds.2007-1201; Heck KE, 2008, J SAFETY RES, V39, P437, DOI 10.1016/j.jsr.2008.03.003; Hull JG, 2012, PSYCHOL POP MEDIA CU, V1, P244, DOI 10.1037/a0029510; Jackson C, 1998, HEALTH EDUC BEHAV, V25, P319, DOI 10.1177/109019819802500307; Jonah BA, 2001, ACCIDENT ANAL PREV, V33, P679, DOI 10.1016/S0001-4575(00)00085-3; Kass SJ, 2007, TRANSPORT RES F-TRAF, V10, P321, DOI 10.1016/j.trf.2006.12.002; KENDALL PC, 1979, J CONSULT CLIN PSYCH, V47, P1020, DOI 10.1037/0022-006X.47.6.1020; Lerner EB, 2001, INFLUENCE DEMOGRAPHI; Lucas K, 2004, COMMUN RES, V31, P499, DOI 10.1177/0093650204267930; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mayhew DR, 2003, ACCIDENT ANAL PREV, V35, P683, DOI 10.1016/S0001-4575(02)00047-7; McKnight AJ, 2003, ACCIDENT ANAL PREV, V35, P921, DOI 10.1016/S0001-4575(02)00100-8; MISCHEL W, 1973, PSYCHOL REV, V80, P252, DOI 10.1037/h0035002; Muthen L, 2007, MUTH N MUTH N; National Highway Traffic Safety Administration, 2010, TRAFF SAF FACTS 2010; National Traffic Safety Administration (NTSA), 1998, NAT SURV SPEED OTH U; Neyens DM, 2008, ACCIDENT ANAL PREV, V40, P254, DOI 10.1016/j.aap.2007.06.005; Oltedal S, 2006, SAFETY SCI, V44, P621, DOI 10.1016/j.ssci.2005.12.003; Pierce J.P, 1993, TOBACCO USE CALIFORN; Pucher J, 2003, TRANSPORT Q, V57, P49; Rhodes N, 2011, ACCIDENT ANAL PREV, V43, P923, DOI 10.1016/j.aap.2010.11.015; Sargent JD, 2010, ADDICTION, V105, P506, DOI 10.1111/j.1360-0443.2009.02782.x; Sargent JD, 2005, PEDIATRICS, V116, P1183, DOI 10.1542/peds.2005-0714; Sargent JD, 2004, PEDIATRICS, V114, P149, DOI 10.1542/peds.114.1.149; Sargent JD, 2003, ARCH PEDIAT ADOL MED, V157, P643, DOI 10.1001/archpedi.157.7.643; Sargent JD, 2002, J ADOLESCENT HEALTH, V31, P449, DOI 10.1016/S1054-139X(02)00399-3; Sargent JD, 2001, BRIT MED J, V323, P1; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Shin PC, 2005, J PUBLIC HEALTH-UK, V27, P318, DOI 10.1093/pubmed/fdi049; Shope JT, 2008, AM J PREV MED, V35, pS261, DOI 10.1016/j.amepre.2008.06.022; Simons-Morton B, 2005, ACCIDENT ANAL PREV, V37, P973, DOI 10.1016/j.aap.2005.04.014; Smart D, 2012, DRIVERS SEAT UNDERST; Stoolmiller M, 2010, PREV SCI, V11, P1, DOI 10.1007/s11121-009-0143-z; Tanski SE, 2010, J STUD ALCOHOL DRUGS, V71, P452, DOI 10.15288/jsad.2010.71.452; Tay R, 2004, IATSS RES, V28, P89, DOI [DOI 10.1016/50386-1112(14)60095-9, DOI 10.1016/S0386-1112(14)60095-9]; Trimpop R, 1997, PERS INDIV DIFFER, V23, P147, DOI 10.1016/S0191-8869(97)00017-2; Trowbridge MJ, 2008, AM J PREV MED, V34, P202, DOI 10.1016/j.amepre.2007.11.013; Vitaglione GD, 2012, J APPL SOC PSYCHOL, V42, P488, DOI 10.1111/j.1559-1816.2011.00783.x; Werneke J, 2012, ACCIDENT ANAL PREV, V45, P610, DOI 10.1016/j.aap.2011.09.048; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; Zhang L, 2008, EMPIRICAL OBSERVATIO; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	65	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113927	10.1371/journal.pone.0113927	http://dx.doi.org/10.1371/journal.pone.0113927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493323	Green Published, gold			2022-12-27	WOS:000346611400024
J	Nagel, O; Guven, C; Theves, M; Driscoll, M; Losert, W; Beta, C				Nagel, Oliver; Guven, Can; Theves, Matthias; Driscoll, Meghan; Losert, Wolfgang; Beta, Carsten			Geometry-Driven Polarity in Motile Amoeboid Cells	PLOS ONE			English	Article							EUKARYOTIC CHEMOTAXIS; MIGRATION; LAMELLIPODIA; CYTOSKELETON; MECHANICS; SIGNALS; ABSENCE; AMEBAS; MODELS	Motile eukaryotic cells, such as leukocytes, cancer cells, and amoeba, typically move inside the narrow interstitial spacings of tissue or soil. While most of our knowledge of actin-driven eukaryotic motility was obtained from cells that move on planar open surfaces, recent work has demonstrated that confinement can lead to strongly altered motile behavior. Here, we report experimental evidence that motile amoeboid cells undergo a spontaneous symmetry breaking in confined interstitial spaces. Inside narrow channels, the cells switch to a highly persistent, unidirectional mode of motion, moving at a constant speed along the channel. They remain in contact with the two opposing channel side walls and alternate protrusions of their leading edge near each wall. Their actin cytoskeleton exhibits a characteristic arrangement that is dominated by dense, stationary actin foci at the side walls, in conjunction with less dense dynamic regions at the leading edge. Our experimental findings can be explained based on an excitable network model that accounts for the confinement-induced symmetry breaking and correctly recovers the spatio-temporal pattern of protrusions at the leading edge. Since motile cells typically live in the narrow interstitial spacings of tissue or soil, we expect that the geometry-driven polarity we report here plays an important role for movement of cells in their natural environment.	[Nagel, Oliver; Theves, Matthias; Beta, Carsten] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany; [Guven, Can; Driscoll, Meghan; Losert, Wolfgang] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University of Potsdam; University System of Maryland; University of Maryland College Park	Beta, C (corresponding author), Univ Potsdam, Inst Phys & Astron, Potsdam, Germany.	beta@uni-potsdam.de		Driscoll, Meghan/0000-0001-7991-5614	Deutsche Forschungsgemeinschaft [BE 3978/3-1, GRK 1558]; National Institute of General Medical Sciences [R01GM085574]; National Science Foundation [PHY1205965]; Volkswagenstiftung; Division Of Physics [1205965] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085574] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Volkswagenstiftung(Volkswagen); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CB, MT, and ON gratefully acknowledge financial support by the Deutsche Forschungsgemeinschaft grant BE 3978/3-1 and GRK 1558 and by the Volkswagenstiftung. WL, MD, and CG acknowledge support from the National Institute of General Medical Sciences grant R01GM085574 and the National Science Foundation grant PHY1205965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037213; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Beta C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/8/083015; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bodeker HU, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/28005; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Camley BA, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062705; Cooper RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033528; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Driscoll MK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002392; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Hecht I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002044; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jilkine A, 2011, PLOS COMPUTATIONAL B, V7; Jowhar D, 2010, INTEGR BIOL-UK, V2, P648, DOI 10.1039/c0ib00110d; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Li L, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046006; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prassler J, 1998, MOL BIOL CELL, V9, P545, DOI 10.1091/mbc.9.3.545; Prentice-Mott HV, 2013, P NATL ACAD SCI USA, V110, P21006, DOI 10.1073/pnas.1317441110; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Scherber C, 2012, INTEGR BIOL-UK, V4, P259, DOI 10.1039/c2ib00106c; Schneider N, 2003, CELL MOTIL CYTOSKEL, V56, P130, DOI 10.1002/cm.10139; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Shi CJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003122; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186	47	20	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113382	10.1371/journal.pone.0113382	http://dx.doi.org/10.1371/journal.pone.0113382			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493548	gold, Green Submitted, Green Published			2022-12-27	WOS:000346611400011
J	Somogyi, E; Esseily, R				Somogyi, Eszter; Esseily, Rana			Mimicry Enhances Observational Learning in 16-Month-Old Infants	PLOS ONE			English	Article							18-MONTH-OLD INFANTS; PROSOCIAL BEHAVIOR; IMITATION; PERCEPTION; CHAMELEON; CHILDREN; RAPPORT; MODELS; PEER	We examined the effect of mimicry on how 16-month-old infants learn by observation a novel tool use action, which consisted of using a rake to retrieve a toy. Across four conditions, we manipulated whether during an initial play phase, an adult mimicked the infant's play or not (testing the effect of mimicry), the infant played with the adult or played alone (controlling the effect of interacting with a contingent partner) and whether the infant saw a demonstration of the tool's use or not (evaluating baseline performance). We found that infants who had been mimicked learned best from a demonstration of the rake's use and performed better than infants who only played with the experimenter without mimicry or played by themselves before the demonstration. As expected, infants did not learn from a demonstration of the rake's use when they played by themselves and thus had no previous interaction with an experimenter. The mechanisms driving this powerful learning effect of mimicry are discussed.	[Somogyi, Eszter; Esseily, Rana] Univ Paris 05, CNRS UMR 8158, Ctr Biomed St Peres, Lab Psychol Percept, F-75006 Paris, France; [Esseily, Rana] Univ Paris Ouest Nanterre Def, Ethol Lab, EA 3456, F-92000 Nanterre, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris Nanterre	Somogyi, E (corresponding author), Univ Paris 05, CNRS UMR 8158, Ctr Biomed St Peres, Lab Psychol Percept, F-75006 Paris, France.	eszter.somogyi@parisdescartes.fr	Somogyi, Eszter/N-1793-2019	Somogyi, Eszter/0000-0002-3935-3933				Agnetta B, 2004, INFANCY, V6, P1, DOI 10.1207/s15327078in0601_1; Ashton-James C, 2007, SOC COGNITION, V25, P518, DOI 10.1521/soco.2007.25.4.518; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; Carpenter M., 2006, IMITATION SOCIAL MIN, P48; Carpenter M, 2013, CHILD DEV, V84, P1511, DOI 10.1111/cdev.12083; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; ECKERMAN CO, 1989, CHILD DEV, V60, P440, DOI 10.2307/1130988; Fawcett C, 2012, INFANT BEHAV DEV, V35, P689, DOI 10.1016/j.infbeh.2012.07.014; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gergely G, 1999, EARLY SOCIAL COGNITION, P101; GRUSEC JE, 1982, CHILD DEV, V53, P636, DOI 10.1111/j.1467-8624.1982.tb03435.x; Gueguen N, 2009, EUROPEAN J SOCIAL SC, V8; Helie S, 2012, NEURAL NETWORKS, V32, P74, DOI 10.1016/j.neunet.2012.02.033; Kiraly I, 2009, J EXP CHILD PSYCHOL, V102, P14, DOI 10.1016/j.jecp.2008.06.003; LAFRANCE M, 1979, US SOC PSYCHOL, V42, P66, DOI 10.2307/3033875; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; LUBIN L, 1981, INT J BEHAV DEV, V4, P443, DOI 10.1177/016502548100400404; MAURER RE, 1983, J COUNS PSYCHOL, V30, P158, DOI 10.1037/0022-0167.30.2.158; Meltzoff A. N., 1999, IMITATION INFANCY, P9; Meltzoff AN., 1990, SELF TRANSITION INFA, P139; NADEL J, 1989, NATO ADV SCI I D-BEH, V51, P131; Nadel J., 1986, IMITATION COMMUNICAT; Nadel J, 2002, IMITATIVE MIND DEVEL; Nielsen M, 2008, DEVELOPMENTAL SCI, V11, P722, DOI 10.1111/j.1467-7687.2008.00722.x; O'Regan K, 2011, IEEE ICDL EPIROB FRO; Over H, 2009, DEVELOPMENTAL SCI, V12, pF1, DOI 10.1111/j.1467-7687.2008.00820.x; Poirel N, 2012, COGNITION EMOTION, V26, P186, DOI 10.1080/02699931.2011.589430; Rat-Fischer L, 2012, J EXP CHILD PSYCHOL, V113, P440, DOI 10.1016/j.jecp.2012.06.001; Stern D.N., 1985, INTERPERSONAL WORLD; van Baaren RB, 2004, J PERS SOC PSYCHOL, V86, P453, DOI 10.1037/0022-3514.86.3.453; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren RB, 2003, J EXP SOC PSYCHOL, V39, P393, DOI 10.1016/S0022-1031(03)00014-3; Witkin H A, 1981, Psychol Issues, P1	34	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113695	10.1371/journal.pone.0113695	http://dx.doi.org/10.1371/journal.pone.0113695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493561	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400018
J	Daniel, J; Sirakova, T; Kolattukudy, P				Daniel, Jaiyanth; Sirakova, Tatiana; Kolattukudy, Pappachan			An Acyl-CoA Synthetase in Mycobacterium tuberculosis Involved in Triacylglycerol Accumulation during Dormancy	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; TRANSPORT; ACTIVATION; PREFERENCE; PROTEINS; INSIGHTS; REVEALS; CLONING; FAMILY	Latent infection with dormant Mycobacterium tuberculosis is one of the major reasons behind the emergence of drug-resistant strains of the pathogen worldwide. In its dormant state, the pathogen accumulates lipid droplets containing triacylglycerol synthesized from fatty acids derived from host lipids. In this study, we show that Rv1206 (FACL6), which is annotated as an acyl-CoA synthetase and resembles eukaryotic fatty acid transport proteins, is able to stimulate fatty acid uptake in E. coli cells. We show that purified FACL6 displays acyl-coenzyme A synthetase activity with a preference towards oleic acid, which is one of the predominant fatty acids in host lipids. Our results indicate that the expression of FACL6 protein in Mycobacterium tuberculosis is significantly increased during in vitro dormancy. The facl6-deficient Mycobacterium tuberculosis mutant displayed a diminished ability to synthesize acyl-coenzyme A in cell-free extracts. Furthermore, during in vitro dormancy, the mutant synthesized lower levels of intracellular triacylglycerol from exogenous fatty acids. Complementation partially restored the lost function. Our results suggest that FACL6 modulates triacylglycerol accumulation as the pathogen enters dormancy by activating fatty acids.	[Daniel, Jaiyanth; Sirakova, Tatiana; Kolattukudy, Pappachan] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Daniel, Jaiyanth] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA	State University System of Florida; University of Central Florida; Purdue University System; Indiana University Purdue University Fort Wayne	Daniel, J (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	danielj@ipfw.edu		Daniel, Jaiyanth/0000-0002-3605-687X	National Institutes of Health [AI46582, AI35272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035272, R01AI046582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI46582 and AI35272 from the National Institutes of Health to PK. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; Dirusso CC, 2008, BBA-MOL CELL BIOL L, V1781, P135, DOI 10.1016/j.bbalip.2008.01.002; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; GINSBURGH CL, 1984, J BIOL CHEM, V259, P8437; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Melton EM, 2013, BIOCHEM BIOPH RES CO, V440, P743, DOI 10.1016/j.bbrc.2013.09.137; Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Sirakova TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051641; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	41	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114877	10.1371/journal.pone.0114877	http://dx.doi.org/10.1371/journal.pone.0114877			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490545	Green Published, gold			2022-12-27	WOS:000347515300089
J	Jia, XH; Zhou, XH; Luo, YQ; Xue, K; Xue, X; Xu, X; Yang, YH; Wu, LY; Zhou, JZ				Jia, Xiaohong; Zhou, Xuhui; Luo, Yiqi; Xue, Kai; Xue, Xian; Xu, Xia; Yang, Yuanhe; Wu, Liyou; Zhou, Jizhong			Effects of Substrate Addition on Soil Respiratory Carbon Release Under Long-Term Warming and Clipping in a Tallgrass Prairie	PLOS ONE			English	Article							CYCLE FEEDBACK; NITROGEN MINERALIZATION; INTERANNUAL VARIABILITY; LITTER DECOMPOSITION; ORGANIC-CARBON; CLIMATE; TEMPERATURE; RESPONSES; BIOMASS; LABILE	Regulatory mechanisms of soil respiratory carbon (C) release induced by substrates (i.e., plant derived substrates) are critical for predicting ecosystem responses to climate change, but the mechanisms are not well understood. In this study, we sampled soils from a long-term field manipulative experiment and conducted a laboratory incubation to explore the role of substrate supply in regulating the differences in soil C release among the experimental treatments, including control, warming, clipping, and warming plus clipping. Three types of substrates (glucose, C-3 and C-4 plant materials) were added with an amount equal to 1% of soil dry weight under the four treatments. We found that the addition of all three substrates significantly stimulated soil respiratory C release in all four warming and clipping treatments. In soils without substrate addition, warming significantly stimulated soil C release but clipping decreased it. However, additions of glucose and C-3 plant materials (C-3 addition) offset the warming effects, whereas C-4 addition still showed the warming-induced stimulation of soil C release. Our results suggest that long-term warming may inhibit microbial capacity for decomposition of C-3 litter but may enhance it for decomposition of C-4 litter. Such warming-induced adaptation of microbial communities may weaken the positive C-cycle feedback to warming due to increased proportion of C-4 species in plant community and decreased litter quality. In contrast, clipping may weaken microbial capacity for warming-induced decomposition of C-4 litter but may enhance it for C-3 litter. Warming- and clipping-induced shifts in microbial metabolic capacity may be strongly associated with changes in plant species composition and could substantially influence soil C dynamics in response to global change.	[Jia, Xiaohong] Chinese Acad Forestry, Inst Desertificat Studies, Beijing 100091, Peoples R China; [Jia, Xiaohong; Xue, Xian] Chinese Acad Sci, Cold & Arid Regions Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou 730000, Peoples R China; [Jia, Xiaohong; Luo, Yiqi; Xue, Kai; Xue, Xian; Xu, Xia; Yang, Yuanhe; Wu, Liyou; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Xuhui] Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn,Minist Educ, Shanghai 200433, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University of Oklahoma System; University of Oklahoma - Norman; Fudan University	Zhou, XH (corresponding author), Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn,Minist Educ, Shanghai 200433, Peoples R China.	zxuhui14@fudan.edu.cn	Zhou, Xuhui/H-4332-2011; 吴, 昊/AAB-1620-2020; Yang, Yuanhe/D-1448-2011; Zhou, Xuhui/O-5727-2019	Zhou, Xuhui/0000-0002-2038-9901; Xue, Kai/0000-0002-5990-4448	Chinese National Natural Science Foundation [41171077, 31370489, 40801002, 41371093, 41471096]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Pujiang Program [12PJ1401400]; "Thousand Young Talents" Program in China; US National Science Foundation (NSF) [DEB 0078325, DEB 0743778]; Terrestrial Carbon Program at the Office of Science (BER); Department of Energy [DEFG02-006ER64319]; Midwestern Regional Center of the National Institute for Climatic Change Research (NICCR) at Michigan Technological University [DE-FC02-06ER64158]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Pujiang Program; "Thousand Young Talents" Program in China; US National Science Foundation (NSF)(National Science Foundation (NSF)); Terrestrial Carbon Program at the Office of Science (BER)(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Midwestern Regional Center of the National Institute for Climatic Change Research (NICCR) at Michigan Technological University	This study was financially supported by the Chinese National Natural Science Foundation (41171077, 31370489, 40801002, 41371093, and 41471096), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, 2012 Shanghai Pujiang Program (12PJ1401400), and the "Thousand Young Talents" Program in China, as well as the US National Science Foundation (NSF) under DEB 0078325 and DEB 0743778, by the Terrestrial Carbon Program at the Office of Science (BER), the Department of Energy (Grants No.: DEFG02-006ER64319), and the Midwestern Regional Center of the National Institute for Climatic Change Research (NICCR) at Michigan Technological University under Award No.: DE-FC02-06ER64158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU JK, 1978, SOIL BIOL BIOCHEM, V10, P117, DOI 10.1016/0038-0717(78)90081-0; Agren GI, 2000, AMBIO, V29, P55, DOI 10.1639/0044-7447(2000)029[0055:TDOOSO]2.0.CO;2; Alef K., 1995, METHODS APPL SOIL MI, P214, DOI [10.1016/B978-012513840-6/50020-3, DOI 10.1016/B978-012513840-6/50020-3]; Ayres E, 2006, SOIL BIOL BIOCHEM, V38, P183, DOI 10.1016/j.soilbio.2005.04.018; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dalias P, 2001, SOIL BIOL BIOCHEM, V33, P1049, DOI 10.1016/S0038-0717(01)00009-8; Edenhofer O., 2014, CONTRIBUTION WORKING; Eliasson PE, 2005, GLOBAL CHANGE BIOL, V11, P167, DOI 10.1111/j.1365-2486.2004.00878.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Franzluebbers AJ, 2001, SOIL BIOL BIOCHEM, V33, P1103, DOI 10.1016/S0038-0717(01)00016-5; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Glinski J., 1985, Soil aeration and its role for plants.; Gray T. R. G., 1976, Symposium, Society for General Microbiology, P327; GRAY T. R. G., 1971, Microbial productivity in soil., P255; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Ito A, 2002, ECOL MODEL, V151, P143, DOI 10.1016/S0304-3800(01)00473-2; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jenny H., 1980, The soil resource.; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MATIN A, 1992, J APPL BACTERIOL, V73, pS49, DOI 10.1111/j.1365-2672.1992.tb03624.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Mertens S, 2001, ECOSYSTEMS, V4, P226, DOI 10.1007/s10021-001-0006-3; NEELY CL, 1991, SOIL BIOL BIOCHEM, V23, P947, DOI 10.1016/0038-0717(91)90175-J; Nguyen C, 2001, SOIL BIOL BIOCHEM, V33, P53, DOI 10.1016/S0038-0717(00)00114-0; Niu SL, 2010, ECOLOGY, V91, P3261, DOI 10.1890/09-1634.1; PAJARI B, 1995, PLANT SOIL, V168, P563, DOI 10.1007/BF00029369; Paul EA, 1998, ASSESSMENT METHODS S, P193; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; SAKAMOTO K, 1994, BIOL FERT SOILS, V17, P39, DOI 10.1007/BF00418670; Saleska SR, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001573; SCHLESER GH, 1982, Z NATURFORSCH A, V37, P287, DOI 10.1515/zna-1982-0316; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Sorensen PL, 2008, SOIL BIOL BIOCHEM, V40, P2344, DOI 10.1016/j.soilbio.2008.05.013; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; USDA, 1979, SOIL SURV MCCLAIN CO; Waldrop MP, 2004, BIOGEOCHEMISTRY, V67, P235, DOI 10.1023/B:BIOG.0000015321.51462.41; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Xia JY, 2013, GLOBAL CHANGE BIOL, V19, P2104, DOI 10.1111/gcb.12172; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Ziegler SE, 2013, SOIL BIOL BIOCHEM, V60, P23, DOI 10.1016/j.soilbio.2013.01.001; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	60	4	5	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114203	10.1371/journal.pone.0114203	http://dx.doi.org/10.1371/journal.pone.0114203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490701	gold, Green Published			2022-12-27	WOS:000347515300020
J	Wan, XG; Cruts, B; Jensen, HJ				Wan, Xiaogeng; Cruts, Bjorn; Jensen, Henrik Jeldtoft			The Causal Inference of Cortical Neural Networks during Music Improvisations	PLOS ONE			English	Article							GENERATION	We present an EEG study of two music improvisation experiments. Professional musicians with high level of improvisation skills were asked to perform music either according to notes (composed music) or in improvisation. Each piece of music was performed in two different modes: strict mode and "let-go" mode. Synchronized EEG data was measured from both musicians and listeners. We used one of the most reliable causality measures: conditional Mutual Information from Mixed Embedding (MIME), to analyze directed correlations between different EEG channels, which was combined with network theory to construct both intra-brain and cross-brain networks. Differences were identified in intra-brain neural networks between composed music and improvisation and between strict mode and "let-go" mode. Particular brain regions such as frontal, parietal and temporal regions were found to play a key role in differentiating the brain activities between different playing conditions. By comparing the level of degree centralities in intra-brain neural networks, we found a difference between the response of musicians and the listeners when comparing the different playing conditions.	[Wan, Xiaogeng; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Wan, Xiaogeng; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Ctr Complex Sci, London, England; [Cruts, Bjorn] Brainmarker BV, Gulpen, Netherlands	Imperial College London; Imperial College London	Jensen, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	h.jensen@imperial.ac.uk						Babiloni C, 2011, CORTEX, V47, P1082, DOI 10.1016/j.cortex.2011.05.006; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Beudel M, 2009, CEREB CORTEX, V19; Bhattacharya J, 2005, SIGNAL PROCESS, V85; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Cruts B, 2012, REPORT STAT ANAL EEG; de Manzano O, 2012, NEUROIMAGE, V63, P272, DOI 10.1016/j.neuroimage.2012.06.024; de Manzano O, 2012, NEUROIMAGE, V59, P772, DOI 10.1016/j.neuroimage.2011.07.016; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Dolan David., 2013, MUSIC PERFORMANCE RE, V6, P1; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Hennig H, 2012, PHYS TODAY, V65, P64, DOI 10.1063/PT.3.1650; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; Kawasaki M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01692; Larson MG, 2008, CIRCULATION, V117, P115, DOI 10.1161/CIRCULATIONAHA.107.654335; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Takahashi DY, 2010, BIOL CYBERN, V103, P463, DOI 10.1007/s00422-010-0410-x; Takahashi DY, 2010, 32 ANN INT C IEEE EM; Vlachos I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016207; Vuust P, 2000, POLYRYTMIK OGMETRIK; Vuust P., 2008, COGN SEMIOT, V2008, P134, DOI [10.3726/81606_134, DOI 10.3726/81606_134]	29	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e112776	10.1371/journal.pone.0112776	http://dx.doi.org/10.1371/journal.pone.0112776			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489852	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300003
J	Haggar, FA; Pereira, G; Preen, D; Holman, CD; Einarsdottir, K				Haggar, Fatima A.; Pereira, Gavin; Preen, David; Holman, C. D'Arcy; Einarsdottir, Kristjana			Adverse Obstetric and Perinatal Outcomes following Treatment of Adolescent and Young Adult Cancer: A Population-Based Cohort Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHILDHOOD-CANCER; PREGNANCY OUTCOMES; REPRODUCTIVE OUTCOMES; PLACENTAL ABRUPTION; FEMALE SURVIVORS; PRETERM BIRTH; WILMS-TUMOR; FERTILITY	Objective: To investigate obstetric and perinatal outcomes among female survivors of adolescent and young adult (AYA) cancers and their offspring. Methods: Using multivariate analysis of statewide linked data, outcomes of all first completed pregnancies (n=1894) in female survivors of AYA cancer diagnosed in Western Australia during the period 1982-2007 were compared with those among females with no cancer history. Comparison pregnancies were matched by maternal age-group, parity and year of delivery. Results: Compared with the non-cancer group, female survivors of AYA cancer had an increased risk of threatened abortion (adjusted relative risk 2.09, 95% confidence interval 1.51-2.74), gestational diabetes (2.65, 2.08-3.57), pre-eclampsia (1.32, 1.04-1.87), post-partum hemorrhage (2.83, 1.92-4.67), cesarean delivery (2.62, 2.22-3.04), and maternal postpartum hospitalization >5 days (3.01, 1.72-5.58), but no excess risk of threatened preterm delivery, antepartum hemorrhage, premature rupture of membranes, failure of labor to progress or retained placenta. Their offspring had an increased risk of premature birth (<37 weeks: 1.68, 1.21-2.08), low birth weight (<2500 g: 1.51, 1.23-2.12), fetal growth restriction (3.27, 2.45-4.56), and neonatal distress indicated by low Apgar score (<7) at 1 minute (2.83, 2.28-3.56), need for resuscitation (1.66, 1.27-2.19) or special care nursery admission (1.44, 1.13-1.78). Congenital abnormalities and perinatal deaths (intrauterine or <= 7 days of birth) were not increased among offspring of survivors. Conclusion: Female survivors of AYA cancer have moderate excess risks of adverse obstetric and perinatal outcomes arising from subsequent pregnancies that may require additional surveillance or intervention.	[Haggar, Fatima A.] Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada; [Haggar, Fatima A.; Preen, David; Holman, C. D'Arcy] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [Pereira, Gavin; Einarsdottir, Kristjana] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Pereira, Gavin] Yale Univ, Sch Med, Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA	University of Ottawa; Ottawa Hospital Research Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia; Yale University	Haggar, FA (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada.	fhaggar@toh.on.ca	Pereira, Gavin/D-7136-2014; Einarsdóttir, Kristjana/E-8337-2011; Preen, David/H-5663-2014	Pereira, Gavin/0000-0003-3740-8117; Einarsdóttir, Kristjana/0000-0003-4931-7650; Preen, David/0000-0002-2982-2169	Cancer Council Western Australia; University of Western Australia; NHMRC Early Career Fellowship grant [1052236]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Cancer Council Western Australia(Cancer Council Western Australia); University of Western Australia; NHMRC Early Career Fellowship grant(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Cancer Council Western Australia and The University of Western Australia. GP received funding from a NHMRC Early Career Fellowship grant 1052236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Ananth CV, 1999, JAMA-J AM MED ASSOC, V282, P1646, DOI 10.1001/jama.282.17.1646; Apgar V, CURR RES ANESTH ANAL, V1, P260; Australian Bureau of Statistics, 2010, BIRTHS AUSTR 2009; Australian Bureau of Statistics, 2006, DROP; Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335; Barr RD, 2011, CANCER-AM CANCER SOC, V117, P2245, DOI 10.1002/cncr.26052; Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Blumenfeld Z, 1999, J SOC GYNECOL INVEST, V6, P229, DOI 10.1016/S1071-5576(99)00028-3; Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; BYRNE J, 1988, MED PEDIATR ONCOL, V16, P233, DOI 10.1002/mpo.2950160403; Chiarelli AM, 2000, EPIDEMIOLOGY, V11, P161, DOI 10.1097/00001648-200003000-00013; Chiarelli AM, 1996, AM J EPIDEMIOL, V143, P83; Chow SM, 2004, INT J RADIAT ONCOL, V59, P992, DOI 10.1016/j.ijrobp.2003.12.023; Clark H, 2007, OBSTET GYNECOL, V110, P849, DOI 10.1097/01.AOG.0000284458.53303.1c; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Critchley Hilary O D, 2002, Hum Fertil (Camb), V5, P61, DOI 10.1080/1464727022000198942; Diehl V, 2003, NEW ENGL J MED, V348, P2386, DOI 10.1056/NEJMoa022473; Garcia-Enguidanos A, 2002, EUR J OBSTET GYN R B, V102, P111, DOI 10.1016/S0301-2115(01)00613-3; GLODE LM, 1981, LANCET, V1, P1132; Green DM, 2010, J CLIN ONCOL, V28, P2824, DOI 10.1200/JCO.2009.27.2922; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; GREEN DM, 1989, CANCER-AM CANCER SOC, V64, P2335, DOI 10.1002/1097-0142(19891201)64:11<2335::AID-CNCR2820641124>3.0.CO;2-7; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; HAWKINS MM, 1989, INT J CANCER, V43, P399, DOI 10.1002/ijc.2910430309; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Howlader N, 2011, SEER CANC STAT REV 1; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Link K, 2004, J CLIN ENDOCR METAB, V89, P5003, DOI 10.1210/jc.2004-0126; LITTLEY MD, 1989, Q J MED, V70, P145; Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475; Lumley J, 2003, BJOG-INT J OBSTET GY, V110, P3, DOI 10.1016/S1470-0328(03)00011-9; Madanat-Harjuoja LM, 2013, ACTA ONCOL, V52, P1152, DOI 10.3109/0284186X.2012.758870; Madanat-Harjuoja LM, 2010, INT J CANCER, V127, P1669, DOI 10.1002/ijc.25157; Magelssen H, 2008, HUM REPROD, V23, P178, DOI 10.1093/humrep/dem362; Mauldin JG, 2001, SEMIN PERINATOL, V25, P215, DOI 10.1053/sper.2001.26419; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mueller BA, 2009, ARCH PEDIAT ADOL MED, V163, P879, DOI 10.1001/archpediatrics.2009.112; Percy C., 1990, INT CLASSIFICATION D; Reulen RC, 2009, CANCER EPIDEM BIOMAR, V18, P2239, DOI 10.1158/1055-9965.EPI-09-0287; SAS Inc, 2009, SAS SOFTW VERS 9 2; Schover Leslie R, 2005, J Natl Cancer Inst Monogr, P2; SEER, 2008, SEER AD YOUNG AD SIT; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; STANLEY FJ, 1994, PAEDIATR PERINAT EP, V8, P433, DOI 10.1111/j.1365-3016.1994.tb00482.x; Stensheim H, 2013, INT J CANCER, V133, P2696, DOI 10.1002/ijc.28292; Szabo I, 1996, Early Pregnancy, V2, P233; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; Threlfall T, 2010, CANC INCIDENCE MORTA; US National Cancer Institute Lance Armstrong Foundation, 2007, CLOS GAP STRAT PLAN; Wo JY, 2009, INT J RADIAT ONCOL, V73, P1304, DOI 10.1016/j.ijrobp.2008.12.016	55	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113292	10.1371/journal.pone.0113292	http://dx.doi.org/10.1371/journal.pone.0113292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485774	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600016
J	Pandya, D; Mariani, M; McHugh, M; Andreoli, M; Sieber, S; He, S; Dowell-Martino, C; Fiedler, P; Scambia, G; Ferlini, C				Pandya, Deep; Mariani, Marisa; McHugh, Mark; Andreoli, Mirko; Sieber, Steven; He, Shiquan; Dowell-Martino, Candice; Fiedler, Paul; Scambia, Giovanni; Ferlini, Cristiano			Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer	PLOS ONE			English	Article							INTERFERON; CHEMOTHERAPY; METABOLISM; MECHANISMS; SIGNATURES; CARCINOMA; THERAPY; SIMPLEX; MIRNA	Serous ovarian cancer (SEOC) is the deadliest gynecologic malignancy. MicroRNAs (miRNAs) are a class of small noncoding RNAs which regulate gene expression and protein translation. MiRNAs are also encoded by viruses with the intent of regulating their own genes and those of the infected cells. This is the first study assessing viral miRNAs in SEOC. MiRNAs sequencing data from 487 SEOC patients were downloaded from the TCGA website and analyzed through in-house sequencing pipeline. To cross-validate TCGA analysis, we measured the expression of miR-H25 by quantitative immunofluorescence in an additional cohort of 161 SEOC patients. Gene, miRNA expression, and cytotoxicity assay were performed on multiple ovarian cancer cell lines transfected with miR-H25 and miR-BART7. Outcome analysis was performed using multivariate Cox and Kaplan-Meier method. Viral miRNAs are more expressed in SEOC than in normal tissues. Moreover, Herpetic viral miRNAs (miR-BART7 from EBV and miR-H25 from HSV-2) are significant and predictive biomarkers of outcome in multivariate Cox analysis. MiR-BART7 correlates with resistance to first line chemotherapy and early death, whereas miR-H25 appears to impart a protective effect and long term survival. Integrated analysis of gene and viral miRNAs expression suggests that miR-BART7 induces directly cisplatin-resistance, while miR-H25 alters RNA processing and affects the expression of noxious human miRNAs such as miR-143. This is the first investigation linking viral miRNA expression to ovarian cancer outcome. Viral miRNAs can be useful to develop biomarkers for early diagnosis and as a potential therapeutic tool to reduce SEOC lethality.	[Pandya, Deep; Mariani, Marisa; McHugh, Mark; Andreoli, Mirko; Sieber, Steven; He, Shiquan; Dowell-Martino, Candice; Fiedler, Paul; Ferlini, Cristiano] Danbury Hosp Res Inst, Danbury, CT 06810 USA; [Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Gynecol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ferlini, C (corresponding author), Danbury Hosp Res Inst, Danbury, CT 06810 USA.	cristiano.ferlini@danhosp.org			AIRC (Associazione Italiana Ricerca sul Cancro) [IG11975]; Associazione OPPO e le sue stanze ONLUS; Ruth C. Donovan Cancer Research Program	AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Associazione OPPO e le sue stanze ONLUS; Ruth C. Donovan Cancer Research Program	Funding: This work was partially supported by a grant from AIRC (Associazione Italiana Ricerca sul Cancro, IG11975), Associazione OPPO e le sue stanze ONLUS, by the Ruth C. Donovan Cancer Research Program and by a liberal donation from Mr. and Mrs. Ruggles. This work is dedicated to Monica DeFeo who lost her courageous battle against cancer at the young age of 53. Sponsors of the study did not have any role in the study conception and management.	[Anonymous], 2012, CANCER DISCOV, V2, P1068, DOI 10.1158/2159-8290.CD-NB2012-129; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benencia F, 2005, HUM GENE THER, V16, P765, DOI 10.1089/hum.2005.16.765; Benencia F, 2008, CANCER BIOL THER, V7, P1194, DOI 10.4161/cbt.7.8.6216; Berek Jonathan S, 2003, J Clin Oncol, V21, p168s, DOI 10.1200/JCO.2003.01.517; Brooks PJ, 2014, ENVIRON MOL MUTAGEN, V55, P77, DOI 10.1002/em.21824; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chan JYW, 2012, ANTICANCER RES, V32, P3201; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Chen B, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-228; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; De Donato M, 2012, J CELL PHYSIOL, V227, P1034, DOI 10.1002/jcp.22813; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Ford JL, 2013, ANN EPIDEMIOL, V23, P275, DOI 10.1016/j.annepidem.2013.02.008; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; McMartin KE, 2012, CLIN TOXICOL, V50, P375, DOI 10.3109/15563650.2012.683197; Miles Gregory D, 2012, BMC Res Notes, V5, P164, DOI 10.1186/1756-0500-5-164; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Nakamori M, 2003, CLIN CANCER RES, V9, P2727; Nowak M, 2010, SCAND J IMMUNOL, V71, P91, DOI 10.1111/j.1365-3083.2009.02350.x; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459	37	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114750	10.1371/journal.pone.0114750	http://dx.doi.org/10.1371/journal.pone.0114750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485872	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600095
J	Hu, Y; Huo, ZH; Liu, CM; Liu, SG; Zhang, N; Yin, KL; Qi, L; Ma, X; Xia, HF				Hu, Yi; Huo, Zheng-Hao; Liu, Chun-Mei; Liu, Shi-Guo; Zhang, Ning; Yin, Kun-Lun; Qi, Lu; Ma, Xu; Xia, Hong-Fei			Functional Study of One Nucleotide Mutation in Pri-MiR-125a Coding Region which Related to Recurrent Pregnancy Loss	PLOS ONE			English	Article							EXPRESSION; MIFEPRISTONE; PROLIFERATION; APOPTOSIS; MICRORNAS; ALTER	MicroRNAs (miRNAs) are short non-coding RNAs which modulate gene expression by binding to complementary segments present in the 3'UTR of the mRNAs of protein coding genes. MiRNAs play very important roles in maintaining normal human body physiology conditions, meanwhile, abnormal miRNA expressions have been found related to many human diseases spanning from psychiatric disorders to malignant cancers. Recently, emerging reports have indicated that disturbed miRNAs expression contributed to the pathogenesis of recurrent pregnancy loss (RPL). In this study, we identified a new mutation site (+29A>G, position relative to pre-miR-125a) by scanning pri-miR-125a coding region in 389 Chinese Han RPL patients. This site was co-existed with two polymorphisms (rs12976445 and rs41275794) in patients heterogeneously and changed the predicted secondary structures of pri-miR-125a. Subsequent in vitro analysis indicated that the A>G mutation reduced mature miR-125a expression, and further led to less efficient inhibition of verified target genes. Functional analysis showed that mutant pri-mir-125a can enhance endometrial stromal cells (ESCs) invasive capacity and increase the sensitivity of ESCs cells to mifepristone. Moreover, we further analyzed the possible molecular mechanism by RIP-chip assay and found that mutant pri-mir-125a disturbed the expression of miR-125a targetome, the functions of which includes embryonic development, cell proliferation, migration and invasion. These data suggest that A>G mutation in pri-miR-125a coding region contributes to the genetic predisposition to RPL by disordering the production of miR-125a, which consequently meddled in gene regulatory network between mir-125a and mRNA.	[Hu, Yi; Liu, Chun-Mei; Zhang, Ning; Yin, Kun-Lun; Qi, Lu; Ma, Xu; Xia, Hong-Fei] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China; [Zhang, Ning; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Hu, Yi] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Huo, Zheng-Hao] Ningxia Med Univ, Sch Basic Med Sci, Dept Biotechnol, Ningxia, Peoples R China; [Liu, Shi-Guo] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Microbiology, CAS; Ningxia Medical University; Qingdao University	Ma, X (corresponding author), Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China.	genetic@263.net.cn; hongfeixia@126.com		Hu, Yi/0000-0002-5432-1438	Natural Science Foundation of China [81370720, 81301446]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from Natural Science Foundation of China (No. 81370720 and No. 81301446). Website: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; CHARD T, 1991, BAILLIERE CLIN OB GY, V5, P179, DOI 10.1016/S0950-3552(05)80077-X; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Hoy AM, 2012, BIOCHEM SOC T, V40, P886, DOI 10.1042/BST20120019; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Li AM, 2005, FERTIL STERIL, V84, P202, DOI 10.1016/j.fertnstert.2005.01.126; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mahajan DK, 1997, FERTIL STERIL, V68, P967, DOI 10.1016/S0015-0282(97)00189-1; Minas V, 2007, MOL HUM REPROD, V13, P663, DOI 10.1093/molehr/gam054; Narvekar N, 2004, J CLIN ENDOCR METAB, V89, P2491, DOI 10.1210/jc.2003-031945; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	19	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114781	10.1371/journal.pone.0114781	http://dx.doi.org/10.1371/journal.pone.0114781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479352	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200128
J	Kumar, CS; Kumar, S				Kumar, Chandra Shekhar; Kumar, Sachin			Species Based Synonymous Codon Usage in Fusion Protein Gene of Newcastle Disease Virus	PLOS ONE			English	Article							CLEAVAGE-ACTIVATION SITE; ESCHERICHIA-COLI; F-PROTEIN; SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC CLEAVAGE; VIRAL REPLICATION; SEQUENCE; BIAS; VIRULENCE; PATHOGENICITY	Newcastle disease is highly pathogenic to poultry and many other avian species. However, the Newcastle disease virus (NDV) has also been reported from many non-avian species. The NDV fusion protein (F) is a major determinant of its pathogenicity and virulence. The functionalities of F gene have been explored for the development of vaccine and diagnostics against NDV. Although the F protein is well studied but the codon usage and its nucleotide composition from NDV isolated from different species have not yet been explored. In present study, we have analyzed the factors responsible for the determination of codon usage in NDV isolated from four major avian host species. The F gene of NDV is analyzed for its base composition and its correlation with the bias in codon usage. Our result showed that random mutational pressure is responsible for codon usage bias in F protein of NDV isolates. Aromaticity, GC3s, and aliphatic index were not found responsible for species based synonymous codon usage bias in F gene of NDV. Moreover, the low amount of codon usage bias and expression level was further confirmed by a low CAI value. The phylogenetic analysis of isolates was found in corroboration with the relatedness of species based on codon usage bias. The relationship between the host species and the NDV isolates from the host does not represent a significant correlation in our study. The present study provides a basic understanding of the mechanism involved in codon usage among species.	[Kumar, Chandra Shekhar; Kumar, Sachin] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Kumar, S (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	sachinku@iitg.ernet.in		Kumar, Chandra Shekhar/0000-0002-1469-3018; Paraskevis, Dimitrios/0000-0001-6167-7152	department of biotechnology [NER-BPMC/2013/134]; department of science and technology [IFA-LSBM-34]; board of research on nuclear sciences [2012/20/37B/06/BRNS]	department of biotechnology; department of science and technology(Department of Science & Technology (India)); board of research on nuclear sciences	The NDV research in our laboratory is currently supported by the department of biotechnology (NER-BPMC/2013/134), the department of science and technology (IFA-LSBM-34), and the board of research on nuclear sciences (2012/20/37B/06/BRNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 1998, NEWCASTLE DIS OTHER; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Cao Hong-wei, 2014, Indian Journal of Virology, V25, P132, DOI 10.1007/s13337-013-0175-7; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Cornax I, 2013, J GEN VIROL, V94, P1189, DOI 10.1099/vir.0.048579-0; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamb R. A, 2005, VIRUS TAXONOMY CLASS, P655; Liu XD, 2010, ARCH VIROL, V155, P685, DOI 10.1007/s00705-010-0631-2; LLOYD AT, 1992, NUCLEIC ACIDS RES, V20, P5289, DOI 10.1093/nar/20.20.5289; MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1995, MICROBIOL IMMUNOL, V39, P1; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Pollock DD, 2000, MOL BIOL EVOL, V17, P1776, DOI 10.1093/oxfordjournals.molbev.a026278; Rao YS, 2011, DNA RES, V18, P499, DOI 10.1093/dnares/dsr035; Reyes A, 1998, MOL BIOL EVOL, V15, P499, DOI 10.1093/oxfordjournals.molbev.a025949; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; SAKAGUCHI T, 1994, J GEN VIROL, V75, P2821, DOI 10.1099/0022-1317-75-10-2821; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Samal S, 2013, J VIROL, V87, P10083, DOI 10.1128/JVI.01446-13; Samal S, 2012, J VIROL, V86, P2501, DOI 10.1128/JVI.06380-11; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; Sharma B, 2012, ARCH VIROL, V157, P1565, DOI 10.1007/s00705-012-1317-8; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Wakamatsu N, 2006, AVIAN DIS, V50, P483, DOI 10.1637/7515-020706R.1; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-146; Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174	42	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114754	10.1371/journal.pone.0114754	http://dx.doi.org/10.1371/journal.pone.0114754			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479071	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200124
J	van den Bogert, B; Meijerink, M; Zoetendal, EG; Wells, JM; Kleerebezem, M				van den Bogert, Bartholomeus; Meijerink, Marjolein; Zoetendal, Erwin G.; Wells, Jerry M.; Kleerebezem, Michiel			Immunomodulatory Properties of Streptococcus and Veillonella Isolates from the Human Small Intestine Microbiota	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; TIGHT JUNCTION PROTEINS; PATCH DENDRITIC CELLS; GUT MICROBIOTA; LACTOBACILLUS-PLANTARUM; LY6C(HI) MONOCYTES; GENOME SEQUENCE; ORAL TOLERANCE; IMMUNE-SYSTEM; IN-VIVO	The human small intestine is a key site for interactions between the intestinal microbiota and the mucosal immune system. Here we investigated the immunomodulatory properties of representative species of commonly dominant small-intestinal microbial communities, including six streptococcal strains (four Streptococcus salivarius, one S. equinus, one S. parasanguinis) one Veillonella parvula strain, one Enterococcus gallinarum strain, and Lactobacillus plantarum WCFS1 as a bench mark strain on human monocyte-derived dendritic cells. The different streptococci induced varying levels of the cytokines IL-8, TNF-alpha, and IL-12p70, while the V. parvula strain showed a strong capacity to induce IL-6. E. gallinarum strain was a potent inducer of cytokines and TLR2/6 signalling. As Streptococcus and Veillonella can potentially interact metabolically and frequently co-occur in ecosystems, immunomodulation by pair-wise combinations of strains were also tested for their combined immunomodulatory properties. Strain combinations induced cytokine responses in dendritic cells that differed from what might be expected on the basis of the results obtained with the individual strains. A combination of (some) streptococci with Veillonella appeared to negate IL-12p70 production, while augmenting IL-8, IL-6, IL-10, and TNF-alpha responses. This suggests that immunomodulation data obtained in vitro with individual strains are unlikely to adequately represent immune responses to mixtures of gut microbiota communities in vivo. Nevertheless, analysing the immune responses of strains representing the dominant species in the intestine may help to identify immunomodulatory mechanisms that influence immune homeostasis.	[van den Bogert, Bartholomeus; Zoetendal, Erwin G.; Kleerebezem, Michiel] TIFN, Wageningen, Netherlands; [van den Bogert, Bartholomeus; Zoetendal, Erwin G.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands; [Kleerebezem, Michiel] NIZO Food Res BV, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Kleerebezem, M (corresponding author), TIFN, Wageningen, Netherlands.	michiel.kleerebezem@wur.nl	Kleerebezem, Michiel/AAT-2078-2021	Meijerink, Martijn/0000-0002-1500-7294; Kleerebezem, Michiel/0000-0001-8552-2235	Top Institute Food and Nutrition, Wageningen, The Netherlands; Netherlands Bioinformatics Centre (NBIC)	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government); Netherlands Bioinformatics Centre (NBIC)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands and by The Netherlands Bioinformatics Centre (NBIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Benyacoub J, 2005, J NUTR, V135, P1171, DOI 10.1093/jn/135.5.1171; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Egland PG, 2004, P NATL ACAD SCI USA, V101, P16917, DOI 10.1073/pnas.0407457101; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ivanov II, 2010, MUCOSAL IMMUNOL, V3, P209, DOI 10.1038/mi.2010.3; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kelly D, 2012, IMMUNOL REV, V245, P27, DOI 10.1111/j.1600-065X.2011.01079.x; KIYONO H, 1982, J EXP MED, V155, P605, DOI 10.1084/jem.155.2.605; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Meijerink M, 2012, FEMS IMMUNOL MED MIC, V65, P488, DOI 10.1111/j.1574-695X.2012.00981.x; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nagano Y, 2012, CURR OPIN IMMUNOL, V24, P392, DOI 10.1016/j.coi.2012.05.007; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Surana NK, 2012, IMMUNOL REV, V245, P13, DOI 10.1111/j.1600-065X.2011.01075.x; Tanaka K, 2004, HISTOL HISTOPATHOL, V19, P907, DOI 10.14670/HH-19.907; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van den Bogert B, 2013, GENOME ANNOUNC, V1; Van den Bogert B, 2011, HDB MOL MICROBIAL EC, VII, P170; Van den Bogert B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083418; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; YAMAZAKI S, 1985, IMMUNOLOGY, V56, P43; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	59	85	107	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114277	10.1371/journal.pone.0114277	http://dx.doi.org/10.1371/journal.pone.0114277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479553	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200064
J	Rajan, D; McCracken, CE; Kopleman, HB; Kyu, SY; Lee, FEH; Lu, XY; Anderson, LJ				Rajan, Devi; McCracken, Courtney E.; Kopleman, Hannah B.; Kyu, Shuya Y.; Lee, F. Eun-Hyung; Lu, Xiaoyan; Anderson, Larry J.			Human Rhinovirus Induced Cytokine/Chemokine Responses in Human Airway Epithelial and Immune Cells	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; BLOOD MONONUCLEAR-CELLS; ASTHMA EXACERBATIONS; MONOCYTIC CELLS; CHILDREN; EXPRESSION; RELEASE; IMMUNIZATION; REPLICATION; PREVALENCE	Infections with human rhinovirus (HRV) are commonly associated with acute upper and lower respiratory tract disease and asthma exacerbations. The role that HRVs play in these diseases suggests it is important to understand host-specific or virus-specific factors that contribute to pathogenesis. Since species A HRVs are often associated with more serious HRV disease than species B HRVs, differences in immune responses they induce should inform disease pathogenesis. To identify species differences in induced responses, we evaluated 3 species A viruses, HRV 25, 31 and 36 and 3 species B viruses, HRV 4, 35 and 48 by exposing human PBMCs to HRV infected Calu-3 cells. To evaluate the potential effect of memory induced by previous HRV infection on study responses, we tested cord blood mononuclear cells that should be HRV naive. There were HRV-associated increases (significant increase compared to mock-infected cells) for one or more HRVs for IP-10 and IL-15 that was unaffected by addition of PBMCs, for MIP-1 alpha, MIP-1 beta, IFN-alpha, and HGF only with addition of PBMCs, and for ENA-78 only without addition of PBMCs. All three species B HRVs induced higher levels, compared to A HRVs, of MIP-1 alpha and MIP-1 beta with PBMCs and ENA-78 without PBMCs. In contrast, addition of CBMCs had less effect and did not induce MIP-1 alpha, MIP-1 beta, or IFN-alpha nor block ENA-78 production. Addition of CBMCs did, however, increase IP-10 levels for HRV 35 and HRV 36 infection. The presence of an effect with PBMCs and no effect with CBMCs for some responses suggest differences between the two types of cells possibly because of the presence of HRV memory responses in PBMCs and not CBMCs or limited response capacity for the immature CBMCs relative to PBMCs. Thus, our results indicate that different HRV strains can induce different patterns of cytokines and chemokines; some of these differences may be due to differences in memory responses induced by past HRV infections, and other differences related to virus factors that can inform disease pathogenesis.	[Rajan, Devi; McCracken, Courtney E.; Kopleman, Hannah B.; Anderson, Larry J.] Emory Childrens Ctr, Dept Pediat, Atlanta, GA 30322 USA; [Kyu, Shuya Y.; Lee, F. Eun-Hyung] Emory Univ, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Lu, Xiaoyan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Anderson, LJ (corresponding author), Emory Childrens Ctr, Dept Pediat, Atlanta, GA 30322 USA.	larry.anderson@emory.edu			NIH - Children's Healthcare of Atlanta [1U19AI095227]; Immunology Core of Emory Children's Pediatric Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095227] Funding Source: NIH RePORTER	NIH - Children's Healthcare of Atlanta; Immunology Core of Emory Children's Pediatric Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH 1U19AI095227 grant, funding from Children's Healthcare of Atlanta, and the Immunology Core of Emory Children's Pediatric Research Center.	ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; Amineva SP, 2011, J GEN VIROL, V92, P2549, DOI 10.1099/vir.0.031302-0; Arakawa M, 2012, J MED MICROBIOL, V61, P410, DOI 10.1099/jmm.0.035006-0; Arden KE, 2010, J CLIN VIROL, V47, P219, DOI 10.1016/j.jcv.2010.01.001; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; COONEY MK, 1975, J IMMUNOL, V114, P635; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Donninger H, 2003, J INFECT DIS, V187, P1809, DOI 10.1086/375246; Garcia C, 2012, PEDIATR INFECT DIS J, V31, P86, DOI 10.1097/INF.0b013e31822dc8c1; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Glanville N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003669; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P216, DOI 10.1016/j.jaci.2007.02.025; Jin Y, 2009, J CLIN MICROBIOL, V47, P2895, DOI 10.1128/JCM.00745-09; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Johnston SL, 1998, J IMMUNOL, V160, P6172; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Lenarczyk A, 2000, CLIN EXP IMMUNOL, V122, P41, DOI 10.1046/j.1365-2249.2000.01328.x; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; McLean GR, 2012, ANTIVIR RES, V95, P193, DOI 10.1016/j.antiviral.2012.06.006; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Olsson S, 2003, CLIN EXP IMMUNOL, V132, P254, DOI 10.1046/j.1365-2249.2003.02148.x; Papadopoulos N G, 2000, Can Respir J, V7, P409; Papadopoulos NG, 2001, CLIN EXP ALLERGY, V31, P1060, DOI 10.1046/j.1365-2222.2001.01112.x; Persson T, 2003, CLIN EXP ALLERGY, V33, P531, DOI 10.1046/j.1365-2222.2003.01609.x; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Rajan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066600; Saedisomeolia A, 2009, J NUTR BIOCHEM, V20, P577, DOI 10.1016/j.jnutbio.2008.06.001; Saedisomeolia A, 2009, BRIT J NUTR, V101, P533, DOI 10.1017/S0007114508025798; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; SCHNYDERCANDRIAN S, 1995, J LEUKOCYTE BIOL, V57, P929, DOI 10.1002/jlb.57.6.929; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Vlasak M, 2003, J VIROL, V77, P6923, DOI 10.1128/JVI.77.12.6923-6930.2003; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Xatzipsalti M, 2008, CLIN EXP ALLERGY, V38, P466, DOI 10.1111/j.1365-2222.2007.02906.x	44	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114322	10.1371/journal.pone.0114322	http://dx.doi.org/10.1371/journal.pone.0114322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500821	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400028
J	Zhang, Y; Zeng, Z; Cao, Y; Du, XD; Wan, Z				Zhang, Yun; Zeng, Zhi; Cao, Yu; Du, Xiaodong; Wan, Zhi			Effect of Urinary Protease Inhibitor (Ulinastatin) on Cardiopulmonary Bypass: A Meta-Analysis for China and Japan	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; CARDIAC-SURGERY; TRYPSIN-INHIBITOR; EXPRESSION; CYTOKINES; TNF	Objectives: A meta-analysis was conducted to investigate the effects of ulinastatin treatment on adult patients undergoing cardiac surgery under cardiopulmonary bypass (CPB). Methods: Seven electronic databases were searched for reports of randomized, controlled trials conducted up to February 2014 in which patients undergoing cardiac surgery with CPB were administered ulinastatin in the perioperative period. Results: Fifty-two studies with 2025 patients were retained for analysis. The results showed that the ulinastatin can attenuate the plasma levels of pro-inflammatory cytokines and enhance the anti-inflammatory cytokine levels in patients undergoing cardiac surgery with CPB. Meanwhile, the ulinastatin had a significant beneficial effect on myocardial injury. The mean differences (MD) and 95% confidence intervals (95% CI) of biochemical markers were -63.54 (-79.36, -47.72) for lactate dehydrogenase, -224.99 (-304.83, -145.14) for creatine kinase, -8.75 (-14.23, -3.28) for creatine kinase-MB, and -0.14 (-0.20, -0.09] for troponin I (all P<0.01). However, neither hemodynamics nor cardiac function improved significantly, except that the MD and 95% CI of mean arterial pressure were 2.50 (0.19, 4.80) (P=0.03). There were no statistically significant differences in the use of inotropes, postoperative bleeding, postoperative complications, the intensive care unit (ICU) stay, and the hospital stay; however, the frequency of auto resuscitation increased significantly (OR 1.98, 95% CI 1.19 to 3.30, P<0.01), the duration of intubation (MD 21.58, 95% CI -2.84 to -0.32, P<0.01) and the duration of mechanical ventilation (MD -3.29, 95% CI -4.41 to -2.17, P<0.01) shortened significantly in patients who were treated with ulinastatin. Conclusions: Ulinastatin can reduce the plasma levels of pro-inflammatory cytokines and elevate anti-inflammatory cytokine in patients from China and Japan undergoing cardiac surgery with CPB. Ulinastatin treatment may have protective effects on myocardial injury, and can increase the frequency of auto resuscitation, shorten the duration of intubation and mechanical ventilation.	[Zhang, Yun; Zeng, Zhi; Cao, Yu; Du, Xiaodong; Wan, Zhi] Sichuan Univ, Dept Emergency, West China Hosp, West China Sch Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wan, Z (corresponding author), Sichuan Univ, Dept Emergency, West China Hosp, West China Sch Med, Chengdu 610064, Sichuan, Peoples R China.	43017541@qq.com		Wan, Zhi/0000-0002-3124-0125	National Natural Science Foundation of China (NSFC) [81201446]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC: 81201446, https://isis.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao HJ, 2006, CHINESE J CLIN MED, V13, P320; Bingyang J, 2007, J CARDIOVASC SURG, V48, P497; BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R; Chen BJ, 2011, J PRACTICAL MED, V27, P1765; Chen H, 2009, CHINESE MED J-PEKING, V122, P883, DOI 10.3760/cma.j.issn.0366-6999.2009.08.001; Chen P, 2003, GUANGDONG MED J, V24, P281; Chen RW, 2007, J CLIN PEDIAT SURG, V6; Chen Shou-Quan, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P730; Chen TT, 2013, HEART SURG FORUM, V16, pE38, DOI 10.1532/HSF98.20121072; Chen X, 2013, MOL MED REP, V8, P29, DOI 10.3892/mmr.2013.1480; [陈煜 Chen Yu], 2005, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V21, P527; Daryapeyma A, 2014, VASC ENDOVASC SURG, V48, P116, DOI 10.1177/1538574413512376; Nogueira NPD, 2013, ACTA TROP, V128, P27, DOI 10.1016/j.actatropica.2013.05.013; Emrich F, 2012, EUR J CARDIO-THORAC, V42, P704, DOI 10.1093/ejcts/ezs119; Gao XG, 2012, GUIDE CHINA MED, V10, P75; He QL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/630835; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hiyama A, 1997, J CARDIOTHOR VASC AN, V11, P580, DOI 10.1016/S1053-0770(97)90008-2; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hu CL, 2013, CLINICS, V68, P1231, DOI 10.6061/clinics/2013(09)10; Hu CL, 2013, AM J EMERG MED, V31, P768, DOI 10.1016/j.ajem.2012.11.012; Itaba S, 2013, DIGEST ENDOSC, V25, P421, DOI 10.1111/den.12014; Ji Hong-wen, 2009, Zhonghua Yi Xue Za Zhi, V89, P175; Jiang B, 2012, CHINESE J EXTRACORPO, V10, P207; Jiang CB, 2009, J PRACTICAL MED, V25, P1860; Jiang Yi-fei, 2008, Zhonghua Yi Xue Za Zhi, V88, P2893; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Kawamura T, 1996, CAN J ANAESTH, V43, P456, DOI 10.1007/BF03018106; Kuang X, 2004, CHINA MED ENG, V12, P26; Laffey JG, 2002, ANESTHESIOLOGY, V97, P215; Li JL, 2009, CHINESE J EXTRACORPO, V7, P8, DOI DOI 10.1016/J.IJID.2009.05.007; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li LW, 2004, J CHINESE PHYS, V6, P1642; Li MR, 2005, CHINESE J PRIMARY ME, V12, P1157; [李倩 Li Qian], 2012, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V29, P1184; Li WD, 2009, J CLIN RES, V26, P1014; [李颖川 Li Yingchuan], 2004, [临床麻醉学杂志, The Journal of Chinical Anesthestology], V20, P69; Liu JD, 2009, CHINESE J EXTRACORPO, V7, P12, DOI DOI 10.1029/2008JA013698.[LINK]; Liu Y, 2005, CHINA J MODERN MED, V15, P1389; Ma L, 2013, NEUROCHEM RES, V38, P1070, DOI 10.1007/s11064-013-1018-z; Matsuno YK, 2006, ELECTROPHORESIS, V27, P2486, DOI 10.1002/elps.200500854; Meldrum DR, 1999, J SURG RES, V85, P185, DOI 10.1006/jsre.1999.5660; [孟冬梅 Meng Dongmei], 2002, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V22, P344; Morjen M, 2013, MATRIX BIOL, V32, P52, DOI 10.1016/j.matbio.2012.11.015; Nakanishi K, 2006, CRIT CARE MED, V34, P1351, DOI 10.1097/01.CCM.0000215110.55899.AE; Oh SY, 2012, KOREAN J ANESTHESIOL, V62, P148, DOI 10.4097/kjae.2012.62.2.148; Park Jae Bum, 2013, Korean J Thorac Cardiovasc Surg, V46, P185, DOI 10.5090/kjtcs.2013.46.3.185; Qi XY, 2010, HERALD MED, V29, P477; Qiang Z, 2004, CHINESE J POSTGRADUA, V27, P24; Ren BH, 2004, J MED POSTGRADUATES, V17, P519; Sablotzki A, 2002, PERFUSION-UK, V17, P103, DOI 10.1191/0267659102pf543oa; Shao B, 2006, CHINESE J CARDIOVASC, V4, P120; Shu Q, 2005, CHINESE J EMERGENCY, V14, P1027; Sierko E, 2012, THROMB RES, V129, pE92, DOI 10.1016/j.thromres.2011.09.005; Sirlak M, 2003, INT J CARDIOL, V92, P43, DOI 10.1016/S0167-5273(03)00038-X; Song JE, 2011, J INT MED RES, V39, P1201, DOI 10.1177/147323001103900408; Song J, 2013, KOREAN J ANESTHESIOL, V64, P334, DOI 10.4097/kjae.2013.64.4.334; Sugita T, 2002, J CARDIOVASC SURG, V43, P437; Sun CY, 2003, AUSTR JAP ADV WORKSH, P38; Talwani R, 2013, DRUG TODAY, V49, P769, DOI 10.1358/dot.2013.49.12.2067249; Ucciferri C, 2013, J MED VIROL, V85, P755, DOI 10.1002/jmv.23543; Wang Dian-jun, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P670; Wang Gu-Yan, 2007, Zhonghua Yi Xue Za Zhi, V87, P2502; Wang X, 2012, J MED THEORY PRACTIC, V25, P1808; Wang YQ, 2008, SHAANXI MED J, V37, P1620; Wei L, 2009, CHINESE J EXTRACORPO, V7, P4; Xu CE, 2013, J CARDIOTHOR VASC AN, V27, P479, DOI 10.1053/j.jvca.2012.11.001; [徐康清 Xu Kangqing], 2002, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V22, P325; [徐康清 Xu Kangqing], 2004, [中华胸心血管外科杂志, Chinese Journal of Thoracic and Cardiovascular Surgery], V20, P7; [薛庆华 XUE Qinghua], 2006, [中国循环杂志, Chinese Circulation Journal], V21, P297; Yu Xiang-you, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P664; [张剑蔚 Zhang Jianwei], 2004, [上海第二医科大学学报, Acta Universitatis Medicinalis Secondae Shanghai], V24, P933; Zhang XL, 2007, CHINESE J EMERGENCY, V16, P50; [赵琦峰 ZHAO Qifeng], 2007, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V27, P199; [赵艳 ZHAO Yan], 2009, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V29, P685; Zhirnov Oleg P., 2011, Antiviral Chemistry & Chemotherapy, V21, P169, DOI 10.3851/IMP1715; Zhong JY, 2007, INT J ANESTHESIOLOGY, V28, P32; Zhou Qi, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P107, DOI 10.3969/j.issn.1672-7347.2010.02.003; Zou Ding-quan, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P420	79	17	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113973	10.1371/journal.pone.0113973	http://dx.doi.org/10.1371/journal.pone.0113973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500819	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700012
J	Husslein, H; Gutschi, M; Leipold, H; Herbst, C; Franz, M; Worda, C				Husslein, Heinrich; Gutschi, Martina; Leipold, Heinz; Herbst, Christoph; Franz, Maximilian; Worda, Christof			Suture Closure versus Non-Closure of Subcutaneous Fat and Cosmetic Outcome after Cesarean Section: A Randomized Controlled Trial	PLOS ONE			English	Article							SKIN CLOSURE; SCAR; DELIVERY; PATIENT; TISSUE; SCALES	Introduction: To investigate the effect of subcutaneous fat suture closure versus non-closure at cesarean section (CS) on long-term cosmetic outcome. Material and Methods: Women undergoing planned or unplanned CS were randomized to either subcutaneous fat suture closure or non-closure using a 1:1 allocation algorithm. Participants and outcome assessors were blinded to group allocation. Scar evaluation was performed after two and six months. Primary outcome measures were Patient and Observer Scar Assessment Scale (POSAS) summary scores six months after surgery. Secondary outcome measures were Vancouver Scar Scale (VSS) summary scores, retraction of the scar below the level of the surrounding skin, duration of surgery, and development of hematoma, seroma, surgical site infection (SSI) or wound disruption. Data were analyzed according to the intention to treat principle. Results: A total of 116 women were randomized and 91 participants, 47 in the closure and 44 in the non-closure group, completed the trial and were analyzed. There were no differences in patient morphometrics or surgery indications between groups. At two and six months no significant differences were found with respect to POSAS or VSS scores between groups. After two months significantly more women in the non-closure group described their scar as being retracted below the level of the skin (36% vs. 15%, p=0.02) whereas no difference was observed at six months. There were significantly more hematomas in the non-closure (25%) compared to the closure group (4%) (p=0.005). There was no difference in duration of surgery, SSI, seroma formation or wound disruption between groups. Conclusions: Suture closure of the subcutaneous fat at CS does not affect long-term cosmetic outcome.	[Husslein, Heinrich; Gutschi, Martina; Leipold, Heinz; Herbst, Christoph; Worda, Christof] Klinikum Klagenfurt Woerthersee, Dept Obstet & Gynecol, A-9020 Klagenfurt, Austria; [Husslein, Heinrich; Franz, Maximilian] Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria	Medical University of Vienna	Husslein, H (corresponding author), Klinikum Klagenfurt Woerthersee, Dept Obstet & Gynecol, Feschnigstr 11, A-9020 Klagenfurt, Austria.	heinrich.husslein@meduniwien.ac.at		Husslein, Heinrich/0000-0003-0585-7444				Anderson ER, 2004, COCHRANE DB SYST REV, V4; Arias CA, 2013, LANCET, V382, P234, DOI 10.1016/S0140-6736(13)60441-9; Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; Brown BC, 2010, J PLAST RECONSTR AES, V63, P1022, DOI 10.1016/j.bjps.2009.03.019; Chelmow D, 2002, J Matern Fetal Neonatal Med, V11, P403, DOI 10.1080/713605560; Chelmow D, 2004, OBSTET GYNECOL, V103, P974, DOI 10.1097/01.AOG.0000124807.76451.47; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cromi A, 2010, AM J OBSTET GYNECOL, V203, DOI DOI 10.1016/J.AJOG.2010.02.001; de Graaf IM, 2012, EUR J OBSTET GYN R B, V165, P47, DOI 10.1016/j.ejogrb.2012.07.019; Draaijers LJ, 2004, PLAST RECONSTR SURG, V113, P1960, DOI 10.1097/01.PRS.0000122207.28773.56; Figueroa D, 2013, OBSTET GYNECOL, V121, P33, DOI [http://10.1097/AOG.0b013e31827a072c, 10.1097/AOG.0b013e31827a072c]; Gaertner I, 2008, EUR J OBSTET GYN R B, V138, P29, DOI 10.1016/j.ejogrb.2007.07.003; Huppelschoten AG, 2013, ACTA OBSTET GYN SCAN, V92, P916, DOI 10.1111/aogs.12142; Idriss N, 2009, SKIN RES TECHNOL, V15, P1, DOI 10.1111/j.1600-0846.2008.00327.x; Islam A, 2011, N AM J MED SCI, V3, P85, DOI 10.4297/najms.2011.385; Mackeen AD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003577.pub3; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; MEYER M, 1991, BRIT J PLAST SURG, V44, P291, DOI 10.1016/0007-1226(91)90074-T; Niessen FB, 1997, ANN PLAS SURG, V39, P254, DOI 10.1097/00000637-199709000-00006; SOMMERLAD BC, 1978, BRIT J PLAST SURG, V31, P34, DOI 10.1016/0007-1226(78)90012-7; SULLIVAN T, 1990, Journal of Burn Care and Rehabilitation, V11, P256, DOI 10.1097/00004630-199005000-00014; THOMAS DW, 1995, J ORAL MAXIL SURG, V53, P442, DOI 10.1016/0278-2391(95)90721-1; Trimbos JB, 2002, J SURG RES, V107, P131, DOI 10.1006/jsre.2002.6486; Tyack Z, 2012, BURNS, V38, P6, DOI 10.1016/j.burns.2011.09.021; van de Kar AL, 2005, PLAST RECONSTR SURG, V116, P514, DOI 10.1097/01.prs.0000172982.43599.d6; van der Wal MBA, 2012, J BURN CARE RES, V33, pE79, DOI 10.1097/BCR.0b013e318239f5dd; Xavier P, 2005, ACTA OBSTET GYN SCAN, V84, P878, DOI 10.1111/j.0001-6349.2005.00631.x	29	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114730	10.1371/journal.pone.0114730	http://dx.doi.org/10.1371/journal.pone.0114730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494177	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400071
J	Li, C; Lin, Y; Huang, YY; Liu, XX; Liang, SL				Li, Cheng; Lin, Ying; Huang, Yuanyuan; Liu, Xiaoxiao; Liang, Shuli			Citrobacter amalonaticus Phytase on the Cell Surface of Pichia pastoris Exhibits High pH Stability as a Promising Potential Feed Supplement	PLOS ONE			English	Article							HEAT-STABLE PHYTASE; ESCHERICHIA-COLI; GENE CLONING; YEAST; EXPRESSION; WALL; CONSTRUCTION; PROTEINS; ACID; PERFORMANCE	Phytase expressed and anchored on the cell surface of Pichia pastoris avoids the expensive and time-consuming steps of protein purification and separation. Furthermore, yeast cells with anchored phytase can be used as a whole-cell biocatalyst. In this study, the phytase gene of Citrobacter amalonaticus was fused with the Pichia pastoris glycosylphosphatidylinositol (GPI)-anchored glycoprotein homologue GCW61. Phytase exposed on the cell surface exhibits a high activity of 6413.5 U/g, with an optimal temperature of 60 degrees C. In contrast to secreted phytase, which has an optimal pH of 5.0, phytase presented on the cell surface is characterized by an optimal pH of 3.0. Moreover, our data demonstrate that phytase anchored on the cell surface exhibits higher pH stability than its secreted counterpart. Interestingly, our in vitro digestion experiments demonstrate that phytase attached to the cell surface is a more efficient enzyme than secreted phytase.	[Li, Cheng; Lin, Ying; Huang, Yuanyuan; Liu, Xiaoxiao; Liang, Shuli] S China Univ Technol, Sch Biosci & Bioengn, Guangdong Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology	Liang, SL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangdong Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China.	shuli@scut.edu.cn	Li, Cheng/AAV-3966-2021	Ying, Lin/0000-0001-8686-7868	National Science and Technology Support Program of China [2013BAD10B01]	National Science and Technology Support Program of China	The research was granted by the National Science and Technology Support Program of China (Project No. 2013BAD10B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104221; Augspurger NR, 2003, J ANIM SCI, V81, P474; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Duquesne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095128; Fernandez-Murga ML, 2008, J BACTERIOL, V190, P3018, DOI 10.1128/JB.01831-07; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; Georgiev D, 2013, EMIR J FOOD AGR, V25, P342, DOI 10.9755/ejfa.v25i5.13633; Graf E., 1983, Journal of the American Oil Chemists' Society, V60, P1861; Greiner R, 2007, PROTEIN J, V26, P577, DOI 10.1007/s10930-007-9100-5; Hamada K, 1998, J BIOL CHEM, V273, P26946, DOI 10.1074/jbc.273.41.26946; Harnpicharnchai P, 2010, FEMS MICROBIOL LETT, V302, P8, DOI 10.1111/j.1574-6968.2009.01811.x; Jorquera M, 2008, MICROBES ENVIRON, V23, P182, DOI 10.1264/jsme2.23.182; Kaur P, 2010, J BIOTECHNOL, V149, P8, DOI 10.1016/j.jbiotec.2010.06.017; KOBORI H, 1992, PROTOPLASMA, V167, P193, DOI 10.1007/BF01403383; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Liang XX, 2013, BIOTECHNOL LETT, V35, P367, DOI 10.1007/s10529-012-1085-2; Liu JH, 2001, ENZYME MICROB TECH, V28, P582, DOI 10.1016/S0141-0229(00)00349-5; Luo HY, 2007, CURR MICROBIOL, V55, P185, DOI 10.1007/s00284-006-0586-4; Mo AY, 2005, BIOTECHNOL BIOPROC E, V10, P576, DOI 10.1007/BF02932297; NELSON TS, 1971, J NUTR, V101, P1289, DOI 10.1093/jn/101.10.1289; Pasamontes L, 1997, APPL ENVIRON MICROB, V63, P1696, DOI 10.1128/AEM.63.5.1696-1700.1997; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Promdonkoy P, 2009, FEMS MICROBIOL LETT, V290, P18, DOI 10.1111/j.1574-6968.2008.01399.x; Rodriguez E, 2000, BIOCHEM BIOPH RES CO, V268, P373, DOI 10.1006/bbrc.2000.2121; SCHREUDER MP, 1993, YEAST, V9, P399, DOI 10.1002/yea.320090410; Sebastian S, 1996, POULTRY SCI, V75, P1516, DOI 10.3382/ps.0751516; Shim JH, 2007, J AGR FOOD CHEM, V55, P4735, DOI 10.1021/jf070217d; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Su GD, 2010, BIOTECHNOL LETT, V32, P1131, DOI 10.1007/s10529-010-0270-4; Su GD, 2010, APPL MICROBIOL BIOT, V86, P1493, DOI 10.1007/s00253-009-2382-0; Tanino T, 2006, BIOTECHNOL PROGR, V22, P989, DOI 10.1021/bp060133+; Tomschy A, 2002, APPL ENVIRON MICROB, V68, P1907, DOI 10.1128/AEM.68.4.1907-1913.2002; Ueda M, 2000, J BIOSCI BIOENG, V90, P125, DOI 10.1263/jbb.90.125; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; Wang QJ, 2007, BIOTECHNOL LETT, V29, P1561, DOI 10.1007/s10529-007-9430-6; Wang Y, 2007, CURR MICROBIOL, V55, P65, DOI 10.1007/s00284-006-0613-5; Wodzinski RJ, 1996, ADV APPL MICROBIOL, V42, P263, DOI 10.1016/S0065-2164(08)70375-7; Wu TH, 2014, J BIOTECHNOL, V175, P1, DOI 10.1016/j.jbiotec.2014.01.034; Zhang L, 2013, APPL ENVIRON MICROB; ZHOU JR, 1995, CRIT REV FOOD SCI, V35, P495, DOI 10.1080/10408399509527712; Zyla K, 2000, POULTRY SCI, V79, P66, DOI 10.1093/ps/79.1.66; Zyla K, 1999, J SCI FOOD AGR, V79, P1841, DOI 10.1002/(SICI)1097-0010(199910)79:13&lt;1841::AID-JSFA463&gt;3.0.CO;2-G	44	9	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114728	10.1371/journal.pone.0114728	http://dx.doi.org/10.1371/journal.pone.0114728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490768	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300071
J	Razavi, M; Fournier, S; Shepard, DS; Ritter, G; Strickler, GK; Stason, WB				Razavi, Moaven; Fournier, Stephen; Shepard, Donald S.; Ritter, Grant; Strickler, Gail K.; Stason, William B.			Effects of Lifestyle Modification Programs on Cardiac Risk Factors	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CLINICAL CARDIOLOGY SUBCOMMITTEE; SECONDARY PREVENTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; METABOLISM SUBCOMMITTEE; REHABILITATION; STATEMENT; EXERCISE	Medicare conducted a payment demonstration to evaluate the effectiveness of two intensive lifestyle modification programs in patients with symptomatic coronary artery disease: the Dr. Dean Ornish Program for Reversing Heart Disease (Ornish) and Cardiac Wellness Program of the Benson-Henry Mind Body Institute. This report describes the changes in cardiac risk factors achieved by each program during the active intervention year and subsequent year of follow-up. The demonstration enrolled 580 participants who had had an acute myocardial infarction, had undergone coronary artery bypass graft surgery or percutaneous coronary intervention within 12 months, or had documented stable angina pectoris. Of these, 98% completed the intense 3-month intervention, 71% the 12-month intervention, and 56% an additional follow-up year. Most cardiac risk factors improved significantly during the intense intervention period in both programs. Favorable changes in cardiac risk factors and functional cardiac capacity were maintained or improved further at 12 and 24 months in participants with active follow-up. Multivariable regressions found that risk-factor improvements were positively associated with abnormal baseline values, Ornish program participation for body mass index and systolic blood pressure, and with coronary artery bypass graft surgery. Expressed levels of motivation to lose weight and maintain weight loss were significant independent predictors of sustained weight loss (p = 0.006). Both lifestyle modification programs achieved well-sustained reductions in cardiac risk factors.	[Razavi, Moaven; Fournier, Stephen; Shepard, Donald S.; Ritter, Grant; Strickler, Gail K.; Stason, William B.] Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02454 USA	Brandeis University	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02454 USA.	shepard@brandeis.edu	Deschepper, Reginald/B-8103-2013	Deschepper, Reginald/0000-0002-4222-3945	Centers for Medicare & Medicaid Services (CMS) [500-95-0060, 500-02-0012-MDBU]; Centers for Disease Control [7R01 DP000339-03]; National Institute on General Medical Sciences [P20GM103644]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services (CMS); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Centers for Medicare & Medicaid Services (CMS, http://cms.hhs.gov/) under contract number 500-95-0060, Task Order 02 to Brandeis University (DSS) and number 500-02-0012-MDBU to the Delmarva Foundation for Medical Care (DSS) (http://www.delmarvafoundation.org/). The analysis received additional support from grant 7R01 DP000339-03 from the Centers for Disease Control (http://www.cdc.gov/) to the Benson-Henry Institute for Mind Body Medicine (WBS) and grant P20GM103644 from the National Institute on General Medical Sciences (http://www.nigms.nih.gov) to the University of Vermont (DSS). The funders had no role in study design (though approved by CMS), data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Centers for Medicare and Medicaid Services (CMS) Cardiac rehabilitation programs, 2014, MED NAT COV DET MA 1; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Delmarva Foundation, 2001, HCFA MED LIF MOD PRO; GOULD KL, 1995, JAMA-J AM MED ASSOC, V274, P894, DOI 10.1001/jama.274.11.894; Jolliffe J, 2001, COCHRANE REV COCHRAN, V1; Kip K, 2008, J AM COLL CARDIOL, V51; Kubilius R, 2012, MED LITH, V48, P116; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; MASAREI JRL, 1984, AM J CLIN NUTR, V40, P468, DOI 10.1093/ajcn/40.3.468; Morrin L, 2000, J Cardiopulm Rehabil, V20, P115, DOI 10.1097/00008483-200003000-00005; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Roger VL, 2012, HEART DIS STROKE STA; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Wenger N. K, 1995, AHCPR PUB	24	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114772	10.1371/journal.pone.0114772	http://dx.doi.org/10.1371/journal.pone.0114772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490202	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300077
J	Zhang, B; Tao, H; Wei, BX; Jin, ZY; Xu, XM; Tian, YQ				Zhang, Bao; Tao, Han; Wei, Benxi; Jin, Zhengyu; Xu, Xueming; Tian, Yaoqi			Characterization of Different Substituted Carboxymethyl Starch Microgels and Their Interactions with Lysozyme	PLOS ONE			English	Article							LINKED HIGH AMYLOSE; CONTROLLED-RELEASE; PARTICLES; HYDROGELS; MECHANISM; KINETICS	A carboxymethyl starch (CMS) microgel system was prepared for the control of uptaking and releasing proteins (lysozyme). The physicochemical properties of microgels in various degrees of substitution (DS) were determined by thermal gravimetric analysis (TGA), swelling degree, and rheological analysis. The microgel particle size mostly ranged from 25 mm to 45 mm. The result obtained from the TGA studies indicated that carboxymethylation decreased the thermal stability of starch, but crosslinking increased the thermal stability of CMS. The CMS microgels showed typical pH sensitivity, and the swelling degree of microgel increased with the increasing of DS and pH, because of the large amounts of carboxyl group ionization. The samples (2.25%) could behave as viscoelastic solids since the storage modulus was larger than the loss modulus over the entire frequency range. The protein uptake increased with increasing pH and DS at low salt concentration. The optimal pH shifted to lower pH with increasing ionic strength. The saturated protein uptake decreased with increasing ionic strength at each pH. The protein was easily released from the microgel with high pH and high salt concentration.	[Zhang, Bao; Wei, Benxi; Jin, Zhengyu; Tian, Yaoqi] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Zhang, Bao; Tao, Han; Wei, Benxi; Jin, Zhengyu; Xu, Xueming] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China; [Jin, Zhengyu; Xu, Xueming] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Jin, ZY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	jinlab2008@yahoo.com; yqtian@jiangnan.edu.cn	Tian, Yaoqi/E-7493-2010	Tian, Yaoqi/0000-0001-5693-8872	National Natural Science Foundation of China [31230057]; Key Technology R&D Program for the 12th Five-Year Plan [2012BAD37B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program for the 12th Five-Year Plan	This work was supported by the National Natural Science Foundation of China (No. 31230057) and the Key Technology R&D Program for the 12th Five-Year Plan (No. 2012BAD37B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7; Capek P, 2010, J THERM ANAL CALORIM, V99, P667, DOI 10.1007/s10973-009-0194-1; Cury BSF, 2009, INT J PHARMACEUT, V371, P8, DOI 10.1016/j.ijpharm.2008.12.010; Eichenbaum GM, 2001, MACROMOLECULES, V34, P6526, DOI 10.1021/ma0124892; Guan Y, 2011, SOFT MATTER, V7, P6375, DOI 10.1039/c0sm01541e; Hansson P, 2012, J PHYS CHEM B, V116, P10964, DOI 10.1021/jp306121h; Hirsch JB, 2002, CEREAL CHEM, V79, P102, DOI 10.1094/CCHEM.2002.79.1.102; Johansson C, 2009, J PHYS CHEM B, V113, P6183, DOI 10.1021/jp900706k; Karg M, 2009, CURR OPIN COLLOID IN, V14, P438, DOI 10.1016/j.cocis.2009.08.002; Lawal OS, 2007, STARCH-STARKE, V59, P224, DOI 10.1002/star.200600594; Lenaerts V, 1998, J CONTROL RELEASE, V53, P225, DOI 10.1016/S0168-3659(97)00256-3; Li X, 2010, CARBOHYD POLYM, V80, P768, DOI 10.1016/j.carbpol.2009.12.025; Li Y, 2012, FOOD HYDROCOLLOID, V28, P28, DOI 10.1016/j.foodhyd.2011.11.011; Li Y, 2011, SOFT MATTER, V7, P10377, DOI 10.1039/c1sm06072d; Li Y, 2009, BIOMACROMOLECULES, V10, P1931, DOI 10.1021/bm900337n; Liu J, 2012, FOOD CHEM, V133, P1196, DOI 10.1016/j.foodchem.2011.05.061; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Mocanu G, 2004, EUR POLYM J, V40, P283, DOI 10.1016/j.eurpolymj.2003.09.019; Muhammad K, 2000, CARBOHYD POLYM, V42, P85, DOI 10.1016/S0144-8617(99)00120-4; Mulhbacher J, 2001, J CONTROL RELEASE, V76, P51, DOI 10.1016/S0168-3659(01)00425-4; Ramazani-Harandi MJ, 2006, POLYM TEST, V25, P470, DOI 10.1016/j.polymertesting.2006.01.011; Rudnik E, 2006, J THERM ANAL CALORIM, V85, P267, DOI 10.1007/s10973-005-7274-7; Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2; Schachschal S, 2010, MACROMOLECULES, V43, P4331, DOI 10.1021/ma100184h; Tan BH, 2010, POLYMER, V51, P3238, DOI 10.1016/j.polymer.2010.04.059; Wang JP, 2001, J AM CHEM SOC, V123, P11284, DOI 10.1021/ja016610w	26	20	20	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114634	10.1371/journal.pone.0114634	http://dx.doi.org/10.1371/journal.pone.0114634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490774	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300061
J	Jee, DY; do Han, K; Kim, EC				Jee, Donghyun; do Han, Kyung; Kim, Eun Chul			Inverse Association between High Blood 25-Hydroxyvitamin D Levels and Diabetic Retinopathy in a Representative Korean Population	PLOS ONE			English	Article								Purpose: To investigate the association between 25-hydroxyvitamin D and diabetic retinopathy (DR). Methods: A population-based cross-sectional study using a nation-wide, systemically stratified, multistage, clustered sampling method included a total of 18,363 subjects aged >= 40 years who participated in the Korean National Health and Nutrition Examination Survey during 2008-2012. All participants participated in standardized interviews, blood 25-hydroxyvitamin D level evaluations, and comprehensive ophthalmic examinations. Seven standard retinal fundus photographs were obtained from both eyes after pupil dilatation. DR was graded according to the modified Airlie House classification system. Results: The blood 25-hydroxyvitamin D levels were 19.2 ng/mL in men and 17.9 ng/mL in women. After adjusting for potential confounders, including age, sex, diabetes duration, hemoglobin A1c levels, and hypertension, the odds ratios (OR) for any DR and proliferative DR among men decreased significantly in the highest blood 25-hydroxyvitamin D level quintile relative to the lowest quintile (OR, 0.37; 95% confidence interval [CI], 0.18-0.76; P for trend =0.004 and OR, 0.15; 95% CI, 0.03-0.83; P for trend =0.043). Conclusions: This study provides the first epidemiologic findings of the inverse relationships of blood 25-hydroxyvitamin D levels with any DR and proliferative DR only in men. Considering anti-angiogenic and anti-fibrotic action of vitamin D, further studies including longitudinal and interventional analysis are warranted.	[Jee, Donghyun; Kim, Eun Chul] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Jee, Donghyun] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [do Han, Kyung] Catholic Univ Korea, Coll Med, Dept Prevent Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Harvard University; Harvard T.H. Chan School of Public Health; Catholic University of Korea	Jee, DY (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	donghyunjee@catholic.ac.kr							0	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e115199	10.1371/journal.pone.0115199	http://dx.doi.org/10.1371/journal.pone.0115199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485770	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600110
J	Melchior, M; Touchette, E; Prokofyeva, E; Chollet, A; Fombonne, E; Elidemir, G; Galera, C				Melchior, Maria; Touchette, Evelyne; Prokofyeva, Elena; Chollet, Aude; Fombonne, Eric; Elidemir, Gulizar; Galera, Cedric			Negative Events in Childhood Predict Trajectories of Internalizing Symptoms Up to Young Adulthood: An 18-Year Longitudinal Study	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; PSYCHIATRIC-DISORDERS; GENDER-DIFFERENCES; EXTERNALIZING PROBLEMS; INHIBITED TEMPERAMENT; DEPRESSIVE SYMPTOMS; BEHAVIORAL SYMPTOMS; POPULATION-SAMPLE; MAJOR DEPRESSION; MEDIATING ROLE	Background: Common negative events can precipitate the onset of internalizing symptoms. We studied whether their occurrence in childhood is associated with mental health trajectories over the course of development. Methods: Using data from the TEMPO study, a French community-based cohort study of youths, we studied the association between negative events in 1991 (when participants were aged 4-16 years) and internalizing symptoms, assessed by the ASEBA family of instruments in 1991, 1999, and 2009 (n=1503). Participants' trajectories of internalizing symptoms were estimated with semi-parametric regression methods (PROC TRAJ). Data were analyzed using multinomial regression models controlled for participants' sex, age, parental family status, socio-economic position, and parental history of depression. Results: Negative childhood events were associated with an increased likelihood of concurrent internalizing symptoms which sometimes persisted into adulthood (multivariate ORs associated with >==3 negative events respectively: high and decreasing internalizing symptoms: 5.54, 95% CI: 3.20-9.58; persistently high internalizing symptoms: 8.94, 95% CI: 2.82-28.31). Specific negative events most strongly associated with youths' persistent internalizing symptoms included: school difficulties (multivariate OR: 5.31, 95% CI: 2.24-12.59), parental stress (multivariate OR: 4.69, 95% CI: 2.02-10.87), serious illness/health problems (multivariate OR: 4.13, 95% CI: 1.76-9.70), and social isolation (multivariate OR: 2.24, 95% CI: 1.00-5.08). Conclusions: Common negative events can contribute to the onset of children's lasting psychological difficulties.	[Melchior, Maria; Prokofyeva, Elena; Chollet, Aude; Elidemir, Gulizar] INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, UMR S 1136, F-75013 Paris, France; [Melchior, Maria; Prokofyeva, Elena; Chollet, Aude; Elidemir, Gulizar] UPMC, Univ Paris 04, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol,UMR S 1136, F-75013 Paris, France; [Touchette, Evelyne] Univ Laval, Sch Psychol, GRIP, Quebec City, PQ, Canada; [Fombonne, Eric] Oregon Hlth & Sci Univ, Inst Brain, Portland, OR 97201 USA; [Galera, Cedric] Univ Bordeaux, Pole Pedopsychiat Univ, Hop Charles Perrens, INSERM,U897, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Laval University; Oregon Health & Science University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Melchior, M (corresponding author), INSERM, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, UMR S 1136, F-75013 Paris, France.	maria.melchior@inserm.fr	Fombonne, Eric/M-4893-2018; Melchior, Maria/E-3992-2017; Galera, Cedric/T-4896-2019	Fombonne, Eric/0000-0002-8605-3538; GALERA, CEDRIC/0000-0003-0549-9608; Bardot, Aude/0000-0002-8784-5051	French Ministry of Health-IReSP (TGIR Cohortes); French Inter-departmental Mission for the fight against drugs and drug addiction (MILDT); French Institute of Cancer (INCa); French Foundation for Research on Psychiatry and Mental Health (FRPSM); French National Research Agency (ANR)	French Ministry of Health-IReSP (TGIR Cohortes); French Inter-departmental Mission for the fight against drugs and drug addiction (MILDT); French Institute of Cancer (INCa); French Foundation for Research on Psychiatry and Mental Health (FRPSM); French National Research Agency (ANR)(French National Research Agency (ANR))	Funding: This study was supported by the French Ministry of Health-IReSP (TGIR Cohortes), the French Inter-departmental Mission for the fight against drugs and drug addiction (MILDT), The French Institute of Cancer (INCa), the French Foundation for Research on Psychiatry and Mental Health (FRPSM). Maria Melchior is the recipient of a Young Researcher Award from the French National Research Agency (ANR). The authors have no financial relationships relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; [Anonymous], 1991, MANUAL CHILD BEHAV C; Asendorpf JB, 2008, DEV PSYCHOL, V44, P997, DOI 10.1037/0012-1649.44.4.997; Ashford J, 2008, J CHILD PSYCHOL PSYC, V49, P774, DOI 10.1111/j.1469-7610.2008.01889.x; Bayer JK, 2008, J CHILD PSYCHOL PSYC, V49, P1166, DOI 10.1111/j.1469-7610.2008.01943.x; Bayer JK, 2011, PEDIATRICS, V128, pE865, DOI 10.1542/peds.2011-0491; Bayer JK, 2011, DEPRESS ANXIETY, V28, P50, DOI 10.1002/da.20743; Bender K, 2011, CHILD WELFARE, V90, P69; Cavalin C, 2007, VIOLENCES SUBIES PER; Conroy S, 2012, J AM ACAD CHILD PSY, V51, P51, DOI 10.1016/j.jaac.2011.10.007; Coohey C, 2010, CHILD ABUSE NEGLECT, V34, P856, DOI 10.1016/j.chiabu.2010.05.001; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; D'Onofrio BM, 2007, J CHILD PSYCHOL PSYC, V48, P667, DOI 10.1111/j.1469-7610.2007.01741.x; Davies PT, 2008, CHILD DEV, V79, P1570, DOI 10.1111/j.1467-8624.2008.01206.x; Dietrich A, 2011, PSYCHOTHER PSYCHOSOM, V80, P62, DOI 10.1159/000318781; Duchesne S, 2010, DEV PSYCHOPATHOL, V22, P361, DOI 10.1017/S0954579410000118; FERDINAND RF, 1995, J AM ACAD CHILD PSY, V34, P680, DOI 10.1097/00004583-199505000-00020; FOMBONNE E, 1994, BRIT J PSYCHIAT, V164, P69, DOI 10.1192/bjp.164.1.69; Fombonne E, 1997, REV EPIDEMIOL SANTE, V45, P29; FOMBONNE E, 1991, J CHILD PSYCHOL PSYC, V32, P677, DOI 10.1111/j.1469-7610.1991.tb00343.x; Gasman I, 2002, EUR CHILD ADOLES PSY, V11, P101, DOI 10.1007/s00787-002-0248-4; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Gladstone GL, 2005, DEPRESS ANXIETY, V22, P103, DOI 10.1002/da.20082; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Grills-Taquechel AE, 2013, ANXIETY STRESS COPIN, V26, P391, DOI 10.1080/10615806.2012.691969; Hamilton JL, 2013, J CLIN CHILD ADOLESC, V42, P332, DOI 10.1080/15374416.2013.777916; Horton R, 2007, LANCET, V370, P9590; Hughes EK, 2010, J FAM PSYCHOL, V24, P115, DOI 10.1037/a0018788; Janssens A, 2009, EUR CHILD ADOLES PSY, V18, P691, DOI 10.1007/s00787-009-0030-y; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kovacs M, 1998, J CHILD PSYCHOL PSYC, V39, P47, DOI 10.1017/S0021963097001765; Lewis KJS, 2012, J AFFECT DISORDERS, V141, P233, DOI 10.1016/j.jad.2012.03.008; Luoma I, 1999, EUR CHILD ADOLES PSY, V8, P29; Maikovich-Fong AK, 2010, CHILD ABUSE NEGLECT, V34, P429, DOI 10.1016/j.chiabu.2009.10.006; Mantymaa M, 2012, CHILD PSYCHIAT HUM D, V43, P153, DOI 10.1007/s10578-011-0255-0; Maxwell M., 1992, FAMILY INTERVIEW GEN; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; Melchior Maria, 2010, Depress Anxiety, V27, P1095, DOI 10.1002/da.20761; Mesman J, 2000, J ABNORM PSYCHOL, V109, P428, DOI 10.1037//0021-843X.109.3.428; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Nagin DS, 2010, J QUANT CRIMINOL, V26, P445, DOI 10.1007/s10940-010-9113-7; Nugent Nicole R, 2011, Clin Child Psychol Psychiatry, V16, P485, DOI 10.1177/1359104511406487; Ormel J, 2005, PSYCHOL MED, V35, P1825, DOI 10.1017/S0033291705005829; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Prior M, 2000, J AM ACAD CHILD PSY, V39, P461, DOI 10.1097/00004583-200004000-00015; Rapee RM, 2010, AM J PSYCHIAT, V167, P1518, DOI 10.1176/appi.ajp.2010.09111619; Redonnet B, 2012, DRUG ALCOHOL DEPEN, V121, P231, DOI 10.1016/j.drugalcdep.2011.09.002; Rubin KH, 2002, CHILD DEV, V73, P483, DOI 10.1111/1467-8624.00419; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Sachs-Ericsson N, 2006, J AFFECT DISORDERS, V93, P71, DOI 10.1016/j.jad.2006.02.014; Shaw DS, 1997, J AM ACAD CHILD PSY, V36, P1760, DOI 10.1097/00004583-199712000-00025; Stanger Catherine, 1994, Eur Child Adolesc Psychiatry, V3, P16, DOI 10.1007/BF01977608; Wickrama KAS, 2012, J ADOLESCENCE, V35, P648, DOI 10.1016/j.adolescence.2011.08.014; Wilkinson PO, 2013, DEV PSYCHOPATHOL, V25, P93, DOI 10.1017/S0954579412000922	56	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114526	10.1371/journal.pone.0114526	http://dx.doi.org/10.1371/journal.pone.0114526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25485875	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600069
J	Baskaran, K; Pugazhendhi, S; Ramakrishna, BS				Baskaran, Kirankumar; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S.			Protective Association of Tumor Necrosis Factor Superfamily 15 (TNFSF15) Polymorphic Haplotype with Ulcerative Colitis and Crohn's Disease in an Indian Population	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENE; TL1A; EXPRESSION; VARIANTS; RISK	Background: Tumor necrosis factor superfamily (TNFSF) proteins are involved in the genesis of inflammatory bowel disease (IBD). We examined the association of seven single nucleotide polymorphisms (SNP) in the TNFSF15 gene with Crohn's disease (CD) and ulcerative colitis (UC) in the Indian population. Methods: Seven SNPs in the TNFSF15 gene (rs10114470, rs3810936, rs6478108, rs4263839, rs6478109, rs7848647 and rs7869487) were genotyped in 309 CD patients, 330 UC patients and 437 healthy controls using the Sequenom iPLEX MassArray platform. Disease associations were evaluated for allelotypes and for genotypes. Results: The minor T alleles and the TT genotypes of rs10114470 and rs3810936 were significantly protectively associated with both CD and UC. The CC genotype of rs6478108, AA genotype of rs4263839, the AA genotype of rs6478109, the TT genotype of rs7848647 and the CC genotype of rs7869487 were all protectively associated with CD but not with UC. Two haplotype blocks could be discerned, one where SNPs rs10114470 and rs3810936 were in tight LD (D' = 0.8) and the other where rs6478108, rs4263839, rs6478109, rs7848647 and rs7869487 were in tight LD (D' 0.92-1.00). The second block of haplotypes were not associated with CD or with UC. The first block of haplotypes was very significantly associated with both CD and UC. Conclusions: Strong associations exist between TNFSF15 gene polymorphisms and IBD (both CD and UC) in the Indian population.	[Baskaran, Kirankumar; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S.] Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore 632004, Tamil Nadu, India; [Ramakrishna, Balakrishnan S.] SRM Inst Med Sci, Chennai 600026, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; SRM Institute of Science & Technology Chennai	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore 632004, Tamil Nadu, India.	wurama@hotmail.com	Srinivasan, Pugazhendhi/M-5184-2019; Ramakrishna, Balakrishnan/D-6808-2015	Srinivasan, Pugazhendhi/0000-0002-1748-1416; Ramakrishna, Balakrishnan/0000-0001-5090-9501				Ahuja V, 2010, J DIGEST DIS, V11, P134, DOI 10.1111/j.1751-2980.2010.00429.x; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Cavallini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060136; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Foster A, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00034; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Michelsen KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004719; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Montgomery SM, 1999, EUR J GASTROEN HEPAT, V11, P543, DOI 10.1097/00042737-199905000-00013; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Picornell Y, 2007, INFLAMM BOWEL DIS, V13, P1333, DOI 10.1002/ibd.20223; PROBERT CSJ, 1993, GUT, V34, P1547, DOI 10.1136/gut.34.11.1547; Pugazhendhi Srinivasan, 2008, Indian J Gastroenterol, V27, P201; Pugazhendhi S, 2013, GENE, V512, P309, DOI 10.1016/j.gene.2012.10.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin OY, 2006, J GASTROEN HEPATOL, V21, P1772, DOI 10.1111/j.1440-1746.2006.04674.x; Ramakrishna BS, 2012, INDIAN J GASTROENTER, V31, P307, DOI 10.1007/s12664-012-0259-0; Sood Ajit, 2007, Indian J Gastroenterol, V26, P285; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x; Zheng L, 2013, EUR J MICROBIOL IMMU, V3, P11, DOI 10.1556/EuJMI.3.2013.1.2	34	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114665	10.1371/journal.pone.0114665	http://dx.doi.org/10.1371/journal.pone.0114665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501099	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400043
J	Huber, F; Meurer, M; Bunina, D; Kats, I; Maeder, CI; Stefl, M; Mongis, C; Knop, M				Huber, Florian; Meurer, Matthias; Bunina, Daria; Kats, Ilia; Maeder, Celine I.; Stefl, Martin; Mongis, Cyril; Knop, Michael			PCR Duplication: A One-Step Cloning-Free Method to Generate Duplicated Chromosomal Loci and Interference-Free Expression Reporters in Yeast	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; PERVASIVE TRANSCRIPTION; MODULES; TRANSFORMATION; GENES; OLIGONUCLEOTIDES; DISRUPTION; CASSETTES; VERSATILE	Here, we report on a novel PCR targeting-based strategy called 'PCR duplication' that enables targeted duplications of genomic regions in the yeast genome using a simple PCR-based approach. To demonstrate its application we first duplicated the promoter of the FAR1 gene in yeast and simultaneously inserted a GFP downstream of it. This created a reporter for promoter activity while leaving the FAR1 gene fully intact. In another experiment, we used PCR duplication to increase the dosage of a gene in a discrete manner, from 1x to 2x. Using TUB4, the gene encoding for the yeast gamma-tubulin, we validated that this led to corresponding increases in the levels of mRNA and protein. PCR duplication is an easy one-step procedure that can be adapted in different ways to permit rapid, disturbance-free investigation of various genomic regulatory elements without the need for ex vivo cloning.	[Huber, Florian; Meurer, Matthias; Bunina, Daria; Kats, Ilia; Maeder, Celine I.; Stefl, Martin; Mongis, Cyril; Knop, Michael] Heidelberg Univ, DKFZ ZMBH Allianz, Zentrum Mol Biol Univ Heidelberg ZMBH, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Knop, M (corresponding author), Heidelberg Univ, DKFZ ZMBH Allianz, Zentrum Mol Biol Univ Heidelberg ZMBH, D-69120 Heidelberg, Germany.	m.knop@zmbh.uni-heidelberg.de	Stefl, Martin/O-1316-2018	Stefl, Martin/0000-0001-8436-5581; Huber, Florian/0000-0001-8265-0856; Kats, Ilia/0000-0001-5220-5671; Bunina, Daria/0000-0002-5885-7440	DFG (Deutsche Forschungsgemeinschaft) [SFB1036]; CellNetworks Cluster of Excellence; Alexander von Humboldt Foundation; HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology); Boehringer Ingelheim Stiftung fur medizinische Grundlagenforschung	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); CellNetworks Cluster of Excellence; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology); Boehringer Ingelheim Stiftung fur medizinische Grundlagenforschung	FH was supported by the SFB1036 of the DFG (Deutsche Forschungsgemeinschaft, www.dfg.de/en), MM and MS by the CellNetworks Cluster of Excellence (www.cellnetworks.uni-hd.de), MS in addition by the Alexander von Humboldt Foundation (www.humboldt-foundation.de/web/home.html), IK by the HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, www.hbigs.uni-heidelberg.de) and DB received funding from the Boehringer Ingelheim Stiftung fur medizinische Grundlagenforschung (www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HICKS JB, 1979, COLD SPRING HARB SYM, V43, P1305, DOI 10.1101/SQB.1979.043.01.149; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Horecka J, 2014, YEAST, V31, P103, DOI 10.1002/yea.2992; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maeder CI, 2007, METHOD MICROBIOL, V36, P55, DOI 10.1016/S0580-9517(06)36004-7; Morrow DM, 1997, GENETICS, V147, P371; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114590	10.1371/journal.pone.0114590	http://dx.doi.org/10.1371/journal.pone.0114590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493941	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000346611400055
J	Meng, J; Bi, SD; Wang, YQ; Zheng, XT; Wang, XL				Meng, Jin; Bi, Shundong; Wang, Yuanqing; Zheng, Xiaoting; Wang, Xiaoli			Dental and Mandibular Morphologies of Arboroharamiya (Haramiyida, Mammalia): A Comparison with Other Haramiyidans and Megaconus and Implications for Mammalian Evolution	PLOS ONE			English	Article							OSSIFIED MECKELS CARTILAGE; MIDDLE-EAR; MULTITUBERCULATE MAMMALS; ALLOTHERIAN MAMMALS; TEETH; DIVERSIFICATION; EUTRICONODONT; ADAPTATIONS; DIVERGENCE; ENGLAND	Background: Two recent studies published in the same issue of Nature reached conflicting conclusions regarding the phylogeny of early mammals: One places the clade containing haramiyidans and multituberculates within the Mammalia and the other separates haramiyidans from multituberculates and places the former outside of the Mammalia. These two contrasting results require that the minimally oldest divergence time of the Mammalia was within the Late Triassic or the Middle Jurassic, respectively. Morphological descriptions of the species named in the two papers were brief, and no comparisons between the newly named species were possible. Principal Findings: Here we present a detailed description of the dentary bone, teeth, occlusal and wear patterns of the haramiyidan Arboroharamiya and compare it with other haramiyidans and Megaconus. Using this new information, we suggest that tooth identifications and orientations of several previously described haramiyidan species are incorrect, and that previous interpretations of haramiyidan occlusal pattern are problematic. We propose that the published upper tooth orientation of Megaconus was problematic and question the number of upper molars, the length of dentition and mandible, and presence of the mandibular middle ear in Megaconus. Conclusions: The additional morphological descriptions and comparisons presented here further support the view that Arboroharamiya, as a derived haramiyidan, shows similarity to multituberculates in tooth and mandible morphologies. Our comparison also suggests that Megaconus lacks many diagnostic features for the family Eleutherodontidae and that its close affinity with multituberculates cannot be ruled out. The detailed morphological data demonstrate that haramiyidans are more similar to multituberculates than to any other mammaliaforms.	[Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Meng, Jin; Bi, Shundong; Wang, Yuanqing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Bi, Shundong] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Zheng, Xiaoting; Wang, Xiaoli] Shandong Tianyu Museum Nat, Pingyi, Shandong, Peoples R China; [Zheng, Xiaoting; Wang, Xiaoli] Linyi Univ, Inst Geol & Paleontol, Linyi, Shandong, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Linyi University	Meng, J (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	jmeng@amnh.org	Xiaoli, Wang/H-1079-2014		National Basic Research Program of China 973 Program [2012CB821906]; National Natural Science Foundation of China [41172016, 41128002, 41372014]; Hundred Talents Programs of the Chinese Academy of Sciences; American Museum of Natural History	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Programs of the Chinese Academy of Sciences(Chinese Academy of Sciences); American Museum of Natural History	This work was supported by the National Basic Research Program of China 973 Program 2012CB821906, National Natural Science Foundation of China (41172016, 41128002 and 41372014), the Hundred Talents Programs of the Chinese Academy of Sciences and the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Averianov A O, 2011, Dokl Biol Sci, V436, P32, DOI 10.1134/S0012496611010042; Bi SD, 2014, NATURE, V514, P579, DOI 10.1038/nature13718; Butler P, 1994, PHILOS T BIOL SCI, P433; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Cifelli RL, 2013, NATURE, V500, P160, DOI 10.1038/500160a; Clemens W.A., 1980, Zitteliana, V5, P51; COPE ED, 1884, AM NAT, V18, P686, DOI DOI 10.1086/273711; Crompton AW, 1974, B BRIT MUS NAT HIST, P399; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn G, 2003, ACTA PALAEONTOL POL, V48, P349; Hahn G, 1973, PALAEONTOGR ABT A, P1; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; Heinrich W.D., 1999, FOSS REC, V2, P159, DOI [10.1002/mmng.1999.4860020112, DOI 10.1002/MMNG.1999.4860020112]; Heinrich W.D., 2001, FOSS REC, V4, P239, DOI [10.5194/fr-4-239-2001, DOI 10.5194/FR-4-239-2001]; Heinrich W.D., 2004, MITTEILUNGEN MUSEUM, V7, P153; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; KERMACK K A, 1983, Acta Palaeontologica Polonica, V28, P147; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KIELANJAWOROWSKA Z, 1994, PALAEONTOLOGY, V37, P17; KRAUSE DW, 1990, J PALEONTOL, V64, P1051, DOI 10.1017/S0022336000019922; Lazzari V, 2010, J MAMM EVOL, V17, P177, DOI 10.1007/s10914-010-9139-5; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Maisch MW, 2005, NATURWISSENSCHAFTEN, V92, P40, DOI 10.1007/s00114-004-0584-y; Marsh O.C., 1880, AM J SCI, V20, P235, DOI 10.2475/ajs.s3-20.117.235; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; McKenna M.C., 1987, P55; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Parrington FR, 1947, P ZOOL SOC LOND, P707; Peyer B, 1956, SCHWEIZERISCHE PALAO, P1; Poche Franz, 1908, Zoologische Annalen Wurzburg, V2; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; SIGOGNEAU-RUSSELL D, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P137; Sigogneau-Russell D, 1988, SCI TERRE, V307, P1045; Sigogneau-Russell D, 1991, NEUES JB GEOLOGIE PA, V2, P119; Sigogneau-Russell D, 1986, NEW FAMILY LOWER PAR, P99; Simpson G. G., 1947, Journal of Paleontology Menasha, V21, P497; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Yuan CX, 2013, SCIENCE, V341, P779, DOI 10.1126/science.1237970; Zheng XT, 2013, NATURE, V500, P199, DOI 10.1038/nature12353; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	54	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113847	10.1371/journal.pone.0113847	http://dx.doi.org/10.1371/journal.pone.0113847			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494181	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400022
J	Rossier, C; Soura, AB; Duthe, G; Findley, S				Rossier, Clementine; Soura, Abdramane Bassiahi; Duthe, Geraldine; Findley, Sally			Non-Communicable Disease Mortality and Risk Factors in Formal and Informal Neighborhoods, Ouagadougou, Burkina Faso: Evidence from a Health and Demographic Surveillance System	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INFECTIOUS-DISEASES; HYPERTENSION; OBESITY; DISPARITIES; LIFE	The expected growth in NCDs in cities is one of the most important health challenges of the coming decades in Sub-Saharan countries. This paper aims to fill the gap in our understanding of socio-economic differentials in NCD mortality and risk in low and middle income neighborhoods in urban Africa. We use data collected in the Ouagadougou Health and Demographic Surveillance System. 409 deaths were recorded between 2009-2011 among 20,836 individuals aged 35 years and older; verbal autopsies and the InterVA program were used to determine the probable cause of death. A random survey asked in 2011 1,039 adults aged 35 and over about tobacco use, heavy alcohol consumption, lack of physical activity and measured their weight, height, and blood pressure. These data reveal a high level of premature mortality due to NCDs in all neighborhoods: NCD mortality increases substantially by age 50. NCD mortality is greater in formal neighborhoods, while adult communicable disease mortality remains high, especially in informal neighborhoods. There is a high prevalence of risk factors for NCDs in the studied neighborhoods, with over one-fourth of the adults being overweight and over one-fourth having hypertension. Better-off residents are more prone to physical inactivity and excessive weight, while vulnerable populations such as widows/divorced individuals and migrants suffer more from higher blood pressure. Females have a significantly lower risk of being smokers or heavy drinkers, while they are more likely to be physically inactive or overweight, especially when married. Muslim individuals are less likely to be smokers or heavy drinkers, but have a higher blood pressure. Everything else being constant, individuals living in formal neighborhoods are more often overweight. The data presented make clear the pressing need to develop effective programs to reduce NCD risk across all types of neighborhoods in African cities, and suggest several entry points for community-based prevention programs.	[Rossier, Clementine] Univ Geneva, Inst Demog & Life Course Studies, Geneva, Switzerland; [Rossier, Clementine; Duthe, Geraldine] Inst Natl Etud Demog, F-75675 Paris, France; [Soura, Abdramane Bassiahi] Univ Ouagadougou, Inst Super Sci Populat, Ouagadougou, Burkina Faso; [Findley, Sally] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Geneva; Columbia University	Rossier, C (corresponding author), Univ Geneva, Inst Demog & Life Course Studies, Geneva, Switzerland.	clementine.rossier@unige.ch			Wellcome Trust [WT081993MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant number WT081993MA (http:///www. wellcome.ac.uk/). Data collection, salaries of ABS, and travels for CR and GD were supported by the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], 2011, GLOBAL STATUS REPORT; [Anonymous], 2012, CONT EP TRANS SUBS A; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Boyer F, 2009, PEUPLEMENT OUAGADOUG; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Chaufan C, 2011, J COMMUN HEALTH, V36, P1032, DOI 10.1007/s10900-011-9406-2; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Doulougou B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-893; Findley S, 2014, BRIDGING GA IN PRESS; Forssas E, 2012, EUR J PUBLIC HEALTH, V22, P305, DOI 10.1093/eurpub/ckr044; Fournet F, 2008, OUAGADOUGOU 1850 200; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5; Niakara A, 2007, T ROY SOC TROP MED H, V101, P1136, DOI 10.1016/j.trstmh.2007.07.002; Ouedraogo HZ, 2008, PUBLIC HEALTH NUTR, V11, P1280, DOI 10.1017/S1368980008002504; Perez-Escamilla R, 2011, AM J CLIN NUTR, V93, p1163S, DOI 10.3945/ajcn.110.003467; Popkin BM, 1998, NUTR REV, V56, P106; Raphael D, 2011, MATURITAS, V69, P22, DOI 10.1016/j.maturitas.2011.02.011; Reidpath DD, 2012, J GLOBAL HLTH, V2; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Rossier C, 2014, REV QUETELE IN PRESS, V2; Rossier C, 2012, INT J EPIDEMIOL, V41, P658, DOI 10.1093/ije/dys090; Solomons NW, 2005, MATERN CHILD NUTR, V1, P204, DOI 10.1111/j.1740-8709.2005.00030.x; United Nations, 2012, WORLD URB PROSP 2011; World Health Organisation, 2010, HIDD CIT UNM OV HLTH; World Health Organization, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2010, M IND MON ALC DRUGS; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113780	10.1371/journal.pone.0113780	http://dx.doi.org/10.1371/journal.pone.0113780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493649	Green Published, gold			2022-12-27	WOS:000346611400019
J	Veldkamp, CLS; Nuijten, MB; Dominguez-Alvarez, L; van Assen, MALM; Wicherts, JM				Veldkamp, Coosje L. S.; Nuijten, Michele B.; Dominguez-Alvarez, Linda; van Assen, Marcel A. L. M.; Wicherts, Jelte M.			Statistical Reporting Errors and Collaboration on Statistical Analyses in Psychological Science	PLOS ONE			English	Article							P-VALUES; PUBLICATION; SCIENTISTS	Statistical analysis is error prone. A best practice for researchers using statistics would therefore be to share data among co-authors, allowing double-checking of executed tasks just as co-pilots do in aviation. To document the extent to which this 'co-piloting' currently occurs in psychology, we surveyed the authors of 697 articles published in six top psychology journals and asked them whether they had collaborated on four aspects of analyzing data and reporting results, and whether the described data had been shared between the authors. We acquired responses for 49.6% of the articles and found that co-piloting on statistical analysis and reporting results is quite uncommon among psychologists, while data sharing among co-authors seems reasonably but not completely standard. We then used an automated procedure to study the prevalence of statistical reporting errors in the articles in our sample and examined the relationship between reporting errors and co-piloting. Overall, 63% of the articles contained at least one p-value that was inconsistent with the reported test statistic and the accompanying degrees of freedom, and 20% of the articles contained at least one p-value that was inconsistent to such a degree that it may have affected decisions about statistical significance. Overall, the probability that a given p-value was inconsistent was over 10%. Co-piloting was not found to be associated with reporting errors.	[Veldkamp, Coosje L. S.; Nuijten, Michele B.; van Assen, Marcel A. L. M.; Wicherts, Jelte M.] Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Methodol & Stat, NL-5000 LE Tilburg, Netherlands; [Dominguez-Alvarez, Linda] Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Org Studies, NL-5000 LE Tilburg, Netherlands	Tilburg University; Tilburg University	Veldkamp, CLS (corresponding author), Tilburg Univ, Tilburg Sch Social & Behav Sci, Dept Methodol & Stat, NL-5000 LE Tilburg, Netherlands.	C.L.S.Veldkamp@tilburguniversity.edu	Nuijten, Michèle B./N-2483-2014; Wicherts, Jelte M./A-2664-2008	Nuijten, Michèle B./0000-0002-1468-8585; Wicherts, Jelte M./0000-0003-2415-2933	Innovational Research Incentives Scheme Vidi from the Netherlands Organization for Scientific Research	Innovational Research Incentives Scheme Vidi from the Netherlands Organization for Scientific Research	The preparation of this article was supported by The Innovational Research Incentives Scheme Vidi from the Netherlands Organization for Scientific Research. Website: (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, 2010, PUBL MAN AM PSYCH AS, V6; American Psychological Association, 2002, AM PSYCH ASS ETH PRI; Bakker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103360; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Balon R, 2005, PSYCHOTHER PSYCHOSOM, V74, P331, DOI 10.1159/000087779; Beaty D, 2004, NAKED PILOT HUMAN FA; Berle D, 2007, INT J METH PSYCH RES, V16, P202, DOI 10.1002/mpr.225; CECI SJ, 1983, AM PSYCHOL, V38, P414, DOI 10.1037/0003-066X.38.4.414; CECI SJ, 1988, SCI TECHNOL HUM VAL, V13, P45, DOI 10.1177/0162243988013001-206; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cronin B, 2003, J AM SOC INF SCI TEC, V54, P855, DOI 10.1002/asi.10278; Cumming G., 2013, PSYCHOL SCI; Epskamp S, 2013, STACHECK EXTRACT STA; Garcia-Berthou Emili, 2004, BMC Med Res Methodol, V4, P13, DOI 10.1186/1471-2288-4-13; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Hubbard R, 2000, EDUC PSYCHOL MEAS, V60, P661, DOI 10.1177/0013164400605001; Krueger J, 2001, AM PSYCHOL, V56, P16, DOI 10.1037//0003-066X.56.1.16; Leggett NC, 2013, Q J EXPT PSYCHOL, P1; Levine TR, 2008, HUM COMMUN RES, V34, P171, DOI 10.1111/j.1468-2958.2008.00317.x; Lindvall M, 2004, COMPUTER, V37, P26, DOI 10.1109/MC.2004.231; Caperos JM, 2013, PSICOTHEMA, V25, P408, DOI 10.7334/psicothema2012.207; MENDENHALL M, 1982, PSYCHOL REP, V51, P1019, DOI 10.2466/pr0.1982.51.3.1019; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; OVER R, 1982, AM PSYCHOL, V37, P996, DOI 10.1037/0003-066X.37.9.996; R Core Team, 2021, R LANGUAGE ENV STAT; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Simonsohn U., 2013, PSYCHOL SCI; STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823; Vines TH, 2013, CURRENT BIOL; Vogeli C, 2006, ACAD MED, V81, P128, DOI 10.1097/00001888-200602000-00007; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wicherts Jelte, 2013, J OPEN PSYCHOL DATA, V1, pe1, DOI [DOI 10.5334/JOPD.E1, 10.5334/jopd.e1, DOI 10.5334/J0PD.E1]; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2012, INTELLIGENCE, V40, P73, DOI 10.1016/j.intell.2012.01.004; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Wicherts JM, 2011, NATURE, V480, P7, DOI 10.1038/480007a; Wiegman DA, 2003, HUMAN ERROR APPROACH; ZUCKERMAN M, 1993, PSYCHOL SCI, V4, P49, DOI 10.1111/j.1467-9280.1993.tb00556.x	39	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114876	10.1371/journal.pone.0114876	http://dx.doi.org/10.1371/journal.pone.0114876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493918	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400082
J	Glencross, DK; Coetzee, LM; Cassim, N				Glencross, Deborah K.; Coetzee, Lindi M.; Cassim, Naseem			An Integrated Tiered Service Delivery Model (ITSDM) Based on Local CD4 Testing Demands Can Improve Turn-Around Times and Save Costs whilst Ensuring Accessible and Scalable CD4 Services across a National Programme	PLOS ONE			English	Article							SOUTH-AFRICA; CARE; HIV; ENUMERATION; INITIATION; SYSTEM; BLOOD; RATES	Background: The South African National Health Laboratory Service (NHLS) responded to HIV treatment initiatives with two-tiered CD4 laboratory services in 2004. Increasing programmatic burden, as more patients access anti-retroviral therapy (ART), has demanded extending CD4 services to meet increasing clinical needs. The aim of this study was to review existing services and develop a service-model that integrated laboratory-based and point-of-care testing (POCT), to extend national coverage, improve local turn-around/(TAT) and contain programmatic costs. Methods: NHLS Corporate Data Warehouse CD4 data, from 60-70 laboratories and 4756 referring health facilities was reviewed for referral laboratory workload, respective referring facility volumes and related TAT, from 2009-2012. Results: An integrated tiered service delivery model (ITSDM) is proposed. Tier-1/POCT delivers CD4 testing at single health-clinics providing ART in hard-to-reach areas (<5 samples/day). Laboratory-based testing is extended with Tier-2/POC-Hubs (processing <= 30-40 CD4 samples/day), consolidating POCT across 8-10 health-clinics with other HIV-related testing and Tier-3/'community' laboratories, serving <= 40 health-clinics, processing <= 150 samples/day. Existing Tier-4/'regional' laboratories serve <= 100 facilities and process,350 samples/day; Tier-5 are high-volume 'metro'/centralized laboratories (>350-1500 tests/day, serving >= 200 health-clinics). Tier-6 provides national support for standardisation, harmonization and quality across the organization. Conclusion: The ITSDM offers improved local TAT by extending CD4 services into rural/remote areas with new Tier-3 or Tier-2/POC-Hub services installed in existing community laboratories, most with developed infrastructure. The advantage of lower laboratory CD4 costs and use of existing infrastructure enables subsidization of delivery of more expensive POC services, into hard-to-reach districts without reasonable access to a local CD4 laboratory. Full ITSDM implementation across 5 service tiers ( as opposed to widespread implementation of POC testing to extend service) can facilitate sustainable 'full service coverage' across South Africa, and save>than R125 million in HIV/AIDS programmatic costs. ITSDM hierarchical parental-support also assures laboratory/POC management, equipment maintenance, quality control and on-going training between tiers.	[Glencross, Deborah K.; Coetzee, Lindi M.] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa; [Glencross, Deborah K.; Coetzee, Lindi M.; Cassim, Naseem] NHLS, Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Glencross, DK (corresponding author), Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa.	debbie.glencross@nhls.ac.za	Cassim, Naseem/AFU-5522-2022; Cassim, Naseem/GLR-4911-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X				Beckman Coulter International, 2014, FLOW CYT; Beckman Coulter International, 2014, BECKM COULT FLOW CYT; Bornheimer S, 2013, DEV BD FACSPRESTO IN; Cassim N, 2014, PLOS ONE IN PRESS; Cassim N, 2012, AFR SOC LAB MED 1 IN; Cassim N, 2014, AFR SOC LAB MED 1 IN; Coetzee LM, 2014, 8 HIV INT M 2014 5 9; Coetzee LM, 2012, COST ANAL MOBILE LAB; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fajardo E, 2014, AIDS; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Glencross DK, 2012, AFR SOC LAB MED 1 IN; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lawrie D, 2010, CYTOM PART B-CLIN CY, V78B, P201, DOI 10.1002/cyto.b.20520; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Massambu C, 2009, AM J CLIN PATHOL, V131, P861, DOI 10.1309/AJCP3ZAAFUPCIXIG; 'Medecins Sans Frontiers' SA, 2013, NEW ROOTS S AFR CHAL; National Department of Health, 2011, NAT STRAT PLAN HIV S; National Department of Health, 2013, POINT CAR TEST POS P; National Department of Health, 2012, NAT HLTH CAR FAC BAS; National Department of Health, 2003, OP PLAN COMPR HIV AI; National Department of Health, 2013, PROGR UPD NAT STRAT; National Department of Health, 2012, NAT HLTH INS PRES NH; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health, 2013, UPD NAT STRAT PLAN H; National Department of Health, 2008, POL GUID IMPL PMTCT; National Health Laboratory Services, 2013, NAT HLTH LAB SERV AN; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P359, DOI 10.1309/AJCPY5ASUEJYQ5RK; Scott LE, 2005, CYTOM PART B-CLIN CY, V67B, P31, DOI 10.1002/cyto.b.20066; Smith H, 2012, GEOGRAPHIC LOCATION; South African National AIDS Council, SANAC PROGR REP NAT; STATSSA-Statistics SA, 2013, MIDY POP EST 2013 PR; STATSSA-Statistics SA, 2011, MIDY POP EST 2011 PR; World Health Organisation, 2002, WHO EM SCAL UP ANT T; World Health Organization, 2008, CONS TECHN OP REC CL	41	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114727	10.1371/journal.pone.0114727	http://dx.doi.org/10.1371/journal.pone.0114727			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490718	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300070
J	Mehrabian, M; Brethour, D; MacIsaac, S; Kim, JK; Gunawardana, CG; Wang, H; Schmitt-Ulms, G				Mehrabian, Mohadeseh; Brethour, Dylan; MacIsaac, Sarah; Kim, Jin Kyu; Gunawardana, C. Geeth; Wang, Hansen; Schmitt-Ulms, Gerold			CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NEUROBLASTOMA-CELLS; CRISPR/CAS; SCRAPIE; CAS9; SPECIFICITY; BACTERIA; ARCHAEA; SYSTEMS; TALEN	The molecular function of the cellular prion protein (PrPC) and the mechanism by which it may contribute to neurotoxicity in prion diseases and Alzheimer's disease are only partially understood. Mouse neuroblastoma Neuro2a cells and, more recently, C2C12 myocytes and myotubes have emerged as popular models for investigating the cellular biology of PrP. Mouse epithelial NMuMG cells might become attractive models for studying the possible involvement of PrP in a morphogenetic program underlying epithelial-to-mesenchymal transitions. Here we describe the generation of PrP knockout clones from these cell lines using CRISPR-Cas9 knockout technology. More specifically, knockout clones were generated with two separate guide RNAs targeting recognition sites on opposite strands within the first hundred nucleotides of the Prnp coding sequence. Several PrP knockout clones were isolated and genomic insertions and deletions near the CRISPR-target sites were characterized. Subsequently, deep quantitative global proteome analyses that recorded the relative abundance of. 3000 proteins (data deposited to ProteomeXchange Consortium) were undertaken to begin to characterize the molecular consequences of PrP deficiency. The levels of similar to 120 proteins were shown to reproducibly correlate with the presence or absence of PrP, with most of these proteins belonging to extracellular components, cell junctions or the cytoskeleton.	[Mehrabian, Mohadeseh; Brethour, Dylan; MacIsaac, Sarah; Kim, Jin Kyu; Gunawardana, C. Geeth; Wang, Hansen; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Brethour, Dylan; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	wang, hansen/I-2510-2019	wang, hansen/0000-0003-4414-3372	Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation; University of Toronto; Ontario Trillium Scholarship; W. Garfield Weston Foundation	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Toronto(University of Toronto); Ontario Trillium Scholarship; W. Garfield Weston Foundation	Work on this project was supported by operating funds generously provided to GS by the Canadian Institute for Health Research (CIHR) and an infrastructure grant from the Canadian Foundation for Innovation. MM received a University of Toronto Fellowship and generous support through an Ontario Trillium Scholarship. DB and GG were supported by CIHR Master's and Postdoctoral Training Awards, respectively. GS gratefully acknowledges funding from the W. Garfield Weston Foundation. Note that funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2012, NAT NEUROSCI, V15, P936, DOI 10.1038/nn.3120; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Cathomen T, 2014, NEW ENGL J MED, V370, P2342, DOI 10.1056/NEJMcibr1403629; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cortes CJ, 2013, INT J CELL BIOL; Crecelius AC, 2008, NEUROREPORT, V19, P1027, DOI 10.1097/WNR.0b013e3283046157; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Flechsig E, 2004, CURR MOL MED, V4, P337, DOI 10.2174/1566524043360645; Fu Y, 2013, NAT BIOTECH; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; Herms JW, 2000, J NEUROCHEM, V75, P1487, DOI 10.1046/j.1471-4159.2000.0751487.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kang SG, 2010, PRION, V4, P32, DOI 10.4161/pri.4.1.11218; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Prusiner SB, 1998, P NATL ACAD SCI USA, V117, P421; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Stella R, 2012, J PROTEOME RES, V11, P523, DOI 10.1021/pr200759m; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Weiss E, 2010, NEUROSCIENCE, V169, P1640, DOI 10.1016/j.neuroscience.2010.06.013; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	46	43	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114594	10.1371/journal.pone.0114594	http://dx.doi.org/10.1371/journal.pone.0114594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490046	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300055
J	Vaziri, ND; Liu, SM; Lau, WL; Khazaeli, M; Nazertehrani, S; Farzaneh, SH; Kieffer, DA; Adams, SH; Martin, RJ				Vaziri, Nosratola D.; Liu, Shu-Man; Lau, Wei Ling; Khazaeli, Mahyar; Nazertehrani, Sohrab; Farzaneh, Seyed H.; Kieffer, Dorothy A.; Adams, Sean H.; Martin, Roy J.			High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease	PLOS ONE			English	Article							GUT BACTERIAL TRANSLOCATION; IMPAIRS BARRIER FUNCTION; STAGE RENAL-DISEASE; INTESTINAL MICROBIOTA; INDOLIC COMPOUNDS; TIGHT JUNCTION; MICROINFLAMMATION; FAILURE; UREMIA	Inflammation is a major mediator of CKD progression and is partly driven by altered gut microbiome and intestinal barrier disruption, events which are caused by: urea influx in the intestine resulting in dominance of urease-possessing bacteria; disruption of epithelial barrier by urea-derived ammonia leading to endotoxemia and bacterial translocation; and restriction of potassium-rich fruits and vegetables which are common sources of fermentable fiber. Restriction of these foods leads to depletion of bacteria that convert indigestible carbohydrates to short chain fatty acids which are important nutrients for colonocytes and regulatory T lymphocytes. We hypothesized that a high resistant starch diet attenuates CKD progression. Male Sprague Dawley rats were fed a chow containing 0.7% adenine for 2 weeks to induce CKD. Rats were then fed diets supplemented with amylopectin (low-fiber control) or high fermentable fiber (amylose maize resistant starch, HAM-RS2) for 3 weeks. CKD rats consuming low fiber diet exhibited reduced creatinine clearance, interstitial fibrosis, inflammation, tubular damage, activation of NF kappa B, upregulation of pro-inflammatory, pro-oxidant, and pro-fibrotic molecules; impaired Nrf2 activity, down-regulation of antioxidant enzymes, and disruption of colonic epithelial tight junction. The high resistant starch diet significantly attenuated these abnormalities. Thus high resistant starch diet retards CKD progression and attenuates oxidative stress and inflammation in rats. Future studies are needed to explore the impact of HAM-RS2 in CKD patients.	[Vaziri, Nosratola D.; Liu, Shu-Man; Lau, Wei Ling; Khazaeli, Mahyar; Nazertehrani, Sohrab; Farzaneh, Seyed H.] Univ Calif Irvine, Div Nephrol, Irvine, CA 92717 USA; [Kieffer, Dorothy A.; Adams, Sean H.; Martin, Roy J.] Univ Calif Davis, Grad Grp Nutr Biol, Sacramento, CA 95817 USA; [Kieffer, Dorothy A.; Adams, Sean H.; Martin, Roy J.] Univ Calif Davis, Dept Nutr, Sacramento, CA 95817 USA; [Kieffer, Dorothy A.; Adams, Sean H.] USDA ARS, Western Human Nutr Res Ctr, Obes & Metab Res Unit, Davis, CA USA	University of California System; University of California Irvine; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Vaziri, ND (corresponding author), Univ Calif Irvine, Div Nephrol, Irvine, CA 92717 USA.	ndvaziri@uci.edu	Liu, Shuman/C-1218-2015; Lau, Wei Ling/AAE-4397-2020; ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319	USDA-ARS Project [5306-51530-019-00]; Danish Council for Strategic Research; ARS [ARS-0426492] Funding Source: Federal RePORTER	USDA-ARS Project; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported in part by intramural USDA-ARS Project 5306-51530-019-00 (SHA) and the Danish Council for Strategic Research (RJM). USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2012, TRANSL RES, V160, P309, DOI 10.1016/j.trsl.2012.03.003; Baer DJ, 2014, J NUTR, V144, P1023, DOI 10.3945/jn.113.185298; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Bossola M, 2009, CLIN J AM SOC NEPHRO, V4, P379, DOI 10.2215/CJN.03490708; Charrier JA, 2013, OBESITY, V21, P2350, DOI 10.1002/oby.20362; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Hendrikx TK, 2009, NEPHROL DIAL TRANSPL, V24, P1969, DOI 10.1093/ndt/gfp005; Kalmokoff M, 2013, J APPL MICROBIOL, V114, P1516, DOI 10.1111/jam.12157; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Keenan MJ, 2012, J NUTRIGENET NUTRIGE, V5, P26, DOI 10.1159/000335319; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; Sakurai H, 1996, BBA-MOL BASIS DIS, V1316, P132, DOI 10.1016/0925-4439(96)00022-1; Shen L, 2011, MOL NUTR FOOD RES, V55, P1499, DOI 10.1002/mnfr.201000605; Shi K, 2014, DIGESTIVE D IN PRESS; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Vaziri ND, 2002, HYPERTENSION, V39, P135, DOI 10.1161/hy0102.100540; Vaziri ND, 2013, AM J NEPHROL, V38, P99, DOI 10.1159/000353764; Vaziri ND, 2013, AM J NEPHROL, V37, P1, DOI 10.1159/000345969; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, AM J NEPHROL, V36, P438, DOI 10.1159/000343886; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020; Vidrine K, 2014, OBESITY, V22, P344, DOI 10.1002/oby.20501; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang FQ, 2012, DIGEST DIS SCI, V57, P2856, DOI 10.1007/s10620-012-2242-0; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Wutzke KD, 2013, ISOT ENVIRON HEALT S, V49, P464, DOI 10.1080/10256016.2013.804519; Younes H, 1999, AM J KIDNEY DIS, V33, P633, DOI 10.1016/S0272-6386(99)70213-1; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	35	188	199	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114881	10.1371/journal.pone.0114881	http://dx.doi.org/10.1371/journal.pone.0114881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490712	Green Published, gold			2022-12-27	WOS:000347515300090
J	Winkler, MA; Dib, C; Ljubimov, AV; Saghizadeh, M				Winkler, Michael A.; Dib, Christian; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh			Targeting miR-146a to Treat Delayed Wound Healing in Human Diabetic Organ-Cultured Corneas	PLOS ONE			English	Article							STEM-CELL DEFICIENCY; C-MET GENE; BASEMENT-MEMBRANE; INTEGRIN ALTERATIONS; MICRORNA; INFLAMMATION; EXPRESSION; CANCER; DIFFERENTIATION; PROLIFERATION	Limbal epithelial stem cells (LESC) residing at the corneal periphery are largely responsible for maintaining corneal optical transparency by continuously supplying new corneal epithelial cells, which mature during their radial migration to the central cornea. Diabetes mellitus (DM) affects all the structures of the eye including the cornea. Frequent epithelial erosions, delayed wound healing, and microbial infections are common alterations of the diabetic eye that can result in vision loss. MicroRNAs (miRNAs) are short non-coding oligonucleotides that regulate gene expression by repressing translation. Our purpose was to understand the role of miR-146a in the human limbal versus central corneal epithelial compartment in normal and pathological conditions such as diabetes mellitus. Using quantitative real-time PCR (QPCR) we found miR-146a enrichment in the limbal corneal compartment. This miRNA was also expressed at higher levels in the diabetic vs. normal limbus. Cell migration and wound closure were significantly delayed in normal and diabetic primary limbal epithelial cells (LEC) transfected with miR-146a. Cells treated with miR-146a had decreased levels of phosphorylated (activated) p38 and EGFR, mediators of epithelial wound healing. Conversely, inhibition of miR-146a significantly enhanced cell migration in both normal and diabetic primary LEC and in diabetic organ-cultured corneas by nearly 40% vs. scrambled miRNA control, accompanied by increased phosphorylated signaling intermediates. Transfection of miR-146a in cultured LEC resulted in an increased immunoreactivity for putative LEC markers Frizzled-7 and K15, whereas inhibition of miR-146a decreased their expressions. These data suggest that miR-146a plays a role in LEC maintenance at the corneal periphery, and its expression is downregulated during their migration towards the central cornea and accompanying terminal differentiation. Furthermore, abnormal miR-146a upregulation may be an important mechanism of delayed wound healing in the diabetic cornea.	[Winkler, Michael A.; Dib, Christian; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Dept Biomed Sci, Eye Program, Los Angeles, CA 90048 USA; [Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Dib, Christian; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saghizadeh, M (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Dept Biomed Sci, Eye Program, Los Angeles, CA 90048 USA.	ghiamm@cshs.org	Ljubimov, Alexander V/E-5883-2013; Ljubimov, Alexander/CAE-9130-2022	Ljubimov, Alexander/0000-0003-2398-5319	NIH [R21 EY022771, R01 EY13431]; Cedars-Sinai Regenerative Medicine Institute grants; NATIONAL EYE INSTITUTE [R01EY025377, R01EY013431, R21EY022771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Regenerative Medicine Institute grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH R21 EY022771, R01 EY13431, and Cedars-Sinai Regenerative Medicine Institute grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2014, CANCER LETT, V351, P134, DOI 10.1016/j.canlet.2014.05.013; Amitai-Lange A., 2014, STEM CELLS; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cavallerano J, 1992, Optom Clin, V2, P93; Cezar-de-Mello PFT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003099; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060317; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chous PA, 2003, DIABETIC EYE DIS, P87; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; HANNA C, 1961, ARCH OPHTHALMOL-CHIC, V65, P695; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huang YQ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-142; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079926; Kabosova A, 2003, EXP EYE RES, V77, P211, DOI 10.1016/S0014-4835(03)00111-8; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kreidberg Jordan A, 2000, CURR OPIN CELL BIOL, V12, P548; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Lehrer MS, 1998, J CELL SCI, V111, P2867; Li Jun, 2010, Chinese Medical Sciences Journal, V25, P65, DOI 10.1016/S1001-9294(10)60024-7; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim P, 2009, SEMIN OPHTHALMOL, V24, P139, DOI 10.1080/08820530902801478; Lin DH, 2013, INVEST OPHTH VIS SCI, V54, P6167, DOI 10.1167/iovs.12-11577; Liu JJ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0092-7; Ljubimov AV, 1998, J HISTOCHEM CYTOCHEM, V46, P1033, DOI 10.1177/002215549804600907; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Saghizadeh M, 2001, AM J PATHOL, V158, P723, DOI 10.1016/S0002-9440(10)64015-1; Saghizadeh M, 2013, INVEST OPHTH VIS SCI, V54, P8172, DOI 10.1167/iovs.13-13233; Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632; Saghizadeh M, 2011, MOL VIS, V17, P2177; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Saghizadeh M, 2010, BRAIN RES BULL, V81, P262, DOI 10.1016/j.brainresbull.2009.10.007; Sanchez-Thorin JC, 1998, INT OPHTHALMOL CLIN, V38, P19, DOI 10.1097/00004397-199838020-00004; Sareen D, 2014, STEM CELL TRANSL MED, V3, P1002, DOI 10.5966/sctm.2014-0076; Schultz R O, 1981, Trans Am Ophthalmol Soc, V79, P180; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; United States Government, 2014, CHILDR FAM INC FACT; Wang BS, 2014, GENET MOL RES, V13, P5426, DOI 10.4238/2014.July.24.22; Wang Q, 2014, INVEST OPHTH VIS SCI, V55, P3986, DOI 10.1167/iovs.13-13076; Wei H, 2014, ENDOCR J; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yan YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080029; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	58	52	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114692	10.1371/journal.pone.0114692	http://dx.doi.org/10.1371/journal.pone.0114692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490205	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300067
J	Kim, ES; Kim, HB; Kim, G; Kim, KH; Park, KH; Lee, S; Choi, YH; Yi, J; Kim, CJ; Song, KH; Choe, PG; Kim, NJ; Lee, YS; Oh, MD				Kim, Eu Suk; Kim, Hong Bin; Kim, Gayeon; Kim, Kye-Hyung; Park, Kyung-Hwa; Lee, Shinwon; Choi, Young Hwa; Yi, Jongyoun; Kim, Chung Jong; Song, Kyoung-Ho; Choe, Pyoeng Gyun; Kim, Nam-Joong; Lee, Yeong-Seon; Oh, Myoung-don		Korea INfectious Dis KIND Study Gr	Clinical and Epidemiological Factors Associated with Methicillin Resistance in Community-Onset Invasive Staphylococcus aureus Infections: Prospective Multicenter Cross-Sectional Study in Korea	PLOS ONE			English	Article							RISK-FACTORS; MRSA INFECTION; CARE; BACTEREMIA; STRAINS; TRANSMISSION; PREDICTORS; MINNESOTA; MORTALITY; FEATURES	Successful empirical therapy of Staphylococcus aureus infections requires the ability to predict methicillin resistance. Our aim was to identify predictors of methicillin resistance in community-onset (CO) invasive S. aureus infections. Sixteen hospitals across Korea participated in this study from May to December 2012. We prospectively included cases of S. aureus infection in which S. aureus was isolated from sterile clinical specimens <= 72 hours after hospitalization. Clinical and epidemiological data were gathered and compared in methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) cases. Community-associated (CA) infections were defined as in previous studies. In total, there were 786 cases of community-onset S. aureus infection, 102 (13.0%) of which were CA-MRSA. In addition to known risk factors, exposure to 3rd generation cephalosporins in the past 6 months [odds ratio (OR), 1.922; 95% confidence interval (CI), 1.176-3.142] and close contact with chronically ill patients in the past month (OR, 2.647; 95% CI, 1.189-5.891) were independent risk factors for MRSA infection. However, no clinical predictors of CA-MRSA were identified. Methicillin resistance, CO infection, and appropriateness of empirical antibiotics were not significantly related to 30-day mortality. MRSA infection should be suspected in patients recently exposed to 3rd generation cephalosporins or chronically-ill patients. There were no reliable predictors of CA-MRSA infection, and mortality was not affected by methicillin resistance.	[Kim, Eu Suk; Kim, Hong Bin; Kim, Chung Jong; Song, Kyoung-Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Kim, Eu Suk; Kim, Hong Bin; Kim, Gayeon; Kim, Chung Jong; Song, Kyoung-Ho; Choe, Pyoeng Gyun; Kim, Nam-Joong; Oh, Myoung-don] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Gayeon; Choe, Pyoeng Gyun; Kim, Nam-Joong; Oh, Myoung-don] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Kim, Kye-Hyung] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan, South Korea; [Park, Kyung-Hwa] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Lee, Shinwon] Daegu Fatima Hosp, Dept Internal Med, Taegu, South Korea; [Choi, Young Hwa] Ajou Univ, Sch Med, Dept Infect Dis, Suwon 441749, South Korea; [Yi, Jongyoun] Pusan Natl Univ, Sch Med, Dept Lab Med, Yangsan, South Korea; [Lee, Yeong-Seon] Korea Natl Inst Hlth, Ctr Infect Dis, Osong, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Pusan National University; Pusan National University Hospital; Chonnam National University; Daegu Fatima Hospital; Ajou University; Pusan National University; Pusan National University Hospital; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Kim, HB (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	hbkimmd@snu.ac.kr; mdohmd@snu.ac.kr	Bin Kim, Hong/J-5452-2012	Bin Kim, Hong/0000-0001-6262-372X; Oh, Myoung-don/0000-0002-2344-7695; Choe, Pyoeng Gyun/0000-0001-6794-7918; Song, Kyoung-Ho/0000-0002-4517-3840; Lee, Shinwon/0000-0001-7652-7093; Kim, Nak-Hyun/0000-0003-1134-1364	Korea Centers for Disease Control and Prevention [2012-E44003-00]	Korea Centers for Disease Control and Prevention	This work was supported by a grant (2012-E44003-00) from the Korea Centers for Disease Control and Prevention, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Buck JM, 2005, EMERG INFECT DIS, V11, P1532, DOI 10.3201/eid1110.050141; Charlebois ED, 2004, CLIN INFECT DIS, V39, P47, DOI 10.1086/421090; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SY, 2012, EUR J CLIN MICROBIOL, V31, P2727, DOI 10.1007/s10096-012-1621-y; Chi Chih-Yu, 2004, J Microbiol Immunol Infect, V37, P16; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Cocchi P, 2013, CLIN MICROBIOL INFEC, V19, P1158, DOI 10.1111/1469-0691.12159; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Dukic VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052722; Farr AM, 2012, INFECT CONT HOSP EP, V33, P725, DOI 10.1086/666329; Forstner C, 2013, CLIN MICROBIOL INFEC, V19, pE291, DOI 10.1111/1469-0691.12169; Graffunder EM, 2002, J ANTIMICROB CHEMOTH, V49, P999, DOI 10.1093/jac/dkf009; Joo EJ, 2012, J HOSP INFECT, V81, P149, DOI 10.1016/j.jhin.2012.04.018; Joo EJ, 2012, J ANTIMICROB CHEMOTH, V67, P1755, DOI 10.1093/jac/dks120; Kim ES, 2007, J ANTIMICROB CHEMOTH, V60, P1108, DOI 10.1093/jac/dkm309; Kim ES, 2011, J CLIN MICROBIOL, V49, P1979, DOI 10.1128/JCM.00098-11; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lee M, 2007, INT J AGING HUM DEV, V64, P245, DOI 10.2190/C4U5-078N-R83L-P1MN; Lee SC, 2013, DIAGN MICR INFEC DIS, V76, P86, DOI 10.1016/j.diagmicrobio.2013.01.017; Matlow A, 2012, PEDIATR INFECT DIS J, V31, P814, DOI 10.1097/INF.0b013e31825c48a0; Miller LG, 2007, CLIN INFECT DIS, V44, P471, DOI 10.1086/511033; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Park C, 2007, J CLIN MICROBIOL, V45, P4021, DOI 10.1128/JCM.01147-07; Park SH, 2009, INFECT CONT HOSP EP, V30, P146, DOI 10.1086/593953; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Skiest DJ, 2007, J INFECTION, V54, P427, DOI 10.1016/j.jinf.2006.09.012; Swartz MN, 2004, NEW ENGL J MED, V350, P904, DOI 10.1056/NEJMcp031807; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Warren DK, 2006, INFECT CONT HOSP EP, V27, P1032, DOI 10.1086/507919; Washio M, 1997, PUBLIC HEALTH, V111, P187, DOI 10.1016/S0033-3506(97)00581-7; Weber SG, 2003, EMERG INFECT DIS, V9, P1415, DOI 10.3201/eid0911.030284; Wooten DA, 2013, RESP MED, V107, P1266, DOI 10.1016/j.rmed.2013.05.006	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114127	10.1371/journal.pone.0114127	http://dx.doi.org/10.1371/journal.pone.0114127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485895	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600043
J	Liaw, YW; Lin, CY; Lai, YS; Yang, TC; Wang, CJ; Whang-Peng, J; Liu, LF; Lin, CP; Nieh, S; Lu, SC; Hwang, JL				Liaw, Yi-Wei; Lin, Chi-Yu; Lai, Yu-Sheng; Yang, Tzu-Chung; Wang, Chau-Jong; Whang-Peng, Jacqueline; Liu, Leroy F.; Lin, Chia-Po; Nieh, Shin; Lu, Shao-Chun; Hwang, Jaulang			A Vaccine Targeted at CETP Alleviates High Fat and High Cholesterol Diet-Induced Atherosclerosis and Non-Alcoholic Steatohepatitis in Rabbit	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CORONARY-HEART-DISEASE; LIVER-DISEASE; CARDIOVASCULAR RISK; INHIBITION; METABOLISM; FC; INFLAMMATION	Low HDL-C levels are associated with atherosclerosis and non-alcoholic steatohepatitis, and increased levels may reduce the risk of these diseases. Inhibition of cholesteryl ester transfer protein (CETP) activity is considered a promising strategy for increasing HDL-C levels. Since CETP is a self-antigen with low immunogenicity, we developed a novel CETP vaccine (Fc-CETP6) to overcome the low immunogenicity of CETP and for long-term inhibition of CETP activity. The vaccine consists of a rabbit IgG Fc domain for antigen delivery to antigen-presenting cells fused to a linear array of 6 repeats of a CETP epitope to efficiently activate B cells. Rabbits were fed a high fat/cholesterol (HFC) diet to induce atherosclerosis and NASH, and immunized with Fc-CETP6 vaccine. The Fc-CETP6 vaccine successfully elicited anti-CETP antibodies and lowered plasma CETP activity. The levels of plasma HDL-C and ApoA-I were higher, and plasma ox-LDL lower, in the Fc-CETP6-immunized rabbits as compared to the unimmunized HFC diet-fed rabbits. Pathological analyses revealed less lipid accumulation and inflammation in the aorta and liver of the Fc-CETP6-immunized rabbits. These results show that the Fc-CETP6 vaccine efficiently elicited antibodies against CETP and reduced susceptibility to both atherosclerosis and steatohepatitis induced by the HFC diet. Our findings suggest that the Fc-CETP6 vaccine may improve atherosclerosis and NASH and has high potential for clinical use.	[Liaw, Yi-Wei; Hwang, Jaulang] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Lai, Yu-Sheng; Yang, Tzu-Chung; Lu, Shao-Chun] Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan; [Lin, Chi-Yu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Whang-Peng, Jacqueline] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Lin, Chia-Po] Bur Food & Drug Anal, Dept Hlth, Div Drug Biol, Taipei, Taiwan; [Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Liaw, Yi-Wei; Lin, Chi-Yu; Hwang, Jaulang] Taipei Med Univ, Coll Med, Dept Biochem, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Defense Medical Center; Chung Shan Medical University; Taipei Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Defense Medical Center; Taipei Medical University	Lu, SC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan.	lsc@ntu.edu.tw; jaulangh@TMU.edu.tw		Liu, Leroy/0000-0001-9396-763X	National Health Research Institutes of Taiwan [NHRI-EX101-10153SI, NHRI-EX102-10153SI]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This study was supported by research grants NHRI-EX101-10153SI (http://goo.gl/bx7Wul) and NHRI-EX102-10153SI (http://goo.gl/w3824A) from the National Health Research Institutes of Taiwan. Dr. Shao-Chun Lu and Dr. Jaulang Hwang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Barter PJ, 2012, J LIPID RES, V53, P1755, DOI 10.1194/jlr.R024075; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; BLAKE WL, 1994, BIOCHEM BIOPH RES CO, V205, P1257, DOI 10.1006/bbrc.1994.2800; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Brousseau ME, 2009, J LIPID RES, V50, P1456, DOI 10.1194/jlr.P800037-JLR200; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Buyssens N, 1996, HEPATOLOGY, V24, P939; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Chang PY, 2004, J LIPID RES, V45, P2116, DOI 10.1194/jlr.M400229-JLR200; Cheng AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033917; Chiang HL, 2012, VACCINE, V30, P7573, DOI 10.1016/j.vaccine.2012.10.041; Clark RW, 2006, J LIPID RES, V47, P537, DOI 10.1194/jlr.M500349-JLR200; Davidson MH, 2003, ATHEROSCLEROSIS, V169, P113, DOI 10.1016/S0021-9150(03)00137-0; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOSSELIN EJ, 1992, J IMMUNOL, V149, P3477; Honey K, 2007, J CLIN INVEST, V117, P282, DOI 10.1172/JCI31253; Hsu CT, 2000, CANCER RES, V60, P3701; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lucero D, 2011, CLIN CHIM ACTA, V412, P587, DOI 10.1016/j.cca.2010.12.012; Musunuru K, 2010, LIPIDS, V45, P907, DOI 10.1007/s11745-010-3408-1; Navab M, 2005, TRENDS CARDIOVAS MED, V15, P158, DOI 10.1016/j.tcm.2005.05.008; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Nicholls SJ, 2008, CIRCULATION, V118, P2506, DOI 10.1161/CIRCULATIONAHA.108.790733; Ogawa T, 2010, AM J PATHOL, V177, P153, DOI 10.2353/ajpath.2010.090895; Ota H, 2006, J VET MED SCI, V68, P1179, DOI 10.1292/jvms.68.1179; Patel S, 2010, ATHEROSCLEROSIS, V212, P392, DOI 10.1016/j.atherosclerosis.2010.05.035; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Qi GF, 2004, VACCINE, V22, P3187, DOI 10.1016/j.vaccine.2004.01.060; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Rhainds D, 2012, FUTUR CARDIOL, V8, P513, DOI [10.2217/FCA.12.25, 10.2217/fca.12.25]; Rittershaus CW, 2000, ARTERIOSCL THROM VAS, V20, P2106, DOI 10.1161/01.ATV.20.9.2106; Smith JD, 2010, CURR OPIN INVEST DR, V11, P989; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; TALL AR, 1986, J LIPID RES, V27, P361; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	45	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e111529	10.1371/journal.pone.0111529	http://dx.doi.org/10.1371/journal.pone.0111529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486007	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600006
J	Ogoma, SB; Ngonyani, H; Simfukwe, ET; Mseka, A; Moore, J; Maia, MF; Moore, SJ; Lorenz, LM				Ogoma, Sheila B.; Ngonyani, Hassan; Simfukwe, Emmanuel T.; Mseka, Antony; Moore, Jason; Maia, Marta F.; Moore, Sarah J.; Lorenz, Lena M.			The Mode of Action of Spatial Repellents and Their Impact on Vectorial Capacity of Anopheles gambiae sensu stricto	PLOS ONE			English	Article							MOSQUITOS DIPTERA; ATTRACTION; BEHAVIOR; PROVINCE; INSECTS; RANGE; BAITS; NETS; PUSH	Malaria vector control relies on toxicity of insecticides used in long lasting insecticide treated nets and indoor residual spraying. This is despite evidence that sub-lethal insecticides reduce human-vector contact and malaria transmission. The impact of sub-lethal insecticides on host seeking and blood feeding of mosquitoes was measured. Taxis boxes distinguished between repellency and attraction inhibition of mosquitoes by measuring response of mosquitoes towards or away from Transfluthrin coils and humans. Protective effective distance of coils and long-term effects on blood feeding were measured in the semi-field tunnel and in a Peet Grady chamber. Laboratory reared pyrethroid susceptible Anopheles gambiae sensu stricto mosquitoes were used. In the taxis boxes, a higher proportion of mosquitoes (67%-82%) were activated and flew towards the human in the presence of Transfluthrin coils. Coils did not hinder attraction of mosquitoes to the human. In the semi-field Tunnel, coils placed 0.3 m from the human reduced feeding by 86% (95% CI [0.66; 0.95]) when used as a "bubble'' compared to 65% (95% CI [0.51; 0.76]) when used as a "point source''. Mosquitoes exposed to coils inside a Peet Grady chamber were delayed from feeding normally for 12 hours but there was no effect on free flying and caged mosquitoes exposed in the semi-field tunnel. These findings indicate that airborne pyrethroids minimize human-vector contact through reduced and delayed blood feeding. This information is useful for the development of target product profiles of spatial repellent products that can be used to complement mainstream malaria vector control tools.	[Ogoma, Sheila B.; Ngonyani, Hassan; Simfukwe, Emmanuel T.; Mseka, Antony; Moore, Jason; Maia, Marta F.; Moore, Sarah J.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Bagamoyo, Tanzania; [Ogoma, Sheila B.; Moore, Jason; Lorenz, Lena M.] London Sch Hyg & Trop Med, London WC1, England; [Maia, Marta F.; Moore, Sarah J.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Maia, Marta F.; Moore, Sarah J.] Univ Basel, Basel, Switzerland	Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Ogoma, SB (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Bagamoyo, Tanzania.	sogoma@ihi.or.tz	Moore, Sarah J/HGE-7143-2022; Maia, Marta/I-6003-2019	Moore, Sarah J/0000-0002-0938-6654; Maia, Marta/0000-0003-3302-5610	Bill and Melinda Gates Foundation [51431]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation with the grant number: 51431. The grant was awarded to SJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bernier U.R., 2006, INSECT REPELLENTS PR, P77; Bernier UR, 2005, J MED ENTOMOL, V42, P306, DOI 10.1603/0022-2585(2005)042[0306:COCASR]2.0.CO;2; Bernier UR, 2007, INSECT REPELLENTS PR, P77; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bugoro H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-287; CHADWICK PR, 1975, B ENTOMOL RES, V65, P97, DOI 10.1017/S0007485300005800; Chavasse DC, 1996, T ROY SOC TROP MED H, V90, P493, DOI 10.1016/S0035-9203(96)90291-6; Cohnstaedt LW, 2011, J VECTOR ECOL, V36, P395, DOI 10.1111/j.1948-7134.2011.00180.x; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; dellaTorre A, 1997, GENETICS, V146, P239; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Dickens JC, 2013, PESTICIDE BIOCH PHYS; Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GILLIES MT, 1970, B ENTOMOL RES, V60, P225, DOI 10.1017/S000748530004075X; GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill N, 2007, BMJ-BRIT MED J, V335, P1001; KENNEDY JS, 1947, B ENTOMOL RES, V37, P593, DOI 10.1017/S0007485300030091; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kitau J, 2010, J AM MOSQUITO CONTR, V26, P287, DOI 10.2987/09-5979.1; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; KNOLS BGJ, 1993, MED VET ENTOMOL, V7, P161, DOI 10.1111/j.1365-2915.1993.tb00670.x; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lorenz LM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-131; Lucas JR, 2007, J AM MOSQUITO CONTR, V23, P47, DOI 10.2987/8756-971X(2007)23[47:ULAFTO]2.0.CO;2; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; MILLER JE, 1994, J MED ENTOMOL, V31, P114, DOI 10.1093/jmedent/31.1.114; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; Obermayr U, 2012, J MED ENTOMOL, V49, P1387, DOI 10.1603/ME12084; Ogoma SB, 2012, PARASIT VECTORS; Ogoma SB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-131; Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-287; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; WHOPES, 2009, GUID EFF TEST MOSQ R; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2; Winney R., 1975, Pyrethrum Post, V13, P17	46	42	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e110433	10.1371/journal.pone.0110433	http://dx.doi.org/10.1371/journal.pone.0110433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485850	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000346907600004
J	Fajardo, J; Lessmann, J; Bonaccorso, E; Devenish, C; Munoz, J				Fajardo, Javier; Lessmann, Janeth; Bonaccorso, Elise; Devenish, Christian; Munoz, Jesus			Combined Use of Systematic Conservation Planning, Species Distribution Modelling, and Connectivity Analysis Reveals Severe Conservation Gaps in a Megadiverse Country (Peru)	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; HABITAT AVAILABILITY; RESERVE SELECTION; SAMPLE-SIZE; AREAS; SENSITIVITY; PERFORMANCE; PREDICTION; SOFTWARE; ECUADOR	Conservation planning is crucial for megadiverse countries where biodiversity is coupled with incomplete reserve systems and limited resources to invest in conservation. Using Peru as an example of a megadiverse country, we asked whether the national system of protected areas satisfies biodiversity conservation needs. Further, to complement the existing reserve system, we identified and prioritized potential conservation areas using a combination of species distribution modeling, conservation planning and connectivity analysis. Based on a set of 2,869 species, including mammals, birds, amphibians, reptiles, butterflies, and plants, we used species distribution models to represent species' geographic ranges to reduce the effect of biased sampling and partial knowledge about species' distributions. A site-selection algorithm then searched for efficient and complementary proposals, based on the above distributions, for a more representative system of protection. Finally, we incorporated connectivity among areas in an innovative post-hoc analysis to prioritize those areas maximizing connectivity within the system. Our results highlight severe conservation gaps in the Coastal and Andean regions, and we propose several areas, which are not currently covered by the existing network of protected areas. Our approach helps to find areas that contribute to creating a more representative, connected and efficient network.	[Fajardo, Javier] Univ Extremadura, Ctr Univ Merida, Merida, Spain; [Fajardo, Javier; Munoz, Jesus] Real Jardin Botan RJB CSIC, Madrid, Spain; [Lessmann, Janeth; Bonaccorso, Elise; Munoz, Jesus] Univ Tecnol Indoamer, Ctr Biodiversidad & Cambio Climat, Quito, Ecuador; [Bonaccorso, Elise] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Devenish, Christian] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Manchester M15 6BH, Lancs, England; [Devenish, Christian] Ctr Ornitol & Biodiversidad CORBIDI, Lima, Peru	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Kansas; Manchester Metropolitan University	Fajardo, J (corresponding author), Univ Extremadura, Ctr Univ Merida, Merida, Spain.	javierfajnolla@gmail.com	Munoz, Jesus/B-7809-2008; Lessmann, Janeth/M-1524-2017; Fajardo, Javier/AAG-7278-2020	Lessmann, Janeth/0000-0002-1502-625X; Fajardo, Javier/0000-0002-0990-9718; Devenish, Christian/0000-0002-5249-0844	CRUE-CEPYME; ATECMA; Ministry of Economy and Competitiveness of Spain [CGL2012-38624-C02-02]; Universidad Tecnologica Indoamerica	CRUE-CEPYME; ATECMA; Ministry of Economy and Competitiveness of Spain(Spanish Government); Universidad Tecnologica Indoamerica	CRUE-CEPYME grants with the cooperation of ATECMA funded JF to perform this study. JM is currently supported by grant CGL2012-38624-C02-02 of the Ministry of Economy and Competitiveness of Spain. The involvement of JL and EB was supported by Universidad Tecnologica Indoamerica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Angulo Pratolongo F, 2009, BIRDLIFE CONSERVATIO, V16, P307; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Ardron J. A., 2008, MARXAN GOOD PRACTICE; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Centro de Datos para la Conservacion Universidad Nacional Agraria La Molina The Natural Conservancy, 2006, PLANIFICACION PARA L; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Delgado-Jaramillo M, 2013, THESIS; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J., 2009, SPATIAL CONSERVATION, P70; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Fernandez-Baca J, 2007, PRIORITIES FOR COAST, P45; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Game ET, 2008, MARXAN USER MANUAL F; Gaston KJ, 2003, CONSERV BIOL, V17, P188, DOI 10.1046/j.1523-1739.2003.01268.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2012, IUCN RED LIST THREAT; Jenkins CN, 2013, PNAS, V110, P1; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Lessmann J, 2014, ECOL EVOL, V4, P2410, DOI 10.1002/ece3.1102; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maddock A, 1999, BIODIVERS CONSERV, V8, P603, DOI 10.1023/A:1008819015819; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mateo RG, 2008, THESIS; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Nakandakari A, 2012, THESIS; Noss R.F., 2006, CONNECTIVITY CONSERV, P587, DOI [10.1017/CBO9780511754821.026, DOI 10.1017/CBO9780511754821.026]; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Possingham H. P., 2006, PRINCIPLES BIOL CONS, P507; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Ridgely R. S., 2012, BIRD SPECIES DISTRIB; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez LO, 2000, AMBIO, V29, P329, DOI 10.1639/0044-7447(2000)029[0329:BDOPDP]2.0.CO;2; Rodriguez LO, 1996, DIVERSIDAD BIOLOGICA; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Sanchez-Cordero Victor, 2005, Biodiversity Informatics, V2, P11; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Schulenberg T.S., 2007, BIRDS PERU REVISED U, P18; SERNANP, 2009, PLAN DIRECTOR DE LAS; SERNANP, 2012, LISTADO DE AREAS PRO; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Underwood JG, 2010, CONSERV BIOL, V24, P162, DOI 10.1111/j.1523-1739.2009.01303.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Velazquez-Tibata J, 2012, REGIONAL ENV CHANGE, V13, P14; Veliz Rosas C, 2008, ZONAS ARIDAS, V12, P36; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Whitehouse JF, 1992, IVTH WORLD CONGRESS; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	77	66	71	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114367	10.1371/journal.pone.0114367	http://dx.doi.org/10.1371/journal.pone.0114367			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479411	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200079
J	Hamaoka, BY; Ghosh, P				Hamaoka, Brent Y.; Ghosh, Partho			Structure of the Essential Plasmodium Host Cell Traversal Protein SPECT1	PLOS ONE			English	Article							HELIX-HELIX PACKING; MEMBRANE-ATTACK; SPOROZOITE; BINDING; FAMILY; DOMAIN	Host cell traversal by Plasmodium, the protozoan cause of malaria, is an essential part of this parasite's virulence. In this process, the parasite enters a host cell through a parasite-induced pore, traverses the host cell, and then exits the host cell. Two P. berghei proteins, SPECT1 and SPECT2, are required for host cell traversal by the sporozoite form of the parasite. In the absence of either, no pore formation is observed. While SPECT2 has sequence homology to pore-forming proteins, SPECT1 has no homology to proteins of known structure or function. Here we present the 2.75 angstrom resolution structure of a slightly truncated version of P. berghei SPECT1. The structure reveals that the protein forms a four-helix bundle, with the rare feature of having all of these helices in parallel or antiparallel alignment. Also notable is the presence of a large, conserved, hydrophobic internal cavity in the protein, which may constitute a ligand-binding site or be indicative of partial instability in SPECT1, or both. The structure of SPECT1 will make possible targeted mutagenesis experiments aimed at understanding its mechanism of action in host cell traversal.	[Hamaoka, Brent Y.; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu			National Institutes of Health (NIH) [T32 CA0092523]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) T32 CA0092523 (BYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Bowie JU, 1997, NAT STRUCT BIOL, V4, P915, DOI 10.1038/nsb1197-915; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FENG YQ, 1991, BIOCHEMISTRY-US, V30, P10150, DOI 10.1021/bi00106a011; FENG YQ, 1994, NAT STRUCT BIOL, V1, P30, DOI 10.1038/nsb0194-30; Formaglio P, 2014, PARASITOL INT, V63, P237, DOI 10.1016/j.parint.2013.07.009; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Garg S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2725; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; KAMTEKAR S, 1995, FASEB J, V9, P1013, DOI 10.1096/fasebj.9.11.7649401; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEDERER F, 1981, J MOL BIOL, V148, P427, DOI 10.1016/0022-2836(81)90185-6; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Mali Sonja, 2008, Morbidity and Mortality Weekly Report, V57, P24; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; Otwinowski Z, METHODS ENZYMOLOGY, P307; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Tavares J, 2013, J EXP MED, V210, P905, DOI 10.1084/jem.20121130; VANDERBERG JP, 1990, J PROTOZOOL, V37, P528, DOI 10.1111/j.1550-7408.1990.tb01260.x; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Walther D, 1998, PROTEINS, V33, P457, DOI 10.1002/(SICI)1097-0134(19981201)33:4<457::AID-PROT1>3.0.CO;2-L; Walther D, 1996, J MOL BIOL, V255, P536, DOI 10.1006/jmbi.1996.0044; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114685	10.1371/journal.pone.0114685	http://dx.doi.org/10.1371/journal.pone.0114685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479287	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200111
J	Shioji, S; Imai, S; Ando, K; Kumagai, K; Matsusue, Y				Shioji, Suguru; Imai, Shinji; Ando, Kosei; Kumagai, Kousuke; Matsusue, Yoshitaka			Extracellular and Intracellular Mechanisms of Mechanotransduction in Three-Dimensionally Embedded Rat Chondrocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN ARTICULAR CHONDROCYTES; COLLAGEN-INDUCED ARTHRITIS; N-TERMINAL KINASE; GENE-EXPRESSION; PROTEOGLYCAN SYNTHESIS; CARTILAGE DESTRUCTION; UP-REGULATION; ATDC5 CELLS; IN-VIVO	Purpose: Articular cartilage homeostasis involves modulation of chondrocyte matrix synthesis in response to mechanical stress (MS). We studied extracellular and intracellular mechanotransduction pathways mediating this response. Methods: We first confirmed rapid up-regulation of the putative chondro-protective cytokine, interleukin (IL)-4, as an immediate response to MS. We then studied the role of IL-4 by investigating responses to exogenous IL-4 or a specific IL-4 inhibitor, combined with MS. Next we investigated the intracellular second messengers. Since chondrocyte phenotype alters according to the extracellular environment, we characterized the response to mechanotransduction in 3-dimensionally embedded chondrocytes. Results: Expression of aggrecan and type II collagen was significantly up-regulated by exogenous IL-4 whereas MS-induced matrix synthesis was inhibited by an IL-4 blocker. Further, MS-induced matrix synthesis was completely blocked by a p38 MAPK inhibitor, while it was only partially blocked by inhibitors of other putative second messengers. Conclusion: IL-4 mediates an extracellular pathway of mechanotransduction, perhaps via an autocrine/paracrine loop, while p38 mediates an intracellular pathway prevalent only in a 3-dimensional environment.	[Shioji, Suguru; Imai, Shinji; Ando, Kosei; Kumagai, Kousuke; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science	Shioji, S (corresponding author), Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 52021, Japan.	sshioji@bella.shiga-med.acjp			Japan Society for the Promotion of Science [22500457]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#22500457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2009, ACTA ORTHOP, V80, P724, DOI 10.3109/17453670903413111; Badger AM, 1998, J IMMUNOL, V161, P467; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bobick BE, 2006, EXP CELL RES, V312, P1079, DOI 10.1016/j.yexcr.2005.12.028; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chai DH, 2010, OSTEOARTHR CARTILAGE, V18, P249, DOI 10.1016/j.joca.2009.09.002; Chaipinyo K, 2004, J ORTHOP RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Eckstein F, 1999, ANAT EMBRYOL, V200, P419, DOI 10.1007/s004290050291; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Joosten LAB, 1997, ARTHRITIS RHEUM, V40, P249, DOI 10.1002/art.1780400209; Jorgensen C, 1998, IMMUNOLOGY, V93, P518; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kong DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069403; KORVER THV, 1992, J RHEUMATOL, V19, P905; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Lubberts E, 1999, J IMMUNOL, V163, P4546; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Millward-Sadler SJ, 2006, OSTEOARTHR CARTILAGE, V14, P991, DOI 10.1016/j.joca.2006.03.013; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x; Rai MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025749; Ridley SH, 1997, J IMMUNOL, V158, P3165; Saito T, 2013, OSTEOARTHR CARTILAGE, V21, P165, DOI 10.1016/j.joca.2012.09.003; Salter DM, 2001, CLIN ORTHOP RELAT R, pS49; Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.3.CO;2-B; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou Y, 2007, OSTEOARTHR CARTILAGE, V15, P884, DOI 10.1016/j.joca.2007.02.001	39	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114327	10.1371/journal.pone.0114327	http://dx.doi.org/10.1371/journal.pone.0114327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479057	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200073
J	Elvira-Recuenco, M; Iturritxa, E; Majada, J; Alia, R; Raposo, R				Elvira-Recuenco, Margarita; Iturritxa, Eugenia; Majada, Juan; Alia, Ricardo; Raposo, Rosa			Adaptive Potential of Maritime Pine (Pinus pinaster) Populations to the Emerging Pitch Canker Pathogen, Fusarium circinatum	PLOS ONE			English	Article							DISEASE RESISTANCE; GENETIC-VARIATION; 1ST REPORT; SUBGLUTINANS; TOLERANCE; RESPONSES; THREAT; SPP.; DIFFERENTIATION; SUSCEPTIBILITY	There is a concern on how emerging pests and diseases will affect the distribution range and adaptability of their host species, especially due to different conditions derived from climate change and growing globalization. Fusarium circinatum, which causes pitch canker disease in Pinus species, is an exotic pathogen of recent introduction in Spain that threatens its maritime pine (P. pinaster) stands. To predict the impact this disease will have on the species, we examine host resistance traits and their genetic architecture. Resistance phenotyping was done in a clonal provenance/progeny trial, using three-year-old cuttings artificially inoculated with the pathogen and maintained under controlled environmental conditions. A total number of 670 ramets were assessed, distributed in 10 populations, with a total of 47 families, 2 to 5 half-sibs per family, and 3-7 ramets per clone. High genetic variation was found at the three hierarchical levels studied: population, family and clone, being both additive and non-additive effects important. Narrow-sense and broad-sense heritability estimates were relatively high, with respective values of 0.43-0.58 and 0.51-0.8, depending on the resistance traits measured (lesion length, lesion length rate, time to wilting, and survival). These values suggest the species' high capacity of evolutionary response to the F. circinatum pathogen. A population originated in Northern Spain was the most resistant, while another from Morocco was the most susceptible. The total number of plants that did not show lesion development or presented a small lesion (length, 30 mm) was 224 out of 670, indicating a high proportion of resistant trees in the offspring within the analyzed populations. We found large differences among populations and considerable genetic variation within populations, which should allow, through natural or artificial selection, the successful adaptation of maritime pine to pitch canker disease.	[Elvira-Recuenco, Margarita; Raposo, Rosa] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr CIFOR, Silviculture & Forest Management Dept, Madrid, Spain; [Iturritxa, Eugenia] Inst Vasco Invest & Desarrollo Agr NEIKER, Vitoria, Spain; [Majada, Juan] Forest & Wood Technol Res Ctr CETEMAS, Principado De Asturias, Spain; [Alia, Ricardo] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr CIFOR, Forest Ecol & Genet Dept, Madrid, Spain; [Alia, Ricardo] Sustainable Forest Management Res Inst, Palencia, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Raposo, R (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr CIFOR, Silviculture & Forest Management Dept, Madrid, Spain.	raposo@inia.es	, Eugenia/AAT-7521-2020; Elvira-Recuenco, Margarita/G-9977-2012; Majada, Juan/AAZ-2999-2021; Raposo, Rosa/A-3185-2012; Alia, Ricardo/B-5160-2011	Elvira-Recuenco, Margarita/0000-0001-6749-3346; Raposo, Rosa/0000-0002-4893-6874; Alia, Ricardo/0000-0002-9426-0967; Iturritxa, Eugenia/0000-0002-6390-5873	Ministerio de Economia y Competitividad [RTA 2012-00015, RTA2010-00120-C02]	Ministerio de Economia y Competitividad(Spanish Government)	This research was supported by Projects RTA 2012-00015 and RTA2010-00120-C02, Ministerio de Economia y Competitividad (Subprograma de Proyectos de I+D orientado a los Recursos y Tecnologias Agrarias en coordinacion con las Comunidades Autonomas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H. M., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P326; Aranda I, 2010, TREE GENET GENOMES, V6, P169, DOI 10.1007/s11295-009-0238-5; Baker R, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1620; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Baradat P, 1997, ANN SCI FOREST, V54, P83, DOI 10.1051/forest:19970107; BARROWSBROADDUS J, 1983, PHYTOPATHOLOGY, V73, P882, DOI 10.1094/Phyto-73-882; BARROWSBROADDUS J, 1984, PHYTOPATHOLOGY, V74, P438, DOI 10.1094/Phyto-74-438; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; Braganca H, 2009, PLANT DIS, V93, P1079, DOI 10.1094/PDIS-93-10-1079A; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2004, PLANT PATHOL, V53, P804, DOI 10.1111/j.1365-3059.2004.01079.x; Brown JKM, 2013, PLANT PATHOL, V62, P83, DOI 10.1111/ppa.12163; Burdon JJ, 2013, CURR OPIN PLANT BIOL, V16, P400, DOI 10.1016/j.pbi.2013.05.003; Burdon RD, 2001, CAN J FOREST RES, V31, P596, DOI 10.1139/cjfr-31-4-596; Carlucci A, 2007, PLANT DIS, V91, P1683, DOI 10.1094/PDIS-91-12-1683C; Chornesky EA, 2005, BIOSCIENCE, V55, P335, DOI 10.1641/0006-3568(2005)055[0335:SPFRTT]2.0.CO;2; Clarke D. D., 1986, Advances in Plant Pathology Volume 5., P161; CORRELL JC, 1991, PLANT DIS, V75, P676, DOI 10.1094/PD-75-0751A; Desprez-Loustau ML, 2006, ANN FOREST SCI, V63, P597, DOI 10.1051/forest:2006040; Dvorak WS, 2007, SOUTH HEMISPH FOR J, V69, P125, DOI 10.2989/SHFJ.2007.69.3.1.351; EPPO (European and Mediterranean Plant Protection Organization), 2006, 1 REP GIBB CIRC FRAN; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Falconer D. S., 1996, INTRO QUANTITATIVE G; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Ganley RJ, 2009, CAN J FOREST RES, V39, P2246, DOI 10.1139/X09-131; Garbelotto M, 2012, EUR J PLANT PATHOL, V133, P101, DOI 10.1007/s10658-011-9928-6; Gaspar MJ, 2013, PLOS ONE, P8; GIBBS JN, 1978, ANNU REV PHYTOPATHOL, V16, P287, DOI 10.1146/annurev.py.16.090178.001443; Gilmour A.R., 2012, ASREML USER GUIDE RE; Gonzalez-Martinez SC, 2004, FOREST ECOL MANAG, V197, P103, DOI 10.1016/j.foreco.2004.05.008; Gordon TR, 2011, FOREST PATHOL, V41, P227, DOI 10.1111/j.1439-0329.2010.00678.x; Gordon TR, 1998, HORTSCIENCE, V33, P868, DOI 10.21273/HORTSCI.33.5.868; Gordon TR, 2001, PLANT DIS, V85, P1128, DOI 10.1094/PDIS.2001.85.11.1128; Griffin GJ, 2000, J FOREST, V98, P22; Grivet D, 2011, MOL BIOL EVOL, V28, P101, DOI 10.1093/molbev/msq190; Hamilton MG, 2013, HEREDITY, V110, P372, DOI 10.1038/hdy.2012.106; Hodge GR, 2000, NEW FOREST, V19, P241, DOI 10.1023/A:1006613021996; Iturritxa E, 2013, FOREST PATHOL, V43, P488, DOI 10.1111/efp.12061; Iturritxa E, 2012, AUSTRALAS PLANT PATH, V41, P601, DOI 10.1007/s13313-012-0160-4; Iturritxa E, 2014, PLANT PATHO IN PRESS; Iturritxa E, 2011, FUNGAL BIOL-UK, V115, P288, DOI 10.1016/j.funbio.2010.12.014; Kayihan GC, 2005, THEOR APPL GENET, V110, P948, DOI 10.1007/s00122-004-1915-2; Kim KW, 2010, PLANT PATHOLOGY J, V26, P394, DOI 10.5423/PPJ.2010.26.4.394; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Lamy J-B, 2011, PLOS ONE, P6; Landeras E, 2005, PLANT DIS, V89, P1015, DOI 10.1094/PD-89-1015A; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Majada J, 2011, NEW FOREST, V41, P399, DOI 10.1007/s11056-010-9232-x; Martin-Rodrigues N, 2013, NEW PHYTOL, V198, P1215, DOI 10.1111/nph.12222; Martinez-Alonso C, 2012, NEW FOREST, V43, P651, DOI 10.1007/s11056-012-9333-9; Matheson A. C., 2006, Australian Forestry, V69, P101; McKinney LV, 2011, HEREDITY, V106, P788, DOI 10.1038/hdy.2010.119; Mitchell RG, 2012, NEW FOREST, V43, P473, DOI 10.1007/s11056-011-9293-5; Ouellette G, 2008, FOREST SYSTEMS, V13, P119; Pautasso M, 2012, EUR J PLANT PATHOL, V133, P295, DOI 10.1007/s10658-012-9936-1; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Perez-Sierra A, 2007, MYCOL RES, V111, P832, DOI 10.1016/j.mycres.2007.05.009; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Roux J, 2007, NEW FOREST, V33, P109, DOI 10.1007/s11056-006-9017-4; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; SAS, 2008, SAS US GUID; SCHOENEWEISS DF, 1975, ANNU REV PHYTOPATHOL, V13, P193, DOI 10.1146/annurev.py.13.090175.001205; Sokal R.R., 2012, BIOMETRY; Sorte CJB, 2013, ECOL LETT, V16, P261, DOI 10.1111/ele.12017; Stenlid J, 2011, FORESTS, V2, P486, DOI 10.3390/f2020486; Storer AJ, 1998, PLANT PATHOL, V47, P649, DOI 10.1046/j.1365-3059.1998.00288.x; Swei A, 2011, OECOLOGIA, V166, P91, DOI 10.1007/s00442-010-1796-9; Vivas M, 2012, FORESTRY, V85, P185, DOI 10.1093/forestry/cpr055; Wingfield MJ, 2008, AUSTRALAS PLANT PATH, V37, P319, DOI 10.1071/AP08036; Zas R, 2011, J ECOL, V99, P1316, DOI 10.1111/j.1365-2745.2011.01872.x	72	26	26	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114971	10.1371/journal.pone.0114971	http://dx.doi.org/10.1371/journal.pone.0114971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500822	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700078
J	Heng, DY; Signorovitch, J; Swallow, E; Li, NX; Zhong, YC; Qin, PG; Zhuo, DY; Wang, XF; Park, J; Stergiopoulos, S; Kollmannsberger, C				Heng, Daniel Y.; Signorovitch, James; Swallow, Elyse; Li, Nanxin; Zhong, Yichen; Qin, Paige; Zhuo, Daisy Y.; Wang, Xufang; Park, Jinhee; Stergiopoulos, Sotirios; Kollmannsberger, Christian			Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies	PLOS ONE			English	Article							SORAFENIB; SUNITINIB; EFFICACY; FAILURE	Objective: The optimal sequencing of targeted therapies for metastatic renal cell carcinoma (mRCC) is unknown. Observational studies with a variety of designs have reported differing results. The objective of this study is to systematically summarize and interpret the published real-world evidence comparing sequential treatment for mRCC. Methods: A search was conducted in Medline and Embase (2009-2013), and conference proceedings from American Society of Clinical Oncology (ASCO), ASCO Genitourinary Cancers Symposium (ASCO-GU), and European Society for Medical Oncology (ESMO) (2011-2013). We systematically reviewed observational studies comparing second-line mRCC treatment with mammalian target of rapamycin inhibitors (mTORi) versus vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKI). Studies were evaluated for 1) use of a retrospective cohort design after initiation of second-line therapy, 2) adjustment for patient characteristics, and 3) use of data from multiple centers. Meta-analyses were conducted for comparisons of overall survival (OS) and progression-free survival (PFS). Results: Ten studies reported OS and exhibited significant heterogeneity in estimated second-line treatment effects (I-2=68%; P=0.001). Four of these were adjusted, multicenter, retrospective cohort studies, and these showed no evidence of heterogeneity (I-2=0%; P=0.61) and a significant association between second-line mTORi (>75% everolimus) and longer OS compared to VEGF TKI (>60% sorafenib) (HR=0.82, 95% CI: 0.68 to 0.98) in a meta-analysis. Seven studies comparing PFS showed significant heterogeneity overall and among the adjusted, multicenter, retrospective cohort studies. Real-world observational data for axitinib outcomes was limited at the time of this study. Conclusions: Real-world studies employed different designs and reported heterogeneous results comparing the effectiveness of second-line mTORi and VEGF TKI in the treatment of mRCC. Within the subset of adjusted, multicenter observational studies, second-line use of mTORi was associated with significantly prolonged survival compared with second-line use of VEGF TKI.	[Heng, Daniel Y.] Univ Calgary, Alberta Hlth Serv Canc Care, Tom Baker Canc Ctr, Dept Med Oncol, Calgary, AB, Canada; [Signorovitch, James; Swallow, Elyse; Li, Nanxin; Zhong, Yichen; Qin, Paige; Zhuo, Daisy Y.] Anal Grp Inc, Boston, MA USA; [Wang, Xufang; Park, Jinhee; Stergiopoulos, Sotirios] Novartis Pharmaceut, E Hanover, NJ USA; [Kollmannsberger, Christian] British Columbia Canc Agcy, Dept Oncol, Vancouver, BC V5Z 4E6, Canada	Alberta Health Services (AHS); Tom Baker Cancer Clinic; University of Calgary; Analysis Group Inc.; Novartis; British Columbia Cancer Agency	Kollmannsberger, C (corresponding author), British Columbia Canc Agcy, Dept Oncol, Vancouver, BC V5Z 4E6, Canada.	ckollmannsberger@bccancer.bc.ca	Zhong, Yichen/AAQ-5282-2020	Zhong, Yichen/0000-0002-1560-3643	Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals Corporation(Novartis)	Novartis Pharmaceuticals Corporation provided financial support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors XW, JP, and SS, but did not have anyadditional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Busch J, 2013, EUR UROL, V64, P62, DOI 10.1016/j.eururo.2012.09.004; Busch J, 2011, EUR UROL, V60, P1163, DOI 10.1016/j.eururo.2011.07.037; Cancer Research UK, 2013, KIDN CANC INC STAT; Chen CC, 2012, CLIN GENITOURIN CANC, V10, P256, DOI 10.1016/j.clgc.2012.04.006; Egger M, 1998, BRIT MED J, V316, P140; Elaidi RT, 2013, ESMO M; Elwood M., 2007, CRITICAL APPRAISAL E, V3rd; Gore ME, 2013, ESMO M; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Harrison MR, 2012, ASCO M, V30, P406; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Heng DYC, 2012, ASCO M, V30, P387; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Iacovelli R, 2013, EUR J CANC; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Lam JS, 2005, WORLD J UROL, V23, P202, DOI 10.1007/s00345-004-0466-0; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Meinert CL, 2012, CLIN TRIALS DESIGN C; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&REG;), 2014, NCCN CLIN PRACT GUID; Park K, 2012, MED ONCOL, V29, P3291, DOI 10.1007/s12032-012-0227-7; R Core Team, 2021, R LANGUAGE ENV STAT; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Ruiz AL, 2013, ESMO M; Signorovitch JE, 2013, ASCO M, V31; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wong MK, 2013, CURR MED RES OPIN	29	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114264	10.1371/journal.pone.0114264	http://dx.doi.org/10.1371/journal.pone.0114264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493562	Green Published, gold			2022-12-27	WOS:000346611400039
J	Opatova, V; Arnedo, MA				Opatova, Vera; Arnedo, Miquel A.			Spiders on a Hot Volcanic Roof: Colonisation Pathways and Phylogeography of the Canary Islands Endemic Trap-Door Spider Titanidiops canariensis (Araneae, Idiopidae)	PLOS ONE			English	Article							WOODLOUSE-HUNTER SPIDERS; GENUS DYSDERA ARANEAE; BAYESIAN SPECIES DELIMITATION; HAPLOTYPE RECONSTRUCTION; MOLECULAR PHYLOGENETICS; POPULATION SUBDIVISION; DIVERGENCE TIMES; DNA-SEQUENCES; NORTH-AFRICA; MITOCHONDRIAL	Studies conducted on volcanic islands have greatly contributed to our current understanding of how organisms diversify. The Canary Islands archipelago, located northwest of the coast of northern Africa, harbours a large number of endemic taxa. Because of their low vagility, mygalomorph spiders are usually absent from oceanic islands. The spider Titanidiops canariensis, which inhabits the easternmost islands of the archipelago, constitutes an exception to this rule. Here, we use a multi-locus approach that combines three mitochondrial and four nuclear genes to investigate the origins and phylogeography of this remarkable trap-door spider. We provide a timeframe for the colonisation of the Canary Islands using two alternative approaches: concatenation and species tree inference in a Bayesian relaxed clock framework. Additionally, we investigate the existence of cryptic species on the islands by means of a Bayesian multi-locus species delimitation method. Our results indicate that T. canariensis colonised the Canary Islands once, most likely during the Miocene, although discrepancies between the timeframes from different approaches make the exact timing uncertain. A complex evolutionary history for the species in the archipelago is revealed, which involves two independent colonisations of Fuerteventura from the ancestral range of T. canariensis in northern Lanzarote and a possible back colonisation of southern Lanzarote. The data further corroborate a previously proposed volcanic refugium, highlighting the impact of the dynamic volcanic history of the island on the phylogeographic patterns of the endemic taxa. T. canariensis includes at least two different species, one inhabiting the Jandia peninsula and central Fuerteventura and one spanning from central Fuerteventura to Lanzarote. Our data suggest that the extant northern African Titanidiops lineages may have expanded to the region after the islands were colonised and, hence, are not the source of colonisation. In addition, T. maroccanus may harbour several cryptic species.	[Opatova, Vera] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; Univ Barcelona, Dept Biol Anim, Barcelona, Spain	University of Barcelona; University of Barcelona	Opatova, V (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain.	Vera.Opatova@gmail.com	Arnedo, Miquel/E-9086-2011; Opatova, Vera/F-3427-2019	Arnedo, Miquel/0000-0003-1402-4727; Opatova, Vera/0000-0002-4324-1344	Spanish Ministry of Science and Innovation (MICINN) [CGL 2009-07639, CGL2012-36863]; Generalitat de Catalunya [2009SGR1462]; ICREA Academia award from the Generalitat de Catalunya;  [AP 2008-01841]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia award from the Generalitat de Catalunya(ICREA); 	This project was funded by Spanish Ministry of Science and Innovation (MICINN) grants CGL 2009-07639 and CGL2012-36863 (both to MA) and additional financial support was provided by project 2009SGR1462 from the Generalitat de Catalunya. VO was supported by a graduate grant (AP 2008-01841). MA was further supported by an ICREA Academia award for excellence in research from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Ancochea E, 1996, J VOLCANOL GEOTH RES, V70, P183, DOI 10.1016/0377-0273(95)00051-8; Andrus N, 2004, TAXON, V53, P333, DOI 10.2307/4135612; [Anonymous], 2021, SPLITS SPECIES LIMIT; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Arnedo MA, 2000, J ARACHNOL, V28, P261, DOI 10.1636/0161-8202(2000)028[0261:SOTGDA]2.0.CO;2; Arnedo MA, 2001, CLADISTICS, V17, P313, DOI 10.1111/j.1096-0031.2001.tb00129.x; Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Baele G, 2012, MOL BIOL EVOLUTION; Bidegaray-Batista L, 2011, BMC EVOLUTIONARY BIO, V11, P317; Bidegaray-Batista L, 2007, MOL ECOL, V16, P3198, DOI 10.1111/j.1365-294X.2007.03351.x; Bloor P, 2008, MOL ECOL, V17, P854, DOI 10.1111/j.1365-294X.2007.03575.x; Bond JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038753; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; BORCHSENIUS F, 2009, FASTGAP 1 2; Brown RM, 2012, MOL PHYLOGENET EVOL, V65, P351, DOI 10.1016/j.ympev.2012.06.009; Brown RP, 2010, SYST BIOL, V59, P119, DOI 10.1093/sysbio/syp082; Burbrink FT, 2011, EVOLUTION, V65, P1851, DOI 10.1111/j.1558-5646.2011.01260.x; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carracedo J. C., 2003, ESTUD GEOL-MADRID, V59, P277, DOI DOI 10.3989/EGEOL.03595-6104; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; Carracedo JC., 1993, REV ACAD CANARIA CIE, V4, P25; Carracedo JC, 2002, CANARY ISLANDS; Carranza S, 2002, MOL PHYLOGENET EVOL, V23, P244, DOI 10.1016/S1055-7903(02)00024-6; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Churchill Tracey B., 1992, Memoirs of the Queensland Museum, V32, P9; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Cox SC, 2010, MOL PHYLOGENET EVOL, V56, P747, DOI 10.1016/j.ympev.2010.03.020; COYLE FA, 1985, J ARACHNOL, V13, P137; COYLE FA, 1985, J ARACHNOL, V13, P291; Decae A.E., 1996, Bulletin of the British Arachnological Society, V10, P161; Dimitrov D, 2008, MOL PHYLOGENET EVOL, V48, P596, DOI 10.1016/j.ympev.2008.04.027; Drummond A.J., 2012, MOL BIOL EVOLUTION; Drummond A. J., 2010, GENEIOUS V 5 3; Eberhard WG, 2006, J ARACHNOL, V34, P254, DOI 10.1636/S03-54.1; Edwards SV, 2000, EVOLUTION, V54, P1839; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Emerson BC, 2000, EVOLUTION, V54, P2081, DOI 10.1111/j.0014-3820.2000.tb01251.x; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujita MK, 2012, TRENDS ECOLOGY EVOLU; Giribet G, 1999, MOL PHYLOGENET EVOL, V11, P296, DOI 10.1006/mpev.1998.0583; Gonzalez A.R., 2012, GEOL TODAY, P53, DOI DOI 10.1111/j.1365-2451.2012.00827.x; Greve C, 2010, MOL PHYLOGE IN PRESS; Griffin DL, 2002, PALAEOGEOGR PALAEOCL, V182, P65, DOI 10.1016/S0031-0182(01)00453-9; Hamilton CA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020156, 10.1371/journal.pone.0026207]; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2013, MOL ECOL, V22, P508, DOI 10.1111/mec.12130; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P386, DOI 10.1006/mpev.2000.0883; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Ibanez JM, 2012, GEOPHYS J INT, V191, P659, DOI 10.1111/j.1365-246X.2012.05629.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Jennings WB, 2005, EVOLUTION, V59, P2033; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kekkonen M, 2014, MOL ECOL RESOUR; Kohler CM, 2010, PALAEOGEOGR PALAEOCL, V285, P66, DOI 10.1016/j.palaeo.2009.10.025; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macias-Hernandez N, 2008, BIOL J LINN SOC, V94, P589, DOI 10.1111/j.1095-8312.2008.01007.x; Macias-Hernandez N, 2013, J HERED, V104, P341, DOI 10.1093/jhered/est008; Macias-Hernandez N, 2013, J ZOOL SYST EVOL RES, V51, P29, DOI 10.1111/jzs.12008; Macias-Hernandez N, 2010, SYST BIODIVERS, V8, P531, DOI 10.1080/14772000.2010.535865; Marino IAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028567; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; McGuire G, 2000, J COMPUT BIOL, V7, P159, DOI 10.1089/10665270050081432; Meco J., 2008, HIST GEOLOGICA CLIMA; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nogales M, 1998, J EVOLUTION BIOL, V11, P481, DOI 10.1007/s000360050101; Opatova V, 2014, INVERTEBR SYST, V28, P361, DOI 10.1071/IS14004; Opatova V, 2013, MOL PHYLOGENET EVOL, V69, P1135, DOI 10.1016/j.ympev.2013.08.002; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Packert M, 2013, MOL PHYLOGENET EVOL, V67, P458, DOI 10.1016/j.ympev.2013.02.010; Paez-Moscoso DJ, 2012, MOL PHYLOGENET EVOL, V65, P805, DOI 10.1016/j.ympev.2012.08.001; Pages M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031123; Pepper M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078110; Pinho C, 2007, MOL ECOL, V16, P1191, DOI 10.1111/j.1365-294X.2007.03230.x; Planas E, 2013, MOL PHYLOGENET EVOL, V67, P414, DOI 10.1016/j.ympev.2013.02.006; Platnick N. I., 2014, WORLD SPIDER CATALOG; Pons J, 2006, MOL ECOL NOTES, V6, P623, DOI 10.1111/j.1471-8286.2006.01353.x; Rambaut A., 2009, FIGTREE V1 3 1 COMPU; Rambaut A, 2009, TRACER V 1 5; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; RAVEN RJ, 1980, J ARACHNOL, V8, P251; Raven RJ, 1988, AM MUS NOVIT, V2929, P1; Raven Robert J., 1994, Memoirs of the Queensland Museum, V35, P291; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Gracia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030239; Sanmartin I, 2010, BIOL LETT; Santos X, 2012, J ZOOL SYST EVOL RES, V50, P210, DOI 10.1111/j.1439-0469.2012.00663.x; Santos-Guerra A., 2002, NATURALEZA ISLAS CAN, P185; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Satler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025355; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon E., 1909, Madrid Memorias de la Sociedad Espanola de Historia Natural, V6; Simon E, 1903, HIST NATURELLE ARAIG, P669; Sistrom M, 2013, MOL PHYLOGENET EVOL, V68, P135, DOI 10.1016/j.ympev.2013.03.007; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Stueben PE, 2010, ZOOL J LINN SOC-LOND, V160, P40, DOI 10.1111/j.1096-3642.2009.00609.x; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Thiv M, 2010, MOL PHYLOGENET EVOL, V54, P607, DOI 10.1016/j.ympev.2009.10.009; Vandergast AG, 2004, MOL ECOL, V13, P1729, DOI 10.1111/j.1365-294X.2004.02179.x; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Wunderlich J, 1995, BEITRAGE ARANEOLOGIE, V4, P385; Wunderlich J., 1992, BEITRAGE ARANEOLOGIE, V1, P1; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	131	37	39	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115078	10.1371/journal.pone.0115078	http://dx.doi.org/10.1371/journal.pone.0115078			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494329	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400093
J	Philip, P; Chaufton, C; Orriols, L; Lagarde, E; Amoros, E; Laumon, B; Akerstedt, T; Taillard, J; Sagaspe, P				Philip, Pierre; Chaufton, Cyril; Orriols, Ludivine; Lagarde, Emmanuel; Amoros, Emmanuelle; Laumon, Bernard; Akerstedt, Torbjorn; Taillard, Jacques; Sagaspe, Patricia			Complaints of Poor Sleep and Risk of Traffic Accidents: A Population-Based Case-Control Study	PLOS ONE			English	Article							CRASHES; DRIVERS	Introduction: This study aimed to determine the sleepiness-related factors associated with road traffic accidents. Methods: A population based case-control study was conducted in 2 French agglomerations. 272 road accident cases hospitalized in emergency units and 272 control drivers matched by time of day and randomly stopped by police forces were included in the study. Odds ratios were calculated for the risk of road traffic accidents. Results: As expected, the main predictive factor for road traffic accidents was having a sleep episode at the wheel just before the accident (OR 9.97, CI 95%: 1.57-63.50, p < 0.05). The increased risk of traffic accidents was 3.35 times higher in subjects who reported very poor quality sleep during the last 3 months (CI 95%: 1.30-8.63, p < 0.05), 1.69 times higher in subjects reporting sleeping 6 hours or fewer per night during the last 3 months (CI 95%: 1.00-2.85, p < 0.05), 2.02 times higher in subjects reporting symptoms of anxiety or nervousness in the previous day (CI 95%: 1.03-3.97, p < 0.05), and 3.29 times higher in subjects reporting taking more than 2 medications in the last 24 h (CI 95%: 1.14-9.44, p < 0.05). Chronic daytime sleepiness measured by the Epworth Sleepiness Scale, expressed heavy snoring and nocturnal leg movements did not explain traffic accidents. Conclusion: Physicians should be attentive to complaints of poor sleep quality and quantity, symptoms of anxiety-nervousness and/ or drug consumption in regular car drivers.	[Philip, Pierre; Chaufton, Cyril; Taillard, Jacques; Sagaspe, Patricia] Univ Bordeaux, USR SANPSY 3413, F-33000 Bordeaux, France; [Philip, Pierre; Chaufton, Cyril; Taillard, Jacques; Sagaspe, Patricia] CNRS, SANPSY, USR 3413, F-33000 Bordeaux, France; [Philip, Pierre; Chaufton, Cyril; Taillard, Jacques; Sagaspe, Patricia] CHU Pellegrin, F-33076 Bordeaux, France; [Orriols, Ludivine; Lagarde, Emmanuel] Univ Bordeaux, INSERM U897, ISPED, Equipe PPCT, F-33000 Bordeaux, France; [Amoros, Emmanuelle; Laumon, Bernard] IFSTTAR, UMRESTTE, TS2, F-69500 Bron, France; [Amoros, Emmanuelle; Laumon, Bernard] Univ Lyon 1, F-69008 Lyon, France; [Akerstedt, Torbjorn] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Stockholm University	Philip, P (corresponding author), Univ Bordeaux, USR SANPSY 3413, F-33000 Bordeaux, France.	pr.philip@free.fr	Taillard, Jacques/H-5063-2018; PHILIP, Pierre/AAS-8889-2020; Lagarde, Emmanuel/F-7132-2013	Taillard, Jacques/0000-0001-9067-8189; PHILIP, Pierre/0000-0003-3267-634X; SAGASPE, Patricia/0000-0003-2845-1199; Lagarde, Emmanuel/0000-0001-8031-7400; Akerstedt, Torbjorn/0000-0001-8049-8504	DSCR (Delegation a la Securite et a la Circulation Routieres, Ministere de l'Interieur France)	DSCR (Delegation a la Securite et a la Circulation Routieres, Ministere de l'Interieur France)	This research was supported by a grant from DSCR (Delegation a la Securite et a la Circulation Routieres, Ministere de l'Interieur France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Martiniuk ALC, 2010, J ADOLESCENT HEALTH, V47, P488, DOI 10.1016/j.jadohealth.2010.03.010; Motak L, 2014, ACCIDENT ANAL PREV, V67, P61, DOI 10.1016/j.aap.2014.02.009; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Roidl E, 2014, ACCIDENT ANAL PREV, V70, P282, DOI 10.1016/j.aap.2014.04.010; Sagaspe P, 2010, J SLEEP RES, V19, P578, DOI 10.1111/j.1365-2869.2009.00818.x; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Wickens CM, 2013, ACCIDENT ANAL PREV, V51, P84, DOI 10.1016/j.aap.2012.10.007	14	46	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114102	10.1371/journal.pone.0114102	http://dx.doi.org/10.1371/journal.pone.0114102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25494198	Green Published, gold			2022-12-27	WOS:000346611400030
J	Bacarizo, J; Martinez-Rodriguez, S; Martin-Garcia, JM; Andujar-Sanchez, M; Ortiz-Salmeron, E; Neira, JL; Camara-Artigas, A				Bacarizo, Julio; Martinez-Rodriguez, Sergio; Manuel Martin-Garcia, Jose; Andujar-Sanchez, Montserrat; Ortiz-Salmeron, Emilia; Luis Neira, Jose; Camara-Artigas, Ana			Electrostatic Effects in the Folding of the SH3 Domain of the c-Src Tyrosine Kinase: pH-Dependence in 3D-Domain Swapping and Amyloid Formation	PLOS ONE			English	Article							TRANSITION-STATE ENSEMBLE; CRYSTALLOGRAPHIC STRUCTURE; GLOBULAR-PROTEINS; BETA-STRANDS; IDENTIFICATION; FIBRIL; AGGREGATION; MECHANISM; DYNAMICS; DIMER	The SH3 domain of the c-Src tyrosine kinase (c-Src-SH3) aggregates to form intertwined dimers and amyloid fibrils at mild acid pHs. In this work, we show that a single mutation of residue Gln128 of this SH3 domain has a significant effect on: (i) its thermal stability; and (ii) its propensity to form amyloid fibrils. The Gln128Glu mutant forms amyloid fibrils at neutral pH but not at mild acid pH, while Gln128Lys and Gln128Arg mutants do not form these aggregates under any of the conditions assayed. We have also solved the crystallographic structures of the wild-type (WT) and Gln128Glu, Gln128Lys and Gln128Arg mutants from crystals obtained at different pHs. At pH 5.0, crystals belong to the hexagonal space group P6(5)22 and the asymmetric unit is formed by one chain of the protomer of the c-Src-SH3 domain in an open conformation. At pH 7.0, crystals belong to the orthorhombic space group P2(1)2(1)2(1), with two molecules at the asymmetric unit showing the characteristic fold of the SH3 domain. Analysis of these crystallographic structures shows that the residue at position 128 is connected to Glu106 at the diverging beta-turn through a cluster of watermolecules. Changes in this hydrogen-bond network lead to the displacement of the c-Src-SH3 distal loop, resulting also in conformational changes of Leu100 that might be related to the binding of proline rich motifs. Our findings show that electrostatic interactions and solvation of residues close to the folding nucleation site of the c-Src-SH3 domain might play an important role during the folding reaction and the amyloid fibril formation.	[Bacarizo, Julio; Martinez-Rodriguez, Sergio; Manuel Martin-Garcia, Jose; Andujar-Sanchez, Montserrat; Ortiz-Salmeron, Emilia; Camara-Artigas, Ana] Univ Almeria, Res Ctr Agr & Food Biotechnol BITAL, Dept Chem & Phys, Almeria 04120, Spain; [Martinez-Rodriguez, Sergio] Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain; [Manuel Martin-Garcia, Jose] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Luis Neira, Jose] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; [Luis Neira, Jose] Biocomputat & Complex Syst Phys Inst, Zaragoza 50009, Spain	Universidad de Almeria; University of Granada; Arizona State University; Arizona State University-Tempe; Universidad Miguel Hernandez de Elche	Camara-Artigas, A (corresponding author), Univ Almeria, Res Ctr Agr & Food Biotechnol BITAL, Dept Chem & Phys, Agrifood Campus Int Excellence CeiA3, Almeria 04120, Spain.	acamara@ual.es	MARTIN GARCIA, JOSE MANUEL/GQA-3160-2022; Sánchez, montserrat Andújar/H-1377-2015; Neira, Jose/ABF-4210-2021; Garcia, Jose Manuel Martin/V-2043-2018; Ortiz-Salmerón, Emilia/H-1381-2015; Camara-Artigas, Ana/M-2252-2019; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; MARTIN GARCIA, JOSE MANUEL/AAB-6838-2020	MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Sánchez, montserrat Andújar/0000-0002-8726-998X; Garcia, Jose Manuel Martin/0000-0002-4558-3858; Ortiz-Salmerón, Emilia/0000-0002-7125-218X; Camara-Artigas, Ana/0000-0003-2197-726X; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858	Spanish Ministry of Science and Innovation and Ministry of Economy and Competitiveness; FEDER [(EU): BIO2009-13261-C02-01/02, BIO2012-39922-C02-01/02, CTQ2013-4493, CSD2008-00005, (EU): P09-CVI-5063, (EU): Prometeo 2013/018]; Andalusian Regional Government (Spain); Valentian Regional Government (Spain); European Synchrotron Radiation Facility (ESRF), Grenoble, France: BAG [MX-1406, MX-1541]; ALBA (Barcelona, Spain) [2012010072, 2012100378]	Spanish Ministry of Science and Innovation and Ministry of Economy and Competitiveness; FEDER(European Commission); Andalusian Regional Government (Spain); Valentian Regional Government (Spain); European Synchrotron Radiation Facility (ESRF), Grenoble, France: BAG; ALBA (Barcelona, Spain)	This research was funded by the Spanish Ministry of Science and Innovation and Ministry of Economy and Competitiveness and FEDER (EU): BIO2009-13261-C02-01/02 (ACA); BIO2012-39922-C02-01/02 (ACA); CTQ2013-4493 (JLN) and CSD2008-00005 (JLN); Andalusian Regional Government (Spain) and FEDER (EU): P09-CVI-5063 (ACA); and Valentian Regional Government (Spain) and FEDER (EU): Prometeo 2013/018 (JLN). Data collection was supported by European Synchrotron Radiation Facility (ESRF), Grenoble, France: BAG proposals MX-1406 (ACA) and MX-1541 (ACA); and ALBA (Barcelona, Spain) proposals 2012010072 (ACA) and 2012100378 (ACA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Ahn HC, 2006, PROTEIN SCI, V15, P2552, DOI 10.1110/ps.062154306; Bacarizo J, 2013, ACTA CRYSTALLOGR D, V69, P756, DOI 10.1107/S0907444913001522; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayro MJ, 2011, J AM CHEM SOC, V133, P13967, DOI 10.1021/ja203756x; Bayro MJ, 2010, BIOCHEMISTRY-US, V49, P7474, DOI 10.1021/bi100864t; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Camara-Artigas A, 2014, J STRUCT BIOL, V186, P195, DOI 10.1016/j.jsb.2014.02.007; Camara-Artigas A, 2009, FEBS LETT, V583, P749, DOI 10.1016/j.febslet.2009.01.036; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Di Nardo AA, 2003, J MOL BIOL, V333, P641, DOI 10.1016/j.jmb.2003.08.035; Ding F, 2005, J MOL BIOL, V350, P1035, DOI 10.1016/j.jmb.2005.05.017; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Domenech R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069307; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Gnanakaran S, 2003, BIOPHYS J, V84, P1548, DOI 10.1016/S0006-3495(03)74966-2; Grantcharova VP, 1997, BIOCHEMISTRY-US, V36, P15685, DOI 10.1021/bi971786p; Grantcharova VP, 2001, J MOL BIOL, V306, P555, DOI 10.1006/jmbi.2000.4352; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Guo WH, 2003, BIOPHYS J, V85, P61, DOI 10.1016/S0006-3495(03)74454-3; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kishan KVR, 2001, PROTEIN SCI, V10, P1046, DOI 10.1110/ps.50401; Klimov DK, 2002, J MOL BIOL, V317, P721, DOI 10.1006/jmbi.2002.5453; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Martin-Garcia JM, 2007, FEBS LETT, V581, P1701, DOI 10.1016/j.febslet.2007.03.059; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Morel B, 2006, J MOL BIOL, V356, P453, DOI 10.1016/j.jmb.2005.11.062; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907; Newcomer ME, 2002, CURR OPIN STRUC BIOL, V12, P48, DOI 10.1016/S0959-440X(02)00288-9; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Rousseau F, 2006, J MOL BIOL, V363, P496, DOI 10.1016/j.jmb.2006.07.061; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Ruzafa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049690; van der Wel PCA, 2012, PRION, V6, P211, DOI 10.4161/pri.18987; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU H, 1993, FEBS LETT, V324, P87, DOI 10.1016/0014-5793(93)81538-B; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x	77	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113224	10.1371/journal.pone.0113224	http://dx.doi.org/10.1371/journal.pone.0113224			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490095	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300006
J	Drwal, MN; Marinello, J; Manzo, SG; Wakelin, LPG; Capranico, G; Griffith, R				Drwal, Malgorzata N.; Marinello, Jessica; Manzo, Stefano G.; Wakelin, Laurence P. G.; Capranico, Giovanni; Griffith, Renate			Novel DNA Topoisomerase II alpha Inhibitors from Combined Ligand- and Structure-Based Virtual Screening	PLOS ONE			English	Article							ANTITUMOR AGENTS; POTENT INHIBITORS; 4-BETA-ARYLAMINO DERIVATIVES; GENETIC ALGORITHM; CYTOTOXIC AGENTS; CLEAVAGE; ANALOGS; 4'-O-DEMETHYLEPIPODOPHYLLOTOXIN; PODOPHYLLOTOXIN; CAMPTOTHECIN	DNA topoisomerases are enzymes responsible for the relaxation of DNA torsional strain, as well as for the untangling of DNA duplexes after replication, and are important cancer drug targets. One class of topoisomerase inhibitors, "poisons'', binds to the transient enzyme-DNA complex which occurs during the mechanism of action, and inhibits the religation of DNA. This ultimately leads to the accumulation of DNA double strand breaks and cell death. Different types of topoisomerases occur in human cells and several poisons of topoisomerase I and II are widely used clinically. However, their use is compromised by a variety of side effects. Recent studies confirm that the inhibition of the alpha-isoform of topoisomerase II is responsible for the cytotoxic effect, whereas the inhibition of the beta-isoform leads to development of adverse drug reactions. Thus, the discovery of agents selective for topoisomerase II alpha is an important strategy for the development of topoisomerase II poisons with improved clinical profiles. Here, we present a computer-aided drug design study leading to the identification of structurally novel topoisomerase IIa poisons. The study combines ligand-and structure-based drug design methods including pharmacophore models, homology modelling, docking, and virtual screening of the National Cancer Institute compound database. From the 8 compounds identified from the computational work, 6 were tested for their capacity to poison topoisomerase II in vitro: 4 showed selective inhibitory activity for the alpha-over the beta-isoform and 3 of these exhibited cytotoxic activity. Thus, our study confirms the applicability of computer-aided methods for the discovery of novel topoisomerase II poisons, and presents compounds which could be investigated further as selective topoisomerase II alpha inhibitors.	[Drwal, Malgorzata N.; Wakelin, Laurence P. G.; Griffith, Renate] UNSW Australia, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Marinello, Jessica; Manzo, Stefano G.; Capranico, Giovanni] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of New South Wales Sydney; University of Bologna	Griffith, R (corresponding author), UNSW Australia, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	r.griffith@unsw.edu.au	Griffith, Renate/A-3584-2015; Drwal, Malgorzata/B-6461-2015; Capranico, Giovanni/K-1678-2014	Griffith, Renate/0000-0001-7739-5686; Capranico, Giovanni/0000-0002-8708-6454; Marinello, Jessica/0000-0002-2356-869X	University of New South Wales, Australia; University International Postgraduate Award (UIPA); Translational Cancer Research Network (TCRN) Australia	University of New South Wales, Australia; University International Postgraduate Award (UIPA); Translational Cancer Research Network (TCRN) Australia	MD acknowledges financial assistance from the University of New South Wales, Australia, in providing a PhD scholarship in the form of a University International Postgraduate Award (UIPA), as well as the Translational Cancer Research Network (TCRN) Australia for providing a Postgraduate Research Scholarship Top-up in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auzanneau C, 2012, MOL PHARMACOL, V82, P134, DOI 10.1124/mol.111.077537; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; BAGULEY BC, 1995, CANCER CHEMOTH PHARM, V36, P244, DOI 10.1007/BF00685854; Bastow KF, 1997, BIOORGAN MED CHEM, V5, P1481, DOI 10.1016/S0968-0896(97)00102-8; BEERS SA, 1988, J NAT PROD, V51, P901, DOI 10.1021/np50059a014; Beretta GL, 2008, TOP CURR CHEM, V283, P1, DOI 10.1007/128_2007_3; Bertozzi D, 2014, MOL CANCER THER, V13, P239, DOI 10.1158/1535-7163.MCT-13-0729; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; Binaschi M, 2000, CANCER RES, V60, P3770; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Capranico G, 1998, BBA-GENE STRUCT EXPR, V1400, P185, DOI 10.1016/S0167-4781(98)00135-3; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Chang JY, 2000, BIOCHEM PHARMACOL, V59, P497, DOI 10.1016/S0006-2952(99)00363-9; CHANG JY, 1991, CANCER RES, V51, P1755; DEISABELLA P, 1995, NUCLEIC ACIDS RES, V23, P223, DOI 10.1093/nar/23.2.223; DRAKE FH, 1987, J BIOL CHEM, V262, P16739; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Drwal MN, 2013, J COMPUT AID MOL DES, V27, P1037, DOI 10.1007/s10822-013-9695-x; Drwal Malgorzata N, 2013, Drug Discov Today Technol, V10, pe395, DOI 10.1016/j.ddtec.2013.02.002; Drwal MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025150; Finlay GJ, 1996, EUR J CANCER, V32A, P708, DOI 10.1016/0959-8049(95)00604-4; HSIANG YH, 1989, MOL PHARMACOL, V36, P371; HU H, 1992, J MED CHEM, V35, P866, DOI 10.1021/jm00083a009; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keller PA, 2000, J MOL GRAPH MODEL, V18, P235, DOI 10.1016/S1093-3263(00)00028-0; LEE KH, 1989, J NAT PROD, V52, P606, DOI 10.1021/np50063a021; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Petronzi C, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-24; POMMIER Y, 1991, J MOL BIOL, V222, P909, DOI 10.1016/0022-2836(91)90585-T; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi Q, 2001, BIOORGAN MED CHEM, V9, P2999, DOI 10.1016/S0968-0896(01)00206-1; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURSTON LS, 1989, J MED CHEM, V32, P604, DOI 10.1021/jm00123a016; THURSTON LS, 1986, J MED CHEM, V29, P1547, DOI 10.1021/jm00158a042; Tumiatti V, 2009, J MED CHEM, V52, P7873, DOI 10.1021/jm901131m; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG ZQ, 1992, J MED CHEM, V35, P871, DOI 10.1021/jm00083a010; WANG ZQ, 1993, PHARMACEUT RES, V10, P343, DOI 10.1023/A:1018923902760; WANG ZQ, 1990, J MED CHEM, V33, P2660, DOI 10.1021/jm00171a050; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; Wu CC, 2013, NUCLEIC ACIDS RES, V41, P10630, DOI 10.1093/nar/gkt828; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xiao ZY, 2004, J MED CHEM, V47, P5140, DOI 10.1021/jm030609l; Xiao ZY, 2004, BIOORGAN MED CHEM, V12, P3339, DOI 10.1016/j.bmc.2004.03.067; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; ZHANG YL, 1992, J NAT PROD, V55, P1100, DOI 10.1021/np50086a011; ZHOU XM, 1991, J MED CHEM, V34, P3346, DOI 10.1021/jm00116a001; ZHOU XM, 1993, PHARMACEUT RES, V10, P214, DOI 10.1023/A:1018978525533; Zhu XK, 1999, J MED CHEM, V42, P2441, DOI 10.1021/jm990055f	55	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114904	10.1371/journal.pone.0114904	http://dx.doi.org/10.1371/journal.pone.0114904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489853	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300093
J	Serfas, BG; Buttner, OB; Florack, A				Serfas, Benjamin G.; Buettner, Oliver B.; Florack, Arnd			Eyes Wide Shopped: Shopping Situations Trigger Arousal in Impulsive Buyers	PLOS ONE			English	Article							PUPIL; TEMPTATION; RESOURCES	The present study proposes arousal as an important mechanism driving buying impulsiveness. We examined the effect of buying impulsiveness on arousal in non-shopping and shopping contexts. In an eye- tracking experiment, we measured pupil dilation while participants viewed and rated pictures of shopping scenes and non-shopping scenes. The results demonstrated that buying impulsiveness is closely associated with arousal as response to viewing pictures of shopping scenes. This pertained for hedonic shopping situations as well as for utilitarian shopping situations. Importantly, the effect did not emerge for non-shopping scenes. Furthermore, we demonstrated that arousal of impulsive buyers is independent from cognitive evaluation of scenes in the pictures.	[Serfas, Benjamin G.; Buettner, Oliver B.; Florack, Arnd] Univ Vienna, Dept Appl Psychol Work Educ & Econ, Vienna, Austria; [Buettner, Oliver B.] Zeppelin Univ, Dept Econ Sci, Friedrichshafen, Germany	University of Vienna; Zeppelin University	Serfas, BG (corresponding author), Univ Vienna, Dept Appl Psychol Work Educ & Econ, Vienna, Austria.	benjamin.serfas@univie.ac.at	Florack, Arnd/A-9137-2008; Serfas, Benjamin G/E-3070-2014; Buttner, Oliver/E-3022-2014	Florack, Arnd/0000-0001-9906-0043; Serfas, Benjamin G/0000-0003-4358-6139; Buttner, Oliver/0000-0001-5037-1895	Marie Curie FP7 Integration Grant within the 7th European Union Framework Program [FP7-PEOPLE-2011-CIG 293577]	Marie Curie FP7 Integration Grant within the 7th European Union Framework Program	This work was supported by a Marie Curie FP7 Integration Grant within the 7th European Union Framework Program to Oliver B. Buttner (FP7-PEOPLE-2011-CIG 293577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Bijleveld E, 2009, PSYCHOL SCI, V20, P1313, DOI 10.1111/j.1467-9280.2009.02443.x; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Buttner OB, 2014, EUR J MARKETING, V48, P1026, DOI 10.1108/EJM-04-2012-0210; Buttner OB, 2014, SOC PSYCHOL PERS SCI, V5, P343, DOI 10.1177/1948550613494024; ELLIOTT R, 1970, J PERS SOC PSYCHOL, V14, P166, DOI 10.1037/h0028686; Faber RJ, 2004, J CONSUM RES, P537; Groeppel-Klein A, 2005, BRAIN RES BULL, V67, P428, DOI 10.1016/j.brainresbull.2005.06.012; Hubert M, 2013, PSYCHOL MARKET, V30, P861, DOI 10.1002/mar.20651; Lang P.J., 2008, A8 U FLOR; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pine KJ, 2011, PERS INDIV DIFFER, V50, P74, DOI 10.1016/j.paid.2010.08.026; Rook DW, 1995, J CONSUM RES, V22, P305, DOI 10.1086/209452; ROOK DW, 1987, J CONSUM RES, V14, P189, DOI 10.1086/209105; Tice DM, 2001, J PERS SOC PSYCHOL, V80, P53, DOI 10.1037//0022-3514.80.1.53; Tsukayama E, 2012, EUR J PERSONALITY, V26, P318, DOI 10.1002/per.841; Verplanken B, 2001, EUR J PERSONALITY, V15, pS71, DOI 10.1002/per.423; Vohs KD, 2007, J CONSUM RES, V33, P537, DOI 10.1086/510228; Zahn TP, 1996, PSYCHOPHYSIOLOGY, V33, P731, DOI 10.1111/j.1469-8986.1996.tb02369.x	21	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114593	10.1371/journal.pone.0114593	http://dx.doi.org/10.1371/journal.pone.0114593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25489955	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300054
J	Bogenschutz, NL; Rodriguez, J; Tsukiyama, T				Bogenschutz, Naomi L.; Rodriguez, Jairo; Tsukiyama, Toshio			Initiation of DNA Replication from Non-Canonical Sites on an Origin-Depleted Chromosome	PLOS ONE			English	Article							SACCHAROMYCES; YEAST; IDENTIFICATION; STABILITY	Eukaryotic DNA replication initiates from multiple sites on each chromosome called replication origins (origins). In the budding yeast Saccharomyces cerevisiae, origins are defined at discrete sites. Regular spacing and diverse firing characteristics of origins are thought to be required for efficient completion of replication, especially in the presence of replication stress. However, a S. cerevisiae chromosome III harboring multiple origin deletions has been reported to replicate relatively normally, and yet how an origin-deficient chromosome could accomplish successful replication remains unknown. To address this issue, we deleted seven well-characterized origins from chromosome VI, and found that these deletions do not cause gross growth defects even in the presence of replication inhibitors. We demonstrated that the origin deletions do cause a strong decrease in the binding of the origin recognition complex. Unexpectedly, replication profiling of this chromosome showed that DNA replication initiates from non-canonical loci around deleted origins in yeast. These results suggest that replication initiation can be unexpectedly flexible in this organism.	[Bogenschutz, Naomi L.; Rodriguez, Jairo; Tsukiyama, Toshio] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Bogenschutz, Naomi L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Bogenschutz, Naomi L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Tsukiyama, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	ttsukiya@fhcrc.org	Rodriguez Lumbiarres, Jairo/E-7944-2018	Rodriguez Lumbiarres, Jairo/0000-0002-6844-974X	NSF [DGE-0718124, GM078259]; Spanish Ministerio de Educacion y Ciencia; National Science Foundation Graduate Research Fellowship Program [DGE-0718124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078259] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Spanish Ministerio de Educacion y Ciencia(Spanish Government); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by NSF DGE-0718124 for NB, and GM078259 for TT. JR was supported in part by a fellowship from the Spanish Ministerio de Educacion y Ciencia. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-0718124. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberis M, 2010, CURR GENOMICS, V11, P199, DOI 10.2174/138920210791110942; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; Dershowitz A, 2007, MOL CELL BIOL, V27, P4652, DOI 10.1128/MCB.01246-06; Diffley JFX, 2010, COLD SPRING HARBOR S; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hawkins M, 2013, CELL REP, V5, P1132, DOI 10.1016/j.celrep.2013.10.014; Kasinathan S, 2014, NAT METHODS, V11, P203, DOI [10.1038/NMETH.2766, 10.1038/nmeth.2766]; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rodriguez J, 2013, GENE DEV, V27, P74, DOI 10.1101/gad.202978.112; Royce TE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-186; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Siow CC, 2012, NUCLEIC ACIDS RES, V40, pD682, DOI 10.1093/nar/gkr1091; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Theis JF, 2007, GENETICS, V177, P1445, DOI 10.1534/genetics.107.074690; Theis JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001227; THOMAS BJ, 1989, GENETICS, V123, P725; van Brabant AJ, 2001, MOL CELL, V7, P705, DOI 10.1016/S1097-2765(01)00216-7; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Viggiani CJ, 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1101/03.PR0T5385; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	32	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114545	10.1371/journal.pone.0114545	http://dx.doi.org/10.1371/journal.pone.0114545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486280	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600075
J	Cai, Q; Wang, B; Coling, D; Zuo, J; Fang, J; Yang, S; Vera, K; Hu, BH				Cai, Qunfeng; Wang, Bo; Coling, Donald; Zuo, Jian; Fang, Jie; Yang, Shiming; Vera, Krystal; Hu, Bo Hua			Reduction in Noise-Induced Functional Loss of the Cochleae in Mice with Pre-Existing Cochlear Dysfunction Due to Genetic Interference of Prestin	PLOS ONE			English	Article							INDUCED HEARING-LOSS; OUTER HAIR-CELLS; LOW-DOSE KANAMYCIN; KNOCKOUT MICE; MOTOR PROTEIN; SALICYLATE; PROTECTION; EXPOSURE; THRESHOLD; ELECTROMOTILITY	Various cochlear pathologies, such as acoustic trauma, ototoxicity and age-related degeneration, cause hearing loss. These pre-existing hearing losses can alter cochlear responses to subsequent acoustic overstimulation. So far, the knowledge on the impacts of pre-existing hearing loss caused by genetic alteration of cochlear genes is limited. Prestin is the motor protein expressed exclusively in outer hair cells in the mammalian cochlea. This motor protein contributes to outer hair cell motility. At present, it is not clear how the interference of prestin function affects cochlear responses to acoustic overstimulation. To address this question, a genetic model of prestin dysfunction in mice was created by inserting an internal ribosome entry site (IRES)-CreERT2-FRT-Neo-FRT cassette into the prestin locus after the stop codon. Homozygous mice exhibit a threshold elevation of auditory brainstem responses with large individual variation. These mice also display a threshold elevation and a shift of the input/output function of the distortion product otoacoustic emission, suggesting a reduction in outer hair cell function. The disruption of prestin function reduces the threshold shifts caused by exposure to a loud noise at 120 dB (sound pressure level) for 1 h. This reduction is positively correlated with the level of pre-noise cochlear dysfunction and is accompanied by a reduced change in Cdh1 expression, suggesting a reduction in molecular responses to the acoustic overstimulation. Together, these results suggest that prestin interference reduces cochlear stress responses to acoustic overstimulation.	[Cai, Qunfeng; Coling, Donald; Vera, Krystal; Hu, Bo Hua] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Wang, Bo; Yang, Shiming] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otolaryngol & Head & Neck Surg, Beijing, Peoples R China; [Zuo, Jian; Fang, Jie] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chinese People's Liberation Army General Hospital; St Jude Children's Research Hospital	Hu, BH (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA.	bhu@buffalo.edu			National Institutes of Health (NIH) [R01DC010154, 2R01DC006471]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010154, R21DC013879, R01DC006471] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Financial support was provided by National Institutes of Health (NIH) (R01DC010154, to Bo Hua Hu), (2R01DC006471, to Jian Zuo), (http://www.nih.gov); and American Lebanese Syrian Associated Charities (ALSAC) (to Jian Zuo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman C, 2008, AUDIOL NEURO-OTOL, V13, P266, DOI 10.1159/000115436; BANCROFT BR, 1991, HEARING RES, V54, P20, DOI 10.1016/0378-5955(91)90132-S; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cai Q, 2013, LARYNGOSCOPE, V123; Cai QF, 2013, J NEUROSCI METH, V219, P240, DOI 10.1016/j.jneumeth.2013.08.010; Cai QF, 2012, NEUROBIOL DIS, V45, P723, DOI 10.1016/j.nbd.2011.10.018; CAMPO P, 1991, HEARING RES, V55, P195, DOI 10.1016/0378-5955(91)90104-H; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Chen GD, 2002, HEARING RES, V172, P186, DOI 10.1016/S0378-5955(02)00582-8; Cheng J, 2011, AM J HUM GENET, V89, P56, DOI 10.1016/j.ajhg.2011.05.027; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Dallos P, 2008, CURR OPIN NEUROBIOL, V18, P370, DOI 10.1016/j.conb.2008.08.016; DIELER R, 1991, J NEUROCYTOL, V20, P637, DOI 10.1007/BF01187066; Fang J, 2012, GENESIS, V50, P124, DOI 10.1002/dvg.20810; Fechter Laurence D., 2002, Noise Health, V4, P49; Fernandez EA, 2010, JARO-J ASSOC RES OTO, V11, P235, DOI 10.1007/s10162-009-0204-9; Hakuba N, 2000, J NEUROSCI, V20, P8750; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hu BH, 2002, HEARING RES, V172, P1, DOI 10.1016/S0378-5955(01)00361-6; Hu BH, 2012, J NEUROSCI, V32, P14927, DOI 10.1523/JNEUROSCI.1588-12.2012; Hu BH, 2010, J NEUROSCI RES, V88, P1812, DOI 10.1002/jnr.22333; HUMES LE, 1984, J ACOUST SOC AM, V76, P1318, DOI 10.1121/1.391447; Kozel PJ, 2002, HEARING RES, V164, P231, DOI 10.1016/S0378-5955(01)00420-8; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; LEBO CP, 1972, LARYNGOSCOPE, V82, P1399, DOI 10.1288/00005537-197208000-00002; Li HZ, 2009, NOISE HEALTH, V11, P26, DOI 10.4103/1463-1741.45310; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; McFadden Sandra L., 2001, Noise Health, V3, P49; Miller JM, 1998, SCAND AUDIOL, V27, P53; Ohlemiller KK, 2011, HEARING RES, V280, P141, DOI 10.1016/j.heares.2011.05.007; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PUEL JL, 1988, HEARING RES, V37, P65, DOI 10.1016/0378-5955(88)90078-0; RAJAN R, 1988, J NEUROPHYSIOL, V60, P549, DOI 10.1152/jn.1988.60.2.549; REITER ER, 1995, J NEUROPHYSIOL, V73, P506, DOI 10.1152/jn.1995.73.2.506; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; SHONE G, 1991, HEARING RES, V56, P173, DOI 10.1016/0378-5955(91)90167-8; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; SPONGR VP, 1992, ARCH OTOLARYNGOL, V118, P157; SUBRAMANIAM M, 1993, HEARING RES, V65, P234, DOI 10.1016/0378-5955(93)90216-N; SUN JC, 1994, LARYNGOSCOPE, V104, P1251; VOLDRICH L, 1979, ARCH OHREN NASEN KEH, V222, P169, DOI 10.1007/BF00456312; WHITLON DS, 1993, J NEUROCYTOL, V22, P1030, DOI 10.1007/BF01235747; WOODFORD CM, 1978, ANN OTO RHINOL LARYN, V87, P117, DOI 10.1177/000348947808700119; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng XY, 1997, HEARING RES, V104, P191, DOI 10.1016/S0378-5955(96)00187-6; Zhu YH, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-26	50	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113990	10.1371/journal.pone.0113990	http://dx.doi.org/10.1371/journal.pone.0113990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486270	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600034
J	Nienhouse, V; Gao, X; Dong, QF; Nelson, DE; Toh, E; McKinley, K; Schreckenberger, P; Shibata, N; Fok, CS; Mueller, ER; Brubaker, L; Wolfe, AJ; Radek, KA				Nienhouse, Vanessa; Gao, Xiang; Dong, Qunfeng; Nelson, David E.; Toh, Evelyn; McKinley, Kathleen; Schreckenberger, Paul; Shibata, Noriko; Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda; Wolfe, Alan J.; Radek, Katherine A.			Interplay between Bladder Microbiota and Urinary Antimicrobial Peptides: Mechanisms for Human Urinary Tract Infection Risk and Symptom Severity	PLOS ONE			English	Article							INVASIVE BACTERIAL-INFECTION; SQUAMOUS-CELL CARCINOMAS; PELVIC FLOOR DISORDERS; HUMAN BETA-DEFENSIN-1; POSTMENOPAUSAL WOMEN; PSORIASIN S100A7; INNATE IMMUNITY; RIBONUCLEASE 7; HUMAN SKIN; DEFENSE	Resident bacterial communities (microbiota) and host antimicrobial peptides (AMPs) are both essential components of normal host innate immune responses that limit infection and pathogen induced inflammation. However, their interdependence has not been investigated in the context of urinary tract infection (UTI) susceptibility. Here, we explored the interrelationship between the urinary microbiota and host AMP responses as mechanisms for UTI risk. Using prospectively collected day of surgery (DOS) urine specimens from female pelvic floor surgery participants, we report that the relative abundance and/or frequency of specific urinary microbiota distinguished between participants who did or did not develop a post-operative UTI. Furthermore, UTI risk significantly correlated with both specific urinary microbiota and beta-defensin AMP levels. Finally, urinary AMP hydrophobicity and protease activity were greater in participants who developed UTI, and correlated positively with both UTI risk and pelvic floor symptoms. These data demonstrate an interdependency between the urinary microbiota, AMP responses and symptoms, and identify a potential mechanism for UTI risk. Assessment of bacterial microbiota and host innate immune AMP responses in parallel may identify increased risk of UTI in certain populations.	[Nienhouse, Vanessa; Radek, Katherine A.] Loyola Univ Chicago, Burn & Shock Trauma Res Inst, Div Hlth Sci, Maywood, IL 60660 USA; [Nienhouse, Vanessa; Shibata, Noriko; Wolfe, Alan J.; Radek, Katherine A.] Loyola Univ Chicago, Dept Microbiol & Immunol, Div Hlth Sci, Maywood, IL USA; [Nienhouse, Vanessa; Schreckenberger, Paul; Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda; Wolfe, Alan J.; Radek, Katherine A.] Loyola Univ Chicago, Stritch Sch Med, Div Hlth Sci, Maywood, IL USA; [Nienhouse, Vanessa; Schreckenberger, Paul; Shibata, Noriko; Wolfe, Alan J.; Radek, Katherine A.] Loyola Univ Chicago, Infect Dis & Immunol Res Inst, Div Hlth Sci, Maywood, IL USA; [Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda] Loyola Univ Chicago, Div Female Pelv Med & Reconstruct Surg, Div Hlth Sci, Dept Obstet Gynecol, Maywood, IL USA; [McKinley, Kathleen; Schreckenberger, Paul] Loyola Univ Chicago, Dept Pathol, Div Hlth Sci, Maywood, IL USA; [Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda] Loyola Univ Chicago, Dept Urol, Div Hlth Sci, Maywood, IL USA; [Radek, Katherine A.] Loyola Univ Chicago, Dept Surg, Div Hlth Sci, Maywood, IL USA; [Nelson, David E.; Toh, Evelyn] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Gao, Xiang; Dong, Qunfeng] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Gao, Xiang; Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Radek, KA (corresponding author), Loyola Univ Chicago, Burn & Shock Trauma Res Inst, Div Hlth Sci, Maywood, IL 60660 USA.	kradek1@luc.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Toh, Evelyn/0000-0003-2932-4060	Loyola University Chicago Stritch School of Medicine Research Funding Committee; Marion and Ralph C. Falk Medical Research Trust; Indiana University Foundation	Loyola University Chicago Stritch School of Medicine Research Funding Committee; Marion and Ralph C. Falk Medical Research Trust; Indiana University Foundation	This study was funded by the Loyola University Chicago Stritch School of Medicine Research Funding Committee and the Marion and Ralph C. Falk Medical Research Trust for KAR, AJW and LB. This study was also funded by the Indiana University Foundation for DEN.	Arao S, 1999, J CLIN MICROBIOL, V37, P553, DOI 10.1128/JCM.37.3.553-557.1999; Barber MD, 2006, AM J OBSTET GYNECOL, V194, P1492, DOI 10.1016/j.ajog.2006.01.076; Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Brown JS, 2001, OBSTET GYNECOL, V98, P1045, DOI 10.1016/S0029-7844(01)01630-1; Brubaker L, 2014, INT UROGYNECOL J, V25, P1179, DOI 10.1007/s00192-013-2325-2; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Clausen ML, 2013, BRIT J DERMATOL, V169, P587, DOI 10.1111/bjd.12419; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Fok CS, 2013, J UROLOGY, V189, P1721, DOI 10.1016/j.juro.2012.11.167; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Foxman B, 2001, J CLIN EPIDEMIOL, V54, P710, DOI 10.1016/S0895-4356(00)00352-8; Gallo RL, 2003, CURR ALLERGY ASTHM R, V3, P402, DOI 10.1007/s11882-003-0074-x; GANZ T, 1993, BLOOD, V82, P641; Ganz T, 2001, J INFECT DIS, V183, pS41, DOI 10.1086/318838; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Khassawneh M, 2010, PEDIATR NEPHROL, V25, P1377, DOI 10.1007/s00467-010-1473-6; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Mahajan ST, 2006, AM J OBSTET GYNECOL, V194, P722, DOI 10.1016/j.ajog.2005.08.043; Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Nielsen KL, 2014, INFECT IMMUN, V82, P1572, DOI 10.1128/IAI.01393-13; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Oottamasathien S, 2011, J UROLOGY, V186, P1684, DOI 10.1016/j.juro.2011.03.099; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Ostergaard M, 1999, ELECTROPHORESIS, V20, P349; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Pham T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.010; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddiqui H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-205; Spencer JD, 2011, KIDNEY INT, V80, P175, DOI 10.1038/ki.2011.109; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Spencer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031712; Stamm WE, 1999, CLIN INFECT DIS, V28, P723, DOI 10.1086/515209; Stothard DR, 1998, INFECT IMMUN, V66, P3618, DOI 10.1128/IAI.66.8.3618-3625.1998; Sturm PDJ, 2006, J CLIN MICROBIOL, V44, P652, DOI 10.1128/JCM.44.2.652-654.2006; Sutkin G, 2010, INT UROGYNECOL J, V21, P955, DOI 10.1007/s00192-010-1137-x; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Vartivarian SE, 1996, ARCH INTERN MED, V156, P433, DOI 10.1001/archinte.156.4.433; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolf R, 2006, J INVEST DERMATOL, V126, P1600, DOI 10.1038/sj.jid.5700210; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wu JM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.046; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	70	71	74	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114185	10.1371/journal.pone.0114185	http://dx.doi.org/10.1371/journal.pone.0114185			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486068	gold, Green Published			2022-12-27	WOS:000346907600045
J	Price, CTD; Abu Kwaik, Y				Price, Christopher T. D.; Abu Kwaik, Yousef			The Transcriptome of Legionella pneumophila-Infected Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; HOST-CELL DEATH; INTRACELLULAR REPLICATION; GLUTAMATE TRANSPORTERS; CONTAINING PHAGOSOME; ARGININE TRANSPORT; MOUSE MACROPHAGES; PROTEIN-SYNTHESIS; IFN-GAMMA	Background: Legionella pneumophila is an intracellular bacterial pathogen that invades and replicates within alveolar macrophages through injection of,300 effector proteins by its Dot/Icm type IV translocation apparatus. The bona fide F-box protein, AnkB, is a nutritional virulence effector that triggers macrophages to generate a surplus of amino acids, which is essential for intravacuolar proliferation. Therefore, the ankB mutant represents a novel genetic tool to determine the transcriptional response of human monocyte-derived macrophages (hMDMs) to actively replicating L. pneumophila. Methodology/Principal Findings: Here, we utilized total human gene microarrays to determine the global transcriptional response of hMDMs to infection by wild type or the ankB mutant of L. pneumophila. The transcriptomes of hMDMs infected with either actively proliferating wild type or non-replicative ankB mutant bacteria were remarkably similar. The transcriptome of infected hMDMs was predominated by up-regulation of inflammatory pathways (IL-10 anti-inflammatory, interferon signaling and amphoterin signaling), anti-apoptosis, and down-regulation of protein synthesis pathways. In addition, L. pneumophila modulated diverse metabolic pathways, particularly those associated with bio-active lipid metabolism, and SLC amino acid transporters expression. Conclusion/Significance: Taken together, the hMDM transcriptional response to L. pneumophila is independent of intra-vacuolar replication of the bacteria and primarily involves modulation of the immune response and metabolic as well as nutritional pathways.	[Price, Christopher T. D.; Abu Kwaik, Yousef] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA; [Abu Kwaik, Yousef] Univ Louisville, Ctr Predict Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Price, CTD (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	christopher.price@louisville.edu; abukwaik@louisville.edu		Abu Kwaik, Yousef/0000-0002-2119-2078	National Institute of Allergy and Infectious Diseases [R01AI069321, R21AI107978]; Commonwealth of Kentucky Research Challenge Trust Fund; National Institutes of Health [2P20GM103436-14, 1P30GM106396-01]; J. G. Brown Cancer Center at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107978, R01AI069321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396, P20GM103436] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Commonwealth of Kentucky Research Challenge Trust Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. G. Brown Cancer Center at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The YAK lab is supported by Public Health Service Awards R01AI069321 and R21AI107978 from the National Institute of Allergy and Infectious Diseases and by the Commonwealth of Kentucky Research Challenge Trust Fund. Part of this work was performed at the University of Louisville Genomics Facility, which is supported by the National Institutes of Health: 2P20GM103436-14, NIH: 1P30GM106396-01 and the J. G. Brown Cancer Center at the University of Louisville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zant A, 2005, INFECT IMMUN, V73, P5339, DOI 10.1128/IAI.73.9.5339-5349.2005; Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Archer KA, 2010, INFECT IMMUN, V78, P2477, DOI 10.1128/IAI.00243-10; Asrat S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004229; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Bartfeld S, 2009, CELL MICROBIOL, V11, P1638, DOI 10.1111/j.1462-5822.2009.01354.x; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00076; Berger UV, 2006, ANAT EMBRYOL, V211, P595, DOI 10.1007/s00429-006-0109-x; Boon JY, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00064; BRIELAND JK, 1995, INFECT IMMUN, V63, P3253, DOI 10.1128/IAI.63.9.3253-3258.1995; Bruckert WM, 2014, INFECT IMMUN, V82, P72, DOI 10.1128/IAI.01079-13; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen Y, 2010, DIAGN MICR INFEC DIS, V66, P253, DOI 10.1016/j.diagmicrobio.2009.11.001; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Degtyar E, 2009, CELL MICROBIOL, V11, P1219, DOI 10.1111/j.1462-5822.2009.01328.x; Deng JC, 2001, INFECT IMMUN, V69, P6382, DOI 10.1128/IAI.69.10.6382-6390.2001; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diehl N, 2013, VIRUSES-BASEL, V5, P3192, DOI 10.3390/v5123192; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Fortier A, 2011, IMMUNOBIOLOGY, V216, P1274, DOI 10.1016/j.imbio.2011.06.008; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; Franco IS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002546; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Sans-Fons MG, 2013, J INFECT DIS, V207, P1684, DOI 10.1093/infdis/jit084; Guo ZH, 2014, MICROBES INFECT, V16, P225, DOI 10.1016/j.micinf.2013.11.007; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Hubber A, 2014, CURR TOP MICROBIOL, V376, P227, DOI 10.1007/82_2013_343; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Ivanov SS, 2014, CURR TOP MICROBIOL, V376, P135, DOI 10.1007/82_2013_344; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Lomma M, 2010, CELL MICROBIOL, V12, P1272, DOI 10.1111/j.1462-5822.2010.01467.x; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00036; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00031; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; MCCUSKER KT, 1991, INFECT IMMUN, V59, P240, DOI 10.1128/IAI.59.1.240-246.1991; McHugh SL, 2000, J LEUKOCYTE BIOL, V67, P863, DOI 10.1002/jlb.67.6.863; Molmeret M, 2004, CELL MICROBIOL, V6, P33, DOI 10.1046/j.1462-5822.2003.00335.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Neild AL, 2003, IMMUNITY, V18, P813, DOI 10.1016/S1074-7613(03)00140-7; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Park DR, 1996, J IMMUNOL, V157, P2528; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2014, ENVIRON MICROBIOL, V16, P350, DOI 10.1111/1462-2920.12290; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00131; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00122; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; Rimaniol AC, 2001, AM J PHYSIOL-CELL PH, V281, pC1964, DOI 10.1152/ajpcell.2001.281.6.C1964; Rimaniol AC, 2000, J IMMUNOL, V164, P5430, DOI 10.4049/jimmunol.164.10.5430; Rolando M, 2014, TRENDS CELL BIOL; Santic M, 2005, INFECT IMMUN, V73, P3166, DOI 10.1128/IAI.73.5.3166-3171.2005; Schmeck B, 2007, EUR RESPIR J, V29, P25, DOI 10.1183/09031936.00141005; Schunder E, 2014, J BIOL CHEM; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Stavrou S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004145; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Tachado SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003324; Tateda K, 1998, CLIN DIAGN LAB IMMUN, V5, P401, DOI 10.1128/CDLI.5.3.401-403.1998; Tattoli I, 2012, BIOL OPEN, V1, P1215, DOI 10.1242/bio.20122840; Viner R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002988; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yoshizawa S, 2005, INFECT IMMUN, V73, P2709, DOI 10.1128/IAI.73.5.2709-2717.2005; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	100	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114914	10.1371/journal.pone.0114914	http://dx.doi.org/10.1371/journal.pone.0114914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485627	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600105
J	Blanc, F; Noblet, V; Philippi, N; Cretin, B; Foucher, J; Armspach, JP; Rousseau, F				Blanc, Frederic; Noblet, Vincent; Philippi, Nathalie; Cretin, Benjamin; Foucher, Jack; Armspach, Jean-Paul; Rousseau, Francois		Alzheimer's Dis Neuroimaging	Right Anterior Insula: Core Region of Hallucinations in Cognitive Neurodegenerative Diseases	PLOS ONE			English	Article							NEUROIMAGING INITIATIVE ADNI; ATTENTIONAL CONTROL NETWORKS; ALZHEIMERS-DISEASE; LEWY BODIES; VISUAL HALLUCINATIONS; PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; DEMENTIA; SYMPTOMS; CRITERIA	Objectives: We investigated the neural basis of hallucinations Alzheimer's disease (AD) by applying voxel-based morphometry (VBM) to anatomical and functional data from the AD Neuroimaging Initiative. Methods: AD patients with hallucinations, based on the Neuropsychiatric Inventory (NPI-Q) (AD-hallu group; n=39), were compared to AD patients without hallucinations matched for age, sex, educational level, handedness and MMSE (AD-c group; n=39). Focal brain volume on MRI was analyzed and compared between the two groups according to the VBM method. We also performed voxel-level correlations between brain volume and hallucinations intensity. A similar paradigm was used for the PET analysis. "Core regions'' (i.e. regions identified in both MRI and PET analyses, simply done by retaining the clusters obtained from the two analyses that are overlapping) were then determined. Results: Regions with relative atrophy in association with hallucinations were: anterior part of the right insula, left superior frontal gyrus and lingual gyri. Regions with relative hypometabolism in association with hallucinations were a large right ventral and dorsolateral prefrontal area. "Core region" in association with hallucinations was the right anterior part of the insula. Correlations between intensity of hallucinations and brain volume were found in the right anterior insula, precentral gyrus, superior temporal gyrus, and left precuneus. Correlations between intensity of hallucinations and brain hypometabolism were found in the left midcingulate gyrus. We checked the neuropathological status and we found that the 4 patients autopsied in the AD-hallu group had the mixed pathology AD and Dementia with Lewy bodies (DLB). Conclusion: Neural basis of hallucinations in cognitive neurodegenerative diseases (AD or AD and DLB) include a right predominant anterior-posterior network, and the anterior insula as the core region. This study is coherent with the top-down/bottom-up hypotheses on hallucinations but also hypotheses of the key involvement of the anterior insula in hallucinations in cognitive neurodegenerative diseases.	[Blanc, Frederic; Philippi, Nathalie; Cretin, Benjamin] Univ Hosp Strasbourg, Neuropsychol Unit, Neurol Serv, Strasbourg, France; [Blanc, Frederic; Noblet, Vincent; Philippi, Nathalie; Cretin, Benjamin; Foucher, Jack; Armspach, Jean-Paul; Rousseau, Francois] Univ Strasbourg, Strasbourg, France; [Blanc, Frederic; Noblet, Vincent; Philippi, Nathalie; Cretin, Benjamin; Foucher, Jack; Armspach, Jean-Paul; Rousseau, Francois] CNRS, ICube Lab, UMR 7357, FMTS, Strasbourg, France; [Blanc, Frederic; Philippi, Nathalie; Cretin, Benjamin] Univ Hosp Strasbourg, CMRR Memory Resources & Res Ctr, Strasbourg, France; [Blanc, Frederic] Univ Hosp Strasbourg, Day Hosp Geriatr, Geriatr Serv, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg	Blanc, F (corresponding author), Univ Hosp Strasbourg, Neuropsychol Unit, Neurol Serv, Strasbourg, France.	Frederic.Blanc@chru-Strasbourg.fr	Noblet, Vincent/B-3992-2009; Noblet, Vincent/ABE-4264-2020; Blanc, Frederic/AAE-7975-2019; rousseau, francois/B-3338-2008	Blanc, Frederic/0000-0002-6714-3247; rousseau, francois/0000-0001-9837-7487	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE ON AGING [P30AG010129, U01AG024904, K01AG030514] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer Health Care; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org) coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI The grantee organization is the Northern California Institute for Research and Education, and the study is data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ballard C, 1999, AM J PSYCHIAT, V156, P1039; Ballard CG, 2004, AM J PSYCHIAT, V161, P843, DOI 10.1176/appi.ajp.161.5.843; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Collerton D, 2005, BEHAV BRAIN SCI, V28, P737; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Jager CA, 2010, INT J GERIATR PSYCH, V25, P988, DOI 10.1002/gps.2448; Diederich NJ, 2005, MOVEMENT DISORD, V20, P130, DOI 10.1002/mds.20308; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; FORSTL H, 1993, ACTA PSYCHIAT SCAND, V87, P395, DOI 10.1111/j.1600-0447.1993.tb03394.x; Goetz CG, 2014, MOVEMENT DISORD, V29, P115, DOI 10.1002/mds.25554; Goldman JG, 2014, BRAIN, V137, P849, DOI 10.1093/brain/awt360; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Holroyd S, 2000, J NEUROPSYCH CLIN N, V12, P25, DOI 10.1176/jnp.12.1.25; HOWANITZ E, 1995, J NERV MENT DIS, V183, P548, DOI 10.1097/00005053-199508000-00008; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Lin SH, 2006, CLIN IMAG, V30, P388, DOI 10.1016/j.clinimag.2006.09.025; McKeith IG, 2000, NEUROLOGY, V54, P1050, DOI 10.1212/WNL.54.5.1050; MCKEITH IG, 1994, BRIT J PSYCHIAT, V165, P324, DOI 10.1192/bjp.165.3.324; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meppelink AM, 2009, BRAIN, V132, P2980, DOI 10.1093/brain/awp223; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Murgatroyd C, 2001, INT J GERIATR PSYCH, V16, P709, DOI 10.1002/gps.426; Nagahama Y, 2010, BRAIN, V133, P557, DOI 10.1093/brain/awp295; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; O'Brien JT, 2008, NEUROIMAGE, V40, P1056, DOI 10.1016/j.neuroimage.2008.01.010; O'Brien JT, 2005, PSYCHIAT RES-NEUROIM, V139, P79, DOI 10.1016/j.pscychresns.2005.04.002; Onofrj M, 2013, BEHAV NEUROL, V27, P479, DOI [10.3233/BEN-129022, 10.1155/2013/703924]; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sanchez-Castaneda C, 2010, MOVEMENT DISORD, V25, P615, DOI 10.1002/mds.22873; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shine JM, 2014, HUM BRAIN MAPP, V35, P2206, DOI 10.1002/hbm.22321; Shine JM, 2011, MOVEMENT DISORD, V26, P2154, DOI 10.1002/mds.23896; Taylor JP, 2011, BRIT J PSYCHIAT, V199, P492, DOI 10.1192/bjp.bp.110.090373; Toledo JB, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-65; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Zhong JG, 2014, EUR J RADIOL, V83, P1870, DOI 10.1016/j.ejrad.2014.06.014	49	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114774	10.1371/journal.pone.0114774	http://dx.doi.org/10.1371/journal.pone.0114774			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479196	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200126
J	Hua, X; Tan, SN; Bandara, HMHN; Fu, YJ; Liu, SG; Smyth, HDC				Hua, Xin; Tan, Shengnan; Bandara, H. M. H. N.; Fu, Yujie; Liu, Siguo; Smyth, Hugh D. C.			Externally Controlled Triggered-Release of Drug from PLGA Micro and Nanoparticles	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; POLYVINYL-ALCOHOL; IN-VITRO; CANDIDA-ALBICANS; NANOSPHERES; FIELD; CIPROFLOXACIN; MICROSPHERES; DELIVERY	Biofilm infections are extremely hard to eradicate and controlled, triggered and controlled drug release properties may prolong drug release time. In this study, the ability to externally control drug release from micro and nanoparticles was investigated. We prepared micro/nanoparticles containing ciprofloxacin (CIP) and magnetic nanoparticles encapsulated in poly (lactic-co-glycolic acid) PLGA. Both micro/nanoparticles were observed to have narrow size distributions. We investigated and compared their passive and externally triggered drug release properties based on their different encapsulation structures for the nano and micro systems. In passive release studies, CIP demonstrated a fast rate of release in first 2 days which then slowed and sustained release for approximately 4 weeks. Significantly, magnetic nanoparticles containing systems all showed ability to have triggered drug release when exposed to an external oscillating magnetic field (OMF). An experiment where the OMF was turned on and off also confirmed the ability to control the drug release in a pulsatile manner. The magnetically triggered release resulted in a 2-fold drug release increase compared with normal passive release. To confirm drug integrity following release, the antibacterial activity of released drug was evaluated in Pseudomonas aeruginosa biofilms in vitro. CIP maintained its antimicrobial activity after encapsulation and triggered release.	[Hua, Xin; Liu, Siguo] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China; [Tan, Shengnan; Fu, Yujie] Northeast Forestry Univ, State Engn Lab Bioresource Ecoutilizat, Harbin, Peoples R China; [Bandara, H. M. H. N.; Smyth, Hugh D. C.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Forestry University - China; University of Texas System; University of Texas Austin	Liu, SG (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China.	siguo_liu@yahoo.com.cn; hugh.smyth@austin.utexas.edu	Bandara, Nihal/O-7287-2014	Bandara, Nihal/0000-0001-7652-2030; Smyth, Hugh/0000-0002-6582-5869	National Heart, Lung, and Blood Institute of the National Institutes of Health [R33HL092812-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092812] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The National Heart, Lung, and Blood Institute of the National Institutes of Health under R33HL092812-03 provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4; Araujo J, 2009, COLLOID SURFACE B, V72, P48, DOI 10.1016/j.colsurfb.2009.03.028; Arnold MM, 2007, J CONTROL RELEASE, V121, P100, DOI 10.1016/j.jconrel.2007.05.039; Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Blum JS, 2008, J CONTROL RELEASE, V129, P66, DOI 10.1016/j.jconrel.2008.04.002; Chiang WL, 2012, SMALL, V8, P3584, DOI 10.1002/smll.201201743; Cirpanli Y, 2005, J MICROENCAPSUL, V22, P877, DOI 10.1080/02652040500273878; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Fernandez-Pacheco R, 2007, J MAGN MAGN MATER, V311, P318, DOI 10.1016/j.jmmm.2006.11.192; Gorner T, 1999, J CONTROL RELEASE, V57, P259, DOI 10.1016/S0168-3659(98)00121-7; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; Hergt R, 2006, J PHYS-CONDENS MAT, V18, pS2919, DOI 10.1088/0953-8984/18/38/S26; Hickey AJ, 2007, J PHARM SCI-US, V96, P1282, DOI 10.1002/jps.20916; Hilger I, 2002, ACAD RADIOL, V9, P198, DOI 10.1016/S1076-6332(03)80171-X; Hu SH, 2011, CHEM COMMUN, V47, P1776, DOI 10.1039/c0cc03998e; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Kini S, 2011, IEEE T MAGN, V47, P2882, DOI 10.1109/TMAG.2011.2158403; Lee SC, 1999, J CONTROL RELEASE, V59, P123, DOI 10.1016/S0168-3659(98)00185-0; Mahmoudi M, 2009, J PHYS CHEM C, V113, P9573, DOI 10.1021/jp9001516; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mao ZW, 2005, J CONTROL RELEASE, V104, P193, DOI 10.1016/j.jconrel.2005.02.005; McCarthy JR, 2007, NANOMEDICINE-UK, V2, P153, DOI 10.2217/17435889.2.2.153; McGill SL, 2009, IEEE T NANOBIOSCI, V8, P33, DOI 10.1109/TNB.2009.2017292; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Page-Clisson ME, 1998, J CONTROL RELEASE, V56, P23, DOI 10.1016/S0168-3659(98)00065-0; PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X; Peng XH, 2008, INT J NANOMED, V3, P311; Petri-Fink A, 2005, BIOMATERIALS, V26, P2685, DOI 10.1016/j.biomaterials.2004.07.023; Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2; Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002; Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; Roca AG, 2012, IEEE T MAGN, V48, P4054, DOI 10.1109/TMAG.2012.2201459; Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X; Shen JM, 2013, ACS APPL MATER INTER, V5, P7014, DOI 10.1021/am401277s; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Subramani K, 2009, CURR NANOSCI, V5, P135, DOI 10.2174/157341309788185406; Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X; WOOD DM, 2006, COCHRANE DB SYST REV, V1; Xu CJ, 2009, J AM CHEM SOC, V131, P15346, DOI 10.1021/ja905938a; Yin JH, 2006, INT J PHARMACEUT, V314, P46, DOI 10.1016/j.ijpharm.2006.01.047; Young JI, 2003, INT J PHARM, V259, P79, DOI 10.1016/S0378-5173(03)00207-2	45	33	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114271	10.1371/journal.pone.0114271	http://dx.doi.org/10.1371/journal.pone.0114271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479357	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200061
J	Kember, G; Ardell, JL; Armour, JA; Zamir, M				Kember, Guy; Ardell, Jeffrey L.; Armour, John A.; Zamir, Mair			Vagal Nerve Stimulation Therapy: What Is Being Stimulated?	PLOS ONE			English	Article							VAGUS NERVE; NEURAL-CONTROL; HEART	Vagal nerve stimulation in cardiac therapy involves delivering electrical current to the vagal sympathetic complex in patients experiencing heart failure. The therapy has shown promise but the mechanisms by which any benefit accrues is not understood. In this paper we model the response to increased levels of stimulation of individual components of the vagal sympathetic complex as a differential activation of each component in the control of heart rate. The model provides insight beyond what is available in the animal experiment in as much as allowing the simultaneous assessment of neuronal activity throughout the cardiac neural axis. The results indicate that there is sensitivity of the neural network to low level subthreshold stimulation. This leads us to propose that the chronic effects of vagal nerve stimulation therapy lie within the indirect pathways that target intrinsic cardiac local circuit neurons because they have the capacity for plasticity.	[Kember, Guy] Dalhousie Univ, Dept Engn Math, Halifax, NS, Canada; [Ardell, Jeffrey L.; Armour, John A.] E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Zamir, Mair] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Zamir, Mair] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	Dalhousie University; East Tennessee State University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Zamir, M (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada.	zamir@uwo.ca			Natural Sciences and Engineering Research Council of Canada; National Institute of Health [348 (HL71830)]; Cyberonics, Inc. (Houston, Texas); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071830] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cyberonics, Inc. (Houston, Texas); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Theoretical work was supported by the Natural Sciences and Engineering Research Council of Canada via two individual discovery grants to GK and MZ. Experimental work was supported by two grants to JLA, one from the National Institute of Health 348 (HL71830) and another from Cyberonics, Inc. (Houston, Texas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Bailey P, 1938, J NEUROPHYSIOL, V1, P405, DOI 10.1152/jn.1938.1.5.405; Beaumont E, 2013, J PHYSIOL-LONDON, V591, P4515, DOI 10.1113/jphysiol.2013.259382; Cook IA, 2014, NEUROSURG CLIN N AM, V25, P103, DOI 10.1016/j.nec.2013.10.002; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Dicarlo L, 2013, J CARD FAIL, V19, P655, DOI 10.1016/j.cardfail.2013.07.002; Foley JO, 1937, J COMP NEUROL, V67, P49, DOI 10.1002/cne.900670104; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Howland Robert H, 2014, Curr Behav Neurosci Rep, V1, P64; Kasanuki H, 1997, CIRCULATION, V95, P2277, DOI 10.1161/01.CIR.95.9.2277; Kember G, 2013, PHYSIOL GENOMICS, V45, P638, DOI 10.1152/physiolgenomics.00027.2013; Kember G, 2013, J THEOR BIOL, V317, P39, DOI 10.1016/j.jtbi.2012.09.024; Kember G, 2011, J THEOR BIOL, V277, P41, DOI 10.1016/j.jtbi.2011.02.013; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P429, DOI 10.1097/00004691-200109000-00007; Krahl SE, 2001, EPILEPSIA, V42, P586, DOI 10.1046/j.1528-1157.2001.09700.x; Nahas Z, 2005, J CLIN PSYCHIAT, V66, P1097, DOI 10.4088/JCP.v66n0902; Osman Faizel, 2010, Indian Pacing Electrophysiol J, V10, P104; RANDALL WC, 1985, AM J PHYSIOL, V248, pH61, DOI 10.1152/ajpheart.1985.248.1.H61; RANDALL WC, 1977, NEURAL REGULATION HE; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Shiozawa P, 2014, ARQ NEURO-PSIQUIAT, V72, P542, DOI 10.1590/0004-282X20140061; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Williamson JW, 2006, EXP PHYSIOL, V91, P51, DOI 10.1113/expphysiol.2005.032037; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; Zare Mohammad, 2014, Adv Biomed Res, V3, P81, DOI 10.4103/2277-9175.127994; Zhang YH, 2011, HEART FAIL REV, V16, P147, DOI 10.1007/s10741-010-9178-2; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	28	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114498	10.1371/journal.pone.0114498	http://dx.doi.org/10.1371/journal.pone.0114498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479368	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200095
J	Liu, JH; Zhou, T; Zhang, ZK; Yang, ZM; Liu, C; Li, WM				Liu, Jin-Hu; Zhou, Tao; Zhang, Zi-Ke; Yang, Zimo; Liu, Chuang; Li, Wei-Min			Promoting Cold-Start Items in Recommender Systems	PLOS ONE			English	Article							NETWORKS	As one of the major challenges, cold-start problem plagues nearly all recommender systems. In particular, new items will be overlooked, impeding the development of new products online. Given limited resources, how to utilize the knowledge of recommender systems and design efficient marketing strategy for new items is extremely important. In this paper, we convert this ticklish issue into a clear mathematical problem based on a bipartite network representation. Under the most widely used algorithm in real e-commerce recommender systems, the so-called item-based collaborative filtering, we show that to simply push new items to active users is not a good strategy. Interestingly, experiments on real recommender systems indicate that to connect new items with some less active users will statistically yield better performance, namely, these new items will have more chance to appear in other users' recommendation lists. Further analysis suggests that the disassortative nature of recommender systems contributes to such observation. In a word, getting in-depth understanding on recommender systems could pave the way for the owners to popularize their cold-start products with low costs.	[Liu, Jin-Hu; Zhou, Tao; Yang, Zimo; Li, Wei-Min] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Liu, Jin-Hu; Zhou, Tao] Univ Elect Sci & Technol China, Big Data Res Ctr, Chengdu 610054, Peoples R China; [Zhang, Zi-Ke; Liu, Chuang] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Zimo] Alibaba Grp, Hangzhou, Zhejiang, Peoples R China; [Li, Wei-Min] Beijing Baifendian Informat Technol Co Ltd, Beijing, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Hangzhou Normal University; Alibaba Group	Zhou, T (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.	zhutou@ustc.edu	chuang, liu/AAH-1377-2021; zhou, tao/GQA-3572-2022	Zhou, Tao/0000-0003-0561-2316	National Natural Science Foundation of China [11222543, 61433014]; Special Project of Sichuan Youth Science and Technology Innovation Research Team [2013TD0006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Project of Sichuan Youth Science and Technology Innovation Research Team	This work was partially supported by the National Natural Science Foundation of China under grant nos. 11222543 and 61433014, and the Special Project of Sichuan Youth Science and Technology Innovation Research Team under grant no. 2013TD0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bunte K, 2012, NEURAL NETWORKS, V26, P159, DOI 10.1016/j.neunet.2011.10.001; Cantador I., 2010, RECSYS, P237, DOI [10.1145/ 1864708.1864756, DOI 10.1145/1864708.1864756]; Deshpande M, 2004, ACM T INFORM SYST, V22, P143, DOI 10.1145/963770.963776; Fee CE, 2009, REV FINANC STUD, V22, P2361, DOI 10.1093/rfs/hhn059; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Goncalves B, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026123; Huang Z, 2004, ACM T INFORM SYST, V22, P116, DOI 10.1145/963770.963775; Huang Z, 2007, MANAGE SCI, V53, P1146, DOI 10.1287/mnsc.1060.0619; Kim HN, 2010, LECT NOTES COMPUTER, P291; Koren Y., 2011, ACM C REC SYST RECSY, P117; Lam S. K., 2004, P 13 INT C WORLD WID, P393, DOI DOI 10.1145/988672.988726; Lambiotte R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066107; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Mehta B, 2007, 2007 INTERNATIONAL CONFERENCE ON INTELLIGENT USER INTERFACES, P14; Mobasher B., 2005, P 2005 WEBKDD WORKSH; Mobasher B, 2007, ACM T INTERNET TECHN, V7, DOI 10.1145/1278366.1278372; Mobasher B, 2006, LECT NOTES ARTIF INT, V4198, P96; Niemann K, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P955; Park Seung-Taek, 2009, P 3 ACM C REC SYST, P21, DOI DOI 10.1145/1639714.1639720; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Ricci F, 2011, RECOMMENDER SYSTEMS HANDBOOK, P1, DOI 10.1007/978-0-387-85820-3_1; Ronen R., 2013, P 7 ACM C REC SYST, P407; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Schein A. I., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P253, DOI 10.1145/564376.564421; Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006; Shardanand U., 1995, Human Factors in Computing Systems. CHI'95 Conference Proceedings, P210, DOI 10.1145/223904.223931; Takacs G., 2007, ACM SIGKDD EXPLOR NE, V9, P80, DOI DOI 10.1145/1345448.134546; Verhoef PC, 2009, J MARKETING, V73, P14, DOI 10.1509/jmkg.73.2.14; Yang ZM, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/68002; Yin D., 2013, P 6 ACM INT C WEB SE, P547, DOI DOI 10.1145/2433396.2433466; Zeng W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06140; Zhang CJ, 2012, PHYSICA A, V391, P1822, DOI 10.1016/j.physa.2011.09.038; Zhang Liang, 2013, Journal of University of Electronic Science and Technology of China, V42, P154, DOI 10.3969/j.issn.1001-0548.2013.01.031; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062624; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhou JL, 2011, J COMPUT SCI TECH-CH, V26, P816, DOI 10.1007/s11390-011-0180-5; Zhou T, 2011, NEW J PHYS, V11; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	52	18	18	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113457	10.1371/journal.pone.0113457	http://dx.doi.org/10.1371/journal.pone.0113457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479013	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200021
J	Rajmil, L; Robles, N; Rodriguez-Arjona, D; Azuara, M; Codina, F; Raat, H; Ravens-Sieberer, U				Rajmil, Luis; Robles, Noemi; Rodriguez-Arjona, Dolors; Azuara, Marta; Codina, Francisco; Raat, Hein; Ravens-Sieberer, Ulrike			Comparison of the Web-Based and Digital Questionnaires of the Spanish and Catalan Versions of the KIDSCREEN-52	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH BEHAVIOR; RELIABILITY; CHILDREN; VALIDITY; ADOLESCENTS; INTERNET; TIME	Background: The objectives of the study were to develop web-based Spanish and Catalan versions of the KIDSCREEN, and to compare scores and psychometric properties with the paper version. Methods: Internet and paper Spanish and Catalan versions of the KIDSCREEN-52 were included in a cross-sectional study in school-age children. Web-based and paper Spanish or Catalan versions of the KIDSCREEN-52 were administered to students aged 8 to 18 years from primary and secondary schools in Palafolls (Barcelona, Spain, n=923). All students completed both web-based and paper versions during school time with an interval of at least 2 hours between administrations. The order of administration was randomized. The KIDSCREEN-52, the Strengths and Difficulties Questionnaire (SDQ), and sociodemographic variables were collected. Missing values, floor and ceiling effects, and internal consistency were compared between both versions, as well as mean score differences, level of agreement, and known groups and construct validity. Results: Participation rate was 77% (n=715). Web-based and paper versions showed low percentage of missing values and similar high ceiling effect (range 0 to 44%). Mean score differences showed an effect size (ES) lower than 0.2 in all dimensions. Internal consistency ranged from 0.7 to 0.88, and degree of agreement was excellent (Intraclass correlation coefficient [ICC] range 0.75 to 0.87). Expected differences were seen by sex, age, socioeconomic status and mental health status. Conclusions: The web-based KIDSCREEN-52 showed similar scale score and reliability and validity than the paper version. It will incorporate the child population in the assessment of quality of life providing a more attractive format.	[Rajmil, Luis; Robles, Noemi; Rodriguez-Arjona, Dolors] Agencia Qualitat & Avaluacio Sanitaries Catalunya, Barcelona, Spain; [Rajmil, Luis] IMIM Inst Hosp Mar Recerca Biomed, Barcelona, Spain; [Rajmil, Luis] Ctr Invest Epidemiol Red CIBERESP, Madrid, Spain; [Azuara, Marta; Codina, Francisco] Corp Salut Maresme & Selva, Calella 08370, Spain; [Raat, Hein] Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Ravens-Sieberer, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, D-20246 Hamburg, Germany	Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Erasmus University Rotterdam; Erasmus MC; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rajmil, L (corresponding author), Agencia Qualitat & Avaluacio Sanitaries Catalunya, Barcelona, Spain.	lrajmil@gencat.cat		Rajmil, Luis/0000-0002-6625-0649; Robles, Noemi/0000-0003-0740-9098	Spanish Ministry of Health [PI12/01296]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The study was financed by the Spanish Ministry of Health (contract number PI12/01296). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Arrindell WA, 2001, BEHAV RES THER, V39, P1227, DOI 10.1016/S0005-7967(00)00104-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Embretson S. E., 2013, ITEM RESPONSE THEORY; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gwaltney CJ, 2008, VALUE HEALTH, V11, P322, DOI 10.1111/j.1524-4733.2007.00231.x; Haverman L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-3; Pardo-Guijarro MJ, 2013, GAC SANIT, V27, P318, DOI 10.1016/j.gaceta.2012.11.003; Lloyd K, 2011, QUAL LIFE RES, V20, P37, DOI 10.1007/s11136-010-9728-z; Mangunkusumo RT, 2006, J SCHOOL HEALTH, V76, P80, DOI 10.1111/j.1746-1561.2006.00072.x; Mangunkusumo RT., 2005, J ADOLESCENT HEALTH, V36, P70, DOI DOI 10.1016/J.JADOHEALTH.2004.02.020; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pardo Cladellas Y, 2007, THESIS U AUTONOMA BA; Prieto L, 1998, MED CLIN-BARCELONA, V110, P142; Raat H, 2007, QUAL LIFE RES, V16, P675, DOI 10.1007/s11136-006-9157-1; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Ravens-Sieberer U, 2014, QUAL LIFE RES, V23, P791, DOI 10.1007/s11136-013-0428-3; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Schreier G, 2014, STUD HEALTH TECHNOL, V200, P22, DOI 10.3233/978-1-61499-393-3-22; Tebe C, 2008, MED CLIN-BARCELONA, V130, P650, DOI 10.1157/13120999; The Kidscreen Group Europe, 2006, KIDSCREEN QUESTIONNA; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867	28	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114527	10.1371/journal.pone.0114527	http://dx.doi.org/10.1371/journal.pone.0114527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25479465	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200097
J	Zhao, CH; Qi, JZ; Tao, WX; He, L; Xu, W; Chan, J; Deng, ZX				Zhao, Chunhua; Qi, Jianzhao; Tao, Weixing; He, Lei; Xu, Wei; Chan, Jason; Deng, Zixin			Characterization of Biosynthetic Genes of Ascamycin/Dealanylascamycin Featuring a 5 '-O-Sulfonamide Moiety in Streptomyces sp. JCM9888	PLOS ONE			English	Article							PEPTIDYL NUCLEOSIDE ANTIBIOTICS; HETEROLOGOUS EXPRESSION; SELECTIVE TOXICITY; PACIDAMYCIN GROUP; BOND FORMATION; CLUSTER; NUCLEOCIDIN; ASCAMYCIN; IDENTIFICATION; SULFOTRANSFERASE	Ascamycin (ACM) and dealanylascamycin (DACM) are nucleoside antibiotics elaborated by Streptomyces sp. JCM9888. The later shows broad spectrum inhibition activity to various gram-positive and gram-negative bacteria, eukaryotic Trypanosoma and is also toxic to mice, while ascamycin is active against very limited microorganisms, such as Xanthomonas. Both compounds share an unusual 5'-O-sulfonamide moiety which is attached to an adenosine nucleoside. In this paper, we first report on the 30 kb gene cluster (23 genes, acmA to acmW) involved in the biosynthesis of these two antibiotics and a biosynthetic assembly line was proposed. Of them, six genes (AcmABGKIW) are hypothetical genes involved in 5'-O-sulfonamide formation. Two flavin adenine dinucleotide (FAD)-dependent chlorinase genes acmX and acmY were characterized which are significantly remote from acmA-W and postulated to be required for adenine C2-halogenation. Notably gene disruption of acmE resulted in a mutant which could only produce dealanylascamycin but was blocked in its ability to biosynthesize ascamycin, revealing its key role of conversion of dealanylascamycin to ascamycin.	[Zhao, Chunhua; Qi, Jianzhao; Tao, Weixing; He, Lei; Xu, Wei; Deng, Zixin] Wuhan Univ, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, Wuhan 430071, Peoples R China; [Zhao, Chunhua; Qi, Jianzhao; Tao, Weixing; He, Lei; Xu, Wei; Deng, Zixin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China; [Chan, Jason] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China	Wuhan University; Wuhan University; Hong Kong University of Science & Technology	Zhao, CH (corresponding author), Wuhan Univ, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, 185 East Lake Rd, Wuhan 430071, Peoples R China.	zhaochunhua@whu.edu.cn; zxdeng@sjtu.edu.cn	Qi, Jianzhao/ABF-3423-2021	Qi, Jianzhao/0000-0003-1418-873X; Chan, K K Jason/0000-0002-7472-7232; Xu, Wei/0000-0003-0653-7805	973 Program, Ministry of Science and Technology, China [2009CB118901, 2012CB721002]; National Natural Science Foundation of China	973 Program, Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge grants from the 973 Program (2009CB118901, 2012CB721002), Ministry of Science and Technology, China, and the National Natural Science Foundation of China. CZ is a recipient of China postdoctoral training project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruntner C, 1999, MOL GEN GENET, V262, P102; Butler A, 2009, NATURE, V460, P848, DOI 10.1038/nature08303; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Chen WQ, 2009, J BIOL CHEM, V284, P10627, DOI 10.1074/jbc.M807534200; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; FLORINI JR, 1966, J BIOL CHEM, V241, P1091; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; ISONO K, 1984, J ANTIBIOT, V37, P670, DOI 10.7164/antibiotics.37.670; JAFFE JJ, 1970, EXP PARASITOL, V28, P535, DOI 10.1016/0014-4894(70)90121-9; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Kalan L, 2013, CHEM BIOL, V20, P1214, DOI 10.1016/j.chembiol.2013.09.006; Kaysser L, 2010, J BIOL CHEM, V285, P12684, DOI 10.1074/jbc.M109.094490; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KIRST HA, 1985, J ANTIBIOT, V38, P575, DOI 10.7164/antibiotics.38.575; KOBASHI K, 1986, ARCH BIOCHEM BIOPHYS, V245, P537, DOI 10.1016/0003-9861(86)90247-X; LACALLE RA, 1992, EMBO J, V11, P785, DOI 10.1002/j.1460-2075.1992.tb05112.x; Li JN, 2011, METAB ENG, V13, P336, DOI 10.1016/j.ymben.2011.01.002; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; MORTON GO, 1969, J AM CHEM SOC, V91, P1535, DOI 10.1021/ja01034a046; Niu GQ, 2013, CHEM BIOL, V20, P34, DOI 10.1016/j.chembiol.2012.10.017; OSADA H, 1986, J ANTIBIOT, V39, P286, DOI 10.7164/antibiotics.39.286; OSADA H, 1985, ANTIMICROB AGENTS CH, V27, P230, DOI 10.1128/AAC.27.2.230; OSADA H, 1986, BIOCHEM J, V233, P459, DOI 10.1042/bj2330459; Rackham EJ, 2010, CHEMBIOCHEM, V11, P1700, DOI 10.1002/cbic.201000200; Sambrook J., 2001, MOL CLONING LAB MANU; SHUMAN DA, 1970, J AM CHEM SOC, V92, P3434, DOI 10.1021/ja00714a035; SHUMAN DA, 1969, J AM CHEM SOC, V91, P3391, DOI 10.1021/ja01040a062; Sudo T, 1996, BIOCHEM J, V319, P99, DOI 10.1042/bj3190099; TAKAHASHI E, 1982, J ANTIBIOT, V35, P939, DOI 10.7164/antibiotics.35.939; Tang XY, 2013, NAT CHEM BIOL, V9, P610, DOI [10.1038/NCHEMBIO.1310, 10.1038/nchembio.1310]; Ubukata M, 1985, Nucleic Acids Symp Ser, P81; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Walsh CT, 2011, ACS CHEM BIOL, V6, P1000, DOI 10.1021/cb200284p; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Wu J, 2012, CHEMBIOCHEM, V13, P1613, DOI 10.1002/cbic.201200173; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Zhang GY, 2012, APPL ENVIRON MICROB, V78, P2393, DOI 10.1128/AEM.07185-11; Zhang WJ, 2011, P NATL ACAD SCI USA, V108, P12249, DOI 10.1073/pnas.1109539108; Zhang WJ, 2010, P NATL ACAD SCI USA, V107, P16828, DOI 10.1073/pnas.1011557107	46	19	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114722	10.1371/journal.pone.0114722	http://dx.doi.org/10.1371/journal.pone.0114722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479601	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200116
J	Kaushik, P; Molinelli, EJ; Miller, ML; Wang, WQ; Korkut, A; Liu, WB; Ju, ZL; Lu, YL; Mills, G; Sander, C				Kaushik, Poorvi; Molinelli, Evan J.; Miller, Martin L.; Wang, Weiqing; Korkut, Anil; Liu, Wenbin; Ju, Zhenlin; Lu, Yiling; Mills, Gordon; Sander, Chris			Spatial Normalization of Reverse Phase Protein Array Data	PLOS ONE			English	Article							MICROARRAYS; NETWORKS; VALIDATION; ACTIVATION; PATHWAYS	Reverse phase protein arrays (RPPA) are an efficient, high-throughput, cost-effective method for the quantification of specific proteins in complex biological samples. The quality of RPPA data may be affected by various sources of error. One of these, spatial variation, is caused by uneven exposure of different parts of an RPPA slide to the reagents used in protein detection. We present a method for the determination and correction of systematic spatial variation in RPPA slides using positive control spots printed on each slide. The method uses a simple bi-linear interpolation technique to obtain a surface representing the spatial variation occurring across the dimensions of a slide. This surface is used to calculate correction factors that can normalize the relative protein concentrations of the samples on each slide. The adoption of the method results in increased agreement between technical and biological replicates of various tumor and cell-line derived samples. Further, in data from a study of the melanoma cell-line SKMEL-133, several slides that had previously been rejected because they had a coefficient of variation (CV) greater than 15%, are rescued by reduction of CV below this threshold in each case. The method is implemented in the R statistical programing language. It is compatible with MicroVigene and SuperCurve, packages commonly used in RPPA data analysis.	[Kaushik, Poorvi; Molinelli, Evan J.; Miller, Martin L.; Wang, Weiqing; Korkut, Anil; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Lu, Yiling; Mills, Gordon] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Liu, Wenbin; Ju, Zhenlin] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kaushik, P (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	pkaushik@cbio.mskcc.org		Miller, Martin L/0000-0003-3161-8690	National Cancer Institute, Systems Biology of Diversity in Cancer [1 U 54 CA148967]; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CANCER INSTITUTE [P30CA016672, U54CA148967] Funding Source: NIH RePORTER	National Cancer Institute, Systems Biology of Diversity in Cancer; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this study was provided by the National Cancer Institute grant 1 U 54 CA148967, Systems Biology of Diversity in Cancer (C. Sander, PI). Additional support was provided by the Tri-Institutional Training Program in Computational Biology and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 2009, PROTEOMICS, V9, P5562, DOI 10.1002/pmic.200900505; Aoki H, 2007, FASEB J, V21, P2918, DOI 10.1096/fj.06-6941com; Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Bender C, 2010, BIOINFORMATICS, V26, pi596, DOI 10.1093/bioinformatics/btq385; Charboneau Lu, 2002, Briefings in Functional Genomics & Proteomics, V1, P305, DOI 10.1093/bfgp/1.3.305; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200; Espina V, 2009, CLIN LAB MED, V29, P1, DOI 10.1016/j.cll.2009.03.001; Espina Virginia, 2008, V441, P113, DOI 10.1007/978-1-60327-047-2_8; Gulmann C, 2009, J PATHOL, V218, P514, DOI 10.1002/path.2561; Havelund BM, 2012, APPL IMMUNOHISTOCHEM; Kevin Coombes WL, 2012, SUPERCURVE; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lavezzari G, 2012, METHODS MOL BIOL, V795, P203, DOI 10.1007/978-1-61779-337-0_14; Liang C, 2004, IBCS 11 ANN INT C CH; Listgarten Jennifer, 2003, Appl Bioinformatics, V2, P219; Ma Y, 2006, CLIN CANCER RES, V12, P4583, DOI 10.1158/1078-0432.CCR-06-0290; Martiny-Baron G, 2011, METHODS MOL BIOL, V785, P79, DOI 10.1007/978-1-61779-286-1_7; Molero C, 2009, PROTEOMICS, V9, P3652, DOI 10.1002/pmic.200800907; Neeley ES, 2012, CANCER INFORM, V11, P77, DOI 10.4137/CIN.S9055; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Nishizuka SS, 2011, METHODS MOL BIOL, V785, P65, DOI 10.1007/978-1-61779-286-1_6; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Silvestri A, 2010, LAB INVEST, V90, P787, DOI 10.1038/labinvest.2010.47; Strosznajder RP, 2005, MOL NEUROBIOL, V31, P149, DOI 10.1385/MN:31:1-3:149; Terfve C, 2012, ADV EXP MED BIOL, V736, P19, DOI 10.1007/978-1-4419-7210-1_2; Troncale S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038686; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; Verdugo RA, 2009, NUCLEIC ACIDS RES, V37, P5610, DOI 10.1093/nar/gkp573; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e97213	10.1371/journal.pone.0097213	http://dx.doi.org/10.1371/journal.pone.0097213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501559	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400001
J	Rybakin, V; Westernberg, L; Fu, G; Kim, HO; Ampudia, J; Sauer, K; Gascoigne, NRJ				Rybakin, Vasily; Westernberg, Luise; Fu, Guo; Kim, Hee-Ok; Ampudia, Jeanette; Sauer, Karsten; Gascoigne, Nicholas R. J.			Allelic Exclusion of TCR alpha-Chains upon Severe Restriction of V alpha Repertoire	PLOS ONE			English	Article							T-CELL-RECEPTOR; POSITIVE SELECTION; EXPRESSION; GENES; INCLUSION; SURFACE	Development of thymocytes through the positive selection checkpoint requires the rearrangement and expression of a suitable T cell receptor (TCR) alpha-chain that can pair with the already-expressed beta-chain to make a TCR that is selectable. That is, it must have sufficient affinity for self MHC-peptide to induce the signals required for differentiation, but not too strong so as to induce cell death. Because both alleles of the alpha-chain continue to rearrange until a positively-selectable heterodimer is formed, thymocytes and T cells can in principle express dual alpha-chains. However, cell-surface expression of two TCRs is comparatively rare in mature T cells because of post-transcriptional regulatory mechanisms termed "phenotypic allelic exclusion". We produced mice transgenic for a rearranged beta-chain and for two unrearranged alpha-chains on a genetic background where endogenous alpha-chains could not be rearranged. Both V alpha 3.2 and V alpha 2 containing alpha-chains were efficiently positively selected, to the extent that a population of dual alpha-chain-bearing cells was not distinguishable from single alpha-chain-expressors. Surprisingly, V alpha 3.2-expressing cells were much more frequent than the V alpha 2 transgene-expressing cells, even though this V alpha 3.2-V beta 5 combination can reconstitute a known selectable TCR. In accord with previous work on the V alpha 3 repertoire, T cells bearing V alpha 3.2 expressed from the rearranged minilocus were predominantly selected into the CD8(+) T cell subpopulation. Because of the dominance of V alpha 3.2 expression over V alpha 2 expressed from the miniloci, the peripheral T cell population was predominantly CD8(+) cells.	[Rybakin, Vasily; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117545, Singapore; [Rybakin, Vasily; Westernberg, Luise; Fu, Guo; Kim, Hee-Ok; Ampudia, Jeanette; Sauer, Karsten; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sauer, Karsten] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National University of Singapore; Scripps Research Institute; Scripps Research Institute	Gascoigne, NRJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, 5 Sci Dr 2, Singapore 117545, Singapore.	micnrjg@nus.edu.sg	Rybakin, Vasily/J-6310-2019	Rybakin, Vasily/0000-0002-5093-1757	NIH [GM065230, GM048002]; National University of Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048002, R01GM065230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM065230 and GM048002 and by National University of Singapore. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health, nor of NUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This is TSRI manuscript number 24007.	ALAM SM, 1995, IMMUNITY, V3, P449; Alam SM, 1998, J IMMUNOL, V160, P3883; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Boyd R, 1998, J IMMUNOL, V161, P1718; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; Dave VP, 1999, J IMMUNOL, V162, P5764; de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Elliott JI, 1996, EUR J IMMUNOL, V26, P953, DOI 10.1002/eji.1830260436; Gascoigne NRJ, 1999, SEMIN IMMUNOL, V11, P337, DOI 10.1006/smim.1999.0190; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; HEATH WR, 1995, EUR J IMMUNOL, V25, P1617, DOI 10.1002/eji.1830250622; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; KOUSKOFF V, 1995, EUR J IMMUNOL, V25, P54, DOI 10.1002/eji.1830250111; Lacorazza HD, 2004, J IMMUNOL, V173, P5591, DOI 10.4049/jimmunol.173.9.5591; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Niederberger N, 2003, J IMMUNOL, V170, P4557, DOI 10.4049/jimmunol.170.9.4557; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PIRCHER H, 1992, EUR J IMMUNOL, V22, P399, DOI 10.1002/eji.1830220217; Sant'Angelo DB, 2001, P NATL ACAD SCI USA, V98, P6824, DOI 10.1073/pnas.121179998; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sim BC, 1998, J IMMUNOL, V160, P1204; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Sim BC, 1998, CURR BIOL, V8, P701, DOI 10.1016/S0960-9822(98)70276-3; Simmons KB, 2012, CELL IMMUNOL, V272, P124, DOI 10.1016/j.cellimm.2011.10.022; UTSUNOMIYA Y, 1989, J IMMUNOL, V143, P2602	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114320	10.1371/journal.pone.0114320	http://dx.doi.org/10.1371/journal.pone.0114320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500569	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400027
J	Balanoff, AM; Bever, GS; Norell, MA				Balanoff, Amy M.; Bever, G. S.; Norell, Mark A.			Reconsidering the Avian Nature of the Oviraptorosaur Brain (Dinosauria: Theropoda)	PLOS ONE			English	Article							ENDOCRANIAL CAVITY; ANATOMY; SIZE; AVES; EAR	The high degree of encephalization characterizing modern birds is the product of a long evolutionary history, our understanding of which is still largely in its infancy. Here we provide a redescription of the endocranial space of the oviraptorosaurian dinosaur Conchoraptor gracilis with the goal of assessing the hypothesis that it shares uniquely derived endocranial characters with crown-group avians. The existence of such features has implications for the transformational history of avian neuroanatomy and suggests that the oviraptorosaur radiation is a product of the immediate stem lineage of birds-after the divergence of Archaeopteryx lithographica. Results derived from an expanded comparative sample indicate that the strong endocranial similarity between Conchoraptor and modern birds largely reflects shared conservation of plesiomorphic features. The few characters that are maintained as being uniquely expressed in these two taxa are more likely products of convergence than homology but still indicate that the oviraptorosaur endocranial cavity has much to teach us about the complex history of avian brain evolution.	[Balanoff, Amy M.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Bever, G. S.] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Balanoff, Amy M.; Bever, G. S.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York Institute Technology; American Museum of Natural History (AMNH)	Balanoff, AM (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	abalanoff@gmail.com			NSF [DEB-0909970]; Columbia University	NSF(National Science Foundation (NSF)); Columbia University	Funding for this project was provided by an NSF Dissertation Improvement Grant (NSF DEB-0909970) to AMB and MAN and a travel award from Columbia University to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Aslan K, 2006, REV MED VET-TOULOUSE, V157, P619; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; BAUMEL JJ, 1968, AM J ANAT, V122, P1, DOI 10.1002/aja.1001220102; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Brusatte SL, 2013, B AM MUS NAT HIST, P3; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Edinger T, 1942, Q REV BIOL, V17, P31, DOI 10.1086/394644; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Hopson J. A., 1979, PALEONEUROLOGY INGAN, P39; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kawabe S, 2013, J ANAT, V223, P495, DOI 10.1111/joa.12109; Ksepka DT, 2012, ZOOL J LINN SOC-LOND, V166, P202, DOI 10.1111/j.1096-3642.2012.00835.x; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; LARSELL O, 1967, THE COMPARATIVE ANAT; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Norell MA, 2009, AM MUS NOVIT, P1; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; OSMOLSKA H, 2004, OSMOISKA HEDITORS DI, P165; Paul G. S., 2002, DINOSAURS AIR EVOLUT; Picasso MBJ, 2010, BRAIN BEHAV EVOLUT, V76, P176, DOI 10.1159/000321173; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Smith NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049584; Turner AH, 2012, B AM MUS NAT HIST, P5; Walsh S, 2011, J SYST PALAEONTOL, V9, P173, DOI 10.1080/14772019.2010.513703; Walsh SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067176; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045	46	28	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113559	10.1371/journal.pone.0113559	http://dx.doi.org/10.1371/journal.pone.0113559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494183	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400015
J	Hui, SSC; Hui, GPS; Xie, YJ				Hui, Stanley Sai-Chuen; Hui, Grace Pui-Sze; Xie, Yao Jie			Association between Physical Activity Knowledge and Levels of Physical Activity in Chinese Adults with Type 2 Diabetes	PLOS ONE			English	Article							NATIONAL-HEALTH; LEISURE-TIME; LIFE-STYLE; US ADULTS; EXERCISE; DIET; PREVENTION; MELLITUS; RECOMMENDATIONS; PREDICTORS	Background: Physical activity (PA) is an important treatment regimen for diabetes. The purposes of this study were to evaluate people's knowledge of how exercise influences wellbeing (termed "PA knowledge'' or "knowledge of PA'' in this paper) and the resulting association with levels of PA in Chinese adults with Type 2 diabetes, and to identify the valuable demographic and lifestyle factors that possibly influence the association between PA knowledge and level of PA. Methods: Two hundred and fifty-eight adults with Type 2 diabetes completed an interviewer-administered survey at a diabetes clinic in Hong Kong. Data on demographics, lifestyle factors and diabetes-related medical indicators were obtained. A 20-item questionnaire was developed to measure PA-related knowledge (one point scored for each correct answer; aggregate score up to 20 points). level of PA was measured by the International Physical Activity Questionnaire. Results: The proportions of correct answers to each question ranged from 19.4 to 90.7%. Compared with poorly educated participants, those with university education level and above had PA knowledge scores 1.7 points higher (14.3 vs. 12.6, P<0.05). Younger, female, and obese participants were more likely to have lower level of PA (all P<0.05). After adjustment for age, gender, (BMI) and education level, the odds of having a moderate-to-high level of PA was 19% greater with 1 unit increase in PA knowledge score [95% confidence interval (CI): 1.09-1.29; P<0.001], this association was strongest in participants with tertiary education level or above [odds ratio (OR): 1.35; 95% CI: 1.03-1.77; P<0.05]. Conclusions: PA knowledge was positively associated with level of PA. Education level significantly influenced the association between PA knowledge and level of PA, leading to the suggestion of vulnerable groups to target for PA improvement in the face of diabetes.	[Hui, Stanley Sai-Chuen; Xie, Yao Jie] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Hong Kong, Peoples R China; [Hui, Grace Pui-Sze] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; United Christian Hospital	Hui, SSC (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Hong Kong, Peoples R China.	hui2162@cuhk.edu.hk	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; HUI, Stanley Sai-chuen/0000-0002-2462-4622				Bandura A., 1986, SOCIAL FDN THOUGHT A; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Department of Health of HKSAR, 2009, LEV PHYS ACT 2009; DISHMAN RK, 1985, PUBLIC HEALTH REP, V100, P158; DISHMAN RK, 1990, EXERCISE, FITNESS, AND HEALTH, P75; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; FORD ES, 1995, DIABETES CARE, V18, P27, DOI 10.2337/diacare.18.1.27; Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706; Hong Kong Sports Development Board, 1999, SPORTS PART SURV 199; Hui SSC, 2001, J AGING PHYS ACTIV, V9, P372, DOI 10.1123/japa.9.4.372; International Diabetes Federation, 2013, IDF DIAB ALT; International Obesity Task Force, 2000, AS PAC PERSP RED OB; Kandula NR, 2005, ANN EPIDEMIOL, V15, P257, DOI 10.1016/j.annepidem.2004.06.006; Kelly Cynthia W, 2007, AAOHN J, V55, P253; Kirk AF, 2007, DIABETIC MED, V24, P809, DOI 10.1111/j.1464-5491.2007.02190.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krug L M, 1991, Diabetes Educ, V17, P185, DOI 10.1177/014572179101700314; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Macfarlane DJ, 2007, J SCI MED SPORT, V10, P45, DOI 10.1016/j.jsams.2006.05.003; Mitchell R, 1994, Asia Pac J Public Health, V7, P218; Morrow JR, 2004, RES Q EXERCISE SPORT, V75, P231, DOI 10.1080/02701367.2004.10609156; Mynarski W, 2012, DIABETES RES CLIN PR, V98, P46, DOI 10.1016/j.diabres.2012.05.024; Nelson KM, 2002, DIABETES, V51, pA61; Ohta T, 1999, J AGING PHYS ACTIV, V7, P231, DOI 10.1123/japa.7.3.231; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; RK D, 1994, ADV EXERCISE ADHEREN, P1; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; VEGA WA, 1987, PREV MED, V16, P696, DOI 10.1016/0091-7435(87)90052-1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhao G, 2008, DIABETIC MED, V25, P221, DOI 10.1111/j.1464-5491.2007.02332.x	35	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115098	10.1371/journal.pone.0115098	http://dx.doi.org/10.1371/journal.pone.0115098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493559	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400095
J	Nishimata, H; Ohara-Nemoto, Y; Baba, TT; Hoshino, T; Fujiwara, T; Shimoyama, Y; Kimura, S; Nemoto, TK				Nishimata, Haruka; Ohara-Nemoto, Yuko; Baba, Tomomi T.; Hoshino, Tomonori; Fujiwara, Taku; Shimoyama, Yu; Kimura, Shigenobu; Nemoto, Takayuki K.			Identification of Dipeptidyl-Peptidase (DPP)5 and DPP7 in Porphyromonas endodontalis, Distinct from Those in Porphyromonas gingivalis	PLOS ONE			English	Article							ROOT-CANAL INFECTIONS; BACTEROIDES-ENDODONTALIS; PREVOTELLA-INTERMEDIA; ESCHERICHIA-COLI; GENOME SEQUENCE; STRAIN W83; BACTERIA; PURIFICATION; FIBROBLASTS; EXPRESSION	Dipeptidyl peptidases (DPPs) that liberate dipeptides from the N-terminal end of oligopeptides are crucial for the growth of Porphyromonas species, anaerobic asaccharolytic gram negative rods that utilize amino acids as energy sources. Porphyromonas endodontalis is a causative agent of periapical lesions with acute symptoms and Asp/Glu-specific DPP11 has been solely characterized in this organism. In this study, we identified and characterized two P. endodontalis DPPs, DPP5 and DPP7. Cell-associated DPP activity toward Lys-Ala-4-methylcoumaryl-7-amide (MCA) was prominent in P. endodontalis ATCC 35406 as compared with the Porphyromonas gingivalis strains ATCC 33277, 16-1, HW24D1, ATCC 49417, W83, W50, and HNA99. The level of hydrolysis of Leu-Asp-MCA by DPP11, GlyPro- MCA by DPP4, and Met-Leu-MCA was also higher than in the P. gingivalis strains. MER236725 and MER278904 are P. endodontalis proteins belong to the S9- and S46-family peptidases, respectively. Recombinant MER236725 exhibited enzymatic properties including substrate specificity, and salt-and pH-dependence similar to P. gingivalis DPP5 belonging to the S9 family. However, the k(cat)/K-m figure (194 mu M(-1)sec(-1)) for the most potent substrate (Lys-Ala-MCA) was 18.4-fold higher as compared to the P. gingivalis entity (10.5 mu M(-1)sec(-1)). In addition, P. endodontalis DPP5 mRNA and protein contents were increased several fold as compared with those in P. gingivalis. Recombinant MER278904 preferentially hydrolyzed Met-Leu-MCA and exhibited a substrate specificity similar to P. gingivalis DPP7 belonging to the S46 family. In accord with the deduced molecular mass of 818 amino acids, a 105-kDa band was immunologically detected, indicating that P. endodontalis DPP7 is an exceptionally large molecule in the DPP7/DPP11/S46 peptidase family. The enhancement of four DPP activities was conclusively demonstrated in P. endodontalis, and remarkable Lys-Ala-MCA-hydrolysis was achieved by qualitative and quantitative potentiation of the DPP5 molecule.	[Nishimata, Haruka; Ohara-Nemoto, Yuko; Baba, Tomomi T.; Nemoto, Takayuki K.] Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Oral Mol Biol, Nagasaki 852, Japan; [Nishimata, Haruka; Hoshino, Tomonori; Fujiwara, Taku] Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Pediat Dent, Nagasaki 852, Japan; [Shimoyama, Yu; Kimura, Shigenobu] Iwate Med Univ, Div Mol Microbiol, Yahaba, Iwate, Japan	Nagasaki University; Nagasaki University; Iwate Medical University	Nemoto, TK (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Oral Mol Biol, Nagasaki 852, Japan.	tnemoto@nagasaki-u.ac.jp		Nemoto, Takayuki K./0000-0002-5007-6260	Japan Society for the Promotion of Science [25462894, 24592809, 24592775]; Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences; Grants-in-Aid for Scientific Research [24592775] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research (C) (#25462894, YON), (C) (#24592809, TKN), (C) (#24592775, SK) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) and a grant of the Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences in 2013 (YON) (http://www.mdp.nagasaki-u.ac.jp/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO Y, 1985, J DENT RES, V64, P106, DOI 10.1177/00220345850640020201; Baba TT, 2013, CELL BIOCHEM FUNCT, V31, P652, DOI 10.1002/cbf.2951; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; BARUA PK, 1989, INFECT IMMUN, V57, P2522, DOI 10.1128/IAI.57.8.2522-2528.1989; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Cao H, 2012, INT ENDOD J, V45, P773, DOI 10.1111/j.1365-2591.2012.02035.x; Carmona C, 1987, NUCLEIC ACIDS RES, V15, P607; Citron DM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P911; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192, DOI 10.1177/10454411010120030101; Flynn TR, 2012, J ORAL MAXIL SURG, V70, P1854, DOI 10.1016/j.joms.2011.09.009; Fouad AF, 2002, J CLIN MICROBIOL, V40, P3223, DOI 10.1128/JCM.40.9.3223-3231.2002; Gomes BPFA, 2005, ORAL MICROBIOL IMMUN, V20, P211, DOI 10.1111/j.1399-302X.2005.00214.x; Gomes BPFA, 2004, ORAL MICROBIOL IMMUN, V19, P71, DOI 10.1046/j.0902-0055.2003.00116.x; GRENIER D, 1994, MICROBIOL-SGM, V140, P873, DOI 10.1099/00221287-140-4-873; Hirai H, 1988, JPN J CONSERV DENT, V31, P616; Ho YC, 2007, J ENDODONT, V33, P437, DOI 10.1016/j.joen.2006.12.022; Kon A, 2002, DENT J IWATE MED U, V27, P187; Kurita-Ochiai T, 2008, J DENT RES, V87, P51, DOI 10.1177/154405910808700108; MURPHY RA, 1974, CAN J MICROBIOL, V20, P1061, DOI 10.1139/m74-164; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Ohara-Nemoto Y, 2002, MICROB PATHOGENESIS, V33, P33, DOI 10.1006/mpat.2002.0515; Ohara-Nemoto Y, 2014, J BIOL CHEM, V289, P5436, DOI 10.1074/jbc.M113.527333; Ohara-Nemoto Y, 2011, J BIOL CHEM, V286, P38115, DOI 10.1074/jbc.M111.278572; Ono T, 2008, ANAL BIOCHEM, V381, P74, DOI 10.1016/j.ab.2008.06.022; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rocas IN, 2011, J ENDODONT, V37, P1206, DOI 10.1016/j.joen.2011.05.026; Rosen G, 2001, ORAL MICROBIOL IMMUN, V16, P326, DOI 10.1034/j.1399-302X.2001.160602.x; Rouf SMA, 2013, FEBS OPEN BIO, V3, P177, DOI 10.1016/j.fob.2013.03.004; Rouf SMA, 2013, BIOCHIMIE, V95, P824, DOI 10.1016/j.biochi.2012.11.019; Sebastian Y, 2013, SHOTGUN ASSEMBLY SEQ; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; SINGER RE, 1981, INFECT IMMUN, V32, P458, DOI 10.1128/IAI.32.2.458-463.1981; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; SUNDQVIST G, 1989, J ENDODONT, V15, P13, DOI 10.1016/S0099-2399(89)80092-5; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; VANSTEENBERGEN TJM, 1984, INT J SYST BACTERIOL, V34, P118, DOI 10.1099/00207713-34-2-118; VANWINKELHOFF AJ, 1985, J CLIN MICROBIOL, V22, P75, DOI 10.1128/JCM.22.1.75-79.1985; Vermout S, 2008, FEMS IMMUNOL MED MIC, V54, P299, DOI 10.1111/j.1574-695X.2008.00479.x; Yabuta M, 1995, APPL MICROBIOL BIOT, V44, P118	43	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114221	10.1371/journal.pone.0114221	http://dx.doi.org/10.1371/journal.pone.0114221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494328	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400037
J	Paskin, TR; Jellies, J; Bacher, J; Beane, WS				Paskin, Taylor R.; Jellies, John; Bacher, Jessica; Beane, Wendy S.			Planarian Phototactic Assay Reveals Differential Behavioral Responses Based on Wavelength	PLOS ONE			English	Article							ULTRAVIOLET VISION; DUGESIA-TIGRINA; LIGHT; REGENERATION; BRAIN; HEAD; EYE; AVOIDANCE; RADIATION; SYSTEMS	Planarians are free-living aquatic flatworms that possess a well-documented photophobic response to light. With a true central nervous system and simple cerebral eyes (ocelli), planarians are an emerging model for regenerative eye research. However, comparatively little is known about the physiology of their photoreception or how their behavior is affected by various wavelengths. Most phototactic studies have examined planarian behavior using white light. Here, we describe a novel planarian behavioral assay to test responses to small ranges of visible wavelengths (red, blue, green), as well as ultraviolet (UV) and infrared (IR) which have not previously been examined. Our data show that planarians display behavioral responses across a range of wavelengths. These responses occur in a hierarchy, with the shortest wavelengths (UV) causing the most intense photophobic responses while longer wavelengths produce no effect (red) or an apparent attraction (IR). In addition, our data reveals that planarian photophobia is comprised of both a general photophobic response (that drives planarians to escape the light source regardless of wavelength) and wavelength-specific responses that encompass specific behavioral reactions to individual wavelengths. Our results serve to improve the understanding of planarian phototaxis and suggest that behavioral studies performed with white light mask a complex behavioral interaction with the environment.	[Paskin, Taylor R.; Jellies, John; Bacher, Jessica; Beane, Wendy S.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA	Western Michigan University	Beane, WS (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	wendy.beane@wmich.edu		Beane, Wendy/0000-0002-3762-1025	Western Michigan University; Faculty Research and Creative Activities Award from the Office of the Vice President for Research at Western Michigan University [W2013-007]	Western Michigan University; Faculty Research and Creative Activities Award from the Office of the Vice President for Research at Western Michigan University	This work was supported by a start-up grant from Western Michigan University to WB and a Faculty Research and Creative Activities Award from the Office of the Vice President for Research at Western Michigan University (W2013-007) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2010, COLD SPRING HARB PER, V2; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Aksoy V, 2012, VISION RES, V67, P28, DOI 10.1016/j.visres.2012.06.013; AREES EA, 1986, PHYSIOL BEHAV, V36, P445, DOI 10.1016/0031-9384(86)90313-6; Asano Y, 1998, J EXP BIOL, V201, P1263; Beane WS, 2012, STEM CELLS DEV, V21, P2085, DOI 10.1089/scd.2011.0605; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Beane WS, 2013, DEVELOPMENT, V140, P313, DOI 10.1242/dev.086900; Bowmaker JK, 1995, PROG RETIN EYE RES, V15, P1; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; CARPENTER KS, 1974, CELL TISSUE RES, V148, P143; Dasheiff BD, 2002, ECOTOX ENVIRON SAFE, V53, P196, DOI 10.1006/eesa.2002.2227; Davidson C, 2011, PERCEPTION, V40, P743, DOI 10.1068/p6949; de Souza SC, 2005, J PHOTOCH PHOTOBIO B, V80, P203, DOI 10.1016/j.jphotobiol.2005.05.002; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GREBE E, 1991, B ENVIRON CONTAM TOX, V46, P866, DOI 10.1007/BF01689731; Hargreaves B, 2003, UV EFFECTS AQUATIC O, P61; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; JACOBS GH, 1992, AM ZOOL, V32, P544; Jellies J, 2014, J COMP PHYSIOL A, P1; Jellies J, 2014, J EXP BIOL, V217, P974, DOI 10.1242/jeb.094243; Jellies J, 2012, J COMP PHYSIOL A, V198, P567, DOI 10.1007/s00359-012-0730-5; JONES FRH, 1971, ANIM BEHAV, V19, P269; Kalafatic M, 2006, FOLIA BIOL, V54, P3; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Matsumoto T, 2005, FISHERIES SCI, V71, P350, DOI 10.1111/j.1444-2906.2005.00971.x; McConnell JV, 1965, SPEC PUBL WORM RUN D; Nakazawa M, 2003, MOL BIOL EVOL, V20, P784, DOI 10.1093/molbev/msg086; NOLTE J, 1972, J GEN PHYSIOL, V59, P167, DOI 10.1085/jgp.59.2.167; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; Orii H, 1998, HYDROBIOLOGIA, V383, P183, DOI 10.1023/A:1003495928829; Osburn C, 2003, UV EFFECTS AQUATIC O, P187; Parker G. H., 1900, AM J PHYSIOL, V4, P373; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pra D, 2005, MUTAT RES-GEN TOX EN, V585, P79, DOI 10.1016/j.mrgentox.2005.04.002; Reddien PW, 2013, DEVELOPMENT, V140, P951, DOI 10.1242/dev.080499; REYNIERSE JH, 1967, J COMP PHYSIOL PSYCH, V63, P366, DOI 10.1037/h0024360; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Shcherbakov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064429; Shcherbakov D, 2012, ZOOLOGY, V115, P233, DOI 10.1016/j.zool.2012.01.005; Shomrat T, 2013, J EXP BIOL, V216, P3799, DOI 10.1242/jeb.087809; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; Stevenson CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015310; Takano T, 2007, DEV GROWTH DIFFER, V49, P383, DOI 10.1111/j.1440-169x.2007.00936.x; Taliaferro WH, 1920, J EXP ZOOL, V31, P59; Umesono Y, 2011, EUR J NEUROSCI, V34, P863, DOI 10.1111/j.1460-9568.2011.07819.x; Van Wolfswinkel JC, 2014, CELL STEM CELL; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wu HPP, 2011, J PHOTOCH PHOTOBIO B, V102, P156, DOI 10.1016/j.jphotobiol.2010.11.003; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zukauskas A, 2009, IEEE J SEL TOP QUANT, V15, P1189, DOI 10.1109/JSTQE.2009.2019113	61	34	34	3	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114708	10.1371/journal.pone.0114708	http://dx.doi.org/10.1371/journal.pone.0114708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493551	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400067
J	Weng, YH; Yang, CY; Chiu, YW				Weng, Yi-Hao; Yang, Chun-Yuh; Chiu, Ya-Wen			Risk Assessment of Adverse Birth Outcomes in Relation to Maternal Age	PLOS ONE			English	Article							INTRAPARTUM STILLBIRTH; CESAREAN-SECTION; WEIGHT INFANTS; UNITED-STATES; POPULATION; ASSOCIATION; PREGNANCY; IMPACT; CHILDBEARING; ANTEPARTUM	Background: Although a number of studies have investigated correlations of maternal age with birth outcomes, an extensive assessment using age as a continuous variable is lacking. In the current study, we estimated age-specific risks of adverse birth outcomes in childbearing women. Method: National population-based data containing maternal and neonatal information were derived from the Health Promotion Administration, Taiwan. A composite adverse birth outcome was defined as at least anyone of stillbirth, preterm birth, low birth weight, macrosomia, neonatal death, congenital anomaly, and small for gestational age (SGA). Singletons were further analyzed for outcomes of live birth in relation to each year of maternal age. A log-binomial model was used to adjust for possible confounders of maternal and neonatal factors. Results: In total, 2,123,751 births between 2001 and 2010 were utilized in the analysis. The risk of a composite adverse birth outcome was significantly higher at extreme maternal ages. In specific, risks of stillbirth, neonatal death, preterm birth, congenital anomaly, and low birth weight were higher at the extremes of maternal age. Furthermore, risk of macrosomia rose proportionally with an increasing maternal age. In contrast, risk of SGA declined proportionally with an increasing maternal age. The log-binomial model showed greater risks at the maternal ages of <26 and > 30 years for a composite adverse birth outcome. Conclusions: Infants born to teenagers and women at advanced age possess greater risks for stillbirth, preterm birth, neonatal death, congenital anomaly, and low birth weight. Pregnancies at advanced age carry an additional risk for macrosomia, while teenage pregnancies carry an additional risk for SGA. The data suggest that the optimal maternal ages to minimize adverse birth outcomes are 26 similar to 30 years.	[Weng, Yi-Hao] Chang Gung Univ Coll Med, Chang Gung Mem Hosp, Dept Pediat, Div Neonatol, Taipei, Taiwan; [Yang, Chun-Yuh] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Chiu, Ya-Wen] Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan; [Chiu, Ya-Wen] Taipei Med Univ, Hlth Policy & Care Res Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University	Chiu, YW (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Master Program Global Hlth & Dev, Taipei, Taiwan.	bettychiu@tmu.edu.tw			Taipei Medical University [TMU101-AE1-B68]; National Health Research Institutes [PH-101-PP-20]; National Science Council [NSC 102-2511-S-038-005]; Chang Gung Memorial Hospital [CMRPG1B0131]	Taipei Medical University; National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by research grants from Taipei Medical University (TMU101-AE1-B68), the National Health Research Institutes (PH-101-PP-20), National Science Council (NSC 102-2511-S-038-005), and Chang Gung Memorial Hospital (CMRPG1B0131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves Joao Guilherme Bezerra, 2012, BMC Res Notes, V5, P531, DOI 10.1186/1756-0500-5-531; Arad I, 2001, EUR J OBSTET GYN R B, V94, P283, DOI 10.1016/S0301-2115(00)00308-0; Bae Jisuk, 2011, J Prev Med Public Health, V44, P111, DOI 10.3961/jpmph.2011.44.3.111; Bakker R, 2011, BJOG-INT J OBSTET GY, V118, P500, DOI 10.1111/j.1471-0528.2010.02823.x; Bateman BT, 2006, AM J OBSTET GYNECOL, V194, P840, DOI 10.1016/j.ajog.2005.08.038; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Buescher Paul A, 2006, N C Med J, V67, P16; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; Goonewardene I. M. R., 2005, Ceylon Medical Journal, V50, P116; Gordon A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-12; Gortzak-Uzan L, 2001, J Matern Fetal Med, V10, P393; Gu SY, 2012, J BIOMED RES, V26, P235, DOI 10.7555/JBR.26.20120037; Hayward CE, 2012, AM J PHYSIOL-ENDOC M, V302, pE233, DOI 10.1152/ajpendo.00192.2011; da Silva CH, 2013, MATERN CHILD HLTH J, V17, P539, DOI 10.1007/s10995-012-1030-y; Hsieh TT, 2010, EUR J OBSTET GYN R B, V148, P21, DOI 10.1016/j.ejogrb.2009.08.022; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Hwang BF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033949; Lin CM, 2004, J FORMOS MED ASSOC, V103, P297; Lin HC, 2004, ACTA OBSTET GYN SCAN, V83, P1178; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Machado CJ, 2006, J BIOSOC SCI, V38, P523, DOI 10.1017/S0021932005026660; Mousiolis A, 2013, J OBSTET GYNAECOL, V33, P28, DOI 10.3109/01443615.2012.730078; Muganyizi PS, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-30; NAEYE RL, 1983, OBSTET GYNECOL, V61, P210; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Phipps MG, 2002, AM J PUBLIC HEALTH, V92, P125, DOI 10.2105/AJPH.92.1.125; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Reichman NE, 1997, FAM PLANN PERSPECT, V29, P268, DOI 10.2307/2953415; Roy K. K., 2006, Indian Journal of Pediatrics, V73, P669, DOI 10.1007/BF02898441; Rueness J, 2012, HUM REPROD, V27, P283, DOI 10.1093/humrep/der347; Salihu HM, 2008, J OBSTET GYNAECOL RE, V34, P843, DOI 10.1111/j.1447-0756.2008.00855.x; Schempf AH, 2007, PAEDIATR PERINAT EP, V21, P34, DOI 10.1111/j.1365-3016.2007.00785.x; Sugiura-Ogasawara M, 2009, AM J REPROD IMMUNOL, V62, P314, DOI 10.1111/j.1600-0897.2009.00741.x; Takimoto H, 2005, J OBSTET GYNAECOL RE, V31, P314, DOI 10.1111/j.1447-0756.2005.00294.x; Tough SC, 2002, PEDIATRICS, V109, P399, DOI 10.1542/peds.109.3.399; Vieira CL, 2012, J PEDIATR ADOL GYNEC, V25, P185, DOI 10.1016/j.jpag.2011.12.070; Wang Y, 2011, ARCH GYNECOL OBSTET, V284, P31, DOI 10.1007/s00404-010-1587-x; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Yadav Siddhartha, 2008, Mcgill J Med, V11, P141	44	71	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114843	10.1371/journal.pone.0114843	http://dx.doi.org/10.1371/journal.pone.0114843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494176	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400078
J	Akram, S; Englitz, B; Elhilali, M; Simon, JZ; Shamma, SA				Akram, Sahar; Englitz, Bernhard; Elhilali, Mounya; Simon, Jonathan Z.; Shamma, Shihab A.			Investigating the Neural Correlates of a Streaming Percept in an Informational-Masking Paradigm	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; COCKTAIL PARTY; SELECTIVE ATTENTION; NEURONAL RESPONSES; REPETITION RATE; REPRESENTATION; MECHANISMS; SOUND; SPEECH; SEGREGATION	Humans routinely segregate a complex acoustic scene into different auditory streams, through the extraction of bottom-up perceptual cues and the use of top-down selective attention. To determine the neural mechanisms underlying this process, neural responses obtained through magnetoencephalography (MEG) were correlated with behavioral performance in the context of an informational masking paradigm. In half the trials, subjects were asked to detect frequency deviants in a target stream, consisting of a rhythmic tone sequence, embedded in a separate masker stream composed of a random cloud of tones. In the other half of the trials, subjects were exposed to identical stimuli but asked to perform a different task-to detect tone-length changes in the randobuildup of the normalized neural responses was significantly faster, mirroring the accelerated buildup of the streaming percepts. Our data thus support close links between the perceptual and neural consequences of the auditory stream segregation.m cloud of tones. In order to verify that the normalized neural response to the target sequence served as an indicator of streaming, we correlated neural responses with behavioral performance under a variety of stimulus parameters (target tone rate, target tone frequency, and the "protection zone", that is, the spectral area with no tones around the target frequency) and attentional states (changing task objective while maintaining the same stimuli). In all conditions that facilitated target/masker streaming behaviorally, MEG normalized neural responses also changed in a manner consistent with the behavior. Thus, attending to the target stream caused a significant increase in power and phase coherence of the responses in recording channels correlated with an increase in the behavioral performance of the listeners. Normalized neural target responses also increased as the protection zone widened and as the frequency of the target tones increased. Finally, when the target sequence rate increased, the	[Akram, Sahar; Englitz, Bernhard; Shamma, Shihab A.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Akram, Sahar; Englitz, Bernhard; Simon, Jonathan Z.; Shamma, Shihab A.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; [Simon, Jonathan Z.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Elhilali, Mounya] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Englitz, Bernhard; Shamma, Shihab A.] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [Englitz, Bernhard] Donders Inst Brain Cognit & Behav, Dept Neurophysiol, Nijmegen, Netherlands	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Radboud University Nijmegen	Akram, S (corresponding author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	sakram@umd.edu	Elhilali, Mounya/A-3396-2010; Englitz, Bernhard/K-7636-2018; Simon, Jonathan Z/A-8196-2008	Elhilali, Mounya/0000-0003-2597-738X; Englitz, Bernhard/0000-0001-9106-0356; Simon, Jonathan Z/0000-0003-0858-0698	National Institutes of Health [1R01AG036424]; NATIONAL INSTITUTE ON AGING [R01AG036424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The funding for this work is provided by National Institutes of Health Grant number 1R01AG036424 (http://www.nih.gov/) to ME and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett EL, 2011, J NEUROPHYSIOL, V106, P849, DOI 10.1152/jn.00559.2010; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bregman AS, 2000, PERCEPT PSYCHOPHYS, V62, P626, DOI 10.3758/BF03212114; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Efron B., 1994, INTRO BOOTSTRAP; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Fisher N., 1995, STAT ANAL CIRCULAR D; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Fishman YI, 2012, J NEUROPHYSIOL, V107, P2366, DOI 10.1152/jn.01010.2011; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Kay S, 1993, ESTIMATION THEORY FU, P465; Kidd G, 2003, J ACOUST SOC AM, V114, P2835, DOI 10.1121/1.1621864; KIDD G, 1995, J ACOUST SOC AM, V98, P1977, DOI 10.1121/1.414459; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Kowalski N, 1996, J NEUROPHYSIOLOGY, V76; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Micheyl C, 2007, HEARING - FROM SENSORY PROCESSING TO PERCEPTION, P267, DOI 10.1007/978-3-540-73009-5_29; Micheyl C, 2010, JARO-J ASSOC RES OTO, V11, P709, DOI 10.1007/s10162-010-0227-2; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paltoglou AE, 2009, HEARING RES, V257, P106, DOI 10.1016/j.heares.2009.08.007; PHILLIPS DP, 1989, J ACOUST SOC AM, V85, P2537, DOI 10.1121/1.397748; Schreiner CE, 1996, J NEUROPHYSIOL, V75, P1283, DOI 10.1152/jn.1996.75.3.1283; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Simon JZ, 2005, J NEUROSCI METH, V149, P64, DOI 10.1016/j.jneumeth.2005.05.005; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Steinschneider M, 2013, HEARING RES, V305, P57, DOI 10.1016/j.heares.2013.05.013; Teki S, 2013, ELIFE, V2, DOI 10.7554/eLife.00699; Tiitinen H, 1997, PROG NEURO-PSYCHOPH, V21, P751, DOI 10.1016/S0278-5846(97)00077-8; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; Vliegen J, 1999, J ACOUST SOC AM, V106, P938, DOI 10.1121/1.427140; Xiang JJ, 2010, J NEUROSCI, V30, P12084, DOI 10.1523/JNEUROSCI.0827-10.2010	51	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114427	10.1371/journal.pone.0114427	http://dx.doi.org/10.1371/journal.pone.0114427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490720	Green Published, gold			2022-12-27	WOS:000347515300040
J	Braun, DL; Kouyos, R; Oberle, C; Grube, C; Joos, B; Fellay, J; McLaren, PJ; Kuster, H; Gunthard, HF				Braun, Dominique L.; Kouyos, Roger; Oberle, Corinna; Grube, Christina; Joos, Beda; Fellay, Jacques; McLaren, Paul J.; Kuster, Herbert; Guenthard, Huldrych F.			A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOCIETY-USA PANEL; EARLY ANTIRETROVIRAL THERAPY; VIROLOGICAL SET-POINT; VIRAL LOAD; CLINICAL-MANIFESTATIONS; INDEPENDENT PREDICTORS; INFECTED PATIENTS; TYPE-1 INFECTION; AIDS	Objective: Best long-term practice in primary HIV-1 infection (PHI) remains unknown for the individual. A risk-based scoring system associated with surrogate markers of HIV-1 disease progression could be helpful to stratify patients with PHI at highest risk for HIV-1 disease progression. Methods: We prospectively enrolled 290 individuals with well-documented PHI in the Zurich Primary HIV-1 Infection Study, an open-label, non-randomized, observational, single-center study. Patients could choose to undergo early antiretroviral treatment (eART) and stop it after one year of undetectable viremia, to go on with treatment indefinitely, or to defer treatment. For each patient we calculated an a priori defined "Acute Retroviral Syndrome Severity Score'' (ARSSS), consisting of clinical and basic laboratory variables, ranging from zero to ten points. We used linear regression models to assess the association between ARSSS and log baseline viral load (VL), baseline CD4(+) cell count, and log viral setpoint (sVL) (i.e. VL measured >= 90 days after infection or treatment interruption). Results: Mean ARSSS was 2.89. CD4(+) cell count at baseline was negatively correlated with ARSSS (p=0.03, n=289), whereas HIV-RNA levels at baseline showed a strong positive correlation with ARSSS (p<0.001, n=290). In the regression models, a 1-point increase in the score corresponded to a 0.10 log increase in baseline VL and a CD4(+) cell count decline of 12/mu l, respectively. In patients with PHI and not undergoing eART, higher ARSSS were significantly associated with higher sVL (p=0.029, n=64). In contrast, in patients undergoing eART with subsequent structured treatment interruption, no correlation was found between sVL and ARSSS (p=0.28, n=40). Conclusion: The ARSSS is a simple clinical score that correlates with the best-validated surrogate markers of HIV-1 disease progression. In regions where ART is not universally available and eART is not standard this score may help identifying patients who will profit the most from early antiretroviral therapy.	[Braun, Dominique L.; Kouyos, Roger; Oberle, Corinna; Grube, Christina; Joos, Beda; Kuster, Herbert; Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Fellay, Jacques; McLaren, Paul J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Fellay, Jacques; McLaren, Paul J.] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Fellay, Jacques; McLaren, Paul J.] Univ Lausanne, Lausanne, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Braun, DL (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	dominique.braun@usz.ch; huldrych.guenthard@usz.ch	Kouyos, Roger/ABB-2291-2021; gunthard, huldrych f/F-1724-2011; Joos, Beda/D-5547-2009; Fellay, Jacques/A-6681-2009; Kouyos, Roger/G-6226-2014	Kouyos, Roger/0000-0002-9220-8348; gunthard, huldrych f/0000-0002-1142-6723; Joos, Beda/0000-0002-3082-8875; Fellay, Jacques/0000-0002-8240-939X; Kouyos, Roger/0000-0002-9220-8348; Kuster, Herbert/0000-0001-6873-0091; Braun, Dominique Laurent/0000-0003-4036-1030; McLaren, Paul/0000-0001-6019-7018	Swiss National Science Foundation [324730-130865, PZ00P3-142411]; University of Zurich's Clinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study''; University Hospital of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich's Clinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study''; University Hospital of Zurich	This work was supported by the Swiss National Science Foundation [grant #324730-130865 to HFG, grant #PZ00P3-142411 to RK] and by the University of Zurich's Clinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study'' to HFG and by the matching fund program of the University Hospital of Zurich to DLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the other authors, no funding was declared.	Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Mata-Marin JA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-181; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; BOUFASSA F, 1995, J INFECT DIS, V171, P1190, DOI 10.1093/infdis/171.5.1190; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; COOPER DA, 1985, LANCET, V1, P537; Daar ES, 2008, CURR OPIN HIV AIDS, V3, P10, DOI 10.1097/COH.0b013e3282f2e295; Dana J, 2004, J EDUC BEHAV STAT, V29, P317, DOI 10.3102/10769986029003317; Desquilbet L, 2004, AIDS, V18, P2361; DORRUCCI M, 1995, AIDS, V9, P597, DOI 10.1097/00002030-199506000-00011; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Finster M, 2005, ANESTHESIOLOGY, V102, P855, DOI 10.1097/00000542-200504000-00022; FOX R, 1987, AIDS, V1, P35; Ghosn J, 2012, JAIDS-J ACQ IMM DEF, V60, pE112, DOI 10.1097/QAI.0b013e31825b6fde; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hoen B, 2005, JAIDS-J ACQ IMM DEF, V40, P307, DOI 10.1097/01.qai.0000182628.66713.31; Hofer CB, 2000, J ACQ IMMUN DEF SYND, V25, P188, DOI 10.1097/00126334-200010010-00014; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; KEET IPM, 1993, AIDS, V7, P51, DOI 10.1097/00002030-199301000-00008; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Lodi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078642; LOES SKD, 1993, CLIN INFECT DIS, V17, P59, DOI 10.1093/clinids/17.1.59; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rieg G, 2007, AIDS RES HUM RETROV, V23, P1257, DOI 10.1089/aid.2006.0311; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Vanhems P, 2002, JAIDS-J ACQ IMM DEF, V31, P318, DOI 10.1097/00126334-200211010-00007; Vanhems P, 1998, CLIN INFECT DIS, V26, P323, DOI 10.1086/516289; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463	57	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114111	10.1371/journal.pone.0114111	http://dx.doi.org/10.1371/journal.pone.0114111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490090	Green Published, Green Accepted, gold			2022-12-27	WOS:000347515300016
J	Ohta, T; Ido, A; Kusano, K; Miura, C; Miura, T				Ohta, Takashi; Ido, Atsushi; Kusano, Kie; Miura, Chiemi; Miura, Takeshi			A Novel Polysaccharide in Insects Activates the Innate Immune System in Mouse Macrophage RAW264 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UDP-L-RHAMNOSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; NITRIC-OXIDE; BOMBYX-MORI; D-GLUCOSE; DROSOPHILA; RECOGNITION; LARVAE	A novel water-soluble polysaccharide was identified in the pupae of the melon fly Bactrocera cucurbitae) as a molecule that activates the mammalian innate immune response. We attempted to purify this innate immune activator using nitric oxide NO) production in mouse RAW264 macrophages as an indicator of immunostimulatory activity. A novel acidic polysaccharide was identified, which we named "dipterose'', with a molecular weight of 1.01 x 10(6) and comprising nine monosaccharides. Dipterose was synthesized in the melon fly itself at the pupal stage. The NO-producing activity of dipterose was approximately equal to that of lipopolysaccharide, a potent immunostimulator. Inhibition of Toll-like receptor 4 TLR4) led to the suppression of NO production by dipterose. Furthermore, dipterose induced the expression of proinflammatory cytokines and interferon beta (IFN beta) and promoted the activation of nuclear factor kappa B (NF-kappa B) in macrophages, indicating that it stimulates the induction of various cytokines in RAW264 cells via the TLR4 signaling pathway. Our results thus suggest that dipterose activates the innate immune response against various pathogenic microorganisms and viral infections. This is the first identification of an innate immune-activating polysaccharide from an animal.	[Ohta, Takashi; Ido, Atsushi; Kusano, Kie; Miura, Chiemi; Miura, Takeshi] Ehime Univ, Southern Ehime Fisheries Res Ctr, Res Grp Reprod Physiol, Ainan, Ehime, Japan	Ehime University	Miura, T (corresponding author), Ehime Univ, Southern Ehime Fisheries Res Ctr, Res Grp Reprod Physiol, Ainan, Ehime, Japan.	miutake@agr.ehime-u.ac.jp	Ido, Atsushi/AAW-6077-2021	Ido, Atsushi/0000-0002-8266-4438	Japan Science and Technology Agency (JST); Japan Science and Technology Agency [AS2113025E]; Japan Society for the Promotion of Science; Bussan Biotech Co., LTD	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bussan Biotech Co., LTD	This work was supported by the Japan Science and Technology Agency (JST), A-step start-up venture program (#AS2113025E) from the Japan Science and Technology Agency (http://www.jst.go.jp), Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (http://kaken.nii.ac.jp/), and Bussan Biotech Co., LTD (http://bussan-bio.co.jp/). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akiyama N, 2000, ANTICANCER RES, V20, P357; Akiyama T, 2011, FOOD HYG SAFE SCI, V52, P40, DOI 10.3358/shokueishi.52.40; Aksoy S, 1997, INSECT MOL BIOL, V6, P183, DOI 10.1111/j.1365-2583.1997.tb00086.x; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; BARANYOVITS FLC, 1978, ENDEAVOUR, V2, P85, DOI 10.1016/0160-9327(78)90061-3; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; BOURTZIS K, 2008, INSECT SYMBIOSIS, V3, P384; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P1301, DOI 10.1016/S1567-5769(03)00118-8; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hirose Y, 2013, J NAT PROD, V76, P554, DOI 10.1021/np300713c; Huis A.V., 2013, EDIBLE INSECTS FUTUR, P187; Ikan R, 1999, NATURALLY OCCURRING; Imamura M, 1999, ARCH INSECT BIOCHEM, V40, P88, DOI 10.1002/(SICI)1520-6327(1999)40:2&lt;88::AID-ARCH3&gt;3.0.CO;2-B; Ishii A, 2007, IMMUNOGENETICS, V59, P281, DOI 10.1007/s00251-007-0193-y; KAMSTEEG J, 1978, FEBS LETT, V91, P281, DOI 10.1016/0014-5793(78)81192-2; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Satyavathi VV, 2014, CELL SIGNAL, V26, P1753, DOI 10.1016/j.cellsig.2014.02.024; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Schuhmann B, 2003, ARCH INSECT BIOCHEM, V53, P125, DOI 10.1002/arch.10091; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang J, 2010, INT J BIOL MACROMOL, V46, P389, DOI 10.1016/j.ijbiomac.2010.02.007; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xiaoming C, 2010, FOREST INSECTSAS FOO; Yang Ping, 2004, Journal of Insect Biotechnology and Sericology, V73, P7; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060781; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	53	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114823	10.1371/journal.pone.0114823	http://dx.doi.org/10.1371/journal.pone.0114823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490773	gold, Green Submitted, Green Published			2022-12-27	WOS:000347515300081
J	Woodard, GE; Ji, Y; Christopherson, GT; Wolcott, KM; Hall, DJ; Jackson, WM; Nesti, LJ				Woodard, Geoffrey E.; Ji, Youngmi; Christopherson, Gregory T.; Wolcott, Karen M.; Hall, David J.; Jackson, Wesley M.; Nesti, Leon J.			Characterization of Discrete Subpopulations of Progenitor Cells in Traumatic Human Extremity Wounds	PLOS ONE			English	Article							STEM-CELLS; MUSCLE; INJURY; EXPRESSION; CD34; DIFFERENTIATION; FIBROCYTES; BONE	Here we show that distinct subpopulations of cells exist within traumatic human extremity wounds, each having the ability to differentiate into multiple cells types in vitro. A crude cell suspension derived from traumatized muscle was positively sorted for CD29, CD31, CD34, CD56 or CD91. The cell suspension was also simultaneously negatively sorted for either CD45 or CD117 to exclude hematopoietic stem cells. These subpopulations varied in terms their total numbers and their abilities to grow, migrate, differentiate and secrete cytokines. While all five subpopulations demonstrated equal abilities to undergo osteogenesis, they were distinct in their ability to undergo adipogenesis and vascular endotheliogenesis. The most abundant subpopulations were CD29+ and CD34+, which overlapped significantly. The CD29+ and CD34+ cells had the greatest proliferative and migratory capacity while the CD56+ subpopulation produced the highest amounts of TGFSS1 and TGFSS2. When cultured under endothelial differentiation conditions the CD29+ and CD34+ cells expressed VE-cadherin, Tie2 and CD31, all markers of endothelial cells. These data indicate that while there are multiple cell types within traumatized muscle that have osteogenic differentiation capacity and may contribute to bone formation in post-traumatic heterotopic ossification (HO), the major contributory cell types are CD29+ and CD34+, which demonstrate endothelial progenitor cell characteristics.	[Woodard, Geoffrey E.; Jackson, Wesley M.; Nesti, Leon J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Ji, Youngmi; Christopherson, Gregory T.; Hall, David J.; Nesti, Leon J.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Wolcott, Karen M.] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Nesti, Leon J.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed Surg, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center	Woodard, GE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA.	gew232000@gmail.com; leonnesti@gmail.com			Military Amputee Research Program at Walter Reed Army Medical Center [P05-A011]; Comprehensive Neurosciences Program [CNP-2008-CR01]; Defense Medical Research and Development Program [D10_1_AR_J5_920]; NIH Intramural Research Program [Z01 AR41131]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041131] Funding Source: NIH RePORTER	Military Amputee Research Program at Walter Reed Army Medical Center; Comprehensive Neurosciences Program; Defense Medical Research and Development Program; NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support was provided by the Military Amputee Research Program at Walter Reed Army Medical Center (P05-A011), the Comprehensive Neurosciences Program (CNP-2008-CR01), the Defense Medical Research and Development Program (D10_1_AR_J5_920) and the NIH Intramural Research Program (Z01 AR41131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aini H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037728; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; ARO HT, 1991, APMIS, V99, P482, DOI 10.1111/j.1699-0463.1991.tb05179.x; Bareja A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090398; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Chen D, 2013, J THROMB HAEMOST, V11, P963, DOI 10.1111/jth.12198; Chen HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097476; Cuenca-Lopez MD, 2008, CELL MOL BIOL, V54, P40, DOI 10.1170/T829; Davis TA, 2013, BONE, V56, P119, DOI 10.1016/j.bone.2013.05.016; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doornberg Job N, 2014, J Bone Joint Surg Am, V96, pe36, DOI 10.2106/JBJS.M.00388; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; FINA L, 1990, BLOOD, V75, P2417; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Hald ES, 2014, TRANSL STROKE RES, V5, P385, DOI 10.1007/s12975-013-0300-3; Hall S, 1997, J ANAT, V190, P57, DOI 10.1046/j.1469-7580.1997.19010057.x; Hildebrand KA, 2004, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000122664.95703.79; Iorio Richard, 2002, J Am Acad Orthop Surg, V10, P409; Jackson WM, 2009, J TISSUE ENG REGEN M, V3, P129, DOI 10.1002/term.149; Jackson WM, 2011, J ORTHOP RES, V29, P1613, DOI 10.1002/jor.21354; Jackson WM, 2011, J CELL MOL MED, V15, P2377, DOI 10.1111/j.1582-4934.2010.01225.x; Ji YM, 2012, ADV EXP MED BIOL, V720, P39, DOI 10.1007/978-1-4614-0254-1_4; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kimura S, 2012, NEPHRON CLIN PRACT, V121, pC16, DOI 10.1159/000341374; Landry PS, 2000, J TRAUMA, V48, P479, DOI 10.1097/00005373-200003000-00018; Lei Y, 2014, EXP CELL RES, V323, P198, DOI 10.1016/j.yexcr.2014.01.011; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Mackie AR, 2011, TEX HEART I J, V38, P474; Massa M, 2005, J CLIN ONCOL, V23, P5688, DOI 10.1200/JCO.2005.09.021; Masuda H, 2013, TRENDS CARDIOVAS MED, V23, P99, DOI 10.1016/j.tcm.2012.09.007; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Mu XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016699; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Oishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056641; Ostrovidov S, 2014, TISSUE ENG B; Otis G, 1883, MED SURG HIST CIVIL; Peterson LT, 1944, J BONE JOINT SURG, V26, P635; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; Sellheyer K, 2010, HAUTARZT, V61, P429, DOI 10.1007/s00105-010-1919-6; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Sueblinvong Viranuj, 2014, Adv Biosci Biotechnol, V5, P19; Uchida N, 2001, J CLIN INVEST, V108, P1071, DOI 10.1172/JCI13297; Verloop RE, 2009, EUR CYTOKINE NETW, V20, P207, DOI 10.1684/ecn.2009.0174; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhang ST, 2013, HISTOL HISTOPATHOL, V28, P725, DOI 10.14670/HH-28.725	56	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114318	10.1371/journal.pone.0114318	http://dx.doi.org/10.1371/journal.pone.0114318			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490403	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300028
J	Barug, D; Goorden, S; Herruer, M; Muller, M; Brohet, R; de Winter, P				Barug, Daan; Goorden, Susan; Herruer, Martien; Muller, Moira; Brohet, Richard; de Winter, Peter			Reference Values for Interleukin-6 and Interleukin-8 in Cord Blood of Healthy Term Neonates and Their Association with Stress-Related Perinatal Factors	PLOS ONE			English	Article							DIAGNOSTIC MARKERS; SEPSIS; INFECTION; IL-6	Background: Automated interleukin assays are promising diagnostic aids for early-onset neonatal sepsis, however, reference values for healthy term neonates are incompletely known. The goal of this study is to determine reference values for interleukin-6 (IL-6) and interleukin-8 (IL-8) in cord blood of healthy term neonates. Methods and Findings: Women were recruited from April 2012 to August 2012. IL-6 and IL-8 levels were measured using an automated immunometric assay (Immulite) in cord blood of 93 healthy term newborns, 60 of them were born via vaginal delivery and 33 by elective caesarean section (ECS). A mean value for IL-8 of 8.1 +/- 3.0 pg/mL was found in cord blood of healthy term neonates, which apply to both vaginal delivery and ECS. Regarding IL-6, two values apply. For vaginal delivery, a median value of 3.3 pg/mL (range, <2 to 9.53 pg/mL) was found, while for ECS, a median value of <2 pg/mL (range, <2 to 48 pg/mL) applies. Conclusions: We propose a reference value of <14.1 pg/mL for IL-8 (mean + 2SD), applying to vaginally delivered and ECS-delivered healthy term newborns. From a clinical point of view, we also propose one reference value for IL-6 to be applied to vaginally delivered and ECS-delivered healthy term newborns, which is <10.2 pg/mL (97.5th percentile total group). These values have to be validated in larger cohorts of neonates, inclusive of those with and without early-onset neonatal sepsis.	[Barug, Daan; de Winter, Peter] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands; [Goorden, Susan; Herruer, Martien] Atal Medial Med Diagnost Ctr, Hoofddorp, Netherlands; [Muller, Moira] Spaarne Hosp, Dept Obstet & Gynaecol, Hoofddorp, Netherlands; [Brohet, Richard] Spaarne Hosp, Res Ctr Linnaeus Inst, Hoofddorp, Netherlands	Spaarne Hospital; Spaarne Hospital; Spaarne Hospital	Barug, D (corresponding author), Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands.	daantjebarug@gmail.com	De Winter, P/N-4317-2019	de Winter, Peter/0000-0002-8476-5312				Abbas A., 2010, CELL MOL IMMUNOL, V6th ed., P267; Arnon S, 2008, CURR OPIN INFECT DIS, V21, P223, DOI 10.1097/QCO.0b013e3282fa15dd; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Cernada M, 2012, ACTA PAEDIATR, V101, pe203, DOI 10.1111/j.1651-2227.2011.02577.x; Dollner H, 2001, BIOL NEONATE, V80, P41, DOI 10.1159/000047118; Fan Y, 2012, WORLD J PEDIATR, V8, P101, DOI 10.1007/s12519-012-0347-3; Franz AR, 2004, PEDIATRICS, V114, P1, DOI 10.1542/peds.114.1.1; Goetzl L, 2002, AM J OBSTET GYNECOL, V187, P834, DOI 10.1067/mob.2002.127135; Haque Khalid N, 2005, Pediatr Crit Care Med, V6, pS45, DOI 10.1097/01.PCC.0000161946.73305.0A; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Krueger M, 2001, BIOL NEONATE, V80, P118, DOI 10.1159/000047130; Kurt ANC, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/31397; Mehr SS, 2001, AM J PERINAT, V18, P313, DOI 10.1055/s-2001-17857; Mishra UK, 2006, ARCH DIS CHILD-FETAL, V91, pF208, DOI 10.1136/adc.2004.064188; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, pF229, DOI 10.1136/adc.2002.023838; Polin RA, 2003, J PEDIATR-US, V143, P3, DOI 10.1016/S0022-3476(03)00271-3; Santana C, 2001, ACTA PAEDIATR, V90, P1176, DOI 10.1080/080352501317061602; Schulpis KH, 2008, CLIN CHEM LAB MED, V46, P1624, DOI 10.1515/CCLM.2008.305; TasciA Y, 2006, EUR J OBSTET GYN R B, V128, P34, DOI 10.1016/j.ejogrb.2005.11.049; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687	21	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114109	10.1371/journal.pone.0114109	http://dx.doi.org/10.1371/journal.pone.0114109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485809	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600042
J	Tolstikov, V; Nikolayev, A; Dong, S; Zhao, G; Kuo, MS				Tolstikov, Vladimir; Nikolayev, Alexander; Dong, Sucai; Zhao, Genshi; Kuo, Ming-Shang			Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; MASS-SPECTROMETRY; NAD BIOSYNTHESIS; PHARMACOLOGICAL INHIBITION; PROFILING PROCEDURES; GAS-CHROMATOGRAPHY; COLORECTAL-CANCER; GASTRIC-CANCER; STRESS; FK866	Nicotinamide phosphoribosyltransferase (NAMPT) plays an important role in cellular bioenergetics. It is responsible for converting nicotinamide to nicotinamide adenine dinucleotide, an essential molecule in cellular metabolism. NAMPT has been extensively studied over the past decade due to its role as a key regulator of nicotinamide adenine dinucleotide-consuming enzymes. NAMPT is also known as a potential target for therapeutic intervention due to its involvement in disease. In the current study, we used a global mass spectrometry-based metabolomic approach to investigate the effects of FK866, a small molecule inhibitor of NAMPT currently in clinical trials, on metabolic perturbations in human cancer cells. We treated A2780 (ovarian cancer) and HCT-116 (colorectal cancer) cell lines with FK866 in the presence and absence of nicotinic acid. Significant changes were observed in the amino acids metabolism and the purine and pyrimidine metabolism. We also observed metabolic alterations in glycolysis, the citric acid cycle (TCA), and the pentose phosphate pathway. To expand the range of the detected polar metabolites and improve data confidence, we applied a global metabolomics profiling platform by using both non-targeted and targeted hydrophilic (HILIC)-LCMS and GC-MS analysis. We used Ingenuity Knowledge Base to facilitate the projection of metabolomics data onto metabolic pathways. Several metabolic pathways showed differential responses to FK866 based on several matches to the list of annotated metabolites. This study suggests that global metabolomics can be useful tool in pharmacological studies of the mechanism of action of drugs at a cellular level.	[Tolstikov, Vladimir; Nikolayev, Alexander; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Discovery Chem & Technol, Indianapolis, IN 46285 USA; [Dong, Sucai; Zhao, Genshi] Eli Lilly & Co, Lilly Res Labs, Canc Signaling & Metab, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Kuo, MS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Discovery Chem & Technol, 893 S Delaware St, Indianapolis, IN 46285 USA.	kuo_ming-shang@lilly.com	Tolstikov, Vladimir/P-2465-2019	Tolstikov, Vladimir/0000-0002-0445-884X	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was supported by Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Galli U, 2008, CHEMMEDCHEM, V3, P771, DOI 10.1002/cmdc.200700311; Galli U, 2013, J MED CHEM, V56, P6279, DOI 10.1021/jm4001049; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tolstikov V, 2013, ASMS MINN MN; Tong L., 2008, U.S. Patent, Patent No. 0020413; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zou W, 2009, ALGORITHMS, V2, DOI 10.3390/a2020638	48	60	60	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114019	10.1371/journal.pone.0114019	http://dx.doi.org/10.1371/journal.pone.0114019			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486521	Green Published, gold			2022-12-27	WOS:000346907600036
J	Wang, HT; Han, YF; Chan, YS; He, JF				Wang, Haitao; Han, Yi-Fan; Chan, Ying-Shing; He, Jufang			Stimulus-Specific Adaptation at the Synapse Level In Vitro	PLOS ONE			English	Article							INFERIOR COLLICULUS; AUDITORY-CORTEX; NEURONS; PLASTICITY; MECHANISMS; NETWORKS; BLOCKADE; BRAIN	Stimulus-specific adaptation (SSA) is observed in many brain regions in humans and animals. SSA of cortical neurons has been proposed to accumulate through relays in ascending pathways. Here, we examined SSA at the synapse level using whole-cell patch-clamp recordings of primary cultured cortical neurons of the rat. First, we found that cultured neurons had high firing capability with 100-Hz current injection. However, neuron firing started to adapt to repeated electrically activated synaptic inputs at 10 Hz. Next, to activate different dendritic inputs, electrical stimulations were spatially separated. Cultured neurons showed similar SSA properties in the oddball stimulation paradigm compared to those reported in vivo. Single neurons responded preferentially to a deviant stimulus over repeated, standard stimuli considering both synapse-driven spikes and excitatory postsynaptic currents (EPSCs). Compared with two closely placed stimulating electrodes that activated highly overlapping dendritic fields, two separately placed electrodes that activated less overlapping dendritic fields elicited greater SSA. Finally, we used glutamate puffing to directly activate postsynaptic glutamate receptors. Neurons showed SSA to two separately placed puffs repeated at 10 Hz. Compared with EPSCs, GABAa receptor-mediated inhibitory postsynaptic currents showed weaker SSA. Heterogeneity of the synaptic inputs was critical for producing SSA, with glutamate receptor desensitization participating in the process. Our findings suggest that postsynaptic fatigue contributes largely to SSA at low frequencies.	[Wang, Haitao; He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Haitao; He, Jufang] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Haitao; He, Jufang] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Han, Yi-Fan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Fac Med, Dept Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Hong Kong Polytechnic University; Hong Kong Polytechnic University; University of Hong Kong; University of Hong Kong	Wang, HT (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	wang_haitao@gibh.ac.cn; jufanghe@cityu.edu.hk	Wang, Haitao/GYV-1262-2022	Wang, Haitao/0000-0002-2436-113X; Han, Yifan/0000-0002-5833-069X; Chan, Ying Shing/0000-0002-6228-1595; HE, Jufang/0000-0002-4288-5957	Hong Kong Research Grants Council [561111, 561212, 561410, CRF09/9, T13-607/12R]; National Key Basic Research Program of China [2012CB966300, 2013CB530900]; National Science Foundation of China [31371114, 31300901]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the Hong Kong Research Grants Council (561111, 561212, 561410, CRF09/9, T13-607/12R), National Key Basic Research Program of China (2012CB966300, 2013CB530900), and National Science Foundation of China (31371114, 31300901). The authors also appreciate the donations from Charlie Lee Foundation and Fong Shu Fook Tong Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abolafia JM, 2011, CEREB CORTEX, V21, P977, DOI 10.1093/cercor/bhq163; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2011, J NEUROSCI, V31, P17306, DOI 10.1523/JNEUROSCI.1915-11.2011; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Ayala YA, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00119; Beck O, 2005, J NEUROPHYSIOL, V94, P363, DOI 10.1152/jn.01287.2004; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boynton GM, 2003, J NEUROSCI, V23, P8781; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Duque D, 2014, J PHYSIOL-LONDON, V592, P729, DOI 10.1113/jphysiol.2013.261941; Escera C, 2014, PSYCHOPHYSIOLOGY, V51, P111, DOI 10.1111/psyp.12156; Eytan D, 2003, J NEUROSCI, V23, P9349; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hershenhoren I, 2014, J NEUROSCI, V34, P3303, DOI 10.1523/JNEUROSCI.2166-13.2014; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; Luo JL, 2010, J BIOL CHEM, V285, P19947, DOI 10.1074/jbc.M110.111286; Malmierca MS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00111; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Perez-Gonzalez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034297; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Thomas JM, 2012, HEARING RES, V291, P34, DOI 10.1016/j.heares.2012.06.004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Varela JA, 1997, J NEUROSCI, V17, P7926; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yu XJ, 2009, J NEUROPHYSIOL, V101, P980, DOI 10.1152/jn.91130.2008; Zhao L, 2011, NEUROSCIENCE, V181, P163, DOI 10.1016/j.neuroscience.2011.01.060; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114537	10.1371/journal.pone.0114537	http://dx.doi.org/10.1371/journal.pone.0114537			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486252	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600073
J	Hellebuyck, T; Van Steendam, K; Deforce, D; Blooi, M; Van Nieuwerburgh, F; Bullaert, E; Ducatelle, R; Haesebrouck, F; Pasmans, F; Martel, A				Hellebuyck, Tom; Van Steendam, Katleen; Deforce, Dieter; Blooi, Mark; Van Nieuwerburgh, Filip; Bullaert, Evelien; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank; Martel, An			Autovaccination Confers Protection against Devriesea agamarum Associated Septicemia but Not Dermatitis in Bearded Dragons (Pogona vitticeps)	PLOS ONE			English	Article							ANTIBODY-RESPONSES; HERPESVIRUS; TORTOISES; ANTIGEN; SURFACE; TURTLE	Devrieseasis caused by Devriesea agamarum is a highly prevalent disease in captive desert lizards, resulting in severe dermatitis and in some cases mass mortality. In this study, we assessed the contribution of autovaccination to devrieseasis control by evaluating the capacity of 5 different formalin-inactivated D. agamarum vaccines to induce a humoral immune response in bearded dragons (Pogona vitticeps). Each vaccine contained one of the following adjuvants: CpG, incomplete Freund's, Ribi, aluminium hydroxide, or curdlan. Lizards were administrated one of the vaccines through subcutaneous injection and booster vaccination was given 3 weeks after primo-vaccination. An indirect ELISA was developed and used to monitor lizard serological responses. Localized adverse effects following subcutaneous immunization were observed in all but the Ribi adjuvanted vaccine group. Following homologous experimental challenge, the incomplete Freund's as well as the Ribi vaccine were observed to confer protection in bearded dragons against the development of D. agamarum associated septicemia but not against dermatitis. Subsequently, two-dimensional gelelectrophoresis followed by immunoblotting and mass spectrometry was conducted with serum obtained from 3 lizards that showed seroconversion after immunisation with the Ribi vaccine. Fructose-bisphosphate aldolase and aldo-keto reductase of D. agamarum reacted with serum from the latter lizards. Based on the demonstrated seroconversion and partial protection against D. agamarum associated disease following the use of formalin-inactivated vaccines as well as the identification of target antigens in Ribi vaccinated bearded dragons, this study provides promising information towards the development of a vaccination strategy to control devrieseasis in captive lizard collections.	[Hellebuyck, Tom; Blooi, Mark; Bullaert, Evelien; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van Steendam, Katleen; Deforce, Dieter; Van Nieuwerburgh, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Blooi, Mark] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium	Ghent University; Ghent University	Hellebuyck, T (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Tom.Hellebuyck@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Haesebrouck, Freddy/0000-0002-1709-933X; Deforce, Dieter LD/0000-0002-0635-661X				Ambrosius H, 1972, C INSERM PHYL ONT ST, P135; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Cooper EL, 1988, BIOL REPTILIA, P298; D'Costa SS, 2000, BIOCHEM BIOPH RES CO, V278, P826, DOI 10.1006/bbrc.2000.3884; DEEB BJ, 1992, J IMMUNOL METHODS, V152, P105, DOI 10.1016/0022-1759(92)90093-9; Devloo R, 2011, VET MICROBIOL, V150, P297, DOI 10.1016/j.vetmic.2011.01.029; Fiebig H, 1973, Allerg Immunol (Leipz), V19, P248; Hellebuyck T, 2011, LETT APPL MICROBIOL, V52, P28, DOI 10.1111/j.1472-765X.2010.02962.x; Hellebuyck T, 2009, VET MICROBIOL, V139, P189, DOI 10.1016/j.vetmic.2009.05.003; Hellebuyck T, 2009, VET MICROBIOL, V134, P267, DOI 10.1016/j.vetmic.2008.08.021; HERBST LH, 1995, VET IMMUNOL IMMUNOP, V46, P317, DOI 10.1016/0165-2427(94)05360-5; Jacobson ER, 2002, SEMIN AVIAN EXOT PET, V11, P33, DOI 10.1053/saep.2002.28239; JACOBSON ER, 1991, J ZOO WILDLIFE MED, V22, P184; Lapidus A, 2009, STAND GENOMIC SCI, V1, P3, DOI 10.4056/sigs.492; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lock BA, 2003, AM J VET RES, V64, P388, DOI 10.2460/ajvr.2003.64.388; Marschang RE, 2001, DEUT TIERARZTL WOCH, V108, P376; Martel A, 2008, INT J SYST EVOL MICR, V58, P2206, DOI 10.1099/ijs.0.65478-0; Origgi FC, 2004, VET PATHOL, V41, P50, DOI 10.1354/vp.41-1-50; Pasmans F, 2002, VET MICROBIOL, V87, P315, DOI 10.1016/S0378-1135(02)00081-0; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SALANITRO SK, 1973, COPEIA, P504; Salway J.G., 2017, METABOLISM GLANCE; Van Steendam K, 2013, INT J LEGAL MED, V127, P287, DOI 10.1007/s00414-012-0747-x; Van Steendam K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3070; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	27	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113084	10.1371/journal.pone.0113084	http://dx.doi.org/10.1371/journal.pone.0113084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479609	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200015
J	Hsieh, YH; Wu, JH; Fang, J; Yang, Y; Lou, J				Hsieh, Ying-Hen; Wu, Jianhong; Fang, Jian; Yang, Yong; Lou, Jie			Quantification of Bird-to-Bird and Bird-toHuman Infections during 2013 Novel H7N9 Avian Influenza Outbreak in China	PLOS ONE			English	Article							PANDEMIC INFLUENZA; REPRODUCTION NUMBER; PERSON TRANSMISSION; VIRUS; STRATEGIES; EPIDEMIC; SPREAD; DENGUE	From February to May, 2013, 132 human avian influenza H7N9 cases were identified in China resulting in 37 deaths. We developed a novel, simple and effective compartmental modeling framework for transmissions among (wild and domestic) birds as well as from birds to human, to infer important epidemiological quantifiers, such as basic reproduction number for bird epidemic, bird-to-human infection rate and turning points of the epidemics, for the epidemic via human H7N9 case onset data and to acquire useful information regarding the bird-to-human transmission dynamics. Estimated basic reproduction number for infections among birds is 4.10 and the mean daily number of human infections per infected bird is 3.16*10(-5) [3.08*10(-5), 3.23*10(-5)]. The turning point of 2013 H7N9 epidemic is pinpointed at April 16 for bird infections and at April 9 for bird-to-human transmissions. Our result reveals very low level of bird-to-human infections, thus indicating minimal risk of widespread bird-to-human infections of H7N9 virus during the outbreak. Moreover, the turning point of the human epidemic, pinpointed at shortly after the implementation of full-scale control and intervention measures initiated in early April, further highlights the impact of timely actions on ending the outbreak. This is the first study where both the bird and human components of an avian influenza epidemic can be quantified using only the human case data.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan; [Wu, Jianhong; Fang, Jian; Yang, Yong] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Wu, Jianhong; Fang, Jian] York Univ, Ctr Dis Modelling, Toronto, ON M3J 2R7, Canada; [Fang, Jian] Harbin Inst Technol, Dept Math, Harbin 150006, Peoples R China; [Lou, Jie] Shanghai Univ, Dept Math, Shanghai, Peoples R China	China Medical University Taiwan; China Medical University Taiwan; York University - Canada; York University - Canada; Harbin Institute of Technology; Shanghai University	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	hsieh@mail.cmu.edu.tw	Wu, Jian/AAU-5221-2020; Hsieh, Ying-Hen/E-9685-2010; Fang, Jian/AAK-7981-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Science Council, Taiwan; Natural Science Foundation of China; International Development Research Centre; Canada Research Chair Program; Natural Sciences and Engineering Research Council of Canada	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Development Research Centre; Canada Research Chair Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding support came from the National Science Council, Taiwan (YHH), the Natural Science Foundation of China (JF and JL), the International Development Research Centre (JW), the Canada Research Chair Program (JW), and the Natural Sciences and Engineering Research Council of Canada (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusto FB, 2010, DISCRETE CONT DYN-B, V13, P1, DOI 10.3934/dcdsb.2009.13.1; ANDERSON R M, 1991; [Anonymous], 2013, HUM INF INFL A H7N9; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; Hsieh YH, 2009, SERIES CONT APPL MAT, V11, P216, DOI DOI 10.1142/9789814261265_; Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66; Iwami S, 2007, MATH BIOSCI, V207, P1, DOI 10.1016/j.mbs.2006.08.001; Kucharski Adam, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.e1473d9bfc99d080ca242139a06c455f; Le Menach A, 2006, P ROY SOC B-BIOL SCI, V273, P2467, DOI 10.1098/rspb.2006.3609; Liu R, 2008, MATH MODEL NAT PHENO, V3, P161, DOI 10.1051/mmnp:2008048; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Ministry of Agriculture of the People's Republic of China, 2013, NO H7N9 VIR FOUND PO; National Health and Family Planning Commission, 2013, NEWS B; Nishiura H, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-30; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024; World Health Organization, 2014, 17 WHO; Wu H, 2013, N ENGL J MED; Wu J, 2008, MATH EPIDEMIOLOGY; Xiao Y, 2014, J THEORETI BIOL, V3521, P3525; Xinhua News Agency, 2013, XINHAUNET NEWS; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2	33	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111834	10.1371/journal.pone.0111834	http://dx.doi.org/10.1371/journal.pone.0111834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479054	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000346907200005
J	Lian, YL; Xu, MY; Zhong, YM; Yang, YQ; Chen, FR; Guo, J				Lian, Yingli; Xu, Meiying; Zhong, Yuming; Yang, Yongqiang; Chen, Fanrong; Guo, Jun			Ammonia Oxidizers in a Pilot-Scale Multilayer Rapid Infiltration System for Domestic Wastewater Treatment	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; NITRITE ACCUMULATION; NITROGEN REMOVAL; ARCHAEA; BACTERIA; SOIL; NITRIFICATION; TEMPERATURE; SEQUENCE	A pilot-scale multilayer rapid infiltration system (MRIS) for domestic wastewater treatment was established and efficient removal of ammonia and chemical oxygen demand (COD) was achieved in this study. The microbial community composition and abundance of ammonia oxidizers were investigated. Efficient biofilms of ammonia oxidizers in the stationary phase (packing material) was formed successfully in the MRIS without special inoculation. DGGE and phylogenetic analyses revealed that proteobacteria dominated in the MRIS. Relative abundance of ammonia-oxidizing archaea (AOA) and ammonia-oxidizing bacteria (AOB) showed contrary tendency. In the flowing phase (water effluent), AOA diversity was significantly correlated with the concentration of dissolve oxygen (DO), NO3-N and NH3-N. AOB abundance was significantly correlated with the concentration of DO and chemical oxygen demand (COD). NH3-N and COD were identified as the key factors to shape AOB community structure, while no variable significantly correlated with that of AOA. AOA might play an important role in the MRIS. This study could reveal key environmental factors affecting the community composition and abundance of ammonia oxidizers in the MRIS.	[Lian, Yingli] S China Univ Technol, Sch Biol Sci & Engn, Guangzhou 510006, Guangdong, Peoples R China; [Lian, Yingli; Xu, Meiying; Zhong, Yuming; Guo, Jun] Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China; [Yang, Yongqiang; Chen, Fanrong] Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou 510640, Guangdong, Peoples R China	South China University of Technology; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	Xu, MY (corresponding author), Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China.	xumy@gdim.cn	Xu, Meiying/AAM-1646-2020; Yang, Yongqiang/S-2732-2019		The Chinese Academy of Sciences [KZCX2-YW-JC105]; Chinese National Programs for High Technology Research and Development (863 Program) [2011AA060904]; Natural Science Foundation of Guangdong Province, China [9351007002000001]	The Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Programs for High Technology Research and Development (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This study was partly funded by innovative Program of The Chinese Academy of Sciences (KZCX2-YW-JC105), the Chinese National Programs for High Technology Research and Development (863 Program) (2011AA060904). The assistance from the Teamwork Project of the Natural Science Foundation of Guangdong Province, China (9351007002000001) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, STANDARD METHODS EXA; Auset M, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003611; BOCK E, 1995, ARCH MICROBIOL, V163, P16, DOI 10.1007/BF00262198; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Boyle-Yarwood SA, 2008, ENVIRON MICROBIOL, V10, P2956, DOI 10.1111/j.1462-2920.2008.01600.x; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gieseke A, 2006, APPL ENVIRON MICROB, V72, P4283, DOI 10.1128/AEM.00241-06; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; JONES RD, 1980, MICROB ECOL, V6, P339, DOI 10.1007/BF02010496; Kim DJ, 2006, BIORESOURCE TECHNOL, V97, P459, DOI 10.1016/j.biortech.2005.03.032; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koops HP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P778, DOI 10.1007/0-387-30745-1_36; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lenz M, 2009, APPL MICROBIOL BIOT, V83, P377, DOI 10.1007/s00253-009-1915-x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mohanakrishnan J, 2011, APPL MICROBIOL BIOT, V91, P1647, DOI 10.1007/s00253-011-3330-3; Mota C, 2005, APPL ENVIRON MICROB, V71, P8565, DOI 10.1128/AEM.71.12.8565-8572.2005; Nicol GW, 2006, TRENDS MICROBIOL, V14, P207, DOI 10.1016/j.tim.2006.03.004; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Park SJ, 2007, J MICROBIOL, V45, P113; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Ruiz G, 2003, WATER RES, V37, P1371, DOI 10.1016/S0043-1354(02)00475-X; Schmidt I, 2003, FEMS MICROBIOL REV, V27, P481, DOI 10.1016/S0168-6445(03)00039-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; Wendroth O., 2004, VADOSE ZONE J, V3, P1057, DOI [10.2136/vzj2004.1057, DOI 10.2136/VZJ2004.1057]; Yoo K, 1999, WATER RES, V33, P145	38	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114723	10.1371/journal.pone.0114723	http://dx.doi.org/10.1371/journal.pone.0114723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479611	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200117
J	Miyaso, H; Nakamura, N; Naito, M; Hirai, S; Matsuno, Y; Itoh, M; Mori, C				Miyaso, Hidenobu; Nakamura, Noriko; Naito, Munekazu; Hirai, Shuichi; Matsuno, Yoshiharu; Itoh, Masahiro; Mori, Chisato			Early Postnatal Exposure to a Low Dose of Decabromodiphenyl Ether Affects Expression of Androgen and Thyroid Hormone Receptor-Alpha and Its Splicing Variants in Mouse Sertoli Cells	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; MESSENGER-RNA; GENE-EXPRESSION; DIPHENYL ETHER; DEVELOPMENTAL EXPOSURE; DEVELOPING LEYDIG; IN-VIVO; TESTIS; SPERMATOGENESIS; BDE-209	Decabromodiphenyl ether (decaBDE) adversely affects reproduction and development. Our previous study showed that postnatal exposure to a low dose of decaBDE (0.025 mg/kg body weight/day) by subcutaneous injection on postnatal days (PNDs) 1 through 5 leads to reductions in testicular size and number of Sertoli cells and sperm, while higher dose of decaBDE (2.5 mg/kg body weight/day) had no significant differences about these. In the present study, we examined the molecular mechanism of these effects on mouse testes following postnatal exposure to a low decaBDE dose. We hypothesized that postnatal exposure to decaBDE may alter levels of serum thyroid hormones (THs) and testosterone, or the level of TH receptor alpha (Thra) transcripts and its splicing variants and androgen receptor (Ar) in Sertoli cells, adversely affecting spermatogenesis. To test this hypothesis, we examined serum TH and testosterone levels and the levels of transcripts of the Ar, Thra and its splicing variants, and Thra splicing factors (Hnrnpa1, Srsf1, and Hnrnph1) with qPCR in isolated mouse Sertoli cells exposed postnatally to decaBDE (0.025, 0.25, and 2.5 mg/kg). Levels of serum testosterone and transcripts encoding Ar, Thra, and its variant, Thra1, declined significantly in Sertoli cells of mice exposed to 0.025 mg decaBDE/kg. No significant differences in serum TH level or Thra2, Hnrnph1, or Srsf1 transcript levels were observed between control and decaBDE-exposed mice. However, the Thra1:Thra2 and Hnrnpa1:Srsf1 ratios were altered in Sertoli cells of mice exposed to 0.025 mg decaBDE/kg but not in cells exposed to 0.25 or 2.5 mg decaBDE/kg. These results indicate that postnatal exposure to a low dose of decaBDE on PNDs 1 through 5 lowers the testosterone level and the levels of Ar and Thra transcripts in Sertoli cells, accompanied by an imbalance in the ratios of Thra splicing variants, resulting in smaller testicular size and impaired spermatogenesis.	[Miyaso, Hidenobu; Matsuno, Yoshiharu; Mori, Chisato] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Miyaso, Hidenobu; Matsuno, Yoshiharu; Mori, Chisato] Chiba Univ, Grad Sch Med, Dept Bioenvironm Med, Chiba, Japan; [Nakamura, Noriko] Marshall Univ, Joan C Edwards Sch Med, Dept Pharmacol Physiol & Toxicol, Huntington, WV USA; [Naito, Munekazu] Aichi Med Univ, Dept Anat, Nagakute, Aichi, Japan; [Hirai, Shuichi; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan	Chiba University; Chiba University; Marshall University; Aichi Medical University; Tokyo Medical University	Mori, C (corresponding author), Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan.	cmori@faculty.chiba-u.jp	HIRAI, SHUICHI/AAQ-6081-2020	Miyaso, Hidenobu/0000-0003-2212-1500	JSPS KAKENHI [20241016, 24710069]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI (grant numbers 20241016 and 24710069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambepola NK, 1998, J ENDOCRINOL, V156, P43, DOI 10.1677/joe.0.1560043; Auwerx J, 1999, CELL, V97, P161; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Fagman H, 2006, DEV DYNAM, V235, P444, DOI 10.1002/dvdy.20653; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hanamura A, 1998, RNA, V4, P430; Hastings ML, 2001, RNA, V7, P859, DOI 10.1017/S1355838201002084; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Jannini EA, 2000, J CLIN ENDOCR METAB, V85, P3453, DOI 10.1210/jc.85.9.3453; JOYCE KL, 1993, J ANDROL, V14, P448; Kim TH, 2009, J TOXICOL ENV HEAL A, V72, P1296, DOI 10.1080/15287390903320742; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Lee E, 2010, J TOXICOL SCI, V35, P535, DOI 10.2131/jts.35.535; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; McDonald TA, 2002, CHEMOSPHERE, V46, P745, DOI 10.1016/S0045-6535(01)00239-9; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Miyaso H, 2012, J TOXICOL SCI, V37, P987, DOI 10.2131/jts.37.987; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Noyes PD, 2013, ENVIRON SCI TECHNOL, V47, P10012, DOI 10.1021/es402650x; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; Ortega FJ, 2009, OBESITY, V17, P2134, DOI 10.1038/oby.2009.110; Rao JN, 2003, J ENDOCRINOL INVEST, V26, P435, DOI 10.1007/BF03345199; ROMERT P, 1973, Z ANAT ENTWICKLUNGS, V139, P319, DOI 10.1007/BF00519971; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SHAN LX, 1995, ENDOCRINOLOGY, V136, P3856, DOI 10.1210/en.136.9.3856; Shan LX, 1997, ENDOCRINOLOGY, V138, P1259, DOI 10.1210/en.138.3.1259; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Thijssen-Timmer DC, 2006, J MOL ENDOCRINOL, V37, P251, DOI 10.1677/jme.1.01914; Timmer DC, 2003, J ENDOCRINOL, V179, P217, DOI 10.1677/joe.0.1790217; Tseng LH, 2008, CHEMOSPHERE, V70, P640, DOI 10.1016/j.chemosphere.2007.06.078; Tseng LH, 2006, TOXICOLOGY, V224, P33, DOI 10.1016/j.tox.2006.04.003; Tseng LH, 2013, ENVIRON TOXICOL, V28, P380, DOI 10.1002/tox.20729; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Zhai Jin-Xia, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P294	40	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114487	10.1371/journal.pone.0114487	http://dx.doi.org/10.1371/journal.pone.0114487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479311	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200094
J	Suzuki, H; Oku, H; Horie, T; Morishita, S; Tonari, M; Oku, K; Okubo, A; Kida, T; Mimura, M; Fukumoto, M; Kojima, S; Takai, S; Ikeda, T				Suzuki, Hiroyuki; Oku, Hidehiro; Horie, Taeko; Morishita, Seita; Tonari, Masahiro; Oku, Kazuma; Okubo, Akiko; Kida, Teruyo; Mimura, Masashi; Fukumoto, Masanori; Kojima, Shota; Takai, Shinji; Ikeda, Tsunehiko			Changes in Expression of Aquaporin-4 and Aquaporin-9 in Optic Nerve after Crushing in Rats	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; DIABETIC-RETINOPATHY; WATER TRANSPORT; BRAIN EDEMA; GLIAL-CELLS; INJURY; KIR4.1; MICE; REGENERATION; SURVIVAL	The purpose of this study was to determine the temporal and spatial changes in the expression of AQP4 and AQP9 in the optic nerve after it is crushed. The left optic nerves of rats were either crushed (crushed group) or sham operated (sham group), and they were excised before, and at 1, 2, 4, 7, and 14 days later. Four optic nerves were pooled for each time point in both groups. The expression of AQP4 and AQP9 was determined by western blot analyses. Immunohistochemistry was used to determine the spatial expression of AQP4, AQP9, and GFAP in the optic nerve. Optic nerve edema was determined by measuring the water content in the optic nerve. The barrier function of the optic nerve vessels was determined by the extravasated Evans blue dye on days 7 and 14. The results showed that the expression of AQP4 was increased on day 1 but the level was significantly lower than that in the sham group on days 4 and 7 (P<0.05). In contrast, the expression of AQP9 gradually increased, and the level was significantly higher than that in the sham group on days 7 and 14 (P<0.05, Tukey-Kramer). The down-regulation of AQP4 was associated with crush-induced optic nerve edema, and the water content of the nerve was significantly increased by 4.3% in the crushed optic nerve from that of the untouched fellow nerve on day 7. The expression of AQP4 and GFAP was reduced at the crushed site where AQP4-negative and AQP9-positive astrocytes were present. The barrier function was impaired at the crushed site on days 7 and 14, restrictedly where AQP4-negative and AQP9-positive astrocytes were present. The presence of AQP9-positive astrocytes at the crushed site may counteract the metabolic damage but this change did not fully compensate for the barrier function defect.	[Suzuki, Hiroyuki; Oku, Hidehiro; Horie, Taeko; Morishita, Seita; Tonari, Masahiro; Oku, Kazuma; Okubo, Akiko; Kida, Teruyo; Mimura, Masashi; Fukumoto, Masanori; Kojima, Shota; Takai, Shinji; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Osaka, Japan	Osaka Medical College	Oku, H (corresponding author), Osaka Med Coll, Dept Ophthalmol, Osaka, Japan.	hidehirooku@aol.com	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219; Mimura, Masashi/0000-0002-2396-5636	Japanese Ministry of Education [25462763]	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Japanese Ministry of Education Grant 25462763 (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bosco A, 2005, INVEST OPHTH VIS SCI, V46, P3869, DOI 10.1167/iovs.05-0385; Cui B, 2012, EXP EYE RES, V98, P37, DOI 10.1016/j.exer.2012.02.013; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Dibaj P, 2007, J NEUROCHEM, V103, P2620, DOI 10.1111/j.1471-4159.2007.04979.x; Dibas A, 2007, PHARMACOL RES, V55, P378, DOI 10.1016/j.phrs.2007.01.021; Dibas A, 2010, MOL VIS, V16, P330; Fukuda M, 2010, EXP EYE RES, V90, P17, DOI 10.1016/j.exer.2009.09.003; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hollborn M, 2012, CURR EYE RES, V37, P524, DOI 10.3109/02713683.2012.658133; Hollborn M, 2011, CURR EYE RES, V36, P850, DOI 10.3109/02713683.2011.593108; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kurimoto T, 2006, NEUROREPORT, V17, P1525, DOI 10.1097/01.wnr.0000234749.80936.54; Li XM, 2014, NEUROL SCI; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Miki A, 2013, AM J PATHOL, V182, P1727, DOI 10.1016/j.ajpath.2013.01.027; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Naka M, 2010, INVEST OPHTH VIS SCI, V51, P4618, DOI 10.1167/iovs.09-4712; Nielsen S, 1997, J NEUROSCI, V17, P171; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Qin YW, 2012, INVEST OPHTH VIS SCI, V53, P3047, DOI 10.1167/iovs.11-9154; Qin YW, 2009, EXP EYE RES, V89, P741, DOI 10.1016/j.exer.2009.06.020; Ransom BR, 1997, GLIA, V21, P134; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schey KL, 2014, BBA-GEN SUBJECTS, V1840, P1513, DOI 10.1016/j.bbagen.2013.10.037; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Yang MH, 2013, BIOSCI REP, V33; Zhang Y, 2011, J INT MED RES, V39, P464, DOI 10.1177/147323001103900214; Zhou JP, 2008, NEUROREPORT, V19, P1, DOI 10.1097/WNR.0b013e3282f2b4eb; Zickler P, 2010, CELL PHYSIOL BIOCHEM, V26, P483, DOI 10.1159/000320571	39	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114694	10.1371/journal.pone.0114694	http://dx.doi.org/10.1371/journal.pone.0114694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479407	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200113
J	Warriner, DR; Brown, AG; Varma, S; Sheridan, PJ; Lawford, P; Hose, DR; Al-Mohammad, A; Shi, YB				Warriner, David R.; Brown, Alistair G.; Varma, Susheel; Sheridan, Paul J.; Lawford, Patricia; Hose, David R.; Al-Mohammad, Abdallah; Shi, Yubing			Closing the Loop: Modelling of Heart Failure Progression from Health to End-Stage Using a Meta-Analysis of Left Ventricular Pressure-Volume Loops	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIAC RESYNCHRONIZATION THERAPY; DILATED CARDIOMYOPATHY; CONDUCTANCE CATHETER; CARDIOVASCULAR MECHANICS; DIAGNOSTIC-ANALYSIS; MATHEMATICAL-MODEL; DIASTOLIC FUNCTION; AMERICAN-COLLEGE; CHAMBER FUNCTION	Introduction: The American Heart Association (AHA)/American College of Cardiology (ACC) guidelines for the classification of heart failure (HF) are descriptive but lack precise and objective measures which would assist in categorising such patients. Our aim was two fold, firstly to demonstrate quantitatively the progression of HF through each stage using a meta-analysis of existing left ventricular (LV) pressure-volume (PV) loop data and secondly use the LV PV loop data to create stage specific HF models. Methods and Results: A literature search yielded 31 papers with PV data, representing over 200 patients in different stages of HF. The raw pressure and volume data were extracted from the papers using a digitising software package and the means were calculated. The data demonstrated that, as HF progressed, stroke volume (SV), ejection fraction (EF%) decreased while LV volumes increased. A 2-element lumped parameter model was employed to model the mean loops and the error was calculated between the loops, demonstrating close fit between the loops. The only parameter that was consistently and statistically different across all the stages was the elastance (Emax). Conclusions: For the first time, the authors have created a visual and quantitative representation of the AHA/ACC stages of LVSD-HF, from normal to end-stage. The study demonstrates that robust, load-independent and reproducible parameters, such as elastance, can be used to categorise and model HF, complementing the existing classification. The modelled PV loops establish previously unknown physiological parameters for each AHA/ACC stage of LVSD-HF, such as LV elastance and highlight that it this parameter alone, in lumped parameter models, that determines the severity of HF. Such information will enable cardiovascular modellers with an interest in HF, to create more accurate models of the heart as it fails.	[Warriner, David R.; Brown, Alistair G.; Varma, Susheel; Sheridan, Paul J.; Lawford, Patricia; Hose, David R.; Shi, Yubing] Univ Sheffield, Med Phys Grp, Dept Cardiovasc Sci, Sheffield S10 2TN, S Yorkshire, England; [Warriner, David R.; Sheridan, Paul J.; Al-Mohammad, Abdallah] Sheffield Teaching Hosp, No Gen Hosp, Dept Cardiol, Sheffield S5 7AU, S Yorkshire, England	University of Sheffield; Northern General Hospital; University of Sheffield	Warriner, DR (corresponding author), Univ Sheffield, Med Phys Grp, Dept Cardiovasc Sci, Sheffield S10 2TN, S Yorkshire, England.	d.r.warriner@sheffield.ac.uk	Shi, Yubing/AAG-8554-2019; Al-Mohammad, Abdallah/I-5663-2019	Shi, Yubing/0000-0002-5462-3321; Al-Mohammad, Abdallah/0000-0001-6517-8692; Warriner, David/0000-0002-1328-1089; Varma, Susheel/0000-0003-1687-2754	Engineering and Physical Sciences Research Council (EPSRC) [R/125661-11-1]; Engineering and Physical Sciences Research Council [EP/H01991X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a grant from the Engineering and Physical Sciences Research Council (EPSRC): Translating biomedical modelling into the heart of the clinic (R/125661-11-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar KA, 2007, CIRCULATION, V115, P1563, DOI 10.1161/CIRCULATIONAHA.106.666818; ARONEY CN, 1989, J AM COLL CARDIOL, V14, P127, DOI 10.1016/0735-1097(89)90062-4; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Dekker ALAJ, 2004, J THORAC CARDIOV SUR, V127, P1641, DOI 10.1016/j.jtcvs.2003.10.052; Feldman MD, 1996, CIRCULATION, V93, P474, DOI 10.1161/01.CIR.93.3.474; Ferrari M, 2005, J HEART LUNG TRANSPL, V24, P226, DOI 10.1016/j.healun.2003.09.044; Hayward CS, 1999, J CARDIOVASC PHARM, V34, P749, DOI 10.1097/00005344-199911000-00018; Hayward CS, 2001, CARDIOVASC RES, V49, P340, DOI 10.1016/S0008-6363(00)00280-7; HERRMANN HC, 1987, J AM COLL CARDIOL, V9, P1117, DOI 10.1016/S0735-1097(87)80316-9; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Kashimura T, 2007, Heart, V93, P151; KASS DA, 1995, CIRCULATION, V91, P2314, DOI 10.1161/01.CIR.91.9.2314; KASS DA, 1992, EUR HEART J, V13, P57, DOI 10.1093/eurheartj/13.suppl_E.57; Kawaguchi AT, 2001, J CARDIAC SURG, V16, P48, DOI 10.1111/j.1540-8191.2001.tb00483.x; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Kim MH, 1999, CIRCULATION, V100, P729, DOI 10.1161/01.CIR.100.7.729; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Lorusso R, 1997, EUR J CARDIO-THORAC, V11, P363, DOI 10.1016/S1010-7940(96)01038-X; MacGowan GA, 1998, J AM COLL CARDIOL, V31, P1344, DOI 10.1016/S0735-1097(98)00105-3; MAGORIEN DJ, 1983, CIRCULATION, V67, P844, DOI 10.1161/01.CIR.67.4.844; Marco TD, 2004, J CARD FAIL, V10, pS96; Mitchell M, 2005, ENGAUGE DIGITIZER; REDINGTON AN, 1988, BRIT HEART J, V59, P23; Remmelink M, 2010, J INVASIVE CARDIOL, V22, P574; Remmelink M, 2009, J AM COLL CARDIOL, V53, P1498, DOI 10.1016/j.jacc.2008.12.058; Schreuder J J, 1991, J Cardiothorac Vasc Anesth, V5, P539, DOI 10.1016/1053-0770(91)90002-B; SCHREUDER JJ, 1995, CIRCULATION, V91, P2010, DOI 10.1161/01.CIR.91.7.2010; Schreuder JJ, 2005, ANN THORAC SURG, V79, P872, DOI 10.1016/j.athoracsur.2004.07.073; Shi Y, 2007, LUMPED PARAMETER CAR; SMITH M, 1974, CHEST, V65, P368, DOI 10.1378/chest.65.4.368; Sonntag S, 2004, J AM COLL CARDIOL, V43, P2177, DOI 10.1016/j.jacc.2004.02.052; Steendijk P, 2006, CIRCULATION, V113, P1295, DOI 10.1161/CIRCULATIONAHA.105.540435; ten Brinke EA, 2010, J THORAC CARDIOV SUR, V140, P1338, DOI 10.1016/j.jtcvs.2010.01.029; THORMANN J, 1990, J CARDIOVASC PHARM, V16, P182, DOI 10.1097/00005344-199008000-00002; THORMANN J, 1989, CARDIOVASC DRUG THER, V3, P145, DOI 10.1007/BF01883858; THORMANN J, 1990, CARDIOVASC DRUG THER, V4, P1403, DOI 10.1007/BF02018269; THORMANN J, 1992, EUR HEART J, V13, P69, DOI 10.1093/eurheartj/13.suppl_E.69; TSURUTA H, 1994, MED BIOL ENG COMPUT, V32, P12, DOI 10.1007/BF02512473; TSURUTA H, 1994, MED BIOL ENG COMPUT, V32, P3, DOI 10.1007/BF02512472; Tulner SAF, 2006, J THORAC CARDIOV SUR, V132, P610, DOI 10.1016/j.jtcvs.2005.12.016; Urheim S, 2002, J AM SOC ECHOCARDIOG, V15, P225, DOI 10.1067/mje.2002.118174	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114153	10.1371/journal.pone.0114153	http://dx.doi.org/10.1371/journal.pone.0114153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479594	Green Published, gold, Green Accepted			2022-12-27	WOS:000346907200047
J	Valdivia, K; Jouanno, E; Volff, JN; Galiana-Arnoux, D; Guyomard, R; Helary, L; Mourot, B; Fostier, A; Quillet, E; Guiguen, Y				Valdivia, Karina; Jouanno, Elodie; Volff, Jean-Nicolas; Galiana-Arnoux, Delphine; Guyomard, Rene; Helary, Louise; Mourot, Brigitte; Fostier, Alexis; Quillet, Edwige; Guiguen, Yann			High Temperature Increases the Masculinization Rate of the All-Female (XX) Rainbow Trout "Mal" Population	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; ONCORHYNCHUS-MYKISS; EMBRYONIC-DEVELOPMENT; DETERMINING GENE; DIFFERENTIATION; CORTISOL; FISH; EXPRESSION; GONADS; CARP	Salmonids are generally considered to have a robust genetic sex determination system with a simple male heterogamety (XX/XY). However, spontaneous masculinization of XX females has been found in a rainbow trout population of gynogenetic doubled haploid individuals. The analysis of this masculinization phenotype transmission supported the hypothesis of the involvement of a recessive mutation (termed mal). As temperature effect on sex differentiation has been reported in some salmonid species, in this study we investigated in detail the potential implication of temperature on masculinization in this XX mal-carrying population. Seven families issued from XX mal-carrying parents were exposed from the time of hatching to different rearing water temperatures ((8, 12 and 18 degrees C), and the resulting sex-ratios were confirmed by histological analysis of both gonads. Our results demonstrate that masculinization rates are strongly increased (up to nearly two fold) at the highest temperature treatment (18 degrees C). Interestingly, we also found clear differences between temperatures on the masculinization of the left versus the right gonads with the right gonad consistently more often masculinized than the left one at lower temperatures (8 and 12 degrees C). However, the masculinization rate is also strongly dependent on the genetic background of the XX mal-carrying families. Thus, masculinization in XX mal-carrying rainbow trout is potentially triggered by an interaction between the temperature treatment and a complex genetic background potentially involving some part of the genetic sex differentiation regulatory cascade along with some minor sex-influencing loci. These results indicate that despite its rather strict genetic sex determinism system, rainbow trout sex differentiation can be modulated by temperature, as described in many other fish species.	[Valdivia, Karina; Jouanno, Elodie; Helary, Louise; Mourot, Brigitte; Fostier, Alexis; Guiguen, Yann] INRA, LPGP Fish Physiol & Gen, UR1037, F-35000 Rennes, France; [Volff, Jean-Nicolas; Galiana-Arnoux, Delphine] Univ Claude Bernard Lyon I ENS, CNRS INRA, IGFL, UMR5242, Lyon 07, France; [Guyomard, Rene] INRA, GABI Genet Anim & Biol Integrat, UMR1313, F-78352 Jouy En Josas, France	INRAE; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guiguen, Y (corresponding author), INRA, LPGP Fish Physiol & Gen, UR1037, F-35000 Rennes, France.	yann.guiguen@rennes.inra.fr		Helary, Louise/0000-0002-2481-2113; Guiguen, Yann/0000-0001-5464-6219	French National Research Agency ("Sexytrout" project) [ANR-2008-GENM-031]; Ministere de la Recherche et de l'Enseignement Superieur	French National Research Agency ("Sexytrout" project)(French National Research Agency (ANR)); Ministere de la Recherche et de l'Enseignement Superieur	This work was supported by the French National Research Agency ("Sexytrout" project, ANR-2008-GENM-031). K.V. received a fellowship from the "Ministere de la Recherche et de l'Enseignement Superieur". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelopoulou R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-13; ASHBY KR, 1957, J EMBRYOL EXP MORPH, V5, P225; Azuma T, 2004, AQUACULTURE, V234, P461, DOI 10.1016/j.aquaculture.2003.11.023; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; BARRY TP, 1995, GEN COMP ENDOCR, V97, P57, DOI 10.1006/gcen.1995.1006; Chevassus B., 1979, BULLETIN FRANCAIS DE PISCICULTURE, P18, DOI 10.1051/kmae:1979006; Chevassus Bernard, 1992, Aquatic Living Resources, V5, P325, DOI 10.1051/alr:1992031; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; Craig JK, 1996, CAN J FISH AQUAT SCI, V53, P141, DOI 10.1139/cjfas-53-1-141; Davidson WS, 2009, SEX DEV, V3, P78, DOI 10.1159/000223073; Fuzzen MLM, 2011, GEN COMP ENDOCR, V170, P604, DOI 10.1016/j.ygcen.2010.11.022; Gabe M, 1968, HISTOLOGICAL TECHNIQ; Gabillard JC, 2003, J EXP ZOOL PART A, V298A, P134, DOI 10.1002/jez.a.10280; Guillevic M, 2008, CYBIUM, V32, P99; Hattori RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006548; Hayashi Y, 2010, MOL REPROD DEV, V77, P679, DOI 10.1002/mrd.21203; Hunter RHF, 1996, MOL REPROD DEV, V45, P392, DOI 10.1002/(SICI)1098-2795(199611)45:3<392::AID-MRD17>3.0.CO;2-0; JALABERT B, 1975, ANN BIOL ANIM BIOCH, V15, P19, DOI 10.1051/rnd:19750103; KOMEN J, 1992, DEV GROWTH DIFFER, V34, P535; KWAIN WH, 1975, J FISH RES BOARD CAN, V32, P397, DOI 10.1139/f75-046; Luhmann LM, 2012, SEX DEV, V6, P247, DOI 10.1159/000339705; Magerhans A, 2010, AQUACULTURE, V306, P63, DOI 10.1016/j.aquaculture.2010.05.015; Magerhans A, 2009, AQUACULTURE, V294, P25, DOI 10.1016/j.aquaculture.2009.05.001; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Mittwoch U, 2001, J EXP ZOOL, V290, P484, DOI 10.1002/jez.1091; Hurk R. van den, 1982, Proceedings of the International Symposium on Reproductive Physiology of Fish, Wageningen, the Netherlands, 2-6 August 1982., P69; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; Price D.J., 1984, P77; Quillet E, 2002, J HERED, V93, P91, DOI 10.1093/jhered/93.2.91; Quillett E, 2004, J FISH BIOL, V64, P1147, DOI 10.1111/j.1095-8649.2004.00373.x; Ruane NM, 2007, GEN COMP ENDOCR, V150, P473, DOI 10.1016/j.ygcen.2006.11.008; Ruane NM, 2005, GEN COMP ENDOCR, V143, P66, DOI 10.1016/j.ygcen.2005.02.024; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Strussmann CA, 2005, J MORPHOL, V265, P190, DOI 10.1002/jmor.10351; Valdivia K, 2013, SEX DEV, V7, P196, DOI 10.1159/000348435; VANDENHURK R, 1985, GEN COMP ENDOCR, V57, P216, DOI 10.1016/0016-6480(85)90266-7; Vandeputte M, 2006, MOL ECOL NOTES, V6, P265, DOI 10.1111/j.1471-8286.2005.01167.x; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; VANLIMBORGH J, 1968, ARCH ANAT MICROSC MO, V57, P79; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Yamaguchi T, 2012, BIOCHEM BIOPH RES CO, V419, P287, DOI 10.1016/j.bbrc.2012.02.012; Yamaguchi T, 2010, ENDOCRINOLOGY, V151, P3900, DOI 10.1210/en.2010-0228; Yamamoto T. O., 1969, P117; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yu ZH, 1998, INT J ANDROL, V21, P53, DOI 10.1046/j.1365-2605.1998.00088.x	48	25	27	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113355	10.1371/journal.pone.0113355	http://dx.doi.org/10.1371/journal.pone.0113355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501353	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400008
J	Uzunoglu, FG; Dethlefsen, E; Hanssen, A; Wrage, M; Deutsch, L; Harms-Effenberger, K; Vashist, YK; Reeh, M; Sauter, G; Simon, R; Bockhorn, M; Pantel, K; Izbicki, JR; Wikman, H				Uzunoglu, Faik G.; Dethlefsen, Ebba; Hanssen, Annkathrin; Wrage, Michaela; Deutsch, Lena; Harms-Effenberger, Katharina; Vashist, Yogesh K.; Reeh, Matthias; Sauter, Guido; Simon, Ronald; Bockhorn, Maximillian; Pantel, Klaus; Izbicki, Jakob R.; Wikman, Harriet			Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CHROMOSOMAL IMBALANCES; 4Q; HETEROZYGOSITY; CARCINOMA; PATTERNS; STAGE; ADENOCARCINOMA; AMPLIFICATION; PROGRESSION; DELETIONS	This study was performed to assess the prognostic relevance of genomic aberrations at chromosome 4q in NSCLC patients. We have previously identified copy number changes at 4q12-q32 to be significantly associated with the early hematogenous dissemination of non-small cell lung cancer (NSCLC), and now aim to narrow down potential hot-spots within this 107 Mb spanning region. Using eight microsatellite markers at position 4q12-35, allelic imbalance (AI) analyses were performed on a preliminary study cohort (n=86). Positions indicating clinicopathological and prognostic associations in AI analyses were further validated in a larger study cohort using fluorescence in situ hybridization (FISH) in 209 NSCLC patients. Losses at positions 4q21.23 and 4q22.1 were shown to be associated with advanced clinicopathological characteristics as well as with shortened disease free (DFS) and overall survival (OS) (DFS: P=0.019; OS: P=0.002). Multivariate analyses identified the losses of 4q21.23-22.1 to be an independent prognostic marker for both DFS and OS in NSCLC (HR 1.64-2.20, all P<0.04), and especially in squamous cell lung cancer (P<0.05). A case report study of a lung cancer patient further revealed a loss of 4q21.23 in disseminated tumor cells (DTCs). Neither gains at the latter positions, nor genomic aberrations at 4q12, 4q31.2 and 4q35.1, indicated a prognostic relevance. In conclusion, our data indicate that loss at 4q21.23-22.1 in NSCLC is of prognostic relevance in NSCLC patients and thus, includes potential new tumor suppressor genes with clinical relevance.	[Uzunoglu, Faik G.; Deutsch, Lena; Harms-Effenberger, Katharina; Vashist, Yogesh K.; Reeh, Matthias; Bockhorn, Maximillian; Izbicki, Jakob R.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Dethlefsen, Ebba; Hanssen, Annkathrin; Wrage, Michaela; Harms-Effenberger, Katharina; Pantel, Klaus; Wikman, Harriet] Univ Med Ctr Hamburg Eppendorf, Inst Tumour Biol, Hamburg, Germany; [Sauter, Guido; Simon, Ronald] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wikman, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Tumour Biol, Hamburg, Germany.	h.wikman@uke.de	Vashist, Yogesh/ABE-4001-2020; Vashist, Yogesh/AAF-3529-2022; Reeh, Matthias/AAB-6917-2022; Vashist, Yogesh/AFH-9205-2022	Wikman, Harriet/0000-0001-6862-0888	Hamburger Krebsgesellschaft e.V., Hamburg, Germany	Hamburger Krebsgesellschaft e.V., Hamburg, Germany	This work was supported by the Hamburger Krebsgesellschaft e.V., Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2010, GENE CHROMOSOME CANC, V49, P596, DOI 10.1002/gcc.20770; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Brosens RPM, 2011, CELL ONCOL, V34, P215, DOI 10.1007/s13402-011-0042-8; Danner BC, 2011, ANN THORAC SURG, V92, P1038, DOI 10.1016/j.athoracsur.2011.04.052; Danner BC, 2011, CANCER GENET-NY, V204, P122, DOI 10.1016/j.cancergen.2010.12.003; FONG KM, 1995, CANCER RES, V55, P4268; FONG KM, 1995, CANCER RES, V55, P220; Goeze A, 2002, J PATHOL, V196, P8, DOI 10.1002/path.1009; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Li RY, 2007, CLIN CANCER RES, V13, P482, DOI 10.1158/1078-0432.CCR-06-1593; Lin SC, CHROMOSOMAL CHANGES; Luebke AM, 2012, PANCREATOLOGY, V12, P16, DOI 10.1016/j.pan.2011.11.001; Pan HJ, 2005, CANCER RES, V65, P1664, DOI 10.1158/0008-5472.CAN-04-3297; Pantel K, 1994, J Hematother, V3, P165, DOI 10.1089/scd.1.1994.3.165; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen I, 1997, CANCER RES, V57, P2331; Petersen S, 2000, BRIT J CANCER, V82, P65; Pikor LA, 2013, LUNG CANCER, V82, P179, DOI 10.1016/j.lungcan.2013.07.025; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Tai ALS, 2004, CANCER, V100, P1918, DOI 10.1002/cncr.20190; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Virmani AK, 1998, GENE CHROMOSOME CANC, V21, P308, DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Wistuba II, 1999, CANCER RES, V59, P1973; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188	26	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113315	10.1371/journal.pone.0113315	http://dx.doi.org/10.1371/journal.pone.0113315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501003	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700007
J	Chen, L; Xu, M; Li, GY; Cai, WX; Zhou, JX				Chen, Lu; Xu, Ming; Li, Gui-Yun; Cai, Wei-Xin; Zhou, Jian-Xin			Incidence, Risk Factors and Consequences of Emergence Agitation in Adult Patients after Elective Craniotomy for Brain Tumor: A Prospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; DELIRIUM; ANESTHESIA; PAIN; SEDATION; OUTCOMES; DYSFUNCTION; EXTUBATION; SURGERY	Emergence agitation is a frequent complication that can have serious consequences during recovery from general anesthesia. However, agitation has been poorly investigated in patients after craniotomy. In this prospective cohort study, adult patients were enrolled after elective craniotomy for brain tumor. The sedation-agitation scale was evaluated during the first 12 hours after surgery. Agitation developed in 35 of 123 patients (29%). Of the agitated patients, 28 (80%) were graded as very and dangerously agitated. By multivariate stepwise logistic regression analysis, independent predictors for agitation included male sex, history of long-term use of anti-depressant drugs or benzodiazepines, frontal approach of the operation, method and duration of anesthesia and presence of endotracheal intubation. Total intravenous anesthesia and balanced anesthesia with short duration were protective factors. Emergence agitation was associated with self-extubation (8.6% vs 0%, P=50.005). Sedatives were administered more in agitated patients than non-agitated patients (85.7% vs 6.8%, P<0.001). In conclusion, emergence agitation was a frequent complication in patients after elective craniotomy for brain tumors. The clarification of risk factors could help to identify the high-risk patients, and then to facilitate the prevention and treatment of agitation. For patients undergoing craniotomy, greater attention should be paid to those receiving a frontal approach for craniotomy and those anesthetized under balanced anesthesia with long duration. More researches are warranted to elucidate whether total intravenous anesthesia could reduce the incidence of agitation after craniotomy.	[Chen, Lu; Xu, Ming; Li, Gui-Yun; Cai, Wei-Xin; Zhou, Jian-Xin] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Dept Crit Care Med, Beijing 100050, Peoples R China	Capital Medical University	Zhou, JX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Dept Crit Care Med, Beijing 100050, Peoples R China.	zhoujx.cn@gmail.com	Chen, Lu/AAH-1632-2020	Chen, Lu/0000-0002-7512-1865				Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bruder N, 1999, J NEUROSURG ANESTH, V11, P282, DOI 10.1097/00008506-199910000-00009; Bruder Nicolas J, 2002, Curr Opin Anaesthesiol, V15, P477, DOI 10.1097/00001503-200210000-00001; Cai YH, 2013, J INT MED RES, V41, P208, DOI 10.1177/0300060513475964; Citerio G, 2012, EUR J ANAESTH, V29, P371, DOI 10.1097/EJA.0b013e32835422db; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gottschalk A, 2007, J NEUROSURG, V106, P210, DOI 10.3171/jns.2007.106.2.210; Himmelseher S, 2001, Curr Opin Anaesthesiol, V14, P483, DOI 10.1097/00001503-200110000-00004; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; Kim YS, 2012, KOREAN J ANESTHESIOL, V63, P48, DOI 10.4097/kjae.2012.63.1.48; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Liang C, 2014, J ANESTH; Liu GY, 2014, GENET MOL RES, V13, P9285, DOI 10.4238/2014.January.24.9; Manninen PH, 1999, CAN J ANAESTH, V46, P7, DOI 10.1007/BF03012507; Mordhorst C, 2010, J NEUROSURG ANESTH, V22, P202, DOI 10.1097/ANA.0b013e3181df0600; Nair S, 2011, BRIT J NEUROSURG, V25, P100, DOI 10.3109/02688697.2010.534199; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Radtke FM, 2010, MINERVA ANESTESIOL, V76, P394; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Rose D. Keith, 1996, Canadian Journal of Anaesthesia, V43, pR116; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Senanarong V, 2004, DEMENT GERIATR COGN, V17, P14, DOI 10.1159/000074080; Sessler CN, 2008, CRIT CARE, V12, DOI 10.1186/cc6148; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P622, DOI 10.1097/00000542-200703000-00026; Tate JA, 2012, QUAL HEALTH RES, V22, P157, DOI 10.1177/1049732311421616; van den Boogaard M, 2012, INT J NURS STUD, V49, P775, DOI 10.1016/j.ijnurstu.2011.11.016; Vonder Haar C, 2013, BEHAV BRAIN RES, V240, P153, DOI 10.1016/j.bbr.2012.11.029; Whitlock EL, 2011, MINERVA ANESTESIOL, V77, P448; Woods JC, 2004, INTENS CARE MED, V30, P1066, DOI 10.1007/s00134-004-2193-9; Yu A, 2013, CRIT CARE MED, V41, P2002, DOI 10.1097/CCM.0b013e31828e96c0; Yu DH, 2010, CAN J ANESTH, V57, P843, DOI 10.1007/s12630-010-9338-9	31	23	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114239	10.1371/journal.pone.0114239	http://dx.doi.org/10.1371/journal.pone.0114239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493435	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400038
J	Fini, C; Costantini, M; Committeri, G				Fini, Chiara; Costantini, Marcello; Committeri, Giorgia			Sharing Space: The Presence of Other Bodies Extends the Space Judged as Near	PLOS ONE			English	Article							AFFECTS PERCEIVED DISTANCE; POSTERIOR PARIETAL CORTEX; MIRROR NEURON SYSTEM; GEOGRAPHICAL SLANT; PERCEPTION; REPRESENTATION; RECOGNITION; MOVEMENTS; GLUCOSE; ECONOMY	Background: As social animals we share the space with other people. It is known that perceived extension of the peripersonal space (the reaching space) is affected by the implicit representation of our own and other's action potentialities. Our issue concerns whether the co-presence of a body in the scene influences our extrapersonal space (beyond reaching distance) categorization. Methodology/Principal Findings: We investigated, through 3D virtual scenes of a realistic environment, whether egocentric spatial categorization can be influenced by the presence of another human body (Exp. 1) and whether the effect is due to her action potentialities or simply to her human-like morphology (Exp. 2). Subjects were asked to judge the location ("Near" or "Far") of a target object located at different distances from their egocentric perspective. In Exp. 1, the judgment was given either in presence of a virtual avatar (Self-with-Other), or a non-corporeal object (Self-with-Object) or nothing (Self). In Exp. 2, the Self condition was replaced by a Self-with-Dummy condition, in which an inanimate body (a wooden dummy) was present. Mean Judgment Transition Thresholds (JTTs) were calculated for each subject in each experimental condition. Self-with-Other condition induced a significant extension of the space judged as "Near'' as compared to both the Self-with-Object condition and the Self condition. Such extension was observed also in Exp. 2 in the Self-with-Dummy condition. Results suggest that the presence of others impacts on our perception of extrapersonal space. This effect holds also when the other is a human-like wooden dummy, suggesting that structural and morphological shapes resembling human bodies are sufficient conditions for the effect to occur. Conclusions: The observed extension of the portion of space judged as near could represent a wider portion of "accessible'' space, thus an advantage in the struggle to survive in presence of other potential competing individuals.	[Fini, Chiara; Costantini, Marcello; Committeri, Giorgia] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy; [Fini, Chiara; Costantini, Marcello; Committeri, Giorgia] Fdn G dAnnunzio, ITAB, Chieti, Italy; [Costantini, Marcello] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Ottawa	Fini, C (corresponding author), Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Lab Neuropsychol & Cognit Neurosci, Chieti, Italy.	chiarafini@unich.it	Committeri, Giorgia/AAC-1035-2022; Fini, Chiara/ABC-5055-2021	Costantini, Marcello/0000-0002-0504-1296; fini, chiara/0000-0002-9939-4745	University G. d'Annunzio funds	University G. d'Annunzio funds	The work was supported by University G. d'Annunzio funds to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Bloesch EK, 2012, PSYCHON B REV, V19, P177, DOI 10.3758/s13423-011-0200-z; Cardellicchio P, 2013, SOC COGN AFFECT NEUR, V8, P455, DOI 10.1093/scan/nss017; Chambon M, 2009, J EXPT SOCIAL PSYCHO, V45, P5; Coello Y, 2007, CONSCIOUS COGN, V16, P667, DOI 10.1016/j.concog.2007.07.003; Cole S, 2013, J EXP PSYCHOL GEN, V142, P18, DOI 10.1037/a0027882; Costantini M, 2011, NEUROPSYCHOLOGIA, V49, P2658, DOI 10.1016/j.neuropsychologia.2011.05.013; Costantini M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017923; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Creem-Regehr SH, 2005, PERCEPTION, V34, P191, DOI 10.1068/p5144; Creem-Regehr SH, 2004, J EXP PSYCHOL HUMAN, V30, P811, DOI 10.1037/0096-1523.30.5.811; Cutting J. E., 1995, PERCEPTION SPACE MOT, V5, P69, DOI DOI 10.1016/B978-012240530-3/50005-5; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ferri F, 2011, NEUROPSYCHOLOGIA, V49, P3519, DOI 10.1016/j.neuropsychologia.2011.09.001; Fini C, COGNITION; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Gallotti M, 2013, TRENDS COGN SCI, V17, P160, DOI 10.1016/j.tics.2013.02.002; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gruasser O.-J., 1983, SPATIALLY ORIENTED B, P327, DOI 10.1007/978-1-4612-5488-1_18; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Kemmerer D, 2006, NEUROPSYCHOLOGIA, V44, P1607, DOI 10.1016/j.neuropsychologia.2006.01.025; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; Loomis JM, 2003, VISUAL PERCEPTION EG; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Oberman LM, 2007, SOC COGN AFFECT NEUR, V2, P62, DOI 10.1093/scan/nsl022; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2003, PSYCHOL SCI, V14, P106, DOI 10.1111/1467-9280.t01-1-01427; Proffitt DR, 2013, TUTORIALS ACTION SCI; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; Shaffer DM, 2013, I-PERCEPTION, V4, P147, DOI 10.1068/i0592; Sugovic M, 2013, EXP BRAIN RES, V226, P383, DOI 10.1007/s00221-013-3447-y; Witt JK, 2011, CURR DIR PSYCHOL SCI, V20, P201, DOI 10.1177/0963721411408770; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880; Witt JK, 2004, PERCEPTION, V33, P577, DOI 10.1068/p5090	43	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114719	10.1371/journal.pone.0114719	http://dx.doi.org/10.1371/journal.pone.0114719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493627	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000346611400068
J	Gao, YJ; Yang, HW				Gao, YingJie; Yang, HongWei			A High-Order, Symplectic, Finite-Difference Time-Domain Scheme for Bioelectromagnetic Applications within the Mother/Fetus Model	PLOS ONE			English	Article							MAXWELLS EQUATIONS; ELECTROMAGNETIC-RADIATION; ABSORPTION RATE; SAR; INTEGRATORS; SCATTERING; DECOMPOSITION; PENETRATION	An explicit high-order, symplectic, finite-difference time-domain (SFDTD) scheme is applied to a bioelectromagnetic simulation using a simple model of a pregnant woman and her fetus. Compared to the traditional FDTD scheme, this scheme maintains the inherent nature of the Hamilton system and ensures energy conservation numerically and a high precision. The SFDTD scheme is used to predict the specific absorption rate (SAR) for a simple model of a pregnant female woman (month 9) using radio frequency (RF) fields from 1.5 Tand 3 T MRI systems (operating at approximately 64 and 128 MHz, respectively). The results suggest that by using a plasma protective layer under the 1.5 T MRI system, the SAR values for the pregnant woman and her fetus are significantly reduced. Additionally, for a 90 degree plasma protective layer, the SAR values are approximately equal to the 120 degree layer and the 180 degree layer, and it is reduced relative to the 60 degree layer. This proves that using a 90 degree plasma protective layer is the most effective and economical angle to use.	[Gao, YingJie; Yang, HongWei] Nanjing Agr Univ, Coll Sci, Dept Phys, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, HW (corresponding author), Nanjing Agr Univ, Coll Sci, Dept Phys, Nanjing, Jiangsu, Peoples R China.	phd_hwyang@aliyun.com						ANDERSON N, 1983, INT J ELECTRON, V54, P861, DOI 10.1080/00207218308938781; Chen YC, 2005, MULTIRESOLUTION TIME; Chin SA, 1997, PHYS LETT A, V226, P344, DOI 10.1016/S0375-9601(97)00003-0; Colak OH, 2008, MICROW OPT TECHN LET, V50, P1958, DOI 10.1002/mop.23535; Diot S, 2012, 1 ECCOMAS YOUNG INV, P24; Fang J., 1989, TIME DOMAIN FINITE D; Georgakopoulos SV, 2002, IEEE ANTENN PROPAG M, V44, P92, DOI 10.1109/MAP.2002.1003639; Georgakopoulos SV, 2002, IEEE ANTENN PROPAG M, V44, P134, DOI 10.1109/74.997945; Hirata A, 2011, PHYS MED BIOL, V56, P4091, DOI 10.1088/0031-9155/56/13/022; Hirono T, 1997, IEEE MICROW GUIDED W, V7, P279, DOI 10.1109/75.622539; Hirono T, 2001, IEEE T MICROW THEORY, V49, P1640, DOI 10.1109/22.942578; IEC Standard, 2004, MED EQ 2, P2; Kainz W, 2003, PHYS MED BIOL, V48, P2551, DOI 10.1088/0031-9155/48/15/319; Krumpholz M, 1996, IEEE T MICROW THEORY, V44, P555, DOI 10.1109/22.491023; Massoudi H, 1979, IEEE T MICROW THEORY, V27, P3251; Nakamura T, 1998, ELECTRON COMM JPN 1, V81, P71, DOI 10.1002/(SICI)1520-6424(199810)81:10<71::AID-ECJA8>3.0.CO;2-S; Nakamura T, 1998, ELECTRON COMM JPN 1, V81, P1, DOI 10.1002/(SICI)1520-6424(199810)81:10<1::AID-ECJA1>3.0.CO;2-D; Peter MC, 2011, COMMUNICATIONS APPL, V6, P1; Saidi F, 2008, MICROW OPT TECHN LET, V50, P1501, DOI 10.1002/mop.23406; Sha WEI, 2008, IEEE T ANTENN PROPAG, V56, P493, DOI 10.1109/TAP.2007.915444; Shao ZH, 2003, J COMPUT PHYS, V189, P427, DOI 10.1016/S0021-9991(03)00226-2; Shao ZH, 2003, IEEE T MICROW THEORY, V51, P856, DOI 10.1109/TMTT.2003.808627; SUZUKI M, 1992, PHYS LETT A, V165, P387, DOI 10.1016/0375-9601(92)90335-J; Togashi T, 2008, IEEE T MICROW THEORY, V56, P554, DOI 10.1109/TMTT.2007.914625; Turkel E, 1997, IEEE ANTENNAS AND PROPAGATION SOCIETY INTERNATIONAL SYMPOSIUM 1997, VOLS 1-4, P2156, DOI 10.1109/APS.1997.625395; Yano M, 2001, ELECTRON COMM JPN 1, V84, P57, DOI 10.1002/1520-6424(200104)84:4<57::AID-ECJA7>3.0.CO;2-J; YOSHIDA H, 1990, PHYS LETT A, V150, P262, DOI 10.1016/0375-9601(90)90092-3; Zhai PW, 2005, APPL OPTICS, V44, P1650, DOI 10.1364/AO.44.001650	28	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114425	10.1371/journal.pone.0114425	http://dx.doi.org/10.1371/journal.pone.0114425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493433	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400045
J	Halwani, R; Al-Kufaidy, R; Vazquez-Tello, A; Pureza, MA; BaHammam, AS; Al-Jahdali, H; Alnassar, SA; Hamid, Q; Al-Muhsen, S				Halwani, Rabih; Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; Pureza, Mary Angeline; BaHammam, Ahmed S.; Al-Jahdali, Hamdan; Alnassar, Sami A.; Hamid, Qutayba; Al-Muhsen, Saleh			IL-17 Enhances Chemotaxis of Primary Human B Cells during Asthma	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AIRWAY INFLAMMATION; RECEPTOR COMPLEX; ALLERGIC-ASTHMA; IGE PRODUCTION; T(H)17 CELLS; BXD2 MICE; P38 MAPK; KAPPA-B; EXPRESSION	IL-17 is a pro-inflammatory mediator that is believed to play a critical role in regulating tissue inflammation during asthma, COPD, as well as other inflammatory disorders. The level of expression of IL-17 has been shown to be upregulated in lung bronchial tissue of asthmatic patients. Several reports have provided further evidence that this cytokine could play a key role in enhancing the migration of inflammatory as well as structural cells of the bronchial lung tissue during asthma and COPD. B cell infiltration to sites of inflammation during inflammatory disorders such as bowel disease, asthma and COPD has been reported. Accordingly, in this study we hypothesized that IL-17 may exert a chemotactic effect on primary B cells during asthma. We observed that B cells from asthmatic patients expressed significantly higher levels of IL-17RA and IL-17RC, compared to those of healthy subjects. Using an in-vitro migration assay, B cells were shown to migrate towards both IL-17A and IL-17F. Interestingly, blocking IL-17A and IL-17F signaling using either anti-IL-17R antibodies or MAP kinase inhibitors prevented in vitro migration of B cell towards IL-17. These observations indicate a direct chemotactic effect of IL-17 cytokines on primary peripheral blood B cells with higher effect being on asthmatic B cells. These findings revealed a key role for IL-17 in enhancing the migration of B cells to the lung tissue during asthma or COPD.	[Halwani, Rabih; Al-Kufaidy, Roua; Vazquez-Tello, Alejandro; Pureza, Mary Angeline; BaHammam, Ahmed S.; Al-Jahdali, Hamdan; Al-Muhsen, Saleh] King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [BaHammam, Ahmed S.] King Saud Univ, Coll Med, Univ Sleep Disorders Ctr, Dept Pulm Med, Riyadh 11461, Saudi Arabia; [Al-Jahdali, Hamdan] King Saud Univ Hlth Sci, Div Pulm, ICU, Dept Med, Riyadh, Saudi Arabia; [Alnassar, Sami A.] King Saud Univ, Coll Med, Div Thorac Surg, Riyadh 11461, Saudi Arabia; [Hamid, Qutayba] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	King Saud University; King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Saud University; McGill University	Al-Muhsen, S (corresponding author), King Saud Univ, Coll Med, Dept Pediat, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia.	almuhsen@ksu.edu.sa	Halwani, Rabih/AAN-1568-2021; BaHammam, Ahmed Salem/B-9037-2008; BaHammam, Ahmed S/D-7521-2011; Al-muhsen, saleh/E-9315-2014	Halwani, Rabih/0000-0002-6516-7771; BaHammam, Ahmed Salem/0000-0002-1706-6167; BaHammam, Ahmed S/0000-0002-1706-6167; Al-muhsen, saleh/0000-0003-3698-9968	National Plan for Science and Technology, King Saud University, Riyadh, Saudi Arabia [10-MED1224-02]	National Plan for Science and Technology, King Saud University, Riyadh, Saudi Arabia(King Saud University)	This work was funded by a grant from the National Plan for Science and Technology, King Saud University, Riyadh, Saudi Arabia (grant number 10-MED1224-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan LA, 2012, J ALLERGY CLIN IMMUN, V130, P977, DOI 10.1016/j.jaci.2012.04.042; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Badr G, 2008, BLOOD, V111, P2744, DOI 10.1182/blood-2007-03-081232; Beier KC, 2004, J ALLERGY CLIN IMMUN, V114, P775, DOI 10.1016/j.jaci.2004.06.024; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Corneth OBJ, 2014, ARTHRITIS RHEUMATOL, V66, P340, DOI 10.1002/art.38229; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Coyle AJ, 1996, J EXP MED, V183, P1303, DOI 10.1084/jem.183.4.1303; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Gopal R, 2013, MUCOSAL IMMUNOL, V6, P972, DOI 10.1038/mi.2012.135; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Hajoui O, 2004, J ALLERGY CLIN IMMUN, V114, P657, DOI 10.1016/j.jaci.2004.05.034; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Joks R, 2011, RECENT PATENTS INFLA, V5, P221, DOI 10.2174/187221311797264919; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Linden A, 2002, ALLERGY, V57, P769, DOI 10.1034/j.1398-9995.2002.02164.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Noronha AM, 2009, J LEUKOCYTE BIOL, V86, P1007, DOI 10.1189/jlb.0309203; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Sarkar S, 2010, CLIN EXP IMMUNOL, V159, P225, DOI 10.1111/j.1365-2249.2009.04016.x; Scanlon KM, 2011, INT ARCH ALLERGY IMM, V156, P51, DOI 10.1159/000322178; Semper AE, 1995, ADV EXP MED BIOL, V378, P135; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; Tan JQ, 1997, J IMMUNOL, V158, P475; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vazquez-Tello A, 2012, INT ARCH ALLERGY IMM, V157, P406, DOI 10.1159/000329527; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wu WT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-152; Wuyts WA, 2005, J HEART LUNG TRANSPL, V24, P875, DOI 10.1016/j.healun.2004.05.003; XIA HZ, 1993, BLOOD, V82, P2806; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Ying S, 2001, J ALLERGY CLIN IMMUN, V107, P686, DOI 10.1067/mai.2001.114339; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	55	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114604	10.1371/journal.pone.0114604	http://dx.doi.org/10.1371/journal.pone.0114604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494178	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400057
J	Kisonaite, M; Zubriene, A; Capkauskaite, E; Smirnov, A; Smirnoviene, J; Kairys, V; Michailoviene, V; Manakova, E; Grazulis, S; Matulis, D				Kisonaite, Migle; Zubriene, Asta; Capkauskaite, Edita; Smirnov, Alexey; Smirnoviene, Joana; Kairys, Visvaldas; Michailoviene, Vilma; Manakova, Elena; Grazulis, Saulius; Matulis, Daumantas			Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; FUNCTIONAL-GROUP CONTRIBUTIONS; LIGAND-BINDING; INHIBITORS; ENTHALPY; MODEL; NONADDITIVITY; COMPENSATION; RECOGNITION; PROTEINS	The early stage of drug discovery is often based on selecting the highest affinity lead compound. To this end the structural and energetic characterization of the binding reaction is important. The binding energetics can be resolved into enthalpic and entropic contributions to the binding Gibbs free energy. Most compound binding reactions are coupled to the absorption or release of protons by the protein or the compound. A distinction between the observed and intrinsic parameters of the binding energetics requires the dissection of the protonation/deprotonation processes. Since only the intrinsic parameters can be correlated with molecular structural perturbations associated with complex formation, it is these parameters that are required for rational drug design. Carbonic anhydrase (CA) isoforms are important therapeutic targets to treat a range of disorders including glaucoma, obesity, epilepsy, and cancer. For effective treatment isoform-specific inhibitors are needed. In this work we investigated the binding and protonation energetics of sixteen [(2-pyrimidinylthio)acetyl]benzenesulfonamide CA inhibitors using isothermal titration calorimetry and fluorescent thermal shift assay. The compounds were built by combining four sulfonamide headgroups with four tailgroups yielding 16 compounds. Their intrinsic binding thermodynamics showed the limitations of the functional group energetic additivity approach used in fragment-based drug design, especially at the level of enthalpies and entropies of binding. Combined with high resolution crystal structural data correlations were drawn between the chemical functional groups on selected inhibitors and intrinsic thermodynamic parameters of CA-inhibitor complex formation.	[Kisonaite, Migle; Zubriene, Asta; Capkauskaite, Edita; Smirnov, Alexey; Smirnoviene, Joana; Michailoviene, Vilma; Matulis, Daumantas] Vilnius State Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, LT-02241 Vilnius, Lithuania; [Kairys, Visvaldas] Vilnius State Univ, Inst Biotechnol, Dept Bioinformat, LT-02241 Vilnius, Lithuania; [Manakova, Elena; Grazulis, Saulius] Vilnius State Univ, Inst Biotechnol, Dept Prot DNA Interact, LT-02241 Vilnius, Lithuania	Vilnius University; Vilnius University; Vilnius University	Matulis, D (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Graiciuno 8, LT-02241 Vilnius, Lithuania.	matulis@ibt.lt	Smirnov, Alexey/AAB-2521-2020; Gražulis, Saulius/J-9056-2015; Smirnovienė, Joana/AAE-9067-2020; Kairys, Visvaldas/K-9893-2013; Matulis, Daumantas/F-9367-2010	Smirnov, Alexey/0000-0001-5361-8232; Gražulis, Saulius/0000-0002-7928-5218; Kairys, Visvaldas/0000-0002-5427-0175; Kisonaite, Migle/0000-0002-1348-154X; Matulis, Daumantas/0000-0002-6178-6276; Smirnoviene, Joana/0000-0001-5503-4775; Capkauskaite, Edita/0000-0003-4335-2981	Research Council of Lithuania [LIG-09/2012]; FP7-REGPOT-1 grant "MoBiLi'' [245721, TD0905, CM0804]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); FP7-REGPOT-1 grant "MoBiLi''	This research was funded by a grant from the Research Council of Lithuania (LIG-09/2012). Authors thank FP7-REGPOT-2009-1 grant "MoBiLi'' agreement No.: 245721, and the COST projects TD0905 and CM0804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2013, J ENZYM INHIB MED CH, V28, P267, DOI 10.3109/14756366.2012.737323; Alterio V, 2012, CHEM REV, V112, P4421, DOI 10.1021/cr200176r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baranauskiene L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-12; Baranauskiene L, 2010, J ENZYM INHIB MED CH, V25, P863, DOI 10.3109/14756360903571685; Baum B, 2010, J MOL BIOL, V397, P1042, DOI 10.1016/j.jmb.2010.02.007; Biela A, 2012, CHEMMEDCHEM, V7, P1423, DOI 10.1002/cmdc.201200206; Capkauskaite E, 2013, BIOORGAN MED CHEM, V21, P6937, DOI 10.1016/j.bmc.2013.09.029; Capkauskaite E, 2012, EUR J MED CHEM, V51, P259, DOI 10.1016/j.ejmech.2012.02.050; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Domsic JF, 2008, J BIOL CHEM, V283, P30766, DOI 10.1074/jbc.M805353200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Garbett NC, 2012, EXPERT OPIN DRUG DIS, V7, P299, DOI 10.1517/17460441.2012.666235; Gitto R, 2010, J MED CHEM, V53, P2401, DOI 10.1021/jm9014026; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hassan MI, 2013, BIOORGAN MED CHEM, V21, P1570, DOI 10.1016/j.bmc.2012.04.044; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Jogaite V, 2013, BIOORGAN MED CHEM, V21, P1431, DOI 10.1016/j.bmc.2012.10.016; Kemp MM, 2012, BIOORGAN MED CHEM, V20, P1979, DOI 10.1016/j.bmc.2011.11.071; KHALIFAH RG, 1993, BIOCHEMISTRY-US, V32, P3058, DOI 10.1021/bi00063a017; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Klinger AL, 2006, J MED CHEM, V49, P3496, DOI 10.1021/jm058279n; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lopez M, 2010, J MED CHEM, V53, P2913, DOI 10.1021/jm901888x; Morkunaite V, 2015, J ENZYM INHIB MED CH, V30, P204, DOI 10.3109/14756366.2014.908291; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsson TSG, 2011, PROTEIN SCI, V20, P1607, DOI 10.1002/pro.692; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pilipuityte V, 2015, J MOL RECOGNIT, V28, P166, DOI 10.1002/jmr.2404; Reynolds CH, 2011, ACS MED CHEM LETT, V2, P433, DOI 10.1021/ml200010k; Rogez-Florent T, 2014, J MOL RECOGNIT, V27, P46, DOI 10.1002/jmr.2330; Ruben AJ, 2006, CHEM BIOL DRUG DES, V67, P2, DOI 10.1111/j.1747-0285.2005.00314.x; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Sudzius J, 2010, BIOORGAN MED CHEM, V18, P7413, DOI 10.1016/j.bmc.2010.09.011; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zubrien A, 2014, J ENZYM INHIB MED CH, V29, P124, DOI 10.3109/14756366.2012.757223	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114106	10.1371/journal.pone.0114106	http://dx.doi.org/10.1371/journal.pone.0114106			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493428	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400031
J	Shivaprakash, KN; Ramesha, BT; Shaanker, RU; Dayanandan, S; Ravikanth, G				Shivaprakash, K. Nagaraju; Ramesha, B. Thimmappa; Shaanker, Ramanan Uma; Dayanandan, Selvadurai; Ravikanth, Gudasalamani			Genetic Structure, Diversity and Long Term Viability of a Medicinal Plant, Nothapodytes nimmoniana Graham. (Icacinaceae), in Protected and Non-Protected Areas in the Western Ghats Biodiversity Hotspot	PLOS ONE			English	Article							TROPICAL TREE; FRAGMENTED POPULATIONS; MICROSATELLITE MARKERS; ALLELIC RICHNESS; AMERICAN GINSENG; BOTTLENECK; PROGRAM; FOREST; INDIA; FLOW	Background and Question: The harvesting of medicinal plants from wild sources is escalating in many parts of the world, compromising the long-term survival of natural populations of medicinally important plants and sustainability of sources of raw material to meet pharmaceutical industry needs. Although protected areas are considered to play a central role in conservation of plant genetic resources, the effectiveness of protected areas for maintaining medicinal plant populations subject to intense harvesting pressure remain largely unknown. We conducted genetic and demographic studies of Nothapodytes nimmoniana Graham, one of the extensively harvested medicinal plant species in the Western Ghats biodiversity hotspot, India to assess the effectiveness of protected areas in long-term maintenance of economically important plant species. Methodology/Principal Findings: The analysis of adults and seedlings of N. nimmoniana in four protected and four non-protected areas using 7 nuclear microsatellite loci revealed that populations that are distributed within protected areas are subject to lower levels of harvesting and maintain higher genetic diversity (H-e=0.816, H-o=0.607, A=18.857) than populations in adjoining non-protected areas (H-e=0.781, H-o=0.511, A=15.571). Furthermore, seedlings in protected areas had significantly higher observed heterozygosity (H-o=0.630) and private alleles as compared to seedlings in adjoining non-protected areas (H-o=0.426). Most populations revealed signatures of recent genetic bottleneck. The prediction of long-term maintenance of genetic diversity using BOTTLESIM indicated that current population sizes of the species are not sufficient to maintain 90% of present genetic diversity for next 100 years. Conclusions/Significance: Overall, these results highlight the need for establishing more protected areas encompassing a large number of adult plants in the Western Ghats to conserve genetic diversity of economically and medicinally important plant species.	[Shivaprakash, K. Nagaraju; Ramesha, B. Thimmappa; Shaanker, Ramanan Uma] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Shivaprakash, K. Nagaraju; Ramesha, B. Thimmappa; Shaanker, Ramanan Uma; Ravikanth, Gudasalamani] Univ Agr Sci, Sch Ecol & Conservat, Bangalore, Karnataka, India; [Shivaprakash, K. Nagaraju] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Shivaprakash, K. Nagaraju] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Shaanker, Ramanan Uma; Dayanandan, Selvadurai; Ravikanth, Gudasalamani] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India; [Shivaprakash, K. Nagaraju; Dayanandan, Selvadurai] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada	University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore; Concordia University - Canada; Concordia University - Canada	Shivaprakash, KN (corresponding author), Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India.	shiva216nagaraju@gmail.com; gravikanth@atree.org	G, Ravikanth/AAI-5668-2020	G, Ravikanth/0000-0002-9399-8580; Uma Shaanker, Ramanan/0000-0003-3100-7654	Department of Biotechnology, India; NSERC-Canada; Canadian Commonwealth Scholarships Program	Department of Biotechnology, India(Department of Biotechnology (DBT) India); NSERC-Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Commonwealth Scholarships Program	The work was supported by the following: Department of Biotechnology, India; NSERC-Canada; and Canadian Commonwealth Scholarships Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich PR, 1998, MOL ECOL, V7, P933, DOI 10.1046/j.1365-294x.1998.00396.x; Andrianoelina O, 2009, ANN BOT-LONDON, V104, P1231, DOI 10.1093/aob/mcp231; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Christine O, 2009, INT J FORESTRY RES; Chung MG, 2000, HEREDITY, V85, P490, DOI 10.1046/j.1365-2540.2000.00781.x; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cruse-Sanders JM, 2004, J HERED, V95, P309, DOI 10.1093/jhered/esh046; Dayanandan S, 1999, MOL ECOL, V8, P1585, DOI 10.1046/j.1365-294x.1999.00735.x; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Ganeshaiah KN, 1998, ECON BOT, V52, P316, DOI 10.1007/BF02862150; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gowda HCH, 2002, CURR SCI INDIA, V83, P1077; Guidugli MC, 2010, GENET MOL BIOL, V33, P131, DOI 10.1590/S1415-47572010000100022; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hundertmark KJ, 2010, CONSERV GENET, V11, P139, DOI 10.1007/s10592-009-0013-z; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kareem VKA, 2011, PLANT GENET RESOUR-C, V9, P506, DOI 10.1017/S1479262111000803; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kumar R, 2000, 100 RED LISTED MED P, P261; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lee CT, 2002, BIOL CONSERV, V104, P107, DOI 10.1016/S0006-3207(01)00159-8; Lemes MR, 2003, MOL ECOL, V12, P2845; Leroux SJ, 2010, BIOL CONSERV, V143, P609, DOI 10.1016/j.biocon.2009.11.018; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Loiselle BA, 1995, BIOTROPICA, V27, P487, DOI 10.2307/2388962; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nageswara Rao M, 2010, BIOREMEDIATION BIODI, V4, P69; Nageswara Rao M, 2001, FOREST GENETIC RESOU, P49; Nantel P, 1996, CONSERV BIOL, V10, P608, DOI 10.1046/j.1523-1739.1996.10020608.x; Ng KKS, 2006, TREE GENET GENOMES, V2, P121, DOI 10.1007/s11295-006-0035-3; Novick RR, 2003, MOL ECOL, V12, P2885, DOI 10.1046/j.1365-294X.2003.01951.x; NWDC (National Wildlife Database Centre), 1999, 1999 WILD LIF I INDI; Pearce F, 1997, NEW SCI, V15, P6; Pimbert M. P., 1997, SOCIAL CHANGE CONSER; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Ramesha BT, 2008, J CHROMATOGR SCI, V46, P362, DOI 10.1093/chromsci/46.4.362; Ramesha BT, 2007, J GENET, V86, P9, DOI 10.1007/s12041-007-0002-2; Ramesha BT, 2008, MOL ECOLOGY RESOURCE, V8, P365; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Ravikanth G, 2009, MANAGEMENT UTILIZATI, P53; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Savolainen O., 2000, Forest conservation genetics: principles and practice, P91, DOI 10.1079/9780851995045.0091; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; Shaanker R. Uma, 2008, P197, DOI 10.1007/978-3-540-74603-4_10; Shaanker RU, 2004, ENVIRON CONSERV, V31, P242, DOI 10.1017/S0376892904001596; Sharma MV, 2011, J PLANT ECOL, V4, P259, DOI 10.1093/jpe/rtq029; Sharma MV, 2010, CURR SCI INDIA, V99, P1444; Sheldon J.W., 1997, ADV EC BOT, VXII; Shivaprakash KN, 2011, THESIS U AGR SCI BAN; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SLATKIN M, 1995, GENETICS, V139, P457; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Tadwalkar MD, 2012, TROP ECOL, V53, P53; Thapa S, 2010, FOREST ECOL MANAG, V259, P641, DOI 10.1016/j.foreco.2009.11.023; Ved DK, 1997, AMRUTH, V1, P2; VRIJENHOEK RC, 1985, SCIENCE, V229, P400, DOI 10.1126/science.229.4711.400; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White GM, 1999, MOL ECOL, V8, P1899, DOI 10.1046/j.1365-294x.1999.00790.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Yamazaki Y, 2003, PHYTOCHEMISTRY, V62, P461, DOI 10.1016/S0031-9422(02)00543-5; Zucchi MI, 2003, GENET MOL BIOL, V26, P449, DOI 10.1590/S1415-47572003000400008	77	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e112769	10.1371/journal.pone.0112769	http://dx.doi.org/10.1371/journal.pone.0112769			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493426	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000346611400010
J	Burlakova, LE; Tulumello, BL; Karatayev, AY; Krebs, RA; Schloesser, DW; Paterson, WL; Griffith, TA; Scott, MW; Crail, T; Zanatta, DT				Burlakova, Lyubov E.; Tulumello, Brianne L.; Karatayev, Alexander Y.; Krebs, Robert A.; Schloesser, Donald W.; Paterson, Wendy L.; Griffith, Traci A.; Scott, Mariah W.; Crail, Todd; Zanatta, David T.			Competitive Replacement of Invasive Congeners May Relax Impact on Native Species: Interactions among Zebra, Quagga, and Native Unionid Mussels	PLOS ONE			English	Article							FRESH-WATER MUSSELS; LAKE ST-CLAIR; DREISSENA-POLYMORPHA PALLAS; GREAT-LAKES; COASTAL WETLAND; NORTH-AMERICA; LAWRENCE-RIVER; BIOCHEMICAL-COMPOSITION; BIVALVES UNIONIDAE; AMBLEMA PLICATA	Determining when and where the ecological impacts of invasive species will be most detrimental and whether the effects of multiple invaders will be superadditive, or subadditive, is critical for developing global management priorities to protect native species in advance of future invasions. Over the past century, the decline of freshwater bivalves of the family Unionidae has been greatly accelerated by the invasion of Dreissena. The purpose of this study was to evaluate the current infestation rates of unionids by zebra (Dreissena polymorpha) and quagga (D. rostriformis bugensis) mussels in the lower Great Lakes region 25 years after they nearly extirpated native unionids. In 2011-2012, we collected infestation data for over 4000 unionids from 26 species at 198 nearshore sites in lakes Erie, Ontario, and St. Clair, the Detroit River, and inland Michigan lakes and compared those results to studies from the early 1990s. We found that the frequency of unionid infestation by Dreissena recently declined, and the number of dreissenids attached to unionids in the lower Great Lakes has fallen almost ten-fold since the early 1990s. We also found that the rate of infestation depends on the dominant Dreissena species in the lake: zebra mussels infested unionids much more often and in greater numbers. Consequently, the proportion of infested unionids, as well as the number and weight of attached dreissenids were lower in waterbodies dominated by quagga mussels. This is the first large-scale systematic study that revealed how minor differences between two taxonomically and functionally related invaders may have large consequences for native communities they invade.	[Burlakova, Lyubov E.; Tulumello, Brianne L.; Karatayev, Alexander Y.; Paterson, Wendy L.] SUNY Buffalo, Great Lakes Ctr, Buffalo, NY 14260 USA; [Burlakova, Lyubov E.] SUNY Buffalo, Res Fdn, Off Sponsored Programs, Buffalo, NY USA; [Krebs, Robert A.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Schloesser, Donald W.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA; [Paterson, Wendy L.; Griffith, Traci A.; Scott, Mariah W.; Zanatta, David T.] Cent Michigan Univ, Inst Great Lakes Res, Dept Biol, Mt Pleasant, MI 48859 USA; [Crail, Todd] Univ Toledo, Lake Erie Ctr, Dept Environm Sci, Toledo, OH 43606 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Cleveland State University; United States Department of the Interior; United States Geological Survey; Central Michigan University; University System of Ohio; University of Toledo	Burlakova, LE (corresponding author), SUNY Buffalo, Great Lakes Ctr, Buffalo, NY 14260 USA.	burlakle@buffalostate.edu	Zanatta, David/AAR-6797-2020	Zanatta, David/0000-0002-3174-071X; Krebs, Robert/0000-0003-3384-5870; Burlakova, Lyubov/0000-0002-2995-919X	U.S. Fish and Wildlife Service (US FWS) via the Great Lakes Fish and Wildlife Restoration Act (GLFWRA) [30191-A-G152]; NSF URM award [0731582]; Research Foundation of SUNY	U.S. Fish and Wildlife Service (US FWS) via the Great Lakes Fish and Wildlife Restoration Act (GLFWRA); NSF URM award; Research Foundation of SUNY	Funding support came from the U.S. Fish and Wildlife Service (US FWS) via the Great Lakes Fish and Wildlife Restoration Act (GLFWRA, project #30191-A-G152). Support for B. Tulumello was also provided by an NSF URM award #0731582 to C. M. Pennuto (SUNY Buffalo State), and L. Burlakova was supported in part by Research Foundation of SUNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the view of GLFWRA, NSF, USGS, or SUNY RF.	Allen DC, 2009, J N AM BENTHOL SOC, V28, P93, DOI 10.1899/07-170.1; ARTER HE, 1989, AQUAT SCI, V51, P87, DOI 10.1007/BF00879296; Baker SM, 2008, AM MIDL NAT, V160, P20, DOI 10.1674/0003-0031(2008)160[20:ZMDPAT]2.0.CO;2; Baker SM, 1997, CAN J FISH AQUAT SCI, V54, P512, DOI 10.1139/cjfas-54-3-512; Baker SM, 2000, AM MIDL NAT, V143, P443, DOI 10.1674/0003-0031(2000)143[0443:PSABCO]2.0.CO;2; Baldwin BS, 2002, CAN J FISH AQUAT SCI, V59, P680, DOI 10.1139/F02-043; bij de Vaate A G Van der Velde R S E W Leuven K C M Heiler, 2014, QUAGGA ZEBRA MUSSELS, V2, P83, DOI [10.1201/b15437-11, DOI 10.1201/B15437-11]; Bodis E, 2014, BIOL INVASIONS, V16, P1373, DOI 10.1007/s10530-013-0575-z; BOGAN AE, 1993, AM ZOOL, V33, P599; Bogan AE, 2008, HYDROBIOLOGIA, V595, P139, DOI 10.1007/s10750-007-9011-7; Bowers R, 2005, HYDROBIOLOGIA, V545, P93, DOI 10.1007/s10750-005-2212-z; Bowers R, 2004, AM MIDL NAT, V151, P286, DOI 10.1674/0003-0031(2004)151[0286:EOHOUU]2.0.CO;2; Bowers RW, 2007, WETLANDS, V27, P203, DOI 10.1672/0277-5212(2007)27[203:FPOZMA]2.0.CO;2; Burlakova LE, 2000, INT REV HYDROBIOL, V85, P529, DOI 10.1002/1522-2632(200011)85:5/6<529::AID-IROH529>3.3.CO;2-F; Carlton JT, 2008, J GREAT LAKES RES, V34, P770, DOI 10.3394/0380-1330-34.4.770; Casper AF, 2010, J GREAT LAKES RES, V36, P184, DOI 10.1016/j.jglr.2009.10.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claxton WT, 1998, CAN J ZOOL, V76, P1269, DOI 10.1139/cjz-76-7-1269; Conn DB, 1993, 3RD P INT ZEBR MUSS, P223; Crail TD, 2011, J GREAT LAKES RES, V37, P199, DOI 10.1016/j.jglr.2010.12.006; Cummings KS, 1992, INHS MANUAL, V5; Diggins TP, 2004, BIOL INVASIONS, V6, P83, DOI 10.1023/B:BINV.0000010124.00582.d3; Dussart GBJ, 1966, LIMNOLOGIE; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fuller P, 2014, NONINDIGENOUS AQUATI; GILLIS PL, 1994, CAN J ZOOL, V72, P1260; Goodrich C, 1932, OCCAS PAP MUS ZOOL U, V238, P8; Gorley C.K., 2006, GETTING STARTED PRIM; Graf Daniel L., 2002, Occasional Papers on Mollusks Museum of Comparative Zoology Harvard University, V6, P175; GRIFFITHS RW, 1991, CAN J FISH AQUAT SCI, V48, P1381, DOI 10.1139/f91-165; Haag WR, 2012, NORTH AMERICAN FRESHWATER MUSSELS: NATURAL HISTORY, ECOLOGY, AND CONSERVATION, P1, DOI 10.1017/CBO9781139048217; HAAG WR, 1993, CAN J FISH AQUAT SCI, V50, P13, DOI 10.1139/f93-002; Hayes Keith R., 2003, P382; HEBERT PDN, 1989, CAN J FISH AQUAT SCI, V46, P1587, DOI 10.1139/f89-202; HEBERT PDN, 1991, CAN J ZOOL, V69, P405, DOI 10.1139/z91-063; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Hollandsworth D, 2011, AM MIDL NAT, V166, P369, DOI 10.1674/0003-0031-166.2.369; HUNTER RD, 1992, NAUTILUS, V106, P60; Karatayev AY, 2014, J GREAT LAKES RES, V40, P550, DOI 10.1016/j.jglr.2014.04.010; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Karatayev AY, 2010, J SHELLFISH RES, V29, P975, DOI 10.2983/035.029.0432; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Karatayev AY, 1998, J SHELLFISH RES, V17, P1219; Karatayev AY, 1997, J SHELLFISH RES, V16, P187; Karatayev AY, 2014, QUAGGA ZEBRA MUSSELS, P695; Karatayev VA, 2013, J GREAT LAKES RES, V39, P622, DOI 10.1016/j.jglr.2013.09.007; Keller RP, 2007, CONSERV BIOL, V21, P191, DOI 10.1111/j.1523-1739.2006.00563.x; Koehl MAR, 1996, ANNU REV ECOL SYST, V27, P501, DOI 10.1146/annurev.ecolsys.27.1.501; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; LEWANDOWSKI K, 1976, Polskie Archiwum Hydrobiologii, V23, P409; Lozano SJ, 2011, STATUS MACROINVERTEB, P1; Lucy F.E., 2014, QUAGGA ZEBRA MUSSELS, V2nd ed., P623; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; MACKIE GL, 1991, HYDROBIOLOGIA, V219, P251, DOI 10.1007/BF00024759; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGoldrick DJ, 2009, J GREAT LAKES RES, V35, P137, DOI 10.1016/j.jglr.2008.11.007; Metcalfe-Smith JL, 1998, J GREAT LAKES RES, V24, P845, DOI 10.1016/S0380-1330(98)70866-4; Mills EL, 2003, CAN J FISH AQUAT SCI, V60, P471, DOI 10.1139/F03-033; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Nalepa TF, 1996, J GREAT LAKES RES, V22, P354, DOI 10.1016/S0380-1330(96)70961-9; NALEPA TF, 1991, J GREAT LAKES RES, V17, P214, DOI 10.1016/S0380-1330(91)71358-0; NALEPA TF, 1994, CAN J FISH AQUAT SCI, V51, P2227, DOI 10.1139/f94-225; Nichols S. Jerrine, 1997, Journal of Shellfish Research, V16, P346; Nichols SJ, 1999, CAN J ZOOL, V77, P423, DOI 10.1139/cjz-77-3-423; Nichols SJ, 1997, NATURE, V389, P921, DOI 10.1038/40039; Patterson MWR, 2005, J GREAT LAKES RES, V31, P223, DOI 10.1016/S0380-1330(05)70316-6; Pennuto CM, 2012, J GREAT LAKES RES, V38, P161, DOI 10.1016/j.jglr.2012.04.002; Peyer SM, 2010, J EXP BIOL, V213, P2602, DOI 10.1242/jeb.042549; Peyer SM, 2009, J EXP BIOL, V212, P2026, DOI 10.1242/jeb.028688; Protasov Alexander A., 1994, Archiwum Rybactwa Polskiego, V2, P257; Rauschert ESJ, 2012, ECOL APPL, V22, P1413, DOI 10.1890/11-2107.1; RICCIARDI A, 1995, CAN J FISH AQUAT SCI, V52, P1449, DOI 10.1139/f95-140; Ricciardi A, 1996, CAN J FISH AQUAT SCI, V53, P1434, DOI 10.1139/cjfas-53-6-1434; Ricciardi A, 1995, CAN J FISH AQUAT SCI, V52, P2695, DOI 10.1139/f95-858; SCHLOESSER D W, 1991, Journal of Shellfish Research, V10, P355; Schloesser Don W., 1999, Northeastern Naturalist, V6, P341, DOI 10.2307/3858274; Schloesser DW, 2006, AM MIDL NAT, V155, P307, DOI 10.1674/0003-0031(2006)155[307:EOFMBU]2.0.CO;2; Schloesser DW, 1996, AM ZOOL, V36, P300; SCHLOESSER DW, 1994, CAN J FISH AQUAT SCI, V51, P2234, DOI 10.1139/f94-226; Schloesser DW, 1998, AM MIDL NAT, V140, P299, DOI 10.1674/0003-0031(1998)140[0299:IOZAQM]2.0.CO;2; SEBESTYEN O, 1938, VERH INT VER LIMNOL, V8, P169; Sherman JJ, 2013, J GREAT LAKES RES, V39, P201, DOI 10.1016/j.jglr.2013.03.001; Silayeva A. A., 2005, VESTNIK TYUMENSKOGO, V5, P112; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sousa R, 2011, FRESHWATER BIOL, V56, P867, DOI 10.1111/j.1365-2427.2010.02532.x; Spoo A, 2008, PEARLY MUSSELS PENNS; Strayer D. L., 2014, QUAGGA ZEBRA MUSSELS, P71; Strayer DL, 2007, J N AM BENTHOL SOC, V26, P111, DOI 10.1899/0887-3593(2007)26[111:EOZMDP]2.0.CO;2; Strayer DL, 2004, BIOSCIENCE, V54, P429, DOI 10.1641/0006-3568(2004)054[0429:CPOPMN]2.0.CO;2; Strayer DL, 1996, FRESHWATER BIOL, V36, P771; Strayer DL, 1999, J N AM BENTHOL SOC, V18, P74, DOI 10.2307/1468010; Strayer DL, 1997, NY STATE MUS MEM, V26; TUCKER JK, 1994, J FRESHWATER ECOL, V9, P129, DOI 10.1080/02705060.1994.9664439; Ward JM, 2007, DIVERS DISTRIB, V13, P155, DOI 10.1111/j.1472-4642.2007.00336.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Watkins JM, 2007, J GREAT LAKES RES, V33, P642, DOI 10.3394/0380-1330(2007)33[642:EFREOD]2.0.CO;2; Watters G.T., 2009, FRESHWATER MUSSELS O; Yang SA, 2011, AM NAT, V177, P110, DOI 10.1086/657433; Zanatta DT, 2002, J GREAT LAKES RES, V28, P479, DOI 10.1016/S0380-1330(02)70599-6; Zanatta DT, NE NAT IN PRESS; Zar J. H., 2010, BIOSTAT ANAL, V5th	102	27	30	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114926	10.1371/journal.pone.0114926	http://dx.doi.org/10.1371/journal.pone.0114926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490103	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300096
J	Grady, A; Bryant, J; Carey, M; Paul, C; Sanson-Fisher, R				Grady, Alice; Bryant, Jamie; Carey, Mariko; Paul, Chris; Sanson-Fisher, Rob			Enablers of the Implementation of Tissue Plasminogen Activator in Acute Stroke Care: A Cross-Sectional Survey	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; EVIDENCE-BASED GUIDELINES; EMERGENCY; THROMBOLYSIS; IMPROVE	Objective: To assess emergency physicians' perceptions of individual and system enablers to the use of tissue Plasminogen Activator in acute stroke. Method: Australian fellows and trainees of Australasian College for Emergency Medicine completed a 57-item online survey assessing enablers to implementation of evidence-based practice across six domains: knowledge, skills, modelling, monitoring, feedback, and maintenance. Demographic and workplace characteristics were obtained. Descriptive statistics were calculated to describe demographic and workplace characteristics of responders, and survey responses. Each domain received an overall score (%) based on the number of responders agreeing with all items within the domain. Results: A total of 429 (13%) Australasian College for Emergency Medicine members responded. 17.7% of respondents reported they and/or their workplace met all knowledge-related enablers, however only 2.3% had all skill-related enablers in place. Of respondents who decide which patients receive tissue Plasminogen Activator treatment, 18.1% agreed that all maintenance-related enablers are in place at their hospital, compared to 6.6% for those who do not decide which patients receive tissue Plasminogen Activator treatment. None of the respondents had all items in place cross all domains. Conclusions: Even when allowing for the low response rate, it seems likely there is a lack of individual and system enablers supporting the implementation of best-practice stroke care in a number of Australian hospitals. Quality improvement programs could target all domains, particularly the skills-training and feedback emergency physicians receive, to aid implementation of tissue Plasminogen Activator treatment for acute stroke.	[Grady, Alice; Bryant, Jamie; Carey, Mariko; Paul, Chris; Sanson-Fisher, Rob] Univ Newcastle, Prior Res Ctr Hlth Behav, Hunter Med Res Inst, Callaghan, NSW 2308, Australia	Hunter Medical Research Institute; University of Newcastle	Grady, A (corresponding author), Univ Newcastle, Prior Res Ctr Hlth Behav, Hunter Med Res Inst, Callaghan, NSW 2308, Australia.	alice.grady@newcastle.edu.au	Bryant, Jamie/G-8000-2013; CAREY, MARIKO/ABC-2842-2021	Bryant, Jamie/0000-0001-9378-5852; CAREY, MARIKO/0000-0002-0549-1115; Sanson-Fisher, Rob/0000-0001-6022-2949	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: CP and RSF have received a financial contribution from Boehringer Ingelheim towards an National Health and Medical Research Council-funded trial. AG, JB and MC have no competing interests to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asch SM, 2005, MED CARE, V43, P667, DOI 10.1097/01.mlr.0000167182.72251.a1; BANDURA A, 1986, SOC FDN THOUGHT ACTI; Bartlett J, 2002, INT J QUAL HEALTH C, V14, P463, DOI 10.1093/intqhc/14.6.463; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Carey M, 2009, INT J QUAL HEALTH C, V21, P37, DOI 10.1093/intqhc/mzn049; Couzigou C, 2005, J HOSP INFECT, V59, P197, DOI 10.1016/j.jhin.2004.09.013; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Gleitman H., 1991, PSYCHOLOGY; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Grol R, 2005, IMPROVING PATIENT CA, P1; Grol R., 2005, IMPROV PATIENT CARE, V41, P57; Hamidon BB, 2007, J CLIN NEUROSCI, V14, P831, DOI 10.1016/j.jocn.2006.03.029; Intercollegiate Stroke Working Party, 2011, NAT SENT STROK AUD; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Marinopoulos Spyridon S, 2007, Evid Rep Technol Assess (Full Rep), P1; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Stroke Foundation, 2013, NAT STROK AUD AC SER; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Shiffman Richard N, 2005, BMC Med Inform Decis Mak, V5, P23, DOI 10.1186/1472-6947-5-23; Slade D, 2008, DISCOURSE COMMUN, V2, P271, DOI 10.1177/1750481308091910; van Wijngaarden JDH, 2009, STROKE, V40, P3390, DOI 10.1161/STROKEAHA.109.559492; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7	33	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114778	10.1371/journal.pone.0114778	http://dx.doi.org/10.1371/journal.pone.0114778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490546	Green Published, gold			2022-12-27	WOS:000347515300079
J	Wheelock, A; Parand, A; Rigole, B; Thomson, A; Miraldo, M; Vincent, C; Sevdalis, N				Wheelock, Ana; Parand, Anam; Rigole, Bruno; Thomson, Angus; Miraldo, Marisa; Vincent, Charles; Sevdalis, Nick			Socio-Psychological Factors Driving Adult Vaccination: A Qualitative Study	PLOS ONE			English	Article							INFLUENZA VACCINATION; HEALTH-CARE; DETERMINANTS; TETANUS	Background: While immunization is one of the most effective and successful public health interventions, there are still up to 30,000 deaths in major developed economies each year due to vaccine-preventable diseases, almost all in adults. In the UK, despite comparatively high vaccination rates among >= 65 s (73%) and, to a lesser extent, at-risk <= 65 s (52%) in 2013/2014, over 10,000 excess deaths were reported the previous influenza season. Adult tetanus vaccines are not routinely recommended in the UK, but may be overly administered. Social influences and risk-perceptions of diseases and vaccines are known to affect vaccine uptake. We aimed to explore the socio-psychological factors that drive adult vaccination in the UK, specifically influenza and tetanus, and to evaluate whether these factors are comparable between vaccines. Methods: 20 in-depth, face-to-face interviews were conducted with members of the UK public who represented a range of socio-demographic characteristics associated with vaccination uptake. We employed qualitative interviewing approaches to reach a comprehensive understanding of the factors influencing adult vaccination decisions. Thematic analysis was used to analyze the data. Results: Participants were classified according to their vaccination status as regular, intermittent and non-vaccinators for influenza, and preventative, injury-led, mixed (both preventative and injury-led) and as non-vaccinators for tetanus. We present our finding around five overarching themes: 1) perceived health and health behaviors; 2) knowledge; 3) vaccination influences; 4) disease appraisal; and 5) vaccination appraisal. Conclusion: The uptake of influenza and tetanus vaccines was largely driven by participants' risk perception of these diseases. The tetanus vaccine is perceived as safe and sufficiently tested, whereas the changing composition of the influenza vaccine is a cause of uncertainty and distrust. To maximize the public health impact of adult vaccines, policy should be better translated into high vaccination rates through evidence-based implementation approaches.	[Wheelock, Ana; Parand, Anam; Sevdalis, Nick] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Rigole, Bruno; Thomson, Angus] Sanofi Pasteur, Lyon, France; [Rigole, Bruno; Thomson, Angus] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Miraldo, Marisa; Vincent, Charles] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England	Imperial College London; Sanofi-Aventis; Sanofi France; University of Oxford; Imperial College London	Wheelock, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England.	a.wheelock@imperial.ac.uk	Sevdalis, Nick/AAJ-6280-2020; Vincent, Charles A/D-1134-2010; Wheelock, Ana/AAE-9248-2019; Sevdalis, Nick/O-1419-2017; Miraldo, Marisa/ABF-2584-2020	Sevdalis, Nick/0000-0001-7560-8924; Vincent, Charles A/0000-0003-0270-0222; Sevdalis, Nick/0000-0001-7560-8924; Miraldo, Marisa/0000-0002-5772-7740; Wheelock, Ana/0000-0003-0855-7252	Sanofi Pasteur [P40006]; UK National Institute for Health Research (NIHR) via the Imperial College's Patient Safety Translational Research Centre; Sanofi Pasteur	Sanofi Pasteur; UK National Institute for Health Research (NIHR) via the Imperial College's Patient Safety Translational Research Centre; Sanofi Pasteur	AW and NS are funded by an unrestricted research grant from Sanofi Pasteur (P40006) and also by the UK National Institute for Health Research (NIHR), via the Imperial College's Patient Safety Translational Research Centre (www.cpssq.org). The fieldwork and associated research costs were funded by Sanofi Pasteur. AW and NS currently have a consultancy agreement as paid scientific advisors in the design of a shingles vaccine survey by Sanofi Pasteur MSD. BR and AT are employed by Sanofi Pasteur. The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health or Sanofi Pasteur. The funders do not have any editorial control over the work reported in this article. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or issues discussed in the manuscript, apart from those disclosed. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Anonymous, 2012, Morbidity and Mortality Weekly Report, V61, P1; [Anonymous], 2014, IMM SURV ASS MON; [Anonymous], 2006, WKLY EPIDEMIOL REC, V20, P197; Bekker HL, 2003, PSYCHOL HEALTH MED, V8, P279, DOI DOI 10.1080/1354850031000135722; Bohmer MM, 2011, HUM VACCINES, V7, P1317, DOI 10.4161/hv.7.12.18130; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Bridges CB, 2013, ANN INTERN MED, V158, P191, DOI 10.7326/0003-4819-158-3-201302050-00584; Cairns G, 2012, SYSTEMATIC LIT REV E; CDC, 2014, CHILDR FLU FLU VACC; Chamberlain D. B., 1989, PRE PERINATAL PSYCHO, V3, P297; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Dexter LJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000851; ECDC, 2014, 20091019EU ECDC; Evans MR, 2007, BRIT J GEN PRACT, V57, P352; Flick U., 1998, INTRO QUALITATIVE RE; Honkanen PO, 1996, PUBLIC HEALTH, V110, P163, DOI 10.1016/S0033-3506(96)80070-9; Institut de Veille Sanitaire, 2013, 2013 VACC SCHED REC, V14-15, P131; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Keenan H, 2007, BRIT J GEN PRACT, V57, P359; Kwong EWY, 2010, J ADV NURS, V66, P2297, DOI 10.1111/j.1365-2648.2010.05397.x; Leask J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-154; Mangtani P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-249; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Meharry PM, 2013, MATERN CHILD HLTH J, V17, P156, DOI 10.1007/s10995-012-0957-3; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; National Vaccine Advisory Committee, 2012, PUBLIC HLTH REP, V127, P11; NHS, 2014, VACC SCHED; NHS, 2014, TET VACC; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; PHE, 2013, TET GREEN BOOK; PHE, 2014, TET CAS AG GROUP YEA; PHE, 2011, UK IMM PROGR GREEN B; PHE, 2014, SEAS FLU VACC UPT 20; PHE, 2013, SURV INFL OTH RESP V; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ramet J, 2007, VACCINE, V25, P780, DOI 10.1016/j.vaccine.2006.09.042; Reynolds T.J., 2001, UNDERSTANDING CONSUM, P40, DOI [10.4324/9781410600844, DOI 10.4324/9781410600844]; Riphagen-Dalhuisen J, 2012, OCCUP ENVIRON MED, V69, P230, DOI 10.1136/oemed-2011-100134; Savage EJ, 2007, EMERG MED J, V24, P417, DOI 10.1136/emj.2007.047399; Silverman D., 1993, INTERPRETING QUALITA; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0; Telford R, 2003, HEALTH EDUC RES, V18, P743, DOI 10.1093/her/cyf059; Thomas RE, 2010, COCHRANE DB SYST REV, V8; Wheelock A, 2013, EXPERT REV VACCINES, P1; Wheelock A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004279; Whitney CG, 2014, MMWR-MORBID MORTAL W, V63, P352; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Zucs P, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-6	48	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113503	10.1371/journal.pone.0113503	http://dx.doi.org/10.1371/journal.pone.0113503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490542	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000347515300009
J	Zhu, YQ; Zhou, SL; Gao, G; Zou, HX; Lei, L				Zhu, Youqing; Zhou, Shilin; Gao, Gui; Zou, Huanxin; Lei, Lin			Extended Emitter Target Tracking Using GM-PHD Filter	PLOS ONE			English	Article							MULTITARGET TRACKING	If equipped with several radar emitters, a target will produce more than one measurement per time step and is denoted as an extended target. However, due to the requirement of all possible measurement set partitions, the exact probability hypothesis density filter for extended target tracking is computationally intractable. To reduce the computational burden, a fast partitioning algorithm based on hierarchy clustering is proposed in this paper. It combines the two most similar cells to obtain new partitions step by step. The pseudo-likelihoods in the Gaussian-mixture probability hypothesis density filter can then be computed iteratively. Furthermore, considering the additional measurement information from the emitter target, the signal feature is also used in partitioning the measurement set to improve the tracking performance. The simulation results show that the proposed method can perform better with lower computational complexity in scenarios with different clutter densities.	[Zhu, Youqing; Zhou, Shilin; Gao, Gui; Zou, Huanxin; Lei, Lin] Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Zhu, YQ (corresponding author), Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China.	zhu_youqing@163.com						Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Gilholm K, 2005, PROC SPIE, V5913, DOI 10.1117/12.618730; Granstrom K., 2010, 2010 13 INT C INFORM, P1, DOI DOI 10.1109/ICIF.2010.5711885; Granstrom K, 2012, IEEE T AERO ELEC SYS, V48, P3268, DOI 10.1109/TAES.2012.6324703; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Li WL, 2014, SIGNAL PROCESS, V94, P48, DOI 10.1016/j.sigpro.2013.06.012; Li WL, 2013, SIGNAL PROCESS, V93, P86, DOI 10.1016/j.sigpro.2012.06.030; Li WL, 2011, SIGNAL PROCESS, V91, P1036, DOI 10.1016/j.sigpro.2010.08.004; Liu J, 2005, IEEE T PATTERN ANAL, V27, P1185, DOI 10.1109/TPAMI.2005.166; Mahler R, 2009, FUSION: 2009 12TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION, VOLS 1-4, P915; Mahler RPS, 2003, IEEE T AERO ELEC SYS, V39, P1152, DOI 10.1109/TAES.2003.1261119; Orguner U., 2011, 14 INT C INFORM FUSI, P65; Panta K, 2009, IEEE T AERO ELEC SYS, V45, P1003, DOI 10.1109/TAES.2009.5259179; Schuhmacher D, 2008, IEEE T SIGNAL PROCES, V56, P3447, DOI 10.1109/TSP.2008.920469; Shieh CS, 2002, IEEE T ANTENN PROPAG, V50, P1120, DOI 10.1109/TAP.2002.801387; Spezio AE, 2002, IEEE T MICROW THEORY, V50, P633, DOI 10.1109/22.989948; Vo BN, 2006, IEEE T SIGNAL PROCES, V54, P4091, DOI 10.1109/TSP.2006.881190; Vo BN, 2005, IEEE T AERO ELEC SYS, V41, P1224, DOI 10.1109/TAES.2005.1561884; Yin JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085884; Zhang YQ, 2013, SIGNAL PROCESS, V93, P2975, DOI 10.1016/j.sigpro.2013.04.006; Zhou XL, 2014, SIGNAL PROCESS, V94, P650, DOI 10.1016/j.sigpro.2013.08.002	22	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114317	10.1371/journal.pone.0114317	http://dx.doi.org/10.1371/journal.pone.0114317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490206	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300027
J	He, YY; Chen, ZY; Liu, XL; Wang, CW; Lu, W				He, Yuyong; Chen, Zhiyu; Liu, Xiaolan; Wang, Chengwei; Lu, Wei			Influence of Trace Elements Mixture on Bacterial Diversity and Fermentation Characteristics of Liquid Diet Fermented with Probiotics under Air-Tight Condition	PLOS ONE			English	Article							LACTIC ACID PRODUCTION; COMPOSITE ANTIMICROBIAL PEPTIDES; BACILLUS-SUBTILIS SPORES; GROWTH-PERFORMANCE; FEED; SUPPLEMENTATION; MICROBIOTA; TOXICITY; IODINE; ZINC	Cu2+, Zn2+, Fe2+ and I- are often supplemented to the diet of suckling and early weaning piglets, but little information is available regarding the effects of different Cu2+, Zn2+, Fe2+ and I- mixtures on bacteria growth, diversity and fermentation characteristics of fermented liquid diet for piglets. Pyrosequencing was performed to investigate the effect of Cu2+, Zn2+, Fe2+ and I- mixtures on the diversity, growth and fermentation characteristics of bacteria in the liquid diet fermented with Bacillus subtilis and Enterococcus faecalis under air-tight condition. Results showed that the mixtures of Cu2+, Zn2+, Fe2+ and I- at different concentrations promoted Bacillus growth, increased bacterial diversity and lactic acid production and lowered pH to about 5. The importance of Cu2+, Zn2+, Fe2+ and I- is different for Bacillus growth with the order Zn2+. Fe2+. Cu2+. I- in a 21-d fermentation and Cu2+. I-. Fe2+. Zn2+ in a 42-d fermentation. Cu2+, Zn2+, Fe2+ and I- is recommended at a level of 150, 60, 150 and 0.6 mg/kg respectively for the production of fermented liquid diet with Bacillus subtilis. The findings improve our understanding of the influence of trace elements on liquid diet fermentation with probiotics and support the proper use of trace elements in the production of fermented liquid diet for piglets.	[He, Yuyong; Chen, Zhiyu; Liu, Xiaolan; Lu, Wei] Jiangxi Agr Univ, Jiangxi Prov Key Lab Anim Nutr, Nanchang, Peoples R China; [Wang, Chengwei] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Science & Technology Normal University	Lu, W (corresponding author), Jiangxi Agr Univ, Jiangxi Prov Key Lab Anim Nutr, Nanchang, Peoples R China.	lw20030508@163.com			Program for Key Science & Technology in Jiangxi Province [20121BBF60032, 20132BBF60039]	Program for Key Science & Technology in Jiangxi Province	This research was funded by Program for Key Science & Technology in Jiangxi Province (20121BBF60032, 20132BBF60039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; BLOOMFIELD SF, 1994, J APPL BACTERIOL, V76, P492, DOI 10.1111/j.1365-2672.1994.tb01107.x; BOYAVAL P, 1989, LAIT, V69, P87, DOI 10.1051/lait:198927; Budhavaram NK, 2009, BIORESOURCE TECHNOL, V100, P5966, DOI 10.1016/j.biortech.2009.01.080; Canibe N, 2007, ANIM FEED SCI TECH, V134, P108, DOI 10.1016/j.anifeedsci.2006.05.005; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Djukic-Vukovic AP, 2012, FOOD CHEM, V134, P1038, DOI 10.1016/j.foodchem.2012.03.011; EDWARDS JL, 1965, APPL MICROBIOL, V13, P851, DOI 10.1128/AEM.13.6.851-857.1965; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gao T, 2012, BIORESOURCE TECHNOL, V121, P105, DOI 10.1016/j.biortech.2012.06.108; Geary TM, 1999, J SCI FOOD AGR, V79, P633, DOI 10.1002/(SICI)1097-0010(19990315)79:4&lt;633::AID-JSFA231&gt;3.0.CO;2-L; Guan S, 2011, WORLD MYCOTOXIN J, V4, P413, DOI 10.3920/WMJ2011.1290; Guan S, 2011, J FOOD AGRIC ENVIRON, V9, P163; Hojberg O, 2003, APPL ENVIRON MICROB, V69, P408, DOI 10.1128/AEM.69.1.408-418.2003; Hyronimus B, 1998, J APPL MICROBIOL, V85, P42, DOI 10.1046/j.1365-2672.1998.00466.x; Jin B, 2001, J CHEM TECHNOL BIOT, V76, P1041, DOI 10.1002/jctb.486; Lee AJ, 2011, INT J FOOD SCI TECH, V46, P1494, DOI 10.1111/j.1365-2621.2011.02644.x; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Michelson T, 2006, ENZYME MICROB TECH, V39, P861, DOI 10.1016/j.enzmictec.2006.01.015; Mikkelsen L. L., 2000, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V70, P919; Missotten JAM, 2010, ARCH ANIM NUTR, V64, P437, DOI 10.1080/1745039X.2010.512725; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Naughton PJ, 2001, BERL MUNCH TIERARZTL, V114, P378; Ohara H, 1996, J FERMENT BIOENG, V81, P272, DOI 10.1016/0922-338X(96)82222-7; Otludil B, 2005, BIOTECHNOL BIOTEC EQ, V19, P105, DOI [10.1080/13102818.2005.10817199, DOI 10.1080/13102818.2005.10817199]; Rathnayake I.V.N., 2010, INT J ENV ENG, V2, P191, DOI [10.5281/zenodo.1071334., DOI 10.5281/ZENODO.1071334]; Robina Ali, 2012, International Journal of Veterinary Science, V1, P98; Romero-Garcia S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-23; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Russell PJ, 1996, J SCI FOOD AGR, V72, P8, DOI 10.1002/(SICI)1097-0010(199609)72:1&lt;8::AID-JSFA646&gt;3.0.CO;2-K; Scholten RHJ, 2002, J ANIM SCI, V80, P1179; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Spilimbergo S., 2003, Innovative Food Science & Emerging Technologies, V4, P161, DOI 10.1016/S1466-8564(02)00089-9; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van Winsen RL, 2001, APPL ENVIRON MICROB, V67, P3071, DOI 10.1128/AEM.67.7.3071-3076.2001; Wang SP, 2011, J FOOD AGRIC ENVIRON, V9, P181; Watanabe K, 2009, WORLD J MICROB BIOT, V25, P803, DOI 10.1007/s11274-008-9952-7; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Xiao H, 2013, J ANIM SCI, V91, P4750, DOI 10.2527/jas.2013-6427; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Zhao D, 2013, APPL MICROBIOL BIOT, V97, P2173, DOI 10.1007/s00253-012-4043-y; Zhao X, 2013, APPL MICROBIOL BIOT, V97, P6477, DOI 10.1007/s00253-013-4970-2	48	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114218	10.1371/journal.pone.0114218	http://dx.doi.org/10.1371/journal.pone.0114218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486254	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600047
J	Wang, SN; Zhang, LL; Huang, KB; Lin, ZZ; Qiao, WG; Pan, SY				Wang, Shengnan; Zhang, Lili; Huang, Kaibin; Lin, Zhenzhou; Qiao, Weiguang; Pan, Suyue			Predictors of Extubation Failure in Neurocritical Patients Identified by a Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CONTROLLED-TRIAL; RISK-FACTORS; PARAMETERS	Background: Prediction of extubation failure, particularly in neurocritical patients, is unique and controversial. We conducted a systematic review and meta-analysis to identify the risk factors for extubation failure in these patients. Methods: A literature search of databases (MEDLINE, EMBASE, the Cochrane Library, and Web of Science) was performed up to August of 2013 to identify trials that evaluated extubation failure predictors. Included trials were either prospective or retrospective cohort studies. Results: Nine studies involving 928 participants were included. The systematic review and meta-analysis revealed that the following were predictive for extubation failure: pneumonia, atelectasis, mechanical ventilation of >24 h, a low Glasgow Coma Scale score (7-9T) (OR=4.96, 95% CI=1.61-15.26, P=0.005), the inability to follow commands (OR=2.07, 95% C=1.15-3.71, P=0.02), especially the command to close the eyes, thick secretion, and no intact gag reflex. Meanwhile, the following were not predictive for extubation failure: sex, secretion volume, coughing upon suctioning, and the inability to follow one command among showing two fingers, wiggling the toes, or coughing on command. Additionally, some traditional weaning parameters were shown to poorly predict extubation failure in neurocritical patients. Conclusions: Besides pneumonia, atelectasis, and the duration of mechanical ventilation, other factors that should be taken into consideration in the prediction of extubation failure when neurocritical patients are weaned from tracheal intubation include neurologic abilities (Glasgow Coma Scale score and following commands), the secretion texture, and the presence of a gag reflex.	[Wang, Shengnan; Zhang, Lili; Huang, Kaibin; Lin, Zhenzhou; Pan, Suyue] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Lili] Second Peoples Hosp Chengdu, Dept Neurol, Chengdu 610017, Peoples R China; [Qiao, Weiguang] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Pan, SY (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou 510515, Guangdong, Peoples R China.	pansuyue82@126.com	Huang, Kaibin/AAC-6346-2019	Pan, Suyue/0000-0003-2744-1984; Huang, Kaibin/0000-0002-3360-7031	President Foundation of Nanfang Hospital, Southern Medical University [2012C004]	President Foundation of Nanfang Hospital, Southern Medical University	The study design was financially supported by President Foundation of Nanfang Hospital, Southern Medical University (2012C004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CD, 2011, NEUROCRIT CARE, V15, P490, DOI 10.1007/s12028-010-9369-7; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beuret P, 2009, INTENS CARE MED, V35, P1090, DOI 10.1007/s00134-009-1404-9; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Castro AAM, 2012, ARCH BRONCONEUMOL, V48, P274, DOI 10.1016/j.arbres.2012.04.010; Chevron V, 1998, CRIT CARE MED, V26, P1049, DOI 10.1097/00003246-199806000-00026; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epstein SK, 2004, CRIT CARE, V8, P310, DOI 10.1186/cc2927; Epstein SK, 2001, CHEST, V120, P1061, DOI 10.1378/chest.120.4.1061; Frutos-Vivar F, 2006, CHEST, V130, P1664, DOI 10.1378/chest.130.6.1664; Khamiees M, 2001, CHEST, V120, P1262, DOI 10.1378/chest.120.4.1262; Ko R, 2009, NEUROCRIT CARE, V10, P269, DOI 10.1007/s12028-008-9181-9; Krishnan JA, 2004, AM J RESP CRIT CARE, V169, P673, DOI 10.1164/rccm.200306-761OC; Kulkarni AP, 2008, INDIAN J CRIT CARE M, V12, P1, DOI 10.4103/0972-5229.40942; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Navalesi P, 2008, CRIT CARE MED, V36, P2986, DOI 10.1097/CCM.0b013e31818b35f2; Rabinstein AA, 2005, NEUROCRIT CARE, V3, P213, DOI 10.1385/NCC:3:3:213; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P929, DOI 10.1001/archneur.65.7.929; Tanios MA, 2006, CRIT CARE MED, V34, P2530, DOI 10.1097/01.CCM.0000236546.98861.25; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; Vidotto MC, 2008, NEUROCRIT CARE, V9, P83, DOI 10.1007/s12028-008-9059-x; Vidotto MC, 2012, RESP CARE, V57, P2059, DOI 10.4187/respcare.01039; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432; Wendell LC, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/248789; Wu JY, 2009, NEUROCRIT CARE, V10, P35, DOI 10.1007/s12028-008-9139-y	29	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112198	10.1371/journal.pone.0112198	http://dx.doi.org/10.1371/journal.pone.0112198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486091	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600007
J	Wilberts, BL; Arruda, PH; Kinyon, JM; Frana, TS; Wang, C; Magstadt, DR; Madson, DM; Patience, JF; Burrough, ER				Wilberts, Bailey L.; Arruda, Paulo H.; Kinyon, Joann M.; Frana, Tim S.; Wang, Chong; Magstadt, Drew R.; Madson, Darin M.; Patience, John F.; Burrough, Eric R.			Investigation of the Impact of Increased Dietary Insoluble Fiber through the Feeding of Distillers Dried Grains with Solubles (DDGS) on the Incidence and Severity of Brachyspira-Associated Colitis in Pigs	PLOS ONE			English	Article							SWINE-DYSENTERY; SERPULINA-HYODYSENTERIAE; EXPERIMENTAL-INFECTION; GROWING PIGS; EXPRESSION; HAMPSONII; IDENTIFICATION; DIGESTIBILITY; FERMENTATION; INOCULATION	Diet has been implicated as a major factor impacting clinical disease expression of swine dysentery and Brachyspira hyodysenteriae colonization. However, the impact of diet on novel pathogenic strongly beta-hemolytic Brachyspira spp. including "B. hampsonii" has yet to be investigated. In recent years, distillers dried grains with solubles (DDGS), a source of insoluble dietary fiber, has been increasingly included in diets of swine. A randomized complete block experiment was used to examine the effect of increased dietary fiber through the feeding of DDGS on the incidence of Brachyspira-associated colitis in pigs. One hundred 4-week-old pigs were divided into five groups based upon inocula (negative control, Brachyspira intermedia, Brachyspira pilosicoli, B. hyodysenteriae or "B. hampsonii'') and fed one of two diets containing no (diet 1) or 30% (diet 2) DDGS. The average days to first positive culture and days post inoculation to the onset of clinical dysentery in the B. hyodysenteriae groups was significantly shorter for diet 2 when compared to diet 1 (P=0.04 and P=0.0009, respectively). A similar difference in the average days to first positive culture and days post inoculation to the onset of clinical dysentery was found when comparing the "B. hampsonii'' groups. In this study, pigs receiving 30% DDGS shed on average one day prior to and developed swine dysentery nearly twice as fast as pigs receiving 0% DDGS. Accordingly, these data suggest a reduction in insoluble fiber through reducing or eliminating DDGS in swine rations should be considered an integral part of any effective disease elimination strategy for swine dysentery.	[Wilberts, Bailey L.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA; [Arruda, Paulo H.; Kinyon, Joann M.; Frana, Tim S.; Wang, Chong; Magstadt, Drew R.; Madson, Darin M.; Burrough, Eric R.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Patience, John F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University	Burrough, ER (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, 1600 S 16th St, Ames, IA 50011 USA.	burrough@iastate.edu	Patience, john F./A-2935-2009; Wang, Chong/AAI-3796-2020	Wang, Chong/0000-0003-4489-4344; Burrough, Eric/0000-0003-4747-9189	Innovative Swine Industry Enhancement Grant Program	Innovative Swine Industry Enhancement Grant Program	Funding: This work was supported by a grant from the Innovative Swine Industry Enhancement Grant Program administered by the Iowa Attorney General's Office. The funding source had no involvement in data collection, analysis and interpretation of data, writing the report, and decision to submit the article for publication.	Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Burrough ER, 2012, J VET DIAGN INVEST, V24, P1025, DOI 10.1177/1040638712457927; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DREAU D, 1994, J ANIM SCI, V72, P2090, DOI 10.2527/1994.7282090x; Durmic Z, 2000, J APPL MICROBIOL, V89, P678, DOI 10.1046/j.1365-2672.2000.01166.x; Hampson DJ, 2012, DIS SWINE, P680; Hansen CF, 2010, J ANIM SCI, V88, P3327, DOI 10.2527/jas.2009-2719; Hansen CF, 2011, BRIT J NUTR, V106, P1506, DOI 10.1017/S000711451100208X; HARRIS DL, 1972, VET MED SM ANIM CLIN, V67, P61; Huisman J., 1991, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V61, P901; Kennedy MJ, 1996, VET MICROBIOL, V49, P21, DOI 10.1016/0378-1135(95)00174-3; Kirkwood RN, 2000, SWINE HEALTH PROD, V8, P73; Klose V, 2010, J APPL MICROBIOL, V108, P1271, DOI 10.1111/j.1365-2672.2009.04521.x; Leser TD, 2000, APPL ENVIRON MICROB, V66, P3290, DOI 10.1128/AEM.66.8.3290-3296.2000; Lindecrona RH, 2003, ANIM SCI, V76, P81, DOI 10.1017/S1357729800053340; Molbak L, 2007, J APPL MICROBIOL, V103, P1853, DOI 10.1111/j.1365-2672.2007.03430.x; Montagne L, 2004, NUTR REV, V62, P105, DOI [10.1301/nr.2004.mar.105-114, 10.1111/j.1753-4887.2004.tb00031.x]; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Pluske JR, 1998, J NUTR, V128, P1737, DOI 10.1093/jn/128.10.1737; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Rubin JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057146; SchmidtWittig U, 1996, ANN NUTR METAB, V40, P343, DOI 10.1159/000177936; Siba PM, 1996, EPIDEMIOL INFECT, V116, P207, DOI 10.1017/S0950268800052456; Thomsen LE, 2007, VET MICROBIOL, V119, P152, DOI 10.1016/j.vetmic.2006.09.004; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; Urriola PE, 2010, J ANIM SCI, V88, P2373, DOI 10.2527/jas.2009-2227; Urriola PE, 2010, J ANIM SCI, V88, P1454, DOI 10.2527/jas.2009-2162; Warneke HL, 2014, J VET DIAGN INVEST, V26, P635, DOI 10.1177/1040638714541114; Wilberts BL, 2014, VET PATHOL, V51, P1096, DOI 10.1177/0300985813516646; Zijlstra RT, 2012, J ANIM SCI, V90, P49, DOI 10.2527/jas.53718	33	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114741	10.1371/journal.pone.0114741	http://dx.doi.org/10.1371/journal.pone.0114741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485776	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600094
J	Bartolo, I; Zakovic, S; Martin, F; Palladino, C; Carvalho, P; Camacho, R; Thamm, S; Clemente, S; Taveira, N				Bartolo, Ines; Zakovic, Suzana; Martin, Francisco; Palladino, Claudia; Carvalho, Patricia; Camacho, Ricardo; Thamm, Sven; Clemente, Sofia; Taveira, Nuno			HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESOURCE-LIMITED SETTINGS; RITONAVIR-BASED REGIMENS; NON-B INFECTIONS; ANTIRETROVIRAL TREATMENT; SUBTYPE C; VIROLOGICAL RESPONSE; NAIVE INDIVIDUALS; GENETIC DIVERSITY; SOUTH-AFRICA	Objectives: To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resistance (TDR) in Angola, five years after ART scale-up. Methods: Population sequencing of the pol gene was performed on 139 plasma samples collected in 2009 from drug-naive HIV-1 infected individuals living in Luanda. HIV-1 subtypes were determined using phylogenetic analysis. Drug resistance mutations were identified using the Calibrated Population Resistance Tool (CPR). Transmission networks were determined using phylogenetic analysis of all Angolan sequences present in the databases. Evolutionary trends were determined by comparison with a similar survey performed in 2001. Results: 47.1% of the viruses were pure subtypes (all except B), 47.1% were recombinants and 5.8% were untypable. The prevalence of subtype A decreased significantly from 2001 to 2009 (40.0% to 10.8%, P=0.0019) while the prevalence of unique recombinant forms (URFs) increased > 2-fold (40.0% to 83.1%, P < 0.0001). The most frequent URFs comprised untypable sequences with subtypes H (U/H, n=7, 10.8%), A (U/A, n=6, 9.2%) and G (G/U, n=4, 6.2%). Newly identified U/H recombinants formed a highly supported monophyletic cluster suggesting a local and common origin. TDR mutation K103N was found in one (0.7%) patient (1.6% in 2001). Out of the 364 sequences sampled for transmission network analysis, 130 (35.7%) were part of a transmission network. Forty eight transmission clusters were identified; the majority (56.3%) comprised sequences sampled in 2008-2010 in Luanda which is consistent with a locally fuelled epidemic. Very low genetic distance was found in 27 transmission pairs sampled in the same year, suggesting recent transmission events. Conclusions: Transmission of drug resistant strains was still negligible in Luanda in 2009, five years after the scale-up of ART. The dominance of small and recent transmission clusters and the emergence of new URFs are consistent with a rising HIV-1 epidemics mainly driven by heterosexual transmission.	[Bartolo, Ines; Martin, Francisco; Palladino, Claudia; Taveira, Nuno] Univ Lisbon, Fac Farm, Ctr Patogenese Mol, Unidade Retrovius & Infeccoes Associadas, P-1699 Lisbon, Portugal; [Bartolo, Ines; Martin, Francisco; Palladino, Claudia; Taveira, Nuno] Univ Lisbon, Fac Farm, Inst Invest Medicamento iMed ULisboa, P-1699 Lisbon, Portugal; [Bartolo, Ines; Zakovic, Suzana; Martin, Francisco; Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Monte De Caparica, Portugal; [Carvalho, Patricia; Camacho, Ricardo] Hosp Egas Moniz, Ctr Hosp Lisboa Ocidental, Mol Biol Lab, Lisbon, Portugal; [Camacho, Ricardo] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Thamm, Sven] Abbott GmbH & Co KG, Wiesbaden, Germany; [Clemente, Sofia] Hosp Divina Providencia, Serv Doencas Infecciosas, Luanda, Angola	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade de Lisboa; KU Leuven; ABBOTT GMBH & CO. KG	Taveira, N (corresponding author), Univ Lisbon, Fac Farm, Ctr Patogenese Mol, Unidade Retrovius & Infeccoes Associadas, P-1699 Lisbon, Portugal.	ntaveira@ff.ul.pt	iMed.ULisboa, EEPHIV/B-4222-2014; Taveira, Nuno C/A-6252-2014; Carvalho, Patrícia Sousa Vindeirinho Albuquerque/HCI-2410-2022; Bártolo, Inês/A-7477-2014; Camacho, Ricardo J/I-7629-2012; Palladino, Claudia/E-2523-2014	Taveira, Nuno C/0000-0003-0176-5585; Bártolo, Inês/0000-0002-2022-8921; Camacho, Ricardo J/0000-0002-9129-3237; Palladino, Claudia/0000-0002-8148-0928	Fundacao para a Ciencia e Tecnologia (FCT), Portugal ["PTDC/SAU-FAR/115290/2009", "PTDC/SAU-EPI/122400/2010", SFRH/BPD/76225/2011, SFRH/BD/87488/2012, SFRH/BPD/77448/2011]; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union; European Union studentship from the Erasmus Mundus Masters in Forensic Sciences; Fundação para a Ciência e a Tecnologia [PTDC/SAU-EPI/122400/2010, PTDC/SAU-FAR/115290/2009] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union; European Union studentship from the Erasmus Mundus Masters in Forensic Sciences; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT) http://www.fct.pt), Portugal, (grants "PTDC/SAU-FAR/115290/2009" and "PTDC/SAU-EPI/122400/2010"), and by Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union. Ines Bartolo was supported by a post-doc fellowship (SFRH/BPD/76225/2011) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. Suzana Zakovic was supported by a European Union studentship from the Erasmus Mundus Masters in Forensic Sciences (http://forensicerasmusmundus.blogs.lincoln.ac.uk/). Francisco Martin was supported by a PhD fellowship (SFRH/BD/87488/2012) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. Claudia Palladino was supported by a post-doc fellowship (SFRH/BPD/77448/2011) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007; Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Castelbranco EPAF, 2010, AIDS RES HUM RETROV, V26, P1313, DOI 10.1089/aid.2010.0111; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Bartolo I, 2005, AIDS RES HUM RETROV, V21, P306, DOI 10.1089/aid.2005.21.306; Bartolo I, 2012, GENETIC DIVERSITY IN MICROORGANISMS, P171; Bartolo I, 2009, ANTIMICROB AGENTS CH, V53, P3156, DOI 10.1128/AAC.00110-09; Bartolo I, 2009, JAIDS-J ACQ IMM DEF, V51, P323, DOI 10.1097/QAI.0b013e3181a24906; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Catumbela E, 2013, LANCET, V382, P17; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; de Meyer S, 2008, AIDS RES HUM RETROV, V24, P379, DOI 10.1089/aid.2007.0173; Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201; FAghokeng A, 2009, ANTIVIR THER, V14, P401; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2006, AIDS REV, V8, P98; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Instituto Nacional de Luta Contra a SIDA - Angola, 2010, UNGASS 2010 REL PROG; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kempf DJ, 2002, ANTIVIR THER, V7, P165; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitner T., 2000, AIDS REV, V2, P241; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Los Alamos Sequence Database, 2014, LOS AL SEQ DAT; Mahnke YD, 2013, AIDS, V27, P697, DOI 10.1097/QAD.0b013e32835ce2e9; Ministerio da Saude de Angola, 2009, B EP VIH SIDA; Afonso JM, 2012, INFECT GENET EVOL, V12, P1458, DOI 10.1016/j.meegid.2012.05.005; Nwobegahay J, 2012, J MED VIROL, V84, P1839, DOI 10.1002/jmv.23348; Pellegrin I, 2006, ANTIVIR THER, V11, P421; Pellegrin I, 2007, ANTIMICROB AGENTS CH, V51, P1473, DOI 10.1128/AAC.00481-06; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poveda E, 2007, J ANTIMICROB CHEMOTH, V60, P885, DOI 10.1093/jac/dkm276; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stanford HIV Drug Resistance Database, 2014, STANF HIV DRUG RES D; Sullivan PS, 2012, AIDS, V26, P175, DOI 10.1097/QAD.0b013e32834ed8c8; van Westen GJP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002899; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; WHO, 2010, ANT THER HIV INF AD; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11	63	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113626	10.1371/journal.pone.0113626	http://dx.doi.org/10.1371/journal.pone.0113626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479241	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907200025
J	Bohon, KS; Wiest, MC				Bohon, Kaitlin S.; Wiest, Michael C.			Role of Medio-Dorsal Frontal and Posterior Parietal Neurons during Auditory Detection Performance in Rats	PLOS ONE			English	Article							SUBJECTIVE SENSORY EXPERIENCE; PREFRONTAL CORTEX; SUSTAINED ATTENTION; CORTICAL AREAS; TACTILE PERCEPTION; VISUAL-PERCEPTION; CONSCIOUSNESS; MECHANISMS; HUMANS; MEMORY	To further characterize the role of frontal and parietal cortices in rat cognition, we recorded action potentials simultaneously from multiple sites in the medio-dorsal frontal cortex and posterior parietal cortex of rats while they performed a two-choice auditory detection task. We quantified neural correlates of task performance, including response movements, perception of a target tone, and the differentiation between stimuli with distinct features (different pitches or durations). A minority of units-15% in frontal cortex, 23% in parietal cortex-significantly distinguished hit trials (successful detections, response movement to the right) from correct rejection trials (correct leftward response to the absence of the target tone). Estimating the contribution of movement-related activity to these responses suggested that more than half of these units were likely signaling correct perception of the auditory target, rather than merely movement direction. In addition, we found a smaller and mostly not overlapping population of units that differentiated stimuli based on task-irrelevant details. The detection-related spiking responses we observed suggest that correlates of perception in the rat are sparsely represented among neurons in the rat's frontal-parietal network, without being concentrated preferentially in frontal or parietal areas.	[Bohon, Kaitlin S.; Wiest, Michael C.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA	Wellesley College	Wiest, MC (corresponding author), Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA.	mwiest@wellesley.edu	Wiest, Michael/ABC-8101-2020		National Science Foundation Integrative Organismal Systems [1121689]	National Science Foundation Integrative Organismal Systems	MCW's work was supported by National Science Foundation Integrative Organismal Systems grant 1121689 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Broussard J, 2006, NEUROSCIENCE, V143, P407, DOI 10.1016/j.neuroscience.2006.08.030; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; DESMEDT JE, 1994, NEUROSCI LETT, V168, P126, DOI 10.1016/0304-3940(94)90432-4; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Hromadka T, 2007, HEARING RES, V229, P180, DOI 10.1016/j.heares.2007.01.002; Jaegle A, 2014, J COGNITIVE NEUROSCI, V26, P422, DOI 10.1162/jocn_a_00494; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; Lafuente Vd, 2006, P NATL ACAD SCI USA, V103, P14266; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Meier P, 2011, J VIS, V11, P22; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nakamura K, 1999, J NEUROPHYSIOL, V82, P2503, DOI 10.1152/jn.1999.82.5.2503; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Posner MI, 2012, NEUROIMAGE, V61, P450, DOI 10.1016/j.neuroimage.2011.12.040; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; REEP RL, 1994, EXP BRAIN RES, V100, P67; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rees G, 2013, ANN NY ACAD SCI, V1296, P4, DOI 10.1111/nyas.12257; Ro T, 2004, J COGNITIVE NEUROSCI, V16, P24, DOI 10.1162/089892904322755520; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008	42	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114064	10.1371/journal.pone.0114064	http://dx.doi.org/10.1371/journal.pone.0114064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479194	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200041
J	Postler, TS; Bixby, JG; Desrosiers, RC; Yuste, E				Postler, Thomas S.; Bixby, Jacqueline G.; Desrosiers, Ronald C.; Yuste, Eloisa			Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41	PLOS ONE			English	Article							HIV-1 ENVELOPE GLYCOPROTEIN; CELL-SURFACE EXPRESSION; TYROSINE-BASED SIGNAL; NEUTRALIZATION SENSITIVITY; CLATHRIN ADAPTER; TYPE-1 MATRIX; TRANSMEMBRANE PROTEINS; MACROPHAGE TROPISM; ENV INCORPORATION; DILEUCINE MOTIF	Previous studies have shown that truncation of the cytoplasmic-domain sequences of the simian immunodeficiency virus (SIV) envelope glycoprotein (Env) just prior to a potential intracellular-trafficking signal of the sequence YIHF can strongly increase Env protein expression on the cell surface, Env incorporation into virions and, at least in some contexts, virion infectivity. Here, all 12 potential intracellular-trafficking motifs (YXX Phi or LL/LI/IL) in the gp41 cytoplasmic domain (gp41CD) of SIVmac239 were analyzed by systematic mutagenesis. One single and 7 sequential combination mutants in this cytoplasmic domain were characterized. Cell-surface levels of Env were not significantly affected by any of the mutations. Most combination mutations resulted in moderate 3- to 8-fold increases in Env incorporation into virions. However, mutation of all 12 potential sites actually decreased Env incorporation into virions. Variant forms with 11 or 12 mutated sites exhibited 3-fold lower levels of inherent infectivity, while none of the other single or combination mutations that were studied significantly affected the inherent infectivity of SIVmac239. These minor effects of mutations in trafficking motifs form a stark contrast to the strong increases in cell-surface expression and Env incorporation which have previously been reported for large truncations of gp41CD. Surprisingly, mutation of potential trafficking motifs in gp41CD of SIVmac316, which differs by only one residue from gp41CD of SIVmac239, effectively recapitulated the increases in Env incorporation into virions observed with gp41CD truncations. Our results indicate that increases in Env surface expression and virion incorporation associated with truncation of SIVmac239 gp41CD are not fully explained by loss of consensus trafficking motifs.	[Postler, Thomas S.; Bixby, Jacqueline G.; Desrosiers, Ronald C.; Yuste, Eloisa] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, New England Primate Res Ctr, Southborough, MA 01772 USA	Harvard University	Yuste, E (corresponding author), Inst Invest Biomed August Pi & Sunyer, AIDS Res Unit, Barcelona, Spain.	EYUSTE@clinic.ub.es	Yuste, Eloisa/R-9493-2019	Yuste, Eloisa/0000-0002-9484-9974; Postler, Thomas/0000-0002-3558-9084	National Institutes of Health [5RO1AI025328, RR00168]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 5RO1AI025328 from the National Institutes of Health (www.nih.gov) to RCD and by base grant RR00168 from the National Institutes of Health (www.nih.gov) to the New England Primate Research Center (Harvard Medical School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Bhakta SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-37; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2000, TRAFFIC, V1, P661, DOI 10.1034/j.1600-0854.2000.010810.x; Breed MW, 2013, J VIROL, V87, P1528, DOI 10.1128/JVI.01928-12; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen BK, 2012, IMMUNOL RES, V54, P133, DOI 10.1007/s12026-012-8320-8; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cole KS, 2001, VIROLOGY, V290, P59; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Fultz PN, 2001, J VIROL, V75, P278, DOI 10.1128/JVI.75.1.278-291.2001; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Hallenberger S, 1997, J VIROL, V71, P1036, DOI 10.1128/JVI.71.2.1036-1045.1997; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; HIRSCH VM, 1989, NATURE, V341, P573, DOI 10.1038/341573a0; Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Kuiken C, 2009, 0903280 LAUR THEOR B; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; MAMMANO F, 1995, J VIROL, V69, P3824, DOI 10.1128/JVI.69.6.3824-3830.1995; Manrique JM, 2001, AIDS RES HUM RETROV, V17, P1615, DOI 10.1089/088922201753342022; Marcon L, 1997, AIDS RES HUM RETROV, V13, P441, DOI 10.1089/aid.1997.13.441; Means RE, 1997, J VIROL, V71, P7895, DOI 10.1128/JVI.71.10.7895-7902.1997; Mori K, 2000, J VIROL, V74, P10852, DOI 10.1128/JVI.74.22.10852-10859.2000; MORI K, 1992, J VIROL, V66, P2067, DOI 10.1128/JVI.66.4.2067-2075.1992; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; RITTER GD, 1993, VIROLOGY, V197, P255, DOI 10.1006/viro.1993.1586; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; ROWELL JF, 1995, J IMMUNOL, V155, P473; Sauter MM, 1996, J CELL BIOL, V132, P795, DOI 10.1083/jcb.132.5.795; SPIES CP, 1994, J VIROL, V68, P585, DOI 10.1128/JVI.68.2.585-591.1994; SPIES CP, 1994, VIROLOGY, V203, P8, DOI 10.1006/viro.1994.1449; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; VERONESE FD, 1989, J VIROL, V63, P1416, DOI 10.1128/JVI.63.3.1416-1419.1989; West JT, 2002, J VIROL, V76, P3338, DOI 10.1128/JVI.76.7.3338-3349.2002; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Yuste E, 2005, J VIROL, V79, P12455, DOI 10.1128/JVI.79.19.12455-12463.2005; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; ZINGLER K, 1993, J VIROL, V67, P2824, DOI 10.1128/JVI.67.5.2824-2831.1993	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114753	10.1371/journal.pone.0114753	http://dx.doi.org/10.1371/journal.pone.0114753			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479017	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200123
J	Welford, RWD; Garzotti, M; Lourenco, CM; Mengel, E; Marquardt, T; Reunert, J; Amraoui, Y; Kolb, SA; Morand, O; Groenen, P				Welford, Richard W. D.; Garzotti, Marco; Lourenco, Charles Marques; Mengel, Eugen; Marquardt, Thorsten; Reunert, Janine; Amraoui, Yasmina; Kolb, Stefan A.; Morand, Olivier; Groenen, Peter			Plasma Lysosphingomyelin Demonstrates Great Potential as a Diagnostic Biomarker for Niemann-Pick Disease Type C in a Retrospective Study	PLOS ONE			English	Article							DRIED BLOOD SPOTS; GLOBOTRIAOSYLSPHINGOSINE	Niemann-Pick disease type C (NP-C) is a devastating, neurovisceral lysosomal storage disorder which is characterised by variable manifestation of visceral signs, progressive neuropsychiatric deterioration and premature death, caused by mutations in the NPC1 and NPC2 genes. Due to the complexity of diagnosis and the availability of an approved therapy in the EU, improved detection of NP-C may have a huge impact on future disease management. At the cellular level dysfunction or deficiency of either the NPC1 or NPC2 protein leads to a complex intracellular endosomal/lysosomal trafficking defect, and organ specific patterns of sphingolipid accumulation. Lysosphingolipids have been shown to be excellent biomarkers of sphingolipidosis in several enzyme deficient lysosomal storage disorders. Additionally, in a recent study the lysosphingolipids, lysosphingomyelin (SPC) and glucosylsphingosine (GlcSph), appeared to be elevated in the plasma of three adult NP-C patients. In order to investigate the clinical utility of SPC and GlcSph as diagnostic markers, an in-depth fit for purpose biomarker assay validation for measurement of these biomarkers in plasma by liquid chromatography-tandem mass spectrometry was performed. Plasma SPC and GlcSph are stable and can be measured accurately, precisely and reproducibly. In a retrospective analysis of 57 NP-C patients and 70 control subjects, median plasma SPC and GlcSph were significantly elevated in NP-C by 2.8-fold and 1.4-fold respectively. For miglustat-naive NP-C patients, aged 2-50 years, the area under the ROC curve was 0.999 for SPC and 0.776 for GlcSph. Plasma GlcSph did not correlate with SPC levels in NP-C patients. The data indicate excellent potential for the use of lysosphingomyelin in NP-C diagnosis, where it could be used to identify NP-C patients for confirmatory genetic testing.	[Welford, Richard W. D.; Garzotti, Marco; Kolb, Stefan A.; Morand, Olivier; Groenen, Peter] Actel Pharmaceut Ltd, Allschwil, Switzerland; [Lourenco, Charles Marques] Hosp Clin Ribeirao Preto, Sao Paulo, Brazil; [Mengel, Eugen; Amraoui, Yasmina] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Paediat & Adolescent Med, Dept Lysosomal Storage Disorder, D-55122 Mainz, Germany; [Marquardt, Thorsten; Reunert, Janine] Klin Kinder & Jugendmed, Munster, Germany	Actelion Pharmaceuticals Ltd; Johannes Gutenberg University of Mainz	Welford, RWD (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	richard.welford@actelion.com			Actelion Pharmaceuticals	Actelion Pharmaceuticals	The study was funded by Actelion Pharmaceuticals. The funders (senior management and board) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Bauer P, 2013, HUM MOL GENET, V22, P4349, DOI 10.1093/hmg/ddt284; Chuang WL, 2014, MOL GENET METAB, V111, P209, DOI 10.1016/j.ymgme.2013.11.012; Chuang WL, 2013, CLIN CHIM ACTA, V419, P73, DOI 10.1016/j.cca.2013.01.017; CROCKER AC, 1961, J NEUROCHEM, V7, P69, DOI 10.1111/j.1471-4159.1961.tb13499.x; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; European Medicines Agency (EMA), 2011, EMEACHMPEWP192217200; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Fast Douglas M, 2009, AAPS J, V11, P238, DOI 10.1208/s12248-009-9100-9; Houghton R, 2009, BIOANALYSIS, V1, P1365, DOI [10.4155/bio.09.139, 10.4155/BIO.09.139]; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Johnson B, 2013, ANN LAB MED, V33, P274, DOI 10.3343/alm.2013.33.4.274; Kodama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029074; Lin N, 2014, J LIPID RES, V55, P338, DOI 10.1194/jlr.D044024; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Mengel E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-166; Patterson MC, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-12; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Rolfs A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079732; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Stampfer M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-35; Stevenson L, 2013, BIOANALYSIS, V5, P2903, DOI 10.4155/bio.13.238; U.S. FDA, 1998, GUIDANCE IND BIOANAL; van Karnebeek CD, 2014, MOL GENET METAB; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Wijburg FA, 2012, NEUROLOGY, V78, P1560, DOI 10.1212/WNL.0b013e3182563b82; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zhang HW, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-82	32	60	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114669	10.1371/journal.pone.0114669	http://dx.doi.org/10.1371/journal.pone.0114669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479233	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200110
J	Shearer, TL; Snell, TW; Hay, ME				Shearer, Tonya L.; Snell, Terry W.; Hay, Mark E.			Gene Expression of Corals in Response to Macroalgal Competitors	PLOS ONE			English	Article							BENTHIC ALGAE; MONTASTRAEA-ANNULARIS; ACROPORA-MILLEPORA; CARIBBEAN CORALS; THERMAL-STRESS; CYANOBACTERIA; TEMPERATURE; RESILIENCE; CONTACT; REEFS	As corals decline and macroalgae proliferate on coral reefs, coral-macroalgal competition becomes more frequent and ecologically important. Whether corals are damaged by these interactions depends on susceptibility of the coral and traits of macroalgal competitors. Investigating changes in gene expression of corals and their intracellular symbiotic algae, Symbiodinium, in response to contact with different macroalgae provides insight into the biological processes and cellular pathways affected by competition with macroalgae. We evaluated the gene expression profiles of coral and Symbiodinium genes from two confamilial corals, Acropora millepora and Montipora digitata, after 6 h and 48 h of contact with four common macroalgae that differ in their allelopathic potency to corals. Contacts with macroalgae affected different biological pathways in the more susceptible (A. millepora) versus the more resistant (M. digitata) coral. Genes of coral hosts and of their associated Symbiodinium also responded in species-specific and time-specific ways to each macroalga. Changes in number and expression intensity of affected genes were greater after 6 h compared to 48 h of contact and were greater following contact with Chlorodesmis fastigiata and Amphiroa crassa than following contact with Galaxaura filamentosa or Turbinaria conoides. We documented a divergence in transcriptional responses between two confamilial corals and their associated Symbiodinium, as well as a diversity of dynamic responses within each coral species with respect to the species of macroalgal competitor and the duration of exposure to that competitor. These responses included early initiation of immune processes by Montipora, which is more resistant to damage after long-term macroalgal contact. Activation of the immune response by corals that better resist algal competition is consistent with the hypothesis that some macroalgal effects on corals may be mediated by microbial pathogens.	[Shearer, Tonya L.; Snell, Terry W.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Science Foundation [OCE 0929119]; National Institutes of Health [U01 TW007401-01]; Teasley Endowment to the Georgia Institute of Technology; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [G12-RR03034]; FOGARTY INTERNATIONAL CENTER [U19TW007401, U01TW007401] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment to the Georgia Institute of Technology; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by the National Science Foundation (OCE 0929119) (http://www.nsf.gov/div/index.jsp?div-oce), the National Institutes of Health (U01 TW007401-01) (http://www.nih.gov), and the Teasley Endowment to the Georgia Institute of Technology. The Morehouse School of Medicine microarray facility is supported by the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) (G12-RR03034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras TD, 2012, J CHEM ECOL, V38, P1203, DOI 10.1007/s10886-012-0204-9; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bay LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061736; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Fisher PL, 2012, CORAL REEFS, V31, P473, DOI 10.1007/s00338-011-0853-0; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; Puill-Stephan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039099; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Shearer TL, 2012, CORAL REEFS, V31, P1177, DOI 10.1007/s00338-012-0943-7; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Thurber RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044246; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x	45	6	7	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114525	10.1371/journal.pone.0114525	http://dx.doi.org/10.1371/journal.pone.0114525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500576	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400034
J	Allmann, S; Mazet, M; Ziebart, N; Bouyssou, G; Fouillen, L; Dupuy, JW; Bonneu, M; Moreau, P; Bringaud, F; Boshart, M				Allmann, Stefan; Mazet, Muriel; Ziebart, Nicole; Bouyssou, Guillaume; Fouillen, Laetitia; Dupuy, Jean-William; Bonneu, Marc; Moreau, Patrick; Bringaud, Frederic; Boshart, Michael			Triacylglycerol Storage in Lipid Droplets in Procyclic Trypanosoma brucei	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LEISHMANIA-MAJOR; BLOOD-STREAM; PHOSPHATE DIKINASE; BETA-OXIDATION; CULTURE FORMS; TSETSE-FLY; METABOLISM; IDENTIFICATION; ORGANELLE	Carbon storage is likely to enable adaptation of trypanosomes to nutritional challenges or bottlenecks during their stage development and migration in the tsetse. Lipid droplets are candidates for this function. This report shows that feeding of T. brucei with oleate results in a 4-5 fold increase in the number of lipid droplets, as quantified by confocal fluorescence microscopy and by flow cytometry of BODIPY 493/503-stained cells. The triacylglycerol (TAG) content also increased 4-5 fold, and labeled oleate is incorporated into TAG. Fatty acid carbon can thus be stored as TAG in lipid droplets under physiological growth conditions in procyclic T. brucei. beta-oxidation has been suggested as a possible catabolic pathway for lipids in T. brucei. A single candidate gene, TFE alpha 1 with coding capacity for a subunit of the trifunctional enzyme complex was identified. TFE alpha 1 is expressed in procyclic T. brucei and present in glycosomal proteomes, Unexpectedly, a TFE alpha 1 gene knock-out mutant still expressed wild-type levels of previously reported NADP-dependent 3-hydroxyacyl-CoA dehydrogenase activity, and therefore, another gene encodes this enzymatic activity. Homozygous Delta tfe alpha 1/Delta tfe alpha 1 null mutant cells show a normal growth rate and an unchanged glycosomal proteome in procyclic T. brucei. The decay kinetics of accumulated lipid droplets upon oleate withdrawal can be fully accounted for by the dilution effect of cell division in wild-type and Delta tfe alpha 1/Delta tfe alpha 1 cells. The absence of net catabolism of stored TAG in procyclic T. brucei, even under strictly glucose-free conditions, does not formally exclude a flux through TAG, in which biosynthesis equals catabolism. Also, the possibility remains that TAG catabolism is completely repressed by other carbon sources in culture media or developmentally activated in post-procyclic stages in the tsetse.	[Allmann, Stefan; Ziebart, Nicole; Boshart, Michael] Univ Munich, Biozentrum, Fak Biol, Martinsried, Germany; [Mazet, Muriel; Bringaud, Frederic] Univ Bordeaux, CNRS, Unite Mixte Rech 5536, Ctr Resonance Magnet Systemes Biol RMSB, Bordeaux, France; [Bouyssou, Guillaume; Fouillen, Laetitia; Moreau, Patrick] Univ Bordeaux, INRA, CNRS, Lab Biogenese Membranaire,Unite Mixte Rech 5200, Villenave Dornon, France; [Dupuy, Jean-William; Bonneu, Marc] Univ Bordeaux, Ctr Genom Fonct, Plateforme Proteome, Bordeaux, France	University of Munich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Boshart, M (corresponding author), Univ Munich, Biozentrum, Fak Biol, Martinsried, Germany.	boshart@lmu.de	FOUILLEN, Laetitia/AAV-9710-2020; Dupuy, Jean-William JWD/F-5335-2012; Boshart, Michael/A-2700-2011	FOUILLEN, Laetitia/0000-0002-1204-9296; Dupuy, Jean-William JWD/0000-0002-2448-4797; Boshart, Michael/0000-0002-5070-2663; Moreau, Patrick/0000-0001-9318-3464	University of Munich; Deutsche Forschungsgemeinschaft (DFG) [1100/6-2]; Agence Nationale de la Recherche (ANR) through grants ACETOTRYP of the ANR-BLANC call; Centre National de la Recherche Scientifique (CNRS); Universite of Bordeaux; Laboratoire d'Excellence (LabEx) ParaFrap [ANR-11-LABX-0024]; Franco-Bavarian University Cooperation Center (BFHZ/CCUFB)	University of Munich; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Agence Nationale de la Recherche (ANR) through grants ACETOTRYP of the ANR-BLANC call(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite of Bordeaux; Laboratoire d'Excellence (LabEx) ParaFrap; Franco-Bavarian University Cooperation Center (BFHZ/CCUFB)	Work in Munich was supported by the University of Munich and grants from Deutsche Forschungsgemeinschaft (DFG) 1100/6-2 to MB. Work in Bordeaux was supported by the Agence Nationale de la Recherche (ANR) through grants ACETOTRYP of the ANR-BLANC-2010 call to FB and PM; FB is also supported by the Centre National de la Recherche Scientifique (CNRS), the Universite of Bordeaux, and the Laboratoire d'Excellence (LabEx) ParaFrap ANR-11-LABX-0024. MB and FB have been supported by a research cooperation grant of the Franco-Bavarian University Cooperation Center (BFHZ/CCUFB). DFG: http://www.dfg.de. ANR: http://www.agence-nationale-recherche.fr/. CNRS: http://www.cnrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta H, 2004, COMP BIOCHEM PHYS B, V138, P347, DOI 10.1016/j.cbpc.2004.04.017; Allmann S, 2013, J BIOL CHEM; Azema L, 2004, BIOCHEM PHARMACOL, V67, P459, DOI 10.1016/j.bcp.2003.09.005; BERMAN JD, 1987, J PARASITOL, V73, P555, DOI 10.2307/3282136; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; BLUM JJ, 1990, J PROTOZOOL, V37, P505, DOI 10.1111/j.1550-7408.1990.tb01256.x; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; BRUN R, 1979, ACTA TROP, V36, P289; CABIB E, 1973, ANN NY ACAD SCI, V210, P192, DOI 10.1111/j.1749-6632.1973.tb47572.x; Charron AJ, 2002, J CELL SCI, V115, P3049; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; Ebikeme CE, 2008, PARASITOLOGY, V135, P585, DOI 10.1017/S0031182008004241; Flaspohler JA, 2010, EUKARYOT CELL, V9, P1702, DOI 10.1128/EC.00106-10; FlorinChristensen M, 1997, MOL BIOCHEM PARASIT, V88, P25, DOI 10.1016/S0166-6851(97)00056-X; Fridberg A, 2008, J CELL SCI, V121, P522, DOI 10.1242/jcs.016741; Gassen A, 2012, NUCLEIC ACIDS RES, V40, P10302, DOI 10.1093/nar/gks801; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Igal RA, 1998, J LIPID RES, V39, P31; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Igoillo-Esteve M, 2011, INT J PARASITOL, V41, P429, DOI 10.1016/j.ijpara.2010.11.002; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalo P, 2009, LIPIDS, V44, P169, DOI 10.1007/s11745-008-3247-5; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; LEBER R, 1995, BBA-BIOMEMBRANES, V1234, P119, DOI 10.1016/0005-2736(94)00270-Y; Liniger M, 2003, INT J PARASITOL, V33, P1319, DOI 10.1016/S0020-7519(03)00182-6; Listenberger LL, 2007, CURRENT PROTOCOLS CE, V35; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Quittnat F, 2004, MOL BIOCHEM PARASIT, V138, P107, DOI 10.1016/j.molbiopara.2004.08.004; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Rotureau B., 2013, CELL MICROBIOL; Rotureau B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00053; STEIGER R F, 1973, Acta Tropica, V30, P64; VAKIRTZI.C, 1972, CAN J BIOCHEM CELL B, V50, P501, DOI 10.1139/o72-068; Venkatesan R, 2013, ACS CHEM BIOL, V8, P1063, DOI 10.1021/cb400007k; VOORHEIS HP, 1980, MOL BIOCHEM PARASIT, V1, P177, DOI 10.1016/0166-6851(80)90016-X; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P311, DOI 10.1007/BF01799383; Wiemer EAC, 1996, MOL BIOCHEM PARASIT, V82, P107, DOI 10.1016/0166-6851(96)02710-7; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; ZOMER AWM, 1995, BBA-LIPID LIPID MET, V1257, P167, DOI 10.1016/0005-2760(95)00066-L	55	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114628	10.1371/journal.pone.0114628	http://dx.doi.org/10.1371/journal.pone.0114628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493940	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400062
J	Lever, M; George, PM; Slow, S; Bellamy, D; Young, JM; Ho, M; McEntyre, CJ; Elmslie, JL; Atkinson, W; Molyneux, SL; Troughton, RW; Frampton, CM; Richards, AM; Chambers, ST				Lever, Michael; George, Peter M.; Slow, Sandy; Bellamy, David; Young, Joanna M.; Ho, Markus; McEntyre, Christopher J.; Elmslie, Jane L.; Atkinson, Wendy; Molyneux, Sarah L.; Troughton, Richard W.; Frampton, Christopher M.; Richards, A. Mark; Chambers, Stephen T.			Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study	PLOS ONE			English	Article							GLYCINE BETAINE; URINE BETAINE; RENAL-DISEASE; PLASMA; HOMOCYSTEINE; ACCUMULATION; DERIVATIVES; METABOLISM; OSMOLYTES; CHOLINE	Background: Betaine is a major osmolyte, also important in methyl group metabolism. Concentrations of betaine, its metabolite dimethylglycine and analog trimethylamine-N-oxide (TMAO) in blood are cardiovascular risk markers. Diabetes disturbs betaine: does diabetes alter associations between betaine-related measures and cardiovascular risk? Methods: Plasma samples were collected from 475 subjects four months after discharge following an acute coronary admission. Death (n=81), secondary acute MI (n=87), admission for heart failure (n=85), unstable angina (n=72) and all cardiovascular events (n=283) were recorded (median follow-up: 1804 days). Results: High and low metabolite concentrations were defined as top or bottom quintile of the total cohort. In subjects with diabetes (n=79), high plasma betaine was associated with increased frequencies of events; significantly for heart failure, hazard ratio 3.1 (1.2-8.2) and all cardiovascular events, HR 2.8 (1.4-5.5). In subjects without diabetes (n=396), low plasma betaine was associated with events; significantly for secondary myocardial infarction, HR 2.1 (1.2-3.6), unstable angina, HR 2.3 (1.3-4.0), and all cardiovascular events, HR 1.4 (1.0-1.9). In diabetes, high TMAO was a marker of all outcomes, HR 2.7 (1.1-7.1) for death, 4.0 (1.6-9.8) for myocardial infarction, 4.6 (2.0-10.7) for heart failure, 9.1 (2.8-29.7) for unstable angina and 2.0 (1.1-3.6) for all cardiovascular events. In subjects without diabetes TMAO was only significant for death, HR 2.7 (1.6-4.8) and heart failure, HR 1.9 (1.1-3.4). Adding the estimated glomerular filtration rate to Cox regression models tended to increase the apparent risks associated with low betaine. Conclusions: Elevated plasma betaine concentration is a marker of cardiovascular risk in diabetes; conversely low plasma betaine concentrations indicate increased risk in the absence of diabetes. We speculate that the difference reflects control of osmolyte retention in tissues. Elevated plasma TMAO is a strong risk marker in diabetes.	[Lever, Michael; George, Peter M.; Slow, Sandy; Bellamy, David; Ho, Markus; McEntyre, Christopher J.; Elmslie, Jane L.; Atkinson, Wendy; Molyneux, Sarah L.] Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand; [Lever, Michael; George, Peter M.; Slow, Sandy; Chambers, Stephen T.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Young, Joanna M.; Frampton, Christopher M.; Richards, A. Mark] Univ Otago, Christchurch Heart Inst, Dept Med, Christchurch, New Zealand	Canterbury Health Laboratories; University of Otago; University of Otago	Lever, M (corresponding author), Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand.	michael.lever@otago.ac.nz	George, Peter M/A-1315-2013; Young, Joanna/ABE-5495-2020	George, Peter M/0000-0001-9100-3466; Molyneux, Sarah/0000-0001-6816-5619; Chambers, Stephen/0000-0002-0698-3285; Troughton, Richard/0000-0001-7484-4036	Heart Foundation of New Zealand [1090]; Maurice and Phyllis Paykel Trust; Health Research Council of New Zealand [02/152]	Heart Foundation of New Zealand; Maurice and Phyllis Paykel Trust; Health Research Council of New Zealand(Health Research Council of New Zealand)	Support from the Heart Foundation of New Zealand (grant 1090) and the Maurice and Phyllis Paykel Trust are acknowledged. The parent CDCS study was funded by the Health Research Council of New Zealand (Programme 02/152). These funding bodies had no role in the conduct of the research or its interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Atkinson W, 2009, NUTR METAB CARDIOVAS, V19, P767, DOI 10.1016/j.numecd.2009.01.004; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; BELL JD, 1991, BIOCHIM BIOPHYS ACTA, V1096, P101, DOI 10.1016/0925-4439(91)90046-C; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Dellow WJ, 1999, DIABETES RES CLIN PR, V43, P91, DOI 10.1016/S0168-8227(98)00115-6; Eisert R, 2005, MAR ECOL PROG SER, V300, P213, DOI 10.3354/meps300213; Ellis KL, 2011, J MOL CELL CARDIOL, V50, P695, DOI 10.1016/j.yjmcc.2011.01.010; Herrmann W, 2007, CURR DRUG METAB, V8, P17, DOI 10.2174/138920007779315008; Hoffmann L, 2013, AM J PHYSIOL-GASTR L, V304, pG835, DOI 10.1152/ajpgi.00332.2012; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; LEVER M, 1994, CLIN CHIM ACTA, V230, P69, DOI 10.1016/0009-8981(94)90090-6; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; Lever M, 2007, CLIN BIOCHEM, V40, P447, DOI 10.1016/j.clinbiochem.2006.10.029; Lever M, 2012, CLIN CHEM LAB MED, V50, P1635, DOI [10.1515/cclm-2017-9910, 10.1515/cclm-2011-0844]; Lever M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-34; Lever M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037883; Lever M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021666; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lever M, 2009, CLIN BIOCHEM, V42, P706, DOI 10.1016/j.clinbiochem.2009.02.001; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Mackay Richard J, 2011, Clin Biochem Rev, V32, P33; McGregor DO, 2001, KIDNEY INT, V59, P2267, DOI 10.1046/j.1523-1755.2001.00743.x; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Schartum-Hansen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069454; Schwab U, 2006, J NUTR, V136, P34, DOI 10.1093/jn/136.1.34; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Storer MK, 2006, J CHROMATOGR A, V1104, P263, DOI 10.1016/j.chroma.2005.11.123; Storer MK, 2006, ANAL CHIM ACTA, V558, P319, DOI 10.1016/j.aca.2005.10.060; Tveitevag Svingen GF, 2013, ARTERIOSCL THROM VAS, V33, P2041, DOI 10.1161/ATVBAHA.113.301714; Ueland PM, 2007, CLIN CHEM, V53, P807, DOI 10.1373/clinchem.2007.085480; Ueland PM, 2005, CLIN CHEM LAB MED, V43, P1069, DOI 10.1515/CCLM.2005.187; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wettstein M, 2000, AM J PHYSIOL-GASTR L, V278, pG227, DOI 10.1152/ajpgi.2000.278.2.G227	41	163	168	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114969	10.1371/journal.pone.0114969	http://dx.doi.org/10.1371/journal.pone.0114969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493436	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400087
J	Schmickl, T; Karsai, I				Schmickl, Thomas; Karsai, Istvan			Sting, Carry and Stock: How Corpse Availability Can Regulate De-Centralized Task Allocation in a Ponerine Ant Colony	PLOS ONE			English	Article							DIVISION-OF-LABOR; NEST CONSTRUCTION BEHAVIOR; HONEY-BEES; SELF-ORGANIZATION; MODEL; WORK; RECRUITMENT; OPTIMIZATION; HYMENOPTERA; POLYETHISM	We develop a model to produce plausible patterns of task partitioning in the ponerine ant Ectatomma ruidum based on the availability of living prey and prey corpses. The model is based on the organizational capabilities of a "common stomach'' through which the colony utilizes the availability of a natural (food) substance as a major communication channel to regulate the income and expenditure of the very same substance. This communication channel has also a central role in regulating task partitioning of collective hunting behavior in a supply & demand-driven manner. Our model shows that task partitioning of the collective hunting behavior in E. ruidum can be explained by regulation due to a common stomach system. The saturation of the common stomach provides accessible information to individual ants so that they can adjust their hunting behavior accordingly by engaging in or by abandoning from stinging or transporting tasks. The common stomach is able to establish and to keep stabilized an effective mix of workforce to exploit the prey population and to transport food into the nest. This system is also able to react to external perturbations in a de-centralized homeostatic way, such as to changes in the prey density or to accumulation of food in the nest. In case of stable conditions the system develops towards an equilibrium concerning colony size and prey density. Our model shows that organization of work through a common stomach system can allow Ectatomma ruidum to collectively forage for food in a robust, reactive and reliable way. The model is compared to previously published models that followed a different modeling approach. Based on our model analysis we also suggest a series of experiments for which our model gives plausible predictions. These predictions are used to formulate a set of testable hypotheses that should be investigated empirically in future experimentation.	[Schmickl, Thomas] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Karsai, Istvan] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	University of Graz; East Tennessee State University	Karsai, I (corresponding author), E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	karsai@etsu.edu		Schmickl, Thomas/0000-0001-8598-7462	European Union [270382]; EU-FET [601074]; FWF (Austrian Science Fund) [P23943-N13]; East Tennessee State University [RDC 12-005M]	European Union(European Commission); EU-FET; FWF (Austrian Science Fund)(Austrian Science Fund (FWF)); East Tennessee State University	TS is supported by the following grants: European Union-Information and Communication Technologies projects EU-ICT 'CoCoRo', no. 270382 and EU-FET 'ASSISI_bf', no. 601074 (http://cordis.europa.eu/fp7/ict/); FWF (Austrian Science Fund) 'REBODIMENT', no. P23943-N13 (http://www.fwf.ac.at/en/). IK was supported by East Tennessee State University Research Development Grant no. RDC 12-005M (http://www.etsu.edu/research/rdc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBOGBA C, 1992, INSECT SOC, V39, P455, DOI 10.1007/BF01240629; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Anderson C, 2001, ANIM BEHAV, V62, P634; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Bonabeau E, 1998, B MATH BIOL, V60, P753, DOI 10.1006/bulm.1998.0041; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; BREED MD, 1990, OECOLOGIA, V84, P117, DOI 10.1007/BF00665604; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Cassill DL, 1999, BEHAV ECOL SOCIOBIOL, V45, P301, DOI 10.1007/s002650050565; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Dechaume-Moncharmont FX, 2005, P ROY SOC B-BIOL SCI, V272, P1689, DOI 10.1098/rspb.2005.3137; DEJEAN A, 1987, SOCIOBIOLOGY, V13, P119; DEJEAN A, 1993, J ETHOL, V11, P43, DOI 10.1007/BF02350005; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Detrain C, 2002, BIOL BULL, V202, P286; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; EBERLEIN RL, 1992, EUR J OPER RES, V59, P216, DOI 10.1016/0377-2217(92)90018-5; Forrester J.W., 1961, IND DYNAMICS; Forrester J.W., 1969, URBAN DYNAMICS; Forrester J. W., 1973, WORLD DYNAMICS; Forrester JW., 1968, PRINCIPLES SYSTEMS; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gordon DM, 2002, COMPLEXITY, V8, P43, DOI [10.1002/cplx.10048, DOI 10.1002/CPLX.10048]; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Hamann H, 2013, B MATH BIOL, V75, P1181, DOI 10.1007/s11538-013-9851-4; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Jeanne RL, 1996, ANIM BEHAV, V52, P473, DOI 10.1006/anbe.1996.0191; Jeanson R, 2007, BEHAV ECOL SOCIOBIOL, V62, P289, DOI 10.1007/s00265-007-0464-5; Johnson BR, 2008, NATURWISSENSCHAFTEN, V95, P523, DOI 10.1007/s00114-008-0354-3; Johnson BR, 2009, AM NAT, V174, P537, DOI 10.1086/605373; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 1998, P NATL ACAD SCI USA, V95, P8665, DOI 10.1073/pnas.95.15.8665; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; Karsai I, 2011, ECOL MODEL, V222, P447, DOI 10.1016/j.ecolmodel.2010.11.002; Labella TH, 2006, ACM T AUTON ADAP SYS, V1, P4, DOI 10.1145/1152934.1152936; Lachaud J.-P., 1990, Actes des Colloques Insectes Sociaux, V6, P151; Lachaud J.-P., 1987, Experientia Supplementum (Basel), V54, P197; Lachaud J. P., 1984, FOLIA ENTOMOL MEX, V61, P159; Lachaud J.-P., 1990, FOLIA ENTOMOL GICA M, V78, P241; LACHAUD JP, 1985, SOCIOBIOLOGY, V11, P133; LACHAUD JP, 1994, ENTOMOL EXP APPL, V72, P145, DOI 10.1007/BF02383549; Oster G.F., 1978, Monographs in Population Biology, pi; Plowright R.C., 1988, P419; PRATT SC, 1989, ETHOLOGY, V81, P313; Ratnieks FLW, 1999, INSECT SOC, V46, P95, DOI 10.1007/s000400050119; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; Schatz B, 1998, ACT COLLOQ INSECT S, V12, P19; Schatz B, 1999, SOCIOBIOLOGY, V34, P605; Schatz B, 1997, BEHAV ECOL SOCIOBIOL, V40, P337, DOI 10.1007/s002650050350; Schatz B, 1996, INSECT SOC, V43, P111, DOI 10.1007/BF01242563; SCHATZ B, 1995, SOCIOBIOLOGY, V26, P269; Schmickl T, 2008, AUTON ROBOT, V25, P171, DOI 10.1007/s10514-007-9073-4; Schmickl T, 2008, MATH COMP MODEL DYN, V14, P101, DOI 10.1080/13873950701846662; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Schmickl T, 2008, ARTIF LIFE, VXI, P529; Schmickl T, 2008, LECT NOTES ARTIF INT, V5040, P383; Schmickl T, 2007, LECT NOTES COMPUT SC, V4433, P144; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; Schmickl T, 2009, ROBOT AUTON SYST, V57, P913, DOI 10.1016/j.robot.2009.06.002; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Stein W., 2005, SIGSAM Bulletin, V39, P61, DOI 10.1145/1101884.1101889; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Sumpter DJT, 2003, BEHAV ECOL SOCIOBIOL, V53, P131, DOI 10.1007/s00265-002-0549-0; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Thenius R, 2005, LECT NOTES ARTIF INT, V3690, P246; Thenius R, 2008, CONNECT SCI, V20, P193, DOI 10.1080/09540090802091982; Thenius R, 2006, LECT NOTES COMPUT SC, V4095, P725; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Theraulaz G, 2002, J THEOR BIOL, V215, P481, DOI 10.1006/jtbi.2001.2518; TOFTS C, 1993, B MATH BIOL, V55, P891, DOI 10.1007/BF02460691; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Volterra V., 1928, Journal du Conseil Copenhague, P3; Volterra V, 1931, LECONS THEORIE MATH; Wedde HF, 2006, J SYST ARCHITECT, V52, P461, DOI 10.1016/j.sysarc.2006.02.005	88	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114611	10.1371/journal.pone.0114611	http://dx.doi.org/10.1371/journal.pone.0114611			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493558	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400060
J	Bowles, EJ; Schiffner, T; Rosario, M; Needham, GA; Ramaswamy, M; McGouran, J; Kessler, B; LaBranche, C; McMichael, AJ; Montefiori, D; Sattentau, QJ; Hanke, T; Stewart-Jones, GBE				Bowles, Emma J.; Schiffner, Torben; Rosario, Maximillian; Needham, Gemma A.; Ramaswamy, Meghna; McGouran, Joanna; Kessler, Benedikt; LaBranche, Celia; McMichael, Andrew J.; Montefiori, David; Sattentau, Quentin J.; Hanke, Tomas; Stewart-Jones, Guillaume B. E.			Comparison of Neutralizing Antibody Responses Elicited from Highly Diverse Polyvalent Heterotrimeric HIV-1 gp140 Cocktail Immunogens versus a Monovalent Counterpart in Rhesus Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; CONSENSUS ENVELOPE GLYCOPROTEIN; MUCOSAL SHIV CHALLENGE; SUBTYPE-B; POTENT NEUTRALIZATION; POLYANIONIC CARBOMER; MASS-SPECTROMETRY; MONOMERIC GP120	Eliciting neutralizing antibodies capable of inactivating a broad spectrum of HIV-1 strains is a major goal of HIV-1 vaccine design. The challenge is that envelopes (Envs) of circulating viruses are almost certainly different from any Env used in a vaccine. A novel immunogen composed of a highly diverse set of gp140 Envs including subtypes A, B, C, D and F was developed to stimulate a more cross-neutralizing antibody response. Env heterotrimers composed of up to 54 different gp140s were produced with the aim of focusing the response to the conserved regions of Env while reducing the dominance of any individual hypervariable region. Heterotrimeric gp140 Envs of inter-and intra-subtype combinations were shown to bind CD4 and a panel of neutralizing monoclonal antibodies with similar affinity to monovalent UG37 gp140. Macaques immunized with six groups of heterotrimer mixtures showed slightly more potent neutralizing antibody responses in TZM-BL tier 1 and A3R5 tier 2 pseudovirus assays than macaques immunized with monovalent Env gp140, and exhibited a marginally greater focus on the CD4-binding site. Carbopol enhanced neutralization when used as an adjuvant instead of RIBI in combination with UG37 gp140. These data indicate that cross-subtype heterotrimeric gp140 Envs may elicit some improvement of the neutralizing antibody response in macaques compared to monovalent gp140 Env.	[Bowles, Emma J.; Rosario, Maximillian; McMichael, Andrew J.; Hanke, Tomas; Stewart-Jones, Guillaume B. E.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Schiffner, Torben; Needham, Gemma A.; Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Ramaswamy, Meghna] Natl Inst Biol Stand & Controls, Ctr AIDS Reagents, Div Retrovirol, Potters Bar, Herts, England; [McGouran, Joanna; Kessler, Benedikt] Univ Oxford, Nuffield Dept Med, Oxford, England; [LaBranche, Celia; Montefiori, David] Duke Univ, Med Ctr, Div Surg Sci, Durham, NC USA; [Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; University of Oxford; National Institute for Biological Standards & Control; University of Oxford; Duke University; University of Oxford; Jenner Institute	Bowles, EJ (corresponding author), Univ Sheffield, Firth Court, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England.	emma.jones@sheffield.ac.uk; guillaume.stewart-jones@ndm.ox.ac.uk	McGouran, Joanna/A-1545-2019; rosario, maxim/O-6098-2019; Rosario, Max/P-3111-2017; Kessler, Benedikt/AAY-8614-2021	McGouran, Joanna/0000-0002-9349-2141; Kessler, Benedikt/0000-0002-8160-2446; Ramaswamy, Meghna/0000-0003-0333-8544; Hanke, Tomas/0000-0002-6076-9546	UK Medical Research Council; University of Oxford; European Commission [EC-FP7-201433 NGIN]; MRC [G0000635, MR/K012037/1, G1001757] Funding Source: UKRI; Medical Research Council [G0000635, MR/K012037/1, G1001757] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Oxford; European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funding sources supporting this study were the UK Medical Research Council, the University of Oxford, and the European Commission (EC-FP7-201433 NGIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; ANDERSON KP, 1989, J INFECT DIS, V160, P960, DOI 10.1093/infdis/160.6.960; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Azizi A, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-25; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Batycka M, 2006, RAPID COMMUN MASS SP, V20, P2074, DOI 10.1002/rcm.2563; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Cho MW, 2001, J VIROL, V75, P2224, DOI 10.1128/JVI.75.5.2224-2234.2001; Cole KS, 1998, J VIROL, V72, P7852, DOI 10.1128/JVI.72.10.7852-7859.1998; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; Dey AK, 2012, VACCINE, V30, P2749, DOI 10.1016/j.vaccine.2012.02.027; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Edo-Matas D, 2010, VIROLOGY, V405, P492, DOI 10.1016/j.virol.2010.06.029; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Graham BS, 1996, ANN INTERN MED, V125, P270, DOI 10.7326/0003-4819-125-4-199608150-00003; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hurwitz Julia L., 2005, Current Drug Targets - Infectious Disorders, V5, P143, DOI 10.2174/1568005054201517; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kim JH, 2003, AIDS RES HUM RETROV, V19, P807, DOI 10.1089/088922203769232601; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; Lai RPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035083; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Mackeen MM, 2010, J PROTEOME RES, V9, P4082, DOI 10.1021/pr100269b; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Muthumani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084234; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rosario M, 2012, AIDS, V26, P275, DOI 10.1097/QAD.0b013e32834ed9b2; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seaman MS, 2007, VIROLOGY, V367, P175, DOI 10.1016/j.virol.2007.05.024; Sellhorn G, 2012, J VIROL, V86, P128, DOI 10.1128/JVI.06363-11; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wegmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015861; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	76	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114709	10.1371/journal.pone.0114709	http://dx.doi.org/10.1371/journal.pone.0114709			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490553	gold, Green Published, Green Accepted			2022-12-27	WOS:000347515300069
J	Alshbool, FZ; Mohan, S				Alshbool, Fatima Z.; Mohan, Subburaman			Differential Expression of Claudin Family Members during Osteoblast and Osteoclast Differentiation: Cldn-1 Is a Novel Positive Regulator of Osteoblastogenesis	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; EPITHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; COLON-CANCER; STEM-CELLS; BONE; OCCLUDIN; PATHWAY; MOUSE	Claudins (Cldns), a family of 27 transmembrane proteins, represent major components of tight junctions. Aside from functioning as tight junctions, Cldns have emerging roles as regulators of cell proliferation and differentiation. While Cldns are known to be expressed and have important functions in various tissues, their expression and function in bone cells is ill-defined. In this study, the expression of Cldns was examined during osteoblast and osteoclast differentiation. The expression of Cldn-1, -7, -11, and -15 was downregulated during early stages of osteoclast differentiation, whereas Cldn-6 was upregulated. Moreover, the expression of several Cldns increased 3-7 fold in fully differentiated osteoclasts. As for osteoblasts, the expression of several Cldns was found to increase more than 10-fold during differentiation, with some peaking at early, and others at late stages. By contrast, only expression of Cldn-12, and -15 decreased during osteoblast differentiation. In subsequent studies, we focused on the role of Cldn-1 in osteoblasts as its expression was increased by more than 10 fold during osteoblast differentiation and was found to be regulated by multiple osteoregulatory agents including IGF-1 and Wnt3a. We evaluated the consequence of lentiviral shRNA-mediated knockdown of Cldn-1 on osteoblast proliferation and differentiation using MC3T3-E1 mouse osteoblasts. Cldn-1 knockdown caused a significant reduction in MC3T3-E1 cell proliferation and ALP activity. Accordingly, expression levels of cyclinD1 and ALP mRNA levels were reduced in Cldn-1 shRNA knockdown cells. We next determined if Cldn-1 regulates the expression of Runx-2 and osterix, master transcription factors of osteoblast differentiation, and found that their levels were reduced significantly as a consequence of Cldn-1 knockdown. Moreover, knocking down Cldn-1 reduced beta-catenin level. In conclusion, the expression of Cldn family members during bone cell differentiation is complex and involves cell type and differentiation stage-dependent regulation. In addition, Cldn-1 is a positive regulator of osteoblast proliferation and differentiation.	[Alshbool, Fatima Z.; Mohan, Subburaman] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92354 USA; [Alshbool, Fatima Z.] Loma Linda Univ, Dept Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Mohan, S (corresponding author), Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.	Subburaman.Mohan@va.gov			National Institutes of Health [R01-AR031062]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant (R01-AR031062 to SM). They have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuazza G, 2006, AM J PHYSIOL-RENAL, V291, pF1132, DOI 10.1152/ajprenal.00063.2006; Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Alshbool FZ, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.200; Alshbool FZ, 2014, ENDOCRINOLOGY, P1173; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Bhat AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037174; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Breiderhoff T, 2012, P NATL ACAD SCI USA, V109, P14241, DOI 10.1073/pnas.1203834109; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593; Dempster David W, 2011, Am J Manag Care, V17 Suppl 6, pS164; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Fujita H, 2011, J ALLERGY CLIN IMMUN, V127, P1612, DOI 10.1016/j.jaci.2011.03.039; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Govoni KE, 2006, GROWTH HORM IGF RES, V16, P49, DOI 10.1016/j.ghir.2005.10.001; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Hatakeyama N, 2008, CELL TISSUE RES, V334, P243, DOI 10.1007/s00441-008-0690-9; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hong YH, 2005, BIOSCI BIOTECH BIOCH, V69, P2117, DOI 10.1271/bbb.69.2117; Hoshino M, 2008, ORAL DIS, V14, P606, DOI 10.1111/j.1601-0825.2007.01427.x; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Linares GR, 2012, J BONE MINER RES, V27, P1553, DOI 10.1002/jbmr.1600; Linares GR, 2011, AM J PHYSIOL-ENDOC M, V301, pE40, DOI 10.1152/ajpendo.00065.2011; Linares GR, 2009, BONE, V44, P795, DOI 10.1016/j.bone.2009.01.003; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Luo Y, 2011, INVEST OPHTH VIS SCI, V52, P7556, DOI 10.1167/iovs.11-7185; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Pope JL, 2013, GUT; Prele CM, 2003, EXP CELL RES, V282, P24, DOI 10.1006/excr.2002.5668; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; SOARES AMV, 1992, J ANAT, V181, P345; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wang LL, 2012, CELL RES, V22, P1082, DOI 10.1038/cr.2012.77; WEINGER JM, 1974, CALC TISS RES, V14, P15, DOI 10.1007/BF02060280; Wongdee K, 2008, HISTOCHEM CELL BIOL, V130, P79, DOI 10.1007/s00418-008-0419-6; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114357	10.1371/journal.pone.0114357	http://dx.doi.org/10.1371/journal.pone.0114357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479235	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200076
J	Gill, KZ; Iwamoto, F; Allen, A; Hoehn, D; Murty, VV; Alobeid, B; Bhagat, G				Gill, Kamraan Z.; Iwamoto, Fabio; Allen, Ashleigh; Hoehn, Daniela; Murty, Vundavalli V.; Alobeid, Bachir; Bhagat, Govind			MYC Protein Expression in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System	PLOS ONE			English	Article							PRIMARY CNS LYMPHOMA; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; PROGNOSTIC-SIGNIFICANCE; POOR-PROGNOSIS; C-MYC; GENE-EXPRESSION; IMMUNOCOMPETENT INDIVIDUALS; IMMUNOPHENOTYPE MIGHT; BCL6 REARRANGEMENTS; PREDICTS SURVIVAL	Primary diffuse large B-cell lymphoma of the central nervous system (CNS DLBCL) is a rare, aggressive subtype of DLBCL, the biology of which is poorly understood. Recent studies have suggested a prognostic role of MYC protein expression in systemic DLBCL, but little is known about the frequency and significance of MYC protein expression in CNS DLBCL. Hence, we investigated MYC protein expression profiles of CNS DLBCL and assessed the relationship between MYC expression and a variety of histopathologic, immunophenotypic, genetic, and clinical features. Fifty-nine CNS DLBCL diagnosed at our institution over the past 13 years were evaluated. The majority of cases (80%) showed centroblastic morphology, and 12 (20%) displayed a perivascular pattern of infiltration. According to the Hans criteria, 41 (69%) cases had a non-germinal center B-cell and 18 (31%) had a germinal center B-cell cell-of-origin (COO) phenotype. Mean MYC protein expression was 50% (median: 50%, range: 10-80%). Forty-three cases (73%) showed MYC overexpression (>= 40%), and 35 (60%) showed MYC/BCL2 coexpression. MYC overexpression was seen in the single case harboring MYC translocation and in the cases showing increased copies of MYC (27%); however, no significant difference in mean MYC expression was seen between groups harboring or lacking MYC aberrations. In our series, age was associated with a significantly increased risk of death, and the perivascular pattern of infiltration was associated with a significantly increased risk of disease progression. Neither MYC expression (with or without BCL2 coexpression) nor other variables, including COO subtype were predictive of clinical outcome. Our findings indicate that the proportion of CNS DLBCL overexpressing MYC is higher compared to systemic DLBCL, and MYC overexpression appears to be independent of genetic MYC abnormalities. Thus, MYC expression and other immunophenotypic markers used for prognostication of systemic DLBCL might not apply to CNS DLBCL due to differences in disease biology.	[Gill, Kamraan Z.; Allen, Ashleigh; Hoehn, Daniela; Murty, Vundavalli V.; Alobeid, Bachir; Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Iwamoto, Fabio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA	Columbia University; Columbia University	Bhagat, G (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	gb96@cumc.columbia.edu	Bhagat, Govind/AAE-9493-2021	Bhagat, Govind/0000-0001-6250-048X	Columbia University Medical Center Department of Pathology and Cell Biology	Columbia University Medical Center Department of Pathology and Cell Biology	This study was funded by intramural funds from the Columbia University Medical Center Department of Pathology and Cell Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Aquino G, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-37; Batchelor TT, 2011, NEUROLOGY, V76, P929, DOI 10.1212/WNL.0b013e31820f2d94; Bellas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098169; Bhagavathi S, 2008, CLIN NEUROPATHOL, V27, P13; Braaten KM, 2003, CLIN CANCER RES, V9, P1063; Braggio E, 2011, CLIN CANCER RES, V17, P4245, DOI 10.1158/1078-0432.CCR-11-0395; Bretones G, 2014, BIOCH BIOPHYS ACTA; Brunn A, 2013, ACTA NEUROPATHOL, V126, P603, DOI 10.1007/s00401-013-1169-7; Cady FM, 2008, J CLIN ONCOL, V26, P4814, DOI 10.1200/JCO.2008.16.1455; Camilleri-Broet S, 2006, BLOOD, V107, P190, DOI 10.1182/blood-2005-03-1024; Chang CC, 2003, ARCH PATHOL LAB MED, V127, P208; D'Haene N, 2008, BRIT J HAEMATOL, V140, P402, DOI 10.1111/j.1365-2141.2007.06929.x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Deckert M, 2014, ACTA NEUROPATHOL, V127, P175, DOI 10.1007/s00401-013-1202-x; Ferreri AJM, 2003, J CLIN ONCOL, V21, P266, DOI 10.1200/JCO.2003.09.139; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Gabay M, 2014, COLD SPRING HARB PER, V4; Gerstner ER, 2010, ARCH NEUROL-CHICAGO, V67, P291, DOI 10.1001/archneurol.2010.3; Gonzalez-Aguilar A, 2012, CLIN CANCER RES, V18, P5203, DOI 10.1158/1078-0432.CCR-12-0845; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Gregory G, 2013, NEURO-ONCOLOGY, V15, P1068, DOI 10.1093/neuonc/not032; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hattab EM, 2010, MODERN PATHOL, V23, P235, DOI 10.1038/modpathol.2009.164; He MX, 2013, NEURO-ONCOLOGY, V15, P727, DOI 10.1093/neuonc/not012; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; JACKSTADT R, 2014, BIOCH BIOPHYS ACTA, P28669; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Jones L, 2010, J EXP MED, V207, P2581, DOI 10.1084/jem.20091071; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kraan W, 2014, LEUKEMIA, V28, P719, DOI 10.1038/leu.2013.348; Levy O, 2008, CANCER, V112, P151, DOI 10.1002/cncr.23149; Lin CH, 2006, CLIN CANCER RES, V12, P1152, DOI 10.1158/1078-0432.CCR-05-1699; Lin P, 2013, CURR HEMATOL MALIG R, V8, P243, DOI 10.1007/s11899-013-0169-y; Link JM, 2014, BIOCH BIOPHYS ACTA; Lossos C, 2014, BR J HAEMATOL, V165; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Meyer PN, 2011, J CLIN ONCOL, V29, P200, DOI 10.1200/JCO.2010.30.0368; Momota H, 2010, J NEURO-ONCOL, V98, P341, DOI 10.1007/s11060-009-0078-z; Montesinos-Rongen M, 2008, LEUKEMIA, V22, P400, DOI 10.1038/sj.leu.2405019; Montesinos-Rongen M, 2004, BLOOD, V103, P1869, DOI 10.1182/blood-2003-05-1465; Montesinos-Rongen M, 2010, ACTA NEUROPATHOL, V120, P529, DOI 10.1007/s00401-010-0709-7; Nozaki M, 1998, ACTA NEUROPATHOL, V95, P505, DOI 10.1007/s004010050831; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Panageas KS, 2005, CANCER-AM CANCER SOC, V104, P2466, DOI 10.1002/cncr.21481; Perry AM, 2014, BRIT J HAEMATOL, V165, P382, DOI 10.1111/bjh.12763; Ponzoni M, 2007, BRIT J HAEMATOL, V138, P316, DOI 10.1111/j.1365-2141.2007.06661.x; Psathas JN, 2014, COLD SPRING HARB PER; Raoux D, 2010, NEUROPATHOLOGY, V30, P232, DOI 10.1111/j.1440-1789.2009.01074.x; Rubenstein JL, 2013, J CLIN ONCOL, V31, P3061, DOI 10.1200/JCO.2012.46.9957; Rubenstein JL, 2006, BLOOD, V107, P3716, DOI 10.1182/blood-2005-03-0897; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Santisteban M, 2007, CLIN TRANSL ONCOL, V9, P465, DOI 10.1007/s12094-007-0086-4; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Shaffer LG, 2009, ISCN INT SYSTEM HUMA, P6; Song MK, 2011, J NEURO-ONCOL, V104, P825, DOI 10.1007/s11060-011-0555-z; Sugita Y, 2007, J NEURO-ONCOL, V82, P249, DOI 10.1007/s11060-006-9281-3; Sung CO, 2011, BLOOD, V117, P1291, DOI 10.1182/blood-2010-07-297861; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takeuchi H, 2007, J NEURO-ONCOL, V84, P141, DOI 10.1007/s11060-007-9363-x; Tzankov A, 2013, MOD PATHOL; Weber T, 2000, BRAIN PATHOL, V10, P73; Wong ET, 2005, NEUROLOGY, V64, P934, DOI 10.1212/WNL.64.5.934	63	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114398	10.1371/journal.pone.0114398	http://dx.doi.org/10.1371/journal.pone.0114398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479599	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200082
J	Sun, J; Sun, K; Chen, S; Yao, LP; Zhang, YQ				Sun, Jing; Sun, Kun; Chen, Sun; Yao, Liping; Zhang, Yuqi			A New Scoring System for Spontaneous Closure Prediction of Perimembranous Ventricular Septal Defects in Children	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; DOPPLER-ECHOCARDIOGRAPHY; ANEURYSM; QUANTITATION; CHILDHOOD; RISK	Background: Perimembranous ventricular septal defect (PMVSD) is a congenital heart aberration, which is surgically treated by patch or device closure, but also can heal without operation as spontaneous closure (SC). Methods: We analyzed data from 1873 PMVSD patients admitted to our hospital during September 2001 and December 2009, in order to establish a Cox regression model for PMVSD SC probability prediction (derivative cohort). Initial contact age, ventricular septal defect (VSD) diameter, shunt flow, aneurysmal tissue of the ventricular membranous septum (ATVMS) development, associated complications, and left ventricular end-diastolic dimension (LVDD) were analyzed for correlations with SC. The derived scoring system based on the coefficients of the model was developed and applied to another cohort with 382 PMVSD patients to evaluate the validity for SC probability forecast (validation cohort). Results: Multivariate Cox regression analysis revealed that SC of PMVSD was associated with age at first contact, defect size, diffuse shunt flow, ATVMS formation, associated complication, as well as increased LVDD, which were used to establish a new scoring system. The area under the receiver operating characteristic (ROC) curve of our predictive scaling was 0.831 (95% CI 0.804-.0858, p<0.001) in the derivative cohort. The scoring system also accurately predicted SC with an area under the ROC curve of 0.863 (95% CI 0.785-0.941, p<0.001) in the validation cohort. Conclusion: Our scoring system using factors affecting SC can predict the probability of SC in PMVSD patients.	[Sun, Jing; Sun, Kun; Chen, Sun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Pediat Heart Ctr, Shanghai 200092, Peoples R China; [Yao, Liping] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Echocardiog, Shanghai 200092, Peoples R China; [Zhang, Yuqi] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat Cardiol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Pediat Heart Ctr, Shanghai 200092, Peoples R China.	sunkun@xinhuamed.com.cn			National Basic Research Program of China [2010CB529501]; National Natural Science Foundation of China [81070134/30772349]; Shanghai Municipal Health Bureau [2013ZYJB0016]; Shanghai Science and Technology Committee [12JC1406600]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	We acknowledge financial support provided by a grant from the National Basic Research Program of China (2010CB529501), the grants from the National Natural Science Foundation of China (81070134/30772349), a grant from Shanghai Municipal Health Bureau (2013ZYJB0016), and the major key project for fundamental research from Shanghai Science and Technology Committee (12JC1406600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butera Gianfranco, 2006, Expert Rev Cardiovasc Ther, V4, P671, DOI 10.1586/14779072.4.5.671; Demirag M Kemal, 2003, Asian Cardiovasc Thorac Ann, V11, P213; Deng HY, 2006, ZHONG GUO LIN CHUANG, V17, P301; Eroglu AG, 2003, PEDIATR CARDIOL, V24, P31, DOI 10.1007/s00246-002-1345-3; FREEDOM RM, 1974, CIRCULATION, V49, P375, DOI 10.1161/01.CIR.49.2.375; Gabriel HM, 2002, J AM COLL CARDIOL, V39, P1066, DOI 10.1016/S0735-1097(02)01706-0; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; IGNASZEWSKI AP, 1994, CAN J CARDIOL, V10, P67; King, 1999, Curr Treat Options Cardiovasc Med, V1, P311, DOI 10.1007/s11936-999-0026-4; Lin MH, 2001, J FORMOS MED ASSOC, V100, P539; Minette MS, 2006, CIRCULATION, V114, P2190, DOI 10.1161/CIRCULATIONAHA.106.618124; Miyake T, 2004, PEDIATR INT, V46, P135, DOI 10.1046/j.1442-200x.2004.01858.x; Mo X, 2001, JIANGSU MED J, V27, P81; NUGENT EW, 1977, CIRCULATION, V56, P82; OMOTO R, 1984, JPN HEART J, V25, P325; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sciomer S, 2007, PULM PHARMACOL THER, V20, P135, DOI 10.1016/j.pupt.2006.03.008; SHIRALI GS, 1995, AM HEART J, V130, P1228, DOI 10.1016/0002-8703(95)90147-7; SOTO B, 1980, BRIT HEART J, V43, P332; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; VANDENHEUVEL F, 1995, BRIT HEART J, V73, P49; Welton MG, 2001, PROGR PEDIAT CARDIOL, V14, P125; Wu MH, 2006, PEDIATRICS, V117, pE262, DOI 10.1542/peds.2005-1255; Zhao QM, 2013, ACTA PAEDIATR, V102, P397, DOI 10.1111/apa.12170; Zhuang J, 1999, Zhonghua Wai Ke Za Zhi, V37, P241	26	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113822	10.1371/journal.pone.0113822	http://dx.doi.org/10.1371/journal.pone.0113822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479616	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200032
J	Thomas, SM; Jeyaraman, M; Hodge, WG; Hutnik, C; Costella, J; Malvankar-Mehta, MS				Thomas, Sera-Melisa; Jeyaraman, Maya; Hodge, William G.; Hutnik, Cindy; Costella, John; Malvankar-Mehta, Monali S.			The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TELE-OPHTHALMOLOGY; INTRAOCULAR-PRESSURE; OPTIC-NERVE; TELEMEDICINE; QUALITY; TELEOPHTHALMOLOGY; HEALTH; TRANSMISSION; IMAGES; CARE	Background: Glaucoma is the leading cause of irreversible visual impairment in the world affecting 60.5 million people worldwide in 2010, which is expected to increase to approximately 79.6 million by 2020. Therefore, glaucoma screening is important to detect, diagnose, and treat patients at the earlier stages to prevent disease progression and vision loss. Teleglaucoma uses stereoscopic digital imaging to take ocular images, which are transmitted electronically to an ocular specialist. The purpose is to synthesize literature to evaluate teleglaucoma, its diagnostic accuracy, healthcare system benefits, and cost-effectiveness. Methods: A systematic search was conducted to help locate published and unpublished studies. Studies which evaluate teleglaucoma as a screening device for glaucoma were included. A meta-analysis was conducted to provide estimates of diagnostic accuracy, diagnostic odds ratio, and the relative percentage of glaucoma cases detected. The improvements to healthcare service quality and cost data were assessed. Results: Of 11237 studies reviewed, 45 were included. Our results indicated that, teleglaucoma is more specific and less sensitive than in-person examination. The pooled estimates of sensitivity was 0.832 [95% CI 0.770, 0.881] and specificity was 0.790 [95% CI 0.668, 0.876]. The relative odds of a positive screen test in glaucoma cases are 18.7 times more likely than a negative screen test in a non-glaucoma cases. Additionally, the mean cost for every case of glaucoma detected was $1098.67 US and of teleglaucoma per patient screened was $922.77 US. Conclusion: Teleglaucoma can accurately discriminate between screen test results with greater odds for positive cases. It detects more cases of glaucoma than in-person examination. Both patients and the healthcare systems benefit from early detection, reduction in wait and travel times, increased specialist referral rates, and cost savings. Teleglaucoma is an effective screening tool for glaucoma specifically for remote and under-services communities.	[Thomas, Sera-Melisa; Jeyaraman, Maya; Hodge, William G.; Malvankar-Mehta, Monali S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Hodge, William G.; Hutnik, Cindy; Malvankar-Mehta, Monali S.] St Josephs Hlth Care London, Ivey Eye Inst, Dept Ophthalmol, London, ON, Canada; [Costella, John] Univ Western Ontario, Allyn & Betty Taylor Lib, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Thomas, SM (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.	sthoma49@uwo.ca	Costella, John/L-9241-2013	Costella, John/0000-0001-6542-6000				Ahmed Rezwan, 2013, W V Med J, V109, P6; Amin S, 2012, CAN OPHTH SOC ANN M; Anton-Lopez Alfonso, 2011, ARVO Annual Meeting Abstract Search and Program Planner, V2011, P251; Arora S, 2014, TELEMED E-HEALTH, V20, P439, DOI 10.1089/tmj.2013.0241; Bank of America, 2014, FOR CURR EXCH; Bank of Canada, DAIL CURR CONV; Canadian National Institute for the Blind (CNIB) and the Canadian Ophthalmology Society, 2009, COSTS VIS LOSS CAN; Centers for Medicare & Medicaid, 2014, MED BEN POL MAN, V100-04; Centers for Medicare & Medicaid Services, 2014, 901705 ICN CTR MED M; Chen LS, 2004, J TELEMED TELECARE, V10, P337, DOI 10.1258/1357633042602035; Damji K, 2013, CAN OPHTH SOC ANN M; de Bont A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-47; de Mul M, 2004, J TELEMED TELECARE, V10, P331, DOI 10.1258/1357633042602107; Eikelboom RH, 1999, INVEST OPHTHALMOL VI, V40; Fansi A, 2003, INVEST OPHTHALMOL VI, V44SU, P3379; Glaucoma Research Society (GRS) of Canada, 2014, GLAUCOMA; Gonzalez F, 2001, MED INFORM INTERNET, V26, P251, DOI 10.1080/14639230110082424; Gupta SC, 2013, INDIAN J MED RES, V138, P531; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1303, DOI 10.1016/j.jclinepi.2011.04.014; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Hatt S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006129.pub2; Ianchulev T, 2005, CURR EYE RES, V30, P1, DOI 10.1080/02713680490522399; INNOVA Medical Ophthalmics, 2014, VEND QUOT; Jin Andrew J, 2004, Int J Circumpolar Health, V63 Suppl 2, P124; Kassam Faazil, 2013, Middle East Afr J Ophthalmol, V20, P142, DOI 10.4103/0974-9233.110619; Kassam F, 2012, J TELEMED TELECARE, V18, P367, DOI 10.1258/jtt.2012.120313; Khouri AS, 2008, TELEMED J E-HEALTH, V14, P261, DOI 10.1089/tmj.2007.0049; Khouri AS, 2007, J TELEMED TELECARE, V13, P337, DOI 10.1258/135763307782215389; Khurana Mona, 2011, ARVO Annual Meeting Abstract Search and Program Planner, V2011, P4228; Kiage Dan, 2013, Middle East Afr J Ophthalmol, V20, P150, DOI 10.4103/0974-9233.110604; Kumar S, 2007, CLIN EXP OPHTHALMOL, V35, P237, DOI 10.1111/j.1442-9071.2007.01457.x; Kumar S, 2006, CLIN EXP OPHTHALMOL, V34, P666, DOI 10.1111/j.1442-9071.2006.01304.x; Labiris G, 2003, J TELEMED TELECARE, V9, P296, DOI 10.1258/135763303769211337; Li HK, 1999, TELEMED J, V5, P283, DOI 10.1089/107830299312032; Michelson G, 2000, J TELEMED TELECARE, V6, P126, DOI 10.1258/1357633001934410; Mohammadi SF, 2013, J OPHTHALMIC VIS RES, V9, P3; Moyer VA, 2013, ANN INTERN MED, V159, P484, DOI 10.7326/0003-4819-159-6-201309170-00686; Ng Mancho, 2009, J Diabetes Sci Technol, V3, P289; Ocular Health Network, 2014, VEND QUOT; Pasquale Louis R, 2007, Optometry, V78, P657, DOI 10.1016/j.optm.2007.04.101; Paul PG, 2006, TELEMED J E-HEALTH, V12, P571, DOI 10.1089/tmj.2006.12.571; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sebastian MA, 2001, INVEST OPHTHALMOL VI, V42; Shahid K, 2012, TELEMED E-HEALTH, V18, P95, DOI 10.1089/tmj.2011.0067; Sogbesan E, 2010, CAN OPHTH SOC ANN M; Staffieri SE, 2011, CLIN EXP OPHTHALMOL, V39, P760, DOI 10.1111/j.1442-9071.2011.02556.x; Swierk T, 2011, OPHTHALMOLOGE, V108, P342, DOI 10.1007/s00347-010-2253-1; The National Coalition for Vision Health, 2009, ENV SCAN VIS HLTH VI; Topcon Canada Inc, 2014, VEND QUOT; Trikalinos T., 2012, AHRQ PUBLICATION; Tuulonen A, 1999, J GLAUCOMA, V8, P367; Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004; Verma S, 2013, CAN OPHTH SOC ANN M; Wegner A, 2003, ARVO M, V44, P3417; Yogesan K, 1999, J GLAUCOMA, V8, P297; Yogesan K, 2000, J TELEMED TELECARE, V6, P41, DOI 10.1258/1357633001933934; Yogesan K, 2000, J TELEMED TELECARE, V6, P96, DOI 10.1258/1357633001934302	61	75	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113779	10.1371/journal.pone.0113779	http://dx.doi.org/10.1371/journal.pone.0113779			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479593	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907200030
J	Wawrousek, K; Noble, S; Korlach, J; Chen, J; Eckert, C; Yu, JP; Maness, PC				Wawrousek, Karen; Noble, Scott; Korlach, Jonas; Chen, Jin; Eckert, Carrie; Yu, Jianping; Maness, Pin-Ching			Genome Annotation Provides Insight into Carbon Monoxide and Hydrogen Metabolism in Rubrivivax gelatinosus	PLOS ONE			English	Article							FE-ONLY HYDROGENASE; IRON-SULFUR PROTEIN; RHODOSPIRILLUM-RUBRUM; PHYSIOLOGICAL CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATOR; TOLERANT HYDROGENASE; OXIDATION PATHWAY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DEHYDROGENASE	We report here the sequencing and analysis of the genome of the purple non-sulfur photosynthetic bacterium Rubrivivax gelatinosus CBS. This microbe is a model for studies of its carboxydotrophic life style under anaerobic condition, based on its ability to utilize carbon monoxide (CO) as the sole carbon substrate and water as the electron acceptor, yielding CO2 and H-2 as the end products. The CO-oxidation reaction is known to be catalyzed by two enzyme complexes, the CO dehydrogenase and hydrogenase. As expected, analysis of the genome of Rx. gelatinosus CBS reveals the presence of genes encoding both enzyme complexes. The CO-oxidation reaction is CO-inducible, which is consistent with the presence of two putative CO-sensing transcription factors in its genome. Genome analysis also reveals the presence of two additional hydrogenases, an uptake hydrogenase that liberates the electrons in H-2 in support of cell growth, and a regulatory hydrogenase that senses H-2 and relays the signal to a two-component system that ultimately controls synthesis of the uptake hydrogenase. The genome also contains two sets of hydrogenase maturation genes which are known to assemble the catalytic metallocluster of the hydrogenase NiFe active site. Collectively, the genome sequence and analysis information reveals the blueprint of an intricate network of signal transduction pathways and its underlying regulation that enables Rx. gelatinosus CBS to thrive on CO or H-2 in support of cell growth.	[Wawrousek, Karen; Eckert, Carrie; Yu, Jianping; Maness, Pin-Ching] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA; [Noble, Scott] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA; [Chen, Jin] Michigan State Univ, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA	University of Wyoming; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Michigan State University	Maness, PC (corresponding author), Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.	pinching.maness@nrel.gov	; ECKERT, CARRIE/V-8199-2017	Yu, Jianping/0000-0003-0466-3197; Wawrousek, Karen/0000-0002-0764-703X; ECKERT, CARRIE/0000-0003-4201-2926	U.S. Department of Energy Fuel Cell Technologies Office; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG02-91ER20021]; University of Wyoming	U.S. Department of Energy Fuel Cell Technologies Office(United States Department of Energy (DOE)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); University of Wyoming	This work was supported by the U.S. Department of Energy Fuel Cell Technologies Office (to SN, CE, JY, and PCM), Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy award number DE-FG02-91ER20021 (to JC), and the University of Wyoming start-up funds (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1980, BIOCHIM BIOPHYS ACTA, V594, P105, DOI 10.1016/0304-4173(80)90007-5; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288; BONAM D, 1987, J BIOL CHEM, V262, P2980; BONAM D, 1984, J BACTERIOL, V159, P693, DOI 10.1128/JB.159.2.693-699.1984; BONAM D, 1989, J BACTERIOL, V171, P3102, DOI 10.1128/jb.171.6.3102-3107.1989; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CHAMPINE JE, 1987, J BACTERIOL, V169, P4784, DOI 10.1128/jb.169.10.4784-4789.1987; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Elsen S, 2003, J BACTERIOL, V185, P7111, DOI 10.1128/JB.185.24.7111-7119.2003; ENSIGN SA, 1991, J BIOL CHEM, V266, P18395; Forzi L, 2005, FEBS J, V272, P4741, DOI 10.1111/j.1742-4658.2005.04889.x; Fox JD, 1996, J BACTERIOL, V178, P1515, DOI 10.1128/jb.178.6.1515-1524.1996; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; Fritsch J, 2014, J BIOL CHEM, V289, P7982, DOI 10.1074/jbc.M113.544668; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hu PS, 2012, J BACTERIOL, V194, P3262, DOI 10.1128/JB.00515-12; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Kerby RL, 2008, J BACTERIOL, V190, P3336, DOI 10.1128/JB.00033-08; Kerby RL, 2011, J BACTERIOL, V193, P774, DOI 10.1128/JB.00794-10; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kunkel A, 1998, EUR J BIOCHEM, V252, P467, DOI 10.1046/j.1432-1327.1998.2520467.x; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lenz O, 1998, P NATL ACAD SCI USA, V95, P12474, DOI 10.1073/pnas.95.21.12474; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Manes PC, 2001, APPL MICROBIOL BIOT, V57, P751, DOI 10.1007/s00253-001-0828-0; Maness PC, 2005, APPL ENVIRON MICROB, V71, P2870, DOI 10.1128/AEM.71.6.2870-2874.2005; Maness PC, 2002, INT J HYDROGEN ENERG, V27, P1407, DOI 10.1016/S0360-3199(02)00107-6; Maness PC, 2002, APPL ENVIRON MICROB, V68, P2633, DOI 10.1128/AEM.68.6.2633-2636.2002; MANESS PC, 1994, APPL BIOCHEM BIOTECH, V45-6, P395, DOI 10.1007/BF02941814; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Nikolskaya AN, 2002, NUCLEIC ACIDS RES, V30, P2453, DOI 10.1093/nar/30.11.2453; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Pelzmann A, 2009, J BIOL CHEM, V284, P9578, DOI 10.1074/jbc.M805354200; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Singer SW, 2006, BBA-BIOENERGETICS, V1757, P1582, DOI 10.1016/j.bbabio.2006.10.003; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; UFFEN RL, 1983, J BACTERIOL, V155, P956, DOI 10.1128/JB.155.3.956-965.1983; Vanzin G, 2010, APPL ENVIRON MICROB, V76, P3715, DOI 10.1128/AEM.02753-09; Vignais PM, 2005, BIOCHEM SOC T, V33, P28, DOI 10.1042/BST0330028; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Watt RK, 1999, J BACTERIOL, V181, P4554, DOI 10.1128/JB.181.15.4554-4560.1999; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065	62	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114551	10.1371/journal.pone.0114551	http://dx.doi.org/10.1371/journal.pone.0114551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479613	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200100
J	Kobayashi, CAN; Leite, AL; Peres-Buzalaf, C; Carvalho, JG; Whitford, GM; Everett, ET; Siqueira, WL; Buzalaf, MAR				Kobayashi, Claudia A. N.; Leite, Aline L.; Peres-Buzalaf, Camila; Carvalho, Juliane G.; Whitford, Gary M.; Everett, Eric T.; Siqueira, Walter L.; Buzalaf, Marilia A. R.			Bone Response to Fluoride Exposure Is Influenced by Genetics	PLOS ONE			English	Article							OSTEOPOROSIS; RESORPTION; MINERALIZATION; OSTEOBLASTS; METABOLISM; FLUOROSIS; PROTEINS; RATS; MICE	Genetic factors influence the effects of fluoride (F) on amelogenesis and bone homeostasis but the underlying molecular mechanisms remain undefined. A label-free proteomics approach was employed to identify and evaluate changes in bone protein expression in two mouse strains having different susceptibilities to develop dental fluorosis and to alter bone quality. In vivo bone formation and histomorphometry after F intake were also evaluated and related to the proteome. Resistant 129P3/J and susceptible A/J mice were assigned to three groups given low-F food and water containing 0, 10 or 50 ppmF for 8 weeks. Plasma was evaluated for alkaline phosphatase activity. Femurs, tibiae and lumbar vertebrae were evaluated using micro-CT analysis and mineral apposition rate (MAR) was measured in cortical bone. For quantitative proteomic analysis, bone proteins were extracted and analyzed using liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), followed by label-free semi-quantitative differential expression analysis. Alterations in several bone proteins were found among the F treatment groups within each mouse strain and between the strains for each F treatment group (ratio >= 1.5 or <= 0.5; p<0.05). Although F treatment had no significant effects on BMD or bone histomorphometry in either strain, MAR was higher in the 50 ppmF 129P3/J mice than in the 50 ppmF A/J mice treated with 50 ppmF showing that F increased bone formation in a strain-specific manner. Also, F exposure was associated with dose-specific and strain-specific alterations in expression of proteins involved in osteogenesis and osteoclastogenesis. In conclusion, our findings confirm a genetic influence in bone response to F exposure and point to several proteins that may act as targets for the differential F responses in this tissue.	[Kobayashi, Claudia A. N.; Leite, Aline L.; Carvalho, Juliane G.; Buzalaf, Marilia A. R.] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Peres-Buzalaf, Camila] Univ Sagrado Coracao, Ctr Ciencias Saude, Bauru, SP, Brazil; [Whitford, Gary M.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA USA; [Everett, Eric T.] Univ N Carolina, Sch Dent, Carolina Ctr Genome Sci, Dept Pediat Dent, Chapel Hill, NC USA; [Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	Universidade de Sao Paulo; Universidade do Sagrado Coracao; University System of Georgia; Augusta University; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario)	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil.	mbuzalaf@fob.usp.br	Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Siqueira, Walter/ABE-4069-2021; Siqueira, Walter/ABE-8924-2020; Everett, Eric/AAP-4459-2021; Peres-Buzalaf, Camila/C-5109-2012; Leite, Aline/J-9748-2012	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Siqueira, Walter/0000-0003-1921-3658; Leite, Aline/0000-0002-2112-1309	Sao Paulo State Research Support Foundation (FAPESP) [2008/01449-3]; CNPq [302448/2009-8, 476393/2008-6]; CAPES [2485-09-5]; NSERC [371813]; NIDCR of the National Institutes of Health [R01DE018104]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018104] Funding Source: NIH RePORTER	Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIDCR of the National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Sao Paulo State Research Support Foundation (FAPESP) (grant 2008/01449-3), CNPq (grants 302448/2009-8 and 476393/2008-6), CAPES (grant 2485-09-5), NSERC (grant 371813) and the NIDCR of the National Institutes of Health under award (grant R01DE018104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Balena R, 1998, OSTEOPOROSIS INT, V8, P428, DOI 10.1007/s001980050087; Bera TK, 2001, MOL CELL BIOL, V21, P7020, DOI 10.1128/MCB.21.20.7020-7024.2001; Brun LR, 2010, BIOMED PHARMACOTHER, V64, P1, DOI 10.1016/j.biopha.2008.10.009; Carvalho JG, 2009, J DENT RES, V88, P1054, DOI 10.1177/0022034509347249; Cheng PT, 1995, CELL MATER, V5, P271; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; Choubisa S L, 2001, Indian J Environ Health, V43, P177; Darden AG, 1996, J BONE MINER RES, V11, P671; DEQUEKER J, 1993, SCHWEIZ MED WSCHR, V123, P2228; DOMENICUCCI C, 1988, BIOCHEM J, V253, P139, DOI 10.1042/bj2530139; DUNIPACE AJ, 1995, J DENT RES, V74, P358, DOI 10.1177/00220345950740011201; ELLIS EM, 1993, P NATL ACAD SCI USA, V90, P10350, DOI 10.1073/pnas.90.21.10350; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Grobler SR, 2009, OPEN DENT J, V3, P48, DOI 10.2174/1874210600903010048; HALL TJ, 1995, BIOCHEM BIOPH RES CO, V207, P280, DOI 10.1006/bbrc.1995.1184; Hamamura K, 2013, J BONE MINER METAB; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Karaoz E, 2004, BIOL TRACE ELEM RES, V102, P199, DOI 10.1385/BTER:102:1-3:199; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Marom R, 2006, J CELL PHYSIOL, V207, P628, DOI 10.1002/jcp.20611; Mousny M, 2008, BONE, V43, P1067, DOI 10.1016/j.bone.2008.07.248; Mousny M, 2006, BONE, V39, P1283, DOI 10.1016/j.bone.2006.06.006; Moxon L N, 1987, Prog Clin Biol Res, V232, P383; OHTA T, 1995, CALCIFIED TISSUE INT, V56, P390, DOI 10.1007/BF00301608; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P20, DOI 10.1159/000325107; Reginster JY, 1998, ANN INTERN MED, V129, P1, DOI 10.7326/0003-4819-129-1-199807010-00001; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Vaananen K, 2005, ADV DRUG DELIVER REV, V57, P959, DOI 10.1016/j.addr.2004.12.018; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Yan D, 2007, BONE, V41, P1036, DOI 10.1016/j.bone.2007.07.018; Yan D, 2011, CELLS TISSUES ORGANS, V194, P261, DOI 10.1159/000324224	36	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114343	10.1371/journal.pone.0114343	http://dx.doi.org/10.1371/journal.pone.0114343			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501567	Green Published, gold			2022-12-27	WOS:000347146700021
J	Bordier, C; Saraux, C; Viblanc, VA; Gachot-Neveu, H; Beaugey, M; Le Maho, Y; Le Bohec, C				Bordier, Celia; Saraux, Claire; Viblanc, Vincent A.; Gachot-Neveu, Helene; Beaugey, Magali; Le Maho, Yvon; Le Bohec, Celine			Inter-Annual Variability of Fledgling Sex Ratio in King Penguins	PLOS ONE			English	Article							APTENODYTES-PATAGONICUS; BODY CONDITION; EL-NINO; POPULATION-DYNAMICS; NATURAL-SELECTION; CLIMATE; SURVIVAL; REPRODUCTION; BIRDS; IDENTIFICATION	As the number of breeding pairs depends on the adult sex ratio in a monogamous species with biparental care, investigating sex-ratio variability in natural populations is essential to understand population dynamics. Using 10 years of data (20002009) in a seasonally monogamous seabird, the king penguin (Aptenodytes patagonicus), we investigated the annual sex ratio at fledging, and the potential environmental causes for its variation. Over more than 4000 birds, the annual sex ratio at fledging was highly variable (ranging from 44.4% to 58.3% of males), and on average slightly biased towards males (51.6%). Yearly variation in sex-ratio bias was neither related to density within the colony, nor to global or local oceanographic conditions known to affect both the productivity and accessibility of penguin foraging areas. However, rising sea surface temperature coincided with an increase in fledging sex-ratio variability. Fledging sex ratio was also correlated with difference in body condition between male and female fledglings. When more males were produced in a given year, their body condition was higher (and reciprocally), suggesting that parents might adopt a sex-biased allocation strategy depending on yearly environmental conditions and/or that the effect of environmental parameters on chick condition and survival may be sex-dependent. The initial bias in sex ratio observed at the juvenile stage tended to return to 1:1 equilibrium upon first breeding attempts, as would be expected from Fisher's classic theory of offspring sex-ratio variation.	[Bordier, Celia; Saraux, Claire; Viblanc, Vincent A.; Gachot-Neveu, Helene; Beaugey, Magali; Le Maho, Yvon; Le Bohec, Celine] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib 647, Strasbourg, France; [Bordier, Celia; Saraux, Claire; Viblanc, Vincent A.; Gachot-Neveu, Helene; Beaugey, Magali; Le Maho, Yvon; Le Bohec, Celine] CNRS, UMR 7178, LIA BioSensib 647, Strasbourg, France; [Saraux, Claire] AgroParisTech ENGREF, Paris, France; [Saraux, Claire] IFREMER, UMR Ecosyst Marin Exploite 212, Sete, France; [Viblanc, Vincent A.] CNRS, UMR 5175, Equipe Ecol Comportementale, Ctr Ecol Fonct & Evolut, Montpellier, France; [Le Bohec, Celine] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Blindern, Norway	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Oslo	Bordier, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Lab Int Associe LIA BioSensib 647, Strasbourg, France.	celia.bordier@gmail.com	LE BOHEC, CELINE/AAD-3589-2022; saraux, claire/AAX-8709-2020; Viblanc, Vincent Alexandre/A-7455-2014	saraux, claire/0000-0001-5061-4009; Viblanc, Vincent Alexandre/0000-0002-4953-659X; LE BOHEC, Celine/0000-0003-0149-6477	Institut Polaire Francais - Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Marie Curie Intra European Fellowship (European Commission) [235962, FP7-PEOPLE-IEF-2008]; AXA Research Fund	Institut Polaire Francais - Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique); Marie Curie Intra European Fellowship (European Commission)(European CommissionEuropean Commission Joint Research Centre); AXA Research Fund(AXA Research Fund)	This work was supported by the Institut Polaire Francais - Paul-Emile Victor, the Fondation Bettencourt-Schueller, the Fondation des Treilles and the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), grants from the Marie Curie Intra European Fellowship (FP7-PEOPLE-IEF-2008, European Commission; project No 235962) (to C.L.B.) and V.A.V. was supported by a postdoctoral fellowship from the AXA Research Fund during the time of writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JA, 1984, BIOL J LINN SOC, V23, P15, DOI 10.1111/j.1095-8312.1984.tb00802.x; Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bowden RM, 2000, P ROY SOC B-BIOL SCI, V267, P1745, DOI 10.1098/rspb.2000.1205; Bried J, 1999, AUK, V116, P504; BULL J J, 1988, P96; Caswell, 2000, MATRIX POPULATION MO; CHARNOV E L, 1982; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; Descamps Sebastien, 2002, Avian Science, V2, P87; DESER C, 1987, J GEOPHYS RES-OCEANS, V92, P14189, DOI 10.1029/JC092iC13p14189; Dobson FS, 2008, ETHOLOGY, V114, P925, DOI 10.1111/j.1439-0310.2008.01545.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Eichhorn G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1436; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Fahlman A, 2006, POLAR BIOL, V29, P609, DOI 10.1007/s00300-005-0096-z; Fisher RA, 1930, GENETICAL THEORY NAT; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; Froget G, 1998, POLAR BIOL, V20, P409, DOI 10.1007/s003000050322; Gauthier-Clerc M, 2002, MAR ECOL PROG SER, V237, P291, DOI 10.3354/meps237291; Gauthier-Clerc M, 2001, ANIM BEHAV, V62, P661, DOI 10.1006/anbe.2001.1803; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Vargas FH, 2007, BIOL CONSERV, V137, P138, DOI 10.1016/j.biocon.2007.02.005; IPCC, 2013, CARBON OTHER BIOGEOC; Kahn NW, 1998, AUK, V115, P1074; Keddar I, 2013, ETHOLOGY, V119, P389, DOI 10.1111/eth.12076; Keyfitz N, 1971, POPULATION FACTS MET; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Le Bohec C, 2005, ANIM BEHAV, V70, P527, DOI 10.1016/j.anbehav.2004.11.012; Le Bohec C, 2007, J ANIM ECOL, V76, P1149, DOI 10.1111/j.1365-2656.2007.01268.x; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; Lee DE, 2009, J MAMMAL, V90, P1, DOI 10.1644/08-MAMM-A-130.1; Mayr E, 1939, AM NAT, V73, P156, DOI 10.1086/280824; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Moreno J, 1997, AUK, V114, P47, DOI 10.2307/4089064; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nager RG, 2000, BEHAV ECOL SOCIOBIOL, V48, P452, DOI 10.1007/s002650000262; Nesterova AP, 2010, BEHAV ECOL SOCIOBIOL, V64, P1145, DOI 10.1007/s00265-010-0930-3; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Olsson O, 1996, J AVIAN BIOL, V27, P7, DOI 10.2307/3676955; Olsson O, 2002, OECOLOGIA, V132, P509, DOI 10.1007/s00442-002-0985-6; Peron C, 2012, P ROY SOC B-BIOL SCI, V279, P2515, DOI 10.1098/rspb.2011.2705; Pincemy G, 2010, ETHOLOGY, V116, P1210, DOI 10.1111/j.1439-0310.2010.01835.x; Pincemy G, 2009, ANIM BEHAV, V78, P1247, DOI 10.1016/j.anbehav.2009.07.041; Putz K, 1998, ECOLOGY, V79, P1905, DOI 10.2307/176698; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saraux C, 2012, ANIM BEHAV, V84, P675, DOI 10.1016/j.anbehav.2012.06.024; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sheldon BC, 1998, HEREDITY, V80, P397, DOI 10.1046/j.1365-2540.1998.00374.x; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stier A, 2014, FUNCT ECOL, V28, P601, DOI 10.1111/1365-2435.12204; Stonehouse B, 1960, SCI REPT FALKLAND IS, V23, P1; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Velando A, 2002, BEHAV ECOL, V13, P443, DOI 10.1093/beheco/13.4.443; Veran S, 2009, ECOL LETT, V12, P129, DOI 10.1111/j.1461-0248.2008.01268.x; Viblanc VA, 2014, FUNCT ECOL, V28, P621, DOI 10.1111/1365-2435.12212; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	71	4	4	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114052	10.1371/journal.pone.0114052	http://dx.doi.org/10.1371/journal.pone.0114052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493708	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400027
J	Wayne, PM; Gow, BJ; Costa, MD; Peng, CK; Lipsitz, LA; Hausdorff, JM; Davis, RB; Walsh, JN; Lough, M; Novak, V; Yeh, GY; Ahn, AC; Macklin, EA; Manor, B				Wayne, Peter M.; Gow, Brian J.; Costa, Madalena D.; Peng, C. -K.; Lipsitz, Lewis A.; Hausdorff, Jeffrey M.; Davis, Roger B.; Walsh, Jacquelyn N.; Lough, Matthew; Novak, Vera; Yeh, Gloria Y.; Ahn, Andrew C.; Macklin, Eric A.; Manor, Brad			Complexity-Based Measures Inform Effects of Tai Chi Training on Standing Postural Control: Cross-Sectional and Randomized Trial Studies	PLOS ONE			English	Article							OLDER-ADULTS; BALANCE CONTROL; PHYSIOLOGICAL COMPLEXITY; CHALLENGES INHERENT; MULTISCALE ENTROPY; STABILITY LIMITS; OPEN-LOOP; FALLS; COMMUNITY; DYNAMICS	Background: Diminished control of standing balance, traditionally indicated by greater postural sway magnitude and speed, is associated with falls in older adults. Tai Chi (TC) is a multisystem intervention that reduces fall risk, yet its impact on sway measures vary considerably. We hypothesized that TC improves the integrated function of multiple control systems influencing balance, quantifiable by the multi-scale "complexity'' of postural sway fluctuations. Objectives: To evaluate both traditional and complexity-based measures of sway to characterize the short- and potential long-term effects of TC training on postural control and the relationships between sway measures and physical function in healthy older adults. Methods: A cross-sectional comparison of standing postural sway in healthy TC-nalve and TC-expert (24.5 +/- 12 yrs experience) adults. TC-nalve participants then completed a 6-month, two-arm, wait-list randomized clinical trial of TC training.Postural sway was assessed before and after the training during standing on a force-plate with eyes-open (EO) and eyes-closed (EC). Anterior-posterior (AP) and medio-lateral (ML) sway speed, magnitude, and complexity (quantified by multiscale entropy) were calculated. Single- legged standing time and Timed-Up-and- Go tests characterized physical function. Results: At baseline, compared to TC-nalve adults (n=60, age 64.5 +/- 7.5 yrs), TC-experts (n=27, age 62.8 +/- 7.5 yrs) exhibited greater complexity of sway in the AP EC (P=0.023), ML EO (P, 0.001), and ML EC (P, 0.001) conditions. Traditional measures of sway speed and magnitude were not significantly lower among TC-experts. Intention-to-treat analyses indicated no significant effects of short-term TC training; however, increases in AP EC and ML EC complexity amongst those randomized to TC were positively correlated with practice hours (P=0.044, P=0.018). Long- and short-term TC training were positively associated with physical function. Conclusion: Multiscale entropy offers a complementary approach to traditional COP measures for characterizing sway during quiet standing, and may be more sensitive to the effects of TC in healthy adults.	[Wayne, Peter M.; Gow, Brian J.; Walsh, Jacquelyn N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Osher Ctr Integrat Med, Boston, MA 02115 USA; [Costa, Madalena D.; Peng, C. -K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA; [Costa, Madalena D.; Peng, C. -K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02115 USA; [Peng, C. -K.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Lipsitz, Lewis A.; Novak, Vera; Manor, Brad] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02115 USA; [Lipsitz, Lewis A.; Lough, Matthew] Hebrew SeniorLife, Inst Aging Res, Roslindale, MA USA; [Hausdorff, Jeffrey M.] Tel Aviv Med Ctr & Sch Med, Dept Neurol, Movement Disorders Unit, Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Davis, Roger B.; Yeh, Gloria Y.; Ahn, Andrew C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Novak, Vera] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Ahn, Andrew C.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Macklin, Eric A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Hebrew SeniorLife; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wayne, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Osher Ctr Integrat Med, Boston, MA 02115 USA.	pwayne@partners.org	Peng, Chung-Kang/N-1308-2019; Macklin, Eric A/E-2955-2013	Peng, Chung-Kang/0000-0003-3666-9833; Macklin, Eric A/0000-0003-1618-3502; Gow, Brian/0000-0002-7682-1943	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) [R21 AT005501-01A1]; Harvard Clinical and Translational Science Center, from the National Center for Research Resourses (NCRR) [UL1 RR025758]; National Institute on Aging (NIA) [R37-AG25037]; NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5R21-DK-084463-02]; National Institutes of Health (NIH)-National Institute on Aging (NIA) [1R01-AG-0287601-A2]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Institutes of Health Award) [8UL1TR000170-05]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (Harvard University); Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R21AT005501] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041785, R00AG030677, R01AG025037] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Harvard Clinical and Translational Science Center, from the National Center for Research Resourses (NCRR); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)-National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Institutes of Health Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (Harvard University); Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by grant number R21 AT005501-01A1 from the National Center for Complementary and Alternative Medicine (NCCAM: http://nccam.nih.gov/) at the National Institutes of Health (NIH: http://www.nih.gov/), and from grant number UL1 RR025758 supporting the Harvard Clinical and Translational Science Center, from the National Center for Research Resourses (NCRR: http://www.nih.gov/about/almanac/organization/NCRR.htm). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, NCRR, or the NIH. Dr. Lipsitz was supported by grant R37-AG25037 from the National Institute on Aging (NIA: http://www.nia. nih.gov/) and the Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife. Dr. Novak has received grants from the NIH-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: http://www.niddk.nih. gov/) (5R21-DK-084463-02) and the National Institutes of Health (NIH)-National Institute on Aging (NIA: http://www.nia.nih.gov/) (1R01-AG-0287601-A2) unrelated to this study. The work in the SAFE lab was conducted with support from Harvard Catalyst (http://catalyst.harvard.edu/) vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner T., 2006, MEASUREMENT EVALUATI, V8th ed.; Burgener SC, 2008, AM J ALZHEIMERS DIS, V23, P382, DOI 10.1177/1533317508317527; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen YS, 2011, ARCH PHYS MED REHAB, V92, P886, DOI 10.1016/j.apmr.2010.12.043; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Fischer M, 2014, USE PRAGMAT IN PRESS, V21; Gatts Strawberry, 2008, V52, P87, DOI 10.1159/000134289; Gillespie L. D., 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146; Guan HW, 2011, AM J CHINESE MED, V39, P251, DOI 10.1142/S0192415X11008798; Gyllensten AL, 2010, ARCH PHYS MED REHAB, V91, P215, DOI 10.1016/j.apmr.2009.10.009; Hakim RM, 2010, PHYS OCCUP THER GERI, V28, P63, DOI 10.3109/02703181003605861; Harmer PeterA., 2008, V52, P124, DOI 10.1159/000134293; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; HEIL DP, 1995, MED SCI SPORT EXER, V27, P599; Hong YL, 2000, BRIT J SPORT MED, V34, P29, DOI 10.1136/bjsm.34.1.29; JACKSON AS, 1995, MED SCI SPORT EXER, V27, P113; Jacobson BH, 1997, PERCEPT MOTOR SKILL, V84, P27, DOI 10.2466/pms.1997.84.1.27; JUDGE JO, 1993, PHYS THER, V73, P254, DOI 10.1093/ptj/73.4.254; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Lan C, 1998, MED SCI SPORT EXER, V30, P345, DOI 10.1097/00005768-199803000-00003; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Li L, 2010, AM J CHINESE MED, V38, P113, DOI 10.1142/S0192415X10007701; Lima BN, 2014, J SPORT SCI MED, V13, P564; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Liu H, 2010, J GERIATR PHYS THER, V33, P103, DOI 10.1097/JPT.0b013e3181eda1c4; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Manor B, 2014, J AM GERIAT IN PRESS; Manor B, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-87; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Manson J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-114; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; Pluchino A, 2012, ARCH PHYS MED REHAB, V93, P1138, DOI 10.1016/j.apmr.2012.01.023; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Rubenstein LZ, 2001, ANN INTERN MED, V135, P686, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00007; Sattin RW, 2005, J AM GERIATR SOC, V53, P1168, DOI 10.1111/j.1532-5415.2005.53375.x; Schneider Ellen Caylor, 2010, N C Med J, V71, P547; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Shumway-Cook A, 2006, MOTOR CONTROL TRANSL, V3; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Taylor-Piliae RE, 2014, ARCH PHYS MED REHAB, V95, P816, DOI 10.1016/j.apmr.2014.01.001; Thurner S, 2002, AUDIOL NEURO-OTOL, V7, P240, DOI 10.1159/000063740; Tousignant M, 2013, DISABIL REHABIL, V35, P1429, DOI 10.3109/09638288.2012.737084; Tsang WW, 2004, ARCH PHYS MED REHAB, V85, P129, DOI 10.1016/j.apmr.2003.02.002; Tsang WWN, 2004, MED SCI SPORT EXER, V36, P648, DOI 10.1249/01.MSS.0000121941.57669.BF; Tsang WWN, 2003, MED SCI SPORT EXER, V35, P1962, DOI 10.1249/01.MSS.0000099110.17311.A2; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P191, DOI 10.1089/acm.2007.7170B; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P95, DOI 10.1089/acm.2007.7170A; Wayne PM, 2013, CONTEMP CLIN TRIALS, V34, P21, DOI 10.1016/j.cct.2012.09.006; Wei Q, 2012, ENTROPY-SWITZ, V14, P2157, DOI 10.3390/e14112157; Wolf SL, 1997, PHYS THER, V77, P371, DOI 10.1093/ptj/77.4.371; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; Wu G, 2002, ARCH PHYS MED REHAB, V83, P1364, DOI 10.1053/apmr.2002.34596; Wu G, 2010, ARCH PHYS MED REHAB, V91, P849, DOI 10.1016/j.apmr.2010.01.024; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047	72	43	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114731	10.1371/journal.pone.0114731	http://dx.doi.org/10.1371/journal.pone.0114731			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494333	gold, Green Submitted, Green Published			2022-12-27	WOS:000346611400072
J	Dong, F; Irshad, H; Oh, EY; Lerwill, MF; Brachtel, EF; Jones, NC; Knoblauch, NW; Montaser-Kouhsari, L; Johnson, NB; Rao, LKF; Faulkner-Jones, B; Wilbur, DC; Schnitt, SJ; Beck, AH				Dong, Fei; Irshad, Humayun; Oh, Eun-Yeong; Lerwill, Melinda F.; Brachtel, Elena F.; Jones, Nicholas C.; Knoblauch, Nicholas W.; Montaser-Kouhsari, Laleh; Johnson, Nicole B.; Rao, Luigi K. F.; Faulkner-Jones, Beverly; Wilbur, David C.; Schnitt, Stuart J.; Beck, Andrew H.			Computational Pathology to Discriminate Benign from Malignant Intraductal Proliferations of the Breast	PLOS ONE			English	Article							NUCLEAR MORPHOMETRIC FEATURES; CARCINOMA IN-SITU; DUCTAL HYPERPLASIA; PROGNOSTIC VALUE; CANCER; EXPRESSION; TISSUE; INTEROBSERVER; DIAGNOSIS; SELECTION	The categorization of intraductal proliferative lesions of the breast based on routine light microscopic examination of histopathologic sections is in many cases challenging, even for experienced pathologists. The development of computational tools to aid pathologists in the characterization of these lesions would have great diagnostic and clinical value. As a first step to address this issue, we evaluated the ability of computational image analysis to accurately classify DCIS and UDH and to stratify nuclear grade within DCIS. Using 116 breast biopsies diagnosed as DCIS or UDH from the Massachusetts General Hospital (MGH), we developed a computational method to extract 392 features corresponding to the mean and standard deviation in nuclear size and shape, intensity, and texture across 8 color channels. We used L1-regularized logistic regression to build classification models to discriminate DCIS from UDH. The top-performing model contained 22 active features and achieved an AUC of 0.95 in cross-validation on the MGH data-set. We applied this model to an external validation set of 51 breast biopsies diagnosed as DCIS or UDH from the Beth Israel Deaconess Medical Center, and the model achieved an AUC of 0.86. The top-performing model contained active features from all color-spaces and from the three classes of features (morphology, intensity, and texture), suggesting the value of each for prediction. We built models to stratify grade within DCIS and obtained strong performance for stratifying low nuclear grade vs. high nuclear grade DCIS (AUC=0.98 in cross-validation) with only moderate performance for discriminating low nuclear grade vs. intermediate nuclear grade and intermediate nuclear grade vs. high nuclear grade DCIS (AUC=0.83 and 0.69, respectively). These data show that computational pathology models can robustly discriminate benign from malignant intraductal proliferative lesions of the breast and may aid pathologists in the diagnosis and classification of these lesions.	[Dong, Fei; Lerwill, Melinda F.; Brachtel, Elena F.; Jones, Nicholas C.; Rao, Luigi K. F.; Wilbur, David C.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Dong, Fei] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Irshad, Humayun; Oh, Eun-Yeong; Knoblauch, Nicholas W.; Montaser-Kouhsari, Laleh; Johnson, Nicole B.; Faulkner-Jones, Beverly; Schnitt, Stuart J.; Beck, Andrew H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Beck, AH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	abeck2@bidmc.harvard.edu		Knoblauch, Nicholas/0000-0002-2890-6520	National Library of Medicine of the National Institutes of Health [K22LM011931]; NATIONAL CANCER INSTITUTE [P50CA168504] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM011931] Funding Source: NIH RePORTER	National Library of Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The research reported in this publication was supported in part by the National Library of Medicine of the National Institutes of Health under Award Number K22LM011931. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAAK JPA, 1985, CANCER, V56, P374, DOI 10.1002/1097-0142(19850715)56:2<374::AID-CNCR2820560229>3.0.CO;2-9; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; CHANG H, 2012, 9 IEEE INT S BIOM IM, P614; Chiusa L, 2000, INT J CANCER, V89, P494, DOI 10.1002/1097-0215(20001120)89:6<494::AID-IJC5>3.0.CO;2-L; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Cui Y, 2007, BREAST CANCER RES TR, V104, P103, DOI 10.1007/s10549-006-9396-4; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dundar MM, 2011, IEEE T BIO-MED ENG, V58, P1977, DOI 10.1109/TBME.2011.2110648; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; GALLOWAY MM, COMPUT GRAPH IMAGE P, V4, P172; Geller BM, 2014, J CLIN PATHOL, V67, P955, DOI 10.1136/jclinpath-2014-202290; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Huisman A, 2010, HUM PATHOL, V41, P751, DOI 10.1016/j.humpath.2009.08.026; Irshad H, 2014, COMPUT MED IMAG GRAP, V38, P390, DOI 10.1016/j.compmedimag.2014.04.003; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Irshad Humayun, 2013, J Pathol Inform, V4, P10, DOI 10.4103/2153-3539.112695; Jain RK, 2011, MODERN PATHOL, V24, P917, DOI 10.1038/modpathol.2011.66; Kane Robert L., 2010, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgq022; Kothari S, 2013, J AM MED INFORM ASSN, V20, P1099, DOI 10.1136/amiajnl-2012-001540; Kronqvist P, 1998, BRIT J CANCER, V78, P800, DOI 10.1038/bjc.1998.582; MacGrogan G, 2008, HISTOPATHOLOGY, V52, P689, DOI 10.1111/j.1365-2559.2008.03016.x; Mommers ECM, 2001, J PATHOL, V193, P33, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH744>3.0.CO;2-Q; Mommers ECM, 2000, ANAL CELL PATHOL, V20, P187, DOI 10.1155/2000/965613; Mommers ECM, 2001, INT J CANCER, V95, P282, DOI 10.1002/1097-0215(20010920)95:5<282::AID-IJC1048>3.0.CO;2-X; Otterbach F, 2000, HISTOPATHOLOGY, V37, P232, DOI 10.1046/j.1365-2559.2000.00882.x; Pantanowitz L, 2013, ARCH PATHOL LAB MED, V137, P1710, DOI 10.5858/arpa.2013-0093-CP; Pellagatti A, 2013, J CLIN ONCOL, V31, P3557, DOI 10.1200/JCO.2012.45.5626; PIENTA KJ, 1991, CANCER, V68, P2012, DOI 10.1002/1097-0142(19911101)68:9<2012::AID-CNCR2820680928>3.0.CO;2-C; ROSAI J, 1991, AM J SURG PATHOL, V15, P209, DOI 10.1097/00000478-199103000-00001; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Schultz NA, 2012, MODERN PATHOL, V25, P1609, DOI 10.1038/modpathol.2012.122; Sharif Razavian A, 2014, CNN FEATURES OFF THE; Tahlan A, 2000, ANAL QUANT CYTOL, V22, P193; Tan PH, 2001, MODERN PATHOL, V14, P937, DOI 10.1038/modpathol.3880415; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VANDIEST PJ, 1989, PATHOL RES PRACT, V185, P612, DOI 10.1016/S0344-0338(89)80204-3; Veta M, 2012, MODERN PATHOL, V25, P1559, DOI 10.1038/modpathol.2012.126	43	65	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114885	10.1371/journal.pone.0114885	http://dx.doi.org/10.1371/journal.pone.0114885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490766	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300091
J	Duval, C; Cohen, C; Chagnoleau, C; Flouret, V; Bourreau, E; Bernerd, F				Duval, Christine; Cohen, Catherine; Chagnoleau, Corinne; Flouret, Virginie; Bourreau, Emilie; Bernerd, Francoise			Key Regulatory Role of Dermal Fibroblasts in Pigmentation as Demonstrated Using a Reconstructed Skin Model: Impact of Photo-Aging	PLOS ONE			English	Article							STEM-CELL FACTOR; HEPATOCYTE GROWTH-FACTOR; NORMAL HUMAN MELANOCYTES; SUN EXPOSURE; HYPERPIGMENTATION; MORPHOGENESIS; KERATINOCYTES; EXPRESSION; MECHANISM; HORMONE	To study cutaneous pigmentation in a physiological context, we have previously developed a functional pigmented reconstructed skin model composed of a melanocyte-containing epidermis grown on a dermal equivalent comprising living fibroblasts. The present studies, using the same model, aimed to demonstrate that dermal fibroblasts influence skin pigmentation up to the macroscopic level. The proof of principle was performed with pigmented skins differing only in the fibroblast component. First, the in vitro system was reconstructed with or without fibroblasts in order to test the global influence of the presence of this cell type. We then assessed the impact of the origin of the fibroblast strain on the degree of pigmentation using fetal versus adult fibroblasts. In both experiments, impressive variation in skin pigmentation at the macroscopic level was observed and confirmed by quantitative parameters related to skin color, melanin content and melanocyte numbers. These data confirmed the responsiveness of the model and demonstrated that dermal fibroblasts do indeed impact the degree of skin pigmentation. We then hypothesized that a physiological state associated with pigmentary alterations such as photo-aging could be linked to dermal fibroblasts modifications that accumulate over time. Pigmentation of skin reconstructed using young unexposed fibroblasts (n=3) was compared to that of tissues containing natural photo-aged fibroblasts (n=3) which express a senescent phenotype. A stimulation of pigmentation in the presence of the natural photo-aged fibroblasts was revealed by a significant increase in the skin color (decrease in Luminance) and an increase in both epidermal melanin content and melanogenic gene expression, thus confirming our hypothesis. Altogether, these data demonstrate that the level of pigmentation of the skin model is influenced by dermal fibroblasts and that natural photo-aged to fibroblasts can contribute to the hyperpigmentation that is associated with photoaging.	[Duval, Christine; Cohen, Catherine; Chagnoleau, Corinne; Flouret, Virginie; Bourreau, Emilie; Bernerd, Francoise] LOreal Res & Innovat, Aulnay Sous Bois, France	L'Oreal Group	Duval, C (corresponding author), LOreal Res & Innovat, Aulnay Sous Bois, France.	cduval@rd.loreal.com			L'Oreal Research Innovation	L'Oreal Research Innovation	The authors received no specific funding for this work. L'Oreal Research & Innovation provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; Bastiaens M, 2004, PIGM CELL RES, V17, P225, DOI 10.1111/j.1600-0749.2004.00131.x; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; BREATHNACH AS, 1991, PIGM CELL RES, V4, P71, DOI 10.1111/j.1600-0749.1991.tb00318.x; BUFFEY JA, 1994, BRIT J DERMATOL, V131, P836, DOI 10.1111/j.1365-2133.1994.tb08586.x; Cardinali G, 2009, EUR J DERMATOL, V19, P469, DOI 10.1684/ejd.2009.0724; Cario-Andre M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x; Castanet J, 1997, ARCH DERMATOL, V133, P1296, DOI 10.1001/archderm.133.10.1296; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Chung H, 2014, J BIOL CHEM, V289, P21751, DOI 10.1074/jbc.M113.541177; CIE, 1986, COL, P29; Duval C, 2001, PIGM CELL RES, V14, P348, DOI 10.1034/j.1600-0749.2001.140506.x; Duval C, 2012, TISSUE ENG PART C-ME, V18, P947, DOI [10.1089/ten.tec.2011.0676, 10.1089/ten.TEC.2011.0676]; Enomoto A, 2011, AM J PATHOL, V178, P679, DOI 10.1016/j.ajpath.2010.10.021; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; Hedley SJ, 1997, PIGM CELL RES, V10, P54, DOI 10.1111/j.1600-0749.1997.tb00466.x; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HOLZLE E, 1992, BRIT J DERMATOL, V127, P48, DOI 10.1111/j.1365-2133.1992.tb16989.x; Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kawabata K, 2014, SKIN RES TECHNOL, V20, P155, DOI 10.1111/srt.12099; Kihira C, 1999, J DERMATOL SCI, V20, P72, DOI 10.1016/S0923-1811(98)00077-2; Kim E, 2013, CANCER RES, V73, P6874, DOI 10.1158/0008-5472.CAN-13-1720; Kovacs D, 2010, BRIT J DERMATOL, V163, P1020, DOI 10.1111/j.1365-2133.2010.09946.x; Lavker Robert M., 1995, P123; Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Mildner M, 2007, J INVEST DERMATOL, V127, P2637, DOI 10.1038/sj.jid.5700938; Monestier S, 2006, BRIT J DERMATOL, V154, P438, DOI 10.1111/j.1365-2133.2005.06996.x; Nakazawa K, 1997, PIGM CELL RES, V10, P382, DOI 10.1111/j.1600-0749.1997.tb00696.x; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Nouveau-Richard S, 2005, J DERMATOL SCI, V40, P187, DOI 10.1016/j.jdermsci.2005.06.006; Okazaki M, 2005, SCAND J PLAST RECONS, V39, P339, DOI 10.1080/02844310500300362; Okazaki M, 2003, BRIT J DERMATOL, V148, P689, DOI 10.1046/j.1365-2133.2003.05283.x; Ortonne JP, 2008, J INVEST DERM SYMP P, V13, P10, DOI 10.1038/jidsymp.2008.7; Pouyani T, 2012, IN VITRO CELL DEV-AN, V48, P493, DOI 10.1007/s11626-012-9541-9; Ramelet AA, 2009, EXP GERONTOL, V44, P208, DOI 10.1016/j.exger.2008.11.004; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Scott G, 1997, J INVEST DERMATOL, V108, P147, DOI 10.1111/1523-1747.ep12332650; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin J, 2012, J EUR ACAD DERMATOL, V26, P1577, DOI 10.1111/j.1468-3083.2011.04223.x; Shishido E, 2001, J INVEST DERMATOL, V117, P627, DOI 10.1046/j.0022-202x.2001.01440.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005; SWOPE VB, 1991, J INVEST DERMATOL, V96, P180, DOI 10.1111/1523-1747.ep12460991; Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Yaar M, 1995, Adv Dermatol, V10, P63; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yamamoto T, 2001, BRIT J DERMATOL, V144, P199, DOI 10.1046/j.1365-2133.2001.03983.x; Zuliani T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070408	64	65	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114182	10.1371/journal.pone.0114182	http://dx.doi.org/10.1371/journal.pone.0114182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490395	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300018
J	Handa, H; Usuba, A; Maddula, S; Baumbach, JI; Mineshita, M; Miyazawa, T				Handa, Hiroshi; Usuba, Ayano; Maddula, Sasidhar; Baumbach, Joerg Ingo; Mineshita, Masamichi; Miyazawa, Teruomi			Exhaled Breath Analysis for Lung Cancer Detection Using Ion Mobility Spectrometry	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; CANINE SCENT DETECTION; BIOMARKERS; DIAGNOSIS; ARRAY; CONDENSATE; MUTATIONS; PROFILES; AIR	Background: Conventional methods for lung cancer detection including computed tomography (CT) and bronchoscopy are expensive and invasive. Thus, there is still a need for an optimal lung cancer detection technique. Methods: The exhaled breath of 50 patients with lung cancer histologically proven by bronchoscopic biopsy samples (32 adenocarcinomas, 10 squamous cell carcinomas, 8 small cell carcinomas), were analyzed using ion mobility spectrometry (IMS) and compared with 39 healthy volunteers. As a secondary assessment, we compared adenocarcinoma patients with and without epidermal growth factor receptor (EGFR) mutation. Results: A decision tree algorithm could separate patients with lung cancer including adenocarcinoma, squamous cell carcinoma and small cell carcinoma. One hundred-fifteen separated volatile organic compound (VOC) peaks were analyzed. Peak-2 noted as n-Dodecane using the IMS database was able to separate values with a sensitivity of 70.0% and a specificity of 89.7%. Incorporating a decision tree algorithm starting with n-Dodecane, a sensitivity of 76% and specificity of 100% was achieved. Comparing VOC peaks between adenocarcinoma and healthy subjects, n-Dodecane was able to separate values with a sensitivity of 81.3% and a specificity of 89.7%. Fourteen patients positive for EGFR mutation displayed a significantly higher n-Dodecane than for the 14 patients negative for EGFR (p<0.01), with a sensitivity of 85.7% and a specificity of 78.6%. Conclusion: In this prospective study, VOC peak patterns using a decision tree algorithm were useful in the detection of lung cancer. Moreover, n-Dodecane analysis from adenocarcinoma patients might be useful to discriminate the EGFR mutation.	[Handa, Hiroshi; Usuba, Ayano; Mineshita, Masamichi; Miyazawa, Teruomi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan; [Maddula, Sasidhar] BioMedicalCtr, B&S Analyt, Dortmund, Germany; [Baumbach, Joerg Ingo] Reutlingen Univ, Fac Appl Chem, Reutlingen, Germany	Saint Marianna University	Miyazawa, T (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan.	miyazawat@marianna-u.ac.jp			Japan Society for Promotion of Science [20410061, 24800068]; Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) [SFB 876]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich)(German Research Foundation (DFG))	This study was supported by the Japan Society for Promotion of Science and by Grants-in-Aid for Scientific Research (20410061, 24800068). Dr. Baumbach was supported by Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) SFB 876 "Providing Information by Resource-Constrained Analysis'', project TB1 "Resource-Constrained Analysis of Spectrometry Data''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader S, 2006, J CHEMOMETR, V20, P128, DOI 10.1002/cem.998; Baumbach JI, 2011, INT J ION MOBIL SPEC, V14, P159, DOI 10.1007/s12127-011-0078-5; Baumbach JI, 2006, ANAL BIOANAL CHEM, V384, P1059, DOI 10.1007/s00216-005-3397-8; Bodeker B, 2010, INT J ION MOBIL SPEC, V13, P177, DOI 10.1007/s12127-010-0044-7; Bodeker B, 2009, INT J ION MOBIL SPEC, V12, P103, DOI 10.1007/s12127-009-0024-y; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P89, DOI 10.1007/s12127-008-0013-6; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P83, DOI 10.1007/s12127-008-0012-7; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P77, DOI 10.1007/s12127-008-0011-8; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Bunkowski A, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046001; Bunkowski A, 2010, INT J ION MOBIL SPEC, V13, P141, DOI 10.1007/s12127-010-0052-7; Chen X, 2005, MEAS SCI TECHNOL, V16, P1535, DOI 10.1088/0957-0233/16/8/001; Darwiche K, 2011, LUNG, V189, P445, DOI 10.1007/s00408-011-9324-1; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Fink T, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027104; GORDON SM, 1985, CLIN CHEM, V31, P1278; Hauschild AC, 2012, GENET MOL RES, V11, P2733, DOI 10.4238/2012.July.10.17; Hauschild AC, 2012, METABOLITES, V2, P733, DOI 10.3390/metabo2040733; Hauschild AC, 2013, METABOLITES, V3, P277, DOI 10.3390/metabo3020277; Junger M, 2010, ANAL BIOANAL CHEM, V396, P471, DOI 10.1007/s00216-009-3168-z; Kreuer S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05423; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Maddula S, 2012, INT J ION MOBIL SPEC, V15, P79, DOI 10.1007/s12127-012-0089-x; Maddula S, 2009, ANAL BIOANAL CHEM, V394, P791, DOI 10.1007/s00216-009-2758-0; Mazzone PJ, 2010, EUR RESPIR MONOGR, P130, DOI 10.1183/1025448x.00018709; Mazzone PJ, 2007, THORAX, V62, P565, DOI 10.1136/thx.2006.072892; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Nana-Sinkam SP, 2013, CHEST, V143, pE30, DOI 10.1378/chest.12-2346; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Paradiso A, 2008, EUR RESPIR J, V32, P1126, DOI 10.1183/09031936.00083008; Peng G, 2008, NANO LETT, V8, P3631, DOI 10.1021/nl801577u; Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Saijo N, 2010, JPN J CLIN ONCOL, V40, pi7, DOI 10.1093/jjco/hyq121; Smolinska A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027105; Westhoff M, 2007, J PHYSIOL PHARMACOL, V58, P739; Westhoff M, 2011, INT J ION MOBIL SPEC, V14, P139, DOI 10.1007/s12127-011-0081-x; Westhoff M, 2009, THORAX, V64, P744, DOI 10.1136/thx.2008.099465; Westhoff M, 2010, INT J ION MOBIL SPEC, V13, P131, DOI 10.1007/s12127-010-0049-2; Zhang D, 2011, LUNG CANCER, V73, P379, DOI 10.1016/j.lungcan.2011.05.018	43	70	76	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114555	10.1371/journal.pone.0114555	http://dx.doi.org/10.1371/journal.pone.0114555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490772	Green Published, gold			2022-12-27	WOS:000347515300051
J	Khalek, WA; Cortade, F; Ollendorff, V; Lapasset, L; Tintignac, L; Chabi, B; Wrutniak-Cabello, C				Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Lapasset, Laure; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal			SIRT3, a Mitochondrial NAD(+)-Dependent Deacetylase, Is Involved in the Regulation of Myoblast Differentiation	PLOS ONE			English	Article							INHIBITS SKELETAL MYOGENESIS; KAPPA-B; CALORIE RESTRICTION; MUSCLE; EXPRESSION; BIOGENESIS; SIRTUINS; OXYGEN; MYOD; RESPIRATION	Sirtuin 3 (SIRT3), one of the seven mammalian sirtuins, is a mitochondrial NAD(+)-dependent deacetylase known to control key metabolic pathways. SIRT3 deacetylases and activates a large number of mitochondrial enzymes involved in the respiratory chain, in ATP production, and in both the citric acid and urea cycles. We have previously shown that the regulation of myoblast differentiation is tightly linked to mitochondrial activity. Since SIRT3 modulates mitochondrial activity, we decide to address its role during myoblast differentiation. For this purpose, we first investigated the expression of endogenous SIRT3 during C2C12 myoblast differentiation. We further studied the impact of SIRT3 silencing on both the myogenic potential and the mitochondrial activity of C2C12 cells. We showed that SIRT3 protein expression peaked at the onset of myoblast differentiation. The inhibition of SIRT3 expression mediated by the stable integration of SIRT3 short inhibitory RNA (SIRT3shRNA) in C2C12 myoblasts, resulted in: 1) abrogation of terminal differentiation - as evidenced by a marked decrease in the myoblast fusion index and a significant reduction of Myogenin, MyoD, Sirtuin 1 and Troponin T protein expression - restored upon MyoD overexpression; 2) a decrease in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and citrate synthase protein expression reflecting an alteration of mitochondrial density; and 3) an increased production of reactive oxygen species (ROS) mirrored by the decreased activity of manganese superoxide dismutase (MnSOD). Altogether our data demonstrate that SIRT3 mainly regulates myoblast differentiation via its influence on mitochondrial activity.	[Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Lapasset, Laure; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] Univ Montpellier I, F-34000 Montpellier, France; [Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Lapasset, Laure; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] Univ Montpellier 2, Montpellier, France; [Lapasset, Laure] IGMM, Inst Genet Mol Montpellier, CNRS UMR5535, Montpellier, France; [Tintignac, Lionel] Univ Basel, Biozentrum, Basel, Switzerland	INRAE; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Basel	Wrutniak-Cabello, C (corresponding author), INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	wrutniak@supagro.inra.fr	Chabi, Beatrice/AAI-6545-2020	Chabi, Beatrice/0000-0002-5604-5668	Institut National de la Recherche Agronomique (INRA); INRA; Ecole Doctorale CBS2	Institut National de la Recherche Agronomique (INRA); INRA; Ecole Doctorale CBS2	This study was supported by funds from the Institut National de la Recherche Agronomique (INRA). WAK was a recipient of doctoral fellowship financed by INRA and Ecole Doctorale CBS2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Laguerre M, 2011, J PHARM PHARMACOL, V63, P531, DOI 10.1111/j.2042-7158.2010.01216.x; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wharton DC., 1967, METHOD ENZYMOL, P245; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhong L, 2011, CELL METAB, V13, P621, DOI 10.1016/j.cmet.2011.05.004	46	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114388	10.1371/journal.pone.0114388	http://dx.doi.org/10.1371/journal.pone.0114388			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489948	gold, Green Published			2022-12-27	WOS:000347515300034
J	Cai, JY; Gong, R; Yan, FJ; Yu, CJ; Liu, L; Wang, W; Lin, Y; Guo, MX; Li, WX; Huang, Z				Cai, Jinyang; Gong, Rui; Yan, Fengjuan; Yu, Chunjie; Liu, Lu; Wang, Wei; Lin, Yi; Guo, Mingxiong; Li, Wenxin; Huang, Zan			ZNF300 Knockdown Inhibits Forced Megakaryocytic Differentiation by Phorbol and Erythrocytic Differentiation by Arabinofuranosyl Cytidine in K562 Cells	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; ERYTHROLEUKEMIC CELLS; COREPRESSOR KAP-1; N-COR; ARA-C; GENES; IDENTIFICATION; CONTRIBUTES; REPRESSION; INDUCTION	Previously, we reported that ZNF300 might play a role in leukemogenesis. In this study, we further investigated the function of ZNF300 in K562 cells undergoing differentiation. We found that ZNF300 upregulation in K562 cells coincided with megakaryocytic differentiation induced by phorbol-12-myristate-13-acetate (PMA) or erythrocytic differentiation induced by cytosine arabinoside (Ara-C), respectively. To further test whether ZNF300 upregulation promoted differentiation, we knocked down ZNF300 and found that ZNF300 knockdown effectively abolished PMA-induced megakaryocytic differentiation, evidenced by decreased CD61 expression. Furthermore, Ara-C-induced erythrocytic differentiation was also suppressed in ZNF300 knockdown cells with decreased c-globin expression and CD235a expression. These observations suggest that ZNF300 may be a critical factor controlling distinct aspects of K562 cells. Indeed, ZNF300 knockdown led to increased cell proliferation. Consistently, ZNF300 knockdown cells exhibited an increased percentage of cells at S phase accompanied by decreased percentage of cells at G0/G1 and G2/M phase. Increased cell proliferation was further supported by the increased expression of cell proliferation marker PCNA and the decreased expression of cell cycle regulator p15 and p27. In addition, MAPK/ERK signaling was significantly suppressed by ZNF300 knockdown. These findings suggest a potential mechanism by which ZNF300 knockdown may impair megakaryocytic and erythrocytic differentiation.	[Cai, Jinyang; Wang, Wei; Li, Wenxin] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Cai, Jinyang; Yan, Fengjuan; Yu, Chunjie; Liu, Lu; Wang, Wei; Lin, Yi; Guo, Mingxiong; Li, Wenxin; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Gong, Rui] Hubei Entry Exit Inspect & Quarantine Bur PR Chin, Hubei Int Travel Healthcare Ctr, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; z-huang@whu.edu.cn	LIN, YI/AAC-3335-2020; Cai, Jinyang/HCH-0290-2022	LIN, YI/0000-0001-8209-1185; Liu, Lu/0000-0001-7984-6671; Cai, Jinyang/0000-0002-7385-8281; Yu, Chunjie/0000-0003-2161-3394; Huang, Zan/0000-0001-5623-6950; Wang, Wei/0000-0001-7429-1013	National Natural Science Foundation of China [81070406, 31371481]; Ph.D. Programs Foundation of Ministry of Education of China [20110141110016]; New Century Excellent Talents in University (NCET) of Ministry of Education of China [NCET-12-0422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); New Century Excellent Talents in University (NCET) of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (Grant Nos. 81070406 and 31371481 to ZH), Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20110141110016 to ZH), and New Century Excellent Talents in University (NCET) of Ministry of Education of China (NCET-12-0422 to ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brzezianska E, 2011, FRONT BIOSCI-LANDMRK, V16, P422, DOI 10.2741/3696; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Ferguson LR, 2007, CELL MOL LIFE SCI, V64, P3105, DOI 10.1007/s00018-007-7303-8; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gou DM, 2004, BBA-GENE STRUCT EXPR, V1676, P203, DOI 10.1016/j.bbaexp.2003.11.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Mark C, 1999, DNA CELL BIOL, V18, P381, DOI 10.1089/104454999315277; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Qiu HL, 2008, CELL MOL BIOL LETT, V13, P391, DOI 10.2478/s11658-008-0005-x; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Takagaki K, 2005, GENES CELLS, V10, P97, DOI 10.1111/j.1365-2443.2005.00821.x; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; WANDA PE, 1989, LEUKEMIA RES, V13, P683, DOI 10.1016/0145-2126(89)90057-X; Wang T, 2012, J CELL MOL MED, V16, P1134, DOI 10.1111/j.1582-4934.2011.01388.x; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wang W, 2012, J BIOL CHEM, V287, P42856, DOI 10.1074/jbc.M112.399923; Xu JH, 2010, LEUKEMIA RES, V34, P1636, DOI 10.1016/j.leukres.2010.04.009; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72	36	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114768	10.1371/journal.pone.0114768	http://dx.doi.org/10.1371/journal.pone.0114768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485965	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600096
J	Lee, JC; Park, BK; Choung, S; Kim, JM; Joung, KH; Lee, JH; Kim, KS; Kim, HJ; Jeong, JW; Dal Rhee, S; Ku, BJ				Lee, Jun Choul; Park, Byung Kil; Choung, Sorim; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; Kim, Koon Soon; Kim, Hyun Jin; Jeong, Jae-Wook; Dal Rhee, Sang; Ku, Bon Jeong			Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GENE; MUTATION	Mitogen-inducible gene 6 (Mig-6) is a negative feedback inhibitor of epidermal growth factor receptor (EGFR) signaling. We previously found that Mig-6 plays a critical role in the regulation of cholesterol homeostasis and in bile acid synthesis. In this study, we investigated the effects of EGFR inhibition to identify a potential new treatment target for hypercholesterolemia. We used a mouse model with conditional ablation of the Mig-6 gene in the liver (Alb(cre/+) Mig-6(f/f); Mig-6(d/d)) to effectively investigate the role of Mig-6 in the regulation of liver function. Mig-6(d/d) mice were treated with either the EGFR inhibitor gefitinib or statin for 6 weeks after administration of a high-fat or standard diet. We then compared lipid profiles and other parameters among each group of mice. After a high-fat diet, Mig-6(d/d) mice showed elevated serum levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and glucose, characteristics resembling hypercholesterolemia in diabetic patients. We observed decreases in serum levels of lipids and glucose in high-fat-diet-fed Mig-6(d/d) mice after 6 weeks of treatment with gefitinib or statin. Furthermore gefitinib-treated mice showed significantly greater decreases in serum levels of total, HDL and LDL cholesterol compared with statin-treated mice. Taken together, these results suggest that EGFR inhibition is effective for the treatment of hypercholesterolemia in high-fat-diet-fed Mig-6(d/d) mice, and our findings provide new insights into the development of possible treatment targets for hypercholesterolemia via modulation of EGFR inhibition.	[Lee, Jun Choul; Choung, Sorim; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; Kim, Koon Soon; Kim, Hyun Jin; Ku, Bon Jeong] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea; [Lee, Jun Choul] Daejeon Vet Hosp, Dept Internal Med, Taejon, South Korea; [Park, Byung Kil; Dal Rhee, Sang] Chungnam Natl Univ, Grad Sch New Drug Dev & Discovery, Dept Drug Dev & Discovery, Taejon, South Korea; [Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Dal Rhee, Sang] Korea Res Inst Chem Technol, Res Ctr Drug Discovery Technol, Div Drug Discovery Res, Taejon, South Korea	Chungnam National University; Chungnam National University; Michigan State University; Korea Research Institute of Chemical Technology (KRICT)	Dal Rhee, S (corresponding author), Chungnam Natl Univ, Grad Sch New Drug Dev & Discovery, Dept Drug Dev & Discovery, Taejon, South Korea.	sdrhee@krict.re.kr; bonjeong@cnu.ac.kr		Lee, Ju Hee/0000-0001-5976-7175; Kim, Hyun Jin/0000-0002-6760-4963; Ku, Bon Jeong/0000-0002-3414-8949	National Research Foundation of Korea (NRF) grant - Korean Government [NRF-2013R1A1A2004719]; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) grant - Korean Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2013R1A1A2004719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Bhatnagar D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a993; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chen YC, 2013, MOL ENDOCRINOL, V27, P162, DOI 10.1210/me.2012-1174; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jin N, 2007, GENESIS, V45, P716, DOI 10.1002/dvg.20348; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Ku BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042915; Lee HY, 2014, CIRC J, V78, P281, DOI 10.1253/circj.CJ-13-1494; Lim S, 2013, INT J CARDIOL, V167, P1696, DOI 10.1016/j.ijcard.2012.10.037; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Nagashima T, 2009, FEBS J, V276, P5239, DOI 10.1111/j.1742-4658.2009.07220.x; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Santos RD, 2014, CURR OPIN LIPIDOL, V25, P183, DOI 10.1097/MOL.0000000000000073; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Wong RWC, 2003, CELL MOL LIFE SCI, V60, P113, DOI 10.1007/s000180300007; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928	27	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114782	10.1371/journal.pone.0114782	http://dx.doi.org/10.1371/journal.pone.0114782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486251	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600099
J	Muthusamy, V; Hossain, F; Thirunavukkarasu, N; Choudhary, M; Saha, S; Bhat, JS; Prasanna, BM; Gupta, HS				Muthusamy, Vignesh; Hossain, Firoz; Thirunavukkarasu, Nepolean; Choudhary, Mukesh; Saha, Supradip; Bhat, Jayant S.; Prasanna, Boddupalli M.; Gupta, Hari S.			Development of beta-Carotene Rich Maize Hybrids through Marker-Assisted Introgression of beta-carotene hydroxylase Allele	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; GENETIC-VARIATION; BLAST RESISTANCE; BIOFORTIFICATION; ACCUMULATION; VARIABILITY; PROVITAMIN; INBREDS; LOCUS; TOOLS	Development of vitamin A-rich cereals can help in alleviating the widespread problem of vitamin A deficiency. We report here significant enhancement of kernel beta-carotene in elite maize genotypes through accelerated marker-assisted backcross breeding. A favourable allele (543 bp) of the beta-carotene hydroxylase (crtRB1) gene was introgressed in the seven elite inbred parents, which were low (1.4 mu g/g) in kernel beta-carotene, by using a crtRB1-specific DNA marker for foreground selection. About 90% of the recurrent parent genome was recovered in the selected progenies within two backcross generations. Concentration of beta-carotene among the crtRB1-introgressed inbreds varied from 8.6 to 17.5 mu g/g - a maximum increase up to 12.6-fold over recurrent parent. The reconstituted hybrids developed from improved parental inbreds also showed enhanced kernel beta-carotene as high as 21.7 mu g/g, compared to 2.6 mu g/g in the original hybrid. The reconstituted hybrids evaluated at two locations possessed similar grain yield to that of original hybrids. These beta-carotene enriched high yielding hybrids can be effectively utilized in the maize biofortification programs across the globe.	[Muthusamy, Vignesh; Hossain, Firoz; Thirunavukkarasu, Nepolean; Choudhary, Mukesh; Prasanna, Boddupalli M.; Gupta, Hari S.] Indian Agr Res Inst, Div Genet, ICAR, New Delhi 110012, India; [Saha, Supradip] Indian Agr Res Inst, Div Agr Chem, ICAR, New Delhi 110012, India; [Bhat, Jayant S.] Indian Agr Res Inst, ICAR, Reg Res Ctr, Dharwad, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Gupta, HS (corresponding author), Borlaug Inst South Asia, New Delhi, India.	hsgupta.53@gmail.com	Muthusamy, Vignesh/AAB-6224-2022; Muthusamy, Vignesh/AAU-5785-2020; Choudhary, Mukesh/AAS-7109-2021; Research, ICAR-Indian Institute of Maize/ABC-7039-2020; Saha, Supradip/X-9912-2019; Saha, Supradip/F-4103-2012	Muthusamy, Vignesh/0000-0003-3169-890X; Saha, Supradip/0000-0002-6655-4001; Boddupalli, Prasanna/0000-0002-5761-2273	Department of Biotechnolgy, Government of India	Department of Biotechnolgy, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnolgy, Government of India under the Project "Development of micronutrient enriched maize through molecular breeding''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; [Anonymous], 2009, WHO GLOBAL DATABASE; AOAC, 1965, OFFICIAL METHODS ANA, V10 th, P744; Atlin GN, 2011, PL BRED RE, V34, P83; Babu R, 2005, THEOR APPL GENET, V111, P888, DOI 10.1007/s00122-005-0011-6; Babu R., 2014, GENOMICS PLANT GENET, V2, DOI [10.1007/978-94-007-7575-6_21, DOI 10.1007/978-94-007-7575-6_21]; Babu R, 2013, THEOR APPL GENET, V126, P389, DOI 10.1007/s00122-012-1987-3; Bjarnason M, 1992, PLANT BREEDING REV, P181; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; BUCKNER B, 1990, PLANT CELL, V2, P867, DOI 10.1105/tpc.2.9.867; Chander S, 2008, J AGR FOOD CHEM, V56, P6506, DOI 10.1021/jf7037967; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Danson JW, 2006, AFR J BIOTECHNOL, V5, P2417; Egesel CO, 2003, CROP SCI, V43, P818, DOI 10.2135/cropsci2003.0818; Farre G., 2013, HDB FOOD FORTIFICATI, V1, P335; Gupta HS, 2009, CURR SCI INDIA, V96, P230; Gupta HS, 2013, PLANT BREEDING, V132, P77, DOI 10.1111/pbr.12009; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hernandez H.H., 1969, CIMMYT RES B, V13; Jelena V, 2008, GENETIKA, V40, P145, DOI DOI 10.2298/GENSR0802145V; Koide Y, 2011, FIELD CROP RES, V123, P19, DOI 10.1016/j.fcr.2011.04.005; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Mangelsdorf PC, 1926, GENETICS, V11, P423; Menkir A, 2008, FOOD CHEM, V109, P521, DOI 10.1016/j.foodchem.2008.01.002; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Naidoo R, 2012, MOL BREEDING, V30, P1207, DOI 10.1007/s11032-012-9709-8; Naqvi S, 2009, P NATL ACAD SCI USA, V106, P7762, DOI 10.1073/pnas.0901412106; Neuffer MG, 1997, MUTANTS MAIZE; Ortiz-Monasterio JI, 2007, J CEREAL SCI, V46, P293, DOI 10.1016/j.jcs.2007.06.005; Perez-Massot E, 2013, GENES NUTR, V8, P29, DOI 10.1007/s12263-012-0315-5; Ribaut JM, 1998, TRENDS PLANT SCI, V3, P236, DOI 10.1016/S1360-1385(98)01240-0; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Shiri M. R., 2013, Crop Breeding Journal, V3, P107; Singh VK, 2012, FIELD CROP RES, V128, P8, DOI 10.1016/j.fcr.2011.12.003; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Vasal S K., 2001, P 7 E S AFR REG MAI, P3; Vignesh M, 2013, J PLANT BIOCHEM BIOT, V22, P401, DOI 10.1007/s13562-012-0168-4; Vignesh M, 2012, INDIAN J GENET PL BR, V72, P189; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang W, 2004, PLANT MOL BIOL REP, V22, P361, DOI 10.1007/BF02772679; Zhang XC, 2012, THEOR APPL GENET, V125, P235, DOI 10.1007/s00122-012-1828-4; Zhu CF, 2008, P NATL ACAD SCI USA, V105, P18232, DOI 10.1073/pnas.0809737105	48	100	102	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113583	10.1371/journal.pone.0113583	http://dx.doi.org/10.1371/journal.pone.0113583			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486271	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600022
J	Harada, PHN; Canziani, ME; Lima, LM; Kamimura, M; Rochitte, CE; Lemos, MM; Cuppari, L; Kalil, R; Draibe, SA; Santos, RD				Harada, Paulo H. N.; Canziani, Maria E.; Lima, Leonardo M.; Kamimura, Maria; Rochitte, Carlos E.; Lemos, Marcelo M.; Cuppari, Lilian; Kalil Filho, Roberto; Draibe, Sergio A.; Santos, Raul D.			Pericardial Fat Is Associated with Coronary Artery Calcification in Non-Dialysis Dependent Chronic Kidney Disease Patients	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; OF-ECHOCARDIOGRAPHYS GUIDELINES; STANDARDS COMMITTEE; RISK-FACTORS; QUANTIFICATION; MORTALITY; CALCIUM; RECOMMENDATIONS; INFLAMMATION; POPULATION	Pericardial fat (PF) a component of visceral adipose tissue has been consistently related to coronary atherosclerosis in the general population. This study evaluated the association between PF and coronary artery calcification (CAC) in non-dialysis dependent chronic kidney disease (CKD) patients. This is a post-hoc cross sectional analysis of the baseline of a prospective cohort of 117 outward CKD patients without manifest coronary artery disease (age, 56.9 +/- 11.0 years, 64.1% males, 95.1% hypertensives, 25.2% diabetics, 15.5% ever smokers, CKD stage 2 to 5 with estimated glomerular filtration rate 36.8 +/- 18.1 ml/min). CAC scores, PF volume and abdominal visceral fat (AVF) areas were measured by computed tomography. The association of PF as a continuous variable with the presence of CAC was analyzed by multivariate logistic regression. CAC (calcium score >0) was present in 59.2% patients. Those presenting CAC were on average 10 years older, had a higher proportion of male gender (78.7% vs. 42.9%, p<0.001), and had higher values of waist circumference (95.9 +/- 10.7 vs. 90.2 +/- 13.2 cm, p=0.02), PF volumes (224.8 +/- 107.6 vs. 139.1 +/- 85.0 cm(3), p<0.01) and AVF areas (109.2 +/- 81.5 vs. 70.2 +/- 62.9 cm(2), p=0.01). In the multivariate analysis, adjusting for age, gender, diabetes, smoking and, left ventricular concentric hypertrophy, PF was significantly associated with the presence of CAC (OR: 1.88 95% CI: 1.03-3.43 per standard deviation). PF remained associated with CAC even with additional adjustments for estimated glomerular filtration rate or serum phosphorus (OR: 1.85 95% CI: 1.00-3.42, p=0.05). PF is independently associated with CAC in non-dialysis dependent CKD patients.	[Harada, Paulo H. N.; Lima, Leonardo M.; Kalil Filho, Roberto; Santos, Raul D.] Univ Sao Paulo, Sch Med, Lipid Clin Heart Inst InCor, Sao Paulo, Brazil; [Canziani, Maria E.; Kamimura, Maria; Lemos, Marcelo M.; Cuppari, Lilian; Draibe, Sergio A.] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [Rochitte, Carlos E.] Univ Sao Paulo, Sch Med, Cardiovasc Magnet Resonance & Computed Tomog Sect, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Santos, RD (corresponding author), Univ Sao Paulo, Sch Med, Lipid Clin Heart Inst InCor, Sao Paulo, Brazil.	raul.santos@incor.usp.br	draibe, sergio antonio/D-9426-2015; Santos, Raul/A-1170-2010; Filho, Roberto Kalil/D-4994-2014; Cuppari, Lilian/C-3394-2012; Canziani, Maria E F/AGI-3240-2022	Santos, Raul/0000-0002-9860-6582; Cuppari, Lilian/0000-0002-5927-9179; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/14201-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant #2011/14201-2 to Leonardo Mateus Lima) (www.fapesp.br). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aoqui C, 2013, EUR J CLIN NUTR, V67, P610, DOI 10.1038/ejcn.2013.66; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; D'Marco LG, 2013, NEPHROL DIAL TRANSPL, V28, P2586, DOI 10.1093/ndt/gft264; Dey D, 2010, ATHEROSCLEROSIS, V209, P136, DOI 10.1016/j.atherosclerosis.2009.08.032; Ehara S, 2011, HEART VESSELS, V26, P487, DOI 10.1007/s00380-010-0082-4; Erturk S, 1996, NEPHROL DIAL TRANSPL, V11, P2050, DOI 10.1093/oxfordjournals.ndt.a027095; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Iacobellis G, 2009, HORM METAB RES, V41, P227, DOI 10.1055/s-0028-1100412; Jung HH, 2006, NEPHROL DIAL TRANSPL, V21, P1915, DOI 10.1093/ndt/gfl118; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kerr JD, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-26; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Marques MD, 2010, ATHEROSCLEROSIS, V209, P481, DOI 10.1016/j.atherosclerosis.2009.10.023; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Rajani R, 2013, J CARDIOVASC COMPUT, V7, P125, DOI 10.1016/j.jcct.2013.02.003; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Russo D, 2011, KIDNEY INT, V80, P112, DOI 10.1038/ki.2011.69; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Shantouf RS, 2010, AM J NEPHROL, V31, P419, DOI 10.1159/000294405; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Turkmen K, 2012, CARDIORENAL MED, V2, P43, DOI 10.1159/000335495; Tuttle KR, 2009, CLIN J AM SOC NEPHRO, V4, P1968, DOI 10.2215/CJN.01250209; Watanabe R, 2010, CLIN J AM SOC NEPHRO, V5, P189, DOI 10.2215/CJN.06240909; Yong HS, 2010, INT J CARDIOVAS IMAG, V26, P53, DOI 10.1007/s10554-009-9542-2; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	32	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114358	10.1371/journal.pone.0114358	http://dx.doi.org/10.1371/journal.pone.0114358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479288	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907200077
J	Shevchenko, V; Gushchin, I; Polovinkin, V; Round, E; Borshchevskiy, V; Utrobin, P; Popov, A; Balandin, T; Buldt, G; Gordeliy, V				Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Round, Ekaterina; Borshchevskiy, Valentin; Utrobin, Petr; Popov, Alexander; Balandin, Taras; Bueldt, Georg; Gordeliy, Valentin			Crystal Structure of Escherichia coli-Expressed Haloarcula marismortui Bacteriorhodopsin I in the Trimeric Form	PLOS ONE			English	Article							PROTEIN-STRUCTURE; DARK-ADAPTATION; RHODOPSIN II; MEMBRANE; CHAIN; PROTEORHODOPSIN; REFINEMENT; ELECTRON; PUMP	Bacteriorhodopsins are a large family of seven-helical transmembrane proteins that function as light-driven proton pumps. Here, we present the crystal structure of a new member of the family, Haloarcula marismortui bacteriorhodopsin I (HmBRI) D94N mutant, at the resolution of 2.5 angstrom. While the HmBRI retinal-binding pocket and proton donor site are similar to those of other archaeal proton pumps, its proton release region is extended and contains additional water molecules. The protein's fold is reinforced by three novel inter-helical hydrogen bonds, two of which result from double substitutions relative to Halobacterium salinarum bacteriorhodopsin and other similar proteins. Despite the expression in Escherichia coli and consequent absence of native lipids, the protein assembles as a trimer in crystals. The unique extended loop between the helices D and E of HmBRI makes contacts with the adjacent protomer and appears to stabilize the interface. Many lipidic hydrophobic tail groups are discernible in the membrane region, and their positions are similar to those of archaeal isoprenoid lipids in the crystals of other proton pumps, isolated from native or native-like sources. All these features might explain the HmBRI properties and establish the protein as a novel model for the microbial rhodopsin proton pumping studies.	[Shevchenko, Vitaly; Round, Ekaterina; Borshchevskiy, Valentin; Balandin, Taras; Gordeliy, Valentin] Res Ctr Julich GmbH, Inst Complex Syst ICS Struct Biochem 6, Julich, Germany; [Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Utrobin, Petr; Bueldt, Georg; Gordeliy, Valentin] Moscow Inst Phys & Technol, Lab Adv Studies Membrane Prot, Dolgoprudnyi, Russia; [Gushchin, Ivan; Polovinkin, Vitaly; Utrobin, Petr; Gordeliy, Valentin] Univ Grenoble Alpes, IBS, Grenoble, France; [Gushchin, Ivan; Polovinkin, Vitaly; Utrobin, Petr; Gordeliy, Valentin] CNRS, IBS, Grenoble, France; [Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] CEA Grenoble, IBS, F-38054 Grenoble, France; [Popov, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Gordeliy, V (corresponding author), Res Ctr Julich GmbH, Inst Complex Syst ICS Struct Biochem 6, Julich, Germany.	valentin.gordeliy@ibs.fr	Borshchevskiy, Valentin I./F-2287-2014; Gushchin, Ivan/AAO-8829-2020; Gushchin, Ivan/K-9197-2015; Popov, Alexander/A-8827-2008; Utrobin, Petr/O-9252-2015; Polovinkin, Vitaly/G-6627-2017; Gordeliy, Valentin I/J-3636-2013; Buldt, Georg/K-5345-2013; Shevchenko, Vitaly/F-2956-2014	Borshchevskiy, Valentin I./0000-0003-4398-9712; Gushchin, Ivan/0000-0002-5348-6070; Gushchin, Ivan/0000-0002-5348-6070; Polovinkin, Vitaly/0000-0002-3630-5565; Gordeliy, Valentin I/0000-0001-5782-5896; Popov, Alexander/0000-0002-3058-8912	ANR France; CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; BMBF (PhoNa - Photonic Nanomaterials); RFBR [13-04-91320, 12-04-31290]; Russian state Program for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science; Fondation Nanosciences	ANR France(French National Research Agency (ANR)); CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement(French Atomic Energy Commission); BMBF (PhoNa - Photonic Nanomaterials)(Federal Ministry of Education & Research (BMBF)); RFBR(Russian Foundation for Basic Research (RFBR)); Russian state Program for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science; Fondation Nanosciences	The work was supported by the program "Chaires d'excellence" edition 2008 of ANR France and CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement. Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials). The work was supported by RFBR (research projects 13-04-91320 and 12-04-31290) and the Russian state Program for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science. The work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). VP is deeply thankful to Fondation Nanosciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Borshchevskiy V, 2010, ACTA CRYSTALLOGR D, V66, P26, DOI 10.1107/S0907444909042838; Borshchevskiy VI, 2011, J MOL BIOL, V409, P813, DOI 10.1016/j.jmb.2011.04.038; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DENCHER NA, 1983, BIOCHEMISTRY-US, V22, P1323, DOI 10.1021/bi00275a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; GERWERT K, BIOCHIMICA ET BIOPHY; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; Hirai T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005769; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; IHARA K, 1994, BIOPHYS J, V67, P1187, DOI 10.1016/S0006-3495(94)80587-9; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; REYNOLDS JA, 1977, P NATL ACAD SCI USA, V74, P2803, DOI 10.1073/pnas.74.7.2803; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeda K, 1998, J MOL BIOL, V283, P463, DOI 10.1006/jmbi.1998.2103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Wang T, 2013, STRUCTURE, V21, P290, DOI 10.1016/j.str.2012.12.018; WICKSTRAND C, BIOCHIMICA ET BIOPHY; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Zhang J, 2013, PROTEINS, V81, P1585, DOI 10.1002/prot.24316	49	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112873	10.1371/journal.pone.0112873	http://dx.doi.org/10.1371/journal.pone.0112873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479443	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200012
J	Wong, MCS; Ching, JYL; Chan, VCW; Shum, JP; Lam, TYT; Luk, AKC; Sung, JJY				Wong, Martin C. S.; Ching, Jessica Y. L.; Chan, Victor C. W.; Shum, Jeffrey P.; Lam, Thomas Y. T.; Luk, Arthur K. C.; Sung, Joseph J. Y.			Should Prior FIT Results Be Incorporated as an Additional Variable to Estimate Risk of Colorectal Neoplasia? A Prospective Study of 5,813 Screening Colonoscopies	PLOS ONE			English	Article							FECAL IMMUNOCHEMICAL TESTS; PROSPECTIVE COHORT; VALIDATED TOOL; CANCER; CHOICE; ASIA; RECOMMENDATIONS; SURVEILLANCE; INDIVIDUALS; MORTALITY	Background: Recent studies showed that previous negative results from faecal immunochemical tests (FITs) for colorectal cancer (CRC) screening was associated with lower risk of advanced neoplasia (AN). We evaluated whether prior FIT results should be included to estimate the risk of AN in 2008-2012. Methods: A community-based screening practice recruited 5,813 asymptomatic residents aged 50 to 70 years in Hong Kong for CRC screening. We included study participants who had (1). positive FIT with subsequent colonoscopy workup (FIT+ group; n=356); (2). negative FIT in three consecutive years and received a colonoscopy (FIT-group; n=857); (3). received colonoscopy without FIT (colonoscopy group; n=473); and (4). received both colonoscopy and FIT at the same time (combined group; n=4,127). One binary logistic regression model evaluated whether prior FIT results were associated with colonoscopy findings of AN. Results: The proportion of participants having AN/CRC was 18.0% (FIT+), 5.5% (FIT-), 8.0% (colonoscopy group), and 4.3% (combined group), respectively. When compared with the colonoscopy group, those in the FIT- group were not significantly more or less likely to have AN/CRC (AOR =0.77, 95% C.I.=0.51 to 1.18, p =0.230). Having one (AOR=0.73, 95% C.I. 0.48-1.12, p=0.151) or three consecutive negative FIT result (AOR=0.98, 95% C.I. 0.60-1.62, p=0.944) were not associated with lower risks of AN/CRC. Subjects in the FIT+ group was 3.32-fold (95% C.I. 2.07 to 5.32, p<0.001) more likely to have AN/CRC. Conclusions: These findings indicated that subjects with negative FIT findings could be risk stratified similarly as those who had not previously received FIT.	[Wong, Martin C. S.; Ching, Jessica Y. L.; Chan, Victor C. W.; Shum, Jeffrey P.; Lam, Thomas Y. T.; Luk, Arthur K. C.; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Martin C. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Sung, Joseph J. Y./R-3203-2018; Wong, Martin/L-4568-2014	Sung, Joseph J. Y./0000-0003-3125-5199; Wong, Martin/0000-0001-7706-9370; Chan, Victor/0000-0001-9178-5031	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	Funding provided by the Hong Kong Jockey Club Charities Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JE, 2012, GASTROENTEROLOGY, V142, P422, DOI 10.1053/j.gastro.2012.01.015; Bensen S, 1999, AM J GASTROENTEROL, V94, P194; Betes M, 2003, AM J GASTROENTEROL, V98, P2648, DOI 10.1016/j.amjgastroenterol.2203.09.041; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; GLOBOCAN, 2012, CANC FACT SHEET COL; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Lane JM, 2010, GASTROENTEROLOGY, V139, P1918, DOI 10.1053/j.gastro.2010.08.005; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2004, GASTROENTEROLOGY, V127, P1841, DOI 10.1053/j.gastro.2004.10.014; Lin OS, 2006, GASTROENTEROLOGY, V131, P1011, DOI 10.1053/j.gastro.2006.08.015; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Ng SC, 2013, ALIMENT PHARM THER, V38, P835, DOI 10.1111/apt.12446; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Sung JJY, 2008, GUT, V57, P1166, DOI 10.1136/gut.2007.146316; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Sung JJY, 2008, AM J GASTROENTEROL, V103, P974, DOI 10.1111/j.1572-0241.2007.01649.x; Tao S, 2014, CLIN GASTROENTEROL H, V12, P478, DOI 10.1016/j.cgh.2013.08.042; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong MCS, 2010, ALIMENT PHARM THER, V32, P74, DOI 10.1111/j.1365-2036.2010.04312.x; Wong MCS, 2014, AM J GASTROENTEROL, V109, P1072, DOI 10.1038/ajg.2014.136; Wong MCS, 2014, GUT, V63, P1130, DOI 10.1136/gutjnl-2013-305639; Wong MCS, 2013, PREV MED, V57, P227, DOI 10.1016/j.ypmed.2013.05.017; Wong MCS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070209, 10.1371/journal.pone.0084321]; Wong MCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060366; Wong MCS, 2012, CANCER CAUSE CONTROL, V23, P1541, DOI 10.1007/s10552-012-0031-x; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114332	10.1371/journal.pone.0114332	http://dx.doi.org/10.1371/journal.pone.0114332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479102	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200074
J	Truong, TC; Than, VT; Kim, W				Thoi Cong Truong; Van Thai Than; Kim, Wonyong			Evolutionary Phylodynamics of Korean Noroviruses Reveals a Novel GII.2/GII.10 Recombination Event	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; ACUTE GASTROENTERITIS; OSAKA CITY; MOLECULAR EPIDEMIOLOGY; HUMAN CALICIVIRUSES; OUTBREAKS; CHILDREN; INFECTIONS; SAPOVIRUS; GII	Viral gastroenteritis is the most common causal agent of public health problems worldwide. Noroviruses cause nonbacterial acute gastroenteritis in humans of all ages. In this study, we investigated the occurrence of norovirus infection in children with acute gastroenteritis admitted to university hospitals in South Korea. We also analyzed the genetic diversity of the viruses and identified novel recombination events among the identified viral strains. Of 502 children with acute gastroenteritis admitted to our three hospitals between January 2011 and March 2012, genotyping of human noroviruses was performed in 171 (34%) norovirus-positive samples. Of these samples, 170 (99.5%) were in genogroup II (GII), while only one (0.5%) was in genogroup I (GI). The most common GII strain was the GII.4-2006b variant (n=96, 56.5%), followed by GII.6 (n=23, 13.5%), GII.12 (n=22, 12.9%), GII.3 (n=20, 11.8%), GII.2 (n=6, 3.5%), GII.b (n=2, 1.2%), and GII.10 (n=1, 0.6%). Potential recombination events (polymerase/capsid) were detected in 39 GII strains (22.9%), and the most frequent genotypes were GII.4/GII.12 (n=12, 30.8%), GII.4/GII.6 (n=12, 30.8%), GII.4/GII.3 (n=8, 20.5%), GII.b/GII.3 (n=3, 7.7%), GII.16/GII.2 (n=2, 5.1%), GII.4/GII.2 (n=1, 2.6%), and GII.2/GII.10 (n=1, 2.6%). For the first time, a novel GII.2/GII.10 recombination was detected; we also identified the GII.16/GII.2 strain for the first time in South Korea. Our data provided important insights into new recombination events, which may prove valuable for predicting the emergence of circulating norovirus strains with global epidemic potential.	[Thoi Cong Truong; Van Thai Than; Kim, Wonyong] Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, W (corresponding author), Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Than, Van-Thai/GPX-9664-2022; Than, Van Thai/AAX-2106-2021		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013-R1A1A2A10012148]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (2013-R1A1A2A10012148) funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambert-Balay K, 2005, J CLIN MICROBIOL, V43, P5179, DOI 10.1128/JCM.43.10.5179-5186.2005; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; Dey SK, 2010, VIRUS GENES, V40, P362, DOI 10.1007/s11262-010-0459-6; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Green KY, 2000, J INFECT DIS, V181, pS322, DOI 10.1086/315591; Hansman GS, 2004, ARCH VIROL, V149, P1673, DOI 10.1007/s00705-004-0345-4; Huh JW, 2009, J CLIN VIROL, V44, P152, DOI 10.1016/j.jcv.2008.11.016; Ike AC, 2006, J CLIN MICROBIOL, V44, P1262, DOI 10.1128/JCM.44.4.1262-1267.2006; Iritani N, 2002, J MED VIROL, V66, P131, DOI 10.1002/jmv.2121; Iritani N, 2008, J CLIN MICROBIOL, V46, P2406, DOI 10.1128/JCM.01993-07; Iritani N, 2012, J MED VIROL, V84, P517, DOI 10.1002/jmv.23211; Jiang X, 1999, ARCH VIROL, V144, P2377, DOI 10.1007/s007050050651; JUKES T H, 1969, P21; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kim EJ, 2010, FOOD SCI BIOTECHNOL, V19, P1089, DOI 10.1007/s10068-010-0153-4; Kim SH, 2005, J CLIN MICROBIOL, V43, P4836, DOI 10.1128/JCM.43.9.4836-4839.2005; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Le VP, 2010, J MED VIROL, V82, P1065, DOI 10.1002/jmv.21761; Lee SG, 2011, APPL ENVIRON MICROB, V77, P1466, DOI 10.1128/AEM.01996-10; LEW JF, 1994, J VIROL, V68, P3391, DOI 10.1128/JVI.68.5.3391-3396.1994; Lochridge VP, 2003, VIRUS GENES, V26, P71, DOI 10.1023/A:1022334323013; Lopman BA, 2002, J CLIN VIROL, V24, P137, DOI 10.1016/S1386-6532(01)00243-8; Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084; Phan TG, 2007, J MED VIROL, V79, P1388, DOI 10.1002/jmv.20924; RAY SC, 1998, SIMPLOT WINDOWS VERS; Ruether IGA, 2012, VIRUS GENES, V44, P237, DOI 10.1007/s11262-011-0697-2; Seah Oh,, 2013, Journal of Bacteriology and Virology, V43, P307, DOI 10.4167/jbv.2013.43.4.307; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton Alice C, 2004, Disaster Manag Response, V2, P4, DOI 10.1016/S1540-2487(03)00130-5; Vidal R, 2006, J CLIN MICROBIOL, V44, P2271, DOI 10.1128/JCM.01890-05; Won YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085063; Wright PJ, 1998, J MED VIROL, V55, P312, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;312::AID-JMV10&gt;3.0.CO;2-G; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009	43	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113966	10.1371/journal.pone.0113966	http://dx.doi.org/10.1371/journal.pone.0113966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500567	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400019
J	Wei, ZH; Spizzo, I; Diep, H; Drummond, GR; Widdop, RE; Vinh, A				Wei, Zihui; Spizzo, Iresha; Diep, Henry; Drummond, Grant R.; Widdop, Robert E.; Vinh, Antony			Differential Phenotypes of Tissue-Infiltrating T Cells during Angiotensin II-Induced Hypertension in Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; BLOOD-PRESSURE; KIDNEY INJURY; MACROPHAGE INFILTRATION; LYMPHOCYTE-RESPONSES; VASCULAR DYSFUNCTION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS	Hypertension remains the leading risk factor for cardiovascular disease (CVD). Experimental hypertension is associated with increased T cell infiltration into blood pressure-controlling organs, such as the aorta and kidney; importantly in absence of T cells of the adaptive immune system, experimental hypertension is significantly blunted. However, the function and phenotype of these T cell infiltrates remains speculative and undefined in the setting of hypertension. The current study compared T cell-derived cytokine and reactive oxygen species (ROS) production from normotensive and hypertensive mice. Splenic, blood, aortic, kidney and brain T cells were isolated from C57BL/6J mice following 14-day vehicle or angiotensin (Ang) II (0.7 mg/kg/day,s.c.) infusion. T cell infiltration was increased in aorta, kidney and brain from hypertensive mice. Cytokine analysis in stimulated T cells indicated an overall Th1 pro-inflammatory phenotype, but a similar proportion (flow cytometry) and quantity (cytometric bead array) of IFN-gamma, TNF-alpha, IL-4 and IL-17 between vehicle-and Ang II-treated groups. Strikingly, elevated T cell-derived production of a chemokine, chemokine C-C motif ligand 2 (CCL2), was observed in aorta (similar to 6-fold) and kidney in response to Ang II, but not in brain, spleen or blood. Moreover, T cell-derived ROS production in aorta was elevated similar to 3-fold in Ang II-treated mice (n=7; P<0.05). Ang II-induced hypertension does not affect the overall T cell cytokine profile, but enhanced T cell-derived ROS production and/or leukocyte recruitment due to elevated CCL2, and this effect may be further amplified with increased infiltration of T cells. We have identified a potential hypertension-specific T cell phenotype that may represent a functional contribution of Tcells to the development of hypertension, and likely several other associated vascular disorders.	[Wei, Zihui; Spizzo, Iresha; Diep, Henry; Drummond, Grant R.; Widdop, Robert E.; Vinh, Antony] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia	Monash University	Vinh, A (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia.	antony.vinh@monash.edu	; Vinh, Antony/I-1563-2014	Widdop, Robert/0000-0002-6515-0435; Vinh, Antony/0000-0001-8367-6134; Drummond, Grant/0000-0001-8556-9738	Monash Larkins Fellowship (AV) and Ramaciotti Foundation Establishment [3227/2011]; Heart Foundation of Australia Postdoctoral Fellowship [PF12M6922]	Monash Larkins Fellowship (AV) and Ramaciotti Foundation Establishment; Heart Foundation of Australia Postdoctoral Fellowship	This work was supported by a Monash Larkins Fellowship (AV) and Ramaciotti Foundation Establishment Grant (3227/2011). AV was supported by a Heart Foundation of Australia Postdoctoral Fellowship (PF12M6922), while ZW received an Australian Postgraduate Award. None of the funding sources outlined above had any role in study design; collection, analysis and interpretation of data; writing of the report; or in the decision to submit the article for publication.	Abbas A.K., 2011, CELLULAR MOL IMMUNOL; Barhoumi T, 2011, HYPERTENSION, V57, P469, DOI 10.1161/HYPERTENSIONAHA.110.162941; Berner B, 2000, J RHEUMATOL, V27, P1128; Bush E, 2000, HYPERTENSION, V36, P360, DOI 10.1161/01.HYP.36.3.360; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; CATT KJ, 1970, CIRC RES, V27, pI177; CATT KJ, 1971, LANCET, V1, P459; Chan CT, 2012, HYPERTENSION, V60, P1207, DOI 10.1161/HYPERTENSIONAHA.112.201251; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Choi YK, 2003, PARASITOL RES, V91, P87, DOI 10.1007/s00436-003-0934-2; Crowley SD, 2008, AM J PHYSIOL-RENAL, V295, pF515, DOI 10.1152/ajprenal.00527.2007; Crowley SD, 2010, AM J PHYSIOL-REG I, V298, pR1089, DOI 10.1152/ajpregu.00373.2009; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; De Miguel C, 2011, AM J PHYSIOL-RENAL, V300, P42; De Miguel C, 2010, AM J PHYSIOL-REG I, V298, pR1136, DOI 10.1152/ajpregu.00298.2009; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gutkowska J, 2011, J HYPERTENS, V29, P1203, DOI 10.1097/HJH.0b013e3283468392; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Harrison DG, 2010, CURR OPIN PHARMACOL, V10, P203, DOI 10.1016/j.coph.2010.01.006; Hilgers KF, 2000, KIDNEY INT, V58, P2408, DOI 10.1046/j.1523-1755.2000.00424.x; Iannone F, 2012, J RHEUMATOL, V39, P1179, DOI 10.3899/jrheum.111125; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Judd E, 2014, J HUM HYPERTENS; Kaly L, 2012, BEST PRACT RES CL RH, V26, P157, DOI 10.1016/j.berh.2012.01.001; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; Lourenco EV, 2009, CURR MOL MED, V9, P242, DOI 10.2174/156652409787847263; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mirkov I, 2012, ACTA PATHOL MICROB C, V121, P211; Ogata H, 1997, J PATHOL, V182, P106; Owen JL, 2007, INT J MOL MED, V20, P129; Owen JL, 2005, CELL IMMUNOL, V235, P122, DOI 10.1016/j.cellimm.2005.08.032; Rodriguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191, DOI 10.1152/ajprenal.0197.2001; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Shang FJ, 2012, MOL MED REP, V5, P1491, DOI 10.3892/mmr.2012.852; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Taherzadeh Z, 2010, AM J PHYSIOL-HEART C, V298, P82; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Venegas-Pont M, 2010, HYPERTENSION, V56, P643, DOI 10.1161/HYPERTENSIONAHA.110.157685; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; WHO, 2013, CARD DIS FACTS SHEET	47	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114895	10.1371/journal.pone.0114895	http://dx.doi.org/10.1371/journal.pone.0114895			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501574	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700064
J	Colombo, F; Trombetta, E; Cetrangolo, P; Maggioni, M; Razini, P; De Santis, F; Torrente, Y; Prati, D; Torresani, E; Porretti, L				Colombo, Federico; Trombetta, Elena; Cetrangolo, Paola; Maggioni, Marco; Razini, Paola; De Santis, Francesca; Torrente, Yvan; Prati, Daniele; Torresani, Erminio; Porretti, Laura			Giant Lysosomes as a Chemotherapy Resistance Mechanism in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TRANSPORTER; VERAPAMIL; CANCER; CHEMORESISTANCE; SEQUESTRATION; INHIBITION; METABOLISM	Despite continuous improvements in therapeutic protocols, cancer-related mortality is still one of the main problems facing public health. The main cause of treatment failure is multi-drug resistance (MDR: simultaneous insensitivity to different anticancer agents), the underlying molecular and biological mechanisms of which include the activity of ATP binding cassette (ABC) proteins and drug compartmentalisation in cell organelles. We investigated the expression of the main ABC proteins and the role of cytoplasmic vacuoles in the MDR of six hepatocellular carcinoma (HCC) cell lines, and confirmed the accumulation of the yellow anticancer drug sunitinib in giant (four lines) and small cytoplasmic vacuoles of lysosomal origin (two lines). ABC expression analyses showed that the main ABC protein harboured by all of the cell lines was PGP, whose expression was not limited to the cell membrane but was also found on lysosomes. MTT assays showed that the cell lines with giant lysosomes were more resistant to sorafenib treatment than those with small lysosomes (p<0.01), and that verapamil incubation can revert this resistance, especially if it is administered after drug pre-incubation. The findings of this study demonstrate the involvement of PGP-positive lysosomes in drug sequestration and MDR in HCC cell lines. The possibility of modulating this mechanism using PGP inhibitors could lead to the development of new targeted strategies to enhance HCC treatment.	[Colombo, Federico; Trombetta, Elena; Cetrangolo, Paola; Torresani, Erminio; Porretti, Laura] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Flow Cytometry & Expt Hepatol Serv, Clin Chem & Microbiol Lab, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Pathol Lab, Milan, Italy; [Razini, Paola; De Santis, Francesca; Torrente, Yvan] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Ctr Dino Ferrari,Stem Cell Lab, Milan, Italy; [Prati, Daniele] Osped A Manzoni, Dept Transfus Med & Hematol, Lecce, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Colombo, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Flow Cytometry & Expt Hepatol Serv, Clin Chem & Microbiol Lab, Milan, Italy.	federico.colombo@policlinico.mi.it	Trombetta, Elena/J-5577-2015; Prati, Daniele/P-8215-2019; Colombo, Federico Simone/J-5586-2015; Maggioni, Marco/AAC-4617-2022; De Santis, Francesca/Q-3453-2019; Trombetta, Elena/O-1408-2019; Porretti, Laura/J-6748-2015	Trombetta, Elena/0000-0002-1933-6415; Prati, Daniele/0000-0002-2281-7498; Colombo, Federico Simone/0000-0003-4480-3481; Maggioni, Marco/0000-0001-8603-8998; De Santis, Francesca/0000-0001-5877-0639; Trombetta, Elena/0000-0002-1933-6415; Porretti, Laura/0000-0001-8100-4262	COPEV (Comitato per la Prevenzione dell'Epatite Virale); Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	COPEV (Comitato per la Prevenzione dell'Epatite Virale); Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	This study was supported by grants from COPEV (Comitato per la Prevenzione dell'Epatite Virale; www.copev.it); "5x1000 funds for the year 2011'' Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (www.policlinico.mi.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 2001, CANCER-AM CANCER SOC, V92, P1577, DOI 10.1002/1097-0142(20010915)92:6<1577::AID-CNCR1484>3.0.CO;2-H; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Colombo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021369; Date S, 2012, ANAL SCI, V28, P201, DOI 10.2116/analsci.28.201; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Falasca M, 2012, EXPERT OPIN INV DRUG, V21, P657, DOI 10.1517/13543784.2012.679339; Fan PS, 2012, CELL BIOCHEM BIOPHYS, V62, P59, DOI 10.1007/s12013-011-9259-4; Fodale V, 2011, CANCER J, V17, P89, DOI 10.1097/PPO.0b013e318212dd3d; Goldman SDB, 2009, BIOANALYSIS, V1, P1445, DOI 10.4155/BIO.09.128; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Huang J, 2011, CELL BIOCHEM BIOPHYS, V59, P127, DOI 10.1007/s12013-010-9125-9; Ifergan I, 2005, CANCER RES, V65, P10952, DOI 10.1158/0008-5472.CAN-05-2021; LEHNERT M, 1991, BLOOD, V77, P348; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma JJ, 2009, ARCH GYNECOL OBSTET, V279, P149, DOI 10.1007/s00404-008-0690-8; Meaney M, 2013, PARASITOLOGY, V140, P1287, DOI 10.1017/S0031182013000759; Mossink MH, 2003, ONCOGENE, V22, P7458, DOI 10.1038/sj.onc.1206947; OZOLS RF, 1987, J CLIN ONCOL, V5, P641, DOI 10.1200/JCO.1987.5.4.641; Relling MV, 1996, THER DRUG MONIT, V18, P350, DOI 10.1097/00007691-199608000-00006; Sun ZG, 2010, TUMORI J, V96, P90, DOI 10.1177/030089161009600115; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Tracy TS, 1999, BRIT J CLIN PHARMACO, V47, P545, DOI 10.1046/j.1365-2125.1999.00923.x; Ughachukwu PO, 2012, ANN MED HEALTH SCI R, V2, P191, DOI 10.4103/2141-9248.105671; Wang XB, 2010, ONCOL REP, V23, P211, DOI 10.3892/or_00000625; Yamagishi Tetsuo, 2013, J Biol Chem, V288, P31761, DOI 10.1074/jbc.M113.514091; Zhu H, 2012, CHINESE MED J-PEKING, V125, P1095, DOI 10.3760/cma.j.issn.0366-6999.2012.06.024	28	31	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114787	10.1371/journal.pone.0114787	http://dx.doi.org/10.1371/journal.pone.0114787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493932	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400076
J	Hou, Q; He, WJ; Hao, HJ; Han, QW; Chen, L; Dong, L; Liu, JJ; Li, X; Zhang, YJ; Ma, YZ; Han, WD; Fu, XB				Hou, Qian; He, Wen-Jun; Hao, Hao-Jie; Han, Qing-Wang; Chen, Li; Dong, Liang; Liu, Jie-Jie; Li, Xiang; Zhang, Ya-Jing; Ma, Ying-Zhi; Han, Wei-Dong; Fu, Xiao-Bing			The Four-Herb Chinese Medicine ANBP Enhances Wound Healing and Inhibits Scar Formation via Bidirectional Regulation of Transformation Growth Factor Pathway	PLOS ONE			English	Article							RABBIT EAR; RAT SKIN; REPAIR; FIBROSIS; MECHANISMS; REGENERATION; INFLAMMATION; FIBROBLASTS; EXPRESSION; CELLS	The four-herb Chinese medicine ANBP is a pulverized mixture of four herbs including Agrimonia Eupatoria (A), Nelumbo Nucifera Gaertn (N), Boswellia Carteri (B) and Pollen Typhae Angustifoliae (P). The combination of the four herbs was first described in Chinese canonical medicine about 2000 years ago for treatment of various trauma disorders, such as hemostasis, antiinflammatory, analgesia, and wound healing, etc. However, the precise mechanisms of ANBP are still unclear. In our study, using rabbit ear hypertrophic scar models of full-thickness skin defect, we showed that local ANBP treatment not only significantly enhanced wound healing by relieving inflammation, increasing formation of granulation tissue and accelerating re-epithelialization, but also reduced scar formation by decreasing collagen production, protuberant height and volume of scars, and increasing collagen maturity. We demonstrated that these effects of ANBP are associated with transforming growth factor (TGF)-beta 1-mediated signalling pathways through Smad-dependent pathways. ANBP treatment significantly increased expression of TGF-beta 1 and Smad2/3 mRNA at the early stage of wound healing, and led to markedly decrease expression of TGF-beta 1 and Smad2/3 compared with the control group after 14 days post-wounding. Taken together, our results defined a bidirectional regulation role of ANBP for TGF-beta 1/Smad pathway in promoting wound healing and alleviating scar formation, which may be an effective therapy for human wounds at the earliest stage.	[Hou, Qian; He, Wen-Jun; Hao, Hao-Jie; Han, Qing-Wang; Chen, Li; Dong, Liang; Liu, Jie-Jie; Li, Xiang; Zhang, Ya-Jing; Ma, Ying-Zhi; Han, Wei-Dong; Fu, Xiao-Bing] Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med, Beijing, Peoples R China; [Hou, Qian] Chinese PLA 148th Hosp, Dept Internal Med, Zibo, Peoples R China; [Fu, Xiao-Bing] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Wound Healing & Cell Biol Lab, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Han, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med, Beijing, Peoples R China.	hanwdrsw69@yahoo.com; fuxiaobing@vip.sina.com	Hao, Haojie/D-6982-2013		National Basic Science and Development Program (973 Programme) [2012CB518103, 2012CB518105]; 863 Projects of Ministry of Science and Technology of China [2013AA020105, 2012AA020502]; National Natural Science Foundation of China [81121004, 81230041, 31100705, 30901564, 81101883]; China Postdoctoral Science Foundation [2013M542517]; Beijing Novel Program [2008B53, 2009A038]; Science and Technology Project of Hunan Provincial Science and Technology Department [2012FJ3012]; Scientific Research Project of Traditional Chinese Medicine in Hunan Province [2012111]	National Basic Science and Development Program (973 Programme)(National Basic Research Program of China); 863 Projects of Ministry of Science and Technology of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Novel Program(Beijing Municipal Science & Technology Commission); Science and Technology Project of Hunan Provincial Science and Technology Department; Scientific Research Project of Traditional Chinese Medicine in Hunan Province	This research was supported in part by the National Basic Science and Development Program (973 Programme, 2012CB518103 and 2012CB518105), the 863 Projects of Ministry of Science and Technology of China (2013AA020105 and 2012AA020502), the National Natural Science Foundation of China (81121004, 81230041, 31100705, 30901564, and 81101883), the China Postdoctoral Science Foundation (2013M542517), the Beijing Novel Program (2008B53, 2009A038), the Science and Technology Project of Hunan Provincial Science and Technology Department (2012FJ3012) and the Scientific Research Project of Traditional Chinese Medicine in Hunan Province (2012111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENTO EP, 1991, CIBA F SYMP, V157, P115; Colwell AS, 2005, PLAST RECONSTR SURG, V116, P1387, DOI 10.1097/01.prs.0000182343.99694.28; Colwell AS, 2005, ADV BIOCHEM ENG BIOT, V93, P83, DOI 10.1007/b99972; Colwell AS, 2003, FRONT BIOSCI-LANDMRK, V8, pS1240, DOI 10.2741/1183; Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hou Q, 2011, CANCER SCI, V102, P1287, DOI 10.1111/j.1349-7006.2011.01933.x; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kim JJ, 2012, J ETHNOPHARMACOL, V140, P213, DOI 10.1016/j.jep.2011.12.035; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Li P, 2011, J PATHOL, V223, P659, DOI 10.1002/path.2831; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; Liu X, 2005, J TRAUMA, V59, P682, DOI 10.1097/01.ta.0000177674.55388.40; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Ohkura N, 2012, BLOOD COAGUL FIBRIN, V23, P254, DOI 10.1097/MBC.0b013e3283504148; Pugazhenthi K, 2008, J PINEAL RES, V44, P387, DOI 10.1111/j.1600-079X.2007.00541.x; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; SHAH M, 1995, J CELL SCI, V108, P985; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tilton Robert, 2010, Chin Med, V5, P30, DOI 10.1186/1749-8546-5-30; Wolcott R D, 2008, J Wound Care, V17, P333; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Xie JL, 2008, WOUND REPAIR REGEN, V16, P576, DOI 10.1111/j.1524-475X.2008.00405.x; Ye M, 2007, RAPID COMMUN MASS SP, V21, P3593, DOI 10.1002/rcm.2832	30	24	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e112274	10.1371/journal.pone.0112274	http://dx.doi.org/10.1371/journal.pone.0112274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489732	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300002
J	Jacot, TA; Nelson, A; Thurman, A; Kashuba, ADM; Archer, DF; Doncel, GF				Jacot, Terry A.; Nelson, Ashley; Thurman, Andrea; Kashuba, Angela D. M.; Archer, David F.; Doncel, Gustavo F.			Development of a Composite Measure of Product Adherence, Protocol Compliance, and Semen Exposure Using DNA and Protein Biomarkers for Topical HIV Prevention Studies	PLOS ONE			English	Article							DYE STAIN ASSAY; PREEXPOSURE PROPHYLAXIS; BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; RIBOSOMAL-RNA; IDENTIFICATION; WOMEN; GEL; INFECTION; TRIALS	Background: Poor and inconsistent use of study products has hindered clinical HIV prevention studies. It is important to be able to monitor product adherence and protocol compliance in order to determine microbicide efficacy and safety more accurately. Current methods for monitoring adherence are subjective, non-specific, or invasive. Herein, we present a composite, objective measure of product adherence and protocol compliance to assess vaginal insertion, semen exposure and drug expulsion utilizing DNA, protein, and drug isolated directly from returned, vaginally used gel applicators. Methods: DNA, vaginal cells, and residual tenofovir were isolated from vaginally inserted applicators. Vaginal and semen biomarkers were amplified using a multiplex PCR to determine vaginal insertion. Vaginal cells were fixed followed by cytokeratin 4 immunocytochemistry to confirm DNA assessment of vaginal insertion. Tenofovir was extracted and quantitated through LC-MS/MS. Results: DNA isolated from vaginally inserted applicators were positive for vaginal bacteria DNA and the control eukaryotic gene, amelogenin, while manually handled, "sham'', applicators were negative for both. Semen exposure was independently determined by simultaneous amplification of one or both Y-chromosomal genes, SRY and TSPY4. Vaginal insertion determination by DNA analysis was further confirmed by positive cytokeratin 4 (CK4) immunocytochemistry of vaginal cells remaining on the gel applicators. On the contrary, sham applicators provided very few cells when swabbed, and they were all negative for CK4. CK4 was not found in epidermal cells from the hand. Drug expulsion was detected through quantitation of residual gel present on the surface of returned applicators. Sham applicators had no detectable tenofovir. Conclusion: Utilizing a composite, triple marker based panel of DNA, protein, and drug present on the surface of returned vaginal gel applicators, it is possible to determine, objectively and non-invasively, product adherence, protocol compliance, and semen exposure in microbicide trials.	[Jacot, Terry A.; Nelson, Ashley; Thurman, Andrea; Archer, David F.; Doncel, Gustavo F.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA; [Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Kashuba, Angela D. M.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA	Eastern Virginia Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jacot, TA (corresponding author), Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA.	jacotta@evms.edu			American people through the United States Agency for International Development (USAID) [GPO-A-00-08-00005-00]; National Institutes of Health NICHD HIV/AIDS IAA [Y1-HD-0083, RO1 HD 07 2705-01, P30 AI50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institutes of Health NICHD HIV/AIDS IAA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under Cooperative agreement GPO-A-00-08-00005-00 to CONRAD, Eastern Virginia Medical School. The views expressed by the authors do not necessarily reflect the view of USAID or the United States Government. This work was also supported by the National Institutes of Health NICHD HIV/AIDS IAA #Y1-HD-0083 (GD), RO1 HD 07 2705-01 (GD), P30 AI50410 (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, LEGAL MED-TOKYO, V14, P160, DOI 10.1016/j.legalmed.2012.01.005; [Anonymous], 2013, WHO HIV AIDS FACT SH; Austin MN, 2009, SEX TRANSM DIS, V36, P368, DOI 10.1097/OLQ.0b013e3181972397; Benschop CCG, 2012, INT J LEGAL MED, V126, P303, DOI 10.1007/s00414-011-0660-8; Fleming RI, 2010, FORENSIC SCI INT-GEN, V4, P311, DOI 10.1016/j.fsigen.2009.11.008; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gallo MF, 2007, INT J STD AIDS, V18, P33, DOI 10.1258/095646207779949899; Gengiah TN, 2014, AIDS BEHAV, V18, P833, DOI 10.1007/s10461-014-0750-y; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Hanson E, 2012, FORENSIC SCI INT-GEN, V6, P548, DOI 10.1016/j.fsigen.2012.01.004; Hemmerling A, 2012, SEX TRANSM DIS, V39, P710, DOI 10.1097/OLQ.0b013e3182641f08; Honda K, 1999, J FORENSIC SCI, V44, P868; Jacot TA, 2013, CONTRACEPTION, V88, P387, DOI 10.1016/j.contraception.2012.11.022; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Katzen LL, 2011, SEX TRANSM DIS, V38, P1050, DOI 10.1097/OLQ.0b013e31822e6160; Keller MJ, 2013, SEX TRANSM DIS, V40, P939, DOI 10.1097/OLQ.0000000000000040; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Marazzo J, 2013, PREEXPOSURE PROPHYLA; Mauck CK, 2008, JAIDS-J ACQ IMM DEF, V49, P64, DOI 10.1097/QAI.0b013e318183a917; Moench TR, 2012, SEX TRANSM DIS, V39, P335, DOI 10.1097/OLQ.0b013e31824790bb; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schulz MM, 2010, J FORENSIC SCI, V55, P492, DOI 10.1111/j.1556-4029.2009.01071.x; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Thurman AR, 2014, SEX TRANSM IN PRESS; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2013, SEX TRANSM DIS, V40, P950, DOI 10.1097/OLQ.0000000000000053; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	37	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114368	10.1371/journal.pone.0114368	http://dx.doi.org/10.1371/journal.pone.0114368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489736	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300032
J	Sun, YY; Pan, J; Mao, SD; Jin, JP				Sun, Yuanyuan; Pan, Jing; Mao, Shudan; Jin, Jieping			IL-17/miR-192/IL-17Rs Regulatory Feedback Loop Facilitates Multiple Myeloma Progression	PLOS ONE			English	Article							KAPPA-B ACTIVATION; T-CELLS; CANCER; IL-17; MICROENVIRONMENT; INTERLEUKIN-17; PROLIFERATION; ANGIOGENESIS; METASTASIS; EXPRESSION	Multiple myeloma (MM) is a clonal plasma cell disorder which constitutes the second most common hematological malignancy, and remains an incurable tumor with poor survival. Recently, interleukin-17 (IL-17), produced locally in the tumor microenvironment, has been reported to play a crucial role in tumor immunity. In this study, we determined that exposure of MM cells to IL-17 had various promotive influences on different aspects of tumor progression. IL-17 significantly induced cell proliferation, inhibited cellular apoptosis, repressed cell adhesion to fibronectin and collagen I, and facilitated cell migration. Exposure to IL-17 also resulted in epithelial-mesenchymal transition (EMT), as evidenced by repression of the epithelial marker E-cadherin, and induction of the mesenchymal marker Vimentin, and EMT transcription factors Snail and Slug. Further experiments showed that IL-17 activated the oncogenic p65 transcription factor, which directly repressed the miR-192 gene via binding to the miR-192 promoter. Loss of miR-192 in MM cells can mimic the effects of IL-17, and was required for the above oncogenic effects of IL-17 on MM. Furthermore, we found that miR-192, and its homologous miR-215 directly targeted the 39-untranslated regions of IL-17Rs, including IL-17RA and RE mRNA. By examining bone marrow specimens derived from MM patients, a negative correlation between miR-192 expression and IL-17 or IL-17RA expression was observed. Also, IL-17 was negatively correlated with E-cadherin and positively with Vimentin. Taken together, our study provides evidence that the IL-17/miR-192/IL-17Rs regulatory feedback loop is manifest in MM and might represent a promising and efficient prognostic marker and therapeutic target for MM.	[Sun, Yuanyuan; Pan, Jing; Mao, Shudan; Jin, Jieping] Liaoning Med Univ, Affiliated Hosp 1, Dept Hematol, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Jin, JP (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Hematol, Jinzhou, Liaoning, Peoples R China.	yihaidaohang@163.com			Foundation of Science and Technology Agency in Liaoning Province [2012225019]	Foundation of Science and Technology Agency in Liaoning Province	This work was supported by the Foundation of Science and Technology Agency in Liaoning Province (2012225019, Research on regulation of IL-17 on myeloma). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Das Roy L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2345; Dogini DB, 2014, GENET MOL BIOL, V37, P285, DOI 10.1590/S1415-47572014000200014; Feng SP, 2011, NUCLEIC ACIDS RES, V39, P6669, DOI 10.1093/nar/gkr232; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Girardin A, 2013, INT J CANCER, V132, P1842, DOI 10.1002/ijc.27855; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huston Alissa, 2006, Future Oncol, V2, P371, DOI 10.2217/14796694.2.3.371; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Li LQ, 2013, CLIN IMMUNOL, V148, P246, DOI 10.1016/j.clim.2013.05.003; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Ludwig Heinz, 2004, Clin Adv Hematol Oncol, V2, P233; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; Omrane I, 2014, IMMUNOL LETT, V158, P189, DOI 10.1016/j.imlet.2014.01.002; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Prabhala RH, 2010, BLOOD, V115, P5385, DOI 10.1182/blood-2009-10-246660; Ribatti D, 2014, ADV EXP MED BIOL, V816, P361, DOI 10.1007/978-3-0348-0837-8_14; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Song XN, 2013, LEUKEMIA RES, V37, P1094, DOI 10.1016/j.leukres.2013.06.022; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Umansky V, 2013, CANCER MICROENVIRON, V6, P169, DOI 10.1007/s12307-012-0126-7; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu LL, 2004, WORLD J GASTROENTERO, V10, P3255, DOI 10.3748/wjg.v10.i22.3255	34	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114647	10.1371/journal.pone.0114647	http://dx.doi.org/10.1371/journal.pone.0114647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489847	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300063
J	Dong, Y; Zhang, T; Li, JJ; Deng, HY; Song, YJ; Zhai, D; Peng, Y; Lu, XL; Liu, MY; Zhao, YX; Yi, ZF				Dong, Yanmin; Zhang, Tao; Li, Jingjie; Deng, Huayun; Song, Yajuan; Zhai, Dong; Peng, Yi; Lu, Xiaoling; Liu, Mingyao; Zhao, Yongxiang; Yi, Zhengfang			Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch Signaling	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; ENDOTHELIAL-CELLS; ACTIN DYNAMICS; BREAST-CANCER; DELTA-NOTCH; IN-VITRO; PHASE-I; APOPTOSIS; ACTIVATION; CADHERIN	While significant progress has been made in understanding the anti-inflammatory and anti-proliferative effects of the natural diterpenoid component Oridonin on tumor cells, little is known about its effect on tumor angiogenesis or metastasis and on the underlying molecular mechanisms. In this study, Oridonin significantly suppressed human umbilical vascular endothelial cells (HUVECs) proliferation, migration, and apillary-like structure formation in vitro. Using aortic ring assay and mouse corneal angiogenesis model, we found that Oridonin inhibited angiogenesis ex vivo and in vivo. In our animal experiments, Oridonin impeded tumor growth and metastasis. Immunohistochemistry analysis further revealed that the expression of CD31 and vWF protein in xenografts was remarkably decreased by the Oridonin. Furthermore, Oridonin reinforced endothelial cell-cell junction and impaired breast cancer cell transendothelial migration. Mechanistically, Oridonin not only down-regulated Jagged2 expression and Notch1 activity but also decreased the expression of their target genes. In conclusion, our results demonstrated an original role of Oridonin in inhibiting tumor angiogenesis and propose a mechanism. This study also provides new evidence supporting the central role of Notch in tumor angiogenesis and suggests that Oridonin could be a potential drug candidate for angiogenesis related diseases.	[Dong, Yanmin; Zhang, Tao; Li, Jingjie; Deng, Huayun; Song, Yajuan; Zhai, Dong; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Dong, Yanmin; Zhang, Tao; Li, Jingjie; Deng, Huayun; Song, Yajuan; Zhai, Dong; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Peng, Yi; Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, Nanning 530021, Guangxi, Peoples R China	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Guangxi Medical University	Zhao, YX (corresponding author), Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, 22 Shuang Yong Rd, Nanning 530021, Guangxi, Peoples R China.	yongxiangzhao@126.com; zfyi@bio.ecnu.edu.cn	lu, xl/HDO-8340-2022	Liu, Mingyao/0000-0001-7339-5048	Major State Basic Research Development Program of China [2015CB910400]; National Natural Science Foundation of China [81272463, 81472788, 81330049]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1128]; Innovation Program of Shanghai Municipal Education Commission [13zz034]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was partially supported by Major State Basic Research Development Program of China (2015CB910400). National Natural Science Foundation of China (81272463, 81472788, 81330049). Program for Changjiang Scholars and Innovative Research Team in University (IRT1128). Innovation Program of Shanghai Municipal Education Commission (13zz034). The Science and Technology Commission of Shanghai Municipality (11DZ2260300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Dai FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052162; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Gao F, 2010, INT J LAB HEMATOL, V32, pE114, DOI 10.1111/j.1751-553X.2009.01147.x; Garcia A, 2012, HISTOL HISTOPATHOL, V27, P151, DOI 10.14670/HH-27.151; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Kang N, 2010, J NAT PROD, V73, P1058, DOI 10.1021/np9008199; Kang N, 2010, CANCER LETT, V294, P147, DOI 10.1016/j.canlet.2010.01.032; Kiec-Wilk B, 2010, J PHYSIOL PHARMACOL, V61, P217; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Lai L, 2012, BRIT J PHARMACOL, V165, P1084, DOI 10.1111/j.1476-5381.2011.01532.x; Lechertier T, 2004, ANTICANCER RES, V24, P4011; Liu H, 2014, TUMOUR BIOL; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Longo N, 2001, BLOOD, V98, P3717, DOI 10.1182/blood.V98.13.3717; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Meade-Tollin LC, 2004, J NAT PROD, V67, P2, DOI 10.1021/np0304114; Mierke CT, 2008, J BIOPHYS, V2008; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pihan GA, 1998, CANCER RES, V58, P3974; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shi W, 2006, J MAMMARY GLAND BIOL, V11, P41, DOI 10.1007/s10911-006-9011-7; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Zabel BA, 2001, MOL CANCER, V10, P73; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhang T, 2014, NEOPLASIA, V16, P665, DOI 10.1016/j.neo.2014.07.009; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	48	46	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113830	10.1371/journal.pone.0113830	http://dx.doi.org/10.1371/journal.pone.0113830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485753	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600028
J	Knitlova, J; Hajkova, V; Voska, L; Elsterova, J; Obrova, B; Melkova, Z				Knitlova, Jarmila; Hajkova, Vera; Voska, Ludek; Elsterova, Jana; Obrova, Barbora; Melkova, Zora			Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection	PLOS ONE			English	Article							SMALLPOX VACCINE; IMMUNE-RESPONSE; VIRUS ANKARA; DENDRITIC CELLS; PROTEIN-KINASE; ANIMAL-MODELS; UNITED-STATES; SKIN-LESIONS; NC/NGA MICE; DERMATITIS	Smallpox vaccine based on live, replicating vaccinia virus (VACV) is associated with several potentially serious and deadly complications. Consequently, a new generation of vaccine based on non-replicating Modified vaccinia virus Ankara (MVA) has been under clinical development. MVA seems to induce good immune responses in blood tests, but it is impossible to test its efficacy in vivo in human. One of the serious complications of the replicating vaccine is eczema vaccinatum (EV) occurring in individuals with atopic dermatitis (AD), thus excluding them from all preventive vaccination schemes. In this study, we first characterized and compared development of eczema vaccinatum in different mouse strains. Nc/Nga, Balb/c and C57BI/6J mice were epicutaneously sensitized with ovalbumin (OVA) or saline control to induce signs of atopic dermatitis and subsequently trans-dermally (t.d.) immunized with VACV strain Western Reserve (WR). Large primary lesions occurred in both mock- and OVA-sensitized Nc/Nga mice, while they remained small in Balb/c and C57BI/6J mice. Satellite lesions developed in both mock-and OVA-sensitized Nc/Nga and in OVA-sensitized Balb/c mice with the rate 40-50%. Presence of mastocytes and eosinophils was the highest in Nc/Nga mice. Consequently, we have chosen Nc/Nga mice as a model of AD/EV and tested efficacy of MVA and Dryvax vaccinations against a lethal intra-nasal (i.n.) challenge with WR, the surrogate of smallpox. Inoculation of MVA intra-muscularly (i.m.) or t.d. resulted in no lesions, while inoculation of Dryvax t.d. yielded large primary and many satellite lesions similar to WR. Eighty three and 92% of mice vaccinated with a single dose of MVA i.m. or t.d., respectively, survived a lethal i.n. challenge with WR without any serious illness, while all Dryvax-vaccinated animals survived. This is the first formal prove of protective immunity against a lethal poxvirus challenge induced by vaccination with MVA in an atopic organism.	[Knitlova, Jarmila; Hajkova, Vera; Elsterova, Jana; Obrova, Barbora; Melkova, Zora] Charles Univ Prague, Fac Med 1, Dept Immunol & Microbiol, Prague 12800 2, Czech Republic; [Voska, Ludek] Inst Clin & Expt Med, Dept Clin & Transplant Pathol, Prague 14021 4, Czech Republic	Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM)	Melkova, Z (corresponding author), Charles Univ Prague, Fac Med 1, Dept Immunol & Microbiol, Studnickova 7, Prague 12800 2, Czech Republic.	zmelk@LF1.cuni.cz	Hájková, Věra/J-7185-2017; Knitlova, Jarmila/AAG-1338-2021; Melkova, Zora/J-4209-2017	Hájková, Věra/0000-0002-2274-4858; Knitlova, Jarmila/0000-0003-4607-4497; Melkova, Zora/0000-0002-9709-2110	Agency of Charles University [100307, PRVOUK-P24/LF1/3]; European Regional Development Fund [CZ.1.05/1.1.00/02.0109]	Agency of Charles University; European Regional Development Fund(European Commission)	This work was supported by Grant Agency of Charles University - project No. 100307 (http://www.cuni.cz/UK-1673. html) (JK); Charles University - project No. PRVOUK-P24/LF1/3 (http://www.cuni.cz/UK-4157. html) (ZM); and European Regional Development Fund -project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec'' (CZ.1.05/1.1.00/02.0109) ((http://www. biocev.eu/en/about/project-in-numbers/) (ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2011, J MOL BIOL, V413, P973, DOI 10.1016/j.jmb.2011.09.025; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Artenstein AW, 2008, REV MED VIROL, V18, P217, DOI 10.1002/rmv.571; Baixeras E, 1998, VIRUS RES, V58, P107, DOI 10.1016/S0168-1702(98)00105-1; Barchichat S, 2002, VIRUS RES, V90, P243, DOI 10.1016/S0168-1702(02)00200-9; Becker Y, 2003, VIRUS GENES, V27, P269, DOI 10.1023/A:1026399916888; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Gutermutha J, 2004, INT ARCH ALLERGY IMM, V135, P262, DOI 10.1159/000082099; Guzman E, 2012, J VIROL, V86, P5452, DOI 10.1128/JVI.00264-12; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Kalbacova M, 2008, VIRUS RES, V135, P53, DOI 10.1016/j.virusres.2008.02.007; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kawakami Yuko, 2007, Allergol Int, V56, P403, DOI 10.2332/allergolint.O-07-486; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kutinova L, 1996, VACCINE, V14, P1045, DOI 10.1016/0264-410X(96)00008-4; KUTINOVA L, 1995, VACCINE, V13, P487, DOI 10.1016/0264-410X(94)00019-J; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liskova J, 2011, VIRUS RES, V160, P40, DOI 10.1016/j.virusres.2011.05.005; Mamessier E, 2005, REV MAL RESPIR, V22, P305, DOI 10.1019/200539977; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Matsumoto M, 1999, J IMMUNOL, V162, P1056; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Miljkovic Z, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-37; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Nemeckova S, 2001, ACTA VIROL, V45, P243; Oyoshi MK, 2012, J INVEST DERMATOL, V132, P1299, DOI 10.1038/jid.2011.409; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Rager KJ, 1998, J VIROL, V72, P1171, DOI 10.1128/JVI.72.2.1171-1176.1998; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; Scott JE, 2007, J ALLERGY CLIN IMMUN, V120, P1382, DOI 10.1016/j.jaci.2007.08.004; Shiohara T, 2004, J DERMATOL SCI, V36, P1, DOI 10.1016/j.jdermsci.2004.02.013; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Townsend MB, 2012, J VIROL; Vestergaard C, 2000, MOL MED TODAY, V6, P209, DOI 10.1016/S1357-4310(00)01683-X; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; von Sonnenburg F, 2014, VACCINE, V32, P5696, DOI 10.1016/j.vaccine.2014.08.022; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wertheimer ER, 2012, VACCINE, V30, P985, DOI 10.1016/j.vaccine.2011.12.049; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yagi R, 2002, J IMMUNOL, V168, P2020, DOI 10.4049/jimmunol.168.4.2020	55	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114374	10.1371/journal.pone.0114374	http://dx.doi.org/10.1371/journal.pone.0114374			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486419	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600050
J	Liu, Y; Yu, JT; Wang, HF; Hao, XK; Yang, YF; Jiang, T; Zhu, XC; Cao, L; Zhang, DQ; Tan, L				Liu, Ying; Yu, Jin-Tai; Wang, Hui-Fu; Hao, Xiao-Ke; Yang, Yu-Fen; Jiang, Teng; Zhu, Xi-Chen; Cao, Lei; Zhang, Dao-Qiang; Tan, Lan			Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; LEWY BODIES; BRAIN; EXPRESSION; GENE; SUSCEPTIBILITY; EPIDEMIOLOGY; DEMENTIA; VOLUME; NM23	Recently, a large meta-analysis of five genome wide association studies (GWAS) identified a novel locus (rs2718058) adjacent to NME8 that played a preventive role in Alzheimer's disease (AD). However, this link between the single nucleotide polymorphism (SNP) rs2718058 and the pathology of AD have not been mentioned yet. Therefore, this study assessed the strength of association between the NME8 rs2718058 genotypes and AD-related measures including the cerebrospinal fluid (CSF) amyloid beta, tau, P-tau concentrations, neuroimaging biomarkers and cognitive performance, in a large cohort from Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used information of a total of 719 individuals, including 211 normal cognition (NC), 346 mild cognitive impairment (MCI) and 162 AD. Although we didn't observe a positive relationship between rs2718058 and AD, it was significantly associated with several AD related endophenotypes. Among the normal cognitively normal participants, the minor allele G carriers showed significantly associated with higher CDRSB score than A allele carriers (P=0.021). Occipital gyrus atrophy were significantly associated with NME8 genotype status (P=0.002), with A allele carriers has more atrophy than the minor allele G carriers in AD patients; lateral ventricle (both right and left) cerebral metabolic rate for glucose (CMRgl) were significantly associated with NME8 genotype (P<0.05), with GA genotype had higher metabolism than GG and AA genotypes in MCI group; the atrophic right hippocampus in 18 months is significantly different between the three group, with GG and AA genotypes had more hippocampus atrophy than GA genotypes in the whole group. Together, our results are consistent with the direction of previous research, suggesting that NME8 rs2718058 appears to play a role in lowering the brain neurodegeneration.	[Liu, Ying; Yu, Jin-Tai; Tan, Lan] Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China; [Yu, Jin-Tai; Tan, Lan] Qingdao Univ, Qingdao Municipal Hosp, Sch Med, Dept Neurol, Qingdao, Peoples R China; [Yu, Jin-Tai; Wang, Hui-Fu; Zhu, Xi-Chen; Cao, Lei; Tan, Lan] Nanjing Med Univ, Qingdao Municipal Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Hao, Xiao-Ke; Zhang, Dao-Qiang] Nanjing Univ Aeronaut & Astronaut, Dept Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Yang, Yu-Fen] Air Beijing Dongjiao Lane Community Hlth, Beijing, Peoples R China; [Jiang, Teng] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Dalian Medical University; Qingdao Municipal Hospital; Qingdao Municipal Hospital; Qingdao University; Nanjing Medical University; Nanjing University of Aeronautics & Astronautics; Nanjing Medical University	Yu, JT (corresponding author), Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China.	yu-jintai@163.com; dr.tanlan@163.com	Yu, Jin-Tai/HDL-7766-2022	Yu, Jin-Tai/0000-0002-7686-0547	ADNI (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Bio-Clinica, Inc; Biogen Idec Inc; Bristol-Myers Squibb Co, F. HoffmannLaRoche Ltd and Genetech, Inc; GE Healthcare; Innogenetics, NV; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development LLC; Medpace, Inc; Merck Co, Inc; Meso Scale Diagnostics, LLC; NeuroRx Research; Novartis Pharmaceuticals, Co, Pfizer, Inc; Piramal Imaging; Servier; Synarc Inc; Takeda Pharmaceutical Co; ADNI clinical sites in Canada; National Natural Science Foundation of China [81171209, 81371406, 81000544]; Jiangsu Natural Science Foundation for Distinguished Young Scholar [BK20130034]; NATIONAL INSTITUTE ON AGING [U24AG021886, U01AG024904] Funding Source: NIH RePORTER	ADNI (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Bio-Clinica, Inc; Biogen Idec Inc(Biogen); Bristol-Myers Squibb Co, F. HoffmannLaRoche Ltd and Genetech, Inc(Bristol-Myers Squibb); GE Healthcare(General ElectricGE Healthcare); Innogenetics, NV; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development LLC; Medpace, Inc; Merck Co, Inc(Merck & Company); Meso Scale Diagnostics, LLC; NeuroRx Research; Novartis Pharmaceuticals, Co, Pfizer, Inc; Piramal Imaging; Servier(Servier); Synarc Inc; Takeda Pharmaceutical Co(Takeda Pharmaceutical Company Ltd); ADNI clinical sites in Canada; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation for Distinguished Young Scholar; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing was funded by ADNI (National Institutes of Health U01 AG024904). ADNI is funded by the National Institute on Aging; the National Institute of Biomedical Imaging and Bioengineering; the Alzheimer's Association; the Alzheimer's Drug Discovery Foundation; Bio-Clinica, Inc; Biogen Idec Inc; Bristol-Myers Squibb Co, F. HoffmannLaRoche Ltd and Genetech, Inc; GE Healthcare; Innogenetics, NV; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development LLC; Medpace, Inc; Merck & Co, Inc; Meso Scale Diagnostics, LLC; NeuroRx Research; Novartis Pharmaceuticals, Co, Pfizer, Inc; Piramal Imaging; Servier; Synarc Inc; and Takeda Pharmaceutical Co. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private-sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization was the Northern California Institute for Research and Education, and the study was coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Natural Science Foundation of China (81171209, 81371406, 81000544) and Jiangsu Natural Science Foundation for Distinguished Young Scholar (No. BK20130034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford JW, 2011, J ALZHEIMERS DIS, V27, P885, DOI 10.3233/JAD-2011-110950; Ashford JW, 2011, J ALZHEIMERS DIS, V26, P1, DOI 10.3233/JAD-2011-0073; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; CALIGO MA, 1995, INT J CANCER, V60, P837, DOI 10.1002/ijc.2910600619; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Erten-Lyons D, 2010, ALZHEIMERS DEMENT, V6, P118, DOI 10.1016/j.jalz.2009.05.663; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; Jiang T, 2012, J ALZHEIMERS DIS, V31, P475, DOI 10.3233/JAD-2012-120640; Kantarci K, 2012, NEUROBIOL AGING, V33, P2091, DOI 10.1016/j.neurobiolaging.2011.09.024; KEIM D, 1992, J CLIN INVEST, V89, P919, DOI 10.1172/JCI115672; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kim SH, 2002, BIOCHEM BIOPH RES CO, V296, P970; Kremen WS, 2012, NEUROBIOL AGING, V33, P1, DOI 10.1016/j.neurobiolaging.2010.02.007; Lahiri DK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-68; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lebedev AV, 2013, J NEUROL, V260, P1104, DOI 10.1007/s00415-012-6768-z; Migliaccio R, 2012, ALZHEIMERS DEMENT, V8, pe71; Migliaccio Raffaella, 2012, Alzheimers Dement, V8, pS78, DOI 10.1016/j.jalz.2012.04.010; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; MOURAD N, 1966, J BIOL CHEM, V241, P271; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Raamana PR, 2014, FRONTIERS NEUROLOGY, V5; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	29	12	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114777	10.1371/journal.pone.0114777	http://dx.doi.org/10.1371/journal.pone.0114777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486118	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600098
J	Pinfield, S; Cox, AM; Smith, J				Pinfield, Stephen; Cox, Andrew M.; Smith, Jen			Research Data Management and Libraries: Relationships, Activities, Drivers and Influences	PLOS ONE			English	Article							SERVICES	The management of research data is now a major challenge for research organisations. Vast quantities of born-digital data are being produced in a wide variety of forms at a rapid rate in universities. This paper analyses the contribution of academic libraries to research data management (RDM) in the wider institutional context. In particular it: examines the roles and relationships involved in RDM, identifies the main components of an RDM programme, evaluates the major drivers for RDM activities, and analyses the key factors influencing the shape of RDM developments. The study is written from the perspective of library professionals, analysing data from 26 semi-structured interviews of library staff from different UK institutions. This is an early qualitative contribution to the topic complementing existing quantitative and case study approaches. Results show that although libraries are playing a significant role in RDM, there is uncertainty and variation in the relationship with other stakeholders such as ITservices and research support offices. Current emphases in RDM programmes are on developments of policies and guidelines, with some early work on technology infrastructures and support services. Drivers for developments include storage, security, quality, compliance, preservation, and sharing with libraries associated most closely with the last three. The paper also highlights a 'jurisdictional' driver in which libraries are claiming a role in this space. A wide range of factors, including governance, resourcing and skills, are identified as influencing ongoing developments. From the analysis, a model is constructed designed to capture the main aspects of an institutional RDM programme. This model helps to clarify the different issues involved in RDM, identifying layers of activity, multiple stakeholders and drivers, and a large number of factors influencing the implementation of any initiative. Institutions may usefully benchmark their activities against the data and model in order to inform ongoing RDM activity.	[Pinfield, Stephen; Cox, Andrew M.; Smith, Jen] Univ Sheffield, Informat Sch, Sheffield, S Yorkshire, England	University of Sheffield	Pinfield, S (corresponding author), Univ Sheffield, Informat Sch, Sheffield, S Yorkshire, England.	s.pinfield@sheffield.ac.uk	Cox, Andrew/J-9568-2016	Cox, Andrew/0000-0002-2587-245X; Pinfield, Stephen/0000-0003-4696-764X; Smith, Jen/0000-0001-5329-0417				Abbott A., 1988, SYSTEM PROFESSIONS; Auckland M., 2012, RESKILLING RES INVES; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carlson J, 2010, STAFFING SUSTAINING, P234; Corrall S, 2013, LIBR TRENDS, V61, P636, DOI 10.1353/lib.2013.0005; Corrall Sheila, 2012, MANAGING RES DATA, P10533; Cox AM, 2013, UPSKILLING LIAISON L, V70; Cox AM, 2014, J LIB INF SCI; Delserone LM, 2008, LIBR TRENDS, V57, P202, DOI 10.1353/lib.0.0032; EPSRC, 2011, EPSRC POL FRAM RES D; Haywood, 2011, INT J DIGIT CURATION, V6, P232, DOI DOI 10.2218/IJDC.V6I2.199; Henty M, 2008, AUSTR LIB INF ASS BI; Jones S., 2014, DELIVERING RES DATA, P89, DOI DOI 10.29085/9781783300242; Jones S, 2013, DEV RDM SERIVCES GUI; Kennan MA, 2011, LIBR MANAGE, V32, P302, DOI 10.1108/01435121111132301; Laney D, 2001, META GROUP RES NOTE, V6, P1; Lewis MJ, 2010, ENVISIONING FUTURE A; Lyon L., 2012, INT J DIGIT CURATION, V7, P126, DOI DOI 10.2218/IJDC.V7I1.220; Mayernik M, 2012, D LIB MAG, V18; McAfee A, 2012, HARVARD BUS REV, V90, P60; National Institutes of Health, 2003, FIN NIH STAT SHAR RE; Nielsen HJ, 2014, J DOC, V70, P221, DOI 10.1108/JD-03-2013-0034; Procter R., 2012, MANAGING RES DATA, P135; Pryor G., 2012, MANAGING RES DATA, DOI [10.29085/9781856048910, DOI 10.29085/9781856048910]; Pryor G., 2013, DELIVERING RES DATA; Royal Society, 2012, SCI OP ENT FIN REP; Shen Y, 2013, J ACAD LIBR, V39, P552, DOI 10.1016/j.acalib.2013.06.002; Tenopir C., 2012, ACAD LIB RES DATA SE; Tenopir C, 2014, LIBR INFORM SCI RES, V36, P84, DOI 10.1016/j.lisr.2013.11.003; Tenopir C, 2013, IFLA J-INT FED LIBR, V39, P70, DOI 10.1177/0340035212473089; Treloar A., 2012, MANAGING RES DATA, P173; Whyte A., 2011, DCC BRIEFING PAPERS; Whyte A., 2014, DELIVERING RES DATA, P59; WILSON J, 2011, INT J DIGIT CURATION, P6	35	51	52	9	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114734	10.1371/journal.pone.0114734	http://dx.doi.org/10.1371/journal.pone.0114734			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25485539	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000346907600091
J	Simonetta, F; Gestermann, N; Bloquet, S; Bourgeois, C				Simonetta, Federico; Gestermann, Nicolas; Bloquet, Stephane; Bourgeois, Christine			Interleukin-7 Optimizes FOXP3+CD4+Regulatory T Cells Reactivity to Interleukin-2 by Modulating CD25 Expression	PLOS ONE			English	Article							HOMEOSTATIC PROLIFERATION; CD127 EXPRESSION; IL-2 RECEPTOR; CUTTING EDGE; FOXP3; TRANSCRIPTION; STIMULATION; LYMPHOPENIA; MAINTENANCE; INDUCTION	The vast majority of Foxp3 regulatory T cells (Treg) exhibits constitutive expression of CD25 (IL-2R alpha), which allows the constitution of the high affinity IL-2R alpha beta gamma receptor, ensuring efficient IL-2 binding by Treg. Maintenance of CD25 expression at Treg surface depends on both cell intrinsic factors and environmental stimuli such as IL-2 itself. Whether other factors can participate to maintenance of CD25 expression in vivo is at present unknown. In the present work we demonstrated that IL-7, a gamma-chain cytokine exerting a crucial role in T cell development and homeostasis, is able and necessary to sustain the expression of high levels of CD25 at Treg surface. We demonstrated that, during in vitro cultures performed in the absence of IL-2, IL-7 is able to sustain CD25 expression at Treg surface through a transcriptional mechanism. By studying mice in which IL-7 signaling is either genetically impaired or increased and by employing adoptive transfer murine models, we demonstrated that IL-7 is necessary for sustained expression of CD25 at Treg surface in vivo. To ascertain the biological impact of IL-7 mediated modulation of CD25 expression, we demonstrated that IL-7 modulation of CD25 expression at Treg surface affected their ability to efficiently bind IL-2 and transduce IL-2 signaling. Finally, we demonstrated that IL-7 dependent modulation of CD25 associated with potentiated IL-2 induced expansion of Treg in vivo. Collectively, our results identify IL-7 as a necessary factor contributing to sustained CD25 expression at Treg surface in vivo thereby affecting their ability to efficiently react to IL-2.	[Simonetta, Federico; Gestermann, Nicolas; Bourgeois, Christine] INSERM, U1012, Le Kremlin Bicetre, France; [Simonetta, Federico; Gestermann, Nicolas; Bourgeois, Christine] Univ Paris Sud, U1012, Le Kremlin Bicetre, France; [Simonetta, Federico] Univ Hosp Geneva, Dept Med Specialties, Div Hematol, Geneva, Switzerland; [Bloquet, Stephane] Univ Paris Sud, Fac Med Paris Sud, Animalerie Centrale, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bourgeois, C (corresponding author), INSERM, U1012, Le Kremlin Bicetre, France.	christine.bourgeois@u-psud.fr	Bourgeois, Christine/L-5944-2018; Simonetta, Federico/CAH-2436-2022; Bourgeois, Christine/ABA-1432-2021	Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Simonetta, Federico/0000-0002-0399-689X	Agence Nationale de la recherche contre le SIDA et les hepatites virales (ANRS); Fondation de France; Fondation pour la recherche medicale (FRM)	Agence Nationale de la recherche contre le SIDA et les hepatites virales (ANRS)(ANRS); Fondation de France(Fondation de France); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Agence Nationale de la recherche contre le SIDA et les hepatites virales (ANRS) and Fondation de France. Federico Simonetta was also supported by the Fondation pour la recherche medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Amado IF, 2013, J EXP MED, V210, P2707, DOI 10.1084/jem.20122759; ARMITAGE RJ, 1990, J IMMUNOL, V144, P938; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bosco N, 2006, J IMMUNOL, V177, P5014, DOI 10.4049/jimmunol.177.8.5014; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Camperio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048303; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; COSTELLO R, 1993, IMMUNOLOGY, V80, P451; Cozzo C, 2003, J IMMUNOL, V171, P5678, DOI 10.4049/jimmunol.171.11.5678; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Dupont G, 2014, CYTOKINE, V69, P146, DOI 10.1016/j.cyto.2014.05.021; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; GRABSTEIN KH, 1990, J IMMUNOL, V144, P3015; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kennedy-Nasser AA, 2014, CLIN CANCER RES, V20, P2215, DOI 10.1158/1078-0432.CCR-13-3205; Kim GY, 2012, J IMMUNOL, V188, P5859, DOI 10.4049/jimmunol.1102328; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; MORRISSEY PJ, 1989, J EXP MED, V169, P707, DOI 10.1084/jem.169.3.707; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Raynor J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00161; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Simonetta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036596; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	54	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113314	10.1371/journal.pone.0113314	http://dx.doi.org/10.1371/journal.pone.0113314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485946	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600018
J	Jamesdaniel, S				Jamesdaniel, Samson			Downstream Targets of Lmo4 Are Modulated by Cisplatin in the Inner Ear of Wistar Rats	PLOS ONE			English	Article							LIM DOMAIN; INDUCED OTOTOXICITY; SIGNAL TRANSDUCER; APOPTOSIS; EXPRESSION; RESPONSES; TRANSCRIPTION; NITRATION; ACTIVATOR; PROTEINS	Lmo4, a transcriptional regulator, appears to be a key player in mediating the cochlear pathology in cisplatin ototoxicity, as it controls cellular responses by modulating the formation of transcriptional complexes. We provided the first evidence of in vivo nitration of Lmo4 in cisplatin ototoxicity. Our data suggested that nitration of Lmo4 and associated decrease in its cochlear expression has the potential to play a pivotal role in cisplatin ototoxicity. However, the Lmo4 interactomes that signal the downstream events in the cochlea are poorly understood. Therefore, custom-made gene arrays were employed to evaluate the modulation of known binding partners or targets of Lmo4, in Wistar rats treated with 16 mg/kg cisplatin. RT-PCR analysis, 3 days post cisplatin treatment, indicated that cisplatin induced up/down regulation of multiple cochlear genes associated with Lmo4 signaling. The cochlear expression of Esr1 was significantly up-regulated by cisplatin treatment, while the expression of Stat3 was down-regulated. Co-treatment with Trolox, an otoprotective antioxidant, attenuated the cisplatin-induced modulation of 5 genes in the cochlea. Consistent with the changes observed at the gene level, immunoblots with anti-Stat3 indicated that cisplatin-induced decrease in cochlear protein levels were attenuated by Trolox co-treatment. These results suggest that cisplatin-induced decreases in the cochlear Lmo4 upon nitration, and associated modulation in the cochlear expression of its binding partners Esr1 and Jak1, probably facilitates the repression of Stat3, a downstream target of Lmo4 implicated in drug mediated apoptosis. Collectively, these findings provide insights on Lmo4 downstream events and indicate a potential role of Jak/Stat transcriptional machinery in relaying the Lmo4 protein signaling in cisplatin-induced ototoxicity.	[Jamesdaniel, Samson] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Jamesdaniel, Samson] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA	Wayne State University; Wayne State University	Jamesdaniel, S (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA.	sjamesdaniel@wayne.edu	Jamesdaniel, Samson/ABA-2616-2021	Jamesdaniel, Samson/0000-0002-5269-9007	National Institute on Deafness and other Communication Disorders, National Institutes of Health [5R03DC010225-03]; National Organization for Hearing Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010225] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Organization for Hearing Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by the National Institute on Deafness and other Communication Disorders, National Institutes of Health (5R03DC010225-03) and by National Organization for Hearing Research (2013-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charitidi K, 2009, HEARING RES, V252, P71, DOI 10.1016/j.heares.2008.12.009; CHU G, 1994, J BIOL CHEM, V269, P787; Deng M, 2006, GENE EXPR PATTERNS, V6, P857, DOI 10.1016/j.modgep.2006.02.005; Jamesdaniel S, 2008, J PROTEOME RES, V7, P3516, DOI 10.1021/pr8002479; Jamesdaniel S, 2012, J BIOL CHEM, V287, P18674, DOI 10.1074/jbc.M111.297960; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; More SS, 2010, J NEUROSCI, V30, P9500, DOI 10.1523/JNEUROSCI.1544-10.2010; Natal C, 2008, APOPTOSIS, V13, P1356, DOI 10.1007/s10495-008-0263-0; Novotny-Diermayr V, 2005, J BIOL CHEM, V280, P12747, DOI 10.1074/jbc.M500175200; Qin ZH, 2012, J NEUROSCI, V32, P4271, DOI 10.1523/JNEUROSCI.6271-11.2012; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Schmitt NC, 2009, J NEUROSCI, V29, P3843, DOI 10.1523/JNEUROSCI.5842-08.2009; Setogawa T, 2006, BIOCHEM BIOPH RES CO, V343, P1186, DOI 10.1016/j.bbrc.2006.03.077; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Tian YP, 2010, CLIN EXP METASTAS, V27, P455, DOI 10.1007/s10585-010-9332-1; Walter S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.026; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Zhao W, 2011, ANTI-CANCER DRUG, V22, P79, DOI 10.1097/CAD.0b013e32833f44fd	26	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115263	10.1371/journal.pone.0115263	http://dx.doi.org/10.1371/journal.pone.0115263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501662	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400088
J	Mosca, S; Nicosia, MGL; Cacciola, SO; Schena, L				Mosca, Saveria; Nicosia, Maria G. Li Destri; Cacciola, Santa O.; Schena, Leonardo			Molecular Analysis of Colletotrichum Species in the Carposphere and Phyllosphere of Olive	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MULTIPLE SEQUENCE ALIGNMENT; ROSELLINIA-NECATRIX; CAUSAL AGENT; DNA BARCODE; ANTHRACNOSE; DIVERSITY; COMMUNITY; ACUTATUM; REGION	A metagenomic approach based on the use of genus specific primers was developed and utilized to characterize Colletotrichum species associated with the olive phyllosphere and carposphere. Selected markers enabled the specific amplification of almost the entire ITS1-5.8S-ITS2 region of the rDNA and its use as barcode gene. The analysis of different olive samples (green and senescent leaves, floral residues, symptomatic and asymptomatic fruits, and litter leaves and mummies) in three different phenological phases (June, October and December) enabled the detection of 12 genotypes associated with 4 phylotypes identified as C. godetiae, C. acutatum s.s., C. gloeosporioides s. s. and C. kahawae. Another three genotypes were not identified at the level of species but were associated with the species complexes of C. acutatum, C. gloeosporioides and C. boninense sensu lato. Colletotrichum godetiae and C. acutatum s.s. were by far the most abundant while C. gloeosporioides s. s. was detected in a limited number of samples whereas ther phylotypes were rarely found. The high incidence of C. acutatum s. s. represents a novelty for Italy and more generally for the Mediterranean basin since it had been previously reported only in Portugal. As regards to the phenological phase, Colletotrichum species were found in a few samples in June and were diffused on all assessed samples in December. According to data new infections on olive tissues mainly occur in the late fall. Furthermore, Colletotrichum species seem to have a saprophytic behavior on floral olive residues. The method developed in the present study proved to be valuable and its future application may contribute to the study of cycle and aetiology of diseases caused by Colletotrichum species in many different pathosystems.	[Mosca, Saveria; Nicosia, Maria G. Li Destri; Schena, Leonardo] Univ Mediterranea, Dipartimento Agr, Reggio Di Calabria, Italy; [Cacciola, Santa O.] Univ Catania, Dipartimento Gest Sistemi Agroalimentari & Ambien, Catania, Italy	Universita Mediterranea di Reggio Calabria; University of Catania	Schena, L (corresponding author), Univ Mediterranea, Dipartimento Agr, Reggio Di Calabria, Italy.	lschena@unirc.it	, Santa Olga Cacciola/H-7416-2019; Li Destri Nicosia, Maria Giulia/AGG-0569-2022; Schena, Leonardo/A-7492-2018	Schena, Leonardo/0000-0002-9737-2593; Mosca, Saveria/0000-0003-4985-8641; Li Destri Nicosia, Maria Giulia/0000-0001-5201-0057	Italian Ministry of Education, University and Research (MIUR) [RBFR10PZ4N]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by grant MIURFIRB 2010 (RBFR10PZ4N) from the Italian Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Agosteo GE, 2002, ACTA HORTIC, P713, DOI 10.17660/ActaHortic.2002.586.152; Agosteo GE, 2005, J PLANT PATHOL, V87, P287; [Anonymous], 1899, BULL SOC MYCOL FR; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Cacciola SO, 2012, J PLANT PATHOL, V94, P29; Cai L, 2009, FUNGAL DIVERS, V39, P183; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Carris LM, 2012, PLANT HLTH INSTRUCTO, P1, DOI [10.1094/PHI-I-2012-0426-01, DOI 10.1094/PHI-I-2012-0426-01]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Damm U, 2012, STUD MYCOL, P1, DOI 10.3114/sim0002; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Damm U, 2009, FUNGAL DIVERS, V39, P45; Damm U, 2013, FUNGAL DIVERS, V61, P29, DOI 10.1007/s13225-013-0255-4; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faedda R, 2011, PHYTOPATHOL MEDITERR, V50, P283; Friedl MA, 2012, MICROBIOL-SGM, V158, P69, DOI 10.1099/mic.0.052555-0; Graniti A., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P457, DOI 10.1111/j.1365-2338.1993.tb01353.x; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindner DL, 2013, ECOL EVOL, V3, P1751, DOI 10.1002/ece3.586; MARTELLI G. P., 1960, Phytopathologia Mediterranea, V1, P31; Martin MP, 1999, EUR J PLANT PATHOL, V105, P733, DOI 10.1023/A:1008785703330; Moral J, 2008, PLANT DIS, V92, P1421, DOI 10.1094/PDIS-92-10-1421; Moral J, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.110913; Moral J, 2009, PLANT DIS, V93, P1028, DOI 10.1094/PDIS-93-10-1028; Moral J, 2012, PHYTOPATHOLOGY, V102, P982, DOI 10.1094/PHYTO-12-11-0344; Moral J, 2009, PHYTOPATHOLOGY, V99, P548, DOI 10.1094/PHYTO-99-5-0548; Peay KG, 2008, BIOSCIENCE, V58, P799, DOI 10.1641/B580907; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruano-Rosa D, 2007, PLANT PATHOL, V56, P251, DOI 10.1111/j.1365-3059.2006.01546.x; Sanzani SM, 2012, POSTHARVEST BIOL TEC, V68, P64, DOI 10.1016/j.postharvbio.2012.02.003; Schena L, 2014, PLANT PATHOL, V63, P437, DOI 10.1111/ppa.12110; Schena L, 2013, J PLANT PATHOL, V95, P7; Schena L, 2002, EUR J PLANT PATHOL, V108, P355, DOI 10.1023/A:1015697813352; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Scibetta S, 2012, J MICROBIOL METH, V88, P356, DOI 10.1016/j.mimet.2011.12.012; SERGEEVA V, 2010, PETRIA, V20, P251; Shivas RG, 2009, FUNGAL DIVERS, V39, P111; Sreenivasaprasad S, 2005, MOL PLANT PATHOL, V6, P361, DOI 10.1111/J.1364-3703.2005.00291.X; Talhinhas P, 2011, PLANT PATHOL, V60, P483, DOI 10.1111/j.1365-3059.2010.02397.x; Talhinhas P, 2009, FEMS MICROBIOL LETT, V296, P31, DOI 10.1111/j.1574-6968.2009.01613.x; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Varzea VMP, 2002, PLANT PATHOL, V51, P202; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Yang YL, 2009, FUNGAL DIVERS, V39, P123	55	38	39	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114031	10.1371/journal.pone.0114031	http://dx.doi.org/10.1371/journal.pone.0114031			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501572	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700013
J	Sun, K; Li, F; Lin, DZ; Qi, YQ; Xu, MT; Li, N; Huang, CL; Ren, M; Li, Y; Yan, L				Sun, Kan; Li, Feng; Lin, Diaozhu; Qi, Yiqin; Xu, Mingtong; Li, Na; Huang, Chulin; Ren, Meng; Li, Yan; Yan, Li			Serum Gamma - Glutamyltransferase Is Associated with Albuminuria: A Population-Based Study	PLOS ONE			English	Article							LOW-GRADE ALBUMINURIA; CHINESE DIABETIC INDIVIDUALS; GLOMERULAR-FILTRATION-RATE; GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; RISK-EVALUATION; HEART-FAILURE; MICROALBUMINURIA; INFLAMMATION	Background: Serum gamma-glutamyltransferase (GGT) is implicated in the pathogenesis of endothelial dysfunction and atherosclerosis. Albuminuria is a marker of endothelial damage and correlated with structural and functional integrity of the vasculature. Our objective was to evaluate the association between serum GGT level and prevalence of albuminuria in a Chinese population. Materials and Methods: We conducted a population-based cross-sectional study in 9,702 subjects aged 40 years or older. Increased urinary albumin excretion was defined according to the urinary albumin-to-creatinine ratio (ACR) ranges greater or equal than 30 mg/g. Low-grade albuminuria was defined according to the highest quartile of ACR in participants without increased urinary albumin excretion. Results: The prevalence of low-grade albuminuria and increased urinary albumin excretion were respectively 23.4% and 6.6% in this population and gradually increased across the sex-specific serum GGT quartiles (all P for trend <0.05). In logistic regression analysis, compared with subjects in the lowest quartile of serum GGT level, the adjusted odds ratios (ORs) in the highest quartile was 1.22 [95% confidence interval (CI), 1.04-1.43] for low-grade albuminuria and 1.55 (95% CI, 1.18-2.04) for increased urinary albumin excretion. In subgroup analysis, significant relationship of serum GGT level with both low-grade albuminuria and increased urinary albumin excretion were detected in women, younger subjects, overweight subjects and in those with hypertension or glomerular filtration rate greater than 90 (all P<0.05). Conclusion: Serum GGT level is associated with urinary albumin excretion in middle-aged and elderly Chinese.	[Sun, Kan; Li, Feng; Lin, Diaozhu; Qi, Yiqin; Xu, Mingtong; Li, Na; Huang, Chulin; Ren, Meng; Li, Yan; Yan, Li] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University	Li, Y (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Endocrinol, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	hfxyl@163.net; threefire@126.com			Natural Science Foundation of Guangdong Province, China [10251008901000010]; 5010 Clinical Medical Project of Sun Yat-sen University [2010010]; Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); 5010 Clinical Medical Project of Sun Yat-sen University; Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases	This work was supported by grants from the Natural Science Foundation of Guangdong Province, China (No. 10251008901000010), 5010 Clinical Medical Project of Sun Yat-sen University (No. 2010010) and grants from the Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Clausen P, 2001, CIRCULATION, V103, P1869; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Diercks GFH, 2002, CAN J CARDIOL, V18, P525; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Karp DR, 2001, J BIOL CHEM, V276, P3798, DOI 10.1074/jbc.M008484200; Katz DH, 2014, CIRCULATION, V129, P42, DOI 10.1161/CIRCULATIONAHA.113.003429; Lee DH, 2005, CLIN CHEM, V51, P1185, DOI 10.1373/clinchem.2004.045872; Lee DH, 2005, ATHEROSCLEROSIS, V178, P327, DOI 10.1016/j.atherosclerosis.2004.08.027; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin D, 2014, METABOLISM; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nerpin Elisabet, 2012, BMC Res Notes, V5, P537, DOI 10.1186/1756-0500-5-537; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Perry IJ, 1998, DIABETES CARE, V21, P732, DOI 10.2337/diacare.21.5.732; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Yamada J, 2006, ATHEROSCLEROSIS, V189, P198, DOI 10.1016/j.atherosclerosis.2005.11.036; Yilmaz MI, 2013, INT UROL NEPHROL, V45, P1071, DOI 10.1007/s11255-012-0354-2	38	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114970	10.1371/journal.pone.0114970	http://dx.doi.org/10.1371/journal.pone.0114970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25500578	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700077
J	Gunzenhauser, J; Wyss, R; Manley, S				Gunzenhaeuser, Julia; Wyss, Romain; Manley, Suliana			A Quantitative Approach to Evaluate the Impact of Fluorescent Labeling on Membrane-Bound HIV-Gag Assembly by Titration of Unlabeled Proteins	PLOS ONE			English	Article							CELL; LOCALIZATION; VISUALIZATION; PARTICLES	The assembly process of the human immunodeficiency virus 1 (HIV-1) is driven by the viral polyprotein Gag. Fluorescence imaging of Gag protein fusions is widely performed and has revealed important information on viral assembly. Gag fusion proteins are commonly co-transfected with an unlabeled form of Gag to prevent labeling artifacts such as morphological defects and decreased infectivity. Although viral assembly is widely studied on individual cells, the efficiency of the co-transfection rescue has never been tested at the single cell level. Here, we first develop a methodology to quantify levels of unlabeled to labeled Gag in single cells using a fluorescent reporter protein for unlabeled Gag and fluorescence correlation spectroscopy. Using super-resolution imaging based on photoactivated localization microscopy (PALM) combined with molecular counting we then study the nanoscale morphology of Gag clusters as a function of unlabeled to labeled Gag ratios in single cells. We show that for a given co-transfection ratio, individual cells express a wide range of protein ratios, necessitating a quantitative read-out for the expression of unlabeled Gag. Further, we show that monomerically labeled Gag assembles into membrane-bound clusters that are morphologically indistinguishable from mixtures of unlabeled and labeled Gag.	[Gunzenhaeuser, Julia; Manley, Suliana] Ecole Polytech Fed Lausanne, Lab Expt Biophys, Lausanne, Switzerland; [Wyss, Romain] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne; Ecole Polytechnique Federale de Lausanne	Manley, S (corresponding author), Ecole Polytech Fed Lausanne, Lab Expt Biophys, Lausanne, Switzerland.	suliana.manley@epfl.ch	Manley, Suliana/D-3818-2012	Manley, Suliana/0000-0002-4755-4778	European Community [243016-PALMassembly]	European Community(European Commission)	European Community's Seventh Framework Programme 243016-PALMassembly, SM JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Charette SJ, 2010, J IMMUNOL METHODS, V353, P148, DOI 10.1016/j.jim.2009.12.007; Chen RH, 1999, AM J PHYSIOL-RENAL, V276, pF777, DOI 10.1152/ajprenal.1999.276.5.F777; Chen Y, 2009, BIOPHYS J, V96, P1961, DOI 10.1016/j.bpj.2008.10.067; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Goedhart J., 2011, PLOS ONE, V6; Gonzalez G, 2011, PLOS ONE, V6; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Malkusch S, 2012, HISTOCHEM CELL BIOL, P1; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Materna SC, 2005, FEMS MICROBIOL LETT, V243, P29, DOI 10.1016/j.femsle.2004.11.035; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Starr TE, 2002, J PHYS CHEM B, V106, P2365, DOI 10.1021/jp012689f; Stirnnagel K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-45; Voelkel C, 2010, P NATL ACAD SCI USA, V107, P7805, DOI 10.1073/pnas.0914517107; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115095	10.1371/journal.pone.0115095	http://dx.doi.org/10.1371/journal.pone.0115095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493438	Green Submitted, gold, Green Published			2022-12-27	WOS:000346611400094
J	Liscovitch, N; French, L				Liscovitch, Noa; French, Leon			Differential Co-Expression between alpha-Synuclein and IFN-gamma Signaling Genes across Development and in Parkinson's Disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTERFERON-GAMMA; HUMAN BRAIN; EXPRESSION; IDENTIFICATION; METAANALYSIS; ASSOCIATION; INVOLVEMENT; ACTIVATION; MUTATION	Expression patterns of the alpha-synuclein gene (SNCA) were studied across anatomy, development, and disease to better characterize its role in the brain. In this postmortem study, negative spatial co-expression between SNCA and 73 interferon-gamma (IFN-gamma) signaling genes was observed across many brain regions. Recent animal studies have demonstrated that IFN-gamma induces loss of dopamine neurons and nigrostriatal degeneration. This opposing pattern between SNCA and IFN-gamma signaling genes increases with age (rho=-0.78). In contrast, a meta-analysis of four microarray experiments representing 126 substantia nigra samples reveals a switch to positive co-expression in Parkinson's disease (p<0.005). Use of genome-wide testing demonstrates this relationship is specific to SNCA (p<0.002). This change in co-expression suggests an immunomodulatory role of SNCA that may provide insight into neurodegeneration. Genes showing similar co-expression patterns have been previously linked to Alzheimer's (ANK1) and Parkinson's disease (UBE2E2, PCMT1, HPRT1 and RIT2).	[Liscovitch, Noa] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [French, Leon] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada	Bar Ilan University; University of Toronto; University Toronto Affiliates; Baycrest	French, L (corresponding author), Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada.	leonfrench@gmail.com			National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	A National Sciences and Engineering Research Council of Canada Postdoctoral fellowship award supports LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, MOVEMENT DISORD, V27, P1104, DOI 10.1002/mds.25035; Attia N, 2007, MOL CELL BIOL, V27, P6093, DOI 10.1128/MCB.00789-07; Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Austin SA, 2011, NEUROCHEM RES, V36, P994, DOI 10.1007/s11064-011-0439-9; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; BAUMEISTER AA, 1985, NEUROSCI BIOBEHAV R, V9, P169, DOI 10.1016/0149-7634(85)90043-0; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chakrabarty P, 2011, NAT NEUROSCI, V14, P694, DOI 10.1038/nn.2829; Chen J, 2015, NEUROBIOL AGING, V36, P394, DOI 10.1016/j.neurobiolaging.2014.08.015; Christopher L, 2014, BRAIN, V137, P2143, DOI 10.1093/brain/awu084; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dinh K, 2009, CYTOKINE, V45, P179, DOI 10.1016/j.cyto.2008.12.004; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Greene JG, 2012, NEUROBIOL DIS, V45, P76, DOI 10.1016/j.nbd.2010.10.022; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Jinnah HA, 2010, BRAIN, V133, P671, DOI 10.1093/brain/awq013; Kalaitzakis ME, 2009, NEUROSCI LETT, V461, P12, DOI 10.1016/j.neulet.2009.05.083; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Keller MF, 2012, HUM MOL GENET, V21, P4996, DOI 10.1093/hmg/dds335; Kim J-H, 2014, EXP NEUROBIOL, V23, P148, DOI DOI 10.5607/EN.2014.23.2.148; Kim SH, 2004, PARKINSONISM RELAT D, V10, pS9, DOI 10.1016/j.parkreldis.2003.11.005; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Markopoulou K, 2014, PARKINSONISM RELAT D, V20, P584, DOI 10.1016/j.parkreldis.2014.02.021; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin ED, 2004, EUR J NEUROSCI, V20, P3085, DOI 10.1111/j.1460-9568.2004.03801.x; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ouazia D, 2014, NEUROSCIENCE, V267, P263, DOI 10.1016/j.neuroscience.2014.03.001; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Ramsey CP, 2010, J NEUROCHEM, V113, P402, DOI 10.1111/j.1471-4159.2010.06605.x; Ritter M, 2005, CYTOKINE, V30, P177, DOI 10.1016/j.cyto.2004.12.013; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Tebow G, 2008, PEDIATRICS, V121, pE1563, DOI 10.1542/peds.2007-2795; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zoubarev A, 2012, BIOINFORMATICS, V28, P2272, DOI 10.1093/bioinformatics/bts430	49	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115029	10.1371/journal.pone.0115029	http://dx.doi.org/10.1371/journal.pone.0115029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493648	Green Published, Green Submitted, gold			2022-12-27	WOS:000346611400089
J	Rao, YH; Hao, R; Wang, B; Yao, TP				Rao, Yanhua; Hao, Rui; Wang, Bin; Yao, Tso-Pang			A Mec17-Myosin II Effector Axis Coordinates Microtubule Acetylation and Actin Dynamics to Control Primary Cilium Biogenesis	PLOS ONE			English	Article							ALPHA-TUBULIN ACETYLTRANSFERASE; BARDET-BIEDL-SYNDROME; MYOSIN-II; HEAVY-CHAIN; CILIOGENESIS; TRAFFICKING; MEMBRANE; CELL; PHOSPHORYLATION; MECHANISMS	Primary cilia are specialized, acetylated microtubule-based signaling processes. Cilium assembly is activated by cellular quiescence and requires reconfiguration of microtubules, the actin cytoskeleton, and vesicular trafficking machinery. How these components are coordinated to activate ciliogenesis remains unknown. Here we identify the microtubule acetyltransferase Mec-17 and myosin II motors as the key effectors in primary cilium biogenesis. We found that myosin IIB (Myh10) is required for cilium formation; however, myosin IIA (Myh9) suppresses it. Myh10 binds and antagonizes Myh9 to increase actin dynamics, which facilitates the assembly of the pericentrosomal preciliary complex (PPC) that supplies materials for cilium growth. Importantly, Myh10 expression is upregulated by serum-starvation and this induction requires Mec-17, which is itself accumulated upon cellular quiescence. Pharmacological stimulation of microtubule acetylation also induces Myh10 expression and cilium formation. Thus cellular quiescence induces Mec17 to couple the production of acetylated microtubules and Myh10, whose accumulation overcomes the inhibitory role of Myh9 and initiates ciliogenesis.	[Rao, Yanhua; Hao, Rui; Wang, Bin; Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	tsopang.yao@duke.edu			National Institutes of Health [2R01-NS054022]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by 2R01-NS054022 (National Institutes of Health) to T.-P.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Liu X, 2013, P NATL ACAD SCI USA, V110, pE33, DOI 10.1073/pnas.1219727110; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	30	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114087	10.1371/journal.pone.0114087	http://dx.doi.org/10.1371/journal.pone.0114087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494100	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400029
J	Rustichini, A; Vostroknutov, A				Rustichini, Aldo; Vostroknutov, Alexander			Merit and Justice: An Experimental Analysis of Attitude to Inequality	PLOS ONE			English	Article							EFFICIENCY	Merit and justice play a crucial role in ethical theory and political philosophy. Some theories view justice as allocation according to merit; others view justice as based on criteria of its own, and take merit and justice as two independent values. We study experimentally how these views are perceived. In our experiment subjects played two games (both against the computer): a game of skill and a game of luck. After each game they observed the earnings of all the subjects in the session, and thus the differences in outcomes. Each subject could reduce the winnings of one other person at a cost. The majority of the subjects used the option to subtract. The decision to subtract and the amount subtracted depended on whether the game was one of skill or luck, and on the distance between the earnings of the subject and those of others. Everything else being equal, subjects subtracted more in luck than in skill. In skill game, but not in luck, the subtraction becomes more likely, and the amount larger, as the distance increases. The results show that individuals considered favorable outcomes in luck to be undeserved, and thus felt more justified in subtracting. In the skill game instead, they considered more favorable outcomes (their own as well as others') as signal of ability and perhaps effort, which thus deserved merit; hence, they felt less motivated to subtract. However, a larger size of the unfavorable gap from the others increased the unpleasantness of poor performance, which in turn motivated larger subtraction. In conclusion, merit is attributed if and only if effort or skill significantly affect the outcome. An inequality of outcomes is viewed differently depending on whether merit causes the difference or not. Thus, merit and justice are strongly linked in the human perception of social order.	[Rustichini, Aldo] Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA; [Vostroknutov, Alexander] Maastricht Univ, Dept Econ, Maastricht, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; Maastricht University	Rustichini, A (corresponding author), Univ Minnesota, Dept Econ, Minneapolis, MN 55455 USA.	aldo.rustichini@gmail.com	Vostroknutov, Alexander/AAC-8089-2020	Vostroknutov, Alexander/0000-0001-6588-7448	NSF [SES 0924896]	NSF(National Science Foundation (NSF))	This research was supported in part by the NSF grant SES 0924896 to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Aristotle, 2000, NICOMACHEAN ETHICS; Bault N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003477; Beckman SR, 2002, SOC CHOICE WELFARE, V19, P349, DOI 10.1007/s003550100116; Beckman SR, 2007, RES ECON INEQUAL, V14, P363, DOI 10.1016/S1049-2585(06)14017-X; Berlekamp E. R., 1979, WINNING WAYS YOUR MA; Cameron AC, 2011, J BUS ECON STAT, V29, P238, DOI 10.1198/jbes.2010.07136; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Charness G, 2014, MANAGE SCI, V60, P38, DOI 10.1287/mnsc.2013.1747; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; CUPIT G, 1996, CAN J PHILOS, V26, P83; FELDMAN F, 1996, MIND, V105, P165, DOI 10.1093/mind/105.417.165; Festinger L, 1954, NEBRASKA S MOTIVATIO; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; KLEINIG J, 1971, AM PHILOS QUART, V8, P71; Miller David, 1996, J POLIT PHILOS, V4, P277, DOI DOI 10.1111/j.1467-9760.1996.tb00053.x; Norton EC, 2004, STATA J, V4, P154, DOI 10.1177/1536867X0400400206; Rawls J., 1971, THEORY JUSTICE; Rawls John, 2001, JUSTICE FAIRNESS RES, P42, DOI DOI 10.2307/J.CTV31XF5V0; Rayo L, 2007, J POLIT ECON, V115, P302, DOI 10.1086/516737; Smith Adam, 1966, THEORY MORAL SENTIME; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; Young M., 1958, RISE MERITOCRACY 187; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zizzo DJ, 2001, ANN EC STAT, P39, DOI [DOI 10.1017/S0266462300006280, DOI 10.2307/20076295]	30	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114512	10.1371/journal.pone.0114512	http://dx.doi.org/10.1371/journal.pone.0114512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490094	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300046
J	Esfahani, ZG; Valizadeh, A				Esfahani, Zahra Ghasemi; Valizadeh, Alireza			Zero-Lag Synchronization Despite Inhomogeneities in a Relay System	PLOS ONE			English	Article							PHASE-RESETTING CURVES; CAT VISUAL-CORTEX; NEURONAL OSCILLATIONS; NETWORKS; MODULATION; MODEL; MECHANISM; RESPONSES; DYNAMICS; FEEDBACK	A novel proposal for the zero-lag synchronization of the delayed coupled neurons, is to connect them indirectly via a third relay neuron. In this study, we develop a Poincare map to investigate the robustness of the synchrony in such a relay system against inhomogeneity in the neurons and synaptic parameters. We show that when the inhomogeneity does not violate the symmetry of the system, synchrony is maintained and in some cases inhomogeneity enhances synchrony. On the other hand if the inhomogeneity breaks the symmetry of the system, zero lag synchrony can not be preserved. In this case we give analytical results for the phase lag of the spiking of the neurons in the stable state.	[Esfahani, Zahra Ghasemi; Valizadeh, Alireza] Inst Adv Studies Basic Sci, Zanjan, Iran	Institute for Advanced Studies in Basic Sciences (IASBS)	Valizadeh, A (corresponding author), Inst Adv Studies Basic Sci, Zanjan, Iran.	valizade@iasbs.ac.ir	Valizadeh, Alireza/R-7972-2019; Valizadeh, Alireza/AAQ-1581-2020	Valizadeh, Alireza/0000-0001-5101-8567; 				Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Ariaratnam JT, 2001, PHYS REV LETT, V86, P4278, DOI 10.1103/PhysRevLett.86.4278; Banerjee R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.027201; Barbour B, 2007, TRENDS NEUROSCI, V30, P622, DOI 10.1016/j.tins.2007.09.005; Bayati M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011925; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; BRAIMAN Y, 1995, NATURE, V378, P465, DOI 10.1038/378465a0; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Canavier C.C., 2006, SCHOLARPEDIA, V1, P1332, DOI [10.4249/scholarpedia.1332, DOI 10.4249/SCHOLARPEDIA.1332, DOI 10.4249/SCH0LARPE-DIA.1332]; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; D'Huys O, 2010, SPIE PHOTONICS EUROP; Englert A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.114102; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Ermentrout GB, 2012, NEURAL COMPUT, V24, P3111, DOI 10.1162/NECO_a_00370; Ermentrout GB, 2012, SPR SER COMPUT NEURO, V6, P207, DOI 10.1007/978-1-4614-0739-3_9; Ermentrout GB, 2010, MATH FDN NEUROSCIENC, V64; Ernst U, 1998, PHYS REV E, V57, P2150, DOI 10.1103/PhysRevE.57.2150; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Flunkert V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.254101; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goel P, 2002, PHYSICA D, V163, P191, DOI 10.1016/S0167-2789(01)00374-8; Gollo LL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003548; Gollo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017756; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Hansel D, 2012, SPR SER COMPUT NEURO, V6, P361, DOI 10.1007/978-1-4614-0739-3_15; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Karbowski J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031902; Lu WL, 2004, IEEE T CIRCUITS-I, V51, P2491, DOI 10.1109/TCSI.2004.838308; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MURPHY JT, 1985, CAN J NEUROL SCI, V12, P11, DOI 10.1017/S0317167100046527; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nowotny T, 2003, J NEUROSCI, V23, P9776; Panchuk A, 2013, INT J BIFURCATION CH, V23; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Sadeghi S, 2014, J COMPUT NEUROSCI, V36, P55, DOI 10.1007/s10827-013-0461-9; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Teramae J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.204103; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 1999, FAST OSCILLATIONS CO; Tsodyks M, 2000, J NEUROSCI, V20; Vaadia E., 1992, INFORM PROCESSING CO, P81; Valizadeh A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144520; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Vicente R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066202; Viriyopase A, 2012, FRONTIERS COMPUTATIO, V6; Wang XJ, 1996, J NEUROSCI, V16, P6402; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Woodman MM, 2011, J COMPUT NEUROSCI, V31, P401, DOI 10.1007/s10827-011-0315-2; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	76	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112688	10.1371/journal.pone.0112688	http://dx.doi.org/10.1371/journal.pone.0112688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486522	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600011
J	Falcon, CR; Masih, D; Gatti, G; Sanchez, MC; Motran, CC; Cervi, L				Falcon, Cristian R.; Masih, Diana; Gatti, Gerardo; Cecilia Sanchez, Maria; Motran, Claudia C.; Cervi, Laura			Fasciola hepatica Kunitz Type Molecule Decreases Dendritic Cell Activation and Their Ability to Induce Inflammatory Responses	PLOS ONE			English	Article							ANTIGENS; MATURATION; TH17	The complete repertoire of proteins with immunomodulatory activity in Fasciola hepatica (Fh) has not yet been fully described. Here, we demonstrated that Fh total extract (TE) reduced LPS-induced DC maturation, and the DC ability to induce allogeneic responses. After TE fractionating, a fraction lower than 10 kDa (F<10 kDa) was able to maintain the TE properties to modulate the DC pro-and anti-inflammatory cytokine production induced by LPS. In addition, TE or F<10 kDa treatment decreased the ability of immature DC to stimulate the allogeneic responses and induced a novo allogeneic CD4+CD25+Foxp3+ T cells. In contrast, treatment of DC with T/L or F<10 kDa plus LPS (F<10/L) induced a regulatory IL-27 dependent mechanism that diminished the proliferative and Th1 and Th17 allogeneic responses. Finally, we showed that a Kunitz type molecule (Fh-KTM), present in F<10 kDa, was responsible for suppressing pro-inflammatory cytokine production in LPS-activated DC, by printing tolerogenic features on DC that impaired their ability to induce inflammatory responses. These results suggest a modulatory role for this protein, which may be involved in the immune evasion mechanisms of the parasite.	[Falcon, Cristian R.] Natl Univ Cordoba, Dept Biol Chem, Fac Chem Sci, CIQUIBIC CONICET, Cordoba, Argentina; [Masih, Diana; Gatti, Gerardo; Cecilia Sanchez, Maria; Motran, Claudia C.; Cervi, Laura] Natl Univ Cordoba, Dept Clin Biochem, Fac Chem Sci, CIQUIBIC CONICET, Cordoba, Argentina; [Gatti, Gerardo] Fdn Advancement Med, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Cervi, L (corresponding author), Natl Univ Cordoba, Dept Biol Chem, Fac Chem Sci, CIQUIBIC CONICET, Cordoba, Argentina.	lcervi@fcq.unc.edu.ar	Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901	FONCyT PICT	FONCyT PICT(ANPCyTFONCyT)	Funding: Funding provided by FONCyT PICT 2005. Categoria I. Temas Abiertos. 32027 Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozas SE, 1995, MOL BIOCHEM PARASIT, V74, P19, DOI 10.1016/0166-6851(95)02478-6; Carranza F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040356; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Cervi L, 2004, VET IMMUNOL IMMUNOP, V97, P97, DOI 10.1016/j.vetimm.2003.08.015; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; Falcon C, 2010, VET IMMUNOL IMMUNOP, V137, P36, DOI 10.1016/j.vetimm.2010.04.007; Falcon CR, 2012, J INFECT DIS, V205, P506, DOI 10.1093/infdis/jir606; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; LaCourse EJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001666; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Mascanfroni I, 2008, FASEB J, V22, P1032, DOI 10.1096/fj.07-8652com; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Robinson MW, 2013, INT J PARASITOL, V43, P283, DOI 10.1016/j.ijpara.2012.11.004; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Shigetomi H, 2010, INFLAMM RES, V59, P679, DOI 10.1007/s00011-010-0205-5; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803	25	35	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114505	10.1371/journal.pone.0114505	http://dx.doi.org/10.1371/journal.pone.0114505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486609	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600064
J	Herdegen, S; Conte, C; Kamal, S; Calin-Jageman, RJ; Calin-Jageman, IE				Herdegen, Samantha; Conte, Catherine; Kamal, Saman; Calin-Jageman, Robert J.; Calin-Jageman, Irina E.			Immediate and Persistent Transcriptional Correlates of Long-Term Sensitization Training at Different CNS Loci in Aplysia californica	PLOS ONE			English	Article							SITE-SPECIFIC SENSITIZATION; NEURONS INNERVATING TAIL; SIPHON-WITHDRAWAL REFLEX; SENSORY NEURONS; SYNAPTIC FACILITATION; PROTEIN-SYNTHESIS; MESSENGER-RNA; GILL-WITHDRAWAL; MEMORY; EXPRESSION	Repeated noxious stimulation produces long-term sensitization of defensive withdrawal reflexes in Aplysia californica, a form of long-term memory that requires changes in both transcription and translation. Previous work has identified 10 transcripts which are rapidly up-regulated after long-term sensitization training in the pleural ganglia. Here we use quantitative PCR to begin examining how these transcriptional changes are expressed in different CNS loci related to defensive withdrawal reflexes at 1 and 24 hours after long-term sensitization training. Specifically, we sample from a) the sensory wedge of the pleural ganglia, which exclusively contains the VC nociceptor cell bodies that help mediate input to defensive withdrawal circuits, b) the remaining pleural ganglia, which contain withdrawal interneurons, and c) the pedal ganglia, which contain many motor neurons. Results from the VC cluster show different temporal patterns of regulation: 1) rapid but transient up-regulation of Aplysia homologs of C/EBP, C/EBP gamma, and CREB1, 2) delayed but sustained up-regulation of BiP, Tolloid/BMP-1, and sensorin, 3) rapid and sustained up-regulation of Egr, GlyT2, VPS36, and an uncharacterized protein (LOC101862095), and 4) an unexpected lack of regulation of Aplysia homologs of calmodulin (CaM) and reductase-related protein (RRP). Changes in the remaining pleural ganglia mirror those found in the VC cluster at 1 hour but with an attenuated level of regulation. Because these samples had almost no expression of the VC-specific transcript sensorin, our data suggests that sensitization training likely induces transcriptional changes in either defensive withdrawal interneurons or neurons unrelated to defensive withdrawal. In the pedal ganglia, we observed only a rapid but transient increase in Egr expression, indicating that long-term sensitization training is likely to induce transcriptional changes in motor neurons but raising the possibility of different transcriptional endpoints in this cell type.	[Herdegen, Samantha; Conte, Catherine; Kamal, Saman; Calin-Jageman, Robert J.; Calin-Jageman, Irina E.] Dominican Univ, Neurosci Program, River Forest, IL 60305 USA		Calin-Jageman, IE (corresponding author), Dominican Univ, Neurosci Program, River Forest, IL 60305 USA.	rcalinjageman@dom.edu; icalinjageman@dom.edu	Calin-Jageman, Robert/K-1311-2019	Calin-Jageman, Robert/0000-0002-9837-6529; Calin-Jageman, Irina/0000-0002-2529-4223	Tellabs Foundation; National Institutes of Health [R15MH090998-01]; Jared-Beach Scholarship program; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH090998] Funding Source: NIH RePORTER	Tellabs Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jared-Beach Scholarship program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This work was supported by a grant from the Tellabs Foundation (http://www.tellabs.com/) and by National Institutes of Health Grant R15MH090998-01 (http://www.nih.gov/). In addition, Catherine Conte's work on this project was supported through the generosity of the Jared-Beach Scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TW, 2012, CURR BIOL, V22, pR705, DOI 10.1016/j.cub.2012.08.011; Abramson C. I., 1994, PRIMER INVERTEBRATE; Acheampong A, 2012, LEARN MEMORY, V19, P159, DOI 10.1101/lm.024638.111; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Antzoulatos EG, 2007, J NEUROSCI, V27, P676, DOI 10.1523/JNEUROSCI.4025-06.2007; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047378; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; BUONOMANO DV, 1992, BRAIN RES, V577, P147, DOI 10.1016/0006-8993(92)90548-N; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; CLEARY LJ, 1995, LEARN MEMORY, V2, P133, DOI 10.1101/lm.2.3-4.133; Cyriac A, 2013, NEUROBIOL LEARN MEM, V102, P43, DOI 10.1016/j.nlm.2013.03.008; DUBUC B, 1991, J EXP BIOL, V156, P315; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Esdin J, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00181; FREDMAN SM, 1979, BRAIN RES BULL, V4, P393, DOI 10.1016/S0361-9230(79)80017-9; Frost L, 1997, J NEUROSCI, V17, P2900; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; HAWKINS RD, 1984, PSYCHOL REV, V91, P375, DOI 10.1037/0033-295X.91.3.375; HENING WA, 1979, BRAIN RES, V179, P231, DOI 10.1016/0006-8993(79)90441-4; Herdegen S, 2014, NEUROBIOL LEARN MEM, V116, P27, DOI 10.1016/j.nlm.2014.07.009; Hermitte G, 1999, NEUROBIOL LEARN MEM, V71, P34, DOI 10.1006/nlme.1998.3858; HICKIE C, 1995, J NEUROPHYSIOL, V74, P307, DOI 10.1152/jn.1995.74.1.307; Hickie C, 1997, EUR J NEUROSCI, V9, P627, DOI 10.1111/j.1460-9568.1997.tb01411.x; Holmes G, 2015, LEARN MEMORY, V22, P11, DOI 10.1101/lm.036970.114; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Illich PA, 1997, J NEUROSCI, V17, P459, DOI 10.1523/JNEUROSCI.17-01-00459.1997; Jung K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-288; Korzus E, 2003, ACTA BIOCHIM POL, V50, P775; Krontiris-Litowitz J, 1999, J COMP PHYSIOL A, V185, P181, DOI 10.1007/s003590050376; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; Lee YS, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-3; Levenson J, 1999, J NEUROSCI, V19, P8094; Liu QR, 1997, J NEUROSCI, V17, P755; Liu RY, 2008, J NEUROSCI, V28, P1970, DOI 10.1523/JNEUROSCI.3848-07.2008; Liu RY, 2011, J NEUROSCI, V31, P6871, DOI 10.1523/JNEUROSCI.5071-10.2011; Liu RY, 2011, LEARN MEMORY, V18, P245, DOI 10.1101/lm.2112111; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; Marinesco S, 2004, J NEUROPHYSIOL, V92, P2468, DOI 10.1152/jn.00209.2004; MONTAROLO P, 1986, SCIENCE; RAYPORT SG, 1983, J NEUROPHYSIOL, V49, P864, DOI 10.1152/jn.1983.49.4.864; RAYPORT SG, 1986, J NEUROSCI, V6, P759; Sangha S, 2003, J EXP BIOL, V206, P1605, DOI 10.1242/jeb.00301; Schacher S, 2000, J NEUROBIOL, V45, P152, DOI 10.1002/1097-4695(20001115)45:3<152::AID-NEU3>3.0.CO;2-0; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; Shields-Johnson ME, 2013, LEARN MEMORY, V20, P1, DOI 10.1101/lm.028084.112; Simmons J. P., 2012, DIALOGUE OFFICIAL NE, V26, P4, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun ZY, 2001, J NEUROBIOL, V46, P41, DOI 10.1002/1097-4695(200101)46:1<41::AID-NEU4>3.0.CO;2-R; Sutton MA, 2004, J NEUROSCI, V24, P3600, DOI 10.1523/JNEUROSCI.1134-03.2004; TRITT SH, 1980, J NEUROPHYSIOL, V43, P581, DOI 10.1152/jn.1980.43.3.581; Wainwright ML, 2004, J NEUROPHYSIOL, V92, P2628, DOI 10.1152/jn.00335.2004; Wainwright ML, 2002, J NEUROSCI, V22, P4132, DOI 10.1523/JNEUROSCI.22-10-04132.2002; Walters ET, 2009, BRAIN BEHAV EVOLUT, V74, P206, DOI 10.1159/000258667; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1522, DOI 10.1152/jn.1983.50.6.1522; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; Walters ET, 2004, J COMP NEUROL, V471, P219, DOI 10.1002/cne.20042; WALTERS ET, 1987, J NEUROSCI, V7, P400; Watanabe H, 2005, NEUROBIOL LEARN MEM, V83, P151, DOI 10.1016/j.nlm.2004.11.003; WOOLF CJ, 1991, TRENDS NEUROSCI, V14, P74, DOI 10.1016/0166-2236(91)90024-O; XU YL, 1994, J NEUROSCI, V14, P3565; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zwartjes RE, 1998, LEARN MEMORY, V4, P478, DOI 10.1101/lm.4.6.478	73	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114481	10.1371/journal.pone.0114481	http://dx.doi.org/10.1371/journal.pone.0114481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486125	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600059
J	Polonsky, JA; Martinez-Pino, I; Nackers, F; Chonzi, P; Manangazira, P; Van Herp, M; Maes, P; Porten, K; Luquero, FJ				Polonsky, Jonathan A.; Martinez-Pino, Isabel; Nackers, Fabienne; Chonzi, Prosper; Manangazira, Portia; Van Herp, Michel; Maes, Peter; Porten, Klaudia; Luquero, Francisco J.			Descriptive Epidemiology of Typhoid Fever during an Epidemic in Harare, Zimbabwe, 2012	PLOS ONE			English	Article							POINT PATTERN-ANALYSIS; RISK-FACTORS; ENVIRONMENTAL-FACTORS; KELANTAN; AREA	Background: Typhoid fever remains a significant public health problem in developing countries. In October 2011, a typhoid fever epidemic was declared in Harare, Zimbabwe - the fourth enteric infection epidemic since 2008. To orient control activities, we described the epidemiology and spatiotemporal clustering of the epidemic in Dzivaresekwa and Kuwadzana, the two most affected suburbs of Harare. Methods: A typhoid fever case-patient register was analysed to describe the epidemic. To explore clustering, we constructed a dataset comprising GPS coordinates of case-patient residences and randomly sampled residential locations (spatial controls). The scale and significance of clustering was explored with Ripley K functions. Cluster locations were determined by a random labelling technique and confirmed using Kulldorff's spatial scan statistic. Principal Findings: We analysed data from 2570 confirmed and suspected case-patients, and found significant spatiotemporal clustering of typhoid fever in two non-overlapping areas, which appeared to be linked to environmental sources. Peak relative risk was more than six times greater than in areas lying outside the cluster ranges. Clusters were identified in similar geographical ranges by both random labelling and Kulldorff's spatial scan statistic. The spatial scale at which typhoid fever clustered was highly localised, with significant clustering at distances up to 4.5 km and peak levels at approximately 3.5 km. The epicentre of infection transmission shifted from one cluster to the other during the course of the epidemic. Conclusions: This study demonstrated highly localised clustering of typhoid fever during an epidemic in an urban African setting, and highlights the importance of spatiotemporal analysis for making timely decisions about targetting prevention and control activities and reinforcing treatment during epidemics. This approach should be integrated into existing surveillance systems to facilitate early detection of epidemics and identify their spatial range.	[Polonsky, Jonathan A.; Martinez-Pino, Isabel; Nackers, Fabienne; Porten, Klaudia; Luquero, Francisco J.] Epictr, Paris, France; [Martinez-Pino, Isabel] European Ctr Dis Prevent & Control, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Chonzi, Prosper] Harare City Hlth Dept, Minist Hlth & Child Welf, Harare, Zimbabwe; [Manangazira, Portia] Epidemiol & Dis Control Directorate, Minist Hlth & Child Welf, Harare, Zimbabwe; [Van Herp, Michel; Maes, Peter] Medecins Sans Frontieres Operat Ctr Brussels, Brussels, Belgium	European Centre for Disease Prevention & Control	Polonsky, JA (corresponding author), Epictr, Paris, France.	jonathan.polonsky@epicentre.msf.org	Nackers, Fabienne/X-6615-2019	Nackers, Fabienne/0000-0001-9870-1910; Polonsky, Jonathan/0000-0002-8634-4255				Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Carlos HA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-39; Chonzi Prosper, 2012, Morbidity and Mortality Weekly Report, V61, P435; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Diggle P.J., 1995, BERNOULLI, V1, DOI [10.2307/3318678, DOI 10.2307/3318678, 10.1002/sim.4780142106]; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Enachescu D, 2009, BIOCYBERN BIOMED ENG, V29, P19; Fernandez MAL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-442; Fernandez MAL, 2011, T ROY SOC TROP MED H, V105, P38, DOI 10.1016/j.trstmh.2010.10.001; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Hinman Sarah E, 2006, Int J Health Geogr, V5, P13, DOI 10.1186/1476-072X-5-13; Kariuki S, 2008, J INFECT DEV COUNTR, V2, P443, DOI 10.3855/jidc.159; Kelsall JE, 1998, J ROY STAT SOC C-APP, V47, P559, DOI 10.1111/1467-9876.00128; Khan MI, 2012, EPIDEMIOL INFECT, V140, P665, DOI 10.1017/S0950268811000938; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Luquero FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019005; Mason PR, 2009, J INFECT DEV COUNTR, V3, P148, DOI 10.3855/jidc.62; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; R Core Team, 2016, R FDN STAT COMP; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Safian N, 2008, MED J INDONES, V17, P175; Shah SA, 2012, SAINS MALAYS, V41, P911; Shi X, 2010, INT J GEOGR INF SCI, V24, P643, DOI 10.1080/13658810902950625; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051823; Toprak D, 2008, INT ARCH PHOTOGRAMM, V37, P1367; Tran HH, 2005, T ROY SOC TROP MED H, V99, P819, DOI 10.1016/j.trstmh.2005.05.007; United Nations Department of Economic and Social Affairs Population Division, 2009, WORLD POP PROSP 2008; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; Waller LA., 2009, SAGE HDB SPATIAL ANA, P299, DOI [https://dx.doi.org/10.4135/9780857020130.n16, DOI 10.4135/9780857020130.N16]; Wheeler DC, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-13; WHO-WORLD HEALTH ORGANIZATION, 2012, REP AD HOC CONS TYPH; World Health Organization Ministry of Health & Child Welfare Zimbabwe, 2012, ZIMBABWE WKLY EPIDEM, V48, P1; World Health Organization Ministry of Health & Child Welfare Zimbabwe, 2010, ZIMBABWE WKLY EPIDEM, V28, P1; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114702	10.1371/journal.pone.0114702	http://dx.doi.org/10.1371/journal.pone.0114702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486292	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600088
J	Zulkifley, MA; Mustafa, MM; Hussain, A; Mustapha, A; Ramli, S				Zulkifley, Mohd Asyraf; Mustafa, Mohd Marzuki; Hussain, Aini; Mustapha, Aouache; Ramli, Suzaimah			Robust Identification of Polyethylene Terephthalate (PET) Plastics through Bayesian Decision	PLOS ONE			English	Article							BOTTLES; SYSTEM	Recycling is one of the most efficient methods for environmental friendly waste management. Among municipal wastes, plastics are the most common material that can be easily recycled and polyethylene terephthalate (PET) is one of its major types. PET material is used in consumer goods packaging such as drinking bottles, toiletry containers, food packaging and many more. Usually, a recycling process is tailored to a specific material for optimal purification and decontamination to obtain high grade recyclable material. The quantity and quality of the sorting process are limited by the capacity of human workers that suffer from fatigue and boredom. Several automated sorting systems have been proposed in the literature that include using chemical, proximity and vision sensors. The main advantages of vision based sensors are its environmentally friendly approach, non-intrusive detection and capability of high throughput. However, the existing methods rely heavily on deterministic approaches that make them less accurate as the variations in PET plastic waste appearance are too high. We proposed a probabilistic approach of modeling the PET material by analyzing the reflection region and its surrounding. Three parameters are modeled by Gaussian and exponential distributions: color, size and distance of the reflection region. The final classification is made through a supervised training method of likelihood ratio test. The main novelty of the proposed method is the probabilistic approach in integrating various PET material signatures that are contaminated by stains under constant lighting changes. The system is evaluated by using four performance metrics: precision, recall, accuracy and error. Our system performed the best in all evaluation metrics compared to the benchmark methods. The system can be further improved by fusing all neighborhood information in decision making and by implementing the system in a graphics processing unit for faster processing speed.	[Zulkifley, Mohd Asyraf; Mustafa, Mohd Marzuki; Hussain, Aini; Mustapha, Aouache] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia; [Ramli, Suzaimah] Univ Pertahanan Nas Malaysia, Fac Def Sci & Technol, Dept Comp Sci, Kuala Lumpur 57000, Malaysia	Universiti Kebangsaan Malaysia; Universiti Pertahanan Nasional Malaysia	Zulkifley, MA (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia.	asyraf@eng.ukm.my	Mustapha, AOUACHE/AFK-0820-2022; Zulkifley, Mohd Asyraf/AAZ-3652-2020; Ramli, Suzaimah/GSD-2541-2022; Mustapha, AOUACHE/AAF-7777-2022; mustafa, marzuki/AHA-9319-2022; Hussain, A./D-6915-2017	Hussain, A./0000-0001-7347-7879; Mustapha, AOUACHE/0000-0003-1629-1183; Zulkifley, Mohd Asyraf/0000-0002-4010-3990	Ministry of Science and Technology Malaysia [06-01-02-SF1005]; Universiti Kebangsaan Malaysia [DPP-2014-009]	Ministry of Science and Technology Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia	Funding: This study was funded by the Ministry of Science and Technology Malaysia (06-01-02-SF1005) and Universiti Kebangsaan Malaysia (DPP-2014-009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcala JM, 2004, MEAS SCI TECHNOL, V15, P371, DOI 10.1088/0957-0233/15/2/009; Bartolome L, 2012, RECENT DEV CHEM RECY, P65; Dahmus JB, 2007, ENVIRON SCI TECHNOL, V41, P7543, DOI 10.1021/es062254b; EEA, 2008, BETT MAN MUN WAST WI; Graham B, 2008, REV OPTICAL TECHNOLO; House B. W., 2011, IEEE INT S SUST SYST, P1, DOI DOI 10.1109/ISSST.2011.5936845; Nikles DE, 2005, MACROMOL MATER ENG, V290, P13, DOI 10.1002/mame.200400186; Park CH, 2008, ENVIRON SCI TECHNOL, V42; Picon A, 2009, IEEE T IND INFORM, V5, P483, DOI 10.1109/TII.2009.2031238; Ramli S., 2010, P 6 INT SIGN PROC IT, P1; Safavi SM, 2010, WASTE MANAGE, V30, P2216, DOI 10.1016/j.wasman.2010.06.023; Scavino Edgar, 2009, Journal of Computer Sciences, V5, P711, DOI 10.3844/jcssp.2009.711.716; Shahbudin S., 2010, 6 INT C SIGN PROC IT, P1, DOI DOI 10.1109/CSPA.2010.5545265; Tachwali Y, 2007, RESOUR CONSERV RECY, V52, P266, DOI 10.1016/j.resconrec.2007.03.008; Takahashi Y, 2008, ENVIRON SCI TECHNOL, V42; van den Broek WHAM, 1998, ANAL CHIM ACTA, V361, P161, DOI 10.1016/S0003-2670(98)00012-9; Wahab D. A., 2006, American Journal of Applied Sciences, V3, P1924, DOI 10.3844/ajassp.2006.1924.1928; Zhang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110159; Zhang H, 2014, WASTE MANAGE, V34, P987, DOI 10.1016/j.wasman.2013.07.015; Zulkifley MA, 2013, IEEE IMAGE PROC, P3162, DOI 10.1109/ICIP.2013.6738651; Zulkifley MA, 2012, EXPERT SYST APPL, V39, P12319, DOI 10.1016/j.eswa.2012.03.004; Zulkifley MA, 2010, INT CONF COMP SCI, P131, DOI 10.1109/ICCSIT.2010.5565166	23	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114518	10.1371/journal.pone.0114518	http://dx.doi.org/10.1371/journal.pone.0114518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485630	Green Submitted, gold, Green Published			2022-12-27	WOS:000346907600066
J	Iunes, DH; Rocha, CBJ; Borges, NCS; Marcon, CO; Pereira, VM; Carvalho, LC				Iunes, Denise H.; Rocha, Carmelia B. J.; Borges, Nathalia C. S.; Marcon, Caroline O.; Pereira, Valeria M.; Carvalho, Leonardo C.			Self-Care Associated with Home Exercises in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							FOOT; PREVENTION; MANAGEMENT; KINEMATICS; PATTERNS; GAIT	The objective of this study was to verify self-care guidelines together with lower limb home exercises alter ankle and foot plantar pressure and alignment in patient with Type 2 Diabetes Mellitus (DM) measuring health and sociodemographic factors. The health factors analyzed were sensitivity and circulation aspects, risk rating, and neuropathy symptom score, ankle and foot alignment (photogrammetry), plantar pressures, and postural stability (baropodometry) before and after administering these guidelines and home exercises in 97 patients type 2 DM during 10 months. The self-care guidelines and exercises changed the forefoot alignment (Right Foot - Initial vs Final, p=0.04; Left Foot, P<0.01), the center of the force displacement in the mediolateral (Right Foot - Initial versus Final, p=0.02; Left Foot, P<0.01), and the anterior-posterior (Right foot - Initial versus Final, p=0.01) direction, and body balance (Initial versus Final, p=0.02). There was no change in the remaining assessed parameters. Self-care associated with the guidelines for home exercises for the lower limbs in patients with type 2 DM are effective in maintaining and improving the alignment of the feet, mediolateral stability and prevention of complications.	[Iunes, Denise H.; Rocha, Carmelia B. J.; Borges, Nathalia C. S.; Marcon, Caroline O.; Carvalho, Leonardo C.] Univ Fed Alfenas, Alfenas, Brazil; [Pereira, Valeria M.] Hlth Municipal State Alfenas, Alfenas, Brazil	Universidade Federal de Alfenas	Iunes, DH (corresponding author), Univ Fed Alfenas, Alfenas, Brazil.	deniseiunes@unifal-mg.edu.br	Iunes, Denise Hollanda/AAF-6014-2019; carvalho, Leonardo LCC/E-4759-2015; Iunes, Denise H/K-6099-2017	Iunes, Denise Hollanda/0000-0003-1396-9980; carvalho, Leonardo LCC/0000-0001-8170-5819; Iunes, Denise H/0000-0003-1396-9980; Carvalho, Leonardo/0000-0001-6511-8315	Research Support Foundation of Minas Gerais [APQ - 01538-10, APQ 02794-11]	Research Support Foundation of Minas Gerais	This project was supported by a grant from the Research Support Foundation of Minas Gerais (APQ - 01538-10 and APQ 02794-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Bargellini I, 2013, J VASC SURG, V57, P1204, DOI 10.1016/j.jvs.2012.10.104; Bonnet C, 2009, J MOTOR BEHAV, V41, P172, DOI 10.3200/JMBR.41.2.172-192; Chand G., 2012, CLINL QUERIES NEPHRO, V2, P144, DOI DOI 10.1016/S2211-9477(12)70009-2; Chao Y, 2013, COLLEGIAN IN PRESS; Chellan Gopi, 2012, Foot (Edinb), V22, P298, DOI 10.1016/j.foot.2012.08.007; Gurney JK, 2013, GAIT POSTURE, V37, P135, DOI 10.1016/j.gaitpost.2012.06.007; Hamill J., 2008, BIOMECHANICAL BASIS; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Kapandji AI, 2010, PHYSL JOINTS LOWER L; Kimball Z, 2013, BURNS, V39, P279, DOI 10.1016/j.burns.2012.06.006; Kivlan Benjamin R, 2011, Foot (Edinb), V21, P84, DOI 10.1016/j.foot.2011.04.004; Lavery LA, 2007, DIABETES CARE, V30, P14, DOI 10.2337/dc06-1600; Medical Research Council, 1981, 45 MED RES COUNC; Moreira Rodrigo O., 2005, Arq Bras Endocrinol Metab, V49, P944, DOI 10.1590/S0004-27302005000600014; Nagase T, 2011, J PLAST RECONSTR AES, V64, P860, DOI 10.1016/j.bjps.2010.12.003; Pollock RD, 2004, DIABETES RES CLIN PR, V64, P117, DOI 10.1016/j.diabres.2003.10.014; Rocha RM, 2009, ACTA PAUL ENFERM, V22, P17, DOI 10.1590/S0103-21002009000100003; Rosenbaum D., 1994, GAIT POSTURE, V2, P191, DOI DOI 10.1016/0966-6362(94)90007-8); Sacco ICN, 2009, CLIN BIOMECH, V24, P687, DOI 10.1016/j.clinbiomech.2009.05.003; Sawacha Z, 2012, GAIT POSTURE, V36, P20, DOI 10.1016/j.gaitpost.2011.12.007; Sawacha Z, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-37; Sawacha Z, 2009, CLIN BIOMECH, V24, P722, DOI 10.1016/j.clinbiomech.2009.07.007; STAHELI LT, 1987, J BONE JOINT SURG AM, V69A, P426; Trombini-Souza Francis, 2009, Fisioter. Pesqui., V16, P205; Van Schie CHM, 2004, DIABETES CARE, V27, P1668, DOI 10.2337/diacare.27.7.1668; Vatankhah N, 2009, PRIM CARE DIABETES, V3, P73, DOI 10.1016/j.pcd.2009.05.003; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	29	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114151	10.1371/journal.pone.0114151	http://dx.doi.org/10.1371/journal.pone.0114151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479542	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200046
J	Pacheco, MTF; Berra, CM; Morais, KLP; Sciani, JM; Branco, VG; Bosch, RV; Chudzinski-Tavassi, AM				Pacheco, Mario T. F.; Berra, Carolina M.; Morais, Katia L. P.; Sciani, Juliana M.; Branco, Vania G.; Bosch, Rosemary V.; Chudzinski-Tavassi, Ana M.			Dynein Function and Protein Clearance Changes in Tumor Cells Induced by a Kunitz-Type Molecule, Amblyomin-X	PLOS ONE			English	Article							PROTEASOME; CANCER; AUTOPHAGY; LOCALIZATION; PROGRESSION; INHIBITOR; RECEPTORS; PATHWAY; COMPLEX; AMBRA1	Amblyomin-X is a Kunitz-type recombinant protein identified from the transcriptome of the salivary glands of the tick Amblyomma cajennense and has anti-coagulant and antitumoral activity. The supposed primary target of this molecule is the proteasome system. Herein, we elucidated intracellular events that are triggered by Amblyomin-X treatment in an attempt to provide new insight into how this serine protease inhibitor, acting on the proteasome, could be comparable with known proteasome inhibitors. The collective results showed aggresome formation after proteasome inhibition that appeared to occur via the non-exclusive ubiquitin pathway. Additionally, Amblyomin-X increased the expression of various chains of the molecular motor dynein in tumor cells, modulated specific ubiquitin linkage signaling and inhibited autophagy activation by modulating mTOR, LC3 and AMBRA1 with probable dynein involvement. Interestingly, one possible role for dynein in the mechanism of action of Amblyomin-X was in the apoptotic response and its crosstalk with autophagy, which involved the factor Bim; however, we observed no changes in the apoptotic response related to dynein in the experiments performed. The characteristics shared among Amblyomin-X and known proteasome inhibitors included NF-kappa B blockage and nascent polypeptide-dependent aggresome formation. Therefore, our study describes a Kunitz-type protein that acts on the proteasome to trigger distinct intracellular events compared to classic known proteasome inhibitors that are small-cell-permeable molecules. In investigating the experiments and literature on Amblyomin-X and the known proteasome inhibitors, we also found differences in the structures of the molecules, intracellular events, dynein involvement and tumor cell type effects. These findings also reveal a possible new target for Amblyomin-X, i.e., dynein, and may serve as a tool for investigating tumor cell death associated with proteasome inhibition.	[Pacheco, Mario T. F.; Berra, Carolina M.; Morais, Katia L. P.; Sciani, Juliana M.; Branco, Vania G.; Bosch, Rosemary V.; Chudzinski-Tavassi, Ana M.] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Morais, Katia L. P.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP)	Chudzinski-Tavassi, AM (corresponding author), Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil.	ana.chudzinski@butantan.gov.br	Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Berra, Carolina/O-1180-2013; Chudzinski-Tavassi, Ana M./I-4167-2012; Sciani, Juliana Mozer/B-6990-2012; Chudzinski-Tavassi, Ana M/X-3772-2018	Berra, Carolina/0000-0002-8964-4499; Sciani, Juliana Mozer/0000-0001-7213-206X; Morais, Katia/0000-0001-8877-5887	Sao Paulo Research Foundation (FAPESP) [2011/05969-4, CAT/CEPID 1998/14307-9, CETICs 2013/07467-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants provided by the Sao Paulo Research Foundation (FAPESP; processes 2011/05969-4, CAT/CEPID 1998/14307-9, and CETICs 2013/07467-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi EM, 2012, BIOMED PHARMACOTHER, V66, P64, DOI 10.1016/j.biopha.2011.11.015; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Batista IFC, 2010, ARCH BIOCHEM BIOPHYS, V493, P151, DOI 10.1016/j.abb.2009.10.009; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cenci S, 2012, JLB, V92, P1; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chuzinski-Tavassi AM, 2010, TOXICON, P1145; Clippinger AJ, 2012, GENE DEV, V26, P2015, DOI 10.1101/gad.196147.112; Cohen S, 2006, BIOCHEM BIOPH RES CO, V345, P7, DOI 10.1016/j.bbrc.2006.04.036; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; DONATI MB, 1984, HAEMOSTASIS, V14, P422; Dorsey BD, 2008, J MED CHEM, V51, P1068, DOI 10.1021/jm7010589; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Fimia GM, 2011, AUTOPHAGY, V7, P115, DOI 10.4161/auto.7.1.14071; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jain S, 2011, CORE EVID, V6, P43, DOI 10.2147/CE.S13838; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1007/s12079-011-0121-7, 10.1038/nrclinonc.2016.206]; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shrum CK, 2008, PNAS, V106, P2647; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Venere M, 2013, CANCER CELL, V23, P135, DOI 10.1016/j.ccr.2013.01.020; Ventura JS, 2013, BIOMED PHARMACOTHER, V67, P192, DOI 10.1016/j.biopha.2012.11.009; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501	45	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111907	10.1371/journal.pone.0111907	http://dx.doi.org/10.1371/journal.pone.0111907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479096	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200006
J	Schaefer, K; Brown, N; Kaye, PM; Lacey, CJ				Schaefer, Katrein; Brown, Najmeeyah; Kaye, Paul M.; Lacey, Charles J.			Cervico-Vaginal Immunoglobulin G Levels Increase Post-Ovulation Independently of Neutrophils	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; FEMALE REPRODUCTIVE-TRACT; MENSTRUAL-CYCLE; GENITAL-TRACT; HUMAN ENDOMETRIUM; ESTROUS-CYCLE; POLYMORPHONUCLEAR LEUKOCYTES; VAGINAL IMMUNIZATION; SECRETORY COMPONENT; MUCOSAL IMMUNITY	The prevalence of sexually transmitted infections (STIs) is often higher in females than in males. Although the reproductive cycle profoundly modulates local immunity in the female reproductive tract (FRT) system, significant gaps in our knowledge of the immunobiology of the FRT still exist. An intriguing and frequently observed characteristic of the FRT is the predominant presence of immunoglobulin (Ig) G in cervico-vaginal secretions. We show here that in the mouse, IgG accumulation was enhanced approximately 5-fold post-ovulation, and was accompanied by an influx of neutrophils into the FRT. To determine whether these two events were causally related, we performed short-term neutrophil depletion experiments at individual stages throughout the estrous cycle. Our results demonstrate that neutrophils were not necessary for cycle-dependent tissue remodeling and cycle progression and that cycle-dependent IgG accumulation occurred independent of neutrophils. We thus conclude that neutrophil influx and IgG accumulation are independent events that occur in the FRT during the reproductive cycle.	[Kaye, Paul M.] Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Kaye, PM (corresponding author), Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	paul.kaye@york.ac.uk		Kaye, Paul/0000-0002-8796-4755	EC; UK Medical Research Council [G1000230]; EUROPRISE Studentship [REE0031-0708-26]; Medical Research Council [G1000230] Funding Source: researchfish; MRC [G1000230] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUROPRISE Studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by an EC FP6 grant for the European HIV Enterprise (EUROPRISE; to CJL; http://ec.europa.eu) and the UK Medical Research Council (G1000230 to PMK; http://www.mrc.ac.uk). KS was supported by an EUROPRISE Studentship (REE0031-0708-26; http://www.europrise.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Arici A, 1998, J CLIN ENDOCR METAB, V83, P1783, DOI 10.1210/jc.83.5.1783; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; BOUVET JP, 1994, INFECT IMMUN, V62, P3957, DOI 10.1128/IAI.62.9.3957-3961.1994; Brannstrom M, 1999, EUR J OBSTET GYN R B, V83, P213, DOI 10.1016/S0301-2115(99)00003-2; Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003; CHIPPERFIELD EJ, 1972, CLIN EXP IMMUNOL, V11, P219; CHIPPERFIELD EJ, 1975, INFECT IMMUN, V11, P215, DOI 10.1128/IAI.11.2.215-221.1975; CHODIRKER WB, 1963, SCIENCE, V142, P1080, DOI 10.1126/science.142.3595.1080; Chua Felix, 2006, Proc Am Thorac Soc, V3, P424, DOI 10.1513/pats.200603-078AW; Cobo ER, 2011, AM J TROP MED HYG, V85, P667, DOI 10.4269/ajtmh.2011.11-0123; Criss AK, 2012, NAT REV MICROBIOL, V10, P178, DOI 10.1038/nrmicro2713; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; CRITCHLEY HOD, 1994, HUM REPROD, V9, P1406, DOI 10.1093/oxfordjournals.humrep.a138719; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DIYACOVO L, 1977, EXPERIENTIA, V33, P392; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; HOCINI H, 1995, SCAND J IMMUNOL, V42, P269, DOI 10.1111/j.1365-3083.1995.tb03653.x; HURLIMANN J, 1978, VIRCHOWS ARCH A, V377, P211, DOI 10.1007/BF00426931; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Johansson M, 2003, CURR OPIN INFECT DIS, V16, P43, DOI 10.1097/00001432-200302000-00008; JUNGI TW, 1977, AM J PHYSIOL, V233, pR59, DOI 10.1152/ajpregu.1977.233.1.R59; Kaushic C, 2011, J REPROD IMMUNOL, V88, P204, DOI 10.1016/j.jri.2010.12.004; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kutteh WH, 1998, AIDS RES HUM RETROV, V14, pS51; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Lindqvist M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020448; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; Milligan GN, 1999, J VIROL, V73, P6380, DOI 10.1128/JVI.73.8.6380-6386.1999; Milligan GN, 2001, J REPROD IMMUNOL, V49, P49, DOI 10.1016/S0165-0378(00)00080-2; Monteiro EF, 2005, SEX TRANSM INFECT, V81, P41, DOI 10.1136/sti.2004.009431; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; RACHMAN F, 1983, J REPROD FERTIL, V69, P17, DOI 10.1530/jrf.0.0690017; Rank RG, 2011, INFECT IMMUN, V79, P3291, DOI 10.1128/IAI.00200-11; Roig de Vargas-Linares, 1971, Acta Physiol Lat Am, V21, P158; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Salamonsen LA, 1999, J REPROD IMMUNOL, V44, P1; Sasaki S, 2009, BIOCHEM BIOPH RES CO, V382, P35, DOI 10.1016/j.bbrc.2009.02.112; Shang L, 2014, J IMMUNOL, V193, P277, DOI 10.4049/jimmunol.1400417; Shen L, 2004, CELL IMMUNOL, V230, P23, DOI 10.1016/j.cellimm.2004.08.004; Shrier LA, 2003, J ADOLESCENT HEALTH, V32, P183, DOI 10.1016/S1054-139X(02)00536-0; Sonoda Y, 1998, J IMMUNOL, V160, P6159; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; USALA SJ, 1989, J REPROD MED, V34, P292; Willis C, 2003, HUM REPROD, V18, P1173, DOI 10.1093/humrep/deg231; WIRA CR, 1977, NATURE, V268, P534, DOI 10.1038/268534a0; WIRA CR, 1980, ENDOCRINOLOGY, V106, P1020, DOI 10.1210/endo-106-3-1020; WIRA CR, 1985, BIOL REPROD, V32, P90, DOI 10.1095/biolreprod32.1.90; Wira CR, 2002, ENDOCRINOLOGY, V143, P2872, DOI 10.1210/en.143.8.2872; WIRA CR, 1987, J IMMUNOL, V138, P4159; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; WUTTKE W, 1993, HUM REPROD, V8, P141, DOI 10.1093/humrep/8.suppl_2.141; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114824	10.1371/journal.pone.0114824	http://dx.doi.org/10.1371/journal.pone.0114824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479383	Green Accepted, Green Published, gold			2022-12-27	WOS:000346907200129
J	Egger, F; Meyer, T; Such, U; Hecksteden, A				Egger, Florian; Meyer, Tim; Such, Ulf; Hecksteden, Anne			Effects of Sodium Bicarbonate on High-Intensity Endurance Performance in Cyclists: A Double-Blind, Randomized Cross-Over Trial	PLOS ONE			English	Article							INTRACELLULAR ACIDOSIS; MUSCLE METABOLISM; LACTATE KINETICS; SKELETAL-MUSCLE; EXERCISE; ALKALOSIS; INGESTION; NAHCO3; PH	Background: While the ergogenic effect of sodium bicarbonate (BICA) on short-term, sprint-type performance has been repeatedly demonstrated, little is known about its effectiveness during prolonged high-intensity exercise in well-trained athletes. Therefore, this study aims to examine the influence of BICA on performance during exhaustive, high-intensity endurance cycling. Methods: This was a single-center, double-blind, randomized, placebo-controlled cross-over study. Twenty-one well-trained cyclists (mean +/- SD: age 24 +/- 8 y, BMI 21.3 +/- 1.7, VO2peak 67.3 +/- 9.8 ml.kg(-1).min(-1)) were randomly allocated to sequences of following interventions: oral ingestion of 0.3 g.kg(-1) BICA or 4 g of sodium chloride (placebo), respectively. One h after ingestion subjects exercised for 30 min at 95% of the individual anaerobic threshold (IAT) followed by 110% IAT until exhaustion. Prior to these constant load tests stepwise incremental exercise tests were conducted under both conditions to determine IAT and VO2peak. Analysis of blood gas parameters, blood lactate (BLa) and gas exchange measurements were conducted before, during and after the tests. The main outcome measure was the time to exhaustion in the constant load test. Results: Cycling time to exhaustion was improved (p<0.05) under BICA (49.5 +/- 11.5 min) compared with placebo (45.0 +/- 9.5 min). No differences in maximal or sub-maximal measures of performance were observed during stepwise incremental tests. BICA ingestion resulted in an increased pH, bicarbonate concentration and BLa before, throughout and after both exercise testing modes. Conclusion: The results suggest that ingestion of BICA may improve prolonged, high-intensity cycling performance.	[Egger, Florian; Meyer, Tim; Such, Ulf; Hecksteden, Anne] Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany	Saarland University	Egger, F (corresponding author), Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany.	florianegger86@gmail.com	Egger, Florian/K-8409-2019					Abbiss CR, 2005, SPORTS MED, V35, P865, DOI 10.2165/00007256-200535100-00004; Allen DG, 1995, ADV EXP MED BIOL, V384, P57; BAKER AJ, 1995, AM J PHYSIOL-CELL PH, V268, pC55, DOI 10.1152/ajpcell.1995.268.1.C55; BELLINGHAM AJ, 1971, J CLIN INVEST, V50, P700, DOI 10.1172/JCI106540; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Cairns SP, 2006, SPORTS MED, V36, P279, DOI 10.2165/00007256-200636040-00001; Carr AJ, 2011, SPORTS MED, V41, P801, DOI 10.2165/11591440-000000000-00000; COSTILL DL, 1984, INT J SPORTS MED, V5, P228, DOI 10.1055/s-2008-1025910; Douroudos II, 2006, MED SCI SPORT EXER, V38, P1746, DOI 10.1249/01.mss.0000230210.60957.67; FRALEY DS, 1977, KIDNEY INT, V12, P354, DOI 10.1038/ki.1977.122; GEORGE KP, 1988, ERGONOMICS, V31, P1639, DOI 10.1080/00140138808966813; Granier PL, 1996, MED SCI SPORT EXER, V28, P692, DOI 10.1097/00005768-199606000-00008; Hollidge-Horvat MG, 2000, AM J PHYSIOL-ENDOC M, V278, pE316, DOI 10.1152/ajpendo.2000.278.2.E316; Juel C, 1997, PHYSIOL REV, V77, P321, DOI 10.1152/physrev.1997.77.2.321; LINDERMAN JK, 1994, SPORTS MED, V18, P75, DOI 10.2165/00007256-199418020-00001; McNaughton L, 1999, EUR J APPL PHYSIOL O, V80, P64, DOI 10.1007/s004210050559; MITCHELL TH, 1990, AM J MED SCI, V300, P88, DOI 10.1097/00000441-199008000-00004; Palmer GS, 1996, INT J SPORTS MED, V17, P293, DOI 10.1055/s-2007-972849; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Potteiger JA, 1996, EUR J APPL PHYSIOL O, V72, P365, DOI 10.1007/BF00599698; Price M, 2003, MED SCI SPORT EXER, V35, P1303, DOI 10.1249/01.MSS.0000079067.46555.3C; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Scharhag-Rosenberger F, 2010, J SCI MED SPORT, V13, P74, DOI 10.1016/j.jsams.2008.12.626; Siegler JC, 2008, INT J SPORTS MED, V29, P545, DOI 10.1055/s-2007-989261; SIGGAARDANDERSEN O, 1988, SCAND J CLIN LAB INV, V48, P7; SJOGAARD G, 1985, AM J PHYSIOL, V248, pR190, DOI 10.1152/ajpregu.1985.248.2.R190; STEGMANN H, 1981, INT J SPORTS MED, V2, P160, DOI 10.1055/s-2008-1034604; Stephens TJ, 2002, MED SCI SPORT EXER, V34, P614, DOI 10.1097/00005768-200204000-00009; SUTTON JR, 1981, CLIN SCI, V61, P331, DOI 10.1042/cs0610331	29	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114729	10.1371/journal.pone.0114729	http://dx.doi.org/10.1371/journal.pone.0114729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494054	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400070
J	Li, C; Zhao, WH; Meng, CX; Ping, H; Qin, GJ; Cao, SJ; Xi, XW; Zhu, Q; Li, XC; Zhang, J				Li, Cheng; Zhao, Wei-Hong; Meng, Chun-Xia; Ping, Hua; Qin, Guo-Juan; Cao, Shu-Jun; Xi, Xiaowei; Zhu, Qian; Li, Xiao-Cui; Zhang, Jian			Contraceptive Use and the Risk of Ectopic Pregnancy: A Multi-Center Case-Control Study	PLOS ONE			English	Article							LEVONORGESTREL EMERGENCY CONTRACEPTION; PELVIC-INFLAMMATORY-DISEASE; HUMAN FALLOPIAN-TUBE; INTRAUTERINE-DEVICE; MICROSURGICAL REVERSAL; ULIPRISTAL ACETATE; RANDOMIZED-TRIAL; WOMEN; STERILIZATION; METAANALYSIS	Objective: To evaluate the association between the risk of ectopic pregnancy (EP) and the use of common contraceptives during the previous and current conception/menstrual cycle. Methods: A multi-center case-control study was conducted in Shanghai. Women diagnosed with EP were recruited as the case group (n=2,411). Women with intrauterine pregnancy (IUP) (n=2,416) and non-pregnant women (n=2,419) were matched as controls at a ratio of 1:1. Information regarding the previous and current use of contraceptives was collected. Multivariate logistic regression analyses were performed to calculate odds ratios (ORs) and the corresponding 95% confidential intervals (CIs). Results: Previous use of intrauterine devices (IUDs) was associated with a slight risk of ectopic pregnancy (AOR(1)=1.87 [95% CI: 1.48-2.37]; AOR(2)=1.84 [1.49-2.27]), and the risk increased with the duration of previous use (P-1 for trend <10(-4), P-2 for trend <10(-4)). The current use of most contraceptives reduced the risk of both unwanted IUP (condom: AOR=0.04 [0.03-0.05]; withdrawal method: AOR=0.10 [0.07-0.13]; calendar rhythm method: AOR=0.54 [0.40-0.73]; oral contraceptive pills [OCPs]: AOR=0.03 [0.02-0.08]; levonorgestrel emergency contraception [LNG-EC]: AOR=0.22 [0.16-0.30]; IUDs: AOR=0.01 [0.005-0.012]; tubal sterilization: AOR=0.01 [0.001-0.022]) and unwanted EP (condom: AOR(1)=0.05 [0.04-0.06]; withdrawal method: AOR(1)=0.13 [0.09-0.19]; calendar rhythm method: AOR(1)=0.66 [0.48-0.91]; OCPs: AOR(1)=0.14 [0.07-0.26]; IUDs: AOR(1)=0.17 [0.13-0.22]; tubal sterilization: AOR(1)=0.04 [0.02-0.08]). However, when contraception failed and pregnancy occurred, current use of OCPs (AOR(2)=4.06 [1.64-10.07]), LNG-EC (AOR(2)=4.87 [3.88-6.10]), IUDs (AOR(2)=21.08 [13.44-33.07]), and tubal sterilization (AOR(2)=7.68 [1.69-34.80]) increased the risk of EP compared with the non-use of contraceptives. Conclusion: Current use of most contraceptives reduce the risk of both IUP and EP. However, if the contraceptive method fails, the proportions of EP may be higher than those of non-users. In the case of contraceptive failure in the current cycle, EP cases should be differentiated according to current use of OCPs, LNG-EC, IUDs, and tubal sterilization. In addition, attention should be paid to women with previous long-term use of IUDs.	[Li, Cheng; Zhao, Wei-Hong; Zhu, Qian; Li, Xiao-Cui; Zhang, Jian] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Meng, Chun-Xia] Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65212 USA; [Ping, Hua] Songjiang Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 201620, Peoples R China; [Qin, Guo-Juan] Minhang Cent Hosp, Dept Obstet & Gynecol, Shanghai 201100, Peoples R China; [Cao, Shu-Jun] Songjiang Cent Hosp, Dept Obstet & Gynecol, Shanghai 201600, Peoples R China; [Xi, Xiaowei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200080, Peoples R China	Shanghai Jiao Tong University; University of Missouri System; University of Missouri Columbia; Shanghai Jiao Tong University	Li, XC (corresponding author), Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	Sisi1113@163.com; zhangjian_ipmch@sjtu.edu.cn	Meng, Chunxia/G-7583-2016; Zhang, Jian/K-8280-2019	Meng, Chunxia/0000-0001-8197-439X; Li, Cheng/0000-0002-7381-4940	Shanghai Scientific and Technical Committee Grants [124119a4802]	Shanghai Scientific and Technical Committee Grants	This work was supported by Shanghai Scientific and Technical Committee Grants (124119a4802). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2895; [Anonymous], 1985, Clin Reprod Fertil, V3, P131; [Anonymous], 2008, OBSTET GYNECOL, V111, P1479, DOI DOI 10.1097/AOG.0B013E31817D201E; [Anonymous], 2011, OBSTET GYNECOL, V118, P184; Backman T, 2004, AM J OBSTET GYNECOL, V190, P50, DOI 10.1016/j.ajog.2003.07.021; Basu A, 2005, EUR J CONTRACEP REPR, V10, P6, DOI 10.1080/13625180400020895; Bouyer J, 2000, FERTIL STERIL, V74, P899, DOI 10.1016/S0015-0282(00)01605-8; Cabar FR, 2009, CONTRACEPTION, V80, P227, DOI 10.1016/j.contraception.2009.02.004; Callegari LS, 2014, CONTRACEPTION; Cleland K, 2010, OBSTET GYNECOL, V115, P1263, DOI [10.1097/AOG.0b013e3181dd22ef, 10.1097/AOG.0b013e3181deff2a]; COSTE J, 1991, AM J EPIDEMIOL, V133, P839, DOI 10.1093/oxfordjournals.aje.a115964; CRAMER DW, 1985, NEW ENGL J MED, V312, P941, DOI 10.1056/NEJM198504113121502; Creinin MD, 2006, OBSTET GYNECOL, V108, P1089, DOI 10.1097/01.AOG.0000239440.02284.45; DALING JR, 1985, NEW ENGL J MED, V312, P937, DOI 10.1056/NEJM198504113121501; Daniels K, 2013, USE EMERGENCY CONTRA, V112, P1; Doherty IA, 2011, SEX TRANSM DIS, V38, P356, DOI 10.1097/OLQ.0b013e3181bc0628; Duenas-Garcia OF, 2011, INT J GYNECOL OBSTET, V114, P153, DOI 10.1016/j.ijgo.2011.02.021; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Gainer E, 2001, CONTRACEPTION, V64, P17, DOI 10.1016/S0010-7824(01)00220-7; Gemzell-Danielsson K, 2013, GYNECOL ENDOCRINOL, V29, P1, DOI 10.3109/09513590.2013.774591; Ghosh B, 2009, CONTRACEPTION, V79, P155, DOI 10.1016/j.contraception.2008.08.006; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Glasier A, 2011, CONTRACEPTION, V84, P363, DOI 10.1016/j.contraception.2011.02.009; Glasier AF, 2010, LANCET, V375, P555, DOI 10.1016/S0140-6736(10)60101-8; Gordts S, 2009, FERTIL STERIL, V92, P1198, DOI 10.1016/j.fertnstert.2008.08.028; Gradison M, 2012, AM FAM PHYSICIAN, V85, P791; Hamoda H, 2004, OBSTET GYNECOL, V104, P1307, DOI 10.1097/01.AOG.0000146286.60138.47; He H, 2013, J PAEDIATR CHILD H, V49, P912, DOI 10.1111/jpc.12426; HO PC, 1993, HUM REPROD, V8, P389, DOI 10.1093/oxfordjournals.humrep.a138057; HOLT VL, 1991, JAMA-J AM MED ASSOC, V266, P242, DOI 10.1001/jama.266.2.242; Jian Z, 2003, EUR J CONTRACEP REPR, V8, P225, DOI 10.1080/713604474; Karaer A, 2006, AUST NZ J OBSTET GYN, V46, P521, DOI 10.1111/j.1479-828X.2006.00653.x; Kazal O, 2012, INT J GYNECOL OBSTET, V117, P82, DOI 10.1016/j.ijgo.2011.11.006; Kim SH, 1997, FERTIL STERIL, V68, P865, DOI 10.1016/S0015-0282(97)00361-0; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Kozinszky Z, 2011, CONTRACEPTION, V83, P281, DOI 10.1016/j.contraception.2010.08.008; Lo SST, 2012, HONG KONG MED J, V18, P299; Mahmood T, 1998, HUM REPROD, V13, P2991, DOI 10.1093/humrep/13.11.2991; Malacova E, 2014, FERTIL STERIL, V101, P728, DOI 10.1016/j.fertnstert.2013.11.127; MARCHBANKS PA, 1988, JAMA-J AM MED ASSOC, V259, P1823, DOI 10.1001/jama.259.12.1823; Mol BWJ, 1995, CONTRACEPTION, V52, P337, DOI 10.1016/0010-7824(95)00221-9; Ngai SW, 2005, HUM REPROD, V20, P307, DOI 10.1093/humrep/deh583; Novikova N, 2007, CONTRACEPTION, V75, P112, DOI 10.1016/j.contraception.2006.08.015; ORY HW, 1981, OBSTET GYNECOL, V57, P137; PARAZZINI F, 1995, CONTRACEPTION, V52, P93, DOI 10.1016/S0010-7824(95)00142-5; Rana P, 2013, ARCH GYNECOL OBSTET, V288, P747, DOI 10.1007/s00404-013-2929-2; Ross J, 2014, INT J STD AIDS, V25, P1, DOI 10.1177/0956462413498714; Shaw JLV, 2010, HUM REPROD UPDATE, V16, P432, DOI 10.1093/humupd/dmp057; Sreshthaputra O, 2013, J RECONSTR MICROSURG, V29, P189, DOI 10.1055/s-0032-1333313; Stirling A, 2002, CONTRACEPTION, V66, P19, DOI 10.1016/S0010-7824(02)00310-4; THORBURN J, 1986, EUR J OBSTET GYN R B, V23, P321, DOI 10.1016/0028-2243(86)90167-X; Tirelli A, 2008, CONTRACEPTION, V77, P328, DOI 10.1016/j.contraception.2008.01.013; Walker JJ, 2007, CLIN OBSTET GYNECOL, V50, P89, DOI 10.1097/GRF.0b013e31802f4f79; Wang CT, 2012, CONTRACEPTION, V85, P570, DOI 10.1016/j.contraception.2011.10.014; Wanggren K, 2008, HUM REPROD, V23, P2359, DOI 10.1093/humrep/den260; WEISS NS, 1985, AM J PUBLIC HEALTH, V75, P67, DOI 10.2105/AJPH.75.1.67; XIONG X, 1995, CONTRACEPTION, V52, P23, DOI 10.1016/0010-7824(95)00120-Y; YANG CP, 1987, FERTIL STERIL, V48, P62; Yu XM, 2013, SEX HEALTH, V10, P424, DOI 10.1071/SH12140; Zheng XY, 2012, CONTRACEPTION, V86, P204, DOI 10.1016/j.contraception.2011.12.006	60	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115031	10.1371/journal.pone.0115031	http://dx.doi.org/10.1371/journal.pone.0115031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493939	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400090
J	Chen, Z; Li, MT; Xu, D; Yang, H; Li, J; Zhao, JL; Zhang, HH; Han, SM; Xu, T; Zeng, XF				Chen, Zhen; Li, Meng-Tao; Xu, Dong; Yang, Hong; Li, Jing; Zhao, Jiu-Liang; Zhang, Heng-Hui; Han, Shao-Mei; Xu, Tao; Zeng, Xiao-Feng			Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; GASTROENTEROPATHY; DIAGNOSIS; DIARRHEA; DISEASE; PATIENT; EDEMA	Objective: Protein-losing enteropathy (PLE) is a complication in some systemic lupus erythematosus (SLE) patients that is often misdiagnosed. With this study, we provide insight into clinical characteristics, laboratory characteristics, diagnostic tests, risk factors, treatment, and prognosis of the disease. Methods: A retrospective, case-control study was performed in 44 patients with SLE-related PLE (PLE group) and 88 patients with active SLE (control group) admitted to our care from January 2000-January 2012. Risk factors for SLE-related PLE were examined, and we analyzed the accuracy of single and combined laboratory characteristics in discriminating SLE-related PLE from active SLE. Serum albumin and C3 levels were measured as outcome during and after treatment with corticosteroids and immunosuppressive agents. Results: The PLE group had lower mean serum albumin and 24-hour urine protein levels, higher mean total plasma cholesterol levels, and greater frequencies of anti-SSA and SSB seropositivity compared with the control group. Anti-SSA seropositivity, hypoalbuminemia, and hypercholesterolemia were independent risk factors for SLE-related PLE. The simultaneous presence of serum albumin (<22 g/l) and 24-hour urine protein (<0.8 g/24 h) had high specificity, positive predictive value, negative predictive value, and positive likelihood ratio, a low negative likelihood ratio and no significant reduction in sensitivity. High dosage of glucocorticosteroid combined with cyclophosphomide were mostly prescribed for SLE-related PLE. Conclusion: SLE-related PLE should be considered when an SLE patient presents with generalized edema, anti-SSA antibody seropositivity, hypercholesterolemia, severe hypoalbuminemia, and low 24-hour urine protein levels. Aggressive treatment for lupus might improve prognosis.	[Chen, Zhen; Li, Meng-Tao; Xu, Dong; Li, Jing; Zhao, Jiu-Liang; Zeng, Xiao-Feng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Chen, Zhen; Li, Meng-Tao; Xu, Dong; Yang, Hong; Li, Jing; Zhao, Jiu-Liang; Han, Shao-Mei; Xu, Tao; Zeng, Xiao-Feng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Zhen; Li, Meng-Tao; Xu, Dong; Li, Jing; Zhao, Jiu-Liang; Zeng, Xiao-Feng] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China; [Yang, Hong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing 100730, Peoples R China; [Zhang, Heng-Hui] Peking Univ, Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China; [Han, Shao-Mei; Xu, Tao] Chinese Acad Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	zengxfpumc@gmail.com	Jiuliang, Zhao/AAW-5669-2020; meng, li/GVT-2063-2022	Jiuliang, Zhao/0000-0001-9308-2858; 	Chinese National Key Technology RD Program; Ministry of Science and Technology [2008BAI59B02, 2012AA02A513]; Chinese National High Technology Research and Development Program; Research Special Fund for Public Welfare Industry of Health, Ministry of Health [201202004]; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' Ministry of Science and Technology [2012ZX09303006-002]	Chinese National Key Technology RD Program(National Key Technology R&D Program); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); Research Special Fund for Public Welfare Industry of Health, Ministry of Health; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' Ministry of Science and Technology	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02), the Chinese National High Technology Research and Development Program, the Ministry of Science and Technology (2012AA02A513), the Research Special Fund for Public Welfare Industry of Health, Ministry of Health (201202004), and the National Major Scientific and Technological Special Project for "Significant New Drugs Development'' Ministry of Science and Technology (2012ZX09303006-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mogairen SM, 2011, RHEUMATOL INT, V31, P995, DOI 10.1007/s00296-011-1827-9; Aoki T, 2002, J GASTROENTEROL, V37, P204, DOI 10.1007/s005350200022; Awazawa R, 2012, J DERMATOL, V39, P454, DOI 10.1111/j.1346-8138.2011.01404.x; Carneiro FOAA, 2012, LUPUS, V21, P445, DOI 10.1177/0961203311425523; Chang JM, 2002, CLIN NEPHROL, V57, P392; Chau TN, 2011, DIGESTION, V84, P199, DOI 10.1159/000327914; Chiu NT, 2001, RADIOLOGY, V219, P86, DOI 10.1148/radiology.219.1.r01ap2986; de Castro GRW, 2005, RHEUMATOL INT, V25, P135, DOI 10.1007/s00296-004-0483-8; Gattorno M, 2002, EUR J PEDIATR, V161, P84, DOI 10.1007/s00431-001-0868-6; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gornisiewicz M, 2001, LUPUS, V10, P835, DOI 10.1191/096120301701548472; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hung J, 2006, NEPHROL DIAL TRANSPL, V21, P2027, DOI 10.1093/ndt/gfl043; Khalesi M, 2013, ACTA GASTRO-ENT BELG, V76, P413; Kim YG, 2008, LUPUS, V17, P575, DOI 10.1177/0961203307087407; Law ST, 2012, LUPUS, V21, P840, DOI 10.1177/0961203312438113; Lee CK, 2002, J RHEUMATOL, V29, P1330; Mok CC, 2006, RHEUMATOLOGY, V45, P425, DOI 10.1093/rheumatology/kei164; Oh DCT, 2006, LUPUS, V15, P102, DOI 10.1191/0961203306lu2251cr; Ossandon A, 2002, LUPUS, V11, P465, DOI 10.1191/0961203302lu233xx; Park JM, 2004, YONSEI MED J, V45, P923, DOI 10.3349/ymj.2004.45.5.923; Parodi A, 2009, ARTHRITIS RHEUM-US, V60, P3388, DOI 10.1002/art.24883; Peng SL, 2009, KELLEYS TXB RHEUMATO, P748; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Rajendiran A, 2012, INTERNAL MED, V51, P3131, DOI 10.2169/internalmedicine.51.8518; Ratnayake Eranda C, 2012, Int Arch Med, V5, P1, DOI 10.1186/1755-7682-5-1; Takenaka H, 2012, J CLIN GASTROENTEROL, V46, P575, DOI 10.1097/MCG.0b013e31823832ac; Tian XP, 2010, WORLD J GASTROENTERO, V16, P2971, DOI 10.3748/wjg.v16.i24.2971; Tsao YT, 2010, AM J EMERG MED, V28; Turkcapar Nuran, 2006, Turk J Gastroenterol, V17, P226; Umar SB, 2010, AM J GASTROENTEROL, V105, P43, DOI 10.1038/ajg.2009.561; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wang YF, 2008, CLIN RHEUMATOL, V27, P1325, DOI 10.1007/s10067-008-0929-6; Wu CC, 2004, NEPHROL DIAL TRANSPL, V19, P2149, DOI 10.1093/ndt/gfh226; Xu D, 2010, LUPUS, V19, P866, DOI 10.1177/0961203310365883; Yazici Y, 2002, LUPUS, V11, P119, DOI 10.1191/0961203302lu152cr; Zheng WJ, 2007, JCR-J CLIN RHEUMATOL, V13, P313, DOI 10.1097/RHU.0b013e31815bf9c6	37	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114684	10.1371/journal.pone.0114684	http://dx.doi.org/10.1371/journal.pone.0114684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490025	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300065
J	Dong, BL; Li, DS; Li, RY; Chen, SCA; Liu, WH; Liu, W; Chen, LQ; Chen, Y; Zhang, X; Tong, ZS; Xia, Y; Xia, P; Wang, Y; Duan, YQ				Dong, Bilin; Li, Dongsheng; Li, Ruoyu; Chen, Sharon C. -A.; Liu, Weihuang; Liu, Wei; Chen, Liuqing; Chen, Yao; Zhang, Xu; Tong, Zhongsheng; Xia, Yun; Xia, Ping; Wang, Yan; Duan, Yiqun			A Chitin-Like Component on Sclerotic Cells of Fonsecaea pedrosoi Inhibits Dectin-1-Mediated Murine Th17 Development by Masking beta-Glucans	PLOS ONE			English	Article							HOST-DEFENSE; CHROMOBLASTOMYCOSIS; RECEPTOR; INFECTION; IMMUNITY; FORMS; RECOGNITION; CYTOKINES; AGENT; FUNGI	Fonsecaea pedrosoi (F. pedrosoi), a major agent of chromoblastomycosis, has been shown to be recognized primarily by C-type lectin receptors (CLRs) in a murine model of chromoblastomycosis. Specifically, the beta-glucan receptor, Dectin-1, mediates Th17 development and consequent recruitment of neutrophils, and is evidenced to have the capacity to bind to saprophytic hyphae of F. pedrosoi in vitro. However, when embedded in tissue, most etiological agents of chromoblastomycosis including F. pedrosoi will transform into the sclerotic cells, which are linked to the greatest survival of melanized fungi in tissue. In this study, using immunocompetent and athymic (nu/nu) murine models infected subcutaneously or intraperitoneally with F. pedrosoi, we demonstrated that T lymphocytes play an active role in the resolution of localized footpad infection, and there existed a significantly decreased expression of Th17-defining transcription factor Ror gamma t and inefficient recruitment of neutrophils in chronically infected spleen where the inoculated mycelium of F. pedrosoi transformed into the sclerotic cells. We also found that Dectin-1-expressing histocytes and neutrophils participated in the enclosure of transformed sclerotic cells in the infectious foci. Furthermore, we induced the formation of sclerotic cells in vitro, and evidenced a significantly decreased binding capacity of human or murine-derived Dectin-1 to the induced sclerotic cells in comparison with the saprophytic mycelial forms. Our analysis of beta-glucans-masking components revealed that it is a chitin-like component, but not the mannose moiety on the sclerotic cells, that interferes with the binding of beta-glucans by human or murine Dectin-1. Notably, we demonstrated that although Dectin-1 contributed to the development of IL-17A-producing CD3+CD4+ murine splenocytes upon in vitro-stimulation by saprophytic F. pedrosoi, the masking effect of chitin components partly inhibited Dectin-1-mediated Th17 development upon in vitro-stimulation by induced sclerotic cells. Therefore, these findings extend our understanding of the chronicity of chromoblastomycosis.	[Dong, Bilin; Li, Dongsheng; Chen, Liuqing; Chen, Yao; Zhang, Xu; Tong, Zhongsheng; Xia, Yun; Xia, Ping; Duan, Yiqun] 1 Hosp Wuhan, Ctr Infect Skin Dis, Dept Dermatol, Wuhan, Peoples R China; [Li, Ruoyu] Peking Univ, Res Ctr Med Mycol, Beijing 100871, Peoples R China; [Chen, Sharon C. -A.] Univ Sydney, Westmead Hosp, ICPMR Pathol W, Ctr Infect Dis & Microbiol,Lab Serv, Westmead, NSW 2145, Australia; [Liu, Weihuang] Wuhan Univ, Med Res Ctr, Wuhan 430072, Peoples R China; [Liu, Wei; Wang, Yan] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	Peking University; University of Sydney; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Tong, ZS (corresponding author), 1 Hosp Wuhan, Ctr Infect Skin Dis, Dept Dermatol, Wuhan, Peoples R China.	zhongshengtong1970@126.com; augustusdong@126.com			National Natural Science Foundation of China [81301376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by grants from National Natural Science Foundation of China (NO: 81301376, BD), http://isisn.nsfc.gov.cn/egrantweb/contract/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO L, 1986, European Journal of Epidemiology, V2, P243, DOI 10.1007/BF00419488; Alviano DS, 2003, RES MICROBIOL, V154, P689, DOI 10.1016/j.resmic.2003.09.002; Ameen M, 2009, CLIN EXP DERMATOL, V34, P849, DOI 10.1111/j.1365-2230.2009.03415.x; Bonifaz A, 2001, MYCOSES, V44, P1, DOI 10.1046/j.1439-0507.2001.00613.x; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BUTTERFIELD W, 1976, MYCOPATHOLOGIA, V58, P59, DOI 10.1007/BF00493594; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; De Hoog GS, 2000, MED MYCOL, V38, P243, DOI 10.1080/mmy.38.s1.243.250; Gartner BN, 2005, EMBO J, V24, P1277; Gimenes VMF, 2005, MICROBES INFECT, V7, P708, DOI 10.1016/j.micinf.2005.01.006; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Jamil A, 2012, MED MYCOL, V50, P99, DOI 10.3109/13693786.2011.571295; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Laan M, 1999, J IMMUNOL, V162, P2347; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050589; Li DS, 2012, AM J DERMATOPATH, V34, P813, DOI 10.1097/DAD.0b013e318252f956; Machado AP, 2011, MYCOSES, V54, P202, DOI 10.1111/j.1439-0507.2009.01792.x; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Ogawa MM, 2003, INT J DERMATOL, V42, P622, DOI 10.1046/j.1365-4362.2003.01814.x; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santos ALS, 2007, FEMS MICROBIOL REV, V31, P570, DOI 10.1111/j.1574-6976.2007.00077.x; SILVA M, 1957, MYCOLOGIA, V49, P318, DOI 10.2307/3755682; Teixeira de Sousa Mda G, 2006, SCAND J IMMUNOL, V64, P595; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Wang H, 2013, CELL BIOCHEM BIOPHYS, V67, P599, DOI 10.1007/s12013-013-9547-2; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wozniak KL, 2006, INFECT IMMUN, V74, P3817, DOI 10.1128/IAI.00317-06	34	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114113	10.1371/journal.pone.0114113	http://dx.doi.org/10.1371/journal.pone.0114113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490199	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300017
J	Howe, SE; Konjufca, VH				Howe, Savannah E.; Konjufca, Vjollca H.			Protein-Coated Nanoparticles Are Internalized by the Epithelial Cells of the Female Reproductive Tract and Induce Systemic and Mucosal Immune Responses	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; GENITAL-TRACT; VACCINE DEVELOPMENT; ANTIBODY-RESPONSES; INTRAVAGINAL IMMUNIZATION; 1-INFECTED INDIVIDUALS; VAGINAL IMMUNIZATION; VIRUS; INFECTION; WOMEN	The female reproductive tract (FRT) includes the oviducts (fallopian tubes), uterus, cervix and vagina. A layer of columnar epithelium separates the endocervix and uterus from the outside environment, while the vagina is lined with stratified squamous epithelium. The mucosa of the FRT is exposed to antigens originating from microflora, and occasionally from infectious microorganisms. Whether epithelial cells (ECs) of the FRT take up (sample) the lumen antigens is not known. To address this question, we examined the uptake of 20-40 nm nanoparticles (NPs) applied vaginally to mice which were not treated with hormones, epithelial disruptors, or adjuvants. We found that 20 and 40 nm NPs are quickly internalized by ECs of the upper FRT and within one hour could be observed in the lymphatic ducts that drain the FRT, as well as in the ileac lymph nodes (ILNs) and the mesenteric lymph nodes (MLNs). Chicken ovalbumin (Ova) conjugated to 20 nm NPs (NP-Ova) when administered vaginally reaches the internal milieu in an immunologically relevant form; thus vaginal immunization of mice with NP-Ova induces systemic IgG to Ova antigen. Most importantly, vaginal immunization primes the intestinal mucosa for secretion of sIgA. Sub-cutaneous (s.c) boosting immunization with Ova in complete Freund's adjuvant (CFA) further elevates the systemic (IgG1 and IgG2c) as well as mucosal (IgG1 and sIgA) antibody titers. These findings suggest that the modes of antigen uptake at mucosal surfaces and pathways of antigen transport are more complex than previously appreciated.	[Howe, Savannah E.; Konjufca, Vjollca H.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Konjufca, VH (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097	Southern Illinois University	Southern Illinois University	This work was supported by the start up funds provided to Vjollca Konjufca by Southern Illinois University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Ballou B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051995; Bienenstock J, 1978, Adv Exp Med Biol, V107, P53; Chachu KA, 2008, J VIROL, V82, P6610, DOI 10.1128/JVI.00141-08; Cu Y, 2011, J CONTROL RELEASE, V156, P258, DOI 10.1016/j.jconrel.2011.06.036; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; CUFF CF, 1990, J VIROL, V64, P1256, DOI 10.1128/JVI.64.3.1256-1263.1990; Dorrell L, 2000, AIDS, V14, P1117, DOI 10.1097/00002030-200006160-00008; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gebert A, 1996, INT REV CYTOL, V167, P91, DOI 10.1016/S0074-7696(08)61346-7; Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003; Howe SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086656; Hunter Z, 2011, VACCINE, V29, P4584, DOI 10.1016/j.vaccine.2011.04.051; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Marks E, 2011, EUR J IMMUNOL, V41, P2642, DOI 10.1002/eji.201041297; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Mestecky J, 2005, AM J REPROD IMMUNOL, V53, P208, DOI 10.1111/j.1600-0897.2005.00267.x; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Mestecky J, 2009, J REPROD IMMUNOL, V83, P196, DOI 10.1016/j.jri.2009.07.005; Nag P, 2004, J INFECT DIS, V190, P1970, DOI 10.1086/425582; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; OWENS RB, 1974, J NATL CANCER I, V52, P1375, DOI 10.1093/jnci/52.4.1375; Raux M, 1999, AIDS RES HUM RETROV, V15, P1365, DOI 10.1089/088922299310070; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Russell MW, 2002, MICROBES INFECT, V4, P667, DOI 10.1016/S1286-4579(02)01585-X; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schleiss MR, 2000, VIRAL IMMUNOL, V13, P155, DOI 10.1089/vim.2000.13.155; Skurnick JH, 2002, J INFECT DIS, V185, P428, DOI 10.1086/338830; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Wegmann F, 2011, HUM VACCINES, V7, P982, DOI 10.4161/hv.7.9.16505; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173	45	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114601	10.1371/journal.pone.0114601	http://dx.doi.org/10.1371/journal.pone.0114601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490456	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300058
J	Jin, CN; Liu, M; Sun, JP; Fang, F; Wen, YN; Yu, CM; Lee, APW				Jin, Chun-Na; Liu, Ming; Sun, Jing-Ping; Fang, Fang; Wen, Yong-Na; Yu, Cheuk-Man; Lee, Alex Pui-Wai			The Prevalence and Prognosis of Resistant Hypertension in Patients with Heart Failure	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; SYSTOLIC BLOOD-PRESSURE; LEFT-VENTRICULAR HYPERTROPHY; LEVELS PREDICT SURVIVAL; UNITED-STATES; ATRIAL-FIBRILLATION; CLINICAL-FEATURES; HIGH-RISK; MORTALITY; OUTCOMES	Background: Resistant hypertension is associated with adverse clinical outcome in hypertensive patients. However, the prognostic significance of resistant hypertension in patients with heart failure remains uncertain. Methods and Results: The 1 year survival and heart failure re-hospitalization rate of 1288 consecutive patients admitted to a university hospital for either newly diagnosed heart failure or an exacerbation of prior chronic heart failure was analyzed. Resistant hypertension was defined as uncontrolled blood pressure (>140/90 mmHg) despite being compliant with an antihypertensive regimen that includes 3 or more drugs (including a diuretic). A total of 176 (13.7%) heart failure patients had resistant hypertension. There was no difference in all cause mortality, cardiovascular mortality, and heart failure related re-hospitalization between patients with versus without resistant hypertension. Diabetes [hazard ratio=1.62, 95% confidence interval=1.13-2.34; P=0.010] and serum sodium >139 mmol/L (hazard ratio=1.54, 95% confidence interval=1.06-2.23; P=0.024) were independently associated with resistant hypertension. Patients with resistant hypertension had a relatively higher survival rate (86.9% vs. 83.8%), although the difference was not significant (log-rank x(2)=1.00, P=0.317). In patients with reduced ejection fraction, heart failure related re-hospitalization was significantly lower in patients with resistant hypertension (45.8% vs. 59.1%, P=0.050). Conclusions: Resistant hypertension appears to be not associated with adverse clinical outcome in patients with heart failure, in fact may be a protective factor for reduced heart failure related re-hospitalization in patients with reduced ejection fraction.	[Jin, Chun-Na; Liu, Ming; Sun, Jing-Ping; Fang, Fang; Wen, Yong-Na; Yu, Cheuk-Man; Lee, Alex Pui-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,Div Cardiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Lee, APW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	alexpwlee@cuhk.edu.hk	Yu, Cheuk-man/P-3747-2015; Lee, Alex Pui-Wai/E-9217-2013; Fang, Fang/B-9912-2017	Lee, Alex Pui-Wai/0000-0002-4120-155X; Fang, Fang/0000-0002-4023-2928				Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Anand IS, 2007, J AM COLL CARDIOL, V49, P32, DOI 10.1016/j.jacc.2006.04.109; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Badheka AO, 2011, AM J CARDIOL, V108, P1283, DOI 10.1016/j.amjcard.2011.06.045; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bisognano JD, 2009, J CARD FAIL, V15, pS63, DOI 10.1016/j.cardfail.2009.06.191; Brophy JM, 2004, AM J MED, V116, P300, DOI 10.1016/j.amjmed.2003.09.035; Buiciuc O, 2011, J CARD FAIL, V17, P907, DOI 10.1016/j.cardfail.2011.08.002; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cygankiewicz I, 2009, AM J CARDIOL, V103, P1003, DOI 10.1016/j.amjcard.2008.11.061; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019; De Blois J, 2010, J CARD FAIL, V16, P225, DOI 10.1016/j.cardfail.2009.12.002; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Goldberg RJ, 2007, ARCH INTERN MED, V167, P490, DOI 10.1001/archinte.167.5.490; Grigorian-Shamagian L, 2008, J CARD FAIL, V14, P561, DOI 10.1016/j.cardfail.2008.03.006; Gupta AK, 2011, J HYPERTENS, V29, P2004, DOI 10.1097/HJH.0b013e32834a8a42; Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002; Hawkins NM, 2007, HEART, V93, P59, DOI 10.1136/hrt.2005.083949; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Kwon BJ, 2010, EUR J HEART FAIL, V12, P1339, DOI 10.1093/eurjhf/hfq157; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee TT, 2006, AM HEART J, V151, P76, DOI 10.1016/j.ahj.2005.03.009; Linssen GCM, 2011, EUR J HEART FAIL, V13, P1111, DOI 10.1093/eurjhf/hfr066; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; McAdam-Marx C, 2009, CLIN THER, V31, P1116, DOI 10.1016/j.clinthera.2009.05.007; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; Nunez J, 2010, EUR J HEART FAIL, V12, P38, DOI 10.1093/eurjhf/hfp176; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Persson H, 2007, J AM COLL CARDIOL, V49, P687, DOI 10.1016/j.jacc.2006.08.062; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Pulignano G, 2002, AM HEART J, V143, P45, DOI 10.1067/mhj.2002.119608; Raphael CE, 2009, HEART, V95, P56, DOI 10.1136/hrt.2007.134973; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Writing Group M, 2012, CIRCULATION, V125, pe2	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114958	10.1371/journal.pone.0114958	http://dx.doi.org/10.1371/journal.pone.0114958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490405	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300098
J	Kumar, AA; Chunda-Liyoka, C; Hennek, JW; Mantina, H; Lee, SYR; Patton, MR; Sambo, P; Sinyangwe, S; Kankasa, C; Chintu, C; Brugnara, C; Stossel, TP; Whitesides, GM				Kumar, Ashok A.; Chunda-Liyoka, Catherine; Hennek, Jonathan W.; Mantina, Hamakwa; Lee, S. Y. Ryan; Patton, Matthew R.; Sambo, Pauline; Sinyangwe, Silvester; Kankasa, Chipepo; Chintu, Chifumbe; Brugnara, Carlo; Stossel, Thomas P.; Whitesides, George M.			Evaluation of a Density-Based Rapid Diagnostic Test for Sickle Cell Disease in a Clinical Setting in Zambia	PLOS ONE			English	Article							ANEMIA; HEMOGLOBIN; CHILDREN; BLOOD; GENE	Although simple and low-cost interventions for sickle cell disease (SCD) exist in many developing countries, child mortality associated with SCD remains high, in part, because of the lack of access to diagnostic tests for SCD. A density-based test using aqueous multiphase systems (SCD-AMPS) is a candidate for a low-cost, point-of-care diagnostic for SCD. In this paper, the field evaluation of SCD-AMPS in a large (n=505) case-control study in Zambia is described. Of the two variations of the SCD-AMPS used, the best system (SCD-AMPS-2) demonstrated a sensitivity of 86% (82-90%) and a specificity of 60% (53-67%). Subsequent analysis identified potential sources of false positives that include clotting, variation between batches of SCD-AMPS, and shipping conditions. Importantly, SCD-AMPS-2 was 84% (62-94%) sensitive in detecting SCD in children between 6 months and 1 year old. In addition to an evaluation of performance, an assessment of end-user operability was done with health workers in rural clinics in Zambia. These health workers rated the SCD-AMPS tests to be as simple to use as lateral flow tests for malaria and HIV.	[Kumar, Ashok A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Chunda-Liyoka, Catherine; Mantina, Hamakwa; Sambo, Pauline; Sinyangwe, Silvester; Kankasa, Chipepo; Chintu, Chifumbe] Univ Teaching Hosp, Dept Pediat, Lusaka, Zambia; [Hennek, Jonathan W.; Lee, S. Y. Ryan; Patton, Matthew R.; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Brugnara, Carlo] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Stossel, Thomas P.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Whitesides, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; University of Zambia; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Chunda-Liyoka, Catherine/AAD-6343-2021	Kumar, Ashok/0000-0002-9345-2481	Blavatnik Biomedical Accelerator Award; Harvard Global Health Institute; Office of Naval Research through the NDSEG Fellowship Program; National Science Foundation; Bill and Melinda Gates Foundation [51308]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCRR and NCATS, NIH) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER	Blavatnik Biomedical Accelerator Award; Harvard Global Health Institute; Office of Naval Research through the NDSEG Fellowship Program(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCRR and NCATS, NIH); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a Blavatnik Biomedical Accelerator Award and by a Research Grant from the Harvard Global Health Institute. A.A.K. acknowledges support from the Office of Naval Research through the NDSEG Fellowship Program and from a Graduate Research Fellowship from the National Science Foundation. J.W.H. was supported through a grant from the Bill and Melinda Gates Foundation (51308). This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NCRR and NCATS, NIH Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Bartolucci P, 2012, BLOOD, V120, P3136, DOI 10.1182/blood-2012-04-424184; Brugnara C, 2003, CLIN CHEM, V49, P1573, DOI 10.1373/49.10.1573; Diallo D, 2002, CURR OPIN HEMATOL, V9, P111, DOI 10.1097/00062752-200203000-00005; EMBURY SH, 1984, J CLIN INVEST, V73, P116, DOI 10.1172/JCI111181; ESTEP TN, 1984, BLOOD, V64, P1270; FABRY ME, 1984, BLOOD, V64, P559; FABRY ME, 1984, BLOOD, V64, P1042; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GOOSSENS W, 1991, CLIN LAB HAEMATOL, V13, P291; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Kumar AA, 2014, P NATL ACAD SCI USA, V111, P14864, DOI 10.1073/pnas.1414739111; LOUDERBACK AL, 1974, CLIN CHEM, V20, P761; Mace CR, 2012, J AM CHEM SOC, V134, P9094, DOI 10.1021/ja303183z; McGann PT, 2013, AM J HEMATOL, V88, P984, DOI 10.1002/ajh.23578; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Piel FB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01671; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; Pollock NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075616; Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; SERJEANT BE, 1974, CLIN CHEM, V20, P666; Steinberg MH, 2005, BRIT J HAEMATOL, V129, P465, DOI 10.1111/j.1365-2141.2005.05411.x; Tubman VN, 2013, AM J HEMATOL, V88, P983, DOI 10.1002/ajh.23602; WHO, 2011, WHO TECH REP SER, V959, P1; Yang XX, 2013, LAB CHIP, V13, P1464, DOI 10.1039/c3lc41302k	27	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114540	10.1371/journal.pone.0114540	http://dx.doi.org/10.1371/journal.pone.0114540			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490722	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300050
J	Reither, K; Katsoulis, L; Beattie, T; Gardiner, N; Lenz, N; Said, K; Mfinanga, E; Pohl, C; Fielding, KL; Jeffery, H; Kagina, BM; Hughes, EJ; Scriba, TJ; Hanekom, WA; Hoff, ST; Bang, P; Kromann, I; Daubenberger, C; Andersen, P; Churchyard, GJ				Reither, Klaus; Katsoulis, Lynn; Beattie, Trevor; Gardiner, Nicolene; Lenz, Nicole; Said, Khadija; Mfinanga, Elirehema; Pohl, Christian; Fielding, Katherine L.; Jeffery, Hannah; Kagina, Benjamin M.; Hughes, Elisabeth J.; Scriba, Thomas J.; Hanekom, Willem A.; Hoff, Soren T.; Bang, Peter; Kromann, Ingrid; Daubenberger, Claudia; Andersen, Peter; Churchyard, Gavin J.			Safety and Immunogenicity of H1/IC31 (R), an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+Lymphocyte Counts Greater than 350 cells/mm(3) : A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; POLYFUNCTIONAL CD4(+); CELL RESPONSES; PROTECTION; PREVENTION; CORRELATE; IMMUNITY	Background: Novel tuberculosis vaccines should be safe, immunogenic, and effective in various population groups, including HIV-infected individuals. In this phase II multi-centre, double-blind, placebo-controlled trial, the safety and immunogenicity of the novel H1/IC31 vaccine, a fusion protein of Ag85B-ESAT-6 (H1) formulated with the adjuvant IC31, was evaluated in HIV-infected adults. Methods: HIV-infected adults with CD4+ T cell counts >350/mm(3) and without evidence of active tuberculosis were enrolled and followed until day 182. H1/IC31 vaccine or placebo was randomly allocated in a 5: 1 ratio. The vaccine was administered intramuscularly at day 0 and 56. Safety assessment was based on medical history, clinical examinations, and blood and urine testing. Immunogenicity was determined by a short-term whole blood intracellular cytokine staining assay. Results: 47 of the 48 randomised participants completed both vaccinations. In total, 459 mild or moderate and 2 severe adverse events were reported. There were three serious adverse events in two vaccinees classified as not related to the investigational product. Local injection site reactions were more common in H1/IC31 versus placebo recipients (65.0% vs. 12.5%, p=0.015). Solicited systemic and unsolicited adverse events were similar by study arm. The baseline CD4+ Tcell count and HIV viral load were similar by study arm and remained constant over time. The H1/IC31 vaccine induced a persistent Th1-immune response with predominately TNF-alpha and IL-2 co-expressing CD4+ T cells, as well as polyfunctional IFN-gamma, TNF-alpha and IL-2 expressing CD4+ T cells. Conclusion: H1/IC31 was well tolerated and safe in HIV-infected adults with a CD4+ Lymphocyte count greater than 350 cells/mm(3). The vaccine did not have an effect on CD4+ T cell count or HIV-1 viral load. H1/IC31 induced a specific and durable Th1-immune response.	[Reither, Klaus; Lenz, Nicole; Pohl, Christian; Daubenberger, Claudia] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Reither, Klaus; Lenz, Nicole; Pohl, Christian; Daubenberger, Claudia] Univ Basel, Basel, Switzerland; [Reither, Klaus; Said, Khadija; Mfinanga, Elirehema; Pohl, Christian] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Katsoulis, Lynn; Beattie, Trevor; Gardiner, Nicolene; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Fielding, Katherine L.; Jeffery, Hannah; Churchyard, Gavin J.] London Sch Hyg & Trop Med, London WC1, England; [Kagina, Benjamin M.; Hughes, Elisabeth J.; Scriba, Thomas J.; Hanekom, Willem A.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Kagina, Benjamin M.; Hughes, Elisabeth J.; Scriba, Thomas J.; Hanekom, Willem A.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Hoff, Soren T.; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Bang, Peter; Kromann, Ingrid] Statens Serum Inst, Dept Vaccine Dev, DK-2300 Copenhagen, Denmark; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of Cape Town; Statens Serum Institut; Statens Serum Institut; University of Witwatersrand	Reither, K (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	Klaus.Reither@unibas.ch	Scriba, Thomas/GPX-2573-2022; Bang, Peter/V-4537-2019; Scriba, Thomas/AAH-9413-2020	Scriba, Thomas/0000-0002-0641-1359; Pohl, Christian/0000-0002-1864-2584; Hanekom, Willem/0000-0003-3070-6154; Reither, Klaus/0000-0001-6195-8237; Andersen, Peter/0000-0002-5869-2551; Jeffery, Hannah/0000-0002-2305-6969; Bang, Peter/0000-0001-6028-0911; Churchyard, Gavin/0000-0002-4269-3699; Daubenberger, Claudia/0000-0001-7136-0642; Kagina, Benjamin/0000-0003-4943-9762	European Developing Countries Clinical Trials Partnership (EDCTP) [IP.2009.32080.002]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European Developing Countries Clinical Trials Partnership (EDCTP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The trial has been funded by the European Developing Countries Clinical Trials Partnership (EDCTP) [IP.2009.32080.002] (http://www.edctp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; CHURCHYARD GJ, 2013, CROI; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Dieye TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067177; ELVANG TT, 2012, PLOS ONE, V7, P39909, DOI DOI 10.1371/J0URNAL.P0NE.0039909; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Mwinga A, 2002, LANCET, V360, P1050, DOI 10.1016/S0140-6736(02)11141-X; Nell AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089612; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Scriba TJ, 2012, AM J RESP CRIT CARE, V185, P769, DOI 10.1164/rccm.201108-1548OC; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; WHO, 2014, GLOB TUB REP 2013; World Health Organization, 2011, NEW WHO REC US COMM	30	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114602	10.1371/journal.pone.0114602	http://dx.doi.org/10.1371/journal.pone.0114602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490675	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347515300059
J	Tolle, F; Wilke, J; Wengel, J; Mayer, G				Tolle, Fabian; Wilke, Julian; Wengel, Jesper; Mayer, Gunter			By-Product Formation in Repetitive PCR Amplification of DNA Libraries during SELEX	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; RNA; ARTIFACTS; SELECTION; APTAMERS; LIGANDS; BIAS; LNA	The selection of nucleic acid aptamers is an increasingly important approach to generate specific ligands binding to virtually any molecule of choice. However, selection-inherent amplification procedures are prone to artificial by-product formation that prohibits the enrichment of target-recognizing aptamers. Little is known about the formation of such by-products when employing nucleic acid libraries as templates. We report on the formation of two different forms of by-products, named ladder-and non-ladder-type observed during repetitive amplification in the course of in vitro selection experiments. Based on sequence information and the amplification behaviour of defined enriched nucleic acid molecules we suppose a molecular mechanism through which these amplification by-products are built. Better understanding of these mechanisms might help to find solutions minimizing by-product formation and improving the success rate of aptamer selection.	[Tolle, Fabian; Wilke, Julian; Mayer, Gunter] Univ Bonn, LIMES Inst, Bonn, Germany; [Wengel, Jesper] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense M, Denmark	University of Bonn; University of Southern Denmark	Mayer, G (corresponding author), Univ Bonn, LIMES Inst, Bonn, Germany.	gmayer@uni-bonn.de		Tolle, Fabian/0000-0002-4221-0167; Wengel, Jesper/0000-0001-9835-1009	Deutsche Forschungsgemeinschaft (DFG) [Ma 3442/4.1]; European Research Concil under the European Union's Seventh Framework program (FP7)/ERC [268776]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Concil under the European Union's Seventh Framework program (FP7)/ERC	Funded by Deutsche Forschungsgemeinschaft to G.M. (DFG Ma 3442/4.1). J.W. acknowledge support from the European Research Concil under the European Union's Seventh Framework program (FP7/2007-2013)/ERC Grant agreement no. 268776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Kalle E, 2013, J MICROBIOL METH, V95, P285, DOI 10.1016/j.mimet.2013.09.014; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Koshkin AA, 1998, TETRAHEDRON LETT, V39, P4381, DOI 10.1016/S0040-4039(98)00706-0; Marshall KA, 1999, J MOL EVOL, V49, P656, DOI 10.1007/PL00006586; Mayer G, 2008, RNA, V14, P524, DOI 10.1261/rna.821908; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Muller J, 2009, CHEM BIOL, V16, P442, DOI 10.1016/j.chembiol.2009.03.007; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Plaxco KW, 2011, TRENDS BIOTECHNOL, V29, P1, DOI 10.1016/j.tibtech.2010.10.005; Raddatz M. S., 2008, ANGEW CHEM, V120, P5268, DOI DOI 10.1002/ANGE.200800216; Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029; Shao KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024910; Svobodova M, 2012, ANAL BIOANAL CHEM, V404, P835, DOI 10.1007/s00216-012-6183-4; Tolle F, 2013, CHEM SCI, V4, P60, DOI 10.1039/c2sc21510a; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	22	54	56	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114693	10.1371/journal.pone.0114693	http://dx.doi.org/10.1371/journal.pone.0114693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490402	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300068
J	Vercelli, M; Lillini, R; Quaglia, A; Micale, RT; La Maestra, S; De Flora, S				Vercelli, Marina; Lillini, Roberto; Quaglia, Alberto; Micale, Rosanna T.; La Maestra, Sebastiano; De Flora, Silvio			Age-Related Mortality Trends in Italy from 1901 to 2008	PLOS ONE			English	Article							EPIDEMIOLOGIC TRANSITION; DEATH; BURDEN	We stratified the Italian population according to age and gender in order to evaluate mortality trends over more than one century. Data covering the 1901-2008 period were used to study the yearly variations in mortality. Fluctuations in age-adjusted mortality curves were analyzed by Join Point Regression Models, identifying Join Points and Annual Percent Changes. A consistent decline in all-cause mortality occurred across the whole period, the most striking variations being observed in the 0-49 years population. In 1901, other and undefined diseases were the main causes of death, followed by infectious, digestive, and respiratory diseases in the 0-49 years population and by respiratory, cardiovascular, and cerebrovascular diseases in the >= 50 years population groups. In 2008 the main causes of death were accidents (males) and tumors (females) in the 0-49 age class, tumors in the 50-69 age class (both genders), and tumors (males) and cardiovascular diseases (females) in the elderly. The results highlight the interplay between age and gender in affecting mortality trends and reflect the dramatic progress in nutritional, lifestyle, socioeconomic, medical, and hygienic conditions.	[Vercelli, Marina; Micale, Rosanna T.; La Maestra, Sebastiano; De Flora, Silvio] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Lillini, Roberto; Quaglia, Alberto] Univ San Martino, Azienda Osped, IRCCS, Descript Epidemiol Unit, Genoa, Italy; [Lillini, Roberto] Univ Vita Salute San Raffaele, Milan, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Vita-Salute San Raffaele University	De Flora, S (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	sdf@unige.it	Lillini, Roberto/AAF-2348-2021	Lillini, Roberto/0000-0001-9872-8670; LA MAESTRA, SEBASTIANO/0000-0003-4939-2124; Vercelli, Marina/0000-0002-9757-2616				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; AIRTUM Working Group, 2009, Epidemiol Prev, V33, P1; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 2013, NONC DIS; Arcaleni E, 2006, ECON HUM BIOL, V4, P24, DOI 10.1016/j.ehb.2005.06.003; Conti S, 1992, Epidemiol Prev, V14, P29; De Flora S, 2005, FASEB J, V19, P892, DOI 10.1096/fj.04-3541rev; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; De Santi A, 2004, 0422 ISTISAN; Frova L, 2011, EPIDEMIOL BIOSTAT PU, V8, P186; Gaylin DS, 1997, SOC SCI MED, V44, P609, DOI 10.1016/S0277-9536(96)00212-2; Heuveline P, 2002, SOC SCI MED, V55, P313, DOI 10.1016/S0277-9536(01)00172-1; Istituto Nazionale di Statistica (ISTAT), 2013, HLTH ALL IT; Istituto Nazionale di Statistica (ISTAT), 1976, SUMM HIST STAT IT 18; Istituto Nazionale di Statistica (ISTAT), 1958, CAUS DEATH 1887 1955; Istituto Nazionale di Statistica (ISTAT), 2011, AN BRIDG COD ICD 9 I; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Mackenbach JP, 2013, INT J EPIDEMIOL, V42, P1100, DOI 10.1093/ije/dyt122; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; National Cancer Institute, 2008, JOINP REGR PROGR VER; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Quaglia A, 2013, SURG ONCOL, V22, pE31, DOI 10.1016/j.suronc.2013.02.010; Schaffar R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-609; SEGI M, 1954, Tohoku J Exp Med, V60, P307; SEGI MITSUO, 1960, TOHOKU JOUR EXPTL MED, V72, P91; Sidorenkov O, 2011, INT J EPIDEMIOL, V40, P1519, DOI 10.1093/ije/dyr145; Suligoi B, 2010, NOT I SUPER SANITA S, V23, P3; United Nations Department of Economic and Social Affairs Population Division, 2012, STESASERA318 POP DIV; Vercelli M, 2013, INT J HYG ENVIR HEAL, V216, P2322; Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114027	10.1371/journal.pone.0114027	http://dx.doi.org/10.1371/journal.pone.0114027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MX	25486606	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600037
J	Xia, JY; Veselenak, RL; Gorder, SR; Bourne, N; Milligan, GN				Xia, Jingya; Veselenak, Ronald L.; Gorder, Summer R.; Bourne, Nigel; Milligan, Gregg N.			Virus-Specific Immune Memory at Peripheral Sites of Herpes Simplex Virus Type 2 (HSV-2) Infection in Guinea Pigs	PLOS ONE			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; ANTIBODY-SECRETING CELLS; FEMALE GENITAL-TRACT; SENSORY GANGLIA; B-CELLS; MICE; REACTIVATION; REINFECTION; RESPONSES	Despite its importance in modulating HSV-2 pathogenesis, the nature of tissue-resident immune memory to HSV-2 is not completely understood. We used genital HSV-2 infection of guinea pigs to assess the type and location of HSV-specific memory cells at peripheral sites of HSV-2 infection. HSV-specific antibody-secreting cells were readily detected in the spleen, bone marrow, vagina/cervix, lumbosacral sensory ganglia, and spinal cord of previously-infected animals. Memory B cells were detected primarily in the spleen and to a lesser extent in bone marrow but not in the genital tract or neural tissues suggesting that the HSV-specific antibody-secreting cells present at peripheral sites of HSV-2 infection represented persisting populations of plasma cells. The antibody produced by these cells isolated from neural tissues of infected animals was functionally relevant and included antibodies specific for HSV-2 glycoproteins and HSV-2 neutralizing antibodies. A vigorous IFN-gamma-secreting T cell response developed in the spleen as well as the sites of HSV-2 infection in the genital tract, lumbosacral ganglia and spinal cord following acute HSV-2 infection. Additionally, populations of HSV-specific tissue-resident memory T cells were maintained at these sites and were readily detected up to 150 days post HSV-2 infection. Unlike the persisting plasma cells, HSV-specific memory T cells were also detected in uterine tissue and cervicothoracic region of the spinal cord and at low levels in the cervicothoracic ganglia. Both HSV-specific CD4(+) and CD8(+) resident memory cell subsets were maintained long-term in the genital tract and sensory ganglia/spinal cord following HSV-2 infection. Together these data demonstrate the long-term maintenance of both humoral and cellular arms of the adaptive immune response at the sites of HSV-2 latency and virus shedding and highlight the utility of the guinea pig infection model to investigate tissue-resident memory in the setting of HSV-2 latency and spontaneous reactivation.	[Xia, Jingya; Veselenak, Ronald L.; Bourne, Nigel; Milligan, Gregg N.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gorder, Summer R.; Bourne, Nigel; Milligan, Gregg N.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Bourne, Nigel; Milligan, Gregg N.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Milligan, GN (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	gnmillig@utmb.edu			John Sealy Memorial Endowment Fund Research Pilot Grant; National Institutes of Health [AI105962]; Sealy Center for Vaccine Development Pre-doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105962] Funding Source: NIH RePORTER	John Sealy Memorial Endowment Fund Research Pilot Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development Pre-doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was funded by a John Sealy Memorial Endowment Fund Research Pilot Grant (GNM) and by grant AI105962 from the National Institutes of Health (NB). JX was supported by a Sealy Center for Vaccine Development Pre-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bourne N, 1999, ANTIVIR RES, V40, P139, DOI 10.1016/S0166-3542(98)00055-2; BROWN ZA, 1987, NEW ENGL J MED, V317, P1246, DOI 10.1056/NEJM198711123172002; COOK ML, 1973, INFECT IMMUN, V7, P272, DOI 10.1128/IAI.7.2.272-288.1973; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; ESIRI MM, 1980, CLIN EXP IMMUNOL, V40, P42; Held K, 2012, J NEUROVIROL, V18, P62, DOI 10.1007/s13365-011-0067-9; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; HULL HF, 1984, J PEDIATR-US, V104, P211, DOI 10.1016/S0022-3476(84)80994-4; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Johansson M, 2003, CURR OPIN INFECT DIS, V16, P43, DOI 10.1097/00001432-200302000-00008; Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08; KLEIN RJ, 1980, J GEN VIROL, V49, P401, DOI 10.1099/0022-1317-49-2-401; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; KOELLE DM, 1994, J INFECT DIS, V169, P956, DOI 10.1093/infdis/169.5.956; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; KOELLE DM, 1994, J VIROL, V68, P2803, DOI 10.1128/JVI.68.5.2803-2810.1994; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; MCBRIDE BW, 1988, VACCINE, V6, P414, DOI 10.1016/0264-410X(88)90141-7; MCKENDALL RR, 1979, INFECT IMMUN, V23, P305, DOI 10.1128/IAI.23.2.305-311.1979; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Milligan GN, 2005, J VIROL, V79, P11537, DOI 10.1128/JVI.79.17.11537-11540.2005; MILLIGAN GN, 1995, VIROLOGY, V206, P234, DOI 10.1016/S0042-6822(95)80038-7; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Milligan GN, 1998, J IMMUNOL, V160, P6093; Ohashi M, 2011, J VIROL, V85, P3030, DOI 10.1128/JVI.02426-10; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Parr EL, 1998, J REPROD IMMUNOL, V38, P15, DOI 10.1016/S0165-0378(97)00081-8; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; Schafer H, 2007, J IMMUNOL METHODS, V328, P106, DOI 10.1016/j.jim.2007.08.012; Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; SIMMONS A, 1985, J VIROL, V53, P944, DOI 10.1128/JVI.53.3.944-948.1985; STANBERRY LR, 1986, J INFECT DIS, V153, P1055, DOI 10.1093/infdis/153.6.1055; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; Tschen SI, 2006, EUR J IMMUNOL, V36, P603, DOI 10.1002/eji.200535123; Tschen SI, 2002, J IMMUNOL, V168, P2922, DOI 10.4049/jimmunol.168.6.2922; Valencia Frances, 2013, Methods Mol Biol, V1030, P315, DOI 10.1007/978-1-62703-484-5_24; van Velzen M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003547; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Walsh PN, 2013, J IMMUNOL METHODS, V394, P84, DOI 10.1016/j.jim.2013.05.007; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	55	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114652	10.1371/journal.pone.0114652	http://dx.doi.org/10.1371/journal.pone.0114652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485971	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907600083
J	Bagchi, S; Vlaeminck, SE; Sauder, LA; Mosquera, M; Neufeld, JD; Boon, N				Bagchi, Samik; Vlaeminck, Siegfried E.; Sauder, Laura A.; Mosquera, Mariela; Neufeld, Josh D.; Boon, Nico			Temporal and Spatial Stability of Ammonia-Oxidizing Archaea and Bacteria in Aquarium Biofilters	PLOS ONE			English	Article							WATER TREATMENT-PLANT; PHYLOGENETIC DIVERSITY; ACTIVATED-SLUDGE; FRESH-WATER; NITRIFICATION; COMMUNITY; SYSTEMS; ANAMMOX; NICHE; SOILS	Nitrifying biofilters are used in aquaria and aquaculture systems to prevent accumulation of ammonia by promoting rapid conversion to nitrate via nitrite. Ammonia-oxidizing archaea (AOA), as opposed to ammonia-oxidizing bacteria (AOB), were recently identified as the dominant ammonia oxidizers in most freshwater aquaria. This study investigated biofilms from fixed-bed aquarium biofilters to assess the temporal and spatial dynamics of AOA and AOB abundance and diversity. Over a period of four months, ammonia-oxidizing microorganisms from six freshwater and one marine aquarium were investigated at 4-5 time points. Nitrogen balances for three freshwater aquaria showed that active nitrification by aquarium biofilters accounted for >= 81-86% of total nitrogen conversion in the aquaria. Quantitative PCR (qPCR) for bacterial and thaumarchaeal ammonia monooxygenase (amoA) genes demonstrated that AOA were numerically dominant over AOB in all six freshwater aquaria tested, and contributed all detectable amoA genes in three aquarium biofilters. In the marine aquarium, however, AOB outnumbered AOA by three to five orders of magnitude based on amoA gene abundances. A comparison of AOA abundance in three carrier materials (fine sponge, rough sponge and sintered glass or ceramic rings) of two three-media freshwater biofilters revealed preferential growth of AOA on fine sponge. Denaturing gel gradient electrophoresis (DGGE) of thaumarchaeal 16S rRNA genes indicated that community composition within a given biofilter was stable across media types. In addition, DGGE of all aquarium biofilters revealed low AOA diversity, with few bands, which were stable over time. Nonmetric multidimensional scaling (NMDS) based on denaturing gradient gel electrophoresis (DGGE) fingerprints of thaumarchaeal 16S rRNA genes placed freshwater and marine aquaria communities in separate clusters. These results indicate that AOA are the dominant ammonia-oxidizing microorganisms in freshwater aquarium biofilters, and that AOA community composition within a given aquarium is stable over time and across biofilter support material types.	[Bagchi, Samik; Vlaeminck, Siegfried E.; Mosquera, Mariela; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium; [Sauder, Laura A.; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Ghent University; University of Waterloo	Boon, N (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol LabMET, Coupure Links 653, B-9000 Ghent, Belgium.	Nico.Boon@UGent.be	Vlaeminck, Siegfried E./B-4203-2014; Boon, Nico/B-4083-2011; Bagchi, Samik/C-1396-2010	Vlaeminck, Siegfried E./0000-0002-2596-8857; Boon, Nico/0000-0002-7734-3103; Bagchi, Samik/0000-0001-9477-2818	Flemish Government [1F2B8M/JDW/2010-2011/10-BTL-IND-01]; Research Foundation Flanders (FWO-Vlaanderen); Natural Sciences and Engineering Council of Canada (NSERC)	Flemish Government(European Commission); Research Foundation Flanders (FWO-Vlaanderen)(FWO); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.B. was supported by a scholarship from the Flemish Government (1F2B8M/JDW/2010-2011/10-BTL-IND-01) on a bilateral cultural cooperation program; S.E.V. was supported as a postdoctoral fellow from the Research Foundation Flanders (FWO-Vlaanderen); and L.S. and J.D.N. were supported by the Natural Sciences and Engineering Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RJE, 2013, ISME J, V7, P1620, DOI 10.1038/ismej.2013.35; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Bernhard AE, 2005, ENVIRON MICROBIOL, V7, P1289, DOI 10.1111/j.1462-2920.2005.00808.x; Bouskill NJ, 2012, ENVIRON MICROBIOL, V14, P714, DOI 10.1111/j.1462-2920.2011.02623.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brown MN, 2013, FEMS MICROBIOL ECOL, V83, P17, DOI 10.1111/j.1574-6941.2012.01448.x; El-Shafai SA, 2004, AQUACULTURE, V232, P117, DOI 10.1016/S0044-8486(03)00516-7; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Foesel BU, 2008, FEMS MICROBIOL ECOL, V63, P192, DOI 10.1111/j.1574-6941.2007.00418.x; Geets J, 2007, APPL MICROBIOL BIOT, V75, P211, DOI 10.1007/s00253-006-0805-8; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Grommen R, 2005, FEMS MICROBIOL ECOL, V52, P1, DOI 10.1016/j.femsec.2004.10.001; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Hovanec TA, 1996, APPL ENVIRON MICROB, V62, P2888, DOI 10.1128/AEM.62.8.2888-2896.1996; Kasuga I, 2010, WATER RES, V44, P5039, DOI 10.1016/j.watres.2010.07.015; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Limpiyakorn T, 2013, APPL MICROBIOL BIOT, V97, P1425, DOI 10.1007/s00253-012-4650-7; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Pedersen LF, 2009, AQUACULTURE, V296, P246, DOI 10.1016/j.aquaculture.2009.08.021; Pitcher A, 2011, ISME J, V5, P1896, DOI 10.1038/ismej.2011.60; Sakami T, 2012, MAR GENOM, V7, P27, DOI 10.1016/j.margen.2012.04.006; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Sauder LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023281; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; Vlaeminck SE, 2011, ENVIRON MICROBIOL, V13, P283, DOI 10.1111/j.1462-2920.2010.02345.x; Vlaeminck SE, 2010, APPL ENVIRON MICROB, V76, P900, DOI 10.1128/AEM.02337-09; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Yool A, 2007, NATURE, V447, P999, DOI 10.1038/nature05885	41	28	28	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113515	10.1371/journal.pone.0113515	http://dx.doi.org/10.1371/journal.pone.0113515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479061	Green Published, gold			2022-12-27	WOS:000346907200022
J	Gmehlin, D; Fuermaier, ABM; Walther, S; Debelak, R; Rentrop, M; Westermann, C; Sharma, A; Tucha, L; Koerts, J; Tucha, O; Weisbrod, M; Aschenbrenner, S				Gmehlin, Dennis; Fuermaier, Anselm B. M.; Walther, Stephan; Debelak, Rudolf; Rentrop, Mirjam; Westermann, Celina; Sharma, Anuradha; Tucha, Lara; Koerts, Janneke; Tucha, Oliver; Weisbrod, Matthias; Aschenbrenner, Steffen			Intraindividual Variability in Inhibitory Function in Adults with ADHD - An Ex-Gaussian Approach	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME VARIABILITY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BORDERLINE PERSONALITY-DISORDER; RESPONSE-INHIBITION; PERFORMANCE; CHILDREN; MODEL; TASK; DISTRACTIBILITY	Objective: Attention deficit disorder (ADHD) is commonly associated with inhibitory dysfunction contributing to typical behavioral symptoms like impulsivity or hyperactivity. However, some studies analyzing intraindividual variability (IIV) of reaction times in children with ADHD (cADHD) question a predominance of inhibitory deficits. IIV is a measure of the stability of information processing and provides evidence that longer reaction times (RT) in inhibitory tasks in cADHD are due to only a few prolonged responses which may indicate deficits in sustained attention rather than inhibitory dysfunction. We wanted to find out, whether a slowing in inhibitory functioning in adults with ADHD (aADHD) is due to isolated slow responses. Methods: Computing classical RT measures (mean RT, SD), ex-Gaussian parameters of IIV (which allow a better separation of reaction time (mu), variability (sigma) and abnormally slow responses (tau) than classical measures) as well as errors of omission and commission, we examined response inhibition in a wellestablished GoNogo task in a sample of aADHD subjects without medication and healthy controls matched for age, gender and education. Results: We did not find higher numbers of commission errors in aADHD, while the number of omissions was significantly increased compared with controls. In contrast to increased mean RT, the distributional parameter mu did not document a significant slowing in aADHD. However, subjects with aADHD were characterized by increased IIV throughout the entire RT distribution as indicated by the parameters sigma and tau as well as the SD of reaction time. Moreover, we found a significant correlation between tau and the number of omission errors. Conclusions: Our findings question a primacy of inhibitory deficits in aADHD and provide evidence for attentional dysfunction. The present findings may have theoretical implications for etiological models of ADHD as well as more practical implications for neuropsychological testing in aADHD.	[Gmehlin, Dennis; Rentrop, Mirjam; Westermann, Celina; Aschenbrenner, Steffen] SRH Klinikum, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany; [Weisbrod, Matthias] SRH Klinikum, Dept Psychiat, Karlsbad, Germany; [Weisbrod, Matthias; Aschenbrenner, Steffen] SudWestAkad Neuropsychol SWAN, Heidelberg, Germany; [Walther, Stephan; Sharma, Anuradha; Weisbrod, Matthias] Heidelberg Univ, Dept Child & Adolescent Psychiat, Sect Expt Psychopathol & Neurophysiol, D-69115 Heidelberg, Germany; [Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Debelak, Rudolf] Schuhfried GmbH, Modling, Austria	Ruprecht Karls University Heidelberg; University of Groningen	Gmehlin, D (corresponding author), SRH Klinikum, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany.	dennis.gmehlin@kkl.srh.de	Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840; Debelak, Rudolf/0000-0001-8900-2106; Sharma, Anuradha/0000-0002-6372-2890				Adams ZW, 2011, PSYCHOL ASSESSMENT, V23, P427, DOI 10.1037/a0022112; *AM PSYCH ASS, 2000, DSM 4; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, ATTENTION DEFICIT HY; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Buzy WM, 2009, CHILD NEUROPSYCHOL, V15, P441, DOI 10.1080/09297040802646991; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Coghill DR, 2013, PSYCHOL MED, P1, DOI DOI 10.1017/S0033291713002547; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; Epstein JN, 2007, J CHILD PSYCHOL PSYC, V48, P899, DOI 10.1111/j.1469-7610.2007.01761.x; Epstein JN, 2010, J INT NEUROPSYCH SOC, V16, P138, DOI 10.1017/S1355617709991111; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Fisher T, 2011, CLIN NEUROPHYSIOL, V122, P2390, DOI 10.1016/j.clinph.2011.05.010; Gooch D, 2012, DEV NEUROPSYCHOL, V37, P453, DOI 10.1080/87565641.2011.650809; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; Hautzinger M, 2011, BECK DEPRESSIONS INV; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Kaiser S., 2012, MANUAL RESPONSE INHI; Kaiser S, 2008, BRAIN COGNITION, V66, P73, DOI 10.1016/j.bandc.2007.05.007; Karalunas SL, 2013, J ABNORM CHILD PSYCH, V41, P837, DOI 10.1007/s10802-013-9715-2; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Kollins SH, 2009, DRUG ALCOHOL DEPEN, V100, P169, DOI 10.1016/j.drugalcdep.2008.09.019; Kooistra L, 2010, J NEURAL TRANSM, V117, P655, DOI 10.1007/s00702-010-0374-y; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; Lampe K, 2007, PSYCHOL MED, V37, P1717, DOI 10.1017/S0033291707000517; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Margraf J, 2011, BECK ANGST INVENTAR; Matzke D, 2009, PSYCHON B REV, V16, P798, DOI 10.3758/PBR.16.5.798; Pazvantoglu O, 2012, J INT NEUROPSYCH SOC, V18, P819, DOI 10.1017/S1355617712000574; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rentrop M, 2010, PSYCHIAT RES, V178, P27, DOI 10.1016/j.psychres.2010.04.009; Rosler M., 2008, HOMBURGER ADHS SKALE; Schweiger A, 2007, J CLIN EXP NEUROPSYC, V29, P100, DOI 10.1080/13803390500519738; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; Vadala R, 2011, FUNCT NEUROL, V26, P117; Valko L, 2010, J NEURAL TRANSM, V117, P1213, DOI 10.1007/s00702-010-0473-9; van Lieshout M, 2013, CLIN PSYCHOL REV, V33, P539, DOI 10.1016/j.cpr.2013.02.003; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Verte S, 2005, DEV PSYCHOPATHOL, V17, P415, DOI 10.1017/S0954579405050200; Wagenmakers EJ, 2007, PSYCHOL REV, V114, P830, DOI 10.1037/0033-295X.114.3.830; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Williams BR, 2007, J CLIN EXP NEUROPSYC, V29, P277, DOI 10.1080/13803390600678020; Wodka EL, 2007, J CLIN EXP NEUROPSYC, V29, P345, DOI 10.1080/13803390600678046	54	41	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112298	10.1371/journal.pone.0112298	http://dx.doi.org/10.1371/journal.pone.0112298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25479234	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200008
J	Hsu, CC; Chou, CY; Chou, CL; Ho, CC; Chen, TJ; Chiang, SC; Wu, MS; Wang, SW; Lee, CY; Chou, YC				Hsu, Chia-Chen; Chou, Chia-Yu; Chou, Chia-Lin; Ho, Chin-Chin; Chen, Tzeng-Ji; Chiang, Shu-Chiung; Wu, Min-Shan; Wang, Sen-Wen; Lee, Chung-Yuan; Chou, Yueh-Ching			Impact of a Warning CPOE System on the Inappropriate Pill Splitting of Prescribed Medications in Outpatients	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; DECISION-SUPPORT; ORDER ENTRY; ERRORS; PRESCRIPTION; PHYSICIAN; PREVENT; TRIAL	Background: Prescribing inappropriate pill splitting is not rare in clinical practice. To reduce inappropriate pill splitting, we developed an automatic warning system linked to a computerized physician order entry (CPOE) system for special oral formulation drugs in outpatient settings. We examined the impact of the warning system on inappropriate prescribing of pill splitting and assess prescribers' responses to the warnings. Methods: Drugs with extended-release or enteric-coated formulations that were not originally intended to be split were recognized as "special oral formulations". A hard-stop system which could examine non-integer doses of drugs with special oral formulations, provide warnings to interrupt inappropriate prescriptions was integrated in CPOE in a medical center since June 2010. We designed an intervention study to compare the inappropriate splitting before and after the implementation of the warning system (baseline period 2010 January to May vs. intervention period 2010 June to 2011 August). During the intervention period, prescription changes in response to a warning were logged and analyzed. Results: A total of 470,611 prescribed drug items with 34 different drugs with special oral formulations were prescribed in the study period. During the 15-month intervention period, 909 warnings for 26 different drugs were triggered among 354,523 prescribed drug items with special oral formulations. The warning rate of inappropriate splitting in the late intervention period was lower than those in baseline period (0.16% vs. 0.61%, incidence rate ratio 0.27, 95% CI 0.23-0.31, P<0.001). In respond to warnings, physicians had to make adjustments, of which the majority was changing to an unsplit pill (72.9%). Conclusions: The interruptive warning system could avoid the prescriptions with inappropriate pill splitting. Accordingly, physicians changed their behavior of prescribing special oral formulations regarding inappropriate pill splitting. We suggest the establishment of such system to target special oral formulations with warnings to prevent inappropriate pill splitting.	[Hsu, Chia-Chen; Chou, Chia-Lin; Ho, Chin-Chin; Wu, Min-Shan; Wang, Sen-Wen; Chou, Yueh-Ching] Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan; [Chou, Chia-Yu] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan; [Chou, Chia-Yu; Chou, Yueh-Ching] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chou, Chia-Yu] Natl Def Med Ctr, Dept Internal Med, Sch Med, Taipei, Taiwan; [Chou, Chia-Yu] Tzu Chi Univ, Dept Med, Hualien, Taiwan; [Chou, Yueh-Ching] Taipei Med Univ, Coll Pharm, Taipei, Taiwan; [Chen, Tzeng-Ji; Chiang, Shu-Chiung] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Sch Med, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Lee, Chung-Yuan] Taipei Vet Gen Hosp, Informat Management Off, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tzu Chi University; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chou, YC (corresponding author), Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan.	ycchou@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021; Hsu, Chia-Chen/AAB-3117-2019; Chiang, Shu-Chiung/GPX-6643-2022		Taipei Veterans General Hospital [V102A-053]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants V102A-053 from the Taipei Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARNOLD RJG, 1993, SOUTHERN MED J, V86, P208; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bhagat S, 2013, INT J SURG, V11, P209, DOI 10.1016/j.ijsu.2013.01.010; Bobb A, 2004, ARCH INTERN MED, V164, P785, DOI 10.1001/archinte.164.7.785; Chou CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070113; Cornish P, 2005, CAN MED ASSOC J, V172, P871, DOI 10.1503/cmaj.050176; Emami S, 2012, J RES PHARM PRACT, V1, P37, DOI 10.4103/2279-042X.99677; Gillaizeau F, 2013, COCHRANE DB SYST REV, V11, DOI [DOI 10.1002/14651858.CD002894.PUB3, 10.1002/14651858.CD002894.pub3, DOI 10.1002/14651858.CD002894.pub3]; Kadmon G, 2009, PEDIATRICS, V124, P935, DOI 10.1542/peds.2008-2737; Lajoinie A, 2014, BR J CLIN P IN PRESS; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 2002, J GEN INTERN MED, V17, P579, DOI 10.1046/j.1525-1497.2002.11056.x; MAZZONE A, 1990, J INT MED RES, V18, P379, DOI 10.1177/030006059001800506; Ministry of Health and Welfare, 2011, REN DRUG LIC SERR HA; Quinzler R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-30; Ranji SR, 2014, BMJ QUAL SAF, V23, P773, DOI 10.1136/bmjqs-2013-002165; Saxena Kshitij, 2011, AMIA Annu Symp Proc, V2011, P1207; Schier JG, 2003, ANN PHARMACOTHER, V37, P1420, DOI 10.1345/aph.1D091; Seidling HM, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.033175; Standing JF, 2005, INT J PHARMACEUT, V300, P56, DOI 10.1016/j.ijpharm.2005.05.006; Strom BL, 2010, ARCH INTERN MED, V170, P1578, DOI 10.1001/archinternmed.2010.324; Tache SV, 2011, ANN PHARMACOTHER, V45, P977, DOI 10.1345/aph.1P627	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114359	10.1371/journal.pone.0114359	http://dx.doi.org/10.1371/journal.pone.0114359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479360	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200078
J	Kaiser, ML; Duncan, FD; Brooke, BD				Kaiser, Maria L.; Duncan, Frances D.; Brooke, Basil D.			Embryonic Development and Rates of Metabolic Activity in Early and Late Hatching Eggs of the Major Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							DIPTERA-CULICIDAE; AEDES-AEGYPTI; TIME; TEMPERATURE; RESISTANCE; SURVIVAL; DESICCATION; ALBITARSIS; SELECTION; PERIOD	Anopheles gambiae eggs generally hatch at the completion of embryo development; two-three days post oviposition. However, staggered or delayed hatching has been observed whereby a single batch of eggs shows marked variation in time-to-hatch, with some eggs hatching 18 days post oviposition or later. The mechanism enabling delayed hatch has not been clearly elucidated but is likely mediated by environmental and genetic factors that either induce diapause or slow embryo development. This study aimed to compare metabolic activity and embryonic development between eggs collected from sub-colonies of the baseline Anopheles gambiae GAH colony previously selected for early or late time-to-hatch. Egg batches from early and late hatch sub-colonies as well as from the baseline colony were monitored for hatching. For both time-to-hatch selected sub-colonies and the baseline colony the majority of eggs hatched on day two post oviposition. Nevertheless, eggs produced by the late hatch sub-colony showed a significantly longer mean time to hatch than those produced by the early hatch sub-colony. The overall proportions that hatched were similar for all egg batches. CO2 output between eggs from early and late hatch sub-colonies showed significant differences only at 3 and 7 days post oviposition where eggs from the early hatch and the late hatch sub-colony were more metabolically active, respectively. No qualitative differences were observed in embryo development between the sub-colonies. It is concluded that all viable embryos develop to maturity at the same rate and that a small proportion then enter a state of diapause enabling them to hatch later. As it has previously been shown that it is possible to at least partially select for late hatch, this characteristic is likely to involve genetic as well as environmental factors. Delayed hatching in An. gambiae is likely an adaptation to maximise reproductive output despite the increased risk of desiccation in an unstable aquatic environment.	[Kaiser, Maria L.; Brooke, Basil D.] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Kaiser, Maria L.; Brooke, Basil D.] NHLS, Ctr Opportunist Trop & Hosp Infect, Natl Inst Communicable Dis, Johannesburg, South Africa; [Duncan, Frances D.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Brooke, BD (corresponding author), Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa.	basilb@nicd.ac.za		Duncan, Frances/0000-0002-0145-8190; Brooke, Basil/0000-0002-8857-1304	Medical Research Council of South Africa; National Research Foundation; Open Society Foundation	Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation; Open Society Foundation	This project was supported by a grant to BDB from the Medical Research Council of South Africa (www.mrc.ac.za). The project was additionally funded by a National Research Foundation award to FDD. MLK was supported by a bursary from the Open Society Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P105; Clements AN, 2000, BIOL MOSQUITOES, P45; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Darrow EM, 1949, J AM HYG, V50, P207; de Carvalho SCG, 2002, MEM I OSWALDO CRUZ, V97, P1117, DOI 10.1590/S0074-02762002000800009; Deane M. P., 1943, AMER JOUR TROP MED, V23, P95; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Ebrahimi B, 2014, J MED ENTOMOL, V51, P580, DOI 10.1603/ME13100; GILLETT J. D., 1955, Bulletin of Entomological Research, V46, P255, DOI 10.1017/S0007485300030893; Gillies M.T., 1987, PUBLICATION S AFRICA, V55; Gillies MT, 1968, ANOPHELINAE AFRICA S, V54; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Impoinvil DE, 2007, J AM MOSQUITO CONTR, V23, P124, DOI 10.2987/8756-971X(2007)23[124:CTATPE]2.0.CO;2; Kaiser ML, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-360; Kambule IN, 2011, PHYSIOL ENTOMOL, V36, P299, DOI 10.1111/j.1365-3032.2011.00792.x; Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; LEONARD DE, 1968, J ECON ENTOMOL, V61, P596, DOI 10.1093/jee/61.3.596; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Monnerat AT, 2002, MEM I OSWALDO CRUZ, V97, P589, DOI 10.1590/S0074-02762002000400026; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Perez MH, 2013, J INSECT PHYSIOL, V59, P318, DOI 10.1016/j.jinsphys.2012.12.007; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Roberts DM, 2001, MED VET ENTOMOL, V15, P215, DOI 10.1046/j.0269-283x.2001.00303.x; Rozeboom LE, 1934, AM J HYG, V20, P496, DOI 10.1093/oxfordjournals.aje.a118088; Shililu JI, 2004, J AM MOSQUITO CONTR, V20, P243; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Tripet F, 2003, AM J TROP MED HYG, V68, P1; TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; Vargas HCM, 2014, J INSECT PHYSIOL, V62, P54, DOI 10.1016/j.jinsphys.2014.02.001; Vinogradova E.B., 2007, DIAPAUSE AQUATIC INV, P83, DOI DOI 10.1007/978-1-4020-5680-2_5; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; WILKINSON RN, 1978, J MED ENTOMOL, V14, P666, DOI 10.1093/jmedent/14.6.666; Woods HA, 2005, J EXP BIOL, V208, P1297, DOI 10.1242/jeb.01525; Woods HA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P594, DOI 10.1086/322169; Yaro AS, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-19	38	6	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114381	10.1371/journal.pone.0114381	http://dx.doi.org/10.1371/journal.pone.0114381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479444	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200080
J	Liu, PH; Zhang, H; Liu, C; Wang, XF; Chen, L; Qin, CL				Liu, Peihong; Zhang, Hua; Liu, Chao; Wang, Xiaofang; Chen, Li; Qin, Chunlin			Inactivation of Fam20C in Cells Expressing Type I Collagen Causes Periodontal Disease in Mice	PLOS ONE			English	Article							OSTEOSCLEROTIC BONE DYSPLASIA; SIBLING PROTEINS; MARFAN-SYNDROME; RAINE SYNDROME; NULL MICE; PERIOSTIN; GENE; MUTATIONS; LIGAMENT; DENTIN	Background: FAM20C is a kinase that phosphorylates secretory proteins. Previous studies have shown that FAM20C plays an essential role in the formation and mineralization of bone, dentin and enamel. The present study analyzed the loss-of-function effects of FAM20C on the health of mouse periodontal tissues. Methods: By crossbreeding 2.3 kb Col 1a1-Cre mice with Fam20C(fl/fl) mice, we created 2.3 kb Col 1a1-Cre; Fam20C(fl/fl) (cKO) mice, in which Fam20C was inactivated in the cells that express Type I collagen. We analyzed the periodontal tissues in the cKO mice using X-ray radiography, histology, scanning electron microscopy and immunohistochemistry approaches. Results: The cKO mice underwent a remarkable loss of alveolar bone and cementum, along with inflammation of the periodontal ligament and formation of periodontal pockets. The osteocytes and lacuno-canalicular networks in the alveolar bone of the cKO mice showed dramatic abnormalities. The levels of bone sialoprotein, osteopontin, dentin matrix protein 1 and dentin sialoprotein were reduced in the Fam20C-deficient alveolar bone and/or cementum, while periostin and fibrillin-1 were decreased in the periodontal ligament of the cKO mice. Conclusion: Loss of Fam20C function leads to periodontal disease in mice. The reduced levels of bone sialoprotein, osteopontin, dentin matrix protein 1, dentin sialoprotein, periostin and fibrillin-1 may contribute to the periodontal defects in the Fam20C-deficient mice.	[Liu, Peihong] Harbin Med Univ, Sch Stomatol, Dept Periodont, Harbin 150001, Heilongjiang, Peoples R China; [Liu, Peihong; Zhang, Hua; Liu, Chao; Wang, Xiaofang; Qin, Chunlin] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Liu, Peihong; Zhang, Hua; Liu, Chao; Wang, Xiaofang; Qin, Chunlin] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX USA; [Chen, Li] Harbin Med Univ, Affiliated Hosp 1, Longjiang Scholar Lab, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harbin Medical University	Chen, L (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Longjiang Scholar Lab, Harbin 150001, Heilongjiang, Peoples R China.	chenlidentist@163.com; cqin@bcd.tamhsc.edu		Zhang, Hua/0000-0002-6789-9343; Wang, Xiaofang/0000-0002-7370-7192	National Natural Science Foundation of China [81171744]; U.S. National Institutes of Health [DE022549]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022549] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Natural Science Foundation of China (Grant No. 81171744), and the U.S. National Institutes of Health Grant DE022549 (to CQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh FK, 2013, AM J MED GENET A, V161, P3155, DOI 10.1002/ajmg.a.36160; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Foster BL, 2013, J DENT RES, V92, P166, DOI 10.1177/0022034512469026; Foster BL, 2012, INT J ORAL SCI, V4, P119, DOI 10.1038/ijos.2012.57; Ganburged G, 2010, CELL TISSUE RES, V341, P381, DOI 10.1007/s00441-010-1021-5; Gibson MP, 2013, J PERIODONTAL RES, V48, P221, DOI 10.1111/j.1600-0765.2012.01523.x; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; MCFARLAND RJ, 1995, ANN NY ACAD SCI, V760, P327, DOI 10.1111/j.1749-6632.1995.tb44649.x; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; PAGE RC, 1981, J PERIODONTOL, V52, P477, DOI 10.1902/jop.1981.52.9.477; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Sawada T, 2006, J HISTOCHEM CYTOCHEM, V54, P1095, DOI 10.1369/jhc.5A6905.2006; Shiga M, 2008, CELL TISSUE RES, V331, P461, DOI 10.1007/s00441-007-0528-x; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Simpson MA, 2009, CLIN GENET, V75, P271, DOI 10.1111/j.1399-0004.2008.01118.x; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Suda N, 2009, J EXP ZOOL PART B, V312B, P503, DOI 10.1002/jez.b.21278; SUN Y, 2010, HEALTH TECHNOL ASSES, V14, P1033, DOI DOI 10.1369/JHC.2010.956771; Tagliabracci VS, 2013, TRENDS BIOCHEM SCI, V38, P121, DOI 10.1016/j.tibs.2012.11.008; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Takeyari S, 2014, BONE, V67, P56, DOI 10.1016/j.bone.2014.06.026; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Ye L, 2008, J DENT RES, V87, P624, DOI 10.1177/154405910808700708; Zhang B, 2010, ORAL DIS, V16, P453, DOI 10.1111/j.1601-0825.2010.01656.x	38	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114396	10.1371/journal.pone.0114396	http://dx.doi.org/10.1371/journal.pone.0114396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479552	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200081
J	Na, HN; Hong, YM; Ye, MB; Park, S; Kim, IB; Nam, JH				Na, Ha-Na; Hong, Young-Mi; Ye, Michael B.; Park, Sooho; Kim, In-Beom; Nam, Jae-Hwan			Adenovirus 36 Attenuates Weight Loss from Exercise but Improves Glycemic Control by Increasing Mitochondrial Activity in the Liver	PLOS ONE			English	Article							ADIPOSE-TISSUE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; OBESITY AGENT; STEM-CELLS; FAT-CELLS; INFLAMMATION; INFECTION	Human adenovirus type 36 (Ad36) as an obesity agent induces adiposity by increasing glucose uptake and promoting chronic inflammation in fat tissues; in contrast, exercise reduces total body fat and inflammation. Our objective was to determine the association between Ad36 and the effects of exercise on inflammation and glycemic control. In the human trials (n=54), Korean children (aged 12-14 years) exercised for 60 min on three occasions each week for 2 months. We compared the body mass index (BMI) Z-scores before and after exercise. C57BL/6 mice were infected with Ad36 and Ad2 as a control, and these mice exercised for 12 weeks postinfection. After the exercise period, we determined the serum parameters and assessed the presence of inflammation and the mitochondrial function in the organs. Ad36-seropositive children who were subjected to a supervised exercise regimen had high BMI Z-scores whereas Ad36-seronegative children had lower scores. Similarly, Ad36-infected mice were resistant to weight loss and exhibited chronic inflammation of their adipose tissues despite frequent exercise. However, Ad36 combined with exercise reduced the levels of serum glucose, nonesterified fatty acids, total cholesterol, and insulin in virus-infected mice. Interestingly, virus infection increased the mitochondrial function in the liver, as demonstrated by the numbers of mitochondria, cytochrome c oxidase activity, and transcription of key mitochondrial genes. Therefore Ad36 counteracts the weight-loss effect of exercise and maintains the chronic inflammatory state, but glycemic control is improved by exercise synergistically because of increased mitochondrial activity in the liver.	[Na, Ha-Na; Park, Sooho; Nam, Jae-Hwan] Catholic Univ Korea, Dept Biotechnol, Puchon, South Korea; [Hong, Young-Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Ye, Michael B.] Gwangju Inst Sci & Technol, Div Liberal Arts & Sci, Kwangju, South Korea; [Kim, In-Beom] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea	Catholic University of Korea; Ewha Womans University; Gwangju Institute of Science & Technology (GIST); Catholic University of Korea	Nam, JH (corresponding author), Catholic Univ Korea, Dept Biotechnol, Puchon, South Korea.	jhnam@catholic.ac.kr	Kim, In-Beom/A-6728-2011		Gyeonggi Regional Research Center of the Catholic University of Korea; Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A1A2039819]; Korean Health Technology R&D Project, Ministry of Health Welfare [HI13C0826]	Gyeonggi Regional Research Center of the Catholic University of Korea; Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Korean Health Technology R&D Project, Ministry of Health Welfare	This work was supported by a grant from the Gyeonggi Regional Research Center of the Catholic University of Korea, the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A1A2039819) and the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI13C0826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren M, 2014, ANN MED; Almgren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041652; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Bouwman JJM, 2008, INT J OBESITY, V32, P892, DOI 10.1038/ijo.2008.36; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Carpenter KC, 2012, COMPARATIVE MED, V62, P21; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Dhurandhar NV, 2011, LANCET INFECT DIS, V11, P963, DOI 10.1016/S1473-3099(11)70274-2; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; Duncan BB, 2003, OBES RES, V11, P1339, DOI 10.1038/oby.2003.181; Duncan BB, 2000, OBES RES, V8, P279, DOI 10.1038/oby.2000.33; Fernaandez-Real JM, 2007, OBESITY, V15, P245, DOI 10.1038/oby.2007.541; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lee YH, 2010, KOREAN J ORTHOD, V40, P40, DOI 10.4041/kjod.2010.40.1.40; Lin WY, 2013, DIABETES CARE, V36, P701, DOI 10.2337/dc12-1089; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mathes WF, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511001905; Na HN, 2012, INT J OBESITY, V36, P195, DOI 10.1038/ijo.2011.89; Na HN, 2010, INT J OBESITY, V34, P89, DOI 10.1038/ijo.2009.207; Na Ha-, 2011, Journal of Bacteriology and Virology, V41, P65; Na HN, 2012, J INFECT DIS, V205, P914, DOI 10.1093/infdis/jir864; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Oelkrug R, 2010, J BIOL CHEM, V285, P21961, DOI 10.1074/jbc.M110.122861; Pasarica M, 2008, STEM CELLS, V26, P969, DOI 10.1634/stemcells.2007-0868; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Rathod MA, 2009, OBESITY, V17, P657, DOI 10.1038/oby.2008.630; Rubin DA, 2010, MED SPORT SCI, V55, P43, DOI 10.1159/000321971; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; van Ginneken V, 2009, MED HYPOTHESES, V72, P383, DOI 10.1016/j.mehy.2008.11.034; Vander Wal JS, 2013, OBESITY FACTS, V6, P269, DOI 10.1159/000353109; Vangipuram SD, 2007, INT J OBESITY, V31, P87, DOI 10.1038/sj.ijo.0803366; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313; Warnberg J, 2010, P NUTR SOC, V69, P400, DOI 10.1017/S0029665110001928	50	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114534	10.1371/journal.pone.0114534	http://dx.doi.org/10.1371/journal.pone.0114534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479564	gold, Green Published			2022-12-27	WOS:000346907200098
J	Wei, T; Li, DS; Marcial, D; Khan, M; Lin, MH; Snape, N; Ghildyal, R; Harrich, D; Spann, K				Wei, Ting; Li, Dongsheng; Marcial, Daneth; Khan, Moshin; Lin, Min-Hsuan; Snape, Natale; Ghildyal, Reena; Harrich, David; Spann, Kirsten			The Eukaryotic Elongation Factor 1A Is Critical for Genome Replication of the Paramyxovirus Respiratory Syncytial Virus	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; FACTOR-I; MATRIX PROTEIN; INFECTED-CELLS; VIRAL-RNA; EF-TU; TRANSLATION; ALPHA; INTERACTS; COMPLEX	The eukaryotic translation factor eEF1A assists replication of many RNA viruses by various mechanisms. Here we show that down-regulation of eEF1A restricts the expression of viral genomic RNA and the release of infectious virus, demonstrating a biological requirement for eEF1A in the respiratory syncytial virus (RSV) life cycle. The key proteins in the replicase/transcriptase complex of RSV; the nucleocapsid (N) protein, phosphoprotein (P) and matrix (M) protein, all associate with eEF1A in RSV infected cells, although N is the strongest binding partner. Using individually expressed proteins, N, but not P or M bound to eEF1A. This study demonstrates a novel interaction between eEF1A and the RSV replication complex, through binding to N protein, to facilitate genomic RNA synthesis and virus production.	[Wei, Ting; Li, Dongsheng; Marcial, Daneth; Khan, Moshin; Lin, Min-Hsuan; Harrich, David] Queensland Inst Med Res Berghofer, Herston, Qld, Australia; [Marcial, Daneth; Snape, Natale; Spann, Kirsten] Univ Queensland, Clin Med Virol Ctr, Herston, Qld, Australia; [Marcial, Daneth; Khan, Moshin; Snape, Natale; Spann, Kirsten] Childrens Hlth Queensland, Sir Albert Sakzewski Virus Res Ctr, Herston, Qld, Australia; [Ghildyal, Reena] Univ Canberra, Ctr Res Therapeut Solut, Canberra, ACT 2601, Australia; [Harrich, David; Spann, Kirsten] Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	University of Queensland; University of Canberra	Harrich, D (corresponding author), Queensland Inst Med Res Berghofer, Herston, Qld, Australia.	David.Harrich@qimr.edu.au; K.Spann@uq.edu.au	Lin, Min-Hsuan/ABA-3334-2020; Spann, Kirsten/B-4524-2013; Harrich, David/H-6668-2016	Spann, Kirsten/0000-0003-0567-8382; Harrich, David/0000-0003-3690-0150; Ghildyal, Reena/0000-0002-3147-4976; Lin, Min-Hsuan/0000-0001-7074-6041	Australian National Health and Medical Research Council [1065121]; Australian Infectious Diseases Research Centre project; Australian National Health and Medical Research Council; Australian Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Infectious Diseases Research Centre project; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This study was funded by the Australian National Health and Medical Research Council Project Grant #1065121 to DH and KS (https://www.nhmrc.gov.au/); Australian Infectious Diseases Research Centre project grant to KS and DH (www.aidrc.org.au/); Australian National Health and Medical Research Council Biomedical Early Career Development Fellowship to TW; and Australian Research Council Future Fellowship to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Collins CL, 2002, J INFECTION, V45, P10, DOI 10.1053/jinf.2001.1016; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Collins PL, 2007, FIELDS VIROLOGY, P1601; Das T, 1998, P NATL ACAD SCI USA, V95, P1449, DOI 10.1073/pnas.95.4.1449; Dreher TW, 1999, J BIOL CHEM, V274, P666, DOI 10.1074/jbc.274.2.666; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Ghildyal R, 2002, J GEN VIROL, V83, P753, DOI 10.1099/0022-1317-83-4-753; Ghildyal R, 2006, FEMS MICROBIOL REV, V30, P692, DOI 10.1111/j.1574-6976.2006.00025.x; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Johnson CM, 2001, J GEN VIROL, V82, P2935, DOI 10.1099/0022-1317-82-12-2935; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kou YH, 2006, J BIOMED SCI, V13, P861, DOI 10.1007/s11373-006-9104-8; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nishikiori M, 2006, J VIROL, V80, P8459, DOI 10.1128/JVI.00545-06; Perrin KM, 2012, PEDIATRICS, V129, P55, DOI 10.1542/peds.2010-2991; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Sasvari Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002438; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Sikora D, 2009, VIROLOGY, V390, P71, DOI 10.1016/j.virol.2009.04.022; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Ulloa L, 1998, VIRUS RES, V53, P13, DOI 10.1016/S0168-1702(97)00121-4; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; Yamaji Y, 2006, VIROLOGY, V347, P100, DOI 10.1016/j.virol.2005.11.031; Yamaji Y, 2010, ARCH VIROL, V155, P263, DOI 10.1007/s00705-009-0571-x	35	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114447	10.1371/journal.pone.0114447	http://dx.doi.org/10.1371/journal.pone.0114447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479059	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200090
J	Chiku, K; Nihira, T; Suzuki, E; Nishimoto, M; Kitaoka, M; Ohtsubo, K; Nakai, H				Chiku, Kazuhiro; Nihira, Takanori; Suzuki, Erika; Nishimoto, Mamoru; Kitaoka, Motomitsu; Ohtsubo, Ken'ichi; Nakai, Hiroyuki			Discovery of Two beta-1,2-Mannoside Phosphorylases Showing Different Chain-Length Specificities from Thermoanaerobacter sp X-514	PLOS ONE			English	Article							CANDIDA-ALBICANS; 4-O-BETA-D-MANNOSYL-D-GLUCOSE PHOSPHORYLASE; BETA-1,2-LINKED OLIGOMANNOSIDES; GLYCOSIDE PHOSPHORYLASES; ENZYMATIC-SYNTHESIS; RUMINOCOCCUS-ALBUS; ESCHERICHIA-COLI; IDENTIFICATION; PROTEIN; MANNAN	We characterized Teth514_1788 and Teth514_1789, belonging to glycoside hydrolase family 130, from Thermoanaerobacter sp. X-514. These two enzymes catalyzed the synthesis of 1,2-beta-oligomannan using beta-1,2-mannobiose and Dmannose as the optimal acceptors, respectively, in the presence of the donor alpha-Dmannose 1-phosphate. Kinetic analysis of the phosphorolytic reaction toward 1,2-beta-oligomannan revealed that these enzymes followed a typical sequential Bi Bi mechanism. The kinetic parameters of the phosphorolysis of 1,2-beta-oligomannan indicate that Teth514_1788 and Teth514_1789 prefer 1,2-beta-oligomannans containing a DP >= 3 and beta-1,2-Man(2), respectively. These results indicate that the two enzymes are novel inverting phosphorylases that exhibit distinct chain-length specificities toward 1,2-beta-oligomannan. Here, we propose 1,2-beta-oligomannan: phosphate alpha-D-mannosyltransferase as the systematic name and 1,2 beta- oligomannan phosphorylase as the short name for Teth514_1788 and beta-1,2-mannobiose: phosphate alpha-D-mannosyltransferase as the systematic name and beta-1-,2-mannobiosephosphorylase as the short name for Teth514_1789.	[Chiku, Kazuhiro; Nihira, Takanori; Suzuki, Erika; Ohtsubo, Ken'ichi; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 95021, Japan; [Nishimoto, Mamoru; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan	Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakai, H (corresponding author), Niigata Univ, Fac Agr, Niigata 95021, Japan.	nakai@agr.niigata-u.ac.jp	Ohtsubo, Kenichi/AAW-1700-2020; Chiku, Kazuhiro/O-3055-2018; Kitaoka, Motomitsu/R-1536-2019	Ohtsubo, Kenichi/0000-0001-9354-3087; Chiku, Kazuhiro/0000-0001-6857-8894; Kitaoka, Motomitsu/0000-0002-0083-1838	JSPS; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by JSPS's program "Grant-in-Aid for Research Activity Start-up", MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers" under the Special Coordination Funds for Promoting Science and Technology, Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, and Grant for Promotion of Niigata University Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; BEYNON LM, 1995, CARBOHYD RES, V272, P231, DOI 10.1016/0008-6215(95)00095-B; CHENG CC, 1979, CARBOHYD RES, V73, P169; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; EKWALL E, 1982, J MED MICROBIOL, V15, P173, DOI 10.1099/00222615-15-2-173; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gerber-Lemaire S, 2009, SPR CARB CH, V35, P13, DOI 10.1039/b905496k; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Hemme CL, 2010, J BACTERIOL, V192, P6494, DOI 10.1128/JB.01064-10; Jaito N, 2014, BIOSCI BIOTECH BIOCH, V78, P263, DOI 10.1080/09168451.2014.882760; Jouault T, 1998, J INFECT DIS, V178, P792, DOI 10.1086/515361; JOUAULT T, 1995, INFECT IMMUN, V63, P2378, DOI 10.1128/IAI.63.6.2378-2381.1995; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Liu Y, 2014, CARBOHYDR R IN PRESS; Lombard V, 2014, NUCL ACIDS IN PRESS; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; MURAO S, 1985, AGR BIOL CHEM TOKYO, V49, P2113, DOI 10.1080/00021369.1985.10867024; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nihira T, 2014, J APPL GLYCOSC, V2, P59, DOI [10.5458/jag.jag.JAG-2013_013, DOI 10.5458/JAG.JAG.JAG-2013_013]; Nihira T., 2013, J APPL GLYCOSCI, V60, P137; Nihira T, 2014, J APPL GLYC IN PRESS; Nihira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086548; Nihira T, 2013, FEBS LETT, V587, P3382, DOI 10.1016/j.febslet.2013.08.038; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; PREVIATO JO, 1982, EXP PARASITOL, V53, P170, DOI 10.1016/0014-4894(82)90058-3; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Sawangwan T, 2009, ORG BIOMOL CHEM, V7, P4267, DOI 10.1039/b912621j; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; SHIBATA N, 1985, ARCH BIOCHEM BIOPHYS, V243, P338, DOI 10.1016/0003-9861(85)90511-9; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Suzuki M, 2009, NEW BIOTECHNOL, V26, P137, DOI 10.1016/j.nbt.2009.07.004	51	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114882	10.1371/journal.pone.0114882	http://dx.doi.org/10.1371/journal.pone.0114882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500577	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400058
J	Roh, JY; Song, BG; Park, WI; Shin, EH; Park, C; Park, MY; Chang, KS; Lee, WG; Lee, HI; Shin, EH				Roh, Jong Yul; Song, Bong Gu; Park, Won Il; Shin, Eun Hee; Park, Chan; Park, Mi-Yeoun; Chang, Kyu Sik; Lee, Wook Gyo; Lee, Hee Il; Shin, E-Hyun			Coincidence between Geographical Distribution of Leptotrombidium scutellare and Scrub Typhus Incidence in South Korea	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; RELATIVE ABUNDANCE; ENDEMIC AREA; TROMBICULIDAE; VECTORS; ACARI; TRANSMISSION; RODENTS	To clarify the geographical distribution of scrub typhus vectors in Korea, a survey of larval trombiculid mites was conducted from 2005 to 2007 by collecting wild small mammals twice a year (spring and autumn) at 24 sites nationwide. A total of 67,325 mites representing 4 genera and 14 species were collected from 783 trapped rodents, corresponding to a chigger index (number of chigger mites per rodent) of 86.0. The predominant mite species were Leptotrombidium pallidum (52.6%), Leptotrombiduim scutellare (27.1%), Leptotrombidium palpale (8.2%), Leptotrombidium orientale (5.6%), and Neotrombicula tamiyai (1.7%). However, the proportions of L. scutellare in southern areas, including endemic provinces such as Jeollabuk-Do (34.3%), Jeollanam-Do (49.0%), and Gyeongsangnam-Do (88%), were relatively higher than in central Korean regions where L. pallidum was predominant. In autumn, the ratio of L. scutellare increased to 42% while the ratio of L. pallidum decreased. The geographical distribution map of the L. scutellare chigger index was identical to the incidence pattern of scrub typhus, whereas those of overall mites and L. pallidum showed no relationship with case incidence patterns. Distribution mapping analysis shows an identical geographical distribution of L. scutellare and epidemic incidence of scrub typhus in South Korea. L. pallidum could be another vector at all other parts of the Korean peninsula, including the eastern and northern regions that have a low level of scrub typhus incidence.	[Roh, Jong Yul; Song, Bong Gu; Park, Won Il; Shin, Eun Hee; Park, Mi-Yeoun; Chang, Kyu Sik; Lee, Wook Gyo; Shin, E-Hyun] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea; [Park, Chan] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Arboviruses, Cheongju, South Korea; [Lee, Hee Il] Korea Natl Inst Hlth, Div Biosafety Evaluat & Control, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Division of Biosafety Evaluation & Control	Shin, EH (corresponding author), Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongju, South Korea.	ehshin@nih.go.kr	Chang, Kyu-Sik/R-6752-2019; Shin, Eun-Hee/D-5757-2012		Korea Centers for Disease Control and Prevention under the budget for health promotion [4800-4851-300]	Korea Centers for Disease Control and Prevention under the budget for health promotion	This work was supported by Korea Centers for Disease Control and Prevention under the budget for health promotion (No. 4800-4851-300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang Woo-Hyun, 1995, Journal of Korean Medical Science, V10, P227; Frances SP, 1999, J MED ENTOMOL, V36, P869, DOI 10.1093/jmedent/36.6.869; KCDC, 2012, NAT NOT DIS SURV SYS; Kim HC, 2010, KOREAN J PARASITOL, V48, P237, DOI 10.3347/kjp.2010.48.3.237; Kuo CC, 2011, MED VET ENTOMOL, V25, P169, DOI 10.1111/j.1365-2915.2010.00941.x; Kweon SS, 2009, EMERG INFECT DIS, V15, P1127, DOI 10.3201/eid1507.080399; Lee HI, 2011, VECTOR-BORNE ZOONOT, V11, P209, DOI 10.1089/vbz.2009.0180; Lee IY, 2009, KOREAN J PARASITOL, V47, P381, DOI 10.3347/kjp.2009.47.4.381; Lee SH, 2012, KOREAN J PARASITOL, V50, P327, DOI 10.3347/kjp.2012.50.4.327; Phasomkusolsil S, 2009, J MED ENTOMOL, V46, P1442, DOI 10.1603/033.046.0628; REE H-I, 1990, Korean Journal of Systematic Zoology, V6, P57; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Ree Han-Il, 1997, Korean Journal of Parasitology, V35, P171, DOI 10.3347/kjp.1997.35.3.171; Ree Han-Il, 1997, Medical Entomology and Zoology, V48, P197; Ree Han-Il, 1992, Korean Journal of Parasitology, V30, P341, DOI 10.3347/kjp.1992.30.4.341; Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6; Takahashi M, 2004, J MED ENTOMOL, V41, P107, DOI 10.1603/0022-2585-41.1.107; TAKAHASHI M, 1988, JPN J EXP MED, V58, P213	18	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113193	10.1371/journal.pone.0113193	http://dx.doi.org/10.1371/journal.pone.0113193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25500568	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400006
J	Gibbs, KD; McGready, J; Bennett, JC; Griffin, K				Gibbs, Kenneth D., Jr.; McGready, John; Bennett, Jessica C.; Griffin, Kimberly			Biomedical Science Ph.D. Career Interest Patterns by Race/Ethnicity and Gender	PLOS ONE			English	Article							DOUBLE BIND; COLOR; UNDERGRADUATE; DIVERSITY; FACULTY; WOMEN	Increasing biomedical workforce diversity remains a persistent challenge. Recent reports have shown that biomedical sciences (BMS) graduate students become less interested in faculty careers as training progresses; however, it is unclear whether or how the career preferences of women and underrepresented minority (URM) scientists change in manners distinct from their better-represented peers. We report results from a survey of 1500 recent American BMS Ph. D. graduates (including 276 URMs) that examined career preferences over the course of their graduate training experiences. On average, scientists from all social backgrounds showed significantly decreased interest in faculty careers at research universities, and significantly increased interest in non-research careers at Ph. D. completion relative to entry. However, group differences emerged in overall levels of interest (at Ph.D. entry and completion), and the magnitude of change in interest in these careers. Multiple logistic regression showed that when controlling for career pathway interest at Ph.D. entry, first-author publication rate, faculty support, research self-efficacy, and graduate training experiences, differences in career pathway interest between social identity groups persisted. All groups were less likely than men from well-represented (WR) racial/ethnic backgrounds to report high interest in faculty careers at research-intensive universities (URM men: OR 0.60, 95% CI: 0.36-0.98, p=0.04; WR women: OR: 0.64, 95% CI: 0.47-0.89, p=0.008; URM women: OR: 0.46, 95% CI: 0.30-0.71, p, 0.001), and URM women were more likely than all other groups to report high interest in non-research careers (OR: 1.93, 95% CI: 1.28-2.90, p=0.002). The persistence of disparities in the career interests of Ph. D. recipients suggests that a supply- side (or "pipeline'') framing of biomedical workforce diversity challenges may limit the effectiveness of efforts to attract and retain the best and most diverse workforce. We propose incorporation of an ecological perspective of career development when considering strategies to enhance the biomedical workforce and professoriate through diversity.	[Gibbs, Kenneth D., Jr.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Bethesda, MD 20892 USA; [Gibbs, Kenneth D., Jr.] NCI, Sci Res & Technol Branch, Behav Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [McGready, John] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Bennett, Jessica C.; Griffin, Kimberly] Univ Maryland, Dept Counseling Higher Educ & Special Educ, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland College Park	Gibbs, KD (corresponding author), NCI, Canc Prevent Fellowship Program, Canc Prevent Div, Bethesda, MD 20892 USA.	kenneth.gibbs@nih.gov; kgriff29@umd.edu		Bennett, Jessica/0000-0003-0414-5103; Gibbs, Kenneth/0000-0002-3532-5396	Burroughs Wellcome Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2014, P NATL ACAD SCI US; [Anonymous], 2014, NATURE, V513, P5, DOI 10.1038/513005a; Antonio AL, 2002, J HIGH EDUC, V73, P582, DOI 10.1353/jhe.2002.0043; Bogdan R.C., 2007, QUALITATIVE RES ED I, V5th ed.; Byars-Winston A, 2011, CBE-LIFE SCI EDUC, V10, P357, DOI 10.1187/cbe.10-12-0145; Carrell SE, 2010, Q J ECON, V125, P1101, DOI 10.1162/qjec.2010.125.3.1101; Davis G, 2005, DOCTORS ORDERS S, V93; Fagerland MW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-78; Ferrini-Mundy J, 2013, SCIENCE, V340, P278, DOI 10.1126/science.1235521; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Gibbs KD, 2013, CBE-LIFE SCI EDUC, V12, P711, DOI 10.1187/cbe.13-02-0021; Griffin K.A., 2011, USING MIXED METHODS; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Hurtado S., 1999, ASHE ERIC HIGHER ED, V26; Hurtado S., 2007, NEW DIRECTIONS STUDE, V120, P7, DOI DOI 10.1002/SS.254; Jolliff L, 2012, AM ASS MED COLL WOME; LENT RW, 1994, J VOCAT BEHAV, V45, P79, DOI 10.1006/jvbe.1994.1027; Levin Kate Ann, 2006, Evid Based Dent, V7, P24, DOI 10.1038/sj.ebd.6400375; Malcom LE, 2011, HARVARD EDUC REV, V81, P162, DOI 10.17763/haer.81.2.a84201x508406327; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; McGee R, 2012, MT SINAI J MED, V79, P397, DOI 10.1002/msj.21310; Merriam S. B., 1998, QUALITATIVE RES GUID; Milem JF., 2005, MAKING DIVERSITY WOR; National Academy of Sciences, 2013, SEEK SOL MAX AM TAL; National Academy of Sciences (US) National Academy of Engineering (US) and Institute of Medicine (US) Committee on Maximizing the Potential of Women in Academic Science and Engineering, 2007, BIAS BARR FULF POT W; National Cancer Institute, 2005, NIH PUBLICATION, V05-3896; National Center for Education Statistics, 1997, DEF NEW RAC ETHN CAT; National Institutes of Health, 2014, RFARM12022 NIH; National Institutes of Health, 2009, GRANTS FUND FREQ ASK; National Institutes of Health, 2012, REP ADV COM IN PRESS; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Research Council, 2011, RES TRAIN BIOM BEH C; National Science Board,, 2020, 1401 NSB; National Science Foundation National Center for Science and Engineering Statistics, 2013, 13304 NSF; Ong M, 2011, HARVARD EDUC REV, V81, P172, DOI 10.17763/haer.81.2.t022245n7x4752v2; Rockey SJ, 2014, NAT MED, V20, P575, DOI 10.1038/nm0614-575; Sauermann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036307; Schiebinger L., 2008, GENDERED INNOVATIONS; Stephan P., 2012, EC SHAPES SCI; Tabak LA, 2011, SCIENCE, V333, P940, DOI 10.1126/science.1211704; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; The National Academy of Sciences, 2011, EXP UND MIN PART; Umbach PD, 2006, RES HIGH EDUC, V47, P317, DOI 10.1007/s11162-005-9391-3; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Wilder EL, 2013, SCIENCE, V342, P798, DOI 10.1126/science.342.6160.798-a	47	116	119	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114736	10.1371/journal.pone.0114736	http://dx.doi.org/10.1371/journal.pone.0114736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493425	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400073
J	von Oheimb, G; Hardtle, W; Eckstein, D; Engelke, HH; Hehnke, T; Wagner, B; Fichtner, A				von Oheimb, Goddert; Haerdtle, Werner; Eckstein, Dieter; Engelke, Hans-Hermann; Hehnke, Timo; Wagner, Bettina; Fichtner, Andreas			Does Forest Continuity Enhance the Resilience of Trees to Environmental Change?	PLOS ONE			English	Article							QUERCUS-PETRAEA LIEBL.; FAGUS-SYLVATICA L.; LAND-USE; BEECH FORESTS; RADIAL GROWTH; SOIL CARBON; RING WIDTH; OAK; CLIMATE; NITROGEN	There is ample evidence that continuously existing forests and afforestations on previously agricultural land differ with regard to ecosystem functions and services such as carbon sequestration, nutrient cycling and biodiversity. However, no studies have so far been conducted on possible long-term ( >100 years) impacts on tree growth caused by differences in the ecological continuity of forest stands. In the present study we analysed the variation in tree-ring width of sessile oak (Quercus petraea (Matt.) Liebl.) trees (mean age 115-136 years) due to different land-use histories (continuously existing forests, afforestations both on arable land and on heathland). We also analysed the relation of growth patterns to soil nutrient stores and to climatic parameters (temperature, precipitation). Tree rings formed between 1896 and 2005 were widest in trees afforested on arable land. This can be attributed to higher nitrogen and phosphorous availability and indicates that former fertilisation may continue to affect the nutritional status of forest soils for more than one century after those activities have ceased. Moreover, these trees responded more strongly to environmental changes-as shown by a higher mean sensitivity of the tree-ring widths-than trees of continuously existing forests. However, the impact of climatic parameters on the variability in tree-ring width was generally small, but trees on former arable land showed the highest susceptibility to annually changing climatic conditions. We assume that incompletely developed humus horizons as well as differences in the edaphon are responsible for the more sensitive response of oak trees of recent forests (former arable land and former heathland) to variation in environmental conditions. We conclude that forests characterised by a long ecological continuity may be better adapted to global change than recent forest ecosystems.	[von Oheimb, Goddert] Tech Univ Dresden, Inst Gen Ecol & Environm Protect, D-01737 Tharandt, Germany; [Haerdtle, Werner; Hehnke, Timo; Fichtner, Andreas] Leuphana Univ Luneburg, Inst Ecol, D-21335 Luneburg, Germany; [Eckstein, Dieter] Univ Hamburg, Ctr Wood Sci, D-21031 Hamburg, Germany; [Engelke, Hans-Hermann] Niedersachsen State Forestry Dept, Forestry Dept Sellhorn, D-29646 Bispingen, Germany; [Wagner, Bettina] Univ Gottingen, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany	Technische Universitat Dresden; Leuphana University Luneburg; University of Hamburg; University of Gottingen	von Oheimb, G (corresponding author), Tech Univ Dresden, Inst Gen Ecol & Environm Protect, Pienner Str 7, D-01737 Tharandt, Germany.	Goddert_v_Oheimb@tu-dresden.de	von Oheimb, Goddert/O-9483-2015; Fichtner, Andreas/AAP-3188-2021; Haerdtle, Werner/B-2568-2016	von Oheimb, Goddert/0000-0001-7408-425X; Fichtner, Andreas/0000-0003-0499-4893; Hardtle, Werner/0000-0002-5599-5792				Assmann T, 1999, BIODIVERS CONSERV, V8, P1499, DOI 10.1023/A:1008974413376; Aubert M, 2010, FOREST ECOL MANAG, V259, P563, DOI 10.1016/j.foreco.2009.11.014; Baeten L, 2011, PLANT ECOL, V212, P901, DOI 10.1007/s11258-010-9876-9; Baeten L, 2010, OECOLOGIA, V163, P1021, DOI 10.1007/s00442-010-1599-z; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; Bauhus J, 2010, ECOSYSTEM GOODS SERV, P96, DOI [10.4324/9781849776417, DOI 10.4324/9781849776417]; BECKER M, 1994, ANN SCI FOREST, V51, P477, DOI 10.1051/forest:19940504; Becker M, 1996, ANN SCI FOREST, V53, P585, DOI 10.1051/forest:19960237; Berges L, 2005, ANN FOREST SCI, V62, P391, DOI 10.1051/forest:2005035; Berges L, 2008, FOREST ECOL MANAG, V255, P567, DOI 10.1016/j.foreco.2007.09.027; Broadmeadow MSJ, 2000, NEW PHYTOL, V146, P437, DOI 10.1046/j.1469-8137.2000.00665.x; Brunet J, 1998, J ECOL, V86, P429, DOI 10.1046/j.1365-2745.1998.00269.x; Burton J, 2010, J SOIL SEDIMENT, V10, P1267, DOI 10.1007/s11368-010-0238-y; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Compton JE, 1998, OECOLOGIA, V116, P536, DOI 10.1007/s004420050619; Cufar K, 2008, TREE-RING RES, V64, P3, DOI 10.3959/2007-12.1; De Schrijver A, 2012, OECOLOGIA, V169, P221, DOI 10.1007/s00442-011-2185-8; Deans JD, 1996, FORESTRY, V69, P5, DOI 10.1093/forestry/69.1.5; Dittmar C, 2003, FOREST ECOL MANAG, V173, P63, DOI 10.1016/S0378-1127(01)00816-7; Drobyshev I, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008033; ECKSTEIN D, 1974, ANGEW BOT, V48, P371; Fang SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061461; Fichtner A, 2014, SOIL BIOL BIOCHEM, V70, P79, DOI 10.1016/j.soilbio.2013.12.015; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Fraterrigo JM, 2006, ECOLOGY, V87, P570, DOI 10.1890/05-0638; Friedrichs DA, 2009, TREE PHYSIOL, V29, P39, DOI 10.1093/treephys/tpn003; Fritts H.C, 1976, TREE RINGS CLIMATE; Goodale CL, 2001, ECOL APPL, V11, P253, DOI 10.1890/1051-0761(2001)011[0253:TLTEOL]2.0.CO;2; Gotmark F, 2005, FOREST ECOL MANAG, V214, P142, DOI 10.1016/j.foreco.2005.04.001; Greiffenhagen A, 2006, GEODERMA, V132, P182, DOI 10.1016/j.geoderma.2005.05.006; Hardtle W, 2014, ECOL INDIC, V45, P45, DOI 10.1016/j.ecolind.2014.03.015; Hardtle W, 2013, ECOSYSTEMS, V16, P1413, DOI 10.1007/s10021-013-9692-x; Hardtle W, 2013, PLANT ECOL, V214, P1147, DOI 10.1007/s11258-013-0239-1; Hardtle W, 2004, FLORA, V199, P134, DOI 10.1078/0367-2530-00142; HEIL GW, 2007, ENV EFFECTS AFFOREST, P1; Hejcman M, 2013, ECOSYSTEMS, V16, P652, DOI 10.1007/s10021-013-9638-3; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Kint V, 2012, EUR J FOREST RES, V131, P609, DOI 10.1007/s10342-011-0535-z; Koerner W, 1999, OECOLOGIA, V121, P421, DOI 10.1007/s004420050947; Lang AC, 2014, J APPL ECOL, V51, P224, DOI 10.1111/1365-2664.12157; Lebourgeois F, 2004, ANN FOREST SCI, V61, P361, DOI 10.1051/forest:2004029; Leuschner C, 2001, FOREST ECOL MANAG, V149, P33, DOI 10.1016/S0378-1127(00)00543-0; Leuschner C, 2014, ECOSYSTEMS, V17, P497, DOI 10.1007/s10021-013-9738-0; Leuschner C, 2013, FOREST ECOL MANAG, V310, P405, DOI 10.1016/j.foreco.2013.08.043; Leuzinger S, 2005, TREE PHYSIOL, V25, P641, DOI 10.1093/treephys/25.6.641; Mattingly WB, 2013, OECOLOGIA, V172, P1147, DOI 10.1007/s00442-012-2568-5; Merian P, 2011, PLANT ECOL, V212, P1855, DOI 10.1007/s11258-011-9959-2; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; MUYS B, 1992, SOIL BIOL BIOCHEM, V24, P1459, DOI 10.1016/0038-0717(92)90133-I; Niemeyer T, 2005, APPL VEG SCI, V8, P183, DOI 10.1111/j.1654-109X.2005.tb00644.x; Norden B, 2001, BIODIVERS CONSERV, V10, P779, DOI 10.1023/A:1016675103935; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pagnutti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075890; Potthast K, 2012, BIOGEOCHEMISTRY, V111, P151, DOI 10.1007/s10533-011-9626-7; RIO MD, PLANT BIOL IN PRESS, DOI DOI 10.1111/P1B.12029; Seidel D, 2013, FOREST ECOL MANAG, V310, P366, DOI 10.1016/j.foreco.2013.08.058; Sidorova OV, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000473; Smith P, 2000, GLOB CHANGE BIOL, V6, P525, DOI 10.1046/j.1365-2486.2000.00331.x; Sparling G. P., 1997, P97; Speer J.H., 2010, FUNDAMENTALS TREE RI; Stan AB, 2010, DENDROCHRONOLOGIA, V28, P135, DOI 10.1016/j.dendro.2009.10.003; Thomas FM, 2000, PLANT ECOL, V147, P95, DOI 10.1023/A:1009841921261; Thomas FM, 2002, FOREST PATHOL, V32, P277, DOI 10.1046/j.1439-0329.2002.00291.x; Trouet V, 2010, DENDROCHRONOLOGIA, V28, P161, DOI 10.1016/j.dendro.2009.10.002; von Oheimb G, 2008, FOREST ECOL MANAG, V255, P1984, DOI 10.1016/j.foreco.2007.12.021; Wang W, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002484; Wazny T., 1991, Dendrochronologia, P35; WESTPHAL C, 2001, BERICHTE FORSCHUNGSZ, V174, P1	70	17	17	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113507	10.1371/journal.pone.0113507	http://dx.doi.org/10.1371/journal.pone.0113507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494042	Green Submitted, Green Published, gold			2022-12-27	WOS:000346611400014
J	Bajardi, P; Paolotti, D; Vespignani, A; Eames, K; Funk, S; Edmunds, WJ; Turbelin, C; Debin, M; Colizza, V; Smallenburg, R; Koppeschaar, C; Franco, AO; Faustino, V; Carnahan, A; Rehn, M; Merletti, F; Douwes, J; Firestone, R; Richiardi, L				Bajardi, Paolo; Paolotti, Daniela; Vespignani, Alessandro; Eames, Ken; Funk, Sebastian; Edmunds, W. John; Turbelin, Clement; Debin, Marion; Colizza, Vittoria; Smallenburg, Ronald; Koppeschaar, Carl; Franco, Ana O.; Faustino, Vitor; Carnahan, AnnaSara; Rehn, Moa; Merletti, Franco; Douwes, Jeroen; Firestone, Ridvan; Richiardi, Lorenzo			Association between Recruitment Methods and Attrition in Internet-Based Studies	PLOS ONE			English	Article							INFLUENZA-LIKE-ILLNESS; HEALTH COMMUNICATION; BIRTH COHORT; BEHAVIOR; PARTICIPANTS; NETHERLANDS; EXPERIENCE; PATTERNS; MEDIA; BIAS	Internet-based systems for epidemiological studies have advantages over traditional approaches as they can potentially recruit and monitor a wider range of individuals in a relatively inexpensive fashion. We studied the association between communication strategies used for recruitment (offline, online, face-to-face) and follow-up participation in nine Internet-based cohorts: the Influenzanet network of platforms for influenza surveillance which includes seven cohorts in seven different European countries, the Italian birth cohort Ninfea and the New Zealand birth cohort ELF. Follow-up participation varied from 43% to 89% depending on the cohort. Although there were heterogeneities among studies, participants who became aware of the study through an online communication campaign compared with those through traditional offline media seemed to have a lower follow-up participation in 8 out of 9 cohorts. There were no clear differences in participation between participants enrolled face-to-face and those enrolled through other offline strategies. An Internet-based campaign for Internet-based epidemiological studies seems to be less effective than an offline one in enrolling volunteers who keep participating in follow-up questionnaires. This suggests that even for Internet-based epidemiological studies an offline enrollment campaign would be helpful in order to achieve a higher participation proportion and limit the cohort attrition.	[Bajardi, Paolo] Univ Turin, Dept Vet Sci, Computat Epidemiol Grp, GECO, Turin, Italy; [Bajardi, Paolo; Paolotti, Daniela; Vespignani, Alessandro; Colizza, Vittoria] ISI Fdn, Turin, Italy; [Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Vespignani, Alessandro] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Eames, Ken; Funk, Sebastian; Edmunds, W. John] London Sch Hyg & Trop Med, London WC1, England; [Turbelin, Clement; Debin, Marion; Colizza, Vittoria] Inst Natl St Rech Med, UMR S 707, Paris, France; [Turbelin, Clement; Debin, Marion; Colizza, Vittoria] Univ Paris 06, UMR S 707, Paris, France; [Smallenburg, Ronald; Koppeschaar, Carl] Aquistointer BV, Amsterdam, Netherlands; [Franco, Ana O.; Faustino, Vitor] Inst Gulbenkian Cincia, Oeiras, Portugal; [Carnahan, AnnaSara; Rehn, Moa] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Turin, Italy; [Merletti, Franco; Richiardi, Lorenzo] CPO Piemonte, Turin, Italy; [Douwes, Jeroen; Firestone, Ridvan] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	University of Turin; Northeastern University; Harvard University; University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Public Health Agency of Sweden; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Massey University	Bajardi, P (corresponding author), Univ Turin, Dept Vet Sci, Computat Epidemiol Grp, GECO, Turin, Italy.	paolo.bajardi@isi.it	Bajardi, Paolo/AAE-2416-2022; Firestone, Riz/AAU-2414-2021; Paolotti, Daniela/K-5740-2016; richiardi, lorenzo/J-3480-2018	Bajardi, Paolo/0000-0001-8865-4495; Firestone, Riz/0000-0003-2834-8044; Paolotti, Daniela/0000-0003-1356-3470; DEBIN, Marion/0000-0002-5146-7642; Colizza, Vittoria/0000-0002-2113-2374; richiardi, lorenzo/0000-0003-0316-9402; de Oliveira Franco, Ana Isabel/0000-0002-9195-965X; Funk, Sebastian/0000-0002-2842-3406; Douwes, Jeroen/0000-0003-3599-4036; Vespignani, Alessandro/0000-0003-3419-4205	EC-ICT IP EPIWORK [231807]; European Research Council [n.ERC-2007-Stg204863]; ISI Foundation; ANR [ANR-12-MONU-0018]; Career Development Fellowship; National Institute for Health Research; Institut de Veille Sanitaire; Compagnia di San Paolo; Piedmont Region; Health Research Council of New Zealand; Massey University; Master in Epidemiology of the University of Turin and Compagnia di San Paolo; Medical Research Council [MR/K021680/1] Funding Source: researchfish; MRC [MR/K021680/1] Funding Source: UKRI	EC-ICT IP EPIWORK; European Research Council(European Research Council (ERC)European Commission); ISI Foundation; ANR(French National Research Agency (ANR)); Career Development Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); Institut de Veille Sanitaire; Compagnia di San Paolo(Compagnia di San Paolo); Piedmont Region(Regione Piemonte); Health Research Council of New Zealand(Health Research Council of New Zealand); Massey University; Master in Epidemiology of the University of Turin and Compagnia di San Paolo; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the EC-ICT IP EPIWORK g.a. no. 231807. PB gratefully acknowledges the European Research Council Ideas contract n.ERC-2007-Stg204863 (EPIFOR) and the ISI Foundation that partially funded this work. The work has been partially funded by the ANR contract no. ANR-12-MONU-0018 (HARMSflu) to VC, MD, CT. KE is funded by a Career Development Fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors(s) and not necessarily those of the NHS, the National Institute of Health research or the Department of Health (UK). The GrippeNet.fr study is partially funded by the Institut de Veille Sanitaire. The Ninfea study is partially funded by the Compagnia di San Paolo and the Piedmont Region. The ELF study was partially funded by the Health Research Council of New Zealand and from Massey University. This work has been supported by the Master in Epidemiology of the University of Turin and Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3010; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Cassell MM, 1998, J HEALTH COMMUN, V3, P71; CHAIKEN S, 1983, J PERS SOC PSYCHOL, V45, P241, DOI 10.1037/0022-3514.45.2.241; Dokkum NFB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-176; Eames KT, 2011, EPIDEMIOL INFECT, V12, P1; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Glasgow RE, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e11; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Kreuter MW, 2004, ANNU REV PUBL HEALTH, V25, P439, DOI 10.1146/annurev.publhealth.25.101802.123000; Mayr A, 2012, J CLIN EPIDEMIOL, V65, P970, DOI 10.1016/j.jclinepi.2012.03.005; Peels DA, 2012, J MED INTERNET RES, V14, P146, DOI 10.2196/jmir.2229; Pizzi C, 2012, J EPIDEMIOL COMMUN H, V66, P976, DOI 10.1136/jech-2011-200065; Richiardi L, 2013, HDB EPIDEMIOLOGY, P439; Richiardi L, 2007, EUR J EPIDEMIOL, V22, P831, DOI 10.1007/s10654-007-9194-2; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1018, DOI 10.1093/ije/dyt103; Richiardi L, 2012, EPIDEMIOLOGY, V23, P175, DOI 10.1097/EDE.0b013e31823b5ee4; Rothman KJ, 2013, INT J EPIDEMIOL, V42; Svensson M, 2012, EUR J EPIDEMIOL, V27, P333, DOI 10.1007/s10654-012-9687-5; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; van Velsen L, 2012, J MED INTERNET RES, V14, P265, DOI 10.2196/jmir.2123; WORCHEL S, 1975, J APPL SOC PSYCHOL, V5, P157, DOI 10.1111/j.1559-1816.1975.tb01305.x	22	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114925	10.1371/journal.pone.0114925	http://dx.doi.org/10.1371/journal.pone.0114925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490045	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000347515300095
J	Chen, YW; Tsai, MY; Pan, HB; Tseng, HH; Hung, YT; Chou, CP				Chen, Ya-Wen; Tsai, Meng-Yuan; Pan, Huay-Ben; Tseng, Hui-Hwa; Hung, Yu-Ting; Chou, Chen-Pin			Gadoxetic Acid-Enhanced MRI and Sonoelastography: Non-Invasive Assessments of Chemoprevention of Liver Fibrosis in Thioacetamide-Induced Rats with Sho-Saiko-To	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; CIRRHOSIS; AGENT; MODEL; CARCINOMA; BIOPSY	Background: This study aimed to compare the performance of gadoxetic acid - enhanced magnetic resonance imaging (MRI) and sonoelastography in evaluating chemopreventive effects of Sho-Saiko-To (SST) in thioacetamide (TAA)-induced early liver fibrosis in rats. Materials and Methods: Ten of Sprague-Dawley rats receiving TAA (200 mg/kg of body weight) intraperitoneal injection were divided into three groups: Group 1 (TAA only, n = 3), Group 2 (TAA +0.25 g/kg SST, n = 4) and Group 3 (TAA+ 1 g/kg SST, n = 3). Core needle liver biopsy at week 2 and liver specimens after sacrifice at week 6 confirmed liver fibrosis using histological examinations, including Sirius red staining, Ishak and Metavir scoring systems. Gadoxetic acid-enhanced MRI and shear-wave sonoelastography were employed to evaluate liver fibrosis. The expression of hepatic transporter organic anion transporter 1 (Oatp1), multidrug-resistant protein 2 (Mrp2) and alpha-smooth muscle actin (alpha-Sma) were also analyzed in each group by immunohistochemistry (IHC) and Western blot. Results: According to histological grading by Sirius red staining, Ishak scores of liver fibrosis in Groups 1, 2 and 3 were 3, 2 and 1, respectively. As shown in gadoxetic acid-enhanced MRI, the ratio of relative enhancement was significantly lower in Group 1 (1.87 +/- 0.21) than in Group 2 of low-dose (2.82 +/- 0.25) and Group 3 of high-dose (2.72 +/- 0.12) SST treatment at 10 minutes after gadoxetic acid intravenous injection (p<0.05). Sonoelastography showed that the mean difference before and after experiments in Groups 1, 2 and 3 were 4.66 +/- 0.1, 4.4 +/- 0.57 and 3 +/- 0.4 KPa (p<0.1), respectively. Chemopreventive effects of SST reduced the Mrp2 protein level (p<0.01) but not Oatp1 and alpha-Sma levels. Conclusion: Sonoelastography and gadoxetic acid-enhanced MRI could monitor the treatment effect of SST in an animal model of early hepatic fibrosis.	[Chen, Ya-Wen] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli 350, Taiwan; [Chen, Ya-Wen] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Tsai, Meng-Yuan; Pan, Huay-Ben; Hung, Yu-Ting; Chou, Chen-Pin] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan; [Tsai, Meng-Yuan; Pan, Huay-Ben; Tseng, Hui-Hwa; Chou, Chen-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Pan, Huay-Ben] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 824, Taiwan; [Tseng, Hui-Hwa] Kaohsiung Vet Gen Hosp, Dept Pathol, Kaohsiung 813, Taiwan; [Chou, Chen-Pin] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; I Shou University; Kaohsiung Veterans General Hospital; Fooyin University	Chou, CP (corresponding author), Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan.	r2207759@ms19.hinet.net	Chen, Ya-Wen/B-1100-2010; Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	Ministry of Science and Technology; National Health Research Institutes, Taiwan [NSC 99-2314-B-075B-006-MY3, NSC 102-2320-B-400004, NHRI CA-103-PP-03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants NSC 99-2314-B-075B-006-MY3, NSC 102-2320-B-400004, NHRI CA-103-PP-03 from Ministry of Science and Technology and National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berzigotti A, 2013, J HEPATOL, V59, P180, DOI 10.1016/j.jhep.2012.12.028; Bruck R, 2001, J HEPATOL, V35, P457, DOI 10.1016/S0168-8278(01)00163-5; Chen TM, 2008, INT J EXP PATHOL, V89, P223, DOI 10.1111/j.1365-2613.2008.00576.x; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Deng G, 2011, J ETHNOPHARMACOL, V136, P83, DOI 10.1016/j.jep.2011.04.008; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317; Guardigli M, 2005, J HISTOCHEM CYTOCHEM, V53, P1451, DOI 10.1369/jhc.5A6621.2005; HARANAKA K, 1985, CANCER IMMUNOL IMMUN, V20, P1; Hope TA, 2012, RADIOLOGY, V264, P423, DOI 10.1148/radiol.12112453; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Kato M, 1998, J INVEST DERMATOL, V111, P640, DOI 10.1046/j.1523-1747.1998.00341.x; Lee JK, 2011, HEPATOL RES, V41, P825, DOI 10.1111/j.1872-034X.2011.00829.x; Libra A, 2006, J PHARMACOL EXP THER, V319, P809, DOI 10.1124/jpet.106.106591; Malaguarnera G, 2012, WORLD J GASTROENTERO, V18, P2756, DOI 10.3748/wjg.v18.i22.2756; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Ohta T, 2006, ACTA MED OKAYAMA, V60, P77; Pascolo L, 1999, BIOCHEM BIOPH RES CO, V257, P746, DOI 10.1006/bbrc.1999.0454; Perez MJ, 2002, J NUTR, V132, P652, DOI 10.1093/jn/132.4.652; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sporea I, 2012, ULTRASCHALL MED, V33, P550, DOI 10.1055/s-0032-1313011; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Tsuda N, 2011, EUR RADIOL, V21, P2542, DOI 10.1007/s00330-011-2228-x; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Van Montfoort JE, 1999, J PHARMACOL EXP THER, V290, P153; Yamamoto H, 2003, GASTROENTEROLOGY, V125, P556, DOI 10.1016/S0016-5085(03)00904-1; Zech Christoph J, 2007, Magn Reson Med Sci, V6, P43, DOI 10.2463/mrms.6.43; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	36	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114756	10.1371/journal.pone.0114756	http://dx.doi.org/10.1371/journal.pone.0114756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490034	Green Published, Green Submitted, gold			2022-12-27	WOS:000347515300075
J	Deng, B; Fu, LQ; Zhang, XP; Zheng, JJ; Peng, LS; Sun, JD; Zhu, HY; Wang, YB; Li, WF; Wu, XX; Wu, D				Deng, Bin; Fu, Luoqin; Zhang, Xiaoping; Zheng, Jiajia; Peng, Lisha; Sun, Jiandong; Zhu, Haiyan; Wang, Yibing; Li, Weifen; Wu, Xuexiang; Wu, Di			The Denitrification Characteristics of Pseudomonas stutzeri SC221-M and Its Application to Water Quality Control in Grass Carp Aquaculture	PLOS ONE			English	Article							AEROBIC DENITRIFICATION; HETEROTROPHIC NITRIFICATION; BACTERIUM; REMOVAL; AMMONIA; NITRATE; EXPRESSION; MECHANISM; BIOLOGY; GENOME	To reduce ammonium and nitrite in aquaculture water, an isolate of the denitrifying bacterium Pseudomonas stutzeri, SC221-M, was obtained. The effects of various nitrogen and carbon sources, the ratio of carbon to nitrogen and temperature on bacterial growth, denitrification rates and the expression levels of nirS and nosZ in SC221-M were studied. The following conditions were determined to be optimal for growth and denitrification in SC221-M: NaNO2 as the nitrogen source, sodium citrate as the carbon source, a carbon to nitrogen ratio range of 4-8, and a temperature range of 20-35 degrees C. Subsequently, SC221-M and the Bacillus cereus BSC24 strain were selected to generate microbial preparations. The results showed that addition of the microbial preparations decreased various hydrochemical parameters, including total dissolved solids, ammonium, nitrite, total nitrogen and the chemical oxygen demand. Nitrogen removal rates were highest on day 9; the removal rates of BSC24, SC221-M, a mixed preparation and a 3 x mixed preparation were 24.5%, 26.6%, 53.9% and 53.4%, respectively. The mixed preparation (SC221-M+BSC24) was more effective at removing nitrogen than either the SC221-M or BSC24 preparation. Roche 454 pyrosequencing and subsequent analysis indicated that the control and other groups formed separate clusters, and the microbial community structure in the water changed significantly after the addition of microbial preparations. These results indicate that the addition of microbial preparations can improve both the water quality and microbial community structure in an experimental aquaculture system. P. stutzeri strain SC221-M and its related microbial preparations are potential candidates for the regulation of water quality in commercial aquaculture systems.	[Deng, Bin; Fu, Luoqin; Zhang, Xiaoping; Zheng, Jiajia; Peng, Lisha; Sun, Jiandong; Zhu, Haiyan; Wang, Yibing; Li, Weifen] Zhejiang Univ, Coll Anim Sci, Inst Anim Nutr & Feed Sci, Key Lab Mol Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Deng, Bin] Guizhou Inst Technol, Sch Pharmaceut Engn, Guiyang, Peoples R China; [Zhang, Xiaoping] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xuexiang] Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China; [Wu, Di] Ctr Dis Control & Prevent, Deyang, Peoples R China	Zhejiang University; Guizhou Institute of Technology; Zhejiang University; Guizhou University; Chinese Center for Disease Control & Prevention	Zhang, XP (corresponding author), Zhejiang Univ, Coll Anim Sci, Inst Anim Nutr & Feed Sci, Key Lab Mol Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangxiaoping403@gmail.com; weifenli@zju.edu.cn	zhu, xueqiong/U-1320-2019; Sun, Jiandong/J-1263-2012	Sun, Jiandong/0000-0003-1288-466X	National Basic Research Program, P. R. China (973 Program) [2009CB118705]; Special Fund for Agro-scientific Research in the Public Interest [201203083]; Foundation of Agricultural Science and Technology Support Project of Guizhou Province [3053]	National Basic Research Program, P. R. China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Foundation of Agricultural Science and Technology Support Project of Guizhou Province	This work was supported by National Basic Research Program, P. R. China (973 Program) 2009CB118705, Special Fund for Agro-scientific Research in the Public Interest, 201203083, and Foundation of Agricultural Science and Technology Support Project of Guizhou Province [2010] 3053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARILLO A, 1981, ECOTOX ENVIRON SAFE, V5, P316, DOI 10.1016/0147-6513(81)90006-3; Borges MT, 2008, MICROB ECOL, V55, P107, DOI 10.1007/s00248-007-9256-8; Bosch R, 1999, GENE, V236, P149, DOI 10.1016/S0378-1119(99)00241-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Garcia-Valdes E, 2003, SYST APPL MICROBIOL, V26, P390, DOI 10.1078/072320203322497428; Henderson SL, 2010, APPL ENVIRON MICROB, V76, P2155, DOI 10.1128/AEM.02993-09; Holt JG, 1994, BERGEYS MANUAL DETER, V75, P121; Hu Z, 2013, ENVIRON SCI POLLUT R, V20, P1059, DOI 10.1007/s11356-012-1018-6; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Kim JK, 2005, BIORESOURCE TECHNOL, V96, P1897, DOI 10.1016/j.biortech.2005.01.040; Kim M, 2008, J BIOSCI BIOENG, V106, P498, DOI 10.1263/jbb.106.498; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Liu FJ, 2002, J ENVIRON SCI-CHINA, V14, P339; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mires D, 1995, ISR J AQUACULT-BAMID, V47, P163; Nimrat S, 2012, VET MICROBIOL, V159, P443, DOI 10.1016/j.vetmic.2012.04.029; Pena A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00113-13; Saleh-Lakha S, 2009, APPL ENVIRON MICROB, V75, P5082, DOI 10.1128/AEM.00777-09; Saleh-Lakha S, 2009, APPL ENVIRON MICROB, V75, P3903, DOI 10.1128/AEM.00080-09; Shan H, 2001, APPL MICROBIOL BIOT, V57, P791; Su JJ, 2001, J APPL MICROBIOL, V90, P457, DOI 10.1046/j.1365-2672.2001.01265.x; Szymanski N, 2003, FUTURE DIRECTIONS ON, P347; Tilak KS, 2007, J ENVIRON BIOL, V28, P45; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yu HY, 2011, J BACTERIOL, V193, P3422, DOI 10.1128/JB.05039-11; Zawadzka AM, 2007, BIOMETALS, V20, P145, DOI 10.1007/s10534-006-9022-2; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhang QL, 2012, BIORESOURCE TECHNOL, V108, P35, DOI 10.1016/j.biortech.2011.12.139; Zhang X, 2013, WORLD J MICROB BIOT; Zhang XP, 2013, WORLD J MICROB BIOT, V29, P1645, DOI 10.1007/s11274-013-1327-z; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	32	23	34	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114886	10.1371/journal.pone.0114886	http://dx.doi.org/10.1371/journal.pone.0114886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489740	Green Submitted, gold, Green Published			2022-12-27	WOS:000347515300092
J	Rozycka, M; Wojtas, M; Jakob, M; Stigloher, C; Grzeszkowiak, M; Mazur, M; Ozyhar, A				Rozycka, Miroslawa; Wojtas, Magdalena; Jakob, Michal; Stigloher, Christian; Grzeszkowiak, Mikolaj; Mazur, Maciej; Ozyhar, Andrzej			Intrinsically Disordered and Pliable Starmaker-Like Protein from Medaka (Oryzias latipes) Controls the Formation of Calcium Carbonate Crystals	PLOS ONE			English	Article							MODULATING BIOMINERALIZATION PROTEINS; NACREOUS LAYER FORMATION; ALPHA-HELICAL STRUCTURE; DYE STAINS-ALL; CIRCULAR-DICHROISM; UNSTRUCTURED PROTEINS; POLYELECTROLYTE DOMAINS; PHOSPHORYLATION SITES; PROCAMBARUS-CLARKII; SECONDARY STRUCTURE	Fish otoliths, biominerals composed of calcium carbonate with a small amount of organic matrix, are involved in the functioning of the inner ear. Starmaker (Stm) from zebrafish (Danio rerio) was the first protein found to be capable of controlling the formation of otoliths. Recently, a gene was identified encoding the Starmaker-like (Stm-l) protein from medaka (Oryzias latipes), a putative homologue of Stm and human dentine sialophosphoprotein. Although there is no sequence similarity between Stm-l and Stm, Stm-l was suggested to be involved in the biomineralization of otoliths, as had been observed for Stm even before. The molecular properties and functioning of Stm-l as a putative regulatory protein in otolith formation have not been characterized yet. A comprehensive biochemical and biophysical analysis of recombinant Stm-l, along with in silico examinations, indicated that Stm-l exhibits properties of a coil-like intrinsically disordered protein. Stm-l possesses an elongated and pliable structure that is able to adopt a more ordered and rigid conformation under the influence of different factors. An in vitro assay of the biomineralization activity of Stm-l indicated that Stm-l affected the size, shape and number of calcium carbonate crystals. The functional significance of intrinsically disordered properties of Stm-l and the possible role of this protein in controlling the formation of calcium carbonate crystals is discussed.	[Rozycka, Miroslawa; Wojtas, Magdalena; Jakob, Michal; Ozyhar, Andrzej] Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland; [Stigloher, Christian] Univ Wurzburg, Bioctr, Div Elect Microscopy, D-97070 Wurzburg, Germany; [Grzeszkowiak, Mikolaj] Adam Mickiewicz Univ, Fac Phys, NanoBioMed Ctr, Poznan, Poland; [Grzeszkowiak, Mikolaj] Wroclaw Univ Technol, Fac Chem, Dept Macromol Phys, PL-50370 Wroclaw, Poland; [Mazur, Maciej] Univ Warsaw, Dept Chem, Warsaw, Poland	Wroclaw University of Science & Technology; University of Wurzburg; Adam Mickiewicz University; Wroclaw University of Science & Technology; University of Warsaw	Ozyhar, A (corresponding author), Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.	andrzej.ozyhar@pwr.edu.pl	Różycka, Mirosława/V-4541-2018; Stigloher, Christian/E-4762-2015	Różycka, Mirosława/0000-0002-8008-6689; Stigloher, Christian/0000-0001-6941-2669; OZYHAR, Andrzej/0000-0002-5874-784X; Mazur, Maciej/0000-0002-9197-5553	Polish Ministry of Science and Higher Education for the Faculty of Chemistry of the Wroclaw University of Technology; National Science Centre [NN 204 1200 40]; European Social Fund within the project Development of common PhD studies in nanotechnology-electronics and photovoltaics in Macromolecular Physics Institute of Polish Academy of Science; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Polish Ministry of Science and Higher Education for the Faculty of Chemistry of the Wroclaw University of Technology; National Science Centre(National Science Centre, Poland); European Social Fund within the project Development of common PhD studies in nanotechnology-electronics and photovoltaics in Macromolecular Physics Institute of Polish Academy of Science; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This work was supported by the statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry of the Wroclaw University of Technology. This work was supported in part by the National Science Centre grant NN 204 1200 40. This work was also supported by the European Social Fund within the project Development of common PhD studies in nanotechnology-electronics and photovoltaics in Macromolecular Physics Institute of Polish Academy of Science and at the Faculty of Physics at Adam Mickiewicz University in Poznan. Publication fee was covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Allemand Denis, 2007, P291, DOI 10.1002/9783527619443.ch17; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bajoghli B, 2009, DEV DYNAM, V238, P2860, DOI 10.1002/dvdy.22093; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Batas B, 1997, J CHROMATOGR A, V766, P109, DOI 10.1016/S0021-9673(96)01020-5; Begg GE, 2001, CURR PROTOC PROTEIN; Begg GE, 1999, CURRENT PROTOCOLS PR, P1078; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borelli G, 2003, J EXP BIOL, V206, P2685, DOI 10.1242/jeb.00479; Borelli G, 2001, CALCIFIED TISSUE INT, V69, P356, DOI 10.1007/s00223-001-2016-8; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; Cui ZJ, 2012, AMINO ACIDS, V43, P505, DOI 10.1007/s00726-011-1175-9; Dai LJ, 2008, J NON-CRYST SOLIDS, V354, P1845, DOI 10.1016/j.jnoncrysol.2007.10.022; DEHAEN C, 1987, ANAL BIOCHEM, V166, P235, DOI 10.1016/0003-2697(87)90570-7; Delak K, 2009, BIOCHEMISTRY-US, V48, P3669, DOI 10.1021/bi900113v; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dong A, 1998, ARCH BIOCHEM BIOPHYS, V355, P275, DOI 10.1006/abbi.1998.0718; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Fujisawa R, 1998, EUR J ORAL SCI, V106, P249, DOI 10.1111/j.1600-0722.1998.tb02183.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; George A, 2005, CELLS TISSUES ORGANS, V181, P232, DOI 10.1159/000091384; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Guibbolini M, 2006, COMP BIOCHEM PHYS A, V145, P99, DOI 10.1016/j.cbpa.2006.05.003; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Inoue H, 2007, PEPTIDES, V28, P566, DOI 10.1016/j.peptides.2006.12.005; Jayaraman G, 1996, BIOCHEM BIOPH RES CO, V222, P33, DOI 10.1006/bbrc.1996.0693; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kaplon TM, 2008, BIOMACROMOLECULES, V9, P2118, DOI 10.1021/bm800135m; Kaplon TM, 2009, BBA-PROTEINS PROTEOM, V1794, P1616, DOI 10.1016/j.bbapap.2009.07.010; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Keene EC, 2010, CRYST GROWTH DES, V10, P1383, DOI 10.1021/cg901389v; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Kim IW, 2006, CRYST GROWTH DES, V6, P1078, DOI 10.1021/cg060056q; Kim IW, 2004, CRYST GROWTH DES, V4, P1113, DOI 10.1021/cg049919a; Klaning E, 2014, BONE; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liao SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02136; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manon F, 2010, ANONYMOUS INSTRUMENT, P431, DOI [DOI 10.1002/9780470602614CH15, 10.1002/9780470602614.ch15.]; Marin Frederic, 2007, P273, DOI 10.1002/9783527619443.ch16; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Mitrea DM, 2012, BIOCOMPUT-PAC SYM, P152; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Payan P, 1999, AM J PHYSIOL-REG I, V277, pR123, DOI 10.1152/ajpregu.1999.277.1.R123; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSS MD, 1984, PHILOS T ROY SOC B, V304, P445, DOI 10.1098/rstb.1984.0038; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Salvay Andres G, 2012, Methods Mol Biol, V896, P91, DOI 10.1007/978-1-4614-3704-8_6; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TAL M, 1985, J BIOL CHEM, V260, P9976; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Walther LE, 2007, J VESTIBUL RES-EQUIL, V17, P89; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weber K, 1972, Methods Enzymol, V26, P3; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Wojtas M, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P3; Wojtas Magdalena, 2012, Methods Mol Biol, V896, P319, DOI 10.1007/978-1-4614-3704-8_21; Wojtas M, 2012, CRYST GROWTH DES, V12, P158, DOI 10.1021/cg200905f; Wustman BA, 2004, BIOPOLYMERS, V74, P363, DOI 10.1002/bip.20086; Wustman BA, 2003, CONNECT TISSUE RES, V44, P10, DOI 10.1080/03008200390152016; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020498; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	125	29	29	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114308	10.1371/journal.pone.0114308	http://dx.doi.org/10.1371/journal.pone.0114308			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490041	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300025
J	Sims, S; Colston, J; Emery, V; Klenerman, P				Sims, Stuart; Colston, Julia; Emery, Vince; Klenerman, Paul			CD73 Is Dispensable for the Regulation of Inflationary CD8(+) T-Cells after Murine Cytomegalovirus Infection and Adenovirus Immunisation	PLOS ONE			English	Article							MEMORY INFLATION; ADENOSINE RECEPTOR; LATENCY; VIRUS	The ecto-5'-nucleotidase (CD73) is expressed by T-cell subsets, myeloid derived suppressive cells and endothelial cells. It works in conjunction with CD39 to regulate the formation and degradation of adenosine in vivo. Adenosine has previously been shown to suppress the proliferation and cytokine secretion of T-cells and recent evidence suggests that inhibition of CD73 has the potential to enhance T-cell directed therapies. Here we utilised a CD73 knockout mouse model to assess the suppressive ability of CD73 on CD8(+) T-cell classical memory and memory "inflation", induced by murine cytomegalovirus (MCMV) infection and adenovirus immunisation. We show that CD73 is dispensable for normal CD8(+) T-cell differentiation and function in both models. Thus CD73 as a suppressor of CD8(+) T-cells is unlikely to play a deterministic role in the generation and functional characteristics of antiviral memory in these settings.	[Sims, Stuart; Colston, Julia; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Emery, Vince] Univ Surrey, Dept Microbial & Cellular Sci, Guildford GU2 5XH, Surrey, England	University of Oxford; University of Surrey	Sims, S (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.	stuart.sims@bsse.ethz.ch; paul.klenerman@ndm.ox.ac.uk	; Emery, Vincent/G-8928-2013	Colston, Julia/0000-0002-3337-2455; klenerman, paul/0000-0003-4307-9161; Emery, Vincent/0000-0001-5893-9756; sims, stuart/0000-0002-6327-0927	Wellcome Trust [MA 091663]; Oxford Martin School	Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Martin School	This work was funded by the Wellcome Trust (MA 091663 and fellowship to Julia Colston) and the Oxford Martin School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bolinger B, 2013, J IMMUNOL, V190, P4162, DOI 10.4049/jimmunol.1202665; Carriere M, 2014, J INFECT DIS, V209, P1321, DOI 10.1093/infdis/jit643; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Gamadia LE, 2004, J IMMUNOL, V172, P6107, DOI 10.4049/jimmunol.172.10.6107; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Humphreys IR, 2010, EUR J IMMUNOL, V40, P2762, DOI 10.1002/eji.200940256; Hutchinson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014646; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kinsey GR, 2012, J AM SOC NEPHROL, V23, P1528, DOI 10.1681/ASN.2012010070; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Lang A, 2009, J IMMUNOL, V183, P8077, DOI 10.4049/jimmunol.0801117; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Marashi SM, 2011, J ALLERGY CLIN IMMUN, V127, P1385, DOI 10.1016/j.jaci.2011.04.001; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Ohta A, 2009, J IMMUNOL, V183, P5487, DOI 10.4049/jimmunol.0901247; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; ROMERO P, 2007, J IMMUNOLOGY; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Swanson PA, 2009, J IMMUNOL, V182, P5198, DOI 10.4049/jimmunol.0900421; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tsuda Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001275; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279	29	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114323	10.1371/journal.pone.0114323	http://dx.doi.org/10.1371/journal.pone.0114323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490556	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300029
J	Jimenez, S; Navarro, V; Moyano, J; Sanchez-Mico, M; Torres, M; Davila, JC; Vizuete, M; Gutierrez, A; Vitorica, J				Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Torres, Manuel; Carlos Davila, Jose; Vizuete, Marisa; Gutierrez, Antonia; Vitorica, Javier			Disruption of Amyloid Plaques Integrity Affects the Soluble Oligomers Content from Alzheimer Disease Brains	PLOS ONE			English	Article							A-BETA OLIGOMERS; MOUSE MODEL; PROTEIN; AGE; ACCUMULATION; PATHOGENESIS; AGGREGATION; PATHOLOGY; DEMENTIA; ISF	The implication of soluble Abeta in the Alzheimer's disease (AD) pathology is currently accepted. In fact, the content of soluble extracellular Abeta species, such as monomeric and/or oligomeric Abeta, seems to correlate with the clinicopathological dysfunction observed in AD patients. However, the nature (monomeric, dimeric or other oligomers), the relative abundance, and the origin (extra-/intraneuronal or plaque-associated), of these soluble species are actually under debate. In this work we have characterized the soluble (defined as soluble in Tris-buffered saline after ultracentrifugation) Abeta, obtained from hippocampal samples of Braak II, Braak III-IV and Braak V-VI patients. Although the content of both Abeta40 and Abeta42 peptides displayed significant increase with pathology progression, our results demonstrated the presence of low, pg/mu g protein, amount of both peptides. This low content could explain the absence (or below detection limits) of soluble Abeta peptides detected by western blots or by immunoprecipitation-western blot analysis. These data were in clear contrast to those published recently by different groups. Aiming to explain the reasons that determine these substantial differences, we also investigated whether the initial homogenization could mobilize Abeta from plaques, using 12-month-old PS1xAPP cortical samples. Our data demonstrated that manual homogenization (using Dounce) preserved the integrity of Abeta plaques whereas strong homogenization procedures (such as sonication) produced a vast redistribution of the Abeta species in all soluble and insoluble fractions. This artifact could explain the dissimilar and somehow controversial data between different groups analyzing human AD samples.	[Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Torres, Manuel; Vizuete, Marisa; Vitorica, Javier] Univ Seville, Fac Farm, Dept Bioquim & Biol Mol, Seville, Spain; [Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Torres, Manuel; Vizuete, Marisa; Vitorica, Javier] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Carlos Davila, Jose; Gutierrez, Antonia] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Fac Ciencias, Dept Biol Celular Gene & Fisiol, E-29071 Malaga, Spain; [Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Carlos Davila, Jose; Vizuete, Marisa; Gutierrez, Antonia; Vitorica, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidad de Malaga; CIBERNED	Gutierrez, A (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Fac Ciencias, Dept Biol Celular Gene & Fisiol, E-29071 Malaga, Spain.	agutierrez@uma.es; vitorica@us.es	Jimenez, Sebastian Jimenez S/K-6168-2017; Navarro Garrido, Victoria/U-2291-2017; Torres, Manuel/F-7963-2016; Sanchez-Mico, Maria V./A-4234-2019; IBIS, ALZHEIMER/O-9867-2015	Jimenez, Sebastian Jimenez S/0000-0002-9151-7587; Navarro Garrido, Victoria/0000-0002-4385-9697; Torres, Manuel/0000-0002-5076-8486; Sanchez-Mico, Maria V./0000-0001-9156-4327; Davila Cansino, Jose Carlos/0000-0001-7016-288X; Gutierrez Perez, Antonia/0000-0002-6264-6152	Fondo de Investigacion Sanitaria (FIS), from Instituto de Salud Carlos III of Spain [PI12/01431, PI12/01439]; Junta de Andalucia [CTS-2035]; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED) [PI2010/08, PI2013/01]	Fondo de Investigacion Sanitaria (FIS), from Instituto de Salud Carlos III of Spain; Junta de Andalucia(Junta de Andalucia); Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED)	This work was supported by Fondo de Investigacion Sanitaria (FIS), from Instituto de Salud Carlos III of Spain, through grants PI12/01431 (to AG) and PI12/01439 (to JV), by Junta de Andalucia (collaborative grant CTS-2035 to JV and AG), and by Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED) (collaborative grants PI2010/08 and PI2013/01 to JV and AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Rijal Upadhaya Ajeet, 2012, Neurobiol Aging, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Rostagno A, 2001, CURRENT PROTOCOLS CE; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005	24	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114041	10.1371/journal.pone.0114041	http://dx.doi.org/10.1371/journal.pone.0114041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485545	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907600039
J	Mill, RW; Alves-Pinto, A; Sumner, CJ				Mill, Robert W.; Alves-Pinto, Ana; Sumner, Christian J.			Decision Criterion Dynamics in Animals Performing an Auditory Detection Task	PLOS ONE			English	Article							SIGNAL-DETECTION; PSYCHOMETRIC FUNCTION; JUDGMENTS; CONTINUUM; CONTRAST; MODELS; REWARD; LAW	Classical signal detection theory attributes bias in perceptual decisions to a threshold criterion, against which sensory excitation is compared. The optimal criterion setting depends on the signal level, which may vary over time, and about which the subject is naive. Consequently, the subject must optimise its threshold by responding appropriately to feedback. Here a series of experiments was conducted, and a computational model applied, to determine how the decision bias of the ferret in an auditory signal detection task tracks changes in the stimulus level. The time scales of criterion dynamics were investigated by means of a yes-no signal-in-noise detection task, in which trials were grouped into blocks that alternately contained easy-and hard-to-detect signals. The responses of the ferrets implied both long-and short-term criterion dynamics. The animals exhibited a bias in favour of responding "yes'' during blocks of harder trials, and vice versa. Moreover, the outcome of each single trial had a strong influence on the decision at the next trial. We demonstrate that the single-trial and block-level changes in bias are a manifestation of the same criterion update policy by fitting a model, in which the criterion is shifted by fixed amounts according to the outcome of the previous trial and decays strongly towards a resting value. The apparent block-level stabilisation of bias arises as the probabilities of outcomes and shifts on single trials mutually interact to establish equilibrium. To gain an intuition into how stable criterion distributions arise from specific parameter sets we develop a Markov model which accounts for the dynamic effects of criterion shifts. Our approach provides a framework for investigating the dynamics of decisions at different timescales in other species (e.g., humans) and in other psychological domains (e.g., vision, memory).	[Mill, Robert W.; Alves-Pinto, Ana; Sumner, Christian J.] MRC, Inst Hearing Res, Nottingham, England		Sumner, CJ (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	chris@ihr.mrc.ac.uk	Sumner, Christian/AAB-8624-2020	Sumner, Christian/0000-0002-2573-7418	MRC Institute of Hearing Research intramural funding; Medical Research Council [MC_U135097127] Funding Source: researchfish; MRC [MC_U135097127] Funding Source: UKRI	MRC Institute of Hearing Research intramural funding(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been fully funded by the MRC Institute of Hearing Research intramural funding (http://www.ihr.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop B, 1998, PSYCHON B REV, V5, P239, DOI 10.3758/BF03212946; Alves-Pinto A, 2012, NEUROSCIENCE, V220, P215, DOI 10.1016/j.neuroscience.2012.06.001; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bishop C. M., 2006, J ELECT IMAG, V16, P140; BLOUGH DS, 1967, SCIENCE, V158, P940, DOI 10.1126/science.158.3803.940; Blough DS, 2001, BEHAV PROCESS, V54, P127, DOI 10.1016/S0376-6357(01)00154-1; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; CLOPTON BM, 1972, J EXP ANAL BEHAV, V17, P473, DOI 10.1901/jeab.1972.17-473; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; DORFMAN DD, 1975, J MATH PSYCHOL, V12, P178, DOI 10.1016/0022-2496(75)90056-5; DORFMAN DD, 1971, J MATH PSYCHOL, V8, P264, DOI 10.1016/0022-2496(71)90017-4; Fechner W, 1860, ELEMENTE PSYCHOPHYSI; Fernberger SW, 1920, J EXP PSYCHOL, V3, P126, DOI 10.1037/h0065212; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Gallistel CR, 2001, J EXP PSYCHOL ANIM B, V27, P354, DOI 10.1037//0097-7403.27.4.354; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; Green DM, 1966, SIGNAL DETECTION THE; Grimmett G., 1992, PROBABILITY RANDOM P; HACK MH, 1963, SCIENCE, V139, P758, DOI 10.1126/science.139.3556.758; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; JESTEADT W, 1977, J EXP PSYCHOL HUMAN, V3, P92, DOI 10.1037/0096-1523.3.1.92; Jones P, 2013, MECH AUDITORY PERCEP; KAC M, 1962, IRE T INFORM THEOR, V8, P126, DOI 10.1109/TIT.1962.1057687; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Macmillan NA, 2005, DETECTION THEORY USE; Marston HM, 1996, COGNITIVE BRAIN RES, V3, P269, DOI 10.1016/0926-6410(96)00012-2; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Stuttgen MC, 2011, J EXP ANAL BEHAV, V96, P155, DOI 10.1901/jeab.2011.96-155; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Talwar SK, 1999, J ACOUST SOC AM, V105, P1784, DOI 10.1121/1.426716; THOMAS EC, 1975, PERCEPT PSYCHOPHYS, V18, P158, DOI 10.3758/BF03204104; TREISMAN M, 1984, PSYCHOL REV, V91, P68, DOI 10.1037/0033-295X.91.1.68; VERPLANCK WS, 1953, J EXP PSYCHOL, V46, P10, DOI 10.1037/h0050386; Wenger MJ, 2006, PSYCHON B REV, V13, P656, DOI 10.3758/BF03193977; Whalen A.D., 1971, DETECTION SIGNALS NO; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilson RC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003150	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114076	10.1371/journal.pone.0114076	http://dx.doi.org/10.1371/journal.pone.0114076			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485733	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000346907600041
J	Seven, J; Polle, A				Seven, Jasmin; Polle, Andrea			Subcellular Nutrient Element Localization and Enrichment in Ecto- and Arbuscular Mycorrhizas of Field-Grown Beech and Ash Trees Indicate Functional Differences	PLOS ONE			English	Article							TEMPERATE DECIDUOUS FOREST; X-RAY-MICROANALYSIS; PINUS-SYLVESTRIS; POLYPHOSPHATE GRANULES; ECTOMYCORRHIZAL FUNGI; COMMUNITY COMPOSITION; FRAXINUS-EXCELSIOR; FAGUS-SYLVATICA; DIVERSITY; ROOTS	Mycorrhizas are the chief organ for plant mineral nutrient acquisition. In temperate, mixed forests, ash roots (Fraxinus excelsior) are colonized by arbuscular mycorrhizal fungi (AM) and beech roots (Fagus sylvatica) by ectomycorrhizal fungi (EcM). Knowledge on the functions of different mycorrhizal species that coexist in the same environment is scarce. The concentrations of nutrient elements in plant and fungal cells can inform on nutrient accessibility and interspecific differences of mycorrhizal life forms. Here, we hypothesized that mycorrhizal fungal species exhibit interspecific differences in mineral nutrient concentrations and that the differences correlate with the mineral nutrient concentrations of their associated root cells. Abundant mycorrhizal fungal species of mature beech and ash trees in a long-term undisturbed forest ecosystem were the EcM Lactarius subdulcis, Clavulina cristata and Cenococcum geophilum and the AM Glomus sp. Mineral nutrient subcellular localization and quantities of the mycorrhizas were analysed after non-aqueous sample preparation by electron dispersive X-ray transmission electron microscopy. Cenococcum geophilum contained the highest sulphur, Clavulina cristata the highest calcium levels, and Glomus, in which cations and P were generally high, exhibited the highest potassium levels. Lactarius subdulcis-associated root cells contained the highest phosphorus levels. The root cell concentrations of K, Mg and P were unrelated to those of the associated fungal structures, whereas S and Ca showed significant correlations between fungal and plant concentrations of those elements. Our results support profound interspecific differences for mineral nutrient acquisition among mycorrhizas formed by different fungal taxa. The lack of correlation between some plant and fungal nutrient element concentrations may reflect different retention of mineral nutrients in the fungal part of the symbiosis. High mineral concentrations, especially of potassium, in Glomus sp. suggest that the well-known influence of tree species on chemical soil properties may be related to their mycorrhizal associates.	[Seven, Jasmin; Polle, Andrea] Busgen Inst, D-37077 Gottingen, Germany		Polle, A (corresponding author), Busgen Inst, Busgenweg 2, D-37077 Gottingen, Germany.	apolle@gwdg.de		Polle, Andrea/0000-0001-8697-6394	German Science Foundation [GRK 1086]; University of Gottingen; Deutsche Forschungsgemeinschaft;  [INST 186/766-1 FUGG]	German Science Foundation(German Research Foundation (DFG)); University of Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	Funding: This study was financially supported by the German Science Foundation (http://www.dfg.de/) by a grant to the Graduate school GRK 1086 "Die Bedeutung der Biodiversitat fur Stoffkreislaufe und biotische Interaktionen in temperaten Laubwaldern" (project A1) to AP and JS and by grant No. INST 186/766-1 FUGG to AP. The publication fund of the University of Gottingen and the Deutsche Forschungsgemeinschaft supported open access publication of this article (http://www.sub.uni-goettingen.de/elektronisches-publizieren/open-access/open-access-publikationsfonds/) by a grant to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R., 1987, COLOR ATLAS ECTOMYCO; Aponte C, 2013, FOREST ECOL MANAG, V309, P36, DOI 10.1016/j.foreco.2013.05.035; ASHFORD AE, 1986, CAN J BOT, V64, P677, DOI 10.1139/b86-086; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BONFANTE P, 1995, NEW PHYTOL, V130, P3, DOI 10.1111/j.1469-8137.1995.tb01810.x; Bonfante-Fasolo P, 2004, MYCORRHIZAL FUNCTION, P65; Bonneville S, 2011, GEOCHIM COSMOCHIM AC, V75, P6988, DOI 10.1016/j.gca.2011.08.041; Bucking H, 2002, J EXP BOT, V53, P1659, DOI 10.1093/jxb/erf011; Bucking H, 1998, MICRON, V29, P53, DOI 10.1016/S0968-4328(97)00059-0; Bucking H, 2000, NEW PHYTOL, V145, P321, DOI 10.1046/j.1469-8137.2000.00574.x; Bucking H, 2000, NEW PHYTOL, V145, P311, DOI 10.1046/j.1469-8137.2000.00572.x; Chen SL, 2014, MATERIALS, V7, P3160, DOI 10.3390/ma7043160; COLPAERT JV, 1992, NEW PHYTOL, V120, P127, DOI 10.1111/j.1469-8137.1992.tb01065.x; Courty PE, 2008, APPL ENVIRON MICROB, V74, P5792, DOI 10.1128/AEM.01592-08; COX G, 1976, NEW PHYTOL, V77, P371, DOI 10.1111/j.1469-8137.1976.tb01526.x; Dickie IA, 2005, J ECOL, V93, P244, DOI 10.1111/j.1365-2745.2005.00977.x; Ducic T, 2008, MYCORRHIZA, V18, P227, DOI 10.1007/s00572-008-0174-5; Emborg J, 1998, FOREST ECOL MANAG, V106, P83, DOI 10.1016/S0378-1127(97)00299-5; Fernandez CW, 2013, SOIL BIOL BIOCHEM, V65, P141, DOI 10.1016/j.soilbio.2013.05.022; FRANZ F, 1995, NOVA HEDWIGIA, V61, P367; FRITZ E, 1989, SCANNING MICROSCOPY, V3, P517; Fritz E, 2007, MICROSC MICROANAL, V13, P233, DOI 10.1017/S1431927607070420; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; Hagerberg D, 2005, MYCORRHIZA, V15, P387, DOI 10.1007/s00572-004-0344-z; HARLEY JL, 1952, NEW PHYTOL, V51, P56, DOI 10.1111/j.1469-8137.1952.tb06115.x; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Kottke I, 1998, MYCORRHIZA, V7, P267, DOI 10.1007/s005720050191; KOTTKE I, 1995, NEW PHYTOL, V129, P411, DOI 10.1111/j.1469-8137.1995.tb04311.x; Kottke I, 1986, TREES-STRUCT FUNCT, V1, P1, DOI 10.1007/BF00197021; Lang C, 2011, TREE PHYSIOL, V31, P531, DOI 10.1093/treephys/tpr042; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Langenbruch C, 2012, PLANT SOIL, V352, P389, DOI 10.1007/s11104-011-1004-7; Leuschner C, 2009, BASIC APPL ECOL, V10, P1, DOI 10.1016/j.baae.2008.06.001; LINGLEE M, 1975, NEW PHYTOL, V75, P551, DOI 10.1111/j.1469-8137.1975.tb01418.x; Marigo G, 2000, TREES-STRUCT FUNCT, V15, P1, DOI 10.1007/s004680000061; McCully ME, 2010, FUNCT PLANT BIOL, V37, P1011, DOI 10.1071/FP10095; Meinen C, 2009, OECOLOGIA, V161, P99, DOI 10.1007/s00442-009-1352-7; Mitchell RJ, 2012, PLANT SOIL, V352, P65, DOI 10.1007/s11104-011-0980-y; Molder A., 2006, WALDOKOLOGIE ONLINE, V3, P83; Olsson PA, 2008, APPL ENVIRON MICROB, V74, P4144, DOI 10.1128/AEM.00376-08; Pena R, 2014, ISME J, V8, P321, DOI 10.1038/ismej.2013.158; Pena R, 2010, APPL ENVIRON MICROB, V76, P1831, DOI 10.1128/AEM.01703-09; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Rineau F, 2010, FUNGAL BIOL-UK, V114, P1007, DOI 10.1016/j.funbio.2010.09.011; Rineau F, 2009, MYCORRHIZA, V19, P493, DOI 10.1007/s00572-009-0249-y; Rumberger MD, 2005, MYCORRHIZA, V15, P307, DOI 10.1007/s00572-005-0350-9; Rumberger MD, 2004, PLANT SOIL, V264, P111, DOI 10.1023/B:PLSO.0000047793.14857.4f; SANDERS FE, 1977, NEW PHYTOL, V78, P257, DOI 10.1111/j.1469-8137.1977.tb04829.x; Scheidegger C, 1998, MYCLORRHIZA STRUCTUR, P205; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Talkner U, 2009, EUR J SOIL SCI, V60, P338, DOI 10.1111/j.1365-2389.2008.01117.x; Talkner U, 2010, PLANT SOIL, V336, P405, DOI 10.1007/s11104-010-0491-2; Taylor Andy F. S., 2005, Mycologist, V19, P102, DOI 10.1017/S0269915X05003034; vanBreemen N, 1997, CAN J FOREST RES, V27, P1110, DOI 10.1139/cjfr-27-7-1110; Wallander H, 2003, FEMS MICROBIOL ECOL, V44, P57, DOI 10.1111/j.1574-6941.2003.tb01090.x; Wang Q, 2011, MYCOL PROG, V10, P323, DOI 10.1007/s11557-010-0705-2	59	18	18	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114672	10.1371/journal.pone.0114672	http://dx.doi.org/10.1371/journal.pone.0114672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486253	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600086
J	Solin, SL; Wang, Y; Mauldin, J; Schultz, LE; Lincow, DE; Brodskiy, PA; Jones, CA; Syrkin-Nikolau, J; Linn, JM; Essner, JJ; Hostetter, JM; Whitley, EM; Cameron, JD; Chou, HH; Severin, AJ; Sakaguchi, DS; McGrail, M				Solin, Staci L.; Wang, Ying; Mauldin, Joshua; Schultz, Laura E.; Lincow, Deborah E.; Brodskiy, Pavel A.; Jones, Crystal A.; Syrkin-Nikolau, Judith; Linn, Jasmine M.; Essner, Jeffrey J.; Hostetter, Jesse M.; Whitley, Elizabeth M.; Cameron, J. Douglas; Chou, Hui-Hsien; Severin, Andrew J.; Sakaguchi, Donald S.; McGrail, Maura			Molecular and Cellular Characterization of a Zebrafish Optic Pathway Tumor Line Implicates Glia-Derived Progenitors in Tumorigenesis	PLOS ONE			English	Article							MULLER GLIA; STEM-CELLS; REGENERATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; SUFFICIENT; TARGET; GROWTH	In this study we describe the molecular and cellular characterization of a zebrafish mutant that develops tumors in the optic pathway. Heterozygous Tg(flk1:RFP) is18 transgenic adults develop tumors of the retina, optic nerve and optic tract. Molecular and genetic mapping demonstrate the tumor phenotype is linked to a high copy number transgene array integrated in the lincRNA gene lincRNAis18/Zv9_00007276 on chromosome 3. TALENs were used to isolate a 147kb deletion allele that removes exons 2-5 of the lincRNAis18 gene. Deletion allele homozygotes are viable and do not develop tumors, indicating loss of function of the lincRNAis18 locus is not the trigger for tumor onset. Optic pathway tumors in the Tg(flk1:RFP) is18 mutant occur with a penetrance of 80-100% by 1 year of age. The retinal tumors are highly vascularized and composed of rosettes of various sizes embedded in a fibrous matrix. Immunohistochemical analysis showed increased expression of the glial markers GFAP and BLBP throughout retinal tumors and in dysplastic optic nerve. We performed transcriptome analysis of pre-tumorous retina and retinal tumor tissue and found changes in gene expression signatures of radial glia and astrocytes (slc1a3), activated glia (atf3, blbp, apoeb), proliferating neural progenitors (foxd3, nestin, cdh2, her9/hes1), and glioma markers (S100 beta, vim). The transcriptome also revealed activation of cAMP, Stat3 and Wnt signal transduction pathways. qRT-PCR confirmed.10-fold overexpression of the Wnt pathway components hbegfa, ascl1a, and insm1a. Together the data indicate Muller glia and/or astrocyte-derived progenitors could contribute to the zebrafish Tg(flk1:RFP) is18 optic pathway tumors.	[Solin, Staci L.; Wang, Ying; Mauldin, Joshua; Schultz, Laura E.; Lincow, Deborah E.; Brodskiy, Pavel A.; Jones, Crystal A.; Syrkin-Nikolau, Judith; Linn, Jasmine M.; Essner, Jeffrey J.; Chou, Hui-Hsien; Sakaguchi, Donald S.; McGrail, Maura] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Hostetter, Jesse M.; Whitley, Elizabeth M.] Iowa State Univ, Dept Vet Pathol, Ames, IA USA; [Cameron, J. Douglas] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN USA; [Severin, Andrew J.] Univ Minnesota, Genome Informat Facil, Off Biotechnol, Minneapolis, MN USA	Iowa State University; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McGrail, M (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	mmcgrail@iastate.edu	McGrail, Maura/AAA-5610-2021	McGrail, Maura/0000-0001-9308-6189; Essner, Jeffrey/0000-0001-8816-3848; Hostetter, Jesse/0000-0002-5555-5121; Brodskiy, Pavel/0000-0002-1951-7734; LINCOW, DEBORAH/0000-0002-3463-5368; Sakaguchi, Donald/0000-0003-4537-0972	Roy J. Carver Charitable Trust [14-14418]; Research to Prevent Blindness; Iowa State University Center for Integrated Animal Genomics; Iowa State University DOE/SULI and CC Research Experience for Undergraduate Programs; Iowa State University IINspire-LSAMP program; Iowa State University Startup funds; NATIONAL CANCER INSTITUTE [R03CA182061] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Iowa State University Center for Integrated Animal Genomics; Iowa State University DOE/SULI and CC Research Experience for Undergraduate Programs; Iowa State University IINspire-LSAMP program; Iowa State University Startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Roy J. Carver Charitable Trust [14-14418 MM], Research to Prevent Blindness [DJC], the Iowa State University Center for Integrated Animal Genomics [JJE, MM, DSS], Iowa State University DOE/SULI and CC Research Experience for Undergraduate Programs [DEL, PAB], Iowa State University IINspire-LSAMP program [CAJ], and Iowa State University Startup funds [MM]. Dr. Cameron is supported in part by an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Neurosciences of the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Banerjee S, 2011, P NATL ACAD SCI USA, V108, P15996, DOI 10.1073/pnas.1019012108; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Blong CC, 2010, J NEUROSCI RES, V88, P1445, DOI 10.1002/jnr.22324; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen YH, 2013, ONCOGENE; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Gallina D, 2014, EXP EYE RES, V123, P121, DOI 10.1016/j.exer.2013.06.019; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Gorsuch RA, 2013, EXP EYE RES; Gorsuch RA, 2014, EXP EYE RES, V123, P131, DOI 10.1016/j.exer.2013.07.012; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ju B, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.10; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Lin NJ, 2012, MOL CANCER RES, V10, P208, DOI 10.1158/1541-7786.MCR-10-0109; McGrail M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018826; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nelson CM, 2012, J COMP NEUROL, V520, P4294, DOI 10.1002/cne.23213; Neve LD, 2012, COMP BIOCHEM PHYS C, V155, P213, DOI 10.1016/j.cbpc.2011.08.006; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ramachandran R, 2012, NAT CELL BIOL, V14, P1013, DOI 10.1038/ncb2586; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Rodriguez EF, 2011, ACTA NEUROPATHOL, V121, P407, DOI 10.1007/s00401-010-0784-9; Rodriguez FJ, 2013, ANNU REV PATHOL-MECH, V8, P361, DOI 10.1146/annurev-pathol-020712-164009; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Saul KE, 2010, COMP BIOCHEM PHYS A, V155, P172, DOI 10.1016/j.cbpa.2009.10.042; Severin AJ, 2010, PLANT PHYSIOL, V154, P3, DOI 10.1104/pp.110.158949; Shibata T, 1997, J NEUROSCI, V17, P9212; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Sun L, 2014, J CHEM-NY, DOI DOI 10.1155/2014/295149; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	44	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114888	10.1371/journal.pone.0114888	http://dx.doi.org/10.1371/journal.pone.0114888			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485542	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600104
J	Sun, LY; Zhao, H; Kang, Y; Shen, XD; Cai, ZY; Shen, JY; He, B; Yang, CD				Sun, Ling-Yue; Zhao, Hang; Kang, Yu; Shen, Xue-dong; Cai, Zong-ye; Shen, Jie-yan; He, Ben; Yang, Cheng-de			Two-Dimensional Echocardiography in the Assessment of Long-Term Prognosis in Patients with Pulmonary Arterial Hypertension	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; AMERICAN-SOCIETY; VASCULAR-RESISTANCE; HEART-FAILURE; TEI-INDEX; GUIDELINES; RECOMMENDATIONS; VALIDATION; CATHETERIZATION	Objective: To investigate the relationship between cardiac diastolic dysfunction and outcomes in patients with pulmonary arterial hypertension (PAH) and to clarify the potential effect of two-dimensional echocardiography (2D-echo) on prognostic value in patients with PAH. Methods: Patients diagnosed with PAH (as WSPH (World Symposia on Pulmonary Hypertension) classification I) confirmed by right heart catheterization (RHC), received targeted monotherapy or combination therapy. 2D-echo parameters, World Health Organization (WHO) functional classification and 6-minute walking distance (6MWD) were recorded. The clinical prognosis of patients was assessed by the correlation between echo parameters and clinical 6MWD using receiver operating characteristic (ROC) curve analysis. Results: Fifty-eight patients were included. Left and right ventricular diastolic dysfunction (LVDD and RVDD) scores measured by 2D-echo had good correlation with 6MWD at baseline (r(LVDD) = -0.699; r(RVDD) = -0.818, both P<0.001) and at last follow-up (r(LVDD) = -0.701; r(RVDD) = -0.666, both P<0.001). Furthermore, bi-ventricular (LVDD+RVDD) scores measured by 2D-echo had a better correlation with 6MWD at baseline and last follow-up (r=-0.831; r=-0.771, both P<0.001). ROC curve analysis showed that the area under curves (AUCs) for LVDD score, RVDD score and (LVDD+RVDD) scores were 0.823 (P<0.0001), 0.737 (P=0.0002), and 0.825 (P<0.0001), respectively. Compared with ROC analysis of other single parameters, cardiac diastolic function score was more accurate in predicting survival in patients with PAH. Conclusion: LVDD score, RVDD score and (LVDD+RVDD) scores yielded a comprehensive quantitative assessment of LV and RV diastolic function that correlated moderately with clinical functional parameters and might be useful in the assessment of PAH.	[Sun, Ling-Yue; Zhao, Hang; Kang, Yu; Shen, Xue-dong; Cai, Zong-ye; Shen, Jie-yan; He, Ben] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Yang, Cheng-de] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	dr_jyshen@sina.cn	Kang, Yu/K-8894-2019	Kang, Yu/0000-0003-0446-0867; Cai, Zongye/0000-0002-4898-1907				Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Blanchard DG, 2009, JACC-CARDIOVASC IMAG, V2, P143, DOI 10.1016/j.jcmg.2008.10.012; Chapman CB, 2013, ECHOCARDIOGR-J CARD, V30, P1022, DOI 10.1111/echo.12185; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Gabler NB, 2012, CIRCULATION, V126, P349, DOI 10.1161/CIRCULATIONAHA.112.105890; Galie N, 2013, J AM COLL CARDIOL, V62, pD1, DOI 10.1016/j.jacc.2013.10.030; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghio S, 2010, INT J CARDIOL, V140, P272, DOI 10.1016/j.ijcard.2008.11.051; Gopal AS, 2007, J AM SOC ECHOCARDIOG, V20, P445, DOI 10.1016/j.echo.2006.10.027; Hsu VM, 2008, J RHEUMATOL, V35, P458; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Inaba T, 2013, CIRC J, V77, P198, DOI 10.1253/circj.CJ-12-0203; Jurcut R, 2011, J AM SOC ECHOCARDIOG, V24, P1109, DOI 10.1016/j.echo.2011.07.016; Kassem E, 2013, AM HEART J, V165, P1024, DOI 10.1016/j.ahj.2013.02.027; Koestenberger M, 2012, CONGENIT HEART DIS, V7, P250, DOI 10.1111/j.1747-0803.2012.00655.x; Kuehne T, 2005, HEART, V91, P1064, DOI 10.1136/hrt.2004.038265; Mauritz GJ, 2012, CHEST, V141, P935, DOI 10.1378/chest.10-3277; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ogihara Y, 2014, J CARDIOL, V63, P149, DOI 10.1016/j.jjcc.2013.07.002; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sato T, 2012, J AM SOC ECHOCARDIOG, V25, P280, DOI 10.1016/j.echo.2011.12.012; Sebbag I, 2001, AM J CARDIOL, V88, P1060, DOI 10.1016/S0002-9149(01)01995-6; Shen JY, 1999, RHEUMATOL INT, V18, P147, DOI 10.1007/s002960050074; Straburzynska-Migaj E, 2007, KARDIOL POL, V65, P1049; Tonelli AR, 2012, CHEST, V141, P1457, DOI 10.1378/chest.11-1903; Van Empel VPM, 2014, J CARD FAIL, V20, P98, DOI 10.1016/j.cardfail.2013.12.010; Vitarelli A, 2012, INT J CARDIOVAS IMAG, V28, P1905, DOI 10.1007/s10554-012-0022-8; Wallentin Guron C, 2005, EUR J ECHOCARDIOGR, V6, P419; Yeo TC, 1998, AM J CARDIOL, V81, P1157, DOI 10.1016/S0002-9149(98)00140-4; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	35	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114443	10.1371/journal.pone.0114443	http://dx.doi.org/10.1371/journal.pone.0114443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485890	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907600056
J	Vincent, EE; Elder, DJE; O'Flaherty, L; Pardo, OE; Dzien, P; Phillips, L; Morgan, C; Pawade, J; May, MT; Sohail, M; Hetzel, MR; Seckl, MJ; Tavare, JM				Vincent, Emma E.; Elder, Douglas J. E.; O'Flaherty, Linda; Pardo, Olivier E.; Dzien, Piotr; Phillips, Lois; Morgan, Carys; Pawade, Joya; May, Margaret T.; Sohail, Muhammad; Hetzel, Martin R.; Seckl, Michael J.; Tavare, Jeremy M.			Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation	PLOS ONE			English	Article							FACTOR-KAPPA-B; RABBIT SKELETAL-MUSCLE; OVARIAN-CANCER CELLS; PANCREATIC-CANCER; BETA-CATENIN; GENE-TRANSCRIPTION; PHOSPHORYLATION; KINASE-3-BETA; INHIBITION; GSK-3-BETA	Background: Glycogen synthase kinase 3 (GSK3) is a central regulator of cellular metabolism, development and growth. GSK3 activity was thought to oppose tumourigenesis, yet recent studies indicate that it may support tumour growth in some cancer types including in non-small cell lung carcinoma (NSCLC). We examined the undefined role of GSK3 protein kinase activity in tissue from human NSCLC. Methods: The expression and protein kinase activity of GSK3 was determined in 29 fresh frozen samples of human NSCLC and patient-matched normal lung tissue by quantitative immunoassay and western blotting for the phosphorylation of three distinct GSK3 substrates in situ (glycogen synthase, RelA and CRMP-2). The proliferation and sensitivity to the small-molecule GSK3 inhibitor; CHIR99021, of NSCLC cell lines (Hcc193, H1975, PC9 and A549) and non-neoplastic type II pneumocytes was further assessed in adherent culture. Results: Expression and protein kinase activity of GSK3 was elevated in 41% of human NSCLC samples when compared to patient-matched control tissue. Phosphorylation of GSK3 alpha/beta at the inhibitory S21/9 residue was a poor biomarker for activity in tumour samples. The GSK3 inhibitor, CHIR99021 dose-dependently reduced the proliferation of three NSCLC cell lines yet was ineffective against type II pneumocytes. Conclusion: NSCLC tumours with elevated GSK3 protein kinase activity may have evolved dependence on the kinase for sustained growth. Our results provide further important rationale for exploring the use of GSK3 inhibitors in treating NSCLC.	[Vincent, Emma E.; Elder, Douglas J. E.; O'Flaherty, Linda; Dzien, Piotr; Morgan, Carys; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Vincent, Emma E.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Pardo, Olivier E.; Seckl, Michael J.] Dept Oncol, London W12 0NN, England; [Phillips, Lois; Hetzel, Martin R.] Bristol Royal Infirm & Gen Hosp, Dept Resp Med, Bristol BS2 8HW, Avon, England; [Pawade, Joya; Sohail, Muhammad] Bristol Royal Infirm & Gen Hosp, Div Histopathol, Bristol BS2 8HW, Avon, England; [May, Margaret T.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England	University of Bristol; McGill University; Bristol Royal Infirmary; Bristol Royal Infirmary; University of Bristol	Vincent, EE (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	emma.vincent@mcgill.ca	Pardo, Oliver/AEM-2071-2022	Pardo, Oliver/0000-0003-2223-1435; Vincent, Emma/0000-0002-8917-7384; Morgan, Carys/0000-0001-7000-2210	CRUK [C16929/A14402]; BBRSC CASE studentship; European Community [259770]; Cancer Research UK [14402] Funding Source: researchfish	CRUK(Cancer Research UK); BBRSC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Community(European Commission); Cancer Research UK(Cancer Research UK)	Funding: The work was supported by a CRUK project grant C16929/A14402 to JMT. JMT was also funded by BBRSC CASE studentship (AstraZeneca cofounder) for EEV and Friends of Oncology. The work was also supported by European Community FP7 under the grant agreement LungTarget (project 259770) awarded to MJS and OEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ban KC, 2003, CANCER LETT, V199, P201, DOI 10.1016/S0304-3835(03)00421-X; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Cho YJ, 2010, APMIS, V118, P782, DOI 10.1111/j.1600-0463.2010.02659.x; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hilliard TS, 2011, ANTI-CANCER DRUG, V22, P978, DOI 10.1097/CAD.0b013e32834ac8fc; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084659; Lim YW, 2010, BIOCHEM BIOPH RES CO, V395, P207, DOI 10.1016/j.bbrc.2010.03.163; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mamaghani S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-132; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pao W, 2004, JNCI-J NATL CANCER I, V96, P1117, DOI 10.1093/jnci/djh244; Pardo OE, 2001, ONCOGENE, V20, P7658, DOI 10.1038/sj.onc.1204994; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Tang QL, 2012, JNCI-J NATL CANCER I, V104, P749, DOI 10.1093/jnci/djs210; Tao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081945; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Vincent EE, 2011, ANTICANCER RES, V31, P1577; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Woodgett JR, 2012, JNCI-J NATL CANCER I, V104, P722, DOI 10.1093/jnci/djs223; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zeng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091231; Zheng HC, 2007, ANTICANCER RES, V27, P3561	48	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114725	10.1371/journal.pone.0114725	http://dx.doi.org/10.1371/journal.pone.0114725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486534	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907600090
J	Karreman, MA; Mercier, L; Schieber, NL; Shibue, T; Schwab, Y; Goetz, JG				Karreman, Matthia A.; Mercier, Luc; Schieber, Nicole L.; Shibue, Tsukasa; Schwab, Yannick; Goetz, Jacky G.			Correlating Intravital Multi-Photon Microscopy to 3D Electron Microscopy of Invading Tumor Cells Using Anatomical Reference Points	PLOS ONE			English	Article							COLLECTIVE INVASION; LIGHT; FLUORESCENCE; ZEBRAFISH; MICROENVIRONMENT; PHOTOOXIDATION; ULTRASTRUCTURE; TOMOGRAPHY; FIXATION; TISSUES	Correlative microscopy combines the advantages of both light and electron microscopy to enable imaging of rare and transient events at high resolution. Performing correlative microscopy in complex and bulky samples such as an entire living organism is a time-consuming and error-prone task. Here, we investigate correlative methods that rely on the use of artificial and endogenous structural features of the sample as reference points for correlating intravital fluorescence microscopy and electron microscopy. To investigate tumor cell behavior in vivo with ultrastructural accuracy, a reliable approach is needed to retrieve single tumor cells imaged deep within the tissue. For this purpose, fluorescently labeled tumor cells were subcutaneously injected into a mouse ear and imaged using two-photon-excitation microscopy. Using near-infrared branding, the position of the imaged area within the sample was labeled at the skin level, allowing for its precise recollection. Following sample preparation for electron microscopy, concerted usage of the artificial branding and anatomical landmarks enables targeting and approaching the cells of interest while serial sectioning through the specimen. We describe here three procedures showing how three-dimensional (3D) mapping of structural features in the tissue can be exploited to accurately correlate between the two imaging modalities, without having to rely on the use of artificially introduced markers of the region of interest. The methods employed here facilitate the link between intravital and nanoscale imaging of invasive tumor cells, enabling correlating function to structure in the study of tumor invasion and metastasis.	[Karreman, Matthia A.; Schieber, Nicole L.; Schwab, Yannick] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Mercier, Luc; Goetz, Jacky G.] INSERM, U1109, MN3T, F-67200 Strasbourg, France; [Mercier, Luc; Goetz, Jacky G.] Univ Strasbourg, F-67000 Strasbourg, France; [Mercier, Luc; Goetz, Jacky G.] Univ Strasbourg, LabEx Medalis, F-67000 Strasbourg, France; [Mercier, Luc; Goetz, Jacky G.] FMTS, F-67000 Strasbourg, France; [Shibue, Tsukasa] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA	European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Massachusetts Institute of Technology (MIT); Whitehead Institute	Schwab, Y (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	schwab@embl.de; jacky.goetz@inserm.fr	GOETZ, Jacky/AAT-1746-2021	GOETZ, Jacky/0000-0003-2842-8116; Karreman, Matthia Andrea/0000-0003-0074-5945; Schwab, Yannick/0000-0001-8027-1836; Schieber, Nicole L./0000-0002-3212-5057	Ligue Contre le Cancer; Inserm; University of Strasbourg; EMBL funds; EMBL Interdisciplinary Post-doctoral fellowship (EIPOD) under Marie Curie Actions (COFUND); INSERM/Region Alsace Ph.D fellowship	Ligue Contre le Cancer(Ligue nationale contre le cancer); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; EMBL funds; EMBL Interdisciplinary Post-doctoral fellowship (EIPOD) under Marie Curie Actions (COFUND); INSERM/Region Alsace Ph.D fellowship(Region Grand-Est)	This work has been supported by research grants from the Ligue Contre le Cancer (JGG), by institutional funding from Inserm and the University of Strasbourg (JGG) and by EMBL funds (YS). MAK is supported by an EMBL Interdisciplinary Post-doctoral fellowship (EIPOD) under Marie Curie Actions (COFUND), and LM is supported by an INSERM/Region Alsace Ph.D fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronskaia AV, 2008, J STRUCT BIOL, V164, P183, DOI 10.1016/j.jsb.2008.07.003; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716; Biel SS, 2003, J MICROSC-OXFORD, V212, P91, DOI 10.1046/j.1365-2818.2003.01227.x; Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; ELBERS PF, 1966, BIOCHIM BIOPHYS ACTA, V112, P318, DOI 10.1016/0926-6585(66)90330-X; Fein MR, 2013, DIS MODEL MECH, V6, P580, DOI 10.1242/dmm.009282; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; Goetz JG, 2014, CELL REP, V6, P799, DOI 10.1016/j.celrep.2014.01.032; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Griffiths G, 1993, FINE STRUCTURE IMMUN, P60; Handschuh S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-44; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hayat MA, 1993, STAINS CYTOCHEMICAL; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Jimenez N, 2010, J MICROSC-OXFORD, V237, P208, DOI 10.1111/j.1365-2818.2009.03329.x; JONES S, 1982, J CLIN PATHOL, V35, P425, DOI 10.1136/jcp.35.4.425; Karreman MA, 2009, BIOL CELL, V101, P287, DOI 10.1042/BC20080076; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kolotuev I, 2012, METHOD CELL BIOL, V111, P203, DOI 10.1016/B978-0-12-416026-2.00011-X; Kolotuev I, 2010, BIOL CELL, V102, P121, DOI 10.1042/BC20090096; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; KUSHIDA H, 1962, J ELECTRON MICROSC, V11, P135; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Liv N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055707; Lucas MS, 2012, METHOD CELL BIOL, V111, P325, DOI 10.1016/B978-0-12-416026-2.00017-0; Maco B, 2014, NAT PROTOC, V9, P1354, DOI 10.1038/nprot.2014.101; Maco B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057405; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Mascaro ALA, 2013, P NATL ACAD SCI USA, V110, P10824, DOI 10.1073/pnas.1219256110; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Polishchuk RS, 2012, METHOD CELL BIOL, V111, P21, DOI 10.1016/B978-0-12-416026-2.00002-9; RAK JW, 1992, BRIT J CANCER, V65, P641, DOI 10.1038/bjc.1992.138; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schieber NL, 2010, METHOD CELL BIOL, V96, P425, DOI 10.1016/S0091-679X(10)96018-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024	56	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114448	10.1371/journal.pone.0114448	http://dx.doi.org/10.1371/journal.pone.0114448			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479106	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200091
J	Larsen, TB; Nielsen, PB; Skjoth, F; Rasmussen, LH; Lip, GYH				Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum; Skjoth, Flemming; Rasmussen, Lars Hvilsted; Lip, Gregory Y. H.			Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; SECONDARY PREVENTION; PULMONARY-EMBOLISM; VEIN THROMBOSIS; WARFARIN; RISK; EVENTS; RIVAROXABAN; CARE; VTE	Background: This study sought to investigate the relative efficacy and safety of non-vitamin K oral anticoagulants (NOACs) for the treatment of venous thromboembolism (VTE) in cancer patients. Methods: A systematic search of the PubMed, EMBASE, and ClinicalTrials.gov databases identified all multicentre, randomised phase III trials investigating the initial use of NOAC against a vitamin K antagonist (VKA) together with subcutaneous heparin or low molecular weight heparin (upstart) for treatment of VTE. Outcomes of interest were recurrent VTE (deep venous thrombosis or pulmonary embolism), and clinically relevant bleeding. Results: Four randomised controlled phase III trials were included, comprising a total of 19,060 patients randomised to either NOAC or VKA. For patients with active cancer (N5759), the analysis on the efficacy outcomes demonstrated a trend in favour of NOAC (OR 0.56, 95% CI 0.28-1.13). Similar, analyses on the safety outcomes comparing NOAC to VKA and enoxaparin demonstrated a trend in favour of NOAC (OR 0.88, 95% CI 0.57-1.35). Conclusion: Point estimates of the effect size suggest an important estimated beneficial effect of NOAC in the treatment of VTE in cancer, in terms of efficacy and safety, but given the small numbers of patients with cancer in the randomised trials, statistical significance was not achieved.	[Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum; Skjoth, Flemming] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum; Skjoth, Flemming; Rasmussen, Lars Hvilsted; Lip, Gregory Y. H.] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	Aalborg University; Aalborg University Hospital; Aalborg University; University of Birmingham	Larsen, TB (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.	tobl@rn.dk	Skjøth, Flemming/AAI-9954-2020; Larsen, Torben Bjerregaard/I-5081-2012	Nielsen, Peter Bronnum/0000-0003-2922-6970; Larsen, Torben Bjerregaard/0000-0002-8485-8674; Skjoth, Flemming/0000-0003-2975-647X	Obel Family Foundation	Obel Family Foundation	The Obel Family Foundation supported this study. The sponsor had no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of this report; or in the decision to submit the paper for publication. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Agnelli G, 2014, INTERN EMERG MED, V9, P559, DOI 10.1007/s11739-013-0985-z; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Akl EA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006650.pub2; Anderson FA, 2007, AM J HEMATOL, V82, P777, DOI 10.1002/ajh.20983; Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Coleman R, 2010, BRIT J CANCER, V102, pS17, DOI 10.1038/sj.bjc.6605601; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Deitcher SR, 2006, CLIN APPL THROMB-HEM, V12, P389, DOI 10.1177/1076029606293692; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gallego P, 2013, THROMB HAEMOSTASIS, V110, P1189, DOI 10.1160/TH13-07-0556; GILLUM RF, 1987, AM HEART J, V114, P1262, DOI 10.1016/0002-8703(87)90212-2; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Hull RD, 2006, AM J MED, V119, P1062, DOI 10.1016/j.amjmed.2006.02.022; Husted S, 2014, THROMB HAEMOSTASIS, V111, P781, DOI 10.1160/TH14-03-0228; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Louzada ML, 2011, BLOOD COAGUL FIBRIN, V22, P86, DOI 10.1097/MBC.0b013e328341f030; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701	31	42	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114445	10.1371/journal.pone.0114445	http://dx.doi.org/10.1371/journal.pone.0114445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479007	gold, Green Submitted, Green Published			2022-12-27	WOS:000346907200089
J	Srinivasan, DG; Abdelhady, A; Stern, DL				Srinivasan, Dayalan G.; Abdelhady, Ahmed; Stern, David L.			Gene Expression Analysis of Parthenogenetic Embryonic Development of the Pea Aphid, Acyrthosiphon pisum, Suggests That Aphid Parthenogenesis Evolved from Meiotic Oogenesis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PERSICAE SULZER HEMIPTERA; SPO11 HOMOLOG; POTATO APHID; MEIOSIS; RECOMBINATION; MOUSE; DNA; CHROMOSOME; ELEMENT	Aphids exhibit a form of phenotypic plasticity, called polyphenism, in which genetically identical females reproduce sexually during one part of the life cycle and asexually (via parthenogenesis) during the remainder of the life cycle. The molecular basis for aphid parthenogenesis is unknown. Cytological observations of aphid parthenogenesis suggest that asexual oogenesis evolved either through a modification of meiosis or from a mitotic process. As a test of these alternatives, we assessed the expression levels and expression patterns of canonical meiotic recombination and germline genes in the sexual and asexual ovaries of the pea aphid, Acyrthosiphon pisum. We observed expression of all meiosis genes in similar patterns in asexual and sexual ovaries, with the exception that some genes encoding Argonaute-family members were not expressed in sexual ovaries. In addition, we observed that asexual aphid tissues accumulated unspliced transcripts of Spo11, whereas sexual aphid tissues accumulated primarily spliced transcripts. In situ hybridization revealed Spo11 transcript in sexual germ cells and undetectable levels of Spo11 transcript in asexual germ cells. We also found that an obligately asexual strain of pea aphid produced little spliced Spo11 transcript. Together, these results suggest that parthenogenetic oogenesis evolved from a meiosis-like, and not a mitosis-like, process and that the aphid reproductive polyphenism may involve a modification of Spo11 gene activity.	[Srinivasan, Dayalan G.; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Srinivasan, Dayalan G.; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Srinivasan, Dayalan G.; Abdelhady, Ahmed] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Rowan University	Srinivasan, DG (corresponding author), Princeton Univ, Howard Hughes Med Inst, Guyot Hall, Princeton, NJ 08544 USA.	srinivasan@rowan.edu		Stern, David/0000-0002-1847-6483	National Institutes of Health NRSA Postdoctoral Fellowship [GM077928]; David and Lucille Packard Foundation Fellowship in Science or Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077928] Funding Source: NIH RePORTER	National Institutes of Health NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucille Packard Foundation Fellowship in Science or Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A National Institutes of Health NRSA Postdoctoral Fellowship (GM077928) to DGS (grants.nih.gov/training/nrsa.htm), and a David and Lucille Packard Foundation Fellowship in Science or Engineering to DLS (www.packard.org) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; BAKER BS, 1978, GENETICS, V90, P531; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Blackman RL, 1996, CHROMOSOME RES, V4, P314, DOI 10.1007/BF02263684; BLACKMAN RL, 1978, INT J INSECT MORPHOL, V7, P33, DOI 10.1016/S0020-7322(78)80013-0; Blackman RL, 1987, WORLD CROP PESTS A, P164; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; BUNING J, 1985, J MORPHOL, V186, P209, DOI 10.1002/jmor.1051860206; COVITZ PA, 1994, GENETICS, V138, P577; Cromie GA, 2007, TRENDS CELL BIOL, V17, P448, DOI 10.1016/j.tcb.2007.07.007; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Guikema JEJ, 2008, J IMMUNOL, V181, P8450, DOI 10.4049/jimmunol.181.12.8450; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Hales DF, 2002, GENET RES, V79, P203, DOI 10.1017/S0016672302005657; Hales DF, 2002, GENET RES, V79, P119, DOI 10.1017/S001667230100550X; Hansen D, 2006, CURR TOP DEV BIOL, V76, P185, DOI 10.1016/S0070-2153(06)76006-9; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Lau NC, 2010, INT J BIOCHEM CELL B, V42, P1334, DOI 10.1016/j.biocel.2010.03.005; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li WX, 2006, CELL RES, V16, P402, DOI 10.1038/sj.cr.7310052; Liao Z, 2010, ARCH INSECT BIOCHEM, V74, P91, DOI 10.1002/arch.20362; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028051; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Metzler-Guillemain C, 2000, CHROMOSOMA, V109, P133, DOI 10.1007/s004120050421; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; MIZUNO K, 1992, GENE, V119, P293, DOI 10.1016/0378-1119(92)90286-X; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; PRINZ S, 1995, NUCLEIC ACIDS RES, V23, P3449, DOI 10.1093/nar/23.17.3449; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Riparbelli MG, 2005, DEV BIOL, V278, P220, DOI 10.1016/j.ydbio.2004.11.009; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Sage J, 1999, MECH DEVELOP, V80, P29, DOI 10.1016/S0925-4773(98)00191-9; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Santucci-Darmanin S, 1999, MAMM GENOME, V10, P423, DOI 10.1007/s003359901016; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Shigenobu S, 2010, INSECT MOL BIOL, V19, P23, DOI 10.1111/j.1365-2583.2009.00946.x; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; Srinivasan DG, 2010, INSECT MOL BIOL, V19, P229, DOI 10.1111/j.1365-2583.2009.00960.x; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wei QY, 1997, PATHOBIOLOGY, V65, P293, DOI 10.1159/000164141; West-Eberhard Mary Jane, 2003, pi; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x	58	11	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115099	10.1371/journal.pone.0115099	http://dx.doi.org/10.1371/journal.pone.0115099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501006	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400071
J	Mikami, Y; Matsuzaki, H; Horie, M; Noguchi, S; Jo, T; Narumoto, O; Kohyama, T; Takizawa, H; Nagase, T; Yamauchi, Y				Mikami, Yu; Matsuzaki, Hirotaka; Horie, Masafumi; Noguchi, Satoshi; Jo, Taisuke; Narumoto, Osamu; Kohyama, Tadashi; Takizawa, Hajime; Nagase, Takahide; Yamauchi, Yasuhiro			Lymphotoxin beta Receptor Signaling Induces IL-8 Production in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; SEVERE ASTHMA; NEUTROPHILIC INFLAMMATION; ENDOTHELIAL-CELLS; TNF SUPERFAMILY; FAMILY-MEMBER; LIGHT; EXPRESSION; PATHWAYS	Asthma-related mortality has been decreasing due to inhaled corticosteroid use, but severe asthma remains a major clinical problem. One characteristic of severe asthma is resistance to steroid therapy, which is related to neutrophilic inflammation. Recently, the tumor necrosis factor superfamily member (TNFSF) 14/LIGHT has been recognized as a key mediator in severe asthmatic airway inflammation. However, the profiles and intracellular mechanisms of cytokine/chemokine production induced in cells by LIGHT are poorly understood. We aimed to elucidate the molecular mechanism of LIGHT-induced cytokine/chemokine production by bronchial epithelial cells. Human bronchial epithelial cells express lymphotoxin beta receptor (LT beta R), but not herpesvirus entry mediator, which are receptors for LIGHT. LIGHT induced various cytokines/chemokines, such as interleukin (IL)-6, oncostatin M, monocyte chemotactic protein-1, growth-regulated protein alpha and IL-8. Specific siRNA for LT beta R attenuated IL-6 and IL-8 production by BEAS-2B and normal human bronchial epithelial cells. LIGHT activated intracellular signaling, such as mitogen-activated protein kinase and nuclear factor-kappa B (NF-kappa B) signaling. LIGHT also induced luciferase activity of NF-kappa B response element, but not of activator protein-1 or serum response element. Specific inhibitors of phosphorylation of extracellular signal-regulated kinase (Erk) and that of inhibitor kappa B attenuated IL-8 production, suggesting that LIGHT-LT beta R signaling induces IL-8 production via the Erk and NF-kappa B pathways. LIGHT, via LT beta R signaling, may contribute to exacerbation of airway neutrophilic inflammation through cytokine and chemokine production by bronchial epithelial cells.	[Mikami, Yu; Matsuzaki, Hirotaka; Horie, Masafumi; Noguchi, Satoshi; Jo, Taisuke; Narumoto, Osamu; Nagase, Takahide; Yamauchi, Yasuhiro] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Kohyama, Tadashi] Teikyo Univ, Mizonokuchi Hosp, Dept Internal Med, Sagamihara, Kanagawa, Japan; [Takizawa, Hajime] Kyorin Univ, Dept Resp Med, Tokyo, Japan	University of Tokyo; Teikyo University; Kyorin University	Yamauchi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan.	YAMAUCHIY-INT@h.u-tokyo.ac.jp		MIKAMI, YU/0000-0003-3262-2958	Japan Society for the Promotion of Science [24591125]; Grants-in-Aid for Scientific Research [24591125] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Research Project Number: 24591125) [http://www.jsps.go.jp/jgrantsinaid/index.html] to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Cheung Timothy C, 2009, Recent Pat DNA Gene Seq, V3, P177; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Duhen T, 2004, EUR J IMMUNOL, V34, P3534, DOI 10.1002/eji.200425598; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Feng EZ, 2013, EXP THER MED, V6, P747, DOI 10.3892/etm.2013.1192; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Godaly G, 1997, INFECT IMMUN, V65, P3451, DOI 10.1128/IAI.65.8.3451-3456.1997; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Ishida S, 2008, J RHEUMATOL, V35, P960; Kaur M, 2013, J PHARMACOL EXP THER, V347, P173, DOI 10.1124/jpet.112.201855; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; Lechner J F, 1985, J TISSUE CULT METHOD, V9, P43; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Mikami Y, 2012, BIOCHEM BIOPH RES CO, V428, P451, DOI 10.1016/j.bbrc.2012.10.097; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Nakagome K, 2012, INT ARCH ALLERGY IMM, V158, P96, DOI 10.1159/000337801; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Plant SR, 2007, J NEUROSCI, V27, P7429, DOI 10.1523/JNEUROSCI.1307-07.2007; Robins S, 2011, AM J RESP CELL MOL, V45, P984, DOI 10.1165/rcmb.2010-0450OC; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Shi JX, 2012, AM J PHYSIOL-LUNG C, V302, pL793, DOI 10.1152/ajplung.00339.2011; Snelgrove RJ, 2011, EUR J PHARMACOL, V667, P1, DOI 10.1016/j.ejphar.2011.05.073; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takata M, 2001, BRIT J PHARMACOL, V134, P753, DOI 10.1038/sj.bjp.0704305; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wang J, 2004, J CLIN INVEST, V113, P826, DOI 10.1172/JCI200420096; Wang J, 2002, EUR J IMMUNOL, V32, P1969, DOI 10.1002/1521-4141(200207)32:7<1969::AID-IMMU1969>3.0.CO;2-M; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	42	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114791	10.1371/journal.pone.0114791	http://dx.doi.org/10.1371/journal.pone.0114791			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501580	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700053
J	Lazarin, GA; Hawthorne, F; Collins, NS; Platt, EA; Evans, EA; Haque, IS				Lazarin, Gabriel A.; Hawthorne, Felicia; Collins, Nicholas S.; Platt, Elizabeth A.; Evans, Eric A.; Haque, Imran S.			Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening Panels	PLOS ONE			English	Article								Professional guidelines dictate that disease severity is a key criterion for carrier screening. Expanded carrier screening, which tests for hundreds to thousands of mutations simultaneously, requires an objective, systematic means of describing a given disease's severity to build screening panels. We hypothesized that diseases with characteristics deemed to be of highest impact would likewise be rated as most severe, and diseases with characteristics of lower impact would be rated as less severe. We describe a pilot test of this hypothesis in which we surveyed 192 health care professionals to determine the impact of specific disease phenotypic characteristics on perceived severity, and asked the same group to rate the severity of selected inherited diseases. The results support the hypothesis: we identified four "Tiers'' of disease characteristics (1-4). Based on these responses, we developed an algorithm that, based on the combination of characteristics normally seen in an affected individual, classifies the disease as Profound, Severe, Moderate, or Mild. This algorithm allows simple classification of disease severity that is replicable and not labor intensive.	[Lazarin, Gabriel A.; Hawthorne, Felicia; Collins, Nicholas S.; Platt, Elizabeth A.; Evans, Eric A.; Haque, Imran S.] Counsyl, San Francisco, CA 94080 USA		Lazarin, GA (corresponding author), Counsyl, San Francisco, CA 94080 USA.	gabriel@counsyl.com			Counsyl, a molecular genetics laboratory	Counsyl, a molecular genetics laboratory	This study was funded by Counsyl, a molecular genetics laboratory that performs carrier screening. Study design, data collection and analysis, and manuscript preparation were all completed by the authors who are currently, or were, employees at Counsyl.	Amos J, 2006, TECHNICAL STANDARDS; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Fedick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059722; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Saigal S, 1999, JAMA-J AM MED ASSOC, V281, P1991, DOI 10.1001/jama.281.21.1991; Schrijver I, 2005, J MOL DIAGN, V7, P375, DOI 10.1016/S1525-1578(10)60567-3; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad	11	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114391	10.1371/journal.pone.0114391	http://dx.doi.org/10.1371/journal.pone.0114391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25494330	Green Published, gold, Green Submitted			2022-12-27	WOS:000346611400044
J	Redding, DW; Mazel, F; Mooers, AO				Redding, David W.; Mazel, Florent; Mooers, Arne O.			Measuring Evolutionary Isolation for Conservation	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; SHAPLEY VALUE; TAXONOMY; AGONY	Conservation planning needs to account for limited resources when choosing those species on which to focus attention and resources. Currently, funding is biased to small sections of the tree of life, such as raptors and carnivores. One new approach for increasing the diversity of species under consideration considers how many close relatives a species has in its evolutionary tree. At least eleven different ways to measure this characteristic on phylogenies for the purposes of setting species-specific priorities for conservation have been proposed. We find that there is much redundancy within the current set, with three pairs of metrics being essentially identical. Non-redundant metrics represent different trade-offs between the unique evolutionary history represented by a species verses its average distance to all other species. Depending on which metric is used, species priority lists can differ as much as 85% for the top 100 species. We call for some consensus on the theory behind these metrics and suggest that all future developments are compared to the current published set, and offer scripts to aid such comparisons.	[Redding, David W.; Mooers, Arne O.] Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada; [Redding, David W.] UCL, Dept Genet Evolut & Environm, Ctr Biodivers Ecol & Conservat, London, England; [Mazel, Florent] Lab Ecol Alpine, Grenoble, France	Simon Fraser University; University of London; University College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Redding, DW (corresponding author), Simon Fraser Univ, Dept Biol, Burnaby, BC V5A 1S6, Canada.	dwredding@gmail.com	Redding, David/M-1766-2019; Mazel, Florent/AFN-6012-2022	Redding, David/0000-0001-8615-1798; Mazel, Florent/0000-0003-0572-9901	Ecosystem Services for Poverty Alleviation (ESPA) programme [NE-J001570-1]; Systematics Society Systematics Research Fund (DWR); NSERC Canada; European Research Council TEEMBIO Seventh Framework Programme [281422]; DFG [FZT 118]; sDiv	Ecosystem Services for Poverty Alleviation (ESPA) programme; Systematics Society Systematics Research Fund (DWR); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Research Council TEEMBIO Seventh Framework Programme; DFG(German Research Foundation (DFG)); sDiv	This work was supported by Ecosystem Services for Poverty Alleviation (ESPA) programme project no. (NE-J001570-1); Systematics Society Systematics Research Fund (DWR); NSERC Canada (AOM); The European Research Council TEEMBIO Seventh Framework Programme grant agreement no. 281422 (FM); and sDiv, the Synthesis Centre for Biodiversity Sciences (DFG FZT 118) (DWR, FM, AOM). The funders had no role in study design, data col<SUP>l</SUP>ection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, NATURE, V348, P493, DOI 10.1038/348493c0; AmphibiaWeb, 2013, INF AMPH BIOL CONS; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; CROZIER RH, 1992, BIOL CONSERV, V61, P11, DOI 10.1016/0006-3207(92)91202-4; Diniz JAF, 2013, TRENDS ECOL EVOL, V28, P689, DOI 10.1016/j.tree.2013.09.003; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fay JJ, 1983, US FED REG, V48, P43098; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Haake CJ, 2008, J MATH BIOL, V56, P479, DOI 10.1007/s00285-007-0126-2; Hartmann K, 2013, J MATH BIOL, V67, P1163, DOI 10.1007/s00285-012-0585-y; Huang JX, 2011, J THEOR BIOL, V276, P99, DOI 10.1016/j.jtbi.2011.01.037; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jetz W, 2014, CURR BIOL, V24, P1; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Maechler M., 2013, CLUSTER CLUSTER ANAL; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Nixon Kevin C., 1992, P216; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; R Core Team, 2021, R LANGUAGE ENV STAT; Red List of Endangered Species, 2012, RED LIST END SPEC; Redding, 2003, THESIS U E ANGLIA NO; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricotta C, 2007, ACTA BIOTHEOR, V55, P23, DOI 10.1007/s10441-007-9008-7; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Volkmann L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088945; Waldron A, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas1221370110, DOI 10.1073/PNAS1221370110]; Wilson D. E., 2005, MAMMAL SPECIES WORLD	36	40	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113490	10.1371/journal.pone.0113490	http://dx.doi.org/10.1371/journal.pone.0113490			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493934	gold, Green Published, Green Submitted			2022-12-27	WOS:000346611400013
J	Miguez-Burbano, MJ; Quiros, C; Lewis, JE; Espinoza, L; Cook, R; Trainor, AB; Richardson, E; Asthana, D				Miguez-Burbano, Maria Jose; Quiros, Clery; Lewis, John E.; Espinoza, Luis; Cook, Robert; Trainor, Allison B.; Richardson, Erika; Asthana, Deshratn			Gender Differences in the Association of Hazardous Alcohol Use with Hypertension in an Urban Cohort of People Living with HIV in South Florida	PLOS ONE			English	Article							BLOOD-PRESSURE; DRINKING PATTERN; CONSUMPTION; RISK; DISEASE; WINE; PREVALENCE	Objective: Industrialized countries are currently experiencing an epidemic of high blood pressure (HBP) extending to people living with HIV (PLWH). Given the prevalence of hazardous alcohol use (HAU), this study examines the relationship between alcohol consumption and hypertension in PLWH. Including a gender analysis is critical, given the high rates of HAU and HIV among females. Method: We followed PLWH including both HAU and non-HAU (200 each). Participants were assessed twice for body weight, blood pressure, alcohol consumption, and other BP-associated lifestyle factors. High blood pressure (defined as systolic/diastolic blood pressure above 140/90 mmHg and/or treatment of HBP) was the primary outcome. Results: Overall prevalence of hypertension was 38% and higher among HAU compared to non-HAU (42% vs. 34%, p=0.02). Less than half with HBP (42%) were receiving treatment for hypertension. Overall, males had a 50% higher risk of HBP than women (odds ratio: 1.5, 95% CI: 1-2.6, p=0.05). However among HAU, females were twice as likely to suffer HBP as their male counterparts (95% CI: 1-3.9, p=0.02). Those HAU who preferred liquor, versus wine, had higher adjusted mean BP (132.6 +/- 18 vs. 122.3 +/- 14 mm Hg, p=0.05). Additional analyses indicated that consumption of >1 standard drink of liquor or beer/day was associated with HBP. Risk of hypertension was noted in those with daily consumption of >3 glasses of wine. For those reporting,1 drink per day, the odds ratio of having HBP was 0.97 (CI: 0.6-0.99, p=0.05). Factors associated with hypertension in the multivariate model included increased age, gender, BMI, HAU particularly of liquor, and smoking. Conclusions: Excessive hypertension burden in this population and its association with HAU and sub-optimal care indicate the need for preventive and educational intervention in PLWH. Analyses highlight the necessity of gender and type-of-beverage specific approaches.	[Miguez-Burbano, Maria Jose; Quiros, Clery; Richardson, Erika] Florida Int Univ, SISH, Miami, FL 33199 USA; [Lewis, John E.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Espinoza, Luis] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Cook, Robert; Trainor, Allison B.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Cook, Robert; Trainor, Allison B.] Univ Florida, Coll Med, Gainesville, FL USA; [Asthana, Deshratn] Univ Miami, Miller Sch Med, Dept Pathol, Dept Psychiat & Behav Sci, Miami, FL 33136 USA	State University System of Florida; Florida International University; University of Miami; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Miami	Miguez-Burbano, MJ (corresponding author), Florida Int Univ, SISH, Miami, FL 33199 USA.	mjmiguez@fiu.edu	Cook, Robert Lewis/ABI-4866-2020	Espinoza, Luis/0000-0003-3279-3116	Southern HIV Alcohol Research Consortium (SHARC) Admin and Research Support Core [U24AA022002]; NIAAA [R01 AA018095]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018095, U24AA022002] Funding Source: NIH RePORTER	Southern HIV Alcohol Research Consortium (SHARC) Admin and Research Support Core; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Some of the work on this paper was supported the Southern HIV Alcohol Research Consortium (SHARC) Admin and Research Support Core, federal grant number U24AA022002 and also by the NIAAA R01 AA018095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedjonov A, 2013, DRUG ALCOHOL REV, V32, P248, DOI 10.1111/j.1465-3362.2012.00521.x; BULPITT CJ, 1987, J HYPERTENS, V5, P85, DOI 10.1097/00004872-198702000-00012; Celio MA, 2016, ALCOHOL CLIN EXP RES, V40, P638, DOI 10.1111/acer.12988; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow DC, 2003, HIV CLIN TRIALS, V4, P411, DOI 10.1310/5E7Q-PGWB-16UE-J48U; Das S, 2010, J ANTIMICROB CHEMOTH, V65, P386, DOI 10.1093/jac/dkp460; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Djousse L, 2009, REV ESP CARDIOL, V62, P603, DOI 10.1016/S0300-8932(09)71326-0; Doumas M, 2010, AM J CARDIOL, V105, P570, DOI 10.1016/j.amjcard.2009.10.027; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Karatzi KN, 2005, AM J HYPERTENS, V18, P1161, DOI 10.1016/j.amjhyper.2005.03.744; Kearney F, 2010, AGE AGEING, V39, P536, DOI 10.1093/ageing/afq083; Khatlb OMN, 2005, CLIN GUIDELINES MANA; Klatsky AL, 1996, CLIN CHIM ACTA, V246, P91, DOI 10.1016/0009-8981(96)06230-4; Leighton F, 2006, CELL BIOCHEM FUNCT, V24, P291, DOI 10.1002/cbf.1269; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; MacMahon S W, 1984, J Hypertens, V2, P85, DOI 10.1097/00004872-198402000-00015; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Matsumoto C, 2014, J CARDIOPULM REHABIL, V34, P159, DOI 10.1097/HCR.0000000000000042; Miguez MJ, 2012, J AIDS CLIN RES, V3, pe109, DOI [10.4172/2155-6113.1000e109, DOI 10.4172/2155-6113.1000E109]; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Schutte AE, 2012, INT J EPIDEMIOL, V41, P1114, DOI 10.1093/ije/dys106; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Skinner H.A., 1984, ALCOHOL DEPENDENCE S; Stamler J, 2000, ANTIVIR THER, V5, P13; Stranges S, 2004, HYPERTENSION, V44, P813, DOI 10.1161/01.HYP.0000146537.03103.f2; STROGATZ DS, 1991, AM J EPIDEMIOL, V133, P442, DOI 10.1093/oxfordjournals.aje.a115911; TREVISAN M, 1987, INT J EPIDEMIOL, V16, P520, DOI 10.1093/ije/16.4.520	30	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113122	10.1371/journal.pone.0113122	http://dx.doi.org/10.1371/journal.pone.0113122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490037	Green Published, gold			2022-12-27	WOS:000347515300005
J	Villada, C; Hidalgo, V; Almela, M; Mastorci, F; Sgoifo, A; Salvador, A				Villada, Carolina; Hidalgo, Vanesa; Almela, Mercedes; Mastorci, Francesca; Sgoifo, Andrea; Salvador, Alicia			Coping with an Acute Psychosocial Challenge: Behavioral and Physiological Responses in Young Women	PLOS ONE			English	Article							MENSTRUAL-CYCLE PHASE; HEART-RATE-VARIABILITY; SOCIAL STRESS TEST; ORAL-CONTRACEPTIVES; CORTISOL RESPONSES; NEGATIVE AFFECT; SEX-DIFFERENCES; ELDERLY ADULTS; PANAS SCALES; IMPACT	Despite the relevance of behavior in understanding individual differences in the strategies used to cope with stressors, behavioral responses and their relationships with psychobiological changes have received little attention. In this study on young women, we aimed at analyzing the associations among different components of the stress response and behavioral coping using a laboratory psychosocial stressor. The Ethological Coding System for Interviews, as well as neuroendocrine, autonomic and mood parameters, were used to measure the stress response in 34 young women (17 free-cycling women in their early follicular phase and 17 oral contraceptive users) subjected to the Trier Social Stress Test (TSST) and a control condition in a crossover design. No significant differences in cardiac autonomic, negative mood and anxiety responses to the stressor were observed between the two groups of women. However, women in the follicular phase showed a higher cortisol response and a larger decrease in positive mood during the social stress episode, as well as greater anxiety overall. Interestingly, the amount of displacement behavior exhibited during the speaking task of the TSST was positively related to anxiety levels preceding the test, but negatively related to baseline and stress response values of heart rate. Moreover, the amount of submissive behavior was negatively related to basal cortisol levels. Finally, eye contact and low-aggressiveness behaviors were associated with a worsening in mood. Overall, these findings emphasize the close relationship between coping behavior and psychobiological reactions, as well as the role of individual variations in the strategy of coping with a psychosocial stressor.	[Villada, Carolina; Hidalgo, Vanesa; Almela, Mercedes; Salvador, Alicia] Univ Valencia, Lab Social Cognit Neurosci, Valencia, Spain; [Mastorci, Francesca] Scuola Super Sant Anna, Inst Life Sci, Extreme Ctr, Pisa, Italy; [Sgoifo, Andrea] Univ Parma, Dept Neurosci, Stress Physiol Lab, I-43100 Parma, Italy	University of Valencia; Scuola Superiore Sant'Anna; University of Parma	Villada, C (corresponding author), Univ Valencia, Lab Social Cognit Neurosci, Valencia, Spain.	carolina.villada@uv.es	Villada, Carolina/ABA-2602-2021; Salvador, Alicia/B-6045-2011; Hidalgo, Vanesa/AAU-7736-2021; Almela, Mercedes/AAE-4481-2021; Sgoifo, Andrea/AAC-6278-2022	Hidalgo, Vanesa/0000-0003-3920-1099; Sgoifo, Andrea/0000-0002-9428-6198; VILLADA, CAROLINA/0000-0003-1071-2362; Salvador, Alicia/0000-0002-8686-8083; Almela, Mercedes/0000-0002-8930-0717	Spanish Education and Science Ministry [PSI2010-21343, FPI/BES-2008-004224, FPU-AP2009-4713]; Generalitat Valenciana [PROMETEO2011-048, ISIC2013/001]	Spanish Education and Science Ministry(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This research was supported by the Spanish Education and Science Ministry (PSI2010-21343, and grants no. FPI/BES-2008-004224, FPU-AP2009-4713) and by the Generalitat Valenciana (PROMETEO2011-048 and ISIC2013/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Almela M, 2011, STRESS, V14, P117, DOI 10.3109/10253890.2010.514671; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; Cannon W.B., 1932, WISDOM BODY; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Childs E, 2010, PSYCHOPHYSIOLOGY, V47, P550, DOI 10.1111/j.1469-8986.2009.00961.x; Cornelisse S, 2011, PSYCHONEUROENDOCRINO, V36, P569, DOI 10.1016/j.psyneuen.2010.09.002; Crespo M., 1997, ANALISIS MODIFICACIO, V23, P797, DOI DOI 10.6018/ANALESPS.29.1.124531; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duchesne A, 2012, BIOL PSYCHOL, V89, P99, DOI 10.1016/j.biopsycho.2011.09.009; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Guillermo CJ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-19; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kelly MM, 2008, J BEHAV THER EXP PSY, V39, P87, DOI 10.1016/j.jbtep.2007.02.003; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kudielka BM, 2004, INT J BEHAV MED, V11, P116, DOI 10.1207/s15327558ijbm1102_8; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P83, DOI 10.1016/S0306-4530(02)00146-4; Kumsta R, 2007, PSYCHONEUROENDOCRINO, V32, P1153, DOI 10.1016/j.psyneuen.2007.08.007; Mohiyeddini C, 2013, STRESS, V16, P384, DOI 10.3109/10253890.2012.755171; Mohiyeddini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056355; Oinonen KA, 2002, J AFFECT DISORDERS, V70, P229, DOI 10.1016/S0165-0327(01)00356-1; Pico-Alfonso MA, 2007, PSYCHONEUROENDOCRINO, V32, P451, DOI 10.1016/j.psyneuen.2007.02.009; Preuss D, 2009, NEUROBIOL LEARN MEM, V92, P318, DOI 10.1016/j.nlm.2009.03.009; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Radespiel-Troger M, 2003, CLIN AUTON RES, V13, P99, DOI 10.1007/s10286-003-0085-7; Rohleder N, 2003, PSYCHONEUROENDOCRINO, V28, P261, DOI 10.1016/S0306-4530(02)00019-7; Roy RA, 2009, J MANIP PHYSIOL THER, V32, P277, DOI 10.1016/j.jmpt.2009.03.003; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Sandin B, 1999, PSICOTHEMA, V11, P37; Seisdedos N, 1988, STATE TRAIT ANXIETY; Sgoifo A, 2003, NEUROSCI BIOBEHAV R, V27, P179, DOI 10.1016/S0149-7634(03)00019-8; Spielberger C.D., 1983, MANUAL STATE TRAIT A; SPRUIJT BM, 1992, PHYSIOL BEHAV, V51, P747, DOI 10.1016/0031-9384(92)90111-E; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Troisi A, 1999, NEUROSCI BIOBEHAV R, V23, P905, DOI 10.1016/S0149-7634(99)00024-X; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; Walder DJ, 2012, PSYCHIAT RES, V197, P314, DOI 10.1016/j.psychres.2011.09.009; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	44	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114640	10.1371/journal.pone.0114640	http://dx.doi.org/10.1371/journal.pone.0114640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25489730	Green Submitted, Green Published, gold			2022-12-27	WOS:000347515300062
J	Wiik, R; Krovel, AV				Wiik, Ragnhild; Krovel, Anne Vatland			Necessity and Effect of Combating Legionella pneumophila in Municipal Shower Systems	PLOS ONE			English	Article							SEQUENCE-BASED SCHEME; LEGIONNAIRES-DISEASE; BIOFILM FORMATION; LARGE OUTBREAK; WATER-SYSTEMS; FLOW; ENUMERATION; SEROGROUPS; CULTURE; AMEBAS	The objective was to obtain research-based, holistic knowledge about necessity and effect of practiced measures against L. pneumophila in municipal shower systems in Stavanger, Norway. The effects of hot water treatment and membrane-filtering were investigated and compared to no intervention at all. The studies were done under real-world conditions. Additionally, a surveillance pilot study of municipal showers in Stavanger was performed. The validity of high total plate count (TPC) as an indication of L. pneumophila was evaluated. A simplified method, named "dripping method", for detection and quantification of L. pneumophila was developed. The sensitivity of the dripping method is 5 colony-forming units of L. pneumophila/ml. The transference of L. pneumophila from shower water to aerosols was studied. Interviews and observational studies among the stakeholders were done in order to identify patterns of communication and behavior in a Legionella risk perspective. No substantial effects of the measures against L. pneumophila were demonstrated, except for a distally placed membrane filter. No significant positive correlation between TPC and L. pneumophila concentrations were found. L. pneumophila serogroup 2-14 was demonstrated in 21% of the 29 buildings tested in the surveillance pilot. Relatively few cells of L. pneumophila were transferred from shower water to aerosols. Anxiety appeared as the major driving force in the risk governance of Legionella. In conclusion, the risk of acquiring Legionnaires' disease from municipal shower systems is evaluated as low and uncertain. By eliminating ineffective approaches, targeted Legionella risk governance can be practiced. Risk management by surveillance is evaluated as appropriate.	[Wiik, Ragnhild; Krovel, Anne Vatland] IRIS Int Res Inst Stavanger, Stavanger, Norway		Wiik, R (corresponding author), BI Norwegian Business Sch, Stavanger, Norway.	ragnhild.wiik@bi.no			Stavanger municipality, Norway	Stavanger municipality, Norway	The work has been funded by Stavanger municipality, Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra S, 2011, APPL ENVIRON MICROB, V77, P1268, DOI 10.1128/AEM.02225-10; Allegra S, 2008, APPL ENVIRON MICROB, V74, P7813, DOI 10.1128/AEM.01364-08; Alleron L, 2013, WATER RES, V47, P6606, DOI 10.1016/j.watres.2013.08.032; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 62221999E ISO; [Anonymous], 1998, 117311998E ISO; Arnold J., 2010, WORK PSYCHOL UNDERST; Bartram Jamie, 2007, P1; Bentham R, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P465; Berg B.L., 2012, QUALITATIVE RES METH, V8th; Borella P, 2004, EMERG INFECT DIS, V10, P457, DOI 10.3201/eid1003.020707; Boshuizen HC, 2001, J INFECT DIS, V184, P515, DOI 10.1086/322049; BOULANGER CA, 1995, APPL ENVIRON MICROB, V61, P1805, DOI 10.1128/AEM.61.5.1805-1809.1995; Bronn P.S., 2005, CORPORATE COMMUNICAT, P167; Chang CW, 2007, J APPL MICROBIOL, V102, P1636, DOI 10.1111/j.1365-2672.2006.03195.x; CIESIELSKI CA, 1984, APPL ENVIRON MICROB, V48, P984, DOI 10.1128/AEM.48.5.984-987.1984; Conza L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002428; Darelid J, 2002, J HOSP INFECT, V50, P213, DOI 10.1053/jhin.2002.1185; Delgado-Viscogliosi P, 2005, APPL ENVIRON MICROB, V71, P4086, DOI 10.1128/AEM.71.7.4086-4096.2005; Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176; Ducret A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-3; ECDC (European Centre for Disease Prevention and Control), 2012, SURV REP LEG DIS EUR, DOI [10.2900/62079, DOI 10.2900/62079]; Edelstein Paul H., 2008, P1; Epalle T, 2014, MICROB ECOL IN PRESS; European Working Group for Legionella Infections (EWGLI), 2011, EWGLI TECHN GUID INV; Farhat M, 2010, J APPL MICROBIOL, V108, P1073, DOI 10.1111/j.1365-2672.2009.04541.x; FARRELL ID, 1990, EPIDEMIOL INFECT, V104, P381, DOI 10.1017/S0950268800047397; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Garasen Helge, 2005, Tidsskr Nor Laegeforen, V125, P1791; Ginevra C, 2009, CLIN INFECT DIS, V49, P184, DOI 10.1086/599825; HARPER D, 1988, J HOSP INFECT, V11, P201, DOI 10.1016/0195-6701(88)90188-0; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Helbig JH, 2002, EUR J CLIN MICROBIOL, V21, P710, DOI 10.1007/s10096-002-0820-3; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; HUSSONG D, 1987, BIO-TECHNOL, V5, P947, DOI 10.1038/nbt0987-947; Joseph Carol, 2008, P35; Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4; Leoni E, 2001, J APPL MICROBIOL, V90, P27, DOI 10.1046/j.1365-2672.2001.01178.x; Liu Z, 2006, J APPL MICROBIOL, V101, P437, DOI 10.1111/j.1365-2672.2006.02970.x; Loret J. F., 2005, Journal of Water and Health, V3, P423; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Luck PC, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P15; Lueck Paul Christian, 2008, P19; Madigan MT, 2009, BROCK BIOL MICROORGA; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; Mampel J, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P398; McCabe S, 2011, CLIN MICROBIOL INFEC, V17, P1517, DOI 10.1111/j.1469-0691.2011.03582.x; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Miuetzner S, 1997, AM J INFECT CONTROL, V25, P452, DOI 10.1016/S0196-6553(97)90066-3; Mouchtouri V, 2007, AM J INFECT CONTROL, V35, P623, DOI 10.1016/j.ajic.2007.01.002; Ohata K, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P431; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Olsen CW, 2009, EUR J CLIN MICROBIOL, V28, P817, DOI 10.1007/s10096-008-0697-x; Pettersen JE, 2008, FOREBYGGING LEGIONEL; Pettersen JE, 2012, 118 NORW I PUBL HLTH; Pettersen JE, 2010, 115 NORW I PUBL HLTH; Ratcliff RM, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P359; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reichardt C, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P501; Renn O., 2008, RISK GOVERNANCE; Ricci ML, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P505; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1842, DOI 10.1128/AEM.60.6.1842-1851.1994; Schoen ME, 2011, WATER RES, V45, P5826, DOI 10.1016/j.watres.2011.08.031; Schousboe M, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P477; Singh T, 2005, J HOSP INFECT, V61, P257, DOI 10.1016/j.jhin.2005.05.001; Skulberg KR, 2006, THESIS U OSLO NORWAY; Steinert M, 1998, ZBL BAKT-INT J MED M, V288, P331; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stout JE, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P469; Stout JE, 2010, AM J INFECT CONTROL, V38, P341, DOI 10.1016/j.ajic.2010.02.002; Strauss A., 1998, BASICS QUALITATIVE R; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; TA AC, 1995, J CLIN MICROBIOL, V33, P2118, DOI 10.1128/JCM.33.8.2118-2123.1995; Garcia MT, 2007, ENVIRON MICROBIOL, V9, P1267, DOI 10.1111/j.1462-2920.2007.01245.x; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; Uzel A, 2010, ENV HLTH PHYS CHEM B; Waines PL, 2011, THESIS U PLYMOUTH UK; Wedege E, 2013, SCAND J INFECT DIS, V45, P59, DOI 10.3109/00365548.2012.710855; West AA, 1992, LEGIONELLA CURRENT S, P201; WHITEHOUSE RLS, 1991, J DENT, V19, P290, DOI 10.1016/0300-5712(91)90075-A; Wiik R, 2011, INDOOR AIR, V21, P328, DOI 10.1111/j.1600-0668.2011.00708.x; Wiik R, 2008, 2008187 IRIS; Wiik R, 1998, RF98029; Yamamoto H, 1996, FEMS MICROBIOL ECOL, V20, P149, DOI 10.1111/j.1574-6941.1996.tb00313.x	86	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114331	10.1371/journal.pone.0114331	http://dx.doi.org/10.1371/journal.pone.0114331			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490721	gold, Green Published, Green Submitted			2022-12-27	WOS:000347515300030
J	Williams, TC; Blackman, ER; Morrison, SS; Gibas, CJ; Oliver, JD				Williams, Tiffany C.; Blackman, Elliot R.; Morrison, Shatavia S.; Gibas, Cynthia J.; Oliver, James D.			Transcriptome Sequencing Reveals the Virulence and Environmental Genetic Programs of Vibrio vulnificus Exposed to Host and Estuarine Conditions	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MANNOSE-SENSITIVE HEMAGGLUTININ; CYCLIC-DI-GMP; BIOFILM FORMATION; PHENOTYPIC EVALUATION; HUMAN SERUM; IRON; PCR; DIGUANYLATE; ADHERENCE	Vibrio vulnificus is a natural inhabitant of estuarine waters worldwide and is of medical relevance due to its ability to cause grievous wound infections and/or fatal septicemia. Genetic polymorphisms within the virulence-correlated gene (vcg) serve as a primary feature to distinguish clinical (C-) genotypes from environmental (E-) genotypes. C-genotypes demonstrate superior survival in human serum relative to E-genotypes, and genome comparisons have allowed for the identification of several putative virulence factors that could potentially aid C-genotypes in disease progression. We used RNA sequencing to analyze the transcriptome of C-genotypes exposed to human serum relative to seawater, which revealed two divergent genetic programs under these two conditions. In human serum, cells displayed a distinct "virulence profile" in which a number of putative virulence factors were upregulated, including genes involved in intracellular signaling, substrate binding and transport, toxin and exoenzyme production, and the heat shock response. Conversely, the "environmental profile" exhibited by cells in seawater revealed upregulation of transcription factors such as rpoS, rpoN, and iscR, as well as genes involved in intracellular signaling, chemotaxis, adherence, and biofilm formation. This dichotomous genetic switch appears to be largely governed by cyclic-di-GMP signaling, and remarkably resembles the dual life-style of V. cholerae as it transitions from host to environment. Furthermore, we found a "general stress response" module, known as the stressosome, to be upregulated in seawater. This signaling system has been well characterized in Gram-positive bacteria, however its role in V. vulnificus is not clear. We examined temporal gene expression patterns of the stressosome and found it to be upregulated in natural estuarine waters indicating that this system plays a role in sensing and responding to the environment. This study advances our understanding of gene regulation in V. vulnificus, and brings to the forefront a number of previously overlooked genetic networks.	[Williams, Tiffany C.; Oliver, James D.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Blackman, Elliot R.; Morrison, Shatavia S.; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Oliver, JD (corresponding author), Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA.	jdoliver@uncc.edu		Morrison, Shatavia S/0000-0002-4658-5951; Blackman, Eric/0000-0002-9405-8435; Gibas, Cynthia/0000-0002-1288-9543	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture [200903571]; Charlotte Research Institute; Duke University Marine Laboratory Mary Derrickson McCurdy Scholar	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Charlotte Research Institute; Duke University Marine Laboratory Mary Derrickson McCurdy Scholar	TCW was supported by the Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture (award no. 200903571) awarded to JDO. Funding for Illumina sequencing was provided by Charlotte Research Institute awarded to CJG. In situ gene expression studies were funded by Duke University Marine Laboratory Mary Derrickson McCurdy Scholar Award granted to JDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice AF, 2008, INFECT IMMUN, V76, P4019, DOI 10.1128/IAI.00208-08; Aronesty E., 2011, EA UTILS COMMAND LIN; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 2013, MICROBIOL-SGM, V159, P1878, DOI 10.1099/mic.0.067900-0; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Efimov V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00393; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gosink KK, 2002, J BACTERIOL, V184, P1767, DOI 10.1128/JB.184.6.1767-1771.2002; Hsiao A, 2008, MOL MICROBIOL, V67, P849, DOI 10.1111/j.1365-2958.2007.06091.x; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jenkins I, 2012, RNA SEQ ANAL EDGER V; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Joseph LA, 2004, J BACTERIOL, V186, P889, DOI 10.1128/JB.186.3.889-893.2004; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Kim HS, 2009, MOL MICROBIOL, V74, P436, DOI 10.1111/j.1365-2958.2009.06875.x; KIM HR, 1993, LIFE SCI, V53, P571, DOI 10.1016/0024-3205(93)90714-E; Kim HY, 2014, FOODBORNE PATHOG DIS, V11, P119, DOI 10.1089/fpd.2013.1581; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Kustusch RJ, 2012, J BACTERIOL, V194, P3250, DOI 10.1128/JB.00155-12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SE, 2000, J BACTERIOL, V182, P3405, DOI 10.1128/JB.182.12.3405-3415.2000; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Litwin CM, 2001, MICROB PATHOGENESIS, V31, P295, DOI 10.1006/mpat.2001.0472; Liu H, 2013, J BACTERIOL PARASITO, P4; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Marotta C, 2011, CERTIFICATE ANAL PRO; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Nielsen AT, 2006, PLOS PATHOG, V2, P933, DOI 10.1371/journal.ppat.0020109; Njoroge J, 2012, INFECT IMMUN, V80, P688, DOI 10.1128/IAI.05921-11; O'Toole R, 1997, MICROBIOL-SGM, V143, P3849, DOI 10.1099/00221287-143-12-3849; Oliver JD, 2006, BIOLOGY OF VIBRIOS, P349; Oliver JD, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P253; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ray VA, 2013, J BACTERIOL, V195, P5402, DOI 10.1128/JB.00689-13; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Rosche TM, 2010, ENV MICROBIOL REP, V2, P128, DOI 10.1111/j.1758-2229.2009.00119.x; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Smith B, 2006, APPL ENVIRON MICROB, V72, P1445, DOI 10.1128/AEM.72.2.1445-1451.2006; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Spinola SM, 2003, INFECT IMMUN, V71, P7178, DOI 10.1128/IAI.71.12.7178-7182.2003; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Valiente E, 2009, FEMS MICROBIOL ECOL, V69, P16, DOI 10.1111/j.1574-6941.2009.00691.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Warner EB, 2008, FOODBORNE PATHOG DIS, V5, P691, DOI 10.1089/fpd.2008.0120; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999; Whitaker WB, 2014, INFECT IMMUN, V82, P544, DOI 10.1128/IAI.01210-13; Williams TC, 2014, APPL ENVIRON MICROB, V80, P1580, DOI 10.1128/AEM.03811-13; WRIGHT AC, 1991, INFECT IMMUN, V59, P192, DOI 10.1128/IAI.59.1.192-197.1991; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541	91	29	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114376	10.1371/journal.pone.0114376	http://dx.doi.org/10.1371/journal.pone.0114376			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489854	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300033
J	Yang, JC; Han, S; Huang, WW; Chen, T; Liu, Y; Pan, SL; Li, SK				Yang, Jingcheng; Han, Shuai; Huang, Wenwen; Chen, Ting; Liu, Yang; Pan, Shangling; Li, Shikang			A Meta-Analysis of MicroRNA Expression in Liver Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; TUMOR-SUPPRESSOR; GENE; MIR-221; APOPTOSIS; TARGETS; PROTEIN; MIRNA; TUMORIGENICITY; ANGIOGENESIS	MicroRNA (miRNA) played an important role in the progression of liver cancer and its diagnostic and prognostic values have been frequently studied. However, different microarray techniques and small sample size led to inconsistent findings in previous studies. We performed a comprehensive meta-analysis of a total of 357 tumor and 283 noncancerous samples from 12 published miRNA expression studies using robust rank aggregation method. As a result, we identified a statistically significant meta-signature of five upregulated (miR-221, miR-222, miR-93, miR-21 and miR-224) and four downregulated (miR-130a, miR-195, miR-199a and miR-375) miRNAs. We then conducted miRNA target prediction and pathway enrichment analysis to find what biological process these miRNAs might affect. We found that most of the pathways were frequently associated with cell signaling and cancer pathogenesis. Thus these miRNAs may involve in the onset and progression of liver cancer and serve as potential diagnostic and therapeutic targets of this malignancy.	[Yang, Jingcheng; Han, Shuai; Huang, Wenwen; Liu, Yang; Li, Shikang] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China; [Chen, Ting] Guangxi Teachers Educ Univ, Coll Comp & Informat Engn, Dept Management Informat Syst, Nanning, Guangxi Zhuang, Peoples R China; [Pan, Shangling] Guangxi Med Univ, Dept Pathophysiol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Nanning Normal University; Guangxi Medical University	Li, SK (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China.	shikangli@hotmail.com	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022; Pan, Shang-Ling/G-9581-2016	Li, Shikang/0000-0002-8187-3676; Han, Shuai/0000-0002-5963-3772	Research Project of Guangxi Colleges and Universities [201203YB035]; Guangxi Key Project of Science and Technology [1355005-4-8]	Research Project of Guangxi Colleges and Universities; Guangxi Key Project of Science and Technology	This study was funded by Research Project of Guangxi Colleges and Universities (201203YB035) and Guangxi Key Project of Science and Technology (1355005-4-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer M, 2014, TUMOUR BIOL; Bandopadhyay M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-721; Bao LL, 2013, CANCER LETT, V337, P226, DOI 10.1016/j.canlet.2013.05.007; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Chang Y, 2012, GASTROENTEROLOGY, V143, P177, DOI 10.1053/j.gastro.2012.04.009; Chung GE, 2010, ONCOL REP, V23, P113, DOI 10.3892/or_00000612; Diaz G, 2013, INT J CANCER, V133, P816, DOI 10.1002/ijc.28075; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; He XX, 2014, ONCOL REP, V32, P1200, DOI 10.3892/or.2014.3306; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang HL, 2014, TUMOR BIOL, V35, P6955, DOI 10.1007/s13277-014-1933-x; Koh YS, 2013, GENES GENOM, V35, P759, DOI 10.1007/s13258-013-0126-0; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li Q, 2014, J GASTROEN HEPATOL, V29, P835, DOI 10.1111/jgh.12429; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma DL, 2012, ONCOL LETT, V4, P483, DOI 10.3892/ol.2012.742; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Park JK, 2011, CANCER RES, V71, P7608, DOI 10.1158/0008-5472.CAN-11-1144; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wallden B, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-140; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang LA, 2010, CANCER BIOL THER, V9, P803, DOI 10.4161/cbt.9.10.11440; Yang XY, 2012, PHARMAZIE, V67, P645, DOI 10.1691/ph.2012.1704; Yu LX, 2014, CANCER EPIDEMIOL, V38, P408, DOI 10.1016/j.canep.2014.05.001; Zhang YZ, 2013, J GASTROEN HEPATOL, V28, P565, DOI 10.1111/j.1440-1746.2012.07271.x	51	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114533	10.1371/journal.pone.0114533	http://dx.doi.org/10.1371/journal.pone.0114533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490558	Green Published, gold, Green Submitted			2022-12-27	WOS:000347515300049
J	Braunreiter, K; Hamlin, S; Lyman-Gingerich, J				Braunreiter, Kara; Hamlin, Shelby; Lyman-Gingerich, Jamie			Identification and Characterization of a Novel Allele of Caenorhabditis elegans bbs-7	PLOS ONE			English	Article							BIEDL SYNDROME PROTEINS; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; ELEGANS; DISEASE; DEFECTS; COMPLEX; MODEL; BBS6	Primary cilia play a role in the sensation of and response to the surrounding environment. Caenorhabditis elegans (C. elegans) have primary cilia only on the distal tips of some dendrites. In order to better understand the relationship between receptor localization to cilia, cilia structure and cilia function, we have characterized a mutation originally identified in a forward genetic screen for mutants with defective PKD-2 ciliary localization. Through behavioral assays and examination of the structure of cilia in the cil-5 (my13) mutant animals, we have found that my13 disrupts not only receptor localization, but also some cilia-mediated sensory behaviors and cilia structural integrity. We have identified the my13 lesion and found that it is a missense mutation in bbs-7, an ortholog of human BBS-7, a gene known to affect human cilia and to be involved in Bardet-Biedl syndrome. Finally, we show that bbs-7(my13) also affects the glia cells which support the cilia.	[Braunreiter, Kara; Hamlin, Shelby; Lyman-Gingerich, Jamie] Univ Wisconsin, Dept Biol, Eau Claire, WI 54701 USA	University of Wisconsin System	Lyman-Gingerich, J (corresponding author), Univ Wisconsin, Dept Biol, Phillips Hall 330, Eau Claire, WI 54701 USA.	lymangjs@uwec.edu			University of Wisconsin-Eau Claire Office of Research and Sponsored Programs; National Institutes of Health AREA Grant [DK88743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK088743] Funding Source: NIH RePORTER	University of Wisconsin-Eau Claire Office of Research and Sponsored Programs; National Institutes of Health AREA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work provided by the University of Wisconsin-Eau Claire Office of Research and Sponsored Programs (JLG, SH, and KB) and the National Institutes of Health AREA Grant (DK88743) (JLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bae YK, 2008, DEV DYNAM, V237, P2021, DOI 10.1002/dvdy.21531; Bae YK, 2008, FRONT BIOSCI-LANDMRK, V13, P5959, DOI 10.2741/3129; Bae YK, 2006, DEVELOPMENT, V133, P3859, DOI 10.1242/dev.02555; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2005, J AM SOC NEPHROL, V16, P305, DOI 10.1681/ASN.2004080645; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Gakovic M, 2011, HUM MOL GENET, V20, P4840, DOI 10.1093/hmg/ddr423; Gascue C, 2012, J CELL SCI, V125, P362, DOI 10.1242/jcs.089375; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Inglis P. N., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.126.2, DOI 10.1895/WORMBOOK.1.126.2]; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Knobel KM, 2008, EXP CELL RES, V314, P825, DOI 10.1016/j.yexcr.2007.10.017; Lee BH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001219; Mok CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002335; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Norris DP, 2012, SCIENCE, V338, P206, DOI 10.1126/science.1230401; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Oikonomou G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001121; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740	44	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113737	10.1371/journal.pone.0113737	http://dx.doi.org/10.1371/journal.pone.0113737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486278	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600023
J	Qiao, ZW; Xia, CM; Shen, S; Corwin, FD; Liu, M; Guan, RJ; Grider, JR; Qiao, LY				Qiao, Zhongwei; Xia, Chunmei; Shen, Shanwei; Corwin, Frank D.; Liu, Miao; Guan, Ruijuan; Grider, John R.; Qiao, Li-Ya			Suppression of the PI3K Pathway In Vivo Reduces Cystitis-Induced Bladder Hypertrophy and Restores Bladder Capacity Examined by Magnetic Resonance Imaging	PLOS ONE			English	Article							RAT URINARY-BLADDER; CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; COLLAGEN EXPRESSION; REGULATES COLLAGEN; MESSENGER-RNA; SMOOTH-MUSCLE; AKT; RECEPTORS; PROTEIN; INFLAMMATION	This study utilized magnetic resonance imaging (MRI) to monitor the real-time status of the urinary bladder in normal and diseased states following cyclophosphamide (CYP)-induced cystitis, and also examined the role of the phosphoinositide 3-kinase (PI3K) pathway in the regulation of urinary bladder hypertrophy in vivo. Our results showed that under MRI visualization the urinary bladder wall was significantly thickened at 8 h and 48 h post CYP injection. The intravesical volume of the urinary bladder was also markedly reduced. Treatment of the cystitis animals with a specific PI3K inhibitor LY294002 reduced cystitis-induced bladder wall thickening and enlarged the intravesical volumes. To confirm the MRI results, we performed H&E stain postmortem and examined the levels of type I collagen by real-time PCR and western blot. Inhibition of the PI3K in vivo reduced the levels of type I collagen mRNA and protein in the urinary bladder ultimately attenuating cystitis-induced bladder hypertrophy. The bladder mass calculated according to MRI data was consistent to the bladder weight measured ex vivo under each drug treatment. MRI results also showed that the urinary bladder from animals with cystitis demonstrated high magnetic signal intensity indicating considerable inflammation of the urinary bladder when compared to normal animals. This was confirmed by examination of the pro-inflammatory factors showing that interleukin (IL)-1 alpha, IL-6 and tumor necrosis factor (TNF)alpha levels in the urinary bladder were increased with cystitis. Our results suggest that MRI can be a useful technique in tracing bladder anatomy and examining bladder hypertrophy in vivo during disease development and the PI3K pathway has a critical role in regulating bladder hypertrophy during cystitis.	[Qiao, Zhongwei] Fudan Univ, Childrens Hosp, Div Radiol, Shanghai 200433, Peoples R China; [Xia, Chunmei; Guan, Ruijuan] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China; [Xia, Chunmei; Shen, Shanwei; Liu, Miao; Grider, John R.; Qiao, Li-Ya] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Corwin, Frank D.] Virginia Commonwealth Univ, Sch Med, Dept Radiol, Richmond, VA USA; [Grider, John R.; Qiao, Li-Ya] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA USA	Fudan University; Fudan University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Qiao, LY (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA.	lqiao2@vcu.edu	Liu, Miao/A-7353-2015	Shen, Shanwei/0000-0002-7701-4406	Shanghai Municipal Medical Guide Project [134119a4100]; Shanghai Municipal Natural Science Foundation [13ZR1403400]; Center for Molecular Imaging at Virginia Commonwealth University; NIH [DK034153, DK077917]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077917, R01DK034153, R56DK034153, R23DK034153] Funding Source: NIH RePORTER	Shanghai Municipal Medical Guide Project; Shanghai Municipal Natural Science Foundation; Center for Molecular Imaging at Virginia Commonwealth University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by grants from Shanghai Municipal Medical Guide Project 134119a4100 to ZWQ; Shanghai Municipal Natural Science Foundation 13ZR1403400 to CMX; Center for Molecular Imaging at Virginia Commonwealth University; NIH DK034153 to JRG; and NIH DK077917 to LYQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas CZ, 2012, AM J PHYSIOL-RENAL, V303, pF1363, DOI 10.1152/ajprenal.00273.2012; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Arms L, 2011, AM J PHYSIOL-RENAL, V301, pF252, DOI 10.1152/ajprenal.00556.2010; Arms L, 2010, AM J PHYSIOL-RENAL, V298, pF589, DOI 10.1152/ajprenal.00628.2009; Aronsson P, 2012, AUTON NEUROSCI-BASIC, V171, P49, DOI 10.1016/j.autneu.2012.10.006; Bitti GT, 2014, RADIOGRAPHICS, V34, P429, DOI 10.1148/rg.342125050; Bjorling DE, 2007, BJU INT, V99, P1523, DOI 10.1111/j.1464-410X.2007.06773.x; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Chang S, 2009, LAB INVEST, V89, P823, DOI 10.1038/labinvest.2009.38; Chung CW, 2010, J BIOL CHEM, V285, P4206, DOI 10.1074/jbc.M109.040444; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; Dinis P, 2004, J NEUROSCI, V24, P11253, DOI 10.1523/JNEUROSCI.2657-04.2004; DOOMS GC, 1986, UROL RADIOL, V8, P156, DOI 10.1007/BF02924099; FISHER MR, 1985, RADIOLOGY, V157, P467, DOI 10.1148/radiology.157.2.4048457; FISHER MR, 1985, RADIOLOGY, V157, P471, DOI 10.1148/radiology.157.2.4048458; GABELLA G, 1990, ANAT EMBRYOL, V182, P409; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Gonzalez EJ, 2013, AM J PHYSIOL-RENAL, V305, pF1265, DOI 10.1152/ajprenal.00042.2013; Grover S, 2011, THER ADV UROL, V3, P19, DOI 10.1177/1756287211398255; HANASH KA, 1969, J UROLOGY, V102, P427, DOI 10.1016/S0022-5347(17)62164-5; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Ito K, 2008, N-S ARCH PHARMACOL, V377, P483, DOI 10.1007/s00210-007-0197-z; Jerde TJ, 2000, UROL RES, V28, P269, DOI 10.1007/s002400000114; Kageyama A, 2008, NEUROSCI LETT, V436, P81, DOI 10.1016/j.neulet.2008.02.065; Kay JC, 2013, EXP NEUROL, V250, P366, DOI 10.1016/j.expneurol.2013.10.015; Kay JC, 2013, EXP NEUROL; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Lee HJ, 2012, CELL TRANSPLANT, V21, P959, DOI 10.3727/096368911X627516; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Lv JW, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/358184; Ma Z, 2011, ANN BIOMED ENG, V39, P2287, DOI 10.1007/s10439-011-0324-3; Malley SE, 2002, PHYSIOL GENOMICS, V9, P5, DOI 10.1152/physiolgenomics.00117.2001; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Merriam FV, 2008, NEUROSCI LETT, V445, P130, DOI 10.1016/j.neulet.2008.08.076; Metcalfe PD, 2010, BJU INT, V106, P1686, DOI 10.1111/j.1464-410X.2010.09445.x; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nasrin S, 2013, J UROLOGY, V189, P1123, DOI 10.1016/j.juro.2012.09.054; Piccoli C W, 1990, Top Magn Reson Imaging, V2, P51; Qiao LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081547; Saitoh C, 2008, J UROLOGY, V179, P359, DOI 10.1016/j.juro.2007.08.090; Sun Y, 2014, TISSUE ENG C; Tamada T, 2009, J MAGN RESON IMAGING, V29, P636, DOI 10.1002/jmri.21689; Tang HY, 2002, AM J PHYSIOL-REG I, V282, pR890, DOI 10.1152/ajpregu.0527.2001; Tubaro Andrea, 2005, Rev Urol, V7 Suppl 6, pS35; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vizzard MA, 2001, J CHEM NEUROANAT, V21, P125, DOI 10.1016/S0891-0618(00)00115-0; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wang CC, 2013, TOXICOL SCI, V131, P302, DOI 10.1093/toxsci/kfs270; Wang ZY, 2013, J UROL; Wong-You-Cheong JJ, 2006, RADIOGRAPHICS, V26, P1847, DOI 10.1148/rg.266065126; Yokoyama K, 2012, GRAEF ARCH CLIN EXP, V250, P15, DOI 10.1007/s00417-011-1766-x; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102; Zhang QL, 2012, REGUL PEPTIDES, V177, P73, DOI 10.1016/j.regpep.2012.05.088; Zhao Y, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5173	56	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114536	10.1371/journal.pone.0114536	http://dx.doi.org/10.1371/journal.pone.0114536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486122	gold, Green Published, Green Submitted			2022-12-27	WOS:000346907600072
J	Rahim, S; Minas, T; Hong, SH; Justvig, S; Celik, H; Kont, YS; Han, J; Kallarakal, AT; Kong, YL; Rudek, MA; Brown, ML; Kallakury, B; Toretsky, JA; Uren, A				Rahim, Said; Minas, Tsion; Hong, Sung-Hyeok; Justvig, Sarah; Celik, Haydar; Kont, Yasemin Saygideger; Han, Jenny; Kallarakal, Abraham T.; Kong, Yali; Rudek, Michelle A.; Brown, Milton L.; Kallakury, Bhaskar; Toretsky, Jeffrey A.; Ueren, Aykut			A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model	PLOS ONE			English	Article							ETS TRANSCRIPTION FACTORS; POLY(ADP-RIBOSE) POLYMERASE; EWS-FLI1; PATHWAY; GENES; REARRANGEMENTS; SPECIFICITY; EXPRESSION; CARCINOMA; SARCOMA	Background: The erythroblastosis virus E26 transforming sequences (ETS) family of transcription factors consists of a highly conserved group of genes that play important roles in cellular proliferation, differentiation, migration and invasion. Chromosomal translocations fusing ETS factors to promoters of androgen responsive genes have been found in prostate cancers, including the most clinically aggressive forms. ERG and ETV1 are the most commonly translocated ETS proteins. Over-expression of these proteins in prostate cancer cells results in a more invasive phenotype. Inhibition of ETS activity by small molecule inhibitors may provide a novel method for the treatment of prostate cancer. Methods and Findings: We recently demonstrated that the small molecule YK-4-279 inhibits biological activity of ETV1 in fusion-positive prostate cancer cells leading to decreased motility and invasion in-vitro. Here, we present data from an in-vivo mouse xenograft model. SCID-beige mice were subcutaneously implanted with fusion-positive LNCaP-luc-M6 and fusion-negative PC-3M-luc-C6 tumors. Animals were treated with YK-4-279, and its effects on primary tumor growth and lung metastasis were evaluated. YK-4-279 treatment resulted in decreased growth of the primary tumor only in LNCaP-luc-M6 cohort. When primary tumors were grown to comparable sizes, YK-4-279 inhibited tumor metastasis to the lungs. Expression of ETV1 target genes MMP7, FKBP10 and GLYATL2 were reduced in YK-4-279 treated animals. ETS fusion-negative PC-3M-luc-C6 xenografts were unresponsive to the compound. Furthermore, YK-4-279 is a chiral molecule that exists as a racemic mixture of R and S enantiomers. We established that (S)-YK-4-279 is the active enantiomer in prostate cancer cells. Conclusion: Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts. Therefore, YK-4-279 or similar compounds may be evaluated as a potential therapeutic tool for treatment of human prostate cancer at different stages.	[Rahim, Said; Minas, Tsion; Hong, Sung-Hyeok; Justvig, Sarah; Celik, Haydar; Kont, Yasemin Saygideger; Han, Jenny; Kallarakal, Abraham T.; Kong, Yali; Brown, Milton L.; Kallakury, Bhaskar; Toretsky, Jeffrey A.; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Rudek, Michelle A.] Univ Baltimore, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21201 USA	Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Baltimore	Uren, A (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	au26@georgetown.edu	Saygideger, Yasemin/E-5089-2018	Saygideger, Yasemin/0000-0003-3293-373X; Celik, Haydar/0000-0003-4314-8438	Department of Defense's Congressionally Directed Medical Research Program [PC111510]; Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH) [P30 CA006973, UL1 RR025005]; Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Shared Instrument Grant) [1S10RR026824-01]; CCSG [P30 CA051008-16]; NATIONAL CANCER INSTITUTE [P30CA006973, R01CA138212, RC4CA156509, R01CA133662, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, S10RR026824] Funding Source: NIH RePORTER	Department of Defense's Congressionally Directed Medical Research Program(United States Department of Defense); Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Shared Instrument Grant); CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	These experiments were primarily supported by a grant from the Department of Defense's Congressionally Directed Medical Research Program (PC111510, PI: Aykut Uren, http://cdmrp.army.mil/). The pharmacokinetic experiments were supported by the Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH grants P30 CA006973 and UL1 RR025005, and the Shared Instrument Grant (1S10RR026824-01), http://grants.nih.gov/grants/oer.htm). Biacore experiments were done at the Genomics and Epigenomics Shared Resource, which is supported by CCSG Grant P30 CA051008-16 (Lou Weiner, PI), http://cancercenters.cancer.gov/grants_funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2007, CANCER RES, V67, P6012; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Barber-Rotenberg JS, 2012, ONCOTARGET, V3, P172; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Gartner EM, 2010, CANCER J, V16, P83, DOI 10.1097/PPO.0b013e3181d78223; Grant TJ, 2012, P NATL ACAD SCI USA, V109, P4503, DOI 10.1073/pnas.1121601109; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hilgard P, 1997, EUR J CANCER, V33, P442; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong SH, 2014, ONCOTARGET, V5, P338, DOI 10.18632/oncotarget.1495; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; KUBINYI H, 1977, J MED CHEM, V20, P625, DOI 10.1021/jm00215a002; Ordonez JL, 2010, ADV ANAT PATHOL, V17, P162, DOI 10.1097/PAP.0b013e3181d98cbf; McConathy Jonathan, 2003, Prim Care Companion J Clin Psychiatry, V5, P70; Patel V, 2002, CANCER RES, V62, P1401; Paulo P, 2012, NEOPLASIA, V14, P600, DOI 10.1593/neo.12600; Rahim S, 2013, AM J TRANSL RES, V5, P254; Rahim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019343; Scatena CD, 2004, PROSTATE, V59, P292, DOI 10.1002/pros.20003; Seo PJ, 2011, TRENDS PLANT SCI, V16, P541, DOI 10.1016/j.tplants.2011.06.001; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	30	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114260	10.1371/journal.pone.0114260	http://dx.doi.org/10.1371/journal.pone.0114260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479232	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200059
J	Rasmussen, G; Monecke, S; Brus, O; Ehricht, R; Soderquist, B				Rasmussen, Gunloeg; Monecke, Stefan; Brus, Ole; Ehricht, Ralf; Soederquist, Bo			Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus aureus Bacteremia Isolates in Sweden	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; BLOOD-STREAM INFECTIONS; POTENTIAL ASSOCIATIONS; RESISTANT; STRAINS; MORTALITY; VIRULENCE; CLONES; GENE	Staphylococcus aureus is one of the major pathogens that causes bacteremia; therefore, it is important to understand the long-term molecular epidemiology of S. aureus bacteremia infections. In particular, little is known about the population structure of methicillin-sensitive S. aureus (MSSA) compared to that of methicillin-resistant S. aureus. We investigated potential changes in the MSSA molecular epidemiology in Orebro County, Sweden, from 1980 through 2010. 400 MSSA bacteremia isolates, the first 100 isolated each decade from 1980 through 2010, were retrospectively identified and analyzed regarding assignment to clonal complexes (CCs), presence of virulence genes and antibiotic resistant determinants with DNA microarray-based genotyping. 24 different CCs were identified. Most isolates (80%) belonged to 6 predominant lineages. Of those, the number of isolates assigned to CC5 and CC15 increased, and those assigned to CC8, CC25, and CC30 decreased. The most prevalent clone, CC45, did not show a significant change in prevalence during the study period. A change in prevalence was observed for some of the virulence genes, mainly attributed with their association to certain CCs. With the exception of the common blaZ gene (encoding penicillinase), antibiotic resistance genes were only sporadically detected. In conclusion, the MSSA population structure was genetically diverse. We observed decadal changes in assignments to five predominant clones, and corresponding changes in the prevalence of some virulence genes linked to CC affiliation. In light of the restrictive antibiotics prescriptions and extensive infection control procedures in Sweden, antibiotic resistance genes were rarely detected and their prevalence unaffected during the study period.	[Rasmussen, Gunloeg; Soederquist, Bo] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Rasmussen, Gunloeg] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Brus, Ole] Orebro Univ Hosp, Clin Epidemiol & Biostat, Orebro, Sweden; [Soederquist, Bo] Orebro Univ Hosp, Dept Lab Med, Clin Microbiol, Orebro, Sweden; [Soederquist, Bo] Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden	Orebro University; Orebro University; Alere; Technische Universitat Dresden; Orebro University; Orebro University; Orebro University	Rasmussen, G (corresponding author), Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden.	gunlog.rasmussen@orebroll.se		Soderquist, Bo/0000-0001-5939-2932	Research Committee of the County Council of Orebro University Hospital	Research Committee of the County Council of Orebro University Hospital	Funding for this study was provided by grants from the Research Committee of the County Council of Orebro University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fenner L, 2008, EUR J CLIN MICROBIOL, V27, P623, DOI 10.1007/s10096-008-0463-0; Ferry Tristan, 2005, Curr Infect Dis Rep, V7, P420, DOI 10.1007/s11908-005-0043-8; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goering RV, 2008, J CLIN MICROBIOL, V46, P2842, DOI 10.1128/JCM.00521-08; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Larsson AK, 2014, EUR J CLIN MICROBIOL, V33, P61, DOI 10.1007/s10096-013-1929-2; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lyytikainen O, 2005, EUR J CLIN MICROBIOL, V24, P399, DOI 10.1007/s10096-005-1345-3; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; Otsuka T, 2006, BIOCHEM BIOPH RES CO, V346, P1234, DOI 10.1016/j.bbrc.2006.06.038; Petersen PJ, 1999, ANTIMICROB AGENTS CH, V43, P738, DOI 10.1128/AAC.43.4.738; Rasmussen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077477; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114276	10.1371/journal.pone.0114276	http://dx.doi.org/10.1371/journal.pone.0114276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479442	Green Published, gold, Green Submitted			2022-12-27	WOS:000346907200063
J	Van Ha, C; Esfahani, MN; Watanabe, Y; Tran, UT; Sulieman, S; Mochida, K; Van Nguyen, D; Tran, LSP				Van Ha, Chien; Esfahani, Maryam Nasr; Watanabe, Yasuko; Uyen Thi Tran; Suiieman, Saad; Mochida, Keiichi; Van Nguyen, Dong; Tran, Lam-Son Phan			Genome-Wide Identification and Expression Analysis of the CaNAC Family Members in Chickpea during Development, Dehydration and ABA Treatments	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTOR; CICER-ARIETINUM L.; MOLECULAR CHARACTERIZATION; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; STRESS-RESPONSE; WATER-DEFICIT; DROUGHT; ARABIDOPSIS; SEQUENCE	The plant-specific NAC transcription factors (TFs) play important roles in regulation of diverse biological processes, including development, growth, cell division and responses to environmental stimuli. In this study, we identified the members of the NAC TF family of chickpea (Cicer arietinum) and assess their expression profiles during plant development and under dehydration and abscisic acid (ABA) treatments in a systematic manner. Seventy-one CaNAC genes were detected from the chickpea genome, including 8 membrane-bound members of which many might be involved in dehydration responses as judged from published literature. Phylogenetic analysis of the chickpea and well-known stress-related Arabidopsis and rice NACs enabled us to predict several putative stress-related CaNACs. By exploring available transcriptome data, we provided a comprehensive expression atlas of CaNACs in various tissues at different developmental stages. With the highest interest in dehydration responses, we examined the expression of the predicted stress-related and membrane-bound CaNACs in roots and leaves of chickpea seedlings, subjected to well-watered (control), dehydration and ABA treatments, using real-time quantitative PCR (RT-qPCR). Nine-teen of the 23 CaNACs examined were found to be dehydration-responsive in chickpea roots and/or leaves in either ABA-dependent or -independent pathway. Our results have provided a solid foundation for selection of promising tissue-specific and/or dehydration-responsive CaNAC candidates for detailed in planta functional analyses, leading to development of transgenic chickpea varieties with improved productivity under drought.	[Van Ha, Chien; Watanabe, Yasuko; Uyen Thi Tran; Suiieman, Saad; Tran, Lam-Son Phan] RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan; [Van Ha, Chien; Van Nguyen, Dong] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell Technol, Agr Genet Inst, Hanoi 100000, Vietnam; [Esfahani, Maryam Nasr] Lorestan Univ, Dept Biol, Khorramabad, Iran; [Suiieman, Saad] Univ Khartoum, Dept Agron, Fac Agr, Khartoum 13314, Sudan; [Mochida, Keiichi] RIKEN Ctr Sustainable Resource Sci, Biomass Res Platform Team, Biomass Engn Program, Cooperat Div, Yokohama, Kanagawa 2300045, Japan	RIKEN; Lorestan University; University of Khartoum; RIKEN	Tran, LSP (corresponding author), RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	son.tran@riken.jp	Tran, Lam-Son P/A-1346-2009; Mochida, Keiichi/T-2866-2019; Mochida, Keiichi/N-9052-2014	Tran, Lam-Son P/0000-0001-9883-9768; Mochida, Keiichi/0000-0003-1299-0024; Mochida, Keiichi/0000-0003-1299-0024	"International Program Associate" of Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan); Ministry of Agriculture and Rural Development of Vietnam [905/HD-KHCN-CNSH]; Ministry of Science and Technology of Vietnam	"International Program Associate" of Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan); Ministry of Agriculture and Rural Development of Vietnam; Ministry of Science and Technology of Vietnam	CVH is supported by a PhD fellowship from "International Program Associate" of Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (http://www.riken.jp/en/careers/programs/ipa/). This work was also supported in part by a grant (Project Code 905/HD-KHCN-CNSH) from the Ministry of Agriculture and Rural Development of Vietnam and the Ministry of Science and Technology of Vietnam to the Research Group of DVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Bampidis VA, 2011, ANIM FEED SCI TECH, V168, P1, DOI 10.1016/j.anifeedsci.2011.04.098; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Esfahani MN, 2014, PLANT J, V79, P964, DOI 10.1111/tpj.12599; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guttikonda SK, 2014, MOL BIOL REP, V41, P7995, DOI 10.1007/s11033-014-3695-3; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kou XH, 2014, PLANT MOL BIOL REP, V32, P501, DOI 10.1007/s11105-013-0655-3; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Lee S, 2014, PLANT SCI, V227, P76, DOI 10.1016/j.plantsci.2014.07.003; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ngwe T, 2012, ANIM SCI J, V83, P43, DOI 10.1111/j.1740-0929.2011.00916.x; Nuruzzaman M, 2012, MOL GENET GENOMICS, V287, P389, DOI 10.1007/s00438-012-0686-8; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Quach TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084886; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubio LA, 2005, J SCI FOOD AGR, V85, P1313, DOI 10.1002/jsfa.1963; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Satheesh V, 2014, MOL BIOL REP, V41, P7763, DOI 10.1007/s11033-014-3669-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shamsi K, 2010, AFR J BIOTECHNOL, V9, P7; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Voitsik AM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-85; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062	68	22	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114107	10.1371/journal.pone.0114107	http://dx.doi.org/10.1371/journal.pone.0114107			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479253	Green Submitted, Green Published, gold			2022-12-27	WOS:000346907200042
J	Chang, D; Gao, F; Slavney, A; Ma, L; Waldman, YY; Sams, AJ; Billing-Ross, P; Madar, A; Spritz, R; Keinan, A				Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Spritz, Richard; Keinan, Alon			Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI INFECTION; ONLINE MENDELIAN INHERITANCE; INFLAMMATORY-BOWEL-DISEASE; SEX-DIFFERENCES; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; GENDER-DIFFERENCES; QUALITY-CONTROL; CROHNS-DISEASE	Many complex human diseases are highly sexually dimorphic, suggesting a potential contribution of the X chromosome to disease risk. However, the X chromosome has been neglected or incorrectly analyzed in most genome-wide association studies (GWAS). We present tailored analytical methods and software that facilitate X-wide association studies (XWAS), which we further applied to reanalyze data from 16 GWAS of different autoimmune and related diseases (AID). We associated several X-linked genes with disease risk, among which (1) ARHGEF6 is associated with Crohn's disease and replicated in a study of ulcerative colitis, another inflammatory bowel disease (IBD). Indeed, ARHGEF6 interacts with a gastric bacterium that has been implicated in IBD. (2) CENPI is associated with three different AID, which is compelling in light of known associations with AID of autosomal genes encoding centromere proteins, as well as established autosomal evidence of pleiotropy between autoimmune diseases. (3) We replicated a previous association of FOXP3, a transcription factor that regulates T-cell development and function, with vitiligo; and (4) we discovered that C1GALT1C1 exhibits sex-specific effect on disease risk in both IBDs. These and other X-linked genes that we associated with AID tend to be highly expressed in tissues related to immune response, participate in major immune pathways, and display differential gene expression between males and females. Combined, the results demonstrate the importance of the X chromosome in autoimmunity, reveal the potential of extensive XWAS, even based on existing data, and provide the tools and incentive to properly include the X chromosome in future studies.	[Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Chang, Diana; Keinan, Alon] Cornell Univ, Program Computat Biol & Med, Ithaca, NY USA; [Slavney, Andrea; Billing-Ross, Paul; Keinan, Alon] Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY USA; [Ma, Li] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Spritz, Richard] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA	Cornell University; Cornell University; Cornell University; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Anschutz Medical Campus	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	ak735@cornell.edu	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Institutes of Health [R01HG006849]; Ellison Medical Foundation; Edward Mallinckrodt, Jr. Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Edward Mallinckrodt, Jr. Foundation	This work was supported in part by National Institutes of Health Grant R01HG006849. AK was also supported by The Ellison Medical Foundation and the Edward Mallinckrodt, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; ALSGEN C, 2013, NEUROBIOL AGING, V0034; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arbiza L, 2014, AM J HUM GENET, V94, P827, DOI 10.1016/j.ajhg.2014.04.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek HY, 2007, ANN NY ACAD SCI, V1096, P18, DOI 10.1196/annals.1397.065; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Bierut LJ, 2002, ALCOHOL RES HEALTH, V26, P208; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chang D, 2014, BIORXIV; Chang D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003820; Choi BG, 2007, ENDOCRIN METAB CLIN, V36, P365, DOI 10.1016/j.ecl.2007.03.011; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton DG, 2009, GENOME MED, V1, DOI 10.1186/gm110; Conde L, 2013, BRIT J HAEMATOL, V162, P858, DOI 10.1111/bjh.12438; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eguchi K, 2001, INTERNAL MED, V40, P275, DOI 10.2169/internalmedicine.40.275; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamdouch K, 2011, CLIN CHIM ACTA, V412, P2267, DOI 10.1016/j.cca.2011.08.024; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heyer E, 2012, MOL ECOL, V21, P597, DOI 10.1111/j.1365-294X.2011.05406.x; Hindorff L., 2013, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Jacob S, 2002, J PINEAL RES, V33, P186, DOI 10.1034/j.1600-079X.2002.02943.x; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jiang B, 2011, J THEOR BIOL, V277, P67, DOI 10.1016/j.jtbi.2011.01.029; Jin X, 2013, INT J MED SCI, V10, P1479, DOI 10.7150/ijms.6934; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawakami Atsushi, 2002, Medical Electron Microscopy, V35, P1, DOI 10.1007/s007950200000; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kemkemer C, 2009, CHROMOSOME RES, V17, P811, DOI 10.1007/s10577-009-9072-8; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lai F, 1999, NEUROLOGY, V53, P331, DOI 10.1212/WNL.53.2.331; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li N, 2014, EUR REV MED PHARMACO, V18, P78; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Ling Hua, 2009, BMC Proc, V3 Suppl 7, pS57; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohmueller KE, 2010, AM J HUM GENET, V86, P978, DOI 10.1016/j.ajhg.2010.03.021; Loley C, 2011, HUM HERED, V71, P23, DOI 10.1159/000323768; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mason KD, 2013, P NATL ACAD SCI USA, V110, P2599, DOI 10.1073/pnas.1215097110; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Matson DR, 2012, GENE DEV, V26, P542, DOI 10.1101/gad.184184.111; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Moretti S, 2009, HISTOL HISTOPATHOL, V24, P849, DOI 10.14670/HH-24.849; Morrow EH, 2013, EVOL APPL, V6, P1208, DOI 10.1111/eva.12097; Muscat JE, 1996, CANCER RES, V56, P5192; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nelson JL, 1997, RHEUM DIS CLIN N AM, V23, P195, DOI 10.1016/S0889-857X(05)70323-9; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pohanka M, 2013, CENT EUR J MED, V8, P369, DOI 10.2478/s11536-013-0177-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Quintero OL, 2012, J AUTOIMMUN, V38, pJ109, DOI 10.1016/j.jaut.2011.10.003; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Selmi C, 2012, AUTOIMMUN REV, V11, pA531, DOI 10.1016/j.autrev.2011.11.024; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stouffer S.A., 1949, ADJUSTMENT ARMY LIFE; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Terry PD, 2009, INFLAMM BOWEL DIS, V15, P134, DOI 10.1002/ibd.20527; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thornton T, 2012, GENET EPIDEMIOL, V36, P438, DOI 10.1002/gepi.21638; THURNHER M, 1992, EUR J IMMUNOL, V22, P1835, DOI 10.1002/eji.1830220724; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weatherhead SC, 2011, J INVEST DERMATOL, V131, P1916, DOI 10.1038/jid.2011.134; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	165	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113684	10.1371/journal.pone.0113684	http://dx.doi.org/10.1371/journal.pone.0113684			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479423	Green Published, Green Submitted, gold			2022-12-27	WOS:000346907200028
J	Chang, YM; Chen, LC; Wang, HY; Chiang, CL; Chang, CT; Chung, YC				Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chiang, Chui-Liang; Chang, Chen-Tien; Chung, Yun-Chin			Characterization of an Acidic Chitinase from Seeds of Black Soybean (Glycine max (L) Merr Tainan No. 3)	PLOS ONE			English	Article							ZEA-MAYS; PURIFICATION	Using 4-methylumbelliferyl-beta-D-N, N', N ''-triacetylchitotrioside (4-MU-GlcNAc(3)) as a substrate, an acidic chitinase was purified from seeds of black soybean (Glycine max Tainan no. 3) by ammonium sulfate fractionation and three successive steps of column chromatography. The purified chitinase was a monomeric enzyme with molecular mass of 20.1 kDa and isoelectric point of 4.34. The enzyme catalyzed the hydrolysis of synthetic substrates p-nitrophenyl N-acetyl chitooligosaccharides with chain length from 3 to 5 (GlcNAc(n), n = 3-5), and pNp-GlcNAc(4) was the most degradable substrate. Using pNp-GlcNAc(4) as a substrate, the optimal pH for the enzyme reaction was 4.0; kinetic parameters K-m and k(cat) were 245 mM and 10.31 min(-1), respectively. This enzyme also showed activity toward CM-chitinRBV, a polymer form of chitin, and N-acetyl chitooligosaccharides, an oligomer form of chitin. The smallest oligomer substrate was an N-acetylglucosamine tetramer. These results suggested that this enzyme was an endo-splitting chitinase with short substrate cleavage activity and useful for biotechnological applications, in particular for the production of N-acetyl chitooligosaccharides.	[Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chang, Chen-Tien; Chung, Yun-Chin] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chiang, Chui-Liang] Cent Taiwan Univ Sci & Technol, Dept Food Sci, Taichung, Taiwan	Providence University - Taiwan; Central Taiwan University Science & Technology	Chang, CT (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	ctchang@pu.edu.tw; ycchun@pu.edu.tw	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Science Council of the Republic of China (Taiwan) [NSC-94-2321-B-126-001]	National Science Council of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China (Taiwan) (NSC-94-2321-B-126-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, APPL MICROBIOL BIOT; [Anonymous], 1999, CHITIN AND CHITINASE; [Anonymous], 2000, ENZYME MICROB TECHNO; BERKELEY RC, 1972, ANAL BIOCHEM, V46, P687, DOI 10.1016/0003-2697(72)90343-0; Chiang Chui-Liang, 2006, Taiwanese Journal of Agricultural Chemistry and Food Science, V44, P207; Chiang CL, 2005, J AGR FOOD CHEM, V53, P7579, DOI 10.1021/jf040472n; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dawson RCM, 1969, DATA BIOCH RES, P483; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hollis T, 1997, ARCH BIOCHEM BIOPHYS, V344, P335, DOI 10.1006/abbi.1997.0225; ISHIGE F, 1991, PLANT CELL PHYSIOL, V32, P681, DOI 10.1093/oxfordjournals.pcp.a078131; Jrudel J, 1989, ANAL BIOCHEM, V178, P62; Koga D, 1999, EXS, V87, P111; Kuo CJ, 2009, BOT STUD, V50, P281; KUROSAKI F, 1989, PHYTOCHEMISTRY, V28, P2989, DOI 10.1016/0031-9422(89)80265-1; Lai LS, 2006, J AGR FOOD CHEM, V54, P8611, DOI 10.1021/jf060888w; LIN ZF, 1992, PROCESS BIOCHEM, V27, P83, DOI 10.1016/0032-9592(92)80014-T; LIU WH, 1968, BIOCHEMISTRY-US, V7, P2886, DOI 10.1021/bi00848a027; MCBRIDE JD, 1993, ELECTROPHORESIS, V14, P165, DOI 10.1002/elps.1150140126; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Park SM, 2002, ENZYME MICROB TECH, V30, P697, DOI 10.1016/S0141-0229(02)00042-X; POWNING RF, 1965, COMP BIOCHEM PHYSIOL, V14, P127, DOI 10.1016/0010-406X(65)90013-7; PUNJA ZK, 1993, J NEMATOL, V25, P526; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; VERBURG JG, 1992, J BIOL CHEM, V267, P3886; WADSWORTH SA, 1984, J AGR FOOD CHEM, V32, P1284, DOI 10.1021/jf00126a018; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; WIRTH SJ, 1990, J MICROBIOL METH, V12, P197, DOI 10.1016/0167-7012(90)90031-Z; Yeboah NA, 1998, PLANT MOL BIOL, V36, P407, DOI 10.1023/A:1005921104288	31	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113596	10.1371/journal.pone.0113596	http://dx.doi.org/10.1371/journal.pone.0113596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25479423	gold, Green Submitted, Green Published			2022-12-27	WOS:000347114900053
J	Moore, HA; Whitmore, D				Moore, Helen A.; Whitmore, David			Circadian Rhythmicity and Light Sensitivity of the Zebrafish Brain	PLOS ONE			English	Article							GENE-EXPRESSION; C-FOS; MESSENGER-RNA; DEEP BRAIN; CLOCK; SYSTEM; CELLS; PHOTORECEPTORS; DIVERSITY; PINEAL	Traditionally, circadian clocks have been thought of as a neurobiological phenomenon. This view changed somewhat over recent years with the discovery of peripheral tissue circadian oscillators. In mammals, however, the suprachiasmatic nucleus (SCN) in the hypothalamus still retains the critical role of a central synchronizer of biological timing. Zebrafish, in contrast, have always reflected a more highly decentralized level of clock organization, as individual cells and tissues contain directly light responsive circadian pacemakers. As a consequence, clock function in the zebrafish brain has remained largely unexplored, and the precise organization of rhythmic and light-sensitive neurons within the brain is unknown. To address this issue, we used the period3 (per3)-luciferase transgenic zebrafish to confirm that multiple brain regions contain endogenous circadian oscillators that are directly light responsive. In addition, in situ hybridization revealed localised neural expression of several rhythmic and light responsive clock genes, including per3, cryptochrome1a (cry1a) and per2. Adult brain nuclei showing significant clock gene expression include the teleost equivalent of the SCN, as well as numerous hypothalamic nuclei, the periventricular grey zone (PGZ) of the optic tectum, and granular cells of the rhombencephalon. To further investigate the light sensitive properties of neurons, expression of c-fos, a marker for neuronal activity, was examined. c-fos mRNA was upregulated in response to changing light conditions in different nuclei within the zebrafish brain. Furthermore, under constant dark (DD) conditions, c-fos shows a significant circadian oscillation. Taken together, these results show that there are numerous areas of the zebrafish central nervous system, which contain deep brain photoreceptors and directly light-entrainable circadian pacemakers. However, there are also multiple brain nuclei, which possess neither, demonstrating a degree of pacemaker complexity that was not previously appreciated.	[Moore, Helen A.; Whitmore, David] UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England	University of London; University College London	Whitmore, D (corresponding author), UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England.	d.whitmore@ucl.ac.uk	Zebrafish, UCL/A-3125-2009	Leary, Eileen/0000-0002-7389-6384	Biotechnology and Biological Sciences Research Council [BB/I004832/1, BB/I003592/1]; Medical Research Council Doctoral Training Account Studentship	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Doctoral Training Account Studentship	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/I004832/1 and BB/I003592/1) and a Medical Research Council Doctoral Training Account Studentship (HAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Bally-Cuif L, 2010, FISH PHYSIOL, V29, P25, DOI 10.1016/S1546-5098(10)02902-X; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Foster RG, 1998, REV REPROD, V3, P145, DOI 10.1530/revreprod/3.3.145; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kaneko M, 2006, P NATL ACAD SCI USA, V103, P14614, DOI 10.1073/pnas.0606563103; Kojima D, 2000, J NEUROSCI, V20, P2845; Kokel D, 2013, J NEUROSCI, V33, P3834, DOI 10.1523/JNEUROSCI.3689-12.2013; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Li XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040508; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; NIR I, 1993, MOL BRAIN RES, V19, P47, DOI 10.1016/0169-328X(93)90147-H; Noche RR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-7; Northcutt RG, 1987, SENSORY BIOL AQUATIC, V8, P515; Norton WHJ, 2008, J COMP NEUROL, V511, P521, DOI 10.1002/cne.21831; Novak CR, 1998, J CHEM NEUROANAT, V14, P87, DOI 10.1016/S0891-0618(97)10019-9; Onodera H, 1999, LIFE SCI, V64, P1127, DOI 10.1016/S0024-3205(99)00041-7; Pando MP, 2001, P NATL ACAD SCI USA, V98, P10178, DOI 10.1073/pnas.181228598; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Ruuskanen JO, 2005, J NEUROCHEM, V94, P1559, DOI 10.1111/j.1471-4159.2005.03305.x; SCHWARTZ WJ, 1994, NEUROSCIENCE, V58, P573, DOI 10.1016/0306-4522(94)90082-5; Sumova A, 1998, BRAIN RES, V801, P254, DOI 10.1016/S0006-8993(98)00619-2; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103	37	77	80	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86176	10.1371/journal.pone.0086176	http://dx.doi.org/10.1371/journal.pone.0086176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465943	gold, Green Submitted, Green Published			2022-12-27	WOS:000330283100121
